ProteinID,Compartments,Cyto,Nsol,NucI,Horg,Lorg,Colour,ProteinsName_Subcell,Entry Name,Protein names,Gene Names,GeneID,Ensembl,Gene Ontology (molecular function),Gene Ontology (biological process),Gene Ontology (cellular component)
Q9NRG9,S4,-1.003351823,-1.154894684,0.930336707,0.485542661,0.161832946,tomato2,AAAS,AAAS_HUMAN,Aladin (Adracalin),AAAS ADRACALA GL003,8086;,"ENST00000209873.9; ENSP00000209873.4; ENSG00000094914.14. [Q9NRG9-1];""ENST00000394384.7; ENSP00000377908.3; ENSG00000094914.14. [Q9NRG9-2]"";""ENST00000708962.1; ENSP00000517437.1; ENSG00000291836.1. [Q9NRG9-2]"";""ENST00000708963.1; ENSP00000517438.1; ENSG00000291836.1. [Q9NRG9-1]"";",0,fertilization [GO:0009566]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of nucleocytoplasmic transport [GO:0046822],centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]
Q86V21,C4,2.1716569,0.132460461,-1.039463438,-1.132655848,-1.321761927,deepskyblue2,AACS,AACS_HUMAN,Acetoacetyl-CoA synthetase (EC 6.2.1.16) (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog),AACS ACSF1,65985;,ENST00000316519.11; ENSP00000324842.6; ENSG00000081760.17. [Q86V21-1];,acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524],fatty acid metabolic process [GO:0006631]; ketone body biosynthetic process [GO:0046951]; positive regulation of insulin secretion [GO:0032024],cytosol [GO:0005829]
Q2M2I8,C3,1.855644545,0.10015281,-0.660551116,-0.369851323,-0.674195892,cyan,AAK1,AAK1_HUMAN,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),AAK1 KIAA1048,22848;,"ENST00000406297.7; ENSP00000385181.3; ENSG00000115977.21. [Q2M2I8-2];""ENST00000409085.9; ENSP00000386456.3; ENSG00000115977.21. [Q2M2I8-1]"";",AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; presynaptic endocytosis [GO:0140238]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of protein localization [GO:0032880],cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; terminal bouton [GO:0043195]
P49588,C4,2.10128306,0.058558106,-1.043925013,-1.084519712,-1.218097856,deepskyblue2,AARS,SYAC_HUMAN,"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)",AARS1 AARS,16;,"ENST00000261772.13; ENSP00000261772.8; ENSG00000090861.17. [P49588-1];""ENST00000674691.1; ENSP00000502247.1; ENSG00000090861.17. [P49588-1]"";""ENST00000674963.1; ENSP00000501924.1; ENSG00000090861.17. [P49588-1]"";""ENST00000675643.1; ENSP00000502797.1; ENSG00000090861.17. [P49588-1]"";",alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA aminoacylation for protein translation [GO:0006418]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]
Q9NRN7,C5,1.706589742,0.515070611,-0.719659426,-0.652672006,-1.005984148,turquoise3,AASDHPPT,ADPPT_HUMAN,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.7) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT) (LYS5 ortholog),AASDHPPT CGI-80 HAH-P HSPC223 x0005,60496;,"ENST00000278618.9; ENSP00000278618.4; ENSG00000149313.11. [Q9NRN7-1];""ENST00000525660.1; ENSP00000437144.1; ENSG00000149313.11. [Q9NRN7-2]"";",holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287],10-formyltetrahydrofolate catabolic process [GO:0009258]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; pantothenate metabolic process [GO:0015939]; protein maturation [GO:0051604],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9NY61,N3,-0.892205259,-1.101018636,1.220207026,0.053168065,0.189867551,grey50,AATF,AATF_HUMAN,Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1),AATF CHE1 DED HSPC277,26574;,"ENST00000619387.5; ENSP00000477848.1; ENSG00000275700.6.;""ENST00000620004.2; ENSP00000481894.1; ENSG00000276072.2."";",leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tau protein binding [GO:0048156],cell adhesion [GO:0007155]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357]; ribosomal small subunit biogenesis [GO:0042274],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; transcription regulator complex [GO:0005667]
Q9BZC7,S1,-0.536306428,-1.006448182,-0.003307093,0.644935146,0.775173915,gold,ABCA2,ABCA2_HUMAN,ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2),ABCA2 ABC2 KIAA1062,20;,"ENST00000341511.11; ENSP00000344155.6; ENSG00000107331.18. [Q9BZC7-3];""ENST00000371605.7; ENSP00000360666.3; ENSG00000107331.18. [Q9BZC7-1]"";""ENST00000614293.5; ENSP00000481105.2; ENSG00000107331.18. [Q9BZC7-4]"";",ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166],central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; intracellular sphingolipid homeostasis [GO:0090156]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]
Q9NRK6,M2,-1.032605319,-1.262998067,0.411940784,1.079870956,-0.096300376,tan4,ABCB10,ABCBA_HUMAN,"ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein) (ABC-me protein) (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2)",ABCB10,23456;,ENST00000344517.5; ENSP00000355637.3; ENSG00000135776.5.;,ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803],erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985],mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]
O75027,M2,-1.228607525,-1.320806027,0.380068105,1.162118553,-0.124017162,tan4,ABCB7,ABCB7_HUMAN,"Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7) (ABC transporter 7 protein)",ABCB7 ABC7,22;,"ENST00000253577.9; ENSP00000253577.3; ENSG00000131269.19. [O75027-2];""ENST00000339447.8; ENSP00000343849.4; ENSG00000131269.19. [O75027-3]"";""ENST00000373394.8; ENSP00000362492.3; ENSG00000131269.19. [O75027-1]"";",ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9NUT2,M2,-0.924829561,-1.216468555,0.391415691,1.027507035,-0.127152168,tan4,ABCB8,MITOS_HUMAN,"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial ATP-binding cassette 1) (M-ABC1) (Mitochondrial sulfonylurea-receptor) (MITOSUR)",ABCB8 MABC1 MITOSUR,11194;,"ENST00000297504.10; ENSP00000297504.6; ENSG00000197150.13. [Q9NUT2-1];""ENST00000358849.9; ENSP00000351717.4; ENSG00000197150.13. [Q9NUT2-2]"";""ENST00000498578.5; ENSP00000418271.1; ENSG00000197150.13. [Q9NUT2-3]"";""ENST00000542328.5; ENSP00000438776.1; ENSG00000197150.13. [Q9NUT2-4]"";",ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805]; transmembrane transport [GO:0055085],ATP-binding cassette (ABC) transporter complex [GO:0043190]; membrane [GO:0016020]; mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P33527,S4,-1.254483072,-1.611662114,0.695711435,0.931893623,-0.072576032,tomato2,ABCC1,MRP1_HUMAN,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),ABCC1 MRP MRP1,4363;,"ENST00000399408.7; ENSP00000382340.4; ENSG00000103222.20. [P33527-9];""ENST00000399410.8; ENSP00000382342.3; ENSG00000103222.20. [P33527-1]"";""ENST00000572882.3; ENSP00000461615.2; ENSG00000103222.20. [P33527-2]"";""ENST00000621144.4; ENSP00000483316.1; ENSG00000278183.4. [P33527-1]"";",ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type vitamin B12 transporter activity [GO:0015420]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled lipid transmembrane transporter activity [GO:0034040]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporter activity [GO:0042910],carboxylic acid transmembrane transport [GO:1905039]; cell chemotaxis [GO:0060326]; cellular response to amyloid-beta [GO:1904646]; cellular response to oxidative stress [GO:0034599]; cobalamin transport [GO:0015889]; cyclic nucleotide transport [GO:0070729]; export across plasma membrane [GO:0140115]; glutathione transmembrane transport [GO:0034775]; heme catabolic process [GO:0042167]; leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; phospholipid translocation [GO:0045332]; positive regulation of inflammatory response [GO:0050729]; response to xenobiotic stimulus [GO:0009410]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid translocation [GO:0099039]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport [GO:0042908]; xenobiotic transport across blood-brain barrier [GO:1990962],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q5T3U5,S1,-1.147732906,-1.133689812,-0.236174377,0.837409958,1.007616397,gold,ABCC10,MRP7_HUMAN,ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7),ABCC10 MRP7 SIMRP7,89845;,"ENST00000244533.7; ENSP00000244533.3; ENSG00000124574.15. [Q5T3U5-2];""ENST00000372530.9; ENSP00000361608.4; ENSG00000124574.15. [Q5T3U5-1]"";",ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626],leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869]; transmembrane transport [GO:0055085],basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]
O15438,S4,-0.673548382,-0.924196869,0.556003309,0.712030308,0.241455357,tomato2,ABCC3,MRP3_HUMAN,ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3),ABCC3 CMOAT2 MLP2 MRP3,8714;,"ENST00000285238.13; ENSP00000285238.8; ENSG00000108846.16. [O15438-1];""ENST00000427699.5; ENSP00000395160.1; ENSG00000108846.16. [O15438-5]"";""ENST00000502426.5; ENSP00000427073.1; ENSG00000108846.16. [O15438-3]"";""ENST00000505699.5; ENSP00000427521.1; ENSG00000108846.16. [O15438-2]"";",ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; glucuronoside transmembrane transporter activity [GO:0015164]; icosanoid transmembrane transporter activity [GO:0071714]; xenobiotic transmembrane transporter activity [GO:0042910],bile acid and bile salt transport [GO:0015721]; leukotriene transport [GO:0071716]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]
O15439,S4,-0.922234845,-1.191777995,0.493610886,0.924229278,0.142944561,tomato2,ABCC4,MRP4_HUMAN,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),ABCC4 MOATB MRP4,10257;,"ENST00000536256.3; ENSP00000442024.1; ENSG00000125257.16. [O15439-4];""ENST00000629385.1; ENSP00000487081.1; ENSG00000125257.16. [O15439-3]"";""ENST00000645237.2; ENSP00000494609.1; ENSG00000125257.16. [O15439-1]"";""ENST00000646439.1; ENSP00000494751.1; ENSG00000125257.16. [O15439-2]"";",15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]
O15440,S4,-0.914111079,-1.157566027,0.457375779,0.818339556,0.401903796,tomato2,ABCC5,MRP5_HUMAN,ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11),ABCC5 MRP5,10057;,"ENST00000265586.10; ENSP00000265586.6; ENSG00000114770.17. [O15440-5];""ENST00000334444.11; ENSP00000333926.6; ENSG00000114770.17. [O15440-1]"";""ENST00000382494.6; ENSP00000371934.2; ENSG00000114770.17. [O15440-4]"";""ENST00000392579.6; ENSP00000376358.2; ENSG00000114770.17. [O15440-2]"";""ENST00000443376.5; ENSP00000416840.1; ENSG00000114770.17. [O15440-3]"";",ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carbohydrate derivative transmembrane transporter activity [GO:1901505]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; heme transmembrane transporter activity [GO:0015232]; macromolecule transmembrane transporter activity [GO:0022884]; organic anion transmembrane transporter activity [GO:0008514]; purine nucleotide transmembrane transporter activity [GO:0015216]; xenobiotic transmembrane transporter activity [GO:0042910],cAMP transport [GO:0070730]; cGMP transport [GO:0070731]; export across plasma membrane [GO:0140115]; folate transmembrane transport [GO:0098838]; glutathione transmembrane transport [GO:0034775]; heme transmembrane transport [GO:0035351]; hyaluronan biosynthetic process [GO:0030213]; purine nucleotide transport [GO:0015865]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P33897,S3,-0.80738956,-0.791474797,-0.061522575,0.897705158,0.332304993,salmon,ABCD1,ABCD1_HUMAN,ATP-binding cassette sub-family D member 1 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy protein) (ALDP),ABCD1 ALD,215;,ENST00000218104.6; ENSP00000218104.3; ENSG00000101986.12.;,ABC-type fatty-acyl-CoA transporter activity [GO:0015607]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; enzyme binding [GO:0019899]; fatty acyl-CoA hydrolase activity [GO:0047617]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817],alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid elongation [GO:0030497]; fatty acid homeostasis [GO:0055089]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid catabolic process [GO:0042758]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisomal membrane transport [GO:0015919]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of mitochondrial depolarization [GO:0051900]; regulation of oxidative phosphorylation [GO:0002082]; sterol homeostasis [GO:0055092]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA catabolic process [GO:0036113],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
P28288,S2,-1.088549542,-1.336111514,-0.035341632,0.967453777,0.450650101,orange,ABCD3,ABCD3_HUMAN,ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70),ABCD3 PMP70 PXMP1,5825;,"ENST00000315713.5; ENSP00000326880.5; ENSG00000117528.14. [P28288-3];""ENST00000370214.9; ENSP00000359233.4; ENSG00000117528.14. [P28288-1]"";",ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803],bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
O14678,S1,-0.743684256,-1.216710846,-0.026234088,0.724877587,0.842276452,gold,ABCD4,ABCD4_HUMAN,Lysosomal cobalamin transporter ABCD4 (EC 7.6.2.8) (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69),ABCD4 PXMP1L,5826;,ENST00000356924.9; ENSP00000349396.4; ENSG00000119688.21.;,ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324],cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760],ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
Q8N2K0,S2,-0.972629012,-1.183960765,0.218123946,0.865718011,0.581261639,orange,ABHD12,ABD12_HUMAN,Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (hABHD12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-),ABHD12 C20orf22,26090;,"ENST00000339157.10; ENSP00000341408.5; ENSG00000100997.20. [Q8N2K0-1];""ENST00000376542.8; ENSP00000365725.3; ENSG00000100997.20. [Q8N2K0-2]"";",acylglycerol lipase activity [GO:0047372]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620],acylglycerol catabolic process [GO:0046464]; adult walking behavior [GO:0007628]; arachidonic acid metabolic process [GO:0019369]; glycerophospholipid catabolic process [GO:0046475]; monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; regulation of inflammatory response [GO:0050727]; response to auditory stimulus [GO:0010996],AMPA glutamate receptor complex [GO:0032281]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q7L211,S1,-1.030701296,-1.195634409,-0.102946502,0.881238613,0.882118814,gold,ABHD13,ABHDD_HUMAN,Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13),ABHD13 C13orf6,84945;,ENST00000375898.4; ENSP00000365063.3; ENSG00000139826.6.;,palmitoyl-(protein) hydrolase activity [GO:0008474],0,dendrite cytoplasm [GO:0032839]; membrane [GO:0016020]
Q96IU4,C3,1.661985201,0.380369694,-0.573342847,-0.615374568,-0.74314423,cyan,ABHD14B,ABHEB_HUMAN,Putative protein-lysine deacylase ABHD14B (EC 2.3.1.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) (CCG1-interacting factor B),ABHD14B CIB,84836;,"ENST00000361143.10; ENSP00000354841.5; ENSG00000114779.20. [Q96IU4-1];""ENST00000395008.6; ENSP00000378455.2; ENSG00000114779.20. [Q96IU4-1]"";""ENST00000483233.5; ENSP00000420065.1; ENSG00000114779.20. [Q96IU4-1]"";""ENST00000525795.1; ENSP00000433388.1; ENSG00000114779.20. [Q96IU4-1]"";",hydrolase activity [GO:0016787]; peptide-lysine-N-acetyltransferase activity [GO:0061733],3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O95870,S3,-0.512393396,-0.770208976,0.181641703,0.757284407,0.410026852,salmon,ABHD16A,ABHGA_HUMAN,Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (hBAT5) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23) (Protein G5),ABHD16A BAT5 G5 NG26 PP199,7920;,"ENST00000395952.8; ENSP00000379282.3; ENSG00000204427.12. [O95870-1];""ENST00000440843.2; ENSP00000410347.2; ENSG00000204427.12. [O95870-2]"";""ENST00000446529.6; ENSP00000395665.2; ENSG00000206403.11. [O95870-1]"";""ENST00000548592.1; ENSP00000448431.1; ENSG00000206403.11. [O95870-2]"";""ENST00000549722.1; ENSP00000447549.1; ENSG00000230475.9. [O95870-2]"";""ENST00000549853.1; ENSP00000447846.1; ENSG00000236063.9. [O95870-2]"";""ENST00000550556.1; ENSP00000447498.1; ENSG00000235676.9. [O95870-2]"";""ENST00000551038.1; ENSP00000449579.1; ENSG00000231488.9. [O95870-2]"";""ENST00000552042.1; ENSP00000448451.1; ENSG00000224552.9. [O95870-2]"";",acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620],monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344],membrane [GO:0016020]
Q6PCB6,S1,-0.718687238,-1.350265604,0.153871263,0.498554969,0.869574682,gold,ABHD17C,AB17C_HUMAN,Alpha/beta hydrolase domain-containing protein 17C (Abhydrolase domain-containing protein 17C) (EC 3.1.2.22),ABHD17C FAM108C1,58489;,"ENST00000258884.5; ENSP00000258884.4; ENSG00000136379.12. [Q6PCB6-1];""ENST00000558464.1; ENSP00000452778.1; ENSG00000136379.12. [Q6PCB6-2]"";",palmitoyl-(protein) hydrolase activity [GO:0008474],negative regulation of protein localization to microtubule [GO:1902817]; positive regulation of protein localization to endosome [GO:1905668]; protein depalmitoylation [GO:0002084]; regulation of postsynapse organization [GO:0099175],dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; recycling endosome membrane [GO:0055038]
P08910,S2,-0.761510147,-1.248935462,0.176961967,0.846091145,0.58245786,orange,ABHD2,ABHD2_HUMAN,Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Lung alpha/beta hydrolase 2) (Progesterone-sensitive lipase) (EC 3.1.1.79) (Protein PHPS1-2),ABHD2 LABH2,11057;,"ENST00000352732.10; ENSP00000268129.5; ENSG00000140526.18.;""ENST00000565973.5; ENSP00000455639.1; ENSG00000140526.18."";",acetylesterase activity [GO:0008126]; acylglycerol lipase activity [GO:0047372]; hormone binding [GO:0042562]; hormone-sensitive lipase activity [GO:0033878]; nuclear steroid receptor activity [GO:0003707]; triglyceride lipase activity [GO:0004806],acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401],acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]
Q9BV23,S2,-1.128766622,-1.176874568,0.360716624,0.843088698,0.594664965,orange,ABHD6,ABHD6_HUMAN,Monoacylglycerol lipase ABHD6 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 6),ABHD6,57406;,"ENST00000295962.8; ENSP00000295962.4; ENSG00000163686.15.;""ENST00000478253.6; ENSP00000420315.1; ENSG00000163686.15."";",acylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620],acylglycerol catabolic process [GO:0046464]; arachidonic acid metabolic process [GO:0019369]; long-term synaptic depression [GO:0060292]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; phospholipid catabolic process [GO:0009395]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178],AMPA glutamate receptor complex [GO:0032281]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]
P00519,C2,1.204252305,0.393470824,-0.292771782,-0.143828372,-0.321506104,aquamarine,ABL1,ABL1_HUMAN,Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150),ABL1 ABL JTK7,25;,"ENST00000318560.6; ENSP00000323315.5; ENSG00000097007.20. [P00519-1];""ENST00000372348.9; ENSP00000361423.2; ENSG00000097007.20. [P00519-2]"";",actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713],"actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; associative learning [GO:0008306]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; canonical NF-kappaB signal transduction [GO:0007249]; cardiac muscle cell proliferation [GO:0060038]; cell-cell adhesion [GO:0098609]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum morphogenesis [GO:0021587]; DN4 thymocyte differentiation [GO:1904157]; DNA conformation change [GO:0071103]; DNA damage response [GO:0006974]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; podocyte apoptotic process [GO:1903210]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite development [GO:1900006]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type II interferon production [GO:0032729]; positive regulation of vasoconstriction [GO:0045907]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein localization to cytoplasmic microtubule plus-end [GO:1904518]; protein modification process [GO:0036211]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of DNA-templated transcription [GO:0006355]; regulation of endocytosis [GO:0030100]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of T cell differentiation [GO:0045580]; response to endoplasmic reticulum stress [GO:0034976]; response to epinephrine [GO:0071871]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]",actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]
P42684,C3,1.614887957,0.105316721,-0.430542325,-0.232401691,-0.606691751,cyan,ABL2,ABL2_HUMAN,Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),ABL2 ABLL ARG,27;,"ENST00000344730.8; ENSP00000339209.3; ENSG00000143322.22. [P42684-10];""ENST00000367623.8; ENSP00000356595.4; ENSG00000143322.22. [P42684-6]"";""ENST00000502732.6; ENSP00000427562.1; ENSG00000143322.22. [P42684-1]"";""ENST00000504405.5; ENSP00000426831.1; ENSG00000143322.22. [P42684-4]"";""ENST00000507173.5; ENSP00000423413.1; ENSG00000143322.22. [P42684-7]"";""ENST00000511413.5; ENSP00000424697.1; ENSG00000143322.22. [P42684-5]"";""ENST00000512653.5; ENSP00000423578.1; ENSG00000143322.22. [P42684-3]"";",actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713],cell adhesion [GO:0007155]; cellular response to retinoic acid [GO:0071300]; epidermal growth factor receptor signaling pathway [GO:0007173]; exploration behavior [GO:0035640]; negative regulation of Rho protein signal transduction [GO:0035024]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of T cell migration [GO:2000406]; protein modification process [GO:0036211]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q12979,C1,1.638829848,0.006578679,-0.49014837,-0.237183894,-0.511156079,lightblue,ABR,ABR_HUMAN,Active breakpoint cluster region-related protein,ABR,29;,"ENST00000291107.6; ENSP00000291107.2; ENSG00000159842.16. [Q12979-2];""ENST00000302538.10; ENSP00000303909.5; ENSG00000159842.16. [Q12979-1]"";""ENST00000543210.6; ENSP00000445198.2; ENSG00000159842.16. [Q12979-3]"";""ENST00000544583.6; ENSP00000442048.2; ENSG00000159842.16. [Q12979-4]"";""ENST00000611009.4; ENSP00000484030.1; ENSG00000276016.4. [Q12979-3]"";""ENST00000611021.3; ENSP00000483168.1; ENSG00000278741.4. [Q12979-2]"";""ENST00000612118.4; ENSP00000481740.1; ENSG00000278741.4. [Q12979-1]"";""ENST00000615642.4; ENSP00000479455.1; ENSG00000278741.4. [Q12979-3]"";""ENST00000620619.4; ENSP00000478880.1; ENSG00000278741.4. [Q12979-4]"";""ENST00000625740.2; ENSP00000486511.1; ENSG00000276016.4. [Q12979-2]"";""ENST00000627258.2; ENSP00000486214.1; ENSG00000278741.4. [Q12979-4]"";",GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085],activation of GTPase activity [GO:0090630]; modulation of chemical synaptic transmission [GO:0050804]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]
Q9P1F3,C4,2.226182584,-0.322082566,-1.519571431,-1.796397193,-2.05527222,deepskyblue2,ABRACL,ABRAL_HUMAN,Costars family protein ABRACL (ABRA C-terminal-like protein),ABRACL C6orf115 HSPC280 PRO2013,58527;,ENST00000367660.4; ENSP00000356632.3; ENSG00000146386.8.;,0,regulation of actin filament-based process [GO:0032970],0
Q9ULW3,N3,-1.082764778,-0.870763312,1.073424763,-0.036410898,0.285915471,grey50,ABT1,ABT1_HUMAN,Activator of basal transcription 1 (hABT1) (Basal transcriptional activator),ABT1,29777;,"ENST00000274849.3; ENSP00000274849.1; ENSG00000146109.5.;""ENST00000709933.1; ENSP00000517947.1; ENSG00000292169.1."";",DNA binding [GO:0003677]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; regulation of transcription by RNA polymerase II [GO:0006357]; small-subunit processome assembly [GO:0034462]; spinal cord motor neuron differentiation [GO:0021522]; transcription by RNA polymerase II [GO:0006366]",nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]
Q9H845,M1,-1.160958295,-0.752522971,0.392960313,1.01676308,-0.367347387,burlywood4,ACAD9,ACAD9_HUMAN,"Complex I assembly factor ACAD9, mitochondrial (Acyl-CoA dehydrogenase family member 9) (ACAD-9) (EC 1.3.8.-)",ACAD9,28976;,"ENST00000308982.12; ENSP00000312618.7; ENSG00000177646.20.;""ENST00000681583.1; ENSP00000506340.1; ENSG00000177646.20."";",acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain fatty acyl-CoA dehydrogenase activity [GO:0070991],long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981],dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q15057,C3,1.764913126,0.079041785,-0.706984944,-0.571224941,-0.672520571,cyan,ACAP2,ACAP2_HUMAN,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",ACAP2 CENTB2 KIAA0041,23527;,ENST00000326793.11; ENSP00000324287.6; ENSG00000114331.16.;,GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872],actin filament-based process [GO:0030029]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],endosome membrane [GO:0010008]; membrane [GO:0016020]; ruffle [GO:0001726]
O75908,C5,1.897571216,0.542991076,-0.901285541,-1.019892939,-1.108769737,turquoise3,ACAT2,SOAT2_HUMAN,Sterol O-acyltransferase 2 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 2) (ACAT-2) (Cholesterol acyltransferase 2),SOAT2 ACACT2 ACAT2,8435;,"ENST00000301466.8; ENSP00000301466.3; ENSG00000167780.12. [O75908-1];""ENST00000542365.1; ENSP00000442234.1; ENSG00000167780.12. [O75908-4]"";",acyltransferase activity [GO:0016746]; cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; sterol O-acyltransferase activity [GO:0004772],cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; intestinal cholesterol absorption [GO:0030299]; low-density lipoprotein particle clearance [GO:0034383]; macrophage derived foam cell differentiation [GO:0010742]; very-low-density lipoprotein particle assembly [GO:0034379],brush border [GO:0005903]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q8NC06,S2,-2.103992827,-1.702166007,0.119289474,1.088686936,0.584652477,orange,ACBD4,ACBD4_HUMAN,Acyl-CoA-binding domain-containing protein 4,ACBD4 HMFT0700,79777;,"ENST00000321854.13; ENSP00000314440.8; ENSG00000181513.15. [Q8NC06-2];""ENST00000376955.8; ENSP00000366154.3; ENSG00000181513.15. [Q8NC06-1]"";""ENST00000398322.7; ENSP00000381367.2; ENSG00000181513.15. [Q8NC06-2]"";""ENST00000431281.5; ENSP00000405969.1; ENSG00000181513.15. [Q8NC06-3]"";""ENST00000586346.5; ENSP00000465484.1; ENSG00000181513.15. [Q8NC06-3]"";""ENST00000591859.5; ENSP00000465610.1; ENSG00000181513.15. [Q8NC06-3]"";""ENST00000619916.4; ENSP00000482750.1; ENSG00000181513.15. [Q8NC06-1]"";",fatty-acyl-CoA binding [GO:0000062],fatty acid metabolic process [GO:0006631],cytoplasm [GO:0005737]
Q5T8D3,S2,-1.215025525,-1.39439666,0.039399208,1.05611596,0.380598471,orange,ACBD5,ACBD5_HUMAN,Acyl-CoA-binding domain-containing protein 5,ACBD5 KIAA1996,91452;,"ENST00000375888.5; ENSP00000365049.1; ENSG00000107897.20. [Q5T8D3-1];""ENST00000375901.5; ENSP00000365066.1; ENSG00000107897.20. [Q5T8D3-4]"";""ENST00000375905.8; ENSP00000365070.4; ENSG00000107897.20. [Q5T8D3-2]"";""ENST00000396271.8; ENSP00000379568.3; ENSG00000107897.20. [Q5T8D3-3]"";""ENST00000679293.1; ENSP00000503631.1; ENSG00000107897.20. [Q5T8D3-2]"";",fatty-acyl-CoA binding [GO:0000062],fatty acid metabolic process [GO:0006631]; pexophagy [GO:0000425],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
Q9BR61,C5,2.127906156,0.272892567,-0.782277205,-0.864993568,-1.131186226,turquoise3,ACBD6,ACBD6_HUMAN,Acyl-CoA-binding domain-containing protein 6,ACBD6,84320;,"ENST00000367595.4; ENSP00000356567.3; ENSG00000230124.8.;""ENST00000642319.1; ENSP00000495710.1; ENSG00000230124.8."";",fatty-acyl-CoA binding [GO:0000062],0,cytosol [GO:0005829]
Q9UKV3,N2,-0.978305883,-0.538378023,1.102433101,0.006031946,-0.12460001,grey70,ACIN1,ACINU_HUMAN,Apoptotic chromatin condensation inducer in the nucleus (Acinus),ACIN1 ACINUS KIAA0670,22985;,"ENST00000262710.5; ENSP00000262710.1; ENSG00000100813.15. [Q9UKV3-1];""ENST00000338631.10; ENSP00000345541.6; ENSG00000100813.15. [Q9UKV3-2]"";""ENST00000357481.6; ENSP00000350073.2; ENSG00000100813.15. [Q9UKV3-3]"";""ENST00000397341.7; ENSP00000380502.3; ENSG00000100813.15. [Q9UKV3-3]"";""ENST00000555053.5; ENSP00000451328.1; ENSG00000100813.15. [Q9UKV3-5]"";",ATP hydrolysis activity [GO:0016887]; enzyme binding [GO:0019899]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723],"apoptotic chromosome condensation [GO:0030263]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380]",ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P53396,C5,1.564069343,0.81766155,-0.779265951,-0.819101685,-0.467622631,turquoise3,ACLY,ACLY_HUMAN,ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme),ACLY,47;,"ENST00000352035.7; ENSP00000253792.2; ENSG00000131473.17. [P53396-1];""ENST00000353196.5; ENSP00000345398.1; ENSG00000131473.17. [P53396-2]"";""ENST00000393896.6; ENSP00000377474.1; ENSG00000131473.17. [P53396-2]"";""ENST00000537919.5; ENSP00000445349.1; ENSG00000131473.17. [P53396-3]"";""ENST00000590151.5; ENSP00000466259.1; ENSG00000131473.17. [P53396-1]"";",ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872],acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107],azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
Q8WXI4,C4,1.96570442,0.284856492,-0.988095274,-0.744406176,-1.157155908,deepskyblue2,ACOT11,ACO11_HUMAN,Acyl-coenzyme A thioesterase 11 (Acyl-CoA thioesterase 11) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 11) (Adipose-associated thioesterase) (Brown fat-inducible thioesterase) (BFIT) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2),ACOT11 BFIT KIAA0707 THEA,26027;,"ENST00000343744.7; ENSP00000340260.2; ENSG00000162390.18. [Q8WXI4-2];""ENST00000371316.3; ENSP00000360366.3; ENSG00000162390.18. [Q8WXI4-1]"";",carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816],acyl-CoA metabolic process [GO:0006637]; fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]
P24666,C4,2.033376852,0.054930074,-0.934799661,-0.819248821,-1.093839741,deepskyblue2,ACP1,PPAC_HUMAN,Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1),ACP1,52;,"ENST00000272065.10; ENSP00000272065.5; ENSG00000143727.16. [P24666-1];""ENST00000272067.11; ENSP00000272067.6; ENSG00000143727.16. [P24666-2]"";""ENST00000407983.7; ENSP00000385404.3; ENSG00000143727.16. [P24666-4]"";",acid phosphatase activity [GO:0003993]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],0,cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; sarcolemma [GO:0042383]
Q8TE99,S1,-0.425252293,-0.802495665,0.130937568,0.674277046,0.872467662,gold,ACPL2,PXYP1_HUMAN,2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2) (Xylosyl phosphatase) (epididymis luminal protein 124),PXYLP1 ACPL2 HEL124 XYLP UNQ370/PRO706,92370;,"ENST00000286353.9; ENSP00000286353.4; ENSG00000155893.13. [Q8TE99-1];""ENST00000393010.6; ENSP00000376733.2; ENSG00000155893.13. [Q8TE99-1]"";",phosphatase activity [GO:0016791],chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
P33121,S3,-0.882429089,-0.798128662,0.267931832,0.85085033,0.4174713,salmon,ACSL1,ACSL1_HUMAN,Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase) (EC 6.2.1.24),ACSL1 FACL1 FACL2 LACS LACS1 LACS2,2180;,"ENST00000281455.7; ENSP00000281455.2; ENSG00000151726.16. [P33121-1];""ENST00000503407.6; ENSP00000425098.2; ENSG00000151726.16. [P33121-2]"";""ENST00000504342.5; ENSP00000425006.1; ENSG00000151726.16. [P33121-1]"";""ENST00000513317.5; ENSP00000426150.1; ENSG00000151726.16. [P33121-3]"";""ENST00000515030.5; ENSP00000422607.1; ENSG00000151726.16. [P33121-1]"";""ENST00000706366.1; ENSP00000516351.1; ENSG00000151726.16. [P33121-3]"";""ENST00000706367.1; ENSP00000516352.1; ENSG00000151726.16. [P33121-1]"";""ENST00000706368.1; ENSP00000516353.1; ENSG00000151726.16. [P33121-3]"";""ENST00000706369.1; ENSP00000516354.1; ENSG00000151726.16. [P33121-1]"";",arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; oleoyl-CoA ligase activity [GO:0090434]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; protein serine/threonine kinase activator activity [GO:0043539],adiponectin-activated signaling pathway [GO:0033211]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of long-chain fatty acid import across plasma membrane [GO:0010747]; response to nutrient [GO:0007584]; response to oleic acid [GO:0034201]; response to organic cyclic compound [GO:0014070]; triglyceride biosynthetic process [GO:0019432]; very long-chain fatty acid metabolic process [GO:0000038]; xenobiotic catabolic process [GO:0042178],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]
O95573,S2,-1.277469713,-1.45015663,0.151970104,0.926976056,0.583764833,orange,ACSL3,ACSL3_HUMAN,Fatty acid CoA ligase Acsl3 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 3) (LACS 3) (Long-chain-fatty-acid--CoA ligase 3) (EC 6.2.1.3) (Medium-chain acyl-CoA ligase Acsl3) (EC 6.2.1.2),ACSL3 ACS3 FACL3 LACS3,2181;,"ENST00000357430.8; ENSP00000350012.3; ENSG00000123983.15.;""ENST00000392066.7; ENSP00000375918.3; ENSG00000123983.15."";""ENST00000679514.1; ENSP00000506361.1; ENSG00000123983.15."";""ENST00000679558.1; ENSP00000504907.1; ENSG00000123983.15."";""ENST00000680147.1; ENSP00000504861.1; ENSG00000123983.15."";""ENST00000680251.1; ENSP00000505400.1; ENSG00000123983.15."";""ENST00000680395.1; ENSP00000505793.1; ENSG00000123983.15."";""ENST00000680684.1; ENSP00000506468.1; ENSG00000123983.15."";""ENST00000680921.1; ENSP00000505940.1; ENSG00000123983.15."";""ENST00000681383.1; ENSP00000505654.1; ENSG00000123983.15."";""ENST00000681697.1; ENSP00000505856.1; ENSG00000123983.15."";",arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; palmitoyl-CoA ligase activity [GO:0090433]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901],fatty acid metabolic process [GO:0006631]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of secretion [GO:0051047]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]
O60488,S3,-0.824042167,-0.624318641,0.098107201,0.870114809,0.453973862,salmon,ACSL4,ACSL4_HUMAN,Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4),ACSL4 ACS4 FACL4 LACS4,2182;,"ENST00000340800.7; ENSP00000339787.2; ENSG00000068366.21. [O60488-1];""ENST00000348502.10; ENSP00000262835.7; ENSG00000068366.21. [O60488-2]"";""ENST00000469796.7; ENSP00000419171.2; ENSG00000068366.21. [O60488-1]"";""ENST00000502391.6; ENSP00000425408.2; ENSG00000068366.21. [O60488-1]"";""ENST00000671846.1; ENSP00000500897.1; ENSG00000068366.21. [O60488-1]"";""ENST00000672282.1; ENSP00000500678.1; ENSG00000068366.21. [O60488-2]"";""ENST00000672401.1; ENSP00000500273.1; ENSG00000068366.21. [O60488-2]"";""ENST00000673016.1; ENSP00000499969.1; ENSG00000068366.21. [O60488-2]"";",arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957],embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of insulin secretion [GO:0032024],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]
Q9NR19,C5,1.629526296,0.696127397,-0.824724868,-0.914637728,-1.315537322,turquoise3,ACSS2,ACSA_HUMAN,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)",ACSS2 ACAS2,55902;,"ENST00000253382.5; ENSP00000253382.5; ENSG00000131069.20. [Q9NR19-2];""ENST00000360596.7; ENSP00000353804.2; ENSG00000131069.20. [Q9NR19-1]"";",acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; propionate-CoA ligase activity [GO:0050218]; transcription coactivator activity [GO:0003713],acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; lipid biosynthetic process [GO:0008610]; long-term memory [GO:0007616]; propionate biosynthetic process [GO:0019542],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]
Q9NZ32,C2,1.541910324,0.171824683,-0.566527374,-0.270974975,-0.11906416,aquamarine,ACTR10,ARP10_HUMAN,Actin-related protein 10 (Actin-related protein 11) (hARP11),ACTR10 ACTR11 ARP10 ARP11,55860;,ENST00000254286.9; ENSP00000254286.4; ENSG00000131966.14.;,0,retrograde axonal transport of mitochondrion [GO:0098958],axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]
Q04771,S4,-0.601984597,-1.337924314,0.251885701,0.90724804,0.369705193,tomato2,ACVR1,ACVR1_HUMAN,Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I),ACVR1 ACVRLK2,90;,"ENST00000263640.7; ENSP00000263640.3; ENSG00000115170.16.;""ENST00000409283.6; ENSP00000387273.2; ENSG00000115170.16."";""ENST00000410057.6; ENSP00000387127.2; ENSG00000115170.16."";""ENST00000424669.6; ENSP00000400767.2; ENSG00000115170.16."";""ENST00000434821.7; ENSP00000405004.1; ENSG00000115170.16."";""ENST00000539637.6; ENSP00000440091.2; ENSG00000115170.16."";""ENST00000672582.1; ENSP00000500605.1; ENSG00000115170.16."";""ENST00000673324.1; ENSP00000500109.1; ENSG00000115170.16."";""ENST00000682025.1; ENSP00000507086.1; ENSG00000115170.16."";""ENST00000682300.1; ENSP00000507102.1; ENSG00000115170.16."";""ENST00000683441.1; ENSP00000508189.1; ENSG00000115170.16."";""ENST00000683487.1; ENSP00000507113.1; ENSG00000115170.16."";""ENST00000683820.1; ENSP00000507727.1; ENSG00000115170.16."";""ENST00000684348.1; ENSP00000508136.1; ENSG00000115170.16."";""ENST00000684595.1; ENSP00000507730.1; ENSG00000115170.16."";","activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase binding [GO:1990782]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]",activin receptor signaling pathway [GO:0032924]; acute inflammatory response [GO:0002526]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion cell fate commitment [GO:0061445]; endocardial cushion formation [GO:0003272]; endocardial cushion fusion [GO:0003274]; gastrulation with mouth forming second [GO:0001702]; germ cell development [GO:0007281]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of signal transduction [GO:0009968]; neural crest cell migration [GO:0001755]; pharyngeal system development [GO:0060037]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell migration [GO:0030335]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ossification [GO:0030278]; smooth muscle cell differentiation [GO:0051145]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular septum morphogenesis [GO:0060412],activin receptor complex [GO:0048179]; apical part of cell [GO:0045177]; BMP receptor complex [GO:0070724]; plasma membrane [GO:0005886]
P07311,C4,2.412308518,-0.221849387,-1.545509244,-1.63130731,-1.921949272,deepskyblue2,ACYP1,ACYP1_HUMAN,"Acylphosphatase-1 (EC 3.6.1.7) (Acylphosphatase, erythrocyte isozyme) (Acylphosphatase, organ-common type isozyme) (Acylphosphate phosphohydrolase 1)",ACYP1 ACYPE,97;,"ENST00000238618.8; ENSP00000238618.3; ENSG00000119640.9. [P07311-1];""ENST00000357971.7; ENSP00000350655.3; ENSG00000119640.9. [P07311-2]"";""ENST00000555694.5; ENSP00000451581.1; ENSG00000119640.9. [P07311-1]"";",acylphosphatase activity [GO:0003998],phosphate-containing compound metabolic process [GO:0006796],0
P14621,C1,1.52973193,0.038005654,-0.392524344,0.120076144,-1.222803177,lightblue,ACYP2,ACYP2_HUMAN,"Acylphosphatase-2 (EC 3.6.1.7) (Acylphosphatase, muscle type isozyme) (Acylphosphate phosphohydrolase 2)",ACYP2 ACYP,98;,ENST00000394666.9; ENSP00000378161.3; ENSG00000170634.13.;,acylphosphatase activity [GO:0003998]; identical protein binding [GO:0042802],phosphate-containing compound metabolic process [GO:0006796],0
O14672,S4,-0.979799314,-1.241236803,0.368629981,0.823846986,0.332788777,tomato2,ADAM10,ADA10_HUMAN,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),ADAM10 KUZ MADM,102;,ENST00000260408.8; ENSP00000260408.3; ENSG00000137845.15. [O14672-1];,endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102],adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cell-cell signaling [GO:0007267]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; extracellular matrix disassembly [GO:0022617]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612],adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; specific granule membrane [GO:0035579]; synaptic membrane [GO:0097060]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]
Q13444,S2,-0.977634248,-1.309883908,0.333539234,0.757693356,0.462953347,orange,ADAM15,ADA15_HUMAN,"Disintegrin and metalloproteinase domain-containing protein 15 (ADAM 15) (EC 3.4.24.-) (Metalloprotease RGD disintegrin protein) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15) (MDC-15) (Metargidin)",ADAM15 MDC15,8751;,"ENST00000271836.10; ENSP00000271836.6; ENSG00000143537.14. [Q13444-2];""ENST00000355956.6; ENSP00000348227.2; ENSG00000143537.14. [Q13444-4]"";""ENST00000356955.7; ENSP00000349436.2; ENSG00000143537.14. [Q13444-1]"";""ENST00000359280.8; ENSP00000352226.4; ENSG00000143537.14. [Q13444-5]"";""ENST00000360674.8; ENSP00000353892.4; ENSG00000143537.14. [Q13444-10]"";""ENST00000368412.7; ENSP00000357397.3; ENSG00000143537.14. [Q13444-9]"";""ENST00000368413.5; ENSP00000357398.1; ENSG00000143537.14. [Q13444-11]"";""ENST00000447332.3; ENSP00000476000.1; ENSG00000143537.14. [Q13444-13]"";""ENST00000449910.6; ENSP00000403843.2; ENSG00000143537.14. [Q13444-3]"";""ENST00000526491.5; ENSP00000432347.1; ENSG00000143537.14. [Q13444-6]"";""ENST00000529473.5; ENSP00000434227.1; ENSG00000143537.14. [Q13444-8]"";""ENST00000531455.5; ENSP00000432927.1; ENSG00000143537.14. [Q13444-12]"";",immunoglobulin receptor binding [GO:0034987]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; SH3 domain binding [GO:0017124],angiogenesis [GO:0001525]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell-matrix adhesion [GO:0007160]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; immune response to tumor cell [GO:0002418]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; male gonad development [GO:0008584]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of receptor binding [GO:1900121]; proteolysis [GO:0006508]; response to hypobaric hypoxia [GO:1990910]; tissue regeneration [GO:0042246],acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]
Q13443,S2,-1.673198032,-1.6612585,0.21667791,0.830389544,0.906217455,orange,ADAM9,ADAM9_HUMAN,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),ADAM9 KIAA0021 MCMP MDC9 MLTNG,8754;,"ENST00000379917.7; ENSP00000369249.3; ENSG00000168615.13. [Q13443-2];""ENST00000487273.7; ENSP00000419446.2; ENSG00000168615.13. [Q13443-1]"";",collagen binding [GO:0005518]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein kinase C binding [GO:0005080]; SH3 domain binding [GO:0017124],amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to antineoplastic agent [GO:0097327]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to laminar fluid shear stress [GO:0034616]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]
P55265,N3,-1.108785964,-1.166115493,0.967930176,-0.013459337,0.57676495,grey50,ADAR,DSRAD_HUMAN,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),ADAR ADAR1 DSRAD G1P1 IFI4,103;,"ENST00000368471.8; ENSP00000357456.3; ENSG00000160710.18. [P55265-5];""ENST00000368474.9; ENSP00000357459.4; ENSG00000160710.18. [P55265-1]"";""ENST00000529168.2; ENSP00000431794.2; ENSG00000160710.18. [P55265-2]"";""ENST00000648231.2; ENSP00000497555.1; ENSG00000160710.18. [P55265-5]"";""ENST00000648311.1; ENSP00000498137.1; ENSG00000160710.18. [P55265-5]"";""ENST00000649022.2; ENSP00000496896.2; ENSG00000160710.18. [P55265-5]"";""ENST00000649749.1; ENSP00000497210.1; ENSG00000160710.18. [P55265-5]"";""ENST00000681683.1; ENSP00000506666.1; ENSG00000160710.18. [P55265-5]"";",DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251],adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]
P78563,N1,-0.690668581,-0.711674915,0.701127915,-0.134482811,0.858536379,grey90,ADARB1,RED1_HUMAN,Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase),ADARB1 ADAR2 DRADA2 RED1,104;,"ENST00000348831.9; ENSP00000015877.6; ENSG00000197381.18. [P78563-2];""ENST00000360697.4; ENSP00000353920.3; ENSG00000197381.18. [P78563-1]"";""ENST00000389861.7; ENSP00000516121.1; ENSG00000197381.18. [P78563-2]"";""ENST00000389863.8; ENSP00000374513.4; ENSG00000197381.18. [P78563-3]"";""ENST00000437626.5; ENSP00000414600.2; ENSG00000197381.18. [P78563-1]"";""ENST00000449478.2; ENSP00000387480.2; ENSG00000197381.18. [P78563-1]"";""ENST00000492414.5; ENSP00000436367.1; ENSG00000197381.18. [P78563-2]"";""ENST00000496664.5; ENSP00000435381.1; ENSG00000197381.18. [P78563-1]"";",double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251],adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innate immune response [GO:0045087]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]
Q7Z6V5,C5,1.742356561,0.785482133,-1.076555191,-1.345357243,-1.482503853,turquoise3,ADAT2,ADAT2_HUMAN,tRNA-specific adenosine deaminase 2 (EC 3.5.4.33) (Deaminase domain-containing protein 1) (tRNA-specific adenosine-34 deaminase subunit ADAT2),ADAT2 DEADC1,134637;,"ENST00000237283.9; ENSP00000237283.8; ENSG00000189007.16. [Q7Z6V5-1];""ENST00000606514.5; ENSP00000475651.1; ENSG00000189007.16. [Q7Z6V5-2]"";",tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270],tRNA wobble adenosine to inosine editing [GO:0002100],nucleoplasm [GO:0005654]
Q96EY9,C5,0.891392744,0.978770096,-0.437852491,-0.625343706,-0.963149293,turquoise3,ADAT3,ADAT3_HUMAN,Probable inactive tRNA-specific adenosine deaminase-like protein 3 (tRNA-specific adenosine-34 deaminase subunit ADAT3),ADAT3 TAD3,113179;,0,catalytic activity [GO:0003824]; metal ion binding [GO:0046872],tRNA processing [GO:0008033],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q86TW2,M2,-0.649245949,-1.122742896,0.404572577,1.036495697,-0.125296484,tan4,ADCK1,ADCK1_HUMAN,AarF domain-containing protein kinase 1 (EC 2.7.-.-),ADCK1,57143;,"ENST00000238561.10; ENSP00000238561.5; ENSG00000063761.16. [Q86TW2-2];""ENST00000341211.5; ENSP00000339663.5; ENSG00000063761.16. [Q86TW2-3]"";",ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of cristae formation [GO:1903852],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q8NI60,M2,-0.944766638,-0.543065132,0.48719188,0.835539395,-0.13982471,tan4,ADCK3,COQ8A_HUMAN,"Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)",COQ8A ADCK3 CABC1 PP265,56997;,"ENST00000366777.4; ENSP00000355739.3; ENSG00000163050.18. [Q8NI60-1];""ENST00000366778.5; ENSP00000355740.1; ENSG00000163050.18. [Q8NI60-3]"";",ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301],phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744],membrane [GO:0016020]; mitochondrion [GO:0005739]
Q96D53,M2,-1.076113115,-0.960243614,0.461628658,0.963881746,-0.10681838,tan4,ADCK4,COQ8B_HUMAN,"Atypical kinase COQ8B, mitochondrial (EC 2.7.-.-) (AarF domain-containing protein kinase 4) (Coenzyme Q protein 8B)",COQ8B ADCK4,79934;,"ENST00000243583.10; ENSP00000243583.5; ENSG00000123815.13. [Q96D53-2];""ENST00000324464.8; ENSP00000315118.3; ENSG00000123815.13. [Q96D53-1]"";""ENST00000594720.6; ENSP00000470876.2; ENSG00000123815.13. [Q96D53-1]"";""ENST00000601967.6; ENSP00000470916.2; ENSG00000123815.13. [Q96D53-1]"";""ENST00000677018.1; ENSP00000503480.1; ENSG00000123815.13. [Q96D53-1]"";""ENST00000678404.1; ENSP00000503944.1; ENSG00000123815.13. [Q96D53-1]"";""ENST00000678419.1; ENSP00000504085.1; ENSG00000123815.13. [Q96D53-1]"";""ENST00000678467.1; ENSP00000504072.1; ENSG00000123815.13. [Q96D53-1]"";""ENST00000679130.1; ENSP00000504845.1; ENSG00000123815.13. [Q96D53-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; kinase activity [GO:0016301]; lipid binding [GO:0008289],cerebellar Purkinje cell layer morphogenesis [GO:0021692]; ubiquinone biosynthetic process [GO:0006744],cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
O60266,S4,-0.908377909,-1.479260435,0.438534317,0.907619645,0.541551555,tomato2,ADCY3,ADCY3_HUMAN,"Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)",ADCY3 KIAA0511,109;,"ENST00000260600.9; ENSP00000260600.5; ENSG00000138031.15. [O60266-1];""ENST00000679454.1; ENSP00000505261.1; ENSG00000138031.15. [O60266-1]"";",adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338],ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]
O43306,S4,-0.618814234,-1.108756455,0.388237238,0.834866508,0.098788618,tomato2,ADCY6,ADCY6_HUMAN,Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase),ADCY6 KIAA0422,112;,"ENST00000307885.4; ENSP00000311405.4; ENSG00000174233.12. [O43306-1];""ENST00000357869.8; ENSP00000350536.4; ENSG00000174233.12. [O43306-1]"";""ENST00000550422.5; ENSP00000446730.1; ENSG00000174233.12. [O43306-2]"";",adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080],adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; blood vessel diameter maintenance [GO:0097746]; cAMP biosynthetic process [GO:0006171]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to forskolin [GO:1904322]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to vasopressin [GO:1904117]; dopamine receptor signaling pathway [GO:0007212]; intracellular signal transduction [GO:0035556]; negative regulation of neuron projection development [GO:0010977]; negative regulation of urine volume [GO:0035811]; renal water homeostasis [GO:0003091],cilium [GO:0005929]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]
O60503,S4,-1.319133506,-1.6479561,0.435639472,0.865704074,0.221619073,tomato2,ADCY9,ADCY9_HUMAN,Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (ACIX) (Adenylyl cyclase 9) (AC9),ADCY9 KIAA0520,115;,ENST00000294016.8; ENSP00000294016.3; ENSG00000162104.10.;,adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P11766,C4,2.143182133,0.413129286,-1.076067397,-1.13513154,-1.42271604,deepskyblue2,ADH5,ADHX_HUMAN,Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284),ADH5 ADHX FDH,128;,ENST00000296412.14; ENSP00000296412.8; ENSG00000197894.12.;,"alcohol dehydrogenase (NAD+) activity, zinc-dependent [GO:0004024]; electron transfer activity [GO:0009055]; fatty acid binding [GO:0005504]; formaldehyde dehydrogenase activity [GO:0018467]; identical protein binding [GO:0042802]; S-(hydroxymethyl)glutathione dehydrogenase (NAD(P)+) activity [GO:0051903]; S-(hydroxymethyl)glutathione dehydrogenase (NAD+) activity [GO:0106322]; S-(hydroxymethyl)glutathione dehydrogenase (NADP+) activity [GO:0106321]; zinc ion binding [GO:0008270]",fatty acid omega-oxidation [GO:0010430]; formaldehyde catabolic process [GO:0046294]; positive regulation of blood pressure [GO:0045777]; respiratory system process [GO:0003016]; response to lipopolysaccharide [GO:0032496]; response to nitrosative stress [GO:0051409]; response to redox state [GO:0051775]; retinoid metabolic process [GO:0001523],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]
Q9BV57,C4,1.959941273,0.223341668,-1.000824701,-1.208942149,-1.434352143,deepskyblue2,ADI1,MTND_HUMAN,Acireductone dioxygenase (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD') (Fe-ARD) (EC 1.13.11.54) (Acireductone dioxygenase (Ni(2+)-requiring)) (ARD) (Ni-ARD) (EC 1.13.11.53) (Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1) (MTCBP-1) (Submergence-induced protein-like factor) (Sip-L),ADI1 MTCBP1 HMFT1638,55256;,"ENST00000327435.11; ENSP00000333666.3; ENSG00000182551.14. [Q9BV57-1];""ENST00000382093.5; ENSP00000371525.5; ENSG00000182551.14. [Q9BV57-2]"";",acireductone dioxygenase (Ni2+-requiring) activity [GO:0010308]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; nickel cation binding [GO:0016151]; oxidoreductase activity [GO:0016491],L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q86V24,S2,-1.005752699,-1.685509476,0.437447091,0.95079348,0.551078617,orange,ADIPOR2,PAQR2_HUMAN,Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II),ADIPOR2 PAQR2,79602;,"ENST00000357103.5; ENSP00000349616.4; ENSG00000006831.10.;""ENST00000645126.2; ENSP00000495699.1; ENSG00000285070.2."";",adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023],adiponectin-activated signaling pathway [GO:0033211]; fatty acid oxidation [GO:0019395]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of cold-induced thermogenesis [GO:0120162]; vascular wound healing [GO:0061042],plasma membrane [GO:0005886]
P55263,C5,1.797711173,0.632067624,-1.225308112,-1.416346899,-1.595769068,turquoise3,ADK,ADK_HUMAN,Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase),ADK,132;,"ENST00000372734.5; ENSP00000361819.3; ENSG00000156110.15. [P55263-2];""ENST00000539909.6; ENSP00000443965.2; ENSG00000156110.15. [P55263-1]"";""ENST00000672429.1; ENSP00000500292.1; ENSG00000156110.15. [P55263-3]"";""ENST00000673027.1; ENSP00000500201.1; ENSG00000156110.15. [P55263-4]"";",adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; deoxyadenosine kinase activity [GO:0004136]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],AMP salvage [GO:0044209]; dAMP salvage [GO:0106383]; dATP biosynthetic process [GO:0006175]; GMP salvage [GO:0032263]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleoside salvage [GO:0006166]; ribonucleoside monophosphate biosynthetic process [GO:0009156],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9H2P0,N2,-1.132875402,0.54924535,0.735405958,-0.216083009,-0.328318529,grey70,ADNP,ADNP_HUMAN,Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein),ADNP ADNP1 KIAA0784,23394;,"ENST00000349014.8; ENSP00000342905.3; ENSG00000101126.18.;""ENST00000371602.9; ENSP00000360662.2; ENSG00000101126.18."";""ENST00000396029.8; ENSP00000379346.3; ENSG00000101126.18."";""ENST00000396032.8; ENSP00000379349.2; ENSG00000101126.18."";""ENST00000621696.5; ENSP00000483881.1; ENSG00000101126.18."";","beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; copper ion binding [GO:0005507]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; peptide binding [GO:0042277]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",cellular response to extracellular stimulus [GO:0031668]; cGMP-mediated signaling [GO:0019934]; estrous cycle [GO:0044849]; intracellular nitric oxide homeostasis [GO:0033484]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of synaptic transmission [GO:0050805]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of axon extension [GO:0045773]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of synapse assembly [GO:0051965]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to carbohydrate [GO:0009743]; response to inorganic substance [GO:0010035]; short-term memory [GO:0007614],axon [GO:0030424]; chromatin [GO:0000785]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]
Q6IQ32,N2,-0.727231178,-0.054305818,0.979351064,0.042202091,-0.341051396,grey70,ADNP2,ADNP2_HUMAN,Activity-dependent neuroprotector homeobox protein 2 (ADNP homeobox protein 2) (Zinc finger protein 508),ADNP2 KIAA0863 ZNF508,22850;,ENST00000262198.9; ENSP00000262198.3; ENSG00000101544.9.;,"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]",nervous system development [GO:0007399]; regulation of gene expression [GO:0010468],chromatin [GO:0000785]; nucleus [GO:0005634]
Q96SZ5,C5,1.53211356,0.361273014,-0.510645986,-0.450324247,-0.752146915,turquoise3,ADO,AEDO_HUMAN,2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase),ADO C10orf22,84890;,ENST00000373783.3; ENSP00000362888.1; ENSG00000181915.6.;,cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506],cellular response to hypoxia [GO:0071456],cytosol [GO:0005829]
Q9NX46,C5,1.39238056,0.498639191,-0.323597455,-0.268921448,-0.731816865,turquoise3,ADPRHL2,ADPRS_HUMAN,ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-),ADPRS ADPRHL2 ARH3,54936;,ENST00000373178.5; ENSP00000362273.4; ENSG00000116863.11.;,"ADP-ribosylserine hydrolase activity [GO:0140292]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; magnesium ion binding [GO:0000287]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]","base-excision repair, gap-filling [GO:0006287]; cellular response to superoxide [GO:0071451]; DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290]",cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]
P25098,C4,1.86989079,0.199988916,-0.800296595,-0.848125641,-1.015033585,deepskyblue2,ADRBK1,ARBK1_HUMAN,Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2),GRK2 ADRBK1 BARK BARK1,156;,ENST00000308595.10; ENSP00000312262.5; ENSG00000173020.11.;,alpha-2A adrenergic receptor binding [GO:0031694]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled receptor kinase activity [GO:0004703]; protein kinase activity [GO:0004672],cardiac muscle contraction [GO:0060048]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; negative regulation of relaxation of smooth muscle [GO:1901081]; negative regulation of striated muscle contraction [GO:0045988]; negative regulation of the force of heart contraction by chemical signal [GO:0003108]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of catecholamine secretion [GO:0033605]; receptor internalization [GO:0031623]; regulation of the force of heart contraction [GO:0002026]; symbiont entry into host cell [GO:0046718]; tachykinin receptor signaling pathway [GO:0007217]; viral genome replication [GO:0019079],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]
Q16186,C1,1.127145184,0.358803914,-0.632928888,-0.75801658,0.320780028,lightblue,ADRM1,ADRM1_HUMAN,Proteasomal ubiquitin receptor ADRM1 (110 kDa cell membrane glycoprotein) (Gp110) (Adhesion-regulating molecule 1) (ARM-1) (Proteasome regulatory particle non-ATPase 13) (hRpn13) (Rpn13 homolog),ADRM1 GP110,11047;,"ENST00000253003.7; ENSP00000253003.2; ENSG00000130706.13.;""ENST00000491935.5; ENSP00000478877.1; ENSG00000130706.13."";",endopeptidase activator activity [GO:0061133]; molecular function inhibitor activity [GO:0140678]; protease binding [GO:0002020]; proteasome binding [GO:0070628],proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; transcription elongation by RNA polymerase II [GO:0006368],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]"
P30566,C5,2.096612914,0.492270264,-1.014755961,-1.116435455,-1.179290182,turquoise3,ADSL,PUR8_HUMAN,Adenylosuccinate lyase (ADSL) (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase),ADSL AMPS,158;,"ENST00000342312.9; ENSP00000341429.6; ENSG00000239900.14. [P30566-2];""ENST00000623063.3; ENSP00000485525.1; ENSG00000239900.14. [P30566-1]"";","(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity [GO:0070626]; identical protein binding [GO:0042802]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]",'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; aerobic respiration [GO:0009060]; AMP biosynthetic process [GO:0006167]; AMP salvage [GO:0044209]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to starvation [GO:0042594],cytosol [GO:0005829]; protein-containing complex [GO:0032991]
Q9UHB7,N4,-1.346481882,1.108682265,0.260557475,-0.439441712,-0.259926592,grey30,AFF4,AFF4_HUMAN,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),AFF4 AF5Q31 MCEF HSPC092,27125;,"ENST00000265343.10; ENSP00000265343.5; ENSG00000072364.13. [Q9UHB7-1];""ENST00000378595.7; ENSP00000367858.3; ENSG00000072364.13. [Q9UHB7-2]"";",0,regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; spermatid development [GO:0007286],euchromatin [GO:0000791]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; super elongation complex [GO:0032783]; transcription elongation factor complex [GO:0008023]
Q9Y4W6,M2,-1.121661517,-1.409849402,0.395822596,1.196585423,-0.158212966,tan4,AFG3L2,AFG32_HUMAN,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),AFG3L2,10939;,ENST00000269143.8; ENSP00000269143.2; ENSG00000141385.12.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
P02771,C4,2.516894026,-0.191624578,-1.089101213,-1.027804649,-1.245929679,deepskyblue2,AFP,FETA_HUMAN,Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin),AFP HPAFP,174;,ENST00000395792.7; ENSP00000379138.2; ENSG00000081051.8.;,metal ion binding [GO:0046872]; small molecule binding [GO:0036094],ovulation from ovarian follicle [GO:0001542]; progesterone metabolic process [GO:0042448],cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]
P52594,C2,1.200071732,0.592745975,-0.129670915,-0.13953731,-0.90831035,aquamarine,AGFG1,AGFG1_HUMAN,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),AGFG1 HRB RAB RIP,3267;,"ENST00000310078.13; ENSP00000312059.7; ENSG00000173744.18. [P52594-1];""ENST00000373671.7; ENSP00000362775.3; ENSG00000173744.18. [P52594-2]"";""ENST00000409171.5; ENSP00000387218.1; ENSG00000173744.18. [P52594-3]"";""ENST00000409979.6; ENSP00000387282.2; ENSG00000173744.18. [P52594-4]"";",DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]
O95081,C1,1.493508255,0.114602817,-0.383992595,-0.377559502,-0.643338427,lightblue,AGFG2,AGFG2_HUMAN,Arf-GAP domain and FG repeat-containing protein 2 (HIV-1 Rev-binding protein-like protein) (Rev/Rex activation domain-binding protein related) (RAB-R),AGFG2 HRBL RABR,3268;,ENST00000300176.9; ENSP00000300176.4; ENSG00000106351.13. [O95081-1];,GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872],0,cytoplasm [GO:0005737]; membrane [GO:0016020]
Q8N302,N4,-0.927152381,1.012137282,-0.043498528,-0.318458144,-0.307678779,grey30,AGGF1,AGGF1_HUMAN,Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (hVG5Q) (G patch domain-containing protein 7) (Vasculogenesis gene on 5q protein),AGGF1 GPATC7 GPATCH7 VG5Q,55109;,"ENST00000312916.12; ENSP00000316109.7; ENSG00000164252.13. [Q8N302-1];""ENST00000506806.1; ENSP00000424733.1; ENSG00000164252.13. [Q8N302-3]"";",nucleic acid binding [GO:0003676],angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]
Q53H12,M2,-1.290837641,-1.514523307,0.455804542,1.195212147,-0.289569917,tan4,AGK,AGK_HUMAN,"Acylglycerol kinase, mitochondrial (hAGK) (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (HsMuLK) (MuLK) (Multi-substrate lipid kinase)",AGK MULK,55750;,"ENST00000492693.5; ENSP00000418789.1; ENSG00000006530.18. [Q53H12-2];""ENST00000575872.2; ENSP00000458417.2; ENSG00000262327.7."";""ENST00000648068.1; ENSP00000498112.1; ENSG00000006530.18. [Q53H12-1]"";""ENST00000649286.2; ENSP00000497280.1; ENSG00000006530.18. [Q53H12-1]"";""ENST00000650547.1; ENSP00000496789.1; ENSG00000006530.18. [Q53H12-1]"";",acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773],ceramide biosynthetic process [GO:0046513]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; protein insertion into mitochondrial inner membrane [GO:0045039],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]
Q9UKV8,N1,-0.185075286,0.359072996,-0.327075514,-0.150411315,0.818016268,grey90,AGO2,AGO2_HUMAN,Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer),AGO2 EIF2C2,27161;,"ENST00000220592.10; ENSP00000220592.5; ENSG00000123908.12. [Q9UKV8-1];""ENST00000519980.5; ENSP00000430176.1; ENSG00000123908.12. [Q9UKV8-2]"";","core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; translation initiation factor activity [GO:0003743]","miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]; translation [GO:0006412]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]
Q9NRZ7,S2,-1.214502336,-1.282449654,0.238016205,0.864256009,0.582040011,orange,AGPAT3,PLCC_HUMAN,1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma),AGPAT3 LPAAT3 UNQ759/PRO1490,56894;,"ENST00000291572.13; ENSP00000291572.8; ENSG00000160216.21. [Q9NRZ7-1];""ENST00000327505.6; ENSP00000332989.2; ENSG00000160216.21. [Q9NRZ7-1]"";""ENST00000398058.5; ENSP00000381135.1; ENSG00000160216.21. [Q9NRZ7-1]"";""ENST00000398061.5; ENSP00000381138.1; ENSG00000160216.21. [Q9NRZ7-1]"";""ENST00000398063.6; ENSP00000381140.2; ENSG00000160216.21. [Q9NRZ7-1]"";""ENST00000546158.1; ENSP00000443510.1; ENSG00000160216.21. [Q9NRZ7-1]"";",1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841],CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]
Q9NUQ2,M2,-1.394160771,-1.398560821,0.332150167,1.150353377,-0.122189136,tan4,AGPAT5,PLCE_HUMAN,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon),AGPAT5,55326;,"ENST00000285518.11; ENSP00000285518.6; ENSG00000155189.12.;""ENST00000646327.2; ENSP00000495562.1; ENSG00000284980.2."";",1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746],acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]
Q86UL3,S2,-1.521459691,-1.495683727,0.214100185,0.920180087,0.644768958,orange,AGPAT6,GPAT4_HUMAN,Glycerol-3-phosphate acyltransferase 4 (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7) (TSARG7),GPAT4 AGPAT6 TSARG7 UNQ551/PRO1108,137964;,ENST00000396987.7; ENSP00000380184.3; ENSG00000158669.11.;,1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420],acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q53EU6,S2,-1.34548185,-1.737836369,0.165312322,0.912507952,0.723830517,orange,AGPAT9,GPAT3_HUMAN,Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3) (hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta) (MAG-1),GPAT3 AGPAT9 MAG1 HMFN0839 UNQ2753/PRO6492,84803;,"ENST00000264409.5; ENSP00000264409.4; ENSG00000138678.11.;""ENST00000395226.6; ENSP00000378651.2; ENSG00000138678.11."";""ENST00000611707.4; ENSP00000482571.1; ENSG00000138678.11."";",1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420],CDP-diacylglycerol biosynthetic process [GO:0016024]; glycerol-3-phosphate metabolic process [GO:0006072]; phosphatidic acid biosynthetic process [GO:0006654]; regulation of TOR signaling [GO:0032006]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
O00468,S3,-1.075945116,-0.524684762,0.128114009,0.635167402,0.7299102,salmon,AGRN,AGRIN_HUMAN,Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)],AGRN AGRIN,375790;,ENST00000379370.7; ENSP00000368678.2; ENSG00000188157.15. [O00468-6];,calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200],clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]
Q8WYP5,N3,-1.339826279,-1.44107748,1.287660958,0.248617395,-0.227197287,grey50,AHCTF1,ELYS_HUMAN,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),AHCTF1 ELYS TMBS62 MSTP108,25909;,"ENST00000326225.3; ENSP00000355465.1; ENSG00000153207.16. [Q8WYP5-3];""ENST00000366508.5; ENSP00000355464.1; ENSG00000153207.16. [Q8WYP5-2]"";""ENST00000648844.2; ENSP00000497061.2; ENSG00000153207.16. [Q8WYP5-1]"";",DNA binding [GO:0003677],cell division [GO:0051301]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P23526,C5,1.95110982,0.52571884,-0.876143009,-1.010015468,-1.07421381,turquoise3,AHCY,SAHH_HUMAN,Adenosylhomocysteinase (AdoHcyase) (EC 3.13.2.1) (S-adenosyl-L-homocysteine hydrolase),AHCY SAHH,191;,"ENST00000217426.7; ENSP00000217426.2; ENSG00000101444.13. [P23526-1];""ENST00000538132.1; ENSP00000442820.1; ENSG00000101444.13. [P23526-2]"";",adenosylhomocysteinase activity [GO:0004013],one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; nucleus [GO:0005634]
O43865,C3,1.606074817,0.170111485,-0.569860673,-0.468965026,-0.865773982,cyan,AHCYL1,SAHH2_HUMAN,S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3)) (IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2) (AdoHcyase 2),AHCYL1 DCAL IRBIT XPVKONA,10768;,"ENST00000359172.3; ENSP00000352092.3; ENSG00000168710.18. [O43865-2];""ENST00000369799.10; ENSP00000358814.5; ENSG00000168710.18. [O43865-1]"";""ENST00000393614.8; ENSP00000377238.4; ENSG00000168710.18. [O43865-2]"";",enzyme regulator activity [GO:0030234]; identical protein binding [GO:0042802]; RNA binding [GO:0003723],angiotensin-activated signaling pathway [GO:0038166]; apoptotic process [GO:0006915]; epithelial fluid transport [GO:0042045]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of monoatomic anion transport [GO:0044070]; regulation of monoatomic ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]
Q96HN2,C1,1.384066425,0.146090858,-0.400008121,-0.282892132,-0.585063801,lightblue,AHCYL2,SAHH3_HUMAN,Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.13.2.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2),AHCYL2 KIAA0828,23382;,"ENST00000325006.8; ENSP00000315931.3; ENSG00000158467.17. [Q96HN2-1];""ENST00000446544.6; ENSP00000413639.2; ENSG00000158467.17. [Q96HN2-2]"";""ENST00000474594.5; ENSP00000420459.1; ENSG00000158467.17. [Q96HN2-4]"";""ENST00000490911.5; ENSP00000420801.1; ENSG00000158467.17. [Q96HN2-3]"";",hydrolase activity [GO:0016787],one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]
Q5TGY3,N1,-1.091597191,-0.892480608,0.595499302,0.001375774,0.894530707,grey90,AHDC1,AHDC1_HUMAN,Transcription factor Gibbin (AT-hook DNA-binding motif-containing protein 1),AHDC1,27245;,"ENST00000247087.10; ENSP00000247087.4; ENSG00000126705.15.;""ENST00000374011.6; ENSP00000363123.2; ENSG00000126705.15."";""ENST00000642245.1; ENSP00000495072.1; ENSG00000126705.15."";""ENST00000642416.1; ENSP00000494394.1; ENSG00000126705.15."";""ENST00000644989.1; ENSP00000495665.1; ENSG00000126705.15."";""ENST00000673934.1; ENSP00000501218.1; ENSG00000126705.15."";",DNA-binding transcription factor activity [GO:0003700]; promoter-enhancer loop anchoring activity [GO:0140585],cell differentiation [GO:0030154]; mesoderm formation [GO:0001707]; skin morphogenesis [GO:0043589],chromosome [GO:0005694]; nucleus [GO:0005634]
O95433,C3,1.782290492,-0.051387975,-0.533187998,-0.417804048,-0.681357038,cyan,AHSA1,AHSA1_HUMAN,Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38),AHSA1 C14orf3 HSPC322,10598;,"ENST00000216479.8; ENSP00000216479.3; ENSG00000100591.8. [O95433-1];""ENST00000535854.6; ENSP00000440108.2; ENSG00000100591.8. [O95433-2]"";",ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879]; protein-folding chaperone binding [GO:0051087],positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]
O95831,M2,-1.186858435,-0.797730497,0.334129148,1.135740202,-0.375384932,tan4,AIFM1,AIFM1_HUMAN,"Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)",AIFM1 AIF PDCD8,9131;,"ENST00000287295.8; ENSP00000287295.3; ENSG00000156709.15. [O95831-1];""ENST00000346424.6; ENSP00000316320.3; ENSG00000156709.15. [O95831-2]"";""ENST00000527892.5; ENSP00000435955.1; ENSG00000156709.15. [O95831-6]"";""ENST00000535724.6; ENSP00000446113.2; ENSG00000156709.15. [O95831-4]"";""ENST00000674997.1; ENSP00000502124.1; ENSG00000156709.15. [O95831-6]"";""ENST00000675050.1; ENSP00000502606.1; ENSG00000156709.15. [O95831-3]"";""ENST00000675774.1; ENSP00000502690.1; ENSG00000156709.15. [O95831-6]"";""ENST00000676229.1; ENSP00000502184.1; ENSG00000156709.15. [O95831-3]"";","DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; poly-ADP-D-ribose binding [GO:0072572]; protein dimerization activity [GO:0046983]",activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nitric oxide [GO:0071732]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; protein import into mitochondrial intermembrane space [GO:0045041]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
O00170,C3,1.487756,0.348025281,-0.475904092,-0.452632085,-0.567089771,cyan,AIP,AIP_HUMAN,AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9),AIP XAP2,9049;,ENST00000279146.8; ENSP00000279146.3; ENSG00000110711.11.;,aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082],protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
Q96IF1,C2,1.366460755,0.261219386,-0.282155443,-0.155682582,-0.605087716,aquamarine,AJUBA,AJUBA_HUMAN,LIM domain-containing protein ajuba,AJUBA JUB,84962;,"ENST00000262713.7; ENSP00000262713.2; ENSG00000129474.17. [Q96IF1-1];""ENST00000397388.7; ENSP00000380543.3; ENSG00000129474.17. [Q96IF1-2]"";",actin filament binding [GO:0051015]; alpha-catenin binding [GO:0045294]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; transcription corepressor activity [GO:0003714],"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; glycerophospholipid biosynthetic process [GO:0046474]; lamellipodium assembly [GO:0030032]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of hippo signaling [GO:0035331]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of cellular response to hypoxia [GO:1900037]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666]; wound healing, spreading of epidermal cells [GO:0035313]",adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; transcription regulator complex [GO:0005667]
P00568,C4,2.114457251,0.375283444,-0.982394959,-1.103028749,-1.330448146,deepskyblue2,AK1,KAD1_HUMAN,Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.10) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase),AK1,203;,"ENST00000373156.5; ENSP00000362249.1; ENSG00000106992.19.;""ENST00000644144.2; ENSP00000494600.1; ENSG00000106992.19."";",adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside triphosphate adenylate kinase activity [GO:0046899],ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside triphosphate biosynthetic process [GO:0009142],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; outer dense fiber [GO:0001520]
P54819,N4,-0.604387139,0.875896993,0.045618523,0.218277256,-0.901861368,grey30,AK2,KAD2_HUMAN,"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]",AK2 ADK2,204;,"ENST00000373449.7; ENSP00000362548.2; ENSG00000004455.18. [P54819-2];""ENST00000672715.1; ENSP00000499935.1; ENSG00000004455.18. [P54819-1]"";",adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524],ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; nucleobase-containing small molecule interconversion [GO:0015949],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; sperm mitochondrial sheath [GO:0097226]
Q92667,M2,-0.98626211,-1.083495919,0.300695053,1.087145903,0.098815197,tan4,AKAP1,AKAP1_HUMAN,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",AKAP1 AKAP149 PRKA1,8165;,"ENST00000314126.4; ENSP00000314075.3; ENSG00000121057.13. [Q92667-2];""ENST00000337714.8; ENSP00000337736.3; ENSG00000121057.13. [Q92667-1]"";""ENST00000481416.5; ENSP00000433212.1; ENSG00000121057.13. [Q92667-2]"";""ENST00000539273.5; ENSP00000443139.1; ENSG00000121057.13. [Q92667-1]"";""ENST00000571629.5; ENSP00000459968.1; ENSG00000121057.13. [Q92667-1]"";""ENST00000572557.5; ENSP00000459895.1; ENSG00000121057.13. [Q92667-1]"";""ENST00000621116.4; ENSP00000478212.1; ENSG00000121057.13. [Q92667-1]"";",protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723],antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q02952,C2,1.021948167,0.313913498,-0.429818375,-0.01511478,-0.033618679,aquamarine,AKAP12,AKA12_HUMAN,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),AKAP12 AKAP250,9590;,"ENST00000253332.5; ENSP00000253332.1; ENSG00000131016.17. [Q02952-1];""ENST00000354675.10; ENSP00000346702.6; ENSG00000131016.17. [Q02952-2]"";""ENST00000359755.5; ENSP00000352794.5; ENSG00000131016.17. [Q02952-3]"";""ENST00000402676.7; ENSP00000384537.2; ENSG00000131016.17. [Q02952-1]"";",adenylate cyclase binding [GO:0008179]; calmodulin binding [GO:0005516]; protein kinase A binding [GO:0051018],adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatic stellate cell activation [GO:0035733]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of vascular permeability [GO:0043116]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hepatic stellate cell migration [GO:0061870]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of oligodendrocyte apoptotic process [GO:1900143]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of protein kinase A signaling [GO:0010738]; regulation of protein kinase C signaling [GO:0090036]; response to electrical stimulus [GO:0051602]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]
Q02040,N3,-1.011721987,-0.681250514,0.817563812,0.025519241,0.497230895,grey50,AKAP17A,AK17A_HUMAN,"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)",AKAP17A CXYorf3 DXYS155E SFRS17A XE7,8227;,"ENST00000313871.9; ENSP00000324827.3; ENSG00000197976.12. [Q02040-1];""ENST00000474361.6; ENSP00000435479.1; ENSG00000197976.12. [Q02040-2]"";""ENST00000711132.1; ENSP00000518597.1; ENSG00000292343.1. [Q02040-1]"";""ENST00000711186.1; ENSP00000518596.1; ENSG00000292343.1. [Q02040-2]"";",protein kinase A binding [GO:0051018]; RNA binding [GO:0003723],B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]
Q9ULX6,N4,-1.205556297,0.509363209,0.245175507,0.035080978,0.439923089,grey30,AKAP8L,AKP8L_HUMAN,A-kinase anchor protein 8-like (AKAP8-like protein) (Helicase A-binding protein 95) (HAP95) (Homologous to AKAP95 protein) (HA95) (Neighbor of A-kinase-anchoring protein 95) (Neighbor of AKAP95),AKAP8L NAKAP NAKAP95 HRIHFB2018,26993;,"ENST00000397410.10; ENSP00000380557.3; ENSG00000011243.19. [Q9ULX6-1];""ENST00000595465.6; ENSP00000470952.1; ENSG00000011243.19. [Q9ULX6-2]"";",DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723],cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear membrane disassembly [GO:0051081]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mRNA export from nucleus [GO:0010793]; RNA splicing [GO:0008380],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904]
P14550,C5,1.920810282,0.381114216,-0.821379008,-0.827803107,-1.078854552,turquoise3,AKR1A1,AK1A1_HUMAN,Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-),AKR1A1 ALDR1 ALR,10327;,"ENST00000351829.9; ENSP00000312606.4; ENSG00000117448.14.;""ENST00000372070.7; ENSP00000361140.3; ENSG00000117448.14."";""ENST00000621846.4; ENSP00000480713.1; ENSG00000117448.14."";",aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; glycerol dehydrogenase [NADP+] activity [GO:0047956]; L-glucuronate reductase activity [GO:0047939]; methylglyoxal reductase (NADPH) (acetol producing) activity [GO:1990002]; S-nitrosoglutathione reductase (NADH) activity [GO:0080007]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163],aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid biosynthetic process [GO:0019853]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; synapse [GO:0045202]
P31749,C1,1.905513214,-0.036364927,-0.649598675,-0.456351074,-0.738328769,lightblue,AKT1,AKT1_HUMAN,RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha),AKT1 PKB RAC,207;,"ENST00000349310.7; ENSP00000270202.4; ENSG00000142208.18. [P31749-1];""ENST00000402615.6; ENSP00000385326.2; ENSG00000142208.18. [P31749-1]"";""ENST00000407796.7; ENSP00000384293.2; ENSG00000142208.18. [P31749-1]"";""ENST00000554581.5; ENSP00000451828.1; ENSG00000142208.18. [P31749-1]"";""ENST00000554848.5; ENSP00000451166.1; ENSG00000142208.18. [P31749-1]"";""ENST00000555528.5; ENSP00000450688.1; ENSG00000142208.18. [P31749-1]"";""ENST00000649815.2; ENSP00000497822.1; ENSG00000142208.18. [P31749-1]"";""ENST00000683722.1; ENSP00000507879.1; ENSG00000142208.18. [P31749-1]"";","14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; potassium channel activator activity [GO:0099104]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein serine/threonine/tyrosine kinase activity [GO:0004712]",activation-induced cell death of T cells [GO:0006924]; anoikis [GO:0043276]; apoptotic mitochondrial changes [GO:0008637]; behavioral response to pain [GO:0048266]; canonical NF-kappaB signal transduction [GO:0007249]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell population proliferation [GO:0008283]; cellular response to cadmium ion [GO:0071276]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptide [GO:1901653]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of protein localization to mitochondrion [GO:0072655]; excitatory postsynaptic potential [GO:0060079]; execution phase of apoptosis [GO:0097194]; fibroblast migration [GO:0010761]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen cell differentiation involved in embryonic placenta development [GO:0060709]; inflammatory response [GO:0006954]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; maintenance of protein location in mitochondrion [GO:0072656]; mammalian oogenesis stage [GO:0022605]; mammary gland epithelial cell differentiation [GO:0060644]; maternal placenta development [GO:0001893]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cilium assembly [GO:1902018]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fatty acid beta-oxidation [GO:0031999]; negative regulation of gene expression [GO:0010629]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of lymphocyte migration [GO:2000402]; negative regulation of macroautophagy [GO:0016242]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein binding [GO:0032091]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein localization to lysosome [GO:0150033]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nitric oxide biosynthetic process [GO:0006809]; non-canonical NF-kappaB signal transduction [GO:0038061]; osteoblast differentiation [GO:0001649]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peripheral nervous system myelin maintenance [GO:0032287]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of mRNA stability [GO:0043488]; regulation of myelination [GO:0031641]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of translation [GO:0006417]; regulation of tRNA methylation [GO:0110002]; regulation of type B pancreatic cell development [GO:2000074]; response to fluid shear stress [GO:0034405]; response to food [GO:0032094]; response to growth factor [GO:0070848]; response to growth hormone [GO:0060416]; response to heat [GO:0009408]; response to insulin-like growth factor stimulus [GO:1990418]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; signal transduction [GO:0007165]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; striated muscle cell differentiation [GO:0051146]; T cell costimulation [GO:0031295]; TOR signaling [GO:0031929]; virus-mediated perturbation of host defense response [GO:0019049],cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; vesicle [GO:0031982]
P31751,C1,1.59553877,0.105384731,-0.567392509,-0.339684979,-0.59396028,lightblue,AKT2,AKT2_HUMAN,RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC protein kinase beta) (RAC-PK-beta),AKT2,208;,"ENST00000311278.10; ENSP00000309428.6; ENSG00000105221.18. [P31751-2];""ENST00000392038.7; ENSP00000375892.2; ENSG00000105221.18. [P31751-1]"";""ENST00000424901.5; ENSP00000399532.2; ENSG00000105221.18. [P31751-2]"";",ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],cellular response to high light intensity [GO:0071486]; cellular response to insulin stimulus [GO:0032869]; fat cell differentiation [GO:0045444]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; organic substance transport [GO:0071702]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of cell migration [GO:0030335]; positive regulation of cell motility [GO:2000147]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to plasma membrane [GO:0072659]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of translation [GO:0006417]; retinal rod cell apoptotic process [GO:0097473]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]
Q9H8T0,C1,1.556105043,0.387862886,-0.430555075,-0.354666522,-0.487128144,lightblue,AKTIP,AKTIP_HUMAN,AKT-interacting protein (Ft1) (Fused toes protein homolog),AKTIP FTS,64400;,"ENST00000300245.8; ENSP00000300245.4; ENSG00000166971.17. [Q9H8T0-2];""ENST00000394657.12; ENSP00000378152.6; ENSG00000166971.17. [Q9H8T0-1]"";""ENST00000570004.5; ENSP00000455874.1; ENSG00000166971.17. [Q9H8T0-1]"";",NEDD8 transferase activity [GO:0019788],apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein neddylation [GO:0045116]; protein transport [GO:0015031],FHF complex [GO:0070695]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q13740,S4,-1.227263178,-1.430490501,0.699070611,0.91674411,-0.081487205,tomato2,ALCAM,CD166_HUMAN,CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166),ALCAM MEMD,214;,"ENST00000306107.9; ENSP00000305988.5; ENSG00000170017.12. [Q13740-1];""ENST00000472644.6; ENSP00000419236.2; ENSG00000170017.12. [Q13740-2]"";",identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102],adaptive immune response [GO:0002250]; axon extension involved in axon guidance [GO:0048846]; cell adhesion [GO:0007155]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; motor neuron axon guidance [GO:0008045]; neuron projection extension [GO:1990138]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]
P47895,C4,2.050905912,-0.017569794,-1.253164962,-1.282394887,-1.305834928,deepskyblue2,ALDH1A3,AL1A3_HUMAN,Retinaldehyde dehydrogenase 3 (RALDH-3) (RalDH3) (EC 1.2.1.36) (Aldehyde dehydrogenase 6) (Aldehyde dehydrogenase family 1 member A3) (ALDH1A3),ALDH1A3 ALDH6,220;,ENST00000329841.10; ENSP00000332256.5; ENSG00000184254.17.;,aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324],apoptotic process [GO:0006915]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P51648,S2,-1.12814215,-1.506074514,0.215164059,0.861000055,0.659641153,orange,ALDH3A2,AL3A2_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 10) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase),ALDH3A2 ALDH10 FALDH,224;,"ENST00000176643.11; ENSP00000176643.6; ENSG00000072210.19. [P51648-1];""ENST00000339618.8; ENSP00000345774.4; ENSG00000072210.19. [P51648-2]"";""ENST00000579855.5; ENSP00000463637.1; ENSG00000072210.19. [P51648-1]"";""ENST00000581518.6; ENSP00000461916.2; ENSG00000072210.19. [P51648-1]"";""ENST00000672357.1; ENSP00000500092.1; ENSG00000072210.19. [P51648-1]"";",3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803],cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
P49189,C1,1.232924047,0.320189371,-0.172713458,0.105148693,-0.993067593,lightblue,ALDH9A1,AL9A1_HUMAN,"4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH) (TMABALDH) (EC 1.2.1.47) (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3) (Formaldehyde dehydrogenase) (EC 1.2.1.46) (Gamma-aminobutyraldehyde dehydrogenase) (EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed]",ALDH9A1 ALDH4 ALDH7 ALDH9,223;,ENST00000354775.5; ENSP00000346827.4; ENSG00000143149.13. [P49189-3];,1-pyrroline dehydrogenase activity [GO:0033737]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; formaldehyde dehydrogenase activity [GO:0018467]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; small molecule binding [GO:0036094],carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P04075,C4,2.188235324,0.080622202,-1.195728349,-1.232232482,-1.36253999,deepskyblue2,ALDOA,ALDOA_HUMAN,Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase),ALDOA ALDA,226;,"ENST00000412304.6; ENSP00000400452.2; ENSG00000149925.22. [P04075-1];""ENST00000563060.6; ENSP00000455800.2; ENSG00000149925.22. [P04075-1]"";""ENST00000569545.5; ENSP00000455700.1; ENSG00000149925.22. [P04075-1]"";""ENST00000642816.3; ENSP00000496166.1; ENSG00000149925.22. [P04075-2]"";""ENST00000643777.4; ENSP00000494188.2; ENSG00000149925.22. [P04075-1]"";",actin binding [GO:0003779]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tubulin binding [GO:0015631],"actin filament organization [GO:0007015]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]",actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; sperm head [GO:0061827]; tertiary granule lumen [GO:1904724]
Q9BT22,S2,-0.966978054,-1.227202446,0.255291873,0.678854443,0.487197102,orange,ALG1,ALG1_HUMAN,"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1)",ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870,56052;,"ENST00000262374.10; ENSP00000262374.5; ENSG00000033011.14. [Q9BT22-1];""ENST00000544428.1; ENSP00000440019.1; ENSG00000033011.14. [Q9BT22-2]"";""ENST00000588623.5; ENSP00000468118.1; ENSG00000033011.14. [Q9BT22-2]"";""ENST00000683739.1; ENSP00000507002.1; ENSG00000033011.14. [Q9BT22-2]"";",chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; mannosyltransferase activity [GO:0000030],dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q2TAA5,S2,-1.135611868,-1.593365872,0.242105137,0.775824434,0.709680679,orange,ALG11,ALG11_HUMAN,"GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (EC 2.4.1.131) (Asparagine-linked glycosylation protein 11 homolog) (Glycolipid 2-alpha-mannosyltransferase)",ALG11 GT8,440138;,ENST00000521508.2; ENSP00000430236.1; ENSG00000253710.5.;,"alpha-1,2-mannosyltransferase activity [GO:0000026]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]",dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q96F25,S4,-0.633443811,-1.280440753,0.48561882,0.722573291,0.529725298,tomato2,ALG14,ALG14_HUMAN,UDP-N-acetylglucosamine transferase subunit ALG14 (Asparagine-linked glycosylation 14 homolog),ALG14,199857;,ENST00000370205.6; ENSP00000359224.4; ENSG00000172339.10.;,protein-membrane adaptor activity [GO:0043495],dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum membrane [GO:0005789]; UDP-N-acetylglucosamine transferase complex [GO:0043541]
Q92685,S2,-1.272124806,-1.601857925,0.211204691,0.915243616,0.507808701,orange,ALG3,ALG3_HUMAN,"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)",ALG3 NOT NOT56L,10195;,"ENST00000397676.8; ENSP00000380793.3; ENSG00000214160.10. [Q92685-1];""ENST00000445626.6; ENSP00000402744.2; ENSG00000214160.10. [Q92685-2]"";","alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]",dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]
Q9Y673,S2,-1.454910224,-1.601411989,0.284597623,0.973144731,0.550116561,orange,ALG5,ALG5_HUMAN,Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog),ALG5 HSPC149,29880;,"ENST00000239891.4; ENSP00000239891.3; ENSG00000120697.10. [Q9Y673-1];""ENST00000443765.6; ENSP00000390533.1; ENSG00000120697.10. [Q9Y673-2]"";",dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581],determination of left/right symmetry [GO:0007368]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9Y672,S2,-1.405178011,-1.70347253,0.305446726,0.9998868,0.401788162,orange,ALG6,ALG6_HUMAN,"Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)",ALG6 My046,29929;,ENST00000263440.6; ENSP00000263440.5; ENSG00000088035.18.;,"dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042281]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]; glucosyltransferase activity [GO:0046527]",dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; oligosaccharide-lipid intermediate biosynthetic process [GO:0006490]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]
Q96Q83,C5,1.522803929,0.440639151,-0.425785218,-0.484453898,-0.747381165,turquoise3,ALKBH3,ALKB3_HUMAN,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (EC 1.14.11.33) (EC 1.14.11.54) (Alkylated DNA repair protein alkB homolog 3) (hABH3) (DEPC-1) (Prostate cancer antigen 1),ALKBH3 ABH3 DEPC1,221120;,"ENST00000302708.9; ENSP00000302232.4; ENSG00000166199.13. [Q96Q83-1];""ENST00000530803.5; ENSP00000436788.1; ENSG00000166199.13. [Q96Q83-2]"";",broad specificity oxidative DNA demethylase activity [GO:0035516]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; mRNA N1-methyladenosine dioxygenase activity [GO:1990930]; oxidative RNA demethylase activity [GO:0035515],cell population proliferation [GO:0008283]; DNA alkylation repair [GO:0006307]; negative regulation of cytoplasmic translation [GO:2000766],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q3KRA9,C1,1.400577221,0.234119006,-0.323891769,-0.106821422,-0.485613571,lightblue,ALKBH6,ALKB6_HUMAN,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6),ALKBH6 ABH6,84964;,"ENST00000252984.11; ENSP00000252984.6; ENSG00000239382.11. [Q3KRA9-1];""ENST00000378875.8; ENSP00000368152.4; ENSG00000239382.11. [Q3KRA9-1]"";",dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],0,cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96BT7,C3,1.92307095,0.033116774,-0.667330544,-0.67173139,-0.716561197,cyan,ALKBH8,ALKB8_HUMAN,Alkylated DNA repair protein alkB homolog 8 (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.229),ALKBH8 ABH8,91801;,"ENST00000260318.6; ENSP00000260318.2; ENSG00000137760.15. [Q96BT7-2];""ENST00000389568.7; ENSP00000374219.3; ENSG00000137760.15. [Q96BT7-1]"";""ENST00000417449.6; ENSP00000397673.3; ENSG00000137760.15. [Q96BT7-1]"";""ENST00000428149.7; ENSP00000415885.2; ENSG00000137760.15. [Q96BT7-1]"";""ENST00000429370.5; ENSP00000391225.1; ENSG00000137760.15. [Q96BT7-3]"";",2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; tRNA (5-carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA (uridine) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],DNA damage response [GO:0006974]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y303,C5,1.938496867,0.312931217,-0.970559858,-0.886633071,-1.081328751,turquoise3,AMDHD2,NAGA_HUMAN,N-acetylglucosamine-6-phosphate deacetylase (GlcNAc 6-P deacetylase) (EC 3.5.1.25) (Amidohydrolase domain-containing protein 2),AMDHD2 CGI-14,51005;,"ENST00000293971.11; ENSP00000293971.6; ENSG00000162066.16. [Q9Y303-1];""ENST00000302956.8; ENSP00000307481.4; ENSG00000162066.16. [Q9Y303-2]"";""ENST00000413459.7; ENSP00000391596.3; ENSG00000162066.16. [Q9Y303-3]"";",metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448],N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],cytosol [GO:0005829]; nucleus [GO:0005634]
Q9UKV5,S3,-0.541506931,-1.022585811,0.079287226,0.730718403,0.550379472,salmon,AMFR,AMFR_HUMAN,E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (gp78),AMFR RNF45,267;,ENST00000290649.10; ENSP00000290649.5; ENSG00000159461.15.;,BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-folding chaperone binding [GO:0051087]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; ubiquitin-ubiquitin ligase activity [GO:0034450],endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; learning or memory [GO:0007611]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical NF-kappaB signal transduction [GO:0038061]; protein autoubiquitination [GO:0051865]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of SREBP signaling pathway [GO:2000638]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; dendrite [GO:0030425]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]
Q86SJ2,S2,-0.985538788,-1.155688065,0.321447598,0.940346119,0.665224048,orange,AMIGO2,AMGO2_HUMAN,Amphoterin-induced protein 2 (AMIGO-2) (Alivin-1) (Differentially expressed in gastric adenocarcinomas) (DEGA),AMIGO2 ALI1,347902;,"ENST00000266581.4; ENSP00000266581.4; ENSG00000139211.7.;""ENST00000429635.1; ENSP00000406020.1; ENSG00000139211.7."";""ENST00000550413.2; ENSP00000449034.1; ENSG00000139211.7."";",0,brain development [GO:0007420]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of programmed cell death [GO:0043069]; positive regulation of synapse assembly [GO:0051965],membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9Y2J4,C2,0.917937524,0.346786427,-0.067394649,0.158115517,-0.531607386,aquamarine,AMOTL2,AMOL2_HUMAN,Angiomotin-like protein 2 (Leman coiled-coil protein) (LCCP),AMOTL2 KIAA0989,51421;,"ENST00000249883.10; ENSP00000249883.5; ENSG00000114019.15. [Q9Y2J4-2];""ENST00000422605.6; ENSP00000409999.2; ENSG00000114019.15. [Q9Y2J4-1]"";""ENST00000513145.1; ENSP00000425475.1; ENSG00000114019.15. [Q9Y2J4-3]"";""ENST00000514516.5; ENSP00000424765.1; ENSG00000114019.15. [Q9Y2J4-4]"";",0,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; establishment of cell polarity involved in ameboidal cell migration [GO:0003365]; hippo signaling [GO:0035329]; regulation of cell migration [GO:0030334]; Wnt signaling pathway [GO:0016055],bicellular tight junction [GO:0005923]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]
Q01433,C4,1.858791388,0.407210129,-0.812501668,-0.878785115,-1.021360938,deepskyblue2,AMPD2,AMPD2_HUMAN,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),AMPD2,271;,"ENST00000256578.8; ENSP00000256578.4; ENSG00000116337.20. [Q01433-1];""ENST00000342115.8; ENSP00000345498.4; ENSG00000116337.20. [Q01433-2]"";""ENST00000528454.5; ENSP00000437164.1; ENSG00000116337.20. [Q01433-5]"";""ENST00000528667.7; ENSP00000436541.2; ENSG00000116337.20. [Q01433-1]"";""ENST00000531203.6; ENSP00000431975.2; ENSG00000116337.20. [Q01433-5]"";""ENST00000531734.6; ENSP00000433739.2; ENSG00000116337.20. [Q01433-2]"";",AMP deaminase activity [GO:0003876]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872],AMP metabolic process [GO:0046033]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264],cytosol [GO:0005829]
Q9UNK9,S1,-0.997461332,-1.190568758,-0.002316324,0.795902262,0.895948817,gold,ANGEL1,ANGE1_HUMAN,Protein angel homolog 1,ANGEL1 KIAA0759,23357;,ENST00000251089.8; ENSP00000251089.3; ENSG00000013523.11.;,3'-5'-RNA exonuclease activity [GO:0000175]; eukaryotic initiation factor 4E binding [GO:0008190]; protein domain specific binding [GO:0019904],0,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q86XL3,S3,-0.373009726,-0.911209671,0.091742734,0.745014751,0.52707896,salmon,ANKLE2,ANKL2_HUMAN,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),ANKLE2 KIAA0692 LEM4,23141;,"ENST00000357997.10; ENSP00000350686.5; ENSG00000176915.15. [Q86XL3-1];""ENST00000542282.5; ENSP00000437807.1; ENSG00000176915.15. [Q86XL3-3]"";""ENST00000542657.5; ENSP00000438551.1; ENSG00000176915.15. [Q86XL3-3]"";",protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888],cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of catalytic activity [GO:0050790],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q8IV38,C1,1.82624116,-0.146016114,-0.766671616,-0.183067689,-0.562449231,lightblue,ANKMY2,ANKY2_HUMAN,Ankyrin repeat and MYND domain-containing protein 2,ANKMY2,57037;,ENST00000306999.7; ENSP00000303570.2; ENSG00000106524.9.;,enzyme binding [GO:0019899]; metal ion binding [GO:0046872],0,cilium [GO:0005929]
Q6UB98,N4,-0.880646537,0.710907344,0.404913927,-0.318386947,0.134395315,grey30,ANKRD12,ANR12_HUMAN,Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein),ANKRD12 ANCO2 KIAA0874,23253;,"ENST00000262126.9; ENSP00000262126.3; ENSG00000101745.17. [Q6UB98-1];""ENST00000400020.7; ENSP00000382897.3; ENSG00000101745.17. [Q6UB98-2]"";",0,0,cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q86W74,S2,-0.836504975,-1.278965442,0.287809726,0.674280675,0.603060581,orange,ANKRD46,ANR46_HUMAN,Ankyrin repeat domain-containing protein 46 (Ankyrin repeat small protein) (ANK-S),ANKRD46,157567;,"ENST00000335659.7; ENSP00000335287.3; ENSG00000186106.11. [Q86W74-2];""ENST00000519597.5; ENSP00000430056.1; ENSG00000186106.11. [Q86W74-2]"";""ENST00000520311.5; ENSP00000428388.1; ENSG00000186106.11. [Q86W74-2]"";""ENST00000520552.5; ENSP00000429015.1; ENSG00000186106.11. [Q86W74-1]"";",0,0,membrane [GO:0016020]
Q6NXT1,C5,1.464204904,0.783762498,-0.395062367,-0.490882973,-0.872847631,turquoise3,ANKRD54,ANR54_HUMAN,Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein),ANKRD54 LIAR,129138;,ENST00000215941.9; ENSP00000215941.4; ENSG00000100124.15. [Q6NXT1-1];,protein kinase regulator activity [GO:0019887]; protein-containing complex binding [GO:0044877],nucleocytoplasmic transport [GO:0006913]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of intracellular signal transduction [GO:1902531],cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634]
Q92625,C4,1.846352538,-0.1533488,-0.652461303,-0.515862439,-0.820480828,deepskyblue2,ANKS1A,ANS1A_HUMAN,Ankyrin repeat and SAM domain-containing protein 1A (Odin),ANKS1A ANKS1 KIAA0229 ODIN,23294;,ENST00000360359.5; ENSP00000353518.3; ENSG00000064999.16. [Q92625-1];,ephrin receptor binding [GO:0046875],ephrin receptor signaling pathway [GO:0048013]; neuron remodeling [GO:0016322]; substrate-dependent cell migration [GO:0006929],cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]
Q9NW15,S2,-1.547771732,-1.454851331,0.136534856,0.895849446,0.717611481,orange,ANO10,ANO10_HUMAN,Anoctamin-10 (Transmembrane protein 16K),ANO10 TMEM16K,55129;,"ENST00000292246.8; ENSP00000292246.3; ENSG00000160746.13. [Q9NW15-1];""ENST00000350459.8; ENSP00000327767.4; ENSG00000160746.13. [Q9NW15-2]"";""ENST00000396091.7; ENSP00000379398.3; ENSG00000160746.13. [Q9NW15-3]"";""ENST00000414522.6; ENSP00000396990.2; ENSG00000160746.13. [Q9NW15-5]"";""ENST00000451430.6; ENSP00000394119.2; ENSG00000160746.13. [Q9NW15-4]"";",calcium-activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229],chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q4KMQ2,S2,-1.119169329,-1.487414346,0.370913876,0.764405737,0.608160123,orange,ANO6,ANO6_HUMAN,Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F),ANO6 TMEM16F,196527;,"ENST00000320560.13; ENSP00000320087.8; ENSG00000177119.17. [Q4KMQ2-1];""ENST00000423947.7; ENSP00000409126.3; ENSG00000177119.17. [Q4KMQ2-2]"";""ENST00000425752.6; ENSP00000391417.2; ENSG00000177119.17. [Q4KMQ2-4]"";""ENST00000441606.2; ENSP00000413137.2; ENSG00000177119.17. [Q4KMQ2-3]"";""ENST00000680201.1; ENSP00000506222.1; ENSG00000177119.17. [Q4KMQ2-1]"";",calcium-activated cation channel activity [GO:0005227]; chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; metal ion binding [GO:0046872]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated monoatomic ion channel activity [GO:0005244],"activation of blood coagulation via clotting cascade [GO:0002543]; bleb assembly [GO:0032060]; blood coagulation [GO:0007596]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; calcium ion transmembrane transport [GO:0070588]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cell volume [GO:0045794]; phosphatidylserine exposure on blood platelet [GO:0097045]; plasma membrane phospholipid scrambling [GO:0017121]; pore complex assembly [GO:0046931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of monoatomic ion transmembrane transport [GO:0034767]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; purinergic nucleotide receptor signaling pathway [GO:0035590]; sodium ion transmembrane transport [GO:0035725]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]
Q9HCE9,S2,-1.115321185,-1.267819233,0.101611927,0.856838403,0.514118952,orange,ANO8,ANO8_HUMAN,Anoctamin-8 (Transmembrane protein 16H),ANO8 KIAA1623 TMEM16H,57719;,ENST00000159087.7; ENSP00000159087.4; ENSG00000074855.11. [Q9HCE9-1];,chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229],chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]
P04083,C4,1.932275775,0.421420041,-1.088166714,-1.165036098,-1.463069223,deepskyblue2,ANXA1,ANXA1_HUMAN,Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35) [Cleaved into: Annexin Ac2-26],ANXA1 ANX1 LPC1,301;,"ENST00000257497.11; ENSP00000257497.6; ENSG00000135046.14.;""ENST00000376911.1; ENSP00000366109.1; ENSG00000135046.14."";",cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; lipid binding [GO:0008289]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102],"actin cytoskeleton organization [GO:0030036]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil activation [GO:0042119]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; signal transduction [GO:0007165]",adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]
P50995,C3,1.731304924,0.279964741,-0.542413562,-0.621271187,-0.795616446,cyan,ANXA11,ANX11_HUMAN,Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50),ANXA11 ANX11,311;,"ENST00000265447.8; ENSP00000265447.5; ENSG00000122359.18. [P50995-2];""ENST00000372231.7; ENSP00000361305.3; ENSG00000122359.18. [P50995-1]"";""ENST00000422982.8; ENSP00000404412.2; ENSG00000122359.18. [P50995-1]"";""ENST00000438331.5; ENSP00000398610.1; ENSG00000122359.18. [P50995-1]"";",calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; MHC class II protein complex binding [GO:0023026]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548],cytokinetic process [GO:0032506]; phagocytosis [GO:0006909]; response to calcium ion [GO:0051592],azurophil granule [GO:0042582]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; specific granule [GO:0042581]; spindle [GO:0005819]; vesicle membrane [GO:0012506]
P08758,C4,2.27380888,0.399744195,-1.218079364,-1.27989855,-1.498112635,deepskyblue2,ANXA5,ANXA5_HUMAN,Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CPB-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha),ANXA5 ANX5 ENX2 PP4,308;,ENST00000296511.10; ENSP00000296511.5; ENSG00000164111.15.;,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylserine binding [GO:0001786]; phospholipase inhibitor activity [GO:0004859]; phospholipid binding [GO:0005543],blood coagulation [GO:0007596]; negative regulation of apoptotic process [GO:0043066]; negative regulation of coagulation [GO:0050819]; response to organic substance [GO:0010033]; signal transduction [GO:0007165],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endothelial microparticle [GO:0072563]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; sarcolemma [GO:0042383]; vesicle membrane [GO:0012506]
Q63HQ0,S1,-1.031936219,-1.216100588,-0.309183344,0.547750644,1.328680876,gold,AP1AR,AP1AR_HUMAN,AP-1 complex-associated regulatory protein (2c18) (Adaptor-related protein complex 1-associated regulatory protein) (Gamma-1-adaptin brefeldin A resistance protein) (GBAR) (Gamma-BAR) (Gamma-A1-adaptin and kinesin interactor) (Gadkin),AP1AR C4orf16 PRO0971,55435;,"ENST00000274000.10; ENSP00000274000.5; ENSG00000138660.12. [Q63HQ0-1];""ENST00000309703.10; ENSP00000309023.6; ENSG00000138660.12. [Q63HQ0-2]"";",AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894],"negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle targeting, trans-Golgi to endosome [GO:0048203]",cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]
O95782,S4,-0.366567014,-0.592313066,0.463876507,0.511187193,0.305487053,tomato2,AP2A1,AP2A1_HUMAN,AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit),AP2A1 ADTAA CLAPA1,160;,"ENST00000354293.10; ENSP00000346246.4; ENSG00000196961.13. [O95782-2];""ENST00000359032.10; ENSP00000351926.4; ENSG00000196961.13. [O95782-1]"";",clathrin adaptor activity [GO:0035615]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; positive regulation of neuron projection development [GO:0010976]; positive regulation of receptor-mediated endocytosis [GO:0048260]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; vesicle-mediated transport [GO:0016192],AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; filopodium tip [GO:0032433]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]
O94973,S3,-0.264731085,-0.485198027,0.49752692,0.513077902,0.160174967,salmon,AP2A2,AP2A2_HUMAN,AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9) (HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit),AP2A2 ADTAB CLAPA2 HIP9 HYPJ KIAA0899,161;,"ENST00000332231.9; ENSP00000327694.5; ENSG00000183020.15. [O94973-2];""ENST00000448903.7; ENSP00000413234.3; ENSG00000183020.15. [O94973-1]"";""ENST00000528815.5; ENSP00000431630.1; ENSG00000183020.15. [O94973-3]"";",clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901],clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; vesicle-mediated transport [GO:0016192],AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; secretory granule membrane [GO:0030667]
Q96CW1,S3,-0.411291941,-0.47008448,0.459036689,0.531815529,0.31099176,salmon,AP2M1,AP2M1_HUMAN,AP-2 complex subunit mu (AP-2 mu chain) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Plasma membrane adaptor AP-2 50 kDa protein),AP2M1 CLAPM1 KIAA0109,1173;,"ENST00000292807.9; ENSP00000292807.5; ENSG00000161203.14. [Q96CW1-1];""ENST00000382456.7; ENSP00000371894.3; ENSG00000161203.14. [Q96CW1-2]"";""ENST00000439647.5; ENSP00000409081.1; ENSG00000161203.14. [Q96CW1-2]"";""ENST00000621863.5; ENSP00000481563.2; ENSG00000161203.14. [Q96CW1-2]"";",clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; low-density lipoprotein particle receptor binding [GO:0050750]; signal sequence binding [GO:0005048]; transmembrane transporter binding [GO:0044325],clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192],AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; extracellular exosome [GO:0070062]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; glutamatergic synapse [GO:0098978]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]
O00203,C1,1.336948057,0.168357065,-0.473572621,-0.250261159,-0.036181641,lightblue,AP3B1,AP3B1_HUMAN,AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain),AP3B1 ADTB3A,8546;,"ENST00000255194.11; ENSP00000255194.7; ENSG00000132842.15. [O00203-1];""ENST00000519295.6; ENSP00000430597.1; ENSG00000132842.15. [O00203-3]"";",GTP-dependent protein binding [GO:0030742]; protein phosphatase binding [GO:0019903],"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; granulocyte differentiation [GO:0030851]; hematopoietic progenitor cell differentiation [GO:0002244]; homeostasis of number of cells [GO:0048872]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; intracellular zinc ion homeostasis [GO:0006882]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mRNA transcription by RNA polymerase II [GO:0042789]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cell surface [GO:0034394]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; respiratory system process [GO:0003016]; single fertilization [GO:0007338]; skin epidermis development [GO:0098773]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; vesicle-mediated transport [GO:0016192]",AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvesicle [GO:1990742]; mitochondrion [GO:0005739]
O14617,C1,1.241679519,-0.016320925,-0.450172723,-0.195893431,-0.17042968,lightblue,AP3D1,AP3D1_HUMAN,AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin),AP3D1 PRO0039,8943;,"ENST00000345016.9; ENSP00000344055.4; ENSG00000065000.20. [O14617-1];""ENST00000643116.3; ENSP00000495274.2; ENSG00000065000.20. [O14617-5]"";",0,"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation, exogenous lipid antigen via MHC class Ib [GO:0048007]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; neurotransmitter receptor transport, postsynaptic endosome to lysosome [GO:0098943]; platelet dense granule organization [GO:0060155]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to membrane [GO:0072657]; protein targeting to vacuole [GO:0006623]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle coating [GO:0016183]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated transport [GO:0016192]; zinc ion import into lysosome [GO:0140916]",AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]
P53677,C1,1.587154244,0.206141291,-0.623863553,-0.450979598,-0.49075081,lightblue,AP3M2,AP3M2_HUMAN,AP-3 complex subunit mu-2 (Adaptor-related protein complex 3 subunit mu-2) (Clathrin assembly protein assembly protein complex 3 mu-2 medium chain) (Clathrin coat assembly protein AP47 homolog 2) (Clathrin coat-associated protein AP47 homolog 2) (Golgi adaptor AP-1 47 kDa protein homolog 2) (HA1 47 kDa subunit homolog 2) (Mu3B-adaptin) (P47B),AP3M2,10947;,"ENST00000396926.8; ENSP00000380132.3; ENSG00000070718.13. [P53677-1];""ENST00000518421.5; ENSP00000428787.1; ENSG00000070718.13. [P53677-1]"";""ENST00000530375.5; ENSP00000431918.1; ENSG00000070718.13. [P53677-2]"";",0,"anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; clathrin-coated vesicle cargo loading, AP-3-mediated [GO:0035654]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; synaptic vesicle coating [GO:0016183]; synaptic vesicle recycling [GO:0036465]",AP-3 adaptor complex [GO:0030123]; AP-type membrane coat adaptor complex [GO:0030119]; axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; presynapse [GO:0098793]
Q9UPM8,C1,1.334877263,-0.339840399,-0.46839864,-0.173135651,0.142537229,lightblue,AP4E1,AP4E1_HUMAN,AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin),AP4E1,23431;,"ENST00000261842.10; ENSP00000261842.5; ENSG00000081014.11. [Q9UPM8-1];""ENST00000560508.1; ENSP00000452976.1; ENSG00000081014.11. [Q9UPM8-2]"";",cargo adaptor activity [GO:0140312],intracellular protein transport [GO:0006886]; protein localization [GO:0008104]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192],AP-4 adaptor complex [GO:0030124]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]
Q96BI3,S2,-1.023097211,-1.139503004,0.266857245,0.737794046,0.618668946,orange,APH1A,APH1A_HUMAN,Gamma-secretase subunit APH-1A (APH-1a) (Aph-1alpha) (Presenilin-stabilization factor),APH1A PSF CGI-78 UNQ579/PRO1141,51107;,"ENST00000360244.8; ENSP00000353380.4; ENSG00000117362.13. [Q96BI3-2];""ENST00000369109.8; ENSP00000358105.3; ENSG00000117362.13. [Q96BI3-1]"";""ENST00000414276.6; ENSP00000397473.2; ENSG00000117362.13. [Q96BI3-3]"";",endopeptidase activator activity [GO:0061133]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674],amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; metanephros development [GO:0001656]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of endopeptidase activity [GO:0010950]; protein processing [GO:0016485],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]
Q06481,S3,-1.027476151,-0.801599431,-0.043974431,0.810924396,0.690223391,salmon,APLP2,APLP2_HUMAN,Amyloid beta precursor like protein 2 (APPH) (Amyloid beta (A4) precursor-like protein 2) (Amyloid protein homolog) (Amyloid-like protein 2) (APLP-2) (CDEI box-binding protein) (CDEBP) (Sperm membrane protein YWK-II),APLP2 APPL2,334;,"ENST00000263574.9; ENSP00000263574.5; ENSG00000084234.18. [Q06481-1];""ENST00000278756.7; ENSP00000278756.7; ENSG00000084234.18. [Q06481-6]"";""ENST00000338167.10; ENSP00000345444.5; ENSG00000084234.18. [Q06481-3]"";""ENST00000345598.9; ENSP00000263575.6; ENSG00000084234.18. [Q06481-5]"";""ENST00000528499.5; ENSP00000435914.1; ENSG00000084234.18. [Q06481-4]"";""ENST00000650012.1; ENSP00000497691.1; ENSG00000084234.18. [Q06481-1]"";",DNA binding [GO:0003677]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; serine-type endopeptidase inhibitor activity [GO:0004867]; transition metal ion binding [GO:0046914],axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; G protein-coupled receptor signaling pathway [GO:0007186],endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]
Q9HDC9,S3,-0.801161986,-1.063296679,0.399653508,0.656288699,0.472753006,salmon,APMAP,APMAP_HUMAN,Adipocyte plasma membrane-associated protein (Protein BSCv),APMAP C20orf3 UNQ1869/PRO4305,57136;,ENST00000217456.3; ENSP00000217456.2; ENSG00000101474.12. [Q9HDC9-1];,arylesterase activity [GO:0004064]; strictosidine synthase activity [GO:0016844],biosynthetic process [GO:0009058],cell surface [GO:0009986]; membrane [GO:0016020]
Q8NCW5,C1,1.494780995,0.354641686,-0.435141884,-0.122869369,-0.939006192,lightblue,APOA1BP,NNRE_HUMAN,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase) (NAXE) (YjeF N-terminal domain-containing protein 1) (YjeF_N1),NAXE AIBP APOA1BP YJEFN1,128240;,"ENST00000368235.8; ENSP00000357218.3; ENSG00000163382.13. [Q8NCW5-1];""ENST00000679702.1; ENSP00000505913.1; ENSG00000163382.13. [Q8NCW5-1]"";""ENST00000680004.1; ENSP00000506275.1; ENSG00000163382.13. [Q8NCW5-1]"";""ENST00000680269.1; ENSP00000505899.1; ENSG00000163382.13. [Q8NCW5-1]"";""ENST00000681054.1; ENSP00000506192.1; ENSG00000163382.13. [Q8NCW5-1]"";""ENST00000681523.1; ENSP00000505349.1; ENSG00000163382.13. [Q8NCW5-1]"";",identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],lipid transport [GO:0006869]; membrane raft distribution [GO:0031580]; negative regulation of angiogenesis [GO:0016525]; nicotinamide nucleotide metabolic process [GO:0046496]; regulation of cholesterol efflux [GO:0010874]; sprouting angiogenesis [GO:0002040],cell body [GO:0044297]; cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]
Q9BUR5,M2,-0.781736169,-1.093788762,0.39047001,1.108565436,-0.277380933,tan4,APOO,MIC26_HUMAN,MICOS complex subunit MIC26 (Apolipoprotein O) (MICOS complex subunit MIC23) (Protein FAM121B),APOO FAM121B MIC23 MIC26 My025 UNQ1866/PRO4302,79135;,ENST00000379226.9; ENSP00000368528.4; ENSG00000184831.14. [Q9BUR5-1];,0,cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; lipid transport [GO:0006869],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; high-density lipoprotein particle [GO:0034364]; low-density lipoprotein particle [GO:0034362]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; very-low-density lipoprotein particle [GO:0034361]
Q6UXV4,M2,-0.679173078,-0.81381094,0.334615663,1.043693356,-0.332289681,tan4,APOOL,MIC27_HUMAN,MICOS complex subunit MIC27 (Apolipoprotein O-like) (Protein FAM121A),APOOL CXorf33 FAM121A MIC27 UNQ8193/PRO23204,139322;,ENST00000373173.7; ENSP00000362268.2; ENSG00000155008.16.;,0,cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007],extracellular region [GO:0005576]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; platelet alpha granule lumen [GO:0031093]; SAM complex [GO:0001401]
P05067,S3,-1.244072435,-0.853688302,0.04517433,0.817853308,0.623234278,salmon,APP,A4_HUMAN,Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31],APP A4 AD1,351;,"ENST00000346798.8; ENSP00000284981.4; ENSG00000142192.22. [P05067-1];""ENST00000348990.9; ENSP00000345463.5; ENSG00000142192.22. [P05067-4]"";""ENST00000354192.7; ENSP00000346129.3; ENSG00000142192.22. [P05067-10]"";""ENST00000357903.7; ENSP00000350578.3; ENSG00000142192.22. [P05067-8]"";""ENST00000358918.7; ENSP00000351796.3; ENSG00000142192.22. [P05067-9]"";""ENST00000440126.7; ENSP00000387483.2; ENSG00000142192.22. [P05067-11]"";",DNA binding [GO:0003677]; enzyme binding [GO:0019899]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein serine/threonine kinase binding [GO:0120283]; PTB domain binding [GO:0051425]; receptor ligand activity [GO:0048018]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914],adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cellular response to amyloid-beta [GO:1904646]; central nervous system development [GO:0007417]; cholesterol metabolic process [GO:0008203]; cognition [GO:0050890]; collateral sprouting in absence of injury [GO:0048669]; cytosolic mRNA polyadenylation [GO:0180011]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G2/M transition of mitotic cell cycle [GO:0000086]; intracellular copper ion homeostasis [GO:0006878]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of excitatory postsynaptic potential [GO:0098815]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuron differentiation [GO:0045665]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of chemokine production [GO:0032722]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of gene expression [GO:0010468]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multicellular organism growth [GO:0040014]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse structure or activity [GO:0050803]; regulation of translation [GO:0006417]; regulation of Wnt signaling pathway [GO:0030111]; response to interleukin-1 [GO:0070555]; response to oxidative stress [GO:0006979]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; visual learning [GO:0008542],apical part of cell [GO:0045177]; axon [GO:0030424]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; presynaptic active zone [GO:0048786]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]
Q9UKG1,C1,1.620483265,-0.023902923,-0.449288576,-0.264217526,-0.530433248,lightblue,APPL1,DP13A_HUMAN,"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)",APPL1 APPL DIP13A KIAA1428,26060;,"ENST00000288266.8; ENSP00000288266.3; ENSG00000157500.12.;""ENST00000650354.1; ENSP00000498115.1; ENSG00000157500.12."";",beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877],adiponectin-activated signaling pathway [GO:0033211]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; insulin receptor signaling pathway [GO:0008286]; maintenance of synapse structure [GO:0099558]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ruffle [GO:0001726]; vesicle membrane [GO:0012506]
P07741,C5,1.976956261,0.343349409,-0.783668139,-0.839382502,-1.009124524,turquoise3,APRT,APT_HUMAN,Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7),APRT,353;,"ENST00000378364.8; ENSP00000367615.3; ENSG00000198931.11. [P07741-1];""ENST00000426324.6; ENSP00000397007.2; ENSG00000198931.11. [P07741-2]"";",adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208],adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; GMP salvage [GO:0032263]; grooming behavior [GO:0007625]; IMP salvage [GO:0032264]; purine ribonucleoside salvage [GO:0006166],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]
Q96P48,C1,1.559707911,0.102378615,-0.320627926,-0.337899493,-0.666201941,lightblue,ARAP1,ARAP1_HUMAN,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2)",ARAP1 CENTD2 KIAA0782,116985;,"ENST00000334211.12; ENSP00000335506.8; ENSG00000186635.16. [Q96P48-4];""ENST00000359373.9; ENSP00000352332.5; ENSG00000186635.16. [Q96P48-3]"";""ENST00000393605.7; ENSP00000377230.3; ENSG00000186635.16. [Q96P48-1]"";""ENST00000393609.8; ENSP00000377233.3; ENSG00000186635.16. [Q96P48-6]"";""ENST00000429686.5; ENSP00000403127.1; ENSG00000186635.16. [Q96P48-7]"";","GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; type 1 angiotensin receptor binding [GO:0031702]",actin filament organization [GO:0007015]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of receptor recycling [GO:0001921]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
P48444,C2,1.065261005,0.316833639,-0.36867547,-0.09460385,-0.042574803,aquamarine,ARCN1,COPD_HUMAN,Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP),ARCN1 COPD,372;,"ENST00000264028.5; ENSP00000264028.4; ENSG00000095139.15. [P48444-1];""ENST00000392859.7; ENSP00000376599.3; ENSG00000095139.15. [P48444-2]"";",RNA binding [GO:0003723],"adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intracellular protein transport [GO:0006886]; pigmentation [GO:0043473]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]
O15033,S2,-1.041294591,-1.150664725,0.237641882,0.738566473,0.616634038,orange,AREL1,AREL1_HUMAN,Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1),AREL1 KIAA0317,9870;,"ENST00000356357.9; ENSP00000348714.4; ENSG00000119682.18. [O15033-1];""ENST00000681599.1; ENSP00000505623.1; ENSG00000119682.18. [O15033-1]"";",ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q9Y6D5,C1,1.452319984,0.038761836,-0.447636846,-0.22411153,-0.374804668,lightblue,ARFGEF2,BIG2_HUMAN,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),ARFGEF2 ARFGEP2 BIG2,10564;,ENST00000371917.5; ENSP00000360985.4; ENSG00000124198.10.;,GABA receptor binding [GO:0050811]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237],endomembrane system organization [GO:0010256]; endosome organization [GO:0007032]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular signal transduction [GO:0035556]; positive regulation of tumor necrosis factor production [GO:0032760]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of ARF protein signal transduction [GO:0032012],asymmetric synapse [GO:0032279]; axonemal microtubule [GO:0005879]; centrosome [GO:0005813]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; symmetric synapse [GO:0032280]; trans-Golgi network [GO:0005802]
Q13795,S1,-0.785119725,-1.431463795,-0.288496952,0.686837783,1.092069024,gold,ARFRP1,ARFRP_HUMAN,ADP-ribosylation factor-related protein 1 (ARF-related protein 1) (ARP),ARFRP1 ARP1,10139;,"ENST00000607873.1; ENSP00000476756.1; ENSG00000101246.20. [Q13795-3];""ENST00000612157.4; ENSP00000479058.1; ENSG00000101246.20. [Q13795-2]"";""ENST00000612256.4; ENSP00000484109.1; ENSG00000101246.20. [Q13795-3]"";""ENST00000614942.4; ENSP00000483130.1; ENSG00000101246.20. [Q13795-4]"";""ENST00000618568.4; ENSP00000481446.1; ENSG00000101246.20. [Q13795-4]"";""ENST00000618838.4; ENSP00000479616.1; ENSG00000101246.20. [Q13795-1]"";""ENST00000619493.4; ENSP00000479940.1; ENSG00000101246.20. [Q13795-1]"";""ENST00000622789.5; ENSP00000483486.1; ENSG00000101246.20. [Q13795-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],"gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; retrograde transport, endosome to Golgi [GO:0042147]; signal transduction [GO:0007165]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]
Q8IWW6,C1,1.38532791,0.21184403,-0.391931695,-0.12113684,-0.395461742,lightblue,ARHGAP12,RHG12_HUMAN,Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12),ARHGAP12,94134;,"ENST00000311380.8; ENSP00000310984.4; ENSG00000165322.18. [Q8IWW6-3];""ENST00000344936.7; ENSP00000345808.2; ENSG00000165322.18. [Q8IWW6-1]"";""ENST00000375250.9; ENSP00000364399.5; ENSG00000165322.18. [Q8IWW6-2]"";""ENST00000396144.8; ENSP00000379448.4; ENSG00000165322.18. [Q8IWW6-4]"";",GTPase activator activity [GO:0005096],"actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis, engulfment [GO:0006911]; signal transduction [GO:0007165]",cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]
Q68EM7,C3,1.647015199,0.154261732,-0.499247079,-0.259606125,-0.63941178,cyan,ARHGAP17,RHG17_HUMAN,Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1),ARHGAP17 RICH1 MSTP066 MSTP110,55114;,"ENST00000289968.11; ENSP00000289968.6; ENSG00000140750.17. [Q68EM7-1];""ENST00000303665.9; ENSP00000303130.5; ENSG00000140750.17. [Q68EM7-2]"";""ENST00000673196.1; ENSP00000500849.1; ENSG00000288353.1. [Q68EM7-2]"";""ENST00000673560.1; ENSP00000500372.1; ENSG00000288353.1. [Q68EM7-1]"";",GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124],actin filament organization [GO:0007015]; calcium-ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of Rac protein signal transduction [GO:0035020]; signal transduction [GO:0007165],bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q9NRY4,C3,1.742562482,0.092823469,-0.550204268,-0.4466218,-0.801994587,cyan,ARHGAP35,RHG35_HUMAN,Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A),ARHGAP35 GRF1 GRLF1 KIAA1722 P190A p190ARHOGAP,2909;,ENST00000672722.1; ENSP00000500409.1; ENSG00000160007.20.;,DNA binding [GO:0003677]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; phospholipid binding [GO:0005543],"axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; camera-type eye development [GO:0043010]; cell migration [GO:0016477]; cellular response to extracellular stimulus [GO:0031668]; central nervous system neuron axonogenesis [GO:0021955]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; forebrain development [GO:0030900]; mammary gland development [GO:0030879]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vascular permeability [GO:0043116]; neural tube closure [GO:0001843]; neuron projection guidance [GO:0097485]; positive regulation of cilium assembly [GO:0045724]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; wound healing, spreading of cells [GO:0044319]",actin cytoskeleton [GO:0015629]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9C0H5,S3,-0.455230209,-0.108814164,0.344021204,0.576862263,0.149120627,salmon,ARHGAP39,RHG39_HUMAN,Rho GTPase-activating protein 39,ARHGAP39 KIAA1688,80728;,"ENST00000276826.5; ENSP00000276826.5; ENSG00000147799.12. [Q9C0H5-1];""ENST00000377307.7; ENSP00000366522.2; ENSG00000147799.12. [Q9C0H5-2]"";",GTPase activator activity [GO:0005096],postsynapse organization [GO:0099173]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]
Q13017,C1,1.579614508,0.1356575,-0.417680779,-0.302893174,-0.607238898,lightblue,ARHGAP5,RHG05_HUMAN,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),ARHGAP5 RHOGAP5,394;,"ENST00000345122.8; ENSP00000371897.1; ENSG00000100852.14. [Q13017-1];""ENST00000396582.6; ENSP00000379827.2; ENSG00000100852.14. [Q13017-3]"";""ENST00000433497.5; ENSP00000407395.1; ENSG00000100852.14. [Q13017-4]"";""ENST00000539826.6; ENSP00000441692.2; ENSG00000100852.14. [Q13017-1]"";""ENST00000556611.5; ENSP00000452222.1; ENSG00000100852.14. [Q13017-2]"";",GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; SH2 domain binding [GO:0042169],cell adhesion [GO:0007155]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]
P52565,C4,2.246955917,0.161589388,-1.222638644,-1.300450146,-1.435336263,deepskyblue2,ARHGDIA,GDIR1_HUMAN,Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha),ARHGDIA GDIA1,396;,"ENST00000269321.12; ENSP00000269321.7; ENSG00000141522.12. [P52565-1];""ENST00000400721.8; ENSP00000383556.4; ENSG00000141522.12. [P52565-2]"";""ENST00000541078.6; ENSP00000441348.2; ENSG00000141522.12. [P52565-1]"";""ENST00000580685.5; ENSP00000464205.1; ENSG00000141522.12. [P52565-1]"";",GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094],negative regulation of apoptotic process [GO:0043066]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic vesicle cycle [GO:0098693]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; Schaffer collateral - CA1 synapse [GO:0098685]
P52566,C4,2.156508338,0.204776661,-1.130994511,-1.365296742,-1.492207816,deepskyblue2,ARHGDIB,GDIR2_HUMAN,Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (Ly-GDI) (Rho-GDI beta),ARHGDIB GDIA2 GDID4 RAP1GN1,397;,"ENST00000228945.9; ENSP00000228945.4; ENSG00000111348.9.;""ENST00000541546.5; ENSP00000440560.1; ENSG00000111348.9."";""ENST00000541644.5; ENSP00000444860.1; ENSG00000111348.9."";",GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; Rho GDP-dissociation inhibitor activity [GO:0005094]; small GTPase binding [GO:0031267],cellular response to redox state [GO:0071461]; negative regulation of trophoblast cell migration [GO:1901164]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]
O15013,C3,1.617798384,0.052147728,-0.500059598,-0.484425444,-0.664551047,cyan,ARHGEF10,ARHGA_HUMAN,Rho guanine nucleotide exchange factor 10,ARHGEF10 KIAA0294,9639;,"ENST00000349830.8; ENSP00000340297.3; ENSG00000104728.16. [O15013-5];""ENST00000398564.5; ENSP00000381571.1; ENSG00000104728.16. [O15013-1]"";""ENST00000518288.5; ENSP00000431012.1; ENSG00000104728.16. [O15013-6]"";""ENST00000520359.5; ENSP00000427909.1; ENSG00000104728.16. [O15013-7]"";""ENST00000610399.4; ENSP00000481974.1; ENSG00000274726.4. [O15013-1]"";""ENST00000619613.4; ENSP00000477988.1; ENSG00000274726.4. [O15013-5]"";""ENST00000631758.1; ENSP00000488343.1; ENSG00000274726.4. [O15013-7]"";""ENST00000633616.1; ENSP00000488463.1; ENSG00000274726.4. [O15013-6]"";",guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894],actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of small GTPase mediated signal transduction [GO:0051056],centrosome [GO:0005813]; cytosol [GO:0005829]
Q9HCE6,C3,1.686057357,-0.029318989,-0.609271365,-0.47036289,-0.672227847,cyan,ARHGEF10L,ARGAL_HUMAN,Rho guanine nucleotide exchange factor 10-like protein (GrinchGEF),ARHGEF10L GRINCHGEF KIAA1626,55160;,"ENST00000361221.8; ENSP00000355060.3; ENSG00000074964.17. [Q9HCE6-1];""ENST00000375415.5; ENSP00000364564.1; ENSG00000074964.17. [Q9HCE6-2]"";",GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085],actin cytoskeleton organization [GO:0030036]; positive regulation of stress fiber assembly [GO:0051496]; regulation of small GTPase mediated signal transduction [GO:0051056]; SREBP signaling pathway [GO:0032933],cytosol [GO:0005829]
Q8TER5,S3,-0.353283705,-0.456246711,0.253691478,0.369362721,0.712882786,salmon,ARHGEF40,ARH40_HUMAN,Rho guanine nucleotide exchange factor 40 (Protein SOLO),ARHGEF40 SOLO,55701;,ENST00000298694.9; ENSP00000298694.4; ENSG00000165801.10. [Q8TER5-1];,guanyl-nucleotide exchange factor activity [GO:0005085],axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886]
Q14155,C1,1.404542156,0.273358412,-0.404233711,-0.282959022,-0.233855022,lightblue,ARHGEF7,ARHG7_HUMAN,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314,8874;,"ENST00000317133.9; ENSP00000325994.5; ENSG00000102606.20. [Q14155-3];""ENST00000375723.5; ENSP00000364875.1; ENSG00000102606.20. [Q14155-6]"";""ENST00000375736.8; ENSP00000364888.4; ENSG00000102606.20. [Q14155-1]"";""ENST00000375739.6; ENSP00000364891.2; ENSG00000102606.20. [Q14155-2]"";""ENST00000375741.6; ENSP00000364893.2; ENSG00000102606.20. [Q14155-4]"";""ENST00000426073.6; ENSP00000397068.2; ENSG00000102606.20. [Q14155-1]"";",gamma-tubulin binding [GO:0043015]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901],ephrin receptor signaling pathway [GO:0048013]; focal adhesion assembly [GO:0048041]; Golgi organization [GO:0007030]; lamellipodium assembly [GO:0030032]; negative regulation of microtubule nucleation [GO:1905833]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of GTPase activity [GO:0043547]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]
Q8NFD5,N4,-0.886514496,0.684842674,0.57129268,-0.417530315,-0.10581006,grey30,ARID1B,ARI1B_HUMAN,AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R),ARID1B BAF250B DAN15 KIAA1235 OSA2,57492;,"ENST00000346085.10; ENSP00000344546.5; ENSG00000049618.25. [Q8NFD5-2];""ENST00000350026.11; ENSP00000055163.8; ENSG00000049618.25. [Q8NFD5-5]"";""ENST00000636930.2; ENSP00000490491.2; ENSG00000049618.25. [Q8NFD5-3]"";",DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713],cellular response to angiotensin [GO:1904385]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; transcription initiation-coupled chromatin remodeling [GO:0045815],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514]
Q9Y4X5,C5,1.771600806,0.726190545,-0.563941653,-0.55827717,-0.858107742,turquoise3,ARIH1,ARI1_HUMAN,E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (H7-AP2) (HHARI) (Monocyte protein 6) (MOP-6) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein) (Ubiquitin-conjugating enzyme E2-binding protein 1),ARIH1 ARI MOP6 UBCH7BP HUSSY-27,25820;,ENST00000379887.9; ENSP00000369217.4; ENSG00000166233.15.;,ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],PKR/eIFalpha signaling [GO:0039585]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
O95376,C5,1.592421096,0.452774653,-0.635889695,-0.600448127,-0.835444838,turquoise3,ARIH2,ARI2_HUMAN,E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.31) (Triad1 protein),ARIH2 ARI2 TRIAD1 HT005,10425;,"ENST00000356401.9; ENSP00000348769.4; ENSG00000177479.20.;""ENST00000449376.5; ENSP00000403222.1; ENSG00000177479.20."";",ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
Q3SXY8,S2,-1.349518216,-1.666520883,0.159054549,0.776063135,0.787414838,orange,ARL13B,AR13B_HUMAN,ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1),ARL13B ARL2L1,200894;,"ENST00000303097.11; ENSP00000306225.7; ENSG00000169379.17. [Q3SXY8-2];""ENST00000394222.8; ENSP00000377769.3; ENSG00000169379.17. [Q3SXY8-1]"";""ENST00000471138.5; ENSP00000420780.1; ENSG00000169379.17. [Q3SXY8-1]"";""ENST00000535334.5; ENSP00000445145.1; ENSG00000169379.17. [Q3SXY8-3]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]
Q9NXU5,S4,-1.239788823,-1.337971436,0.452301962,0.869988382,0.425227425,tomato2,ARL15,ARL15_HUMAN,ADP-ribosylation factor-like protein 15 (ADP-ribosylation factor-related protein 2) (ARF-related protein 2),ARL15 ARFRP2,54622;,ENST00000504924.6; ENSP00000433427.1; ENSG00000185305.12.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924],0,extracellular exosome [GO:0070062]
Q9H0F7,C1,1.834500939,-0.229373919,-0.553418471,-0.241367135,-0.94615076,lightblue,ARL6,ARL6_HUMAN,ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein),ARL6 BBS3,84100;,"ENST00000335979.6; ENSP00000337722.2; ENSG00000113966.11. [Q9H0F7-1];""ENST00000462412.3; ENSP00000418740.2; ENSG00000113966.11. [Q9H0F7-1]"";""ENST00000463745.6; ENSP00000419619.1; ENSG00000113966.11. [Q9H0F7-1]"";""ENST00000493990.5; ENSP00000418057.1; ENSG00000113966.11. [Q9H0F7-1]"";""ENST00000631834.2; ENSP00000488530.2; ENSG00000113966.11. [Q9H0F7-2]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543],cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; protein localization to cilium [GO:0061512]; protein polymerization [GO:0051258]; protein targeting to membrane [GO:0006612]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055],axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]
O75915,S3,-0.626841317,-0.935017831,0.358557229,0.626477945,0.64507534,salmon,ARL6IP5,PRAF3_HUMAN,PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27),ARL6IP5 DERP11 JWA PRA2 PRAF3 HSPC127,10550;,ENST00000273258.4; ENSP00000273258.3; ENSG00000144746.7.;,0,cellular response to organic cyclic compound [GO:0071407]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; learning or memory [GO:0007611]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of transport [GO:0051051]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031],cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]
Q96BM9,S1,-0.752806389,-0.797001085,-0.297302641,0.705805669,0.912124739,gold,ARL8A,ARL8A_HUMAN,ADP-ribosylation factor-like protein 8A (ADP-ribosylation factor-like protein 10B) (Novel small G protein indispensable for equal chromosome segregation 2),ARL8A ARL10B GIE2,127829;,ENST00000272217.7; ENSP00000272217.2; ENSG00000143862.8.;,alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],anterograde axonal transport [GO:0008089]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; protein transport [GO:0015031],axon cytoplasm [GO:1904115]; azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; synapse [GO:0045202]
Q9NVJ2,S1,-1.20781801,-1.466739906,-0.419509569,0.885970561,0.917569517,gold,ARL8B,ARL8B_HUMAN,ADP-ribosylation factor-like protein 8B (EC 3.6.5.2) (ADP-ribosylation factor-like protein 10C) (Novel small G protein indispensable for equal chromosome segregation 1),ARL8B ARL10C GIE1,55207;,"ENST00000256496.8; ENSP00000256496.3; ENSG00000134108.14. [Q9NVJ2-1];""ENST00000419534.2; ENSP00000402996.2; ENSG00000134108.14. [Q9NVJ2-2]"";",alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],anterograde axonal transport [GO:0008089]; antigen processing and presentation following phagocytosis [GO:0002747]; antigen processing and presentation of polysaccharide antigen via MHC class II [GO:0002505]; autophagosome-lysosome fusion [GO:0061909]; calcium ion regulated lysosome exocytosis [GO:1990927]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; early endosome to Golgi transport [GO:0034498]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; late endosome to lysosome transport [GO:1902774]; lysosome localization [GO:0032418]; natural killer cell mediated cytotoxicity [GO:0042267]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; protein localization to early endosome [GO:1902946]; protein transport [GO:0015031]; viral exocytosis [GO:0046754],axon cytoplasm [GO:1904115]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; midbody [GO:0030496]; spindle midzone [GO:0051233]; synapse [GO:0045202]
Q8N2F6,M2,-1.300579364,-1.665718608,0.396990593,1.203277558,-0.121390695,tan4,ARMC10,ARM10_HUMAN,Armadillo repeat-containing protein 10 (Splicing variant involved in hepatocarcinogenesis protein),ARMC10 SVH PSEC0198,83787;,"ENST00000323716.8; ENSP00000319412.3; ENSG00000170632.14. [Q8N2F6-1];""ENST00000425331.5; ENSP00000397969.1; ENSG00000170632.14. [Q8N2F6-5]"";""ENST00000428183.6; ENSP00000396654.2; ENSG00000170632.14. [Q8N2F6-3]"";""ENST00000441711.6; ENSP00000413619.2; ENSG00000170632.14. [Q8N2F6-2]"";""ENST00000454559.5; ENSP00000405612.1; ENSG00000170632.14. [Q8N2F6-4]"";""ENST00000541300.5; ENSP00000440463.1; ENSG00000170632.14. [Q8N2F6-6]"";",DNA binding domain binding [GO:0050692]; p53 binding [GO:0002039],negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of growth rate [GO:0040010],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q6NXE6,C3,1.980616846,-0.0867159,-0.651368932,-0.592672893,-0.869661179,cyan,ARMC6,ARMC6_HUMAN,Armadillo repeat-containing protein 6,ARMC6,93436;,"ENST00000269932.10; ENSP00000269932.6; ENSG00000105676.14. [Q6NXE6-2];""ENST00000392335.6; ENSP00000376147.2; ENSG00000105676.14. [Q6NXE6-2]"";""ENST00000392336.7; ENSP00000376148.3; ENSG00000105676.14. [Q6NXE6-1]"";""ENST00000535612.6; ENSP00000444156.1; ENSG00000105676.14. [Q6NXE6-1]"";",0,hematopoietic progenitor cell differentiation [GO:0002244],cytosol [GO:0005829]
Q9UH62,M2,-0.859528012,-1.060576492,0.312389944,1.075117528,-0.178626748,tan4,ARMCX3,ARMX3_HUMAN,Armadillo repeat-containing X-linked protein 3 (ARM protein lost in epithelial cancers on chromosome X 3) (Protein ALEX3),ARMCX3 ALEX3 BM-017 UNQ2517/PRO6007,51566;,"ENST00000341189.8; ENSP00000340672.4; ENSG00000102401.20.;""ENST00000471229.7; ENSP00000454483.1; ENSG00000102401.20."";""ENST00000537169.1; ENSP00000439032.1; ENSG00000102401.20."";",0,axonal transport of mitochondrion [GO:0019896]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104],axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
O15511,C3,1.769303142,-0.003426098,-0.550385934,-0.770321587,-0.720805748,cyan,ARPC5,ARPC5_HUMAN,Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC),ARPC5 ARC16,10092;,"ENST00000294742.6; ENSP00000294742.6; ENSG00000162704.16. [O15511-2];""ENST00000359856.11; ENSP00000352918.6; ENSG00000162704.16. [O15511-1]"";",actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200],actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; regulation of actin filament polymerization [GO:0030833],actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]
Q9H2C2,S2,-1.55723335,-1.813082325,0.27077872,0.979846996,0.476500577,orange,ARV1,ARV1_HUMAN,Protein ARV1 (hARV1),ARV1 HT035,64801;,ENST00000310256.7; ENSP00000312458.2; ENSG00000173409.14.;,0,bile acid metabolic process [GO:0008206]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; intracellular sterol transport [GO:0032366]; regulation of cholesterol metabolic process [GO:0090181]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of plasma membrane sterol distribution [GO:0097036]; sphingolipid metabolic process [GO:0006665]; sterol metabolic process [GO:0016125],cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]
Q13510,S3,-1.702696085,-0.372032792,-0.126288731,0.881542721,0.558829909,salmon,ASAH1,ASAH1_HUMAN,Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (Glycosylceramide deacylase) (EC 3.5.1.109) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein) (PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta],ASAH1 ASAH HSD-33 HSD33,427;,"ENST00000314146.10; ENSP00000326970.10; ENSG00000104763.20. [Q13510-3];""ENST00000381733.9; ENSP00000371152.4; ENSG00000104763.20. [Q13510-2]"";""ENST00000635998.1; ENSP00000490506.1; ENSG00000104763.20. [Q13510-1]"";""ENST00000637790.2; ENSP00000490272.1; ENSG00000104763.20. [Q13510-1]"";","ceramidase activity [GO:0102121]; fatty acid amide hydrolase activity [GO:0017064]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acylsphingosine amidohydrolase activity [GO:0017040]; nuclear receptor binding [GO:0016922]; transcription corepressor activity [GO:0003714]",cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]
Q9ULH1,C1,1.470140456,0.058102621,-0.42968488,-0.206153556,-0.515320235,lightblue,ASAP1,ASAP1_HUMAN,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",ASAP1 DDEF1 KIAA1249 PAG2,50807;,ENST00000518721.6; ENSP00000429900.1; ENSG00000153317.15. [Q9ULH1-1];,"cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]",cilium assembly [GO:0060271]; Golgi to plasma membrane protein transport [GO:0043001]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of cilium assembly [GO:0045724]; positive regulation of membrane tubulation [GO:1903527]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175],cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; podosome [GO:0002102]; trans-Golgi network membrane [GO:0032588]
Q9H765,C2,1.072480446,0.240053405,-0.281944394,-0.11673128,-0.285890625,aquamarine,ASB8,ASB8_HUMAN,Ankyrin repeat and SOCS box protein 8 (ASB-8),ASB8 PP14212,140461;,"ENST00000317697.8; ENSP00000320893.3; ENSG00000177981.11.;""ENST00000536549.5; ENSP00000445622.1; ENSG00000177981.11."";",0,intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567],cytosol [GO:0005829]
Q9NR48,N3,-0.844417793,-0.923165442,0.790878954,-0.047552495,0.609081358,grey50,ASH1L,ASH1L_HUMAN,Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.359) (EC 2.1.1.367) (ASH1-like protein) (huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H),ASH1L KIAA1420 KMT2H,55870;,"ENST00000368346.7; ENSP00000357330.3; ENSG00000116539.14. [Q9NR48-1];""ENST00000392403.8; ENSP00000376204.3; ENSG00000116539.14. [Q9NR48-2]"";""ENST00000677213.1; ENSP00000503315.1; ENSG00000116539.14. [Q9NR48-2]"";""ENST00000678117.1; ENSP00000504629.1; ENSG00000116539.14. [Q9NR48-2]"";""ENST00000679097.1; ENSP00000503265.1; ENSG00000116539.14. [Q9NR48-2]"";",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9me2 methyltransferase activity [GO:0140947]; metal ion binding [GO:0046872],decidualization [GO:0046697]; flagellated sperm motility [GO:0030317]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; methylation [GO:0032259]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; single fertilization [GO:0007338]; skeletal system development [GO:0001501]; tarsal gland development [GO:1903699]; transcription by RNA polymerase II [GO:0006366]; uterine gland development [GO:1903709]; uterus morphogenesis [GO:0061038],bicellular tight junction [GO:0005923]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UBL3,N4,-1.254297005,0.731807421,0.494276944,-0.442382025,-0.121557641,grey30,ASH2L,ASH2L_HUMAN,Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein),ASH2L ASH2L1,9070;,"ENST00000343823.11; ENSP00000340896.5; ENSG00000129691.16. [Q9UBL3-1];""ENST00000428278.6; ENSP00000395310.2; ENSG00000129691.16. [Q9UBL3-3]"";""ENST00000521652.5; ENSP00000430259.1; ENSG00000129691.16. [Q9UBL3-2]"";",beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; transcription cis-regulatory region binding [GO:0000976],DNA damage response [GO:0006974]; hemopoiesis [GO:0030097]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627]; transcription initiation-coupled chromatin remodeling [GO:0045815],euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]
O95671,C4,1.870846109,0.301746024,-0.673080115,-0.615169161,-0.945200865,deepskyblue2,ASMTL,ASML_HUMAN,Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)],ASMTL,8623;,"ENST00000381317.9; ENSP00000370718.3; ENSG00000169093.16. [O95671-1];""ENST00000381333.9; ENSP00000370734.4; ENSG00000169093.16. [O95671-2]"";""ENST00000534940.6; ENSP00000446410.1; ENSG00000169093.16. [O95671-3]"";""ENST00000711192.1; ENSP00000518598.1; ENSG00000292339.1. [O95671-3]"";""ENST00000711196.1; ENSP00000518599.1; ENSG00000292339.1. [O95671-2]"";""ENST00000711197.1; ENSP00000518600.1; ENSG00000292339.1. [O95671-1]"";",dTTP diphosphatase activity [GO:0036218]; nucleoside triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; UTP diphosphatase activity [GO:0036221],methylation [GO:0032259]; nucleotide metabolic process [GO:0009117],cytosol [GO:0005829]
O43681,C2,1.140621988,-0.065329389,-0.276061405,0.110314981,0.097862826,aquamarine,ASNA1,GET3_HUMAN,"ATPase GET3 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Guided entry of tail-anchored proteins factor 3, ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I)",GET3 ARSA ASNA1 TRC40,439;,"ENST00000357332.8; ENSP00000349887.3; ENSG00000198356.12.;""ENST00000591090.5; ENSP00000466379.1; ENSG00000198356.12."";",arsenite transmembrane transporter activity [GO:0015105]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; membrane insertase activity [GO:0032977]; metal ion binding [GO:0046872],protein insertion into ER membrane [GO:0045048]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; GET complex [GO:0043529]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q12797,S2,-1.236189927,-1.473123011,0.233209798,0.944533248,0.479354124,orange,ASPH,ASPH_HUMAN,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),ASPH BAH,444;,"ENST00000356457.9; ENSP00000348841.5; ENSG00000198363.18. [Q12797-2];""ENST00000379449.11; ENSP00000368762.5; ENSG00000198363.18. [Q12797-7]"";""ENST00000379454.9; ENSP00000368767.4; ENSG00000198363.18. [Q12797-1]"";""ENST00000389204.9; ENSP00000373856.4; ENSG00000198363.18. [Q12797-3]"";""ENST00000445642.6; ENSP00000394013.4; ENSG00000198363.18. [Q12797-11]"";""ENST00000517847.7; ENSP00000429954.2; ENSG00000198363.18. [Q12797-8]"";""ENST00000517903.5; ENSP00000430245.1; ENSG00000198363.18. [Q12797-5]"";""ENST00000518068.5; ENSP00000429286.1; ENSG00000198363.18. [Q12797-6]"";""ENST00000522603.5; ENSP00000436188.1; ENSG00000198363.18. [Q12797-4]"";""ENST00000522835.5; ENSP00000429160.1; ENSG00000198363.18. [Q12797-9]"";""ENST00000541428.5; ENSP00000437864.1; ENSG00000198363.18. [Q12797-10]"";",calcium ion binding [GO:0005509]; electron transfer activity [GO:0009055]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325],"activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion homeostasis [GO:0055074]; calcium ion transmembrane transport [GO:0070588]; cell population proliferation [GO:0008283]; cellular response to calcium ion [GO:0071277]; detection of calcium ion [GO:0005513]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; muscle contraction [GO:0006936]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021]",calcium channel complex [GO:0034704]; cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; junctional sarcoplasmic reticulum membrane [GO:0014701]; plasma membrane [GO:0005886]; sarcoplasmic reticulum lumen [GO:0033018]; sarcoplasmic reticulum membrane [GO:0033017]
Q9BZE9,C5,1.430572079,0.600616576,-0.647196438,-0.709727832,-0.531147092,turquoise3,ASPSCR1,ASPC1_HUMAN,Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9),ASPSCR1 ASPL RCC17 TUG UBXD9 UBXN9,79058;,"ENST00000306729.11; ENSP00000306625.7; ENSG00000169696.16. [Q9BZE9-2];""ENST00000306739.9; ENSP00000302176.4; ENSG00000169696.16. [Q9BZE9-1]"";""ENST00000580534.5; ENSP00000462329.1; ENSG00000169696.16. [Q9BZE9-3]"";",0,glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]
P00966,C5,1.937714934,0.295066458,-0.787685421,-1.049708143,-0.89548997,turquoise3,ASS1,ASSY_HUMAN,Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase),ASS1 ASS,445;,"ENST00000352480.10; ENSP00000253004.6; ENSG00000130707.18.;""ENST00000372393.7; ENSP00000361469.2; ENSG00000130707.18."";""ENST00000372394.5; ENSP00000361471.1; ENSG00000130707.18."";",amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643],acute-phase response [GO:0006953]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050],cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]
Q8NBU5,M2,-0.843251475,-0.978074938,0.310247604,0.968308597,-0.011557114,tan4,ATAD1,ATAD1_HUMAN,Outer mitochondrial transmembrane helix translocase (EC 7.4.2.-) (ATPase family AAA domain-containing protein 1) (hATAD1) (Thorase),ATAD1 FNP001,84896;,"ENST00000308448.11; ENSP00000339017.4; ENSG00000138138.14. [Q8NBU5-1];""ENST00000328142.3; ENSP00000339016.2; ENSG00000138138.14. [Q8NBU5-1]"";""ENST00000680024.1; ENSP00000506333.1; ENSG00000138138.14. [Q8NBU5-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; membrane protein dislocase activity [GO:0140567],"extraction of mislocalized protein from mitochondrial outer membrane [GO:0140570]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; positive regulation of receptor internalization [GO:0002092]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]",cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; postsynaptic membrane [GO:0045211]
Q6PL18,N3,-1.186254243,-1.356219985,1.447231097,0.116131072,-1.004200162,grey50,ATAD2,ATAD2_HUMAN,ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA),ATAD2 L16 PRO2000,29028;,ENST00000287394.10; ENSP00000287394.5; ENSG00000156802.13. [Q6PL18-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393],nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription [GO:0045893]; transcription initiation-coupled chromatin remodeling [GO:0045815],extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9ULI0,N3,-1.221422359,-1.327616628,1.474456057,0.142297799,-0.924257926,grey50,ATAD2B,ATD2B_HUMAN,ATPase family AAA domain-containing protein 2B,ATAD2B KIAA1240,54454;,ENST00000238789.10; ENSP00000238789.5; ENSG00000119778.15. [Q9ULI0-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577],nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; transcription initiation-coupled chromatin remodeling [GO:0045815],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NVI7,M2,-0.737593509,-1.048198043,0.444112892,1.003125643,-0.216913159,tan4,ATAD3A,ATD3A_HUMAN,ATPase family AAA domain-containing protein 3A,ATAD3A,55210;,"ENST00000378755.9; ENSP00000368030.5; ENSG00000197785.14. [Q9NVI7-1];""ENST00000378756.8; ENSP00000368031.3; ENSG00000197785.14. [Q9NVI7-2]"";""ENST00000536055.6; ENSP00000439290.1; ENSG00000197785.14. [Q9NVI7-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802],antiviral innate immune response [GO:0140374]; DNA damage response [GO:0006974]; HRI-mediated signaling [GO:0140468]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; regulation of cell growth [GO:0001558],mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]
Q5T9A4,M2,-0.95646692,-1.475479963,0.317196655,0.987930408,-0.345434271,tan4,ATAD3B,ATD3B_HUMAN,ATPase family AAA domain-containing protein 3B (AAA-TOB3),ATAD3B KIAA1273 TOB3,83858;,ENST00000673477.1; ENSP00000500094.1; ENSG00000160072.20. [Q5T9A4-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],mitochondrion organization [GO:0007005],ficolin-1-rich granule membrane [GO:0101003]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]
Q96QE3,N3,-0.975544625,-1.096998888,1.098760088,0.08243451,0.425874197,grey50,ATAD5,ATAD5_HUMAN,ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein),ATAD5 C17orf41 Elg1 FRAG1,79915;,ENST00000321990.5; ENSP00000313171.4; ENSG00000176208.9. [Q96QE3-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860],cell population proliferation [GO:0008283]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770],Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]
O95260,C5,1.75105311,0.717278079,-0.903813411,-1.03161111,-1.087736559,turquoise3,ATE1,ATE1_HUMAN,Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1),ATE1,11101;,"ENST00000224652.12; ENSP00000224652.6; ENSG00000107669.19. [O95260-1];""ENST00000369043.8; ENSP00000358039.3; ENSG00000107669.19. [O95260-2]"";""ENST00000685007.1; ENSP00000508990.1; ENSG00000107669.19. [O95260-2]"";",arginyl-tRNA--protein transferase activity [GO:0004057],proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]
P18846,N4,-0.940401597,0.882963618,0.409927896,-0.154978805,-0.106608978,grey30,ATF1,ATF1_HUMAN,Cyclic AMP-dependent transcription factor ATF-1 (cAMP-dependent transcription factor ATF-1) (Activating transcription factor 1) (Protein TREB36),ATF1,466;,ENST00000262053.8; ENSP00000262053.3; ENSG00000123268.9. [P18846-1];,"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",cAMP-mediated signaling [GO:0019933]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cobalt ion [GO:0032025]; response to purine-containing compound [GO:0014074],ATF1-ATF4 transcription factor complex [GO:1990590]; ATF4-CREB1 transcription factor complex [GO:1990589]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]
P18848,N3,-1.484614071,-0.44619848,0.814976622,0.515275802,0.104153207,grey50,ATF4,ATF4_HUMAN,Cyclic AMP-dependent transcription factor ATF-4 (cAMP-dependent transcription factor ATF-4) (Activating transcription factor 4) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (Tax-responsive enhancer element-binding protein 67) (TaxREB67),ATF4 CREB2 TXREB,468;,"ENST00000337304.2; ENSP00000336790.2; ENSG00000128272.18.;""ENST00000396680.3; ENSP00000379912.1; ENSG00000128272.18."";""ENST00000404241.6; ENSP00000384587.2; ENSG00000128272.18."";""ENST00000674568.2; ENSP00000501783.2; ENSG00000128272.18."";""ENST00000674835.2; ENSP00000502610.2; ENSG00000128272.18."";""ENST00000674920.3; ENSP00000501863.1; ENSG00000128272.18."";""ENST00000676346.2; ENSP00000502400.2; ENSG00000128272.18."";""ENST00000679776.1; ENSP00000505360.1; ENSG00000128272.18."";","cAMP response element binding protein binding [GO:0008140]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",bone mineralization [GO:0030282]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; endoplasmic reticulum unfolded protein response [GO:0030968]; gamma-aminobutyric acid signaling pathway [GO:0007214]; gluconeogenesis [GO:0006094]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; intracellular calcium ion homeostasis [GO:0006874]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; L-asparagine metabolic process [GO:0070982]; lens fiber cell morphogenesis [GO:0070309]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron differentiation [GO:0030182]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of apoptotic process [GO:0043065]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of DNA-templated transcription [GO:0006355]; regulation of osteoblast differentiation [GO:0045667]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636]; transcription by RNA polymerase II [GO:0006366],ATF1-ATF4 transcription factor complex [GO:1990590]; ATF4-CREB1 transcription factor complex [GO:1990589]; centrosome [GO:0005813]; CHOP-ATF4 complex [GO:1990617]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite membrane [GO:0032590]; Lewy body core [GO:1990037]; neuron projection [GO:0043005]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]
P18850,S3,-0.827373179,-0.95016582,0.143067605,0.885140274,0.482940653,salmon,ATF6,ATF6A_HUMAN,Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha],ATF6,22926;,"ENST00000367942.4; ENSP00000356919.3; ENSG00000118217.7.;""ENST00000681738.1; ENSP00000505025.1; ENSG00000118217.7."";""ENST00000681801.1; ENSP00000505998.1; ENSG00000118217.7."";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",ATF6-mediated unfolded protein response [GO:0036500]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein folding [GO:0006457]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; visual perception [GO:0007601],chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]
O94817,C3,1.822051049,0.217502307,-0.62330216,-0.487663682,-0.721307032,cyan,ATG12,ATG12_HUMAN,Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like),ATG12 APG12 APG12L,9140;,"ENST00000500945.2; ENSP00000425164.1; ENSG00000145782.13. [O94817-4];""ENST00000509910.2; ENSP00000425107.1; ENSG00000145782.13. [O94817-1]"";",0,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; glycophagy [GO:0061723]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of viral translation [GO:1904973]; regulation of autophagosome maturation [GO:1901096],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]
O75143,C5,1.729190644,0.417813248,-0.691362445,-0.55424948,-0.780988277,turquoise3,ATG13,ATG13_HUMAN,Autophagy-related protein 13,ATG13 KIAA0652,9776;,"ENST00000359513.8; ENSP00000352500.4; ENSG00000175224.17. [O75143-1];""ENST00000524625.5; ENSP00000433543.1; ENSG00000175224.17. [O75143-2]"";""ENST00000526508.5; ENSP00000431974.1; ENSG00000175224.17. [O75143-1]"";""ENST00000528494.5; ENSP00000432412.1; ENSG00000175224.17. [O75143-5]"";""ENST00000529655.5; ENSP00000433756.1; ENSG00000175224.17. [O75143-2]"";""ENST00000530500.5; ENSP00000434390.1; ENSG00000175224.17. [O75143-4]"";""ENST00000683050.1; ENSP00000507809.1; ENSG00000175224.17. [O75143-5]"";",protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539],autophagosome assembly [GO:0000045]; mitophagy [GO:0000423]; negative regulation of cell population proliferation [GO:0008285]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagy [GO:0010508]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein localization to phagophore assembly site [GO:0034497]; regulation of protein lipidation [GO:1903059]; response to mitochondrial depolarisation [GO:0098780],Atg1/ULK1 kinase complex [GO:1990316]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]
Q676U5,C3,1.682549813,0.306223931,-0.630250328,-0.493129108,-0.683474198,cyan,ATG16L1,A16L1_HUMAN,Autophagy-related protein 16-1 (APG16-like 1),ATG16L1 APG16L UNQ9393/PRO34307,55054;,"ENST00000347464.9; ENSP00000318259.6; ENSG00000085978.22. [Q676U5-5];""ENST00000373525.9; ENSP00000362625.5; ENSG00000085978.22. [Q676U5-4]"";""ENST00000392017.9; ENSP00000375872.4; ENSG00000085978.22. [Q676U5-1]"";""ENST00000392020.8; ENSP00000375875.4; ENSG00000085978.22. [Q676U5-2]"";""ENST00000625501.3; ENSP00000487542.1; ENSG00000281089.3. [Q676U5-1]"";""ENST00000626623.2; ENSP00000487298.1; ENSG00000281089.3. [Q676U5-5]"";""ENST00000630066.2; ENSP00000487446.1; ENSG00000281089.3. [Q676U5-2]"";""ENST00000630204.2; ENSP00000487455.1; ENSG00000281089.3. [Q676U5-4]"";",GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like protein transferase activity [GO:0019787],autophagosome assembly [GO:0000045]; C-terminal protein lipidation [GO:0006501]; corpus callosum development [GO:0022038]; defense response to virus [GO:0051607]; hippocampus development [GO:0021766]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095]
Q96BY7,C3,1.60741695,-0.006771816,-0.436091042,-0.325185313,-0.522774819,cyan,ATG2B,ATG2B_HUMAN,Autophagy-related protein 2 homolog B,ATG2B C14orf103,55102;,ENST00000359933.6; ENSP00000353010.4; ENSG00000066739.12.;,lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-membrane adaptor activity [GO:0043495],autophagosome assembly [GO:0000045]; glycophagy [GO:0061723]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709],endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; phagophore [GO:0061908]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]
Q9NT62,C4,1.977781482,-0.180653058,-0.601512546,-0.73436499,-0.947855395,deepskyblue2,ATG3,ATG3_HUMAN,Ubiquitin-like-conjugating enzyme ATG3 (EC 2.3.2.-) (Autophagy-related protein 3) (APG3-like) (hApg3) (Protein PC3-96),ATG3 APG3 APG3L,64422;,"ENST00000283290.10; ENSP00000283290.5; ENSG00000144848.11. [Q9NT62-1];""ENST00000402314.6; ENSP00000385943.2; ENSG00000144848.11. [Q9NT62-2]"";",Atg12 transferase activity [GO:0019777]; Atg8-family conjugating enzyme activity [GO:0141046]; Atg8-family ligase activity [GO:0019776]; enzyme binding [GO:0019899]; ubiquitin-like protein transferase activity [GO:0019787],autophagosome assembly [GO:0000045]; glycophagy [GO:0061723]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; negative regulation of phagocytosis [GO:0050765]; nucleophagy [GO:0044804]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of cilium assembly [GO:1902017],Atg12-Atg5-Atg16 complex [GO:0034274]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]
Q9Y4P1,C4,2.201285413,-0.007067961,-1.046067858,-1.186834796,-1.498298909,deepskyblue2,ATG4B,ATG4B_HUMAN,Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 1) (Autophagin-1) (Autophagy-related protein 4 homolog B) (HsAPG4B) (hAPG4B),ATG4B APG4B AUTL1 KIAA0943,23192;,"ENST00000402096.5; ENSP00000384661.1; ENSG00000168397.17. [Q9Y4P1-4];""ENST00000404914.8; ENSP00000384259.3; ENSG00000168397.17. [Q9Y4P1-1]"";""ENST00000405546.7; ENSP00000383964.3; ENSG00000168397.17. [Q9Y4P1-6]"";",cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786]; scaffold protein binding [GO:0097110],aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; mitophagy [GO:0000423]; otolith mineralization completed early in development [GO:0031173]; piecemeal microautophagy of the nucleus [GO:0034727]; protein delipidation [GO:0051697]; protein localization to phagophore assembly site [GO:0034497]; protein processing [GO:0016485]; protein transport [GO:0015031]; proteolysis [GO:0006508],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]
Q96DT6,C2,1.578130074,0.174521727,-0.553639675,-0.389581467,-0.210691026,aquamarine,ATG4C,ATG4C_HUMAN,Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 3) (Autophagin-3) (Autophagy-related protein 4 homolog C) (HsAPG4C),ATG4C APG4C AUTL1 AUTL3,84938;,"ENST00000317868.9; ENSP00000322159.4; ENSG00000125703.15.;""ENST00000371120.7; ENSP00000360161.3; ENSG00000125703.15."";",cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786],aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; protein delipidation [GO:0051697]; protein processing [GO:0016485]; protein transport [GO:0015031]; proteolysis [GO:0006508],cytoplasm [GO:0005737]
Q9H1Y0,C3,1.768096194,0.238524296,-0.671230096,-0.407969312,-0.662316891,cyan,ATG5,ATG5_HUMAN,Autophagy protein 5 (APG5-like) (Apoptosis-specific protein),ATG5 APG5L ASP,9474;,"ENST00000343245.7; ENSP00000343313.3; ENSG00000057663.16. [Q9H1Y0-1];""ENST00000369076.8; ENSP00000358072.3; ENSG00000057663.16. [Q9H1Y0-1]"";""ENST00000635758.2; ENSP00000490493.1; ENSG00000057663.16. [Q9H1Y0-2]"";",Atg8-family ligase activity [GO:0019776],aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chaperone-mediated autophagy [GO:0061684]; chromatin organization [GO:0006325]; establishment of localization in cell [GO:0051649]; heart contraction [GO:0060047]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; mucus secretion [GO:0070254]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of mucus secretion [GO:0070257]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of viral translation [GO:1904973]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fluoride [GO:1902617]; response to fungus [GO:0009620]; response to iron(II) ion [GO:0010040]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; phagocytic vesicle membrane [GO:0030670]; phagophore [GO:0061908]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]
O95352,C4,2.024943657,0.23849168,-0.920665652,-0.891136895,-1.123066213,deepskyblue2,ATG7,ATG7_HUMAN,Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein),ATG7 APG7L,10533;,"ENST00000354449.7; ENSP00000346437.3; ENSG00000197548.13. [O95352-1];""ENST00000354956.9; ENSP00000347042.5; ENSG00000197548.13. [O95352-2]"";""ENST00000446450.6; ENSP00000412580.2; ENSG00000197548.13. [O95352-3]"";""ENST00000685771.1; ENSP00000509725.1; ENSG00000197548.13. [O95352-1]"";""ENST00000693202.1; ENSP00000510336.1; ENSG00000197548.13. [O95352-1]"";",Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803],autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; defense response to virus [GO:0051607]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511],axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; phagophore assembly site [GO:0000407]; secretory granule lumen [GO:0034774]
Q7Z3C6,S1,-0.3991093,-1.202265754,-0.237061695,0.239353793,1.204720268,gold,ATG9A,ATG9A_HUMAN,Autophagy-related protein 9A (APG9-like 1) (mATG9),ATG9A APG9L1,79065;,"ENST00000361242.9; ENSP00000355173.4; ENSG00000198925.12. [Q7Z3C6-1];""ENST00000396761.6; ENSP00000379983.2; ENSG00000198925.12. [Q7Z3C6-1]"";""ENST00000409033.7; ENSP00000386482.3; ENSG00000198925.12. [Q7Z3C6-3]"";""ENST00000409422.5; ENSP00000386535.1; ENSG00000198925.12. [Q7Z3C6-2]"";""ENST00000409618.5; ENSP00000386710.1; ENSG00000198925.12. [Q7Z3C6-1]"";",phospholipid scramblase activity [GO:0017128],autophagosome assembly [GO:0000045]; bone morphogenesis [GO:0060349]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed necrotic cell death [GO:0097300]; protein localization to phagophore assembly site [GO:0034497]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]
P31939,C4,2.0914331,0.444051333,-1.093329429,-1.210863771,-1.253492965,deepskyblue2,ATIC,PUR9_HUMAN,"Bifunctional purine biosynthesis protein ATIC (AICAR transformylase/inosine monophosphate cyclohydrolase) (ATIC) [Cleaved into: Bifunctional purine biosynthesis protein ATIC, N-terminally processed] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR formyltransferase) (AICAR transformylase); Inosine 5'-monophosphate cyclohydrolase (IMP cyclohydrolase) (EC 3.5.4.10) (IMP synthase) (Inosinicase)]",ATIC PURH OK/SW-cl.86,471;,"ENST00000236959.14; ENSP00000236959.9; ENSG00000138363.15. [P31939-1];""ENST00000435675.5; ENSP00000415935.1; ENSG00000138363.15. [P31939-2]"";",cadherin binding [GO:0045296]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803],'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; animal organ regeneration [GO:0031100]; brainstem development [GO:0003360]; cellular response to interleukin-7 [GO:0098761]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dihydrofolate metabolic process [GO:0046452]; GMP biosynthetic process [GO:0006177]; nucleobase-containing compound metabolic process [GO:0006139]; response to inorganic substance [GO:0010035]; tetrahydrofolate biosynthetic process [GO:0046654],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q8NHH9,S1,-1.375213288,-1.217277833,-0.011915837,0.541058286,1.149826124,gold,ATL2,ATLA2_HUMAN,Atlastin-2 (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) (ARL-6-interacting protein 2) (Aip-2),ATL2 ARL6IP2,64225;,"ENST00000378954.9; ENSP00000368237.4; ENSG00000119787.14. [Q8NHH9-1];""ENST00000402054.5; ENSP00000384062.1; ENSG00000119787.14. [Q8NHH9-3]"";""ENST00000419554.6; ENSP00000415336.2; ENSG00000119787.14. [Q8NHH9-2]"";""ENST00000452935.6; ENSP00000390743.2; ENSG00000119787.14. [Q8NHH9-5]"";""ENST00000651368.1; ENSP00000498813.1; ENSG00000119787.14. [Q8NHH9-3]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; membrane [GO:0016020]
Q6DD88,S1,-1.342301202,-1.249459501,0.15512563,0.645666932,0.888299742,gold,ATL3,ATLA3_HUMAN,Atlastin-3 (EC 3.6.5.-),ATL3,25923;,ENST00000398868.8; ENSP00000381844.3; ENSG00000184743.13.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; protein homooligomerization [GO:0051260],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; membrane [GO:0016020]
P98196,S2,-1.263210741,-1.565629519,0.205912963,0.744019372,0.891532669,orange,ATP11A,AT11A_HUMAN,Phospholipid-transporting ATPase IH (EC 7.6.2.1) (ATPase IS) (ATPase class VI type 11A) (P4-ATPase flippase complex alpha subunit ATP11A),ATP11A ATPIH ATPIS KIAA1021,23250;,"ENST00000375645.8; ENSP00000364796.3; ENSG00000068650.19.;""ENST00000487903.5; ENSP00000420387.1; ENSG00000068650.19."";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556],in utero embryonic development [GO:0001701]; phospholipid translocation [GO:0045332]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane lipid distribution [GO:0097035],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]
Q9Y2G3,S1,-1.167566254,-1.449357043,0.078676316,0.568722961,1.116590375,gold,ATP11B,AT11B_HUMAN,Phospholipid-transporting ATPase IF (EC 7.6.2.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B),ATP11B ATPIF ATPIR KIAA0956,23200;,ENST00000323116.10; ENSP00000321195.5; ENSG00000058063.16.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; monoatomic ion transmembrane transporter activity [GO:0015075]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine floppase activity [GO:0090556],aminophospholipid transport [GO:0015917]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; phospholipid translocation [GO:0045332],azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]
Q8NB49,S2,-1.263676338,-1.456450315,0.1509257,0.840486896,0.822820096,orange,ATP11C,AT11C_HUMAN,Phospholipid-transporting ATPase IG (EC 7.6.2.1) (ATPase IQ) (ATPase class VI type 11C) (P4-ATPase flippase complex alpha subunit ATP11C),ATP11C ATPIG ATPIQ,286410;,"ENST00000327569.7; ENSP00000332756.3; ENSG00000101974.15. [Q8NB49-1];""ENST00000361648.6; ENSP00000355165.2; ENSG00000101974.15. [Q8NB49-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylethanolamine flippase activity [GO:0090555]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556],monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]
Q9HD20,S2,-0.965848005,-1.23882828,0.203060743,0.855039961,0.561642602,orange,ATP13A1,AT131_HUMAN,Endoplasmic reticulum transmembrane helix translocase (EC 7.4.2.-) (Endoplasmic reticulum P5A-ATPase),ATP13A1 ATP13A KIAA1825 CGI-152,57130;,"ENST00000291503.9; ENSP00000291503.5; ENSG00000105726.17. [Q9HD20-2];""ENST00000357324.11; ENSP00000349877.6; ENSG00000105726.17. [Q9HD20-1]"";",ABC-type manganese transporter activity [GO:0015410]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; membrane protein dislocase activity [GO:0140567]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662],extraction of mislocalized protein from ER membrane [GO:0140569]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; protein transport [GO:0015031]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9NQ11,S1,-1.097424468,-1.35084215,-0.478430534,0.804826061,1.065500599,gold,ATP13A2,AT132_HUMAN,Polyamine-transporting ATPase 13A2 (EC 7.6.2.-),ATP13A2 PARK9,23400;,"ENST00000326735.13; ENSP00000327214.8; ENSG00000159363.19. [Q9NQ11-1];""ENST00000341676.9; ENSP00000341115.5; ENSG00000159363.19. [Q9NQ11-2]"";""ENST00000452699.5; ENSP00000413307.1; ENSG00000159363.19. [Q9NQ11-3]"";","ABC-type polyamine transporter activity [GO:0015417]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; cupric ion binding [GO:1903135]; manganese ion binding [GO:0030145]; P-type ion transporter activity [GO:0015662]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; polyamine transmembrane transporter activity [GO:0015203]; zinc ion binding [GO:0008270]",autophagosome organization [GO:1905037]; autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to zinc ion [GO:0071294]; extracellular exosome biogenesis [GO:0097734]; intracellular calcium ion homeostasis [GO:0006874]; intracellular iron ion homeostasis [GO:0006879]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; lipid homeostasis [GO:0055088]; lysosomal transport [GO:0007041]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of lysosomal protein catabolic process [GO:1905166]; peptidyl-aspartic acid autophosphorylation [GO:1990938]; polyamine transmembrane transport [GO:1902047]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein autophosphorylation [GO:0046777]; protein localization to lysosome [GO:0061462]; regulation of autophagosome size [GO:0016243]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of endopeptidase activity [GO:0052548]; regulation of intracellular protein transport [GO:0033157]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of neuron apoptotic process [GO:0043523]; regulation of protein localization to nucleus [GO:1900180]; regulation of ubiquitin-specific protease activity [GO:2000152]; spermine transmembrane transport [GO:1903710]; transmembrane transport [GO:0055085],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; transport vesicle [GO:0030133]; vesicle [GO:0031982]
Q9H7F0,S2,-1.056273992,-1.463768392,0.218134919,0.797039591,0.698483605,orange,ATP13A3,AT133_HUMAN,Polyamine-transporting ATPase 13A3 (ATPase family homolog up-regulated in senescence cells 1) (Putrescine transporting ATPase) (EC 7.6.2.16),ATP13A3 AFURS1,79572;,"ENST00000439040.6; ENSP00000416508.1; ENSG00000133657.17. [Q9H7F0-1];""ENST00000645538.1; ENSP00000494471.1; ENSG00000133657.17. [Q9H7F0-1]"";",ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358]; polyamine transmembrane transporter activity [GO:0015203],intracellular calcium ion homeostasis [GO:0006874]; polyamine transmembrane transport [GO:1902047],early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]
P05023,S4,-1.221600036,-1.54057218,0.523865613,1.033930508,0.056754367,tomato2,ATP1A1,AT1A1_HUMAN,Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1),ATP1A1,476;,"ENST00000295598.10; ENSP00000295598.5; ENSG00000163399.16. [P05023-1];""ENST00000369496.8; ENSP00000358508.4; ENSG00000163399.16. [P05023-3]"";""ENST00000537345.5; ENSP00000445306.1; ENSG00000163399.16. [P05023-4]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; protein-folding chaperone binding [GO:0051087]; sodium ion binding [GO:0031402]; steroid hormone binding [GO:1990239]; transmembrane transporter binding [GO:0044325],cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to steroid hormone stimulus [GO:0071383]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of glucocorticoid biosynthetic process [GO:0031947]; negative regulation of heart contraction [GO:0045822]; osmosensory signaling pathway [GO:0007231]; positive regulation of heart contraction [GO:0045823]; positive regulation of striated muscle contraction [GO:0045989]; potassium ion import across plasma membrane [GO:1990573]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of sodium ion transport [GO:0002028]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to glycoside [GO:1903416]; response to xenobiotic stimulus [GO:0009410]; sodium ion export across plasma membrane [GO:0036376],apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; organelle membrane [GO:0031090]; photoreceptor inner segment membrane [GO:0060342]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]
P50993,S4,-1.223619951,-1.517211019,0.552209204,1.141462153,0.137956345,tomato2,ATP1A2,AT1A2_HUMAN,Sodium/potassium-transporting ATPase subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-2),ATP1A2 KIAA0778,477;,ENST00000361216.8; ENSP00000354490.3; ENSG00000018625.15.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; phosphatase activity [GO:0016791]; potassium ion binding [GO:0030955]; protein heterodimerization activity [GO:0046982]; protein-folding chaperone binding [GO:0051087]; sodium ion binding [GO:0031402]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239],"adult locomotory behavior [GO:0008344]; amygdala development [GO:0021764]; ATP metabolic process [GO:0046034]; behavioral fear response [GO:0001662]; cardiac muscle contraction [GO:0060048]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cellular response to mechanical stimulus [GO:0071260]; cellular response to steroid hormone stimulus [GO:0071383]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; L-ascorbic acid metabolic process [GO:0019852]; locomotion [GO:0040011]; locomotory exploration behavior [GO:0035641]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization [GO:0086009]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of calcium ion transmembrane transport [GO:1903170]; negative regulation of calcium:sodium antiporter activity [GO:1903280]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of striated muscle contraction [GO:0045988]; neuronal action potential propagation [GO:0019227]; neurotransmitter uptake [GO:0001504]; olfactory cortex development [GO:0021989]; positive regulation of heart contraction [GO:0045823]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; proton transmembrane transport [GO:1902600]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051946]; regulation of muscle contraction [GO:0006937]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of smooth muscle contraction [GO:0006940]; regulation of striated muscle contraction [GO:0006942]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of the force of heart contraction [GO:0002026]; regulation of vasoconstriction [GO:0019229]; relaxation of cardiac muscle [GO:0055119]; response to auditory stimulus [GO:0010996]; response to glycoside [GO:1903416]; response to nicotine [GO:0035094]; response to potassium ion [GO:0035864]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814]; transport across blood-brain barrier [GO:0150104]; visual learning [GO:0008542]",caveola [GO:0005901]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; T-tubule [GO:0030315]
P05026,S4,-1.452978238,-1.551141664,0.524042002,0.91448126,0.172847461,tomato2,ATP1B1,AT1B1_HUMAN,Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1),ATP1B1 ATP1B,481;,"ENST00000367815.9; ENSP00000356789.3; ENSG00000143153.14. [P05026-1];""ENST00000367816.5; ENSP00000356790.1; ENSG00000143153.14. [P05026-1]"";""ENST00000689522.1; ENSP00000509039.1; ENSG00000143153.14. [P05026-1]"";""ENST00000690184.1; ENSP00000509517.1; ENSG00000143153.14. [P05026-1]"";",ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; MHC class II protein complex binding [GO:0023026]; P-type sodium:potassium-exchanging transporter activity [GO:0005391]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674],ATP metabolic process [GO:0046034]; cardiac muscle contraction [GO:0060048]; cell adhesion [GO:0007155]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; innate immune response [GO:0045087]; intracellular calcium ion homeostasis [GO:0006874]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; monoatomic cation transmembrane transport [GO:0098655]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of P-type sodium:potassium-exchanging transporter activity [GO:1903408]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport into plasma membrane raft [GO:0044861]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression [GO:0010468]; relaxation of cardiac muscle [GO:0055119]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]; T-tubule [GO:0030315]
P54709,S4,-0.8011603,-1.03690188,0.468085962,0.868654914,0.123410573,tomato2,ATP1B3,AT1B3_HUMAN,Sodium/potassium-transporting ATPase subunit beta-3 (Sodium/potassium-dependent ATPase subunit beta-3) (ATPB-3) (CD antigen CD298),ATP1B3,483;,ENST00000286371.8; ENSP00000286371.3; ENSG00000069849.11. [P54709-1];,ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; protein-macromolecule adaptor activity [GO:0030674],intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; membrane repolarization [GO:0086009]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of sodium ion export across plasma membrane [GO:1903278]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; sodium ion export across plasma membrane [GO:0036376]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; sodium:potassium-exchanging ATPase complex [GO:0005890]; sperm flagellum [GO:0036126]
P16615,S2,-1.082434409,-1.300557245,0.182625237,0.879800671,0.571606614,orange,ATP2A2,AT2A2_HUMAN,"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 7.2.2.10) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)",ATP2A2 ATP2B,488;,"ENST00000308664.10; ENSP00000311186.6; ENSG00000174437.18. [P16615-2];""ENST00000539276.7; ENSP00000440045.2; ENSG00000174437.18. [P16615-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; lncRNA binding [GO:0106222]; P-type calcium transporter activity [GO:0005388]; P-type calcium transporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086039]; S100 protein binding [GO:0044548]; transmembrane transporter binding [GO:0044325],autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport from cytosol to endoplasmic reticulum [GO:1903515]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell adhesion [GO:0007155]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epidermis development [GO:0008544]; ER-nucleus signaling pathway [GO:0006984]; intracellular calcium ion homeostasis [GO:0006874]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of heart contraction [GO:0045822]; negative regulation of receptor binding [GO:1900121]; neuron cellular homeostasis [GO:0070050]; organelle localization by membrane tethering [GO:0140056]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; positive regulation of heart rate [GO:0010460]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of the force of heart contraction [GO:0002026]; relaxation of cardiac muscle [GO:0055119]; response to endoplasmic reticulum stress [GO:0034976]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; transition between fast and slow fiber [GO:0014883],calcium ion-transporting ATPase complex [GO:0090534]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; longitudinal sarcoplasmic reticulum [GO:0014801]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; ribbon synapse [GO:0097470]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]
P20020,S4,-1.253952969,-1.50338465,0.523673869,0.992061439,-0.017195266,tomato2,ATP2B1,AT2B1_HUMAN,Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1),ATP2B1 PMCA1,490;,"ENST00000359142.8; ENSP00000352054.3; ENSG00000070961.17. [P20020-2];""ENST00000428670.8; ENSP00000392043.3; ENSG00000070961.17. [P20020-3]"";""ENST00000551310.2; ENSP00000447041.2; ENSG00000070961.17. [P20020-2]"";""ENST00000705822.1; ENSP00000516172.1; ENSG00000070961.17. [P20020-5]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; molecular function inhibitor activity [GO:0140678]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165],calcium ion export across plasma membrane [GO:1990034]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of bone mineralization [GO:0030501]; positive regulation of calcium ion transport [GO:0051928]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of vascular associated smooth muscle contraction [GO:0003056],basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]
P23634,S4,-1.062663637,-1.392339134,0.520599107,1.026137598,0.050228237,tomato2,ATP2B4,AT2B4_HUMAN,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),ATP2B4 ATP2B2 MXRA1,493;,"ENST00000341360.7; ENSP00000340930.2; ENSG00000058668.16. [P23634-2];""ENST00000357681.10; ENSP00000350310.5; ENSG00000058668.16. [P23634-6]"";""ENST00000705901.1; ENSP00000516177.1; ENSG00000058668.16. [P23634-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080],calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018]
P98194,S1,-1.157403824,-1.413919391,-0.160340141,0.914874718,1.040783535,gold,ATP2C1,AT2C1_HUMAN,Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1) (SPCA1),ATP2C1 KIAA1347 PMR1L HUSSY-28,27032;,"ENST00000328560.12; ENSP00000329664.8; ENSG00000017260.20. [P98194-2];""ENST00000359644.7; ENSP00000352665.3; ENSG00000017260.20. [P98194-9]"";""ENST00000422190.6; ENSP00000402677.2; ENSG00000017260.20. [P98194-5]"";""ENST00000428331.6; ENSP00000395809.2; ENSG00000017260.20. [P98194-1]"";""ENST00000504381.5; ENSP00000425320.2; ENSG00000017260.20. [P98194-8]"";""ENST00000504948.5; ENSP00000423330.1; ENSG00000017260.20. [P98194-4]"";""ENST00000507488.6; ENSP00000421326.3; ENSG00000017260.20. [P98194-7]"";""ENST00000508532.5; ENSP00000424783.1; ENSG00000017260.20. [P98194-1]"";""ENST00000510168.6; ENSP00000427461.1; ENSG00000017260.20. [P98194-1]"";""ENST00000513801.5; ENSP00000422872.1; ENSG00000017260.20. [P98194-3]"";""ENST00000533801.6; ENSP00000432956.3; ENSG00000017260.20. [P98194-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; P-type calcium transporter activity [GO:0005388]; P-type manganese transporter activity [GO:0140613],actin cytoskeleton organization [GO:0030036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; intracellular calcium ion homeostasis [GO:0006874]; intracellular manganese ion homeostasis [GO:0030026]; manganese ion transport [GO:0006828]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; trans-Golgi network membrane organization [GO:0098629],cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
P25705,M2,-1.221992008,-1.211910499,0.362251561,1.179857107,-0.189397295,tan4,ATP5A1,ATPA_HUMAN,"ATP synthase subunit alpha, mitochondrial (ATP synthase F1 subunit alpha)",ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM,498;,"ENST00000282050.6; ENSP00000282050.2; ENSG00000152234.16. [P25705-1];""ENST00000398752.11; ENSP00000381736.5; ENSG00000152234.16. [P25705-1]"";""ENST00000590665.5; ENSP00000467037.1; ENSG00000152234.16. [P25705-3]"";""ENST00000593152.6; ENSP00000465477.2; ENSG00000152234.16. [P25705-2]"";","ADP binding [GO:0043531]; angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]",ATP biosynthetic process [GO:0006754]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nitric oxide [GO:0071732]; lipid metabolic process [GO:0006629]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to ethanol [GO:0045471]; response to muscle activity [GO:0014850],"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"
P06576,M2,-0.852687196,-0.851735906,0.351398927,0.98240501,-0.205650941,tan4,ATP5B,ATPB_HUMAN,"ATP synthase subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)",ATP5F1B ATP5B ATPMB ATPSB,506;,ENST00000262030.8; ENSP00000262030.3; ENSG00000110955.9.;,"angiostatin binding [GO:0043532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; MHC class I protein binding [GO:0042288]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",angiogenesis [GO:0001525]; ATP biosynthetic process [GO:0006754]; cellular response to interleukin-7 [GO:0098761]; generation of precursor metabolites and energy [GO:0006091]; lipid metabolic process [GO:0006629]; negative regulation of cell adhesion involved in substrate-bound cell migration [GO:0006933]; osteoblast differentiation [GO:0001649]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453],"cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, catalytic core [GO:0005754]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]"
P36542,M2,-1.255703327,-1.400708907,0.368247941,1.1727319,-0.182975035,tan4,ATP5C1,ATPG_HUMAN,"ATP synthase subunit gamma, mitochondrial (ATP synthase F1 subunit gamma) (F-ATPase gamma subunit)",ATP5F1C ATP5C ATP5C1 ATP5CL1,509;,"ENST00000335698.4; ENSP00000338568.4; ENSG00000165629.20. [P36542-2];""ENST00000356708.12; ENSP00000349142.7; ENSG00000165629.20. [P36542-1]"";","proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; RNA binding [GO:0003723]",ATP biosynthetic process [GO:0006754]; oxidative phosphorylation [GO:0006119]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"
P30049,M2,-1.084825402,-0.621075643,0.391740433,1.048190076,-0.245004926,tan4,ATP5D,ATPD_HUMAN,"ATP synthase subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)",ATP5F1D ATP5D,513;,"ENST00000215375.7; ENSP00000215375.1; ENSG00000099624.8.;""ENST00000395633.5; ENSP00000378995.1; ENSG00000099624.8."";""ENST00000591660.5; ENSP00000464863.1; ENSG00000099624.8."";","proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]",aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to copper ion [GO:0046688],"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1) [GO:0000275]; mitochondrion [GO:0005739]"
P24539,M2,-0.954193533,-1.195396667,0.328826589,1.118665359,-0.069039356,tan4,ATP5F1,AT5F1_HUMAN,"ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase peripheral stalk-membrane subunit b) (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b) (ATPase subunit b)",ATP5PB ATP5F1,515;,ENST00000369722.8; ENSP00000358737.3; ENSG00000116459.11.;,proton transmembrane transporter activity [GO:0015078],proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; substantia nigra development [GO:0021762],"membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; nucleus [GO:0005634]"
O75947,M2,-1.391384229,-1.591422824,0.348906465,1.285792675,-0.17843109,tan4,ATP5H,ATP5H_HUMAN,"ATP synthase subunit d, mitochondrial (ATPase subunit d) (ATP synthase peripheral stalk subunit d)",ATP5PD ATP5H My032,10476;,"ENST00000301587.9; ENSP00000301587.4; ENSG00000167863.12. [O75947-1];""ENST00000344546.8; ENSP00000344230.4; ENSG00000167863.12. [O75947-2]"";",proton transmembrane transporter activity [GO:0015078],proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]"
P56385,M2,-0.804226633,-1.122711513,0.294696134,1.14615289,-0.243877348,tan4,ATP5I,ATP5I_HUMAN,"ATP synthase subunit e, mitochondrial (ATPase subunit e) (ATP synthase membrane subunit e) [Cleaved into: ATP synthase subunit e, mitochondrial, N-terminally processed]",ATP5ME ATP5I ATP5K,521;,ENST00000304312.5; ENSP00000306003.4; ENSG00000169020.10.;,proton transmembrane transporter activity [GO:0015078],proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]"
P18859,M2,-1.440432424,-1.523028517,0.355684856,1.197681029,-0.168063389,tan4,ATP5J,ATP5J_HUMAN,"ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6) (ATP synthase peripheral stalk subunit F6)",ATP5PF ATP5A ATP5J ATPM,522;,"ENST00000284971.8; ENSP00000284971.3; ENSG00000154723.13. [P18859-1];""ENST00000400087.7; ENSP00000382959.3; ENSG00000154723.13. [P18859-1]"";""ENST00000400090.7; ENSP00000382962.3; ENSG00000154723.13. [P18859-1]"";""ENST00000400093.3; ENSP00000382965.3; ENSG00000154723.13. [P18859-1]"";""ENST00000400094.5; ENSP00000382966.1; ENSG00000154723.13. [P18859-1]"";""ENST00000457143.6; ENSP00000389649.2; ENSG00000154723.13. [P18859-2]"";",proton transmembrane transporter activity [GO:0015078],proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; substantia nigra development [GO:0021762],"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]"
P48047,M2,-1.251826247,-1.30391279,0.447000235,1.102167336,-0.158641036,tan4,ATP5O,ATPO_HUMAN,"ATP synthase subunit O, mitochondrial (ATP synthase peripheral stalk subunit OSCP) (Oligomycin sensitivity conferral protein) (OSCP)",ATP5PO ATP5O ATPO,539;,ENST00000290299.7; ENSP00000290299.2; ENSG00000241837.7.;,"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]",ATP biosynthetic process [GO:0006754]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600],"mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase, stator stalk [GO:0000274]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]"
Q99766,M1,-0.833890332,-0.611540144,0.446456955,0.940140856,-0.338230293,burlywood4,ATP5S,ATP5S_HUMAN,"ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Distal membrane arm assembly complex 2-like protein) (Mitochondrial ATP synthase regulatory component factor B)",DMAC2L ATP5S ATPW,27109;,"ENST00000245448.11; ENSP00000245448.7; ENSG00000125375.18. [Q99766-3];""ENST00000311459.12; ENSP00000308334.8; ENSG00000125375.18. [Q99766-1]"";""ENST00000426751.7; ENSP00000389246.3; ENSG00000125375.18. [Q99766-2]"";""ENST00000554204.7; ENSP00000451583.3; ENSG00000125375.18. [Q99766-1]"";""ENST00000554438.6; ENSP00000509859.1; ENSG00000125375.18. [Q99766-1]"";""ENST00000554951.6; ENSP00000494641.2; ENSG00000125375.18. [Q99766-1]"";""ENST00000557421.7; ENSP00000506374.1; ENSG00000125375.18. [Q99766-1]"";""ENST00000672419.1; ENSP00000499920.1; ENSG00000125375.18. [Q99766-3]"";""ENST00000672910.1; ENSP00000500502.1; ENSG00000125375.18. [Q99766-3]"";",metal ion binding [GO:0046872]; proton transmembrane transporter activity [GO:0015078],ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600],"cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]"
Q9NW81,M2,-1.377682969,-1.307072026,0.291664382,1.032977908,-0.094827055,tan4,ATP5SL,DMAC2_HUMAN,Distal membrane-arm assembly complex protein 2 (ATP synthase subunit s-like protein),DMAC2 ATP5SL,55101;,"ENST00000221943.14; ENSP00000221943.8; ENSG00000105341.19. [Q9NW81-1];""ENST00000301183.15; ENSP00000301183.9; ENSG00000105341.19. [Q9NW81-3]"";""ENST00000417807.7; ENSP00000403910.2; ENSG00000105341.19. [Q9NW81-4]"";""ENST00000438807.7; ENSP00000397413.3; ENSG00000105341.19. [Q9NW81-2]"";""ENST00000589970.5; ENSP00000466485.1; ENSG00000105341.19. [Q9NW81-6]"";""ENST00000592922.6; ENSP00000467205.1; ENSG00000105341.19. [Q9NW81-5]"";",0,mitochondrial respiratory chain complex I assembly [GO:0032981]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],mitochondrion [GO:0005739]; SCF ubiquitin ligase complex [GO:0019005]
Q15904,S2,-1.13003495,-1.339805931,0.14264099,0.826727763,0.633588549,orange,ATP6AP1,VAS1_HUMAN,V-type proton ATPase subunit S1 (V-ATPase subunit S1) (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1),ATP6AP1 ATP6IP1 ATP6S1 VATPS1 XAP3,537;,ENST00000369762.7; ENSP00000358777.2; ENSG00000071553.18.;,ATPase activator activity [GO:0001671]; small GTPase binding [GO:0031267]; transporter activator activity [GO:0141109],cellular response to increased oxygen levels [GO:0036295]; endosomal lumen acidification [GO:0048388]; endosome to plasma membrane protein transport [GO:0099638]; Golgi lumen acidification [GO:0061795]; intracellular iron ion homeostasis [GO:0006879]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; osteoclast development [GO:0036035]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035],clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672]
O75787,S3,-0.502880505,-1.006584477,0.147323504,0.84233347,0.582121155,salmon,ATP6AP2,RENR_HUMAN,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adapter) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (ATP6M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor N-terminal fragment; Renin receptor C-terminal fragment],ATP6AP2 ATP6IP2 CAPER ELDF10 HT028 MSTP009 PSEC0072,10159;,"ENST00000636409.1; ENSP00000489819.1; ENSG00000182220.15. [O75787-2];""ENST00000636580.2; ENSP00000490083.1; ENSG00000182220.15. [O75787-1]"";",signaling receptor activity [GO:0038023],angiotensin maturation [GO:0002003]; central nervous system maturation [GO:0021626]; endosomal lumen acidification [GO:0048388]; eye pigmentation [GO:0048069]; Golgi lumen acidification [GO:0061795]; head morphogenesis [GO:0060323]; intracellular pH reduction [GO:0051452]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600]; regulation of MAPK cascade [GO:0043408]; rostrocaudal neural tube patterning [GO:0021903]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035],"autophagosome membrane [GO:0000421]; axon [GO:0030424]; clathrin-coated vesicle membrane [GO:0030665]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672]; tertiary granule membrane [GO:0070821]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"
Q93050,S1,-0.657650317,-1.12340114,-0.232063462,0.561402805,0.998295685,gold,ATP6V0A1,VPP1_HUMAN,V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1),ATP6V0A1 ATP6N1 ATP6N1A VPP1,535;,"ENST00000264649.10; ENSP00000264649.5; ENSG00000033627.18. [Q93050-3];""ENST00000343619.9; ENSP00000342951.3; ENSG00000033627.18. [Q93050-2]"";""ENST00000393829.6; ENSP00000377415.2; ENSG00000033627.18. [Q93050-1]"";""ENST00000703901.1; ENSP00000515539.1; ENSG00000033627.18. [Q93050-2]"";","ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035],"clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"
Q9Y487,S1,-0.943233204,-1.279169164,-0.1343187,0.739695067,1.194428485,gold,ATP6V0A2,VPP2_HUMAN,V-type proton ATPase 116 kDa subunit a 2 (V-ATPase 116 kDa subunit a 2) (Lysosomal H(+)-transporting ATPase V0 subunit a 2) (TJ6) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2),ATP6V0A2,23545;,ENST00000330342.8; ENSP00000332247.2; ENSG00000185344.15.;,"ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",cellular response to increased oxygen levels [GO:0036295]; Golgi lumen acidification [GO:0061795]; immune response [GO:0006955]; intracellular iron ion homeostasis [GO:0006879]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; vacuolar acidification [GO:0007035],"acrosomal vesicle [GO:0001669]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; transmembrane transporter complex [GO:1902495]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"
P61421,S1,-0.613871274,-1.092181285,-0.215772165,0.751203826,0.892443038,gold,ATP6V0D1,VA0D1_HUMAN,V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (32 kDa accessory protein) (V-ATPase 40 kDa accessory protein) (V-ATPase AC39 subunit) (p39) (Vacuolar proton pump subunit d 1),ATP6V0D1 ATP6D VPATPD,9114;,ENST00000290949.8; ENSP00000290949.3; ENSG00000159720.13.;,"protein-containing complex binding [GO:0044877]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; intracellular iron ion homeostasis [GO:0006879]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034],"apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; synaptic vesicle membrane [GO:0030672]; transmembrane transporter complex [GO:1902495]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"
Q04656,S2,-0.915753402,-1.255483065,0.092014433,0.839675088,0.76488304,orange,ATP7A,ATP7A_HUMAN,Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein),ATP7A MC1 MNK,538;,"ENST00000341514.11; ENSP00000345728.6; ENSG00000165240.22. [Q04656-1];""ENST00000685264.1; ENSP00000510136.1; ENSG00000165240.22. [Q04656-1]"";""ENST00000686133.1; ENSP00000509233.1; ENSG00000165240.22. [Q04656-1]"";""ENST00000686543.1; ENSP00000509477.1; ENSG00000165240.22. [Q04656-5]"";""ENST00000687086.1; ENSP00000509566.1; ENSG00000165240.22. [Q04656-1]"";""ENST00000692908.1; ENSP00000508627.1; ENSG00000165240.22. [Q04656-5]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; protein-folding chaperone binding [GO:0051087]; small GTPase binding [GO:0031267]; superoxide dismutase copper chaperone activity [GO:0016532],blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion homeostasis [GO:0055070]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; elastin biosynthetic process [GO:0051542]; epinephrine metabolic process [GO:0042414]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; hair follicle morphogenesis [GO:0031069]; in utero embryonic development [GO:0001701]; intracellular copper ion homeostasis [GO:0006878]; lactation [GO:0007595]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of iron ion transmembrane transport [GO:0034760]; neuron projection morphogenesis [GO:0048812]; norepinephrine metabolic process [GO:0042415]; peptidyl-lysine modification [GO:0018205]; pigmentation [GO:0043473]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of response to wounding [GO:1903036]; positive regulation of tyrosinase activity [GO:0032773]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; pyramidal neuron development [GO:0021860]; regulation of oxidative phosphorylation [GO:0002082]; removal of superoxide radicals [GO:0019430]; response to iron(III) ion [GO:0010041]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tryptophan metabolic process [GO:0006568],apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; microvillus [GO:0005902]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]
P35670,S1,-0.579724789,-1.084497634,0.042110385,0.70870904,0.745402353,gold,ATP7B,ATP7B_HUMAN,Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa],ATP7B PWD WC1 WND,540;,"ENST00000242839.10; ENSP00000242839.5; ENSG00000123191.17. [P35670-1];""ENST00000400366.6; ENSP00000383217.3; ENSG00000123191.17. [P35670-3]"";""ENST00000674147.2; ENSP00000500964.2; ENSG00000123191.17. [P35670-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581],copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; lactation [GO:0007595]; monoatomic ion transmembrane transport [GO:0034220]; protein maturation by copper ion transfer [GO:0015680]; response to copper ion [GO:0046688]; sequestering of calcium ion [GO:0051208]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]
O43520,S4,-1.090935594,-1.439306724,0.550663169,0.887570848,0.204387125,tomato2,ATP8B1,AT8B1_HUMAN,Phospholipid-transporting ATPase IC (EC 7.6.2.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1),ATP8B1 ATPIC FIC1 PFIC,5205;,ENST00000648908.2; ENSP00000497896.1; ENSG00000081923.15.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; cardiolipin binding [GO:1901612]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556],apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; Golgi organization [GO:0007030]; inner ear receptor cell development [GO:0060119]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of DNA-templated transcription [GO:0045892]; phospholipid translocation [GO:0045332]; regulation of chloride transport [GO:2001225]; regulation of microvillus assembly [GO:0032534]; regulation of plasma membrane organization [GO:1903729]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve formation [GO:0021650]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; trans-Golgi network [GO:0005802]
O75110,S1,-0.747303986,-1.258258974,0.148260046,0.598297052,0.990618211,gold,ATP9A,ATP9A_HUMAN,Probable phospholipid-transporting ATPase IIA (EC 7.6.2.1) (ATPase class II type 9A),ATP9A ATPIIA KIAA0611,10079;,ENST00000338821.6; ENSP00000342481.5; ENSG00000054793.14. [O75110-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020],"endocytosis [GO:0006897]; negative regulation of exosomal secretion [GO:1903542]; neuron projection morphogenesis [GO:0048812]; phospholipid translocation [GO:0045332]; regulation of endocytic recycling [GO:2001135]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]
O43861,S1,-0.719463868,-1.112361846,-0.203812003,0.596046849,0.964506997,gold,ATP9B,ATP9B_HUMAN,Probable phospholipid-transporting ATPase IIB (EC 7.6.2.1) (ATPase class II type 9B),ATP9B ATPIIB NEO1L HUSSY-20,374868;,"ENST00000307671.12; ENSP00000304500.7; ENSG00000166377.21. [O43861-2];""ENST00000426216.6; ENSP00000398076.2; ENSG00000166377.21. [O43861-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287],"endocytosis [GO:0006897]; phospholipid translocation [GO:0045332]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",endosome [GO:0005768]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
Q5TC12,M1,-0.869285699,-0.075806101,0.457380098,0.933258354,-0.666860485,burlywood4,ATPAF1,ATPF1_HUMAN,ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog),ATPAF1 ATP11,64756;,"ENST00000532925.5; ENSP00000435732.1; ENSG00000123472.13. [Q5TC12-3];""ENST00000574428.6; ENSP00000459167.2; ENSG00000123472.13. [Q5TC12-1]"";",protein-containing complex stabilizing activity [GO:0140777],mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
O75882,S3,-1.205451694,-0.628383315,0.179300151,0.684819036,0.757128327,salmon,ATRN,ATRN_HUMAN,Attractin (DPPT-L) (Mahogany homolog),ATRN KIAA0548 MGCA,8455;,"ENST00000262919.10; ENSP00000262919.5; ENSG00000088812.18. [O75882-1];""ENST00000446916.2; ENSP00000416587.2; ENSG00000088812.18. [O75882-2]"";",carbohydrate binding [GO:0030246]; signaling receptor activity [GO:0038023],cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; myelination [GO:0042552]; pigmentation [GO:0043473]; regulation of multicellular organism growth [GO:0040014],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]
P46100,N2,-1.3724744,-0.073307026,1.075972508,0.153277012,-0.635534098,grey70,ATRX,ATRX_HUMAN,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),ATRX RAD54L XH2,546;,"ENST00000373344.11; ENSP00000362441.4; ENSG00000085224.23. [P46100-1];""ENST00000395603.7; ENSP00000378967.3; ENSG00000085224.23. [P46100-4]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; chromo shadow domain binding [GO:0070087]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064],"cellular response to hydroxyurea [GO:0072711]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of DNA-templated transcription [GO:0006355]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283]; subtelomeric heterochromatin formation [GO:0031509]; transcription by RNA polymerase II [GO:0006366]","chromosome, subtelomeric region [GO:0099115]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]"
P54253,N4,-0.541794951,0.989343452,-0.050399657,-0.30127671,-0.282698874,grey30,ATXN1,ATX1_HUMAN,Ataxin-1 (Spinocerebellar ataxia type 1 protein),ATXN1 ATX1 SCA1,6310;,"ENST00000244769.8; ENSP00000244769.3; ENSG00000124788.19. [P54253-1];""ENST00000436367.6; ENSP00000416360.1; ENSG00000124788.19. [P54253-1]"";",DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266],brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; RNA processing [GO:0006396]; social behavior [GO:0035176],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P54252,C5,1.740256813,0.399649642,-0.539365266,-0.516199887,-0.93728965,turquoise3,ATXN3,ATX3_HUMAN,Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein),ATXN3 ATX3 MJD MJD1 SCA3,4287;,"ENST00000340660.10; ENSP00000339110.6; ENSG00000066427.25. [P54252-3];""ENST00000502250.5; ENSP00000425322.1; ENSG00000066427.25. [P54252-5]"";""ENST00000503767.5; ENSP00000426697.1; ENSG00000066427.25. [P54252-4]"";""ENST00000532032.5; ENSP00000437157.1; ENSG00000066427.25. [P54252-1]"";""ENST00000644486.2; ENSP00000496695.1; ENSG00000066427.25. [P54252-2]"";",ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; ubiquitin protein ligase binding [GO:0031625],actin cytoskeleton organization [GO:0030036]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; chemical synaptic transmission [GO:0007268]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of TORC1 signaling [GO:1904262]; nervous system development [GO:0007399]; nucleotide-excision repair [GO:0006289]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex [GO:1904327]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202]
Q96GX2,C3,1.815871615,0.205739081,-0.628160925,-0.661849816,-0.977401984,cyan,ATXN7L3B,A7L3B_HUMAN,Ataxin-7-like protein 3B,ATXN7L3B,552889;,ENST00000519948.4; ENSP00000430000.2; ENSG00000253719.4.;,0,regulation of gene expression [GO:0010468],cytoplasm [GO:0005737]
Q9Y679,S3,-0.650760852,-1.12804053,0.260328916,0.683917789,0.559824612,salmon,AUP1,AUP1_HUMAN,Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1),AUP1,550;,"ENST00000377526.4; ENSP00000366748.3; ENSG00000115307.17. [Q9Y679-2];""ENST00000425118.5; ENSP00000403430.1; ENSG00000115307.17. [Q9Y679-3]"";",ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625],"ERAD pathway [GO:0036503]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipophagy [GO:0061724]; protein localization to lipid droplet [GO:1990044]; response to virus [GO:0009615]; retrograde protein transport, ER to cytosol [GO:0030970]",autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; membrane [GO:0016020]
Q96GD4,N3,-0.48951219,-0.549513399,0.988785075,0.117947185,-0.153339843,grey50,AURKB,AURKB_HUMAN,Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B),AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5,9212;,"ENST00000316199.10; ENSP00000313950.6; ENSG00000178999.13. [Q96GD4-5];""ENST00000534871.5; ENSP00000443869.1; ENSG00000178999.13. [Q96GD4-4]"";""ENST00000578549.5; ENSP00000462207.1; ENSG00000178999.13. [Q96GD4-2]"";""ENST00000585124.6; ENSP00000463999.1; ENSG00000178999.13. [Q96GD4-1]"";",ATP binding [GO:0005524]; kinase binding [GO:0019900]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],abscission [GO:0009838]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell cycle G2/M phase transition [GO:0044839]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic spindle assembly [GO:0090307]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of cytokinesis [GO:0032466]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of cytokinesis [GO:0032467]; positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore [GO:1905116]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of mitotic sister chromatid separation [GO:1901970]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of chromosome segregation [GO:0051983]; regulation of cytokinesis [GO:0032465]; regulation of signal transduction by p53 class mediator [GO:1901796]; spindle organization [GO:0007051],"chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]"
Q8NBF6,C1,0.784862568,-0.181542823,-0.497629072,0.023205035,0.582211409,lightblue,AVL9,AVL9_HUMAN,Late secretory pathway protein AVL9 homolog,AVL9 KIAA0241,23080;,ENST00000318709.9; ENSP00000315568.4; ENSG00000105778.20. [Q8NBF6-1];,0,cell migration [GO:0016477],cytoplasm [GO:0005737]; membrane [GO:0016020]; recycling endosome [GO:0055037]
Q9UPN4,N1,-0.51220343,-0.098022246,-0.265230996,0.177017448,0.996173091,grey90,AZI1,CP131_HUMAN,Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1),CEP131 AZI1 KIAA1118,22994;,"ENST00000269392.8; ENSP00000269392.4; ENSG00000141577.14. [Q9UPN4-1];""ENST00000374782.7; ENSP00000363914.3; ENSG00000141577.14. [Q9UPN4-3]"";""ENST00000450824.7; ENSP00000393583.2; ENSG00000141577.14. [Q9UPN4-2]"";",protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288],acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; manchette [GO:0002177]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; sperm head-tail coupling apparatus [GO:0120212]
P61769,S3,-1.020056875,-0.396121126,0.206194818,0.754513059,0.472288778,salmon,B2M,B2MG_HUMAN,Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3],B2M CDABP0092 HDCMA22P,567;,"ENST00000559916.1; ENSP00000453350.1; ENSG00000166710.23.;""ENST00000561424.5; ENSP00000453191.1; ENSG00000166710.23."";""ENST00000617605.4; ENSP00000481426.1; ENSG00000273686.4."";""ENST00000631573.1; ENSP00000488548.1; ENSG00000273686.4."";""ENST00000631728.1; ENSP00000488321.1; ENSG00000273686.4."";""ENST00000648006.3; ENSP00000497910.1; ENSG00000166710.23."";",identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; peptide antigen binding [GO:0042605]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198],"amyloid fibril formation [GO:1990000]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; cellular response to iron ion [GO:0071281]; cellular response to iron(III) ion [GO:0071283]; cellular response to nicotine [GO:0071316]; intracellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826]; learning or memory [GO:0007611]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron projection development [GO:0010977]; negative regulation of receptor binding [GO:1900121]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of cellular senescence [GO:2000774]; positive regulation of ferrous iron binding [GO:1904434]; positive regulation of immune response [GO:0050778]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor binding [GO:1900122]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of transferrin receptor binding [GO:1904437]; protein homotetramerization [GO:0051289]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; regulation of iron ion transport [GO:0034756]; response to molecule of bacterial origin [GO:0002237]; sensory perception of smell [GO:0007608]; T cell differentiation in thymus [GO:0033077]; T cell mediated cytotoxicity [GO:0001913]",cytosol [GO:0005829]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; HFE-transferrin receptor complex [GO:1990712]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; MHC class I protein complex [GO:0042612]; MHC class II protein complex [GO:0042613]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]
Q96L58,S1,-1.216661956,-1.541453848,-0.043497865,0.941018097,0.888242985,gold,B3GALT6,B3GT6_HUMAN,"Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6)",B3GALT6,126792;,ENST00000379198.5; ENSP00000368496.2; ENSG00000176022.7.;,galactosylxylosylprotein 3-beta-galactosyltransferase activity [GO:0047220]; UDP-galactosyltransferase activity [GO:0035250],chondroitin sulfate biosynthetic process [GO:0030206]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; protein O-linked glycosylation [GO:0006493]; proteoglycan biosynthetic process [GO:0030166],Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
O94766,S1,-0.549479928,-0.828674397,-0.070519307,0.791701249,0.6863889,gold,B3GAT3,B3GA3_HUMAN,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)",B3GAT3,26229;,"ENST00000265471.10; ENSP00000265471.5; ENSG00000149541.10. [O94766-1];""ENST00000534026.5; ENSP00000432474.1; ENSG00000149541.10. [O94766-2]"";",galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity [GO:0015018]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; protein phosphatase activator activity [GO:0072542],carbohydrate metabolic process [GO:0005975]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; dermatan sulfate proteoglycan biosynthetic process [GO:0050651]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of catalytic activity [GO:0043085]; positive regulation of intracellular protein transport [GO:0090316]; protein glycosylation [GO:0006486],cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
O43505,S1,-0.690129488,-0.902670395,0.024772102,0.79297826,0.74653988,gold,B3GNT1,B4GA1_HUMAN,"Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)",B4GAT1 B3GNT1 B3GNT6,11041;,ENST00000311181.5; ENSP00000309096.4; ENSG00000174684.7.;,"glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]",axon guidance [GO:0007411]; keratan sulfate biosynthetic process [GO:0018146]; protein O-linked mannosylation [GO:0035269],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q9NY97,S1,-1.050143616,-0.939443629,-0.078034427,0.670998953,0.924884013,gold,B3GNT2,B3GN2_HUMAN,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (EC 2.4.1.149) (Beta-1,3-N-acetylglucosaminyltransferase 1) (BGnT-1) (Beta-1,3-Gn-T1) (Beta3Gn-T1) (Beta-1,3-galactosyltransferase 7) (Beta-1,3-GalTase 7) (Beta3Gal-T7) (Beta3GalT7) (b3Gal-T7) (Beta-3-Gx-T7) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 7) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2) (BGnT-2) (Beta-1,3-Gn-T2) (Beta-1,3-N-acetylglucosaminyltransferase 2) (Beta3Gn-T2) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 7)",B3GNT2 B3GALT7 B3GNT1,10678;,"ENST00000301998.5; ENSP00000305595.4; ENSG00000170340.11. [Q9NY97-1];""ENST00000405767.1; ENSP00000384692.1; ENSG00000170340.11. [Q9NY97-1]"";","beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity [GO:0008457]; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity [GO:0008499]",axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; keratan sulfate biosynthetic process [GO:0018146]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein O-linked glycosylation [GO:0006493]; sensory perception of smell [GO:0007608],Golgi membrane [GO:0000139]
P15291,S1,-0.948561119,-1.004338294,-0.191358687,0.742947176,0.971290001,gold,B4GALT1,B4GT1_HUMAN,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]",B4GALT1 GGTB2,2683;,ENST00000379731.5; ENSP00000369055.4; ENSG00000086062.13. [P15291-1];,"alpha-tubulin binding [GO:0043014]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; galactosyltransferase activity [GO:0008378]; identical protein binding [GO:0042802]; lactose synthase activity [GO:0004461]; manganese ion binding [GO:0030145]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250]",acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; lactose biosynthetic process [GO:0005989]; lipid metabolic process [GO:0006629]; macrophage migration [GO:1905517]; negative regulation of epithelial cell proliferation [GO:0050680]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circulating fibrinogen levels [GO:0061755]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046],azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; desmosome [GO:0030057]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667]
O60512,S1,-0.785343701,-0.738276893,-0.1376113,0.61817311,0.829302343,gold,B4GALT3,B4GT3_HUMAN,"Beta-1,4-galactosyltransferase 3 (Beta-1,4-GalTase 3) (Beta4Gal-T3) (b4Gal-T3) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3)",B4GALT3,8703;,"ENST00000319769.10; ENSP00000320965.5; ENSG00000158850.15. [O60512-1];""ENST00000367998.5; ENSP00000356977.1; ENSG00000158850.15. [O60512-1]"";""ENST00000622395.4; ENSP00000480428.1; ENSG00000158850.15. [O60512-1]"";","beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]",carbohydrate metabolic process [GO:0005975]; galactosylceramide biosynthetic process [GO:0006682]; glycosylation [GO:0070085]; protein glycosylation [GO:0006486],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]
O60513,S1,-1.464090416,-1.366066447,-0.24366953,0.806357367,1.058097755,gold,B4GALT4,B4GT4_HUMAN,"Beta-1,4-galactosyltransferase 4 (Beta-1,4-GalTase 4) (Beta4Gal-T4) (b4Gal-T4) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Lactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4)",B4GALT4 UNQ552/PRO1109,8702;,"ENST00000359213.7; ENSP00000352144.3; ENSG00000121578.13.;""ENST00000393765.7; ENSP00000377360.2; ENSG00000121578.13."";""ENST00000483209.5; ENSP00000420161.1; ENSG00000121578.13."";",galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250],carbohydrate metabolic process [GO:0005975]; glycosylation [GO:0070085]; keratan sulfate biosynthetic process [GO:0018146]; lactosylceramide biosynthetic process [GO:0001572]; membrane lipid metabolic process [GO:0006643]; protein glycosylation [GO:0006486],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
O43286,S1,-1.291822912,-1.209219173,-0.064863661,0.722019817,1.051501363,gold,B4GALT5,B4GT5_HUMAN,"Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (Glucosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5)",B4GALT5,9334;,ENST00000371711.4; ENSP00000360776.4; ENSG00000158470.5.;,"galactosyltransferase activity [GO:0008378]; metal ion binding [GO:0046872]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]",carbohydrate metabolic process [GO:0005975]; central nervous system myelination [GO:0022010]; central nervous system neuron axonogenesis [GO:0021955]; ganglioside biosynthetic process via lactosylceramide [GO:0010706]; glycoprotein biosynthetic process [GO:0009101]; glycosylation [GO:0070085]; neuron maturation [GO:0042551]; O-glycan processing [GO:0016266]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; positive regulation of embryonic development [GO:0040019]; protein glycosylation [GO:0006486]; regulation of protein stability [GO:0031647],Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]
Q9Y5Z0,S1,-0.81212888,-1.295906056,0.193136632,0.634123032,0.805624268,gold,BACE2,BACE2_HUMAN,Beta-secretase 2 (EC 3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase),BACE2 AEPLC ALP56 ASP21 CDA13 UNQ418/PRO852,25825;,"ENST00000328735.10; ENSP00000333854.6; ENSG00000182240.16. [Q9Y5Z0-3];""ENST00000330333.11; ENSP00000332979.6; ENSG00000182240.16. [Q9Y5Z0-1]"";""ENST00000347667.5; ENSP00000327528.4; ENSG00000182240.16. [Q9Y5Z0-2]"";",aspartic-type endopeptidase activity [GO:0004190],amyloid-beta metabolic process [GO:0050435]; glucose homeostasis [GO:0042593]; melanosome organization [GO:0032438]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
O95817,C5,1.736520423,0.543197066,-0.752433506,-0.819573996,-0.98132515,turquoise3,BAG3,BAG3_HUMAN,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),BAG3 BIS,9531;,ENST00000369085.8; ENSP00000358081.4; ENSG00000151929.10.;,adenyl-nucleotide exchange factor activity [GO:0000774]; cadherin binding [GO:0045296]; dynein intermediate chain binding [GO:0045505]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087],aggresome assembly [GO:0070842]; autophagosome assembly [GO:0000045]; cellular response to heat [GO:0034605]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated autophagy [GO:0061684]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; positive regulation of aggrephagy [GO:1905337]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein transport along microtubule [GO:0098840]; striated muscle cell apoptotic process [GO:0010658],aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; stress fiber [GO:0001725]; Z disc [GO:0030018]
P46379,C2,0.62408829,0.304866758,-0.177893733,0.055796963,0.082054196,aquamarine,BAG6,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),BAG6 BAT3 G3,7917;,"ENST00000211379.9; ENSP00000211379.5; ENSG00000204463.14. [P46379-2];""ENST00000361076.9; ENSP00000354368.5; ENSG00000096155.15. [P46379-1]"";""ENST00000362049.10; ENSP00000354875.6; ENSG00000204463.14. [P46379-5]"";""ENST00000375976.8; ENSP00000365143.4; ENSG00000204463.14. [P46379-2]"";""ENST00000383446.8; ENSP00000372938.4; ENSG00000096155.15. [P46379-2]"";""ENST00000383448.6; ENSP00000372940.2; ENSG00000096155.15. [P46379-2]"";""ENST00000417144.5; ENSP00000412110.1; ENSG00000229524.10. [P46379-2]"";""ENST00000419847.5; ENSP00000389121.1; ENSG00000233348.10. [P46379-2]"";""ENST00000439687.6; ENSP00000402856.2; ENSG00000204463.14. [P46379-4]"";""ENST00000442479.6; ENSP00000413698.2; ENSG00000229524.10. [P46379-2]"";""ENST00000443182.6; ENSP00000410156.2; ENSG00000233348.10. [P46379-2]"";""ENST00000449450.6; ENSP00000397894.2; ENSG00000229524.10. [P46379-1]"";""ENST00000451932.6; ENSP00000390966.2; ENSG00000233348.10. [P46379-1]"";""ENST00000551350.5; ENSP00000447546.2; ENSG00000229524.10. [P46379-5]"";""ENST00000552116.2; ENSP00000447946.2; ENSG00000233348.10. [P46379-5]"";""ENST00000552605.4; ENSP00000446525.2; ENSG00000096155.15. [P46379-5]"";""ENST00000613474.4; ENSP00000478966.1; ENSG00000227761.10. [P46379-4]"";""ENST00000615143.1; ENSP00000482413.1; ENSG00000229524.10. [P46379-4]"";""ENST00000615224.2; ENSP00000477951.1; ENSG00000228760.10. [P46379-4]"";""ENST00000615725.4; ENSP00000479238.1; ENSG00000233348.10. [P46379-4]"";""ENST00000617635.2; ENSP00000484238.1; ENSG00000096155.15. [P46379-4]"";""ENST00000621056.2; ENSP00000477867.1; ENSG00000234651.10. [P46379-4]"";""ENST00000676615.2; ENSP00000502941.1; ENSG00000204463.14. [P46379-3]"";",Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; molecular adaptor activity [GO:0060090]; molecular function activator activity [GO:0140677]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381],apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ERAD pathway [GO:0036503]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein [GO:0036506]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q16611,M2,-0.785206022,-1.337998929,0.366535048,0.985844462,-0.31952398,tan4,BAK1,BAK_HUMAN,Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK) (Bcl-2-like protein 7) (Bcl2-L-7),BAK1 BAK BCL2L7 CDN1,578;,"ENST00000374467.4; ENSP00000363591.3; ENSG00000030110.14. [Q16611-1];""ENST00000442998.6; ENSP00000391258.2; ENSG00000030110.14. [Q16611-2]"";",BH domain binding [GO:0051400]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325],activation of cysteine-type endopeptidase activity [GO:0097202]; animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; establishment of localization in cell [GO:0051649]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to organic cyclic compound [GO:0014070]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],BAK complex [GO:0097145]; Bcl-2 family protein complex [GO:0097136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930]
Q99728,N1,-0.96515848,-0.392145186,0.618400938,-0.069001349,0.6860174,grey90,BARD1,BARD1_HUMAN,BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1),BARD1,580;,"ENST00000260947.9; ENSP00000260947.4; ENSG00000138376.11. [Q99728-1];""ENST00000617164.5; ENSP00000480470.1; ENSG00000138376.11. [Q99728-2]"";""ENST00000620057.4; ENSP00000481988.1; ENSG00000138376.11. [Q99728-4]"";",kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842],cellular response to ionizing radiation [GO:0071479]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle [GO:0045786]; negative regulation of mRNA 3'-end processing [GO:0031441]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein catabolic process [GO:0045732]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325]; tissue homeostasis [GO:0001894],BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
Q07812,C3,1.340299618,-0.428114124,-0.256935342,0.258647601,-0.519297346,cyan,BAX,BAX_HUMAN,Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4),BAX BCL2L4,581;,"ENST00000293288.12; ENSP00000293288.8; ENSG00000087088.21. [Q07812-2];""ENST00000345358.12; ENSP00000263262.9; ENSG00000087088.21. [Q07812-1]"";""ENST00000354470.7; ENSP00000346461.3; ENSG00000087088.21. [Q07812-4]"";""ENST00000356483.8; ENSP00000348871.4; ENSG00000087088.21. [Q07812-5]"";""ENST00000415969.6; ENSP00000389971.2; ENSG00000087088.21. [Q07812-8]"";""ENST00000515540.5; ENSP00000426328.1; ENSG00000087088.21. [Q07812-3]"";",BH domain binding [GO:0051400]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],apoptotic mitochondrial changes [GO:0008637]; apoptotic process [GO:0006915]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic process involved in mammary gland involution [GO:0060057]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell apoptotic process [GO:1904019]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; motor neuron apoptotic process [GO:0097049]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of motor neuron apoptotic process [GO:2000673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of reproductive process [GO:2000243]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein insertion into mitochondrial membrane [GO:0051204]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; supramolecular fiber organization [GO:0097435]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],BAK complex [GO:0097145]; BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pore complex [GO:0046930]
Q9NRL2,N3,-1.292505736,-1.040946099,0.800643865,-2.26E-04,0.865305011,grey50,BAZ1A,BAZ1A_HUMAN,Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1),BAZ1A ACF1 WCRF180 HSPC317,11177;,"ENST00000358716.8; ENSP00000351555.4; ENSG00000198604.11. [Q9NRL2-2];""ENST00000360310.6; ENSP00000353458.1; ENSG00000198604.11. [Q9NRL2-1]"";""ENST00000382422.6; ENSP00000371859.2; ENSG00000198604.11. [Q9NRL2-1]"";",DNA binding [GO:0003677]; metal ion binding [GO:0046872],chromatin remodeling [GO:0006338]; DNA-templated DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of heterochromatin formation [GO:0031445]; regulation of transcription by RNA polymerase II [GO:0006357],ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]
Q9UIG0,N3,-1.160540538,-1.30778651,1.403960199,0.0893543,-0.509313277,grey50,BAZ1B,BAZ1B_HUMAN,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF,9031;,"ENST00000339594.9; ENSP00000342434.4; ENSG00000009954.11. [Q9UIG0-1];""ENST00000404251.1; ENSP00000385442.1; ENSG00000009954.11. [Q9UIG0-1]"";",ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AXY142 kinase activity [GO:0140801]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; zinc ion binding [GO:0008270],chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; negative regulation of mitotic chromosome condensation [GO:1905213]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; post-translational protein modification [GO:0043687]; regulation of transcription by RNA polymerase II [GO:0006357],B-WICH complex [GO:0110016]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; WICH complex [GO:0090535]
Q9UIF9,N3,-1.147979902,-1.150330715,1.305485161,-0.059064917,-0.088036463,grey50,BAZ2A,BAZ2A_HUMAN,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),BAZ2A KIAA0314 TIP5,11176;,ENST00000551812.5; ENSP00000446880.1; ENSG00000076108.12. [Q9UIF9-1];,DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723],chromatin remodeling [GO:0006338]; DNA methylation-dependent heterochromatin formation [GO:0006346]; DNA-templated transcription [GO:0006351]; heterochromatin formation [GO:0031507]; negative regulation of transcription by RNA polymerase I [GO:0016479]; rDNA heterochromatin formation [GO:0000183]; regulation of DNA-templated transcription [GO:0006355]; RNA polymerase I preinitiation complex assembly [GO:0001188],chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; NoRC complex [GO:0090536]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; rDNA heterochromatin [GO:0033553]
Q9UIF8,N3,-1.003817349,-1.04563369,1.25773911,0.258189586,-0.580192233,grey50,BAZ2B,BAZ2B_HUMAN,Bromodomain adjacent to zinc finger domain protein 2B (hWALp4),BAZ2B KIAA1476,29994;,"ENST00000392782.5; ENSP00000376533.1; ENSG00000123636.19. [Q9UIF8-5];""ENST00000392783.7; ENSP00000376534.2; ENSG00000123636.19. [Q9UIF8-1]"";",DNA binding [GO:0003677]; metal ion binding [GO:0046872],chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634]
Q96PG8,M2,-0.797618639,-0.973675912,0.359120767,0.90526628,0.113136137,tan4,BBC3,BBC3B_HUMAN,"Bcl-2-binding component 3, isoforms 3/4 (JFY-1) (p53 up-regulated modulator of apoptosis)",BBC3 PUMA,27113;,"ENST00000300880.11; ENSP00000300880.7; ENSG00000105327.18. [Q96PG8-1];""ENST00000449228.5; ENSP00000404503.1; ENSG00000105327.18. [Q96PG8-2]"";",ATPase binding [GO:0051117],apoptotic process [GO:0006915]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; release of cytochrome c from mitochondria [GO:0001836],mitochondrion [GO:0005739]
Q9UHQ4,S2,-1.560354356,-1.568880845,0.159522092,0.878234308,0.794098978,orange,BCAP29,BAP29_HUMAN,B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29),BCAP29 BAP29,55973;,"ENST00000005259.9; ENSP00000005259.4; ENSG00000075790.12. [Q9UHQ4-1];""ENST00000379117.6; ENSP00000368412.2; ENSG00000075790.12. [Q9UHQ4-1]"";""ENST00000445771.6; ENSP00000400718.2; ENSG00000075790.12. [Q9UHQ4-2]"";""ENST00000640518.4; ENSP00000491801.4; ENSG00000283852.4. [Q9UHQ4-1]"";""ENST00000640915.4; ENSP00000490977.4; ENSG00000283852.4. [Q9UHQ4-1]"";",0,apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
P51572,S2,-1.334795094,-1.558018092,0.158412904,0.939467417,0.659566105,orange,BCAP31,BAP31_HUMAN,B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) (6C6-AG tumor-associated antigen) (Protein CDM) (p28),BCAP31 BAP31 DXS1357E,10134;,"ENST00000345046.12; ENSP00000343458.6; ENSG00000185825.17. [P51572-1];""ENST00000458587.8; ENSP00000392330.2; ENSG00000185825.17. [P51572-2]"";""ENST00000647529.1; ENSP00000494052.1; ENSG00000185825.17. [P51572-1]"";""ENST00000672675.1; ENSP00000499882.1; ENSG00000185825.17. [P51572-1]"";",MHC class I protein binding [GO:0042288]; protein-containing complex binding [GO:0044877],"apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein targeting to mitochondrion [GO:0006626]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]
P56945,C3,1.778683734,-0.059576896,-0.530973147,-0.499693262,-0.716500923,cyan,BCAR1,BCAR1_HUMAN,Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas),BCAR1 CAS CASS1 CRKAS,9564;,"ENST00000162330.10; ENSP00000162330.5; ENSG00000050820.17. [P56945-1];""ENST00000393420.10; ENSP00000377072.6; ENSG00000050820.17. [P56945-3]"";""ENST00000393422.6; ENSP00000377074.2; ENSG00000050820.17. [P56945-7]"";""ENST00000418647.7; ENSP00000391669.3; ENSG00000050820.17. [P56945-6]"";""ENST00000420641.7; ENSP00000392708.3; ENSG00000050820.17. [P56945-2]"";""ENST00000535626.6; ENSP00000440370.2; ENSG00000050820.17. [P56945-4]"";""ENST00000538440.6; ENSP00000443841.2; ENSG00000050820.17. [P56945-8]"";""ENST00000542031.6; ENSP00000440415.2; ENSG00000050820.17. [P56945-5]"";",protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],actin filament organization [GO:0007015]; antigen receptor-mediated signaling pathway [GO:0050851]; B cell receptor signaling pathway [GO:0050853]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; G protein-coupled receptor signaling pathway [GO:0007186]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell migration [GO:0010595]; regulation of apoptotic process [GO:0042981]; regulation of cell growth [GO:0001558]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; membrane [GO:0016020]; ruffle [GO:0001726]
Q9H6U6,C3,1.807871962,0.095226241,-0.614605729,-0.457531423,-0.698850882,cyan,BCAS3,BCAS3_HUMAN,BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3) (GAOB1),BCAS3,54828;,"ENST00000390652.9; ENSP00000375067.4; ENSG00000141376.24. [Q9H6U6-1];""ENST00000407086.8; ENSP00000385323.2; ENSG00000141376.24. [Q9H6U6-2]"";""ENST00000408905.7; ENSP00000386173.2; ENSG00000141376.24. [Q9H6U6-3]"";""ENST00000588462.5; ENSP00000468592.1; ENSG00000141376.24. [Q9H6U6-8]"";""ENST00000588874.5; ENSP00000464825.1; ENSG00000141376.24. [Q9H6U6-6]"";""ENST00000589222.5; ENSP00000466078.1; ENSG00000141376.24. [Q9H6U6-7]"";",acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear receptor binding [GO:0016922]; phosphatidylinositol binding [GO:0035091],angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956]; response to estrogen [GO:0043627]; response to starvation [GO:0042594],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]
O95999,C4,1.983076743,0.403800216,-0.917541011,-1.094431806,-1.519105272,deepskyblue2,BCL10,BCL10_HUMAN,B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10) (Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein) (hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator) (CIPER) (Cellular homolog of vCARMEN) (cCARMEN) (Cellular-E10) (c-E10) (Mammalian CARD-containing adapter molecule E10) (mE10),BCL10 CIPER CLAP,8915;,ENST00000648566.1; ENSP00000498104.1; ENSG00000142867.14.;,CARD domain binding [GO:0050700]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; protease binding [GO:0002020]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625],adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; B cell apoptotic process [GO:0001783]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; immunoglobulin mediated immune response [GO:0016064]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of mature B cell apoptotic process [GO:0002906]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell receptor signaling pathway [GO:0050862]; programmed cell death [GO:0012501]; protein homooligomerization [GO:0051260]; response to food [GO:0032094]; T cell apoptotic process [GO:0070231]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224],CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]
Q07817,M2,-0.361252624,-1.095274108,0.215181508,0.95542435,0.218735624,tan4,BCL2L1,B2CL1_HUMAN,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),BCL2L1 BCL2L BCLX,598;,"ENST00000307677.5; ENSP00000302564.4; ENSG00000171552.14. [Q07817-1];""ENST00000376055.9; ENSP00000365223.4; ENSG00000171552.14. [Q07817-2]"";""ENST00000376062.6; ENSP00000365230.2; ENSG00000171552.14. [Q07817-1]"";""ENST00000420488.6; ENSP00000390760.2; ENSG00000171552.14. [Q07817-1]"";""ENST00000422920.2; ENSP00000411252.2; ENSG00000171552.14. [Q07817-2]"";""ENST00000434194.2; ENSP00000401173.2; ENSG00000171552.14. [Q07817-1]"";""ENST00000439267.2; ENSP00000389688.2; ENSG00000171552.14. [Q07817-1]"";""ENST00000456404.6; ENSP00000395545.2; ENSG00000171552.14. [Q07817-1]"";""ENST00000676582.1; ENSP00000503725.1; ENSG00000171552.14. [Q07817-1]"";""ENST00000676942.1; ENSP00000504536.1; ENSG00000171552.14. [Q07817-1]"";""ENST00000677194.1; ENSP00000504387.1; ENSG00000171552.14. [Q07817-1]"";""ENST00000678563.1; ENSP00000504237.1; ENSG00000171552.14. [Q07817-1]"";",BH domain binding [GO:0051400]; BH3 domain binding [GO:0051434]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901],apoptotic mitochondrial changes [GO:0008637]; apoptotic process in bone marrow cell [GO:0071839]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to gamma radiation [GO:0071480]; defense response to virus [GO:0051607]; dendritic cell apoptotic process [GO:0097048]; dendritic cell proliferation [GO:0044565]; ectopic germ cell programmed cell death [GO:0035234]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of developmental process [GO:0051093]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of reproductive process [GO:2000242]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of mononuclear cell proliferation [GO:0032946]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; spermatogenesis [GO:0007283],Bcl-2 family protein complex [GO:0097136]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; synaptic vesicle membrane [GO:0030672]
O43521,S4,-1.150877353,-1.177786,0.410059047,0.879589089,0.118300141,tomato2,BCL2L11,B2L11_HUMAN,Bcl-2-like protein 11 (Bcl2-L-11) (Bcl2-interacting mediator of cell death),BCL2L11 BIM,10018;,"ENST00000308659.12; ENSP00000309226.8; ENSG00000153094.25. [O43521-2];""ENST00000393256.8; ENSP00000376943.2; ENSG00000153094.25. [O43521-1]"";""ENST00000405953.6; ENSP00000384641.1; ENSG00000153094.25. [O43521-17]"";""ENST00000415458.5; ENSP00000393781.1; ENSG00000153094.25. [O43521-16]"";""ENST00000431217.1; ENSP00000394640.1; ENSG00000153094.25. [O43521-10]"";""ENST00000436733.5; ENSP00000403727.1; ENSG00000153094.25. [O43521-14]"";""ENST00000437029.5; ENSP00000412892.1; ENSG00000153094.25. [O43521-8]"";""ENST00000439718.1; ENSP00000411137.1; ENSG00000153094.25. [O43521-7]"";""ENST00000452231.5; ENSP00000391292.1; ENSG00000153094.25. [O43521-9]"";",microtubule binding [GO:0008017]; protein kinase binding [GO:0019901],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; B cell homeostasis [GO:0001782]; cell-matrix adhesion [GO:0007160]; cellular response to glucocorticoid stimulus [GO:0071385]; developmental pigmentation [GO:0048066]; ear development [GO:0043583]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; kidney development [GO:0001822]; male gonad development [GO:0008584]; mammary gland development [GO:0030879]; meiosis I [GO:0007127]; myeloid cell homeostasis [GO:0002262]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of T cell apoptotic process [GO:0070234]; post-embryonic development [GO:0009791]; regulation of apoptotic process [GO:0042981]; regulation of developmental pigmentation [GO:0048070]; regulation of organ growth [GO:0046620]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; thymocyte apoptotic process [GO:0070242]; thymus development [GO:0048538]; tube formation [GO:0035148],Bcl-2 family protein complex [GO:0097136]; BIM-BCL-2 complex [GO:0097141]; BIM-BCL-xl complex [GO:0097140]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q9BXK5,M2,-0.862006675,-1.081233108,0.315520721,1.126771585,-0.172748243,tan4,BCL2L13,B2L13_HUMAN,Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1),BCL2L13 MIL1 CD003,23786;,"ENST00000317582.10; ENSP00000318883.5; ENSG00000099968.18. [Q9BXK5-1];""ENST00000399782.5; ENSP00000382682.1; ENSG00000099968.18. [Q9BXK5-2]"";""ENST00000418951.6; ENSP00000410019.3; ENSG00000099968.18. [Q9BXK5-4]"";""ENST00000493680.5; ENSP00000434764.1; ENSG00000099968.18. [Q9BXK5-2]"";""ENST00000543133.5; ENSP00000437667.1; ENSG00000099968.18. [Q9BXK5-4]"";",cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981],membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q86UU0,N4,-0.646438756,1.392698132,-0.346052651,-0.637261051,-1.098812196,grey30,BCL9L,BCL9L_HUMAN,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),BCL9L DLNB11,283149;,"ENST00000334801.7; ENSP00000335320.3; ENSG00000186174.13. [Q86UU0-1];""ENST00000683865.1; ENSP00000507778.1; ENSG00000186174.13. [Q86UU0-1]"";",beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713],canonical Wnt signaling pathway [GO:0060070]; myoblast differentiation [GO:0045445]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell population maintenance [GO:0035019]; transcription by RNA polymerase II [GO:0006366],beta-catenin-TCF complex [GO:1990907]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6W2J9,N2,-0.759086929,-0.055099989,0.783358526,0.172896795,0.156871665,grey70,BCOR,BCOR_HUMAN,BCL-6 corepressor (BCoR),BCOR KIAA1575,54880;,"ENST00000342274.8; ENSP00000345923.4; ENSG00000183337.18. [Q6W2J9-2];""ENST00000378444.9; ENSP00000367705.4; ENSG00000183337.18. [Q6W2J9-1]"";""ENST00000378455.8; ENSP00000367716.4; ENSG00000183337.18. [Q6W2J9-4]"";""ENST00000397354.7; ENSP00000380512.3; ENSG00000183337.18. [Q6W2J9-2]"";""ENST00000406200.4; ENSP00000384485.3; ENSG00000183337.18. [Q6W2J9-1]"";""ENST00000615339.2; ENSP00000483217.2; ENSG00000183337.18. [Q6W2J9-1]"";""ENST00000672922.2; ENSP00000499892.2; ENSG00000183337.18. [Q6W2J9-1]"";""ENST00000673391.1; ENSP00000500446.1; ENSG00000183337.18. [Q6W2J9-2]"";""ENST00000679513.1; ENSP00000505761.1; ENSG00000183337.18. [Q6W2J9-1]"";""ENST00000680831.1; ENSP00000505507.1; ENSG00000183337.18. [Q6W2J9-1]"";",DNA-binding transcription factor binding [GO:0140297]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; negative regulation of bone mineralization [GO:0030502]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of tooth mineralization [GO:0070171]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; roof of mouth development [GO:0060021]; specification of axis polarity [GO:0065001],BCOR complex [GO:0140261]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y276,M2,-1.178198865,-1.294672497,0.38214339,1.091172319,-0.11460394,tan4,BCS1L,BCS1_HUMAN,Mitochondrial chaperone BCS1 (h-BCS1) (BCS1-like protein),BCS1L BCS1,617;,"ENST00000359273.8; ENSP00000352219.3; ENSG00000074582.15.;""ENST00000392109.5; ENSP00000375957.1; ENSG00000074582.15."";""ENST00000392110.6; ENSP00000375958.2; ENSG00000074582.15."";""ENST00000392111.7; ENSP00000375959.2; ENSG00000074582.15."";""ENST00000412366.5; ENSP00000406494.1; ENSG00000074582.15."";""ENST00000431802.5; ENSP00000413908.1; ENSG00000074582.15."";""ENST00000439945.5; ENSP00000404999.1; ENSG00000074582.15."";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrial respiratory chain complex III assembly [GO:0034551]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979],mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]
Q02338,M2,-0.975918373,-1.335506372,0.349977449,1.114084738,-0.172759571,tan4,BDH1,BDH_HUMAN,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) (Short chain dehydrogenase/reductase family 9C member 1)",BDH1 BDH SDR9C1,622;,"ENST00000358186.6; ENSP00000350914.2; ENSG00000161267.12.;""ENST00000392378.6; ENSP00000376183.2; ENSG00000161267.12."";""ENST00000392379.6; ENSP00000376184.1; ENSG00000161267.12."";""ENST00000612690.3; ENSP00000484421.1; ENSG00000275544.4."";""ENST00000617317.2; ENSP00000482744.1; ENSG00000275544.4."";",3-hydroxybutyrate dehydrogenase activity [GO:0003858],steroid metabolic process [GO:0008202],intracellular membrane-bounded organelle [GO:0043231]; matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q9BUT1,C5,1.816702679,0.486784309,-0.577281644,-0.711136201,-1.160633468,turquoise3,BDH2,DHRS6_HUMAN,Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.-) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (EC 1.1.1.30) (4-oxo-L-proline reductase) (EC 1.1.1.104) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1),BDH2 DHRS6 SDR15C1 UNQ6308/PRO20933,56898;,ENST00000296424.9; ENSP00000296424.4; ENSG00000164039.15. [Q9BUT1-1];,"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; 4-oxoproline reductase activity [GO:0016617]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]",epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; heme metabolic process [GO:0042168]; intracellular sequestering of iron ion [GO:0006880]; siderophore biosynthetic process [GO:0019290],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q5T5X7,N3,-1.174157543,-0.652086222,1.034845363,0.362863692,-0.167810625,grey50,BEND3,BEND3_HUMAN,BEN domain-containing protein 3,BEND3 KIAA1553,57673;,"ENST00000369042.6; ENSP00000358038.1; ENSG00000178409.14.;""ENST00000429433.3; ENSP00000411268.2; ENSG00000178409.14."";",rDNA binding [GO:0000182],DNA methylation-dependent heterochromatin formation [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP metabolic process [GO:1903580]; protein homooligomerization [GO:0051260]; rDNA heterochromatin formation [GO:0000183],heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
O15155,S1,-1.353480011,-1.808648265,-0.004077756,0.798472442,0.989745185,gold,BET1,BET1_HUMAN,BET1 homolog (hBET1) (Golgi vesicular membrane-trafficking protein p18),BET1,10282;,"ENST00000222547.8; ENSP00000222547.3; ENSG00000105829.13. [O15155-1];""ENST00000433727.5; ENSP00000391228.1; ENSG00000105829.13. [O15155-2]"";",SNAP receptor activity [GO:0005484],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; vesicle fusion with Golgi apparatus [GO:0048280],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]
Q9NYM9,S1,-1.02457565,-1.360163507,-0.226089945,0.705531087,1.040246271,gold,BET1L,BET1L_HUMAN,BET1-like protein (Golgi SNARE with a size of 15 kDa) (GOS-15) (GS15) (Vesicle transport protein GOS15),BET1L GS15,51272;,ENST00000382762.8; ENSP00000372210.3; ENSG00000177951.18.;,SNAP receptor activity [GO:0005484],"protein transport [GO:0015031]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SNARE complex [GO:0031201]
P55957,C3,1.821638397,-0.251668424,-0.500523778,-0.450189246,-0.76627741,cyan,BID,BID_HUMAN,BH3-interacting domain death agonist (p22 BID) (BID) [Cleaved into: BH3-interacting domain death agonist p15 (p15 BID); BH3-interacting domain death agonist p13 (p13 BID); BH3-interacting domain death agonist p11 (p11 BID)],BID,637;,"ENST00000317361.11; ENSP00000318822.7; ENSG00000015475.19. [P55957-2];""ENST00000342111.9; ENSP00000344594.5; ENSG00000015475.19. [P55957-3]"";""ENST00000399765.5; ENSP00000382667.1; ENSG00000015475.19. [P55957-4]"";""ENST00000399767.6; ENSP00000382669.1; ENSG00000015475.19. [P55957-4]"";""ENST00000551952.5; ENSP00000449236.1; ENSG00000015475.19. [P55957-1]"";""ENST00000614949.4; ENSP00000477773.1; ENSG00000015475.19. [P55957-4]"";""ENST00000622694.5; ENSP00000480414.1; ENSG00000015475.19. [P55957-1]"";",cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; death receptor binding [GO:0005123]; ubiquitin protein ligase binding [GO:0031625],apoptotic mitochondrial changes [GO:0008637]; establishment of protein localization to membrane [GO:0090150]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial outer membrane permeabilization [GO:0097345]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein targeting to mitochondrion [GO:0006626]; protein-containing complex assembly [GO:0065003]; regulation of epithelial cell proliferation [GO:0050678]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of T cell proliferation [GO:0042129]; release of cytochrome c from mitochondria [GO:0001836]; signal transduction in response to DNA damage [GO:0042770]; supramolecular fiber organization [GO:0097435],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
O00499,C3,1.80202897,0.344901925,-0.758572002,-0.746898127,-0.871236317,cyan,BIN1,BIN1_HUMAN,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1),BIN1 AMPHL,274;,"ENST00000259238.8; ENSP00000259238.4; ENSG00000136717.15. [O00499-11];""ENST00000316724.10; ENSP00000316779.5; ENSG00000136717.15. [O00499-1]"";""ENST00000346226.7; ENSP00000315411.3; ENSG00000136717.15. [O00499-2]"";""ENST00000348750.8; ENSP00000259237.5; ENSG00000136717.15. [O00499-9]"";""ENST00000351659.7; ENSP00000315388.3; ENSG00000136717.15. [O00499-3]"";""ENST00000352848.8; ENSP00000315284.4; ENSG00000136717.15. [O00499-8]"";""ENST00000357970.7; ENSP00000350654.3; ENSG00000136717.15. [O00499-5]"";""ENST00000376113.6; ENSP00000365281.2; ENSG00000136717.15. [O00499-10]"";""ENST00000393040.7; ENSP00000376760.3; ENSG00000136717.15. [O00499-6]"";""ENST00000393041.7; ENSP00000376761.3; ENSG00000136717.15. [O00499-4]"";""ENST00000409400.1; ENSP00000386797.1; ENSG00000136717.15. [O00499-7]"";",actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; clathrin binding [GO:0030276]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein-folding chaperone binding [GO:0051087]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156],cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018]
Q9NQY0,C1,1.159759408,0.041849663,-0.214382139,0.019284617,-0.46957528,lightblue,BIN3,BIN3_HUMAN,Bridging integrator 3,BIN3,55909;,"ENST00000276416.11; ENSP00000276416.6; ENSG00000147439.14. [Q9NQY0-1];""ENST00000519513.5; ENSP00000430423.1; ENSG00000147439.14. [Q9NQY0-2]"";",cytoskeletal anchor activity [GO:0008093],actin cortical patch localization [GO:0051666]; actin filament organization [GO:0007015]; cytoskeleton-dependent cytokinesis [GO:0061640]; division septum assembly [GO:0000917]; endocytosis [GO:0006897]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; plasma membrane tubulation [GO:0097320]; protein localization [GO:0008104]; regulation of lamellipodium assembly [GO:0010591]; skeletal muscle fiber development [GO:0048741]; unidimensional cell growth [GO:0009826],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]
Q13490,C1,1.457574883,0.248532098,-0.43492616,-0.315955653,-0.43835513,lightblue,BIRC2,BIRC2_HUMAN,Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2),BIRC2 API1 MIHB RNF48,329;,"ENST00000227758.7; ENSP00000227758.2; ENSG00000110330.10. [Q13490-1];""ENST00000530675.5; ENSP00000431723.1; ENSG00000110330.10. [Q13490-2]"";""ENST00000613397.4; ENSP00000477613.1; ENSG00000110330.10. [Q13490-1]"";",cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; FBXO family protein binding [GO:0098770]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],"apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; cell surface receptor signaling pathway [GO:0007166]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of necroptotic process [GO:0060546]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; non-canonical NF-kappaB signal transduction [GO:0038061]; placenta development [GO:0001890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cysteine-type endopeptidase activity [GO:2000116]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of necroptotic process [GO:0060544]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]",CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nucleus [GO:0005634]; XY body [GO:0001741]
O15392,N3,-0.292729431,-0.690747246,1.058070027,0.169930961,-0.245905479,grey50,BIRC5,BIRC5_HUMAN,Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin),BIRC5 API4 IAP4,332;,"ENST00000374948.6; ENSP00000364086.1; ENSG00000089685.15. [O15392-3];""ENST00000590449.1; ENSP00000465868.1; ENSG00000089685.15. [O15392-7]"";""ENST00000590925.6; ENSP00000467336.1; ENSG00000089685.15. [O15392-4]"";""ENST00000592734.5; ENSP00000466617.1; ENSG00000089685.15. [O15392-6]"";",cobalt ion binding [GO:0050897]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],apoptotic process [GO:0006915]; cell division [GO:0051301]; establishment of chromosome localization [GO:0051303]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970]; protein phosphorylation [GO:0006468]; protein-containing complex localization [GO:0031503]; sensory perception of sound [GO:0007605],"centriole [GO:0005814]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; survivin complex [GO:1990713]"
Q9NR09,C1,1.531677348,-0.098117764,-0.583278819,-0.411609805,-0.026900961,lightblue,BIRC6,BIRC6_HUMAN,Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),BIRC6 KIAA1289,57448;,ENST00000421745.7; ENSP00000393596.2; ENSG00000115760.16.;,cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712],centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]
P54132,N1,-1.173190764,-0.710725431,0.401561216,-0.149002855,1.110292883,grey90,BLM,BLM_HUMAN,"RecQ-like DNA helicase BLM (EC 5.6.2.4) (Bloom syndrome protein) (DNA 3'-5' helicase BLM) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3)",BLM RECQ2 RECQL3,641;,"ENST00000355112.8; ENSP00000347232.3; ENSG00000197299.13.;""ENST00000680772.1; ENSP00000506117.1; ENSG00000197299.13."";","3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; molecular function activator activity [GO:0140677]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]",cellular response to camptothecin [GO:0072757]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; positive regulation of DNA-templated transcription [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-templated DNA replication [GO:0090329]; replication fork processing [GO:0031297]; resolution of DNA recombination intermediates [GO:0071139]; response to X-ray [GO:0010165]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; RecQ family helicase-topoisomerase III complex [GO:0031422]; replication fork [GO:0005657]
P30043,C5,1.96371047,0.191066958,-0.858292624,-0.842049218,-0.999362742,turquoise3,BLVRB,BLVRB_HUMAN,Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.-) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR) (S-nitroso-CoA-assisted nitrosyltransferase) (SNO-CoA-assisted nitrosyltransferase) (EC 2.6.99.-),BLVRB FLR SCAN,645;,ENST00000263368.9; ENSP00000263368.3; ENSG00000090013.11.;,biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)H) activity [GO:0004074]; biliverdin reductase (NADPH) activity [GO:0106277]; FMN reductase (NAD(P)H) activity [GO:0008752]; FMN reductase (NADH) activity [GO:0052874]; FMN reductase (NADPH) activity [GO:0052873]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; riboflavin reductase (NADPH) activity [GO:0042602],heme catabolic process [GO:0042167]; megakaryocyte differentiation [GO:0030219]; negative regulation of insulin receptor signaling pathway [GO:0046627],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q9H2G9,S3,-0.73175059,-0.898901474,-0.128894601,0.922436882,0.657210126,salmon,BLZF1,GO45_HUMAN,Golgin-45 (Basic leucine zipper nuclear factor 1) (JEM-1) (p45 basic leucine-zipper nuclear factor),BLZF1 JEM1,8548;,"ENST00000329281.6; ENSP00000327541.2; ENSG00000117475.14. [Q9H2G9-1];""ENST00000367807.7; ENSP00000356781.3; ENSG00000117475.14. [Q9H2G9-2]"";""ENST00000367808.8; ENSP00000356782.3; ENSG00000117475.14. [Q9H2G9-1]"";",enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625],Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001],cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NSY1,S4,-0.501228891,-0.688920237,0.532773768,0.846866544,0.190737917,tomato2,BMP2K,BMP2K_HUMAN,BMP-2-inducible protein kinase (BIKe) (EC 2.7.11.1),BMP2K BIKE HRIHFB2017,55589;,"ENST00000502613.3; ENSP00000424668.2; ENSG00000138756.19. [Q9NSY1-1];""ENST00000502871.5; ENSP00000421768.1; ENSG00000138756.19. [Q9NSY1-2]"";",AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; phosphatase regulator activity [GO:0019208]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],positive regulation of Notch signaling pathway [GO:0045747]; regulation of bone mineralization [GO:0030500]; regulation of clathrin-dependent endocytosis [GO:2000369],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]
P36894,S2,-1.36027049,-1.316095032,0.301950714,0.94039197,0.658305393,orange,BMPR1A,BMR1A_HUMAN,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),BMPR1A ACVRLK3 ALK3,657;,"ENST00000372037.8; ENSP00000361107.2; ENSG00000107779.15.;""ENST00000480152.3; ENSP00000483569.2; ENSG00000107779.15."";""ENST00000635816.2; ENSP00000489707.1; ENSG00000107779.15."";""ENST00000636056.2; ENSP00000490273.1; ENSG00000107779.15."";""ENST00000638429.1; ENSP00000492290.1; ENSG00000107779.15."";","ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]",angiogenesis [GO:0001525]; atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart formation [GO:0060914]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm structural organization [GO:0048352]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; HFE-transferrin receptor complex [GO:1990712]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q13873,S4,-0.498224038,-0.759948112,0.298600731,0.810589499,0.377506057,tomato2,BMPR2,BMPR2_HUMAN,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),BMPR2 PPH1,659;,"ENST00000374574.2; ENSP00000363702.2; ENSG00000204217.16. [Q13873-2];""ENST00000374580.10; ENSP00000363708.4; ENSG00000204217.16. [Q13873-1]"";","activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta receptor activity [GO:0005024]",anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lung vasculature development [GO:0060426]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235]
Q14692,N3,-1.091802864,-1.223743907,1.172201633,-0.068278984,0.302412356,grey50,BMS1,BMS1_HUMAN,Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog),BMS1 BMS1L KIAA0187,9790;,ENST00000374518.6; ENSP00000363642.4; ENSG00000165733.8.;,ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511],"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]",90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q12981,S2,-1.229234602,-1.49281004,0.197047918,0.880002155,0.703432855,orange,BNIP1,SEC20_HUMAN,Vesicle transport protein SEC20 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 1) (Transformation-related gene 8 protein) (TRG-8),BNIP1 NIP1 SEC20L TRG8,662;,"ENST00000231668.13; ENSP00000231668.9; ENSG00000113734.18. [Q12981-1];""ENST00000351486.10; ENSP00000239215.7; ENSG00000113734.18. [Q12981-4]"";""ENST00000352523.10; ENSP00000239214.8; ENSG00000113734.18. [Q12981-3]"";""ENST00000393770.4; ENSP00000377365.4; ENSG00000113734.18. [Q12981-2]"";",calcium-induced calcium release activity [GO:0048763]; SNAP receptor activity [GO:0005484],"apoptotic process [GO:0006915]; apoptotic process in response to mitochondrial fragmentation [GO:0140208]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic process [GO:0043066]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; SNARE complex [GO:0031201]
Q12983,M2,-0.621592011,-1.508002947,0.186643622,1.138040804,0.009513152,tan4,BNIP3,BNIP3_HUMAN,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,BNIP3 NIP3,664;,ENST00000368636.9; ENSP00000357625.6; ENSG00000176171.12.;,GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],autophagic cell death [GO:0048102]; autophagy of mitochondrion [GO:0000422]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; negative regulation of apoptotic process [GO:0043066]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial membrane permeability [GO:0046902]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649],cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]
Q6PGQ7,C5,1.928735628,0.628709842,-0.880208953,-0.794832077,-0.923478042,turquoise3,BORA,BORA_HUMAN,Protein aurora borealis (HsBora),BORA C13orf34,79866;,"ENST00000390667.11; ENSP00000375082.6; ENSG00000136122.18. [Q6PGQ7-1];""ENST00000651477.1; ENSP00000498664.1; ENSG00000136122.18. [Q6PGQ7-1]"";""ENST00000652266.1; ENSP00000498882.1; ENSG00000136122.18. [Q6PGQ7-2]"";",protein kinase binding [GO:0019901],cell division [GO:0051301]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein localization [GO:0032880],cytoplasm [GO:0005737]; cytosol [GO:0005829]; meiotic spindle [GO:0072687]; nucleus [GO:0005634]
O95861,C3,1.866356369,0.125319542,-0.605905147,-0.555515655,-1.098913832,cyan,BPNT1,BPNT1_HUMAN,"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (3'-phosphoadenosine 5'-phosphate phosphatase) (PAP phosphatase) (Bisphosphate 3'-nucleotidase 1) (BPntase 1) (HsPIP) (Inositol-polyphosphate 1-phosphatase) (EC 3.1.3.57)",BPNT1,10380;,"ENST00000322067.12; ENSP00000318852.7; ENSG00000162813.18. [O95861-1];""ENST00000414869.6; ENSP00000410348.2; ENSG00000162813.18. [O95861-4]"";""ENST00000469520.6; ENSP00000446828.1; ENSG00000162813.18. [O95861-1]"";""ENST00000544404.5; ENSP00000444398.1; ENSG00000162813.18. [O95861-3]"";","3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]",3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytosol [GO:0005829]
P15056,C3,1.783995735,-0.048567786,-0.534457276,-0.4773791,-0.711340371,cyan,BRAF,BRAF_HUMAN,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),BRAF BRAF1 RAFB1,673;,ENST00000646891.2; ENSP00000493543.1; ENSG00000157764.14.;,ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110],"animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; response to cAMP [GO:0051591]; response to peptide hormone [GO:0043434]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542]",cell body [GO:0044297]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]
P46736,C2,1.3206364,0.286084983,-0.367114207,-0.582828133,-0.312335185,aquamarine,BRCC3,BRCC3_HUMAN,Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36),BRCC3 BRCC36 C6.1A CXorf53,79184;,"ENST00000330045.12; ENSP00000328641.7; ENSG00000185515.16. [P46736-2];""ENST00000340647.8; ENSP00000344103.4; ENSG00000185515.16. [P46736-3]"";""ENST00000369459.6; ENSP00000358471.2; ENSG00000185515.16. [P46736-5]"";""ENST00000369462.5; ENSP00000358474.1; ENSG00000185515.16. [P46736-1]"";",cysteine-type deubiquitinase activity [GO:0004843]; enzyme regulator activity [GO:0030234]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593],cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; positive regulation of DNA repair [GO:0045739]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165],BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]
O95696,N3,-0.651003084,-0.909235117,1.181464737,0.139410589,-0.421388042,grey50,BRD1,BRD1_HUMAN,Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2),BRD1 BRL BRPF2,23774;,"ENST00000216267.12; ENSP00000216267.8; ENSG00000100425.19. [O95696-1];""ENST00000404034.5; ENSP00000384076.1; ENSG00000100425.19. [O95696-1]"";""ENST00000404760.6; ENSP00000385858.1; ENSG00000100425.19. [O95696-2]"";""ENST00000457780.3; ENSP00000410042.3; ENSG00000100425.19. [O95696-2]"";",histone binding [GO:0042393]; histone reader activity [GO:0140566]; metal ion binding [GO:0046872],chromatin remodeling [GO:0006338]; erythrocyte maturation [GO:0043249]; positive regulation of erythrocyte differentiation [GO:0045648]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]; response to immobilization stress [GO:0035902],dendrite [GO:0030425]; histone H3-K14 acetyltransferase complex [GO:0036409]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]
P25440,N2,-1.358522176,0.550048003,0.985573139,-0.3264715,-1.054838628,grey70,BRD2,BRD2_HUMAN,Bromodomain-containing protein 2 (O27.1.1),BRD2 KIAA9001 RING3,6046;,"ENST00000374825.9; ENSP00000363958.4; ENSG00000204256.14. [P25440-1];""ENST00000374831.8; ENSP00000363964.4; ENSG00000204256.14. [P25440-1]"";""ENST00000383108.6; ENSP00000372588.2; ENSG00000234507.9. [P25440-1]"";""ENST00000395287.5; ENSP00000378702.1; ENSG00000204256.14. [P25440-2]"";""ENST00000399527.5; ENSP00000382443.1; ENSG00000215077.10. [P25440-2]"";""ENST00000399528.5; ENSP00000382444.1; ENSG00000215077.10. [P25440-1]"";""ENST00000399529.7; ENSP00000382445.3; ENSG00000215077.10. [P25440-1]"";""ENST00000414731.6; ENSP00000391246.2; ENSG00000234704.9."";""ENST00000436979.5; ENSP00000405634.1; ENSG00000235307.12. [P25440-3]"";""ENST00000438194.6; ENSP00000401791.2; ENSG00000234507.9. [P25440-1]"";""ENST00000442863.5; ENSP00000410994.1; ENSG00000234507.9. [P25440-2]"";""ENST00000448067.5; ENSP00000412885.1; ENSG00000235307.12. [P25440-2]"";""ENST00000449085.4; ENSP00000409145.3; ENSG00000204256.14. [P25440-1]"";""ENST00000449118.5; ENSP00000399009.1; ENSG00000234704.9."";""ENST00000549126.4; ENSP00000449380.2; ENSG00000235307.12. [P25440-1]"";""ENST00000552587.4; ENSP00000449609.1; ENSG00000235307.12. [P25440-1]"";""ENST00000678250.1; ENSP00000502900.1; ENSG00000204256.14. [P25440-1]"";",acetylation-dependent protein binding [GO:0140033]; chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577]; protein serine/threonine kinase activity [GO:0004674],chromatin looping [GO:0140588]; neural tube closure [GO:0001843]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O60885,N4,-0.969169238,0.933747747,0.470176279,-0.498723034,-0.904480433,grey30,BRD4,BRD4_HUMAN,Bromodomain-containing protein 4 (Protein HUNK1),BRD4 HUNK1,23476;,"ENST00000263377.6; ENSP00000263377.1; ENSG00000141867.19. [O60885-1];""ENST00000360016.9; ENSP00000353112.4; ENSG00000141867.19. [O60885-3]"";""ENST00000371835.8; ENSP00000360901.3; ENSG00000141867.19. [O60885-2]"";""ENST00000679869.1; ENSP00000506350.1; ENSG00000141867.19. [O60885-1]"";",chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone reader activity [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; P-TEFb complex binding [GO:0106140]; p53 binding [GO:0002039]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357],chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8TDN6,N3,-0.970338584,-1.165436283,1.188729095,-0.223314576,0.290665884,grey50,BRIX1,BRX1_HUMAN,Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2),BRIX1 BRIX BXDC2,55299;,ENST00000336767.6; ENSP00000338862.5; ENSG00000113460.13.;,RNA binding [GO:0003723]; rRNA binding [GO:0019843],rRNA processing [GO:0006364],chromosome [GO:0005694]; nucleolus [GO:0005730]
Q5VW32,C5,1.762083729,0.324778987,-0.693774263,-0.723212199,-0.969506537,turquoise3,BROX,BROX_HUMAN,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),BROX BROFTI C1orf58,148362;,"ENST00000340934.10; ENSP00000343742.5; ENSG00000162819.12. [Q5VW32-1];""ENST00000539697.5; ENSP00000441080.1; ENSG00000162819.12. [Q5VW32-2]"";""ENST00000612948.4; ENSP00000478496.1; ENSG00000162819.12. [Q5VW32-2]"";",0,mitotic nuclear membrane reassembly [GO:0007084],extracellular exosome [GO:0070062]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]
P55201,N3,-0.827577659,-0.74796002,1.18298165,0.142326403,-0.331740468,grey50,BRPF1,BRPF1_HUMAN,Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140),BRPF1 BR140,7862;,"ENST00000383829.7; ENSP00000373340.2; ENSG00000156983.17. [P55201-2];""ENST00000433861.6; ENSP00000402485.2; ENSG00000156983.17. [P55201-4]"";""ENST00000683743.1; ENSP00000507469.1; ENSG00000156983.17. [P55201-1]"";""ENST00000684199.1; ENSP00000506921.1; ENSG00000156983.17. [P55201-2]"";""ENST00000684333.1; ENSP00000508256.1; ENSG00000156983.17. [P55201-3]"";",acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9ULD4,N2,-0.893298027,-0.674238517,1.178657601,0.039558769,-0.191237213,grey70,BRPF3,BRPF3_HUMAN,Bromodomain and PHD finger-containing protein 3,BRPF3 KIAA1286,27154;,"ENST00000339717.11; ENSP00000345419.7; ENSG00000096070.19. [Q9ULD4-2];""ENST00000357641.10; ENSP00000350267.6; ENSG00000096070.19. [Q9ULD4-1]"";""ENST00000534694.5; ENSP00000434501.1; ENSG00000096070.19. [Q9ULD4-3]"";",metal ion binding [GO:0046872],chromatin remodeling [GO:0006338]; positive regulation of DNA replication [GO:0045740]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; extracellular region [GO:0005576]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleus [GO:0005634]
Q9NSI6,N3,-1.288461573,-1.115202281,1.269051094,0.288420157,-0.515192205,grey50,BRWD1,BRWD1_HUMAN,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),BRWD1 C21orf107 WDR9,54014;,"ENST00000333229.6; ENSP00000330753.2; ENSG00000185658.14. [Q9NSI6-1];""ENST00000341322.4; ENSP00000342106.4; ENSG00000185658.14. [Q9NSI6-4]"";""ENST00000342449.8; ENSP00000344333.3; ENSG00000185658.14. [Q9NSI6-2]"";""ENST00000380800.7; ENSP00000370178.3; ENSG00000185658.14. [Q9NSI6-3]"";",0,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96G97,S2,-1.374363801,-1.086463734,0.252236472,0.774478885,0.734416916,orange,BSCL2,BSCL2_HUMAN,Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein),BSCL2,26580;,"ENST00000278893.11; ENSP00000278893.7; ENSG00000168000.16. [Q96G97-3];""ENST00000360796.10; ENSP00000354032.5; ENSG00000168000.16. [Q96G97-4]"";""ENST00000403550.5; ENSP00000385561.1; ENSG00000168000.16. [Q96G97-2]"";""ENST00000407022.7; ENSP00000384080.3; ENSG00000168000.16. [Q96G97-2]"";""ENST00000421906.5; ENSP00000413209.1; ENSG00000168000.16. [Q96G97-2]"";""ENST00000524862.6; ENSP00000433888.2; ENSG00000168000.16. [Q96G97-4]"";""ENST00000679883.1; ENSP00000505838.1; ENSG00000168000.16. [Q96G97-4]"";",phospholipid binding [GO:0005543],fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of cold-induced thermogenesis [GO:0120162],endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]
P35613,S4,-0.692258493,-0.987874693,0.383245818,0.944093071,0.039219727,tomato2,BSG,BASI_HUMAN,Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147),BSG UNQ6505/PRO21383,682;,"ENST00000333511.9; ENSP00000333769.3; ENSG00000172270.22. [P35613-1];""ENST00000346916.9; ENSP00000344707.4; ENSG00000172270.22. [P35613-3]"";""ENST00000353555.9; ENSP00000343809.4; ENSG00000172270.22. [P35613-2]"";""ENST00000545507.6; ENSP00000473664.1; ENSG00000172270.22. [P35613-3]"";""ENST00000573784.6; ENSP00000473393.2; ENSG00000172270.22. [P35613-3]"";""ENST00000576984.3; ENSP00000473528.2; ENSG00000172270.22. [P35613-3]"";""ENST00000680065.1; ENSP00000506020.1; ENSG00000172270.22. [P35613-3]"";",cadherin binding [GO:0045296]; mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618],angiogenesis [GO:0001525]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial tube morphogenesis [GO:0061154]; neural retina development [GO:0003407]; neutrophil chemotaxis [GO:0030593]; odontogenesis of dentin-containing tooth [GO:0042475]; photoreceptor cell maintenance [GO:0045494]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of matrix metallopeptidase secretion [GO:1904466]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of viral entry into host cell [GO:0046598]; protein localization to plasma membrane [GO:0072659]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434],acrosomal membrane [GO:0002080]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]
Q96Q07,S3,0.061394784,-0.572522927,-0.019917101,0.347078315,0.800426322,salmon,BTBD9,BTBD9_HUMAN,BTB/POZ domain-containing protein 9,BTBD9 KIAA1880,114781;,"ENST00000314100.10; ENSP00000323408.6; ENSG00000183826.19. [Q96Q07-3];""ENST00000419706.6; ENSP00000415365.2; ENSG00000183826.19. [Q96Q07-2]"";""ENST00000481247.6; ENSP00000418751.1; ENSG00000183826.19. [Q96Q07-1]"";""ENST00000649492.1; ENSP00000497066.1; ENSG00000183826.19. [Q96Q07-1]"";",0,"adult locomotory behavior [GO:0008344]; circadian behavior [GO:0048512]; circadian sleep/wake cycle, non-REM sleep [GO:0042748]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal-level iron ion homeostasis [GO:0060586]; regulation of synaptic vesicle endocytosis [GO:1900242]; sensory perception of temperature stimulus [GO:0050951]; serotonin metabolic process [GO:0042428]",cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]
P20290,C5,1.025070337,1.073672724,-0.644129915,-0.783658475,-0.880298613,turquoise3,BTF3,BTF3_HUMAN,Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta) (NAC-beta) (RNA polymerase B transcription factor 3),BTF3 NACB OK/SW-cl.8,689;,"ENST00000335895.12; ENSP00000338516.8; ENSG00000145741.17. [P20290-2];""ENST00000380591.8; ENSP00000369965.3; ENSG00000145741.17. [P20290-1]"";",RNA binding [GO:0003723],in utero embryonic development [GO:0001701]; negative regulation of protein localization to endoplasmic reticulum [GO:1905551]; protein transport [GO:0015031],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]
Q96K17,C5,1.251230848,0.835707966,-0.674471615,-0.716496163,-1.131402481,turquoise3,BTF3L4,BT3L4_HUMAN,Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4),BTF3L4,91408;,"ENST00000313334.13; ENSP00000360664.4; ENSG00000134717.18. [Q96K17-1];""ENST00000472944.6; ENSP00000436712.1; ENSG00000134717.18. [Q96K17-2]"";""ENST00000489308.6; ENSP00000434824.1; ENSG00000134717.18. [Q96K17-3]"";",0,0,0
Q7KYR7,S4,-0.506480445,-0.728840958,0.320055003,0.581176539,0.308954376,tomato2,BTN2A1,BT2A1_HUMAN,Butyrophilin subfamily 2 member A1,BTN2A1 BT2.1 BTF1,11120;,"ENST00000312541.10; ENSP00000312158.5; ENSG00000112763.17. [Q7KYR7-2];""ENST00000429381.5; ENSP00000416945.1; ENSG00000112763.17. [Q7KYR7-4]"";""ENST00000469185.5; ENSP00000419043.1; ENSG00000112763.17. [Q7KYR7-6]"";""ENST00000541522.5; ENSP00000443909.1; ENSG00000112763.17. [Q7KYR7-5]"";""ENST00000709935.1; ENSP00000517949.1; ENSG00000292170.1. [Q7KYR7-2]"";""ENST00000709937.1; ENSP00000517951.1; ENSG00000292170.1. [Q7KYR7-4]"";""ENST00000709938.1; ENSP00000517952.1; ENSG00000292170.1. [Q7KYR7-6]"";""ENST00000709940.1; ENSP00000517954.1; ENSG00000292170.1. [Q7KYR7-5]"";",signaling receptor binding [GO:0005102],lipid metabolic process [GO:0006629]; regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852],external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]
O43683,C2,1.111022478,0.300916148,-0.229558459,-0.191861332,-0.38486003,aquamarine,BUB1,BUB1_HUMAN,Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A),BUB1 BUB1L,699;,"ENST00000302759.11; ENSP00000302530.6; ENSG00000169679.15. [O43683-1];""ENST00000409311.5; ENSP00000386701.1; ENSG00000169679.15. [O43683-2]"";""ENST00000535254.6; ENSP00000441013.1; ENSG00000169679.15. [O43683-3]"";",ATP binding [GO:0005524]; histone H2A kinase activity [GO:0140995]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000720]; regulation of chromosome segregation [GO:0051983]; regulation of sister chromatid cohesion [GO:0007063]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]
O60566,C3,1.807376771,-0.08854955,-0.673492906,-0.376435222,-0.67831908,cyan,BUB1B,BUB1B_HUMAN,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1),BUB1B BUBR1 MAD3L SSK1,701;,"ENST00000287598.11; ENSP00000287598.7; ENSG00000156970.13. [O60566-1];""ENST00000412359.7; ENSP00000398470.3; ENSG00000156970.13. [O60566-3]"";",ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]",anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]
Q7Z3E2,C5,1.404974584,0.708738064,-0.531416864,-0.446602664,-0.881751765,turquoise3,C10orf118,CC186_HUMAN,Coiled-coil domain-containing protein 186 (CTCL tumor antigen HD-CL-01/L14-2),CCDC186 C10orf118,55088;,"ENST00000369287.8; ENSP00000358293.3; ENSG00000165813.20.;""ENST00000648613.1; ENSP00000498136.1; ENSG00000165813.20."";",small GTPase binding [GO:0031267],insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; response to bacterium [GO:0009617]; vesicle cytoskeletal trafficking [GO:0099518],trans-Golgi network [GO:0005802]
Q96JN0,N3,-1.013678677,-0.969589325,1.125684072,-0.270525989,0.230270213,grey50,C10orf12,LCOR_HUMAN,Ligand-dependent corepressor (LCoR) (Mblk1-related protein 2),LCOR C10orf12 KIAA1795 MLR2,84458;,"ENST00000356016.7; ENSP00000348298.2; ENSG00000196233.14. [Q96JN0-1];""ENST00000371097.8; ENSP00000360138.3; ENSG00000196233.14. [Q96JN0-1]"";""ENST00000371103.8; ENSP00000360144.3; ENSG00000196233.14. [Q96JN0-1]"";""ENST00000421806.4; ENSP00000490116.2; ENSG00000196233.14. [Q96JN0-3]"";""ENST00000540664.6; ENSP00000443431.1; ENSG00000196233.14. [Q96JN0-2]"";""ENST00000675471.1; ENSP00000502633.1; ENSG00000196233.14. [Q96JN0-1]"";""ENST00000675537.1; ENSP00000501560.1; ENSG00000196233.14. [Q96JN0-1]"";""ENST00000675971.1; ENSP00000501639.1; ENSG00000196233.14. [Q96JN0-1]"";",DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; nuclear estrogen receptor binding [GO:0030331]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; ubiquitin-specific protease binding [GO:1990381],cellular response to estradiol stimulus [GO:0071392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96D05,S3,-0.618310359,-0.802519744,0.296364494,0.503573725,0.686668769,salmon,C10orf35,F241B_HUMAN,Protein FAM241B,FAM241B C10orf35,219738;,ENST00000373279.6; ENSP00000362376.4; ENSG00000171224.9. [Q96D05-1];,0,0,intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
Q9H8K7,C2,0.929299342,0.164058443,-0.15261276,0.044575305,-0.096226536,aquamarine,C10orf88,PAAT_HUMAN,ATPase PAAT (EC 3.6.1.-) (Protein associated with ABC transporters) (PAAT),PAAT C10orf88,80007;,ENST00000481909.2; ENSP00000419126.1; ENSG00000119965.13.;,ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802],0,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]
Q9H3H3,C5,1.904853196,0.379128991,-0.891180232,-1.129151488,-1.138729811,turquoise3,C11orf68,CK068_HUMAN,UPF0696 protein C11orf68 (Basophilic leukemia-expressed protein Bles03) (Protein p5326),C11orf68 BLES03,83638;,"ENST00000438576.3; ENSP00000398350.2; ENSG00000175573.7. [Q9H3H3-3];""ENST00000449692.3; ENSP00000409681.3; ENSG00000175573.7. [Q9H3H3-2]"";""ENST00000530188.1; ENSP00000433914.1; ENSG00000175573.7. [Q9H3H3-1]"";",RNA binding [GO:0003723],0,0
Q6UW78,M2,-0.731719952,-1.053381354,0.314045411,1.018277727,0.082979885,tan4,C11orf83,UQCC3_HUMAN,Ubiquinol-cytochrome-c reductase complex assembly factor 3 (Assembly factor CBP4 homolog),UQCC3 C11orf83 UNQ655/PRO1286,790955;,"ENST00000377953.4; ENSP00000367189.3; ENSG00000204922.5.;""ENST00000531323.1; ENSP00000432692.1; ENSG00000204922.5."";",cardiolipin binding [GO:1901612]; phosphatidic acid binding [GO:0070300],"ATP biosynthetic process [GO:0006754]; cristae formation [GO:0042407]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]",cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q9HB07,C5,1.530594811,0.816372966,-0.781071735,-0.941671151,-1.368756232,turquoise3,C12orf10,MYG1_HUMAN,MYG1 exonuclease (EC 3.1.-.-),MYG1 C12orf10,60314;,"ENST00000267103.10; ENSP00000267103.5; ENSG00000139637.14.;""ENST00000708949.1; ENSP00000517432.1; ENSG00000291835.1."";",nuclease activity [GO:0004518],locomotory exploration behavior [GO:0035641],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8WUH6,C3,2.184185298,-0.339229351,-0.77367669,-0.363553734,-1.157181142,cyan,C12orf23,TM263_HUMAN,Transmembrane protein 263,TMEM263 C12orf23,90488;,"ENST00000280756.9; ENSP00000280756.4; ENSG00000151135.10.;""ENST00000547081.1; ENSP00000449106.1; ENSG00000151135.10."";""ENST00000547242.5; ENSP00000446537.1; ENSG00000151135.10."";""ENST00000548125.5; ENSP00000449785.1; ENSG00000151135.10."";""ENST00000550344.5; ENSP00000446717.1; ENSG00000151135.10."";""ENST00000551813.1; ENSP00000450350.1; ENSG00000151135.10."";",0,0,membrane [GO:0016020]
Q8N999,C4,2.065414056,0.356196067,-1.021600423,-1.049165905,-1.360962281,deepskyblue2,C12orf29,RLIG1_HUMAN,RNA ligase 1 (EC 6.5.1.3) (RNA ligase) (Rnl),RLIG1 C12orf29,91298;,"ENST00000356891.4; ENSP00000349358.3; ENSG00000133641.18. [Q8N999-1];""ENST00000453037.7; ENSP00000402018.2; ENSG00000133641.18. [Q8N999-2]"";""ENST00000550333.5; ENSP00000448194.1; ENSG00000133641.18. [Q8N999-2]"";""ENST00000552121.5; ENSP00000447327.1; ENSG00000133641.18. [Q8N999-2]"";",ATP binding [GO:0005524]; RNA ligase (ATP) activity [GO:0003972],hematopoietic progenitor cell differentiation [GO:0002244]; protein adenylylation [GO:0018117]; response to reactive oxygen species [GO:0000302]; RNA repair [GO:0042245],0
Q9NQ89,C2,1.367524153,0.319942112,-0.400926205,-0.271351349,-0.421395582,aquamarine,C12orf4,FERY3_HUMAN,Ferry endosomal RAB5 effector complex subunit 3 (Fy-3),FERRY3 C12orf4,57102;,"ENST00000261250.8; ENSP00000261250.3; ENSG00000047621.12.;""ENST00000545746.5; ENSP00000439996.1; ENSG00000047621.12."";",0,regulation of mast cell degranulation [GO:0043304],cytoplasm [GO:0005737]; early endosome [GO:0005769]; protein-containing complex [GO:0032991]
Q96C57,N4,-1.066850109,0.976279023,0.393934148,-0.395459312,-0.308918968,grey30,C12orf43,CSTOS_HUMAN,Protein CUSTOS,CUSTOS C12orf43,64897;,ENST00000288757.7; ENSP00000288757.5; ENSG00000157895.11.;,0,negative regulation of Wnt signaling pathway [GO:0030178]; Spemann organizer formation [GO:0060061]; Wnt signaling pathway [GO:0016055],nuclear envelope [GO:0005635]
Q9BSB4,C1,1.664906238,0.375434784,-0.453173618,-0.340579483,-0.678733404,lightblue,C12orf44,ATGA1_HUMAN,Autophagy-related protein 101,ATG101 C12orf44 PP894,60673;,ENST00000336854.9; ENSP00000338990.4; ENSG00000123395.15.;,identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],autophagosome assembly [GO:0000045]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of autophagy [GO:0010508]; regulation of protein lipidation [GO:1903059],Atg1/ULK1 kinase complex [GO:1990316]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; phagophore assembly site [GO:0000407]
Q9H741,S3,-0.466504565,-0.773705738,0.004400899,0.775803699,0.741215364,salmon,C12orf49,SPRNG_HUMAN,SREBP regulating gene protein (SREBF pathway regulator in Golgi 1),SPRING1 C12orf49 SPRING,79794;,ENST00000261318.5; ENSP00000261318.3; ENSG00000111412.6.;,0,positive regulation of SREBP signaling pathway [GO:2000640],Golgi membrane [GO:0000139]
Q9NQ88,C4,2.094009296,0.243928132,-1.143389997,-1.171329879,-1.381565478,deepskyblue2,C12orf5,TIGAR_HUMAN,"Fructose-2,6-bisphosphatase TIGAR (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator) (TP53-induced glycolysis regulatory phosphatase)",TIGAR C12orf5,57103;,ENST00000179259.6; ENSP00000179259.4; ENSG00000078237.7.;,"fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]","cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; glucose catabolic process to lactate via pyruvate [GO:0019661]; glycolytic process [GO:0006096]; intestinal epithelial cell development [GO:0060576]; mitophagy [GO:0000423]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitophagy [GO:1901525]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of DNA repair [GO:0045739]; positive regulation of hexokinase activity [GO:1903301]; positive regulation of pentose-phosphate shunt [GO:1905857]; reactive oxygen species metabolic process [GO:0072593]; regulation of pentose-phosphate shunt [GO:0043456]; regulation of response to DNA damage checkpoint signaling [GO:1902153]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to xenobiotic stimulus [GO:0009410]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]
Q99622,C5,1.464515792,0.526889556,-0.565639802,-0.651629737,-0.95978283,turquoise3,C12orf57,C10_HUMAN,Protein C10,C12orf57 C10,113246;,"ENST00000229281.6; ENSP00000229281.5; ENSG00000111678.11.;""ENST00000545581.5; ENSP00000440602.1; ENSG00000111678.11."";",0,camera-type eye morphogenesis [GO:0048593]; cognition [GO:0050890]; corpus callosum morphogenesis [GO:0021540]; post-embryonic development [GO:0009791]; psychomotor behavior [GO:0036343]; regulation of skeletal muscle contraction [GO:0014819]; third ventricle development [GO:0021678],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]
Q69YU5,M2,-1.466822759,-1.291712932,0.384407006,1.156257384,-0.051223555,tan4,C12orf73,UQCC6_HUMAN,Ubiquinol-cytochrome c reductase complex assembly factor 6 (Protein BRAWNIN),UQCC6 BR BRAWNIN C12orf73,728568;,"ENST00000378090.9; ENSP00000367330.4; ENSG00000204954.10.;""ENST00000547945.5; ENSP00000449839.1; ENSG00000204954.10."";""ENST00000549478.1; ENSP00000448771.1; ENSG00000204954.10."";""ENST00000553183.5; ENSP00000446981.1; ENSG00000204954.10."";",0,mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex III assembly [GO:0034551],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9NWQ9,C4,2.093827561,0.226362228,-0.883346709,-0.8845356,-1.290037861,deepskyblue2,C14orf119,CN119_HUMAN,Uncharacterized protein C14orf119,C14orf119 My028,55017;,"ENST00000319074.6; ENSP00000322238.4; ENSG00000179933.6.;""ENST00000554203.1; ENSP00000450861.1; ENSG00000179933.6."";",0,0,cytosol [GO:0005829]; mitochondrion [GO:0005739]
Q9BXV9,C5,1.479261872,0.924438683,-0.919293452,-0.929288659,-1.274866602,turquoise3,C14orf142,GON7_HUMAN,EKC/KEOPS complex subunit GON7,GON7 C14orf142,84520;,"ENST00000306954.5; ENSP00000306320.4; ENSG00000170270.5.;""ENST00000621279.2; ENSP00000478863.1; ENSG00000275619.2."";",0,tRNA threonylcarbamoyladenosine modification [GO:0002949],cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96S19,C4,2.120981959,-0.047513154,-0.768454943,-0.971425277,-1.12274932,deepskyblue2,C16orf13,MTL26_HUMAN,Methyltransferase-like 26,METTL26 JFP2 C16orf13,84326;,"ENST00000301686.13; ENSP00000445926.2; ENSG00000130731.16. [Q96S19-1];""ENST00000338401.8; ENSP00000444140.2; ENSG00000130731.16. [Q96S19-3]"";""ENST00000397664.8; ENSP00000440475.2; ENSG00000130731.16. [Q96S19-5]"";""ENST00000397665.6; ENSP00000444460.2; ENSG00000130731.16. [Q96S19-6]"";""ENST00000397666.6; ENSP00000440765.2; ENSG00000130731.16. [Q96S19-4]"";",0,0,0
Q96GQ5,S3,-0.705076539,-0.933564575,0.266526606,0.692485226,0.545929108,salmon,C16orf58,RUSF1_HUMAN,RUS family member 1,RUSF1 C16orf58,64755;,ENST00000327237.7; ENSP00000317579.2; ENSG00000140688.18. [Q96GQ5-1];,0,0,membrane [GO:0016020]
Q9BSU1,C4,2.086858539,-0.090667917,-0.842929952,-0.729217284,-1.110960829,deepskyblue2,C16orf70,PHAF1_HUMAN,Phagosome assembly factor 1,PHAF1 C16orf6 C16orf70,80262;,"ENST00000219139.8; ENSP00000219139.3; ENSG00000125149.12. [Q9BSU1-1];""ENST00000569600.5; ENSP00000455182.1; ENSG00000125149.12. [Q9BSU1-1]"";",0,Golgi to plasma membrane protein transport [GO:0043001],dendrite [GO:0030425]; phagophore assembly site [GO:0000407]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]
Q96GS4,S1,-0.685268559,-0.621504185,-0.455393704,0.536208076,1.034990824,gold,C17orf59,BORC6_HUMAN,BLOC-1-related complex subunit 6 (Lysosome-dispersing protein) (Lyspersin),BORCS6 C17orf59,54785;,ENST00000389017.6; ENSP00000373669.4; ENSG00000196544.8.;,identical protein binding [GO:0042802],lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196],BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]
Q9BQA9,S2,-0.821969701,-1.421608331,0.273539508,0.923751781,0.530484551,orange,C17orf62,CYBC1_HUMAN,Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein) (Eros),CYBC1 C17orf62 EROS,79415;,"ENST00000306645.10; ENSP00000307765.5; ENSG00000178927.19. [Q9BQA9-1];""ENST00000434650.6; ENSP00000401626.2; ENSG00000178927.19. [Q9BQA9-2]"";""ENST00000437807.6; ENSP00000388909.2; ENSG00000178927.19. [Q9BQA9-1]"";""ENST00000577436.5; ENSP00000464633.1; ENSG00000178927.19. [Q9BQA9-2]"";""ENST00000577696.6; ENSP00000463215.2; ENSG00000178927.19. [Q9BQA9-1]"";""ENST00000577732.5; ENSP00000463228.1; ENSG00000178927.19. [Q9BQA9-1]"";""ENST00000578919.6; ENSP00000464080.1; ENSG00000178927.19. [Q9BQA9-1]"";""ENST00000585064.5; ENSP00000463846.1; ENSG00000178927.19. [Q9BQA9-1]"";""ENST00000585080.5; ENSP00000462529.1; ENSG00000178927.19. [Q9BQA9-1]"";""ENST00000585115.2; ENSP00000513957.1; ENSG00000178927.19. [Q9BQA9-2]"";""ENST00000698819.1; ENSP00000513955.1; ENSG00000178927.19. [Q9BQA9-1]"";""ENST00000698820.1; ENSP00000513956.1; ENSG00000178927.19. [Q9BQA9-2]"";",0,innate immune response [GO:0045087]; respiratory burst after phagocytosis [GO:0045728],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q9BSJ5,M2,-0.743805992,-0.750956479,0.318331804,1.038164631,-0.184260992,tan4,C17orf80,CQ080_HUMAN,Mitochondrial nucleoid-associated protein 1 (Cell migration-inducing gene 3 protein) (Human lung cancer oncogene 8 protein) (HLC-8) (Protein C17orf80),MTNAP1 C17orf80 HLC8 MIG3,55028;,"ENST00000268942.12; ENSP00000268942.8; ENSG00000141219.16. [Q9BSJ5-2];""ENST00000359042.6; ENSP00000351937.2; ENSG00000141219.16. [Q9BSJ5-1]"";""ENST00000426147.6; ENSP00000396970.2; ENSG00000141219.16. [Q9BSJ5-3]"";""ENST00000535032.7; ENSP00000440551.2; ENSG00000141219.16. [Q9BSJ5-1]"";""ENST00000577615.5; ENSP00000464132.1; ENSG00000141219.16. [Q9BSJ5-2]"";",0,0,extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]
Q53F19,N3,-0.906490549,-0.469344542,0.957912603,-0.087664856,0.439239519,grey50,C17orf85,NCBP3_HUMAN,Nuclear cap-binding protein subunit 3 (Protein ELG),NCBP3 C17orf85,55421;,ENST00000389005.6; ENSP00000373657.4; ENSG00000074356.17. [Q53F19-1];,mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339],7-methylguanosine mRNA capping [GO:0006370]; defense response to virus [GO:0051607]; mRNA export from nucleus [GO:0006406]; mRNA transcription by RNA polymerase II [GO:0042789]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; snRNA export from nucleus [GO:0006408],cytoplasm [GO:0005737]; nuclear cap binding complex [GO:0005846]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA cap binding complex [GO:0034518]
Q32NC0,N3,-1.235466217,-1.055676546,0.596565714,-0.140435096,1.098208439,grey50,C18orf21,CR021_HUMAN,UPF0711 protein C18orf21 (HBV X-transactivated gene 13 protein) (HBV XAg-transactivated protein 13),C18orf21 XTP13 PNAS-124 PNAS-131,83608;,"ENST00000333234.5; ENSP00000329492.5; ENSG00000141428.17. [Q32NC0-2];""ENST00000592875.6; ENSP00000465517.1; ENSG00000141428.17. [Q32NC0-1]"";""ENST00000610527.4; ENSP00000480486.1; ENSG00000141428.17. [Q32NC0-2]"";",0,0,0
Q96B23,N4,0.316204761,1.510012136,-0.684810964,-0.948118899,-1.36920573,grey30,C18orf25,ARK2N_HUMAN,Protein ARK2N (ARKadia-like protein 1) (Arkadia (RNF111) N-terminal like PKA signaling regulator protein 2N),ARK2N ARKL1 C18orf25,147339;,"ENST00000615052.5; ENSP00000481626.1; ENSG00000152242.11. [Q96B23-1];""ENST00000619301.4; ENSP00000480074.1; ENSG00000152242.11. [Q96B23-2]"";",transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630],negative regulation of viral life cycle [GO:1903901]; ubiquitin-dependent protein catabolic process [GO:0006511],chromatin [GO:0000785]; nucleus [GO:0005634]
Q8TCD1,S2,-2.177756188,-1.900276471,0.229787976,0.903423352,0.59888833,orange,C18orf32,CR032_HUMAN,UPF0729 protein C18orf32 (Putative NF-kappa-B-activating protein 200),C18orf32,497661;,"ENST00000318240.8; ENSP00000323199.3; ENSG00000177576.12.;""ENST00000582392.2; ENSP00000462538.1; ENSG00000177576.12."";""ENST00000613385.4; ENSP00000480941.1; ENSG00000177576.12."";",0,positive regulation of canonical NF-kappaB signal transduction [GO:0043123],endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]
Q9BSF4,M2,-0.455723758,-0.992757201,0.306194191,0.869928464,-0.177660589,tan4,C19orf52,TIM29_HUMAN,Mitochondrial import inner membrane translocase subunit Tim29 (TIM29),TIMM29 c19orf52,90580;,ENST00000270502.7; ENSP00000270502.5; ENSG00000142444.7.;,protein transporter activity [GO:0140318],protein insertion into mitochondrial inner membrane [GO:0045039],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]
Q5XKP0,M2,-1.674506657,-1.70647014,0.462880337,1.212370652,-0.295078134,tan4,C19orf70,MIC13_HUMAN,MICOS complex subunit MIC13 (Protein P117),MICOS13 C19orf70 MIC13 QIL1,125988;,ENST00000309324.9; ENSP00000309561.3; ENSG00000174917.9.;,0,cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007],MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401]
Q9NS00,S1,-1.140966005,-1.361936627,-0.292369278,0.74414665,1.010005412,gold,C1GALT1,C1GLT_HUMAN,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)",C1GALT1,56913;,"ENST00000223122.4; ENSP00000223122.2; ENSG00000106392.11. [Q9NS00-1];""ENST00000402468.3; ENSP00000384550.3; ENSG00000106392.11. [Q9NS00-2]"";""ENST00000436587.7; ENSP00000389176.2; ENSG00000106392.11. [Q9NS00-1]"";",glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166],angiogenesis [GO:0001525]; intestinal epithelial cell development [GO:0060576]; kidney development [GO:0001822]; protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q96EU7,S1,-0.984295225,-1.358910741,-0.218537412,0.793420124,1.01431003,gold,C1GALT1C1,C1GLC_HUMAN,"C1GALT1-specific chaperone 1 (C38H2-like protein 1) (C38H2-L1) (Core 1 beta1,3-galactosyltransferase 2) (C1Gal-T2) (C1GalT2) (Core 1 beta3-Gal-T2) (Core 1 beta3-galactosyltransferase-specific molecular chaperone)",C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310,29071;,"ENST00000304661.6; ENSP00000304364.5; ENSG00000171155.8.;""ENST00000371313.2; ENSP00000360363.2; ENSG00000171155.8."";""ENST00000673177.1; ENSP00000500356.1; ENSG00000288368.1."";""ENST00000673568.1; ENSP00000500561.1; ENSG00000288368.1."";",glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263],platelet activation [GO:0030168]; platelet morphogenesis [GO:0036344]; protein O-linked glycosylation [GO:0006493],extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]
Q8NDD1,N2,-1.040533575,-1.050662353,1.263094691,0.106297765,-0.028521495,grey70,C1orf131,CA131_HUMAN,Uncharacterized protein C1orf131,C1orf131 cPERP-A,128061;,"ENST00000366649.7; ENSP00000355609.2; ENSG00000143633.13. [Q8NDD1-1];""ENST00000366651.7; ENSP00000355611.3; ENSG00000143633.13. [Q8NDD1-6]"";",RNA binding [GO:0003723],ribosomal small subunit biogenesis [GO:0042274],chromosome [GO:0005694]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]
Q96HA4,S2,-0.679838933,-1.290711497,0.46707515,0.954547094,0.351076144,orange,C1orf159,CA159_HUMAN,Uncharacterized protein C1orf159,C1orf159 UNQ2998/PRO9739,54991;,"ENST00000379319.5; ENSP00000368623.1; ENSG00000131591.18. [Q96HA4-4];""ENST00000379325.7; ENSP00000368629.3; ENSG00000131591.18. [Q96HA4-3]"";""ENST00000379339.5; ENSP00000368644.1; ENSG00000131591.18. [Q96HA4-1]"";""ENST00000421241.7; ENSP00000400736.2; ENSG00000131591.18. [Q96HA4-4]"";",0,0,membrane [GO:0016020]
Q9H425,C2,0.970457821,-0.407579999,0.090835008,0.424330641,-0.277696395,aquamarine,C1orf198,CA198_HUMAN,Uncharacterized protein C1orf198,C1orf198,84886;,"ENST00000366663.10; ENSP00000355623.5; ENSG00000119280.17. [Q9H425-1];""ENST00000470540.5; ENSP00000428172.1; ENSG00000119280.17. [Q9H425-3]"";""ENST00000523410.1; ENSP00000430967.1; ENSG00000119280.17. [Q9H425-2]"";",0,0,cytosol [GO:0005829]
A1L170,M1,-0.707490588,-0.756569114,0.626253145,0.737963183,-0.342182534,burlywood4,C1orf226,CA226_HUMAN,Uncharacterized protein C1orf226,C1orf226,400793;,"ENST00000426197.2; ENSP00000413150.2; ENSG00000239887.6. [A1L170-2];""ENST00000458626.4; ENSP00000437071.1; ENSG00000239887.6. [A1L170-1]"";",0,0,0
Q5SWX8,S2,-0.995103144,-1.326907056,0.233121593,0.837065131,0.558075001,orange,C1orf27,ODR4_HUMAN,Protein odr-4 homolog (hODR-4) (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1),ODR4 C1orf27 TTG1 TTG1A,54953;,"ENST00000287859.11; ENSP00000287859.6; ENSG00000157181.16. [Q5SWX8-1];""ENST00000367470.8; ENSP00000356440.3; ENSG00000157181.16. [Q5SWX8-2]"";""ENST00000419367.8; ENSP00000395084.3; ENSG00000157181.16. [Q5SWX8-4]"";",0,protein localization [GO:0008104],membrane [GO:0016020]
Q9BV19,C5,1.938798546,0.717457071,-1.047336926,-1.282122318,-1.426578173,turquoise3,C1orf50,CA050_HUMAN,Uncharacterized protein C1orf50,C1orf50,79078;,ENST00000372525.7; ENSP00000361603.4; ENSG00000164008.17.;,identical protein binding [GO:0042802],0,0
Q07021,M1,-1.552220555,-0.032540863,0.323571232,1.023620139,-0.761394185,burlywood4,C1QBP,C1QBP_HUMAN,"Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33) (SF2AP32)",C1QBP GC1QBP HABP1 SF2P32,708;,ENST00000225698.8; ENSP00000225698.4; ENSG00000108561.8.;,adrenergic receptor binding [GO:0031690]; complement component C1q complex binding [GO:0001849]; deoxyribonuclease inhibitor activity [GO:0060703]; enzyme inhibitor activity [GO:0004857]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134],"apoptotic process [GO:0006915]; complement activation, classical pathway [GO:0006958]; cytosolic ribosome assembly [GO:0042256]; DNA damage response [GO:0006974]; immune response [GO:0006955]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon production [GO:0032689]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380]",cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9BUV8,S2,-1.458458598,-1.721785872,0.08464304,1.189567931,0.57444364,orange,C20orf24,RCAF1_HUMAN,GEL complex subunit OPTI (Obligate partner of TMCO1 insertase) (Rab5-interacting protein) (RIP5) (Respirasome Complex Assembly Factor 1),RAB5IF C20orf24 OPTI RCAF1 PNAS-11,55969;,"ENST00000342422.3; ENSP00000341213.3; ENSG00000101084.19. [Q9BUV8-5];""ENST00000344795.8; ENSP00000340164.3; ENSG00000101084.19. [Q9BUV8-2]"";""ENST00000373852.9; ENSP00000362958.5; ENSG00000101084.19. [Q9BUV8-1]"";""ENST00000483815.5; ENSP00000432510.1; ENSG00000101084.19. [Q9BUV8-4]"";""ENST00000492721.5; ENSP00000435871.1; ENSG00000101084.19. [Q9BUV8-4]"";",0,mitochondrial respirasome assembly [GO:0097250]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063],endoplasmic reticulum membrane [GO:0005789]; mitochondrial respirasome [GO:0005746]; multi-pass translocon complex [GO:0160064]
Q9GZN8,C5,1.865921786,0.217332091,-0.638038149,-0.694251288,-0.842320335,turquoise3,C20orf27,ADSSP_HUMAN,Adipose-secreted signaling protein,ADISSP C20orf27,54976;,"ENST00000217195.12; ENSP00000217195.8; ENSG00000101220.18. [Q9GZN8-2];""ENST00000379772.4; ENSP00000369097.4; ENSG00000101220.18. [Q9GZN8-1]"";""ENST00000399672.5; ENSP00000382580.1; ENSG00000101220.18. [Q9GZN8-1]"";",protein phosphatase 1 binding [GO:0008157],adaptive thermogenesis [GO:1990845]; glucose homeostasis [GO:0042593]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511],extracellular space [GO:0005615]
Q9Y426,S2,-0.979874047,-1.207856424,0.245725804,0.791099058,0.578919437,orange,C2CD2,C2CD2_HUMAN,C2 domain-containing protein 2 (Transmembrane protein 24-like),C2CD2 C21orf25 C21orf258 TMEM24L,25966;,"ENST00000329623.11; ENSP00000329302.7; ENSG00000157617.17. [Q9Y426-2];""ENST00000380486.4; ENSP00000369853.3; ENSG00000157617.17. [Q9Y426-1]"";",0,0,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]
O14523,S3,-0.765139249,-0.742172279,0.324003236,0.711388826,0.484563178,salmon,C2CD2L,C2C2L_HUMAN,Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like) (C2CD2-like) (Transmembrane protein 24),C2CD2L KIAA0285 TMEM24 DLNB23,9854;,"ENST00000336702.7; ENSP00000338885.3; ENSG00000172375.14. [O14523-2];""ENST00000648610.2; ENSP00000497391.1; ENSG00000172375.14. [O14523-1]"";",insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526],positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774],cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; plasma membrane [GO:0005886]
Q9NWW7,N1,-0.83370631,-0.662472806,0.238701385,0.19188735,1.000362645,grey90,C2orf42,CB042_HUMAN,Uncharacterized protein C2orf42,C2orf42,54980;,"ENST00000264434.7; ENSP00000264434.2; ENSG00000115998.8.;""ENST00000420306.1; ENSP00000404515.1; ENSG00000115998.8."";",0,0,nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9H6V9,S3,-0.684474437,-0.810884203,0.01604405,0.816258908,0.662632659,salmon,C2orf43,LDAH_HUMAN,Lipid droplet-associated hydrolase (EC 3.1.1.13) (Lipid droplet-associated serine hydrolase) (hLDAH),LDAH C2orf43,60526;,"ENST00000237822.8; ENSP00000237822.3; ENSG00000118961.15. [Q9H6V9-1];""ENST00000541941.5; ENSP00000440570.1; ENSG00000118961.15. [Q9H6V9-4]"";""ENST00000619656.4; ENSP00000483067.1; ENSG00000118961.15. [Q9H6V9-4]"";""ENST00000626491.2; ENSP00000487592.1; ENSG00000118961.15. [Q9H6V9-3]"";",sterol esterase activity [GO:0004771],cholesterol homeostasis [GO:0042632]; intracellular triglyceride homeostasis [GO:0035356]; lipid catabolic process [GO:0016042]; lipid droplet fusion [GO:0160077]; lipid storage [GO:0019915],endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]
Q8WWC4,M2,-1.349927849,-1.33317133,0.402776874,1.12236808,-0.166770888,tan4,C2orf47,MAIP1_HUMAN,"m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1)",MAIP1 C2orf47,79568;,"ENST00000295079.6; ENSP00000295079.2; ENSG00000162972.11.;""ENST00000392290.6; ENSP00000376111.1; ENSG00000162972.11."";",ribosome binding [GO:0043022],calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]
Q9BVC5,N4,-0.894235912,1.3436827,-0.402689055,-0.807684398,-0.29397366,grey30,C2orf49,ASHWN_HUMAN,Ashwin,C2orf49,79074;,ENST00000258457.7; ENSP00000258457.2; ENSG00000135974.10. [Q9BVC5-1];,0,"embryonic morphogenesis [GO:0048598]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]
Q8N8R5,C1,1.456646208,0.155060754,-0.238672279,0.077073037,-0.936582666,lightblue,C2orf69,CB069_HUMAN,Mitochondrial protein C2orf69,C2orf69,205327;,ENST00000319974.6; ENSP00000312770.5; ENSG00000178074.6.;,0,oxidative phosphorylation [GO:0006119],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; respirasome [GO:0070469]
Q6NW34,N1,-0.668003526,-1.007260414,0.567893857,-0.110283458,1.124245308,grey90,C3orf17,NEPRO_HUMAN,Nucleolus and neural progenitor protein,NEPRO C3orf17,25871;,"ENST00000314400.10; ENSP00000320251.5; ENSG00000163608.15. [Q6NW34-1];""ENST00000383675.6; ENSP00000373173.2; ENSG00000163608.15. [Q6NW34-2]"";",0,negative regulation of neuron differentiation [GO:0045665]; positive regulation of Notch signaling pathway [GO:0045747],nucleolus [GO:0005730]; nucleus [GO:0005634]
Q6P1S2,M2,-0.825712436,-1.004122151,0.39510764,1.119075676,-0.058325882,tan4,C3orf33,CC033_HUMAN,Protein C3orf33 (Protein AC3-33),C3orf33 MSTP052,285315;,"ENST00000340171.7; ENSP00000342512.2; ENSG00000174928.16. [Q6P1S2-1];""ENST00000534941.2; ENSP00000445446.1; ENSG00000174928.16. [Q6P1S2-2]"";",0,negative regulation of ERK1 and ERK2 cascade [GO:0070373]; regulation of DNA-binding transcription factor activity [GO:0051090],extracellular space [GO:0005615]; membrane [GO:0016020]
Q8NDZ4,S1,-1.12702024,-1.353536649,-0.178562348,0.911052165,0.873862937,gold,C3orf58,DIK2A_HUMAN,Divergent protein kinase domain 2A (Deleted in autism protein 1) (Golgi Protein of 49 kDa) (GoPro49) (Hypoxia and AKT-induced stem cell factor) (HASF),DIPK2A C3orf58 DIA1,205428;,"ENST00000315691.8; ENSP00000320081.4; ENSG00000181744.9. [Q8NDZ4-1];""ENST00000495414.5; ENSP00000417382.1; ENSG00000181744.9. [Q8NDZ4-2]"";",0,cardiac muscle cell proliferation [GO:0060038]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; positive regulation of protein kinase C activity [GO:1900020]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],COPI vesicle coat [GO:0030126]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]
Q0P651,M2,-0.97988071,-0.81426876,0.501083135,1.043589405,-0.067082768,tan4,C4orf29,ABD18_HUMAN,Protein ABHD18 (Alpha/beta hydrolase domain-containing protein 18) (Abhydrolase domain-containing protein 18),ABHD18 C4orf29,0,ENST00000444616.5; ENSP00000397229.1; ENSG00000164074.17. [Q0P651-1];,0,0,extracellular region [GO:0005576]
Q8WVX3,S2,-1.158692976,-1.445784069,0.332647592,0.785191142,0.526747937,orange,C4orf3,CD003_HUMAN,Uncharacterized protein C4orf3 (Hepatitis C virus F protein-transactivated protein 1) (HCV F-transactivated protein 1),C4orf3,401152;,"ENST00000399075.6; ENSP00000382026.4; ENSG00000164096.13. [Q8WVX3-2];""ENST00000504110.2; ENSP00000485697.1; ENSG00000164096.13. [Q8WVX3-1]"";",0,0,endoplasmic reticulum membrane [GO:0005789]
Q8NC54,S1,-1.436176428,-1.791857129,-0.302863261,0.797610799,1.189464396,gold,C5orf15,KCT2_HUMAN,Keratinocyte-associated transmembrane protein 2,KCT2 C5orf15 HTGN29,56951;,ENST00000231512.5; ENSP00000231512.3; ENSG00000113583.8.;,0,0,membrane [GO:0016020]
Q7Z6I8,N2,-0.998942628,-0.73289951,1.228970384,0.218978595,-0.743048263,grey70,C5orf24,CE024_HUMAN,UPF0461 protein C5orf24,C5orf24,134553;,"ENST00000338051.4; ENSP00000337044.4; ENSG00000181904.9. [Q7Z6I8-1];""ENST00000394976.4; ENSP00000378427.3; ENSG00000181904.9. [Q7Z6I8-1]"";""ENST00000435259.2; ENSP00000395764.2; ENSG00000181904.9. [Q7Z6I8-1]"";""ENST00000504727.1; ENSP00000421647.1; ENSG00000181904.9. [Q7Z6I8-2]"";",0,0,0
Q9H6K1,C3,1.774042598,0.183821217,-0.491690951,-0.516156072,-0.783223828,cyan,C6orf106,ILRUN_HUMAN,Protein ILRUN (Inflammation and lipid regulator with UBA-like and NBR1-like domains protein),ILRUN C6orf106,64771;,"ENST00000374023.8; ENSP00000363135.3; ENSG00000196821.10. [Q9H6K1-1];""ENST00000374026.7; ENSP00000363138.3; ENSG00000196821.10. [Q9H6K1-2]"";",ubiquitin binding [GO:0043130],innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon production [GO:0032480],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]
Q9H993,C4,2.067353563,0.459349245,-1.123699303,-1.228665615,-1.372957822,deepskyblue2,C6orf211,ARMT1_HUMAN,Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1),ARMT1 C6orf211,79624;,ENST00000367294.4; ENSP00000356263.3; ENSG00000146476.11.;,enzyme binding [GO:0019899]; fructose 6-phosphate aldolase activity [GO:0097023]; fructose-1-phosphatase activity [GO:0103026]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein carboxyl O-methyltransferase activity [GO:0051998]; protein-glutamate O-methyltransferase activity [GO:0008983]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],DNA damage response [GO:0006974]; methylation [GO:0032259],0
O95873,S1,-1.100925247,-1.205650111,0.003104664,0.4386753,1.017209226,gold,C6orf47,CF047_HUMAN,Uncharacterized protein C6orf47 (Protein G4),C6orf47 G4,57827;,"ENST00000366431.2; ENSP00000375392.1; ENSG00000235360.2.;""ENST00000366432.2; ENSP00000375400.1; ENSG00000203623.4."";""ENST00000375911.2; ENSP00000365076.1; ENSG00000204439.4."";""ENST00000413113.1; ENSP00000395128.1; ENSG00000226103.2."";""ENST00000418357.1; ENSP00000398221.1; ENSG00000226531.2."";""ENST00000431256.1; ENSP00000406870.1; ENSG00000228435.2."";""ENST00000442972.1; ENSP00000407188.1; ENSG00000228177.2."";",0,0,0
Q6UWU4,S3,-0.927211737,-0.888037279,0.276474845,0.796180175,0.576930222,salmon,C6orf89,CF089_HUMAN,Bombesin receptor-activated protein C6orf89 (Amfion),C6orf89 BRAP UNQ177/PRO203,221477;,"ENST00000355190.7; ENSP00000347322.3; ENSG00000198663.17. [Q6UWU4-2];""ENST00000359359.6; ENSP00000352316.2; ENSG00000198663.17. [Q6UWU4-3]"";""ENST00000373685.1; ENSP00000362789.1; ENSG00000198663.17. [Q6UWU4-1]"";""ENST00000480824.7; ENSP00000475947.1; ENSG00000198663.17. [Q6UWU4-1]"";",0,chromatin remodeling [GO:0006338]; epithelial cell proliferation [GO:0050673]; positive regulation of cell cycle [GO:0045787]; wound healing [GO:0042060],cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]
Q9BUW7,C5,1.795585077,0.610283602,-0.814227812,-0.864032036,-1.071005239,turquoise3,C9orf16,BBLN_HUMAN,Bublin coiled-coil protein (UPF0184 protein C9orf16),BBLN C9orf16 EST00098,79095;,ENST00000372994.2; ENSP00000362085.1; ENSG00000171159.5.;,molecular adaptor activity [GO:0060090],intermediate filament bundle assembly [GO:0045110],anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; subapical part of cell [GO:0120219]
Q5T6V5,C5,2.028923927,0.290957289,-0.920612259,-0.97611734,-1.09643176,turquoise3,C9orf64,QNG1_HUMAN,Queuosine 5'-phosphate N-glycosylase/hydrolase (EC 3.2.2.-) (Q-nucleotide N-glycosylase 1) (Queuine salvage protein QNG1) (Queuosine-nucleotide N-glycosylase/hydrolase),QNG1 C9orf64,84267;,ENST00000376344.8; ENSP00000365522.3; ENSG00000165118.15.;,hydrolase activity [GO:0016787],nucleoside salvage [GO:0043174]; tRNA-guanine transglycosylation [GO:0101030],0
Q96MD7,N4,-0.820475286,1.332048553,-0.192680372,-0.528153551,-0.343763187,grey30,C9orf85,CI085_HUMAN,Uncharacterized protein C9orf85,C9orf85,138241;,"ENST00000334731.7; ENSP00000334289.2; ENSG00000155621.15. [Q96MD7-1];""ENST00000377031.7; ENSP00000366230.3; ENSG00000155621.15. [Q96MD7-3]"";""ENST00000479413.1; ENSP00000433086.1; ENSG00000155621.15. [Q96MD7-2]"";",0,0,0
Q96LW7,M2,-0.579844325,-0.931985808,0.36128634,0.831522515,-0.19350647,tan4,C9orf89,CAR19_HUMAN,Caspase recruitment domain-containing protein 19 (Bcl10-interacting CARD protein) (BinCARD),CARD19 C9orf89,84270;,"ENST00000375464.7; ENSP00000364613.2; ENSG00000165233.18. [Q96LW7-2];""ENST00000466409.1; ENSP00000437237.1; ENSG00000165233.18. [Q96LW7-1]"";",CARD domain binding [GO:0050700],negative regulation of canonical NF-kappaB signal transduction [GO:0043124],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q9Y6J0,N2,-0.846693851,-0.34588009,0.903873555,0.221430666,-0.139173862,grey70,CABIN1,CABIN_HUMAN,Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN),CABIN1 KIAA0330,23523;,"ENST00000263119.10; ENSP00000263119.5; ENSG00000099991.18. [Q9Y6J0-1];""ENST00000398319.6; ENSP00000381364.2; ENSG00000099991.18. [Q9Y6J0-1]"";""ENST00000405822.6; ENSP00000384694.2; ENSG00000099991.18. [Q9Y6J0-2]"";",protein phosphatase inhibitor activity [GO:0004864],cell surface receptor signaling pathway [GO:0007166]; nucleosome assembly [GO:0006334],aggresome [GO:0016235]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9HB71,C3,1.788621649,0.162749361,-0.734430727,-0.675688789,-0.908216093,cyan,CACYBP,CYBP_HUMAN,Calcyclin-binding protein (CacyBP) (hCacyBP) (S100A6-binding protein) (Siah-interacting protein),CACYBP S100A6BP SIP PNAS-107,27101;,"ENST00000367679.7; ENSP00000356652.2; ENSG00000116161.18. [Q9HB71-1];""ENST00000405362.1; ENSP00000385771.1; ENSG00000116161.18. [Q9HB71-3]"";""ENST00000406752.1; ENSP00000384139.1; ENSG00000116161.18. [Q9HB71-2]"";""ENST00000613570.4; ENSP00000479414.1; ENSG00000116161.18. [Q9HB71-3]"";",protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625],cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507],beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]
Q05682,C1,1.654265438,0.113829708,-0.815202613,-0.771607003,0.156504399,lightblue,CAD,CALD1_HUMAN,Caldesmon (CDM),CALD1 CAD CDM,800;,"ENST00000361675.7; ENSP00000354826.2; ENSG00000122786.20. [Q05682-1];""ENST00000361901.6; ENSP00000354513.2; ENSG00000122786.20. [Q05682-4]"";""ENST00000393118.7; ENSP00000376826.2; ENSG00000122786.20. [Q05682-3]"";""ENST00000417172.5; ENSP00000398826.1; ENSG00000122786.20. [Q05682-4]"";""ENST00000422748.5; ENSP00000395710.1; ENSG00000122786.20. [Q05682-6]"";""ENST00000424922.5; ENSP00000393621.1; ENSG00000122786.20. [Q05682-5]"";",actin binding [GO:0003779]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; myosin binding [GO:0017022]; tropomyosin binding [GO:0005523],actin filament bundle assembly [GO:0051017]; angiogenesis [GO:0001525]; muscle contraction [GO:0006936],actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myofibril [GO:0030016]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]
Q8NFZ8,S4,-0.620651049,-0.695185042,0.412667955,0.860313314,0.083906172,tomato2,CADM4,CADM4_HUMAN,Cell adhesion molecule 4 (Immunoglobulin superfamily member 4C) (IgSF4C) (Nectin-like protein 4) (NECL-4) (TSLC1-like protein 2),CADM4 IGSF4C NECL4 TSLL2,199731;,ENST00000222374.3; ENSP00000222374.1; ENSG00000105767.3.;,protein phosphatase binding [GO:0019903]; receptor tyrosine kinase binding [GO:0030971]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184],homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; regulation of cell motility [GO:2000145]; regulation of cell population proliferation [GO:0042127]; regulation of protein phosphorylation [GO:0001932]; regulation of Rac protein signal transduction [GO:0035020]; regulation of wound healing [GO:0061041],cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; membrane [GO:0016020]
Q9P1Z2,C1,1.249699874,0.243803609,-0.499709236,-0.049753811,-0.467122692,lightblue,CALCOCO1,CACO1_HUMAN,Calcium-binding and coiled-coil domain-containing protein 1 (Calphoglin) (Coiled-coil coactivator protein) (Sarcoma antigen NY-SAR-3),CALCOCO1 KIAA1536 PP13275 UNQ2436/PRO4996,57658;,"ENST00000262059.8; ENSP00000262059.4; ENSG00000012822.16. [Q9P1Z2-3];""ENST00000430117.6; ENSP00000397189.2; ENSG00000012822.16. [Q9P1Z2-4]"";""ENST00000548263.5; ENSP00000447647.1; ENSG00000012822.16. [Q9P1Z2-2]"";""ENST00000550804.6; ENSP00000449960.1; ENSG00000012822.16. [Q9P1Z2-1]"";",beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]
P27797,N4,-1.199913626,0.677524044,-0.233600857,0.493367912,-0.096356491,grey30,CALR,CALR_HUMAN,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60),CALR CRTC,811;,"ENST00000316448.10; ENSP00000320866.4; ENSG00000179218.15.;""ENST00000586967.2; ENSP00000466037.2; ENSG00000179218.15."";",calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; DNA binding [GO:0003677]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; ERAD pathway [GO:0036503]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein localization to nucleus [GO:0034504]; protein maturation by protein folding [GO:0022417]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of DNA-templated transcription [GO:0006355]; regulation of meiotic nuclear division [GO:0040020]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; sequestering of calcium ion [GO:0051208]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]
O43852,N4,-0.845128817,0.630638889,-0.245083357,0.472012649,0.031221265,grey30,CALU,CALU_HUMAN,Calumenin (Crocalbin) (IEF SSP 9302),CALU,813;,"ENST00000249364.9; ENSP00000249364.4; ENSG00000128595.17. [O43852-1];""ENST00000449187.7; ENSP00000408838.2; ENSG00000128595.17. [O43852-2]"";""ENST00000479257.5; ENSP00000420381.1; ENSG00000128595.17. [O43852-3]"";""ENST00000535011.6; ENSP00000442110.1; ENSG00000128595.17. [O43852-10]"";""ENST00000542996.7; ENSP00000438248.1; ENSG00000128595.17. [O43852-4]"";",calcium ion binding [GO:0005509],0,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; sarcoplasmic reticulum lumen [GO:0033018]
Q13557,C1,1.510509746,0.448234862,-0.672821828,-0.509794698,-0.081728056,lightblue,CAMK2D,KCC2D_HUMAN,Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17),CAMK2D CAMKD,817;,"ENST00000296402.9; ENSP00000296402.5; ENSG00000145349.20. [Q13557-8];""ENST00000342666.9; ENSP00000339740.5; ENSG00000145349.20. [Q13557-1]"";""ENST00000379773.6; ENSP00000369098.2; ENSG00000145349.20. [Q13557-8]"";""ENST00000394522.7; ENSP00000378030.3; ENSG00000145349.20. [Q13557-10]"";""ENST00000394524.7; ENSP00000378032.3; ENSG00000145349.20. [Q13557-12]"";""ENST00000508738.5; ENSP00000422566.1; ENSG00000145349.20. [Q13557-9]"";""ENST00000515496.5; ENSP00000423482.1; ENSG00000145349.20. [Q13557-3]"";""ENST00000683023.1; ENSP00000507073.1; ENSG00000145349.20. [Q13557-1]"";""ENST00000699047.1; ENSP00000514099.1; ENSG00000145349.20. [Q13557-6]"";""ENST00000699048.1; ENSP00000514100.1; ENSG00000145349.20. [Q13557-11]"";""ENST00000699381.1; ENSP00000514346.1; ENSG00000145349.20. [Q13557-6]"";",ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel inhibitor activity [GO:0019871]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325],cardiac muscle cell contraction [GO:0086003]; cellular response to calcium ion [GO:0071277]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; negative regulation of sodium ion transmembrane transport [GO:1902306]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cell growth [GO:0001558]; regulation of cellular localization [GO:0060341]; regulation of heart contraction [GO:0008016]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane depolarization [GO:0003254]; regulation of relaxation of cardiac muscle [GO:1901897]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; regulation of the force of heart contraction [GO:0002026]; regulation of transcription by RNA polymerase II [GO:0006357]; relaxation of cardiac muscle [GO:0055119],calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]
Q13555,C1,1.572207422,0.384989606,-0.664140781,-0.523615732,-0.12350165,lightblue,CAMK2G,KCC2G_HUMAN,Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17),CAMK2G CAMK CAMK-II CAMKG,818;,"ENST00000305762.11; ENSP00000307082.7; ENSG00000148660.22. [Q13555-4];""ENST00000322635.7; ENSP00000315599.3; ENSG00000148660.22. [Q13555-5]"";""ENST00000351293.7; ENSP00000277853.5; ENSG00000148660.22. [Q13555-10]"";""ENST00000680035.1; ENSP00000505103.1; ENSG00000148660.22. [Q13555-11]"";",ATP binding [GO:0005524]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310],cell differentiation [GO:0030154]; insulin secretion [GO:0030073]; nervous system development [GO:0007399]; regulation of calcium ion transport [GO:0051924]; regulation of neuron projection development [GO:0010975]; regulation of skeletal muscle adaptation [GO:0014733],calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum membrane [GO:0033017]
P49069,S2,-1.118205755,-1.237102186,0.205195429,0.806293042,0.505105614,orange,CAMLG,CAMLG_HUMAN,Guided entry of tail-anchored proteins factor CAMLG (Calcium signal-modulating cyclophilin ligand),CAMLG CAML GET2,819;,ENST00000297156.4; ENSP00000297156.2; ENSG00000164615.6.;,ubiquitin protein ligase binding [GO:0031625],B cell homeostasis [GO:0001782]; defense response [GO:0006952]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; receptor recycling [GO:0001881]; signal transduction [GO:0007165]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; membrane [GO:0016020]
Q8WVQ1,S1,-1.272674883,-1.606473218,-0.288088486,0.975184763,1.024143216,gold,CANT1,CANT1_HUMAN,Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107),CANT1 SHAPY,124583;,"ENST00000302345.6; ENSP00000307674.2; ENSG00000171302.17. [Q8WVQ1-1];""ENST00000392446.10; ENSP00000376241.4; ENSG00000171302.17. [Q8WVQ1-1]"";""ENST00000591773.5; ENSP00000467437.1; ENSG00000171302.17. [Q8WVQ1-1]"";""ENST00000620915.4; ENSP00000477798.1; ENSG00000171302.17. [Q8WVQ1-1]"";",ADP phosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; GDP phosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; UDP phosphatase activity [GO:0045134],positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteoglycan biosynthetic process [GO:0030166],endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]
P27824,S2,-1.403649897,-1.680008382,0.193700374,0.919732152,0.583016534,orange,CANX,CALX_HUMAN,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),CANX,821;,"ENST00000247461.9; ENSP00000247461.4; ENSG00000127022.16. [P27824-1];""ENST00000452673.6; ENSP00000391646.2; ENSG00000127022.16. [P27824-1]"";""ENST00000502296.6; ENSP00000424745.2; ENSG00000127022.16. [P27824-1]"";""ENST00000504734.5; ENSP00000424063.1; ENSG00000127022.16. [P27824-1]"";""ENST00000506654.6; ENSP00000426555.2; ENSG00000127022.16. [P27824-3]"";""ENST00000509563.2; ENSP00000421434.2; ENSG00000127022.16. [P27824-1]"";""ENST00000513246.6; ENSP00000421813.2; ENSG00000127022.16. [P27824-1]"";""ENST00000638425.1; ENSP00000492372.1; ENSG00000283777.2. [P27824-1]"";""ENST00000638706.2; ENSP00000492868.1; ENSG00000283777.2. [P27824-1]"";""ENST00000639938.1; ENSP00000491760.1; ENSG00000283777.2. [P27824-1]"";""ENST00000680006.1; ENSP00000505129.1; ENSG00000127022.16. [P27824-3]"";""ENST00000680013.1; ENSP00000506078.1; ENSG00000127022.16. [P27824-1]"";""ENST00000680042.1; ENSP00000505960.1; ENSG00000127022.16. [P27824-1]"";""ENST00000680092.1; ENSP00000505202.1; ENSG00000127022.16. [P27824-1]"";""ENST00000680618.1; ENSP00000506583.1; ENSG00000127022.16. [P27824-1]"";""ENST00000680827.1; ENSP00000506051.1; ENSG00000127022.16. [P27824-3]"";""ENST00000681072.1; ENSP00000505526.1; ENSG00000127022.16. [P27824-1]"";""ENST00000681168.1; ENSP00000506021.1; ENSG00000127022.16. [P27824-1]"";""ENST00000681476.1; ENSP00000506003.1; ENSG00000127022.16. [P27824-1]"";""ENST00000681674.1; ENSP00000505013.1; ENSG00000127022.16. [P27824-1]"";""ENST00000681712.1; ENSP00000506061.1; ENSG00000127022.16. [P27824-1]"";""ENST00000681733.1; ENSP00000506568.1; ENSG00000127022.16. [P27824-1]"";""ENST00000681903.1; ENSP00000506509.1; ENSG00000127022.16. [P27824-1]"";",calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082],clathrin-dependent endocytosis [GO:0072583]; ERAD pathway [GO:0036503]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein secretion [GO:0009306]; synaptic vesicle endocytosis [GO:0048488]; viral protein processing [GO:0019082],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular exosome [GO:0070062]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965]; presynapse [GO:0098793]
P07384,C4,1.842482102,0.113019397,-0.699997233,-0.689173289,-0.809671019,deepskyblue2,CAPN1,CAN1_HUMAN,Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP),CAPN1 CANPL1 PIG30,823;,"ENST00000279247.11; ENSP00000279247.7; ENSG00000014216.16.;""ENST00000524773.5; ENSP00000434176.1; ENSG00000014216.16."";""ENST00000527323.5; ENSP00000431984.1; ENSG00000014216.16."";""ENST00000533129.5; ENSP00000431686.1; ENSG00000014216.16."";""ENST00000533820.5; ENSP00000435272.1; ENSG00000014216.16."";",calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; peptidase activity [GO:0008233],mammary gland involution [GO:0060056]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; receptor catabolic process [GO:0032801]; regulation of catalytic activity [GO:0050790]; regulation of macroautophagy [GO:0016241]; regulation of NMDA receptor activity [GO:2000310]; self proteolysis [GO:0097264],calpain complex [GO:0110158]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
P17655,C4,1.895224404,-0.029720994,-0.778900776,-0.742029679,-0.974320198,deepskyblue2,CAPN2,CAN2_HUMAN,Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain),CAPN2 CANPL2,824;,"ENST00000295006.6; ENSP00000295006.5; ENSG00000162909.18. [P17655-1];""ENST00000433674.6; ENSP00000413158.2; ENSG00000162909.18. [P17655-2]"";",calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type peptidase activity [GO:0008234]; cytoskeletal protein binding [GO:0008092]; enzyme binding [GO:0019899]; protein-containing complex binding [GO:0044877],behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cytoskeleton organization [GO:0051493]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612],calpain complex [GO:0110158]; chromatin [GO:0000785]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]
O15484,S4,-0.808534133,-1.376676534,0.453666454,0.810400622,0.578852085,tomato2,CAPN5,CAN5_HUMAN,Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3),CAPN5 NCL3,726;,"ENST00000529629.5; ENSP00000432332.1; ENSG00000149260.18.;""ENST00000531028.2; ENSP00000467244.2; ENSG00000149260.18."";""ENST00000648180.1; ENSP00000498132.1; ENSG00000149260.18."";",calcium-dependent cysteine-type endopeptidase activity [GO:0004198],proteolysis [GO:0006508]; signal transduction [GO:0007165],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; synapse [GO:0045202]
P04632,C4,1.882270294,0.080904539,-0.737701267,-0.641665598,-1.046421332,deepskyblue2,CAPNS1,CPNS1_HUMAN,Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit),CAPNS1 CAPN4 CAPNS,826;,"ENST00000246533.8; ENSP00000246533.2; ENSG00000126247.11.;""ENST00000588815.5; ENSP00000464849.1; ENSG00000126247.11."";",calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198],positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241],calpain complex [GO:0110158]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q13938,C4,2.063403866,0.374364042,-0.992314565,-1.155197993,-1.328911591,deepskyblue2,CAPS,CAYP1_HUMAN,Calcyphosin (Calcyphosine),CAPS,828;,ENST00000588776.8; ENSP00000465883.2; ENSG00000105519.18. [Q13938-4];,calcium ion binding [GO:0005509],intracellular signal transduction [GO:0035556],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; vesicle [GO:0031982]
Q6P4E1,S1,-1.206426181,-1.341050522,-0.198668406,0.788631896,1.018852809,gold,CASC4,GOLM2_HUMAN,Protein GOLM2 (Cancer susceptibility candidate gene 4 protein) (CASC4) (Golgi membrane protein 2),GOLM2 CASC4 UNQ2573/PRO6308,113201;,"ENST00000299957.11; ENSP00000299957.6; ENSG00000166734.20. [Q6P4E1-4];""ENST00000345795.6; ENSP00000335063.4; ENSG00000166734.20. [Q6P4E1-2]"";""ENST00000557945.5; ENSP00000453720.1; ENSG00000166734.20. [Q6P4E1-3]"";",0,0,Golgi apparatus [GO:0005794]; membrane [GO:0016020]
O14936,M1,-0.984864418,-0.956758846,0.506222887,0.774617847,-0.011918874,burlywood4,CASK,CSKP_HUMAN,Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog),CASK LIN2,8573;,"ENST00000378154.3; ENSP00000367396.2; ENSG00000147044.23. [O14936-6];""ENST00000378163.7; ENSP00000367405.1; ENSG00000147044.23. [O14936-1]"";""ENST00000644347.1; ENSP00000494183.1; ENSG00000147044.23. [O14936-3]"";""ENST00000645566.1; ENSP00000494788.1; ENSG00000147044.23. [O14936-2]"";""ENST00000646120.2; ENSP00000495291.2; ENSG00000147044.23. [O14936-4]"";",ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102],calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; establishment of localization in cell [GO:0051649]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of neurotransmitter secretion [GO:0046928]; regulation of synaptic vesicle exocytosis [GO:2000300],actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]
P55210,C5,1.91670775,0.641731308,-0.979285757,-1.087261349,-1.4816609,turquoise3,CASP7,CASP7_HUMAN,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7 MCH3,840;,"ENST00000345633.8; ENSP00000298701.7; ENSG00000165806.21. [P55210-1];""ENST00000369315.5; ENSP00000358321.1; ENSG00000165806.21. [P55210-1]"";""ENST00000369318.8; ENSP00000358324.4; ENSG00000165806.21. [P55210-1]"";""ENST00000369331.8; ENSP00000358337.3; ENSG00000165806.21. [P55210-2]"";""ENST00000452490.3; ENSP00000398107.2; ENSG00000165806.21. [P55210-4]"";""ENST00000614447.4; ENSP00000478285.1; ENSG00000165806.21. [P55210-2]"";""ENST00000621345.4; ENSP00000480584.1; ENSG00000165806.21. [P55210-1]"";""ENST00000621607.4; ENSP00000478999.1; ENSG00000165806.21. [P55210-3]"";",aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; RNA binding [GO:0003723],apoptotic process [GO:0006915]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to staurosporine [GO:0072734]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; fibroblast apoptotic process [GO:0044346]; heart development [GO:0007507]; lymphocyte apoptotic process [GO:0070227]; neuron apoptotic process [GO:0051402]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P20810,C5,1.790560047,0.81504855,-0.950416566,-1.304190034,-1.485240448,turquoise3,CAST,ICAL_HUMAN,Calpastatin (Calpain inhibitor) (Sperm BS-17 component),CAST,831;,"ENST00000309190.9; ENSP00000312523.5; ENSG00000153113.24. [P20810-8];""ENST00000338252.7; ENSP00000343421.3; ENSG00000153113.24. [P20810-2]"";""ENST00000341926.7; ENSP00000339914.3; ENSG00000153113.24. [P20810-1]"";""ENST00000395812.6; ENSP00000379157.2; ENSG00000153113.24. [P20810-9]"";""ENST00000395813.5; ENSP00000379158.2; ENSG00000153113.24. [P20810-1]"";""ENST00000508830.5; ENSP00000425721.1; ENSG00000153113.24. [P20810-6]"";""ENST00000510756.6; ENSP00000422176.2; ENSG00000153113.24. [P20810-4]"";""ENST00000674984.1; ENSP00000501713.1; ENSG00000153113.24. [P20810-10]"";""ENST00000675033.1; ENSP00000501659.1; ENSG00000153113.24. [P20810-4]"";""ENST00000675179.1; ENSP00000501872.1; ENSG00000153113.24. [P20810-6]"";",cadherin binding [GO:0045296]; calcium-dependent cysteine-type endopeptidase inhibitor activity [GO:0010859]; endopeptidase inhibitor activity [GO:0004866]; RNA binding [GO:0003723],inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; presynaptic active zone organization [GO:1990709],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]
Q03135,S4,-1.165142954,-1.316372648,0.38847065,0.842891845,0.547272104,tomato2,CAV1,CAV1_HUMAN,Caveolin-1,CAV1 CAV,857;,"ENST00000341049.7; ENSP00000339191.2; ENSG00000105974.13. [Q03135-1];""ENST00000393467.1; ENSP00000377110.1; ENSG00000105974.13. [Q03135-2]"";""ENST00000393468.1; ENSP00000377111.1; ENSG00000105974.13. [Q03135-2]"";""ENST00000405348.6; ENSP00000384348.1; ENSG00000105974.13. [Q03135-2]"";",ATPase binding [GO:0051117]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inward rectifier potassium channel inhibitor activity [GO:0070320]; molecular adaptor activity [GO:0060090]; nitric-oxide synthase binding [GO:0050998]; oxysterol binding [GO:0008142]; patched binding [GO:0005113]; peptidase activator activity [GO:0016504]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein sequestering activity [GO:0140311]; protein tyrosine kinase inhibitor activity [GO:0030292]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325],angiogenesis [GO:0001525]; angiotensin-activated signaling pathway [GO:0038166]; apoptotic signaling pathway [GO:0097190]; basement membrane organization [GO:0071711]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; canonical Wnt signaling pathway [GO:0060070]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell differentiation [GO:0030154]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to hyperoxia [GO:0071455]; cellular response to misfolded protein [GO:0071218]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cholesterol homeostasis [GO:0042632]; cholesterol transport [GO:0030301]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell proliferation [GO:0001935]; establishment of localization in cell [GO:0051649]; fibroblast proliferation [GO:0048144]; glandular epithelial cell differentiation [GO:0002067]; insulin receptor internalization [GO:0038016]; intracellular calcium ion homeostasis [GO:0006874]; intracellular nitric oxide homeostasis [GO:0033484]; lactation [GO:0007595]; lipid storage [GO:0019915]; maintenance of protein location in cell [GO:0032507]; mammary gland development [GO:0030879]; mammary gland involution [GO:0060056]; MAPK cascade [GO:0000165]; membrane depolarization [GO:0051899]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of anoikis [GO:2000811]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of inward rectifier potassium channel activity [GO:1903609]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of necroptotic process [GO:0060546]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-tyrosine autophosphorylation [GO:1900085]; negative regulation of pinocytosis [GO:0048550]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell migration [GO:0030335]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of vasoconstriction [GO:0045907]; post-transcriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane raft [GO:0044860]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of blood coagulation [GO:0030193]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization during action potential [GO:0098903]; regulation of peptidase activity [GO:0052547]; regulation of ruffle assembly [GO:1900027]; regulation of smooth muscle contraction [GO:0006940]; regulation of the force of heart contraction by chemical signal [GO:0003057]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; response to bacterium [GO:0009617]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to progesterone [GO:0032570]; skeletal muscle tissue development [GO:0007519]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641]; vasculogenesis [GO:0001570]; vasoconstriction [GO:0042310]; vesicle organization [GO:0016050],acrosomal membrane [GO:0002080]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cell cortex [GO:0005938]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
P51636,S4,-0.852366385,-1.528303312,0.161070479,0.56273357,0.576410567,tomato2,CAV2,CAV2_HUMAN,Caveolin-2,CAV2,858;,"ENST00000222693.5; ENSP00000222693.4; ENSG00000105971.15. [P51636-1];""ENST00000343213.2; ENSP00000345679.2; ENSG00000105971.15. [P51636-3]"";",D1 dopamine receptor binding [GO:0031748]; molecular adaptor activity [GO:0060090]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; scaffold protein binding [GO:0097110],basement membrane organization [GO:0071711]; caveola assembly [GO:0070836]; cell differentiation [GO:0030154]; endoplasmic reticulum organization [GO:0007029]; endothelial cell proliferation [GO:0001935]; insulin receptor signaling pathway [GO:0008286]; mitochondrion organization [GO:0007005]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of skeletal muscle cell proliferation [GO:0014859]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation by host of viral process [GO:0044794]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of mitotic nuclear division [GO:0007088]; skeletal muscle cell proliferation [GO:0014856]; skeletal muscle fiber development [GO:0048741]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle organization [GO:0016050]; viral release from host cell [GO:0019076],acrosomal membrane [GO:0002080]; caveola [GO:0005901]; caveolar macromolecular signaling complex [GO:0002095]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; transport vesicle [GO:0030133]
Q13951,C5,1.588228526,0.376398252,-0.409714063,-0.672285467,-1.019545636,turquoise3,CBFB,PEBB_HUMAN,Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit),CBFB,865;,"ENST00000290858.11; ENSP00000290858.6; ENSG00000067955.15. [Q13951-1];""ENST00000412916.7; ENSP00000415151.2; ENSG00000067955.15. [Q13951-2]"";",sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713],"cell maturation [GO:0048469]; definitive hemopoiesis [GO:0060216]; lymphocyte differentiation [GO:0030098]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]",core-binding factor complex [GO:0016513]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
P22681,C4,1.767244483,0.014260976,-0.626042579,-0.641368599,-0.91460712,deepskyblue2,CBL,CBL_HUMAN,E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL),CBL CBL2 RNF55,867;,ENST00000264033.6; ENSP00000264033.3; ENSG00000110395.8.;,cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; ephrin receptor binding [GO:0046875]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response [GO:0006974]; entry of bacterium into host cell [GO:0035635]; male gonad development [GO:0008584]; mast cell degranulation [GO:0043303]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; regulation of Rap protein signal transduction [GO:0032487]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to starvation [GO:0042594]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; ubiquitin-dependent endocytosis [GO:0070086]; ubiquitin-dependent protein catabolic process [GO:0006511],cilium [GO:0005929]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
P16152,C5,2.13726995,0.192596613,-0.950028152,-0.837741481,-1.305760587,turquoise3,CBR1,CBR1_HUMAN,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1)",CBR1 CBR CRN SDR21C1,873;,"ENST00000290349.11; ENSP00000290349.6; ENSG00000159228.13. [P16152-1];""ENST00000530908.5; ENSP00000434613.1; ENSG00000159228.13. [P16152-2]"";","15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin-E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]",cyclooxygenase pathway [GO:0019371]; epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]
O75828,C4,2.003340466,0.237195574,-1.026279911,-1.064131109,-1.385641578,deepskyblue2,CBR3,CBR3_HUMAN,Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase 3) (Quinone reductase CBR3) (EC 1.6.5.10) (Short chain dehydrogenase/reductase family 21C member 2),CBR3 SDR21C2,874;,ENST00000290354.6; ENSP00000290354.5; ENSG00000159231.6.;,3-keto sterol reductase activity [GO:0000253]; carbonyl reductase (NADPH) activity [GO:0004090]; NADPH binding [GO:0070402]; NADPH dehydrogenase (quinone) activity [GO:0008753],cognition [GO:0050890]; phylloquinone catabolic process [GO:0042376]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]
P35520,C4,2.006487283,0.302158416,-0.815176008,-0.772486654,-1.02231204,deepskyblue2,CBS,CBS_HUMAN,Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase),CBS,102724560;875;,"ENST00000352178.9; ENSP00000344460.5; ENSG00000160200.18. [P35520-1];""ENST00000359624.7; ENSP00000352643.3; ENSG00000160200.18. [P35520-1]"";""ENST00000398158.5; ENSP00000381225.1; ENSG00000160200.18. [P35520-1]"";""ENST00000398165.8; ENSP00000381231.4; ENSG00000160200.18. [P35520-1]"";",carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625],blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; DNA protection [GO:0042262]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-cysteine catabolic process [GO:0019448]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q13185,N4,-0.843890242,0.962169783,0.552286788,-0.557958792,-0.973860469,grey30,CBX3,CBX3_HUMAN,Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein),CBX3,11335;,"ENST00000337620.8; ENSP00000336687.4; ENSG00000122565.19.;""ENST00000396386.7; ENSP00000379670.2; ENSG00000122565.19."";",chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein domain specific binding [GO:0019904]; transcription coregulator binding [GO:0001221],chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; rhythmic process [GO:0048511],"chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; site of DNA damage [GO:0090734]; spindle [GO:0005819]"
P45973,N2,-1.037818553,0.051899258,1.258535602,-0.216143122,-1.087733025,grey70,CBX5,CBX5_HUMAN,Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha),CBX5 HP1A,23468;,"ENST00000209875.9; ENSP00000209875.4; ENSG00000094916.16.;""ENST00000439541.6; ENSP00000401009.2; ENSG00000094916.16."";""ENST00000550411.5; ENSP00000449207.1; ENSG00000094916.16."";",chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021],DNA damage response [GO:0006974]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122],"chromocenter [GO:0010369]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]"
Q9HC52,N3,-1.211989496,-0.753137297,0.944539249,-0.245677007,0.79107016,grey50,CBX8,CBX8_HUMAN,Chromobox protein homolog 8 (Polycomb 3 homolog) (Pc3) (hPc3) (Rectachrome 1),CBX8 PC3 RC1,57332;,ENST00000269385.9; ENSP00000269385.4; ENSG00000141570.11.;,chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; single-stranded RNA binding [GO:0003727]; ubiquitin-protein transferase activator activity [GO:0097027],cellular response to hydrogen peroxide [GO:0070301]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA repair [GO:0045739],chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]
Q5T0F9,C5,1.579564105,0.409638019,-0.433199315,-0.443395544,-0.646571262,turquoise3,CC2D1B,C2D1B_HUMAN,Coiled-coil and C2 domain-containing protein 1B (Five prime repressor element under dual repression-binding protein 2) (FRE under dual repression-binding protein 2) (Freud-2),CC2D1B KIAA1836 LGD1,200014;,"ENST00000284376.8; ENSP00000284376.3; ENSG00000154222.15. [Q5T0F9-2];""ENST00000371586.6; ENSP00000360642.2; ENSG00000154222.15. [Q5T0F9-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8IX12,N4,-1.256725346,1.125530713,0.117703057,-0.68923446,-0.623615873,grey30,CCAR1,CCAR1_HUMAN,Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain),CCAR1 CARP1 DIS,55749;,"ENST00000265872.11; ENSP00000265872.6; ENSG00000060339.14. [Q8IX12-1];""ENST00000543719.5; ENSP00000445254.1; ENSG00000060339.14. [Q8IX12-2]"";",nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630],apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q8N163,N4,-0.675244117,0.619010633,0.208394589,-0.384710951,0.549269924,grey30,CCAR2,CCAR2_HUMAN,Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC),CCAR2 DBC1 KIAA1967,57805;,"ENST00000308511.9; ENSP00000310670.4; ENSG00000158941.17. [Q8N163-1];""ENST00000389279.7; ENSP00000373930.3; ENSG00000158941.17. [Q8N163-1]"";",adenyl-nucleotide exchange factor activity [GO:0000774]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; unfolded protein binding [GO:0051082],DNA damage response [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]
Q16773,C5,1.94216153,0.240090749,-0.647368818,-0.493775908,-1.118115435,turquoise3,CCBL1,KAT1_HUMAN,Kynurenine--oxoglutarate transaminase 1 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase) (EC 4.4.1.13) (Glutamine transaminase K) (GTK) (Glutamine--phenylpyruvate transaminase) (EC 2.6.1.64) (Kynurenine aminotransferase 1) (Kynurenine aminotransferase I) (KATI) (Kynurenine--oxoglutarate transaminase I),KYAT1 CCBL1,883;,"ENST00000302586.8; ENSP00000302227.3; ENSG00000171097.14. [Q16773-1];""ENST00000320665.10; ENSP00000317342.6; ENSG00000171097.14. [Q16773-2]"";",cysteine-S-conjugate beta-lyase activity [GO:0047804]; glutamine-phenylpyruvate transaminase activity [GO:0047316]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170],biosynthetic process [GO:0009058]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053]; response to bacterium [GO:0009617],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]
Q9NWR8,M2,-1.059467699,-1.517353701,0.361625066,1.090742938,-0.29954609,tan4,CCDC109B,MCUB_HUMAN,"Calcium uniporter regulatory subunit MCUb, mitochondrial (MCUb) (Coiled-coil domain-containing protein 109B)",MCUB CCDC109B,55013;,ENST00000394650.7; ENSP00000378145.4; ENSG00000005059.16.;,calcium channel inhibitor activity [GO:0019855],calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of calcium import into the mitochondrion [GO:0110099]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; regulation of macrophage activation [GO:0043030]; skeletal muscle tissue regeneration [GO:0043403],calcium channel complex [GO:0034704]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; uniplex complex [GO:1990246]
Q96NT0,S2,-0.928127859,-1.357273131,0.296735238,0.736783836,0.565056198,orange,CCDC115,CC115_HUMAN,Coiled-coil domain-containing protein 115,CCDC115,84317;,"ENST00000259229.7; ENSP00000259229.2; ENSG00000136710.10. [Q96NT0-1];""ENST00000651709.1; ENSP00000499101.1; ENSG00000136710.10. [Q96NT0-2]"";",unfolded protein binding [GO:0051082],cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]
Q8IWD4,N4,-0.097564602,1.477003274,-0.488007392,-0.801824492,-0.963631306,grey30,CCDC117,CC117_HUMAN,Coiled-coil domain-containing protein 117,CCDC117,150275;,"ENST00000249064.9; ENSP00000249064.4; ENSG00000159873.10. [Q8IWD4-1];""ENST00000421503.6; ENSP00000387827.2; ENSG00000159873.10. [Q8IWD4-4]"";""ENST00000448492.6; ENSP00000389478.2; ENSG00000159873.10. [Q8IWD4-3]"";",0,positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739],cytoplasm [GO:0005737]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]
Q96BQ5,M2,-1.211805029,-1.323185825,0.334204794,1.20732287,-0.275661193,tan4,CCDC127,CC127_HUMAN,Coiled-coil domain-containing protein 127,CCDC127,133957;,ENST00000296824.4; ENSP00000296824.2; ENSG00000164366.4.;,0,0,0
Q96JG6,C1,1.353796088,0.153305396,-0.35454158,-0.190032932,-0.384467541,lightblue,CCDC132,VPS50_HUMAN,Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50),VPS50 CCDC132 KIAA1861,55610;,"ENST00000251739.9; ENSP00000251739.5; ENSG00000004766.17. [Q96JG6-2];""ENST00000305866.10; ENSP00000307666.5; ENSG00000004766.17. [Q96JG6-1]"";""ENST00000544910.5; ENSP00000443104.1; ENSG00000004766.17. [Q96JG6-3]"";",SNARE binding [GO:0000149],endocytic recycling [GO:0032456]; protein transport [GO:0015031],EARP complex [GO:1990745]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]
Q9H6E4,S3,-1.254227673,-0.469075802,0.133468313,0.946016756,0.370101528,salmon,CCDC134,CC134_HUMAN,Coiled-coil domain-containing protein 134,CCDC134,79879;,ENST00000255784.6; ENSP00000255784.5; ENSG00000100147.14.;,0,angiogenesis [GO:0001525]; embryonic hemopoiesis [GO:0035162]; embryonic liver development [GO:1990402]; placenta development [GO:0001890]; regulation of ossification [GO:0030278]; ventricular system development [GO:0021591],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]
Q6PK04,N3,-1.092098274,-0.993771662,0.881494736,-0.146608607,0.8603023,grey50,CCDC137,CC137_HUMAN,Coiled-coil domain-containing protein 137,CCDC137 cPERP-B,339230;,"ENST00000329214.13; ENSP00000329360.8; ENSG00000185298.13.;""ENST00000575223.5; ENSP00000458884.1; ENSG00000185298.13."";",RNA binding [GO:0003723],0,chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]
Q49A88,S1,-0.459421369,-0.554586782,-0.135582213,0.408787242,0.87750518,gold,CCDC14,CCD14_HUMAN,Coiled-coil domain-containing protein 14,CCDC14,64770;,"ENST00000485727.5; ENSP00000418002.1; ENSG00000175455.16. [Q49A88-2];""ENST00000488653.6; ENSP00000420180.3; ENSG00000175455.16. [Q49A88-6]"";""ENST00000489746.5; ENSP00000418403.1; ENSG00000175455.16. [Q49A88-2]"";",0,protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]
Q9P0B6,S3,-0.784760494,-1.033134484,0.229099842,0.909433177,0.494642693,salmon,CCDC167,CC167_HUMAN,Coiled-coil domain-containing protein 167,CCDC167 C6orf129 HSPC265,154467;,ENST00000373408.4; ENSP00000362507.3; ENSG00000198937.9.;,0,0,membrane [GO:0016020]
O60826,C1,1.317553627,0.444175177,-0.4316639,-0.233775024,-0.127804077,lightblue,CCDC22,CCD22_HUMAN,Coiled-coil domain-containing protein 22,CCDC22 CXorf37 JM1,28952;,ENST00000376227.4; ENSP00000365401.3; ENSG00000101997.13.;,cullin family protein binding [GO:0097602],cytoplasmic sequestering of NF-kappaB [GO:0007253]; endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; intracellular copper ion homeostasis [GO:0006878]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein transport [GO:0015031],centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]
Q86WR0,C5,1.83509085,0.448129802,-0.81414173,-1.063129704,-1.221027929,turquoise3,CCDC25,CCD25_HUMAN,Coiled-coil domain-containing protein 25,CCDC25,55246;,"ENST00000356537.9; ENSP00000348933.4; ENSG00000147419.19. [Q86WR0-1];""ENST00000522915.5; ENSP00000428000.1; ENSG00000147419.19. [Q86WR0-2]"";",DNA binding [GO:0003677],positive regulation of cell motility [GO:2000147],endomembrane system [GO:0012505]; plasma membrane [GO:0005886]
Q96MW1,C4,2.226620486,-0.026282541,-1.21214951,-1.370585707,-1.420639934,deepskyblue2,CCDC43,CCD43_HUMAN,Coiled-coil domain-containing protein 43,CCDC43,124808;,"ENST00000315286.13; ENSP00000323782.7; ENSG00000180329.14. [Q96MW1-1];""ENST00000457422.6; ENSP00000400845.1; ENSG00000180329.14. [Q96MW1-2]"";",0,0,cytosol [GO:0005829]
Q96A33,S2,-1.344151625,-1.695491394,0.190207516,1.014906606,0.508833764,orange,CCDC47,CCD47_HUMAN,PAT complex subunit CCDC47 (Calumin) (Coiled-coil domain-containing protein 47),CCDC47 GK001 MSTP041 PSEC0077,57003;,"ENST00000225726.10; ENSP00000225726.5; ENSG00000108588.15. [Q96A33-1];""ENST00000403162.7; ENSP00000384888.3; ENSG00000108588.15. [Q96A33-1]"";""ENST00000582252.1; ENSP00000463577.1; ENSG00000108588.15. [Q96A33-2]"";",calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022]; RNA binding [GO:0003723],endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; osteoblast differentiation [GO:0001649]; post-embryonic development [GO:0009791]; protein insertion into ER membrane [GO:0045048],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; multi-pass translocon complex [GO:0160064]; protein folding chaperone complex [GO:0101031]; rough endoplasmic reticulum membrane [GO:0030867]
Q8IVM0,C3,1.677323104,0.522476681,-0.459405212,-0.585015444,-0.802463942,cyan,CCDC50,CCD50_HUMAN,Coiled-coil domain-containing protein 50 (Protein Ymer),CCDC50 C3orf6,152137;,"ENST00000392455.9; ENSP00000376249.4; ENSG00000152492.15. [Q8IVM0-2];""ENST00000392456.4; ENSP00000376250.4; ENSG00000152492.15. [Q8IVM0-1]"";",ubiquitin protein ligase binding [GO:0031625],sensory perception of sound [GO:0007605],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q96ER9,M2,-0.696767614,-1.132340258,0.400353563,1.007396925,-0.360504839,tan4,CCDC51,MITOK_HUMAN,Mitochondrial potassium channel (MITOK) (Coiled-coil domain-containing protein 51),CCDC51 MITOK,79714;,"ENST00000395694.7; ENSP00000379047.2; ENSG00000164051.14. [Q96ER9-1];""ENST00000412398.6; ENSP00000401194.2; ENSG00000164051.14. [Q96ER9-2]"";""ENST00000442740.1; ENSP00000392898.1; ENSG00000164051.14. [Q96ER9-2]"";""ENST00000447018.5; ENSP00000412300.1; ENSG00000164051.14. [Q96ER9-2]"";",mitochondrial ATP-gated potassium channel activity [GO:0062156],cell volume homeostasis [GO:0006884]; mitochondrial potassium ion transmembrane transport [GO:0140141]; potassium ion transmembrane transport [GO:0071805],mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]
Q4VC31,N4,-0.885325813,1.224180819,-0.134172916,0.043133844,-1.10579422,grey30,CCDC58,MIX23_HUMAN,Protein MIX23 (Coiled-coil domain-containing protein 58),MIX23 CCDC58,131076;,ENST00000291458.9; ENSP00000291458.5; ENSG00000160124.9.;,0,0,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]
Q16204,C5,1.567314244,0.68290188,-0.626991515,-0.828022183,-1.084042268,turquoise3,CCDC6,CCDC6_HUMAN,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),CCDC6 D10S170 TST1,8030;,ENST00000263102.7; ENSP00000263102.6; ENSG00000108091.11.;,identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],0,cytoskeleton [GO:0005856]; cytosol [GO:0005829]
Q9Y6R9,S1,-0.864205445,-1.354418182,-0.298910705,0.35138459,1.354462791,gold,CCDC61,CCD61_HUMAN,Centrosomal protein CCDC61 (Coiled-coil domain-containing protein 61) (VFL3 homolog),CCDC61,729440;,"ENST00000536603.5; ENSP00000444279.1; ENSG00000104983.8. [Q9Y6R9-2];""ENST00000594087.1; ENSP00000469466.1; ENSG00000104983.8. [Q9Y6R9-2]"";""ENST00000595358.5; ENSP00000471454.1; ENSG00000104983.8. [Q9Y6R9-1]"";",identical protein binding [GO:0042802]; microtubule binding [GO:0008017],cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]
Q9BR77,S1,-0.615644276,-0.765799531,0.070372373,0.468386064,0.884147698,gold,CCDC77,CCD77_HUMAN,Coiled-coil domain-containing protein 77,CCDC77,84318;,"ENST00000239830.9; ENSP00000239830.4; ENSG00000120647.10. [Q9BR77-1];""ENST00000412006.6; ENSP00000412925.2; ENSG00000120647.10. [Q9BR77-2]"";""ENST00000422000.5; ENSP00000391870.1; ENSG00000120647.10. [Q9BR77-2]"";""ENST00000540180.5; ENSP00000440554.1; ENSG00000120647.10. [Q9BR77-2]"";",0,0,centrosome [GO:0005813]; membrane [GO:0016020]
A6NKD9,C5,1.60437408,0.508003791,-0.422409688,-0.382698455,-0.812196979,turquoise3,CCDC85C,CC85C_HUMAN,Coiled-coil domain-containing protein 85C,CCDC85C,317762;,ENST00000380243.9; ENSP00000369592.4; ENSG00000205476.9.;,0,cerebral cortex development [GO:0021987],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; bicellular tight junction [GO:0005923]
Q9H6F5,N3,-1.061790148,-0.91200299,0.936817425,-0.064055107,0.589252279,grey50,CCDC86,CCD86_HUMAN,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),CCDC86 CYCLON,79080;,"ENST00000227520.10; ENSP00000227520.5; ENSG00000110104.13. [Q9H6F5-1];""ENST00000545580.1; ENSP00000440906.1; ENSG00000110104.13. [Q9H6F5-2]"";",RNA binding [GO:0003723],0,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9GZT6,M2,-1.389562098,-1.651719306,0.413498755,1.194489165,-0.193395047,tan4,CCDC90B,CC90B_HUMAN,"Coiled-coil domain-containing protein 90B, mitochondrial",CCDC90B CUA003 MDS011 MDS025,60492;,"ENST00000455220.6; ENSP00000390990.3; ENSG00000137500.10. [Q9GZT6-3];""ENST00000529689.6; ENSP00000434724.1; ENSG00000137500.10. [Q9GZT6-1]"";",0,0,mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]
Q7Z6B0,C5,1.666414966,0.648600012,-0.654595494,-0.796546979,-1.139349072,turquoise3,CCDC91,CCD91_HUMAN,Coiled-coil domain-containing protein 91 (GGA-binding partner) (p56 accessory protein),CCDC91 GGABP HSD8,55297;,"ENST00000381259.5; ENSP00000370658.1; ENSG00000123106.11. [Q7Z6B0-1];""ENST00000536442.6; ENSP00000445660.2; ENSG00000123106.11. [Q7Z6B0-1]"";""ENST00000539107.5; ENSP00000440513.1; ENSG00000123106.11. [Q7Z6B0-3]"";""ENST00000545336.5; ENSP00000438040.1; ENSG00000123106.11. [Q7Z6B0-1]"";",0,Golgi to lysosome transport [GO:0090160]; protein transport [GO:0015031],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]
Q53HC0,C1,0.972836848,0.649273846,-0.39741249,-0.398568953,0.292054087,lightblue,CCDC92,CCD92_HUMAN,Coiled-coil domain-containing protein 92 (Limkain beta-2),CCDC92,80212;,"ENST00000238156.8; ENSP00000238156.3; ENSG00000119242.9. [Q53HC0-1];""ENST00000545135.5; ENSP00000439526.1; ENSG00000119242.9. [Q53HC0-2]"";""ENST00000545891.5; ENSP00000440024.1; ENSG00000119242.9. [Q53HC0-2]"";""ENST00000614047.2; ENSP00000479437.2; ENSG00000275035.2. [Q53HC0-2]"";""ENST00000631749.1; ENSP00000487695.1; ENSG00000275035.2. [Q53HC0-2]"";""ENST00000632401.1; ENSP00000488830.1; ENSG00000275035.2. [Q53HC0-1]"";",identical protein binding [GO:0042802],innate immune response [GO:0045087]; regulation of defense response to virus [GO:0050688],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]
Q567U6,C1,1.265137253,0.423778379,-0.452794755,-0.289844959,-0.353139478,lightblue,CCDC93,CCD93_HUMAN,Coiled-coil domain-containing protein 93,CCDC93,54520;,ENST00000376300.7; ENSP00000365477.2; ENSG00000125633.11.;,0,endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]
Q96F63,C2,0.359983619,0.827795965,-0.334581226,-0.628179345,0.06062618,aquamarine,CCDC97,CCD97_HUMAN,Coiled-coil domain-containing protein 97,CCDC97,90324;,ENST00000269967.4; ENSP00000269967.2; ENSG00000142039.4.;,0,0,nucleus [GO:0005634]
P14635,C2,1.174683101,0.202197814,-0.189274197,0.119416822,-0.255194021,aquamarine,CCNB1,CCNB1_HUMAN,G2/mitotic-specific cyclin-B1,CCNB1 CCNB,891;,"ENST00000256442.10; ENSP00000256442.5; ENSG00000134057.15. [P14635-1];""ENST00000505500.5; ENSP00000424588.1; ENSG00000134057.15. [P14635-2]"";",cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; patched binding [GO:0005113]; protein kinase binding [GO:0019901]; ubiquitin-like protein ligase binding [GO:0044389],cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; in utero embryonic development [GO:0001701]; mitotic cell cycle phase transition [GO:0044772]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266],centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922]
P51946,N4,-0.233917013,1.162469791,-0.049346487,-0.374317083,-0.677839941,grey30,CCNH,CCNH_HUMAN,Cyclin-H (MO15-associated protein) (p34) (p37),CCNH,902;,"ENST00000256897.9; ENSP00000256897.4; ENSG00000134480.17.;""ENST00000713562.1; ENSP00000518855.1; ENSG00000134480.17."";",cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538],protein stabilization [GO:0050821]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation at RNA polymerase II promoter [GO:0006367],CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]
O60563,N4,-1.174548748,0.906512763,0.151458948,-0.243681836,0.149877841,grey30,CCNT1,CCNT1_HUMAN,Cyclin-T1 (CycT1) (Cyclin-T),CCNT1,904;,"ENST00000261900.8; ENSP00000261900.3; ENSG00000129315.12. [O60563-1];""ENST00000417344.2; ENSP00000399845.2; ENSG00000129315.12. [O60563-2]"";""ENST00000618666.4; ENSP00000481035.1; ENSG00000129315.12. [O60563-2]"";",7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; molecular condensate scaffold activity [GO:0140693]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976],"cell division [GO:0051301]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]",cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-TEFb complex [GO:0070691]
O60583,N4,-1.169977213,1.00671287,0.140500785,-0.206129086,0.177951181,grey30,CCNT2,CCNT2_HUMAN,Cyclin-T2 (CycT2),CCNT2,905;,"ENST00000264157.10; ENSP00000264157.5; ENSG00000082258.13. [O60583-1];""ENST00000295238.11; ENSP00000295238.6; ENSG00000082258.13. [O60583-2]"";",7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223],"cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription by RNA polymerase II [GO:0006366]",cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q8N7R7,S4,-1.135211991,-1.241856274,0.454373323,0.841760155,0.48385752,tomato2,CCNYL1,CCYL1_HUMAN,Cyclin-Y-like protein 1,CCNYL1,151195;,"ENST00000295414.8; ENSP00000295414.3; ENSG00000163249.13. [Q8N7R7-1];""ENST00000339882.9; ENSP00000342344.5; ENSG00000163249.13. [Q8N7R7-2]"";""ENST00000392209.7; ENSP00000376045.3; ENSG00000163249.13. [Q8N7R7-3]"";",cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; protein kinase binding [GO:0019901],cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; nervous system development [GO:0007399]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of protein phosphorylation [GO:0001932]; spermatogenesis [GO:0007283],plasma membrane [GO:0005886]
Q9ULG6,S2,-1.376843215,-1.665470611,0.050683331,1.018024602,0.559484508,orange,CCPG1,CCPG1_HUMAN,Cell cycle progression protein 1 (Cell cycle progression restoration protein 8),CCPG1 CCP8 CPR8 KIAA1254,9236;,"ENST00000310958.10; ENSP00000311656.6; ENSG00000260916.8. [Q9ULG6-1];""ENST00000425574.7; ENSP00000415128.3; ENSG00000260916.8. [Q9ULG6-3]"";""ENST00000442196.8; ENSP00000403400.3; ENSG00000260916.8. [Q9ULG6-5]"";""ENST00000569205.5; ENSP00000454456.1; ENSG00000260916.8. [Q9ULG6-1]"";",0,positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944],membrane [GO:0016020]
O14618,C3,1.562092957,0.344265816,-0.554638762,-0.581797126,-0.901015899,cyan,CCS,CCS_HUMAN,Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone),CCS,9973;,ENST00000533244.6; ENSP00000436318.1; ENSG00000173992.9.;,cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein-disulfide reductase activity [GO:0015035]; superoxide dismutase copper chaperone activity [GO:0016532],cellular response to oxidative stress [GO:0034599]; protein maturation by copper ion transfer [GO:0015680]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
P78371,C1,1.156840682,0.438079874,-0.613996981,-0.592634926,0.451425396,lightblue,CCT2,TCPB_HUMAN,T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) (Chaperonin containing T-complex polypeptide 1 subunit 2),CCT2 99D8.1 CCTB,10576;,"ENST00000299300.11; ENSP00000299300.6; ENSG00000166226.13. [P78371-1];""ENST00000543146.2; ENSP00000445471.2; ENSG00000166226.13. [P78371-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666],azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]
P49368,C1,1.071549793,0.370739234,-0.572725652,-0.520248751,0.413012871,lightblue,CCT3,TCPG_HUMAN,T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (Chaperonin containing T-complex polypeptide 1 subunit 3) (hTRiC5),CCT3 CCTG TRIC5,7203;,"ENST00000295688.8; ENSP00000295688.3; ENSG00000163468.15. [P49368-1];""ENST00000368259.6; ENSP00000357242.2; ENSG00000163468.15. [P49368-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082],binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821],cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199]
P50991,C1,1.167238655,0.39882414,-0.607175669,-0.586780489,0.211563871,lightblue,CCT4,TCPD_HUMAN,T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Chaperonin containing T-complex polypeptide 1 subunit 4) (Stimulator of TAR RNA-binding),CCT4 CCTD SRB,10575;,"ENST00000394440.8; ENSP00000377958.3; ENSG00000115484.15. [P50991-1];""ENST00000544079.2; ENSP00000443061.1; ENSG00000115484.15. [P50991-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082],binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666],cell body [GO:0044297]; cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; zona pellucida receptor complex [GO:0002199]
P48643,C1,1.227375744,0.457762759,-0.695030731,-0.699430492,0.329563192,lightblue,CCT5,TCPE_HUMAN,T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) (Chaperonin containing T-complex polypeptide 1 subunit 5),CCT5 CCTE KIAA0098,22948;,"ENST00000280326.9; ENSP00000280326.4; ENSG00000150753.12. [P48643-1];""ENST00000506600.1; ENSP00000423052.1; ENSG00000150753.12. [P48643-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082],binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615],cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]
P40227,C1,1.197792125,0.409347301,-0.739582699,-0.690142652,0.366892143,lightblue,CCT6A,TCPZ_HUMAN,T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (Chaperonin containing T-complex polypeptide 1 subunit 6A) (HTR3) (Tcp20),CCT6A CCT6 CCTZ,908;,"ENST00000275603.9; ENSP00000275603.4; ENSG00000146731.11. [P40227-1];""ENST00000335503.3; ENSP00000352019.2; ENSG00000146731.11. [P40227-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987],chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821],chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]
Q99832,C1,1.098609745,0.394514117,-0.584201753,-0.62219786,0.340562858,lightblue,CCT7,TCPH_HUMAN,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (Chaperonin containing T-complex polypeptide 1 subunit 7) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]",CCT7 CCTH NIP7-1,10574;,"ENST00000258091.10; ENSP00000258091.5; ENSG00000135624.17. [Q99832-1];""ENST00000398422.2; ENSP00000381456.2; ENSG00000135624.17. [Q99832-2]"";""ENST00000539919.5; ENSP00000437824.1; ENSG00000135624.17. [Q99832-3]"";""ENST00000540468.5; ENSP00000442058.1; ENSG00000135624.17. [Q99832-4]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082],binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821],cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]
P50990,C1,1.21784191,0.44266945,-0.747990274,-0.706784134,0.261289636,lightblue,CCT8,TCPQ_HUMAN,T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Chaperonin containing T-complex polypeptide 1 subunit 8) (Renal carcinoma antigen NY-REN-15),CCT8 C21orf112 CCTQ KIAA0002,10694;,"ENST00000286788.9; ENSP00000286788.4; ENSG00000156261.13. [P50990-1];""ENST00000540844.5; ENSP00000442730.1; ENSG00000156261.13. [P50990-3]"";""ENST00000626972.2; ENSP00000486921.1; ENSG00000156261.13. [P50990-2]"";""ENST00000707884.1; ENSP00000517017.1; ENSG00000291533.1. [P50990-1]"";""ENST00000707885.1; ENSP00000517018.1; ENSG00000291533.1. [P50990-2]"";""ENST00000707892.1; ENSP00000517020.1; ENSG00000291533.1. [P50990-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; cadherin binding [GO:0045296]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082],binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821],azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774]; zona pellucida receptor complex [GO:0002199]
Q6YHK3,S3,-0.86251747,-0.949208353,0.224479691,0.720687185,0.707500177,salmon,CD109,CD109_HUMAN,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),CD109 CPAMD7,135228;,"ENST00000287097.6; ENSP00000287097.4; ENSG00000156535.15. [Q6YHK3-1];""ENST00000422508.6; ENSP00000404475.2; ENSG00000156535.15. [Q6YHK3-2]"";""ENST00000437994.6; ENSP00000388062.2; ENSG00000156535.15. [Q6YHK3-4]"";",serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431],hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; side of membrane [GO:0098552]
P48509,S4,-0.802418247,-1.402436706,0.324431392,0.830456871,0.458540787,tomato2,CD151,CD151_HUMAN,CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151),CD151 TSPAN24,977;,"ENST00000322008.9; ENSP00000324101.4; ENSG00000177697.19.;""ENST00000397420.9; ENSP00000380565.3; ENSG00000177697.19."";""ENST00000397421.5; ENSP00000380566.1; ENSG00000177697.19."";""ENST00000530726.5; ENSP00000432385.1; ENSG00000177697.19."";",integrin binding [GO:0005178],"cell adhesion [GO:0007155]; cell migration [GO:0016477]; positive regulation of cell migration [GO:0030335]; positive regulation of endocytosis [GO:0045807]; T cell proliferation [GO:0042098]; wound healing, spreading of cells [GO:0044319]",basement membrane [GO:0005604]; cell surface [GO:0009986]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q5ZPR3,S4,-0.466255535,-1.091072716,0.360079148,0.722484344,0.361924441,tomato2,CD276,CD276_HUMAN,CD276 antigen (4Ig-B7-H3) (B7 homolog 3) (B7-H3) (Costimulatory molecule) (CD antigen CD276),CD276 B7H3 PSEC0249 UNQ309/PRO352,80381;,"ENST00000318424.9; ENSP00000320058.5; ENSG00000103855.18. [Q5ZPR3-2];""ENST00000318443.10; ENSP00000320084.5; ENSG00000103855.18. [Q5ZPR3-1]"";""ENST00000561213.5; ENSP00000452736.1; ENSG00000103855.18. [Q5ZPR3-4]"";""ENST00000564751.5; ENSP00000454940.1; ENSG00000103855.18. [Q5ZPR3-2]"";",signaling receptor binding [GO:0005102],positive regulation of T cell proliferation [GO:0042102]; positive regulation of type II interferon production [GO:0032729]; regulation of cytokine production [GO:0001817]; regulation of immune response [GO:0050776]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852],external side of plasma membrane [GO:0009897]; membrane [GO:0016020]
Q9Y5K6,C5,1.712625963,0.489697457,-0.704447914,-0.771826362,-1.001386516,turquoise3,CD2AP,CD2AP_HUMAN,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),CD2AP,23607;,ENST00000359314.5; ENSP00000352264.5; ENSG00000198087.7.;,actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],"actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; adipose tissue development [GO:0060612]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction organization [GO:0045216]; collateral sprouting [GO:0048668]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; filopodium assembly [GO:0046847]; glucose import [GO:0046323]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; localization of cell [GO:0051674]; lymph node development [GO:0048535]; maintenance of blood-brain barrier [GO:0035633]; male gonad development [GO:0008584]; membrane organization [GO:0061024]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor signaling pathway [GO:0038180]; neurotrophin TRK receptor signaling pathway [GO:0048011]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; podocyte differentiation [GO:0072112]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein secretion [GO:0009306]; protein-containing complex assembly [GO:0065003]; Rab protein signal transduction [GO:0032482]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of synaptic plasticity [GO:0048167]; renal albumin absorption [GO:0097018]; response to glial cell derived neurotrophic factor [GO:1990790]; response to insulin [GO:0032868]; response to oxidative stress [GO:0006979]; response to transforming growth factor beta [GO:0071559]; response to virus [GO:0009615]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; substrate-dependent cell migration, cell extension [GO:0006930]; synapse organization [GO:0050808]; T cell receptor signaling pathway [GO:0050852]; transforming growth factor beta1 production [GO:0032905]",actin cytoskeleton [GO:0015629]; axon [GO:0030424]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; growth cone [GO:0030426]; late endosome [GO:0005770]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]
O15446,N1,-0.715054788,-0.325323207,0.444477716,-0.291561831,1.015613812,grey90,CD3EAP,RPA34_HUMAN,DNA-directed RNA polymerase I subunit RPA34 (A34.5) (Antisense to ERCC-1 protein) (ASE-1) (CD3-epsilon-associated protein) (CD3E-associated protein) (DNA-directed RNA polymerase I subunit G) (RNA polymerase I-associated factor PAF49),POLR1G ASE1 CAST CD3EAP PAF49,10849;,"ENST00000309424.8; ENSP00000310966.3; ENSG00000117877.11. [O15446-1];""ENST00000589804.1; ENSP00000465099.1; ENSG00000117877.11. [O15446-2]"";",RNA binding [GO:0003723],cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; rRNA transcription [GO:0009303]; transcription initiation at RNA polymerase I promoter [GO:0006361],chromosome [GO:0005694]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; RNA polymerase I transcription regulator complex [GO:0000120]
P16070,S4,-0.913960045,-1.05445018,0.309977645,0.893450338,0.2943829,tomato2,CD44,CD44_HUMAN,CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44),CD44 LHR MDU2 MDU3 MIC4,960;,"ENST00000263398.11; ENSP00000263398.6; ENSG00000026508.21. [P16070-12];""ENST00000278386.10; ENSP00000278386.6; ENSG00000026508.21. [P16070-19]"";""ENST00000352818.8; ENSP00000309732.6; ENSG00000026508.21. [P16070-18]"";""ENST00000415148.6; ENSP00000389830.2; ENSG00000026508.21. [P16070-4]"";""ENST00000428726.8; ENSP00000398632.2; ENSG00000026508.21. [P16070-1]"";""ENST00000433892.6; ENSP00000392331.2; ENSG00000026508.21. [P16070-10]"";""ENST00000434472.6; ENSP00000404447.2; ENSG00000026508.21. [P16070-11]"";",collagen binding [GO:0005518]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888],"cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of lamellipodium morphogenesis [GO:2000392]; T cell activation [GO:0042110]; wound healing, spreading of cells [GO:0044319]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lamellipodium membrane [GO:0031258]; macrophage migration inhibitory factor receptor complex [GO:0035692]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]
P15529,S4,-1.143943562,-1.273407372,0.417042818,0.974955387,0.253178114,tomato2,CD46,MCP_HUMAN,Membrane cofactor protein (TLX) (Trophoblast leukocyte common antigen) (CD antigen CD46),CD46 MCP MIC10,4179;,"ENST00000322875.8; ENSP00000313875.4; ENSG00000117335.21. [P15529-2];""ENST00000322918.9; ENSP00000314664.5; ENSG00000117335.21. [P15529-9]"";""ENST00000354848.5; ENSP00000346912.1; ENSG00000117335.21. [P15529-3]"";""ENST00000357714.5; ENSP00000350346.1; ENSG00000117335.21. [P15529-4]"";""ENST00000358170.6; ENSP00000350893.2; ENSG00000117335.21. [P15529-1]"";""ENST00000360212.6; ENSP00000353342.2; ENSG00000117335.21. [P15529-7]"";""ENST00000367041.5; ENSP00000356008.1; ENSG00000117335.21. [P15529-12]"";""ENST00000367042.6; ENSP00000356009.1; ENSG00000117335.21. [P15529-11]"";""ENST00000367047.5; ENSP00000356014.1; ENSG00000117335.21. [P15529-16]"";""ENST00000480003.5; ENSP00000418471.1; ENSG00000117335.21. [P15529-6]"";",cadherin binding [GO:0045296]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618],"adaptive immune response [GO:0002250]; complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation, classical pathway [GO:0045959]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of Notch signaling pathway [GO:0008593]; sequestering of extracellular ligand from receptor [GO:0035581]; single fertilization [GO:0007338]; T cell mediated immunity [GO:0002456]",cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; inner acrosomal membrane [GO:0002079]; plasma membrane [GO:0005886]
Q08722,S2,-1.174159745,-1.386876167,0.421618699,0.850885377,0.526899492,orange,CD47,CD47_HUMAN,Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47),CD47 MER6,961;,"ENST00000355354.13; ENSP00000347512.7; ENSG00000196776.17. [Q08722-3];""ENST00000361309.6; ENSP00000355361.5; ENSG00000196776.17. [Q08722-1]"";",cell-cell adhesion mediator activity [GO:0098632]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; thrombospondin receptor activity [GO:0070053],angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; ATP export [GO:1904669]; cell migration [GO:0016477]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-12 [GO:0071349]; cellular response to type II interferon [GO:0071346]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of phagocytosis [GO:0050765]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of inflammatory response [GO:0050729]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phagocytosis [GO:0050766]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of T cell activation [GO:0050870]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of interleukin-10 production [GO:0032653]; regulation of interleukin-12 production [GO:0032655]; regulation of interleukin-6 production [GO:0032675]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of tumor necrosis factor production [GO:0032680]; regulation of type II interferon production [GO:0032649],cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]
P08174,S3,-0.634943347,-1.013034292,0.284626779,0.763226227,0.674505664,salmon,CD55,DAF_HUMAN,Complement decay-accelerating factor (CD antigen CD55),CD55 CR DAF,1604;,"ENST00000314754.12; ENSP00000316333.8; ENSG00000196352.18. [P08174-2];""ENST00000367064.9; ENSP00000356031.4; ENSG00000196352.18. [P08174-1]"";""ENST00000644836.1; ENSP00000495518.1; ENSG00000196352.18. [P08174-3]"";""ENST00000645323.1; ENSP00000496251.1; ENSG00000196352.18. [P08174-5]"";",lipid binding [GO:0008289]; virus receptor activity [GO:0001618],"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation [GO:0045916]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of T cell cytokine production [GO:0002726]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; respiratory burst [GO:0045730]",cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; side of membrane [GO:0098552]; transport vesicle [GO:0030133]
P19256,S4,-1.797331205,-1.966356117,0.489944688,0.891666783,0.378257144,tomato2,CD58,LFA3_HUMAN,Lymphocyte function-associated antigen 3 (Ag3) (Surface glycoprotein LFA-3) (CD antigen CD58),CD58 LFA3,965;,"ENST00000369489.10; ENSP00000358501.5; ENSG00000116815.16. [P19256-1];""ENST00000457047.6; ENSP00000409080.2; ENSG00000116815.16. [P19256-3]"";""ENST00000464088.5; ENSP00000432773.1; ENSG00000116815.16. [P19256-2]"";",signaling receptor binding [GO:0005102],cell-cell adhesion [GO:0098609]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; heterotypic cell-cell adhesion [GO:0034113]; positive regulation of interleukin-8 production [GO:0032757],cell surface [GO:0009986]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]
P08962,S1,-1.93880151,-1.620420112,-0.160873617,0.647738769,1.371888368,gold,CD63,CD63_HUMAN,CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Lysosome integral membrane protein 1) (Limp1) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63),CD63 MLA1 TSPAN30,967;,"ENST00000257857.9; ENSP00000257857.4; ENSG00000135404.12. [P08962-1];""ENST00000420846.7; ENSP00000393502.3; ENSG00000135404.12. [P08962-1]"";""ENST00000546939.5; ENSP00000447356.1; ENSG00000135404.12. [P08962-3]"";""ENST00000549117.5; ENSP00000447730.1; ENSG00000135404.12. [P08962-1]"";""ENST00000550776.5; ENSP00000448091.1; ENSG00000135404.12. [P08962-3]"";""ENST00000552692.5; ENSP00000449337.1; ENSG00000135404.12. [P08962-1]"";""ENST00000552754.5; ENSP00000446807.1; ENSG00000135404.12. [P08962-2]"";",0,cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],"azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]"
P60033,S2,-1.655608677,-2.418066709,0.137410272,0.9505327,0.918250212,orange,CD81,CD81_HUMAN,CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81),CD81 TAPA1 TSPAN28,975;,ENST00000263645.10; ENSP00000263645.5; ENSG00000110651.13.;,cholesterol binding [GO:0015485]; integrin binding [GO:0005178]; MHC class II protein binding [GO:0042289]; MHC class II protein complex binding [GO:0023026]; transferrin receptor binding [GO:1990459]; virus receptor activity [GO:0001618],"CD4-positive, alpha-beta T cell costimulation [GO:0035783]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; immunological synapse formation [GO:0001771]; macrophage fusion [GO:0034238]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; osteoclast fusion [GO:0072675]; positive regulation of adaptive immune memory response [GO:1905676]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein catabolic process in the vacuole [GO:1904352]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of receptor clustering [GO:1903911]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to lysosome [GO:0061462]; protein localization to plasma membrane [GO:0072659]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; regulation of protein stability [GO:0031647]",basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; plasma membrane [GO:0005886]; tetraspanin-enriched microdomain [GO:0097197]; vesicle [GO:0031982]
P14209,S4,-1.656221757,-1.336078136,0.37347513,0.948487746,0.273173802,tomato2,CD99,CD99_HUMAN,CD99 antigen (12E7) (E2 antigen) (Protein MIC2) (T-cell surface glycoprotein E2) (CD antigen CD99),CD99 MIC2 MIC2X MIC2Y,4267;,"ENST00000381187.8; ENSP00000370582.3; ENSG00000002586.20. [P14209-3];""ENST00000381192.10; ENSP00000370588.3; ENSG00000002586.20. [P14209-1]"";""ENST00000482405.7; ENSP00000494027.1; ENSG00000002586.20. [P14209-2]"";""ENST00000611428.5; ENSP00000479999.1; ENSG00000002586.20. [P14209-2]"";""ENST00000623253.4; ENSP00000485545.1; ENSG00000002586.20. [P14209-2]"";""ENST00000711155.1; ENSP00000518644.1; ENSG00000292348.1. [P14209-2]"";""ENST00000711159.1; ENSP00000518647.1; ENSG00000292348.1. [P14209-2]"";""ENST00000711160.1; ENSP00000518648.1; ENSG00000292348.1. [P14209-1]"";""ENST00000711164.1; ENSP00000518650.1; ENSG00000292348.1. [P14209-3]"";""ENST00000711165.1; ENSP00000518651.1; ENSG00000292348.1. [P14209-2]"";",0,homotypic cell-cell adhesion [GO:0034109]; positive regulation of neutrophil extravasation [GO:2000391]; T cell extravasation [GO:0072683],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]
Q8IWY9,C3,1.513398395,0.063370634,-0.394399545,-0.240185638,-0.483855615,cyan,CDAN1,CDAN1_HUMAN,Codanin-1,CDAN1 UNQ664/PRO1295,146059;,ENST00000356231.4; ENSP00000348564.3; ENSG00000140326.13. [Q8IWY9-2];,0,chromatin organization [GO:0006325]; import into nucleus [GO:0051170]; protein localization [GO:0008104],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O75794,C3,1.841569681,0.16310352,-0.714019983,-0.701835744,-1.025414853,cyan,CDC123,CD123_HUMAN,Translation initiation factor eIF2 assembly protein (Cell division cycle protein 123 homolog) (Protein D123) (HT-1080) (PZ32),CDC123 C10orf7 D123,8872;,ENST00000281141.9; ENSP00000281141.4; ENSG00000151465.14.;,ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein folding chaperone [GO:0044183],eukaryotic translation initiation factor 2 complex assembly [GO:1905143],cytoplasm [GO:0005737]
P30305,C2,0.82381106,0.741083659,-0.148935109,-0.134592136,-0.64610315,aquamarine,CDC25B,MPIP2_HUMAN,M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B),CDC25B CDC25HU2,994;,"ENST00000245960.10; ENSP00000245960.5; ENSG00000101224.18. [P30305-1];""ENST00000340833.4; ENSP00000339170.4; ENSG00000101224.18. [P30305-3]"";""ENST00000439880.6; ENSP00000405972.2; ENSG00000101224.18. [P30305-2]"";",phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725],cell division [GO:0051301]; female meiosis I [GO:0007144]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; oocyte maturation [GO:0001556]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; positive regulation of mitotic cell cycle [GO:0045931]; protein phosphorylation [GO:0006468],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]
P30307,C4,1.815369545,-0.178199628,-0.659511867,-0.786993907,-1.129010721,deepskyblue2,CDC25C,MPIP3_HUMAN,M-phase inducer phosphatase 3 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25C),CDC25C,995;,"ENST00000323760.11; ENSP00000321656.6; ENSG00000158402.21. [P30307-1];""ENST00000415130.6; ENSP00000392631.2; ENSG00000158402.21. [P30307-4]"";""ENST00000513970.5; ENSP00000424795.1; ENSG00000158402.21. [P30307-1]"";""ENST00000514555.5; ENSP00000425470.1; ENSG00000158402.21. [P30307-2]"";",phosphoprotein phosphatase activity [GO:0004721]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; WW domain binding [GO:0050699],cell division [GO:0051301]; cell population proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of G2/MI transition of meiotic cell cycle [GO:0110032]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic nuclear division [GO:0007088]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
P49427,C1,1.653290382,0.18795122,-0.391711867,-0.475100272,-0.718871935,lightblue,CDC34,UB2R1_HUMAN,Ubiquitin-conjugating enzyme E2 R1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme R1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme R1) (Ubiquitin-conjugating enzyme E2-32 kDa complementing) (Ubiquitin-conjugating enzyme E2-CDC34) (Ubiquitin-protein ligase R1),CDC34 UBCH3 UBE2R1,997;,ENST00000215574.9; ENSP00000215574.2; ENSG00000099804.9.;,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],cellular response to interferon-beta [GO:0035458]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to growth factor [GO:0070848]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q16543,C3,1.688428955,0.413485417,-0.7683544,-0.638581664,-0.848874438,cyan,CDC37,CDC37_HUMAN,"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]",CDC37 CDC37A,11140;,ENST00000222005.7; ENSP00000222005.1; ENSG00000105401.9.;,heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein-folding chaperone binding [GO:0051087]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082],positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; post-transcriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; regulation of type II interferon-mediated signaling pathway [GO:0060334],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; HSP90-CDC37 chaperone complex [GO:1990565]; protein folding chaperone complex [GO:0101031]
O60508,N3,-1.005943211,-1.001676194,0.868201123,0.014885069,0.704951798,grey50,CDC40,PRP17_HUMAN,Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17),CDC40 EHB3 PRP17 PRPF17,51362;,"ENST00000307731.2; ENSP00000304370.1; ENSG00000168438.15.;""ENST00000368932.5; ENSP00000357928.1; ENSG00000168438.15."";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],"embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U2-type catalytic step 2 spliceosome [GO:0071007]
P60953,C2,0.647911984,-0.589885506,0.021562759,0.496185676,0.180365524,aquamarine,CDC42,CDC42_HUMAN,Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein),CDC42,998;,"ENST00000315554.15; ENSP00000314458.8; ENSG00000070831.18. [P60953-1];""ENST00000344548.8; ENSP00000341072.3; ENSG00000070831.18. [P60953-2]"";""ENST00000400259.5; ENSP00000383118.1; ENSG00000070831.18. [P60953-2]"";""ENST00000411827.2; ENSP00000398327.2; ENSG00000070831.18. [P60953-2]"";""ENST00000656825.1; ENSP00000499457.1; ENSG00000070831.18. [P60953-2]"";""ENST00000662562.2; ENSP00000499612.1; ENSG00000070831.18. [P60953-2]"";""ENST00000695796.1; ENSP00000512176.1; ENSG00000070831.18. [P60953-2]"";""ENST00000695797.1; ENSP00000512177.1; ENSG00000070831.18. [P60953-2]"";""ENST00000695798.1; ENSP00000512178.1; ENSG00000070831.18. [P60953-2]"";""ENST00000695799.1; ENSP00000512179.1; ENSG00000070831.18. [P60953-2]"";""ENST00000695800.1; ENSP00000512180.1; ENSG00000070831.18. [P60953-2]"";""ENST00000695802.1; ENSP00000512182.1; ENSG00000070831.18. [P60953-2]"";""ENST00000695857.1; ENSP00000512222.1; ENSG00000070831.18. [P60953-1]"";""ENST00000695860.1; ENSP00000512225.1; ENSG00000070831.18. [P60953-1]"";",apolipoprotein A-I receptor binding [GO:0034191]; G protein activity [GO:0003925]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630],"actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cellular response to type II interferon [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; embryonic heart tube development [GO:0035050]; endocytosis [GO:0006897]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; Golgi organization [GO:0007030]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; modification of synaptic structure [GO:0099563]; modulation by host of viral process [GO:0044788]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; organelle transport along microtubule [GO:0072384]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of synapse structural plasticity [GO:0051835]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; regulation of mitotic nuclear division [GO:0007088]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of postsynapse organization [GO:0099175]; regulation of stress fiber assembly [GO:0051492]; sprouting angiogenesis [GO:0002040]; submandibular salivary gland formation [GO:0060661]; substantia nigra development [GO:0021762]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322]
Q9H3Q1,C2,1.256578893,0.512474767,-0.440083197,-0.223748629,-0.687309984,aquamarine,CDC42EP4,BORG4_HUMAN,Cdc42 effector protein 4 (Binder of Rho GTPases 4),CDC42EP4 BORG4 CEP4,23580;,"ENST00000335793.4; ENSP00000338258.3; ENSG00000179604.10. [Q9H3Q1-1];""ENST00000439510.2; ENSP00000404270.2; ENSG00000179604.10. [Q9H3Q1-2]"";",RNA binding [GO:0003723]; small GTPase binding [GO:0031267],cellular response to type II interferon [GO:0071346]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of pseudopodium assembly [GO:0031274]; regulation of cell shape [GO:0008360]; Rho protein signal transduction [GO:0007266],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule cytoskeleton [GO:0015630]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]
Q99459,N1,-1.073795641,-0.85060213,0.664859522,-0.22636783,1.077264455,grey90,CDC5L,CDC5L_HUMAN,Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein),CDC5L KIAA0432 PCDC5RP,988;,ENST00000371477.4; ENSP00000360532.3; ENSG00000096401.8.;,"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; WD40-repeat domain binding [GO:0071987]","DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]
Q6P1J9,N4,-0.843738728,0.856607413,0.49770552,-0.302926823,-0.527459109,grey30,CDC73,CDC73_HUMAN,Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein),CDC73 C1orf28 HRPT2,79577;,ENST00000367435.5; ENSP00000356405.4; ENSG00000134371.14.;,RNA polymerase II complex binding [GO:0000993],cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; protein destabilization [GO:0031648]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],"Cdc73/Paf1 complex [GO:0016593]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q69YH5,N2,-1.253429916,-0.538116159,1.012949101,0.1860012,0.19222253,grey70,CDCA2,CDCA2_HUMAN,Cell division cycle-associated protein 2 (Recruits PP1 onto mitotic chromatin at anaphase protein) (Repo-Man),CDCA2,157313;,ENST00000330560.8; ENSP00000328228.3; ENSG00000184661.14. [Q69YH5-1];,0,cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088],chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96FF9,N2,-1.081137359,-0.260117279,1.202470943,0.069690184,-0.700691119,grey70,CDCA5,CDCA5_HUMAN,Sororin (Cell division cycle-associated protein 5) (p35),CDCA5,113130;,ENST00000275517.8; ENSP00000275517.3; ENSG00000146670.10.;,chromatin binding [GO:0003682]; protein-containing complex binding [GO:0044877],cell division [GO:0051301]; double-strand break repair [GO:0006302]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of exit from mitosis [GO:0031536],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q96GN5,N3,-0.987654288,-1.200587863,1.30332232,0.310565396,-0.506229075,grey50,CDCA7L,CDA7L_HUMAN,Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2),CDCA7L HR1 JPO2 R1,55536;,"ENST00000356195.9; ENSP00000348523.5; ENSG00000164649.20. [Q96GN5-4];""ENST00000373934.4; ENSP00000363045.4; ENSG00000164649.20. [Q96GN5-5]"";""ENST00000406877.8; ENSP00000383986.3; ENSG00000164649.20. [Q96GN5-1]"";",0,positive regulation of cell population proliferation [GO:0008284]; regulation of DNA-templated transcription [GO:0006355],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q53HL2,N3,-1.421176815,-1.663808362,1.185852492,0.293896014,0.118361132,grey50,CDCA8,BOREA_HUMAN,Borealin (Cell division cycle-associated protein 8) (Dasra-B) (hDasra-B) (Pluripotent embryonic stem cell-related gene 3 protein),CDCA8 PESCRG3,55143;,"ENST00000327331.2; ENSP00000316121.2; ENSG00000134690.11.;""ENST00000373055.6; ENSP00000362146.1; ENSG00000134690.11."";",0,chromosome organization [GO:0051276]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970],"chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]"
P06493,C5,1.478229907,0.356402074,-0.334912974,-0.503426093,-0.640166552,turquoise3,CDK1,CDK1_HUMAN,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),CDK1 CDC2 CDC28A CDKN1 P34CDC2,983;,"ENST00000316629.8; ENSP00000325970.4; ENSG00000170312.17. [P06493-2];""ENST00000373809.2; ENSP00000362915.2; ENSG00000170312.17. [P06493-2]"";""ENST00000395284.8; ENSP00000378699.3; ENSG00000170312.17. [P06493-1]"";",ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; virus receptor activity [GO:0001618],animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to organic cyclic compound [GO:0071407]; centrosome cycle [GO:0007098]; chromosome condensation [GO:0030261]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast proliferation [GO:0048144]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; pronuclear fusion [GO:0007344]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902423]; regulation of circadian rhythm [GO:0042752]; regulation of embryonic development [GO:0045995]; regulation of Schwann cell differentiation [GO:0014038]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to ethanol [GO:0045471]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cyclin A1-CDK1 complex [GO:0097121]; cyclin A2-CDK1 complex [GO:0097122]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]"
Q14004,N1,-1.255893333,-0.030499356,0.189600995,-0.392919394,1.026481859,grey90,CDK13,CDK13_HUMAN,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),CDK13 CDC2L CDC2L5 CHED KIAA1791,8621;,"ENST00000181839.10; ENSP00000181839.4; ENSG00000065883.18. [Q14004-1];""ENST00000340829.10; ENSP00000340557.5; ENSG00000065883.18. [Q14004-2]"";",ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA binding [GO:0003723]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],"alternative mRNA splicing, via spliceosome [GO:0000380]; hemopoiesis [GO:0030097]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of signal transduction [GO:0009966]",cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q00537,S3,0.138052423,-0.470401277,0.337753704,0.628087961,0.077104269,salmon,CDK17,CDK17_HUMAN,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),CDK17 PCTAIRE2 PCTK2,5128;,"ENST00000261211.8; ENSP00000261211.3; ENSG00000059758.8. [Q00537-1];""ENST00000543119.6; ENSP00000444459.2; ENSG00000059758.8. [Q00537-2]"";",ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],protein phosphorylation [GO:0006468],cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q00535,C1,1.443878982,0.305901407,-0.380446521,-0.205702463,-0.580205031,lightblue,CDK5,CDK5_HUMAN,Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit),CDK5 CDKN5 PSSALRE,1020;,"ENST00000297518.4; ENSP00000297518.4; ENSG00000164885.13. [Q00535-2];""ENST00000485972.6; ENSP00000419782.1; ENSG00000164885.13. [Q00535-1]"";",acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],"axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]",axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]
Q96JB5,S2,-1.321796195,-1.299551797,0.102822777,0.943835526,0.55209815,orange,CDK5RAP3,CK5P3_HUMAN,CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53) (LXXLL/leucine-zipper-containing ARF-binding protein) (Protein HSF-27),CDK5RAP3 IC53 LZAP MSTP016 OK/SW-cl.114 PP1553,80279;,"ENST00000338399.9; ENSP00000344683.4; ENSG00000108465.15. [Q96JB5-1];""ENST00000536708.6; ENSP00000438886.2; ENSG00000108465.15. [Q96JB5-4]"";",cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-like protein ligase binding [GO:0044389],apoptotic nuclear changes [GO:0030262]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of reticulophagy [GO:0140501]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron differentiation [GO:0045664]; regulation of phosphatase activity [GO:0010921]; rescue of stalled ribosome [GO:0072344]; response to endoplasmic reticulum stress [GO:0034976]; ribosome disassembly [GO:0032790],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q00534,C5,1.58298454,0.417161786,-0.716953635,-0.485339491,-0.779924067,turquoise3,CDK6,CDK6_HUMAN,Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),CDK6 CDKN6,1021;,"ENST00000265734.8; ENSP00000265734.4; ENSG00000105810.10.;""ENST00000424848.3; ENSP00000397087.3; ENSG00000105810.10."";",ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; protein serine kinase activity [GO:0106310],astrocyte development [GO:0014002]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to organic substance [GO:0010033]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],centrosome [GO:0005813]; cyclin D1-CDK6 complex [GO:0097131]; cyclin D2-CDK6 complex [GO:0097132]; cyclin D3-CDK6 complex [GO:0097133]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]
P50750,N4,-0.737410135,0.784871365,0.18537183,-0.296136431,0.311832039,grey30,CDK9,CDK9_HUMAN,Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit),CDK9 CDC2L4 TAK,1025;,ENST00000373264.5; ENSP00000362361.4; ENSG00000136807.14. [P50750-1];,7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription coactivator binding [GO:0001223]; transcription elongation factor activity [GO:0003711],cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of protein localization to chromatin [GO:0120186]; nucleus localization [GO:0051647]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]; transcription initiation at RNA polymerase II promoter [GO:0006367],cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-TEFb complex [GO:0070691]; PML body [GO:0016605]; transcription elongation factor complex [GO:0008023]
Q5VV42,S2,-1.030429929,-1.179856398,0.132762308,0.786529203,0.616902807,orange,CDKAL1,CDKAL_HUMAN,Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase),CDKAL1,54901;,"ENST00000274695.8; ENSP00000274695.4; ENSG00000145996.11. [Q5VV42-1];""ENST00000378610.1; ENSP00000367873.1; ENSG00000145996.11. [Q5VV42-1]"";""ENST00000613575.4; ENSP00000481755.1; ENSG00000145996.11. [Q5VV42-3]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; N6-threonylcarbomyladenosine methylthiotransferase activity [GO:0035598]; tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase [GO:0061712]",maintenance of translational fidelity [GO:1990145]; tRNA methylthiolation [GO:0035600],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]
Q96HQ2,N4,-0.829021375,0.968583954,-0.205107137,-0.246705998,0.154188362,grey30,CDKN2AIPNL,C2AIL_HUMAN,CDKN2AIP N-terminal-like protein (CDKN2A-interacting protein N-terminal-like protein),CDKN2AIPNL,91368;,"ENST00000395009.3; ENSP00000378456.3; ENSG00000237190.4. [Q96HQ2-2];""ENST00000458198.3; ENSP00000394183.2; ENSG00000237190.4. [Q96HQ2-1]"";",0,0,0
Q4KMG0,S2,-0.886347569,-0.616233674,0.355060297,0.843316692,0.52796477,orange,CDON,CDON_HUMAN,Cell adhesion molecule-related/down-regulated by oncogenes,CDON CDO,50937;,"ENST00000263577.11; ENSP00000263577.7; ENSG00000064309.16. [Q4KMG0-2];""ENST00000392693.7; ENSP00000376458.3; ENSG00000064309.16. [Q4KMG0-1]"";""ENST00000531738.6; ENSP00000432901.2; ENSG00000064309.16. [Q4KMG0-2]"";""ENST00000684078.1; ENSP00000507318.1; ENSG00000064309.16. [Q4KMG0-1]"";",0,anterior/posterior pattern specification [GO:0009952]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; embryonic body morphogenesis [GO:0010172]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; lens development in camera-type eye [GO:0002088]; myoblast fusion [GO:0007520]; nervous system development [GO:0007399]; neuroblast proliferation [GO:0007405]; neuron differentiation [GO:0030182]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal muscle satellite cell differentiation [GO:0014816]; smoothened signaling pathway [GO:0007224],plasma membrane [GO:0005886]
Q86X02,C2,1.15587264,0.325781308,-0.346251012,-0.156166542,-0.557047819,aquamarine,CDR2L,CDR2L_HUMAN,Cerebellar degeneration-related protein 2-like (Paraneoplastic 62 kDa antigen),CDR2L HUMPPA,30850;,ENST00000337231.5; ENSP00000336587.5; ENSG00000109089.7.;,identical protein binding [GO:0042802],Golgi to secretory granule transport [GO:0055107]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]
O95674,S3,-0.874788964,-1.057836849,0.1600313,0.73143943,0.538365417,salmon,CDS2,CDS2_HUMAN,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),CDS2,8760;,"ENST00000450570.1; ENSP00000403205.1; ENSG00000101290.14. [O95674-2];""ENST00000460006.6; ENSP00000419879.1; ENSG00000101290.14. [O95674-1]"";",phosphatidate cytidylyltransferase activity [GO:0004605],CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042]; phosphatidylglycerol biosynthetic process [GO:0006655],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]
Q9UKY7,C4,2.019462868,0.479650417,-1.199043113,-1.398893767,-1.490378045,deepskyblue2,CDV3,CDV3_HUMAN,Protein CDV3 homolog,CDV3 H41,55573;,"ENST00000264993.8; ENSP00000264993.3; ENSG00000091527.17. [Q9UKY7-1];""ENST00000420115.6; ENSP00000413272.2; ENSG00000091527.17. [Q9UKY7-3]"";""ENST00000431519.6; ENSP00000391955.2; ENSG00000091527.17. [Q9UKY7-2]"";",0,0,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
P17676,N2,-0.878920426,-0.441727187,1.140558913,0.148374228,-0.385016492,grey70,CEBPB,CEBPB_HUMAN,CCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (LAP) (Liver-enriched inhibitory protein) (LIP) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5),CEBPB TCF5 PP9092,1051;,ENST00000303004.5; ENSP00000305422.3; ENSG00000172216.6. [P17676-1];,"chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; kinase binding [GO:0019900]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]",acute-phase response [GO:0006953]; brown fat cell differentiation [GO:0050873]; cellular response to amino acid stimulus [GO:0071230]; defense response to bacterium [GO:0042742]; embryonic placenta development [GO:0001892]; granuloma formation [GO:0002432]; hepatocyte proliferation [GO:0072574]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; mammary gland epithelial cell differentiation [GO:0060644]; mammary gland epithelial cell proliferation [GO:0033598]; myeloid cell development [GO:0061515]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of dendritic cell differentiation [GO:2001198]; regulation of DNA-templated transcription [GO:0006355]; regulation of interleukin-6 production [GO:0032675]; regulation of odontoblast differentiation [GO:1901329]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; T-helper 1 cell activation [GO:0035711]; transcription by RNA polymerase II [GO:0006366],"C/EBP complex [GO:1990647]; CHOP-C/EBP complex [GO:0036488]; chromatin [GO:0000785]; condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]"
Q03701,N3,-1.458498652,-1.547927649,1.433117883,-0.075067925,-0.030425071,grey50,CEBPZ,CEBPZ_HUMAN,CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor),CEBPZ CBF2,10153;,ENST00000234170.10; ENSP00000234170.5; ENSG00000115816.15.;,RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],positive regulation of transcription by RNA polymerase II [GO:0045944],CCAAT-binding factor complex [GO:0016602]; nucleus [GO:0005634]
Q92879,N1,-0.863566276,-0.345958491,0.645640912,0.077261092,0.686928326,grey90,CELF1,CELF1_HUMAN,CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2),CELF1 BRUNOL2 CUGBP CUGBP1 NAB50,10658;,"ENST00000310513.10; ENSP00000308386.5; ENSG00000149187.19. [Q92879-2];""ENST00000358597.7; ENSP00000351409.3; ENSG00000149187.19. [Q92879-1]"";""ENST00000361904.7; ENSP00000354639.3; ENSG00000149187.19. [Q92879-3]"";""ENST00000395290.6; ENSP00000378705.2; ENSG00000149187.19. [Q92879-6]"";""ENST00000395292.6; ENSP00000378706.2; ENSG00000149187.19. [Q92879-3]"";""ENST00000532048.5; ENSP00000435926.1; ENSG00000149187.19. [Q92879-4]"";",BRE binding [GO:0042835]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723],"embryo development ending in birth or egg hatching [GO:0009792]; germ cell development [GO:0007281]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splice site recognition [GO:0006376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; post-transcriptional gene silencing [GO:0016441]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of inflammatory response [GO:0050727]; regulation of RNA splicing [GO:0043484]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinucleolar compartment [GO:0097356]; ribonucleoprotein complex [GO:1990904]
Q9NYQ7,S3,-0.508844652,-0.912945874,0.176049966,0.629103778,0.446754443,salmon,CELSR3,CELR3_HUMAN,Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2),CELSR3 CDHF11 EGFL1 FMI1 KIAA0812 MEGF2,1951;,ENST00000164024.5; ENSP00000164024.4; ENSG00000008300.17. [Q9NYQ7-1];,calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],"cell-cell adhesion [GO:0098609]; dopaminergic neuron axon guidance [GO:0036514]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",membrane [GO:0016020]; plasma membrane [GO:0005886]
P07199,N3,-1.131909368,-0.893425056,1.383234375,0.048840048,-0.645275705,grey50,CENPB,CENPB_HUMAN,Major centromere autoantigen B (Centromere protein B) (CENP-B),CENPB,1059;,ENST00000379751.5; ENSP00000369075.4; ENSG00000125817.8.;,centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; satellite DNA binding [GO:0003696]; sequence-specific DNA binding [GO:0043565],0,"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"
Q03188,N3,-1.144229163,-1.25079334,1.452526053,0.044405281,-0.732381798,grey50,CENPC,CENPC_HUMAN,Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1) (Interphase centromere complex protein 7),CENPC CENPC1 ICEN7,1060;,"ENST00000273853.11; ENSP00000273853.6; ENSG00000145241.11. [Q03188-1];""ENST00000506882.5; ENSP00000426078.1; ENSG00000145241.11. [Q03188-2]"";",centromeric DNA binding [GO:0019237]; DNA binding [GO:0003677]; identical protein binding [GO:0042802],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]; spindle attachment to meiosis I kinetochore [GO:0051455],"condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; inner kinetochore [GO:0000939]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]"
Q92674,N3,-0.827365644,-1.056143406,1.447247615,0.123933711,-0.690069027,grey50,CENPI,CENPI_HUMAN,Centromere protein I (CENP-I) (FSH primary response protein 1) (Follicle-stimulating hormone primary response protein) (Interphase centromere complex protein 19) (Leucine-rich primary response protein 1),CENPI FSHPRH1 ICEN19 LRPR1,2491;,"ENST00000372926.5; ENSP00000362017.1; ENSG00000102384.14. [Q92674-2];""ENST00000372927.5; ENSP00000362018.1; ENSG00000102384.14. [Q92674-1]"";""ENST00000682095.1; ENSP00000507927.1; ENSG00000102384.14. [Q92674-1]"";""ENST00000684367.1; ENSP00000507595.1; ENSG00000102384.14. [Q92674-1]"";",0,CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059]; mitotic sister chromatid segregation [GO:0000070]; sex differentiation [GO:0007548],cytosol [GO:0005829]; inner kinetochore [GO:0000939]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96H22,N3,-1.102890612,-1.253308048,1.372350073,0.025056934,-0.662394634,grey50,CENPN,CENPN_HUMAN,Centromere protein N (CENP-N) (Interphase centromere complex protein 32),CENPN C16orf60 ICEN32 BM-309,55839;,"ENST00000299572.9; ENSP00000299572.5; ENSG00000166451.14. [Q96H22-2];""ENST00000305850.10; ENSP00000305608.5; ENSG00000166451.14. [Q96H22-1]"";""ENST00000393335.7; ENSP00000377007.3; ENSG00000166451.14. [Q96H22-3]"";""ENST00000428963.6; ENSP00000393991.2; ENSG00000166451.14. [Q96H22-5]"";""ENST00000439957.7; ENSP00000395235.3; ENSG00000166451.14. [Q96H22-4]"";""ENST00000709369.1; ENSP00000517649.1; ENSG00000291964.1. [Q96H22-1]"";""ENST00000709370.1; ENSP00000517650.1; ENSG00000291964.1. [Q96H22-2]"";""ENST00000709371.1; ENSP00000517651.1; ENSG00000291964.1. [Q96H22-4]"";""ENST00000709372.1; ENSP00000517652.1; ENSG00000291964.1. [Q96H22-3]"";""ENST00000709374.1; ENSP00000517653.1; ENSG00000291964.1. [Q96H22-5]"";",0,CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059],cytosol [GO:0005829]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BU64,N2,-0.697205522,-1.314899427,1.093491412,-0.008092971,0.001620836,grey70,CENPO,CENPO_HUMAN,Centromere protein O (CENP-O) (Interphase centromere complex protein 36),CENPO ICEN36 MCM21R,79172;,"ENST00000260662.2; ENSP00000260662.1; ENSG00000138092.11. [Q9BU64-1];""ENST00000380834.7; ENSP00000370214.2; ENSG00000138092.11. [Q9BU64-1]"";""ENST00000473706.5; ENSP00000417787.1; ENSG00000138092.11. [Q9BU64-2]"";",0,centromere complex assembly [GO:0034508]; chromosome segregation [GO:0007059],cytosol [GO:0005829]; inner kinetochore [GO:0000939]; Mis6-Sim4 complex [GO:0031511]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6IPU0,N3,-1.04925825,-1.409747147,1.307849753,0.078005178,-0.117304959,grey50,CENPP,CENPP_HUMAN,Centromere protein P (CENP-P),CENPP,401541;,"ENST00000375579.7; ENSP00000364729.3; ENSG00000188312.15. [Q6IPU0-2];""ENST00000375587.8; ENSP00000364737.3; ENSG00000188312.15. [Q6IPU0-1]"";""ENST00000707232.1; ENSP00000516797.1; ENSG00000291348.1. [Q6IPU0-1]"";""ENST00000707234.1; ENSP00000516799.1; ENSG00000291348.1. [Q6IPU0-2]"";",0,CENP-A containing chromatin assembly [GO:0034080]; chromosome segregation [GO:0007059],cytosol [GO:0005829]; inner kinetochore [GO:0000939]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q7L2Z9,N1,-1.396094476,-1.116019722,1.003960927,0.158627072,0.486603844,grey90,CENPQ,CENPQ_HUMAN,Centromere protein Q (CENP-Q),CENPQ C6orf139,55166;,ENST00000335783.4; ENSP00000337289.2; ENSG00000031691.7.;,0,chromosome segregation [GO:0007059]; metaphase chromosome alignment [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96BT3,N3,-0.552178106,-0.780205311,1.182461758,-0.063975585,-0.446331158,grey50,CENPT,CENPT_HUMAN,Centromere protein T (CENP-T) (Interphase centromere complex protein 22),CENPT C16orf56 ICEN22,80152;,"ENST00000440851.6; ENSP00000400140.2; ENSG00000102901.13. [Q96BT3-1];""ENST00000562787.6; ENSP00000457810.1; ENSG00000102901.13. [Q96BT3-1]"";",DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],cell division [GO:0051301]; chromosome organization [GO:0051276]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278],"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; inner kinetochore [GO:0000939]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q71F23,N1,-1.140537931,-1.126251228,0.89115189,0.142234189,0.707737236,grey90,CENPU,CENPU_HUMAN,Centromere protein U (CENP-U) (Centromere protein of 50 kDa) (CENP-50) (Interphase centromere complex protein 24) (KSHV latent nuclear antigen-interacting protein 1) (MLF1-interacting protein) (Polo-box-interacting protein 1),CENPU ICEN24 KLIP1 MLF1IP PBIP1,79682;,ENST00000281453.10; ENSP00000281453.5; ENSG00000151725.12. [Q71F23-1];,0,chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059],centriolar satellite [GO:0034451]; cytosol [GO:0005829]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8N8E3,C2,1.277025914,0.187331956,-0.182746273,-0.088429159,-0.527032897,aquamarine,CEP112,CE112_HUMAN,Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46),CEP112 CCDC46,201134;,"ENST00000317442.12; ENSP00000320592.5; ENSG00000154240.18. [Q8N8E3-2];""ENST00000392769.6; ENSP00000376522.2; ENSG00000154240.18. [Q8N8E3-1]"";""ENST00000535342.7; ENSP00000442784.2; ENSG00000154240.18. [Q8N8E3-1]"";",0,receptor localization to synapse [GO:0097120],centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]
Q6ZU80,M2,-0.51540016,-0.736957527,0.250754839,0.966483826,-0.17597182,tan4,CEP128,CE128_HUMAN,Centrosomal protein of 128 kDa (Cep128),CEP128 C14orf145 C14orf61,145508;,"ENST00000216517.10; ENSP00000216517.6; ENSG00000100629.17. [Q6ZU80-3];""ENST00000281129.7; ENSP00000281129.3; ENSG00000100629.17. [Q6ZU80-2]"";""ENST00000555265.6; ENSP00000451162.1; ENSG00000100629.17. [Q6ZU80-2]"";",0,protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; spindle pole [GO:0000922]
Q8TEP8,C2,0.720638845,0.069754025,-0.07642478,0.43977132,-0.351270012,aquamarine,CEP192,CE192_HUMAN,Centrosomal protein of 192 kDa (Cep192) (Cep192/SPD-2),CEP192 KIAA1569 PP8407,55125;,ENST00000506447.5; ENSP00000427550.1; ENSG00000101639.19. [Q8TEP8-3];,phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901],centriole replication [GO:0007099]; centrosome-templated microtubule nucleation [GO:0090222]; mitotic spindle assembly [GO:0090307]; protein localization to centrosome [GO:0071539]; response to bacterium [GO:0009617],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; procentriole [GO:0120098]; procentriole replication complex [GO:0120099]
Q9C0F1,C1,1.611491459,-0.177031985,-0.255547668,0.089944789,-0.332849892,lightblue,CEP44,CEP44_HUMAN,Centrosomal protein of 44 kDa (Cep44) (HBV PreS1-transactivated protein 3) (PS1TP3),CEP44 KIAA1712,80817;,"ENST00000296519.6; ENSP00000296519.4; ENSG00000164118.13. [Q9C0F1-1];""ENST00000396791.7; ENSP00000380009.3; ENSG00000164118.13. [Q9C0F1-1]"";""ENST00000426172.3; ENSP00000408221.1; ENSG00000164118.13. [Q9C0F1-2]"";""ENST00000457424.6; ENSP00000389427.2; ENSG00000164118.13. [Q9C0F1-2]"";""ENST00000503780.6; ENSP00000423153.1; ENSG00000164118.13. [Q9C0F1-1]"";",microtubule binding [GO:0008017],centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922]
Q5JTW2,C1,0.77859774,-0.70153183,-0.192928594,0.18652959,0.647575391,lightblue,CEP78,CEP78_HUMAN,Centrosomal protein of 78 kDa (Cep78),CEP78 C9orf81,84131;,"ENST00000376597.9; ENSP00000365782.4; ENSG00000148019.14. [Q5JTW2-2];""ENST00000415759.6; ENSP00000399286.2; ENSG00000148019.14. [Q5JTW2-5]"";""ENST00000424347.6; ENSP00000411284.2; ENSG00000148019.14. [Q5JTW2-1]"";""ENST00000642669.1; ENSP00000495681.1; ENSG00000148019.14. [Q5JTW2-5]"";""ENST00000643273.2; ENSP00000496423.2; ENSG00000148019.14. [Q5JTW2-3]"";",0,cilium organization [GO:0044782],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]
Q6P2H3,C3,1.666634457,0.30082137,-0.530928143,-0.499554783,-0.728431501,cyan,CEP85,CEP85_HUMAN,Centrosomal protein of 85 kDa (Cep85) (Coiled-coil domain-containing protein 21),CEP85 CCDC21,64793;,"ENST00000252992.8; ENSP00000252992.4; ENSG00000130695.16. [Q6P2H3-1];""ENST00000451429.8; ENSP00000417002.3; ENSG00000130695.16. [Q6P2H3-2]"";""ENST00000640292.2; ENSP00000492362.2; ENSG00000130695.16. [Q6P2H3-4]"";",identical protein binding [GO:0042802],cell migration [GO:0016477]; centriole assembly [GO:0098534]; centriole replication [GO:0007099]; chromosome segregation [GO:0007059]; negative regulation of protein kinase activity [GO:0006469]; regulation of mitotic centrosome separation [GO:0046602],cell cortex [GO:0005938]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]
Q96ST8,S4,-0.361916026,-0.628887146,0.403689135,0.695327736,0.085230726,tomato2,CEP89,CEP89_HUMAN,Centrosomal protein of 89 kDa (Cep89) (Centrosomal protein 123) (Cep123) (Coiled-coil domain-containing protein 123),CEP89 CCDC123,84902;,ENST00000305768.10; ENSP00000306105.4; ENSG00000121289.18. [Q96ST8-1];,0,chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; spindle pole [GO:0000922]; synapse [GO:0045202]
Q8TCT0,S2,-1.178164473,-1.25459672,0.213703549,0.720376101,0.783498101,orange,CERK,CERK1_HUMAN,Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4),CERK KIAA1646,64781;,ENST00000216264.13; ENSP00000216264.8; ENSG00000100422.14. [Q8TCT0-1];,ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; dihydroceramide kinase activity [GO:0102773]; magnesium ion binding [GO:0000287],ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q96G23,S3,-0.663414579,-1.011256706,0.267636434,0.714866608,0.461545238,salmon,CERS2,CERS2_HUMAN,Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Sphingosine N-acyltransferase CERS2) (EC 2.3.1.24) (Tumor metastasis-suppressor gene 1 protein) (Very-long-chain ceramide synthase CERS2) (EC 2.3.1.297),CERS2 LASS2 TMSG1,29956;,"ENST00000271688.10; ENSP00000271688.6; ENSG00000143418.20.;""ENST00000368954.10; ENSP00000357950.5; ENSG00000143418.20."";",DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291],ceramide biosynthetic process [GO:0046513]; negative regulation of axon regeneration [GO:0048681]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation involved in axon regeneration [GO:1905045]; regulation of lipid metabolic process [GO:0019216]; response to immobilization stress [GO:0035902]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
P23528,C4,2.051641895,0.504795688,-0.992691016,-1.091863518,-1.43652631,deepskyblue2,CFL1,COF1_HUMAN,"Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)",CFL1 CFL,1072;,"ENST00000308162.10; ENSP00000309629.5; ENSG00000172757.13.;""ENST00000525451.6; ENSP00000432660.1; ENSG00000172757.13."";",actin filament binding [GO:0051015],actin cytoskeleton organization [GO:0030036]; actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; cytoskeleton organization [GO:0007010]; establishment of spindle localization [GO:0051293]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; positive regulation by host of viral process [GO:0044794]; positive regulation of embryonic development [GO:0040019]; regulation of cell morphogenesis [GO:0022604]; regulation of dendritic spine morphogenesis [GO:0061001]; response to virus [GO:0009615]; Rho protein signal transduction [GO:0007266],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]; vesicle [GO:0031982]
Q99675,S2,-0.925203361,-1.365841213,0.287497664,0.848989372,0.663617278,orange,CGRRF1,CGRF1_HUMAN,Cell growth regulator with RING finger domain protein 1 (Cell growth regulatory gene 19 protein) (RING finger protein 197),CGRRF1 CGR19 RNF197,10668;,ENST00000216420.12; ENSP00000216420.7; ENSG00000100532.13.;,metal ion binding [GO:0046872],negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell cycle [GO:0051726],endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]
Q13111,N2,-1.314864759,-0.741377725,1.245318176,0.242511295,-0.385703584,grey70,CHAF1A,CAF1A_HUMAN,Chromatin assembly factor 1 subunit A (CAF-1 subunit A) (Chromatin assembly factor I p150 subunit) (CAF-I 150 kDa subunit) (CAF-I p150) (hp150),CHAF1A CAF CAF1P150,10036;,ENST00000301280.10; ENSP00000301280.4; ENSG00000167670.16. [Q13111-1];,chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; identical protein binding [GO:0042802]; unfolded protein binding [GO:0051082],DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334],CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q9NX63,M2,-1.285458572,-1.315652141,0.435009321,1.232914705,-0.334137251,tan4,CHCHD3,MIC19_HUMAN,MICOS complex subunit MIC19 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 3),CHCHD3 MIC19 MINOS3,54927;,ENST00000262570.10; ENSP00000262570.5; ENSG00000106554.13.;,molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902],cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053],extracellular exosome [GO:0070062]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; SAM complex [GO:0001401]
Q9BRQ6,M2,-0.89130272,-1.166334134,0.361920574,1.127239864,-0.34282452,tan4,CHCHD6,MIC25_HUMAN,MICOS complex subunit MIC25 (Coiled-coil-helix cristae morphology protein 1) (Coiled-coil-helix-coiled-coil-helix domain-containing protein 6),CHCHD6 CHCM1 MIC25,84303;,ENST00000290913.8; ENSP00000290913.3; ENSG00000159685.11.;,0,cristae formation [GO:0042407]; DNA damage response [GO:0006974]; inner mitochondrial membrane organization [GO:0007007],cytosol [GO:0005829]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]
O14646,N3,-1.073870665,-1.137815612,1.085253664,0.496022679,-0.298421029,grey50,CHD1,CHD1_HUMAN,Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1),CHD1,1105;,ENST00000614616.5; ENSP00000483667.1; ENSG00000153922.12. [O14646-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; methylated histone binding [GO:0035064],chromatin remodeling [GO:0006338]; nucleosome organization [GO:0034728]; positive regulation by host of viral transcription [GO:0043923],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O14647,N3,-0.942915237,-1.149066872,1.278626597,0.241965922,-0.454685371,grey50,CHD2,CHD2_HUMAN,Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2),CHD2,1106;,"ENST00000394196.9; ENSP00000377747.4; ENSG00000173575.24. [O14647-1];""ENST00000420239.7; ENSP00000406581.2; ENSG00000173575.24. [O14647-3]"";""ENST00000626874.2; ENSP00000486629.1; ENSG00000173575.24. [O14647-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],DNA damage response [GO:0006974]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; muscle organ development [GO:0007517]; nucleosome organization [GO:0034728],chromatin [GO:0000785]; nucleus [GO:0005634]
Q12873,N1,-1.032061749,-0.675453555,0.345781899,-0.386866985,1.150303498,grey90,CHD3,CHD3_HUMAN,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),CHD3,1107;,"ENST00000330494.12; ENSP00000332628.7; ENSG00000170004.19. [Q12873-1];""ENST00000358181.8; ENSP00000350907.4; ENSG00000170004.19. [Q12873-2]"";""ENST00000380358.9; ENSP00000369716.4; ENSG00000170004.19. [Q12873-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270],centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605]
Q14839,N2,-1.050619772,0.450302846,0.615636358,-0.079890475,-0.149788096,grey70,CHD4,CHD4_HUMAN,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),CHD4,1108;,"ENST00000544040.7; ENSP00000440542.2; ENSG00000111642.16. [Q14839-1];""ENST00000645095.1; ENSP00000496634.1; ENSG00000111642.16. [Q14839-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],chromatin remodeling [GO:0006338]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; regulation of synapse assembly [GO:0051963]; terminal button organization [GO:0072553],"centrosome [GO:0005813]; cerebellar granule cell to Purkinje cell synapse [GO:0150048]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; site of DNA damage [GO:0090734]"
Q8TD26,N1,-1.041055929,-0.810970042,-0.004494196,-0.080674775,1.352588535,grey90,CHD6,CHD6_HUMAN,Chromodomain-helicase-DNA-binding protein 6 (CHD-6) (EC 3.6.4.12) (ATP-dependent helicase CHD6) (Radiation-induced gene B protein),CHD6 CHD5 KIAA1335 RIGB,84181;,"ENST00000373222.3; ENSP00000362319.3; ENSG00000124177.16. [Q8TD26-2];""ENST00000373233.8; ENSP00000362330.3; ENSG00000124177.16. [Q8TD26-1]"";","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; transcription coregulator binding [GO:0001221]",cell redox homeostasis [GO:0045454]; chromatin remodeling [GO:0006338]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q3L8U1,N4,-0.966289396,0.669682935,0.346088441,0.164778043,-0.059576614,grey30,CHD9,CHD9_HUMAN,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.12) (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),CHD9 KIAA0308 KISH2 PRIC320 AD-013 x0008,80205;,"ENST00000398510.7; ENSP00000381522.3; ENSG00000177200.18. [Q3L8U1-1];""ENST00000447540.6; ENSP00000396345.2; ENSG00000177200.18. [Q3L8U1-1]"";""ENST00000564845.5; ENSP00000455307.1; ENSG00000177200.18. [Q3L8U1-2]"";""ENST00000566029.5; ENSP00000457466.1; ENSG00000177200.18. [Q3L8U1-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386],0,cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q8NE62,M2,-0.626510258,-0.698180952,0.343751881,0.963654979,-0.247373587,tan4,CHDH,CHDH_HUMAN,"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)",CHDH,55349;,ENST00000315251.11; ENSP00000319851.5; ENSG00000016391.11.;,choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660],choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285],mitochondrial inner membrane [GO:0005743]
Q8IWX8,N2,-1.14022623,-0.020562085,0.805448837,-0.025727691,0.239879255,grey70,CHERP,CHERP_HUMAN,Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6),CHERP DAN26 SCAF6,10523;,ENST00000546361.7; ENSP00000439856.2; ENSG00000085872.15.;,RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325],intracellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]
Q9UKJ5,S4,-0.809339816,-1.366988007,0.457433011,0.872811676,0.353024453,tomato2,CHIC2,CHIC2_HUMAN,Cysteine-rich hydrophobic domain-containing protein 2 (BrX-like translocated in leukemia),CHIC2 BTL,26511;,ENST00000263921.8; ENSP00000263921.3; ENSG00000109220.11.;,0,0,Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]
P35790,C3,1.745811608,0.293471312,-0.473458365,-0.459860176,-0.752607458,cyan,CHKA,CHKA_HUMAN,Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82),CHKA CHK CKI,1119;,"ENST00000265689.9; ENSP00000265689.4; ENSG00000110721.12. [P35790-1];""ENST00000356135.9; ENSP00000348454.4; ENSG00000110721.12. [P35790-2]"";",ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713],CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]
P24386,C3,1.833029292,0.301690238,-0.628058334,-0.502483059,-0.931883496,cyan,CHM,RAE1_HUMAN,Rab proteins geranylgeranyltransferase component A 1 (Choroideremia protein) (Rab escort protein 1) (REP-1) (TCD protein),CHM REP1 TCD,1121;,"ENST00000357749.7; ENSP00000350386.2; ENSG00000188419.14. [P24386-1];""ENST00000615443.1; ENSP00000484306.1; ENSG00000188419.14. [P24386-2]"";",GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267],intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]
P26374,C4,1.948886263,0.227472614,-0.820579839,-0.767591122,-0.986725479,deepskyblue2,CHML,RAE2_HUMAN,Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2) (REP-2),CHML REP2,1122;,ENST00000366553.3; ENSP00000355511.1; ENSG00000203668.3.;,GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],intracellular protein transport [GO:0006886]; protein geranylgeranylation [GO:0018344]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rab-protein geranylgeranyltransferase complex [GO:0005968]
O43633,C1,1.547905449,0.138128912,-0.476630049,-0.320495729,-0.39096151,lightblue,CHMP2A,CHM2A_HUMAN,Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1),CHMP2A BC2 CHMP2,27243;,"ENST00000312547.7; ENSP00000310440.1; ENSG00000130724.10.;""ENST00000596708.2; ENSP00000471961.2; ENSG00000130724.10."";""ENST00000597848.2; ENSP00000469453.2; ENSG00000130724.10."";""ENST00000600118.6; ENSP00000469240.1; ENSG00000130724.10."";""ENST00000601220.5; ENSP00000472680.1; ENSG00000130724.10."";",phosphatidylcholine binding [GO:0031210]; protein domain specific binding [GO:0019904],autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; membrane invagination [GO:0010324]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of centriole elongation [GO:1903723]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; chromatin [GO:0000785]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]
Q9H444,C4,1.91067723,0.327859377,-1.122088505,-0.77423966,-1.229850042,deepskyblue2,CHMP4B,CHM4B_HUMAN,Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2) (hSnf7-2) (Vacuolar protein sorting-associated protein 32-2) (Vps32-2) (hVps32-2),CHMP4B C20orf178 SHAX1,128866;,ENST00000217402.3; ENSP00000217402.2; ENSG00000101421.4.;,cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; exit from mitosis [GO:0010458]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; maintenance of lens transparency [GO:0036438]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nervous system process [GO:0050877]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein polymerization [GO:0051258]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding [GO:0046755]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane coat [GO:0030117]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]
Q9NZZ3,C5,1.785858488,0.533554747,-0.860398785,-0.808985955,-0.764519731,turquoise3,CHMP5,CHMP5_HUMAN,Charged multivesicular body protein 5 (Chromatin-modifying protein 5) (SNF7 domain-containing protein 2) (Vacuolar protein sorting-associated protein 60) (Vps60) (hVps60),CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2,51510;,"ENST00000223500.9; ENSP00000223500.7; ENSG00000086065.14. [Q9NZZ3-1];""ENST00000419016.6; ENSP00000442725.1; ENSG00000086065.14. [Q9NZZ3-2]"";",cadherin binding [GO:0045296],autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; erythrocyte differentiation [GO:0030218]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding [GO:0046755]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]
Q96FZ7,S3,-0.591740992,-0.970759385,0.070586345,0.732031532,0.642131296,salmon,CHMP6,CHMP6_HUMAN,Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20) (Vps20) (hVps20),CHMP6 VPS20,79643;,ENST00000325167.9; ENSP00000317468.5; ENSG00000176108.9.;,protein-containing complex binding [GO:0044877],autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; ESCRT III complex assembly [GO:1904902]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle budding from membrane [GO:0006900]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886]
Q9UHD1,C4,2.039191155,0.242622055,-0.830389332,-0.893656526,-1.18828068,deepskyblue2,CHORDC1,CHRD1_HUMAN,Cysteine and histidine-rich domain-containing protein 1 (CHORD domain-containing protein 1) (CHORD-containing protein 1) (CHP-1) (Protein morgana),CHORDC1 CHP1,26973;,"ENST00000320585.11; ENSP00000319255.6; ENSG00000110172.12. [Q9UHD1-1];""ENST00000457199.6; ENSP00000401080.2; ENSG00000110172.12. [Q9UHD1-2]"";""ENST00000646618.2; ENSP00000496744.1; ENSG00000285023.2. [Q9UHD1-1]"";""ENST00000647220.1; ENSP00000494044.1; ENSG00000285023.2. [Q9UHD1-2]"";",ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; zinc ion binding [GO:0008270],centrosome duplication [GO:0051298]; chaperone-mediated protein folding [GO:0061077]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824],0
Q8IZ52,S1,-1.08767005,-1.207988992,0.069717762,0.759444629,0.738360943,gold,CHPF,CHSS2_HUMAN,Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2),CHPF CSS2 UNQ651/PRO1281,79586;,"ENST00000243776.11; ENSP00000243776.6; ENSG00000123989.15. [Q8IZ52-1];""ENST00000535926.3; ENSP00000445571.1; ENSG00000123989.15. [Q8IZ52-4]"";",glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],chondroitin sulfate biosynthetic process [GO:0030206],cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; mitochondrial matrix [GO:0005759]
Q9P2E5,S3,-0.985381117,-1.085922253,0.03083731,0.769469373,0.740947863,salmon,CHPF2,CHPF2_HUMAN,Chondroitin sulfate glucuronyltransferase (EC 2.4.1.226) (CSGlcA-T) (Chondroitin glucuronyltransferase) (Chondroitin polymerizing factor 2) (ChPF-2) (Chondroitin synthase 3) (ChSy-3) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase),CHPF2 CHSY3 CSGLCAT KIAA1402 UNQ299/PRO339,54480;,ENST00000035307.7; ENSP00000035307.2; ENSG00000033100.17. [Q9P2E5-1];,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],chondroitin sulfate biosynthetic process [GO:0030206],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q8WUD6,S2,-0.701156291,-1.189637192,0.162971635,0.902101414,0.748567265,orange,CHPT1,CHPT1_HUMAN,Cholinephosphotransferase 1 (hCPT1) (EC 2.7.8.2) (AAPT1-like protein) (Diacylglycerol cholinephosphotransferase 1),CHPT1 CPT1 MSTP022,56994;,"ENST00000229266.8; ENSP00000229266.3; ENSG00000111666.11. [Q8WUD6-1];""ENST00000552351.5; ENSP00000447887.1; ENSG00000111666.11. [Q8WUD6-2]"";",diacylglycerol binding [GO:0019992]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; metal ion binding [GO:0046872],CDP-choline pathway [GO:0006657]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; platelet activating factor biosynthetic process [GO:0006663]; regulation of cell growth [GO:0001558],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
P30532,S3,-1.48026186,-0.492278754,0.372834837,0.695954191,0.565968775,salmon,CHRNA5,ACHA5_HUMAN,Neuronal acetylcholine receptor subunit alpha-5,CHRNA5 NACHRA5,1138;,ENST00000299565.9; ENSP00000299565.5; ENSG00000169684.13.;,acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; chemical synaptic transmission [GO:0007268]; membrane depolarization [GO:0051899]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; dopaminergic synapse [GO:0098691]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]
Q9NPF2,S1,-0.685654936,-0.781018047,-0.098311192,0.62073924,0.943446452,gold,CHST11,CHSTB_HUMAN,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),CHST11,50515;,"ENST00000303694.6; ENSP00000305725.5; ENSG00000171310.11. [Q9NPF2-1];""ENST00000549260.5; ENSP00000450004.1; ENSG00000171310.11. [Q9NPF2-2]"";",chondroitin 4-sulfotransferase activity [GO:0047756]; N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146],apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179],Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9NRB3,S1,-0.946934959,-1.368675571,0.036192284,0.717909789,0.901564656,gold,CHST12,CHSTC_HUMAN,Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2) (Sulfotransferase Hlo),CHST12 UNQ500/PRO1017,55501;,"ENST00000258711.7; ENSP00000258711.6; ENSG00000136213.10.;""ENST00000618655.2; ENSP00000481912.1; ENSG00000136213.10."";",3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; chondroitin 4-sulfotransferase activity [GO:0047756]; sulfotransferase activity [GO:0008146],carbohydrate biosynthetic process [GO:0016051]; chondroitin sulfate biosynthetic process [GO:0030206]; dermatan sulfate biosynthetic process [GO:0030208]; proteoglycan biosynthetic process [GO:0030166],Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q8NCH0,S1,-0.973830635,-1.297836126,-0.164591911,0.863474021,0.973884426,gold,CHST14,CHSTE_HUMAN,Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1),CHST14 D4ST1 UNQ1925/PRO4400,113189;,ENST00000306243.7; ENSP00000307297.6; ENSG00000169105.8.;,N-acetylgalactosamine 4-O-sulfotransferase activity [GO:0001537]; phosphate ion binding [GO:0042301]; sulfotransferase activity [GO:0008146],carbohydrate biosynthetic process [GO:0016051]; dermatan sulfate biosynthetic process [GO:0030208]; dermatan sulfate proteoglycan metabolic process [GO:0050655],extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q7LGC8,S1,-0.751072008,-1.456168367,-0.181555574,0.720147315,1.117866845,gold,CHST3,CHST3_HUMAN,Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (EC 2.8.2.21) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (C6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0),CHST3,9469;,ENST00000373115.5; ENSP00000362207.4; ENSG00000122863.6.;,chondroitin 6-sulfotransferase activity [GO:0008459]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517]; proteoglycan sulfotransferase activity [GO:0050698],carbohydrate metabolic process [GO:0005975]; chondroitin sulfate biosynthetic process [GO:0030206]; N-acetylglucosamine metabolic process [GO:0006044]; sulfur compound metabolic process [GO:0006790]; T cell homeostasis [GO:0043029],Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]
Q86X52,S1,-0.849260757,-1.219570776,-0.152218557,0.846571567,0.870035806,gold,CHSY1,CHSS1_HUMAN,Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1),CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487,22856;,ENST00000254190.4; ENSP00000254190.3; ENSG00000131873.7.;,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate biosynthetic process [GO:0030206]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9Y3Y2,N3,-1.070504266,-1.254546062,0.94635391,-0.04330259,0.674744385,grey50,CHTOP,CHTOP_HUMAN,Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein) (SRAG),CHTOP C1orf77 FOP HT031 PP7704,26097;,"ENST00000368690.7; ENSP00000357679.4; ENSG00000160679.14. [Q9Y3Y2-3];""ENST00000368694.8; ENSP00000357683.3; ENSG00000160679.14. [Q9Y3Y2-1]"";""ENST00000403433.5; ENSP00000385228.1; ENSG00000160679.14. [Q9Y3Y2-4]"";",methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],chromatin remodeling [GO:0006338]; mRNA export from nucleus [GO:0006406]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of helicase activity [GO:0051096],nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex [GO:0000346]
O76071,C3,1.641258353,0.114525034,-0.624844803,-0.500380673,-0.653190053,cyan,CIAO1,CIAO1_HUMAN,Probable cytosolic iron-sulfur protein assembly protein CIAO1 (WD repeat-containing protein 39),CIAO1 CIA1 WDR39,9391;,ENST00000488633.2; ENSP00000418287.1; ENSG00000144021.3.;,0,chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of cell population proliferation [GO:0008284]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of transcription by RNA polymerase II [GO:0006357],CIA complex [GO:0097361]; cytoplasm [GO:0005737]; MMXD complex [GO:0071817]
Q6FI81,C5,1.785756924,0.381786883,-0.681798368,-0.641962959,-0.838455283,turquoise3,CIAPIN1,CPIN1_HUMAN,Anamorsin (Cytokine-induced apoptosis inhibitor 1) (Fe-S cluster assembly protein DRE2 homolog),CIAPIN1 CUA001 PRO0915,57019;,"ENST00000394391.9; ENSP00000377914.4; ENSG00000005194.15. [Q6FI81-1];""ENST00000567518.5; ENSP00000456114.1; ENSG00000005194.15. [Q6FI81-3]"";","2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]",apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066],cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q99828,S2,-0.74543933,-1.387214468,0.334204788,0.702784009,0.669957767,orange,CIB1,CIB1_HUMAN,Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28),CIB1 CIB KIP PRKDCIP,10519;,"ENST00000328649.11; ENSP00000333873.6; ENSG00000185043.13. [Q99828-1];""ENST00000612800.1; ENSP00000479860.1; ENSG00000185043.13. [Q99828-2]"";",calcium ion binding [GO:0005509]; calcium-dependent protein kinase inhibitor activity [GO:0008427]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase inhibitor activity [GO:0030291]; protein-membrane adaptor activity [GO:0043495]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325],angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell division [GO:0051301]; cellular response to growth factor stimulus [GO:0071363]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic microtubule organization [GO:0031122]; DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; endomitotic cell cycle [GO:0007113]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of neuron projection development [GO:0010977]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; platelet formation [GO:0030220]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell division [GO:0051302]; regulation of cell population proliferation [GO:0042127]; response to ischemia [GO:0002931]; spermatid development [GO:0007286]; thrombopoietin-mediated signaling pathway [GO:0038163],apical plasma membrane [GO:0016324]; axon [GO:0030424]; cell periphery [GO:0071944]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; vesicle [GO:0031982]
Q96RK0,N4,-0.573293688,1.041461756,0.020998616,-0.349097452,-0.353201922,grey30,CIC,CIC_HUMAN,Protein capicua homolog,CIC KIAA0306,23152;,"ENST00000575354.6; ENSP00000458663.2; ENSG00000079432.9. [Q96RK0-2];""ENST00000681038.1; ENSP00000505728.1; ENSG00000079432.9. [Q96RK0-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]; social behavior [GO:0035176],chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q969X6,N3,-0.888451178,-0.859495315,1.302524275,-0.067281628,-0.311393243,grey50,CIRH1A,UTP4_HUMAN,U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component),UTP4 CIRH1A cPERP-E KIAA1988,84916;,"ENST00000314423.12; ENSP00000327179.7; ENSG00000141076.18. [Q969X6-1];""ENST00000352319.8; ENSP00000339164.4; ENSG00000141076.18. [Q969X6-2]"";""ENST00000563094.5; ENSP00000456622.1; ENSG00000141076.18. [Q969X6-3]"";""ENST00000575702.3; ENSP00000458843.2; ENSG00000262788.3."";",RNA binding [GO:0003723],"maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of DNA-templated transcription [GO:0006355]; ribosomal small subunit biogenesis [GO:0042274]",90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]
Q9NZ45,M2,-0.509566146,-0.84248794,0.363528181,0.998177336,-0.251323947,tan4,CISD1,CISD1_HUMAN,CDGSH iron-sulfur domain-containing protein 1 (Cysteine transaminase CISD1) (EC 2.6.1.3) (MitoNEET),CISD1 C10orf70 ZCD1 MDS029,55847;,ENST00000333926.6; ENSP00000363041.4; ENSG00000122873.12.;,"2 iron, 2 sulfur cluster binding [GO:0051537]; identical protein binding [GO:0042802]; L-cysteine transaminase activity [GO:0047801]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]",protein maturation by [2Fe-2S] cluster transfer [GO:0106034]; regulation of autophagy [GO:0010506]; regulation of cellular respiration [GO:0043457],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q8N5K1,S3,-0.783571032,-0.988914241,0.242052908,0.817486941,0.467185443,salmon,CISD2,CISD2_HUMAN,CDGSH iron-sulfur domain-containing protein 2 (Endoplasmic reticulum intermembrane small protein) (MitoNEET-related 1 protein) (Miner1) (Nutrient-deprivation autophagy factor-1) (NAF-1),CISD2 CDGSH2 ERIS ZCD2,493856;,ENST00000273986.10; ENSP00000273986.4; ENSG00000145354.12.;,"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]",autophagy [GO:0006914]; regulation of autophagy [GO:0010506],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear endoplasmic reticulum [GO:0097038]; protein-containing complex [GO:0032991]
Q8IYA6,N1,-0.965236831,-0.913812139,0.2060294,0.203886489,1.112779756,grey90,CKAP2L,CKP2L_HUMAN,Cytoskeleton-associated protein 2-like (Radial fiber and mitotic spindle protein) (Radmis),CKAP2L,150468;,ENST00000302450.11; ENSP00000305204.6; ENSG00000169607.13. [Q8IYA6-1];,0,0,centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]
Q07065,S2,-1.253647326,-1.568990842,0.037849976,1.067193985,0.463737596,orange,CKAP4,CKAP4_HUMAN,Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63),CKAP4,10970;,ENST00000378026.5; ENSP00000367265.4; ENSG00000136026.14.;,RNA binding [GO:0003723],0,azurophil granule membrane [GO:0035577]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; specific granule membrane [GO:0035579]
P12277,C4,2.050986307,0.365513573,-0.91744651,-1.229036591,-1.272326055,deepskyblue2,CKB,KCRB_HUMAN,Creatine kinase B-type (EC 2.7.3.2) (Brain creatine kinase) (B-CK) (Creatine kinase B chain) (Creatine phosphokinase B-type) (CPK-B),CKB CKBB,1152;,ENST00000348956.7; ENSP00000299198.2; ENSG00000166165.14.;,ATP binding [GO:0005524]; creatine kinase activity [GO:0004111]; ubiquitin protein ligase binding [GO:0031625],futile creatine cycle [GO:0140651]; phosphocreatine biosynthetic process [GO:0046314]; substantia nigra development [GO:0021762],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
P33552,C5,1.312746643,0.56531677,-0.356094415,-0.54839855,-0.6929972,turquoise3,CKS2,CKS2_HUMAN,Cyclin-dependent kinases regulatory subunit 2 (CKS-2),CKS2,1164;,ENST00000314355.7; ENSP00000364976.3; ENSG00000123975.5.;,chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130],cell division [GO:0051301]; fibroblast proliferation [GO:0048144]; meiosis I [GO:0007127]; mitotic cell cycle phase transition [GO:0044772]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357],cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005]
Q96S66,S2,-1.153051745,-1.607141795,0.164909853,0.824008993,0.576956272,orange,CLCC1,CLCC1_HUMAN,Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1),CLCC1 KIAA0761 MCLC,23155;,"ENST00000302500.5; ENSP00000306552.4; ENSG00000121940.17. [Q96S66-3];""ENST00000348264.6; ENSP00000337243.2; ENSG00000121940.17. [Q96S66-4]"";""ENST00000356970.6; ENSP00000349456.2; ENSG00000121940.17. [Q96S66-1]"";""ENST00000369969.7; ENSP00000358986.3; ENSG00000121940.17. [Q96S66-1]"";""ENST00000369970.8; ENSP00000358987.3; ENSG00000121940.17. [Q96S66-2]"";""ENST00000674849.1; ENSP00000502251.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000675508.1; ENSP00000502836.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000675654.1; ENSP00000502648.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000675956.1; ENSP00000502457.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000685014.1; ENSP00000510582.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000685104.1; ENSP00000508473.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000685497.1; ENSP00000509420.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000685540.1; ENSP00000510352.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000685628.1; ENSP00000509075.1; ENSG00000121940.17. [Q96S66-2]"";""ENST00000686078.1; ENSP00000510291.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000686434.1; ENSP00000508570.1; ENSG00000121940.17. [Q96S66-2]"";""ENST00000686776.1; ENSP00000509013.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000686821.1; ENSP00000508563.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000687226.1; ENSP00000509162.1; ENSG00000121940.17. [Q96S66-2]"";""ENST00000687328.1; ENSP00000508816.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000687449.1; ENSP00000508982.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000687591.1; ENSP00000509036.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000687734.1; ENSP00000510543.1; ENSG00000121940.17. [Q96S66-2]"";""ENST00000687865.1; ENSP00000509218.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000688285.1; ENSP00000509990.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000688610.1; ENSP00000510524.1; ENSG00000121940.17. [Q96S66-3]"";""ENST00000688778.1; ENSP00000510715.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000689189.1; ENSP00000510675.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000689351.1; ENSP00000508607.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000689359.1; ENSP00000508884.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000689991.1; ENSP00000508952.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000690509.1; ENSP00000510142.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000690756.1; ENSP00000509544.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000690781.1; ENSP00000510137.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000690874.1; ENSP00000510602.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000691513.1; ENSP00000509584.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000691556.1; ENSP00000509451.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000691731.1; ENSP00000509533.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000692404.1; ENSP00000510666.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000692511.1; ENSP00000510067.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000692795.1; ENSP00000509960.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000693089.1; ENSP00000509330.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000693336.1; ENSP00000509936.1; ENSG00000121940.17. [Q96S66-1]"";""ENST00000693673.1; ENSP00000509782.1; ENSG00000121940.17. [Q96S66-1]"";",chloride channel activity [GO:0005254],0,chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nuclear membrane [GO:0031965]
P51788,S1,-0.971029752,-1.514533742,0.032411024,0.831260641,0.914409505,gold,CLCN2,CLCN2_HUMAN,Chloride channel protein 2 (ClC-2),CLCN2,1181;,"ENST00000265593.9; ENSP00000265593.4; ENSG00000114859.16. [P51788-1];""ENST00000344937.11; ENSP00000345056.7; ENSG00000114859.16. [P51788-3]"";""ENST00000434054.6; ENSP00000400425.2; ENSG00000114859.16. [P51788-4]"";""ENST00000457512.1; ENSP00000391928.1; ENSG00000114859.16. [P51788-5]"";",voltage-gated chloride channel activity [GO:0005247],"acinar cell differentiation [GO:0090425]; cell differentiation involved in salivary gland development [GO:0060689]; chloride transport [GO:0006821]; lung development [GO:0030324]; phagocytosis, engulfment [GO:0006911]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of aldosterone biosynthetic process [GO:0032347]; retina development in camera-type eye [GO:0060041]",astrocyte end-foot [GO:0097450]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; myelin sheath [GO:0043209]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]
P51790,S1,-1.060203729,-1.186247346,-0.166004303,0.458648719,1.252370505,gold,CLCN3,CLCN3_HUMAN,H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3),CLCN3,1182;,"ENST00000347613.9; ENSP00000261514.5; ENSG00000109572.16. [P51790-2];""ENST00000360642.7; ENSP00000353857.3; ENSG00000109572.16. [P51790-4]"";""ENST00000513761.6; ENSP00000424603.1; ENSG00000109572.16. [P51790-1]"";",antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320],"adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; endosomal lumen acidification [GO:0048388]; negative regulation of cell volume [GO:0045794]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of pH [GO:0006885]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401]",axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle membrane [GO:0012506]
P51795,S1,-1.400391942,-1.785471373,-0.110275527,0.544390152,1.150154337,gold,CLCN5,CLCN5_HUMAN,H(+)/Cl(-) exchange transporter 5 (Chloride channel protein 5) (ClC-5) (Chloride transporter ClC-5),CLCN5 CLCK2,1184;,"ENST00000307367.2; ENSP00000304257.2; ENSG00000171365.17. [P51795-1];""ENST00000376088.7; ENSP00000365256.3; ENSG00000171365.17. [P51795-2]"";""ENST00000376091.8; ENSP00000365259.3; ENSG00000171365.17. [P51795-2]"";""ENST00000376108.7; ENSP00000365276.3; ENSG00000171365.17. [P51795-1]"";""ENST00000642885.1; ENSP00000496632.1; ENSG00000171365.17. [P51795-1]"";",antiporter activity [GO:0015297]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; voltage-gated chloride channel activity [GO:0005247],chloride transport [GO:0006821]; endocytosis [GO:0006897]; monoatomic ion transmembrane transport [GO:0034220]; renal system process [GO:0003014],apical part of cell [GO:0045177]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]
P51797,S1,-0.81219702,-0.903978619,-0.055589881,0.62338911,1.081467501,gold,CLCN6,CLCN6_HUMAN,H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6),CLCN6 KIAA0046,1185;,"ENST00000312413.10; ENSP00000308367.7; ENSG00000011021.23. [P51797-6];""ENST00000346436.11; ENSP00000234488.9; ENSG00000011021.23. [P51797-1]"";""ENST00000376496.4; ENSP00000365679.3; ENSG00000011021.23. [P51797-5]"";",antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247],cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; monoatomic ion transmembrane transport [GO:0034220]; response to mechanical stimulus [GO:0009612]; signal transduction [GO:0007165],endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]
P51798,S1,-0.580366728,-0.909305107,-0.090524887,0.669654061,0.765111884,gold,CLCN7,CLCN7_HUMAN,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),CLCN7,1186;,ENST00000382745.9; ENSP00000372193.4; ENSG00000103249.19. [P51798-1];,antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; voltage-gated chloride channel activity [GO:0005247],transepithelial chloride transport [GO:0030321],chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]
Q9NY35,S2,-0.953070462,-1.586682774,0.411838159,0.969598688,0.302481288,orange,CLDND1,CLDN1_HUMAN,Claudin domain-containing protein 1 (Membrane protein GENX-3745),CLDND1 C3orf4 HSPC174 PSEC0054 UNQ2511/PRO6000,56650;,"ENST00000341181.11; ENSP00000340247.6; ENSG00000080822.17. [Q9NY35-1];""ENST00000394180.6; ENSP00000377734.2; ENSG00000080822.17. [Q9NY35-1]"";""ENST00000394185.6; ENSP00000377739.2; ENSG00000080822.17. [Q9NY35-1]"";""ENST00000503004.5; ENSP00000421226.1; ENSG00000080822.17. [Q9NY35-1]"";""ENST00000510545.5; ENSP00000423590.1; ENSG00000080822.17. [Q9NY35-1]"";""ENST00000511081.5; ENSP00000424669.1; ENSG00000080822.17. [Q9NY35-3]"";""ENST00000513287.5; ENSP00000426869.1; ENSG00000080822.17. [Q9NY35-1]"";",0,0,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]
O00299,C4,2.092003778,0.433508807,-1.317954352,-1.278947515,-1.65227487,deepskyblue2,CLIC1,CLIC1_HUMAN,Chloride intracellular channel protein 1 (Chloride channel ABP) (Glutaredoxin-like oxidoreductase CLIC1) (EC 1.8.-.-) (Glutathione-dependent dehydroascorbate reductase CLIC1) (EC 1.8.5.1) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC),CLIC1 G6 NCC27,1192;,"ENST00000375779.6; ENSP00000364934.2; ENSG00000213719.8.;""ENST00000375780.6; ENSP00000364935.2; ENSG00000213719.8."";""ENST00000375784.8; ENSP00000364940.3; ENSG00000213719.8."";""ENST00000383404.6; ENSP00000372896.2; ENSG00000206394.8."";""ENST00000383405.6; ENSP00000372897.2; ENSG00000206394.8."";""ENST00000395892.5; ENSP00000379229.1; ENSG00000213719.8."";""ENST00000400052.7; ENSP00000382926.3; ENSG00000206394.8."";""ENST00000400058.5; ENSP00000382931.1; ENSG00000206394.8."";""ENST00000415179.5; ENSP00000409247.1; ENSG00000226248.6."";""ENST00000418285.6; ENSP00000407791.2; ENSG00000226417.6."";""ENST00000420458.5; ENSP00000410965.1; ENSG00000226651.6."";""ENST00000422167.6; ENSP00000407429.2; ENSG00000226248.6."";""ENST00000423055.5; ENSP00000406968.1; ENSG00000226417.6."";""ENST00000423143.5; ENSP00000404589.1; ENSG00000223639.6."";""ENST00000423804.5; ENSP00000409979.1; ENSG00000230685.6."";""ENST00000425464.6; ENSP00000401292.2; ENSG00000223639.6."";""ENST00000431921.5; ENSP00000408357.1; ENSG00000226248.6."";""ENST00000433916.5; ENSP00000391395.1; ENSG00000226651.6."";""ENST00000434202.5; ENSP00000400532.1; ENSG00000226651.6."";""ENST00000435242.5; ENSP00000412217.1; ENSG00000226417.6."";""ENST00000438708.5; ENSP00000406088.1; ENSG00000226248.6."";""ENST00000438750.5; ENSP00000404037.1; ENSG00000223639.6."";""ENST00000442045.5; ENSP00000400280.1; ENSG00000226417.6."";""ENST00000447338.5; ENSP00000413330.1; ENSG00000230685.6."";""ENST00000447369.5; ENSP00000408094.1; ENSG00000230685.6."";""ENST00000451546.5; ENSP00000416211.1; ENSG00000223639.6."";""ENST00000456863.6; ENSP00000406335.2; ENSG00000226651.6."";""ENST00000457485.6; ENSP00000398056.2; ENSG00000230685.6."";""ENST00000614673.1; ENSP00000480256.1; ENSG00000230685.6."";""ENST00000614982.1; ENSP00000477623.1; ENSG00000206394.8."";""ENST00000616760.1; ENSP00000479808.1; ENSG00000213719.8."";""ENST00000618288.1; ENSP00000479501.1; ENSG00000226417.6."";""ENST00000619727.1; ENSP00000482255.1; ENSG00000226651.6."";""ENST00000621055.1; ENSP00000478930.1; ENSG00000226248.6."";""ENST00000622613.1; ENSP00000484581.1; ENSG00000223639.6."";",cadherin binding [GO:0045296]; chloride channel activity [GO:0005254],chloride transport [GO:0006821]; platelet aggregation [GO:0070527]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of mitochondrial membrane potential [GO:0051881]; signal transduction [GO:0007165],blood microparticle [GO:0072562]; brush border [GO:0005903]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]
Q9Y696,C4,2.057769251,0.290855554,-0.906643729,-0.955346364,-1.251394383,deepskyblue2,CLIC4,CLIC4_HUMAN,Chloride intracellular channel protein 4 (Glutaredoxin-like oxidoreductase CLIC4) (EC 1.8.-.-) (Intracellular chloride ion channel protein p64H1),CLIC4,25932;,"ENST00000374379.9; ENSP00000363500.4; ENSG00000169504.15.;""ENST00000488683.1; ENSP00000436538.1; ENSG00000169504.15."";",chloride channel activity [GO:0005254],angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; chloride transport [GO:0006821]; endothelial cell morphogenesis [GO:0001886]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; fertilization [GO:0009566]; keratinocyte differentiation [GO:0030216]; multicellular organism growth [GO:0035264]; negative regulation of cell migration [GO:0030336]; regulation of cytoskeleton organization [GO:0051493]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuolar acidification [GO:0007035],actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microvillus [GO:0005902]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
P30622,C4,1.868938985,0.342092521,-0.909026858,-0.981509959,-1.311267239,deepskyblue2,CLIP1,CLIP1_HUMAN,CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin),CLIP1 CYLN1 RSN,6249;,"ENST00000302528.11; ENSP00000303585.7; ENSG00000130779.22. [P30622-1];""ENST00000358808.6; ENSP00000351665.2; ENSG00000130779.22. [P30622-1]"";""ENST00000537178.5; ENSP00000445531.1; ENSG00000130779.22. [P30622-2]"";""ENST00000620786.5; ENSP00000479322.1; ENSG00000130779.22. [P30622-3]"";",identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],cytoplasmic microtubule organization [GO:0031122]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; positive regulation of microtubule polymerization [GO:0031116],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; ruffle [GO:0001726]
Q9HAZ1,N3,-0.974865707,-0.895880301,0.976333983,0.075338972,0.268624359,grey50,CLK4,CLK4_HUMAN,Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4),CLK4,57396;,ENST00000316308.9; ENSP00000316948.4; ENSG00000113240.14.;,ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],regulation of RNA splicing [GO:0043484],nucleus [GO:0005634]
Q13286,S1,-0.762228211,-0.852581704,-0.154171823,0.704483715,1.117061779,gold,CLN3,CLN3_HUMAN,Battenin (Batten disease protein) (Protein CLN3),CLN3 BTS,1201;,"ENST00000333496.14; ENSP00000329171.9; ENSG00000188603.22. [Q13286-7];""ENST00000355477.10; ENSP00000347660.7; ENSG00000188603.22. [Q13286-2]"";""ENST00000357806.11; ENSP00000350457.7; ENSG00000188603.22. [Q13286-6]"";""ENST00000359984.12; ENSP00000353073.9; ENSG00000188603.22. [Q13286-1]"";""ENST00000360019.8; ENSP00000353116.3; ENSG00000188603.22. [Q13286-7]"";""ENST00000565316.6; ENSP00000456117.1; ENSG00000188603.22. [Q13286-3]"";""ENST00000569030.5; ENSP00000454680.1; ENSG00000188603.22. [Q13286-5]"";""ENST00000569430.7; ENSP00000454229.1; ENSG00000188603.22. [Q13286-1]"";""ENST00000636147.2; ENSP00000490105.1; ENSG00000188603.22. [Q13286-1]"";",calcium-dependent protein binding [GO:0048306]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; sulfatide binding [GO:0120146],"actin cytoskeleton organization [GO:0030036]; action potential [GO:0001508]; amyloid precursor protein catabolic process [GO:0042987]; associative learning [GO:0008306]; autophagosome maturation [GO:0097352]; autophagosome-lysosome fusion [GO:0061909]; blood vessel endothelial cell migration [GO:0043534]; ceramide transport [GO:0035627]; glycerophospholipid biosynthetic process [GO:0046474]; glycolipid transport [GO:0046836]; Golgi to lysosome transport [GO:0090160]; intracellular water homeostasis [GO:0009992]; ionotropic glutamate receptor signaling pathway [GO:0035235]; L-arginine transmembrane transport [GO:1903826]; learning or memory [GO:0007611]; lysosomal lumen acidification [GO:0007042]; lysosomal lumen pH elevation [GO:0035752]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; membrane organization [GO:0061024]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of proteolysis [GO:0045861]; neuromuscular process controlling balance [GO:0050885]; phagosome-lysosome docking [GO:0090384]; phagosome-lysosome fusion [GO:0090385]; plasma membrane raft organization [GO:0044857]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of pinocytosis [GO:0048549]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to plasma membrane [GO:0072659]; protein processing [GO:0016485]; receptor-mediated endocytosis [GO:0006898]; regulation of arginine biosynthetic process [GO:1900079]; regulation of autophagosome maturation [GO:1901096]; regulation of autophagosome size [GO:0016243]; regulation of cellular response to osmotic stress [GO:0106049]; regulation of cytoskeleton organization [GO:0051493]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of fibroblast migration [GO:0010762]; regulation of filopodium assembly [GO:0051489]; regulation of modification of synaptic structure [GO:1905244]; regulation of phagosome maturation [GO:1905162]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein processing [GO:0070613]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic transmission, GABAergic [GO:0032228]; regulation of synaptic transmission, glutamatergic [GO:0051966]; renal potassium excretion [GO:0036359]; vesicle transport along microtubule [GO:0047496]",autolysosome [GO:0044754]; autophagosome [GO:0005776]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]
Q9H078,M1,-1.005446577,-0.330131955,0.331392281,0.861473542,-0.090033894,burlywood4,CLPB,CLPB_HUMAN,"Mitochondrial disaggregase (EC 3.6.1.-) (Suppressor of potassium transport defect 3) [Cleaved into: Mitochondrial disaggregase, cleaved form]",CLPB SKD3,81570;,"ENST00000294053.9; ENSP00000294053.3; ENSG00000162129.15. [Q9H078-1];""ENST00000340729.9; ENSP00000340385.5; ENSG00000162129.15. [Q9H078-3]"";""ENST00000538039.6; ENSP00000441518.1; ENSG00000162129.15. [Q9H078-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545],antiviral innate immune response [GO:0140374]; cellular response to heat [GO:0034605]; granulocyte differentiation [GO:0030851]; RIG-I signaling pathway [GO:0039529],cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]
O96005,S2,-1.296909034,-1.777575879,0.114984735,0.863207571,0.630272413,orange,CLPTM1,CLPT1_HUMAN,Putative lipid scramblase CLPTM1 (Cleft lip and palate transmembrane protein 1),CLPTM1,1209;,"ENST00000337392.10; ENSP00000336994.4; ENSG00000104853.16. [O96005-1];""ENST00000541297.6; ENSP00000442011.1; ENSG00000104853.16. [O96005-4]"";""ENST00000546079.5; ENSP00000443192.1; ENSG00000104853.16. [O96005-3]"";",GABA receptor binding [GO:0050811],cell differentiation [GO:0030154]; regulation of T cell differentiation in thymus [GO:0033081],endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q96KA5,S2,-1.265580513,-1.537105335,0.222951773,0.813150739,0.537947871,orange,CLPTM1L,CLP1L_HUMAN,Lipid scramblase CLPTM1L (Cisplatin resistance-related protein 9) (CRR9p) (Cleft lip and palate transmembrane protein 1-like protein) (CLPTM1-like protein),CLPTM1L CRR9,81037;,"ENST00000320895.10; ENSP00000313854.5; ENSG00000049656.14. [Q96KA5-1];""ENST00000620010.3; ENSP00000480372.1; ENSG00000274811.3. [Q96KA5-1]"";",phospholipid scramblase activity [GO:0017128],apoptotic process [GO:0006915],endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
O75153,C5,1.562118991,0.447046591,-0.563905372,-0.628051172,-0.712995719,turquoise3,CLUH,CLU_HUMAN,Clustered mitochondria protein homolog,CLUH KIAA0664,23277;,"ENST00000435359.5; ENSP00000388872.1; ENSG00000132361.18.;""ENST00000570628.6; ENSP00000458986.1; ENSG00000132361.18."";",mRNA binding [GO:0003729],intracellular distribution of mitochondria [GO:0048312]; mitochondrion organization [GO:0007005],cytoplasm [GO:0005737]
Q8NFW8,N1,-0.803228017,0.449259621,-0.057948239,-0.308065241,0.735623334,grey90,CMAS,NEUA_HUMAN,N-acylneuraminate cytidylyltransferase (EC 2.7.7.43) (CMP-N-acetylneuraminic acid synthase) (CMP-NeuNAc synthase),CMAS,55907;,"ENST00000229329.7; ENSP00000229329.2; ENSG00000111726.13. [Q8NFW8-1];""ENST00000534981.5; ENSP00000446239.1; ENSG00000111726.13. [Q8NFW8-2]"";",N-acylneuraminate cytidylyltransferase activity [GO:0008781],N-acetylneuraminate metabolic process [GO:0006054],membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96DG6,C5,2.164883622,0.215843707,-0.872016744,-1.240405765,-1.290056853,turquoise3,CMBL,CMBL_HUMAN,Carboxymethylenebutenolidase homolog (EC 3.1.-.-),CMBL,134147;,ENST00000296658.4; ENSP00000296658.3; ENSG00000164237.9.;,hydrolase activity [GO:0016787],xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9NRP2,M1,-1.081332895,-0.71559762,0.331625838,0.987504641,0.055932317,burlywood4,CMC2,COXM2_HUMAN,COX assembly mitochondrial protein 2 homolog,CMC2 C16orf61 DC13,56942;,"ENST00000219400.8; ENSP00000219400.3; ENSG00000103121.9.;""ENST00000564249.5; ENSP00000456841.1; ENSG00000103121.9."";""ENST00000565650.5; ENSP00000455457.2; ENSG00000103121.9."";""ENST00000565914.5; ENSP00000455723.1; ENSG00000103121.9."";""ENST00000709304.1; ENSP00000517609.1; ENSG00000291948.1."";""ENST00000709314.1; ENSP00000517614.1; ENSG00000291948.1."";""ENST00000709315.1; ENSP00000517615.1; ENSG00000291948.1."";""ENST00000709318.1; ENSP00000517618.1; ENSG00000291948.1."";",0,0,mitochondrion [GO:0005739]
P30085,C4,2.097601485,0.535386784,-1.088746541,-1.329535381,-1.655213148,deepskyblue2,CMPK1,KCY_HUMAN,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),CMPK1 CMK CMPK UCK UMK UMPK,51727;,"ENST00000371873.10; ENSP00000360939.5; ENSG00000162368.15. [P30085-3];""ENST00000699075.1; ENSP00000514114.1; ENSG00000162368.15. [P30085-1]"";",ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; cytidylate kinase activity [GO:0004127]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862]; uridine kinase activity [GO:0004849],'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; nucleobase-containing small molecule interconversion [GO:0015949]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BQ75,N1,-1.239190067,-0.484236323,0.655631817,0.112205034,0.874693236,grey90,CMSS1,CMS1_HUMAN,Protein CMSS1 (Cms1 ribosomal small subunit homolog),CMSS1 C3orf26,84319;,"ENST00000421999.8; ENSP00000410396.2; ENSG00000184220.12. [Q9BQ75-1];""ENST00000489081.5; ENSP00000419161.1; ENSG00000184220.12. [Q9BQ75-2]"";",RNA binding [GO:0003723],0,0
Q8IYT2,C2,0.95240612,0.514597787,-0.197424829,-0.32631798,-0.24675361,aquamarine,CMTR2,CMTR2_HUMAN,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (HMTr2) (MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog),CMTR2 AFT FTSJD1,55783;,"ENST00000338099.9; ENSP00000337512.5; ENSG00000180917.18.;""ENST00000434935.7; ENSP00000411148.2; ENSG00000180917.18."";",mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483],7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q96KP4,C4,2.113982515,0.392050168,-0.981594148,-1.053427403,-1.172795813,deepskyblue2,CNDP2,CNDP2_HUMAN,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase),CNDP2 CN2 CPGL HEL-S-13 PEPA,55748;,"ENST00000324262.9; ENSP00000325548.4; ENSG00000133313.15. [Q96KP4-1];""ENST00000324301.12; ENSP00000325756.8; ENSG00000133313.15. [Q96KP4-2]"";""ENST00000579847.5; ENSP00000462311.1; ENSG00000133313.15. [Q96KP4-1]"";",alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573],proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]
Q8N9A8,S2,-2.552286314,-2.238207872,0.72019084,0.794793508,0.771728079,orange,CNEP1R1,NEPR1_HUMAN,Nuclear envelope phosphatase-regulatory subunit 1 (NEP1-R1) (Transmembrane protein 188),CNEP1R1 C16orf69 TMEM188,255919;,"ENST00000427478.7; ENSP00000394224.2; ENSG00000205423.12. [Q8N9A8-1];""ENST00000458059.7; ENSP00000405635.3; ENSG00000205423.12. [Q8N9A8-2]"";""ENST00000565457.5; ENSP00000456686.1; ENSG00000205423.12. [Q8N9A8-1]"";""ENST00000566482.5; ENSP00000456294.1; ENSG00000205423.12. [Q8N9A8-3]"";""ENST00000568890.5; ENSP00000456913.1; ENSG00000205423.12. [Q8N9A8-3]"";",0,lipid metabolic process [GO:0006629]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of triglyceride biosynthetic process [GO:0010867]; protein localization to nucleus [GO:0034504],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Nem1-Spo7 phosphatase complex [GO:0071595]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]
Q99439,C3,1.941093253,0.084134131,-0.658301875,-0.605240651,-0.861912431,cyan,CNN2,CNN2_HUMAN,"Calponin-2 (Calponin H2, smooth muscle) (Neutral calponin)",CNN2,1265;,"ENST00000263097.9; ENSP00000263097.2; ENSG00000064666.15. [Q99439-1];""ENST00000348419.7; ENSP00000340129.2; ENSG00000064666.15. [Q99439-2]"";",actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516],actin filament organization [GO:0007015]; actomyosin structure organization [GO:0031032]; cellular response to mechanical stimulus [GO:0071260]; cytoskeleton organization [GO:0007010]; establishment of localization in cell [GO:0051649]; hemopoiesis [GO:0030097]; macrophage migration [GO:1905517]; negative regulation of macrophage migration [GO:1905522]; negative regulation of phagocytosis [GO:0050765]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; regulation of actin filament-based process [GO:0032970]; regulation of mononuclear cell proliferation [GO:0032944]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; membrane [GO:0016020]; specific granule lumen [GO:0035580]; stress fiber [GO:0001725]; tertiary granule lumen [GO:1904724]
Q8NE01,S2,-1.551745118,-1.842682476,0.479798335,0.898591829,0.395677287,orange,CNNM3,CNNM3_HUMAN,Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3),CNNM3 ACDP3,26505;,"ENST00000305510.4; ENSP00000305449.3; ENSG00000168763.16. [Q8NE01-1];""ENST00000377060.7; ENSP00000366260.3; ENSG00000168763.16. [Q8NE01-2]"";",transmembrane transporter activity [GO:0022857],magnesium ion homeostasis [GO:0010960]; monoatomic ion transport [GO:0006811],membrane [GO:0016020]; plasma membrane [GO:0005886]
Q6P4Q7,S4,-1.317158567,-1.618975359,0.586858966,0.931489841,0.132882453,tomato2,CNNM4,CNNM4_HUMAN,Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4),CNNM4 ACDP4 KIAA1592,26504;,ENST00000377075.3; ENSP00000366275.2; ENSG00000158158.12. [Q6P4Q7-1];,magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081],enamel mineralization [GO:0070166]; intracellular monoatomic cation homeostasis [GO:0030003]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; visual perception [GO:0007601],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
O95628,C5,1.423366588,0.64109375,-0.469575796,-0.522268261,-0.763295609,turquoise3,CNOT4,CNOT4_HUMAN,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),CNOT4 NOT4,4850;,"ENST00000315544.6; ENSP00000326731.5; ENSG00000080802.21. [O95628-1];""ENST00000361528.8; ENSP00000354673.4; ENSG00000080802.21. [O95628-8]"";""ENST00000414802.5; ENSP00000416532.1; ENSG00000080802.21. [O95628-5]"";""ENST00000423368.6; ENSP00000406777.2; ENSG00000080802.21. [O95628-4]"";""ENST00000428680.6; ENSP00000399108.2; ENSG00000080802.21. [O95628-2]"";""ENST00000451834.5; ENSP00000388491.1; ENSG00000080802.21. [O95628-9]"";""ENST00000541284.6; ENSP00000445508.1; ENSG00000080802.21. [O95628-10]"";""ENST00000707064.1; ENSP00000516715.1; ENSG00000080802.21. [O95628-1]"";",metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842],nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]
P09543,S3,-0.751985219,-0.272245856,0.089278685,0.682800287,0.388546594,salmon,CNP,CN37_HUMAN,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",CNP,1267;,"ENST00000393888.1; ENSP00000377466.1; ENSG00000173786.17. [P09543-2];""ENST00000393892.8; ENSP00000377470.2; ENSG00000173786.17. [P09543-1]"";","2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]",adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636]; substantia nigra development [GO:0021762],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143]; synapse [GO:0045202]
Q9BT09,N4,-0.544168391,0.549990419,-0.199853874,0.491826432,-0.070756944,grey30,CNPY3,CNPY3_HUMAN,Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein),CNPY3 CTG4A ERDA5 PRAT4A TNRC5 HSPC084 UNQ1934/PRO4409,10695;,ENST00000372836.5; ENSP00000361926.4; ENSG00000137161.18. [Q9BT09-1];,signaling receptor binding [GO:0005102],innate immune response [GO:0045087],endoplasmic reticulum lumen [GO:0005788]
Q6PJW8,S2,-1.010701262,-1.377739425,0.101791602,0.848499055,0.572783575,orange,CNST,CNST_HUMAN,Consortin,CNST C1orf71,163882;,"ENST00000366512.7; ENSP00000355469.3; ENSG00000162852.14. [Q6PJW8-2];""ENST00000366513.9; ENSP00000355470.4; ENSG00000162852.14. [Q6PJW8-1]"";",connexin binding [GO:0071253]; phosphatase binding [GO:0019902],positive regulation of Golgi to plasma membrane protein transport [GO:0042998],intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]
Q7Z7A1,C2,0.666249814,-0.001112318,-0.023336143,0.467425499,-0.348464566,aquamarine,CNTRL,CNTRL_HUMAN,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),CNTRL CEP1 CEP110,11064;,"ENST00000373850.6; ENSP00000362956.1; ENSG00000119397.19. [Q7Z7A1-2];""ENST00000373855.7; ENSP00000362962.1; ENSG00000119397.19. [Q7Z7A1-1]"";",0,aorta development [GO:0035904]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; ventricular septum development [GO:0003281],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]
Q9GZY4,M2,-1.948353193,-2.270669405,0.420725368,1.242078719,0.044020292,tan4,COA1,COA1_HUMAN,Cytochrome c oxidase assembly factor 1 homolog (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa),COA1 C7orf44 MITRAC15,55744;,"ENST00000223336.11; ENSP00000223336.6; ENSG00000106603.20.;""ENST00000310564.10; ENSP00000312100.6; ENSG00000106603.20."";""ENST00000395879.5; ENSP00000379218.1; ENSG00000106603.20."";""ENST00000415076.6; ENSP00000400759.1; ENSG00000106603.20."";""ENST00000438444.5; ENSP00000395586.1; ENSG00000106603.20."";""ENST00000446330.6; ENSP00000416406.1; ENSG00000106603.20."";""ENST00000446564.5; ENSP00000413777.1; ENSG00000106603.20."";",0,mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9Y2R0,M2,-1.557559162,-1.445058933,0.377353403,1.312806967,-0.270974368,tan4,COA3,COA3_HUMAN,"Cytochrome c oxidase assembly factor 3 homolog, mitochondrial (Coiled-coil domain-containing protein 56) (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kDa)",COA3 CCDC56 MITRAC12 HSPC009,28958;,ENST00000328434.8; ENSP00000354762.5; ENSG00000183978.8.;,0,mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of mitochondrial translation [GO:0070131],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q96BR5,N4,-1.084716383,1.036463511,0.042417397,0.17294982,-0.715300356,grey30,COA7,COA7_HUMAN,Cytochrome c oxidase assembly factor 7 (Beta-lactamase hcp-like protein) (Respiratory chain assembly factor 1) (Sel1 repeat-containing protein 1),COA7 C1orf163 RESA1 SELRC1,65260;,ENST00000371538.5; ENSP00000360593.3; ENSG00000162377.6.;,0,0,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q13057,C1,1.619103865,0.174597308,-0.375995963,-0.185549261,-0.871847543,lightblue,COASY,COASY_HUMAN,Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)],COASY PSEC0106,80347;,"ENST00000393818.3; ENSP00000377406.1; ENSG00000068120.15. [Q13057-1];""ENST00000421097.6; ENSP00000393564.2; ENSG00000068120.15. [Q13057-1]"";""ENST00000590958.5; ENSP00000464814.1; ENSG00000068120.15. [Q13057-2]"";",ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595],coenzyme A biosynthetic process [GO:0015937],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]
Q9H9E3,C2,1.072472755,-0.050793656,-0.381136626,0.138083018,0.148149292,aquamarine,COG4,COG4_HUMAN,Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4),COG4,25839;,ENST00000482252.5; ENSP00000432802.1; ENSG00000103051.21. [Q9H9E3-2];,identical protein binding [GO:0042802],"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]
Q9Y5P4,C3,1.83849659,-0.163046851,-0.671011502,-0.469590549,-0.622892734,cyan,COL4A3BP,CERT_HUMAN,Ceramide transfer protein (hCERT) (Collagen type IV alpha-3-binding protein) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11),CERT1 CERT COL4A3BP STARD11,10087;,"ENST00000261415.12; ENSP00000261415.8; ENSG00000113163.19. [Q9Y5P4-1];""ENST00000405807.10; ENSP00000383996.4; ENSG00000113163.19. [Q9Y5P4-3]"";""ENST00000643780.2; ENSP00000495760.1; ENSG00000113163.19. [Q9Y5P4-1]"";""ENST00000644072.2; ENSP00000494110.2; ENSG00000113163.19. [Q9Y5P4-1]"";""ENST00000644445.1; ENSP00000496243.1; ENSG00000113163.19. [Q9Y5P4-2]"";""ENST00000645483.1; ENSP00000493563.1; ENSG00000113163.19. [Q9Y5P4-2]"";""ENST00000646511.1; ENSP00000495446.1; ENSG00000113163.19. [Q9Y5P4-2]"";",ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; ceramide transfer activity [GO:0120017]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphatidylinositol-4-phosphate binding [GO:0070273],cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; ceramide metabolic process [GO:0006672]; ceramide transport [GO:0035627]; endoplasmic reticulum organization [GO:0007029]; ER to Golgi ceramide transport [GO:0035621]; heart morphogenesis [GO:0003007]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; intermembrane lipid transfer [GO:0120009]; intermembrane sphingolipid transfer [GO:0120012]; lipid homeostasis [GO:0055088]; mitochondrion organization [GO:0007005]; muscle contraction [GO:0006936]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q9H0A8,C1,1.509334145,0.218249693,-0.374350878,-0.22764685,-0.366211995,lightblue,COMMD4,COMD4_HUMAN,COMM domain-containing protein 4,COMMD4,54939;,"ENST00000267935.13; ENSP00000267935.8; ENSG00000140365.16. [Q9H0A8-1];""ENST00000338995.10; ENSP00000340867.6; ENSG00000140365.16. [Q9H0A8-2]"";""ENST00000480484.5; ENSP00000433662.1; ENSG00000140365.16. [Q9H0A8-1]"";""ENST00000567195.5; ENSP00000457693.1; ENSG00000140365.16. [Q9H0A8-3]"";",0,0,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q7Z4G1,C1,1.634587397,0.309890596,-0.73299093,-0.430207167,-0.579112823,lightblue,COMMD6,COMD6_HUMAN,COMM domain-containing protein 6,COMMD6 MSTP076,170622;,"ENST00000355801.4; ENSP00000348054.4; ENSG00000188243.14. [Q7Z4G1-2];""ENST00000377615.7; ENSP00000366841.3; ENSG00000188243.14. [Q7Z4G1-1]"";""ENST00000682242.1; ENSP00000506987.1; ENSG00000188243.14. [Q7Z4G1-1]"";",NF-kappaB binding [GO:0051059],negative regulation of NF-kappaB transcription factor activity [GO:0032088],cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q86VU5,M2,-1.156673029,-1.130222873,0.412009132,1.130387115,-0.070037588,tan4,COMTD1,CMTD1_HUMAN,Catechol O-methyltransferase domain-containing protein 1 (EC 2.1.1.-),COMTD1 UNQ766/PRO1558,118881;,ENST00000372538.8; ENSP00000361616.3; ENSG00000165644.11.;,O-methyltransferase activity [GO:0008171]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],methylation [GO:0032259],membrane [GO:0016020]
P53621,C1,0.804313094,-0.026551545,-0.220445904,0.145332257,0.333967432,lightblue,COPA,COPA_HUMAN,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin],COPA,1314;,"ENST00000241704.8; ENSP00000241704.7; ENSG00000122218.17. [P53621-1];""ENST00000368069.7; ENSP00000357048.3; ENSG00000122218.17. [P53621-2]"";",hormone activity [GO:0005179]; structural molecule activity [GO:0005198],"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]
P35606,C2,0.956270697,0.257815407,-0.409214791,-0.033051118,0.118745547,aquamarine,COPB2,COPB2_HUMAN,Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102),COPB2,9276;,"ENST00000333188.10; ENSP00000329419.4; ENSG00000184432.11. [P35606-1];""ENST00000507777.6; ENSP00000422295.1; ENSG00000184432.11. [P35606-2]"";""ENST00000512242.6; ENSP00000427185.2; ENSG00000184432.11. [P35606-2]"";""ENST00000514508.2; ENSP00000422469.2; ENSG00000184432.11. [P35606-2]"";",structural molecule activity [GO:0005198],"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]
Q9Y678,C2,0.960477189,0.171017916,-0.310491306,0.022957984,-2.14E-04,aquamarine,COPG1,COPG1_HUMAN,Coatomer subunit gamma-1 (Gamma-1-coat protein) (Gamma-1-COP),COPG1 COPG,22820;,ENST00000314797.10; ENSP00000325002.6; ENSG00000181789.14.;,structural molecule activity [GO:0005198],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of Golgi localization [GO:0051683]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; organelle transport along microtubule [GO:0072384]; protein secretion [GO:0009306],COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]
Q9BT78,C2,1.256129116,0.745286698,-0.523204946,-0.602557361,-0.297427312,aquamarine,COPS4,CSN4_HUMAN,COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4),COPS4 CSN4,51138;,"ENST00000264389.7; ENSP00000264389.2; ENSG00000138663.9. [Q9BT78-1];""ENST00000509093.5; ENSP00000425976.1; ENSG00000138663.9. [Q9BT78-2]"";",deNEDDylase activity [GO:0019784],protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434],cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]
Q9UBW8,C2,1.103581356,0.731801917,-0.505314877,-0.418967878,-0.226614056,aquamarine,COPS7A,CSN7A_HUMAN,COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (Dermal papilla-derived protein 10) (JAB1-containing signalosome subunit 7a),COPS7A CSN7A DERP10,50813;,"ENST00000229251.7; ENSP00000229251.3; ENSG00000111652.10.;""ENST00000534877.5; ENSP00000438363.1; ENSG00000111652.10."";""ENST00000534947.5; ENSP00000446039.1; ENSG00000111652.10."";""ENST00000539735.5; ENSP00000441852.1; ENSG00000111652.10."";""ENST00000543155.6; ENSP00000438115.1; ENSG00000111652.10."";",0,COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434],COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P61923,C2,1.183602923,0.372421012,-0.409516155,-0.137970788,-0.225746645,aquamarine,COPZ1,COPZ1_HUMAN,Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP),COPZ1 COPZ CGI-120 HSPC181,22818;,"ENST00000262061.7; ENSP00000262061.2; ENSG00000111481.10. [P61923-1];""ENST00000455864.6; ENSP00000410620.2; ENSG00000111481.10. [P61923-3]"";""ENST00000549043.5; ENSP00000449270.1; ENSG00000111481.10. [P61923-4]"";""ENST00000552362.5; ENSP00000448444.1; ENSG00000111481.10. [P61923-5]"";",0,"intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]
Q96H96,M2,-2.103697029,-2.028726157,0.459900092,1.278594253,-0.053905091,tan4,COQ2,COQ2_HUMAN,"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)",COQ2 CL640,27235;,"ENST00000311461.7; ENSP00000311835.7; ENSG00000173085.15. [Q96H96-3];""ENST00000311469.9; ENSP00000310873.4; ENSG00000173085.15. [Q96H96-4]"";""ENST00000647002.2; ENSP00000495761.2; ENSG00000173085.15. [Q96H96-1]"";",4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; 4-hydroxybenzoate nonaprenyltransferase activity [GO:0047293]; 4-hydroxybenzoate octaprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659],glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],mitochondrial inner membrane [GO:0005743]
Q9NZJ6,S3,-1.171296528,-0.653304462,0.231906844,0.910659968,0.321554318,salmon,COQ3,COQ3_HUMAN,"Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114)",COQ3 UG0215E05,51805;,ENST00000254759.8; ENSP00000254759.3; ENSG00000132423.12.;,"2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [GO:0008425]; 3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity [GO:0010420]; 3-demethylubiquinol-n 3-O-methyltransferase activity [GO:0061542]; O-methyltransferase activity [GO:0008171]","glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]",extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142]
Q99807,S3,-1.36180283,-1.134048303,0.288688773,0.859421007,0.454406811,salmon,COQ7,COQ7_HUMAN,"5-demethoxyubiquinone hydroxylase, mitochondrial (DMQ hydroxylase) (EC 1.14.99.60) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)",COQ7,10229;,"ENST00000321998.10; ENSP00000322316.5; ENSG00000167186.11. [Q99807-1];""ENST00000544894.6; ENSP00000442923.2; ENSG00000167186.11. [Q99807-2]"";""ENST00000568985.5; ENSP00000456734.1; ENSG00000167186.11. [Q99807-1]"";","3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",determination of adult lifespan [GO:0008340]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744],chromosome [GO:0005694]; extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142]
O75208,M1,-1.177234572,-0.372202433,0.300448069,0.832115984,-0.219807754,burlywood4,COQ9,COQ9_HUMAN,"Ubiquinone biosynthesis protein COQ9, mitochondrial",COQ9 C16orf49 HSPC326 PSEC0129,57017;,ENST00000262507.11; ENSP00000262507.5; ENSG00000088682.14. [O75208-1];,lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803],"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142]
Q12887,M2,-0.60290008,-1.191734906,0.30923905,1.153195955,-0.098360226,tan4,COX10,COX10_HUMAN,"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)",COX10,1352;,"ENST00000261643.8; ENSP00000261643.3; ENSG00000006695.12. [Q12887-1];""ENST00000664217.1; ENSP00000499396.1; ENSG00000006695.12. [Q12887-1]"";",farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495],aerobic respiration [GO:0009060]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; lipid metabolic process [GO:0006629]; mitochondrial fission [GO:0000266]; respiratory chain complex IV assembly [GO:0008535],cytochrome complex [GO:0070069]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]
Q9Y6N1,M2,-0.931556877,-1.382989762,0.430393525,1.141216708,-0.197808587,tan4,COX11,COX11_HUMAN,"Cytochrome c oxidase assembly protein COX11, mitochondrial",COX11,1353;,"ENST00000299335.8; ENSP00000299335.3; ENSG00000166260.13. [Q9Y6N1-1];""ENST00000572558.5; ENSP00000459302.1; ENSG00000166260.13. [Q9Y6N1-2]"";""ENST00000576370.5; ENSP00000459901.1; ENSG00000166260.13. [Q9Y6N1-1]"";",copper ion binding [GO:0005507]; electron transfer activity [GO:0009055],ATP biosynthetic process [GO:0006754]; intracellular monoatomic cation homeostasis [GO:0030003],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]
Q96I36,M2,-1.055350083,-1.47530044,0.253692848,1.075067798,-0.032750875,tan4,COX14,COX14_HUMAN,Cytochrome c oxidase assembly protein COX14,COX14 C12orf62,84987;,"ENST00000317943.6; ENSP00000326052.2; ENSG00000178449.9.;""ENST00000548985.1; ENSP00000447776.1; ENSG00000178449.9."";""ENST00000550487.6; ENSP00000446524.1; ENSG00000178449.9."";""ENST00000550654.1; ENSP00000450331.1; ENSG00000178449.9."";",0,mitochondrial cytochrome c oxidase assembly [GO:0033617],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q7KZN9,M2,-0.881049583,-0.978826026,0.225161244,0.922558097,0.051234934,tan4,COX15,COX15_HUMAN,Heme A synthase COX15 (HAS) (EC 1.17.99.9) (Cytochrome c oxidase assembly protein COX15 homolog),COX15,1355;,"ENST00000016171.6; ENSP00000016171.6; ENSG00000014919.13. [Q7KZN9-1];""ENST00000370483.9; ENSP00000359514.5; ENSG00000014919.13. [Q7KZN9-2]"";","cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme biosynthetic process [GO:0006783]; respiratory gaseous exchange by respiratory system [GO:0007585],cytochrome complex [GO:0070069]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q9P0S2,M2,-0.542399602,-0.7985909,0.305494952,0.954294021,-0.140205422,tan4,COX16,COX16_HUMAN,"Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial (hCOX16)",COX16 C14orf112 HSPC203 PTD019,51241;,ENST00000389912.7; ENSP00000374562.5; ENSG00000133983.16.;,0,mitochondrial cytochrome c oxidase assembly [GO:0033617],mitochondrial inner membrane [GO:0005743]
Q14061,N4,-1.322251206,1.121083182,0.005338635,0.144832124,-1.278600127,grey30,COX17,COX17_HUMAN,Cytochrome c oxidase copper chaperone,COX17,10063;,"ENST00000261070.7; ENSP00000261070.2; ENSG00000138495.7.;""ENST00000468918.5; ENSP00000417805.1; ENSG00000138495.7."";""ENST00000497116.1; ENSP00000417923.1; ENSG00000138495.7."";",copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]; enzyme activator activity [GO:0008047],copper ion transport [GO:0006825]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytochrome-c oxidase activity [GO:1904960],cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]
Q8N8Q8,M2,-1.813189619,-2.132356461,0.403226518,1.321226903,-0.014748441,tan4,COX18,COX18_HUMAN,"Cytochrome c oxidase assembly protein COX18, mitochondrial (COX18Hs) (Cytochrome c oxidase assembly protein 18)",COX18 OXA1L2,285521;,"ENST00000295890.8; ENSP00000295890.4; ENSG00000163626.17. [Q8N8Q8-1];""ENST00000449739.6; ENSP00000394583.2; ENSG00000163626.17. [Q8N8Q8-3]"";""ENST00000510031.1; ENSP00000424978.1; ENSG00000163626.17. [Q8N8Q8-2]"";",membrane insertase activity [GO:0032977],mitochondrial cytochrome c oxidase assembly [GO:0033617]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein insertion into mitochondrial membrane [GO:0051204]; respiratory chain complex IV assembly [GO:0008535],mitochondrial inner membrane [GO:0005743]
Q5RI15,M2,-1.005056085,-1.303050414,0.353232572,1.094084729,-0.06992655,tan4,COX20,COX20_HUMAN,"Cytochrome c oxidase assembly protein COX20, mitochondrial",COX20 FAM36A,116228;,"ENST00000366528.3; ENSP00000355486.3; ENSG00000203667.10. [Q5RI15-2];""ENST00000411948.7; ENSP00000406327.2; ENSG00000203667.10. [Q5RI15-1]"";",0,mitochondrial cytochrome c oxidase assembly [GO:0033617],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
P13073,M2,-0.998832555,-0.981694515,0.385777243,1.037611195,-0.095893619,tan4,COX4I1,COX41_HUMAN,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1)",COX4I1 COX4,1327;,"ENST00000253452.8; ENSP00000253452.2; ENSG00000131143.10.;""ENST00000561569.5; ENSP00000457015.1; ENSG00000131143.10."";""ENST00000562336.5; ENSP00000457513.1; ENSG00000131143.10."";",cytochrome-c oxidase activity [GO:0004129],"cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]",cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
P10606,M2,-0.591047573,-0.94990366,0.358081366,1.011468835,-0.143872049,tan4,COX5B,COX5B_HUMAN,"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)",COX5B,1329;,"ENST00000258424.3; ENSP00000258424.2; ENSG00000135940.7.;""ENST00000708077.1; ENSP00000517083.1; ENSG00000291596.1."";",cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872],"cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory gaseous exchange by respiratory system [GO:0007585]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]
P14854,M2,-0.902317851,-0.588325417,0.402028708,0.900494173,-0.141382841,tan4,COX6B1,CX6B1_HUMAN,Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1) (COX VIb-1),COX6B1 COX6B,1340;,"ENST00000392201.1; ENSP00000376037.2; ENSG00000126267.11.;""ENST00000592141.6; ENSP00000466818.2; ENSG00000126267.11."";""ENST00000649813.2; ENSP00000497926.1; ENSG00000126267.11."";",cytochrome-c oxidase activity [GO:0004129],"cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; substantia nigra development [GO:0021762]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]
P09669,M2,-1.042870862,-1.154084016,0.350514326,1.114539748,-0.129492392,tan4,COX6C,COX6C_HUMAN,Cytochrome c oxidase subunit 6C (Cytochrome c oxidase polypeptide VIc),COX6C,1345;,"ENST00000297564.6; ENSP00000297564.2; ENSG00000164919.11.;""ENST00000517682.6; ENSP00000429714.1; ENSG00000164919.11."";""ENST00000518171.5; ENSP00000429755.1; ENSG00000164919.11."";""ENST00000520271.5; ENSP00000428150.1; ENSG00000164919.11."";""ENST00000520468.7; ENSP00000428895.1; ENSG00000164919.11."";""ENST00000520517.5; ENSP00000429991.1; ENSG00000164919.11."";""ENST00000522934.5; ENSP00000428702.1; ENSG00000164919.11."";""ENST00000522940.5; ENSP00000428965.1; ENSG00000164919.11."";""ENST00000523016.1; ENSP00000429707.1; ENSG00000164919.11."";""ENST00000524245.5; ENSP00000429410.1; ENSG00000164919.11."";",0,"cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]
P14406,M2,-1.621924558,-2.079962639,0.475337947,1.254708076,-0.040131334,tan4,COX7A2,CX7A2_HUMAN,"Cytochrome c oxidase subunit 7A2, mitochondrial (Cytochrome c oxidase subunit VIIa-liver/heart) (Cytochrome c oxidase subunit VIIa-L) (Cytochrome c oxidase subunit VIIaL)",COX7A2 COX7AL,1347;,ENST00000684430.2; ENSP00000506727.1; ENSG00000112695.13.;,oxidoreductase activity [GO:0016491],"cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]",mitochondrial membrane [GO:0031966]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex IV [GO:0005751]
O14548,M2,-1.063368252,-1.387914509,0.372276996,1.179795141,-0.075176619,tan4,COX7A2L,COX7R_HUMAN,"Cytochrome c oxidase subunit 7A-related protein, mitochondrial (COX7a-related protein) (Cytochrome c oxidase subunit VIIa-related protein) (EB1)",COX7A2L COX7AR COX7RP,9167;,"ENST00000234301.3; ENSP00000234301.2; ENSG00000115944.15.;""ENST00000378669.5; ENSP00000367938.1; ENSG00000115944.15."";",cytochrome-c oxidase activity [GO:0004129],"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial respirasome assembly [GO:0097250]; regulation of oxidative phosphorylation [GO:0002082]",mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]
P24311,M2,-1.719017132,-1.550364925,0.490203236,1.152159995,-0.085630366,tan4,COX7B,COX7B_HUMAN,"Cytochrome c oxidase subunit 7B, mitochondrial (Cytochrome c oxidase polypeptide VIIb)",COX7B,1349;,ENST00000650309.2; ENSP00000497474.1; ENSG00000131174.7.;,cytochrome-c oxidase activity [GO:0004129],"cellular respiration [GO:0045333]; central nervous system development [GO:0007417]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]
P15954,M2,-1.273516223,-1.203620786,0.410257595,1.085658612,-0.241806298,tan4,COX7C,COX7C_HUMAN,"Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc)",COX7C,1350;,"ENST00000247655.4; ENSP00000247655.3; ENSG00000127184.13.;""ENST00000509578.1; ENSP00000425759.1; ENSG00000127184.13."";",0,"cellular respiration [GO:0045333]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]
O75976,S1,-1.006988135,-1.216737839,-0.233838911,0.8006733,1.025555313,gold,CPD,CBPD_HUMAN,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),CPD,1362;,"ENST00000225719.9; ENSP00000225719.4; ENSG00000108582.12. [O75976-1];""ENST00000543464.6; ENSP00000444443.2; ENSG00000108582.12. [O75976-2]"";",metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270],peptide metabolic process [GO:0006518]; protein processing [GO:0016485],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]
O75131,C3,1.889717693,0.191664239,-0.764726678,-0.74062035,-0.923854453,cyan,CPNE3,CPNE3_HUMAN,Copine-3 (Copine III),CPNE3 CPN3 KIAA0636,8895;,ENST00000517490.6; ENSP00000477590.1; ENSG00000085719.13.;,calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723],cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335],azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P36551,N4,-0.986360422,0.860678534,0.044731517,0.240213713,-0.89785524,grey30,CPOX,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3)",CPOX CPO CPX,1371;,ENST00000647941.2; ENSP00000497326.1; ENSG00000080819.9. [P36551-1];,coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; protoporphyrinogen IX biosynthetic process [GO:0006782],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]
Q16630,N4,-0.859147951,1.41435027,-0.281043835,-0.804016899,-0.828679273,grey30,CPSF6,CPSF6_HUMAN,Cleavage and polyadenylation specificity factor subunit 6 (Cleavage and polyadenylation specificity factor 68 kDa subunit) (CPSF 68 kDa subunit) (Cleavage factor Im complex 68 kDa subunit) (CFIm68) (Pre-mRNA cleavage factor Im 68 kDa subunit) (Protein HPBRII-4/7),CPSF6 CFIM68,11052;,"ENST00000266679.8; ENSP00000266679.8; ENSG00000111605.18. [Q16630-2];""ENST00000435070.7; ENSP00000391774.2; ENSG00000111605.18. [Q16630-1]"";",exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723],"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]",cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; membrane [GO:0016020]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]
P50416,M2,-0.91557566,-1.098331594,0.296138753,0.927058519,0.111900286,tan4,CPT1A,CPT1A_HUMAN,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",CPT1A CPT1,1374;,"ENST00000265641.10; ENSP00000265641.4; ENSG00000110090.13. [P50416-1];""ENST00000376618.6; ENSP00000365803.2; ENSG00000110090.13. [P50416-2]"";""ENST00000539743.5; ENSP00000446108.1; ENSG00000110090.13. [P50416-1]"";""ENST00000540367.5; ENSP00000439084.1; ENSG00000110090.13. [P50416-2]"";",carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; protein-macromolecule adaptor activity [GO:0030674],aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
P23786,M1,-1.343462473,-0.693105457,0.402197724,0.816711921,-0.184195116,burlywood4,CPT2,CPT2_HUMAN,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)",CPT2 CPT1,1376;,ENST00000371486.4; ENSP00000360541.3; ENSG00000157184.7.;,acyltransferase activity [GO:0016746]; carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095],carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; in utero embryonic development [GO:0001701]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of cold-induced thermogenesis [GO:0120162],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P29373,C4,2.204196383,0.006147283,-1.008843796,-0.997303413,-1.32675518,deepskyblue2,CRABP2,RABP2_HUMAN,Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II),CRABP2,1382;,"ENST00000368221.1; ENSP00000357204.1; ENSG00000143320.9.;""ENST00000368222.8; ENSP00000357205.3; ENSG00000143320.9."";""ENST00000621784.4; ENSP00000482841.1; ENSG00000143320.9."";",cyclin binding [GO:0030332]; fatty acid binding [GO:0005504]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinoid binding [GO:0005501]; retinol binding [GO:0019841],embryonic forelimb morphogenesis [GO:0035115]; epidermis development [GO:0008544]; fatty acid transport [GO:0015908]; positive regulation of collateral sprouting [GO:0048672]; regulation of DNA-templated transcription [GO:0006355]; retinoic acid metabolic process [GO:0042573]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96SW2,C5,1.652372244,0.521549357,-0.547552586,-0.588967058,-0.755786585,turquoise3,CRBN,CRBN_HUMAN,Protein cereblon,CRBN AD-006,51185;,"ENST00000231948.9; ENSP00000231948.4; ENSG00000113851.16. [Q96SW2-1];""ENST00000432408.6; ENSP00000412499.2; ENSG00000113851.16. [Q96SW2-2]"";",metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325],locomotory exploration behavior [GO:0035641]; negative regulation of monoatomic ion transmembrane transport [GO:0034766]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of Wnt signaling pathway [GO:0030177]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q92793,N4,-0.71973564,1.502407952,-0.367061047,-0.959827133,-1.162739929,grey30,CREBBP,CBP_HUMAN,CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-),CREBBP CBP,1387;,"ENST00000262367.10; ENSP00000262367.5; ENSG00000005339.15. [Q92793-1];""ENST00000382070.7; ENSP00000371502.3; ENSG00000005339.15. [Q92793-2]"";",acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase activity [GO:0120300]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],canonical NF-kappaB signal transduction [GO:0007249]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of DNA-templated transcription [GO:0006355]; regulation of smoothened signaling pathway [GO:0008589]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]
Q96HD1,S2,-1.393876994,-1.722729992,0.383579644,0.86830019,0.576820552,orange,CRELD1,CREL1_HUMAN,Protein disulfide isomerase CRELD1 (EC 5.3.4.1) (Cysteine-rich with EGF-like domain protein 1),CRELD1 CIRRIN UNQ188/PRO214,78987;,"ENST00000326434.9; ENSP00000321856.5; ENSG00000163703.20. [Q96HD1-2];""ENST00000383811.8; ENSP00000373322.3; ENSG00000163703.20. [Q96HD1-1]"";""ENST00000452070.6; ENSP00000393643.2; ENSG00000163703.20. [Q96HD1-1]"";""ENST00000682783.1; ENSP00000508358.1; ENSG00000163703.20. [Q96HD1-1]"";""ENST00000684493.1; ENSP00000507127.1; ENSG00000163703.20. [Q96HD1-1]"";",calcium ion binding [GO:0005509]; protein disulfide isomerase activity [GO:0003756],cardiac septum development [GO:0003279]; endocardial cushion development [GO:0003197],collagen-containing extracellular matrix [GO:0062023]; membrane [GO:0016020]
Q9NZV1,S3,-1.567336272,-0.822905952,0.124307147,0.805031989,0.576476805,salmon,CRIM1,CRIM1_HUMAN,Cysteine-rich motor neuron 1 protein (CRIM-1) (Cysteine-rich repeat-containing protein S52) [Cleaved into: Processed cysteine-rich motor neuron 1 protein],CRIM1 S52 UNQ1886/PRO4330,51232;,ENST00000280527.7; ENSP00000280527.2; ENSG00000150938.10.;,insulin-like growth factor receptor activity [GO:0005010]; PDZ domain binding [GO:0030165]; serine-type endopeptidase inhibitor activity [GO:0004867],negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399],extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P46108,C5,1.892032687,0.506529452,-0.933161834,-0.814204969,-0.968831978,turquoise3,CRK,CRK_HUMAN,Adapter molecule crk (Proto-oncogene c-Crk) (p38),CRK,1398;,"ENST00000300574.3; ENSP00000300574.2; ENSG00000167193.8. [P46108-1];""ENST00000398970.5; ENSP00000381942.5; ENSG00000167193.8. [P46108-2]"";",cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; insulin-like growth factor receptor binding [GO:0005159]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; protein phosphorylated amino acid binding [GO:0045309]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin protein ligase binding [GO:0031625],actin cytoskeleton organization [GO:0030036]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to endothelin [GO:1990859]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nitric oxide [GO:0071732]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; negative regulation of cell motility [GO:2000146]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of wound healing [GO:0061045]; neuron migration [GO:0001764]; positive regulation of cell growth [GO:0030307]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; protein localization to membrane [GO:0072657]; reelin-mediated signaling pathway [GO:0038026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of GTPase activity [GO:0043087]; regulation of intracellular signal transduction [GO:1902531]; regulation of signal transduction [GO:0009966]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholecystokinin [GO:0061847]; response to hepatocyte growth factor [GO:0035728]; response to hydrogen peroxide [GO:0042542]; response to peptide [GO:1901652]; response to yeast [GO:0001878],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
P46109,C5,1.910493827,0.623117662,-0.894648707,-0.984952052,-1.165832806,turquoise3,CRKL,CRKL_HUMAN,Crk-like protein,CRKL,1399;,"ENST00000354336.8; ENSP00000346300.3; ENSG00000099942.13.;""ENST00000411769.1; ENSP00000396646.1; ENSG00000099942.13."";",cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591],acetylcholine receptor signaling pathway [GO:0095500]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; Ras protein signal transduction [GO:0007265]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of T cell migration [GO:2000404]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]
Q8IUI8,C4,1.930108437,0.478048559,-0.856866635,-0.935169412,-1.103639202,deepskyblue2,CRLF3,CRLF3_HUMAN,Cytokine receptor-like factor 3 (Cytokine receptor-like molecule 9) (CREME-9) (Cytokine receptor-related protein 4) (Type I cytokine receptor-like factor p48),CRLF3 CREME9 CRLM9 CYTOR4 P48,51379;,ENST00000324238.7; ENSP00000318804.6; ENSG00000176390.12. [Q8IUI8-1];,DNA binding [GO:0003677]; identical protein binding [GO:0042802],negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O75718,S3,-1.119927597,-0.169093028,0.154763541,0.734519253,0.176540257,salmon,CRTAP,CRTAP_HUMAN,Cartilage-associated protein,CRTAP CASP,10491;,ENST00000320954.11; ENSP00000323696.5; ENSG00000170275.15.;,0,chaperone-mediated protein folding [GO:0061077]; collagen fibril organization [GO:0030199]; negative regulation of post-translational protein modification [GO:1901874]; protein stabilization [GO:0050821]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]
Q6UUV9,C4,2.145529336,0.338892742,-0.971840883,-1.244300991,-1.567535285,deepskyblue2,CRTC1,CRTC1_HUMAN,CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1),CRTC1 KIAA0616 MECT1 TORC1 WAMTP1,23373;,"ENST00000321949.13; ENSP00000323332.7; ENSG00000105662.16. [Q6UUV9-1];""ENST00000338797.10; ENSP00000345001.5; ENSG00000105662.16. [Q6UUV9-2]"";",cAMP response element binding protein binding [GO:0008140],energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q53ET0,C5,1.475159283,0.555421088,-0.477391053,-0.478352956,-0.777847002,turquoise3,CRTC2,CRTC2_HUMAN,CREB-regulated transcription coactivator 2 (Transducer of regulated cAMP response element-binding protein 2) (TORC-2) (Transducer of CREB protein 2),CRTC2 TORC2,200186;,ENST00000368633.2; ENSP00000357622.1; ENSG00000160741.17.;,cAMP response element binding protein binding [GO:0008140],gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6UUV7,C5,1.390160678,0.401378412,-0.351547275,-0.384889644,-0.683309135,turquoise3,CRTC3,CRTC3_HUMAN,CREB-regulated transcription coactivator 3 (Transducer of regulated cAMP response element-binding protein 3) (TORC-3) (Transducer of CREB protein 3),CRTC3 TORC3,64784;,"ENST00000268184.11; ENSP00000268184.6; ENSG00000140577.17. [Q6UUV7-1];""ENST00000420329.6; ENSP00000416573.2; ENSG00000140577.17. [Q6UUV7-3]"";""ENST00000691029.1; ENSP00000510507.1; ENSG00000140577.17. [Q6UUV7-1]"";",cAMP response element binding protein binding [GO:0008140],energy homeostasis [GO:0097009]; lipid catabolic process [GO:0016042]; macrophage activation [GO:0042116]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of lipid catabolic process [GO:0050995]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P55060,C1,1.528084882,0.097725337,-0.415763311,-0.241346339,-0.441319652,lightblue,CSE1L,XPO2_HUMAN,Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter),CSE1L CAS XPO2,1434;,"ENST00000262982.3; ENSP00000262982.2; ENSG00000124207.17. [P55060-1];""ENST00000396192.7; ENSP00000379495.3; ENSG00000124207.17. [P55060-4]"";",nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267],protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P41240,C3,1.832558097,0.067103786,-0.75352494,-0.568400063,-0.828613197,cyan,CSK,CSK_HUMAN,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),CSK,1445;,"ENST00000220003.14; ENSP00000220003.9; ENSG00000103653.17.;""ENST00000439220.6; ENSP00000414764.2; ENSG00000103653.17."";""ENST00000567571.5; ENSP00000454906.1; ENSG00000103653.17."";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782],adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
P04080,C4,2.112121101,-0.17686949,-0.88915851,-1.007465704,-1.022006032,deepskyblue2,CSTB,CYTB_HUMAN,Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B),CSTB CST6 STFB,1476;,ENST00000291568.7; ENSP00000291568.6; ENSG00000160213.10.;,cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; protease binding [GO:0002020]; RNA binding [GO:0003723],adult locomotory behavior [GO:0008344]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]
Q12996,N2,-1.310023197,0.43848203,0.908403507,-0.220044097,-0.197807885,grey70,CSTF3,CSTF3_HUMAN,Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit) (CSTF 77 kDa subunit) (CstF-77),CSTF3,1479;,"ENST00000323959.9; ENSP00000315791.4; ENSG00000176102.13. [Q12996-1];""ENST00000431742.2; ENSP00000393064.2; ENSG00000176102.13. [Q12996-3]"";""ENST00000438862.6; ENSP00000388711.2; ENSG00000176102.13. [Q12996-2]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; RNA 3'-end processing [GO:0031123]",mRNA cleavage stimulating factor complex [GO:0005848]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13363,N4,-0.256954423,1.134962001,-0.065133087,-0.409306485,-0.589646784,grey30,CTBP1,CTBP1_HUMAN,C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-),CTBP1 CTBP,1487;,"ENST00000290921.10; ENSP00000290921.6; ENSG00000159692.18. [Q13363-1];""ENST00000382952.8; ENSP00000372411.3; ENSG00000159692.18. [Q13363-2]"";""ENST00000703138.1; ENSP00000515195.1; ENSG00000159692.18. [Q13363-2]"";""ENST00000703163.1; ENSP00000515211.1; ENSG00000159692.18. [Q13363-2]"";","chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein domain specific binding [GO:0019904]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]",negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; viral genome replication [GO:0019079]; white fat cell differentiation [GO:0050872],GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic active zone cytoplasmic component [GO:0098831]; transcription repressor complex [GO:0017053]
P49711,N1,-1.241597894,-0.715943554,0.528930489,-0.634665545,1.145286431,grey90,CTCF,CTCF_HUMAN,Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog),CTCF,10664;,"ENST00000264010.10; ENSP00000264010.4; ENSG00000102974.16. [P49711-1];""ENST00000401394.6; ENSP00000384707.1; ENSG00000102974.16. [P49711-2]"";""ENST00000642819.1; ENSP00000494408.1; ENSG00000102974.16. [P49711-1]"";""ENST00000644753.1; ENSP00000493495.1; ENSG00000102974.16. [P49711-1]"";""ENST00000645699.1; ENSP00000495348.1; ENSG00000102974.16. [P49711-1]"";""ENST00000646076.1; ENSP00000494538.1; ENSG00000102974.16. [P49711-1]"";","chromatin insulator sequence binding [GO:0043035]; chromatin loop anchoring activity [GO:0140587]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]","chromatin looping [GO:0140588]; chromosome segregation [GO:0007059]; epigenetic regulation of gene expression [GO:0040029]; genomic imprinting [GO:0071514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of centromeric sister chromatid cohesion [GO:0070602]","chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q9Y5B0,N4,0.122259013,1.224997875,-0.358234491,-0.485851302,-0.80282582,grey30,CTDP1,CTDP1_HUMAN,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),CTDP1 FCP1,9150;,"ENST00000075430.11; ENSP00000075430.7; ENSG00000060069.18. [Q9Y5B0-4];""ENST00000613122.5; ENSP00000484525.2; ENSG00000060069.18. [Q9Y5B0-1]"";",myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096],cell division [GO:0051301]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription elongation by RNA polymerase II [GO:0006368],centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]
P32929,C4,1.967128925,0.179055538,-0.864975473,-0.989407703,-1.154635025,deepskyblue2,CTH,CGL_HUMAN,Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2),CTH,1491;,"ENST00000346806.2; ENSP00000311554.2; ENSG00000116761.12. [P32929-2];""ENST00000370938.8; ENSP00000359976.3; ENSG00000116761.12. [P32929-1]"";""ENST00000411986.6; ENSP00000413407.2; ENSG00000116761.12. [P32929-3]"";",calmodulin binding [GO:0005516]; cystathionine gamma-lyase activity [GO:0004123]; homocysteine desulfhydrase activity [GO:0047982]; identical protein binding [GO:0042802]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; selenocystathionine gamma-lyase activity [GO:0098606],cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; endoplasmic reticulum unfolded protein response [GO:0030968]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein homotetramerization [GO:0051289]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P35221,S4,-0.835507835,-1.256612158,0.561160595,0.869710258,0.005911078,tomato2,CTNNA1,CTNA1_HUMAN,Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13),CTNNA1,1495;,"ENST00000302763.12; ENSP00000304669.7; ENSG00000044115.21. [P35221-1];""ENST00000540387.5; ENSP00000438476.1; ENSG00000044115.21. [P35221-3]"";",actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; gamma-catenin binding [GO:0045295]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; vinculin binding [GO:0017166],apical junction assembly [GO:0043297]; axon regeneration [GO:0031103]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to indole-3-methanol [GO:0071681]; epithelial cell-cell adhesion [GO:0090136]; establishment or maintenance of cell polarity [GO:0007163]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; gap junction assembly [GO:0016264]; integrin-mediated signaling pathway [GO:0007229]; male gonad development [GO:0008584]; negative regulation of cell motility [GO:2000146]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of protein localization to nucleus [GO:1900181]; neuroblast proliferation [GO:0007405]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization [GO:0008104]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224],acrosomal vesicle [GO:0001669]; actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zonula adherens [GO:0005915]
P35222,M1,-0.863899005,-0.901947654,0.539352837,0.769796848,0.027277567,burlywood4,CTNNB1,CTNB1_HUMAN,Catenin beta-1 (Beta-catenin),CTNNB1 CTNNB OK/SW-cl.35 PRO2286,1499;,"ENST00000349496.11; ENSP00000344456.5; ENSG00000168036.18.;""ENST00000396183.7; ENSP00000379486.3; ENSG00000168036.18."";""ENST00000396185.8; ENSP00000379488.3; ENSG00000168036.18."";""ENST00000405570.6; ENSP00000385604.1; ENSG00000168036.18."";""ENST00000431914.6; ENSP00000412219.2; ENSG00000168036.18."";""ENST00000433400.6; ENSP00000387455.2; ENSG00000168036.18."";""ENST00000441708.2; ENSP00000401599.2; ENSG00000168036.18."";""ENST00000450969.6; ENSP00000409302.2; ENSG00000168036.18."";""ENST00000642248.1; ENSP00000495244.1; ENSG00000168036.18."";""ENST00000642315.1; ENSP00000495076.1; ENSG00000168036.18."";""ENST00000642426.1; ENSP00000495719.1; ENSG00000168036.18."";""ENST00000642992.1; ENSP00000496385.1; ENSG00000168036.18."";""ENST00000643031.1; ENSP00000495450.1; ENSG00000168036.18."";""ENST00000643297.1; ENSP00000494677.1; ENSG00000168036.18."";""ENST00000643541.1; ENSP00000494411.1; ENSG00000168036.18."";""ENST00000643977.1; ENSP00000494053.1; ENSG00000168036.18."";""ENST00000643992.1; ENSP00000493610.1; ENSG00000168036.18."";""ENST00000644867.1; ENSP00000495992.1; ENSG00000168036.18."";""ENST00000645210.1; ENSP00000496180.1; ENSG00000168036.18."";""ENST00000645320.1; ENSP00000495360.1; ENSG00000168036.18."";""ENST00000645982.1; ENSP00000494845.1; ENSG00000168036.18."";""ENST00000646369.1; ENSP00000494914.1; ENSG00000168036.18."";""ENST00000646725.1; ENSP00000496021.1; ENSG00000168036.18."";""ENST00000647390.1; ENSP00000493533.1; ENSG00000168036.18."";",alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625],"acinar cell differentiation [GO:0090425]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; apoptotic signaling pathway [GO:0097190]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; hypothalamus development [GO:0021854]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung epithelial cell differentiation [GO:0060487]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal stem cell differentiation [GO:0072497]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; myoblast proliferation [GO:0051450]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; oocyte development [GO:0048599]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; outflow tract morphogenesis [GO:0003151]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of protein ubiquitination [GO:0031396]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of synapse assembly [GO:0051963]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; transcription by RNA polymerase II [GO:0006366]","adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]"
Q9NSA3,C5,1.982369175,0.424383077,-1.193444461,-0.993309641,-1.368078556,turquoise3,CTNNBIP1,CNBP1_HUMAN,Beta-catenin-interacting protein 1 (Inhibitor of beta-catenin and Tcf-4),CTNNBIP1 ICAT,56998;,"ENST00000377256.1; ENSP00000366466.1; ENSG00000178585.15.;""ENST00000377258.5; ENSP00000366468.1; ENSG00000178585.15."";""ENST00000377263.6; ENSP00000366474.1; ENSG00000178585.15."";""ENST00000400904.7; ENSP00000383696.3; ENSG00000178585.15."";",armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013],anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription initiation by RNA polymerase II [GO:0060633]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of vascular permeability involved in acute inflammatory response [GO:0002528]; Wnt signaling pathway [GO:0016055],beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8WYA6,N4,-0.738284245,0.5975405,0.337132986,-0.007875937,-0.14245784,grey30,CTNNBL1,CTBL1_HUMAN,Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (Testis development protein NYD-SP19),CTNNBL1 C20orf33 PP8304,56259;,"ENST00000361383.11; ENSP00000355050.6; ENSG00000132792.21. [Q8WYA6-1];""ENST00000373469.1; ENSP00000362568.1; ENSG00000132792.21. [Q8WYA6-3]"";""ENST00000373473.5; ENSP00000362572.1; ENSG00000132792.21. [Q8WYA6-2]"";""ENST00000628103.2; ENSP00000487198.1; ENSG00000132792.21. [Q8WYA6-4]"";",enzyme binding [GO:0019899],"adaptive immune response [GO:0002250]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]",centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]
O60716,M1,-0.704375122,-0.835634682,0.510913749,0.729754153,-0.017317855,burlywood4,CTNND1,CTND1_HUMAN,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),CTNND1 KIAA0384,1500;,"ENST00000358694.10; ENSP00000351527.6; ENSG00000198561.16. [O60716-5];""ENST00000361332.8; ENSP00000354823.4; ENSG00000198561.16. [O60716-2]"";""ENST00000361391.10; ENSP00000354785.6; ENSG00000198561.16. [O60716-6]"";""ENST00000361796.9; ENSP00000354907.5; ENSG00000198561.16. [O60716-3]"";""ENST00000399050.10; ENSP00000382004.5; ENSG00000198561.16. [O60716-1]"";""ENST00000415361.6; ENSP00000403518.2; ENSG00000198561.16. [O60716-17]"";""ENST00000426142.6; ENSP00000409930.2; ENSG00000198561.16. [O60716-21]"";""ENST00000428599.6; ENSP00000413586.2; ENSG00000198561.16. [O60716-5]"";""ENST00000524630.5; ENSP00000436543.1; ENSG00000198561.16. [O60716-5]"";""ENST00000525902.5; ENSP00000434672.1; ENSG00000198561.16. [O60716-27]"";""ENST00000526357.5; ENSP00000433334.1; ENSG00000198561.16. [O60716-10]"";""ENST00000526772.5; ENSP00000433158.1; ENSG00000198561.16. [O60716-29]"";""ENST00000526938.5; ENSP00000432041.1; ENSG00000198561.16. [O60716-7]"";""ENST00000527467.5; ENSP00000434900.1; ENSG00000198561.16. [O60716-25]"";""ENST00000528232.5; ENSP00000435266.1; ENSG00000198561.16. [O60716-19]"";""ENST00000528621.5; ENSP00000432243.1; ENSG00000198561.16. [O60716-13]"";""ENST00000529526.5; ENSP00000436323.1; ENSG00000198561.16. [O60716-13]"";""ENST00000529873.5; ENSP00000435494.1; ENSG00000198561.16. [O60716-14]"";""ENST00000529986.5; ENSP00000437156.1; ENSG00000198561.16. [O60716-21]"";""ENST00000530094.5; ENSP00000437327.1; ENSG00000198561.16. [O60716-18]"";""ENST00000530748.5; ENSP00000436744.1; ENSG00000198561.16. [O60716-11]"";""ENST00000531014.5; ENSP00000432623.1; ENSG00000198561.16. [O60716-26]"";""ENST00000532245.5; ENSP00000434017.1; ENSG00000198561.16. [O60716-21]"";""ENST00000532463.5; ENSP00000432075.1; ENSG00000198561.16. [O60716-21]"";""ENST00000532649.5; ENSP00000435379.1; ENSG00000198561.16. [O60716-13]"";""ENST00000532787.5; ENSP00000434949.1; ENSG00000198561.16. [O60716-22]"";""ENST00000532844.5; ENSP00000433276.1; ENSG00000198561.16. [O60716-9]"";""ENST00000533667.5; ENSP00000437051.1; ENSG00000198561.16. [O60716-30]"";""ENST00000534579.5; ENSP00000435789.1; ENSG00000198561.16. [O60716-13]"";""ENST00000673683.1; ENSP00000500962.1; ENSG00000198561.16. [O60716-5]"";",beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein sequestering activity [GO:0140311]; protein tyrosine kinase binding [GO:1990782]; signaling receptor binding [GO:0005102],cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein stabilization [GO:0050821]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt signaling pathway [GO:0016055],"adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; Schaffer collateral - CA1 synapse [GO:0098685]; zonula adherens [GO:0005915]"
P17812,C4,2.032468655,0.021044884,-0.812225044,-0.760725989,-0.976056272,deepskyblue2,CTPS1,PYRG1_HUMAN,CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1),CTPS1 CTPS,1503;,"ENST00000372616.1; ENSP00000361699.1; ENSG00000171793.17. [P17812-1];""ENST00000470271.6; ENSP00000497901.2; ENSG00000171793.17. [P17812-1]"";""ENST00000649124.2; ENSP00000497744.1; ENSG00000171793.17. [P17812-1]"";""ENST00000650070.2; ENSP00000497602.1; ENSG00000171793.17. [P17812-1]"";""ENST00000696070.1; ENSP00000512372.1; ENSG00000171793.17. [P17812-2]"";",ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802],'de novo' CTP biosynthetic process [GO:0044210]; B cell proliferation [GO:0042100]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; nucleobase-containing compound metabolic process [GO:0006139]; pyrimidine nucleobase biosynthetic process [GO:0019856]; response to xenobiotic stimulus [GO:0009410]; T cell proliferation [GO:0042098],cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]
Q9NRF8,C3,1.694669301,0.055129607,-0.602807718,-0.455159024,-0.808265838,cyan,CTPS2,PYRG2_HUMAN,CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2),CTPS2,56474;,"ENST00000359276.9; ENSP00000352222.4; ENSG00000047230.15.;""ENST00000380241.7; ENSP00000369590.3; ENSG00000047230.15."";""ENST00000443824.5; ENSP00000401264.1; ENSG00000047230.15."";",ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802],'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856]; pyrimidine nucleotide metabolic process [GO:0006220],cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q6PD62,N4,-1.079988273,0.876629373,0.609664332,-0.342850289,-0.530389617,grey30,CTR9,CTR9_HUMAN,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),CTR9 KIAA0155 SH2BP1,9646;,ENST00000361367.7; ENSP00000355013.2; ENSG00000198730.9.;,RNA polymerase II complex binding [GO:0000993]; SH2 domain binding [GO:0042169],"blastocyst growth [GO:0001832]; blastocyst hatching [GO:0001835]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; inner cell mass cell differentiation [GO:0001826]; interleukin-6-mediated signaling pathway [GO:0070102]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; trophectodermal cell differentiation [GO:0001829]; Wnt signaling pathway [GO:0016055]",Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]
Q9P2B4,C5,0.923077412,0.899106648,-0.421060746,-0.509712057,-0.597907436,turquoise3,CTTNBP2NL,CT2NL_HUMAN,CTTNBP2 N-terminal-like protein,CTTNBP2NL KIAA1433,55917;,ENST00000271277.11; ENSP00000271277.6; ENSG00000143079.15.;,protein phosphatase 2A binding [GO:0051721],negative regulation of transmembrane transport [GO:0034763]; negative regulation of transporter activity [GO:0032410]; protein dephosphorylation [GO:0006470],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; FAR/SIN/STRIPAK complex [GO:0090443]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]
Q2VPK5,C4,2.037439846,0.067151001,-0.747810876,-0.802027116,-1.007723942,deepskyblue2,CTU2,CTU2_HUMAN,Cytoplasmic tRNA 2-thiolation protein 2 (Cytosolic thiouridylase subunit 2),CTU2 C16orf84 NCS2,348180;,"ENST00000312060.9; ENSP00000308617.5; ENSG00000174177.13. [Q2VPK5-5];""ENST00000453996.7; ENSP00000388320.2; ENSG00000174177.13. [Q2VPK5-1]"";",nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049],protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],cytosol [GO:0005829]; protein-containing complex [GO:0032991]
Q9H467,C5,1.797708174,0.680263783,-0.760170274,-0.794805677,-1.348869686,turquoise3,CUEDC2,CUED2_HUMAN,CUE domain-containing protein 2,CUEDC2 C10orf66 HOYS6,79004;,ENST00000369937.5; ENSP00000358953.4; ENSG00000107874.11.;,ubiquitin binding [GO:0043130],negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of macrophage cytokine production [GO:0010936],cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]
Q13616,C2,0.999013499,0.739542251,-0.202000543,-0.37164966,-0.309529507,aquamarine,CUL1,CUL1_HUMAN,Cullin-1 (CUL-1),CUL1,8454;,"ENST00000325222.9; ENSP00000326804.3; ENSG00000055130.18.;""ENST00000409469.5; ENSP00000387160.1; ENSG00000055130.18."";""ENST00000602748.5; ENSP00000473318.1; ENSG00000055130.18."";""ENST00000662716.1; ENSP00000499277.1; ENSG00000055130.18."";""ENST00000663044.1; ENSP00000499398.1; ENSG00000055130.18."";""ENST00000665936.1; ENSP00000499255.1; ENSG00000055130.18."";",protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625],animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005]
Q8IWT3,C1,1.10119929,-0.171323028,-0.377099442,-0.204887824,0.345738098,lightblue,CUL9,CUL9_HUMAN,Cullin-9 (CUL-9) (UbcH7-associated protein 1) (p53-associated parkin-like cytoplasmic protein),CUL9 H7AP1 KIAA0708 PARC,23113;,ENST00000252050.9; ENSP00000252050.4; ENSG00000112659.14. [Q8IWT3-1];,ATP binding [GO:0005524]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],microtubule cytoskeleton organization [GO:0000226]; protein ubiquitination [GO:0016567]; regulation of mitotic nuclear division [GO:0007088]; ubiquitin-dependent protein catabolic process [GO:0006511],cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]
P39880,S3,-1.27968999,-0.402181965,0.22269985,0.728665304,0.540884844,salmon,CUX1,CUX1_HUMAN,Homeobox protein cut-like 1 (CCAAT displacement protein) (CDP) (CDP/Cux p200) (Homeobox protein cux-1) [Cleaved into: CDP/Cux p110],CUX1 CUTL1,1523;,"ENST00000292535.12; ENSP00000292535.7; ENSG00000257923.12. [P39880-1];""ENST00000360264.7; ENSP00000353401.3; ENSG00000257923.12. [P39880-3]"";""ENST00000425244.6; ENSP00000409745.2; ENSG00000257923.12. [P39880-9]"";""ENST00000546411.7; ENSP00000450125.3; ENSG00000257923.12. [P39880-1]"";""ENST00000549414.6; ENSP00000446630.2; ENSG00000257923.12. [P39880-2]"";""ENST00000550008.6; ENSP00000447373.2; ENSG00000257923.12. [P39880-5]"";""ENST00000556210.1; ENSP00000451558.1; ENSG00000257923.12. [P39880-6]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite morphogenesis [GO:0050775]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9HCG8,N2,-1.160850615,-0.176312526,0.785915463,0.119114647,0.30142281,grey70,CWC22,CWC22_HUMAN,Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb),CWC22 KIAA1604 NCM,57703;,ENST00000410053.8; ENSP00000387006.3; ENSG00000163510.14.;,RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]; regulation of mRNA splicing, via spliceosome [GO:0048024]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]
P78310,S4,-1.206830558,-1.540386504,0.522384997,0.983890419,0.358274836,tomato2,CXADR,CXAR_HUMAN,Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR),CXADR CAR,1525;,"ENST00000284878.12; ENSP00000284878.7; ENSG00000154639.19. [P78310-1];""ENST00000356275.10; ENSP00000348620.6; ENSG00000154639.19. [P78310-3]"";""ENST00000400165.5; ENSP00000383029.1; ENSG00000154639.19. [P78310-4]"";""ENST00000400166.5; ENSP00000383030.1; ENSG00000154639.19. [P78310-5]"";""ENST00000400169.1; ENSP00000383033.1; ENSG00000154639.19. [P78310-6]"";",beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618],actin cytoskeleton organization [GO:0030036]; AV node cell to bundle of His cell communication [GO:0086067]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; cardiac muscle cell development [GO:0055013]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633],acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
A2AJT9,N3,-0.942410782,-1.019178399,0.881574812,0.183445671,0.303390157,grey50,CXorf23,BCLA3_HUMAN,BCLAF1 and THRAP3 family member 3,BCLAF3 CXorf23,256643;,"ENST00000379682.9; ENSP00000369004.4; ENSG00000173681.17. [A2AJT9-1];""ENST00000379687.8; ENSP00000369009.3; ENSG00000173681.17. [A2AJT9-2]"";",DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712],positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592]; mitochondrion [GO:0005739]
Q8TB03,C3,1.963818814,-0.013182581,-0.607412956,-0.43582952,-0.844508477,cyan,CXorf38,CX038_HUMAN,Uncharacterized protein CXorf38,CXorf38,159013;,"ENST00000327877.10; ENSP00000330488.5; ENSG00000185753.13. [Q8TB03-1];""ENST00000378421.1; ENSP00000367677.1; ENSG00000185753.13. [Q8TB03-2]"";""ENST00000378426.5; ENSP00000367683.1; ENSG00000185753.13. [Q8TB03-2]"";",0,0,0
Q9P0U4,N4,-1.189386192,0.994223051,0.223316974,-0.59396652,-0.39368151,grey30,CXXC1,CXXC1_HUMAN,CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1),CXXC1 CFP1 CGBP PCCX1 PHF18,30827;,"ENST00000285106.11; ENSP00000285106.6; ENSG00000154832.16. [Q9P0U4-1];""ENST00000412036.6; ENSP00000390475.1; ENSG00000154832.16. [Q9P0U4-2]"";",cis-regulatory region sequence-specific DNA binding [GO:0000987]; methylated histone binding [GO:0035064]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270],positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355],cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]
P00167,S3,-0.459036552,-0.722308619,0.213996993,0.684332217,0.512229217,salmon,CYB5A,CYB5_HUMAN,Cytochrome b5 (Microsomal cytochrome b5 type A) (MCB5),CYB5A CYB5,1528;,"ENST00000340533.9; ENSP00000341625.4; ENSG00000166347.19. [P00167-1];""ENST00000397914.4; ENSP00000381011.4; ENSG00000166347.19. [P00167-3]"";""ENST00000494131.6; ENSP00000436461.2; ENSG00000166347.19. [P00167-2]"";",cytochrome-c oxidase activity [GO:0004129]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872],0,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]
O43169,S2,-0.949795686,-1.217693435,0.231260451,0.91441728,0.493715033,orange,CYB5B,CYB5B_HUMAN,Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform),CYB5B CYB5M OMB5,80777;,ENST00000307892.13; ENSP00000308430.8; ENSG00000103018.18.;,enzyme activator activity [GO:0008047]; heme binding [GO:0020037]; metal ion binding [GO:0046872],nitric oxide biosynthetic process [GO:0006809]; response to oxidative stress [GO:0006979]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nitric-oxide synthase complex [GO:1903958]
Q8WUJ1,S3,-0.783087049,-0.915599786,0.386266474,0.770573284,0.548527842,salmon,CYB5D2,NEUFC_HUMAN,Neuferricin (Cytochrome b5 domain-containing protein 2),CYB5D2,124936;,"ENST00000301391.8; ENSP00000301391.4; ENSG00000167740.10. [Q8WUJ1-1];""ENST00000575251.5; ENSP00000458903.1; ENSG00000167740.10. [Q8WUJ1-3]"";""ENST00000577075.6; ENSP00000458352.2; ENSG00000167740.10. [Q8WUJ1-3]"";",heme binding [GO:0020037],neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666],endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020]
P00387,S2,-1.143172385,-1.434563733,0.272962779,0.86789917,0.471543553,orange,CYB5R3,NB5R3_HUMAN,NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1),CYB5R3 DIA1,1727;,"ENST00000352397.10; ENSP00000338461.6; ENSG00000100243.22. [P00387-1];""ENST00000402438.6; ENSP00000385679.1; ENSG00000100243.22. [P00387-2]"";""ENST00000407623.8; ENSP00000384834.3; ENSG00000100243.22. [P00387-2]"";""ENST00000687198.1; ENSP00000508492.1; ENSG00000100243.22. [P00387-2]"";""ENST00000688117.1; ENSP00000509015.1; ENSG00000100243.22. [P00387-3]"";""ENST00000692152.1; ENSP00000509317.1; ENSG00000100243.22. [P00387-2]"";","ADP binding [GO:0043531]; AMP binding [GO:0016208]; cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; NAD binding [GO:0051287]",blood circulation [GO:0008015]; cholesterol biosynthetic process [GO:0006695]; nitric oxide biosynthetic process [GO:0006809],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958]
Q7L1T6,C5,1.91870525,0.352286129,-0.567849346,-0.63861404,-0.896882268,turquoise3,CYB5R4,NB5R4_HUMAN,Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R),CYB5R4 NCB5OR,51167;,ENST00000369681.10; ENSP00000358695.3; ENSG00000065615.14.;,"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]",bicarbonate transport [GO:0015701]; cell development [GO:0048468]; detection of oxygen [GO:0003032]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]
P08574,M2,-0.729292989,-1.045839153,0.335229889,1.077563438,-0.049991115,tan4,CYC1,CY1_HUMAN,"Cytochrome c1, heme protein, mitochondrial (EC 7.1.1.8) (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)",CYC1,1537;,ENST00000318911.5; ENSP00000317159.4; ENSG00000179091.5.;,heme binding [GO:0020037]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121],"cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to glucagon [GO:0033762]",membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
P0DTL6,N4,-0.661623583,1.246381806,-0.233194826,-0.270493148,-0.716167436,grey30,CYHR1,ZTRF1_HUMAN,Zinc finger TRAF-type-containing protein 1 (Cysteine and histidine-rich protein 1),ZFTRAF1 CYHR1 KIAA0496,157542;50626;84773;,ENST00000530374.6; ENSP00000433769.1; ENSG00000187954.14. [P0DTL6-5];,zinc ion binding [GO:0008270],0,perinuclear region of cytoplasm [GO:0048471]
Q6UW02,S2,-1.307392271,-1.531141773,0.144071346,0.893330558,0.678413194,orange,CYP20A1,CP20A_HUMAN,Cytochrome P450 20A1 (EC 1.14.-.-),CYP20A1 UNQ667/PRO1301,57404;,ENST00000356079.9; ENSP00000348380.4; ENSG00000119004.17. [Q6UW02-1];,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",0,membrane [GO:0016020]
Q16850,S2,-1.414602472,-1.773271568,0.287441479,0.927300307,0.717123784,orange,CYP51A1,CP51A_HUMAN,Lanosterol 14-alpha demethylase (LDM) (EC 1.14.14.154) (CYPLI) (Cytochrome P450 51A1) (CYP51A1) (Cytochrome P450-14DM) (Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-alpha demethylase),CYP51A1 CYP51,1595;,"ENST00000003100.13; ENSP00000003100.8; ENSG00000001630.18. [Q16850-1];""ENST00000450723.5; ENSP00000406757.1; ENSG00000001630.18. [Q16850-2]"";",heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; sterol 14-demethylase activity [GO:0008398],cholesterol biosynthetic process [GO:0006695]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
O00622,S3,-1.408415116,-0.914418458,0.200816059,0.486767147,0.848745351,salmon,CYR61,CCN1_HUMAN,CCN family member 1 (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1),CCN1 CYR61 GIG1 IGFBP10,3491;,ENST00000451137.7; ENSP00000398736.2; ENSG00000142871.18.;,extracellular matrix binding [GO:0050840]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; integrin binding [GO:0005178],"apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]",collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]
Q15438,C2,1.232463527,0.428910308,-0.243662608,-0.176032531,-0.52870912,aquamarine,CYTH1,CYH1_HUMAN,"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (SEC7 homolog B2-1)",CYTH1 D17S811E PSCD1,9267;,"ENST00000446868.8; ENSP00000389095.3; ENSG00000108669.18. [Q15438-1];""ENST00000585509.5; ENSP00000465940.1; ENSG00000108669.18. [Q15438-3]"";""ENST00000589297.5; ENSP00000466512.1; ENSG00000108669.18. [Q15438-3]"";""ENST00000591455.5; ENSP00000465665.1; ENSG00000108669.18. [Q15438-2]"";",guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289],establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]
O43739,C2,1.11611557,0.382001901,-0.203090701,-0.122246413,-0.449838741,aquamarine,CYTH3,CYH3_HUMAN,"Cytohesin-3 (ARF nucleotide-binding site opener 3) (Protein ARNO3) (General receptor of phosphoinositides 1) (Grp1) (PH, SEC7 and coiled-coil domain-containing protein 3)",CYTH3 ARNO3 GRP1 PSCD3,9265;,ENST00000350796.8; ENSP00000297044.7; ENSG00000008256.17. [O43739-2];,"guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]",establishment of epithelial cell polarity [GO:0090162]; Golgi vesicle transport [GO:0048193]; positive regulation of cell adhesion [GO:0045785]; regulation of ARF protein signal transduction [GO:0032012],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ruffle [GO:0001726]
Q9Y4D1,S4,-1.386614774,-1.564522458,0.505555287,1.003546455,0.315778581,tomato2,DAAM1,DAAM1_HUMAN,Disheveled-associated activator of morphogenesis 1,DAAM1 KIAA0666,23002;,"ENST00000360909.8; ENSP00000354162.3; ENSG00000100592.16. [Q9Y4D1-2];""ENST00000395125.1; ENSP00000378557.1; ENSG00000100592.16. [Q9Y4D1-1]"";",actin binding [GO:0003779]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267],"actin cytoskeleton organization [GO:0030036]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",ciliary basal body [GO:0036064]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]
Q14118,S3,-0.991510142,-0.42258783,0.340934536,0.700382457,0.401270441,salmon,DAG1,DAG1_HUMAN,Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)],DAG1,1605;,"ENST00000308775.7; ENSP00000312435.2; ENSG00000173402.13.;""ENST00000418588.6; ENSP00000405859.2; ENSG00000173402.13."";""ENST00000421560.6; ENSP00000412067.2; ENSG00000173402.13."";""ENST00000428779.7; ENSP00000401382.3; ENSG00000173402.13."";""ENST00000430636.2; ENSP00000401805.2; ENSG00000173402.13."";""ENST00000431960.6; ENSP00000388833.2; ENSG00000173402.13."";""ENST00000435508.8; ENSP00000415321.4; ENSG00000173402.13."";""ENST00000452060.7; ENSP00000410145.3; ENSG00000173402.13."";""ENST00000452317.6; ENSP00000387859.2; ENSG00000173402.13."";""ENST00000466701.2; ENSP00000513216.1; ENSG00000173402.13."";""ENST00000469139.2; ENSP00000501165.2; ENSG00000173402.13."";""ENST00000496474.2; ENSP00000513217.1; ENSG00000173402.13."";""ENST00000673708.1; ENSP00000501140.1; ENSG00000173402.13."";""ENST00000697271.1; ENSP00000513218.1; ENSG00000173402.13."";",actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; protein-containing complex binding [GO:0044877]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; virus receptor activity [GO:0001618],angiogenesis involved in wound healing [GO:0060055]; axon guidance [GO:0007411]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; heart morphogenesis [GO:0003007]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; morphogenesis of an epithelial sheet [GO:0002011]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; nerve development [GO:0021675]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein transport [GO:0015031]; regulation of embryonic cell shape [GO:0016476]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; regulation of synaptic plasticity [GO:0048167]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to muscle activity [GO:0014850]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; skeletal muscle tissue regeneration [GO:0043403],adherens junction [GO:0005912]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; collagen-containing extracellular matrix [GO:0062023]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]
Q8NCG7,S1,-0.278418731,-1.15882856,-0.247409118,0.259044956,1.068315092,gold,DAGLB,DGLB_HUMAN,Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta),DAGLB,221955;,"ENST00000297056.11; ENSP00000297056.6; ENSG00000164535.15. [Q8NCG7-1];""ENST00000425398.6; ENSP00000391171.2; ENSG00000164535.15. [Q8NCG7-4]"";",acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806],arachidonic acid metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727],lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q3LXA3,C5,1.996412796,0.484825149,-0.817842012,-0.791702584,-1.103190797,turquoise3,DAK,TKFC_HUMAN,Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)],TKFC DAK,26007;,ENST00000394900.8; ENSP00000378360.3; ENSG00000149476.16. [Q3LXA3-1];,ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354],carbohydrate metabolic process [GO:0005975]; carbohydrate phosphorylation [GO:0046835]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
P07108,C4,2.438621879,0.183891222,-1.366129935,-1.351864817,-1.687957556,deepskyblue2,DBI,ACBP_HUMAN,Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP),DBI,1622;,"ENST00000311521.8; ENSP00000311117.4; ENSG00000155368.18. [P07108-2];""ENST00000355857.8; ENSP00000348116.3; ENSG00000155368.18. [P07108-1]"";""ENST00000393103.2; ENSP00000376815.2; ENSG00000155368.18. [P07108-3]"";""ENST00000409094.5; ENSP00000386486.1; ENSG00000155368.18. [P07108-2]"";""ENST00000535757.5; ENSP00000439012.1; ENSG00000155368.18. [P07108-2]"";""ENST00000627093.2; ENSP00000486281.1; ENSG00000155368.18. [P07108-4]"";""ENST00000627305.2; ENSP00000486361.1; ENSG00000155368.18. [P07108-5]"";",benzodiazepine receptor binding [GO:0030156]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA binding [GO:0036042],fatty acid metabolic process [GO:0006631]; negative regulation of protein lipidation [GO:1903060]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of phospholipid transport [GO:2001140],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; perinuclear endoplasmic reticulum [GO:0097038]; protein-lipid complex [GO:0032994]
Q9H9R9,C4,2.351228645,0.059767715,-1.335773594,-1.339087735,-1.681158389,deepskyblue2,DBNDD1,DBND1_HUMAN,Dysbindin domain-containing protein 1,DBNDD1,79007;,"ENST00000002501.11; ENSP00000002501.6; ENSG00000003249.15. [Q9H9R9-1];""ENST00000304733.8; ENSP00000306407.3; ENSG00000003249.15. [Q9H9R9-2]"";",0,0,cytoplasm [GO:0005737]
Q9UJU6,C4,2.068504467,0.06269956,-0.916236646,-0.893093515,-1.195211303,deepskyblue2,DBNL,DBNL_HUMAN,Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7),DBNL CMAP SH3P7 PP5423,28988;,"ENST00000440166.5; ENSP00000415173.1; ENSG00000136279.21. [Q9UJU6-5];""ENST00000448521.6; ENSP00000411701.1; ENSG00000136279.21. [Q9UJU6-1]"";""ENST00000456905.5; ENSP00000416421.1; ENSG00000136279.21. [Q9UJU6-6]"";""ENST00000468694.5; ENSP00000417653.1; ENSG00000136279.21. [Q9UJU6-3]"";""ENST00000490734.6; ENSP00000417749.2; ENSG00000136279.21. [Q9UJU6-4]"";""ENST00000494774.5; ENSP00000419992.1; ENSG00000136279.21. [Q9UJU6-2]"";",actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973],adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; neuron projection morphogenesis [GO:0048812]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; synapse assembly [GO:0007416],anchoring junction [GO:0070161]; cell cortex [GO:0005938]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]
Q9NV06,N3,-0.726780177,-0.956152254,1.124008863,0.004066079,0.181781738,grey50,DCAF13,DCA13_HUMAN,DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1),DCAF13 WDSOF1 HSPC064,25879;,ENST00000612750.5; ENSP00000484962.1; ENSG00000164934.15. [Q9NV06-1];,nuclear estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],"decidualization [GO:0046697]; epigenetic programming in the zygotic pronuclei [GO:0044725]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; oocyte growth [GO:0001555]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; rRNA processing [GO:0006364]; spindle assembly involved in female meiosis [GO:0007056]",cell junction [GO:0030054]; centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q96PD2,S2,-1.128598107,-0.971762587,0.344527218,0.867030068,0.357894944,orange,DCBLD2,DCBD2_HUMAN,"Discoidin, CUB and LCCL domain-containing protein 2 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1) (Endothelial and smooth muscle cell-derived neuropilin-like protein)",DCBLD2 CLCP1 ESDN,131566;,"ENST00000326840.11; ENSP00000321573.6; ENSG00000057019.16. [Q96PD2-1];""ENST00000326857.9; ENSP00000321646.9; ENSG00000057019.16. [Q96PD2-2]"";",signaling receptor activity [GO:0038023],intracellular receptor signaling pathway [GO:0030522]; negative regulation of cell growth [GO:0030308]; wound healing [GO:0042060],cell surface [GO:0009986]; plasma membrane [GO:0005886]
P32321,C5,2.207695223,0.343477258,-1.312004742,-1.267039062,-1.46647741,turquoise3,DCTD,DCTD_HUMAN,Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase),DCTD,1635;,"ENST00000357067.7; ENSP00000349576.3; ENSG00000129187.15. [P32321-2];""ENST00000438320.7; ENSP00000398194.2; ENSG00000129187.15. [P32321-1]"";""ENST00000510370.5; ENSP00000424017.1; ENSG00000129187.15. [P32321-1]"";",dCMP deaminase activity [GO:0004132]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],cytidine deamination [GO:0009972]; nucleoside salvage [GO:0043174]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q14203,C1,1.43018787,0.239415082,-0.596080847,-0.366790642,-0.215014916,lightblue,DCTN1,DCTN1_HUMAN,Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued),DCTN1,1639;,"ENST00000394003.7; ENSP00000377571.3; ENSG00000204843.13. [Q14203-6];""ENST00000409240.5; ENSP00000386406.1; ENSG00000204843.13. [Q14203-3]"";""ENST00000409438.5; ENSP00000387270.1; ENSG00000204843.13. [Q14203-5]"";""ENST00000409567.7; ENSP00000386843.3; ENSG00000204843.13. [Q14203-4]"";""ENST00000628224.3; ENSP00000487279.2; ENSG00000204843.13. [Q14203-1]"";""ENST00000633691.1; ENSP00000487724.1; ENSG00000204843.13. [Q14203-2]"";",microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631],"cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; establishment of mitotic spindle orientation [GO:0000132]; maintenance of synapse structure [GO:0099558]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear membrane disassembly [GO:0051081]; nuclear migration [GO:0007097]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; ventral spinal cord development [GO:0021517]",axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; cell leading edge [GO:0031252]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein complex [GO:0030286]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]
Q13561,C1,1.515733884,0.331129049,-0.689879055,-0.548857724,-0.234735616,lightblue,DCTN2,DCTN2_HUMAN,Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit) (DCTN-50) (p50 dynamitin),DCTN2 DCTN50,10540;,"ENST00000434715.7; ENSP00000408910.3; ENSG00000175203.17. [Q13561-2];""ENST00000543672.6; ENSP00000439376.2; ENSG00000175203.17. [Q13561-3]"";""ENST00000548249.6; ENSP00000447824.1; ENSG00000175203.17. [Q13561-1]"";",identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507],melanosome transport [GO:0032402]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]
Q9UJW0,C2,1.33316691,0.207921259,-0.517182926,-0.278121593,-0.203630715,aquamarine,DCTN4,DCTN4_HUMAN,Dynactin subunit 4 (Dyn4) (Dynactin subunit p62),DCTN4,51164;,"ENST00000424236.5; ENSP00000411251.1; ENSG00000132912.13. [Q9UJW0-2];""ENST00000446090.6; ENSP00000414906.2; ENSG00000132912.13. [Q9UJW0-3]"";""ENST00000447998.7; ENSP00000416968.2; ENSG00000132912.13. [Q9UJW0-1]"";",0,0,cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]
Q9BTE1,C1,1.685774701,0.217110756,-0.700850095,-0.369564467,-0.228857567,lightblue,DCTN5,DCTN5_HUMAN,Dynactin subunit 5 (Dynactin subunit p25),DCTN5,84516;,"ENST00000300087.7; ENSP00000300087.2; ENSG00000166847.10. [Q9BTE1-1];""ENST00000563998.5; ENSP00000454691.1; ENSG00000166847.10. [Q9BTE1-2]"";""ENST00000568272.1; ENSP00000455685.1; ENSG00000166847.10. [Q9BTE1-3]"";",0,aorta development [GO:0035904]; coronary vasculature development [GO:0060976]; ventricular septum development [GO:0003281],centrosome [GO:0005813]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]
O00399,C1,1.80630525,0.430750785,-0.654181055,-0.608363771,-0.533362196,lightblue,DCTN6,DCTN6_HUMAN,Dynactin subunit 6 (Dynactin subunit p27) (Protein WS-3),DCTN6 WS3,10671;,ENST00000221114.8; ENSP00000221114.3; ENSG00000104671.8.;,dynein complex binding [GO:0070840],mitotic spindle organization [GO:0007052],centrosome [GO:0005813]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; kinetochore [GO:0000776]
Q9H773,C5,1.755635417,0.416689111,-0.768844372,-0.776711601,-0.943897971,turquoise3,DCTPP1,DCTP1_HUMAN,dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein),DCTPP1 XTP3TPA CDA03,79077;,ENST00000319285.5; ENSP00000322524.4; ENSG00000179958.10.;,dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556],dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96GG9,C5,1.871373145,0.649864824,-0.962083141,-1.207927675,-1.419531644,turquoise3,DCUN1D1,DCNL1_HUMAN,DCN1-like protein 1 (DCNL1) (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene),DCUN1D1 DCN1 DCUN1L1 RP42 SCCRO,54165;,ENST00000292782.9; ENSP00000292782.4; ENSG00000043093.15.;,cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182],positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]; regulation of protein ubiquitination [GO:0031396],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
Q8IWE4,S4,-0.795178845,-1.137242645,0.374012489,0.859557865,0.177838898,tomato2,DCUN1D3,DCNL3_HUMAN,DCN1-like protein 3 (DCNL3) (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3) (Squamous cell carcinoma-related oncogene 3),DCUN1D3 SCCRO3,123879;,"ENST00000324344.9; ENSP00000319482.3; ENSG00000188215.10.;""ENST00000563934.1; ENSP00000454762.1; ENSG00000188215.10."";",cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182],negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]
O94760,C5,1.72555846,0.518442897,-0.871594059,-0.847108085,-1.077204337,turquoise3,DDAH1,DDAH1_HUMAN,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)",DDAH1 DDAH,23576;,"ENST00000284031.13; ENSP00000284031.8; ENSG00000153904.21. [O94760-1];""ENST00000426972.8; ENSP00000411189.4; ENSG00000153904.21. [O94760-2]"";",amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872],arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; nitric oxide metabolic process [GO:0046209]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of systemic arterial blood pressure [GO:0003073],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q92466,N4,-0.689898042,1.158645354,-0.327710532,-0.577841591,0.178626829,grey30,DDB2,DDB2_HUMAN,DNA damage-binding protein 2 (DDB p48 subunit) (DDBb) (Damage-specific DNA-binding protein 2) (UV-damaged DNA-binding protein 2) (UV-DDB 2),DDB2,1643;,"ENST00000256996.9; ENSP00000256996.4; ENSG00000134574.12. [Q92466-1];""ENST00000378600.7; ENSP00000367863.3; ENSG00000134574.12. [Q92466-2]"";""ENST00000378601.7; ENSP00000367864.3; ENSG00000134574.12. [Q92466-5]"";""ENST00000378603.7; ENSP00000367866.3; ENSG00000134574.12. [Q92466-4]"";""ENST00000616278.4; ENSP00000478411.1; ENSG00000134574.12. [Q92466-3]"";",damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877],cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; UV-damage excision repair [GO:0070914],cell junction [GO:0030054]; chromatin [GO:0000785]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734]
O94830,C1,1.791634916,-0.236491237,-0.813388837,-0.478152513,-0.377825105,lightblue,DDHD2,DDHD2_HUMAN,"Phospholipase DDHD2 (EC 3.1.1.-) (DDHD domain-containing protein 2) (KIAA0725p) (SAM, WWE and DDHD domain-containing protein 1)",DDHD2 KIAA0725 SAMWD1,23259;,"ENST00000397166.7; ENSP00000380352.2; ENSG00000085788.14. [O94830-1];""ENST00000517385.5; ENSP00000429017.1; ENSG00000085788.14. [O94830-2]"";""ENST00000520272.6; ENSP00000429932.2; ENSG00000085788.14. [O94830-1]"";",metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806],lipid droplet organization [GO:0034389]; locomotory behavior [GO:0007626]; mitochondrial fission [GO:0000266]; positive regulation of mitochondrial fission [GO:0090141]; triglyceride catabolic process [GO:0019433]; visual learning [GO:0008542],centriolar satellite [GO:0034451]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]
Q5TDH0,C5,1.562285367,0.666907476,-0.637709343,-0.620677317,-0.934408624,turquoise3,DDI2,DDI2_HUMAN,Protein DDI1 homolog 2 (EC 3.4.23.-),DDI2,84301;,ENST00000480945.6; ENSP00000417748.1; ENSG00000197312.13. [Q5TDH0-1];,aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130],cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647],chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]
P39656,S2,-1.178285495,-1.431829074,0.315884253,0.890518011,0.437897131,orange,DDOST,OST48_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit),DDOST KIAA0115 OST48 OK/SW-cl.45,1650;,ENST00000415136.6; ENSP00000399457.3; ENSG00000244038.11. [P39656-1];,enzyme activator activity [GO:0008047],protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110],azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]
Q08345,S3,-0.737318009,-0.634436326,0.31193886,0.749646998,0.358040759,salmon,DDR1,DDR1_HUMAN,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE,780;,"ENST00000259875.11; ENSP00000259875.7; ENSG00000137332.19. [Q08345-2];""ENST00000324771.12; ENSP00000318217.8; ENSG00000204580.14. [Q08345-1]"";""ENST00000376567.6; ENSP00000365751.2; ENSG00000204580.14. [Q08345-2]"";""ENST00000376568.8; ENSP00000365752.3; ENSG00000204580.14. [Q08345-1]"";""ENST00000376569.7; ENSP00000365753.3; ENSG00000204580.14. [Q08345-2]"";""ENST00000376570.8; ENSP00000365754.4; ENSG00000204580.14. [Q08345-2]"";""ENST00000376575.7; ENSP00000365759.4; ENSG00000204580.14. [Q08345-4]"";""ENST00000383377.6; ENSP00000372868.2; ENSG00000137332.19. [Q08345-1]"";""ENST00000400410.5; ENSP00000383261.1; ENSG00000137332.19. [Q08345-2]"";""ENST00000400411.5; ENSP00000383262.1; ENSG00000137332.19. [Q08345-2]"";""ENST00000400414.5; ENSP00000383265.1; ENSG00000137332.19. [Q08345-1]"";""ENST00000400486.5; ENSP00000383334.1; ENSG00000215522.11. [Q08345-2]"";""ENST00000400488.5; ENSP00000383336.1; ENSG00000215522.11. [Q08345-2]"";""ENST00000400489.7; ENSP00000383337.3; ENSG00000215522.11. [Q08345-2]"";""ENST00000400491.5; ENSP00000383338.1; ENSG00000215522.11. [Q08345-1]"";""ENST00000400492.5; ENSP00000383339.1; ENSG00000215522.11. [Q08345-1]"";""ENST00000412329.5; ENSP00000391805.1; ENSG00000230456.10. [Q08345-1]"";""ENST00000415092.5; ENSP00000405540.1; ENSG00000230456.10. [Q08345-2]"";""ENST00000418800.6; ENSP00000407699.2; ENSG00000204580.14. [Q08345-2]"";""ENST00000419412.5; ENSP00000416183.1; ENSG00000234078.10. [Q08345-2]"";""ENST00000421229.6; ENSP00000415730.2; ENSG00000234078.10. [Q08345-2]"";""ENST00000427053.6; ENSP00000416145.2; ENSG00000230456.10. [Q08345-2]"";""ENST00000429699.5; ENSP00000401397.1; ENSG00000234078.10. [Q08345-1]"";""ENST00000430933.5; ENSP00000397769.1; ENSG00000234078.10. [Q08345-1]"";""ENST00000449518.5; ENSP00000414285.1; ENSG00000230456.10. [Q08345-1]"";""ENST00000452441.5; ENSP00000405039.1; ENSG00000204580.14. [Q08345-1]"";""ENST00000453510.5; ENSP00000401208.1; ENSG00000230456.10. [Q08345-2]"";""ENST00000454612.6; ENSP00000406091.2; ENSG00000204580.14. [Q08345-2]"";""ENST00000454774.5; ENSP00000400393.1; ENSG00000234078.10. [Q08345-2]"";""ENST00000482873.6; ENSP00000421978.1; ENSG00000204580.14. [Q08345-4]"";""ENST00000508312.5; ENSP00000422442.1; ENSG00000204580.14. [Q08345-6]"";""ENST00000513240.5; ENSP00000427552.1; ENSG00000204580.14. [Q08345-5]"";""ENST00000548133.4; ENSP00000449611.2; ENSG00000230456.10. [Q08345-1]"";""ENST00000548962.5; ENSP00000448115.2; ENSG00000230456.10. [Q08345-6]"";""ENST00000549026.3; ENSP00000449238.2; ENSG00000215522.11. [Q08345-6]"";""ENST00000550384.5; ENSP00000447474.2; ENSG00000234078.10. [Q08345-6]"";""ENST00000550395.5; ENSP00000449255.2; ENSG00000215522.11. [Q08345-1]"";""ENST00000552068.5; ENSP00000449190.2; ENSG00000234078.10. [Q08345-1]"";""ENST00000552721.4; ENSP00000449307.2; ENSG00000137332.19. [Q08345-6]"";""ENST00000553015.5; ENSP00000448377.2; ENSG00000137332.19. [Q08345-1]"";""ENST00000617572.3; ENSP00000479195.1; ENSG00000215522.11. [Q08345-4]"";""ENST00000618059.2; ENSP00000479204.1; ENSG00000234078.10. [Q08345-4]"";""ENST00000620318.4; ENSP00000484588.1; ENSG00000137332.19. [Q08345-4]"";""ENST00000621544.4; ENSP00000484013.1; ENSG00000230456.10. [Q08345-4]"";",ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q96HY6,S2,-1.253867377,-1.326613871,0.101431749,0.900919001,0.452438819,orange,DDRGK1,DDRGK_HUMAN,DDRGK domain-containing protein 1 (Dashurin) (UFM1-binding and PCI domain-containing protein 1),DDRGK1 C20orf116 UFBP1,65992;,ENST00000354488.8; ENSP00000346483.3; ENSG00000198171.13. [Q96HY6-1];,RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin-like protein ligase binding [GO:0044389]; UFM1-modified protein reader activity [GO:0141185],cartilage development [GO:0051216]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of reticulophagy [GO:0140501]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein K69-linked ufmylation [GO:1990592]; protein localization to endoplasmic reticulum [GO:0070972]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of protein stability [GO:0031647]; rescue of stalled ribosome [GO:0072344]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709]; ribosome disassembly [GO:0032790],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleolus [GO:0005730]
Q13206,N3,-1.128552822,-1.239939891,1.320692839,0.03349898,-0.207877183,grey50,DDX10,DDX10_HUMAN,Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10),DDX10,1662;,ENST00000322536.8; ENSP00000314348.3; ENSG00000178105.12.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],anterior head development [GO:0097065]; rRNA processing [GO:0006364],nucleus [GO:0005634]
Q9NVP1,N3,-1.409811356,-1.478131122,1.306736922,-0.035411644,0.059658159,grey50,DDX18,DDX18_HUMAN,ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb),DDX18 cPERP-D,8886;,ENST00000263239.7; ENSP00000263239.2; ENSG00000088205.13.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]",chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]
Q9UHI6,N1,-0.120584873,-0.41253817,-0.292600643,-0.150717639,1.226456656,grey90,DDX20,DDX20_HUMAN,Probable ATP-dependent RNA helicase DDX20 (EC 3.6.1.15) (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3),DDX20 DP103 GEMIN3,11218;,"ENST00000369702.5; ENSP00000358716.4; ENSG00000064703.13. [Q9UHI6-1];""ENST00000533164.6; ENSP00000434085.1; ENSG00000064703.13. [Q9UHI6-2]"";""ENST00000679724.1; ENSP00000505857.1; ENSG00000064703.13. [Q9UHI6-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; RNA helicase activity [GO:0003724],negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; RNA processing [GO:0006396]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]
Q9GZR7,N3,-1.140240023,-1.167677227,0.81280806,-0.227478392,0.872825029,grey50,DDX24,DDX24_HUMAN,ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24),DDX24,57062;,"ENST00000613280.4; ENSP00000482106.1; ENSG00000273761.5. [Q9GZR7-1];""ENST00000618456.2; ENSP00000478630.1; ENSG00000273761.5. [Q9GZR7-2]"";""ENST00000621632.5; ENSP00000481495.1; ENSG00000089737.19. [Q9GZR7-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],RNA metabolic process [GO:0016070],membrane [GO:0016020]; nucleolus [GO:0005730]
Q9NUL7,S3,-1.082990475,-0.989086703,0.19214755,0.711116615,0.606566587,salmon,DDX28,DDX28_HUMAN,Probable ATP-dependent RNA helicase DDX28 (EC 3.6.4.13) (Mitochondrial DEAD box protein 28),DDX28 MDDX28,55794;,ENST00000332395.7; ENSP00000332340.6; ENSG00000182810.7.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843],mitochondrial large ribosomal subunit assembly [GO:1902775],cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]
Q9H8H2,N3,-1.289573897,-1.254492347,0.819578554,-0.277110726,0.780528559,grey50,DDX31,DDX31_HUMAN,ATP-dependent DNA helicase DDX31 (EC 5.6.2.-) (DEAD box protein 31) (Helicain) (Probable ATP-dependent RNA helicase DDX31) (EC 3.6.4.13),DDX31,64794;,"ENST00000372159.8; ENSP00000361232.4; ENSG00000125485.18. [Q9H8H2-5];""ENST00000480876.3; ENSP00000479697.2; ENSG00000125485.18. [Q9H8H2-6]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],ribosome biogenesis [GO:0042254],Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]
O00148,N2,-0.667698982,0.142328826,0.877084154,-0.211239948,0.028895196,grey70,DDX39A,DX39A_HUMAN,ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49),DDX39A DDX39,10212;,"ENST00000242776.9; ENSP00000242776.3; ENSG00000123136.15. [O00148-1];""ENST00000324340.13; ENSP00000322749.8; ENSG00000123136.15. [O00148-2]"";""ENST00000454233.6; ENSP00000392929.2; ENSG00000123136.15. [O00148-3]"";""ENST00000588692.5; ENSP00000467862.1; ENSG00000123136.15. [O00148-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],"mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]",cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13838,N2,-0.592158734,0.013467343,0.832056249,-0.24401446,0.034634265,grey70,DDX39B,DX39B_HUMAN,Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein),DDX39B BAT1 UAP56,7919;,"ENST00000383508.6; ENSP00000373000.2; ENSG00000215425.11. [Q13838-1];""ENST00000396172.6; ENSP00000379475.1; ENSG00000198563.14. [Q13838-1]"";""ENST00000400295.5; ENSP00000383151.1; ENSG00000215425.11. [Q13838-1]"";""ENST00000400296.5; ENSP00000383152.1; ENSG00000215425.11. [Q13838-1]"";""ENST00000412106.5; ENSP00000393712.1; ENSG00000225073.10. [Q13838-1]"";""ENST00000412330.5; ENSP00000398775.1; ENSG00000225859.10. [Q13838-1]"";""ENST00000413678.5; ENSP00000391463.1; ENSG00000229496.10. [Q13838-1]"";""ENST00000414440.5; ENSP00000411853.1; ENSG00000229496.10. [Q13838-1]"";""ENST00000415689.5; ENSP00000390999.1; ENSG00000225073.10. [Q13838-1]"";""ENST00000416863.5; ENSP00000407419.1; ENSG00000229496.10. [Q13838-1]"";""ENST00000430784.5; ENSP00000399030.1; ENSG00000235439.10. [Q13838-1]"";""ENST00000431360.5; ENSP00000404695.1; ENSG00000235439.10. [Q13838-1]"";""ENST00000441425.5; ENSP00000388880.1; ENSG00000230624.10. [Q13838-1]"";""ENST00000445218.5; ENSP00000411136.1; ENSG00000225859.10. [Q13838-1]"";""ENST00000448296.5; ENSP00000405560.1; ENSG00000225859.10. [Q13838-1]"";""ENST00000453138.5; ENSP00000387994.1; ENSG00000230624.10. [Q13838-1]"";""ENST00000456476.5; ENSP00000400326.1; ENSG00000225073.10. [Q13838-1]"";""ENST00000456666.5; ENSP00000394160.1; ENSG00000230624.10. [Q13838-1]"";""ENST00000458640.5; ENSP00000416269.1; ENSG00000198563.14. [Q13838-1]"";","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; ATP-dependent protein binding [GO:0043008]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]","mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; RNA export from nucleus [GO:0006405]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]
Q9H0S4,N3,-0.591710257,-0.748304321,0.854337621,-0.004169109,0.559664969,grey50,DDX47,DDX47_HUMAN,Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47),DDX47,51202;,"ENST00000352940.8; ENSP00000319578.6; ENSG00000213782.7. [Q9H0S4-2];""ENST00000358007.7; ENSP00000350698.3; ENSG00000213782.7. [Q9H0S4-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y6V7,N2,-0.783507267,-0.275719862,0.957742073,-0.054195066,0.108369229,grey70,DDX49,DDX49_HUMAN,Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49),DDX49,54555;,ENST00000247003.9; ENSP00000247003.3; ENSG00000105671.12. [Q9Y6V7-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P17844,N1,-1.123657001,-0.473115821,0.715436521,0.035837565,0.658661654,grey90,DDX5,DDX5_HUMAN,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),DDX5 G17P1 HELR HLR1,1655;,"ENST00000225792.10; ENSP00000225792.5; ENSG00000108654.16. [P17844-1];""ENST00000450599.7; ENSP00000403085.3; ENSG00000108654.16. [P17844-1]"";""ENST00000577922.6; ENSP00000464337.2; ENSG00000108654.16. [P17844-1]"";""ENST00000585111.2; ENSP00000463168.2; ENSG00000108654.16. [P17844-1]"";""ENST00000676785.1; ENSP00000504794.1; ENSG00000108654.16. [P17844-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332],"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
Q9BQ39,N3,-0.899770892,-1.004099665,1.048721628,-0.215464717,0.592860413,grey50,DDX50,DDX50_HUMAN,ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2),DDX50,79009;,ENST00000373585.8; ENSP00000362687.3; ENSG00000107625.14.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],0,membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]
Q8N8A6,N3,-1.211428168,-1.169472094,1.171384984,0.159235343,0.288712166,grey50,DDX51,DDX51_HUMAN,ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51),DDX51,317781;,"ENST00000397333.4; ENSP00000380495.3; ENSG00000185163.10.;""ENST00000673535.1; ENSP00000500171.1; ENSG00000288503.1."";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],rRNA processing [GO:0006364],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]
Q9Y2R4,N2,-1.073415725,-1.217651272,1.145663983,0.021970963,0.334882206,grey70,DDX52,DDX52_HUMAN,Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52),DDX52 ROK1 HUSSY-19,11056;,"ENST00000615769.2; ENSP00000480030.1; ENSG00000277594.2.;""ENST00000617633.5; ENSP00000479504.1; ENSG00000278053.5."";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],maturation of SSU-rRNA [GO:0030490],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q8NHQ9,N1,-1.509266502,-0.898288969,-0.348468693,-0.381774795,1.530335863,grey90,DDX55,DDX55_HUMAN,ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55),DDX55 KIAA1595,57696;,"ENST00000238146.9; ENSP00000238146.3; ENSG00000111364.16. [Q8NHQ9-1];""ENST00000421670.3; ENSP00000442332.1; ENSG00000111364.16. [Q8NHQ9-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],0,cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9NY93,N3,-0.841723857,-1.001537748,1.098887693,-0.212712005,0.364076382,grey50,DDX56,DDX56_HUMAN,Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56),DDX56 DDX21 NOH61,54606;,"ENST00000258772.10; ENSP00000258772.5; ENSG00000136271.11. [Q9NY93-1];""ENST00000431640.5; ENSP00000393488.1; ENSG00000136271.11. [Q9NY93-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613],defense response to virus [GO:0051607]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of type I interferon production [GO:0032480]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364],cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]
O95786,C3,1.946708882,0.225838682,-0.660999012,-0.630386,-0.745471172,cyan,DDX58,RIGI_HUMAN,Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),RIGI DDX58,23586;,"ENST00000379868.6; ENSP00000369197.2; ENSG00000107201.11. [O95786-2];""ENST00000379883.3; ENSP00000369213.2; ENSG00000107201.11. [O95786-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587]
O15121,S2,-0.878378512,-1.177771589,0.282504571,0.729293658,0.548558196,orange,DEGS1,DEGS1_HUMAN,Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Cell migration-inducing gene 15 protein) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1) (Membrane lipid desaturase) (Retinol isomerase) (EC 5.2.1.-),DEGS1 DES1 MLD MIG15,8560;,ENST00000323699.9; ENSP00000316476.4; ENSG00000143753.14.;,electron transfer activity [GO:0009055]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284],ceramide biosynthetic process [GO:0046513]; myelin maintenance [GO:0043217]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]
Q5VZ89,C2,1.258912844,0.034422962,-0.334968192,-0.06157014,-0.096776806,aquamarine,DENND4C,DEN4C_HUMAN,DENN domain-containing protein 4C,DENND4C C9orf55 C9orf55B,55667;,"ENST00000434457.7; ENSP00000473469.1; ENSG00000137145.21. [Q5VZ89-7];""ENST00000602925.5; ENSP00000473565.1; ENSG00000137145.21. [Q5VZ89-1]"";",guanyl-nucleotide exchange factor activity [GO:0005085],cellular response to insulin stimulus [GO:0032869]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; retromer complex [GO:0030904]
O43583,C4,2.259080958,0.002953735,-1.433467258,-1.493158269,-1.509178445,deepskyblue2,DENR,DENR_HUMAN,Density-regulated protein (DRP) (Protein DRP1) (Smooth muscle cell-associated protein 3) (SMAP-3),DENR DRP1 H14,8562;,ENST00000280557.11; ENSP00000280557.6; ENSG00000139726.11.;,mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743],formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188],0
O75140,C2,0.827434218,0.426021856,-0.410437107,-0.249619735,0.171529002,aquamarine,DEPDC5,DEPD5_HUMAN,GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5),DEPDC5 KIAA0645,9681;,"ENST00000382111.6; ENSP00000371545.2; ENSG00000100150.20. [O75140-5];""ENST00000382112.8; ENSP00000371546.4; ENSG00000100150.20. [O75140-10]"";""ENST00000400242.8; ENSP00000383101.3; ENSG00000100150.20. [O75140-2]"";""ENST00000400248.7; ENSP00000383107.1; ENSG00000100150.20. [O75140-1]"";""ENST00000400249.7; ENSP00000383108.3; ENSG00000100150.20. [O75140-4]"";""ENST00000535622.6; ENSP00000440210.1; ENSG00000100150.20. [O75140-8]"";""ENST00000642696.1; ENSP00000495917.1; ENSG00000100150.20. [O75140-1]"";""ENST00000644331.1; ENSP00000494406.1; ENSG00000100150.20. [O75140-4]"";""ENST00000645711.1; ENSP00000493489.1; ENSG00000100150.20. [O75140-9]"";""ENST00000646755.1; ENSP00000496532.1; ENSG00000100150.20. [O75140-2]"";""ENST00000651528.2; ENSP00000498382.1; ENSG00000100150.20. [O75140-10]"";",GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508],cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]
Q9GZP9,S2,-1.246248917,-1.612354045,0.21033609,0.947332677,0.604239717,orange,DERL2,DERL2_HUMAN,Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa),DERL2 DER2 FLANA CGI-101 SBBI53,51009;,ENST00000158771.9; ENSP00000158771.4; ENSG00000072849.11.;,protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047],"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]",early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; late endosome [GO:0005770]; membrane [GO:0016020]
O00273,C5,1.408151185,0.820940401,-0.858438331,-1.006143654,-1.23007905,turquoise3,DFFA,DFFA_HUMAN,DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD),DFFA DFF1 DFF45 H13,1676;,"ENST00000377036.2; ENSP00000366235.2; ENSG00000160049.12. [O00273-2];""ENST00000377038.8; ENSP00000366237.3; ENSG00000160049.12. [O00273-1]"";",deoxyribonuclease inhibitor activity [GO:0060703]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183],apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; thymocyte apoptotic process [GO:0070242],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
P98153,S3,-0.893915665,-1.01987223,0.12999235,0.807915795,0.622225612,salmon,DGCR2,IDD_HUMAN,Integral membrane protein DGCR2/IDD,DGCR2 IDD KIAA0163,9993;,"ENST00000263196.12; ENSP00000263196.7; ENSG00000070413.21. [P98153-1];""ENST00000537045.5; ENSP00000440062.1; ENSG00000070413.21. [P98153-2]"";",carbohydrate binding [GO:0030246],animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cognition [GO:0050890],membrane [GO:0016020]
Q8WYQ5,N1,-0.920285713,-0.663863173,0.024584441,-0.373593424,1.372342293,grey90,DGCR8,DGCR8_HUMAN,Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8),DGCR8 C22orf12 DGCRK6 LP4941,54487;,"ENST00000351989.8; ENSP00000263209.3; ENSG00000128191.17. [Q8WYQ5-1];""ENST00000407755.2; ENSP00000384726.1; ENSG00000128191.17. [Q8WYQ5-3]"";""ENST00000457069.2; ENSP00000409625.2; ENSG00000128191.17. [Q8WYQ5-1]"";",double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-RNA adaptor activity [GO:0140517],DNA damage response [GO:0006974]; positive regulation of pre-miRNA processing [GO:2000633]; primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; site of double-strand break [GO:0035861]
Q15392,S2,-1.181133842,-1.084925494,0.351602244,0.829243098,0.614902384,orange,DHCR24,DHC24_HUMAN,Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol Delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1),DHCR24 KIAA0018,1718;,"ENST00000371269.9; ENSP00000360316.3; ENSG00000116133.13. [Q15392-1];""ENST00000436604.2; ENSP00000416585.2; ENSG00000116133.13. [Q15392-1]"";","delta24(24-1) sterol reductase activity [GO:0000246]; delta24-sterol reductase activity [GO:0050614]; enzyme binding [GO:0019899]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; peptide antigen binding [GO:0042605]",amyloid precursor protein catabolic process [GO:0042987]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; male genitalia development [GO:0030539]; membrane organization [GO:0061024]; negative regulation of cell population proliferation [GO:0008285]; plasminogen activation [GO:0031639]; protein localization [GO:0008104]; Ras protein signal transduction [GO:0007265]; response to hormone [GO:0009725]; skin development [GO:0043588]; steroid metabolic process [GO:0008202]; tissue development [GO:0009888],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleus [GO:0005634]
Q9UBM7,S2,-0.915979482,-1.296692995,0.314544743,0.832014475,0.423686096,orange,DHCR7,DHCR7_HUMAN,7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Delta7-sterol reductase) (Sterol Delta(7)-reductase) (Sterol reductase SR-2),DHCR7 D7SR,1717;,"ENST00000355527.8; ENSP00000347717.4; ENSG00000172893.18.;""ENST00000407721.6; ENSP00000384739.2; ENSG00000172893.18."";""ENST00000525346.6; ENSP00000435707.3; ENSG00000172893.18."";""ENST00000526780.6; ENSP00000435668.2; ENSG00000172893.18."";",7-dehydrocholesterol reductase activity [GO:0047598]; NADP binding [GO:0050661],brassinosteroid biosynthetic process [GO:0016132]; cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]
Q86SQ9,S3,-0.717388666,-0.870381693,0.097685483,0.864839936,0.584207796,salmon,DHDDS,DHDDS_HUMAN,Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m),DHDDS HDS,79947;,"ENST00000236342.12; ENSP00000236342.7; ENSG00000117682.18. [Q86SQ9-1];""ENST00000360009.6; ENSP00000353104.2; ENSG00000117682.18. [Q86SQ9-2]"";""ENST00000525682.6; ENSP00000434984.1; ENSG00000117682.18. [Q86SQ9-4]"";""ENST00000526219.5; ENSP00000434219.1; ENSG00000117682.18. [Q86SQ9-3]"";""ENST00000528557.6; ENSP00000515248.1; ENSG00000117682.18. [Q86SQ9-1]"";",dehydrodolichyl diphosphate synthase activity [GO:0045547]; metal ion binding [GO:0046872],dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094],dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
P00374,C4,1.991498156,0.263025485,-1.362194511,-1.30174576,-1.471226156,deepskyblue2,DHFR,DYR_HUMAN,Dihydrofolate reductase (EC 1.5.1.3),DHFR,1719;,"ENST00000439211.7; ENSP00000396308.2; ENSG00000228716.7. [P00374-1];""ENST00000504396.1; ENSP00000421334.1; ENSG00000228716.7. [P00374-2]"";""ENST00000505337.5; ENSP00000426474.1; ENSG00000228716.7. [P00374-1]"";",dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825],axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],cytosol [GO:0005829]; mitochondrion [GO:0005739]
Q02127,M2,-0.990799856,-1.422960401,0.341319261,1.096022352,-0.180581986,tan4,DHODH,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",DHODH,1723;,ENST00000219240.9; ENSP00000219240.4; ENSG00000102967.12.;,dihydroorotase activity [GO:0004151]; dihydroorotate dehydrogenase (quinone) activity [GO:0106430]; dihydroorotate dehydrogenase activity [GO:0004152],'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; pyrimidine ribonucleotide biosynthetic process [GO:0009220]; UDP biosynthetic process [GO:0006225],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q96LJ7,S2,-0.90951943,-0.980473089,0.143199299,0.990731312,0.488489116,orange,DHRS1,DHRS1_HUMAN,Dehydrogenase/reductase SDR family member 1 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 19C member 1) (Protein SDR19C1),DHRS1 SDR19C1,115817;,"ENST00000288111.12; ENSP00000288111.7; ENSG00000157379.14.;""ENST00000396813.5; ENSP00000380027.1; ENSG00000157379.14."";""ENST00000644514.2; ENSP00000496132.1; ENSG00000284868.2."";""ENST00000647514.1; ENSP00000493735.1; ENSG00000284868.2."";","carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]",0,endoplasmic reticulum [GO:0005783]
O75911,S2,-1.061127877,-1.289204306,0.114722753,0.855716925,0.657000582,orange,DHRS3,DHRS3_HUMAN,Short-chain dehydrogenase/reductase 3 (EC 1.1.1.300) (DD83.1) (Retinal short-chain dehydrogenase/reductase 1) (retSDR1) (Retinol dehydrogenase 17) (Short chain dehydrogenase/reductase family 16C member 1),DHRS3 RDH17 SDR16C1 UNQ2424/PRO4983,9249;,ENST00000616661.5; ENSP00000480439.1; ENSG00000162496.9. [O75911-1];,all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; electron transfer activity [GO:0009055]; nucleotide binding [GO:0000166],bone morphogenesis [GO:0060349]; cardiac septum morphogenesis [GO:0060411]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; outflow tract morphogenesis [GO:0003151]; regulation of ossification [GO:0030278]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; roof of mouth development [GO:0060021]; visual perception [GO:0007601],endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; photoreceptor outer segment membrane [GO:0042622]
Q9Y394,S2,-1.252443446,-1.545627743,0.196404463,0.829459255,0.649212172,orange,DHRS7,DHRS7_HUMAN,Dehydrogenase/reductase SDR family member 7 (EC 1.1.1.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Protein SDR34C1),DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448,51635;,"ENST00000216500.9; ENSP00000216500.5; ENSG00000100612.14. [Q9Y394-1];""ENST00000536410.6; ENSP00000442993.2; ENSG00000100612.14. [Q9Y394-2]"";""ENST00000557185.6; ENSP00000451882.1; ENSG00000100612.14. [Q9Y394-1]"";","all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",0,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q8N5I4,S2,-1.684472742,-1.411019355,0.321835044,0.902476887,0.683180085,orange,DHRSX,DHRSX_HUMAN,Dehydrogenase/reductase SDR family member on chromosome X (EC 1.1.-.-) (DHRSXY) (Short chain dehydrogenase/reductase family 46C member 1) (Short chain dehydrogenase/reductase family 7C member 6),DHRSX CXorf11 DHRS5X SDR46C1 SDR7C6 UNQ6508/PRO21433,207063;,"ENST00000334651.11; ENSP00000334113.5; ENSG00000169084.15.;""ENST00000711204.1; ENSP00000518604.1; ENSG00000292338.1."";",oxidoreductase activity [GO:0016491],positive regulation of autophagy [GO:0010508],extracellular region [GO:0005576]
O60231,N4,-0.753990981,0.860375931,0.272548619,-0.304831793,-0.102616583,grey30,DHX16,DHX16_HUMAN,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),DHX16 DBP2 DDX16 KIAA0577 PRP2,8449;,"ENST00000376442.8; ENSP00000365625.3; ENSG00000204560.10.;""ENST00000383577.8; ENSP00000373071.4; ENSG00000206486.8."";""ENST00000417308.6; ENSP00000390938.2; ENSG00000233561.6."";""ENST00000421095.6; ENSP00000396193.2; ENSG00000226171.6."";""ENST00000424672.6; ENSP00000389862.2; ENSG00000233418.8."";""ENST00000451456.6; ENSP00000408956.2; ENSG00000233049.6."";""ENST00000458094.6; ENSP00000393958.2; ENSG00000231377.6."";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; molecular adaptor activity [GO:0060090]; pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ubiquitin binding [GO:0043130],"antiviral innate immune response [GO:0140374]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]
Q7L2E3,S1,-0.799077492,-0.865940531,0.185953033,0.508255501,0.841214006,gold,DHX30,DHX30_HUMAN,ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30),DHX30 DDX30 KIAA0890,22907;,"ENST00000445061.6; ENSP00000405620.1; ENSG00000132153.15. [Q7L2E3-1];""ENST00000446256.6; ENSP00000392601.3; ENSG00000132153.15. [Q7L2E3-1]"";""ENST00000457607.1; ENSP00000394682.1; ENSG00000132153.15. [Q7L2E3-2]"";""ENST00000619982.4; ENSP00000483160.1; ENSG00000132153.15. [Q7L2E3-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]
Q9H6R0,N3,-0.995603776,-0.823526676,1.191759979,0.064575255,0.028653566,grey50,DHX33,DHX33_HUMAN,ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33),DHX33 DDX33,56919;,ENST00000225296.8; ENSP00000225296.3; ENSG00000005100.13. [Q9H6R0-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9H2U1,N1,-0.097399404,-0.411655078,0.097201298,-0.243363516,1.128285894,grey90,DHX36,DHX36_HUMAN,ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein),DHX36 DDX36 KIAA1488 MLEL1 RHAU,170506;,"ENST00000308361.10; ENSP00000309296.6; ENSG00000174953.14. [Q9H2U1-3];""ENST00000329463.9; ENSP00000330113.5; ENSG00000174953.14. [Q9H2U1-2]"";""ENST00000496811.6; ENSP00000417078.1; ENSG00000174953.14. [Q9H2U1-1]"";","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription cis-regulatory region binding [GO:0000976]","3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]"
Q8IY37,N1,-1.111980282,-0.797328669,0.511659299,-0.198815991,0.977489961,grey90,DHX37,DHX37_HUMAN,Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37),DHX37 DDX37 KIAA1517,57647;,ENST00000308736.7; ENSP00000311135.2; ENSG00000150990.9.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511],"brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]",cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q8IX18,N4,-0.723189382,0.852009844,0.096867596,-0.113426378,-0.230792795,grey30,DHX40,DHX40_HUMAN,Probable ATP-dependent RNA helicase DHX40 (EC 3.6.4.13) (DEAH box protein 40) (Protein PAD),DHX40 DDX40 ARG147,79665;,"ENST00000251241.9; ENSP00000251241.4; ENSG00000108406.10. [Q8IX18-1];""ENST00000425628.7; ENSP00000388749.3; ENSG00000108406.10. [Q8IX18-4]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],0,0
Q08211,N1,-0.961729925,-0.762360182,0.743428624,-0.115308937,0.898746432,grey90,DHX9,DHX9_HUMAN,ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (DExH-box helicase 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II) (RNA helicase A),DHX9 DDX9 LKP NDH2,1660;,ENST00000367549.4; ENSP00000356520.3; ENSG00000135829.17. [Q08211-1];,3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside triphosphate diphosphatase activity [GO:0047429]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosome binding [GO:0043022]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142],"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to tumor necrosis factor [GO:0071356]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA transport [GO:0051028]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral transcription [GO:0050434]; protein localization to cytoplasmic stress granule [GO:1903608]; protein-containing complex assembly [GO:0065003]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; rhythmic process [GO:0048511]; RISC complex assembly [GO:0070922]; RNA secondary structure unwinding [GO:0010501]",actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]
Q9NR28,N4,-0.701605276,0.580048734,0.097461655,0.295691055,-0.375935906,grey30,DIABLO,DBLOH_HUMAN,"Diablo IAP-binding mitochondrial protein (Diablo homolog, mitochondrial) (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase) (Smac) [Cleaved into: Diablo IAP-binding mitochondrial protein, cleaved form]",DIABLO SMAC,56616;,"ENST00000353548.11; ENSP00000320343.6; ENSG00000184047.21. [Q9NR28-3];""ENST00000464942.7; ENSP00000442360.2; ENSG00000184047.21. [Q9NR28-1]"";",0,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]
O60610,C3,1.706425194,-0.070018495,-0.580900888,-0.45493773,-0.741069053,cyan,DIAPH1,DIAP1_HUMAN,Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1),DIAPH1 DIAP1,1729;,"ENST00000389054.8; ENSP00000373706.4; ENSG00000131504.18. [O60610-1];""ENST00000518047.5; ENSP00000428268.2; ENSG00000131504.18. [O60610-3]"";",actin binding [GO:0003779]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325],actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cellular response to histamine [GO:0071420]; cytoskeleton organization [GO:0007010]; protein localization to microtubule [GO:0035372]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule-based process [GO:0032886]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; secretory granule membrane [GO:0030667]
Q9BTC0,N4,-1.222449625,0.641066971,0.233315994,-0.333038421,0.157202465,grey30,DIDO1,DIDO1_HUMAN,Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1),DIDO1 C20orf158 DATF1 KIAA0333,11083;,"ENST00000266070.8; ENSP00000266070.4; ENSG00000101191.17. [Q9BTC0-4];""ENST00000354665.8; ENSP00000346692.4; ENSG00000101191.17. [Q9BTC0-3]"";""ENST00000370366.1; ENSP00000359391.1; ENSG00000101191.17. [Q9BTC0-2]"";""ENST00000370368.5; ENSP00000359394.1; ENSG00000101191.17. [Q9BTC0-3]"";""ENST00000370371.8; ENSP00000359397.4; ENSG00000101191.17. [Q9BTC0-3]"";""ENST00000395340.5; ENSP00000378749.1; ENSG00000101191.17. [Q9BTC0-1]"";""ENST00000395343.6; ENSP00000378752.1; ENSG00000101191.17. [Q9BTC0-4]"";",metal ion binding [GO:0046872]; RNA binding [GO:0003723],apoptotic signaling pathway [GO:0097190]; DNA-templated transcription [GO:0006351],cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]
Q9UNQ2,N1,-0.961810013,-0.702711713,-0.048289749,-0.281234876,1.313975462,grey90,DIMT1,DIM1_HUMAN,"Dimethyladenosine transferase (EC 2.1.1.183) (18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (18S rRNA dimethylase) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)",DIMT1 DIMT1L HUSSY-05,27292;,ENST00000199320.9; ENSP00000199320.4; ENSG00000086189.11.;,"18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity [GO:0052909]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]",positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q14689,C2,1.149826089,0.322996563,-0.199656622,-0.095539095,-0.24095231,aquamarine,DIP2A,DIP2A_HUMAN,Disco-interacting protein 2 homolog A (DIP2 homolog A) (EC 6.2.1.1),DIP2A C21orf106 DIP2 KIAA0184,23181;,"ENST00000400274.5; ENSP00000383133.1; ENSG00000160305.18. [Q14689-6];""ENST00000417564.3; ENSP00000392066.2; ENSG00000160305.18. [Q14689-1]"";""ENST00000435722.7; ENSP00000415089.3; ENSG00000160305.18. [Q14689-2]"";""ENST00000457905.7; ENSP00000393434.3; ENSG00000160305.18. [Q14689-4]"";""ENST00000466639.5; ENSP00000430249.1; ENSG00000160305.18. [Q14689-3]"";",acetate-CoA ligase activity [GO:0003987],acetyl-CoA biosynthetic process [GO:0006085]; dendritic spine morphogenesis [GO:0060997]; negative regulation of gene expression [GO:0010629]; positive regulation of peptidyl-lysine acetylation [GO:2000758],cell surface [GO:0009986]; dendritic spine [GO:0043197]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q9P265,C2,1.134078792,0.218333227,-0.433161741,-0.053883229,-0.104547942,aquamarine,DIP2B,DIP2B_HUMAN,Disco-interacting protein 2 homolog B (DIP2 homolog B),DIP2B KIAA1463,57609;,ENST00000301180.10; ENSP00000301180.5; ENSG00000066084.13.;,alpha-tubulin binding [GO:0043014],negative regulation of axon extension [GO:0030517]; nervous system development [GO:0007399]; positive regulation of peptidyl-lysine acetylation [GO:2000758],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perikaryon [GO:0043204]
Q8TF46,C2,0.820143607,0.529235653,-0.394541873,-0.502363803,0.211202825,aquamarine,DIS3L,DI3L1_HUMAN,DIS3-like exonuclease 1 (EC 3.1.13.1),DIS3L DIS3L1 KIAA1955,115752;,"ENST00000319194.9; ENSP00000321583.5; ENSG00000166938.13. [Q8TF46-4];""ENST00000319212.9; ENSP00000321711.4; ENSG00000166938.13. [Q8TF46-1]"";",3'-5'-RNA exonuclease activity [GO:0000175]; enzyme binding [GO:0019899]; exoribonuclease II activity [GO:0008859]; RNA binding [GO:0003723],mRNA catabolic process [GO:0006402]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075],centrosome [GO:0005813]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q8IYB7,C1,1.965267621,-0.060827157,-1.010566977,-0.924180074,-0.373540447,lightblue,DIS3L2,DI3L2_HUMAN,DIS3-like exonuclease 2 (hDIS3L2) (EC 3.1.13.-),DIS3L2 FAM6A,129563;,"ENST00000273009.10; ENSP00000273009.6; ENSG00000144535.20. [Q8IYB7-3];""ENST00000325385.12; ENSP00000315569.7; ENSG00000144535.20. [Q8IYB7-1]"";""ENST00000390005.9; ENSP00000374655.5; ENSG00000144535.20. [Q8IYB7-2]"";""ENST00000409401.7; ENSP00000386594.3; ENSG00000144535.20. [Q8IYB7-4]"";""ENST00000433430.5; ENSP00000391175.1; ENSG00000144535.20. [Q8IYB7-5]"";""ENST00000445090.5; ENSP00000388999.1; ENSG00000144535.20. [Q8IYB7-4]"";",3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; RNA nuclease activity [GO:0004540],cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; mRNA catabolic process [GO:0006402]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process [GO:0000956]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827],cytoplasm [GO:0005737]; P-body [GO:0000932]
O60832,N3,-0.913630475,-0.747286641,1.137958262,0.070255798,0.187433687,grey50,DKC1,DKC1_HUMAN,H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),DKC1 NOLA4,1736;,ENST00000369550.10; ENSP00000358563.5; ENSG00000130826.19. [O60832-1];,box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004],box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]
P10515,S3,-1.189169525,-0.779349163,0.161515204,0.866925862,0.626280987,salmon,DLAT,ODP2_HUMAN,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)",DLAT DLTA,1737;,"ENST00000280346.11; ENSP00000280346.7; ENSG00000150768.18.;""ENST00000713569.1; ENSP00000518862.1; ENSG00000150768.18."";",dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; identical protein binding [GO:0042802],acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099],intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]
Q12959,M1,-0.8447506,-0.850691445,0.539093717,0.80756965,-0.090919349,burlywood4,DLG1,DLG1_HUMAN,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg),DLG1,1739;,"ENST00000346964.6; ENSP00000345731.2; ENSG00000075711.21. [Q12959-2];""ENST00000357674.9; ENSP00000350303.6; ENSG00000075711.21. [Q12959-4]"";""ENST00000392382.6; ENSP00000376187.2; ENSG00000075711.21. [Q12959-3]"";""ENST00000419354.5; ENSP00000407531.1; ENSG00000075711.21. [Q12959-1]"";""ENST00000422288.6; ENSP00000413238.1; ENSG00000075711.21. [Q12959-5]"";""ENST00000443183.5; ENSP00000396658.1; ENSG00000075711.21. [Q12959-9]"";""ENST00000448528.6; ENSP00000391732.2; ENSG00000075711.21. [Q12959-1]"";""ENST00000450955.5; ENSP00000411278.1; ENSG00000075711.21. [Q12959-4]"";""ENST00000452595.5; ENSP00000398939.1; ENSG00000075711.21. [Q12959-8]"";""ENST00000655488.1; ENSP00000499657.1; ENSG00000075711.21. [Q12959-3]"";""ENST00000659716.1; ENSP00000499602.1; ENSG00000075711.21. [Q12959-3]"";""ENST00000661453.1; ENSP00000499514.1; ENSG00000075711.21. [Q12959-3]"";""ENST00000663148.1; ENSP00000499384.1; ENSG00000075711.21. [Q12959-3]"";""ENST00000666007.1; ENSP00000499793.1; ENSG00000075711.21. [Q12959-5]"";""ENST00000667157.1; ENSP00000499414.1; ENSG00000075711.21. [Q12959-4]"";""ENST00000669565.1; ENSP00000499413.1; ENSG00000075711.21. [Q12959-4]"";""ENST00000670455.1; ENSP00000499542.1; ENSG00000075711.21. [Q12959-4]"";""ENST00000670935.1; ENSP00000499437.1; ENSG00000075711.21. [Q12959-1]"";""ENST00000671185.1; ENSP00000499580.1; ENSG00000075711.21. [Q12959-3]"";",cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; ionotropic glutamate receptor binding [GO:0035255]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325],actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060]
Q8TDM6,S3,-0.456752702,-0.153202318,0.329049572,0.560905575,0.268687097,salmon,DLG5,DLG5_HUMAN,Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG),DLG5 KIAA0583 PDLG,9231;,"ENST00000372391.7; ENSP00000361467.2; ENSG00000151208.17. [Q8TDM6-1];""ENST00000614211.2; ENSP00000484894.1; ENSG00000274429.2. [Q8TDM6-1]"";",beta-catenin binding [GO:0008013]; cytoskeletal protein binding [GO:0008092]; signaling receptor complex adaptor activity [GO:0030159],apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; metanephric collecting duct development [GO:0072205]; midbrain development [GO:0030901]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of T cell proliferation [GO:0042130]; neuroepithelial cell differentiation [GO:0060563]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of hippo signaling [GO:0035332]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of synapse assembly [GO:0051965]; postsynapse organization [GO:0099173]; protein localization to adherens junction [GO:0071896]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; zonula adherens assembly [GO:0045186],adherens junction [GO:0005912]; cell junction [GO:0030054]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]
Q15398,C4,1.975413352,0.242676753,-0.835058163,-0.939121698,-1.105477652,deepskyblue2,DLGAP5,DLGP5_HUMAN,Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein) (HURP),DLGAP5 DLG7 KIAA0008,9787;,"ENST00000247191.7; ENSP00000247191.2; ENSG00000126787.13. [Q15398-2];""ENST00000395425.6; ENSP00000378815.2; ENSG00000126787.13. [Q15398-3]"";",microtubule binding [GO:0008017],centrosome localization [GO:0051642]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; regulation of mitotic cell cycle [GO:0007346]; signaling [GO:0023052],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]
Q9Y222,N4,0.517126234,1.075397877,-0.188949433,-0.593896394,-0.74049295,grey30,DMTF1,DMTF1_HUMAN,Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1),DMTF1 DMP1,9988;,"ENST00000331242.12; ENSP00000332171.7; ENSG00000135164.19. [Q9Y222-1];""ENST00000394703.9; ENSP00000378193.5; ENSG00000135164.19. [Q9Y222-1]"";""ENST00000412139.6; ENSP00000407941.2; ENSG00000135164.19. [Q9Y222-2]"";""ENST00000425406.5; ENSP00000411908.1; ENSG00000135164.19. [Q9Y222-4]"";""ENST00000432937.6; ENSP00000412532.2; ENSG00000135164.19. [Q9Y222-5]"";""ENST00000447863.5; ENSP00000389774.1; ENSG00000135164.19. [Q9Y222-3]"";""ENST00000579677.5; ENSP00000464596.1; ENSG00000135164.19. [Q9Y222-2]"";""ENST00000584619.5; ENSP00000464092.1; ENSG00000135164.19. [Q9Y222-2]"";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P51530,C2,1.180202428,0.214221858,-0.282816577,-0.130696118,-0.195490849,aquamarine,DNA2,DNA2_HUMAN,DNA replication ATP-dependent helicase/nuclease DNA2 (hDNA2) (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)],DNA2 DNA2L KIAA0083,1763;,"ENST00000358410.8; ENSP00000351185.3; ENSG00000138346.16. [P51530-1];""ENST00000399179.6; ENSP00000382132.3; ENSG00000138346.16. [P51530-2]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]","base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; G-quadruplex DNA unwinding [GO:0044806]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; nucleic acid metabolic process [GO:0090304]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]","chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q9NVR5,C4,1.73247745,0.146628781,-0.792227004,-0.670852777,-1.043378074,deepskyblue2,DNAAF2,KTU_HUMAN,"Protein kintoun (Dynein assembly factor 2, axonemal)",DNAAF2 C14orf104 KTU,55172;,"ENST00000298292.13; ENSP00000298292.8; ENSG00000165506.15. [Q9NVR5-1];""ENST00000406043.3; ENSP00000384862.3; ENSG00000165506.15. [Q9NVR5-2]"";",0,axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of left/right asymmetry [GO:0061966]; establishment of localization in cell [GO:0051649]; in utero embryonic development [GO:0001701]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158]; protein stabilization [GO:0050821]; response to retinoic acid [GO:0032526],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; protein folding chaperone complex [GO:0101031]
Q96EY1,M2,-0.949411575,-0.923171323,0.420635148,1.005776764,-0.161441854,tan4,DNAJA3,DNJA3_HUMAN,"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",DNAJA3 HCA57 TID1,9093;,"ENST00000262375.11; ENSP00000262375.4; ENSG00000103423.14. [Q96EY1-1];""ENST00000355296.8; ENSP00000347445.4; ENSG00000103423.14. [Q96EY1-2]"";""ENST00000431375.6; ENSP00000393970.2; ENSG00000103423.14. [Q96EY1-3]"";""ENST00000612103.4; ENSP00000477570.1; ENSG00000276726.4. [Q96EY1-1]"";""ENST00000614397.4; ENSP00000479815.1; ENSG00000276726.4. [Q96EY1-2]"";",ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; type II interferon receptor binding [GO:0005133]; unfolded protein binding [GO:0051082],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase-mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]
Q9UBS4,S3,-1.053480278,-0.216484792,0.041687019,0.723695284,0.336495792,salmon,DNAJB11,DJB11_HUMAN,DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4),DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080,51726;,"ENST00000265028.8; ENSP00000265028.3; ENSG00000090520.12.;""ENST00000439351.5; ENSP00000414398.1; ENSG00000090520.12."";",misfolded protein binding [GO:0051787]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082],mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding [GO:0006457]; protein maturation [GO:0051604],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]
Q9NXW2,S2,-1.090942736,-1.322648405,0.222157276,0.854697432,0.481078642,orange,DNAJB12,DJB12_HUMAN,DnaJ homolog subfamily B member 12,DNAJB12,54788;,ENST00000444643.8; ENSP00000403313.2; ENSG00000148719.16. [Q9NXW2-1];,Hsp70 protein binding [GO:0030544],cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; protein-containing complex assembly [GO:0065003],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]
Q8TBM8,S2,-1.111663142,-1.579813732,0.212647023,0.970038744,0.595118105,orange,DNAJB14,DJB14_HUMAN,DnaJ homolog subfamily B member 14,DNAJB14 UNQ9427/PRO34683,79982;,ENST00000442697.7; ENSP00000404381.2; ENSG00000164031.17. [Q8TBM8-1];,Hsp70 protein binding [GO:0030544],cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein-containing complex assembly [GO:0065003],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]
Q9UDY4,C5,1.521279999,0.567701515,-0.602695122,-0.533607122,-0.727590731,turquoise3,DNAJB4,DNJB4_HUMAN,DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog) (HSP40 homolog) (Heat shock protein 40 homolog) (Human liver DnaJ-like protein),DNAJB4 DNAJW HLJ1,11080;,ENST00000370763.6; ENSP00000359799.5; ENSG00000162616.9.;,ATPase activator activity [GO:0001671]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018]
Q96KC8,S2,-1.059053275,-1.140326718,0.222305333,0.860238057,0.501484795,orange,DNAJC1,DNJC1_HUMAN,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),DNAJC1 HTJ1,64215;,ENST00000376980.8; ENSP00000366179.3; ENSG00000136770.11.;,ATPase activator activity [GO:0001671]; DNA binding [GO:0003677]; protein-folding chaperone binding [GO:0051087],negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]
Q8IXB1,S3,-1.294494047,0.027543351,-0.025180487,0.680507303,0.300847936,salmon,DNAJC10,DJC10_HUMAN,DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr),DNAJC10 ERDJ5 UNQ495/PRO1012,54431;,"ENST00000264065.12; ENSP00000264065.6; ENSG00000077232.19. [Q8IXB1-1];""ENST00000537515.5; ENSP00000441560.1; ENSG00000077232.19. [Q8IXB1-3]"";""ENST00000616986.5; ENSP00000479930.1; ENSG00000077232.19. [Q8IXB1-2]"";""ENST00000680480.1; ENSP00000505358.1; ENSG00000077232.19. [Q8IXB1-3]"";","ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; disulfide oxidoreductase activity [GO:0015036]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein-disulfide reductase activity [GO:0015035]; protein-folding chaperone binding [GO:0051087]",ERAD pathway [GO:0036503]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of ATP-dependent activity [GO:0032781]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]
Q9NVH1,M2,-0.615056875,-0.780666559,0.310113215,0.89077586,-0.179355108,tan4,DNAJC11,DJC11_HUMAN,DnaJ homolog subfamily C member 11,DNAJC11,55735;,"ENST00000294401.11; ENSP00000294401.7; ENSG00000007923.17. [Q9NVH1-3];""ENST00000377577.10; ENSP00000366800.5; ENSG00000007923.17. [Q9NVH1-1]"";",0,cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007],MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; SAM complex [GO:0001401]
O75165,S1,-0.714159775,-1.313047084,-0.285587028,0.447833961,1.249435658,gold,DNAJC13,DJC13_HUMAN,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),DNAJC13 KIAA0678 RME8,23317;,ENST00000260818.11; ENSP00000260818.6; ENSG00000138246.17.;,0,endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]
Q9Y2G8,S2,-1.429053558,-1.724089416,0.374576919,0.802471257,0.555908796,orange,DNAJC16,DJC16_HUMAN,DnaJ homolog subfamily C member 16 (Endoplasmic reticulum DNA J domain-containing protein 8) (ER-resident protein ERdj8) (ERdj8),DNAJC16 ERDJ8 KIAA0962,23341;,"ENST00000375847.8; ENSP00000365007.3; ENSG00000116138.13. [Q9Y2G8-1];""ENST00000616884.4; ENSP00000480224.1; ENSG00000116138.13. [Q9Y2G8-2]"";",0,regulation of autophagosome size [GO:0016243],endoplasmic reticulum membrane [GO:0005789]
Q96DA6,M2,-0.617278861,-0.92048333,0.370960191,0.962443474,-0.094685415,tan4,DNAJC19,TIM14_HUMAN,Mitochondrial import inner membrane translocase subunit TIM14 (DnaJ homolog subfamily C member 19),DNAJC19 TIM14 TIMM14,131118;,"ENST00000382564.8; ENSP00000372005.2; ENSG00000205981.9. [Q96DA6-1];""ENST00000479269.5; ENSP00000419191.1; ENSG00000205981.9. [Q96DA6-2]"";""ENST00000491873.5; ENSP00000420767.1; ENSG00000205981.9. [Q96DA6-2]"";",ATPase activator activity [GO:0001671],genitalia development [GO:0048806]; intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626]; regulation of cardiolipin metabolic process [GO:1900208]; visual perception [GO:0007601],"inner mitochondrial membrane protein complex [GO:0098800]; matrix side of mitochondrial inner membrane [GO:0099617]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; PAM complex, Tim23 associated import motor [GO:0001405]; protein-containing complex [GO:0032991]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]"
Q9H1X3,S2,-0.974975897,-1.143209462,0.176382,0.906435593,0.412282582,orange,DNAJC25,DJC25_HUMAN,DnaJ homolog subfamily C member 25,DNAJC25,548645;552891;,ENST00000313525.4; ENSP00000320650.3; ENSG00000059769.20. [Q9H1X3-1];,0,protein folding [GO:0006457],endoplasmic reticulum membrane [GO:0005789]
Q13217,S3,-1.262508875,0.069631304,-0.008378768,0.742854365,0.15489076,salmon,DNAJC3,DNJC3_HUMAN,"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)",DNAJC3 P58IPK PRKRI,5611;,ENST00000602402.6; ENSP00000473631.1; ENSG00000102580.15.;,misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein-folding chaperone binding [GO:0051087],cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]
Q96LL9,M2,-0.734352636,-0.979043702,0.341050374,1.118818184,0.069417479,tan4,DNAJC30,DJC30_HUMAN,"DnaJ homolog subfamily C member 30, mitochondrial (Williams-Beuren syndrome chromosomal region 18 protein)",DNAJC30 WBSCR18,84277;,ENST00000395176.3; ENSP00000378605.1; ENSG00000176410.8.;,0,ATP biosynthetic process [GO:0006754]; brain development [GO:0007420]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706],mitochondrial inner membrane [GO:0005743]
Q9H3Z4,S1,-1.010067416,-1.273802894,0.090213303,0.730805682,0.969217325,gold,DNAJC5,DNJC5_HUMAN,DnaJ homolog subfamily C member 5 (Ceroid-lipofuscinosis neuronal protein 4) (Cysteine string protein) (CSP),DNAJC5 CLN4,80331;,"ENST00000360864.9; ENSP00000354111.4; ENSG00000101152.12. [Q9H3Z4-1];""ENST00000470551.1; ENSP00000434744.1; ENSG00000101152.12. [Q9H3Z4-2]"";""ENST00000703637.1; ENSP00000515413.1; ENSG00000101152.12. [Q9H3Z4-2]"";",ATP-dependent protein binding [GO:0043008],chaperone-mediated protein folding [GO:0061077]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; regulated exocytosis [GO:0045055]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle exocytosis [GO:0016079],azurophil granule membrane [GO:0035577]; chromaffin granule membrane [GO:0042584]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]
Q99615,C3,1.64118223,0.529526314,-0.455932127,-0.458606988,-1.043715065,cyan,DNAJC7,DNJC7_HUMAN,DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2),DNAJC7 TPR2 TTC2,7266;,"ENST00000316603.12; ENSP00000313311.7; ENSG00000168259.17. [Q99615-2];""ENST00000426588.7; ENSP00000394327.2; ENSG00000168259.17. [Q99615-2]"";""ENST00000457167.9; ENSP00000406463.2; ENSG00000168259.17. [Q99615-1]"";""ENST00000590774.6; ENSP00000465340.2; ENSG00000168259.17. [Q99615-2]"";""ENST00000674166.1; ENSP00000501364.1; ENSG00000168259.17. [Q99615-2]"";""ENST00000674252.1; ENSP00000501366.1; ENSG00000168259.17. [Q99615-2]"";""ENST00000674287.1; ENSP00000501482.1; ENSG00000168259.17. [Q99615-2]"";""ENST00000674303.1; ENSP00000501468.1; ENSG00000168259.17. [Q99615-2]"";",ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072],chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
P50570,C3,1.524200705,0.194854175,-0.443838684,-0.363767435,-0.511054106,cyan,DNM2,DYN2_HUMAN,Dynamin-2 (EC 3.6.5.5) (Dynamin 2) (Dynamin II),DNM2 DYN2,1785;,"ENST00000355667.11; ENSP00000347890.6; ENSG00000079805.19. [P50570-1];""ENST00000359692.10; ENSP00000352721.6; ENSG00000079805.19. [P50570-2]"";""ENST00000389253.9; ENSP00000373905.4; ENSG00000079805.19. [P50570-4]"";""ENST00000408974.8; ENSP00000386192.3; ENSG00000079805.19. [P50570-3]"";""ENST00000585892.5; ENSP00000468734.1; ENSG00000079805.19. [P50570-5]"";","enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]",actin filament bundle organization [GO:0061572]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; membrane organization [GO:0061024]; membrane tubulation [GO:0097749]; negative regulation of membrane tubulation [GO:1903526]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; post-Golgi vesicle-mediated transport [GO:0006892]; protein polymerization [GO:0051258]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]; vesicle scission [GO:0099050],centriole [GO:0005814]; centrosome [GO:0005813]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; synapse [GO:0045202]; uropod [GO:0001931]
Q6XZF7,C1,1.257225322,0.095914761,-0.326690532,0.070652472,-0.27141198,lightblue,DNMBP,DNMBP_HUMAN,Dynamin-binding protein (Scaffold protein Tuba),DNMBP ARHGEF36 KIAA1010 TUBA,23268;,ENST00000324109.9; ENSP00000315659.4; ENSG00000107554.17. [Q6XZF7-1];,guanyl-nucleotide exchange factor activity [GO:0005085],cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202]
Q9H147,N1,-1.415696063,-0.784294625,0.464258286,0.215463542,0.870458045,grey90,DNTTIP1,TDIF1_HUMAN,Deoxynucleotidyltransferase terminal-interacting protein 1 (Terminal deoxynucleotidyltransferase-interacting factor 1) (TdIF1) (TdT-interacting factor 1),DNTTIP1 C20orf167 TDIF1,116092;,ENST00000372622.8; ENSP00000361705.3; ENSG00000101457.13.;,DNA binding [GO:0003677]; nucleosome binding [GO:0031491]; protein homodimerization activity [GO:0042803],0,chromosome [GO:0005694]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q5QJE6,N3,-1.038783032,-0.913938127,1.244099626,0.069438254,-0.220133235,grey50,DNTTIP2,TDIF2_HUMAN,Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2),DNTTIP2 ERBP TDIF2,30836;,ENST00000436063.7; ENSP00000411010.2; ENSG00000067334.14.;,RNA binding [GO:0003723],ribosomal small subunit biogenesis [GO:0042274]; RNA processing [GO:0006396],chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q9BZ29,S3,-0.697268661,-0.327815566,0.107476701,0.810658875,0.369402365,salmon,DOCK9,DOCK9_HUMAN,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1),DOCK9 KIAA1058 ZIZ1,23348;,"ENST00000376460.5; ENSP00000365643.1; ENSG00000088387.22. [Q9BZ29-5];""ENST00000627024.2; ENSP00000487551.1; ENSG00000088387.22. [Q9BZ29-6]"";""ENST00000652315.1; ENSP00000498761.1; ENSG00000088387.22. [Q9BZ29-1]"";",cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085],positive regulation of GTPase activity [GO:0043547]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]
Q9BU89,C5,1.776389346,0.521161622,-0.610102691,-0.63743829,-0.971347808,turquoise3,DOHH,DOHH_HUMAN,Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1),DOHH HLRC1,83475;,"ENST00000427575.6; ENSP00000398882.1; ENSG00000129932.10.;""ENST00000672935.1; ENSP00000500806.1; ENSG00000129932.10."";",deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506],peptidyl-lysine modification to peptidyl-hypusine [GO:0008612],cytosol [GO:0005829]
Q8TEK3,N3,-1.07828461,-0.88188409,0.938086003,0.027747287,0.538838537,grey50,DOT1L,DOT1L_HUMAN,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",DOT1L KIAA1814 KMT4,84444;,ENST00000398665.8; ENSP00000381657.3; ENSG00000104885.19. [Q8TEK3-2];,DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; heterochromatin formation [GO:0031507]; methylation [GO:0032259]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; telomere organization [GO:0032200],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q92785,N4,-1.047379751,0.814970822,0.740012718,-0.385344877,-0.11535342,grey30,DPF2,REQU_HUMAN,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",DPF2 BAF45D REQ UBID4,5977;,"ENST00000415073.6; ENSP00000399714.2; ENSG00000133884.11. [Q92785-2];""ENST00000528416.6; ENSP00000436901.1; ENSG00000133884.11. [Q92785-1]"";",H3K9me3 modified histone binding [GO:0062072]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714],apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]
Q9BQC3,C4,2.053921187,0.445634914,-0.638932132,-0.779145495,-1.003622809,deepskyblue2,DPH2,DPH2_HUMAN,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2),DPH2 DPH2L2,1802;,"ENST00000255108.8; ENSP00000255108.3; ENSG00000132768.14. [Q9BQC3-1];""ENST00000396758.6; ENSP00000379981.2; ENSG00000132768.14. [Q9BQC3-2]"";","2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",protein histidyl modification to diphthamide [GO:0017183],cytosol [GO:0005829]; protein-containing complex [GO:0032991]
Q96FX2,C4,2.35756283,0.192732622,-1.936718527,-2.160632648,-2.095214926,deepskyblue2,DPH3,DPH3_HUMAN,Diphthamide biosynthesis protein 3 (CSL-type zinc finger-containing protein 2) (DelGEF-interacting protein 1) (DelGIP1),DPH3 DESR1 ZCSL2,285381;,"ENST00000383775.4; ENSP00000373285.4; ENSG00000154813.10. [Q96FX2-2];""ENST00000488423.2; ENSP00000419599.1; ENSG00000154813.10. [Q96FX2-1]"";",ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986],negative regulation of protein secretion [GO:0050709]; positive regulation of binding [GO:0051099]; protein histidyl modification to diphthamide [GO:0017183]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9H2P9,C5,1.973600786,0.293255861,-0.901216778,-0.850277993,-1.003139768,turquoise3,DPH5,DPH5_HUMAN,Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase),DPH5 AD-018 CGI-30 HSPC143 NPD015,51611;,"ENST00000342173.11; ENSP00000339630.7; ENSG00000117543.22. [Q9H2P9-6];""ENST00000370109.8; ENSP00000359127.3; ENSG00000117543.22. [Q9H2P9-1]"";""ENST00000427040.3; ENSP00000394364.3; ENSG00000117543.22. [Q9H2P9-1]"";""ENST00000488176.1; ENSP00000418282.1; ENSG00000117543.22. [Q9H2P9-1]"";",diphthine methyl ester synthase activity [GO:0141133]; diphthine synthase activity [GO:0004164],methylation [GO:0032259]; protein histidyl modification to diphthamide [GO:0017183],cytosol [GO:0005829]
Q9BTV6,C5,1.747064276,0.28604393,-0.778318889,-0.657404183,-1.048020774,turquoise3,DPH7,DPH7_HUMAN,Diphthine methyltransferase (EC 3.1.1.97) (Diphthamide biosynthesis protein 7) (WD repeat-containing protein 85),DPH7 C9orf112 WDR85,92715;,ENST00000277540.7; ENSP00000277540.2; ENSG00000148399.13.;,diphthine methylesterase activity [GO:0061685],protein histidyl modification to diphthamide [GO:0017183],cytoplasm [GO:0005737]
O60762,S2,-1.034754958,-1.138970727,0.324601577,0.686892607,0.557414925,orange,DPM1,DPM1_HUMAN,Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1),DPM1,8813;,ENST00000371588.10; ENSP00000360644.5; ENSG00000000419.14.;,alcohol binding [GO:0043178]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannose binding [GO:0005537]; metal ion binding [GO:0046872],dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269],dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]
Q9P2X0,S3,-0.687811779,-0.709634082,0.225965134,0.718417163,0.443694773,salmon,DPM3,DPM3_HUMAN,Dolichol-phosphate mannosyltransferase subunit 3 (Dolichol-phosphate mannose synthase subunit 3) (DPM synthase subunit 3) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 3) (Mannose-P-dolichol synthase subunit 3) (MPD synthase subunit 3) (Prostin-1),DPM3,54344;,"ENST00000341298.3; ENSP00000344338.3; ENSG00000179085.8. [Q9P2X0-1];""ENST00000368399.1; ENSP00000357384.1; ENSG00000179085.8. [Q9P2X0-2]"";""ENST00000368400.5; ENSP00000357385.5; ENSG00000179085.8. [Q9P2X0-1]"";",enzyme activator activity [GO:0008047],carbohydrate metabolic process [GO:0005975]; dolichol metabolic process [GO:0019348]; GPI anchor biosynthetic process [GO:0006506]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406]; protein mannosylation [GO:0035268]; protein O-linked mannosylation [GO:0035269]; regulation of protein stability [GO:0031647],dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mannosyltransferase complex [GO:0031501]; membrane [GO:0016020]
Q9NY33,C4,1.97453916,0.461523974,-1.039750415,-1.048862373,-1.21631,deepskyblue2,DPP3,DPP3_HUMAN,Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III) (Enkephalinase B),DPP3,10072;,"ENST00000530165.5; ENSP00000436941.1; ENSG00000254986.8. [Q9NY33-4];""ENST00000531863.6; ENSP00000432782.2; ENSG00000254986.8. [Q9NY33-1]"";""ENST00000541961.5; ENSP00000440502.1; ENSG00000254986.8. [Q9NY33-1]"";",aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; metalloexopeptidase activity [GO:0008235]; zinc ion binding [GO:0008270],protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q2PZI1,S2,-0.978810346,-1.509408285,0.26320065,0.878902225,0.557703222,orange,DPY19L1,D19L1_HUMAN,Protein C-mannosyl-transferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1),DPY19L1 GA0500 KIAA0877,23333;,ENST00000310974.8; ENSP00000308695.4; ENSG00000173852.16. [Q2PZI1-1];,mannosyltransferase activity [GO:0000030],protein glycosylation [GO:0006486],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]
Q6ZPD9,S2,-1.333497867,-1.413031326,0.244916583,0.809691422,0.595821404,orange,DPY19L3,D19L3_HUMAN,Protein C-mannosyl-transferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3),DPY19L3,147991;,"ENST00000342179.9; ENSP00000344937.4; ENSG00000178904.19. [Q6ZPD9-1];""ENST00000392250.7; ENSP00000376081.2; ENSG00000178904.19. [Q6ZPD9-1]"";",mannosyltransferase activity [GO:0000030],protein glycosylation [GO:0006486],endoplasmic reticulum membrane [GO:0005789]; nuclear inner membrane [GO:0005637]
Q7Z388,S2,-0.761903551,-1.339025497,0.339700342,0.76280872,0.502768744,orange,DPY19L4,D19L4_HUMAN,Probable C-mannosyltransferase DPY19L4 (EC 2.4.1.-) (Dpy-19-like protein 4) (Protein dpy-19 homolog 4),DPY19L4,286148;,ENST00000414645.6; ENSP00000389630.2; ENSG00000156162.16.;,mannosyltransferase activity [GO:0000030],0,nuclear inner membrane [GO:0005637]
Q12882,C4,1.973890194,0.292001934,-0.94698158,-0.895649855,-1.048651853,deepskyblue2,DPYD,DPYD_HUMAN,Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase),DPYD,1806;,"ENST00000306031.5; ENSP00000307107.5; ENSG00000188641.14. [Q12882-2];""ENST00000370192.8; ENSP00000359211.3; ENSG00000188641.14. [Q12882-1]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]",beta-alanine biosynthetic process [GO:0019483]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; purine nucleobase catabolic process [GO:0006145]; pyrimidine nucleobase catabolic process [GO:0006208]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212],cytoplasm [GO:0005737]; cytosol [GO:0005829]
P55039,C4,1.873948666,-0.013396319,-0.691814831,-0.642747622,-0.831233863,deepskyblue2,DRG2,DRG2_HUMAN,Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-),DRG2,1819;,ENST00000225729.8; ENSP00000225729.3; ENSG00000108591.10.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NRR4,N1,-1.045602644,-0.731218386,0.304398094,-0.131993016,1.199555986,grey90,DROSHA,RNC_HUMAN,Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241),DROSHA RN3 RNASE3L RNASEN,29102;,"ENST00000344624.8; ENSP00000339845.3; ENSG00000113360.17. [Q9NRR4-1];""ENST00000511367.6; ENSP00000425979.2; ENSG00000113360.17. [Q9NRR4-1]"";""ENST00000513349.5; ENSP00000424161.1; ENSG00000113360.17. [Q9NRR4-4]"";",DEAD/H-box RNA helicase binding [GO:0017151]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; SMAD binding [GO:0046332],defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; miRNA metabolic process [GO:0010586]; positive regulation of gene expression [GO:0010628]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; regulation of inflammatory response [GO:0050727]; regulation of miRNA metabolic process [GO:2000628]; regulation of regulatory T cell differentiation [GO:0045589]; rRNA processing [GO:0006364],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microprocessor complex [GO:0070877]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]
O14972,C2,1.319435952,0.616175432,-0.549630593,-0.323089041,-0.173706474,aquamarine,DSCR3,VP26C_HUMAN,Vacuolar protein sorting-associated protein 26C (Down syndrome critical region protein 3) (Down syndrome critical region protein A),VPS26C DCRA DSCR3 DSCRA,10311;,"ENST00000309117.11; ENSP00000311399.6; ENSG00000157538.14. [O14972-1];""ENST00000476950.5; ENSP00000419496.1; ENSG00000157538.14. [O14972-2]"";",0,endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886],endosome [GO:0005768]; nucleus [GO:0005634]
P60981,C4,2.02064851,0.379595199,-0.917012082,-0.922069976,-1.182876032,deepskyblue2,DSTN,DEST_HUMAN,Destrin (Actin-depolymerizing factor) (ADF),DSTN ACTDP DSN,11034;,"ENST00000246069.12; ENSP00000246069.6; ENSG00000125868.16. [P60981-1];""ENST00000474024.5; ENSP00000476975.1; ENSG00000125868.16. [P60981-2]"";",actin filament binding [GO:0051015],actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; cell motility [GO:0048870]; positive regulation of actin filament depolymerization [GO:0030836],actin cytoskeleton [GO:0015629]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]
Q8TEA8,C5,1.643546291,0.573498347,-0.73371204,-0.777483863,-1.289642462,turquoise3,DTD1,DTD1_HUMAN,D-aminoacyl-tRNA deacylase 1 (DTD) (EC 3.1.1.96) (DNA-unwinding element-binding protein B) (DUE-B) (Gly-tRNA(Ala) deacylase) (Histidyl-tRNA synthase-related),DTD1 C20orf88 DUEB HARS2,92675;,ENST00000377452.4; ENSP00000366672.4; ENSG00000125821.13.;,D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049],DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399],cytoplasm [GO:0005737]; nucleus [GO:0005634]
O60941,M1,-0.494258743,-0.773767381,0.50234195,0.645267891,-0.154665218,burlywood4,DTNB,DTNB_HUMAN,Dystrobrevin beta (DTN-B) (Beta-dystrobrevin),DTNB,1838;,"ENST00000404103.7; ENSP00000385482.3; ENSG00000138101.20. [O60941-4];""ENST00000405222.5; ENSP00000384787.1; ENSG00000138101.20. [O60941-5]"";""ENST00000406818.8; ENSP00000384084.3; ENSG00000138101.20. [O60941-1]"";""ENST00000407038.7; ENSP00000384767.3; ENSG00000138101.20. [O60941-2]"";""ENST00000407661.7; ENSP00000385193.3; ENSG00000138101.20. [O60941-7]"";",zinc ion binding [GO:0008270],neuron differentiation [GO:0030182]; synaptic signaling [GO:0099536],basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]
Q96EV8,C2,1.110886076,0.703558509,-0.474575194,-0.416401438,-0.521061653,aquamarine,DTNBP1,DTBP1_HUMAN,Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein),DTNBP1 BLOC1S8 My031,84062;,"ENST00000338950.9; ENSP00000344718.5; ENSG00000047579.20. [Q96EV8-2];""ENST00000344537.10; ENSP00000341680.6; ENSG00000047579.20. [Q96EV8-1]"";",0,actin cytoskeleton organization [GO:0030036]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; kidney development [GO:0001822]; melanosome organization [GO:0032438]; memory [GO:0007613]; negative regulation of dendritic spine morphogenesis [GO:0061002]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transmembrane transport [GO:0071806]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of synaptic vesicle exocytosis [GO:2000300]; retina development in camera-type eye [GO:0060041],axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672]
P23919,C1,1.328599467,0.189245025,-0.207386342,-0.034998845,-0.791020125,lightblue,DTYMK,KTHY_HUMAN,Thymidylate kinase (EC 2.7.4.9) (dTMP kinase),DTYMK CDC8 TMPK TYMK,1841;,ENST00000305784.7; ENSP00000304802.2; ENSG00000168393.13. [P23919-1];,ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798],cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627]; thymidine biosynthetic process [GO:0046105],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q9UNI6,C5,1.59546288,0.723172322,-0.53985572,-0.619592833,-1.028458683,turquoise3,DUSP12,DUS12_HUMAN,Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity tyrosine phosphatase YVH1),DUSP12,11266;,ENST00000367943.5; ENSP00000356920.4; ENSG00000081721.12.;,kinase binding [GO:0019900]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270],dephosphorylation [GO:0016311]; protein modification process [GO:0036211],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O95147,C2,0.824737171,0.560423777,-0.007844652,-0.080658069,-0.400175575,aquamarine,DUSP14,DUS14_HUMAN,Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48) (MKP-1-like protein tyrosine phosphatase) (MKP-L) (Mitogen-activated protein kinase phosphatase 6) (MAP kinase phosphatase 6) (MKP-6),DUSP14 MKP6,11072;,"ENST00000613659.1; ENSP00000484091.1; ENSG00000276023.5.;""ENST00000614294.2; ENSP00000478406.1; ENSG00000275932.2."";""ENST00000614411.1; ENSP00000477653.1; ENSG00000276023.5."";""ENST00000617516.5; ENSP00000478595.1; ENSG00000276023.5."";""ENST00000632468.1; ENSP00000487886.1; ENSG00000275932.2."";""ENST00000633870.1; ENSP00000488882.1; ENSG00000275932.2."";",MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; myosin phosphatase activity [GO:0017018]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723],0,0
P51452,C5,2.121874498,0.155817665,-1.024910651,-0.94137306,-1.139072777,turquoise3,DUSP3,DUS3_HUMAN,Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR),DUSP3 VHR,1845;,ENST00000226004.8; ENSP00000226004.2; ENSG00000108861.9. [P51452-1];,cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor tyrosine kinase binding [GO:0030971],cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893],cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O14641,C1,1.302504613,0.056421665,-0.163291122,-0.017166573,-0.535785081,lightblue,DVL2,DVL2_HUMAN,Segment polarity protein dishevelled homolog DVL-2 (Dishevelled-2) (DSH homolog 2),DVL2,1856;,ENST00000005340.10; ENSP00000005340.4; ENSG00000004975.12.;,frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],"canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in neural plate elongation [GO:0022007]; heart development [GO:0007507]; heart looping [GO:0001947]; intracellular signal transduction [GO:0035556]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; segment specification [GO:0007379]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",aggresome [GO:0016235]; apical part of cell [GO:0045177]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q14204,C1,1.484817927,0.0424561,-0.563955178,-0.459771286,0.030628792,lightblue,DYNC1H1,DYHC1_HUMAN,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325,1778;,ENST00000360184.10; ENSP00000348965.4; ENSG00000197102.14.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569]; RNA binding [GO:0003723],cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of spindle localization [GO:0051293]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; retrograde axonal transport [GO:0008090]; stress granule assembly [GO:0034063],axon cytoplasm [GO:1904115]; azurophil granule lumen [GO:0035578]; cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]
Q13409,C1,1.855148833,0.093327697,-0.894086904,-0.918054439,-0.536640522,lightblue,DYNC1I2,DC1I2_HUMAN,"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)",DYNC1I2 DNCI2 DNCIC2,1781;,"ENST00000340296.8; ENSP00000339430.4; ENSG00000077380.16. [Q13409-3];""ENST00000397119.8; ENSP00000380308.3; ENSG00000077380.16. [Q13409-1]"";""ENST00000409197.5; ENSP00000386397.1; ENSG00000077380.16. [Q13409-3]"";""ENST00000409317.5; ENSP00000386591.1; ENSG00000077380.16. [Q13409-2]"";""ENST00000409453.5; ENSP00000386886.1; ENSG00000077380.16. [Q13409-5]"";""ENST00000409773.5; ENSP00000386415.1; ENSG00000077380.16. [Q13409-1]"";""ENST00000410079.7; ENSP00000386522.3; ENSG00000077380.16. [Q13409-7]"";""ENST00000508530.5; ENSP00000423339.1; ENSG00000077380.16. [Q13409-6]"";""ENST00000709730.1; ENSP00000517843.1; ENSG00000292102.1. [Q13409-3]"";""ENST00000709731.1; ENSP00000517844.1; ENSG00000292102.1. [Q13409-1]"";""ENST00000709732.1; ENSP00000517845.1; ENSG00000292102.1. [Q13409-7]"";""ENST00000709735.1; ENSP00000517847.1; ENSG00000292102.1. [Q13409-6]"";""ENST00000709736.1; ENSP00000517848.1; ENSG00000292102.1. [Q13409-3]"";""ENST00000709738.1; ENSP00000517850.1; ENSG00000292102.1. [Q13409-2]"";""ENST00000709739.1; ENSP00000517851.1; ENSG00000292102.1. [Q13409-1]"";""ENST00000709741.1; ENSP00000517853.1; ENSG00000292102.1. [Q13409-5]"";",dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule motor activity [GO:0003777],microtubule-based movement [GO:0007018]; transport along microtubule [GO:0010970],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]
Q9Y6G9,C1,1.510045321,0.201837802,-0.662112373,-0.498416458,-0.056846082,lightblue,DYNC1LI1,DC1L1_HUMAN,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic) (DLIC-1)",DYNC1LI1 DNCLI1,51143;,ENST00000273130.9; ENSP00000273130.4; ENSG00000144635.9.;,ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; GDP binding [GO:0019003]; molecular adaptor activity [GO:0060090]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723],cell division [GO:0051301]; early endosome to recycling endosome transport [GO:0061502]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of vesicle-mediated transport [GO:0060627],centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; ficolin-1-rich granule membrane [GO:0101003]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; spindle pole [GO:0000922]
O43237,C1,1.659100222,-0.004474661,-0.725593858,-0.643499705,-0.28083288,lightblue,DYNC1LI2,DC1L2_HUMAN,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55)",DYNC1LI2 DNCLI2 LIC2,1783;,"ENST00000258198.7; ENSP00000258198.2; ENSG00000135720.13. [O43237-1];""ENST00000443351.6; ENSP00000394289.2; ENSG00000135720.13. [O43237-2]"";",ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; identical protein binding [GO:0042802],cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018],centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule [GO:0005874]
Q9NP97,C1,1.556998374,0.274018603,-0.825450179,-0.70004803,-0.366869513,lightblue,DYNLRB1,DLRB1_HUMAN,"Dynein light chain roadblock-type 1 (Bithoraxoid-like protein) (BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1)",DYNLRB1 BITH DNCL2A DNLC2A ROBLD1 HSPC162,83658;,"ENST00000300469.13; ENSP00000300469.9; ENSG00000125971.18. [Q9NP97-2];""ENST00000357156.7; ENSP00000349679.2; ENSG00000125971.18. [Q9NP97-1]"";""ENST00000480759.1; ENSP00000513022.1; ENSG00000125971.18. [Q9NP97-2]"";",dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777],microtubule-based movement [GO:0007018]; visual behavior [GO:0007632],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; membrane [GO:0016020]; microtubule [GO:0005874]
P51808,C1,1.673542636,0.201743208,-0.787606753,-0.42853511,-0.228541826,lightblue,DYNLT3,DYLT3_HUMAN,Dynein light chain Tctex-type 3 (Protein 91/23) (T-complex-associated testis-expressed 1-like),DYNLT3 TCTE1L TCTE1XL,6990;,ENST00000378578.9; ENSP00000367841.4; ENSG00000165169.11.;,dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802],cell division [GO:0051301]; microtubule-based movement [GO:0007018]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of mitotic cell cycle [GO:0007346],cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; mitotic spindle astral microtubule [GO:0061673]; nucleus [GO:0005634]
Q13627,C2,1.318189536,0.242945122,-0.058340514,-0.315041423,-0.439849769,aquamarine,DYRK1A,DYR1A_HUMAN,Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.11.23) (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB),DYRK1A DYRK MNB MNBH,1859;,"ENST00000338785.8; ENSP00000342690.3; ENSG00000157540.22. [Q13627-5];""ENST00000398956.2; ENSP00000381929.2; ENSG00000157540.22. [Q13627-3]"";""ENST00000398960.7; ENSP00000381932.2; ENSG00000157540.22. [Q13627-1]"";""ENST00000643624.1; ENSP00000493627.1; ENSG00000157540.22. [Q13627-2]"";""ENST00000644942.1; ENSP00000494544.1; ENSG00000157540.22. [Q13627-1]"";""ENST00000645424.1; ENSP00000494897.1; ENSG00000157540.22. [Q13627-4]"";""ENST00000646548.1; ENSP00000495908.1; ENSG00000157540.22. [Q13627-2]"";""ENST00000647188.2; ENSP00000494572.1; ENSG00000157540.22. [Q13627-2]"";""ENST00000647425.1; ENSP00000496748.1; ENSG00000157540.22. [Q13627-2]"";",actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; histone H3T45 kinase activity [GO:0140857]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631],"amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]",axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
Q86Y13,S1,-0.157063525,-0.633033151,-0.246616785,0.115029207,0.952360824,gold,DZIP3,DZIP3_HUMAN,E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3) (RING-type E3 ubiquitin transferase DZIP3) (RNA-binding ubiquitin ligase of 138 kDa) (hRUL138),DZIP3 KIAA0675,9666;,"ENST00000361582.8; ENSP00000355028.3; ENSG00000198919.13. [Q86Y13-1];""ENST00000463306.1; ENSP00000419981.1; ENSG00000198919.13. [Q86Y13-1]"";""ENST00000495008.5; ENSP00000418871.1; ENSG00000198919.13. [Q86Y13-2]"";",metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]
O00559,S1,-1.148003324,-1.582438939,-0.229829455,0.831354544,1.093787506,gold,EBAG9,RCAS1_HUMAN,Receptor-binding cancer antigen expressed on SiSo cells (Cancer-associated surface antigen RCAS1) (Estrogen receptor-binding fragment-associated gene 9 protein),EBAG9 RCAS1,9166;,"ENST00000337573.10; ENSP00000337675.5; ENSG00000147654.16. [O00559-1];""ENST00000395785.7; ENSP00000379131.2; ENSG00000147654.16. [O00559-1]"";""ENST00000531677.5; ENSP00000432082.1; ENSG00000147654.16. [O00559-2]"";""ENST00000614147.1; ENSP00000477734.1; ENSG00000147654.16. [O00559-2]"";""ENST00000620557.4; ENSP00000477645.1; ENSG00000147654.16. [O00559-1]"";""ENST00000699338.1; ENSP00000514313.1; ENSG00000147654.16. [O00559-1]"";",peptidase activator activity involved in apoptotic process [GO:0016505],adaptive immune memory response involving T cells and B cells [GO:0090717]; regulation of cell growth [GO:0001558]; T cell mediated cytotoxicity [GO:0001913],Golgi membrane [GO:0000139]; secretory granule [GO:0030141]
Q99848,N3,-1.07346964,-1.278730886,1.244578188,-0.181531986,0.203693913,grey50,EBNA1BP2,EBP2_HUMAN,Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40),EBNA1BP2 EBP2,10969;,ENST00000236051.3; ENSP00000236051.2; ENSG00000117395.13.;,RNA binding [GO:0003723],ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],"chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]"
Q15125,S4,-0.784459803,-0.97501996,0.350067513,0.755965248,0.484863408,tomato2,EBP,EBP_HUMAN,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein)",EBP,10682;,ENST00000495186.6; ENSP00000417052.1; ENSG00000147155.11.;,C-8 sterol isomerase activity [GO:0000247]; cholestenol delta-isomerase activity [GO:0047750]; identical protein binding [GO:0042802]; steroid delta-isomerase activity [GO:0004769],cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via desmosterol [GO:0033489]; cholesterol biosynthetic process via lathosterol [GO:0033490]; cholesterol metabolic process [GO:0008203]; hemopoiesis [GO:0030097]; ossification involved in bone maturation [GO:0043931],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]
O95905,C1,1.831565618,-0.043630675,-0.705164621,-0.625811318,-0.53095506,lightblue,ECD,ECD_HUMAN,Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1),ECD,11319;,"ENST00000372979.9; ENSP00000362070.4; ENSG00000122882.11. [O95905-1];""ENST00000430082.6; ENSP00000401566.1; ENSG00000122882.11. [O95905-3]"";""ENST00000454759.6; ENSP00000395786.1; ENSG00000122882.11. [O95905-2]"";",histone acetyltransferase binding [GO:0035035],fibroblast proliferation [GO:0048144]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P42892,S1,-1.040673946,-1.241739569,0.091282368,0.581908325,1.010049814,gold,ECE1,ECE1_HUMAN,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),ECE1,1889;,"ENST00000264205.10; ENSP00000264205.6; ENSG00000117298.16. [P42892-4];""ENST00000357071.8; ENSP00000349581.4; ENSG00000117298.16. [P42892-2]"";""ENST00000374893.11; ENSP00000364028.6; ENSG00000117298.16. [P42892-1]"";""ENST00000415912.6; ENSP00000405088.2; ENSG00000117298.16. [P42892-3]"";",endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; hormone catabolic process [GO:0042447]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; protein processing [GO:0016485]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492],early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093]
O75521,S3,-1.413490672,-0.449334502,0.040545951,0.891794125,0.069424691,salmon,ECI2,ECI2_HUMAN,"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)",ECI2 DRS1 HCA88 PECI,10455;,ENST00000380118.8; ENSP00000369461.3; ENSG00000198721.13. [O75521-1];,delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062],fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]
Q9BQ95,M2,-0.868973806,-1.109175759,0.269136083,1.095892354,-0.171745513,tan4,ECSIT,ECSIT_HUMAN,"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (Protein SITPEC)",ECSIT,51295;,"ENST00000252440.11; ENSP00000252440.6; ENSG00000130159.15. [Q9BQ95-2];""ENST00000270517.12; ENSP00000270517.6; ENSG00000130159.15. [Q9BQ95-1]"";""ENST00000417981.6; ENSP00000412712.1; ENSG00000130159.15. [Q9BQ95-3]"";""ENST00000591104.5; ENSP00000466559.1; ENSG00000130159.15. [Q9BQ95-4]"";""ENST00000688351.1; ENSP00000508502.1; ENSG00000130159.15. [Q9BQ95-1]"";""ENST00000690346.1; ENSP00000510792.1; ENSG00000130159.15. [Q9BQ95-1]"";",molecular adaptor activity [GO:0060090],cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; regulation of oxidoreductase activity [GO:0051341]; regulation of protein complex stability [GO:0061635]; toll-like receptor 4 signaling pathway [GO:0034142],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9H8V3,S1,-0.791735465,-0.571510301,0.157550589,0.595365454,0.79405183,gold,ECT2,ECT2_HUMAN,Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene),ECT2,1894;,"ENST00000232458.9; ENSP00000232458.5; ENSG00000114346.14. [Q9H8V3-4];""ENST00000392692.8; ENSP00000376457.3; ENSG00000114346.14. [Q9H8V3-1]"";""ENST00000417960.5; ENSP00000415876.1; ENSG00000114346.14. [Q9H8V3-2]"";""ENST00000441497.6; ENSP00000412259.2; ENSG00000114346.14. [Q9H8V3-4]"";""ENST00000540509.5; ENSP00000443160.2; ENSG00000114346.14. [Q9H8V3-4]"";",GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],"activation of GTPase activity [GO:0090630]; activation of protein kinase activity [GO:0032147]; bicellular tight junction assembly [GO:0070830]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein import into nucleus [GO:0042307]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of cytokinesis, actomyosin contractile ring assembly [GO:2000431]; regulation of protein kinase activity [GO:0045859]; regulation of small GTPase mediated signal transduction [GO:0051056]",bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BV94,S3,-0.856615122,-0.404082679,0.187644761,0.726223839,0.423519866,salmon,EDEM2,EDEM2_HUMAN,ER degradation-enhancing alpha-mannosidase-like protein 2,EDEM2 C20orf31 C20orf49 UNQ573/PRO1135,55741;,"ENST00000374491.3; ENSP00000363615.2; ENSG00000088298.13. [Q9BV94-2];""ENST00000374492.8; ENSP00000363616.3; ENSG00000088298.13. [Q9BV94-1]"";","calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]","carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; mannoprotein catabolic process [GO:0006058]; positive regulation of retrograde protein transport, ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; viral protein processing [GO:0019082]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]
Q9BZQ6,S3,-1.369613672,-0.230283841,0.212400579,0.678029479,0.426965639,salmon,EDEM3,EDEM3_HUMAN,"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)",EDEM3 C1orf22,80267;,ENST00000318130.13; ENSP00000318147.7; ENSG00000116406.20. [Q9BZQ6-1];,"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486]; response to unfolded protein [GO:0006986],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020]
O60869,C5,0.790424324,1.269571862,-0.641960008,-0.990436855,-0.994658299,turquoise3,EDF1,EDF1_HUMAN,Endothelial differentiation-related factor 1 (EDF-1) (Multiprotein-bridging factor 1) (MBF1),EDF1,8721;,"ENST00000224073.6; ENSP00000224073.1; ENSG00000107223.13. [O60869-1];""ENST00000371648.4; ENSP00000360711.4; ENSG00000107223.13. [O60869-2]"";""ENST00000371649.5; ENSP00000360712.1; ENSG00000107223.13. [O60869-3]"";",calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713],endothelial cell differentiation [GO:0045446]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of lipid metabolic process [GO:0019216],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P68104,C4,1.873716243,0.305102494,-0.857940766,-0.857973053,-1.035936542,deepskyblue2,EEF1A1,EF1A1_HUMAN,Elongation factor 1-alpha 1 (EF-1-alpha-1) (EC 3.6.5.-) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7),EEF1A1 EEF1A EF1A LENG7,1915;,"ENST00000309268.11; ENSP00000339053.4; ENSG00000156508.19.;""ENST00000316292.13; ENSP00000339063.7; ENSG00000156508.19."";""ENST00000331523.7; ENSP00000330054.2; ENSG00000156508.19."";""ENST00000356303.7; ENSP00000348651.3; ENSG00000156508.19."";""ENST00000455918.2; ENSP00000392366.2; ENSG00000156508.19."";""ENST00000615060.5; ENSP00000479055.2; ENSG00000156508.19."";""ENST00000676710.1; ENSP00000504335.1; ENSG00000156508.19."";""ENST00000677236.1; ENSP00000503192.1; ENSG00000156508.19."";""ENST00000678508.1; ENSP00000503249.1; ENSG00000156508.19."";""ENST00000678702.1; ENSP00000503823.1; ENSG00000156508.19."";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049],cellular response to epidermal growth factor stimulus [GO:0071364]; positive regulation by host of viral genome replication [GO:0044829]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414],cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; eukaryotic translation elongation factor 1 complex [GO:0005853]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774]
P24534,C2,1.17022909,0.797521766,-0.760106171,-0.688644355,-0.344674285,aquamarine,EEF1B2,EF1B_HUMAN,Elongation factor 1-beta (EF-1-beta),EEF1B2 EEF1B EF1B,1933;,"ENST00000236957.9; ENSP00000236957.5; ENSG00000114942.15.;""ENST00000392222.7; ENSP00000376056.2; ENSG00000114942.15."";""ENST00000445505.6; ENSP00000407730.2; ENSG00000114942.15."";""ENST00000635728.1; ENSP00000489993.1; ENSG00000283391.3."";""ENST00000636275.2; ENSP00000490326.1; ENSG00000283391.3."";""ENST00000637452.2; ENSP00000490885.2; ENSG00000283391.3."";",guanyl-nucleotide exchange factor activity [GO:0005085]; translation elongation factor activity [GO:0003746],translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]
P29692,C2,1.173603517,0.772137558,-0.668152338,-0.554675263,-0.30979542,aquamarine,EEF1D,EF1D_HUMAN,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),EEF1D EF1D,1936;,"ENST00000317198.10; ENSP00000317399.6; ENSG00000104529.19. [P29692-1];""ENST00000395119.7; ENSP00000378551.3; ENSG00000104529.19. [P29692-1]"";""ENST00000419152.7; ENSP00000388261.2; ENSG00000104529.19. [P29692-1]"";""ENST00000442189.6; ENSP00000391944.2; ENSG00000104529.19. [P29692-2]"";""ENST00000524624.5; ENSP00000435697.1; ENSG00000104529.19. [P29692-3]"";""ENST00000526838.5; ENSP00000436507.1; ENSG00000104529.19. [P29692-4]"";""ENST00000528610.5; ENSP00000431763.1; ENSG00000104529.19. [P29692-3]"";""ENST00000529272.5; ENSP00000434872.1; ENSG00000104529.19. [P29692-1]"";""ENST00000529516.6; ENSP00000431742.2; ENSG00000104529.19. [P29692-4]"";""ENST00000530191.6; ENSP00000436542.2; ENSG00000104529.19. [P29692-1]"";""ENST00000530445.6; ENSP00000436933.2; ENSG00000104529.19. [P29692-1]"";""ENST00000531218.6; ENSP00000434448.2; ENSG00000104529.19. [P29692-1]"";""ENST00000533494.6; ENSP00000433412.2; ENSG00000104529.19. [P29692-1]"";""ENST00000534377.6; ENSP00000431460.2; ENSG00000104529.19. [P29692-3]"";""ENST00000534380.6; ENSP00000433611.2; ENSG00000104529.19. [P29692-1]"";""ENST00000614575.4; ENSP00000478340.2; ENSG00000273594.4. [P29692-1]"";""ENST00000615067.4; ENSP00000479653.1; ENSG00000273594.4. [P29692-1]"";""ENST00000615698.4; ENSP00000483527.1; ENSG00000273594.4. [P29692-1]"";""ENST00000618139.4; ENSP00000484536.2; ENSG00000104529.19. [P29692-2]"";""ENST00000619144.4; ENSP00000477608.1; ENSG00000273594.4. [P29692-2]"";""ENST00000620155.3; ENSP00000480505.1; ENSG00000273594.4. [P29692-2]"";""ENST00000631698.1; ENSP00000488672.1; ENSG00000273594.4. [P29692-4]"";""ENST00000632587.1; ENSP00000487680.1; ENSG00000273594.4. [P29692-1]"";""ENST00000632675.1; ENSP00000488026.1; ENSG00000273594.4. [P29692-3]"";""ENST00000632965.1; ENSP00000488275.1; ENSG00000273594.4. [P29692-3]"";","cadherin binding [GO:0045296]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; guanyl-nucleotide exchange factor activity [GO:0005085]; heat shock protein binding [GO:0031072]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; translation elongation factor activity [GO:0003746]; translation factor activity, RNA binding [GO:0008135]",cellular response to heat [GO:0034605]; cellular response to ionizing radiation [GO:0071479]; cytoplasmic translational elongation [GO:0002182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P26641,C2,1.146573773,0.702768488,-0.67437445,-0.580470502,-0.360339138,aquamarine,EEF1G,EF1G_HUMAN,Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma),EEF1G EF1G PRO1608,1937;,ENST00000329251.5; ENSP00000331901.4; ENSG00000254772.10. [P26641-1];,cadherin binding [GO:0045296]; translation elongation factor activity [GO:0003746],response to virus [GO:0009615]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]
P13639,C4,2.13221073,0.096275267,-1.005074448,-1.049867895,-1.216837602,deepskyblue2,EEF2,EF2_HUMAN,Elongation factor 2 (EF-2) (EC 3.6.5.-),EEF2 EF2,1938;,ENST00000309311.7; ENSP00000307940.5; ENSG00000167658.16.;,cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746],hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414],aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]
O00418,C4,2.063636513,0.24027295,-1.014063772,-1.156019396,-1.153040692,deepskyblue2,EEF2K,EF2K_HUMAN,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),EEF2K,29904;,ENST00000263026.10; ENSP00000263026.5; ENSG00000103319.12.;,"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]",cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]
O75071,S1,-1.605546832,-1.51020349,-0.224784667,0.902764907,1.008929326,gold,EFCAB14,EFC14_HUMAN,EF-hand calcium-binding domain-containing protein 14,EFCAB14 KIAA0494,9813;,ENST00000371933.8; ENSP00000361001.3; ENSG00000159658.15.;,calcium ion binding [GO:0005509],0,0
P98172,S2,-1.046461546,-0.867460961,0.34263042,0.924238279,0.126727178,orange,EFNB1,EFNB1_HUMAN,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2) [Cleaved into: Ephrin-B1 C-terminal fragment (Ephrin-B1 CTF); Ephrin-B1 intracellular domain (Ephrin-B1 ICD)],EFNB1 EFL3 EPLG2 LERK2,1947;,ENST00000204961.5; ENSP00000204961.4; ENSG00000090776.6.;,ephrin receptor binding [GO:0046875],axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; embryonic pattern specification [GO:0009880]; ephrin receptor signaling pathway [GO:0048013]; neural crest cell migration [GO:0001755]; positive regulation of T cell proliferation [GO:0042102]; regulation of autophagosome assembly [GO:2000785]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]
Q14156,S4,-0.947966908,-1.240091025,0.416520607,0.852288997,0.391010963,tomato2,EFR3A,EFR3A_HUMAN,Protein EFR3 homolog A (Protein EFR3-like),EFR3A KIAA0143,23167;,"ENST00000254624.10; ENSP00000254624.5; ENSG00000132294.15. [Q14156-1];""ENST00000519656.1; ENSP00000428086.1; ENSG00000132294.15. [Q14156-2]"";",0,phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659],cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q7Z2Z2,C3,1.570880463,0.346874463,-0.539194337,-0.390008612,-0.610394303,cyan,EFTUD1,EFL1_HUMAN,Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A),EFL1 EFTUD1 FAM42A,79631;,"ENST00000268206.12; ENSP00000268206.7; ENSG00000140598.16. [Q7Z2Z2-1];""ENST00000359445.8; ENSP00000352418.3; ENSG00000140598.16. [Q7Z2Z2-2]"";""ENST00000696330.1; ENSP00000512564.1; ENSG00000140598.16. [Q7Z2Z2-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039],cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]
P00533,S4,-0.874001908,-1.125267366,0.335074505,0.777838181,0.442602276,tomato2,EGFR,EGFR_HUMAN,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),EGFR ERBB ERBB1 HER1,1956;,"ENST00000275493.7; ENSP00000275493.2; ENSG00000146648.21. [P00533-1];""ENST00000342916.7; ENSP00000342376.3; ENSG00000146648.21. [P00533-4]"";""ENST00000344576.7; ENSP00000345973.2; ENSG00000146648.21. [P00533-3]"";""ENST00000420316.6; ENSP00000413843.2; ENSG00000146648.21. [P00533-2]"";",actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618],"activation of phospholipase C activity [GO:0007202]; astrocyte activation [GO:0048143]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; neuron projection morphogenesis [GO:0048812]; ossification [GO:0001503]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mucus secretion [GO:0070257]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; protein insertion into membrane [GO:0051205]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; vasodilation [GO:0042311]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]"
Q8NDI1,C1,1.805470138,-0.035326462,-0.574041874,-0.213054786,-0.592045727,lightblue,EHBP1,EHBP1_HUMAN,EH domain-binding protein 1,EHBP1 KIAA0903 NACSIN,23301;,"ENST00000263991.9; ENSP00000263991.5; ENSG00000115504.15. [Q8NDI1-1];""ENST00000405015.7; ENSP00000384143.3; ENSG00000115504.15. [Q8NDI1-3]"";""ENST00000405289.5; ENSP00000385524.1; ENSG00000115504.15. [Q8NDI1-2]"";""ENST00000431489.6; ENSP00000403783.1; ENSG00000115504.15. [Q8NDI1-3]"";",0,endocytosis [GO:0006897]; protein transport [GO:0015031],cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q8N9N8,C5,1.447320634,0.527545217,-0.827619845,-0.71799214,-0.66297128,turquoise3,EIF1AD,EIF1A_HUMAN,Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein) (Haponin),EIF1AD,84285;,"ENST00000312234.6; ENSP00000309175.2; ENSG00000175376.9.;""ENST00000526451.5; ENSP00000436644.1; ENSG00000175376.9."";""ENST00000527249.5; ENSP00000435439.1; ENSG00000175376.9."";""ENST00000529964.5; ENSP00000435942.2; ENSG00000175376.9."";""ENST00000533544.6; ENSP00000434056.1; ENSG00000175376.9."";",RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743],0,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NZJ5,S2,-1.067040724,-1.4807495,0.122231041,0.924271644,0.615904788,orange,EIF2AK3,E2AK3_HUMAN,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK),EIF2AK3 PEK PERK,9451;,ENST00000303236.9; ENSP00000307235.3; ENSG00000172071.15.;,ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; ossification [GO:0001503]; peptidyl-serine phosphorylation [GO:0018105]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q9P2K8,C2,1.123530783,0.355229482,-0.335393934,-0.132515211,-0.008772234,aquamarine,EIF2AK4,E2AK4_HUMAN,eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein),EIF2AK4 GCN2 KIAA1338,440275;,"ENST00000263791.10; ENSP00000263791.5; ENSG00000128829.12. [Q9P2K8-1];""ENST00000559624.5; ENSP00000453148.1; ENSG00000128829.12. [Q9P2K8-3]"";",ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049],adaptive immune response [GO:0002250]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; eiF2alpha phosphorylation in response to endoplasmic reticulum stress [GO:0036492]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of cytoplasmic translational initiation in response to stress [GO:1990625]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]
Q14232,C1,1.130999285,0.352673141,-0.623222479,-0.497226792,0.461828624,lightblue,EIF2B1,EI2BA_HUMAN,Translation initiation factor eIF2B subunit alpha (eIF2B GDP-GTP exchange factor subunit alpha),EIF2B1 EIF2BA,1967;,"ENST00000424014.7; ENSP00000416250.2; ENSG00000111361.13. [Q14232-1];""ENST00000537073.1; ENSP00000444183.1; ENSG00000111361.13. [Q14232-2]"";",guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; translation initiation factor activity [GO:0003743],cytoplasmic translational initiation [GO:0002183]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q13542,C3,1.668395322,0.126462119,-0.606145167,-0.747194124,-0.934665775,cyan,EIF4EBP2,4EBP2_HUMAN,Eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2) (eIF4E-binding protein 2),EIF4EBP2,1979;,ENST00000373218.5; ENSP00000362314.4; ENSG00000148730.7.;,eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371],insulin receptor signaling pathway [GO:0008286]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of translational initiation [GO:0045947]; regulation of synaptic plasticity [GO:0048167]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; translation [GO:0006412],cytoplasm [GO:0005737]; intracellular non-membrane-bounded organelle [GO:0043232]; neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]; postsynapse [GO:0098794]
Q15056,C5,1.698715521,0.786051211,-0.852801855,-1.140507025,-1.031287412,turquoise3,EIF4H,IF4H_HUMAN,Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein),EIF4H KIAA0038 WBSCR1 WSCR1,7458;,"ENST00000265753.13; ENSP00000265753.8; ENSG00000106682.16. [Q15056-1];""ENST00000353999.6; ENSP00000265754.8; ENSG00000106682.16. [Q15056-2]"";""ENST00000678438.1; ENSP00000504679.1; ENSG00000106682.16. [Q15056-2]"";","cadherin binding [GO:0045296]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]",developmental growth [GO:0048589]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953],cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]
P56537,C5,0.899198081,0.525421383,-0.011411914,-0.690618702,-0.401072745,turquoise3,EIF6,IF6_HUMAN,Eukaryotic translation initiation factor 6 (eIF-6) (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP)),EIF6 EIF3A ITGB4BP OK/SW-cl.27,3692;,"ENST00000374436.7; ENSP00000363559.3; ENSG00000242372.9. [P56537-1];""ENST00000374443.7; ENSP00000363566.3; ENSG00000242372.9. [P56537-2]"";""ENST00000374450.8; ENSP00000363574.3; ENSG00000242372.9. [P56537-1]"";""ENST00000675032.1; ENSP00000502429.1; ENSG00000242372.9. [P56537-1]"";",ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743],assembly of large subunit precursor of preribosome [GO:1902626]; cytosolic ribosome assembly [GO:0042256]; maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; synapse [GO:0045202]"
Q15717,N3,-0.938303911,-1.071374159,0.81216877,-0.325521087,0.764409824,grey50,ELAVL1,ELAV1_HUMAN,ELAV-like protein 1 (Hu-antigen R) (HuR),ELAVL1 HUR,1994;,"ENST00000407627.7; ENSP00000385269.1; ENSG00000066044.15. [Q15717-1];""ENST00000596459.5; ENSP00000472197.1; ENSG00000066044.15. [Q15717-1]"";",double-stranded RNA binding [GO:0003725]; lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723],3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA destabilization [GO:0061157]; mRNA stabilization [GO:0048255]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of translation [GO:0045727]; post-transcriptional gene silencing [GO:0016441]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of stem cell population maintenance [GO:2000036],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; sarcoplasm [GO:0016528]
O00472,N4,-0.721449327,0.933248768,0.237834268,-0.224668177,-0.214321131,grey30,ELL2,ELL2_HUMAN,RNA polymerase II elongation factor ELL2,ELL2,22936;,ENST00000237853.9; ENSP00000237853.4; ENSG00000118985.16. [O00472-1];,cis-regulatory region sequence-specific DNA binding [GO:0000987],positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription elongation by RNA polymerase II [GO:0006368],nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]
Q96JJ3,C1,1.421600174,0.178767265,-0.377047858,-0.155592169,-0.180472935,lightblue,ELMO2,ELMO2_HUMAN,Engulfment and cell motility protein 2 (Protein ced-12 homolog A) (hCed-12A),ELMO2 CED12A KIAA1834,63916;,"ENST00000290246.11; ENSP00000290246.6; ENSG00000062598.18. [Q96JJ3-1];""ENST00000372176.5; ENSP00000361249.1; ENSG00000062598.18. [Q96JJ3-3]"";""ENST00000396391.5; ENSP00000379673.1; ENSG00000062598.18. [Q96JJ3-1]"";",receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124],actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell motility [GO:0048870]; phagocytosis [GO:0006909],cytosol [GO:0005829]; membrane [GO:0016020]
Q8IZ81,S2,-0.952497474,-1.117737727,0.28098692,0.845835383,0.50599943,orange,ELMOD2,ELMD2_HUMAN,ELMO domain-containing protein 2,ELMOD2,255520;,ENST00000323570.8; ENSP00000326342.3; ENSG00000179387.10.;,GTPase activator activity [GO:0005096],defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688],membrane [GO:0016020]
Q6PJG2,N1,-1.17560732,-0.65446596,0.475414699,0.176623137,0.851857313,grey90,ELMSAN1,MDEAS_HUMAN,Mitotic deacetylase-associated SANT domain protein (ELM2 and SANT domain-containing protein 1),MIDEAS C14orf117 C14orf43 ELMSAN1,91748;,"ENST00000286523.9; ENSP00000286523.5; ENSG00000156030.14.;""ENST00000394071.6; ENSP00000377634.2; ENSG00000156030.14."";",DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714],negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357],histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]
Q9BW60,S2,-1.147857614,-1.427008579,0.356549191,0.749316377,0.65513731,orange,ELOVL1,ELOV1_HUMAN,Very long chain fatty acid elongase 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Elongation of very long chain fatty acids protein 1) (Very long chain 3-ketoacyl-CoA synthase 1) (Very long chain 3-oxoacyl-CoA synthase 1),ELOVL1 SSC1 CGI-88,64834;,"ENST00000372458.8; ENSP00000361536.3; ENSG00000066322.15. [Q9BW60-1];""ENST00000413844.3; ENSP00000416024.2; ENSG00000066322.15. [Q9BW60-2]"";""ENST00000621943.4; ENSP00000477602.1; ENSG00000066322.15. [Q9BW60-1]"";",fatty acid elongase activity [GO:0009922],"alpha-linolenic acid metabolic process [GO:0036109]; ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; linoleic acid metabolic process [GO:0043651]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q96EB1,C4,1.945817804,0.273512366,-0.835902476,-0.822788893,-0.978841116,deepskyblue2,ELP4,ELP4_HUMAN,Elongator complex protein 4 (hELP4) (PAX6 neighbor gene protein),ELP4 C11orf19 PAXNEB,26610;,"ENST00000379163.10; ENSP00000368461.5; ENSG00000109911.19. [Q96EB1-3];""ENST00000640961.2; ENSP00000492152.1; ENSG00000109911.19. [Q96EB1-1]"";",phosphorylase kinase regulator activity [GO:0008607],regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; transcription elongation by RNA polymerase II [GO:0006368]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; elongator holoenzyme complex [GO:0033588]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]
Q8N766,S3,-0.786295546,-1.106725697,0.139243631,0.7856277,0.455055136,salmon,EMC1,EMC1_HUMAN,ER membrane protein complex subunit 1,EMC1 KIAA0090 PSEC0263,23065;,"ENST00000375199.7; ENSP00000364345.3; ENSG00000127463.16. [Q8N766-2];""ENST00000375208.7; ENSP00000364354.3; ENSG00000127463.16. [Q8N766-4]"";""ENST00000477853.6; ENSP00000420608.1; ENSG00000127463.16. [Q8N766-1]"";",0,protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; protein-containing complex [GO:0032991]
Q5UCC4,S2,-1.249305763,-1.424128676,0.299128525,1.010008195,0.488604016,orange,EMC10,EMC10_HUMAN,ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1),EMC10 C19orf63 INM02 UNQ764/PRO1556,284361;,"ENST00000334976.11; ENSP00000334037.6; ENSG00000161671.17. [Q5UCC4-1];""ENST00000376918.7; ENSP00000366117.2; ENSG00000161671.17. [Q5UCC4-2]"";",0,angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; membrane [GO:0016020]
Q9P0I2,S2,-1.27365309,-1.561908822,0.188067455,0.969843276,0.4982413,orange,EMC3,EMC3_HUMAN,ER membrane protein complex subunit 3 (Transmembrane protein 111),EMC3 TMEM111,55831;,"ENST00000245046.7; ENSP00000245046.2; ENSG00000125037.13. [Q9P0I2-1];""ENST00000470827.3; ENSP00000474771.2; ENSG00000125037.13. [Q9P0I2-1]"";",0,protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q5J8M3,S2,-0.652653038,-1.024496069,0.079828178,0.901718661,0.443865386,orange,EMC4,EMC4_HUMAN,ER membrane protein complex subunit 4 (Cell proliferation-inducing gene 17 protein) (Transmembrane protein 85),EMC4 TMEM85 HSPC184 PIG17,51234;,"ENST00000249209.8; ENSP00000249209.4; ENSG00000128463.13. [Q5J8M3-2];""ENST00000267750.9; ENSP00000267750.4; ENSG00000128463.13. [Q5J8M3-1]"";",0,apoptotic process [GO:0006915]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9NPA0,S3,-0.705459238,-0.926769359,0.222573431,0.867685286,0.47340104,salmon,EMC7,EMC7_HUMAN,Endoplasmic reticulum membrane protein complex subunit 7 (ER membrane protein complex subunit 7),EMC7 C11orf3 C15orf24 HT022 UNQ905/PRO1926,56851;,ENST00000256545.9; ENSP00000256545.4; ENSG00000134153.10.;,carbohydrate binding [GO:0030246],protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
O43402,S3,-0.683000383,-1.103344251,0.11421215,0.807194046,0.475691662,salmon,EMC8,EMC8_HUMAN,ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B),EMC8 C16orf2 C16orf4 COX4AL COX4NB FAM158B NOC4,10328;,"ENST00000253457.8; ENSP00000253457.3; ENSG00000131148.9. [O43402-1];""ENST00000435200.2; ENSP00000391730.1; ENSG00000131148.9. [O43402-2]"";",0,protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],cytoplasm [GO:0005737]; EMC complex [GO:0072546]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]
P50402,S4,-1.092737644,-1.268646241,0.756787056,0.636498311,0.155085398,tomato2,EMD,EMD_HUMAN,Emerin,EMD EDMD STA,2010;,"ENST00000369842.9; ENSP00000358857.4; ENSG00000102119.12.;""ENST00000683627.1; ENSP00000507533.1; ENSG00000102119.12."";",actin binding [GO:0003779]; beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296],cellular response to growth factor stimulus [GO:0071363]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fibroblast proliferation [GO:0048147]; nuclear membrane organization [GO:0071763]; positive regulation of protein export from nucleus [GO:0046827]; regulation of canonical Wnt signaling pathway [GO:0060828]; skeletal muscle cell differentiation [GO:0035914],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; TMEM240-body [GO:0160045]
Q32P44,C2,1.358161106,0.632954511,-0.599348996,-0.61421608,-0.074208867,aquamarine,EML3,EMAL3_HUMAN,Echinoderm microtubule-associated protein-like 3 (EMAP-3),EML3,256364;,"ENST00000394773.7; ENSP00000378254.2; ENSG00000149499.12. [Q32P44-1];""ENST00000494448.5; ENSP00000431752.1; ENSG00000149499.12. [Q32P44-3]"";""ENST00000529309.5; ENSP00000434513.1; ENSG00000149499.12. [Q32P44-2]"";",microtubule binding [GO:0008017],cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; mitotic metaphase chromosome alignment [GO:0007080]; regulation of mitotic spindle assembly [GO:1901673],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle microtubule [GO:1990498]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]
Q9HC35,C5,1.584858317,0.470623837,-0.621590164,-0.742797684,-0.855420697,turquoise3,EML4,EMAL4_HUMAN,Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120),EML4 C2orf2 EMAPL4,27436;,"ENST00000318522.10; ENSP00000320663.5; ENSG00000143924.19. [Q9HC35-1];""ENST00000402711.6; ENSP00000385059.2; ENSG00000143924.19. [Q9HC35-2]"";",alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017],attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]
P54851,S2,-2.703427338,-3.170869268,0.318523446,0.929712716,0.217043004,orange,EMP2,EMP2_HUMAN,Epithelial membrane protein 2 (EMP-2) (Protein XMP),EMP2 XMP,2013;,"ENST00000359543.8; ENSP00000352540.3; ENSG00000213853.10.;""ENST00000536829.1; ENSP00000445712.1; ENSG00000213853.10."";",integrin binding [GO:0005178]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901],actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; bleb assembly [GO:0032060]; blood vessel endothelial cell migration [GO:0043534]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; early endosome to late endosome transport [GO:0045022]; embryo implantation [GO:0007566]; embryonic process involved in female pregnancy [GO:0060136]; heart formation [GO:0060914]; membrane raft assembly [GO:0001765]; natural killer cell proliferation [GO:0001787]; neutrophil migration [GO:1990266]; plasma membrane raft assembly [GO:0044854]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of cell-matrix adhesion [GO:0001952]; regulation of endothelial cell migration [GO:0010594]; regulation of glomerular filtration [GO:0003093]; regulation of kinase activity [GO:0043549]; regulation of vasculogenesis [GO:2001212]; T cell mediated cytotoxicity [GO:0001913],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q8N8S7,C5,1.354913558,0.575571205,-0.339561643,-0.424857966,-0.762249616,turquoise3,ENAH,ENAH_HUMAN,Protein enabled homolog,ENAH MENA,55740;,"ENST00000366843.7; ENSP00000355808.2; ENSG00000154380.19. [Q8N8S7-2];""ENST00000366844.7; ENSP00000355809.2; ENSG00000154380.19. [Q8N8S7-1]"";",actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699],actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411],cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202]
O94919,S1,-1.492179001,-1.491166404,0.188227504,0.689381338,1.120928016,gold,ENDOD1,ENDD1_HUMAN,Endonuclease domain-containing 1 protein (EC 3.1.30.-),ENDOD1 KIAA0830,23052;,ENST00000278505.5; ENSP00000278505.4; ENSG00000149218.5.;,endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],innate immune response [GO:0045087],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]
Q14249,N4,-1.143163499,0.750554674,0.052855475,0.122041193,-0.271129498,grey30,ENDOG,NUCG_HUMAN,"Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-)",ENDOG,2021;,ENST00000372642.5; ENSP00000361725.4; ENSG00000167136.7.;,DNA endonuclease activity [GO:0004520]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; RNA endonuclease activity [GO:0004521]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],apoptotic DNA fragmentation [GO:0006309]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; in utero embryonic development [GO:0001701]; mitochondrial DNA catabolic process [GO:0032043]; negative regulation of TOR signaling [GO:0032007]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of mitochondrial DNA replication [GO:0090297]; response to antibiotic [GO:0046677]; response to tumor necrosis factor [GO:0034612],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
P06733,C4,2.096533975,0.444450218,-1.250447568,-1.527191092,-1.639665209,deepskyblue2,ENO1,ENOA_HUMAN,Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein),ENO1 ENO1L1 MBPB1 MPB1,2023;,ENST00000234590.10; ENSP00000234590.4; ENSG00000074800.16. [P06733-1];,"cadherin binding [GO:0045296]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]",canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of muscle contraction [GO:0045933]; positive regulation of plasminogen activation [GO:0010756]; response to virus [GO:0009615],cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; M band [GO:0031430]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]
P13929,C4,2.304669705,0.431327429,-1.406062056,-1.873075882,-1.87234288,deepskyblue2,ENO3,ENOB_HUMAN,Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase),ENO3,2027;,"ENST00000323997.10; ENSP00000324105.6; ENSG00000108515.18. [P13929-1];""ENST00000518175.1; ENSP00000431087.1; ENSG00000108515.18. [P13929-1]"";""ENST00000519584.5; ENSP00000430636.1; ENSG00000108515.18. [P13929-3]"";""ENST00000519602.6; ENSP00000430055.2; ENSG00000108515.18. [P13929-1]"";",magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634],canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]
Q9UHY7,C5,2.07417506,0.32619004,-0.935080584,-0.965647312,-1.181628704,turquoise3,ENOPH1,ENOPH_HUMAN,"Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)",ENOPH1 MASA MSTP145,58478;,"ENST00000273920.8; ENSP00000273920.3; ENSG00000145293.17. [Q9UHY7-1];""ENST00000505846.5; ENSP00000427209.1; ENSG00000145293.17. [Q9UHY7-2]"";","2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]",L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],cytosol [GO:0005829]; nucleus [GO:0005634]
O43768,C4,1.921635437,0.230683017,-1.095911095,-1.054919976,-1.207448832,deepskyblue2,ENSA,ENSA_HUMAN,Alpha-endosulfine (ARPP-19e),ENSA,2029;,"ENST00000271690.12; ENSP00000271690.7; ENSG00000143420.19. [O43768-2];""ENST00000339643.9; ENSP00000341743.5; ENSG00000143420.19. [O43768-3]"";""ENST00000361532.9; ENSP00000354835.5; ENSG00000143420.19. [O43768-5]"";""ENST00000361631.9; ENSP00000355239.5; ENSG00000143420.19. [O43768-7]"";""ENST00000362052.7; ENSP00000355220.7; ENSG00000143420.19. [O43768-8]"";""ENST00000369014.10; ENSP00000358010.6; ENSG00000143420.19. [O43768-1]"";""ENST00000503241.1; ENSP00000424242.1; ENSG00000143420.19. [O43768-9]"";""ENST00000503345.1; ENSP00000421458.1; ENSG00000143420.19. [O43768-8]"";""ENST00000509582.5; ENSP00000426110.1; ENSG00000143420.19. [O43768-8]"";""ENST00000513281.5; ENSP00000422343.1; ENSG00000143420.19. [O43768-6]"";",ion channel inhibitor activity [GO:0008200]; phosphatase inhibitor activity [GO:0019212]; potassium channel inhibitor activity [GO:0019870]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; signaling receptor binding [GO:0005102],cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of protein dephosphorylation [GO:0035308]; regulation of insulin secretion [GO:0050796]; response to nutrient [GO:0007584],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]
Q9Y227,S1,-1.307560202,-1.344520836,-0.364575851,0.880951923,0.998404804,gold,ENTPD4,ENTP4_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42),ENTPD4 KIAA0392 LALP70 LYSAL1,9583;,"ENST00000358689.9; ENSP00000351520.4; ENSG00000197217.13. [Q9Y227-1];""ENST00000417069.6; ENSP00000408573.2; ENSG00000197217.13. [Q9Y227-2]"";",CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134],CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256],autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]
O75354,S1,-1.202958258,-1.295714447,-0.108674149,0.801164596,0.902150673,gold,ENTPD6,ENTP6_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 6 (NTPDase 6) (EC 3.6.1.6) (CD39 antigen-like 2),ENTPD6 CD39L2 IL6ST2,955;,"ENST00000354989.9; ENSP00000347084.5; ENSG00000197586.13. [O75354-2];""ENST00000360031.6; ENSP00000353131.2; ENSG00000197586.13. [O75354-3]"";""ENST00000376652.9; ENSP00000365840.4; ENSG00000197586.13. [O75354-1]"";","CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [GO:0008894]; IDP phosphatase activity [GO:1990003]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134]",nucleoside diphosphate catabolic process [GO:0009134]; response to calcium ion [GO:0051592]; response to magnesium ion [GO:0032026],cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P11171,M1,-0.464765114,-0.897745289,0.645984982,0.804544605,-0.306969595,burlywood4,EPB41,EPB41_HUMAN,Protein 4.1 (P4.1) (4.1R) (Band 4.1) (EPB4.1) (Erythrocyte membrane protein band 4.1),EPB41 E41P,2035;,"ENST00000343067.9; ENSP00000345259.4; ENSG00000159023.23. [P11171-1];""ENST00000347529.7; ENSP00000290100.6; ENSG00000159023.23. [P11171-5]"";""ENST00000373797.2; ENSP00000362903.1; ENSG00000159023.23. [P11171-7]"";""ENST00000373798.5; ENSP00000362904.1; ENSG00000159023.23. [P11171-1]"";""ENST00000373800.7; ENSP00000362906.3; ENSG00000159023.23. [P11171-4]"";",1-phosphatidylinositol binding [GO:0005545]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; phosphoprotein binding [GO:0051219]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200],actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to cell cortex [GO:1904778]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport [GO:0051924]; regulation of intestinal absorption [GO:1904478],basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spectrin-associated cytoskeleton [GO:0014731]
Q9HCM4,S4,-1.222233591,-1.396305494,0.469385135,0.925515098,0.214143389,tomato2,EPB41L5,E41L5_HUMAN,Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5),EPB41L5 KIAA1548,57669;,"ENST00000263713.10; ENSP00000263713.5; ENSG00000115109.14. [Q9HCM4-1];""ENST00000331393.8; ENSP00000329687.4; ENSG00000115109.14. [Q9HCM4-2]"";""ENST00000443124.5; ENSP00000393722.1; ENSG00000115109.14. [Q9HCM4-2]"";""ENST00000443902.6; ENSP00000393856.2; ENSG00000115109.14. [Q9HCM4-4]"";""ENST00000452780.1; ENSP00000390439.1; ENSG00000115109.14. [Q9HCM4-3]"";",cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904],"actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm morphogenesis [GO:0048319]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]",adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]
P29317,S4,-1.010545978,-1.457541629,0.422488881,0.891313865,0.275061637,tomato2,EPHA2,EPHA2_HUMAN,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),EPHA2 ECK,1969;,ENST00000358432.8; ENSP00000351209.5; ENSG00000142627.13. [P29317-1];,ATP binding [GO:0005524]; cadherin binding [GO:0045296]; ephrin receptor activity [GO:0005003]; growth factor binding [GO:0019838]; molecular function activator activity [GO:0140677]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618],activation of GTPase activity [GO:0090630]; axial mesoderm formation [GO:0048320]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cAMP metabolic process [GO:0046058]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell motility [GO:0048870]; defense response to Gram-positive bacterium [GO:0050830]; ephrin receptor signaling pathway [GO:0048013]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinocyte differentiation [GO:0030216]; lens fiber cell morphogenesis [GO:0070309]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of angiogenesis [GO:0016525]; negative regulation of chemokine production [GO:0032682]; negative regulation of lymphangiogenesis [GO:1901491]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; notochord cell development [GO:0060035]; notochord formation [GO:0014028]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; pericyte cell differentiation [GO:1904238]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of cell migration [GO:0030335]; positive regulation of protein localization to plasma membrane [GO:1903078]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of lamellipodium assembly [GO:0010591]; response to growth factor [GO:0070848]; skeletal system development [GO:0001501]; vasculogenesis [GO:0001570],cell surface [GO:0009986]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; tight junction [GO:0070160]
P29323,S4,-1.020575471,-1.176777223,0.341463954,0.885340142,0.339899191,tomato2,EPHB2,EPHB2_HUMAN,Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2],EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5,2048;,"ENST00000374630.8; ENSP00000363761.3; ENSG00000133216.17. [P29323-2];""ENST00000374632.7; ENSP00000363763.3; ENSG00000133216.17. [P29323-3]"";""ENST00000400191.7; ENSP00000383053.3; ENSG00000133216.17. [P29323-1]"";",amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; transmembrane-ephrin receptor activity [GO:0005005],"angiogenesis [GO:0001525]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; B cell activation [GO:0042113]; camera-type eye morphogenesis [GO:0048593]; cellular response to amyloid-beta [GO:1904646]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system projection neuron axonogenesis [GO:0021952]; commissural neuron axon guidance [GO:0071679]; corpus callosum development [GO:0022038]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; ephrin receptor signaling pathway [GO:0048013]; hindbrain tangential cell migration [GO:0021934]; inner ear morphogenesis [GO:0042472]; learning [GO:0007612]; learning or memory [GO:0007611]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of Ras protein signal transduction [GO:0046580]; nervous system development [GO:0007399]; neuron projection retraction [GO:0106028]; optic nerve morphogenesis [GO:0021631]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphorylation [GO:0016310]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of tumor necrosis factor production [GO:0032760]; postsynaptic membrane assembly [GO:0097104]; regulation of autophagosome assembly [GO:2000785]; regulation of behavioral fear response [GO:2000822]; regulation of blood coagulation [GO:0030193]; regulation of body fluid levels [GO:0050878]; regulation of filopodium assembly [GO:0051489]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of T-helper 17 type immune response [GO:2000316]; retinal ganglion cell axon guidance [GO:0031290]; roof of mouth development [GO:0060021]; tight junction assembly [GO:0120192]; trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission [GO:0099557]; urogenital system development [GO:0001655]; vesicle-mediated intercellular transport [GO:0110077]",axon [GO:0030424]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]
P54760,S4,-0.621201821,-1.057141042,0.325699503,0.785221222,0.219052295,tomato2,EPHB4,EPHB4_HUMAN,Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11),EPHB4 HTK MYK1 TYRO11,2050;,"ENST00000358173.8; ENSP00000350896.3; ENSG00000196411.10. [P54760-1];""ENST00000616502.4; ENSP00000482702.1; ENSG00000196411.10. [P54760-3]"";",ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; ephrin receptor signaling pathway [GO:0048013]; heart morphogenesis [GO:0003007]; protein autophosphorylation [GO:0046777],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
P07099,S2,-1.161971063,-1.417181224,0.161016598,0.750759814,0.6485785,orange,EPHX1,HYEP_HUMAN,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH),EPHX1 EPHX EPOX,2052;,"ENST00000272167.10; ENSP00000272167.5; ENSG00000143819.13.;""ENST00000366837.5; ENSP00000355802.4; ENSG00000143819.13."";""ENST00000614058.4; ENSP00000480004.1; ENSG00000143819.13."";",cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142],arachidonic acid metabolic process [GO:0019369]; aromatic compound catabolic process [GO:0019439]; epoxide metabolic process [GO:0097176]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]
O75616,M1,-1.239907523,-0.589052628,0.351114051,0.75659393,0.042000802,burlywood4,ERAL1,ERAL1_HUMAN,"GTPase Era, mitochondrial (H-ERA) (hERA) (Conserved ERA-like GTPase) (CEGA) (ERA-W) (ERA-like protein 1)",ERAL1 HERA,26284;,ENST00000254928.10; ENSP00000254928.5; ENSG00000132591.12. [O75616-1];,GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843],ribosomal small subunit assembly [GO:0000028],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
P04626,S4,-0.97732843,-1.249096408,0.439636879,0.799205701,0.528497112,tomato2,ERBB2,ERBB2_HUMAN,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),ERBB2 HER2 MLN19 NEU NGL,2064;,"ENST00000269571.10; ENSP00000269571.4; ENSG00000141736.14. [P04626-1];""ENST00000406381.6; ENSP00000385185.2; ENSG00000141736.14. [P04626-5]"";""ENST00000541774.5; ENSP00000446466.1; ENSG00000141736.14. [P04626-4]"";""ENST00000584601.5; ENSP00000462438.1; ENSG00000141736.14. [P04626-5]"";",ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase activity [GO:0004713]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase I core binding [GO:0001042]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888],cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERBB2-ERBB4 signaling pathway [GO:0038135]; heart development [GO:0007507]; immature T cell proliferation in thymus [GO:0033080]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; negative regulation of apoptotic process [GO:0043066]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; neurogenesis [GO:0022008]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of angiogenesis [GO:0045765]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of microtubule-based process [GO:0032886]; Schwann cell development [GO:0014044]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; wound healing [GO:0042060],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; ERBB3:ERBB2 complex [GO:0038143]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; semaphorin receptor complex [GO:0002116]
Q96RT1,M1,-1.154523069,-0.781749301,0.559674134,0.933113418,-0.148927423,burlywood4,ERBB2IP,ERBIN_HUMAN,Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2),ERBIN ERBB2IP KIAA1225 LAP2,55914;,"ENST00000284037.10; ENSP00000284037.4; ENSG00000112851.16. [Q96RT1-1];""ENST00000380938.6; ENSP00000370325.2; ENSG00000112851.16. [Q96RT1-4]"";""ENST00000380943.6; ENSP00000370330.2; ENSG00000112851.16. [Q96RT1-2]"";""ENST00000506030.6; ENSP00000426632.1; ENSG00000112851.16. [Q96RT1-8]"";""ENST00000508515.2; ENSP00000422015.1; ENSG00000112851.16. [Q96RT1-7]"";""ENST00000511297.5; ENSP00000422766.1; ENSG00000112851.16. [Q96RT1-9]"";""ENST00000699000.1; ENSP00000514078.1; ENSG00000112851.16. [Q96RT1-2]"";""ENST00000699001.1; ENSP00000514079.1; ENSG00000112851.16. [Q96RT1-7]"";",ErbB-2 class receptor binding [GO:0005176]; signaling receptor binding [GO:0005102]; structural constituent of cytoskeleton [GO:0005200],basal protein localization [GO:0045175]; cell adhesion [GO:0007155]; cellular response to tumor necrosis factor [GO:0071356]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; integrin-mediated signaling pathway [GO:0007229]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; protein targeting [GO:0006605]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; signal transduction [GO:0007165],basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hemidesmosome [GO:0030056]; neuromuscular junction [GO:0031594]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic specialization [GO:0099572]
Q8IUD2,C5,1.562584866,0.688224726,-0.484744947,-0.52084045,-0.851676608,turquoise3,ERC1,RB6I2_HUMAN,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2),ERC1 ELKS KIAA1081 RAB6IP2,23085;,"ENST00000347735.10; ENSP00000340054.6; ENSG00000082805.21. [Q8IUD2-4];""ENST00000360905.9; ENSP00000354158.3; ENSG00000082805.21. [Q8IUD2-1]"";""ENST00000397203.7; ENSP00000380386.4; ENSG00000082805.21. [Q8IUD2-1]"";""ENST00000440394.7; ENSP00000410064.2; ENSG00000082805.21. [Q8IUD2-2]"";""ENST00000543086.7; ENSP00000438546.1; ENSG00000082805.21. [Q8IUD2-3]"";""ENST00000545948.5; ENSP00000442976.1; ENSG00000082805.21. [Q8IUD2-5]"";""ENST00000589028.6; ENSP00000468263.1; ENSG00000082805.21. [Q8IUD2-1]"";",cadherin binding [GO:0045296]; PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882],"I-kappaB phosphorylation [GO:0007252]; maintenance of presynaptic active zone structure [GO:0048790]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein transport [GO:0015031]; regulation of DNA-templated transcription [GO:0006355]; regulation of synaptic plasticity [GO:0048167]; retrograde transport, endosome to Golgi [GO:0042147]",centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton of presynaptic active zone [GO:0048788]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]
Q2NKX8,C4,2.00502231,-0.139604703,-0.679993215,-0.579627705,-0.920821754,deepskyblue2,ERCC6L,ERC6L_HUMAN,DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15),ERCC6L PICH,54821;,ENST00000334463.4; ENSP00000334675.3; ENSG00000186871.7.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386],cell division [GO:0051301],cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]
P50548,C5,1.527762294,0.380314824,-0.408120578,-0.374021917,-0.751013533,turquoise3,ERF,ERF_HUMAN,ETS domain-containing transcription factor ERF (Ets2 repressor factor) (PE-2),ERF,2077;,"ENST00000222329.9; ENSP00000222329.3; ENSG00000105722.10. [P50548-1];""ENST00000440177.6; ENSP00000388173.2; ENSG00000105722.10. [P50548-2]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; sequence-specific DNA binding [GO:0043565]",negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q969X5,S1,-0.757947264,-0.958819617,0.115398349,0.509786251,0.886267631,gold,ERGIC1,ERGI1_HUMAN,Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32),ERGIC1 ERGIC32 KIAA1181 HT034,57222;,"ENST00000393784.8; ENSP00000377374.3; ENSG00000113719.17. [Q969X5-1];""ENST00000687901.1; ENSP00000509817.1; ENSG00000113719.17. [Q969X5-2]"";""ENST00000693299.1; ENSP00000509429.1; ENSG00000113719.17. [Q969X5-2]"";",0,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
Q96RQ1,S1,-1.18079636,-1.244853163,-0.075725343,0.803096007,0.980420107,gold,ERGIC2,ERGI2_HUMAN,Endoplasmic reticulum-Golgi intermediate compartment protein 2,ERGIC2 ERV41 PTX1 CDA14,51290;,ENST00000360150.9; ENSP00000353270.4; ENSG00000087502.19.;,0,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; retrograde transporter complex, Golgi to ER [GO:0061852]; transporter complex [GO:1990351]"
Q9Y282,S1,-1.095888987,-1.299235491,-0.085349819,0.803869455,0.949663198,gold,ERGIC3,ERGI3_HUMAN,Endoplasmic reticulum-Golgi intermediate compartment protein 3 (Serologically defined breast cancer antigen NY-BR-84),ERGIC3 C20orf47 ERV46 SDBCAG84 CGI-54 PRO0989,51614;,"ENST00000348547.7; ENSP00000341358.2; ENSG00000125991.21. [Q9Y282-1];""ENST00000357394.8; ENSP00000349970.4; ENSG00000125991.21. [Q9Y282-3]"";",0,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of intracellular protein transport [GO:0090316]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]","COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; retrograde transporter complex, Golgi to ER [GO:0061852]; transporter complex [GO:1990351]"
Q96DZ1,S2,-1.183036787,-1.402760064,0.162803598,0.946550324,0.585234899,orange,ERLEC1,ERLEC_HUMAN,Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin) (XTP3-transactivated gene B protein),ERLEC1 C2orf30 XTP3TPB UNQ1878/PRO4321,27248;,"ENST00000185150.9; ENSP00000185150.4; ENSG00000068912.15. [Q96DZ1-1];""ENST00000378239.5; ENSP00000367485.5; ENSG00000068912.15. [Q96DZ1-2]"";""ENST00000405123.7; ENSP00000385629.3; ENSG00000068912.15. [Q96DZ1-3]"";",unfolded protein binding [GO:0051082],"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]",endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]
O75477,S2,-1.113110812,-1.424523209,0.214970892,0.901407702,0.473724072,orange,ERLIN1,ERLN1_HUMAN,Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1) (Protein KE04) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1) (SPFH domain-containing protein 1),ERLIN1 C10orf69 KE04 KEO4 SPFH1,10613;,"ENST00000407654.7; ENSP00000384900.3; ENSG00000107566.14.;""ENST00000421367.7; ENSP00000410964.2; ENSG00000107566.14."";",cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625],cholesterol metabolic process [GO:0008203]; ERAD pathway [GO:0036503]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; regulation of cholesterol biosynthetic process [GO:0045540]; SREBP signaling pathway [GO:0032933],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]
O94905,S2,-1.2863605,-1.337214929,0.215146868,0.933363064,0.527652671,orange,ERLIN2,ERLN2_HUMAN,Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2),ERLIN2 C8orf2 SPFH2 UNQ2441/PRO5003/PRO9924,11160;,"ENST00000335171.10; ENSP00000335220.6; ENSG00000147475.17. [O94905-2];""ENST00000518586.5; ENSP00000427847.1; ENSG00000147475.17. [O94905-3]"";""ENST00000519638.3; ENSP00000428112.1; ENSG00000147475.17. [O94905-1]"";""ENST00000523107.5; ENSP00000473292.1; ENSG00000147475.17. [O94905-3]"";""ENST00000523887.5; ENSP00000429903.1; ENSG00000147475.17. [O94905-3]"";""ENST00000648919.1; ENSP00000497100.1; ENSG00000147475.17. [O94905-2]"";",cholesterol binding [GO:0015485]; ubiquitin protein ligase binding [GO:0031625],cholesterol metabolic process [GO:0008203]; ERAD pathway [GO:0036503]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of fatty acid biosynthetic process [GO:0045717]; regulation of cholesterol biosynthetic process [GO:0045540]; SREBP signaling pathway [GO:0032933],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q7Z2K6,S2,-1.017143921,-1.220358186,0.38076669,0.76284044,0.448222045,orange,ERMP1,ERMP1_HUMAN,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),ERMP1 FXNA KIAA1815,79956;,"ENST00000339450.10; ENSP00000340427.5; ENSG00000099219.15. [Q7Z2K6-1];""ENST00000462592.5; ENSP00000417160.1; ENSG00000099219.15. [Q7Z2K6-1]"";""ENST00000487088.6; ENSP00000432986.2; ENSG00000099219.15. [Q7Z2K6-1]"";""ENST00000688202.1; ENSP00000510190.1; ENSG00000099219.15. [Q7Z2K6-1]"";""ENST00000689268.1; ENSP00000509900.1; ENSG00000099219.15. [Q7Z2K6-1]"";""ENST00000689364.1; ENSP00000509092.1; ENSG00000099219.15. [Q7Z2K6-1]"";""ENST00000690284.1; ENSP00000509328.1; ENSG00000099219.15. [Q7Z2K6-1]"";",metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235],cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
O75460,S3,-1.004493431,-1.061301079,0.170126975,0.894898431,0.48854002,salmon,ERN1,ERN1_HUMAN,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],ERN1 IRE1,2081;,"ENST00000433197.4; ENSP00000401445.2; ENSG00000178607.17. [O75460-1];""ENST00000606895.2; ENSP00000475519.1; ENSG00000178607.17. [O75460-2]"";",ADP binding [GO:0043531]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521]; unfolded protein binding [GO:0051082],"cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976]",AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]
P30040,N4,-1.03985163,0.45535671,-0.138036246,0.594260652,0.015476003,grey30,ERP29,ERP29_HUMAN,Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31),ERP29 C12orf8 ERP28,10961;,"ENST00000261735.4; ENSP00000261735.3; ENSG00000089248.7. [P30040-1];""ENST00000455836.1; ENSP00000412083.1; ENSG00000089248.7. [P30040-2]"";",protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087],intracellular protein transport [GO:0006886]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; protein folding [GO:0006457]; protein secretion [GO:0009306]; protein unfolding [GO:0043335]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; membrane [GO:0016020]; smooth endoplasmic reticulum [GO:0005790]; transport vesicle [GO:0030133]
Q5FWF5,N2,-1.034096691,-0.432321846,0.951634941,0.113721449,0.383470035,grey70,ESCO1,ESCO1_HUMAN,N-acetyltransferase ESCO1 (EC 2.3.1.-) (CTF7 homolog 1) (Establishment factor-like protein 1) (EFO1) (EFO1p) (hEFO1) (Establishment of cohesion 1 homolog 1) (ECO1 homolog 1) (ESO1 homolog 1),ESCO1 EFO1 KIAA1911,114799;,"ENST00000269214.10; ENSP00000269214.4; ENSG00000141446.11. [Q5FWF5-1];""ENST00000383276.1; ENSP00000372763.1; ENSG00000141446.11. [Q5FWF5-2]"";",acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270],mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062],chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9H501,N3,-1.105733649,-0.83576214,0.981530374,-0.016932497,0.504639906,grey50,ESF1,ESF1_HUMAN,ESF1 homolog (ABT1-associated protein),ESF1 ABTAP C20orf6 HDCMC28P,51575;,"ENST00000202816.5; ENSP00000202816.1; ENSG00000089048.15.;""ENST00000617257.2; ENSP00000480783.2; ENSG00000089048.15."";",RNA binding [GO:0003723],rRNA processing [GO:0006364],extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P11474,N2,-0.942519475,-0.017195965,0.660472242,0.392557225,-0.008934465,grey70,ESRRA,ERR1_HUMAN,Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1),ESRRA ERR1 ESRL1 NR3B1,2101;,"ENST00000000442.11; ENSP00000000442.6; ENSG00000173153.17. [P11474-1];""ENST00000405666.5; ENSP00000384851.1; ENSG00000173153.17. [P11474-1]"";""ENST00000677967.1; ENSP00000503245.1; ENSG00000173153.17. [P11474-2]"";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; estrogen response element binding [GO:0034056]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]",intracellular steroid hormone receptor signaling pathway [GO:0030518]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BSJ8,S1,-1.06619889,-1.410416144,0.179435085,0.609394344,0.88463883,gold,ESYT1,ESYT1_HUMAN,Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein),ESYT1 FAM62A KIAA0747 MBC2,23344;,"ENST00000267113.4; ENSP00000267113.4; ENSG00000139641.13. [Q9BSJ8-2];""ENST00000394048.10; ENSP00000377612.5; ENSG00000139641.13. [Q9BSJ8-1]"";",calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; phospholipid transfer activity [GO:0120014],endoplasmic reticulum-plasma membrane tethering [GO:0061817]; intermembrane lipid transfer [GO:0120009],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]
A0FGR8,S1,-0.907048271,-1.149156303,0.157878206,0.709841253,0.787407709,gold,ESYT2,ESYT2_HUMAN,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),ESYT2 FAM62B KIAA1228,57488;,ENST00000652148.1; ENSP00000499020.1; ENSG00000117868.18. [A0FGR8-2];,cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091],endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]
P62495,C3,1.500208879,0.350162126,-0.502193928,-0.364198292,-0.612452018,cyan,ETF1,ERF1_HUMAN,Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Protein Cl1) (TB3-1),ETF1 ERF1 RF1 SUP45L1,2107;,"ENST00000360541.10; ENSP00000353741.5; ENSG00000120705.13. [P62495-1];""ENST00000499810.6; ENSP00000421288.1; ENSG00000120705.13. [P62495-2]"";","aminoacyl-tRNA hydrolase activity [GO:0004045]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; translation release factor activity [GO:0003747]; translation release factor activity, codon specific [GO:0016149]; translation termination factor activity [GO:0008079]","cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translational termination [GO:0006415]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; translation release factor complex [GO:0018444]
P13804,M1,-1.643175787,0.225795983,0.343583273,0.894653286,-1.151251878,burlywood4,ETFA,ETFA_HUMAN,"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)",ETFA,2108;,"ENST00000433983.6; ENSP00000399273.2; ENSG00000140374.17. [P13804-2];""ENST00000557943.6; ENSP00000452762.1; ENSG00000140374.17. [P13804-1]"";""ENST00000690610.1; ENSP00000510473.1; ENSG00000140374.17. [P13804-1]"";",electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904],electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q16134,M2,-1.239580373,-1.421284674,0.391471296,1.181298773,-0.053894117,tan4,ETFDH,ETFD_HUMAN,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)",ETFDH,2110;,"ENST00000307738.5; ENSP00000303552.5; ENSG00000171503.13. [Q16134-3];""ENST00000511912.6; ENSP00000426638.1; ENSG00000171503.13. [Q16134-1]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]",electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]
Q9NVH0,M2,-1.170561853,-1.365266573,0.385538126,1.132742588,-0.113983113,tan4,EXD2,EXD2_HUMAN,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2),EXD2 C14orf114 EXDL2,55218;,"ENST00000312994.9; ENSP00000313140.5; ENSG00000081177.19. [Q9NVH0-1];""ENST00000409014.5; ENSP00000386915.1; ENSG00000081177.19. [Q9NVH0-2]"";""ENST00000409018.7; ENSP00000387331.3; ENSG00000081177.19. [Q9NVH0-1]"";""ENST00000409242.5; ENSP00000386839.1; ENSG00000081177.19. [Q9NVH0-2]"";""ENST00000409675.5; ENSP00000386762.1; ENSG00000081177.19. [Q9NVH0-2]"";""ENST00000409949.5; ENSP00000386632.1; ENSG00000081177.19. [Q9NVH0-2]"";""ENST00000685843.1; ENSP00000510642.1; ENSG00000081177.19. [Q9NVH0-1]"";",3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]
Q9Y2C4,M2,-1.037366262,-1.377710885,0.386239207,1.175682084,-0.068271623,tan4,EXOG,EXOG_HUMAN,"Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1)",EXOG ENDOGL1 ENDOGL2 ENGL,9941;,"ENST00000287675.10; ENSP00000287675.5; ENSG00000157036.13. [Q9Y2C4-1];""ENST00000422077.6; ENSP00000404305.2; ENSG00000157036.13. [Q9Y2C4-4]"";",5'-3' exonuclease activity [GO:0008409]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA endonuclease activity [GO:0004521]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],apoptotic DNA fragmentation [GO:0006309],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q01780,N1,-0.995338908,-0.974026055,0.381281596,-0.350089393,1.351290338,grey90,EXOSC10,EXOSX_HUMAN,Exosome complex component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2),EXOSC10 PMSCL PMSCL2 RRP6,5394;,"ENST00000304457.11; ENSP00000307307.7; ENSG00000171824.14. [Q01780-2];""ENST00000376936.9; ENSP00000366135.4; ENSG00000171824.14. [Q01780-1]"";",3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034],"CUT catabolic process [GO:0071034]; DNA repair [GO:0006281]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; ribosomal small subunit biogenesis [GO:0042274]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]",cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]
Q9NQT5,N1,-0.86367191,-0.686875472,0.31791136,-0.433982319,1.394655899,grey90,EXOSC3,EXOS3_HUMAN,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),EXOSC3 RRP40 CGI-102,51010;,"ENST00000327304.10; ENSP00000323046.4; ENSG00000107371.14. [Q9NQT5-1];""ENST00000396521.3; ENSP00000379775.3; ENSG00000107371.14. [Q9NQT5-2]"";""ENST00000465229.5; ENSP00000418422.1; ENSG00000107371.14. [Q9NQT5-2]"";""ENST00000679059.1; ENSP00000503947.1; ENSG00000107371.14. [Q9NQT5-2]"";",3'-5'-RNA exonuclease activity [GO:0000175]; RNA binding [GO:0003723],"CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; mRNA catabolic process [GO:0006402]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U4 snRNA 3'-end processing [GO:0034475]",cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NQT4,N1,-0.60474715,-0.561347716,0.270480724,-0.526607385,1.143377164,grey90,EXOSC5,EXOS5_HUMAN,Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B),EXOSC5 CML28 RRP46,56915;,ENST00000221233.9; ENSP00000221233.3; ENSG00000077348.10.;,3'-5'-RNA exonuclease activity [GO:0000175]; DNA binding [GO:0003677]; RNA binding [GO:0003723],defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q06265,N1,-0.98719603,-0.230699869,0.258686197,-0.563743911,1.290340954,grey90,EXOSC9,EXOS9_HUMAN,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),EXOSC9 PMSCL1,5393;,"ENST00000243498.10; ENSP00000243498.5; ENSG00000123737.13. [Q06265-1];""ENST00000379663.7; ENSP00000368984.3; ENSG00000123737.13. [Q06265-2]"";",3'-5'-RNA exonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; immune response [GO:0006955]; mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]",cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q93063,S2,-0.95852701,-1.275577176,0.152756732,0.800446907,0.621290342,orange,EXT2,EXT2_HUMAN,Exostosin-2 (EC 2.4.1.224) (Exostosin glycosyltransferase 2) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Heparan sulfate co-polymerase subunit EXT1) (Multiple exostoses protein 2),EXT2,2132;,"ENST00000343631.4; ENSP00000342656.3; ENSG00000151348.16. [Q93063-1];""ENST00000358681.8; ENSP00000351509.4; ENSG00000151348.16. [Q93063-2]"";""ENST00000395673.8; ENSP00000379032.4; ENSG00000151348.16. [Q93063-1]"";""ENST00000533608.7; ENSP00000431173.2; ENSG00000151348.16. [Q93063-1]"";""ENST00000682993.1; ENSP00000507580.1; ENSG00000151348.16. [Q93063-1]"";""ENST00000683000.1; ENSP00000508361.1; ENSG00000151348.16. [Q93063-1]"";",glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982],"cellular response to fibroblast growth factor stimulus [GO:0044344]; chondrocyte differentiation [GO:0002062]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal-level water homeostasis [GO:0050891]; ossification [GO:0001503]; polysaccharide biosynthetic process [GO:0000271]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541]
O43909,S1,-1.195760967,-1.246076607,0.004272525,0.905337754,0.809809659,gold,EXTL3,EXTL3_HUMAN,Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3),EXTL3 EXTL1L EXTR1 KIAA0519,2137;,"ENST00000220562.9; ENSP00000220562.4; ENSG00000012232.10.;""ENST00000696177.1; ENSP00000512467.1; ENSG00000012232.10."";""ENST00000696178.1; ENSP00000512468.1; ENSG00000012232.10."";""ENST00000696184.1; ENSP00000512473.1; ENSG00000012232.10."";""ENST00000696186.1; ENSP00000512474.1; ENSG00000012232.10."";",glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500],heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; positive regulation of cell growth [GO:0030307]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein glycosylation [GO:0006486],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P15311,C1,1.684271868,0.139112101,-0.654696785,-0.332165119,-0.510840342,lightblue,EZR,EZRI_HUMAN,Ezrin (Cytovillin) (Villin-2) (p81),EZR VIL2,7430;,"ENST00000337147.11; ENSP00000338934.7; ENSG00000092820.19.;""ENST00000367075.4; ENSP00000356042.3; ENSG00000092820.19."";",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548],actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; astral microtubule organization [GO:0030953]; cellular response to cAMP [GO:0071320]; cortical microtubule organization [GO:0043622]; establishment of centrosome localization [GO:0051660]; establishment of endothelial barrier [GO:0061028]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; filopodium assembly [GO:0046847]; intestinal D-glucose absorption [GO:0001951]; leukocyte cell-cell adhesion [GO:0007159]; membrane to membrane docking [GO:0022614]; microvillus assembly [GO:0030033]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to plasma membrane [GO:1903078]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein kinase A signaling [GO:0010737]; protein localization to cell cortex [GO:0072697]; protein localization to plasma membrane [GO:0072659]; protein-containing complex localization [GO:0031503]; receptor internalization [GO:0031623]; regulation of cell shape [GO:0008360]; regulation of microvillus length [GO:0032532]; regulation of organelle assembly [GO:1902115]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376]; terminal web assembly [GO:1902896],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell periphery [GO:0071944]; cell projection [GO:0042995]; ciliary basal body [GO:0036064]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; uropod [GO:0001931]; vesicle [GO:0031982]
O60427,S2,-1.162673157,-1.672199765,0.240739909,0.893797712,0.617469328,orange,FADS1,FADS1_HUMAN,Acyl-CoA (8-3)-desaturase (EC 1.14.19.44) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase) (Fatty acid desaturase 1),FADS1 FADSD5,3992;,"ENST00000433932.5; ENSP00000405087.1; ENSG00000149485.19. [O60427-2];""ENST00000542506.5; ENSP00000441403.1; ENSG00000149485.19. [O60427-2]"";","acyl-CoA delta5-desaturase activity [GO:0062076]; C-5 sterol desaturase activity [GO:0000248]; linoleoyl-CoA desaturase activity [GO:0016213]; omega-6 fatty acid desaturase activity [GO:0045485]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]",alpha-linolenic acid metabolic process [GO:0036109]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; icosanoid biosynthetic process [GO:0046456]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; phospholipid biosynthetic process [GO:0008654]; regulation of cell differentiation [GO:0045595]; regulation of DNA-templated transcription [GO:0006355]; unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]
Q96CS3,S2,-0.990788081,-1.190792928,0.17969719,0.835344392,0.474355105,orange,FAF2,FAF2_HUMAN,FAS-associated factor 2 (UBX domain-containing protein 3B) (UBX domain-containing protein 8),FAF2 ETEA KIAA0887 UBXD8 UBXN3B,23197;,ENST00000261942.7; ENSP00000261942.6; ENSG00000113194.13.;,lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],"ERAD pathway [GO:0036503]; lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]",azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]
P16930,C4,2.22152989,0.505011914,-1.338204214,-1.546645563,-1.576142197,deepskyblue2,FAH,FAAA_HUMAN,Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase),FAH,2184;,"ENST00000261755.9; ENSP00000261755.5; ENSG00000103876.14. [P16930-1];""ENST00000407106.5; ENSP00000385080.1; ENSG00000103876.14. [P16930-1]"";""ENST00000561421.6; ENSP00000453347.2; ENSG00000103876.14. [P16930-1]"";",fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872],arginine catabolic process [GO:0006527]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; lipid metabolic process [GO:0006629]; tyrosine catabolic process [GO:0006572],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9NVQ4,C3,1.93811611,0.278977285,-0.818735864,-0.779190564,-1.017894258,cyan,FAIM,FAIM1_HUMAN,Fas apoptotic inhibitory molecule 1,FAIM FAIM1,55179;,"ENST00000338446.8; ENSP00000342805.4; ENSG00000158234.13. [Q9NVQ4-2];""ENST00000360570.8; ENSP00000353775.3; ENSG00000158234.13. [Q9NVQ4-3]"";""ENST00000393034.6; ENSP00000376754.2; ENSG00000158234.13. [Q9NVQ4-1]"";""ENST00000393035.6; ENSP00000376755.2; ENSG00000158234.13. [Q9NVQ4-1]"";""ENST00000464668.5; ENSP00000417642.1; ENSG00000158234.13. [Q9NVQ4-1]"";",0,apoptotic process [GO:0006915]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042],cytoplasm [GO:0005737]
Q9BTL3,N4,-0.653566939,1.127708996,-0.130397275,-0.672866678,-0.148311895,grey30,FAM103A1,RAMAC_HUMAN,RNA guanine-N7 methyltransferase activating subunit (Protein FAM103A1) (RNA guanine-7 methyltransferase activating subunit) (RNMT-activating mRNA cap methyltransferase subunit) (RNMT-activating mini protein) (RAM),RAMAC C15orf18 FAM103A1 RAMMET,83640;,ENST00000304191.4; ENSP00000307181.3; ENSG00000169612.4.;,enzyme activator activity [GO:0008047]; molecular function activator activity [GO:0140677]; RNA binding [GO:0003723],7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259]; RNA 5'-cap (guanine-N7)-methylation [GO:0106005],mRNA cap methyltransferase RNMT:RAMAC complex [GO:0160130]; mRNA capping enzyme complex [GO:0031533]; nucleus [GO:0005634]
Q96BN8,C3,1.851918556,-0.196732991,-0.742642344,-0.542162753,-0.784002901,cyan,FAM105B,OTUL_HUMAN,Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby),OTULIN FAM105B,90268;,ENST00000284274.5; ENSP00000284274.4; ENSG00000154124.6.;,cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234],innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]
Q9H098,C4,2.180411927,0.612542514,-1.152362503,-1.342806433,-1.866399787,deepskyblue2,FAM107B,F107B_HUMAN,Protein FAM107B,FAM107B C10orf45,83641;,"ENST00000181796.7; ENSP00000181796.2; ENSG00000065809.14. [Q9H098-2];""ENST00000378458.6; ENSP00000367719.2; ENSG00000065809.14. [Q9H098-1]"";""ENST00000378462.5; ENSP00000367723.1; ENSG00000065809.14. [Q9H098-1]"";""ENST00000378465.7; ENSP00000367726.3; ENSG00000065809.14. [Q9H098-1]"";""ENST00000378467.8; ENSP00000367728.4; ENSG00000065809.14. [Q9H098-1]"";""ENST00000378470.5; ENSP00000367731.1; ENSG00000065809.14. [Q9H098-1]"";""ENST00000468747.5; ENSP00000418120.1; ENSG00000065809.14. [Q9H098-1]"";""ENST00000478076.5; ENSP00000417782.1; ENSG00000065809.14. [Q9H098-1]"";""ENST00000479731.5; ENSP00000419603.1; ENSG00000065809.14. [Q9H098-1]"";""ENST00000496330.5; ENSP00000418330.1; ENSG00000065809.14. [Q9H098-1]"";""ENST00000622567.4; ENSP00000479842.1; ENSG00000065809.14. [Q9H098-1]"";",0,0,0
Q96PZ2,N1,-1.223983317,-1.165144471,-0.003263958,-0.382692716,1.58679483,grey90,FAM111A,F111A_HUMAN,Serine protease FAM111A (EC 3.4.21.-),FAM111A KIAA1895,63901;,"ENST00000361723.7; ENSP00000355264.3; ENSG00000166801.17.;""ENST00000420244.6; ENSP00000406683.1; ENSG00000166801.17."";""ENST00000527629.6; ENSP00000436128.2; ENSG00000166801.17."";""ENST00000528737.5; ENSP00000434435.1; ENSG00000166801.17."";""ENST00000529985.3; ENSP00000502754.2; ENSG00000166801.17."";""ENST00000531147.1; ENSP00000431631.1; ENSG00000166801.17."";""ENST00000531408.6; ENSP00000432821.2; ENSG00000166801.17."";""ENST00000533703.1; ENSP00000433154.1; ENSG00000166801.17."";""ENST00000674617.1; ENSP00000501786.1; ENSG00000166801.17."";""ENST00000675163.1; ENSP00000501952.1; ENSG00000166801.17."";""ENST00000675806.2; ENSP00000501617.2; ENSG00000166801.17."";""ENST00000676340.1; ENSP00000501909.1; ENSG00000166801.17."";""ENST00000676459.1; ENSP00000501771.1; ENSG00000166801.17."";""ENST00000682018.1; ENSP00000507215.1; ENSG00000166801.17."";",peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697],DNA damage response [GO:0006974]; DNA replication [GO:0006260]; negative regulation of viral genome replication [GO:0045071]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; replication fork processing [GO:0031297],chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NRY5,C1,1.002000802,-0.231934061,-0.269119176,0.260121807,0.158182838,lightblue,FAM114A2,F1142_HUMAN,Protein FAM114A2,FAM114A2 C5orf3,10827;,"ENST00000351797.9; ENSP00000341597.4; ENSG00000055147.19.;""ENST00000520667.5; ENSP00000430384.1; ENSG00000055147.19."";""ENST00000522858.5; ENSP00000430489.1; ENSG00000055147.19."";",purine nucleotide binding [GO:0017076],0,0
Q9NZB2,N1,-0.523041757,-0.981060242,-0.505158543,-0.23742987,1.527262856,grey90,FAM120A,F120A_HUMAN,Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated SRC activator) (Protein FAM120A),FAM120A C9orf10 KIAA0183 OSSA,23196;,"ENST00000277165.11; ENSP00000277165.5; ENSG00000048828.18. [Q9NZB2-1];""ENST00000375389.7; ENSP00000364538.3; ENSG00000048828.18. [Q9NZB2-2]"";",RNA binding [GO:0003723],0,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q8NC44,S1,-0.636345768,-0.748631103,0.011433341,0.328158198,0.912873182,gold,FAM134A,RETR2_HUMAN,Reticulophagy regulator 2,RETREG2 C2orf17 FAM134A MAG2,79137;,ENST00000430297.7; ENSP00000395249.2; ENSG00000144567.11.;,endoplasmic reticulum-autophagosome adaptor activity [GO:0140506],collagen catabolic process [GO:0030574]; endoplasmic reticulum organization [GO:0007029]; reticulophagy [GO:0061709],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q86VR2,S1,-0.534377716,-0.725268686,0.049720732,0.450888642,0.996695016,gold,FAM134C,RETR3_HUMAN,Reticulophagy regulator 3,RETREG3 FAM134C,162427;,ENST00000309428.10; ENSP00000309432.4; ENSG00000141699.11. [Q86VR2-1];,endoplasmic reticulum-autophagosome adaptor activity [GO:0140506],collagen catabolic process [GO:0030574]; endoplasmic reticulum tubular network organization [GO:0071786]; positive regulation of neuron projection development [GO:0010976]; reticulophagy [GO:0061709],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; protein-containing complex [GO:0032991]
Q96C01,N4,-1.283907819,1.234983601,-0.05477786,-0.033653278,-1.115138525,grey30,FAM136A,F136A_HUMAN,Protein FAM136A,FAM136A,84908;,ENST00000037869.8; ENSP00000037869.3; ENSG00000035141.10.;,0,0,cytoplasm [GO:0005737]
Q8N612,C2,1.457393019,0.318760444,-0.270314211,-0.112617496,-0.291344125,aquamarine,FAM160A2,FHI1B_HUMAN,FHF complex subunit HOOK-interacting protein 1B (FHIP1B) (FTS- and Hook-interacting protein) (FHIP),FHIP1B C11orf56 FAM160A2 KIAA1759,84067;,"ENST00000265978.8; ENSP00000265978.4; ENSG00000051009.11. [Q8N612-2];""ENST00000449352.7; ENSP00000416918.3; ENSG00000051009.11. [Q8N612-1]"";",0,early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031],FHF complex [GO:0070695]
Q5W0V3,C1,1.600453135,0.092623842,-0.384290898,-0.152772563,-0.378822641,lightblue,FAM160B1,FHI2A_HUMAN,FHF complex subunit HOOK interacting protein 2A (FHIP2A),FHIP2A FAM160B1 KIAA1600,57700;,"ENST00000369248.9; ENSP00000358251.4; ENSG00000151553.16. [Q5W0V3-1];""ENST00000369250.7; ENSP00000358253.3; ENSG00000151553.16. [Q5W0V3-2]"";",0,0,0
Q96A26,M2,-0.964884923,-1.507257473,0.301149594,1.104704116,-0.114448744,tan4,FAM162A,F162A_HUMAN,Protein FAM162A (E2-induced gene 5 protein) (Growth and transformation-dependent protein) (HGTD-P),FAM162A C3orf28 E2IG5 DC16 FWP001,26355;,ENST00000477892.5; ENSP00000419088.1; ENSG00000114023.16.;,0,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cellular response to hypoxia [GO:0071456]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of release of cytochrome c from mitochondria [GO:0090200],cytosol [GO:0005829]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]
Q92567,C5,1.549905453,0.365041601,-0.498100244,-0.671959753,-1.000376044,turquoise3,FAM168A,F168A_HUMAN,Protein FAM168A (Tongue cancer chemotherapy resistance-associated protein 1),FAM168A KIAA0280 TCRP1,23201;,"ENST00000064778.8; ENSP00000064778.4; ENSG00000054965.11. [Q92567-1];""ENST00000356467.5; ENSP00000348852.4; ENSG00000054965.11. [Q92567-2]"";""ENST00000450446.6; ENSP00000390501.2; ENSG00000054965.11. [Q92567-3]"";",0,positive regulation of base-excision repair [GO:1905053],0
Q9BQD7,M2,-1.345455891,-1.453398003,0.412700216,1.107543518,-0.1283077,tan4,FAM173A,ANKMT_HUMAN,Adenine nucleotide translocase lysine N-methyltransferase (ANT-KMT) (EC 2.1.1.-),ANTKMT C16orf24 FAM173A RJD7,65990;,ENST00000569529.6; ENSP00000454380.1; ENSG00000103254.10.;,histone methyltransferase activity [GO:0042054]; protein-lysine N-methyltransferase activity [GO:0016279],peptidyl-lysine trimethylation [GO:0018023]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706],mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]
Q6P4H8,M2,-0.465454745,-1.107781176,0.500295097,1.061206768,-0.244078714,tan4,FAM173B,ACKMT_HUMAN,ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (hFAM173B),ATPSCKMT FAM173B,134145;,"ENST00000510047.5; ENSP00000420876.1; ENSG00000150756.14. [Q6P4H8-2];""ENST00000511437.6; ENSP00000422338.1; ENSG00000150756.14. [Q6P4H8-1]"";",histone methyltransferase activity [GO:0042054]; protein-lysine N-methyltransferase activity [GO:0016279],"peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]",mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739]
Q15018,C5,1.765413698,0.510098824,-0.857159309,-0.803475293,-0.87049688,turquoise3,FAM175B,ABRX2_HUMAN,BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (Protein FAM175B),ABRAXAS2 ABRO1 FAM175B KIAA0157,23172;,ENST00000298492.6; ENSP00000298492.5; ENSG00000165660.8.;,microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593],attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931],BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]
Q8N128,S1,-1.238000828,-1.213835794,0.102584149,0.674122677,1.005250855,gold,FAM177A1,F177A_HUMAN,Protein FAM177A1,FAM177A1 C14orf24,283635;,"ENST00000280987.9; ENSP00000280987.4; ENSG00000151327.14. [Q8N128-2];""ENST00000382406.7; ENSP00000371843.3; ENSG00000151327.14. [Q8N128-1]"";""ENST00000555211.6; ENSP00000451508.2; ENSG00000151327.14. [Q8N128-1]"";""ENST00000699514.1; ENSP00000514409.1; ENSG00000151327.14. [Q8N128-1]"";""ENST00000699515.1; ENSP00000514410.1; ENSG00000151327.14. [Q8N128-1]"";",0,0,0
Q8IX21,N2,-0.725730139,-0.246058379,0.821999857,0.153843944,0.146255831,grey70,FAM178A,SLF2_HUMAN,SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1),SLF2 C10orf6 FAM178A,55719;,"ENST00000238961.9; ENSP00000238961.3; ENSG00000119906.13. [Q8IX21-1];""ENST00000370269.3; ENSP00000359292.3; ENSG00000119906.13. [Q8IX21-2]"";""ENST00000609386.1; ENSP00000476379.1; ENSG00000119906.13. [Q8IX21-3]"";",protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625],chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to site of double-strand break [GO:1990166]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"
Q9UK61,N3,-0.762523847,-0.848799767,1.095711976,0.06587538,-0.122603728,grey50,FAM208A,TASOR_HUMAN,Protein TASOR (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140) (Transgene activation suppressor protein),TASOR C3orf63 FAM208A KIAA1105,23272;,"ENST00000355628.9; ENSP00000347845.5; ENSG00000163946.14. [Q9UK61-4];""ENST00000431842.6; ENSP00000399410.2; ENSG00000163946.14. [Q9UK61-2]"";""ENST00000493960.6; ENSP00000417509.2; ENSG00000163946.14. [Q9UK61-3]"";""ENST00000683822.1; ENSP00000508241.1; ENSG00000163946.14. [Q9UK61-1]"";",chromatin binding [GO:0003682]; RNA binding [GO:0003723],"anterior/posterior axis specification, embryo [GO:0008595]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]; protein localization to heterochromatin [GO:0097355]",heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]
Q5VWN6,N2,-0.701417169,-0.648244194,1.11044382,0.069566581,0.00740191,grey70,FAM208B,TASO2_HUMAN,Protein TASOR 2,TASOR2 C10orf18 FAM208B KIAA2006,54906;,"ENST00000328090.9; ENSP00000328426.5; ENSG00000108021.22. [Q5VWN6-1];""ENST00000695737.1; ENSP00000512130.1; ENSG00000108021.22. [Q5VWN6-1]"";""ENST00000695834.1; ENSP00000512207.1; ENSG00000108021.22. [Q5VWN6-1]"";",0,"negative regulation of gene expression, epigenetic [GO:0045814]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]
O75063,S3,-0.506647907,-0.759118,-0.045528731,0.720204394,0.646788596,salmon,FAM20B,XYLK_HUMAN,Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase),FAM20B KIAA0475,9917;,ENST00000263733.5; ENSP00000263733.4; ENSG00000116199.12.;,"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]",proteoglycan biosynthetic process [GO:0030166],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]
Q96ND0,M2,-0.816070464,-1.119997668,0.311655133,1.165426614,-0.175160702,tan4,FAM210A,F210A_HUMAN,Protein FAM210A,FAM210A C18orf19,125228;,"ENST00000322247.7; ENSP00000323635.3; ENSG00000177150.13.;""ENST00000402563.5; ENSP00000386115.1; ENSG00000177150.13."";""ENST00000651643.1; ENSP00000498370.1; ENSG00000177150.13."";",0,0,cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]
Q92520,S1,-1.148593792,-1.460427954,-0.205333249,0.829982559,1.104722872,gold,FAM3C,FAM3C_HUMAN,Protein FAM3C (Interleukin-like EMT inducer),FAM3C ILEI GS3786,10447;,ENST00000359943.8; ENSP00000353025.3; ENSG00000196937.11.;,carbohydrate binding [GO:0030246]; cytokine activity [GO:0005125],0,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089]
F6W5V1,S1,-0.825590089,-1.082194396,0.003636678,0.759309119,0.870073678,gold,FAM47E-STBD1,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A,#N/A
Q9BSJ6,S3,-0.577281382,-0.36897606,0.414124033,0.607026781,0.220648523,salmon,FAM64A,PIMRE_HUMAN,Protein PIMREG (CALM-interactor expressed in thymus and spleen) (PICALM-interacting mitotic regulator) (Regulator of chromosome segregation protein 1),PIMREG CATS FAM64A RCS1,54478;,"ENST00000250056.12; ENSP00000250056.8; ENSG00000129195.16. [Q9BSJ6-1];""ENST00000572447.6; ENSP00000459235.1; ENSG00000129195.16. [Q9BSJ6-2]"";""ENST00000576056.5; ENSP00000458534.1; ENSG00000129195.16. [Q9BSJ6-2]"";",0,cell division [GO:0051301],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q6ZS17,C1,1.419344717,-0.283917176,-0.32391137,0.020538764,-0.150906169,lightblue,FAM65A,RIPR1_HUMAN,Rho family-interacting cell polarization regulator 1,RIPOR1 FAM65A KIAA1930,79567;,"ENST00000042381.9; ENSP00000042381.4; ENSG00000039523.20. [Q6ZS17-2];""ENST00000379312.7; ENSP00000368614.3; ENSG00000039523.20. [Q6ZS17-1]"";""ENST00000422602.8; ENSP00000400099.2; ENSG00000039523.20. [Q6ZS17-4]"";""ENST00000428437.6; ENSP00000389456.2; ENSG00000039523.20. [Q6ZS17-3]"";",14-3-3 protein binding [GO:0071889],cellular response to chemokine [GO:1990869]; cellular response to starvation [GO:0009267]; establishment of Golgi localization [GO:0051683]; negative regulation of Rho guanyl-nucleotide exchange factor activity [GO:2001107]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to Golgi apparatus [GO:0034067]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; vesicle membrane [GO:0012506]
Q5T7M9,S1,-0.751562658,-1.173218966,-0.116701689,0.908656348,0.857065844,gold,FAM69A,DIK1A_HUMAN,Divergent protein kinase domain 1A (Protein FAM69A),DIPK1A FAM69A,388650;,"ENST00000370310.5; ENSP00000359333.4; ENSG00000154511.12. [Q5T7M9-1];""ENST00000615519.4; ENSP00000483279.1; ENSG00000154511.12. [Q5T7M9-2]"";",0,0,endoplasmic reticulum membrane [GO:0005789]
Q8NAN2,M2,-0.907863801,-1.259864571,0.356707915,1.074191273,-0.06750873,tan4,FAM73A,MIGA1_HUMAN,Mitoguardin 1 (Protein FAM73A),MIGA1 FAM73A,374986;,ENST00000710932.1; ENSP00000518551.1; ENSG00000180488.17. [Q8NAN2-1];,protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],mitochondrial fusion [GO:0008053],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q7L4E1,M2,-0.773072779,-1.587719296,0.485728686,0.926188681,0.140451971,tan4,FAM73B,MIGA2_HUMAN,Mitoguardin 2 (Protein FAM73B),MIGA2 C9orf54 FAM73B PSEC0112,84895;,"ENST00000358369.8; ENSP00000351138.4; ENSG00000148343.19. [Q7L4E1-1];""ENST00000439290.5; ENSP00000391603.1; ENSG00000148343.19. [Q7L4E1-2]"";""ENST00000445183.5; ENSP00000396618.1; ENSG00000148343.19. [Q7L4E1-3]"";""ENST00000684074.1; ENSP00000506871.1; ENSG00000148343.19. [Q7L4E1-1]"";",protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],bone development [GO:0060348]; mitochondrial fusion [GO:0008053],mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]
Q8TAV0,N4,-1.071056703,1.143999767,0.052046133,-0.256897181,-0.103024934,grey30,FAM76A,FA76A_HUMAN,Protein FAM76A,FAM76A,199870;,"ENST00000010299.10; ENSP00000010299.6; ENSG00000009780.16. [Q8TAV0-3];""ENST00000234549.11; ENSP00000234549.7; ENSG00000009780.16. [Q8TAV0-4]"";""ENST00000373949.5; ENSP00000363060.1; ENSG00000009780.16. [Q8TAV0-2]"";""ENST00000373954.11; ENSP00000363065.5; ENSG00000009780.16. [Q8TAV0-1]"";""ENST00000419687.6; ENSP00000395150.2; ENSG00000009780.16. [Q8TAV0-5]"";",0,0,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]
Q5HYJ3,N4,-1.592966561,1.253147425,-0.007684636,-0.649654333,-0.05631553,grey30,FAM76B,FA76B_HUMAN,Protein FAM76B,FAM76B,143684;,"ENST00000358780.10; ENSP00000351631.5; ENSG00000077458.13. [Q5HYJ3-1];""ENST00000398187.6; ENSP00000381248.2; ENSG00000077458.13. [Q5HYJ3-3]"";""ENST00000543641.5; ENSP00000444087.1; ENSG00000077458.13. [Q5HYJ3-3]"";",0,0,nuclear speck [GO:0016607]
Q9UBU6,S2,-1.058319401,-1.104962392,0.093941379,0.767726137,0.607423142,orange,FAM8A1,FA8A1_HUMAN,Protein FAM8A1 (Autosomal highly conserved protein),FAM8A1 AHCP,51439;,ENST00000259963.4; ENSP00000259963.3; ENSG00000137414.7.;,0,ERAD pathway [GO:0036503],Hrd1p ubiquitin ligase complex [GO:0000836]
Q9H5X1,C1,1.683954115,-0.118854561,-0.517878105,-0.121781387,-0.596007385,lightblue,FAM96A,CIA2A_HUMAN,Cytosolic iron-sulfur assembly component 2A (MIP18 family protein FAM96A),CIAO2A CIA2A FAM96A,84191;,"ENST00000300030.8; ENSP00000300030.3; ENSG00000166797.11. [Q9H5X1-1];""ENST00000380290.7; ENSP00000369644.3; ENSG00000166797.11. [Q9H5X1-2]"";""ENST00000557835.5; ENSP00000454079.1; ENSG00000166797.11. [Q9H5X1-2]"";",metal ion binding [GO:0046872],chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by [4Fe-4S] cluster transfer [GO:0106035]; protein maturation by iron-sulfur cluster transfer [GO:0097428],CIA complex [GO:0097361]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q8WVX9,S2,-1.048452801,-1.411995506,-0.115832988,1.034297647,0.484616818,orange,FAR1,FACR1_HUMAN,Fatty acyl-CoA reductase 1 (EC 1.2.1.84) (Male sterility domain-containing protein 2),FAR1 MLSTD2 UNQ2423/PRO4981,84188;,ENST00000354817.8; ENSP00000346874.3; ENSG00000197601.14.;,alcohol-forming long-chain fatty acyl-CoA reductase activity [GO:0102965]; alcohol-forming very long-chain fatty acyl-CoA reductase activity [GO:0080019]; oxidoreductase activity [GO:0016491],ether lipid biosynthetic process [GO:0008611]; glycerophospholipid biosynthetic process [GO:0046474]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025],peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
O94887,M1,-0.750351738,-1.050995528,0.555940632,0.891782877,-0.064389293,burlywood4,FARP2,FARP2_HUMAN,"FERM, ARHGEF and pleckstrin domain-containing protein 2 (FERM domain-including RhoGEF) (FIR) (FERM, RhoGEF and pleckstrin domain-containing protein 2) (Pleckstrin homology domain-containing family C member 3) (PH domain-containing family C member 3)",FARP2 KIAA0793 PLEKHC3,9855;,"ENST00000264042.8; ENSP00000264042.3; ENSG00000006607.14. [O94887-1];""ENST00000373287.8; ENSP00000362384.4; ENSG00000006607.14. [O94887-2]"";""ENST00000627550.2; ENSP00000486597.1; ENSG00000006607.14. [O94887-3]"";",cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085],actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; semaphorin-plexin signaling pathway [GO:0071526],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]
Q9Y285,N4,0.297593918,1.076446061,-0.38160298,-0.611750242,-0.587002106,grey30,FARSA,SYFA_HUMAN,Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (CML33) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS),FARSA FARS FARSL FARSLA,2193;,"ENST00000314606.9; ENSP00000320309.3; ENSG00000179115.11. [Q9Y285-1];""ENST00000423140.6; ENSP00000396548.2; ENSG00000179115.11. [Q9Y285-2]"";",ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; tRNA binding [GO:0000049],phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]
Q9NSD9,N4,0.367314359,1.242668813,-0.460160691,-0.735400586,-0.619509457,grey30,FARSB,SYFB_HUMAN,Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS),FARSB FARSLB FRSB HSPC173,10056;,ENST00000281828.8; ENSP00000281828.6; ENSG00000116120.11. [Q9NSD9-1];,ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723],phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; phenylalanine-tRNA ligase complex [GO:0009328]
P25445,S4,-1.409906749,-1.585320721,0.487823491,0.956873839,0.337301221,tomato2,FAS,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),FAS APT1 FAS1 TNFRSF6,355;,"ENST00000355279.2; ENSP00000347426.2; ENSG00000026103.25. [P25445-7];""ENST00000357339.7; ENSP00000349896.2; ENSG00000026103.25. [P25445-6]"";""ENST00000479522.6; ENSP00000424113.1; ENSG00000026103.25. [P25445-3]"";""ENST00000484444.6; ENSP00000420975.1; ENSG00000026103.25. [P25445-2]"";""ENST00000488877.6; ENSP00000425159.1; ENSG00000026103.25. [P25445-4]"";""ENST00000492756.7; ENSP00000422453.1; ENSG00000026103.25. [P25445-5]"";""ENST00000494410.5; ENSP00000423755.1; ENSG00000026103.25. [P25445-4]"";""ENST00000652046.1; ENSP00000498466.1; ENSG00000026103.25. [P25445-1]"";""ENST00000697036.1; ENSP00000513060.1; ENSG00000026103.25. [P25445-4]"";",calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; signaling receptor activity [GO:0038023]; tumor necrosis factor receptor activity [GO:0005031],activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; Fas signaling pathway [GO:0036337]; immune response [GO:0006955]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of protein phosphorylation [GO:0001934]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165],CD95 death-inducing signaling complex [GO:0031265]; cell surface [GO:0009986]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]
Q14296,S1,-1.016822486,-1.227861935,0.298688227,0.533573618,0.976393693,gold,FASTK,FASTK_HUMAN,Fas-activated serine/threonine kinase (FAST kinase) (EC 2.7.11.1) (EC 2.7.11.8),FASTK,10922;,"ENST00000297532.11; ENSP00000297532.6; ENSG00000164896.21. [Q14296-1];""ENST00000353841.6; ENSP00000324817.6; ENSG00000164896.21. [Q14296-2]"";""ENST00000482571.2; ENSP00000418516.1; ENSG00000164896.21. [Q14296-3]"";",ATP binding [GO:0005524]; Fas-activated serine/threonine kinase activity [GO:0033867]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723],apoptotic signaling pathway [GO:0097190]; mitochondrial RNA processing [GO:0000963]; protein phosphorylation [GO:0006468]; regulation of mitochondrial mRNA stability [GO:0044528]; regulation of RNA splicing [GO:0043484],mitochondrial matrix [GO:0005759]; ribonucleoprotein granule [GO:0035770]
Q53R41,M1,-0.969442489,-0.489627159,0.426207981,0.884261739,0.015910501,burlywood4,FASTKD1,FAKD1_HUMAN,"FAST kinase domain-containing protein 1, mitochondrial",FASTKD1 KIAA1800,79675;,"ENST00000453153.7; ENSP00000400513.2; ENSG00000138399.18. [Q53R41-1];""ENST00000453929.6; ENSP00000403229.2; ENSG00000138399.18. [Q53R41-2]"";",RNA binding [GO:0003723],mitochondrial RNA metabolic process [GO:0000959]; mitochondrial RNA processing [GO:0000963]; regulation of mitochondrial mRNA stability [GO:0044528],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]
Q9NYY8,M1,-1.04532496,-0.419323799,0.399469366,0.84914904,-0.184996018,burlywood4,FASTKD2,FAKD2_HUMAN,"FAST kinase domain-containing protein 2, mitochondrial",FASTKD2 KIAA0971,22868;,"ENST00000236980.10; ENSP00000236980.6; ENSG00000118246.14. [Q9NYY8-1];""ENST00000402774.8; ENSP00000385990.3; ENSG00000118246.14. [Q9NYY8-1]"";""ENST00000403094.3; ENSP00000384929.3; ENSG00000118246.14. [Q9NYY8-1]"";",RNA binding [GO:0003723]; rRNA binding [GO:0019843],apoptotic process [GO:0006915]; mitochondrial large ribosomal subunit assembly [GO:1902775]; mitochondrial RNA processing [GO:0000963]; mitochondrial translation [GO:0032543]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; RNA processing [GO:0006396],mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]
Q14CZ7,S3,-0.918794387,-0.742129973,0.315015192,0.740006876,0.289584321,salmon,FASTKD3,FAKD3_HUMAN,"FAST kinase domain-containing protein 3, mitochondrial",FASTKD3,79072;,ENST00000264669.10; ENSP00000264669.5; ENSG00000124279.12.;,RNA binding [GO:0003723],mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial RNA processing [GO:0000963]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein granule [GO:0035770]
Q7L8L6,M1,-1.277330175,-0.49039552,0.463215822,0.951564474,-0.511512517,burlywood4,FASTKD5,FAKD5_HUMAN,"FAST kinase domain-containing protein 5, mitochondrial",FASTKD5 KIAA1792,60493;,"ENST00000380266.4; ENSP00000369618.3; ENSG00000215251.5.;""ENST00000687419.1; ENSP00000510780.1; ENSG00000215251.5."";""ENST00000688674.1; ENSP00000510078.1; ENSG00000215251.5."";""ENST00000692371.1; ENSP00000510038.1; ENSG00000215251.5."";",RNA binding [GO:0003723]; rRNA binding [GO:0019843],mitochondrial RNA processing [GO:0000963]; mRNA processing [GO:0006397]; regulation of mitochondrial mRNA stability [GO:0044528],mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]
Q14517,S3,-0.984158567,-0.646361261,0.121155619,0.805141093,0.361209246,salmon,FAT1,FAT1_HUMAN,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",FAT1 CDHF7 FAT,2195;,ENST00000441802.7; ENSP00000406229.2; ENSG00000083857.15.;,calcium ion binding [GO:0005509],actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cellular response to angiotensin [GO:1904385]; epithelial cell morphogenesis [GO:0003382]; establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis [GO:0003412]; establishment or maintenance of cell polarity [GO:0007163]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lens development in camera-type eye [GO:0002088]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754],apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
P22087,N3,-1.214400344,-1.342593558,1.341540888,0.177005922,-0.277086028,grey50,FBL,FBRL_HUMAN,rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin),FBL FIB1 FLRN,2091;,"ENST00000221801.8; ENSP00000221801.2; ENSG00000105202.9.;""ENST00000625241.3; ENSP00000487390.1; ENSG00000280548.4."";",ATPase binding [GO:0051117]; histone H2AQ104 methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]; U6 snRNA 2'-O-ribose methyltransferase activity [GO:0180021],box C/D sno(s)RNA 3'-end processing [GO:0000494]; osteoblast differentiation [GO:0001649]; ribosomal small subunit biogenesis [GO:0042274]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254],box C/D methylation guide snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]
Q8WUP2,C5,1.266105862,0.735611203,-0.335850032,-0.504854391,-0.968088098,turquoise3,FBLIM1,FBLI1_HUMAN,Filamin-binding LIM protein 1 (FBLP-1) (Migfilin) (Mitogen-inducible 2-interacting protein) (MIG2-interacting protein),FBLIM1 FBLP1,54751;,"ENST00000332305.5; ENSP00000364920.2; ENSG00000162458.13. [Q8WUP2-3];""ENST00000375766.8; ENSP00000364921.3; ENSG00000162458.13. [Q8WUP2-1]"";""ENST00000375771.5; ENSP00000364926.1; ENSG00000162458.13. [Q8WUP2-1]"";""ENST00000441801.6; ENSP00000416387.2; ENSG00000162458.13. [Q8WUP2-2]"";",filamin binding [GO:0031005]; metal ion binding [GO:0046872],cell-cell adhesion [GO:0098609]; regulation of cell shape [GO:0008360]; regulation of integrin activation [GO:0033623],cell junction [GO:0030054]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; focal adhesion [GO:0005925]; stress fiber [GO:0001725]
Q9HAH7,N4,-0.788731534,1.019768029,-0.036604342,-0.102111327,-0.235734604,grey30,FBRS,FBRS_HUMAN,Probable fibrosin-1,FBRS FBS FBS1,64319;,ENST00000287468.5; ENSP00000287468.5; ENSG00000156860.16. [Q9HAH7-2];,0,0,0
Q9UKA2,M2,-0.361852903,-1.284504453,0.23873196,1.037303842,-0.157263153,tan4,FBXL4,FBXL4_HUMAN,F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4) (F-box protein FBL4/FBL5),FBXL4 FBL4 FBL5,26235;,"ENST00000229971.2; ENSP00000229971.1; ENSG00000112234.9.;""ENST00000369244.7; ENSP00000358247.1; ENSG00000112234.9."";",0,autophagy of mitochondrion [GO:0000422]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; nuclear speck [GO:0016607]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]
Q86XK2,N1,-1.154850884,-0.731187316,0.769328192,0.134246564,0.796750035,grey90,FBXO11,FBX11_HUMAN,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),FBXO11 FBX11 PRMT9 VIT1 UG063H01,80204;,"ENST00000402508.5; ENSP00000385398.1; ENSG00000138081.22. [Q86XK2-6];""ENST00000403359.8; ENSP00000384823.4; ENSG00000138081.22. [Q86XK2-1]"";",protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
Q9NVF7,N2,-1.27711556,-0.809033155,0.716919107,0.373887315,0.529396522,grey70,FBXO28,FBX28_HUMAN,F-box only protein 28,FBXO28 CENP-30 KIAA0483,23219;,"ENST00000366862.10; ENSP00000355827.5; ENSG00000143756.12. [Q9NVF7-1];""ENST00000424254.6; ENSP00000416888.2; ENSG00000143756.12. [Q9NVF7-2]"";",identical protein binding [GO:0042802],protein polyubiquitination [GO:0000209],kinetochore [GO:0000776]
Q9UK99,C5,1.682626827,0.755677153,-0.711485901,-0.900382403,-1.008001022,turquoise3,FBXO3,FBX3_HUMAN,F-box only protein 3,FBXO3 FBX3,26273;,"ENST00000265651.8; ENSP00000265651.3; ENSG00000110429.14. [Q9UK99-1];""ENST00000448981.6; ENSP00000408836.2; ENSG00000110429.14. [Q9UK99-2]"";""ENST00000530401.5; ENSP00000433781.1; ENSG00000110429.14. [Q9UK99-3]"";",ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842],protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; response to lipopolysaccharide [GO:0032496]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]
Q8TB52,C3,1.735958295,0.503247234,-0.626593258,-0.594226498,-0.876114654,cyan,FBXO30,FBX30_HUMAN,F-box only protein 30,FBXO30 FBX30,84085;,ENST00000237281.5; ENSP00000237281.3; ENSG00000118496.5.;,ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],protein ubiquitination [GO:0016567],cytosol [GO:0005829]
Q969U6,C5,1.484707206,0.471221963,-0.292398461,-0.360702983,-0.575382783,turquoise3,FBXW5,FBXW5_HUMAN,F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5),FBXW5 FBW5 PP3971,54461;,ENST00000325285.8; ENSP00000313034.3; ENSG00000159069.14. [Q969U6-1];,protein kinase binding [GO:0019901],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]
Q9Y324,N2,-1.150642716,-1.08525176,1.107716332,0.048493803,0.248557597,grey70,FCF1,FCF1_HUMAN,rRNA-processing protein FCF1 homolog,FCF1 C14orf111 CGI-35,51077;,ENST00000341162.8; ENSP00000344393.4; ENSG00000119616.11.;,RNA binding [GO:0003723],ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
O94868,C2,1.061340026,0.342207511,-0.277598282,-0.004357706,-0.290191595,aquamarine,FCHSD2,FCSD2_HUMAN,F-BAR and double SH3 domains protein 2 (Carom) (Protein nervous wreck 1) (NWK1) (SH3 multiple domains protein 3),FCHSD2 KIAA0769 SH3MD3,9873;,"ENST00000311172.11; ENSP00000308978.7; ENSG00000137478.15. [O94868-2];""ENST00000409418.9; ENSP00000386722.4; ENSG00000137478.15. [O94868-1]"";""ENST00000409853.5; ENSP00000386314.1; ENSG00000137478.15. [O94868-3]"";","phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]",clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; protein transport [GO:0015031]; regulation of actin filament polymerization [GO:0030833],anchoring junction [GO:0070161]; clathrin-coated pit [GO:0005905]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stereocilium shaft [GO:0120043]
P37268,S2,-0.991886033,-1.30049396,0.39716293,0.756176047,0.565880247,orange,FDFT1,FDFT_HUMAN,Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase 1),FDFT1,2222;,"ENST00000220584.9; ENSP00000220584.4; ENSG00000079459.14. [P37268-1];""ENST00000443614.6; ENSP00000390367.2; ENSG00000079459.14. [P37268-5]"";""ENST00000528643.5; ENSP00000431649.1; ENSG00000079459.14. [P37268-3]"";""ENST00000528812.5; ENSP00000431749.1; ENSG00000079459.14. [P37268-2]"";""ENST00000530337.6; ENSP00000431852.2; ENSG00000079459.14. [P37268-1]"";""ENST00000530664.5; ENSP00000432331.1; ENSG00000079459.14. [P37268-2]"";""ENST00000615631.4; ENSP00000481481.1; ENSG00000079459.14. [P37268-1]"";""ENST00000622850.3; ENSP00000484122.1; ENSG00000079459.14. [P37268-2]"";""ENST00000647069.3; ENSP00000495060.2; ENSG00000284967.3. [P37268-5]"";""ENST00000647178.2; ENSP00000496723.1; ENSG00000284967.3. [P37268-1]"";""ENST00000710773.1; ENSP00000518476.1; ENSG00000284967.3. [P37268-2]"";""ENST00000710774.1; ENSP00000518477.1; ENSG00000284967.3. [P37268-1]"";""ENST00000710775.1; ENSP00000518478.1; ENSG00000284967.3. [P37268-1]"";""ENST00000710778.1; ENSP00000518480.1; ENSG00000284967.3. [P37268-3]"";""ENST00000710780.1; ENSP00000518482.1; ENSG00000284967.3. [P37268-2]"";""ENST00000710781.1; ENSP00000518483.1; ENSG00000284967.3. [P37268-2]"";",farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; farnesyltranstransferase activity [GO:0004311]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996],cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate metabolic process [GO:0045338]; steroid biosynthetic process [GO:0006694],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
P14324,C5,1.824038796,0.509728192,-0.715971286,-0.802021191,-1.135452264,turquoise3,FDPS,FPPS_HUMAN,"Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)",FDPS FPS KIAA1293,2224;,"ENST00000356657.10; ENSP00000349078.6; ENSG00000160752.15. [P14324-1];""ENST00000368356.9; ENSP00000357340.4; ENSG00000160752.15. [P14324-1]"";""ENST00000447866.5; ENSP00000391755.1; ENSG00000160752.15. [P14324-2]"";""ENST00000467076.5; ENSP00000480142.1; ENSG00000160752.15. [P14324-2]"";""ENST00000612683.1; ENSP00000478235.1; ENSG00000160752.15. [P14324-2]"";",dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]
P16591,C3,1.643598942,0.270345391,-0.570700266,-0.500911965,-0.72642387,cyan,FER,FER_HUMAN,Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer),FER TYK3,2241;,"ENST00000281092.9; ENSP00000281092.4; ENSG00000151422.14. [P16591-1];""ENST00000618353.1; ENSP00000484767.1; ENSG00000151422.14. [P16591-3]"";",ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase 1 binding [GO:0008157]; protein tyrosine kinase activity [GO:0004713],actin cytoskeleton organization [GO:0030036]; adherens junction assembly [GO:0034333]; adherens junction disassembly [GO:0120179]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; germ cell development [GO:0007281]; insulin receptor signaling pathway [GO:0008286]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of STAT protein [GO:0007260],adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O95684,C2,1.001541653,0.319461828,-0.406859234,-0.053982089,-0.215121421,aquamarine,FGFR1OP,CEP43_HUMAN,Centrosomal protein 43 (FGFR1 oncogene partner),CEP43 FGFR1OP FOP,11116;,"ENST00000349556.5; ENSP00000230248.6; ENSG00000213066.14. [O95684-2];""ENST00000366847.9; ENSP00000355812.3; ENSG00000213066.14. [O95684-1]"";""ENST00000705170.1; ENSP00000516073.1; ENSG00000213066.14. [O95684-3]"";",protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292],cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284],cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q8N441,S3,-0.948103007,-0.530308188,0.261529061,0.704560759,0.563267042,salmon,FGFRL1,FGRL1_HUMAN,Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5),FGFRL1 FGFR5 FHFR UNQ480/PRO943,53834;,"ENST00000264748.6; ENSP00000264748.6; ENSG00000127418.15.;""ENST00000398484.6; ENSP00000381498.2; ENSG00000127418.15."";""ENST00000504138.5; ENSP00000423091.1; ENSG00000127418.15."";""ENST00000510644.6; ENSP00000425025.1; ENSG00000127418.15."";",fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802],cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; diaphragm development [GO:0060539]; heart valve morphogenesis [GO:0003179]; negative regulation of cell population proliferation [GO:0008285]; skeletal system development [GO:0001501]; ventricular septum morphogenesis [GO:0060412],cell-cell contact zone [GO:0044291]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]
Q9Y613,C1,1.593614992,0.023382414,-0.394051898,-0.315177455,-0.580921184,lightblue,FHOD1,FHOD1_HUMAN,FH1/FH2 domain-containing protein 1 (Formin homolog overexpressed in spleen 1) (FHOS) (Formin homology 2 domain-containing protein 1),FHOD1 FHOS FHOS1,29109;,ENST00000258201.9; ENSP00000258201.4; ENSG00000135723.14.;,actin filament binding [GO:0051015]; identical protein binding [GO:0042802],cortical actin cytoskeleton organization [GO:0030866]; establishment of centrosome localization [GO:0051660]; nuclear migration [GO:0007097]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stress fiber assembly [GO:0051492],bleb [GO:0032059]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96SL8,N1,-0.83396687,-0.187929533,-0.23482464,-0.464197466,1.261459814,grey90,FIZ1,FIZ1_HUMAN,Flt3-interacting zinc finger protein 1 (Zinc finger protein 798),FIZ1 ZNF798,84922;,ENST00000221665.5; ENSP00000221665.2; ENSG00000179943.8.;,metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q9NWM8,N4,-0.765368146,0.389075167,-0.126108662,0.545551144,0.195634997,grey30,FKBP14,FKB14_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase),FKBP14 FKBP22 UNQ322/PRO381,55033;,ENST00000222803.10; ENSP00000222803.5; ENSG00000106080.11.;,calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],0,endoplasmic reticulum lumen [GO:0005788]
Q00688,C5,1.344233823,0.933846142,-0.738231669,-0.992511654,-0.65798001,turquoise3,FKBP3,FKBP3_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase),FKBP3 FKBP25,2287;,"ENST00000216330.7; ENSP00000216330.3; ENSG00000100442.11.;""ENST00000396062.4; ENSP00000379374.3; ENSG00000100442.11."";",FK506 binding [GO:0005528]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023],0,nucleus [GO:0005634]
Q02790,C5,1.805162528,0.427163187,-0.842201138,-1.00157002,-1.167721366,turquoise3,FKBP4,FKBP4_HUMAN,"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]",FKBP4 FKBP52,2288;,ENST00000001008.6; ENSP00000001008.4; ENSG00000004478.8.;,ATP binding [GO:0005524]; copper-dependent protein binding [GO:0032767]; FK506 binding [GO:0005528]; GTP binding [GO:0005525]; heat shock protein binding [GO:0031072]; nuclear glucocorticoid receptor binding [GO:0035259]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; tau protein binding [GO:0048156],androgen receptor signaling pathway [GO:0030521]; chaperone-mediated protein folding [GO:0061077]; copper ion transport [GO:0006825]; embryo implantation [GO:0007566]; male sex differentiation [GO:0046661]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; prostate gland development [GO:0030850]; protein folding [GO:0006457]; protein-containing complex localization [GO:0031503]; steroid hormone receptor complex assembly [GO:0006463],axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]
Q14318,S2,-1.022102345,-1.147683798,0.179156965,0.961047381,0.41059137,orange,FKBP8,FKBP8_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase),FKBP8 FKBP38,23770;,"ENST00000222308.8; ENSP00000222308.4; ENSG00000105701.16. [Q14318-1];""ENST00000596558.6; ENSP00000472302.1; ENSG00000105701.16. [Q14318-1]"";""ENST00000597960.7; ENSP00000471700.1; ENSG00000105701.16. [Q14318-2]"";""ENST00000608443.6; ENSP00000476767.1; ENSG00000105701.16. [Q14318-2]"";",calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding chaperone [GO:0044183],apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; camera-type eye development [GO:0043010]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; neuron fate specification [GO:0048665]; positive regulation of BMP signaling pathway [GO:0030513]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of gene expression [GO:0010468]; regulation of mitophagy [GO:1901524]; smoothened signaling pathway [GO:0007224],cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]
Q9UIM3,C4,1.84842978,0.191462215,-0.607999104,-0.719307238,-0.904322991,deepskyblue2,FKBPL,FKBPL_HUMAN,FK506-binding protein-like (WAF-1/CIP1 stabilizing protein 39) (WISp39),FKBPL DIR1 NG7,63943;,"ENST00000375156.4; ENSP00000364298.3; ENSG00000204315.4.;""ENST00000425378.2; ENSP00000397530.2; ENSG00000230907.2."";""ENST00000443350.2; ENSP00000398812.2; ENSG00000223666.2."";""ENST00000456854.2; ENSP00000412439.2; ENSG00000224200.2."";",0,regulation of blood vessel branching [GO:1905553]; response to radiation [GO:0009314],cytosol [GO:0005829]; extracellular region [GO:0005576]
Q9H9S5,S1,-1.11628711,-1.354091981,-0.170611147,0.883881773,0.955590204,gold,FKRP,FKRP_HUMAN,Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase),FKRP,79147;,"ENST00000318584.10; ENSP00000326570.4; ENSG00000181027.11.;""ENST00000391909.7; ENSP00000375776.2; ENSG00000181027.11."";","dystroglycan binding [GO:0002162]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; filtration diaphragm assembly [GO:0036058]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle contraction [GO:0006936]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein import [GO:0017038]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; reproductive process [GO:0022414]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403],cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; skeletal muscle myofibril [GO:0098723]
O75072,S1,-1.018773269,-1.429425379,-0.153379841,0.932988459,0.920001776,gold,FKTN,FKTN_HUMAN,Ribitol-5-phosphate transferase FKTN (EC 2.7.8.-) (Fukutin) (Fukuyama-type congenital muscular dystrophy protein) (Ribitol-5-phosphate transferase),FKTN FCMD,2218;,"ENST00000223528.6; ENSP00000223528.2; ENSG00000106692.15. [O75072-1];""ENST00000357998.10; ENSP00000350687.6; ENSG00000106692.15. [O75072-1]"";""ENST00000448551.6; ENSP00000399140.2; ENSG00000106692.15. [O75072-2]"";","phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of JNK cascade [GO:0046329]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049],cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]
Q8NFG4,C1,1.356030697,0.07296623,-0.473402023,-0.044737011,-0.178007791,lightblue,FLCN,FLCN_HUMAN,Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein),FLCN BHD,201163;,"ENST00000285071.9; ENSP00000285071.4; ENSG00000154803.13. [Q8NFG4-1];""ENST00000389169.9; ENSP00000373821.5; ENSG00000154803.13. [Q8NFG4-2]"";",enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877],cell proliferation involved in kidney development [GO:0072111]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lysosome localization [GO:0032418]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glycolytic process [GO:0045820]; negative regulation of lysosome organization [GO:1905672]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of pro-B cell differentiation [GO:2000973]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]; transforming growth factor beta receptor signaling pathway [GO:0007179],centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FNIP-folliculin RagC/D GAP [GO:1990877]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P21333,C5,1.283119249,0.689205441,-0.52540302,-0.558491866,-0.84661068,turquoise3,FLNA,FLNA_HUMAN,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),FLNA FLN FLN1,2316;,"ENST00000360319.9; ENSP00000353467.4; ENSG00000196924.19. [P21333-2];""ENST00000369850.10; ENSP00000358866.3; ENSG00000196924.19. [P21333-1]"";",actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325],"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]",actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018]
O75369,C5,1.008645116,0.899526431,-0.484058259,-0.520628722,-0.85187974,turquoise3,FLNB,FLNB_HUMAN,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),FLNB FLN1L FLN3 TABP TAP,2317;,"ENST00000295956.9; ENSP00000295956.5; ENSG00000136068.16. [O75369-1];""ENST00000358537.7; ENSP00000351339.3; ENSG00000136068.16. [O75369-2]"";""ENST00000429972.6; ENSP00000415599.2; ENSG00000136068.16. [O75369-9]"";""ENST00000490882.5; ENSP00000420213.1; ENSG00000136068.16. [O75369-8]"";",actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723],actin cytoskeleton organization [GO:0030036]; cellular response to type II interferon [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]
O75955,S2,-1.161139465,-1.34779962,0.172858031,0.810954815,0.73087464,orange,FLOT1,FLOT1_HUMAN,Flotillin-1,FLOT1,10211;,"ENST00000376389.8; ENSP00000365569.3; ENSG00000137312.15. [O75955-1];""ENST00000383382.8; ENSP00000372873.4; ENSG00000206379.12. [O75955-1]"";""ENST00000383562.8; ENSP00000373056.4; ENSG00000206480.11. [O75955-1]"";""ENST00000436822.6; ENSP00000391438.2; ENSG00000232280.9. [O75955-1]"";""ENST00000444632.6; ENSP00000388861.2; ENSG00000230143.9. [O75955-1]"";",ionotropic glutamate receptor binding [GO:0035255]; protease binding [GO:0002020],"axonogenesis [GO:0007409]; cellular response to exogenous dsRNA [GO:0071360]; dsRNA transport [GO:0033227]; extracellular matrix disassembly [GO:0022617]; plasma membrane raft assembly [GO:0044854]; plasma membrane raft organization [GO:0044857]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell junction assembly [GO:1901890]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cytokine production [GO:0001819]; positive regulation of endocytosis [GO:0045807]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of neurotransmitter uptake [GO:0051580]; regulation of receptor internalization [GO:0002090]; regulation of Rho protein signal transduction [GO:0035023]; response to endoplasmic reticulum stress [GO:0034976]",adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; sarcolemma [GO:0042383]; uropod [GO:0001931]
Q14254,S2,-1.100421873,-1.399033643,-0.053969933,0.928918985,0.64286879,orange,FLOT2,FLOT2_HUMAN,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),FLOT2 ESA1 M17S1,2319;,ENST00000394908.9; ENSP00000378368.3; ENSG00000132589.16.;,protease binding [GO:0002020],anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of establishment of T cell polarity [GO:1903905]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982]
Q9Y5Y0,S4,-1.438835654,-1.673466052,0.460364034,0.973018525,0.08185076,tomato2,FLVCR1,FLVC1_HUMAN,Heme transporter FLVCR1 (Feline leukemia virus subgroup C receptor-related protein 1) (Feline leukemia virus subgroup C receptor) (hFLVCR),FLVCR1 FLVCR,28982;,ENST00000366971.9; ENSP00000355938.4; ENSG00000162769.13. [Q9Y5Y0-1];,heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232],blood vessel development [GO:0001568]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system morphogenesis [GO:0048704]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; head morphogenesis [GO:0060323]; heme biosynthetic process [GO:0006783]; heme export [GO:0097037]; heme transport [GO:0015886]; in utero embryonic development [GO:0001701]; intracellular iron ion homeostasis [GO:0006879]; mitochondrial transport [GO:0006839]; multicellular organism growth [GO:0035264]; regulation of organ growth [GO:0046620]; spleen development [GO:0048536],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q96PY5,S4,-0.4672578,-1.153823278,0.320400793,0.860767933,0.260100743,tomato2,FMNL2,FMNL2_HUMAN,Formin-like protein 2 (Formin homology 2 domain-containing protein 2),FMNL2 FHOD2 KIAA1902,114793;,ENST00000288670.14; ENSP00000288670.9; ENSG00000157827.20. [Q96PY5-3];,actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; small GTPase binding [GO:0031267],cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360],cytosol [GO:0005829]
Q96RU3,C3,1.651176557,0.001030519,-0.5742273,-0.461716478,-0.731919463,cyan,FNBP1,FNBP1_HUMAN,Formin-binding protein 1 (Formin-binding protein 17) (hFBP17),FNBP1 FBP17 KIAA0554,23048;,"ENST00000355681.3; ENSP00000347907.3; ENSG00000187239.19. [Q96RU3-3];""ENST00000446176.7; ENSP00000413625.1; ENSG00000187239.19. [Q96RU3-1]"";""ENST00000703532.1; ENSP00000515358.1; ENSG00000187239.19. [Q96RU3-2]"";",identical protein binding [GO:0042802]; lipid binding [GO:0008289],endocytosis [GO:0006897]; signal transduction [GO:0007165],cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]
Q5T0N5,C3,1.654187795,0.193690916,-0.592787025,-0.478177555,-0.732234442,cyan,FNBP1L,FBP1L_HUMAN,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),FNBP1L C1orf39 TOCA1,54874;,"ENST00000260506.12; ENSP00000260506.8; ENSG00000137942.18. [Q5T0N5-4];""ENST00000271234.13; ENSP00000271234.7; ENSG00000137942.18. [Q5T0N5-1]"";""ENST00000370253.6; ENSP00000359275.2; ENSG00000137942.18. [Q5T0N5-3]"";",cadherin binding [GO:0045296]; GTPase binding [GO:0051020]; lipid binding [GO:0008289],autophagy [GO:0006914]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q8N3X1,N4,-0.666695915,1.147325963,-0.100265488,-0.629040995,-0.19662789,grey30,FNBP4,FNBP4_HUMAN,Formin-binding protein 4 (Formin-binding protein 30),FNBP4 FBP30 KIAA1014,23360;,"ENST00000263773.10; ENSP00000263773.5; ENSG00000109920.13. [Q8N3X1-1];""ENST00000646180.2; ENSP00000494562.1; ENSG00000285182.2. [Q8N3X1-1]"";",0,0,nucleoplasm [GO:0005654]
Q9Y2H6,S2,-1.29519624,-1.602977793,0.097830795,0.978379588,0.599562743,orange,FNDC3A,FND3A_HUMAN,Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts),FNDC3A FNDC3 HUGO KIAA0970,22862;,"ENST00000398316.7; ENSP00000381362.3; ENSG00000102531.16. [Q9Y2H6-2];""ENST00000492622.6; ENSP00000417257.1; ENSG00000102531.16. [Q9Y2H6-1]"";""ENST00000541916.5; ENSP00000441831.1; ENSG00000102531.16. [Q9Y2H6-1]"";",RNA binding [GO:0003723],cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; vesicle membrane [GO:0012506]
Q53EP0,S2,-1.179421623,-1.470137133,0.098135829,0.938194359,0.544192377,orange,FNDC3B,FND3B_HUMAN,Fibronectin type III domain-containing protein 3B (Factor for adipocyte differentiation 104) (HCV NS5A-binding protein 37),FNDC3B FAD104 NS5ABP37 UNQ2421/PRO4979/PRO34274,64778;,"ENST00000336824.8; ENSP00000338523.4; ENSG00000075420.13. [Q53EP0-1];""ENST00000415807.7; ENSP00000411242.2; ENSG00000075420.13. [Q53EP0-1]"";""ENST00000416957.5; ENSP00000389094.1; ENSG00000075420.13. [Q53EP0-1]"";""ENST00000421757.5; ENSP00000408496.1; ENSG00000075420.13. [Q53EP0-3]"";""ENST00000423424.5; ENSP00000392471.1; ENSG00000075420.13. [Q53EP0-3]"";",RNA binding [GO:0003723],0,membrane [GO:0016020]
Q8TF40,C1,1.626885129,0.122229359,-0.615042775,-0.252220285,-0.346771527,lightblue,FNIP1,FNIP1_HUMAN,Folliculin-interacting protein 1,FNIP1 KIAA1961,96459;,"ENST00000307968.11; ENSP00000309266.7; ENSG00000217128.13. [Q8TF40-3];""ENST00000510461.6; ENSP00000421985.1; ENSG00000217128.13. [Q8TF40-1]"";""ENST00000511848.1; ENSP00000425619.1; ENSG00000217128.13. [Q8TF40-2]"";",ATPase inhibitor activity [GO:0042030]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; protein-folding chaperone binding [GO:0051087],B cell apoptotic process [GO:0001783]; B cell differentiation [GO:0030183]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lysosome organization [GO:1905672]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of pro-B cell differentiation [GO:2000973]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]
Q9P0K8,N4,0.21626386,0.880103948,-0.16588632,-0.051140148,-0.593812603,grey30,FOXJ2,FOXJ2_HUMAN,Forkhead box protein J2 (Fork head homologous X),FOXJ2 FHX,55810;,"ENST00000162391.8; ENSP00000162391.3; ENSG00000065970.9. [Q9P0K8-1];""ENST00000428177.2; ENSP00000403411.2; ENSG00000065970.9. [Q9P0K8-2]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell differentiation [GO:0110059]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P85037,N4,-0.592682503,1.168770664,-0.311490049,-0.553224036,-0.092394323,grey30,FOXK1,FOXK1_HUMAN,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),FOXK1 MNF,221937;,ENST00000328914.5; ENSP00000328720.4; ENSG00000164916.11. [P85037-1];,"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; intracellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q01167,N4,-0.698175011,1.032225242,0.037178154,-0.339858253,0.238499539,grey30,FOXK2,FOXK2_HUMAN,Forkhead box protein K2 (G/T-mismatch specific binding protein) (nGTBP) (Interleukin enhancer-binding factor 1),FOXK2 ILF ILF1,3607;,"ENST00000335255.10; ENSP00000335677.5; ENSG00000141568.21. [Q01167-1];""ENST00000473637.6; ENSP00000436108.2; ENSG00000141568.21. [Q01167-2]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; magnesium ion binding [GO:0000287]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",canonical glycolysis [GO:0061621]; intracellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594],chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O43524,C5,1.883953378,0.633057926,-0.797543221,-0.749842887,-1.05441074,turquoise3,FOXO3,FOXO3_HUMAN,Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1),FOXO3 FKHRL1 FOXO3A,2309;,"ENST00000343882.10; ENSP00000339527.6; ENSG00000118689.15. [O43524-1];""ENST00000406360.2; ENSP00000385824.1; ENSG00000118689.15. [O43524-1]"";""ENST00000540898.1; ENSP00000446316.1; ENSG00000118689.15. [O43524-2]"";","beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; mitochondrial transcription factor activity [GO:0034246]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]","antral ovarian follicle growth [GO:0001547]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cellular response to amyloid-beta [GO:1904646]; cellular response to corticosterone stimulus [GO:0071386]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; initiation of primordial ovarian follicle growth [GO:0001544]; mitochondrial transcription [GO:0006390]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuronal stem cell population maintenance [GO:0097150]; oocyte maturation [GO:0001556]; ovulation from ovarian follicle [GO:0001542]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of muscle atrophy [GO:0014737]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; response to dexamethasone [GO:0071548]; response to fatty acid [GO:0070542]; response to starvation [GO:0042594]; response to water-immersion restraint stress [GO:1990785]; response to xenobiotic stimulus [GO:0009410]; tumor necrosis factor-mediated signaling pathway [GO:0033209]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription repressor complex [GO:0090571]
Q96CU9,M2,-0.931563911,-0.784216403,0.431311997,1.014087761,-0.216243138,tan4,FOXRED1,FXRD1_HUMAN,FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-),FOXRED1 FP634,55572;,ENST00000263578.10; ENSP00000263578.5; ENSG00000110074.12. [Q96CU9-1];,oxidoreductase activity [GO:0016491],mitochondrial respiratory chain complex I assembly [GO:0032981],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O14772,C3,2.112539366,0.211655339,-0.867634982,-0.709623469,-0.991380017,cyan,FPGT,FPGT_HUMAN,Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase),FPGT GFPP,8790;,"ENST00000370894.9; ENSP00000359931.4; ENSG00000254685.8. [O14772-3];""ENST00000534056.5; ENSP00000432819.1; ENSG00000254685.8. [O14772-2]"";",catalytic activity [GO:0003824]; fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525],fucose metabolic process [GO:0006004],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q7Z6J6,S4,-1.05094148,-1.241817899,0.39045014,0.856236517,0.477259801,tomato2,FRMD5,FRMD5_HUMAN,FERM domain-containing protein 5,FRMD5,84978;,ENST00000417257.6; ENSP00000403067.1; ENSG00000171877.21. [Q7Z6J6-1];,cytoskeletal protein binding [GO:0008092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901],actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334],adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; membrane [GO:0016020]
Q6ZNA5,S1,-1.071269491,-1.319788675,0.003390277,0.549559362,1.164855213,gold,FRRS1,FRRS1_HUMAN,Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2),FRRS1 SDFR2 SDR2,391059;,"ENST00000287474.9; ENSP00000287474.4; ENSG00000156869.14. [Q6ZNA5-2];""ENST00000646001.2; ENSP00000496583.2; ENSG00000156869.14. [Q6ZNA5-1]"";","metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]",intracellular iron ion homeostasis [GO:0006879],membrane [GO:0016020]
Q8WU20,S4,-0.527699638,-0.704973981,0.368469105,0.69275592,0.256054228,tomato2,FRS2,FRS2_HUMAN,Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (Suc1-associated neurotrophic factor target 1) (SNT-1),FRS2,10818;,"ENST00000397997.6; ENSP00000381083.2; ENSG00000166225.9.;""ENST00000549921.6; ENSP00000450048.1; ENSG00000166225.9."";""ENST00000550389.5; ENSP00000447241.1; ENSG00000166225.9."";",fibroblast growth factor receptor binding [GO:0005104]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatase activator activity [GO:0019211]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],"anterior/posterior axis specification, embryo [GO:0008595]; cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; lens fiber cell development [GO:0070307]; lens placode formation involved in camera-type eye formation [GO:0046619]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; regulation of apoptotic process [GO:0042981]; regulation of epithelial cell proliferation [GO:0050678]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ventricular septum development [GO:0003281]",adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q16658,C5,2.035144753,0.176597222,-0.922645936,-0.904604358,-1.031612457,turquoise3,FSCN1,FSCN1_HUMAN,Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55),FSCN1 FAN1 HSN SNL,6624;,ENST00000382361.8; ENSP00000371798.3; ENSG00000075618.18.;,actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723],actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]
Q9UET6,C1,1.540720665,-0.08311758,-0.50454344,-0.394201272,0.306458972,lightblue,FTSJ1,TRM7_HUMAN,tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1),FTSJ1 JM23,24140;,"ENST00000019019.6; ENSP00000019019.2; ENSG00000068438.15. [Q9UET6-2];""ENST00000348411.3; ENSP00000326948.2; ENSG00000068438.15. [Q9UET6-1]"";",S-adenosyl-L-methionine binding [GO:1904047]; tRNA (cytidine(32)-2'-O)-methyltransferase activity [GO:0106339]; tRNA (guanine(34)-2'-O)-methyltransferase activity [GO:0106340]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175],cytoplasmic translation [GO:0002181]; neurogenesis [GO:0022008]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128]; wobble position ribose methylation [GO:0002130],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q9BWH2,M2,-0.450149819,-1.337388831,0.402535686,0.94068492,0.070198972,tan4,FUNDC2,FUND2_HUMAN,FUN14 domain-containing protein 2 (Cervical cancer proto-oncogene 3 protein) (HCC-3) (Hepatitis C virus core-binding protein 6),FUNDC2 HCBP6 DC44 HCC3 PD03104,65991;,ENST00000369498.8; ENSP00000358510.3; ENSG00000165775.18.;,"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]",intracellular triglyceride homeostasis [GO:0035356]; regulation of platelet activation [GO:0010543],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
P09958,S1,-1.099712959,-1.006234924,-0.060756436,0.683773917,0.773182908,gold,FURIN,FURIN_HUMAN,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE),FURIN FUR PACE PCSK3,5045;,"ENST00000268171.8; ENSP00000268171.2; ENSG00000140564.13.;""ENST00000610579.4; ENSP00000484952.1; ENSG00000140564.13."";""ENST00000618099.4; ENSP00000483552.1; ENSG00000140564.13."";""ENST00000680053.1; ENSP00000506143.1; ENSG00000140564.13."";",endopeptidase activity [GO:0004175]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; nerve growth factor binding [GO:0048406]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252]; serine-type endopeptidase inhibitor activity [GO:0004867]; serine-type peptidase activity [GO:0008236],amyloid fibril formation [GO:1990000]; blastocyst formation [GO:0001825]; collagen catabolic process [GO:0030574]; cytokine precursor processing [GO:0140447]; dibasic protein processing [GO:0090472]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of transforming growth factor beta1 production [GO:0032911]; nerve growth factor production [GO:0032902]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; plasma lipoprotein particle remodeling [GO:0034369]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of viral entry into host cell [GO:0046598]; protein maturation [GO:0051604]; protein processing [GO:0016485]; regulation of cholesterol transport [GO:0032374]; regulation of endopeptidase activity [GO:0052548]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction [GO:0009966]; secretion by cell [GO:0032940]; signal peptide processing [GO:0006465]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral life cycle [GO:0019058]; viral protein processing [GO:0019082]; viral translation [GO:0019081]; zymogen activation [GO:0031638],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]
Q9BYC5,S1,-0.889601501,-1.109871024,-0.10418053,0.855084196,0.806164914,gold,FUT8,FUT8_HUMAN,"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)",FUT8,2530;,"ENST00000342677.10; ENSP00000345865.6; ENSG00000033170.17. [Q9BYC5-2];""ENST00000360689.9; ENSP00000353910.5; ENSG00000033170.17. [Q9BYC5-1]"";""ENST00000394586.6; ENSP00000378087.2; ENSG00000033170.17. [Q9BYC5-1]"";""ENST00000557164.5; ENSP00000452433.1; ENSG00000033170.17. [Q9BYC5-3]"";""ENST00000673929.1; ENSP00000501213.1; ENSG00000033170.17. [Q9BYC5-1]"";",alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124],fibroblast migration [GO:0010761]; GDP-L-fucose metabolic process [GO:0046368]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; N-glycan processing [GO:0006491]; oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; receptor metabolic process [GO:0043112]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
P51116,N1,-0.626142526,-0.225718978,-0.261883812,-0.082325222,1.215368476,grey90,FXR2,FXR2_HUMAN,RNA-binding protein FXR2 (FXR2P) (FMR1 autosomal homolog 2),FXR2 FMR1L2,9513;,ENST00000250113.12; ENSP00000250113.7; ENSG00000129245.13.;,identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182],"animal organ development [GO:0048513]; dentate gyrus development [GO:0021542]; mRNA destabilization [GO:0061157]; mRNA transport [GO:0051028]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]
Q96QD9,N3,-1.292329832,-1.478603194,1.016269342,-0.012694193,0.707356341,grey50,FYTTD1,UIF_HUMAN,UAP56-interacting factor (Forty-two-three domain-containing protein 1) (Protein 40-2-3),FYTTD1 UIF,84248;,"ENST00000241502.9; ENSP00000241502.3; ENSG00000122068.13. [Q96QD9-1];""ENST00000415708.6; ENSP00000393746.2; ENSG00000122068.13. [Q96QD9-2]"";""ENST00000418169.5; ENSP00000400191.1; ENSG00000122068.13. [Q96QD9-4]"";""ENST00000424384.2; ENSP00000394631.2; ENSG00000122068.13. [Q96QD9-3]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],mRNA export from nucleus [GO:0006406],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]
Q14332,S3,-0.725049415,-1.228948199,0.273198135,0.740312254,0.443368153,salmon,FZD2,FZD2_HUMAN,Frizzled-2 (Fz-2) (hFz2) (FzE2),FZD2,2535;,ENST00000315323.5; ENSP00000323901.3; ENSG00000180340.7.;,G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],"canonical Wnt signaling pathway [GO:0060070]; cell-cell signaling [GO:0007267]; cochlea morphogenesis [GO:0090103]; endothelial cell differentiation [GO:0045446]; hard palate development [GO:0060022]; inner ear receptor cell development [GO:0060119]; membranous septum morphogenesis [GO:0003149]; muscular septum morphogenesis [GO:0003150]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; sensory perception of smell [GO:0007608]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]
O60353,S4,-1.050026613,-1.239798969,0.361189587,0.929130278,0.462344355,tomato2,FZD6,FZD6_HUMAN,Frizzled-6 (Fz-6) (hFz6),FZD6,8323;,"ENST00000358755.5; ENSP00000351605.4; ENSG00000164930.12. [O60353-1];""ENST00000522566.5; ENSP00000429055.1; ENSG00000164930.12. [O60353-1]"";""ENST00000523739.5; ENSP00000429528.1; ENSG00000164930.12. [O60353-2]"";",G protein-coupled receptor activity [GO:0004930]; ubiquitin protein ligase binding [GO:0031625]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],"canonical Wnt signaling pathway [GO:0060070]; cell proliferation in midbrain [GO:0033278]; embryonic nail plate morphogenesis [GO:0035880]; establishment of body hair planar orientation [GO:0048105]; hair follicle development [GO:0001942]; inner ear morphogenesis [GO:0042472]; midbrain morphogenesis [GO:1904693]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; neural tube closure [GO:0001843]; non-canonical Wnt signaling pathway [GO:0035567]; platelet activation [GO:0030168]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]
O75084,S4,-1.034685982,-1.001394618,0.363933286,0.815912362,0.493335484,tomato2,FZD7,FZD7_HUMAN,Frizzled-7 (Fz-7) (hFz7) (FzE3),FZD7,8324;,ENST00000286201.3; ENSP00000286201.1; ENSG00000155760.3.;,"frizzled binding [GO:0005109]; G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]","canonical Wnt signaling pathway [GO:0060070]; cellular response to retinoic acid [GO:0071300]; mesenchymal to epithelial transition [GO:0060231]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of ectodermal cell fate specification [GO:0042666]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphorylation [GO:0042327]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA-templated transcription [GO:0006355]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; stem cell population maintenance [GO:0019827]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation in thymus [GO:0033077]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]
P11413,C4,1.95815083,0.161318145,-0.928445422,-0.765956241,-1.105459267,deepskyblue2,G6PD,G6PD_HUMAN,Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49),G6PD,2539;,"ENST00000369620.6; ENSP00000358633.2; ENSG00000160211.20. [P11413-2];""ENST00000393562.10; ENSP00000377192.3; ENSG00000160211.20. [P11413-1]"";""ENST00000393564.7; ENSP00000377194.2; ENSG00000160211.20. [P11413-1]"";""ENST00000696429.1; ENSP00000512624.1; ENSG00000160211.20. [P11413-1]"";""ENST00000696430.1; ENSP00000512625.1; ENSG00000160211.20. [P11413-1]"";",glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; identical protein binding [GO:0042802]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803],"cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]",centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
O95166,C1,1.584922292,0.165883625,-0.82114698,-0.15461694,-0.418354622,lightblue,GABARAP,GBRAP_HUMAN,Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein) (MM46),GABARAP FLC3B HT004,11337;,ENST00000302386.10; ENSP00000306866.5; ENSG00000170296.10.;,beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625],autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; chemical synaptic transmission [GO:0007268]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein targeting [GO:0006605]; protein transport [GO:0015031]; regulation of Rac protein signal transduction [GO:0035020],actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; synapse [GO:0045202]
Q9H0R8,C3,1.631823804,0.123397378,-0.584432792,-0.265596159,-0.266029404,cyan,GABARAPL1,GBRL1_HUMAN,Gamma-aminobutyric acid receptor-associated protein-like 1 (Early estrogen-regulated protein) (GABA(A) receptor-associated protein-like 1) (Glandular epithelial cell protein 1) (GEC-1),GABARAPL1 GEC1,23710;,"ENST00000266458.10; ENSP00000266458.5; ENSG00000139112.11. [Q9H0R8-1];""ENST00000421801.6; ENSP00000411256.2; ENSG00000139112.11. [Q9H0R8-2]"";""ENST00000543602.5; ENSP00000445857.1; ENSG00000139112.11. [Q9H0R8-2]"";""ENST00000545887.1; ENSP00000444186.1; ENSG00000139112.11. [Q9H0R8-1]"";",beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; phosphatidylethanolamine binding [GO:0008429]; phospholipid binding [GO:0005543]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625],autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; glycophagy [GO:0061723],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]
Q06546,N4,-0.213332848,1.304400952,-0.221246854,-0.508049336,-0.931474958,grey30,GABPA,GABPA_HUMAN,GA-binding protein alpha chain (GABP subunit alpha) (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60),GABPA E4TF1A,2551;,"ENST00000354828.7; ENSP00000346886.3; ENSG00000154727.11.;""ENST00000400075.4; ENSP00000382948.3; ENSG00000154727.11."";","chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",blastocyst formation [GO:0001825]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8TAE8,S3,-1.195797751,-0.947263468,0.234247173,1.023999439,0.447690863,salmon,GADD45GIP1,G45IP_HUMAN,"Large ribosomal subunit protein mL64 (39S ribosomal protein L59, mitochondrial) (MRP-L59) (CKII beta-associating protein) (CR6-interacting factor 1) (CRIF1) (Growth arrest and DNA damage-inducible proteins-interacting protein 1) (Papillomavirus L2-interacting nuclear protein 1) (PLINP) (PLINP-1) (p53-responsive gene 6 protein)",GADD45GIP1 MRPL59 PLINP1 PRG6,90480;,ENST00000316939.3; ENSP00000323065.1; ENSG00000179271.3.;,0,mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q14376,C5,2.012616536,0.399463166,-0.907169999,-1.037146427,-1.246107372,turquoise3,GALE,GALE_HUMAN,UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase),GALE,2582;,"ENST00000374497.7; ENSP00000363621.3; ENSG00000117308.15. [Q14376-1];""ENST00000617979.5; ENSP00000483375.1; ENSG00000117308.15. [Q14376-1]"";",identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974],galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499],cytosol [GO:0005829]
P51570,C5,1.67057781,0.386756662,-0.632114629,-0.815403275,-1.013811224,turquoise3,GALK1,GALK1_HUMAN,Galactokinase (EC 2.7.1.6) (Galactose kinase),GALK1 GALK,2584;,"ENST00000225614.6; ENSP00000225614.1; ENSG00000108479.13.;""ENST00000588479.6; ENSP00000465930.1; ENSG00000108479.13."";",ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534],galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]
Q01415,C5,1.868044603,0.377710806,-0.673772456,-0.729120504,-0.96833733,turquoise3,GALK2,GALK2_HUMAN,N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2),GALK2 GK2,2585;,"ENST00000327171.7; ENSP00000316632.3; ENSG00000156958.15. [Q01415-2];""ENST00000560031.6; ENSP00000453129.1; ENSG00000156958.15. [Q01415-1]"";",ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858],carbohydrate metabolic process [GO:0005975]; galactose metabolic process [GO:0006012],cytosol [GO:0005829]
Q10472,S1,-1.240676428,-1.460649104,-0.178357315,1.004086128,0.792277148,gold,GALNT1,GALT1_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form],GALNT1,2589;,"ENST00000269195.6; ENSP00000269195.4; ENSG00000141429.14. [Q10472-1];""ENST00000591081.1; ENSP00000466411.1; ENSG00000141429.14. [Q10472-2]"";""ENST00000591924.5; ENSP00000465699.1; ENSG00000141429.14. [Q10472-2]"";",carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243]; viral protein processing [GO:0019082],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]
Q86SR1,S1,-1.017682303,-1.226584911,-0.1745806,0.8865088,0.876097206,gold,GALNT10,GLT10_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10),GALNT10,55568;,"ENST00000297107.11; ENSP00000297107.6; ENSG00000164574.16. [Q86SR1-1];""ENST00000377661.2; ENSP00000366889.2; ENSG00000164574.16. [Q86SR1-2]"";""ENST00000425427.6; ENSP00000415210.2; ENSG00000164574.16. [Q86SR1-3]"";",carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q8NCW6,S1,-0.827969927,-1.44498444,-0.149045995,0.897978231,0.901962651,gold,GALNT11,GLT11_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),GALNT11,63917;,"ENST00000415421.5; ENSP00000410093.1; ENSG00000178234.13. [Q8NCW6-2];""ENST00000422997.6; ENSP00000389449.3; ENSG00000178234.13. [Q8NCW6-2]"";""ENST00000430044.7; ENSP00000395122.2; ENSG00000178234.13. [Q8NCW6-1]"";""ENST00000434507.5; ENSP00000416787.1; ENSG00000178234.13. [Q8NCW6-1]"";",carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q10471,S1,-1.250936806,-1.384786365,-0.265475411,0.980465884,0.966516026,gold,GALNT2,GALT2_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],GALNT2,2590;,ENST00000366672.5; ENSP00000355632.4; ENSG00000143641.10. [Q10471-1];,carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],O-glycan processing [GO:0016266]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]
Q86SF2,S1,-1.228642395,-1.409995761,-0.151005523,0.95663826,0.877646825,gold,GALNT7,GALT7_HUMAN,N-acetylgalactosaminyltransferase 7 (EC 2.4.1.41) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7),GALNT7,51809;,ENST00000265000.9; ENSP00000265000.4; ENSG00000109586.12.;,carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],carbohydrate metabolic process [GO:0005975]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
P04406,C5,2.105046804,0.255920366,-1.083651875,-1.177753936,-1.362262844,turquoise3,GAPDH,G3P_HUMAN,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),GAPDH GAPD CDABP0047 OK/SW-cl.12,2597;,"ENST00000229239.10; ENSP00000229239.5; ENSG00000111640.15. [P04406-1];""ENST00000396858.5; ENSP00000380067.1; ENSG00000111640.15. [P04406-2]"";""ENST00000396859.5; ENSP00000380068.1; ENSG00000111640.15. [P04406-1]"";""ENST00000396861.5; ENSP00000380070.1; ENSG00000111640.15. [P04406-1]"";""ENST00000619601.1; ENSP00000478864.1; ENSG00000111640.15. [P04406-2]"";",aspartic-type endopeptidase inhibitor activity [GO:0019828]; disordered domain specific binding [GO:0097718]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605],antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to type II interferon [GO:0071346]; defense response to fungus [GO:0050832]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of translation [GO:0017148]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production [GO:0001819]; positive regulation of type I interferon production [GO:0032481]; protein stabilization [GO:0050821]; regulation of macroautophagy [GO:0016241],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GAIT complex [GO:0097452]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982]
Q9NY12,N3,-1.157377654,-1.41571903,1.289359995,-0.167643737,0.240882293,grey50,GAR1,GAR1_HUMAN,H/ACA ribonucleoprotein complex subunit 1 (Nucleolar protein family A member 1) (snoRNP protein GAR1),GAR1 NOLA1,54433;,"ENST00000226796.7; ENSP00000226796.6; ENSG00000109534.17. [Q9NY12-1];""ENST00000394631.7; ENSP00000378127.3; ENSG00000109534.17. [Q9NY12-1]"";",box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004],"box H/ACA scaRNP complex [GO:0072589]; box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; chromosome, telomeric region [GO:0000781]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697]"
P41250,C4,1.758862392,0.215102461,-0.714239926,-0.487818585,-1.040739402,deepskyblue2,GARS,GARS_HUMAN,Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1),GARS1 GARS,2617;,ENST00000389266.8; ENSP00000373918.3; ENSG00000106105.15. [P41250-1];,ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transferase activity [GO:0016740],diadenosine tetraphosphate biosynthetic process [GO:0015966]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141]
P22102,C4,2.139586062,0.001669705,-0.992738533,-0.96620161,-1.247601684,deepskyblue2,GART,PUR2_HUMAN,Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)],GART PGFT PRGS,2618;,"ENST00000361093.9; ENSP00000354388.5; ENSG00000159131.17. [P22102-2];""ENST00000381815.9; ENSP00000371236.4; ENSG00000159131.17. [P22102-1]"";""ENST00000381831.7; ENSP00000371253.3; ENSG00000159131.17. [P22102-1]"";""ENST00000381839.7; ENSP00000371261.3; ENSG00000159131.17. [P22102-1]"";""ENST00000571089.2; ENSP00000459532.2; ENSG00000262473.5."";""ENST00000573055.5; ENSP00000459391.2; ENSG00000262473.5."";""ENST00000575273.5; ENSP00000461700.2; ENSG00000262473.5."";",ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644],'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; tetrahydrofolate biosynthetic process [GO:0046654],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q8WUU5,N1,-1.022463383,-0.120238465,0.546230012,-0.264160698,0.773049043,grey90,GATAD1,GATD1_HUMAN,GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein),GATAD1 ODAG,57798;,ENST00000287957.5; ENSP00000287957.3; ENSG00000157259.8.;,sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P04062,S1,-0.754767326,-0.568382032,-0.340240879,0.751778439,0.846222495,gold,GBA,GBA1_HUMAN,Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Beta-glucosylceramidase 1) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Glucosylceramidase beta 1) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),GBA1 GBA GC GLUC,2629;,"ENST00000327247.9; ENSP00000314508.5; ENSG00000177628.16. [P04062-1];""ENST00000368373.8; ENSP00000357357.3; ENSG00000177628.16. [P04062-1]"";""ENST00000427500.7; ENSP00000402577.2; ENSG00000177628.16. [P04062-5]"";""ENST00000428024.3; ENSP00000397986.2; ENSG00000177628.16. [P04062-4]"";",galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295],antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein-containing complex disassembly [GO:0043243]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of lysosomal protein catabolic process [GO:1905165]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802]
Q9HCG7,S3,-0.788148459,-0.810385569,0.180247831,0.686003539,0.597141638,salmon,GBA2,GBA2_HUMAN,Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase),GBA2 KIAA1605 SPG46 AD035,57704;,"ENST00000378094.4; ENSP00000367334.4; ENSG00000070610.14. [Q9HCG7-2];""ENST00000378103.7; ENSP00000367343.3; ENSG00000070610.14. [Q9HCG7-1]"";",beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295],bile acid metabolic process [GO:0008206]; carbohydrate metabolic process [GO:0005975]; central nervous system development [GO:0007417]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]
Q04446,C5,1.589575234,0.664069173,-0.645634564,-0.825047949,-0.833359031,turquoise3,GBE1,GLGB_HUMAN,"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)",GBE1,2632;,ENST00000429644.7; ENSP00000410833.2; ENSG00000114480.13.;,"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]",generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; negative regulation of neuron apoptotic process [GO:0043524],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P32456,C4,1.924795347,0.461163249,-0.86133198,-0.95363022,-1.290740075,deepskyblue2,GBP2,GBP2_HUMAN,Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2),GBP2,2634;,"ENST00000370466.4; ENSP00000359497.3; ENSG00000162645.13.;""ENST00000464839.5; ENSP00000434282.1; ENSG00000162645.13."";",endopeptidase inhibitor activity [GO:0004866]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; protein homodimerization activity [GO:0042803],activation of innate immune response [GO:0002218]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; immune response [GO:0006955]; positive regulation of AIM2 inflammasome complex assembly [GO:0140973]; positive regulation of pyroptosis [GO:0140639]; protein localization to nucleus [GO:0034504],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
P48507,C4,2.060897621,0.173080439,-0.849089899,-0.700871343,-1.052461346,deepskyblue2,GCLM,GSH0_HUMAN,Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit),GCLM GLCLR,2730;,"ENST00000370238.8; ENSP00000359258.3; ENSG00000023909.10. [P48507-1];""ENST00000615724.1; ENSP00000484507.1; ENSG00000023909.10. [P48507-2]"";",enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877],apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]
Q02742,S1,-0.813333475,-1.199345567,-0.155306897,0.782591011,0.983962168,gold,GCNT1,GCNT1_HUMAN,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2 beta-1,6-N-acetylglucosaminyltransferase) (C2GlcNAcT) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT) (Core 2 GNT) (Leukocyte type core 2 beta-1,6-N-acetylglucosaminyltransferase) (C2GnT-L)",GCNT1 NACGT2,2650;,"ENST00000376730.5; ENSP00000365920.4; ENSG00000187210.14.;""ENST00000442371.5; ENSP00000415454.1; ENSG00000187210.14."";""ENST00000444201.6; ENSP00000390703.2; ENSG00000187210.14."";","beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity [GO:0003829]","cell adhesion molecule production [GO:0060352]; glycoprotein biosynthetic process [GO:0009101]; kidney morphogenesis [GO:0060993]; leukocyte tethering or rolling [GO:0050901]; O-glycan processing [GO:0016266]; O-glycan processing, core 2 [GO:0016268]; positive regulation of leukocyte tethering or rolling [GO:1903238]; response to insulin [GO:0032868]; tissue morphogenesis [GO:0048729]",extracellular space [GO:0005615]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]
P23434,M1,-1.87029992,0.486987022,0.23169997,0.872117007,-1.503692434,burlywood4,GCSH,GCSH_HUMAN,"Glycine cleavage system H protein, mitochondrial (Lipoic acid-containing protein)",GCSH,2653;,"ENST00000315467.9; ENSP00000319531.3; ENSG00000140905.11.;""ENST00000709349.1; ENSP00000517634.1; ENSG00000291958.1."";",aminomethyltransferase activity [GO:0004047],glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249],cytoplasm [GO:0005737]; glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q8TB36,M2,-1.503807324,-1.443270758,0.373605464,1.231956755,-0.225229797,tan4,GDAP1,GDAP1_HUMAN,Ganglioside-induced differentiation-associated protein 1 (GDAP1),GDAP1,54332;,"ENST00000220822.12; ENSP00000220822.7; ENSG00000104381.14. [Q8TB36-1];""ENST00000674865.1; ENSP00000502437.1; ENSG00000104381.14. [Q8TB36-2]"";""ENST00000675944.1; ENSP00000502673.1; ENSG00000104381.14. [Q8TB36-2]"";",0,cellular response to vitamin D [GO:0071305]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]
Q9NZC3,S2,-1.255097862,-1.268501814,0.393436048,0.769410588,0.675651028,orange,GDE1,GDE1_HUMAN,Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16) (RGS16-interacting membrane protein),GDE1 MIR16,51573;,ENST00000353258.8; ENSP00000261386.3; ENSG00000006007.12.;,glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872],ethanolamine metabolic process [GO:0006580]; glycerophospholipid catabolic process [GO:0046475]; lipid metabolic process [GO:0006629]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644],cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P50395,C4,2.151546711,0.112028703,-1.187994385,-1.059922211,-1.198584171,deepskyblue2,GDI2,GDIB_HUMAN,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),GDI2 RABGDIB,2665;,"ENST00000380181.7; ENSP00000369528.3; ENSG00000057608.17. [P50395-2];""ENST00000380191.9; ENSP00000369538.4; ENSG00000057608.17. [P50395-1]"";",GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]
Q8N9F7,S2,-0.823358782,-1.39969771,0.25368659,0.812164154,0.53186312,orange,GDPD1,GDPD1_HUMAN,Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1),GDPD1 GDE4,284161;,"ENST00000284116.9; ENSP00000284116.4; ENSG00000153982.11. [Q8N9F7-1];""ENST00000581140.5; ENSP00000463273.1; ENSG00000153982.11. [Q8N9F7-3]"";""ENST00000581276.5; ENSP00000464690.1; ENSG00000153982.11. [Q8N9F7-2]"";",lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081],glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]
Q7L5L3,S2,-1.190304565,-1.602223647,0.23365791,0.915778532,0.456468421,orange,GDPD3,GDPD3_HUMAN,Lysophospholipase D GDPD3 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 7) (Glycerophosphodiester phosphodiesterase domain-containing protein 3),GDPD3 GDE7,79153;,ENST00000406256.8; ENSP00000384363.3; ENSG00000102886.15. [Q7L5L3-2];,lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081],glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291]; phosphatidylcholine catabolic process [GO:0034638],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]
Q8TEQ6,C1,0.38151065,0.323082934,-0.406373199,-0.22330035,0.710214045,lightblue,GEMIN5,GEMI5_HUMAN,Gem-associated protein 5 (Gemin5),GEMIN5,25929;,ENST00000285873.8; ENSP00000285873.6; ENSG00000082516.9.;,mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622],"mRNA splicing, via spliceosome [GO:0000398]; protein-containing complex assembly [GO:0065003]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]
Q9UJY5,C2,1.087619143,0.40853151,-0.376665056,-0.061895137,-0.230094271,aquamarine,GGA1,GGA1_HUMAN,"ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1)",GGA1,26088;,"ENST00000325180.12; ENSP00000321288.8; ENSG00000100083.19. [Q9UJY5-4];""ENST00000343632.9; ENSP00000341344.4; ENSG00000100083.19. [Q9UJY5-1]"";""ENST00000381756.9; ENSP00000371175.5; ENSG00000100083.19. [Q9UJY5-6]"";""ENST00000406772.5; ENSP00000385287.1; ENSG00000100083.19. [Q9UJY5-3]"";",phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130],"Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]
Q9NZ52,C2,0.9996658,0.314117444,-0.265659674,0.008321286,-0.172663051,aquamarine,GGA3,GGA3_HUMAN,"ADP-ribosylation factor-binding protein GGA3 (Golgi-localized, gamma ear-containing, ARF-binding protein 3)",GGA3 KIAA0154,23163;,"ENST00000537686.6; ENSP00000438085.3; ENSG00000125447.18. [Q9NZ52-1];""ENST00000538886.5; ENSP00000446421.2; ENSG00000125447.18. [Q9NZ52-2]"";""ENST00000578348.5; ENSP00000463288.1; ENSG00000125447.18. [Q9NZ52-3]"";""ENST00000582717.5; ENSP00000462081.1; ENSG00000125447.18. [Q9NZ52-4]"";""ENST00000649398.1; ENSP00000496890.1; ENSG00000125447.18. [Q9NZ52-1]"";",phosphatidylinositol binding [GO:0035091]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130],Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of lysosomal protein catabolic process [GO:1905167]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein targeting to lysosome [GO:0006622]; regulation of protein stability [GO:0031647],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; protein-containing complex [GO:0032991]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]
O75223,C4,2.19639536,0.265510264,-1.313424866,-1.423949198,-1.555508008,deepskyblue2,GGCT,GGCT_HUMAN,Gamma-glutamylcyclotransferase (EC 4.3.2.9) (Cytochrome c-releasing factor 21),GGCT C7orf24 CRF21,79017;,"ENST00000005374.10; ENSP00000005374.6; ENSG00000006625.18. [O75223-2];""ENST00000275428.9; ENSP00000275428.4; ENSG00000006625.18. [O75223-1]"";""ENST00000409144.5; ENSP00000386610.1; ENSG00000006625.18. [O75223-3]"";""ENST00000409390.5; ENSP00000387235.1; ENSG00000006625.18. [O75223-4]"";",gamma-glutamylcyclotransferase activity [GO:0003839]; protein homodimerization activity [GO:0042803],release of cytochrome c from mitochondria [GO:0001836],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P38435,S2,-1.074749073,-1.147734048,0.313754107,0.786654109,0.525496679,orange,GGCX,VKGC_HUMAN,Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase),GGCX GC,2677;,"ENST00000233838.9; ENSP00000233838.3; ENSG00000115486.13. [P38435-1];""ENST00000430215.7; ENSP00000408045.3; ENSG00000115486.13. [P38435-2]"";",gamma-glutamyl carboxylase activity [GO:0008488]; vitamin binding [GO:0019842],blood coagulation [GO:0007596]; protein modification process [GO:0036211]; vitamin K metabolic process [GO:0042373],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9H3K2,M2,-0.777301362,-1.32697326,0.366750546,1.083085475,-0.025178456,tan4,GHITM,GHITM_HUMAN,Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5),GHITM DERP2 MICS1 TMBIM5 My021 UNQ244/PRO281,27069;,"ENST00000372134.6; ENSP00000361207.3; ENSG00000165678.22.;""ENST00000686247.1; ENSP00000509112.1; ENSG00000165678.22."";""ENST00000686583.1; ENSP00000510236.1; ENSG00000165678.22."";""ENST00000687085.1; ENSP00000510576.1; ENSG00000165678.22."";""ENST00000688802.1; ENSP00000509674.1; ENSG00000165678.22."";""ENST00000690067.1; ENSP00000508495.1; ENSG00000165678.22."";""ENST00000690283.1; ENSP00000508559.1; ENSG00000165678.22."";""ENST00000690920.1; ENSP00000509697.1; ENSG00000165678.22."";""ENST00000691155.1; ENSP00000510216.1; ENSG00000165678.22."";""ENST00000691609.1; ENSP00000509708.1; ENSG00000165678.22."";",calcium:proton antiporter activity [GO:0015369],apoptotic process [GO:0006915]; calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial potassium ion transmembrane transport [GO:0140141]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448],extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9NU53,S1,-1.688873878,-1.745193411,-0.066947903,1.022770462,0.84889111,gold,GINM1,GINM1_HUMAN,Glycoprotein integral membrane protein 1,GINM1 C6orf72 UNQ710/PRO1361,116254;,ENST00000367419.10; ENSP00000356389.5; ENSG00000055211.14.;,0,0,membrane [GO:0016020]
O14908,C1,1.196246872,0.314740018,-0.209169516,-0.092099306,-0.397025819,lightblue,GIPC1,GIPC1_HUMAN,PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2) (TIP-2),GIPC1 C19orf3 GIPC RGS19IP1,10755;,"ENST00000345425.6; ENSP00000340698.1; ENSG00000123159.16. [O14908-1];""ENST00000393028.5; ENSP00000376748.1; ENSG00000123159.16. [O14908-2]"";""ENST00000393033.9; ENSP00000376753.3; ENSG00000123159.16. [O14908-1]"";""ENST00000586027.5; ENSP00000466747.1; ENSG00000123159.16. [O14908-1]"";""ENST00000591349.5; ENSP00000467077.1; ENSG00000123159.16. [O14908-2]"";",actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; signaling receptor binding [GO:0005102],cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]
Q9UHE5,N4,-1.366339466,0.590766108,-0.482137324,0.604837096,0.014606137,grey30,GLA,NAT8_HUMAN,N-acetyltransferase 8 (EC 2.3.1.-) (Acetyltransferase 2) (ATase2) (Camello-like protein 1) (Cysteinyl-conjugate N-acetyltransferase) (CCNAT) (EC 2.3.1.80),NAT8 CML1 GLA TSC501,9027;,"ENST00000272425.4; ENSP00000272425.3; ENSG00000144035.4.;""ENST00000707634.1; ENSP00000516938.1; ENSG00000291479.1."";","cysteine-S-conjugate N-acetyltransferase activity [GO:0047198]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; N-acetyltransferase activity [GO:0008080]",amyloid fibril formation [GO:1990000]; glutathione metabolic process [GO:0006749]; peptidyl-lysine N6-acetylation [GO:0018003]; positive regulation of gene expression [GO:0010628],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; membrane [GO:0016020]
O94923,S1,-1.378660978,-1.704277138,-0.227765587,0.916598748,1.044350881,gold,GLCE,GLCE_HUMAN,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),GLCE KIAA0836,26035;,ENST00000261858.7; ENSP00000261858.2; ENSG00000138604.10.;,"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]",heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]; negative regulation of cell projection organization [GO:0031345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of SMAD protein signal transduction [GO:0060391],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q53GS7,N2,-1.149338763,-1.334636717,1.107537588,0.36415079,0.034290251,grey70,GLE1,GLE1_HUMAN,mRNA export factor GLE1 (hGLE1) (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1),GLE1 GLE1L,2733;,"ENST00000309971.9; ENSP00000308622.5; ENSG00000119392.16. [Q53GS7-1];""ENST00000372770.4; ENSP00000361856.4; ENSG00000119392.16. [Q53GS7-2]"";",identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369],mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleolus [GO:0005730]
Q92896,S1,-0.961743359,-1.258619064,-0.189454168,0.777676902,0.839324604,gold,GLG1,GSLG1_HUMAN,Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160),GLG1 CFR1 ESL1 MG160,2734;,"ENST00000205061.9; ENSP00000205061.5; ENSG00000090863.12. [Q92896-2];""ENST00000422840.7; ENSP00000405984.3; ENSG00000090863.12. [Q92896-1]"";""ENST00000447066.6; ENSP00000406946.2; ENSG00000090863.12. [Q92896-3]"";",fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102],bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein processing [GO:0016485]; regulation of chondrocyte differentiation [GO:0032330]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]
Q9H4G4,S2,-1.302610221,-1.488850283,0.194076679,0.934824495,0.540365782,orange,GLIPR2,GAPR1_HUMAN,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),GLIPR2 C9orf19 GAPR1,152007;,ENST00000377960.9; ENSP00000367196.4; ENSG00000122694.16.;,protein homodimerization activity [GO:0042803],positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]
Q9HC38,C4,2.009111567,0.247123614,-1.002730588,-1.043901152,-1.328774111,deepskyblue2,GLOD4,GLOD4_HUMAN,Glyoxalase domain-containing protein 4,GLOD4 C17orf25 CGI-150 My027,51031;,"ENST00000301328.9; ENSP00000301328.5; ENSG00000167699.14. [Q9HC38-1];""ENST00000301329.11; ENSP00000301329.6; ENSG00000167699.14. [Q9HC38-2]"";",cadherin binding [GO:0045296],0,extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]
P35754,C3,1.727845975,0.136107079,-0.703259484,-0.789214814,-1.120078479,cyan,GLRX,GLRX1_HUMAN,Glutaredoxin-1 (Thioltransferase-1) (TTase-1),GLRX GRX,2745;,"ENST00000237858.11; ENSP00000237858.6; ENSG00000173221.14.;""ENST00000379979.8; ENSP00000369314.4; ENSG00000173221.14."";""ENST00000505427.1; ENSP00000427353.1; ENSG00000173221.14."";""ENST00000508780.5; ENSP00000422708.1; ENSG00000173221.14."";""ENST00000512469.2; ENSP00000424636.2; ENSG00000173221.14."";",glutathione disulfide oxidoreductase activity [GO:0015038]; sodium channel regulator activity [GO:0017080],nucleobase-containing small molecule interconversion [GO:0015949]; positive regulation of membrane potential [GO:0045838],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
O76003,C5,1.910424668,0.326948166,-0.743691042,-0.822321042,-1.146181176,turquoise3,GLRX3,GLRX3_HUMAN,Glutaredoxin-3 (PKC-interacting cousin of thioredoxin) (PICOT) (PKC-theta-interacting protein) (PKCq-interacting protein) (Thioredoxin-like protein 2),GLRX3 PICOT TXNL2 HUSSY-22,10539;,"ENST00000331244.10; ENSP00000330836.5; ENSG00000108010.12.;""ENST00000368644.5; ENSP00000357633.1; ENSG00000108010.12."";""ENST00000481034.1; ENSP00000435445.1; ENSG00000108010.12."";",identical protein binding [GO:0042802]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723],[2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; intracellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; protein maturation by iron-sulfur cluster transfer [GO:0097428]; regulation of the force of heart contraction [GO:0002026],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; iron-sulfur cluster assembly complex [GO:1990229]; nucleus [GO:0005634]; Z disc [GO:0030018]
O94925,M1,-0.963828128,0.018424601,0.411269508,0.818319165,-0.688668176,burlywood4,GLS,GLSK_HUMAN,"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]",GLS GLS1 KIAA0838,2744;,"ENST00000320717.8; ENSP00000317379.3; ENSG00000115419.14. [O94925-1];""ENST00000338435.9; ENSP00000340689.4; ENSG00000115419.14. [O94925-3]"";",glutaminase activity [GO:0004359],chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; intracellular glutamate homeostasis [GO:0090461]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]
Q68CQ7,S1,-1.358330468,-1.495787888,-0.286922451,0.879431716,1.025780571,gold,GLT8D1,GL8D1_HUMAN,Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-),GLT8D1 GALA4A AD-017 MSTP137 UNQ572/PRO1134,55830;,"ENST00000266014.11; ENSP00000266014.5; ENSG00000016864.19. [Q68CQ7-1];""ENST00000394783.7; ENSP00000378263.3; ENSG00000016864.19. [Q68CQ7-1]"";""ENST00000478968.6; ENSP00000419612.2; ENSG00000016864.19. [Q68CQ7-1]"";""ENST00000491606.5; ENSP00000418853.1; ENSG00000016864.19. [Q68CQ7-1]"";",UDP-glycosyltransferase activity [GO:0008194],0,Golgi apparatus [GO:0005794]; membrane [GO:0016020]
Q9NZM5,N3,-1.089911615,-1.135306693,0.986265672,-0.132299082,0.75958948,grey50,GLTSCR2,NOP53_HUMAN,Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (Protein interacting with carboxyl terminus 1) (PICT-1) (p60),NOP53 GLT GLTSCR2 PICT1,29997;,ENST00000246802.10; ENSP00000246802.4; ENSG00000105373.19.;,5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723],cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P15104,C5,1.727634957,0.413905712,-0.965373081,-0.909822495,-0.621978357,turquoise3,GLUL,GLNA_HUMAN,Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Palmitoyltransferase GLUL) (EC 2.3.1.225),GLUL GLNS,2752;,"ENST00000311223.9; ENSP00000307900.5; ENSG00000135821.19.;""ENST00000331872.11; ENSP00000356537.6; ENSG00000135821.19."";""ENST00000339526.8; ENSP00000344958.4; ENSG00000135821.19."";""ENST00000417584.6; ENSP00000398320.2; ENSG00000135821.19."";",ATP binding [GO:0005524]; glutamine synthetase activity [GO:0004356]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],angiogenesis [GO:0001525]; cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization to nucleolus [GO:1904749]; regulation of sprouting angiogenesis [GO:1903670]; response to glucose [GO:0009749]; ribosome biogenesis [GO:0042254],cell body [GO:0044297]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glial cell projection [GO:0097386]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q96IK5,N3,-0.556094816,-1.114482715,1.13564259,0.270508887,-0.421189611,grey50,GMCL1,GMCL1_HUMAN,Germ cell-less protein-like 1 (Spermatogenesis-associated protein 29),GMCL1 BTBD13 GCL SPATA29,64395;,ENST00000282570.4; ENSP00000282570.3; ENSG00000087338.5.;,identical protein binding [GO:0042802],germ cell development [GO:0007281]; spermatogenesis [GO:0007283],nuclear matrix [GO:0016363]; nucleus [GO:0005634]
P60983,C4,2.111966856,0.482932904,-1.119747997,-1.302464118,-1.585244667,deepskyblue2,GMFB,GMFB_HUMAN,Glia maturation factor beta (GMF-beta),GMFB,2764;,ENST00000358056.8; ENSP00000350757.3; ENSG00000197045.14.;,actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; protein kinase inhibitor activity [GO:0004860],actin filament debranching [GO:0071846]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; nervous system development [GO:0007399]; protein phosphorylation [GO:0006468],cortical actin cytoskeleton [GO:0030864]
Q9P107,C1,1.510008699,0.158651429,-0.401409016,-0.172504364,-0.685675411,lightblue,GMIP,GMIP_HUMAN,GEM-interacting protein (GMIP),GMIP,51291;,"ENST00000203556.9; ENSP00000203556.3; ENSG00000089639.11. [Q9P107-1];""ENST00000587238.5; ENSP00000467054.1; ENSG00000089639.11. [Q9P107-2]"";",GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872],intracellular signal transduction [GO:0035556]; negative regulation of GTPase activity [GO:0034260]; regulation of small GTPase mediated signal transduction [GO:0051056],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q96IJ6,C5,1.708806498,0.559585653,-0.776296185,-0.708702863,-1.232561193,turquoise3,GMPPA,GMPPA_HUMAN,Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha),GMPPA,29926;,"ENST00000313597.10; ENSP00000315925.6; ENSG00000144591.20. [Q96IJ6-1];""ENST00000341142.8; ENSP00000340760.3; ENSG00000144591.20. [Q96IJ6-1]"";""ENST00000358215.8; ENSP00000350949.3; ENSG00000144591.20. [Q96IJ6-1]"";""ENST00000373908.5; ENSP00000363016.1; ENSG00000144591.20. [Q96IJ6-1]"";""ENST00000373917.7; ENSP00000363027.3; ENSG00000144591.20. [Q96IJ6-2]"";""ENST00000622191.2; ENSP00000478700.2; ENSG00000144591.20. [Q96IJ6-1]"";""ENST00000683946.1; ENSP00000506941.1; ENSG00000144591.20. [Q96IJ6-1]"";",transferase activity [GO:0016740],biosynthetic process [GO:0009058],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]
Q9Y5P6,C5,1.568506534,0.286748218,-0.640229721,-0.726240008,-0.774130546,turquoise3,GMPPB,GMPPB_HUMAN,Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta),GMPPB,29925;,"ENST00000308375.10; ENSP00000309092.6; ENSG00000173540.14. [Q9Y5P6-2];""ENST00000308388.7; ENSP00000311130.6; ENSG00000173540.14. [Q9Y5P6-1]"";""ENST00000480687.5; ENSP00000418565.1; ENSG00000173540.14. [Q9Y5P6-1]"";",GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase (GTP) activity [GO:0004475],GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486],cytoplasm [GO:0005737]
Q9P2T1,C5,2.021361746,0.266717912,-0.960451312,-1.098586003,-1.022107032,turquoise3,GMPR2,GMPR2_HUMAN,GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2),GMPR2,51292;,"ENST00000355299.8; ENSP00000347449.4; ENSG00000100938.19. [Q9P2T1-1];""ENST00000399440.7; ENSP00000382369.2; ENSG00000100938.19. [Q9P2T1-1]"";""ENST00000420554.6; ENSP00000392859.2; ENSG00000100938.19. [Q9P2T1-2]"";""ENST00000456667.7; ENSP00000405743.3; ENSG00000100938.19. [Q9P2T1-3]"";""ENST00000559836.5; ENSP00000453299.1; ENSG00000100938.19. [Q9P2T1-1]"";""ENST00000642276.1; ENSP00000496504.1; ENSG00000284752.3. [Q9P2T1-1]"";""ENST00000643803.1; ENSP00000495708.1; ENSG00000284752.3. [Q9P2T1-3]"";""ENST00000644066.1; ENSP00000494224.1; ENSG00000284752.3. [Q9P2T1-1]"";""ENST00000645781.1; ENSP00000496234.1; ENSG00000284752.3. [Q9P2T1-2]"";""ENST00000647320.3; ENSP00000495583.1; ENSG00000284752.3. [Q9P2T1-1]"";",GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872],GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144],cytosol [GO:0005829]; GMP reductase complex [GO:1902560]
Q14344,S4,-1.065077959,-1.195007372,0.461547443,0.851402548,0.24996236,tomato2,GNA13,GNA13_HUMAN,Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13),GNA13,10672;,"ENST00000439174.7; ENSP00000400717.2; ENSG00000120063.10. [Q14344-1];""ENST00000541118.1; ENSP00000439647.1; ENSG00000120063.10. [Q14344-2]"";",D5 dopamine receptor binding [GO:0031752]; G protein activity [GO:0003925]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872],adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; platelet activation [GO:0030168]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P63096,S4,-0.825613929,-1.36882449,0.378454401,0.844242151,0.357799337,tomato2,GNAI1,GNAI1_HUMAN,Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein),GNAI1,2770;,"ENST00000351004.8; ENSP00000343027.3; ENSG00000127955.17. [P63096-1];""ENST00000442586.2; ENSP00000391439.2; ENSG00000127955.17. [P63096-1]"";""ENST00000457358.7; ENSP00000410572.2; ENSG00000127955.17. [P63096-2]"";""ENST00000648098.1; ENSP00000497717.1; ENSG00000127955.17. [P63096-1]"";""ENST00000648306.1; ENSP00000497773.1; ENSG00000127955.17. [P63096-1]"";""ENST00000648412.1; ENSP00000497051.1; ENSG00000127955.17. [P63096-1]"";""ENST00000648476.1; ENSP00000497179.1; ENSG00000127955.17. [P63096-1]"";""ENST00000648663.1; ENSP00000497379.1; ENSG00000127955.17. [P63096-1]"";""ENST00000648832.1; ENSP00000497765.1; ENSG00000127955.17. [P63096-1]"";""ENST00000648877.1; ENSP00000497760.1; ENSG00000127955.17. [P63096-1]"";""ENST00000648953.1; ENSP00000496800.1; ENSG00000127955.17. [P63096-1]"";""ENST00000649225.1; ENSP00000496829.1; ENSG00000127955.17. [P63096-1]"";""ENST00000649267.1; ENSP00000497315.1; ENSG00000127955.17. [P63096-1]"";""ENST00000649487.1; ENSP00000498091.1; ENSG00000127955.17. [P63096-1]"";""ENST00000649796.2; ENSP00000497260.1; ENSG00000127955.17. [P63096-1]"";""ENST00000649855.1; ENSP00000497754.1; ENSG00000127955.17. [P63096-1]"";",D2 dopamine receptor binding [GO:0031749]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287],adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell division [GO:0051301]; cellular response to forskolin [GO:1904322]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of protein localization to cell cortex [GO:1904778]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of mitotic spindle organization [GO:0060236]; response to peptide hormone [GO:0043434],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
P04899,S4,-0.458144695,-0.834158937,0.291967085,0.741041837,0.291125378,tomato2,GNAI2,GNAI2_HUMAN,Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein),GNAI2 GNAI2B,2771;,"ENST00000266027.9; ENSP00000266027.6; ENSG00000114353.17. [P04899-6];""ENST00000313601.11; ENSP00000312999.6; ENSG00000114353.17. [P04899-1]"";""ENST00000422163.5; ENSP00000406871.1; ENSG00000114353.17. [P04899-5]"";""ENST00000440628.5; ENSP00000395736.1; ENSG00000114353.17. [P04899-6]"";""ENST00000451956.1; ENSP00000406369.1; ENSG00000114353.17. [P04899-3]"";",G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140199]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of synaptic transmission [GO:0050805]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of calcium ion transport [GO:0051924]; response to nutrient [GO:0007584]; signal transduction [GO:0007165],cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; midbody [GO:0030496]; neuronal dense core vesicle [GO:0098992]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]
P08754,S4,-1.095188267,-1.308616096,0.355324113,0.855341699,0.435686346,tomato2,GNAI3,GNAI3_HUMAN,Guanine nucleotide-binding protein G(i) subunit alpha-3 (G(i) alpha-3),GNAI3,2773;,ENST00000369851.7; ENSP00000358867.4; ENSG00000065135.12.;,G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell division [GO:0051301]; dopamine receptor signaling pathway [GO:0007212]; GTP metabolic process [GO:0046039]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of macroautophagy [GO:0016239],centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
P50148,S4,-1.012721383,-1.169043773,0.369093101,0.928180087,0.46215815,tomato2,GNAQ,GNAQ_HUMAN,Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q),GNAQ GAQ,2776;,ENST00000286548.9; ENSP00000286548.4; ENSG00000156052.11.;,G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],"action potential [GO:0001508]; activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; blood coagulation [GO:0007596]; entrainment of circadian clock [GO:0009649]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; glutamate receptor signaling pathway [GO:0007215]; negative regulation of protein kinase activity [GO:0006469]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phototransduction, visible light [GO:0007603]; protein stabilization [GO:0050821]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of platelet activation [GO:0010543]",cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; nuclear membrane [GO:0031965]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; synapse [GO:0045202]
P84996,S4,-0.70128057,-0.771055417,0.331059161,0.759162987,0.350664095,tomato2,GNAS,ALEX_HUMAN,Protein ALEX (Alternative gene product encoded by XL-exon),GNAS GNAS1,2778;,0,0,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone development [GO:0060348]; cognition [GO:0050890]; developmental growth [GO:0048589]; hair follicle placode formation [GO:0060789]; platelet aggregation [GO:0070527]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of signal transduction [GO:0009966],cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]
P19086,S4,-0.740773967,-1.12215976,0.236874683,0.950381927,0.561125433,tomato2,GNAZ,GNAZ_HUMAN,Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha),GNAZ,2781;,ENST00000615612.2; ENSP00000478892.1; ENSG00000128266.9.;,adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor binding [GO:0001664]; G protein-coupled serotonin receptor binding [GO:0031821]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled serotonin receptor signaling pathway [GO:0098664]; negative regulation of insulin secretion [GO:0046676],cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; heterotrimeric G-protein complex [GO:0005834]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]
P62873,S4,-0.726076096,-1.131405321,0.423762289,0.777043269,0.457915368,tomato2,GNB1,GBB1_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1),GNB1,2782;,"ENST00000378609.9; ENSP00000367872.3; ENSG00000078369.19. [P62873-1];""ENST00000610897.4; ENSP00000481878.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703692.1; ENSP00000515427.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703693.1; ENSP00000515428.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703694.1; ENSP00000515429.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703696.1; ENSP00000515431.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703697.1; ENSP00000515432.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703699.1; ENSP00000515433.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703700.1; ENSP00000515434.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703701.1; ENSP00000515435.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703702.1; ENSP00000515436.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703703.1; ENSP00000515437.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703704.1; ENSP00000515438.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703706.1; ENSP00000515440.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703708.1; ENSP00000515442.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703709.1; ENSP00000515443.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703710.1; ENSP00000515444.1; ENSG00000078369.19. [P62873-1]"";""ENST00000703711.1; ENSP00000515445.1; ENSG00000078369.19. [P62873-1]"";",GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159],adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; cell population proliferation [GO:0008283]; cellular response to catecholamine stimulus [GO:0071870]; cellular response to prostaglandin E stimulus [GO:0071380]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; Ras protein signal transduction [GO:0007265]; retina development in camera-type eye [GO:0060041]; sensory perception of taste [GO:0050909]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; synapse [GO:0045202]
Q9BYB4,C3,1.801195624,0.123275264,-0.613720428,-0.689361374,-0.731731232,cyan,GNB1L,GNB1L_HUMAN,Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF),GNB1L GY2 KIAA1645 WDR14 FKSG1,54584;,"ENST00000329517.11; ENSP00000331313.6; ENSG00000185838.14. [Q9BYB4-1];""ENST00000403325.5; ENSP00000385154.1; ENSG00000185838.14. [Q9BYB4-1]"";""ENST00000405009.5; ENSP00000384626.1; ENSG00000185838.14. [Q9BYB4-2]"";",0,DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974],cytoplasm [GO:0005737]; nucleus [GO:0005634]
P62879,S4,-0.916716685,-1.170449209,0.391869679,0.853943148,0.40914814,tomato2,GNB2,GBB2_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2),GNB2,2783;,"ENST00000303210.9; ENSP00000305260.4; ENSG00000172354.10. [P62879-1];""ENST00000393924.1; ENSP00000377501.1; ENSG00000172354.10. [P62879-1]"";""ENST00000393926.5; ENSP00000377503.1; ENSG00000172354.10. [P62879-1]"";""ENST00000419828.5; ENSP00000390543.1; ENSG00000172354.10. [P62879-2]"";""ENST00000427895.5; ENSP00000400286.1; ENSG00000172354.10. [P62879-2]"";",GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159],G protein-coupled receptor signaling pathway [GO:0007186]; regulation of potassium ion transmembrane transport [GO:1901379],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; heterotrimeric G-protein complex [GO:0005834]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982]
O14775,C5,1.473421535,0.470690232,-0.327655237,-0.535999929,-0.608482504,turquoise3,GNB5,GNB5_HUMAN,Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5),GNB5,10681;,"ENST00000261837.12; ENSP00000261837.7; ENSG00000069966.19. [O14775-1];""ENST00000358784.11; ENSP00000351635.7; ENSG00000069966.19. [O14775-2]"";""ENST00000396335.8; ENSP00000379626.4; ENSG00000069966.19. [O14775-3]"";",G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein-folding chaperone binding [GO:0051087]; signaling receptor complex adaptor activity [GO:0030159],dark adaptation [GO:1990603]; dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway [GO:0007186]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; presynapse [GO:0098793]
Q13823,N3,-1.002229081,-1.064222925,0.8412809,-0.094875021,0.911082276,grey50,GNL2,NOG2_HUMAN,Nucleolar GTP-binding protein 2 (Autoantigen NGP-1),GNL2 NGP1,29889;,ENST00000373062.8; ENSP00000362153.3; ENSG00000134697.13.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723],ribosome biogenesis [GO:0042254],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]
O15228,S2,-1.202085875,-1.290614828,-0.087611593,1.007803594,0.510708817,orange,GNPAT,GNPAT_HUMAN,Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DAPAT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase),GNPAT DAPAT DHAPAT,8443;,ENST00000366647.9; ENSP00000355607.4; ENSG00000116906.13. [O15228-1];,glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; glycerone-phosphate O-acyltransferase activity [GO:0016287],cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; membrane organization [GO:0061024]; paranodal junction assembly [GO:0030913]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]; triglyceride biosynthetic process [GO:0019432],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
Q8TDQ7,C4,1.925974165,0.447609028,-0.968830658,-1.067305141,-1.125308218,deepskyblue2,GNPDA2,GNPI2_HUMAN,Glucosamine-6-phosphate isomerase 2 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 2) (GNPDA 2) (GlcN6P deaminase 2) (Glucosamine-6-phosphate isomerase SB52),GNPDA2 GNP2,132789;,"ENST00000295448.8; ENSP00000295448.3; ENSG00000163281.12. [Q8TDQ7-1];""ENST00000507534.5; ENSP00000427423.1; ENSG00000163281.12. [Q8TDQ7-4]"";""ENST00000507917.5; ENSP00000425868.1; ENSG00000163281.12. [Q8TDQ7-5]"";""ENST00000509756.1; ENSP00000424061.1; ENSG00000163281.12. [Q8TDQ7-3]"";",glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853],carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q96EK6,C5,1.966791769,0.601954152,-0.897281327,-1.227055425,-1.203220915,turquoise3,GNPNAT1,GNA1_HUMAN,Glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase),GNPNAT1 GNA1,64841;,"ENST00000216410.8; ENSP00000216410.3; ENSG00000100522.10.;""ENST00000650397.1; ENSP00000496934.1; ENSG00000100522.10."";",glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; identical protein binding [GO:0042802],UDP-N-acetylglucosamine biosynthetic process [GO:0006048],cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]
Q3T906,S1,-1.107842422,-1.518565326,-0.096722042,0.96652221,0.889504834,gold,GNPTAB,GNPTA_HUMAN,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],GNPTAB GNPTA KIAA1208,79158;,"ENST00000299314.12; ENSP00000299314.7; ENSG00000111670.16. [Q3T906-1];""ENST00000549940.5; ENSP00000449150.1; ENSG00000111670.16. [Q3T906-2]"";",calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976],carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q92805,S3,-0.943397631,-0.082708093,-0.249383156,0.55784734,0.666026761,salmon,GOLGA1,GOGA1_HUMAN,Golgin subfamily A member 1 (Golgin-97),GOLGA1,2800;,ENST00000373555.9; ENSP00000362656.4; ENSG00000136935.14.;,0,0,acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]
Q08379,S1,-1.095896658,-1.238825365,-0.17039518,0.898724403,0.810954671,gold,GOLGA2,GOGA2_HUMAN,Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95),GOLGA2,2801;,ENST00000421699.8; ENSP00000416097.4; ENSG00000167110.19. [Q08379-1];,cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905],asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225],cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]
Q08378,C2,0.739783718,0.862500311,-0.573715075,-0.472241531,-0.249625444,aquamarine,GOLGA3,GOGA3_HUMAN,Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa) (GCP170) (Golgin-160),GOLGA3,2802;,"ENST00000204726.9; ENSP00000204726.3; ENSG00000090615.16. [Q08378-1];""ENST00000450791.8; ENSP00000410378.2; ENSG00000090615.16. [Q08378-1]"";""ENST00000456883.7; ENSP00000409303.2; ENSG00000090615.16. [Q08378-2]"";""ENST00000545875.4; ENSP00000442603.1; ENSG00000090615.16. [Q08378-4]"";",cadherin binding [GO:0045296],0,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q13439,N4,-0.637581996,0.617943266,-0.261160333,0.406549275,0.358318995,grey30,GOLGA4,GOGA4_HUMAN,Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230),GOLGA4,2803;,"ENST00000356847.8; ENSP00000349305.4; ENSG00000144674.19. [Q13439-5];""ENST00000361924.7; ENSP00000354486.2; ENSG00000144674.19. [Q13439-1]"";",GTPase binding [GO:0051020]; small GTPase binding [GO:0031267],Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle transport [GO:0048193]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
Q8TBA6,S1,-1.319126899,-1.435329781,-0.137786426,0.942810981,0.895560461,gold,GOLGA5,GOGA5_HUMAN,Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein),GOLGA5 RETII RFG5 PIG31,9950;,ENST00000163416.7; ENSP00000163416.2; ENSG00000066455.13. [Q8TBA6-1];,protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]
Q7Z5G4,S4,-0.74427524,-1.241056973,0.33885485,0.820962276,0.336017873,tomato2,GOLGA7,GOGA7_HUMAN,Golgin subfamily A member 7 (Golgi complex-associated protein of 16 kDa),GOLGA7 GCP16 HDCKB03P HSPC041,51125;,"ENST00000357743.9; ENSP00000350378.4; ENSG00000147533.19. [Q7Z5G4-1];""ENST00000405786.3; ENSP00000386030.2; ENSG00000147533.19. [Q7Z5G4-3]"";""ENST00000518270.6; ENSP00000429329.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000687203.1; ENSP00000510742.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000694872.1; ENSP00000511557.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000694873.1; ENSP00000511558.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000694875.1; ENSP00000511560.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000694877.1; ENSP00000511562.1; ENSG00000147533.19. [Q7Z5G4-3]"";""ENST00000694878.1; ENSP00000511563.1; ENSG00000147533.19. [Q7Z5G4-3]"";""ENST00000694883.1; ENSP00000511567.1; ENSG00000147533.19. [Q7Z5G4-3]"";""ENST00000694884.1; ENSP00000511568.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000694886.1; ENSP00000511569.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000694887.1; ENSP00000511570.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000694911.1; ENSP00000511586.1; ENSG00000147533.19. [Q7Z5G4-1]"";""ENST00000694916.1; ENSP00000511591.1; ENSG00000147533.19. [Q7Z5G4-1]"";",0,Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein stabilization [GO:0050821]; protein targeting to membrane [GO:0006612],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; palmitoyltransferase complex [GO:0002178]; tertiary granule lumen [GO:1904724]
Q2TAP0,S4,-1.095856872,-1.190804943,0.456352765,0.683328587,0.546462874,tomato2,GOLGA7B,GOG7B_HUMAN,Golgin subfamily A member 7B,GOLGA7B C10orf132 C10orf133,401647;,ENST00000370602.6; ENSP00000359634.1; ENSG00000155265.12.;,enzyme binding [GO:0019899],protein targeting to membrane [GO:0006612],Golgi membrane [GO:0000139]; palmitoyltransferase complex [GO:0002178]; plasma membrane [GO:0005886]
Q14789,S1,-1.234327596,-1.215567578,-0.275005537,0.835534209,1.036086228,gold,GOLGB1,GOGB1_HUMAN,Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein) (GCP372) (Giantin) (Macrogolgin),GOLGB1,2804;,"ENST00000340645.10; ENSP00000341848.5; ENSG00000173230.17. [Q14789-1];""ENST00000393667.8; ENSP00000377275.3; ENSG00000173230.17. [Q14789-2]"";",RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565],Golgi organization [GO:0007030]; protein localization to pericentriolar material [GO:1905793]; regulation of DNA-templated transcription [GO:0006355],cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]
O00461,S1,-1.039651278,-1.405473753,-0.327291245,0.810680282,0.935802148,gold,GOLIM4,GOLI4_HUMAN,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",GOLIM4 GIMPC GOLPH4 GPP130,27333;,ENST00000470487.6; ENSP00000417354.1; ENSG00000173905.9.;,0,0,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133]
Q8NBJ4,S1,-0.942420096,-1.16784429,-0.188931521,0.748573555,0.970274958,gold,GOLM1,GOLM1_HUMAN,Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2),GOLM1 C9orf155 GOLPH2 PSEC0242 UNQ686/PRO1326,51280;,"ENST00000388711.7; ENSP00000373363.3; ENSG00000135052.16. [Q8NBJ4-1];""ENST00000388712.7; ENSP00000373364.3; ENSG00000135052.16. [Q8NBJ4-1]"";",0,nucleus organization [GO:0006997]; regulation of lipid metabolic process [GO:0019216],endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]
Q9H4A5,C2,1.069290614,0.218143597,-0.397144224,-0.058708515,-0.112294307,aquamarine,GOLPH3L,GLP3L_HUMAN,Golgi phosphoprotein 3-like (GPP34-related protein),GOLPH3L GPP34R,55204;,ENST00000271732.8; ENSP00000271732.3; ENSG00000143457.11. [Q9H4A5-1];,cargo adaptor activity [GO:0140312]; phosphatidylinositol-4-phosphate binding [GO:0070273],"Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; positive regulation of protein secretion [GO:0050714]; protein targeting to Golgi apparatus [GO:0140450]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]
Q9Y3E0,S1,-1.007261489,-1.327518578,0.072516063,0.919596776,0.990460772,gold,GOLT1B,GOT1B_HUMAN,Vesicle transport protein GOT1B (Germ cell tumor 2) (Golgi transport 1 homolog B) (Putative NF-kappa-B-activating protein 470) (hGOT1a),GOLT1B GCT2 GOT1A CGI-141 HDCMA39P UNQ432/PRO793,51026;,ENST00000229314.10; ENSP00000229314.4; ENSG00000111711.10.;,0,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; protein-containing complex [GO:0032991]
Q9BQQ3,S1,-0.953320774,-1.391047796,0.033722732,0.993395264,0.816476084,gold,GORASP1,GORS1_HUMAN,Golgi reassembly-stacking protein 1 (Golgi peripheral membrane protein p65) (Golgi phosphoprotein 5) (GOLPH5) (Golgi reassembly-stacking protein of 65 kDa) (GRASP65),GORASP1 GOLPH5 GRASP65,64689;,"ENST00000319283.8; ENSP00000313869.3; ENSG00000114745.15. [Q9BQQ3-1];""ENST00000431601.6; ENSP00000403552.1; ENSG00000114745.15. [Q9BQQ3-3]"";""ENST00000452389.7; ENSP00000403167.2; ENSG00000114745.15. [Q9BQQ3-2]"";",metal ion binding [GO:0046872],establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; negative regulation of dendrite morphogenesis [GO:0050774]; protein N-linked glycosylation [GO:0006487]; protein transport [GO:0015031],cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q9H8Y8,S1,-0.459327829,-0.597327978,-0.178173088,0.695184445,0.768777802,gold,GORASP2,GORS2_HUMAN,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),GORASP2 GOLPH6,26003;,ENST00000234160.5; ENSP00000234160.4; ENSG00000115806.13. [Q9H8Y8-1];,0,cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle assembly [GO:0070925]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283],cis-Golgi network [GO:0005801]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
O95249,S1,-0.918063985,-1.106970694,-0.128062773,0.75801285,0.884402177,gold,GOSR1,GOSR1_HUMAN,Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) (GOS-28),GOSR1 GS28,9527;,"ENST00000225724.9; ENSP00000225724.5; ENSG00000108587.16. [O95249-1];""ENST00000467337.6; ENSP00000462638.1; ENSG00000108587.16. [O95249-2]"";",SNAP receptor activity [GO:0005484],"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]",cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]
Q9HCL2,M2,-1.146758381,-1.543466653,0.350789413,1.120433396,-0.108386381,tan4,GPAM,GPAT1_HUMAN,"Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15)",GPAM GPAT1 KIAA1560,57678;,ENST00000348367.9; ENSP00000265276.4; ENSG00000119927.14.;,glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420],activated T cell proliferation [GO:0050798]; activation-induced cell death of T cells [GO:0006924]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerol-3-phosphate metabolic process [GO:0006072]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cytokine production [GO:0001817]; response to glucose [GO:0009749]; triglyceride biosynthetic process [GO:0019432],mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]
Q5T3I0,N1,-1.313038317,-1.194346555,0.610227098,-0.061537173,0.923207671,grey90,GPATCH4,GPTC4_HUMAN,G patch domain-containing protein 4,GPATCH4 GPATC4,0,"ENST00000710324.2; ENSP00000518204.1; ENSG00000292251.1. [Q5T3I0-1];""ENST00000710336.1; ENSP00000518217.1; ENSG00000292251.1. [Q5T3I0-3]"";",RNA binding [GO:0003723],0,nucleolus [GO:0005730]
Q9UKJ3,N4,-1.368681585,0.850661067,0.362580191,-0.157305505,-0.023770682,grey30,GPATCH8,GPTC8_HUMAN,G patch domain-containing protein 8,GPATCH8 GPATC8 KIAA0553,23131;,"ENST00000587228.5; ENSP00000468719.1; ENSG00000186566.13. [Q9UKJ3-3];""ENST00000591680.6; ENSP00000467556.1; ENSG00000186566.13. [Q9UKJ3-1]"";",metal ion binding [GO:0046872]; RNA binding [GO:0003723],0,nucleus [GO:0005634]
Q9NPB8,C5,1.852163129,0.464186038,-0.848017818,-0.97782173,-1.25588436,turquoise3,GPCPD1,GPCP1_HUMAN,Glycerophosphocholine phosphodiesterase GPCPD1 (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 5),GPCPD1 GDE5 KIAA1434,56261;,ENST00000379019.7; ENSP00000368305.4; ENSG00000125772.14.;,glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070],glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519],cytosol [GO:0005829]
Q8N335,C1,1.705096385,0.166514419,-0.502600886,-0.167891775,-0.654594259,lightblue,GPD1L,GPD1L_HUMAN,Glycerol-3-phosphate dehydrogenase 1-like protein (GPD1-L) (EC 1.1.1.8),GPD1L KIAA0089,23171;,ENST00000282541.10; ENSP00000282541.6; ENSG00000152642.11.;,glycerol-3-phosphate dehydrogenase (NAD+) activity [GO:0141152]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; NAD metabolic process [GO:0019674]; NADH metabolic process [GO:0006734]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase C signaling [GO:0090038]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of sodium ion transport [GO:0010765]; regulation of heart rate [GO:0002027]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; ventricular cardiac muscle cell action potential [GO:0086005],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
P43304,M2,-1.024259408,-1.278624175,0.371859697,1.13396205,-0.227459768,tan4,GPD2,GPDM_HUMAN,"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (mitohondrial glycerophosphate dehydrogenase gene) (mGDH) (mtGPD)",GPD2,2820;,"ENST00000310454.10; ENSP00000308610.5; ENSG00000115159.17. [P43304-1];""ENST00000409674.5; ENSP00000386425.1; ENSG00000115159.17. [P43304-1]"";""ENST00000409861.5; ENSP00000386626.1; ENSG00000115159.17. [P43304-1]"";""ENST00000438166.7; ENSP00000409708.2; ENSG00000115159.17. [P43304-1]"";",calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368],glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerophosphate shuttle [GO:0006127],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
P06744,C4,2.108711942,0.428289954,-1.059278949,-1.147722147,-1.247620656,deepskyblue2,GPI,G6PI_HUMAN,Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36),GPI,2821;,"ENST00000356487.11; ENSP00000348877.3; ENSG00000105220.17. [P06744-1];""ENST00000588991.7; ENSP00000465858.3; ENSG00000105220.17. [P06744-2]"";",carbohydrate derivative binding [GO:0097367]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625],carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574],ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]
Q9HCN4,C3,1.662474858,-0.050371858,-0.540586739,-0.295079595,-0.657865543,cyan,GPN1,GPN1_HUMAN,GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1),GPN1 MBDIN RPAP4 XAB1 HUSSY-23,11321;,"ENST00000264718.7; ENSP00000264718.3; ENSG00000198522.14. [Q9HCN4-5];""ENST00000407583.7; ENSP00000384255.3; ENSG00000198522.14. [Q9HCN4-4]"";""ENST00000424214.5; ENSP00000398115.1; ENSG00000198522.14. [Q9HCN4-2]"";""ENST00000458167.6; ENSP00000412170.2; ENSG00000198522.14. [Q9HCN4-3]"";""ENST00000503738.5; ENSP00000427269.1; ENSG00000198522.14. [Q9HCN4-3]"";""ENST00000515877.5; ENSP00000424678.1; ENSG00000198522.14. [Q9HCN4-2]"";""ENST00000610189.2; ENSP00000476446.1; ENSG00000198522.14. [Q9HCN4-1]"";""ENST00000616939.4; ENSP00000484680.1; ENSG00000198522.14. [Q9HCN4-5]"";",ATP hydrolysis activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],0,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q9UHW5,C1,1.581082301,0.144265921,-0.530960488,-0.480680938,-0.452288241,lightblue,GPN3,GPN3_HUMAN,GPN-loop GTPase 3 (ATP-binding domain 1 family member C),GPN3 ATPBD1C AD-009 UNQ1876/PRO4319,51184;,"ENST00000228827.8; ENSP00000228827.3; ENSG00000111231.9. [Q9UHW5-1];""ENST00000537466.6; ENSP00000443068.2; ENSG00000111231.9. [Q9UHW5-2]"";""ENST00000543199.5; ENSP00000442770.1; ENSG00000111231.9. [Q9UHW5-3]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],0,protein-containing complex [GO:0032991]
Q5VW38,S1,-1.278298649,-1.7540179,-0.434199239,0.874253808,1.098735938,gold,GPR107,GP107_HUMAN,Protein GPR107 (Lung seven transmembrane receptor 1),GPR107 KIAA1624 LUSTR1,57720;,"ENST00000347136.11; ENSP00000336988.7; ENSG00000148358.21. [Q5VW38-2];""ENST00000372406.5; ENSP00000361483.1; ENSG00000148358.21. [Q5VW38-1]"";",clathrin heavy chain binding [GO:0032050],clathrin-dependent endocytosis [GO:0072583],clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q9NPR9,S1,-1.549313489,-1.506961523,-0.336242354,0.671936547,1.297191931,gold,GPR108,GP108_HUMAN,Protein GPR108 (Lung seven transmembrane receptor 2),GPR108 LUSTR2,56927;,ENST00000264080.12; ENSP00000264080.5; ENSG00000125734.16.;,0,negative regulation of toll-like receptor signaling pathway [GO:0034122]; regulation of immune response [GO:0050776],cis-Golgi network membrane [GO:0033106]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]
Q8IWK6,S4,-0.979823425,-1.178672108,0.375110602,0.912269711,0.22243423,tomato2,GPR125,AGRA3_HUMAN,Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125),ADGRA3 GPR125 UNQ556/PRO1113,166647;,"ENST00000334304.10; ENSP00000334952.5; ENSG00000152990.14. [Q8IWK6-1];""ENST00000502482.1; ENSP00000421006.1; ENSG00000152990.14. [Q8IWK6-2]"";""ENST00000508133.5; ENSP00000422606.1; ENSG00000152990.14. [Q8IWK6-4]"";",G protein-coupled receptor activity [GO:0004930],cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q86SQ4,S3,-1.122187761,-0.91106778,0.148474661,0.804550455,0.777017445,salmon,GPR126,AGRG6_HUMAN,Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)],ADGRG6 DREG GPR126 VIGR,57211;,"ENST00000230173.10; ENSP00000230173.6; ENSG00000112414.15. [Q86SQ4-1];""ENST00000296932.13; ENSP00000296932.8; ENSG00000112414.15. [Q86SQ4-2]"";""ENST00000367608.6; ENSP00000356580.2; ENSG00000112414.15. [Q86SQ4-4]"";""ENST00000367609.8; ENSP00000356581.3; ENSG00000112414.15. [Q86SQ4-3]"";",collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236],adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; nervous system development [GO:0007399]; Schwann cell differentiation [GO:0014037],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q86V85,S1,-2.337449599,-2.00958236,0.067545261,0.798870329,0.942556724,gold,GPR180,GP180_HUMAN,Integral membrane protein GPR180 (Intimal thickness-related receptor),GPR180 ITR,160897;,ENST00000376958.5; ENSP00000366157.4; ENSG00000152749.8.;,0,G protein-coupled receptor signaling pathway [GO:0007186]; response to pheromone [GO:0019236],membrane [GO:0016020]
O43194,S4,-1.173530588,-1.49049293,0.541746516,1.148475042,0.133344206,tomato2,GPR39,GPR39_HUMAN,G-protein coupled receptor 39,GPR39,2863;,ENST00000329321.4; ENSP00000327417.3; ENSG00000183840.8.;,G protein-coupled receptor activity [GO:0004930]; metal ion binding [GO:0046872],G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886]
Q9Y653,S3,-0.549989903,-0.92252044,0.157403768,0.714629596,0.568330522,salmon,GPR56,AGRG1_HUMAN,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)],ADGRG1 GPR56 TM7LN4 TM7XN1 UNQ540/PRO1083,9289;,"ENST00000388813.9; ENSP00000373465.5; ENSG00000205336.14. [Q9Y653-2];""ENST00000456916.5; ENSP00000398034.2; ENSG00000205336.14. [Q9Y653-3]"";""ENST00000540164.6; ENSP00000444911.2; ENSG00000205336.14. [Q9Y653-2]"";""ENST00000562558.6; ENSP00000456620.1; ENSG00000205336.14. [Q9Y653-2]"";""ENST00000562631.7; ENSP00000455351.2; ENSG00000205336.14. [Q9Y653-2]"";""ENST00000565976.6; ENSP00000454933.2; ENSG00000205336.14. [Q9Y653-1]"";""ENST00000567835.5; ENSP00000456794.1; ENSG00000205336.14. [Q9Y653-1]"";""ENST00000568908.5; ENSP00000457456.1; ENSG00000205336.14. [Q9Y653-2]"";""ENST00000568909.5; ENSP00000455215.1; ENSG00000205336.14. [Q9Y653-1]"";""ENST00000673126.2; ENSP00000500185.2; ENSG00000205336.14. [Q9Y653-1]"";",collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; heparin binding [GO:0008201],adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-cell signaling [GO:0007267]; cerebral cortex radial glia-guided migration [GO:0021801]; cerebral cortex regionalization [GO:0021796]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic stem cell homeostasis [GO:0061484]; layer formation in cerebral cortex [GO:0021819]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron migration [GO:2001223]; neural precursor cell proliferation [GO:0061351]; positive regulation of cell adhesion [GO:0045785]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Rho protein signal transduction [GO:0035025]; protein kinase C signaling [GO:0070528]; Rho protein signal transduction [GO:0007266]; seminiferous tubule development [GO:0072520]; vascular endothelial growth factor production [GO:0010573],extracellular exosome [GO:0070062]; glial limiting end-foot [GO:0097451]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]
Q8NFJ5,S1,-1.408178361,-1.501000648,-0.077209279,0.716802347,1.115088309,gold,GPRC5A,RAI3_HUMAN,Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1) (PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1),GPRC5A GPCR5A RAI3 RAIG1,9052;,"ENST00000014914.6; ENSP00000014914.6; ENSG00000013588.10.;""ENST00000713574.1; ENSP00000518866.1; ENSG00000013588.10."";",cadherin binding [GO:0045296]; G protein-coupled receptor activity [GO:0004930]; protein kinase activator activity [GO:0030295],negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; signal transduction [GO:0007165],cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; vesicle [GO:0031982]
Q86YR5,C3,1.949473833,-0.004841745,-0.554907086,-0.501092817,-0.70328719,cyan,GPSM1,GPSM1_HUMAN,G-protein-signaling modulator 1 (Activator of G-protein signaling 3),GPSM1 AGS3,26086;,"ENST00000291775.3; ENSP00000291775.3; ENSG00000160360.13. [Q86YR5-2];""ENST00000392944.5; ENSP00000376673.1; ENSG00000160360.13. [Q86YR5-2]"";""ENST00000429455.5; ENSP00000390705.1; ENSG00000160360.13. [Q86YR5-2]"";",G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092],cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
P36969,C3,1.976736024,0.143281487,-0.782785333,-0.582898434,-1.071305586,cyan,GPX4,GPX4_HUMAN,Phospholipid hydroperoxide glutathione peroxidase GPX4 (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4) (EC 1.11.1.9),GPX4,2879;,"ENST00000354171.13; ENSP00000346103.7; ENSG00000167468.20. [P36969-1];""ENST00000611653.4; ENSP00000483655.1; ENSG00000167468.20. [P36969-2]"";",glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430],arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of ferroptosis [GO:0110076]; phospholipid metabolic process [GO:0006644]; protein polymerization [GO:0051258]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q8TED1,S4,-0.674537863,-0.798102194,0.241513734,0.694535231,0.457399014,tomato2,GPX8,GPX8_HUMAN,Probable glutathione peroxidase 8 (GPx-8) (GSHPx-8) (EC 1.11.1.9),GPX8 UNQ847/PRO1785,493869;,ENST00000503787.6; ENSP00000423822.1; ENSG00000164294.14.;,glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601],cellular response to oxidative stress [GO:0034599],endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]
Q96CP6,S2,-0.906726988,-1.446878189,0.173609762,0.751877213,0.542849145,orange,GRAMD1A,ASTRA_HUMAN,Protein Aster-A (GRAM domain-containing protein 1A),GRAMD1A KIAA1533,57655;,"ENST00000317991.10; ENSP00000441032.1; ENSG00000089351.15. [Q96CP6-1];""ENST00000411896.6; ENSP00000439267.1; ENSG00000089351.15. [Q96CP6-2]"";""ENST00000680623.1; ENSP00000505404.1; ENSG00000089351.15. [Q96CP6-3]"";",cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020],autophagy [GO:0006914]; cellular response to cholesterol [GO:0071397]; intracellular sterol transport [GO:0032366],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]
Q96HH9,S2,-0.878005584,-1.082187495,0.151511621,0.864259765,0.614979402,orange,GRAMD3,GRM2B_HUMAN,GRAM domain-containing protein 2B (HCV NS3-transactivated protein 2),GRAMD2B GRAMD3 NS3TP2,65983;,"ENST00000285689.8; ENSP00000285689.3; ENSG00000155324.10. [Q96HH9-1];""ENST00000511134.1; ENSP00000426088.1; ENSG00000155324.10. [Q96HH9-4]"";""ENST00000513040.5; ENSP00000426120.1; ENSG00000155324.10. [Q96HH9-3]"";""ENST00000542322.5; ENSP00000441876.1; ENSG00000155324.10. [Q96HH9-2]"";""ENST00000544396.5; ENSP00000444049.1; ENSG00000155324.10. [Q96HH9-5]"";",identical protein binding [GO:0042802],0,cytoplasmic microtubule [GO:0005881]
Q6IC98,S2,-1.255405336,-1.528810037,0.312700595,0.689218245,0.767163243,orange,GRAMD4,GRAM4_HUMAN,GRAM domain-containing protein 4 (Death-inducing protein),GRAMD4 DIP KIAA0767,23151;,"ENST00000361034.7; ENSP00000354313.3; ENSG00000075240.17. [Q6IC98-1];""ENST00000406902.6; ENSP00000385689.1; ENSG00000075240.17. [Q6IC98-1]"";""ENST00000408031.1; ENSP00000385851.1; ENSG00000075240.17. [Q6IC98-2]"";",0,apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280],endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]
Q9UBQ7,C1,1.483288069,0.433466115,-0.337860694,-0.129382964,-1.32101925,lightblue,GRHPR,GRHPR_HUMAN,Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81),GRHPR GLXR MSTP035,9380;,"ENST00000318158.11; ENSP00000313432.6; ENSG00000137106.18. [Q9UBQ7-1];""ENST00000494290.1; ENSP00000432021.1; ENSG00000137106.18. [Q9UBQ7-2]"";",carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803],carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487],catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]
Q4V328,C5,1.520577948,0.689105215,-0.606900095,-0.769242087,-0.977628788,turquoise3,GRIPAP1,GRAP1_HUMAN,GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)],GRIPAP1 KIAA1167,56850;,"ENST00000376423.8; ENSP00000365606.5; ENSG00000068400.14. [Q4V328-1];""ENST00000593475.6; ENSP00000469842.2; ENSG00000068400.14. [Q4V328-4]"";""ENST00000611757.4; ENSP00000515491.1; ENSG00000068400.14. [Q4V328-2]"";""ENST00000710115.1; ENSP00000518067.1; ENSG00000292219.1. [Q4V328-1]"";""ENST00000710116.1; ENSP00000518068.1; ENSG00000292219.1. [Q4V328-4]"";""ENST00000710199.1; ENSP00000518120.1; ENSG00000292219.1. [Q4V328-2]"";",guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255],"negative regulation of receptor clustering [GO:1903910]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]",axon [GO:0030424]; blood microparticle [GO:0072562]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]
Q12849,S3,-1.225254649,-0.850241426,0.197169036,0.797413138,0.777362983,salmon,GRSF1,GRSF1_HUMAN,G-rich sequence factor 1 (GRSF-1),GRSF1,2926;,"ENST00000254799.11; ENSP00000254799.6; ENSG00000132463.15. [Q12849-1];""ENST00000502323.5; ENSP00000425430.1; ENSG00000132463.15. [Q12849-5]"";",G-quadruplex RNA binding [GO:0002151]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],anterior/posterior pattern specification [GO:0009952]; mitochondrial RNA catabolic process [GO:0000957]; morphogenesis of embryonic epithelium [GO:0016331]; mRNA processing [GO:0006397]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; regulation of RNA splicing [GO:0043484]; tRNA processing [GO:0008033],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]
Q14687,N4,-0.785633298,0.869786159,0.05279072,-0.346597101,0.155934061,grey30,GSE1,GSE1_HUMAN,Genetic suppressor element 1,GSE1 KIAA0182,23199;,"ENST00000253458.12; ENSP00000253458.6; ENSG00000131149.19. [Q14687-1];""ENST00000393243.5; ENSP00000376934.1; ENSG00000131149.19. [Q14687-3]"";""ENST00000405402.6; ENSP00000384839.2; ENSG00000131149.19. [Q14687-2]"";",0,0,0
Q8TF76,N1,-1.174619859,-1.061540315,0.762122149,0.312094298,0.856011244,grey90,GSG2,HASP_HUMAN,Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase),HASPIN GSG2,83903;,ENST00000325418.5; ENSP00000325290.4; ENSG00000177602.5. [Q8TF76-1];,ATP binding [GO:0005524]; histone H3T3 kinase activity [GO:0072354]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],"intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]; protein phosphorylation [GO:0006468]",centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]
P49840,C3,1.798610119,0.222907259,-0.548009301,-0.4530274,-0.920970986,cyan,GSK3A,GSK3A_HUMAN,Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1),GSK3A,2931;,"ENST00000222330.8; ENSP00000222330.3; ENSG00000105723.13.;""ENST00000453535.1; ENSP00000412663.1; ENSG00000105723.13."";",ATP binding [GO:0005524]; protein kinase A catalytic subunit binding [GO:0034236]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],"autosome genomic imprinting [GO:0141068]; cardiac left ventricle morphogenesis [GO:0003214]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-3 [GO:0036016]; cellular response to lithium ion [GO:0071285]; dopamine receptor signaling pathway [GO:0007212]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; insulin receptor signaling pathway [GO:0008286]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of glycogen synthase activity, transferring glucose-1-phosphate [GO:1904227]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; negative regulation of UDP-glucose catabolic process [GO:0010905]; nervous system development [GO:0007399]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071879]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of autophagy [GO:0010508]; positive regulation of gene expression [GO:0010628]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of heart contraction [GO:0045823]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein phosphorylation [GO:0006468]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitophagy [GO:1901524]; regulation of neuron projection development [GO:0010975]; regulation of systemic arterial blood pressure [GO:0003073]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055]",apical dendrite [GO:0097440]; axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proximal dendrite [GO:1990635]
P49841,C3,1.770669537,0.201775821,-0.610546266,-0.508983801,-0.929805291,cyan,GSK3B,GSK3B_HUMAN,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),GSK3B,2932;,"ENST00000264235.13; ENSP00000264235.9; ENSG00000082701.17. [P49841-1];""ENST00000316626.6; ENSP00000324806.5; ENSG00000082701.17. [P49841-2]"";",ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625],beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; dopamine receptor signaling pathway [GO:0007212]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; glycogen metabolic process [GO:0005977]; heart valve development [GO:0003170]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of protein-containing complex assembly [GO:0031334]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082],axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Wnt signalosome [GO:1990909]
P06396,C4,2.017818122,0.242774684,-0.794296454,-0.783295734,-1.063268072,deepskyblue2,GSN,GELS_HUMAN,Gelsolin (AGEL) (Actin-depolymerizing factor) (ADF) (Brevin),GSN,2934;,"ENST00000373808.8; ENSP00000362914.3; ENSG00000148180.22. [P06396-3];""ENST00000373818.8; ENSP00000362924.4; ENSG00000148180.22. [P06396-1]"";""ENST00000373823.7; ENSP00000362929.2; ENSG00000148180.22. [P06396-2]"";""ENST00000432226.7; ENSP00000404226.2; ENSG00000148180.22. [P06396-2]"";""ENST00000545652.6; ENSP00000445823.1; ENSG00000148180.22. [P06396-4]"";","actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]","actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; amyloid fibril formation [GO:1990000]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to type II interferon [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]",actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; blood microparticle [GO:0072562]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcoplasm [GO:0016528]; secretory granule lumen [GO:0034774]
P15170,C4,1.755360476,-0.062938056,-0.673184151,-0.794841238,-0.881514976,deepskyblue2,GSPT1,ERF3A_HUMAN,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog),GSPT1 ERF3A,2935;,"ENST00000420576.6; ENSP00000399539.2; ENSG00000103342.13. [P15170-1];""ENST00000434724.7; ENSP00000398131.2; ENSG00000103342.13. [P15170-3]"";""ENST00000439887.6; ENSP00000408399.2; ENSG00000103342.13. [P15170-2]"";""ENST00000563468.5; ENSP00000454351.1; ENSG00000103342.13. [P15170-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747],"G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; translation release factor complex [GO:0018444]
P00390,C5,1.789088154,0.362465539,-0.640202854,-0.567347496,-0.998172411,turquoise3,GSR,GSHR_HUMAN,"Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7)",GSR GLUR GRD1,2936;,"ENST00000221130.11; ENSP00000221130.5; ENSG00000104687.14. [P00390-1];""ENST00000537535.5; ENSP00000438845.1; ENSG00000104687.14. [P00390-5]"";""ENST00000541648.5; ENSP00000444559.1; ENSG00000104687.14. [P00390-4]"";""ENST00000546342.5; ENSP00000445516.1; ENSG00000104687.14. [P00390-3]"";",electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione-disulfide reductase (NADPH) activity [GO:0004362]; NADP binding [GO:0050661],cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
P48637,C5,1.839758133,0.502187302,-0.710931853,-0.660593235,-0.961405217,turquoise3,GSS,GSHB_HUMAN,Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase),GSS,2937;,"ENST00000451957.2; ENSP00000407517.2; ENSG00000100983.12. [P48637-2];""ENST00000643188.1; ENSP00000493903.1; ENSG00000100983.12. [P48637-1]"";""ENST00000644793.1; ENSP00000495750.1; ENSG00000100983.12. [P48637-1]"";""ENST00000646735.1; ENSP00000493763.1; ENSG00000100983.12. [P48637-2]"";""ENST00000651619.1; ENSP00000498303.1; ENSG00000100983.12. [P48637-1]"";",ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],amino acid metabolic process [GO:0006520]; nervous system development [GO:0007399]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P78417,C5,1.988736579,0.382856835,-0.919495653,-0.952182746,-1.293560787,turquoise3,GSTO1,GSTO1_HUMAN,Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R),GSTO1 GSTTLP28,9446;,"ENST00000369710.8; ENSP00000358724.4; ENSG00000148834.13. [P78417-2];""ENST00000369713.10; ENSP00000358727.5; ENSG00000148834.13. [P78417-1]"";""ENST00000539281.5; ENSP00000441488.1; ENSG00000148834.13. [P78417-3]"";",glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491],cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9UHL9,M1,-0.780841425,-0.597900188,0.743535684,0.535683931,0.05741108,burlywood4,GTF2IRD1,GT2D1_HUMAN,General transcription factor II-I repeat domain-containing protein 1 (GTF2I repeat domain-containing protein 1) (General transcription factor III) (MusTRD1/BEN) (Muscle TFII-I repeat domain-containing protein 1) (Slow-muscle-fiber enhancer-binding protein) (USE B1-binding protein) (Williams-Beuren syndrome chromosomal region 11 protein) (Williams-Beuren syndrome chromosomal region 12 protein),GTF2IRD1 CREAM1 GTF3 MUSTRD1 RBAP2 WBSCR11 WBSCR12,9569;,"ENST00000265755.7; ENSP00000265755.3; ENSG00000006704.11. [Q9UHL9-1];""ENST00000424337.7; ENSP00000408477.2; ENSG00000006704.11. [Q9UHL9-2]"";""ENST00000455841.6; ENSP00000397566.2; ENSG00000006704.11. [Q9UHL9-3]"";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transition between slow and fast fiber [GO:0014886],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q92664,C2,0.569352271,1.009147565,-0.652795835,-0.943786987,-0.021488945,aquamarine,GTF3A,TF3A_HUMAN,Transcription factor IIIA (TFIIIA),GTF3A,2971;,ENST00000381140.10; ENSP00000370532.5; ENSG00000122034.17. [Q92664-1];,5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],ribosomal large subunit biogenesis [GO:0042273]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8WUA4,N1,-0.616126915,-0.685455596,0.273529225,0.110158669,0.917290016,grey90,GTF3C2,TF3C2_HUMAN,General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta),GTF3C2 KIAA0011,2976;,"ENST00000264720.8; ENSP00000264720.3; ENSG00000115207.15. [Q8WUA4-1];""ENST00000359541.6; ENSP00000352536.2; ENSG00000115207.15. [Q8WUA4-1]"";",RNA polymerase III general transcription initiation factor activity [GO:0000995],5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797],nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]
A4D1E9,S3,-1.123103605,-0.873312347,0.308916125,0.677095844,0.363181432,salmon,GTPBP10,GTPBA_HUMAN,GTP-binding protein 10 (Protein obg homolog 2) (ObgH2),GTPBP10 OBGH2 UG0751c10,85865;,"ENST00000222511.11; ENSP00000222511.7; ENSG00000105793.16. [A4D1E9-1];""ENST00000257659.12; ENSP00000257659.8; ENSG00000105793.16. [A4D1E9-2]"";""ENST00000380058.7; ENSP00000369398.3; ENSG00000105793.16. [A4D1E9-3]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723],ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]
O43824,M2,-1.454262716,-0.697240708,0.450627245,0.960177609,-0.040274058,tan4,GTPBP6,GTPB6_HUMAN,Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like),GTPBP6 PGPL,8225;,"ENST00000326153.10; ENSP00000316598.5; ENSG00000178605.14.;""ENST00000711233.1; ENSP00000518626.1; ENSG00000292358.1."";",GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022],0,cytoplasm [GO:0005737]
Q8N3Z3,M2,-0.846193308,-0.840814737,0.506435406,0.952441597,-0.18869942,tan4,GTPBP8,GTPB8_HUMAN,GTP-binding protein 8,GTPBP8,29083;,"ENST00000295864.9; ENSP00000295864.5; ENSG00000163607.18. [Q8N3Z3-3];""ENST00000383677.7; ENSP00000373175.3; ENSG00000163607.18. [Q8N3Z3-2]"";""ENST00000383678.8; ENSP00000373176.2; ENSG00000163607.18. [Q8N3Z3-1]"";""ENST00000485330.5; ENSP00000418877.1; ENSG00000163607.18. [Q8N3Z3-2]"";",GTP binding [GO:0005525]; metal ion binding [GO:0046872],0,mitochondrion [GO:0005739]
Q8N442,M1,-1.34090154,-0.609993487,0.441415189,0.899313233,-0.309019813,burlywood4,GUF1,GUF1_HUMAN,"Translation factor GUF1, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1) (Ribosomal back-translocase)",GUF1,60558;,ENST00000281543.6; ENSP00000281543.5; ENSG00000151806.14.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial ribosome binding [GO:0097177],positive regulation of translation [GO:0045727]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q16774,C1,0.950039164,0.158528785,-0.101063648,0.431616137,-1.063838901,lightblue,GUK1,KGUA_HUMAN,Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1),GUK1 GMK GMPK,2987;,"ENST00000366728.6; ENSP00000355689.2; ENSG00000143774.18. [Q16774-3];""ENST00000366730.5; ENSP00000355691.1; ENSG00000143774.18. [Q16774-1]"";""ENST00000453943.6; ENSP00000401832.2; ENSG00000143774.18. [Q16774-2]"";",ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385],dATP metabolic process [GO:0046060]; dGDP biosynthetic process [GO:0006185]; dGMP metabolic process [GO:0046054]; GDP biosynthetic process [GO:0046711]; GDP-mannose metabolic process [GO:0019673]; glycoprotein transport [GO:0034436]; nucleobase-containing small molecule interconversion [GO:0015949]; phosphorylation [GO:0016310]; purine nucleotide metabolic process [GO:0006163]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; photoreceptor inner segment [GO:0001917]
P07305,N3,-1.511573095,-1.36356635,1.211918828,-0.402882864,0.443952461,grey50,H1F0,H10_HUMAN,"Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed]",H1-0 H1F0 H1FV,3005;,ENST00000340857.4; ENSP00000344504.2; ENSG00000189060.6. [P07305-1];,chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527],chromosome condensation [GO:0030261]; heterochromatin formation [GO:0031507]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; positive regulation of transcription regulatory region DNA binding [GO:2000679],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]
Q92522,N1,-1.165883689,-0.739652001,0.146054678,-0.480357387,1.38090848,grey90,H1FX,H1X_HUMAN,Histone H1.10 (Histone H1x),H1-10 H1FX,8971;,ENST00000333762.6; ENSP00000329662.4; ENSG00000184897.7.;,cadherin binding [GO:0045296]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527],chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334],chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]
O75367,N3,-1.056014409,-1.309320288,1.463920615,0.076111258,-0.866137861,grey50,H2AFY,H2AY_HUMAN,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205),MACROH2A1 H2AFY,9555;,"ENST00000304332.8; ENSP00000302572.4; ENSG00000113648.17. [O75367-3];""ENST00000312469.8; ENSP00000310169.4; ENSG00000113648.17. [O75367-2]"";""ENST00000510038.1; ENSP00000424971.1; ENSG00000113648.17. [O75367-1]"";""ENST00000511689.6; ENSP00000423563.1; ENSG00000113648.17. [O75367-1]"";",ADP-D-ribose binding [GO:0072570]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976],"DNA repair [GO:0006281]; epigenetic regulation of gene expression [GO:0040029]; establishment of protein localization to chromatin [GO:0071169]; heterochromatin formation [GO:0031507]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of lipid metabolic process [GO:0019216]; regulation of NAD metabolic process [GO:1902688]; regulation of oxidative phosphorylation [GO:0002082]; regulation of response to oxidative stress [GO:1902882]; sex-chromosome dosage compensation [GO:0007549]; transcription initiation-coupled chromatin remodeling [GO:0045815]","Barr body [GO:0001740]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; sex chromatin [GO:0001739]; site of DNA damage [GO:0090734]"
P40939,M2,-1.107411813,-0.948678048,0.430050981,1.03872323,-0.041459233,tan4,HADHA,ECHA_HUMAN,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]",HADHA HADH,3030;,"ENST00000380649.8; ENSP00000370023.3; ENSG00000084754.12. [P40939-1];""ENST00000646483.1; ENSP00000496185.1; ENSG00000084754.12. [P40939-2]"";",3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; NAD+ binding [GO:0070403]; protein-containing complex binding [GO:0044877],cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410],mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]
P55084,M2,-1.132511559,-0.930582869,0.448499734,1.03910537,-0.03356256,tan4,HADHB,ECHB_HUMAN,"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]",HADHB MSTP029,3032;,"ENST00000317799.10; ENSP00000325136.5; ENSG00000138029.14. [P55084-1];""ENST00000545822.2; ENSP00000442665.1; ENSG00000138029.14. [P55084-2]"";",3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; lncRNA binding [GO:0106222]; RNA binding [GO:0003723],cellular response to lipopolysaccharide [GO:0071222]; fatty acid beta-oxidation [GO:0006635]; gene expression [GO:0010467],endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q16775,C1,1.479040766,0.395540298,-0.440962988,0.048400075,-1.165458249,lightblue,HAGH,GLO2_HUMAN,"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)",HAGH GLO2 HAGH1,3029;,"ENST00000397353.6; ENSP00000380511.2; ENSG00000063854.13. [Q16775-2];""ENST00000397356.8; ENSP00000380514.3; ENSG00000063854.13. [Q16775-1]"";""ENST00000455446.6; ENSP00000406552.2; ENSG00000063854.13. [Q16775-3]"";",hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872],glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
P12081,C4,2.070807489,0.312240525,-1.089758829,-1.254326122,-1.25028505,deepskyblue2,HARS,HARS1_HUMAN,"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)",HARS1 HARS HRS,3035;,"ENST00000307633.7; ENSP00000304668.3; ENSG00000170445.16. [P12081-3];""ENST00000438307.6; ENSP00000411511.2; ENSG00000170445.16. [P12081-2]"";""ENST00000457527.6; ENSP00000387893.2; ENSG00000170445.16. [P12081-4]"";""ENST00000504156.7; ENSP00000425634.1; ENSG00000170445.16. [P12081-1]"";",ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723],histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]
Q68CZ6,C1,1.541171153,-0.021283267,-0.417328311,-0.171312197,-0.526712369,lightblue,HAUS3,HAUS3_HUMAN,HAUS augmin-like complex subunit 3,HAUS3 C4orf15,79441;,"ENST00000243706.8; ENSP00000243706.4; ENSG00000214367.10. [Q68CZ6-1];""ENST00000443786.3; ENSP00000392903.2; ENSG00000214367.10. [Q68CZ6-1]"";""ENST00000506763.5; ENSP00000427350.1; ENSG00000214367.10. [Q68CZ6-2]"";",0,cell division [GO:0051301]; centrosome cycle [GO:0007098]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]
Q9BT25,C1,1.358628969,0.178398307,-0.288538439,-0.030594055,-0.322702334,lightblue,HAUS8,HAUS8_HUMAN,HAUS augmin-like complex subunit 8 (HEC1/NDC80-interacting centrosome-associated protein 1) (Sarcoma antigen NY-SAR-48),HAUS8 HICE1,93323;,"ENST00000253669.10; ENSP00000253669.4; ENSG00000131351.15. [Q9BT25-1];""ENST00000448593.6; ENSP00000395298.1; ENSG00000131351.15. [Q9BT25-3]"";""ENST00000593360.1; ENSP00000470829.1; ENSG00000131351.15. [Q9BT25-2]"";",microtubule binding [GO:0008017],cell division [GO:0051301]; centrosome cycle [GO:0007098]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; mitotic spindle microtubule [GO:1990498]; nuclear microtubule [GO:0005880]; spindle pole [GO:0000922]
O00165,M2,-0.747301553,-0.905354213,0.298461251,0.978738634,0.017141468,tan4,HAX1,HAX1_HUMAN,HCLS1-associated protein X-1 (HS1-associating protein X-1) (HAX-1) (HS1-binding protein 1) (HSP1BP-1),HAX1 HS1BP1,10456;,"ENST00000328703.12; ENSP00000329002.7; ENSG00000143575.16. [O00165-1];""ENST00000447768.7; ENSP00000403848.2; ENSG00000143575.16. [O00165-6]"";""ENST00000457918.6; ENSP00000411448.2; ENSG00000143575.16. [O00165-5]"";""ENST00000483970.7; ENSP00000435088.1; ENSG00000143575.16. [O00165-2]"";""ENST00000696932.1; ENSP00000512979.1; ENSG00000143575.16. [O00165-1]"";""ENST00000696941.1; ENSP00000512986.1; ENSG00000143575.16. [O00165-3]"";""ENST00000697592.1; ENSP00000513356.1; ENSG00000143575.16. [O00165-3]"";""ENST00000697830.1; ENSP00000513452.1; ENSG00000143575.16. [O00165-3]"";",interleukin-1 binding [GO:0019966]; signaling adaptor activity [GO:0035591],cellular response to cytokine stimulus [GO:0071345]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; negative regulation of apoptotic process [GO:0043066]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin filament organization [GO:0110053]; regulation of actin filament polymerization [GO:0030833]; regulation of apoptotic process [GO:0042981]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of protein targeting to mitochondrion [GO:1903214],actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum [GO:0005783]; lamellipodium [GO:0030027]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; P-body [GO:0000932]; sarcoplasmic reticulum [GO:0016529]; transcription regulator complex [GO:0005667]
P53701,M2,-1.017538327,-1.235505809,0.351511735,1.113061678,-0.096022917,tan4,HCCS,CCHL_HUMAN,Holocytochrome c-type synthase (EC 4.4.1.17) (Cytochrome c-type heme lyase),HCCS CCHL,3052;,"ENST00000321143.8; ENSP00000326579.4; ENSG00000004961.15.;""ENST00000380762.5; ENSP00000370139.4; ENSG00000004961.15."";""ENST00000380763.7; ENSP00000370140.3; ENSG00000004961.15."";",heme binding [GO:0020037]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872],animal organ morphogenesis [GO:0009887]; cytochrome c-heme linkage [GO:0018063],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
P51610,N4,-0.636544495,0.973731659,0.129908795,-0.618782534,-0.373275674,grey30,HCFC1,HCFC1_HUMAN,Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6],HCFC1 HCF1 HFC1,3054;,ENST00000310441.12; ENSP00000309555.7; ENSG00000172534.14. [P51610-1];,cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713],chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein-containing complex assembly [GO:0043254]; release from viral latency [GO:0019046],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]
Q92769,N4,-0.72689555,0.521116814,0.419986988,-0.387919292,0.199096871,grey30,HDAC2,HDAC2_HUMAN,Histone deacetylase 2 (HD2) (EC 3.5.1.98) (Protein deacylase HDAC2) (EC 3.5.1.-),HDAC2,3066;,"ENST00000368632.6; ENSP00000357621.2; ENSG00000196591.12. [Q92769-3];""ENST00000519065.6; ENSP00000430432.1; ENSG00000196591.12. [Q92769-1]"";""ENST00000519108.5; ENSP00000430008.1; ENSG00000196591.12. [Q92769-3]"";",chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone decrotonylase activity [GO:0160009]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein lysine deacetylase activity [GO:0033558]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],behavioral response to ethanol [GO:0048149]; cardiac muscle hypertrophy [GO:0003300]; cellular response to dopamine [GO:1903351]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin formation [GO:0031507]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein modification process [GO:0036211]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to amphetamine [GO:0001975]; response to amyloid-beta [GO:1904645]; response to caffeine [GO:0031000]; response to cocaine [GO:0042220]; response to hyperoxia [GO:0055093]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to xenobiotic stimulus [GO:0009410],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; Sin3-type complex [GO:0070822]"
P56524,C5,1.355828434,0.382305628,-0.427351906,-0.380310933,-0.633165115,turquoise3,HDAC4,HDAC4_HUMAN,Histone deacetylase 4 (HD4) (EC 3.5.1.98),HDAC4 KIAA0288,9759;,ENST00000345617.7; ENSP00000264606.3; ENSG00000068024.18. [P56524-1];,DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; potassium ion binding [GO:0030955]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270],"B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; inflammatory response [GO:0006954]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; protein sumoylation [GO:0016925]; regulation of protein binding [GO:0043393]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to interleukin-1 [GO:0070555]; type I interferon-mediated signaling pathway [GO:0060337]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]
Q9UKV0,C2,0.996200646,0.4304078,-0.145587809,-0.103794803,-0.316525605,aquamarine,HDAC7,HDAC9_HUMAN,Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR),HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR,9734;,"ENST00000401921.5; ENSP00000383912.1; ENSG00000048052.25. [Q9UKV0-6];""ENST00000405010.7; ENSP00000384382.3; ENSG00000048052.25. [Q9UKV0-3]"";""ENST00000406451.8; ENSP00000384657.3; ENSG00000048052.25. [Q9UKV0-5]"";""ENST00000417496.6; ENSP00000401669.2; ENSG00000048052.25. [Q9UKV0-8]"";""ENST00000428307.6; ENSP00000395655.2; ENSG00000048052.25. [Q9UKV0-9]"";""ENST00000432645.6; ENSP00000410337.2; ENSG00000048052.25. [Q9UKV0-1]"";""ENST00000441542.7; ENSP00000408617.2; ENSG00000048052.25. [Q9UKV0-7]"";""ENST00000456174.6; ENSP00000388568.2; ENSG00000048052.25. [Q9UKV0-10]"";""ENST00000524023.1; ENSP00000430036.1; ENSG00000048052.25. [Q9UKV0-11]"";""ENST00000686413.1; ENSP00000509161.1; ENSG00000048052.25. [Q9UKV0-7]"";",DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; histone H3K14 deacetylase activity [GO:0031078]; histone H3K9 deacetylase activity [GO:0032129]; histone H4K16 deacetylase activity [GO:0034739]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],"B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; cholesterol homeostasis [GO:0042632]; heart development [GO:0007507]; inflammatory response [GO:0006954]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of striated muscle cell differentiation [GO:0051153]; response to amphetamine [GO:0001975]",cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]
Q9BY41,C5,1.820477788,0.648091139,-0.726797681,-0.836752415,-1.138952293,turquoise3,HDAC8,HDAC8_HUMAN,Histone deacetylase 8 (HD8) (EC 3.5.1.98) (Protein deacetylase HDAC8) (EC 3.5.1.-) (Protein decrotonylase HDAC8) (EC 3.5.1.-),HDAC8 HDACL1 CDA07,55869;,"ENST00000373554.6; ENSP00000362655.1; ENSG00000147099.21. [Q9BY41-8];""ENST00000373556.8; ENSP00000362657.3; ENSG00000147099.21. [Q9BY41-7]"";""ENST00000373559.8; ENSP00000362660.4; ENSG00000147099.21. [Q9BY41-6]"";""ENST00000373573.9; ENSP00000362674.3; ENSG00000147099.21. [Q9BY41-1]"";""ENST00000373589.9; ENSP00000362691.4; ENSG00000147099.21. [Q9BY41-4]"";""ENST00000439122.7; ENSP00000414486.2; ENSG00000147099.21. [Q9BY41-5]"";""ENST00000649116.1; ENSP00000497925.1; ENSG00000147099.21. [Q9BY41-8]"";",DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone decrotonylase activity [GO:0160009]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; protein lysine deacetylase activity [GO:0033558],chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204],cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q7Z4H3,C5,1.751630572,0.282126303,-0.620543932,-0.568644313,-0.83730144,turquoise3,HDDC2,HDDC2_HUMAN,5'-deoxynucleotidase HDDC2 (EC 3.1.3.89) (HD domain-containing protein 2) (Hepatitis C virus NS5A-transactivated protein 2) (HCV NS5A-transactivated protein 2),HDDC2 C6orf74 NS5ATP2 CGI-130,51020;,"ENST00000318787.13; ENSP00000316242.9; ENSG00000111906.18. [Q7Z4H3-3];""ENST00000398153.7; ENSP00000381220.1; ENSG00000111906.18. [Q7Z4H3-1]"";""ENST00000609477.5; ENSP00000476969.1; ENSG00000111906.18. [Q7Z4H3-3]"";",5'-deoxynucleotidase activity [GO:0002953]; metal ion binding [GO:0046872],0,0
Q08623,C5,1.94346322,0.459401032,-1.054952187,-1.13436195,-1.113394805,turquoise3,HDHD1,HDHD1_HUMAN,Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase),PUDP DXF68S1E FAM16AX GS1 HDHD1 HDHD1A,8226;,"ENST00000381077.10; ENSP00000370467.6; ENSG00000130021.15. [Q08623-1];""ENST00000412827.6; ENSP00000406260.2; ENSG00000130021.15. [Q08623-2]"";""ENST00000424830.6; ENSP00000396452.2; ENSG00000130021.15. [Q08623-4]"";""ENST00000486446.3; ENSP00000430995.2; ENSG00000130021.15. [Q08623-3]"";",metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738],nucleotide metabolic process [GO:0009117],cytosol [GO:0005829]
Q00341,N4,0.135117114,1.060700442,-0.36507399,-0.418801937,-0.480679229,grey30,HDLBP,VIGLN_HUMAN,Vigilin (High density lipoprotein-binding protein) (HDL-binding protein),HDLBP HBP VGL,3069;,"ENST00000310931.10; ENSP00000312042.4; ENSG00000115677.18. [Q00341-1];""ENST00000391975.5; ENSP00000375836.1; ENSG00000115677.18. [Q00341-1]"";""ENST00000391976.6; ENSP00000375837.2; ENSG00000115677.18. [Q00341-1]"";""ENST00000427183.6; ENSP00000399139.2; ENSG00000115677.18. [Q00341-2]"";",cadherin binding [GO:0045296]; lipid binding [GO:0008289]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],cholesterol metabolic process [GO:0008203]; lipid transport [GO:0006869],cytoplasm [GO:0005737]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9H583,N3,-1.058582815,-1.097640783,1.298742933,-0.087992477,-0.310105843,grey50,HEATR1,HEAT1_HUMAN,"HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed]",HEATR1 BAP28 UTP10,55127;,ENST00000366582.8; ENSP00000355541.3; ENSG00000119285.11.;,RNA binding [GO:0003723]; snoRNA binding [GO:0030515],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; ribosomal small subunit biogenesis [GO:0042274]",90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]
Q9NRV9,C3,1.744699515,0.253618283,-0.503539051,-0.3892516,-1.117879041,cyan,HEBP1,HEBP1_HUMAN,Heme-binding protein 1 (p22HBP),HEBP1 HBP,50865;,ENST00000014930.9; ENSP00000014930.4; ENSG00000013583.10.;,heme binding [GO:0020037],circadian rhythm [GO:0007623],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]
Q9Y4D8,C1,0.733604364,-0.100698337,-0.357722807,-0.071651813,0.727071552,lightblue,HECTD4,HECD4_HUMAN,Probable E3 ubiquitin-protein ligase HECTD4 (EC 2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4),HECTD4 C12orf51 KIAA0614,0,0,ubiquitin-protein transferase activity [GO:0004842],glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein ubiquitination [GO:0016567],membrane [GO:0016020]
Q8NG08,C5,1.263369247,0.486585515,-0.334894216,-0.410338684,-0.429583551,turquoise3,HELB,HELB_HUMAN,DNA helicase B (hDHB) (EC 3.6.4.12),HELB,92797;,"ENST00000247815.9; ENSP00000247815.5; ENSG00000127311.10. [Q8NG08-1];""ENST00000440906.6; ENSP00000396955.2; ENSG00000127311.10. [Q8NG08-2]"";""ENST00000545134.1; ENSP00000443287.1; ENSG00000127311.10. [Q8NG08-1]"";",5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein-containing complex binding [GO:0044877]; single-stranded DNA helicase activity [GO:0017116],"DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, synthesis of primer [GO:0006269]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]
P42694,N1,-0.278177273,0.268921686,-0.163128689,0.013690176,0.686043407,grey90,HELZ,HELZ_HUMAN,Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein),HELZ DRHC KIAA0054,9931;,"ENST00000358691.10; ENSP00000351524.5; ENSG00000198265.12. [P42694-1];""ENST00000579953.5; ENSP00000463727.1; ENSG00000198265.12. [P42694-2]"";",ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194],cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P granule [GO:0043186]
Q9BYK8,N1,-0.309656811,-0.780399281,-0.383180046,-0.161615695,1.376788268,grey90,HELZ2,HELZ2_HUMAN,"3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein)",HELZ2 KIAA1769 PRIC285,85441;,ENST00000427522.6; ENSP00000393257.2; ENSG00000130589.16. [Q9BYK8-2];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; exoribonuclease II activity [GO:0008859]; metal ion binding [GO:0046872]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],positive regulation of transcription by RNA polymerase II [GO:0045944]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; P granule [GO:0043186]
Q15751,C1,1.392118778,-0.326915262,-0.628333616,-0.458731619,0.282747981,lightblue,HERC1,HERC1_HUMAN,Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619),HERC1,8925;,ENST00000443617.7; ENSP00000390158.2; ENSG00000103657.14.;,guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin-protein transferase activity [GO:0004842],autophagy [GO:0006914]; cerebellar Purkinje cell differentiation [GO:0021702]; corpus callosum development [GO:0022038]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]
O95714,S1,-0.033808212,-0.97925234,-0.213513954,0.466510922,0.914519029,gold,HERC2,HERC2_HUMAN,E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2),HERC2,8924;,ENST00000261609.13; ENSP00000261609.8; ENSG00000128731.18.;,guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9UII4,N1,-0.507873054,-0.951581195,-0.060531932,0.140794209,1.323717612,grey90,HERC5,HERC5_HUMAN,E3 ISG15--protein ligase HERC5 (EC 2.3.2.-) (Cyclin-E-binding protein 1) (HECT domain and RCC1-like domain-containing protein 5),HERC5 CEB1 CEBP1,51191;,ENST00000264350.8; ENSP00000264350.3; ENSG00000138646.9.;,ISG15 transferase activity [GO:0042296]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],defense response to virus [GO:0051607]; innate immune response [GO:0045087]; ISG15-protein conjugation [GO:0032020]; PKR/eIFalpha signaling [GO:0039585]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of defense response to virus [GO:0050688]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]
Q9NQE9,S3,-0.170138401,-0.264965311,-0.011242573,0.599424587,0.59091402,salmon,HINT3,HINT3_HUMAN,Adenosine 5'-monophosphoramidase HINT3 (EC 3.9.1.-) (Histidine triad nucleotide-binding protein 3) (HINT-3),HINT3,135114;,ENST00000229633.7; ENSP00000229633.5; ENSG00000111911.7.;,adenosine 5'-monophosphoramidase activity [GO:0043530]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166],0,cytoplasm [GO:0005737]; nucleus [GO:0005634]
O00291,M1,-0.73864558,-0.445301573,0.63302185,0.743160719,-0.325592779,burlywood4,HIP1,HIP1_HUMAN,Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I),HIP1,3092;,"ENST00000336926.11; ENSP00000336747.6; ENSG00000127946.17. [O00291-1];""ENST00000434438.6; ENSP00000410300.2; ENSG00000127946.17. [O00291-3]"";""ENST00000616821.4; ENSP00000484528.1; ENSG00000127946.17. [O00291-4]"";","actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]",actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of receptor-mediated endocytosis [GO:0048260]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149],clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]
Q9BW71,N4,-0.304548118,1.334931373,-0.450208914,-0.894626505,-0.958403171,grey30,HIRIP3,HIRP3_HUMAN,HIRA-interacting protein 3,HIRIP3,8479;,"ENST00000279392.8; ENSP00000279392.3; ENSG00000149929.16. [Q9BW71-1];""ENST00000564026.1; ENSP00000456824.1; ENSG00000149929.16. [Q9BW71-3]"";",0,chromatin organization [GO:0006325],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P16401,N3,-1.387351227,-1.18120622,1.127771655,-0.263406348,0.515502479,grey50,HIST1H1B,H15_HUMAN,Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3),H1-5 H1F5 HIST1H1B,3009;,ENST00000331442.5; ENSP00000330074.4; ENSG00000184357.5.;,chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527],chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; establishment of protein localization to chromatin [GO:0071169]; muscle organ development [GO:0007517]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; protein stabilization [GO:0050821],chromatin [GO:0000785]; chromosome [GO:0005694]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]
P16403,N3,-1.995007255,-1.418541114,1.162900148,-0.312407352,0.512644144,grey50,HIST1H1C,H12_HUMAN,Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1),H1-2 H1F2 HIST1H1C,3006;,ENST00000343677.4; ENSP00000339566.3; ENSG00000187837.4.;,chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527],chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334],euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634]
P10412,N3,-1.986553269,-1.399349951,1.176598114,-0.29708179,0.580478496,grey50,HIST1H1E,H14_HUMAN,Histone H1.4 (Histone H1b) (Histone H1s-4),H1-4 H1F4 HIST1H1E,3008;,ENST00000304218.6; ENSP00000307705.4; ENSG00000168298.7.;,chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527],chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334],euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleosome [GO:0000786]; nucleus [GO:0005634]
Q5TEC6,N3,-1.686425065,-1.940198921,1.644939257,-0.184298444,-1.19129018,grey50,HIST2H3PS2,H37_HUMAN,Histone H3-7,H3-7 H3-2 HIST2H3PS2,0,"ENST00000392948.5; ENSP00000476960.1; ENSG00000273213.4.;""ENST00000609879.2; ENSP00000499501.1; ENSG00000273213.4."";",DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],0,nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]
P04439,S2,-1.087068895,-1.21722046,0.307856462,0.88133551,0.620347729,orange,HLA-A,HLAA_HUMAN,"HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A) (HLA-A)",HLA-A HLAA,3105;,"ENST00000376809.10; ENSP00000366005.5; ENSG00000206503.14. [P04439-1];""ENST00000396634.5; ENSP00000379873.1; ENSG00000206503.14. [P04439-1]"";""ENST00000706901.1; ENSP00000516612.1; ENSG00000206503.14. [P04439-1]"";""ENST00000706903.1; ENSP00000516614.1; ENSG00000206503.14. [P04439-1]"";""ENST00000706905.1; ENSP00000516616.1; ENSG00000206503.14. [P04439-1]"";",beta-2-microglobulin binding [GO:0030881]; CD8 receptor binding [GO:0042610]; peptide antigen binding [GO:0042605]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]; TAP binding [GO:0046977]; TAP complex binding [GO:0062061],"antibacterial humoral response [GO:0019731]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; CD8-positive, alpha-beta T cell activation [GO:0036037]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; immune response [GO:0006955]; innate immune response [GO:0045087]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of CD8-positive, alpha-beta T cell activation [GO:2001187]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; T cell mediated cytotoxicity [GO:0001913]; T cell mediated cytotoxicity directed against tumor cell target [GO:0002419]; T cell receptor signaling pathway [GO:0050852]",cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]
P10321,S2,-1.036985319,-1.398902838,0.166408673,0.917567486,0.540278787,orange,HLA-C,HLAC_HUMAN,"HLA class I histocompatibility antigen, C alpha chain (HLA-C) (HLA-Cw) (Human leukocyte antigen C)",HLA-C HLAC,3107;,ENST00000376228.10; ENSP00000365402.5; ENSG00000204525.18. [P10321-1];,peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; TAP binding [GO:0046977],"adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; immune response [GO:0006955]; innate immune response [GO:0045087]; positive regulation of T cell mediated cytotoxicity [GO:0001916]",cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]
P13747,S2,-0.813898669,-1.213224015,0.222266508,0.892726301,0.499026054,orange,HLA-E,HLAE_HUMAN,"HLA class I histocompatibility antigen, alpha chain E (MHC class I antigen E) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain E (sHLA-E)]",HLA-E HLA-6.2 HLAE,3133;,"ENST00000376630.5; ENSP00000365817.4; ENSG00000204592.9.;""ENST00000383597.6; ENSP00000373091.4; ENSG00000206493.7."";""ENST00000415289.4; ENSP00000409910.2; ENSG00000229252.6."";""ENST00000415649.4; ENSP00000390707.2; ENSG00000233904.6."";""ENST00000425603.4; ENSP00000402694.2; ENSG00000236632.5."";""ENST00000427936.4; ENSP00000397420.2; ENSG00000230254.7."";""ENST00000444683.4; ENSP00000400458.2; ENSG00000225201.6."";",beta-2-microglobulin binding [GO:0030881]; MHC class I protein binding [GO:0042288]; natural killer cell lectin-like receptor binding [GO:0046703]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608],"adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of exogenous peptide antigen via MHC class Ib [GO:0002477]; CD8-positive, alpha-beta T cell activation [GO:0036037]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; natural killer cell tolerance induction [GO:0002519]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of antibody-dependent cellular cytotoxicity [GO:0001815]; positive regulation of CD8-positive, alpha-beta T cell activation [GO:2001187]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated immunity [GO:0002717]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of natural killer cell mediated immunity [GO:0002715]",cell surface [GO:0009986]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; MHC class I protein complex [GO:0042612]; MHC class Ib protein complex [GO:0032398]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]
P30511,S2,-1.315869128,-1.265488939,0.277513625,1.010449249,0.631081424,orange,HLA-F,HLAF_HUMAN,"HLA class I histocompatibility antigen, alpha chain F (CDA12) (HLA F antigen) (Leukocyte antigen F) (MHC class I antigen F)",HLA-F HLA-5.4 HLAF,3134;,"ENST00000259951.12; ENSP00000259951.6; ENSG00000204642.14. [P30511-3];""ENST00000334668.8; ENSP00000334263.4; ENSG00000204642.14. [P30511-1]"";""ENST00000359076.7; ENSP00000351977.3; ENSG00000206509.13. [P30511-2]"";""ENST00000376848.8; ENSP00000366044.4; ENSG00000229698.11. [P30511-2]"";""ENST00000376861.5; ENSP00000366057.1; ENSG00000204642.14. [P30511-1]"";""ENST00000383515.6; ENSP00000373007.2; ENSG00000137403.19. [P30511-2]"";""ENST00000420067.5; ENSP00000393535.1; ENSG00000235220.10. [P30511-2]"";""ENST00000434407.6; ENSP00000397376.2; ENSG00000204642.14. [P30511-2]"";""ENST00000440590.5; ENSP00000399835.1; ENSG00000237508.10. [P30511-2]"";",14-3-3 protein binding [GO:0071889]; beta-2-microglobulin binding [GO:0030881]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979],"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of exogenous peptide antigen via MHC class Ib [GO:0002477]; immune response [GO:0006955]; negative regulation of natural killer cell cytokine production [GO:0002728]; negative regulation of natural killer cell degranulation [GO:0043322]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of T cell cytokine production [GO:0002725]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of T cell mediated cytotoxicity [GO:0001916]",cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; MHC class Ib protein complex [GO:0032398]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]
Q14527,N2,-0.58372364,0.065451087,0.78830218,0.107241389,-0.210981229,grey70,HLTF,HLTF_HUMAN,Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3),HLTF HIP116A RNF80 SMARCA3 SNF2L3 ZBU1,6596;,"ENST00000310053.10; ENSP00000308944.5; ENSG00000071794.16. [Q14527-1];""ENST00000392912.6; ENSP00000376644.2; ENSG00000071794.16. [Q14527-1]"";""ENST00000494055.5; ENSP00000420429.1; ENSG00000071794.16. [Q14527-1]"";","ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]",DNA repair [GO:0006281]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767],cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]
Q8TCT9,S2,-1.652106104,-1.804121789,0.175344535,0.93701782,0.657907364,orange,HM13,HM13_HUMAN,Minor histocompatibility antigen H13 (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase),HM13 H13 IMP1 PSL3 SPP MSTP086,81502;,"ENST00000340852.9; ENSP00000343032.5; ENSG00000101294.19. [Q8TCT9-1];""ENST00000398174.9; ENSP00000381237.3; ENSG00000101294.19. [Q8TCT9-2]"";""ENST00000674240.1; ENSP00000501423.1; ENSG00000101294.19. [Q8TCT9-4]"";","aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]","cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; signal peptide processing [GO:0006465]",cell surface [GO:0009986]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]
Q9NP66,N2,-1.170548552,-0.467293301,1.208650979,0.036872672,-0.408322344,grey70,HMG20A,HM20A_HUMAN,High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1),HMG20A HMGX1 HMGXB1,10363;,"ENST00000336216.9; ENSP00000336856.4; ENSG00000140382.15. [Q9NP66-1];""ENST00000381714.7; ENSP00000371133.3; ENSG00000140382.15. [Q9NP66-1]"";",DNA binding [GO:0003677]; identical protein binding [GO:0042802],chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468],nucleus [GO:0005634]
P04035,S3,-0.958658204,-0.992332314,0.154530483,0.848332618,0.638748604,salmon,HMGCR,HMDH_HUMAN,3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34),HMGCR,3156;,"ENST00000287936.9; ENSP00000287936.4; ENSG00000113161.17. [P04035-1];""ENST00000343975.9; ENSP00000340816.5; ENSG00000113161.17. [P04035-2]"";""ENST00000511206.5; ENSP00000426745.1; ENSG00000113161.17. [P04035-1]"";""ENST00000680940.1; ENSP00000505561.1; ENSG00000113161.17. [P04035-1]"";""ENST00000681271.1; ENSP00000505805.1; ENSG00000113161.17. [P04035-1]"";""ENST00000681410.1; ENSP00000506232.1; ENSG00000113161.17. [P04035-1]"";",coenzyme A binding [GO:0120225]; GTPase regulator activity [GO:0030695]; hydroxymethylglutaryl-CoA reductase (NADPH) activity [GO:0004420]; NADPH binding [GO:0070402],cholesterol biosynthetic process [GO:0006695]; coenzyme A metabolic process [GO:0015936]; isoprenoid biosynthetic process [GO:0008299]; long-term synaptic potentiation [GO:0060291]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; regulation of ERK1 and ERK2 cascade [GO:0070372]; sterol biosynthetic process [GO:0016126]; visual learning [GO:0008542],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; peroxisomal membrane [GO:0005778]
Q01581,C4,2.142408032,0.313650586,-1.040296474,-1.10648174,-1.467272181,deepskyblue2,HMGCS1,HMCS1_HUMAN,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)",HMGCS1 HMGCS,3157;,"ENST00000325110.11; ENSP00000322706.6; ENSG00000112972.15.;""ENST00000433297.2; ENSP00000399402.2; ENSG00000112972.15."";",hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; protein homodimerization activity [GO:0042803],"acetyl-CoA metabolic process [GO:0006084]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process, mevalonate pathway [GO:0010142]; lipid metabolic process [GO:0006629]",cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q9UGU5,N2,-1.00256438,-0.302809707,0.734531384,-0.132293925,0.504684736,grey70,HMGXB4,HMGX4_HUMAN,HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG),HMGXB4 HMG2L1 HMGBCG,10042;,ENST00000216106.6; ENSP00000216106.5; ENSG00000100281.14.;,DNA binding [GO:0003677]; identical protein binding [GO:0042802],endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NURF complex [GO:0016589]
P30519,S2,-1.135554402,-1.326907475,0.17575519,0.920722602,0.648362788,orange,HMOX2,HMOX2_HUMAN,Heme oxygenase 2 (HO-2) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 2 soluble form],HMOX2 HO2,3163;,"ENST00000219700.10; ENSP00000219700.6; ENSG00000103415.12. [P30519-1];""ENST00000398595.7; ENSP00000381595.3; ENSG00000103415.12. [P30519-1]"";""ENST00000406590.6; ENSP00000385100.2; ENSG00000103415.12. [P30519-1]"";""ENST00000414777.5; ENSP00000391637.1; ENSG00000103415.12. [P30519-1]"";""ENST00000458134.7; ENSP00000394103.3; ENSG00000103415.12. [P30519-1]"";""ENST00000570646.6; ENSP00000459214.1; ENSG00000103415.12. [P30519-1]"";""ENST00000575120.5; ENSP00000460926.1; ENSG00000103415.12. [P30519-2]"";""ENST00000612525.4; ENSP00000481295.1; ENSG00000277424.4. [P30519-1]"";""ENST00000615778.4; ENSP00000484422.1; ENSG00000277424.4. [P30519-1]"";""ENST00000619528.4; ENSP00000484423.1; ENSG00000103415.12. [P30519-1]"";""ENST00000619913.4; ENSP00000484467.1; ENSG00000103415.12. [P30519-1]"";""ENST00000620445.3; ENSP00000478785.1; ENSG00000277424.4. [P30519-1]"";""ENST00000621065.4; ENSP00000481811.1; ENSG00000277424.4. [P30519-1]"";""ENST00000622146.4; ENSP00000483319.2; ENSG00000277424.4. [P30519-1]"";""ENST00000631540.1; ENSP00000487673.1; ENSG00000277424.4. [P30519-1]"";""ENST00000631677.1; ENSP00000488579.1; ENSG00000277424.4. [P30519-1]"";""ENST00000632458.1; ENSP00000488880.1; ENSG00000277424.4. [P30519-1]"";""ENST00000633319.1; ENSP00000488769.1; ENSG00000277424.4. [P30519-2]"";",heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872],heme catabolic process [GO:0042167]; heme oxidation [GO:0006788]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]
Q13151,N1,-1.137234799,-0.762118703,0.724660999,-0.140528428,1.045128982,grey90,HNRNPA0,ROA0_HUMAN,Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0),HNRNPA0 HNRPA0,10949;,ENST00000314940.7; ENSP00000316042.4; ENSG00000177733.7.;,mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723],3'-UTR-mediated mRNA stabilization [GO:0070935]; inflammatory response [GO:0006954]; mRNA processing [GO:0006397]; response to lipopolysaccharide [GO:0032496],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]
P09651,N3,-0.893628834,-1.039308919,0.786131942,-0.347971756,0.854298004,grey50,HNRNPA1,ROA1_HUMAN,"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]",HNRNPA1 HNRPA1,3178;,"ENST00000340913.11; ENSP00000341826.7; ENSG00000135486.19. [P09651-1];""ENST00000546500.5; ENSP00000448617.1; ENSG00000135486.19. [P09651-2]"";""ENST00000547276.5; ENSP00000447260.1; ENSG00000135486.19. [P09651-3]"";""ENST00000547566.5; ENSP00000449913.1; ENSG00000135486.19. [P09651-2]"";""ENST00000550482.2; ENSP00000446486.2; ENSG00000135486.19. [P09651-2]"";""ENST00000677210.1; ENSP00000503610.1; ENSG00000135486.19. [P09651-1]"";",DNA binding [GO:0003677]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; telomeric repeat-containing RNA binding [GO:0061752],"cellular response to glucose starvation [GO:0042149]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear export [GO:0051168]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA export from nucleus [GO:0006405]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]
P22626,N3,-1.269517441,-1.091686035,1.013035067,-0.175093998,0.479458851,grey50,HNRNPA2B1,ROA2_HUMAN,Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1),HNRNPA2B1 HNRPA2B1,3181;,"ENST00000354667.8; ENSP00000346694.4; ENSG00000122566.22. [P22626-1];""ENST00000356674.8; ENSP00000349101.8; ENSG00000122566.22. [P22626-1]"";""ENST00000360787.8; ENSP00000354021.4; ENSG00000122566.22. [P22626-1]"";""ENST00000608362.2; ENSP00000497298.1; ENSG00000122566.22. [P22626-2]"";""ENST00000618183.5; ENSP00000478691.2; ENSG00000122566.22. [P22626-2]"";""ENST00000676497.1; ENSP00000503836.1; ENSG00000122566.22. [P22626-2]"";""ENST00000676524.1; ENSP00000504831.1; ENSG00000122566.22. [P22626-2]"";""ENST00000676746.1; ENSP00000504329.1; ENSG00000122566.22. [P22626-1]"";""ENST00000676749.1; ENSP00000504799.1; ENSG00000122566.22. [P22626-2]"";""ENST00000676903.1; ENSP00000504660.1; ENSG00000122566.22. [P22626-2]"";""ENST00000677339.1; ENSP00000503242.1; ENSG00000122566.22. [P22626-2]"";""ENST00000677396.1; ENSP00000503703.1; ENSG00000122566.22. [P22626-2]"";""ENST00000677574.1; ENSP00000503021.1; ENSG00000122566.22. [P22626-2]"";""ENST00000677631.1; ENSP00000503452.1; ENSG00000122566.22. [P22626-2]"";""ENST00000677656.1; ENSP00000503060.1; ENSG00000122566.22. [P22626-2]"";""ENST00000677839.1; ENSP00000504439.1; ENSG00000122566.22. [P22626-2]"";""ENST00000677906.1; ENSP00000503870.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678431.1; ENSP00000503833.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678449.1; ENSP00000503375.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678501.1; ENSP00000503961.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678675.1; ENSP00000503476.1; ENSG00000122566.22. [P22626-1]"";""ENST00000678697.1; ENSP00000503047.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678779.1; ENSP00000503429.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678884.1; ENSP00000503501.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678935.1; ENSP00000504023.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678962.1; ENSP00000504721.1; ENSG00000122566.22. [P22626-2]"";""ENST00000678998.1; ENSP00000503460.1; ENSG00000122566.22. [P22626-2]"";""ENST00000679001.1; ENSP00000503514.1; ENSG00000122566.22. [P22626-1]"";""ENST00000679021.1; ENSP00000503885.1; ENSG00000122566.22. [P22626-1]"";""ENST00000679123.1; ENSP00000503360.1; ENSG00000122566.22. [P22626-1]"";""ENST00000679243.1; ENSP00000504415.1; ENSG00000122566.22. [P22626-2]"";""ENST00000679318.1; ENSP00000504571.1; ENSG00000122566.22. [P22626-2]"";",G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; single-stranded telomeric DNA binding [GO:0043047],"G-quadruplex DNA unwinding [GO:0044806]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; primary miRNA processing [GO:0031053]; RNA transport [GO:0050658]","Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]"
P51991,N3,-1.05677629,-0.921163158,0.955248221,-0.138581172,0.50294774,grey50,HNRNPA3,ROA3_HUMAN,Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3),HNRNPA3 HNRPA3,220988;,"ENST00000392524.7; ENSP00000376309.2; ENSG00000170144.22. [P51991-1];""ENST00000411529.6; ENSP00000408487.1; ENSG00000170144.22. [P51991-2]"";""ENST00000435711.5; ENSP00000416340.1; ENSG00000170144.22. [P51991-1]"";""ENST00000676629.1; ENSP00000503593.1; ENSG00000170144.22. [P51991-1]"";""ENST00000676874.1; ENSP00000503186.1; ENSG00000170144.22. [P51991-2]"";""ENST00000678111.1; ENSP00000504135.1; ENSG00000170144.22. [P51991-1]"";""ENST00000679159.1; ENSP00000504152.1; ENSG00000170144.22. [P51991-1]"";",mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
Q99729,N1,-1.441128507,-0.392489032,0.74847717,-0.306699883,1.086721651,grey90,HNRNPAB,ROAA_HUMAN,Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBEC1-binding protein 1) (ABBP-1),HNRNPAB ABBP1 HNRPAB,3182;,"ENST00000355836.9; ENSP00000348093.5; ENSG00000197451.12. [Q99729-3];""ENST00000358344.8; ENSP00000351108.3; ENSG00000197451.12. [Q99729-2]"";""ENST00000504898.5; ENSP00000425031.1; ENSG00000197451.12. [Q99729-2]"";""ENST00000506259.5; ENSP00000427465.1; ENSG00000197451.12. [Q99729-3]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],"epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA demethylation [GO:1901537]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]
P07910,N3,-1.282296102,-1.523987992,1.115149389,0.05088902,0.392018219,grey50,HNRNPC,HNRPC_HUMAN,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),HNRNPC HNRPC,3183;,"ENST00000420743.6; ENSP00000404848.2; ENSG00000092199.19. [P07910-1];""ENST00000430246.6; ENSP00000442816.1; ENSG00000092199.19. [P07910-2]"";""ENST00000553300.6; ENSP00000450544.1; ENSG00000092199.19. [P07910-2]"";""ENST00000554455.5; ENSP00000451291.1; ENSG00000092199.19. [P07910-1]"";""ENST00000554969.5; ENSP00000450725.1; ENSG00000092199.19. [P07910-2]"";""ENST00000555883.5; ENSP00000450629.1; ENSG00000092199.19. [P07910-4]"";""ENST00000556628.5; ENSP00000451652.1; ENSG00000092199.19. [P07910-3]"";""ENST00000556897.5; ENSP00000451176.1; ENSG00000092199.19. [P07910-2]"";""ENST00000557201.5; ENSP00000452276.1; ENSG00000092199.19. [P07910-1]"";",identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; nucleosomal DNA binding [GO:0031492]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],"3'-UTR-mediated mRNA stabilization [GO:0070935]; chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of telomere maintenance via telomerase [GO:0032211]; osteoblast differentiation [GO:0001649]; RNA splicing [GO:0008380]",actin cytoskeleton [GO:0015629]; catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]
Q14103,N1,-1.180218978,0.015558183,0.390380633,-0.432537296,1.029740853,grey90,HNRNPD,HNRPD_HUMAN,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),HNRNPD AUF1 HNRPD,3184;,"ENST00000313899.12; ENSP00000313199.7; ENSG00000138668.20. [Q14103-1];""ENST00000352301.8; ENSP00000305860.6; ENSG00000138668.20. [Q14103-2]"";""ENST00000353341.8; ENSP00000313327.6; ENSG00000138668.20. [Q14103-3]"";""ENST00000503822.2; ENSP00000422615.2; ENSG00000138668.20. [Q14103-4]"";""ENST00000507010.6; ENSP00000421952.2; ENSG00000138668.20. [Q14103-1]"";""ENST00000703971.1; ENSP00000515597.1; ENSG00000138668.20. [Q14103-2]"";",chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to nitric oxide [GO:0071732]; cellular response to putrescine [GO:1904586]; cerebellum development [GO:0021549]; circadian regulation of translation [GO:0097167]; CRD-mediated mRNA stabilization [GO:0070934]; hepatocyte dedifferentiation [GO:1990828]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of gene expression [GO:0010629]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere capping [GO:1904355]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of telomere maintenance [GO:0032204]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to rapamycin [GO:1901355]; response to sodium phosphate [GO:1904383]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mCRD-mediated mRNA stability complex [GO:0106002]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]
O14979,N3,-1.393986743,-1.044299661,1.031164337,5.82E-04,0.704183771,grey50,HNRNPDL,HNRDL_HUMAN,Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1),HNRNPDL HNRPDL JKTBP,9987;,"ENST00000295470.10; ENSP00000295470.5; ENSG00000152795.18. [O14979-1];""ENST00000349655.8; ENSP00000338552.5; ENSG00000152795.18. [O14979-2]"";""ENST00000502762.4; ENSP00000422040.1; ENSG00000152795.18. [O14979-1]"";""ENST00000507721.5; ENSP00000480156.1; ENSG00000152795.18. [O14979-2]"";""ENST00000602300.5; ENSP00000473677.1; ENSG00000152795.18. [O14979-2]"";""ENST00000621267.4; ENSP00000483254.1; ENSG00000152795.18. [O14979-1]"";""ENST00000630114.2; ENSP00000486452.1; ENSG00000152795.18. [O14979-2]"";""ENST00000630827.1; ENSP00000485954.1; ENSG00000152795.18. [O14979-2]"";",DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],regulation of gene expression [GO:0010468]; RNA processing [GO:0006396],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]
P31943,N2,-0.708173426,0.059507655,0.745206414,-0.068945801,0.353545503,grey70,HNRNPH1,HNRH1_HUMAN,"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]",HNRNPH1 HNRPH HNRPH1,3187;,"ENST00000356731.9; ENSP00000349168.5; ENSG00000169045.19.;""ENST00000393432.9; ENSP00000377082.4; ENSG00000169045.19."";""ENST00000442819.6; ENSP00000397797.2; ENSG00000169045.19."";""ENST00000505811.6; ENSP00000424087.2; ENSG00000169045.19."";""ENST00000513225.6; ENSP00000426518.2; ENSG00000169045.19."";""ENST00000515158.6; ENSP00000421695.2; ENSG00000169045.19."";""ENST00000515714.6; ENSP00000425343.2; ENSG00000169045.19."";""ENST00000521116.6; ENSP00000429661.2; ENSG00000169045.19."";""ENST00000638505.3; ENSP00000492076.2; ENSG00000284254.4."";""ENST00000710500.1; ENSP00000518308.1; ENSG00000284254.4."";""ENST00000710502.1; ENSP00000518309.1; ENSG00000284254.4."";""ENST00000710510.1; ENSP00000518316.1; ENSG00000284254.4."";""ENST00000710511.1; ENSP00000518317.1; ENSG00000284254.4."";""ENST00000710512.1; ENSP00000518318.1; ENSG00000284254.4."";""ENST00000710513.1; ENSP00000518319.1; ENSG00000284254.4."";""ENST00000710515.1; ENSP00000518321.1; ENSG00000284254.4."";",identical protein binding [GO:0042802]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
P55795,N2,-0.674873455,0.053130994,0.6828274,-0.12217352,0.384790284,grey70,HNRNPH2,HNRH2_HUMAN,"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]",HNRNPH2 FTP3 HNRPH2,3188;,ENST00000316594.6; ENSP00000361927.2; ENSG00000126945.9.;,RNA binding [GO:0003723],regulation of RNA splicing [GO:0043484],cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]
P31942,N3,-1.231979027,-1.115215837,1.073307647,-0.031037864,0.419730628,grey50,HNRNPH3,HNRH3_HUMAN,Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) (Heterogeneous nuclear ribonucleoprotein 2H9) (hnRNP 2H9),HNRNPH3 HNRPH3,3189;,"ENST00000265866.12; ENSP00000265866.7; ENSG00000096746.18. [P31942-1];""ENST00000354695.5; ENSP00000346726.5; ENSG00000096746.18. [P31942-2]"";",RNA binding [GO:0003723],"epithelial cell differentiation [GO:0030855]; mRNA splicing, via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]
P61978,N4,-0.621693511,0.577474097,0.507842862,-0.284901911,0.153055597,grey30,HNRNPK,HNRPK_HUMAN,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),HNRNPK HNRPK,3190;,"ENST00000351839.7; ENSP00000317788.4; ENSG00000165119.22. [P61978-1];""ENST00000360384.9; ENSP00000353552.5; ENSG00000165119.22. [P61978-1]"";""ENST00000376263.8; ENSP00000365439.3; ENSG00000165119.22. [P61978-2]"";""ENST00000376281.8; ENSP00000365458.4; ENSG00000165119.22. [P61978-2]"";""ENST00000457156.6; ENSP00000409456.2; ENSG00000165119.22. [P61978-3]"";""ENST00000704004.1; ENSP00000515617.1; ENSG00000165119.22. [P61978-3]"";""ENST00000704005.1; ENSP00000515618.1; ENSG00000165119.22. [P61978-2]"";""ENST00000704006.1; ENSP00000515619.1; ENSG00000165119.22. [P61978-1]"";""ENST00000704011.1; ENSP00000515624.1; ENSG00000165119.22. [P61978-2]"";""ENST00000704051.1; ENSP00000515654.1; ENSG00000165119.22. [P61978-1]"";""ENST00000704052.1; ENSP00000515655.1; ENSG00000165119.22. [P61978-1]"";""ENST00000704053.1; ENSP00000515656.1; ENSG00000165119.22. [P61978-1]"";""ENST00000704057.1; ENSP00000515660.1; ENSG00000165119.22. [P61978-2]"";""ENST00000704058.1; ENSP00000515661.1; ENSG00000165119.22. [P61978-1]"";""ENST00000704059.1; ENSP00000515662.1; ENSG00000165119.22. [P61978-2]"";",cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]; signal transduction [GO:0007165]",catalytic step 2 spliceosome [GO:0071013]; cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; ribonucleoprotein complex [GO:1990904]
P14866,N3,-1.617485664,-1.455308689,1.0597907,-0.151901466,0.260034836,grey50,HNRNPL,HNRPL_HUMAN,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),HNRNPL HNRPL P/OKcl.14,3191;,"ENST00000221419.10; ENSP00000221419.4; ENSG00000104824.18. [P14866-1];""ENST00000600873.5; ENSP00000470231.1; ENSG00000104824.18. [P14866-2]"";""ENST00000634237.1; ENSP00000489244.1; ENSG00000282947.2. [P14866-2]"";""ENST00000634753.1; ENSP00000489021.1; ENSG00000282947.2. [P14866-1]"";",mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976],"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]
P52272,N1,-1.084897799,-0.345214509,0.430840558,0.141513514,0.916116557,grey90,HNRNPM,HNRPM_HUMAN,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),HNRNPM HNRPM NAGR1,4670;,"ENST00000325495.9; ENSP00000325376.2; ENSG00000099783.13. [P52272-1];""ENST00000348943.7; ENSP00000325732.2; ENSG00000099783.13. [P52272-2]"";",mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; spliceosomal complex [GO:0005681]; synapse [GO:0045202]
O43390,N3,-1.22553491,-1.053906865,0.979377713,-0.054167625,0.592852499,grey50,HNRNPR,HNRPR_HUMAN,Heterogeneous nuclear ribonucleoprotein R (hnRNP R),HNRNPR HNRPR,10236;,"ENST00000302271.11; ENSP00000304405.6; ENSG00000125944.22. [O43390-1];""ENST00000374612.5; ENSP00000363741.1; ENSG00000125944.22. [O43390-1]"";""ENST00000374616.7; ENSP00000363745.3; ENSG00000125944.22. [O43390-2]"";""ENST00000463552.6; ENSP00000502509.2; ENSG00000125944.22. [O43390-3]"";""ENST00000478691.5; ENSP00000474437.1; ENSG00000125944.22. [O43390-4]"";""ENST00000634263.1; ENSP00000489371.1; ENSG00000282958.5. [O43390-1]"";""ENST00000634634.2; ENSP00000488941.1; ENSG00000282958.5. [O43390-3]"";""ENST00000634713.1; ENSP00000488945.1; ENSG00000282958.5. [O43390-2]"";""ENST00000634766.2; ENSP00000489252.1; ENSG00000282958.5. [O43390-1]"";""ENST00000635150.1; ENSP00000489275.1; ENSG00000282958.5. [O43390-4]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]
Q9BUJ2,N1,-0.734852665,0.027259343,0.088146117,-0.331587161,0.924564866,grey90,HNRNPUL1,HNRL1_HUMAN,Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5) (E1B-AP5),HNRNPUL1 E1BAP5 HNRPUL1,11100;,"ENST00000378215.8; ENSP00000367460.3; ENSG00000105323.18. [Q9BUJ2-3];""ENST00000392006.8; ENSP00000375863.2; ENSG00000105323.18. [Q9BUJ2-1]"";""ENST00000593587.5; ENSP00000472629.1; ENSG00000105323.18. [Q9BUJ2-4]"";""ENST00000595018.5; ENSP00000473132.1; ENSG00000105323.18. [Q9BUJ2-4]"";""ENST00000602130.5; ENSP00000470687.1; ENSG00000105323.18. [Q9BUJ2-2]"";",enzyme binding [GO:0019899]; RNA binding [GO:0003723],response to virus [GO:0009615]; RNA processing [GO:0006396],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]
Q86VS8,C3,1.616816739,0.181897142,-0.592479501,-0.469968745,-0.746120815,cyan,HOOK3,HOOK3_HUMAN,Protein Hook homolog 3 (h-hook3) (hHK3),HOOK3,84376;,ENST00000307602.9; ENSP00000305699.3; ENSG00000168172.9.;,dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017],cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]
Q5SSJ5,N1,-1.046221755,-0.777564449,0.784282128,-0.38709003,0.880746645,grey90,HP1BP3,HP1B3_HUMAN,Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74),HP1BP3,50809;,"ENST00000312239.10; ENSP00000312625.5; ENSG00000127483.19. [Q5SSJ5-1];""ENST00000375000.5; ENSP00000364139.1; ENSG00000127483.19. [Q5SSJ5-5]"";""ENST00000375003.6; ENSP00000364142.2; ENSG00000127483.19. [Q5SSJ5-3]"";""ENST00000438032.6; ENSP00000403039.2; ENSG00000127483.19. [Q5SSJ5-1]"";",DNA binding [GO:0003677]; nucleosome binding [GO:0031491],cellular response to hypoxia [GO:0071456]; heterochromatin organization [GO:0070828]; nucleosome assembly [GO:0006334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of nucleus size [GO:0097298],chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleosome [GO:0000786]; nucleus [GO:0005634]
Q9Y251,S3,-1.633107148,-0.578287578,-0.158299961,0.718416318,1.007924161,salmon,HPSE,HPSE_HUMAN,Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit],HPSE HEP HPA HPA1 HPR1 HPSE1 HSE1,10855;,"ENST00000311412.10; ENSP00000308107.5; ENSG00000173083.16. [Q9Y251-1];""ENST00000405413.6; ENSP00000384262.2; ENSG00000173083.16. [Q9Y251-1]"";""ENST00000509906.5; ENSP00000421038.1; ENSG00000173083.16. [Q9Y251-4]"";""ENST00000512196.5; ENSP00000423265.1; ENSG00000173083.16. [Q9Y251-3]"";""ENST00000513463.1; ENSP00000421365.1; ENSG00000173083.16. [Q9Y251-2]"";",beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; syndecan binding [GO:0045545],angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin metabolic process [GO:0030202]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; response to organic substance [GO:0010033]; vascular wound healing [GO:0061042],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]
P01112,S4,-0.714506222,-0.976647842,0.299919443,0.733832334,0.369615384,tomato2,HRAS,RASH_HUMAN,"GTPase HRas (EC 3.6.5.2) (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed]",HRAS HRAS1,3265;,"ENST00000311189.8; ENSP00000309845.7; ENSG00000174775.18. [P01112-1];""ENST00000397594.7; ENSP00000380722.3; ENSG00000174775.18. [P01112-2]"";""ENST00000397596.6; ENSP00000380723.2; ENSG00000174775.18. [P01112-1]"";""ENST00000417302.7; ENSP00000388246.1; ENSG00000174775.18. [P01112-2]"";""ENST00000451590.5; ENSP00000407586.1; ENSG00000174775.18. [P01112-1]"";""ENST00000493230.5; ENSP00000434023.1; ENSG00000174775.18. [P01112-2]"";""ENST00000610977.3; ENSP00000480686.1; ENSG00000276536.4. [P01112-1]"";""ENST00000615062.2; ENSP00000482366.1; ENSG00000276536.4. [P01112-1]"";""ENST00000616241.4; ENSP00000480317.1; ENSG00000276536.4. [P01112-2]"";""ENST00000631404.1; ENSP00000488757.1; ENSG00000276536.4. [P01112-1]"";""ENST00000631967.1; ENSP00000488225.1; ENSG00000276536.4. [P01112-2]"";""ENST00000634098.1; ENSP00000488296.1; ENSG00000276536.4. [P01112-2]"";",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-membrane adaptor activity [GO:0043495],adipose tissue development [GO:0060612]; animal organ morphogenesis [GO:0009887]; cell surface receptor signaling pathway [GO:0007166]; cellular response to gamma radiation [GO:0071480]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; defense response to protozoan [GO:0042832]; endocytosis [GO:0006897]; fibroblast proliferation [GO:0048144]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway [GO:0097193]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; oncogene-induced cell senescence [GO:0090402]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type II interferon production [GO:0032729]; positive regulation of wound healing [GO:0090303]; Ras protein signal transduction [GO:0007265]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; GTPase complex [GO:1905360]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q53T59,C4,2.046630665,-0.088051817,-0.782610905,-0.896652448,-1.041804654,deepskyblue2,HS1BP3,H1BP3_HUMAN,HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3),HS1BP3,64342;,ENST00000304031.8; ENSP00000305193.3; ENSG00000118960.13.;,phosphatidylinositol binding [GO:0035091],regulation of apoptotic process [GO:0042981],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]
Q7LGA3,S1,-1.107671425,-2.185199093,-0.4288516,1.007841141,0.987204979,gold,HS2ST1,HS2ST_HUMAN,Heparan sulfate 2-O-sulfotransferase 1 (2-O-sulfotransferase) (2OST) (EC 2.8.2.-),HS2ST1 HS2ST KIAA0448,9653;,"ENST00000370550.10; ENSP00000359581.4; ENSG00000153936.18. [Q7LGA3-1];""ENST00000370551.8; ENSP00000359582.3; ENSG00000153936.18. [Q7LGA3-3]"";",heparan sulfate 2-O-sulfotransferase activity [GO:0004394],"gene expression [GO:0010467]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin metabolic process [GO:0030202]; ureteric bud formation [GO:0060676]",Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q96MM7,S1,-1.102986354,-1.010857022,0.009327797,0.781274721,0.684686711,gold,HS6ST2,H6ST2_HUMAN,Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST-2) (EC 2.8.2.-),HS6ST2 PSEC0092,90161;,"ENST00000370833.7; ENSP00000359870.3; ENSG00000171004.19. [Q96MM7-4];""ENST00000370836.6; ENSP00000359873.2; ENSG00000171004.19. [Q96MM7-1]"";""ENST00000406696.5; ENSP00000384013.5; ENSG00000171004.19. [Q96MM7-3]"";""ENST00000521489.5; ENSP00000429473.1; ENSG00000171004.19. [Q96MM7-4]"";""ENST00000640529.2; ENSP00000491722.2; ENSG00000171004.19. [Q96MM7-3]"";",heparan sulfate 6-O-sulfotransferase activity [GO:0017095],"heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]",Golgi membrane [GO:0000139]
O75506,C5,1.604238571,0.385565214,-0.887171527,-0.569707588,-0.99649046,turquoise3,HSBP1,HSBP1_HUMAN,Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13) (NPC-A-13),HSBP1 HSF1BP,3281;,"ENST00000433866.7; ENSP00000392896.2; ENSG00000230989.8.;""ENST00000570259.1; ENSP00000458007.1; ENSG00000230989.8."";",identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714],axonal transport of mitochondrion [GO:0019896]; cellular heat acclimation [GO:0070370]; endodermal cell differentiation [GO:0035987]; negative regulation of transcription by RNA polymerase II [GO:0000122],axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8NBQ5,S2,-1.30894729,-1.393246896,-0.030109654,0.910802737,0.583090721,orange,HSD17B11,DHB11_HUMAN,Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Cutaneous T-cell lymphoma-associated antigen HD-CL-03) (CTCL-associated antigen HD-CL-03) (Dehydrogenase/reductase SDR family member 8) (Retinal short-chain dehydrogenase/reductase 2) (retSDR2) (Short chain dehydrogenase/reductase family 16C member 2),HSD17B11 DHRS8 PAN1B SDR16C2 PSEC0029 UNQ207/PRO233,51170;,ENST00000358290.9; ENSP00000351035.4; ENSG00000198189.11.;,"estradiol 17-beta-dehydrogenase [NAD(P)] activity [GO:0004303]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; steroid dehydrogenase activity [GO:0016229]",androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]
Q53GQ0,S2,-0.910570017,-1.316704069,0.174209556,0.848763598,0.563371588,orange,HSD17B12,DHB12_HUMAN,Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 1),HSD17B12 SDR12C1,51144;,"ENST00000278353.10; ENSP00000278353.4; ENSG00000149084.13. [Q53GQ0-1];""ENST00000395700.4; ENSP00000379052.4; ENSG00000149084.13. [Q53GQ0-2]"";",collagen binding [GO:0005518]; estradiol 17-beta-dehydrogenase [NAD(P)] activity [GO:0004303]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; oxidoreductase activity [GO:0016491]; very-long-chain 3-oxoacyl-CoA reductase activity [GO:0141040],"estrogen biosynthetic process [GO:0006703]; extracellular matrix organization [GO:0030198]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cell-substrate adhesion [GO:0010811]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; fatty acid elongase complex [GO:0009923]
P56937,S2,-1.376698975,-1.233953444,0.25186358,0.950396917,0.307971531,orange,HSD17B7,DHB7_HUMAN,3-keto-steroid reductase/17-beta-hydroxysteroid dehydrogenase 7 (17-beta-hydroxysteroid dehydrogenase 7) (17-beta-HSD 7) (3-keto-steroid reductase) (EC 1.1.1.270) (Dihydrotestosterone oxidoreductase) (EC 1.1.1.210) (Estradiol 17-beta-dehydrogenase 7) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 37C member 1),HSD17B7 17HSD7 SDR37C1 UNQ2563/PRO6243,51478;,ENST00000254521.8; ENSP00000254521.3; ENSG00000132196.16. [P56937-1];,"3-keto sterol reductase activity [GO:0000253]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; estradiol 17-beta-dehydrogenase [NAD(P)] activity [GO:0004303]",androgen metabolic process [GO:0008209]; cholesterol biosynthetic process [GO:0006695]; estrogen biosynthetic process [GO:0006703],endoplasmic reticulum membrane [GO:0005789]
Q3SXM5,M2,-0.752644307,-1.091247806,0.319131167,1.131544763,-0.209588665,tan4,HSDL1,HSDL1_HUMAN,Inactive hydroxysteroid dehydrogenase-like protein 1 (Short chain dehydrogenase/reductase family 12C member 3),HSDL1 SDR12C3,83693;,"ENST00000219439.9; ENSP00000219439.4; ENSG00000103160.12. [Q3SXM5-1];""ENST00000434463.7; ENSP00000407437.3; ENSG00000103160.12. [Q3SXM5-2]"";",0,0,intermediate filament cytoskeleton [GO:0045111]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]
P07900,C5,1.851315064,0.587020321,-0.843121602,-0.91151691,-1.052363495,turquoise3,HSP90AA1,HS90A_HUMAN,Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Heat shock protein family C member 1) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38),HSP90AA1 HSP90A HSPC1 HSPCA,3320;,"ENST00000216281.13; ENSP00000216281.8; ENSG00000080824.19. [P07900-1];""ENST00000334701.11; ENSP00000335153.7; ENSG00000080824.19. [P07900-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTP binding [GO:0005525]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; Rho GDP-dissociation inhibitor binding [GO:0051022]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134],activation of innate immune response [GO:0002218]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to heat [GO:0034605]; cellular response to virus [GO:0098586]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial transport [GO:0006839]; neuron migration [GO:0001764]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell size [GO:0045793]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; regulation of apoptotic process [GO:0042981]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle contraction [GO:0003009]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004],apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524]
P08238,C5,1.816831278,0.188832147,-0.784846541,-0.84522794,-0.997602536,turquoise3,HSP90AB1,HS90B_HUMAN,Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84) (Heat shock protein family C member 3),HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB,3326;,"ENST00000353801.7; ENSP00000325875.3; ENSG00000096384.20.;""ENST00000371554.2; ENSP00000360609.1; ENSG00000096384.20."";""ENST00000371646.10; ENSP00000360709.5; ENSG00000096384.20."";""ENST00000620073.4; ENSP00000481908.1; ENSG00000096384.20."";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; ATP-dependent protein folding chaperone [GO:0140662]; cadherin binding [GO:0045296]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; receptor ligand inhibitor activity [GO:0141069]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062],aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]
Q0VDF9,C5,1.364921878,0.840478197,-0.703570236,-0.854727168,-0.867711014,turquoise3,HSPA14,HSP7E_HUMAN,Heat shock 70 kDa protein 14 (HSP70-like protein 1) (Heat shock protein HSP60) (Heat shock protein family A member 14),HSPA14 HSP60 HSP70L1,51182;,ENST00000378372.8; ENSP00000367623.3; ENSG00000187522.16.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183],'de novo' cotranslational protein folding [GO:0051083]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein refolding [GO:0042026],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]
P34932,C5,1.520212683,0.851305865,-0.799122534,-0.979652509,-0.942236146,turquoise3,HSPA4,HSP74_HUMAN,Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2) (Heat shock protein family H member 2),HSPA4 APG2 HSPH2,3308;,ENST00000304858.7; ENSP00000302961.2; ENSG00000170606.16. [P34932-1];,adenyl-nucleotide exchange factor activity [GO:0000774]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
O95757,C5,1.520008501,0.713077102,-0.728979283,-0.847225393,-0.946210748,turquoise3,HSPA4L,HS74L_HUMAN,Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Heat shock protein family H member 3) (Heat-shock protein family A member 4-like protein) (HSPA4-like protein) (Osmotic stress protein 94),HSPA4L APG1 HSPH3 OSP94,22824;,"ENST00000296464.9; ENSP00000296464.3; ENSG00000164070.12.;""ENST00000508776.5; ENSP00000422482.1; ENSG00000164070.12."";",adenyl-nucleotide exchange factor activity [GO:0000774]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
P04792,C4,2.011556833,0.108696572,-0.940343239,-1.002956538,-1.019780495,deepskyblue2,HSPB1,HSPB1_HUMAN,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Heat shock protein family B member 1) (Stress-responsive protein 27) (SRP27),HSPB1 HSP27 HSP28,3315;,ENST00000248553.7; ENSP00000248553.6; ENSG00000106211.10.;,identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; unfolded protein binding [GO:0051082],anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein refolding [GO:0042026]; regulation of autophagy [GO:0010506]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],axon cytoplasm [GO:1904115]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018]
Q9UJY1,C3,1.84134899,0.316748487,-0.521298468,-0.829615893,-0.864978863,cyan,HSPB8,HSPB8_HUMAN,Heat shock protein beta-8 (HspB8) (Alpha-crystallin C chain) (E2-induced gene 1 protein) (Heat shock protein family B member 8) (Protein kinase H11) (Small stress protein-like protein HSP22),HSPB8 CRYAC E2IG1 HSP22 PP1629,26353;,ENST00000281938.7; ENSP00000281938.3; ENSG00000152137.8.;,identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],cellular response to unfolded protein [GO:0034620]; positive regulation of aggrephagy [GO:1905337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]
Q9NZL4,C3,1.718436629,0.250700261,-0.516257032,-0.633966686,-0.772829577,cyan,HSPBP1,HPBP1_HUMAN,Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-binding protein 2) (HspBP2) (Hsp70-interacting protein 1) (Hsp70-interacting protein 2),HSPBP1 HSPBP PP1845,23640;,"ENST00000255631.9; ENSP00000255631.4; ENSG00000133265.11. [Q9NZL4-1];""ENST00000433386.7; ENSP00000398244.1; ENSG00000133265.11. [Q9NZL4-1]"";""ENST00000587922.5; ENSP00000467574.1; ENSG00000133265.11. [Q9NZL4-1]"";",adenyl-nucleotide exchange factor activity [GO:0000774]; enzyme inhibitor activity [GO:0004857]; molecular sequestering activity [GO:0140313]; ubiquitin protein ligase binding [GO:0031625],positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein folding [GO:0006457],endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]
Q92598,C5,1.674677096,0.708392329,-0.749457766,-0.925372953,-0.830137992,turquoise3,HSPH1,HS105_HUMAN,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1),HSPH1 HSP105 HSP110 KIAA0201,10808;,"ENST00000320027.10; ENSP00000318687.5; ENSG00000120694.20. [Q92598-1];""ENST00000380405.7; ENSP00000369768.4; ENSG00000120694.20. [Q92598-2]"";""ENST00000630972.2; ENSP00000487365.1; ENSG00000120694.20. [Q92598-4]"";",adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q9BUP3,S3,-0.557016969,-0.58931818,0.126284809,0.75208435,0.500271664,salmon,HTATIP2,HTAI2_HUMAN,Oxidoreductase HTATIP2 (EC 1.1.1.-) (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2),HTATIP2 CC3 TIP30,10553;,"ENST00000419348.6; ENSP00000392985.2; ENSG00000109854.14. [Q9BUP3-3];""ENST00000421577.6; ENSP00000397752.2; ENSG00000109854.14. [Q9BUP3-1]"";""ENST00000443524.6; ENSP00000387876.2; ENSG00000109854.14. [Q9BUP3-1]"";""ENST00000451739.7; ENSP00000394259.2; ENSG00000109854.14. [Q9BUP3-1]"";""ENST00000530266.5; ENSP00000436548.1; ENSG00000109854.14. [Q9BUP3-2]"";""ENST00000532081.1; ENSP00000432107.1; ENSG00000109854.14. [Q9BUP3-2]"";""ENST00000532505.1; ENSP00000432338.1; ENSG00000109854.14. [Q9BUP3-2]"";",oxidoreductase activity [GO:0016491]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713],angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; negative regulation of apoptotic process [GO:0043066]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]
P42858,C1,1.119417872,0.20432149,-0.378372327,-0.137047096,-0.029979795,lightblue,HTT,HD_HUMAN,"Huntingtin (Huntington disease protein) (HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]",HTT HD IT15,3064;,ENST00000355072.11; ENSP00000347184.5; ENSG00000197386.14.;,beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; transmembrane transporter binding [GO:0044325],"apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of mitophagy [GO:1901526]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]",autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]
Q2TAA2,C5,1.719221659,0.75080418,-0.781718474,-0.597725273,-1.043456446,turquoise3,IAH1,IAH1_HUMAN,Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-),IAH1,285148;,"ENST00000470914.5; ENSP00000419224.1; ENSG00000134330.19. [Q2TAA2-2];""ENST00000482918.5; ENSP00000419110.1; ENSG00000134330.19. [Q2TAA2-2]"";""ENST00000497473.6; ENSP00000417580.1; ENSG00000134330.19. [Q2TAA2-1]"";","hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]",lipid catabolic process [GO:0016042],0
P14735,C5,1.646996992,0.383311417,-0.661328595,-0.672532487,-1.076774393,turquoise3,IDE,IDE_HUMAN,Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin),IDE,3416;,"ENST00000265986.11; ENSP00000265986.6; ENSG00000119912.18. [P14735-1];""ENST00000371581.9; ENSP00000360637.5; ENSG00000119912.18. [P14735-2]"";",ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270],amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]
O75874,C4,2.094908598,0.335903319,-1.046900302,-1.03023384,-1.290822723,deepskyblue2,IDH1,IDHC_HUMAN,Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (IDH1) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDPc) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase),IDH1 PICD,3417;,"ENST00000345146.7; ENSP00000260985.2; ENSG00000138413.14.;""ENST00000415913.5; ENSP00000390265.1; ENSG00000138413.14."";""ENST00000446179.5; ENSP00000410513.1; ENSG00000138413.14."";",cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803],2-oxoglutarate metabolic process [GO:0006103]; female gonad development [GO:0008585]; glutathione metabolic process [GO:0006749]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; regulation of phospholipid biosynthetic process [GO:0071071]; regulation of phospholipid catabolic process [GO:0060696]; response to oxidative stress [GO:0006979]; response to steroid hormone [GO:0048545]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]
Q13907,C5,1.773685594,0.287328679,-0.540645316,-0.31482468,-1.253178069,turquoise3,IDI1,IDI1_HUMAN,Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1),IDI1,3422;,"ENST00000381344.8; ENSP00000370748.3; ENSG00000067064.13. [Q13907-2];""ENST00000429642.2; ENSP00000401879.2; ENSG00000067064.13. [Q13907-1]"";",isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872],cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240]; isoprenoid biosynthetic process [GO:0008299],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisome [GO:0005777]
P22304,N4,-1.362031241,0.59668329,-0.308922084,0.710216377,0.146028914,grey30,IDS,IDS_HUMAN,Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain],IDS SIDS,3423;,"ENST00000340855.11; ENSP00000339801.6; ENSG00000010404.18. [P22304-1];""ENST00000370441.8; ENSP00000359470.4; ENSG00000010404.18. [P22304-2]"";""ENST00000466323.5; ENSP00000418264.1; ENSG00000010404.18. [P22304-3]"";",calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423],dermatan sulfate catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200],cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]
Q13325,C4,1.936083836,-0.082445653,-0.923542869,-0.812130203,-0.758514012,deepskyblue2,IFIT5,IFIT5_HUMAN,Interferon-induced protein with tetratricopeptide repeats 5 (IFIT-5) (Interferon-induced 58 kDa protein) (Retinoic acid- and interferon-inducible 58 kDa protein) (P58),IFIT5 ISG58 RI58,24138;,"ENST00000371795.5; ENSP00000360860.4; ENSG00000152778.10. [Q13325-1];""ENST00000681348.1; ENSP00000505706.1; ENSG00000152778.10. [Q13325-2]"";",double-stranded DNA binding [GO:0003690]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049],defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]
P17181,S2,-1.239393401,-1.493875494,0.261055597,0.840555311,0.609199316,orange,IFNAR1,INAR1_HUMAN,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1),IFNAR1 IFNAR,3454;,"ENST00000270139.8; ENSP00000270139.3; ENSG00000142166.15. [P17181-1];""ENST00000652450.2; ENSP00000498654.1; ENSG00000142166.15. [P17181-4]"";""ENST00000700080.1; ENSP00000514785.1; ENSG00000142166.15. [P17181-4]"";""ENST00000703515.1; ENSP00000515348.1; ENSG00000142166.15. [P17181-1]"";""ENST00000703556.1; ENSP00000515372.1; ENSG00000142166.15. [P17181-1]"";",cytokine binding [GO:0019955]; JAK pathway signal transduction adaptor activity [GO:0008269]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905],cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; positive regulation of cellular respiration [GO:1901857]; response to lipopolysaccharide [GO:0032496]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]
P15260,S2,-1.047005687,-1.188868526,0.175688051,0.959350138,0.629857319,orange,IFNGR1,INGR1_HUMAN,Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119),IFNGR1,3459;,ENST00000367739.9; ENSP00000356713.5; ENSG00000027697.16. [P15260-1];,cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; type II interferon receptor activity [GO:0004906],astrocyte activation [GO:0048143]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; microglial cell activation [GO:0001774]; negative regulation of amyloid-beta clearance [GO:1900222]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of gene expression [GO:0010628]; positive regulation of tumor necrosis factor production [GO:0032760]; response to virus [GO:0009615]; signal transduction [GO:0007165]; type II interferon-mediated signaling pathway [GO:0060333]; type III interferon-mediated signaling pathway [GO:0038196],membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9BW83,C5,1.943955395,0.427768203,-1.056288302,-1.029953347,-1.211308953,turquoise3,IFT27,IFT27_HUMAN,Intraflagellar transport protein 27 homolog (Putative GTP-binding protein RAY-like) (Rab-like protein 4),IFT27 RABL4 RAYL,11020;,"ENST00000340630.9; ENSP00000343593.5; ENSG00000100360.15. [Q9BW83-2];""ENST00000433985.7; ENSP00000393541.2; ENSG00000100360.15. [Q9BW83-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],cilium assembly [GO:0060271]; cochlea development [GO:0090102]; inner ear receptor cell stereocilium organization [GO:0060122]; intracellular protein transport [GO:0006886]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]
Q8WYA0,C1,1.180718001,0.322590857,-0.487147484,-0.271140929,-0.136577161,lightblue,IFT81,IFT81_HUMAN,Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1),IFT81 CDV1,28981;,"ENST00000242591.10; ENSP00000242591.5; ENSG00000122970.16. [Q8WYA0-1];""ENST00000361948.8; ENSP00000355372.4; ENSG00000122970.16. [Q8WYA0-3]"";""ENST00000552912.5; ENSP00000449718.1; ENSG00000122970.16. [Q8WYA0-1]"";",tubulin binding [GO:0015631],cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]
Q13099,C1,1.25203034,0.287294476,-0.51763397,-0.158002321,-0.107496587,lightblue,IFT88,IFT88_HUMAN,Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737 homolog) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10),IFT88 TG737 TTC10,8100;,"ENST00000319980.10; ENSP00000323580.6; ENSG00000032742.18. [Q13099-1];""ENST00000351808.10; ENSP00000261632.5; ENSG00000032742.18. [Q13099-2]"";",kinesin binding [GO:0019894],cilium assembly [GO:0060271]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; non-motile cilium assembly [GO:1905515]; positive regulation of cilium assembly [GO:0045724]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; response to silicon dioxide [GO:0034021],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; intraciliary transport particle B [GO:0030992]; manchette [GO:0002177]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212]
P08069,S4,-1.114413135,-1.536326422,0.453165576,0.978060188,0.306162133,tomato2,IGF1R,IGF1R_HUMAN,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],IGF1R,3480;,ENST00000650285.1; ENSP00000497069.1; ENSG00000140443.15.;,ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor activity [GO:0005009]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein transporter activity [GO:0140318]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877],amyloid-beta clearance [GO:0097242]; axonogenesis [GO:0007409]; cardiac atrium development [GO:0003230]; cellular response to aldosterone [GO:1904045]; cellular response to amyloid-beta [GO:1904646]; cellular response to angiotensin [GO:1904385]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to progesterone stimulus [GO:0071393]; cellular response to testosterone stimulus [GO:0071394]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to zinc ion starvation [GO:0034224]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; dendritic spine maintenance [GO:0097062]; establishment of cell polarity [GO:0030010]; estrous cycle [GO:0044849]; hippocampus development [GO:0021766]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of muscle cell apoptotic process [GO:0010656]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; protein autophosphorylation [GO:0046777]; regulation of JNK cascade [GO:0046328]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to L-glutamate [GO:1902065]; response to nicotine [GO:0035094]; response to vitamin E [GO:0033197]; signal transduction [GO:0007165]; transcytosis [GO:0045056],alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; axon [GO:0030424]; caveola [GO:0005901]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein kinase complex [GO:1902911]; receptor complex [GO:0043235]; T-tubule [GO:0030315]
Q9Y6M1,N1,-0.70626902,-0.817467384,-0.33972742,-0.15595221,1.479743317,grey90,IGF2BP2,IF2B2_HUMAN,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),IGF2BP2 IMP2 VICKZ2,10644;,"ENST00000346192.7; ENSP00000320204.5; ENSG00000073792.16. [Q9Y6M1-1];""ENST00000382199.7; ENSP00000371634.3; ENSG00000073792.16. [Q9Y6M1-2]"";""ENST00000421047.3; ENSP00000413787.3; ENSG00000073792.16. [Q9Y6M1-3]"";","mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182]; translation regulator activity, nucleic acid binding [GO:0090079]",anatomical structure morphogenesis [GO:0009653]; cold-induced thermogenesis [GO:0106106]; CRD-mediated mRNA stabilization [GO:0070934]; energy homeostasis [GO:0097009]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]
P11717,S1,-0.941408375,-1.174669683,-0.255955794,0.60244272,1.186496346,gold,IGF2R,MPRI_HUMAN,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),IGF2R MPRI,3482;,ENST00000356956.6; ENSP00000349437.1; ENSG00000197081.16.;,enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor activity [GO:0005010]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023],animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]
O75054,S4,-0.714687389,-1.05149932,0.278869172,0.792006686,0.310965529,tomato2,IGSF3,IGSF3_HUMAN,Immunoglobulin superfamily member 3 (IgSF3) (Glu-Trp-Ile EWI motif-containing protein 3) (EWI-3),IGSF3 EWI3 KIAA0466,3321;,"ENST00000318837.6; ENSP00000321184.6; ENSG00000143061.18. [O75054-2];""ENST00000369483.5; ENSP00000358495.1; ENSG00000143061.18. [O75054-2]"";""ENST00000369486.8; ENSP00000358498.4; ENSG00000143061.18. [O75054-1]"";",0,lacrimal gland development [GO:0032808],cell surface [GO:0009986]; membrane [GO:0016020]
Q969P0,S3,-0.609067185,-1.104841879,0.238723629,0.752704261,0.448432873,salmon,IGSF8,IGSF8_HUMAN,Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316),IGSF8 CD81P3 EWI2 KCT4,93185;,"ENST00000314485.12; ENSP00000316664.7; ENSG00000162729.14. [Q969P0-1];""ENST00000368086.5; ENSP00000357065.1; ENSG00000162729.14. [Q969P0-1]"";""ENST00000614243.4; ENSP00000477565.1; ENSG00000162729.14. [Q969P0-1]"";",0,cell motility [GO:0048870]; nervous system development [GO:0007399]; single fertilization [GO:0007338]; skeletal muscle tissue development [GO:0007519],extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q13123,N2,-1.074380607,-0.097791634,0.98544644,0.002185762,0.240434246,grey70,IK,RED_HUMAN,Protein Red (Cytokine IK) (IK factor) (Protein RER),IK RED RER,3550;,ENST00000417647.7; ENSP00000396301.2; ENSG00000113141.19.;,identical protein binding [GO:0042802],"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]",chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; U2-type precatalytic spliceosome [GO:0071005]
Q70UQ0,S2,-1.387678629,-1.659005332,0.151316159,1.056425541,0.512502117,orange,IKBIP,IKIP_HUMAN,Inhibitor of nuclear factor kappa-B kinase-interacting protein (I kappa-B kinase-interacting protein) (IKBKB-interacting protein) (IKK-interacting protein),IKBIP IKIP,121457;,"ENST00000299157.5; ENSP00000299157.4; ENSG00000166130.15. [Q70UQ0-4];""ENST00000342502.6; ENSP00000343471.2; ENSG00000166130.15. [Q70UQ0-1]"";""ENST00000393042.3; ENSP00000376762.3; ENSG00000166130.15. [Q70UQ0-3]"";",0,response to X-ray [GO:0010165],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleolus [GO:0005730]
P78552,S1,-0.946813455,-1.243725866,0.073733007,0.83273514,0.844115142,gold,IL13RA1,I13R1_HUMAN,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1),IL13RA1 IL13R IL13RA,3597;,"ENST00000371642.1; ENSP00000360705.1; ENSG00000131724.11. [P78552-2];""ENST00000371666.8; ENSP00000360730.3; ENSG00000131724.11. [P78552-1]"";",cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896],cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; positive regulation of cell population proliferation [GO:0008284],external side of plasma membrane [GO:0009897]; interleukin-13 receptor complex [GO:0005898]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q8NAC3,S2,-1.139167263,-1.413560803,0.346893691,0.973898723,0.860336152,orange,IL17RC,I17RC_HUMAN,Interleukin-17 receptor C (IL-17 receptor C) (IL-17RC) (Interleukin-17 receptor homolog) (IL17Rhom) (Interleukin-17 receptor-like protein) (IL-17RL) (ZcytoR14),IL17RC UNQ6118/PRO20040/PRO38901,84818;,"ENST00000295981.7; ENSP00000295981.3; ENSG00000163702.21. [Q8NAC3-1];""ENST00000383812.9; ENSP00000373323.4; ENSG00000163702.21. [Q8NAC3-3]"";""ENST00000403601.8; ENSP00000384969.3; ENSG00000163702.21. [Q8NAC3-2]"";""ENST00000413608.2; ENSP00000396064.1; ENSG00000163702.21. [Q8NAC3-5]"";""ENST00000416074.6; ENSP00000395315.3; ENSG00000163702.21. [Q8NAC3-7]"";""ENST00000455057.5; ENSP00000407894.1; ENSG00000163702.21. [Q8NAC3-6]"";""ENST00000483582.5; ENSP00000512844.1; ENSG00000163702.21. [Q8NAC3-4]"";""ENST00000696816.1; ENSP00000512897.1; ENSG00000163702.21. [Q8NAC3-8]"";",coreceptor activity [GO:0015026]; interleukin-17 receptor activity [GO:0030368]; signaling receptor binding [GO:0005102],defense response to fungus [GO:0050832]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; interleukin-17A-mediated signaling pathway [GO:0038173]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-6 production [GO:0032755],cell surface [GO:0009986]; plasma membrane [GO:0005886]
Q9NPH3,S4,-1.053654617,-1.108613238,0.302027999,0.830532189,0.753520543,tomato2,IL1RAP,IL1AP_HUMAN,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (EC 3.2.2.6) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3),IL1RAP C3orf13 IL1R3,3556;,"ENST00000072516.7; ENSP00000072516.3; ENSG00000196083.11. [Q9NPH3-1];""ENST00000317757.8; ENSP00000314807.3; ENSG00000196083.11. [Q9NPH3-5]"";""ENST00000342550.6; ENSP00000345829.2; ENSG00000196083.11. [Q9NPH3-3]"";""ENST00000413869.5; ENSP00000416296.1; ENSG00000196083.11. [Q9NPH3-3]"";""ENST00000422485.5; ENSP00000409352.1; ENSG00000196083.11. [Q9NPH3-2]"";""ENST00000422940.5; ENSP00000387371.1; ENSG00000196083.11. [Q9NPH3-2]"";""ENST00000439062.6; ENSP00000401132.1; ENSG00000196083.11. [Q9NPH3-1]"";""ENST00000447382.6; ENSP00000390541.1; ENSG00000196083.11. [Q9NPH3-1]"";","coreceptor activity [GO:0015026]; interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD+ nucleosidase activity [GO:0003953]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]",immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-33-mediated signaling pathway [GO:0038172]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q6UWB1,S4,-1.025728016,-1.29446596,0.296221173,0.856790823,0.486223673,tomato2,IL27RA,I27RA_HUMAN,Interleukin-27 receptor subunit alpha (IL-27 receptor subunit alpha) (IL-27R subunit alpha) (IL-27R-alpha) (IL-27RA) (Cytokine receptor WSX-1) (Cytokine receptor-like 1) (Type I T-cell cytokine receptor) (TCCR) (ZcytoR1),IL27RA CRL1 TCCR WSX1 UNQ296/PRO336,9466;,"ENST00000263379.4; ENSP00000263379.1; ENSG00000104998.4.;""ENST00000672064.1; ENSP00000500946.1; ENSG00000288185.1."";",cytokine binding [GO:0019955]; interleukin-27 receptor activity [GO:0045509]; transmembrane signaling receptor activity [GO:0004888],cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell extravasation [GO:2000408]; negative regulation of T-helper 17 type immune response [GO:2000317]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of type II interferon production [GO:0032729]; regulation of isotype switching to IgG isotypes [GO:0048302],external side of plasma membrane [GO:0009897]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
P40189,S2,-1.048349218,-1.300214297,0.184476277,0.861749254,0.720890256,orange,IL6ST,IL6RB_HUMAN,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130),IL6ST,3572;,"ENST00000381294.8; ENSP00000370694.3; ENSG00000134352.21. [P40189-3];""ENST00000381298.7; ENSP00000370698.2; ENSG00000134352.21. [P40189-1]"";""ENST00000502326.7; ENSP00000462158.1; ENSG00000134352.21. [P40189-1]"";""ENST00000522633.2; ENSP00000435399.1; ENSG00000134352.21. [P40189-2]"";""ENST00000698645.1; ENSP00000513858.1; ENSG00000134352.21. [P40189-1]"";",ciliary neurotrophic factor receptor activity [GO:0004897]; ciliary neurotrophic factor receptor binding [GO:0005127]; coreceptor activity [GO:0015026]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-27 receptor activity [GO:0045509]; protein tyrosine kinase activator activity [GO:0030296]; scaffold protein binding [GO:0097110],ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; glycogen metabolic process [GO:0005977]; interleukin-11-mediated signaling pathway [GO:0038154]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; leukemia inhibitory factor signaling pathway [GO:0048861]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of neuron apoptotic process [GO:0043524]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540],ciliary neurotrophic factor receptor complex [GO:0070110]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q12905,N1,-1.211129804,-1.044569732,0.688430457,-0.264082589,1.05200559,grey90,ILF2,ILF2_HUMAN,Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa),ILF2 NF45 PRO3063,3608;,ENST00000361891.9; ENSP00000355011.4; ENSG00000143621.17.;,DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723],positive regulation of DNA-templated transcription [GO:0045893],cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]
Q12906,N1,-1.146126266,-1.014792959,0.599555414,-0.187809261,1.036623813,grey90,ILF3,ILF3_HUMAN,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),ILF3 DRBF MPHOSPH4 NF90,3609;,"ENST00000250241.12; ENSP00000250241.8; ENSG00000129351.18. [Q12906-5];""ENST00000407004.8; ENSP00000384660.2; ENSG00000129351.18. [Q12906-6]"";""ENST00000588657.6; ENSP00000468181.1; ENSG00000129351.18. [Q12906-7]"";""ENST00000589998.6; ENSP00000465219.1; ENSG00000129351.18. [Q12906-2]"";""ENST00000590261.5; ENSP00000468156.1; ENSG00000129351.18. [Q12906-1]"";""ENST00000592763.5; ENSP00000465515.1; ENSG00000129351.18. [Q12906-4]"";",DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; virus receptor activity [GO:0001618],defense response to virus [GO:0051607]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
A1L0T0,S2,-0.991108821,-1.222745599,0.202982193,0.80828264,0.573751292,orange,ILVBL,HACL2_HUMAN,2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein),ILVBL AHAS HACL2,10994;,ENST00000263383.8; ENSP00000263383.3; ENSG00000105135.16.;,acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q96T52,M2,-0.977550056,-1.50446405,0.516962627,0.948044161,0.02980155,tan4,IMMP2L,IMP2L_HUMAN,Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein),IMMP2L,83943;,"ENST00000331762.7; ENSP00000329553.3; ENSG00000184903.10. [Q96T52-1];""ENST00000405709.7; ENSP00000384966.2; ENSG00000184903.10. [Q96T52-1]"";""ENST00000447215.5; ENSP00000388327.1; ENSG00000184903.10. [Q96T52-2]"";""ENST00000452895.5; ENSP00000399353.1; ENSG00000184903.10. [Q96T52-1]"";",endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252],blood circulation [GO:0008015]; brain development [GO:0007420]; cerebellum vasculature development [GO:0061300]; DNA damage response [GO:0006974]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801],mitochondrial inner membrane [GO:0005743]; mitochondrial inner membrane peptidase complex [GO:0042720]
Q16891,M2,-1.337906964,-1.386357684,0.389962582,1.195866189,-0.393441984,tan4,IMMT,MIC60_HUMAN,MICOS complex subunit MIC60 (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89),IMMT HMP MIC60 MINOS2 PIG4 PIG52,10989;,"ENST00000410111.8; ENSP00000387262.3; ENSG00000132305.22. [Q16891-1];""ENST00000442664.6; ENSP00000407788.2; ENSG00000132305.22. [Q16891-4]"";""ENST00000449247.6; ENSP00000396899.2; ENSG00000132305.22. [Q16891-2]"";",RNA binding [GO:0003723],cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; neuron cellular homeostasis [GO:0070050],membrane [GO:0016020]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]
O00425,N3,-0.762509461,-0.97333501,1.092026761,-0.029040757,0.319369779,grey50,IMP3,IF2B3_HUMAN,Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer) (hKOC) (VICKZ family member 3),IGF2BP3 IMP3 KOC1 VICKZ3,10643;,"ENST00000258729.8; ENSP00000258729.3; ENSG00000136231.14. [O00425-1];""ENST00000619562.4; ENSP00000480267.1; ENSG00000136231.14. [O00425-2]"";",mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182],anatomical structure morphogenesis [GO:0009653]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; translation [GO:0006412],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]
Q96G21,N3,-0.634167028,-0.757288036,1.094368647,-0.212551677,0.195941151,grey50,IMP4,IMP4_HUMAN,U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4) (Brix domain-containing protein 4),IMP4 BXDC4,92856;,ENST00000259239.8; ENSP00000259239.3; ENSG00000136718.10.;,rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515],maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]
P29218,C3,1.976719336,-0.010815475,-0.82129985,-0.757099639,-0.872634424,cyan,IMPA1,IMPA1_HUMAN,Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1),IMPA1 IMPA,3612;,"ENST00000256108.10; ENSP00000256108.5; ENSG00000133731.10. [P29218-1];""ENST00000311489.8; ENSP00000311803.4; ENSG00000133731.10. [P29218-2]"";""ENST00000449740.6; ENSP00000408526.2; ENSG00000133731.10. [P29218-3]"";",identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803],inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q9P2X3,C3,2.096103217,0.015301455,-0.707790149,-0.800742372,-1.1294103,cyan,IMPACT,IMPCT_HUMAN,Protein IMPACT (Imprinted and ancient gene protein homolog),IMPACT,55364;,ENST00000284202.9; ENSP00000284202.4; ENSG00000154059.11. [Q9P2X3-1];,actin binding [GO:0003779]; protein sequestering activity [GO:0140311]; ribosome binding [GO:0043022],cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; intracellular signal transduction [GO:0035556]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection extension [GO:1990138]; positive regulation of neuron differentiation [GO:0045666]; regulation of cytoplasmic translational initiation in response to stress [GO:1990611]; regulation of translational initiation [GO:0006446],cytoplasm [GO:0005737]
Q9NX62,S1,-1.089032425,-1.240042911,-0.251009552,0.80765563,1.079064223,gold,IMPAD1,IMPA3_HUMAN,"Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase (Golgi-resident PAP phosphatase) (gPAPP) (EC 3.1.3.7) (3'(2'), 5'-bisphosphate nucleotidase 2) (Inositol monophosphatase domain-containing protein 1) (Myo-inositol monophosphatase A3) (Phosphoadenosine phosphate 3'-nucleotidase)",BPNT2 IMPA3 IMPAD1,54928;,ENST00000262644.9; ENSP00000262644.4; ENSG00000104331.9.;,"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; 3',5'-nucleotide bisphosphate phosphatase activity [GO:0097657]; 3'-nucleotidase activity [GO:0008254]; metal ion binding [GO:0046872]",chondrocyte development [GO:0002063]; chondroitin sulfate metabolic process [GO:0030204]; embryonic digit morphogenesis [GO:0042733]; endochondral ossification [GO:0001958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; post-embryonic development [GO:0009791]; skeletal system development [GO:0001501],cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]
P20839,C2,1.412279718,0.667555201,-0.949401622,-0.936516151,-0.005049149,aquamarine,IMPDH1,IMDH1_HUMAN,Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I),IMPDH1 IMPD1,3614;,"ENST00000338791.11; ENSP00000345096.6; ENSG00000106348.19. [P20839-6];""ENST00000348127.11; ENSP00000265385.8; ENSG00000106348.19. [P20839-3]"";""ENST00000354269.9; ENSP00000346219.5; ENSG00000106348.19. [P20839-5]"";""ENST00000419067.6; ENSP00000399400.2; ENSG00000106348.19. [P20839-7]"";""ENST00000480861.5; ENSP00000420185.1; ENSG00000106348.19. [P20839-4]"";""ENST00000496200.5; ENSP00000420803.1; ENSG00000106348.19. [P20839-2]"";",DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723],GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]
Q9NQS7,N3,-1.020358606,-1.115963378,1.141408443,0.303680388,-0.262473957,grey50,INCENP,INCE_HUMAN,Inner centromere protein,INCENP,3619;,"ENST00000278849.4; ENSP00000278849.4; ENSG00000149503.13. [Q9NQS7-2];""ENST00000394818.8; ENSP00000378295.3; ENSG00000149503.13. [Q9NQS7-1]"";",molecular function activator activity [GO:0140677],chromosome segregation [GO:0007059]; meiotic spindle midzone assembly [GO:0051257]; metaphase chromosome alignment [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of mitotic sister chromatid separation [GO:1901970],"central element [GO:0000801]; chromocenter [GO:0010369]; chromosome passenger complex [GO:0032133]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]"
Q9UK53,N1,-1.090359054,0.399669745,0.532088951,-0.306962089,0.745203005,grey90,ING1,ING1_HUMAN,Inhibitor of growth protein 1,ING1,3621;,"ENST00000333219.9; ENSP00000328436.8; ENSG00000153487.13. [Q9UK53-2];""ENST00000338450.7; ENSP00000345202.7; ENSG00000153487.13. [Q9UK53-4]"";""ENST00000375775.4; ENSP00000364930.3; ENSG00000153487.13. [Q9UK53-3]"";",metal ion binding [GO:0046872]; methylated histone binding [GO:0035064],negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; protein import into nucleus [GO:0006606]; regulation of programmed cell death [GO:0043067],nucleus [GO:0005634]; Sin3-type complex [GO:0070822]
Q8WYH8,N2,-1.632748065,-0.508423795,1.238799723,0.181227322,-0.404146957,grey70,ING5,ING5_HUMAN,Inhibitor of growth protein 5 (p28ING5),ING5,84289;,"ENST00000313552.11; ENSP00000322142.7; ENSG00000168395.16. [Q8WYH8-1];""ENST00000406941.5; ENSP00000385937.1; ENSG00000168395.16. [Q8WYH8-2]"";",chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064],apoptotic signaling pathway [GO:0097190]; DNA replication-dependent chromatin disassembly [GO:0140889]; fibroblast proliferation [GO:0048144]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein acetylation [GO:0006473]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of developmental process [GO:0050793]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706],histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9ULG1,N3,-0.958418891,-0.966751594,0.861022648,-0.109179174,0.81663216,grey50,INO80,INO80_HUMAN,Chromatin-remodeling ATPase INO80 (hINO80) (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80) (INO80 complex subunit A),INO80 INO80A INOC1 KIAA1259,54617;,ENST00000648947.1; ENSP00000497609.1; ENSG00000128908.19.;,"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; histone binding [GO:0042393]",cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; spindle assembly [GO:0051225]; telomere maintenance [GO:0000723]; UV-damage excision repair [GO:0070914],cytosol [GO:0005829]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]
Q9C086,N3,-1.399084464,-1.092120245,0.585122862,-0.062425838,0.941829004,grey50,INO80B,IN80B_HUMAN,INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4),INO80B HMGA1L4 PAPA1 ZNHIT4,83444;,ENST00000233331.12; ENSP00000233331.7; ENSG00000115274.15.;,metal ion binding [GO:0046872],chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P49441,C5,2.18162373,0.373799663,-0.979607519,-0.892349117,-1.169419286,turquoise3,INPP1,INPP_HUMAN,Inositol polyphosphate 1-phosphatase (IPP) (IPPase) (EC 3.1.3.57),INPP1,3628;,"ENST00000322522.8; ENSP00000325423.4; ENSG00000151689.13.;""ENST00000392329.7; ENSP00000376142.2; ENSG00000151689.13."";","inositol-1,3,4-trisphosphate 1-phosphatase activity [GO:0052829]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]",phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165],cytosol [GO:0005829]
Q96PE3,C3,1.746707451,-0.045285667,-0.39754226,-0.389243576,-0.616648493,cyan,INPP4A,INP4A_HUMAN,"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)",INPP4A,3631;,"ENST00000409016.8; ENSP00000386704.3; ENSG00000040933.16. [Q96PE3-2];""ENST00000409540.7; ENSP00000387294.3; ENSG00000040933.16. [Q96PE3-4]"";""ENST00000409851.8; ENSP00000386777.4; ENSG00000040933.16. [Q96PE3-3]"";""ENST00000523221.1; ENSP00000427722.1; ENSG00000040933.16. [Q96PE3-1]"";","inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]",inositol phosphate metabolic process [GO:0043647]; phosphatidylinositol biosynthetic process [GO:0006661]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]
Q14642,S4,-0.818439656,-1.313396662,0.367314337,0.926124576,0.26237826,tomato2,INPP5A,I5P1_HUMAN,"Inositol polyphosphate-5-phosphatase A (EC 3.1.3.56) (43 kDa inositol polyphosphate 5-phosphatase) (Type I inositol 1,4,5-trisphosphate 5-phosphatase) (5PTase)",INPP5A 5PTASE,3632;,ENST00000368594.8; ENSP00000357583.3; ENSG00000068383.19.;,"inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]",inositol phosphate metabolic process [GO:0043647]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; phosphatidylinositol dephosphorylation [GO:0046856],dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9BT40,S1,-1.425719406,-1.439763793,0.107363394,0.57902149,0.985700446,gold,INPP5K,INP5K_HUMAN,"Inositol polyphosphate 5-phosphatase K (EC 3.1.3.56) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86) (Phosphatidylinositol-4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Skeletal muscle and kidney-enriched inositol phosphatase)",INPP5K PPS SKIP,51763;,"ENST00000320345.10; ENSP00000318476.6; ENSG00000132376.20. [Q9BT40-2];""ENST00000406424.8; ENSP00000385177.4; ENSG00000132376.20. [Q9BT40-2]"";""ENST00000421807.7; ENSP00000413937.2; ENSG00000132376.20. [Q9BT40-1]"";","inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; lipid phosphatase activity [GO:0042577]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]",actin cytoskeleton organization [GO:0030036]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of renal water transport [GO:2001153]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; ruffle assembly [GO:0097178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]
O15357,C3,1.547181904,0.218731215,-0.419330034,-0.405066575,-0.587701864,cyan,INPPL1,SHIP2_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)",INPPL1 SHIP2,3636;,"ENST00000298229.7; ENSP00000298229.2; ENSG00000165458.15. [O15357-1];""ENST00000538751.5; ENSP00000444619.1; ENSG00000165458.15. [O15357-2]"";","actin binding [GO:0003779]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]",actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of actin filament organization [GO:0110053]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],basal plasma membrane [GO:0009925]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle pole [GO:0000922]
Q9Y5U4,S2,-2.369097367,-2.219725281,0.229894955,1.085658849,0.610518781,orange,INSIG2,INSI2_HUMAN,Insulin-induced gene 2 protein (INSIG-2),INSIG2,51141;,ENST00000245787.9; ENSP00000245787.4; ENSG00000125629.16.;,oxysterol binding [GO:0008142]; protein sequestering activity [GO:0140311],cellular response to insulin stimulus [GO:0032869]; cholesterol biosynthetic process [GO:0006695]; cranial suture morphogenesis [GO:0060363]; inner ear morphogenesis [GO:0042472]; middle ear morphogenesis [GO:0042474]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of steroid biosynthetic process [GO:0010894]; roof of mouth development [GO:0060021]; SREBP signaling pathway [GO:0032933]; SREBP-SCAP complex retention in endoplasmic reticulum [GO:0036316]; triglyceride metabolic process [GO:0006641],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SREBP-SCAP-Insig complex [GO:0032937]
P06213,S4,-1.030256339,-1.327460227,0.462345924,0.901192484,0.294234573,tomato2,INSR,INSR_HUMAN,Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta],INSR,3643;,"ENST00000302850.10; ENSP00000303830.4; ENSG00000171105.14. [P06213-1];""ENST00000341500.9; ENSP00000342838.4; ENSG00000171105.14. [P06213-2]"";",amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; cargo receptor activity [GO:0038024]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor activity [GO:0005009]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor I binding [GO:0031994]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; PTB domain binding [GO:0051425],activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; adrenal gland development [GO:0030325]; amyloid-beta clearance [GO:0097242]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; dendritic spine maintenance [GO:0097062]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; insulin receptor signaling pathway [GO:0008286]; learning [GO:0007612]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; memory [GO:0007613]; neuron projection maintenance [GO:1990535]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of receptor internalization [GO:0002092]; positive regulation of respiratory burst [GO:0060267]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of female gonad development [GO:2000194]; symbiont entry into host cell [GO:0046718]; transport across blood-brain barrier [GO:0150104],axon [GO:0030424]; caveola [GO:0005901]; dendrite membrane [GO:0032590]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; insulin receptor complex [GO:0005899]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q68E01,N4,-1.018357569,0.625715917,0.667731705,-0.397722407,-0.280709761,grey30,INTS3,INT3_HUMAN,Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A),INTS3 C1orf193 C1orf60,65123;,"ENST00000318967.7; ENSP00000318641.2; ENSG00000143624.14. [Q68E01-2];""ENST00000435409.6; ENSP00000404290.2; ENSG00000143624.14. [Q68E01-2]"";""ENST00000512605.4; ENSP00000425437.1; ENSG00000143624.14. [Q68E01-3]"";""ENST00000571768.5; ENSP00000458631.1; ENSG00000262826.5. [Q68E01-2]"";""ENST00000576030.5; ENSP00000460221.1; ENSG00000262826.5. [Q68E01-2]"";""ENST00000576422.4; ENSP00000459907.1; ENSG00000262826.5. [Q68E01-3]"";",0,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; response to ionizing radiation [GO:0010212]; snRNA processing [GO:0016180],cytoplasm [GO:0005737]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; SOSS complex [GO:0070876]
Q5JU85,C2,1.271367128,0.168568511,-0.211422142,0.03682735,-0.350561666,aquamarine,IQSEC2,IQEC2_HUMAN,IQ motif and SEC7 domain-containing protein 2,IQSEC2 KIAA0522,23096;,"ENST00000375365.2; ENSP00000364514.2; ENSG00000124313.19. [Q5JU85-3];""ENST00000639161.2; ENSP00000491796.1; ENSG00000124313.19. [Q5JU85-4]"";""ENST00000642864.1; ENSP00000495726.1; ENSG00000124313.19. [Q5JU85-2]"";""ENST00000674510.1; ENSP00000502054.1; ENSG00000124313.19. [Q5JU85-2]"";",guanyl-nucleotide exchange factor activity [GO:0005085],"actin cytoskeleton organization [GO:0030036]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; regulation of ARF protein signal transduction [GO:0032012]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]",cytoplasm [GO:0005737]; Schaffer collateral - CA1 synapse [GO:0098685]
Q9NWZ3,C3,1.86749965,-0.109173912,-0.557089085,-0.409662009,-0.818861121,cyan,IRAK4,IRAK4_HUMAN,Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64),IRAK4,51135;,"ENST00000440781.6; ENSP00000408734.2; ENSG00000198001.16. [Q9NWZ3-2];""ENST00000551736.5; ENSP00000446490.1; ENSG00000198001.16. [Q9NWZ3-1]"";""ENST00000613694.5; ENSP00000479889.3; ENSG00000198001.16. [Q9NWZ3-1]"";",ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-33-mediated signaling pathway [GO:0038172]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of smooth muscle cell proliferation [GO:0048661]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224],cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P48200,C1,1.645124492,0.271976083,-0.796616012,-0.670904338,-0.407848696,lightblue,IREB2,IREB2_HUMAN,Iron-responsive element-binding protein 2 (IRE-BP 2) (Iron regulatory protein 2) (IRP2),IREB2,3658;,"ENST00000258886.13; ENSP00000258886.8; ENSG00000136381.13. [P48200-1];""ENST00000560440.5; ENSP00000452938.1; ENSG00000136381.13. [P48200-2]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]",citrate metabolic process [GO:0006101]; erythrocyte homeostasis [GO:0034101]; establishment of localization in cell [GO:0051649]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; mRNA stabilization [GO:0048255]; multicellular organismal-level iron ion homeostasis [GO:0060586]; osteoclast differentiation [GO:0030316]; post-embryonic development [GO:0009791]; protoporphyrinogen IX biosynthetic process [GO:0006782]; regulation of translation [GO:0006417]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]
Q8IU81,N4,-0.679221584,1.057977827,-0.015271373,-0.148207718,-0.511459244,grey30,IRF2BP1,I2BP1_HUMAN,Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1) (Probable E3 ubiquitin-protein ligase IRF2BP1) (EC 2.3.2.27) (Probable RING-type E3 ubiquitin transferase IRF2BP1),IRF2BP1,26145;,ENST00000302165.5; ENSP00000307265.3; ENSG00000170604.5.;,metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630],negative regulation of transcription by RNA polymerase II [GO:0000122]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9H1B7,N4,-1.046873505,1.328746476,-0.193868595,-0.464428605,-0.898510105,grey30,IRF2BPL,I2BPL_HUMAN,Probable E3 ubiquitin-protein ligase IRF2BPL (EC 2.3.2.27) (Enhanced at puberty protein 1) (Interferon regulatory factor 2-binding protein-like),IRF2BPL C14orf4 EAP1 KIAA1865 My039,64207;,ENST00000238647.5; ENSP00000238647.3; ENSG00000119669.5.;,metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],development of secondary female sexual characteristics [GO:0046543]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q14653,C4,2.099359362,0.114864961,-0.79679163,-0.832444688,-1.089044935,deepskyblue2,IRF3,IRF3_HUMAN,Interferon regulatory factor 3 (IRF-3),IRF3,3661;,"ENST00000309877.11; ENSP00000310127.6; ENSG00000126456.16. [Q14653-1];""ENST00000377139.8; ENSP00000366344.3; ENSG00000126456.16. [Q14653-1]"";""ENST00000442265.2; ENSP00000400378.2; ENSG00000126456.16. [Q14653-5]"";""ENST00000596765.5; ENSP00000470512.1; ENSG00000126456.16. [Q14653-3]"";""ENST00000597198.5; ENSP00000469113.1; ENSG00000126456.16. [Q14653-1]"";""ENST00000599223.5; ENSP00000471358.1; ENSG00000126456.16. [Q14653-2]"";""ENST00000600022.5; ENSP00000472700.1; ENSG00000126456.16. [Q14653-3]"";""ENST00000601291.5; ENSP00000471896.1; ENSG00000126456.16. [Q14653-4]"";","DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; DNA damage response [GO:0006974]; immune system process [GO:0002376]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage apoptotic process [GO:0071888]; MDA-5 signaling pathway [GO:0039530]; mRNA transcription [GO:0009299]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; programmed necrotic cell death [GO:0097300]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in regulation of gene expression [GO:0023019]; toll-like receptor 4 signaling pathway [GO:0034142]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; type I interferon-mediated signaling pathway [GO:0060337],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q00978,C5,1.021251114,0.927918382,-0.444567225,-0.598297574,-0.930190254,turquoise3,IRF9,IRF9_HUMAN,Interferon regulatory factor 9 (IRF-9) (IFN-alpha-responsive transcription factor subunit) (ISGF3 p48 subunit) (Interferon-stimulated gene factor 3 gamma) (ISGF-3 gamma) (Transcriptional regulator ISGF3 subunit gamma),IRF9 ISGF3G,10379;,"ENST00000396864.8; ENSP00000380073.3; ENSG00000213928.10.;""ENST00000646071.2; ENSP00000494792.1; ENSG00000285048.2."";""ENST00000699071.1; ENSP00000514112.1; ENSG00000213928.10."";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ISGF3 complex [GO:0070721]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P35568,C3,1.749512986,0.302355492,-0.556425679,-0.590975385,-0.701236356,cyan,IRS1,IRS1_HUMAN,Insulin receptor substrate 1 (IRS-1),IRS1,3667;,ENST00000305123.6; ENSP00000304895.4; ENSG00000169047.6.;,insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphotyrosine residue binding [GO:0001784]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],cellular response to fatty acid [GO:0071398]; cellular response to insulin stimulus [GO:0032869]; cytokine-mediated signaling pathway [GO:0019221]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to insulin [GO:0032868]; signal transduction [GO:0007165],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9Y4H2,C1,1.590519371,0.156613846,-0.369139426,-0.281919139,-0.444040127,lightblue,IRS2,IRS2_HUMAN,Insulin receptor substrate 2 (IRS-2),IRS2,8660;,ENST00000375856.5; ENSP00000365016.3; ENSG00000185950.9.;,14-3-3 protein binding [GO:0071889]; insulin receptor binding [GO:0005158]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],brain development [GO:0007420]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide [GO:1901653]; epithelial cell migration [GO:0010631]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; mammary gland development [GO:0030879]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of kinase activity [GO:0033673]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of glucose import [GO:0046326]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of type B pancreatic cell proliferation [GO:1904692]; regulation of lipid metabolic process [GO:0019216]; response to glucose [GO:0009749]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q9H9L3,N3,-1.383391391,-1.234557305,0.82081367,-0.043768696,0.847874661,grey50,ISG20L2,I20L2_HUMAN,Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-),ISG20L2 HSD-38 HSD38,81875;,"ENST00000313146.10; ENSP00000323424.6; ENSG00000143319.17.;""ENST00000368219.2; ENSP00000357202.2; ENSG00000143319.17."";",3'-5'-RNA exonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723],ribosome biogenesis [GO:0042254],nucleolus [GO:0005730]; nucleus [GO:0005634]
P53990,C3,1.515764622,-0.254643033,-0.558927526,-0.265184421,-0.475949661,cyan,IST1,IST1_HUMAN,IST1 homolog (hIST1) (Charged multivesicular body protein 8) (CHMP8) (Putative MAPK-activating protein PM28),IST1 KIAA0174,9798;,"ENST00000329908.12; ENSP00000330408.8; ENSG00000182149.21. [P53990-3];""ENST00000378798.9; ENSP00000368075.5; ENSG00000182149.21. [P53990-2]"";""ENST00000378799.11; ENSP00000368076.6; ENSG00000182149.21. [P53990-4]"";""ENST00000535424.5; ENSP00000438399.1; ENSG00000182149.21. [P53990-5]"";""ENST00000538850.5; ENSP00000463711.1; ENSG00000182149.21. [P53990-6]"";""ENST00000541571.6; ENSP00000455860.1; ENSG00000182149.21. [P53990-4]"";""ENST00000544564.5; ENSP00000457844.1; ENSG00000182149.21. [P53990-4]"";""ENST00000606369.5; ENSP00000475853.1; ENSG00000182149.21. [P53990-6]"";",cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877],abscission [GO:0009838]; cell division [GO:0051301]; collateral sprouting [GO:0048668]; cytoskeleton-dependent cytokinesis [GO:0061640]; ESCRT III complex disassembly [GO:1904903]; establishment of protein localization [GO:0045184]; multivesicular body assembly [GO:0036258]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]
Q8TB96,S1,-1.1459726,-1.549644838,0.085174272,0.661754336,1.013984674,gold,ITFG1,TIP_HUMAN,T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin),ITFG1 LNKN-1 TIP CDA08,81533;,ENST00000320640.11; ENSP00000319918.6; ENSG00000129636.13.;,0,0,extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
Q9H0X4,S4,-0.856772643,-1.377963468,0.419411236,0.75547996,0.449114681,tomato2,ITFG3,F234A_HUMAN,Protein FAM234A (Protein ITFG3),FAM234A C16orf9 ITFG3,83986;,"ENST00000301678.7; ENSP00000301678.3; ENSG00000167930.17. [Q9H0X4-1];""ENST00000301679.7; ENSP00000301679.2; ENSG00000167930.17. [Q9H0X4-2]"";""ENST00000399932.8; ENSP00000382814.3; ENSG00000167930.17. [Q9H0X4-1]"";""ENST00000654053.1; ENSP00000499447.1; ENSG00000167930.17. [Q9H0X4-2]"";""ENST00000659283.1; ENSP00000499694.1; ENSG00000167930.17. [Q9H0X4-2]"";""ENST00000666018.1; ENSP00000499687.1; ENSG00000167930.17. [Q9H0X4-2]"";",0,0,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; membrane [GO:0016020]
P17301,S4,-0.975662948,-1.40968799,0.418540074,0.823183918,0.259053202,tomato2,ITGA2,ITA2_HUMAN,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b),ITGA2 CD49B,3673;,ENST00000296585.10; ENSP00000296585.5; ENSG00000164171.11.;,amyloid-beta binding [GO:0001540]; collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; collagen receptor activity [GO:0038064]; heparan sulfate proteoglycan binding [GO:0043395]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618],"animal organ morphogenesis [GO:0009887]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; collagen-activated signaling pathway [GO:0038065]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; focal adhesion assembly [GO:0048041]; hepatocyte differentiation [GO:0070365]; hypotonic response [GO:0006971]; integrin-mediated signaling pathway [GO:0007229]; mammary gland development [GO:0030879]; mesodermal cell differentiation [GO:0048333]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell projection organization [GO:0031346]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of translation [GO:0045727]; positive regulation of transmission of nerve impulse [GO:0051971]; response to amine [GO:0014075]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to muscle activity [GO:0014850]; response to parathyroid hormone [GO:0071107]; response to xenobiotic stimulus [GO:0009410]; skin morphogenesis [GO:0043589]; substrate-dependent cell migration [GO:0006929]",axon terminus [GO:0043679]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; integrin alpha2-beta1 complex [GO:0034666]; integrin complex [GO:0008305]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
P26006,S4,-0.781000147,-1.273684231,0.314511448,0.825983524,0.361982655,tomato2,ITGA3,ITA3_HUMAN,Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain],ITGA3 MSK18,3675;,"ENST00000007722.11; ENSP00000007722.7; ENSG00000005884.18. [P26006-1];""ENST00000320031.13; ENSP00000315190.8; ENSG00000005884.18. [P26006-2]"";",collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982],cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; dendritic spine maintenance [GO:0097062]; exploration behavior [GO:0035640]; heart development [GO:0007507]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; lung development [GO:0030324]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; mesodermal cell differentiation [GO:0048333]; negative regulation of cell projection organization [GO:0031345]; negative regulation of Rho protein signal transduction [GO:0035024]; nephron development [GO:0072006]; neuron migration [GO:0001764]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of BMP signaling pathway [GO:0030510]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of Wnt signaling pathway [GO:0030111]; renal filtration [GO:0097205]; response to gonadotropin [GO:0034698]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skin development [GO:0043588]; synaptic membrane adhesion [GO:0099560],basolateral plasma membrane [GO:0016323]; cell periphery [GO:0071944]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone filopodium [GO:1990812]; integrin alpha3-beta1 complex [GO:0034667]; integrin complex [GO:0008305]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone membrane [GO:0048787]; receptor complex [GO:0043235]; synaptic membrane [GO:0097060]
P08648,S4,-0.895998684,-1.152460626,0.416584502,0.863568939,0.413921231,tomato2,ITGA5,ITA5_HUMAN,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain],ITGA5 FNRA,3678;,ENST00000293379.9; ENSP00000293379.4; ENSG00000161638.11.;,calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; integrin binding [GO:0005178]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; virus receptor activity [GO:0001618],"angiogenesis [GO:0001525]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; endodermal cell differentiation [GO:0035987]; female pregnancy [GO:0007565]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte cell-cell adhesion [GO:0007159]; memory [GO:0007613]; negative regulation of anoikis [GO:2000811]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; wound healing, spreading of epidermal cells [GO:0035313]",alphav-beta3 integrin-vitronectin complex [GO:0071062]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha5-beta1 complex [GO:0034674]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ruffle [GO:0001726]
P23229,S4,-1.130727362,-1.549716272,0.469805862,0.914827516,0.388620457,tomato2,ITGA6,ITA6_HUMAN,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)],ITGA6,3655;,"ENST00000409080.6; ENSP00000386896.1; ENSG00000091409.16. [P23229-3];""ENST00000409532.5; ENSP00000386614.1; ENSG00000091409.16. [P23229-7]"";""ENST00000442250.6; ENSP00000406694.1; ENSG00000091409.16. [P23229-1]"";""ENST00000458358.5; ENSP00000394169.1; ENSG00000091409.16. [P23229-5]"";""ENST00000684293.1; ENSP00000508249.1; ENSG00000091409.16. [P23229-2]"";",cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132],cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to organic cyclic compound [GO:0071407]; ectodermal cell differentiation [GO:0010668]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skin morphogenesis [GO:0043589],adherens junction [GO:0005912]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integrin alpha6-beta1 complex [GO:0034675]; integrin alpha6-beta4 complex [GO:0034676]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]
P06756,S4,-1.071185861,-1.409222349,0.327687477,0.876675906,0.461776966,tomato2,ITGAV,ITAV_HUMAN,Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain],ITGAV MSK8 VNRA VTNR,3685;,"ENST00000261023.8; ENSP00000261023.3; ENSG00000138448.13. [P06756-1];""ENST00000374907.7; ENSP00000364042.3; ENSG00000138448.13. [P06756-2]"";""ENST00000433736.6; ENSP00000404291.2; ENSG00000138448.13. [P06756-3]"";",coreceptor activity [GO:0015026]; extracellular matrix binding [GO:0050840]; extracellular matrix protein binding [GO:1990430]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; opsonin binding [GO:0001846]; protease binding [GO:0002020]; protein kinase C binding [GO:0005080]; transforming growth factor beta binding [GO:0050431]; virus receptor activity [GO:0001618]; voltage-gated calcium channel activity [GO:0005245],"angiogenesis [GO:0001525]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; calcium ion transmembrane transport [GO:0070588]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; endodermal cell differentiation [GO:0035987]; entry into host cell by a symbiont-containing vacuole [GO:0085017]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of entry of bacterium into host cell [GO:2000536]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of phagocytosis [GO:0050764]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiont entry into host cell [GO:0046718]; transforming growth factor beta production [GO:0071604]; vasculogenesis [GO:0001570]; wound healing, spreading of epidermal cells [GO:0035313]",alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; integrin alphav-beta1 complex [GO:0034682]; integrin alphav-beta3 complex [GO:0034683]; integrin alphav-beta5 complex [GO:0034684]; integrin alphav-beta6 complex [GO:0034685]; integrin alphav-beta8 complex [GO:0034686]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]
P05556,S4,-1.051387048,-1.412466829,0.427582939,0.87566639,0.342069993,tomato2,ITGB1,ITB1_HUMAN,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29),ITGB1 FNRB MDF2 MSK12,3688;,"ENST00000302278.8; ENSP00000303351.3; ENSG00000150093.20. [P05556-1];""ENST00000396033.6; ENSP00000379350.2; ENSG00000150093.20. [P05556-1]"";""ENST00000417122.7; ENSP00000404546.3; ENSG00000150093.20. [P05556-1]"";""ENST00000423113.6; ENSP00000388694.1; ENSG00000150093.20. [P05556-5]"";""ENST00000437302.6; ENSP00000398029.2; ENSG00000150093.20. [P05556-1]"";""ENST00000676460.1; ENSP00000504641.1; ENSG00000150093.20. [P05556-2]"";""ENST00000676659.1; ENSP00000502979.1; ENSG00000150093.20. [P05556-4]"";""ENST00000677310.1; ENSP00000504508.1; ENSG00000150093.20. [P05556-3]"";""ENST00000677999.1; ENSP00000503546.1; ENSG00000150093.20. [P05556-1]"";""ENST00000678701.1; ENSP00000504205.1; ENSG00000150093.20. [P05556-1]"";""ENST00000678766.1; ENSP00000503538.1; ENSG00000150093.20. [P05556-3]"";""ENST00000678943.1; ENSP00000503916.1; ENSG00000150093.20. [P05556-1]"";""ENST00000678952.1; ENSP00000504444.1; ENSG00000150093.20. [P05556-1]"";""ENST00000678989.1; ENSP00000502882.1; ENSG00000150093.20. [P05556-1]"";",actin binding [GO:0003779]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; collagen binding involved in cell-matrix adhesion [GO:0098639]; coreceptor activity [GO:0015026]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; magnesium ion binding [GO:0000287]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618],"axon extension [GO:0048675]; B cell differentiation [GO:0030183]; basement membrane organization [GO:0071711]; calcium-independent cell-matrix adhesion [GO:0007161]; cardiac cell fate specification [GO:0060912]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; CD40 signaling pathway [GO:0023035]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cellular defense response [GO:0006968]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; dendrite morphogenesis [GO:0048813]; establishment of mitotic spindle orientation [GO:0000132]; extracellular matrix organization [GO:0030198]; formation of radial glial scaffolds [GO:0021943]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell migration [GO:0008354]; heterotypic cell-cell adhesion [GO:0034113]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; in utero embryonic development [GO:0001701]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; maintenance of blood-brain barrier [GO:0035633]; mesodermal cell differentiation [GO:0048333]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast fate specification [GO:0048626]; myoblast fusion [GO:0007520]; negative regulation of anoikis [GO:2000811]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of vasoconstriction [GO:0045906]; neuroblast proliferation [GO:0007405]; phagocytosis [GO:0006909]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of wound healing [GO:0090303]; reactive gliosis [GO:0150103]; receptor internalization [GO:0031623]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710]; regulation of inward rectifier potassium channel activity [GO:1901979]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse pruning [GO:1905806]; sarcomere organization [GO:0045214]; visual learning [GO:0008542]; wound healing, spreading of epidermal cells [GO:0035313]",cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glial cell projection [GO:0097386]; integrin alpha1-beta1 complex [GO:0034665]; integrin alpha10-beta1 complex [GO:0034680]; integrin alpha11-beta1 complex [GO:0034681]; integrin alpha2-beta1 complex [GO:0034666]; integrin alpha3-beta1 complex [GO:0034667]; integrin alpha4-beta1 complex [GO:0034668]; integrin alpha5-beta1 complex [GO:0034674]; integrin alpha6-beta1 complex [GO:0034675]; integrin alpha7-beta1 complex [GO:0034677]; integrin alpha8-beta1 complex [GO:0034678]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta1 complex [GO:0034682]; integrin complex [GO:0008305]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic membrane [GO:0097060]
P16144,S4,-0.900013053,-1.171249862,0.317204793,0.911099929,0.461580845,tomato2,ITGB4,ITB4_HUMAN,Integrin beta-4 (GP150) (CD antigen CD104),ITGB4,3691;,"ENST00000200181.8; ENSP00000200181.3; ENSG00000132470.14. [P16144-1];""ENST00000449880.7; ENSP00000400217.2; ENSG00000132470.14. [P16144-3]"";""ENST00000450894.7; ENSP00000405536.3; ENSG00000132470.14. [P16144-2]"";""ENST00000579662.5; ENSP00000463651.1; ENSG00000132470.14. [P16144-2]"";",G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; metal ion binding [GO:0046872],autophagy [GO:0006914]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; mesodermal cell differentiation [GO:0048333]; nail development [GO:0035878]; peripheral nervous system myelin formation [GO:0032290]; response to wounding [GO:0009611]; skin morphogenesis [GO:0043589]; trophoblast cell migration [GO:0061450],basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin complex [GO:0008305]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q9Y287,S1,-1.405635798,-1.651186994,-0.081812532,0.83839651,0.944546139,gold,ITM2B,ITM2B_HUMAN,"Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri) [Cleaved into: BRI2, membrane form (Mature BRI2) (mBRI2); BRI2 intracellular domain (BRI2 ICD); BRI2C, soluble form; Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)]",ITM2B BRI BRI2,9445;,"ENST00000378549.5; ENSP00000367811.5; ENSG00000136156.15. [Q9Y287-2];""ENST00000647800.2; ENSP00000497221.1; ENSG00000136156.15. [Q9Y287-1]"";",amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524],negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; nervous system development [GO:0007399],endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]
Q9NQX7,S1,-0.67154259,-1.082942581,-0.072887524,0.792912931,0.860467146,gold,ITM2C,ITM2C_HUMAN,Integral membrane protein 2C (Cerebral protein 14) (Transmembrane protein BRI3) [Cleaved into: CT-BRI3],ITM2C BRI3 hucep-14 NPD018 PSEC0047,81618;,"ENST00000326407.10; ENSP00000322100.6; ENSG00000135916.16. [Q9NQX7-3];""ENST00000326427.11; ENSP00000322730.6; ENSG00000135916.16. [Q9NQX7-1]"";""ENST00000335005.10; ENSP00000335121.6; ENSG00000135916.16. [Q9NQX7-2]"";",amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524],negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of neuron projection development [GO:0010977]; neuron differentiation [GO:0030182]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q9BY32,C3,1.889175954,0.073403173,-0.785956913,-0.698815602,-1.093261438,cyan,ITPA,ITPA_HUMAN,Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (Putative oncogene protein hlc14-06-p),ITPA C20orf37 My049 OK/SW-cl.9,3704;,"ENST00000380113.8; ENSP00000369456.3; ENSG00000125877.13. [Q9BY32-1];""ENST00000399838.3; ENSP00000382732.3; ENSG00000125877.13. [Q9BY32-3]"";""ENST00000455664.6; ENSP00000413282.1; ENSG00000125877.13. [Q9BY32-2]"";",dITP diphosphatase activity [GO:0035870]; identical protein binding [GO:0042802]; ITP diphosphatase activity [GO:0036220]; metal ion binding [GO:0046872]; nucleoside triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; XTP diphosphatase activity [GO:0036222],chromosome organization [GO:0051276]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; ITP catabolic process [GO:0006193]; nucleoside triphosphate catabolic process [GO:0009143],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]
Q96DU7,C4,1.882695517,0.158237016,-0.688486985,-0.731581612,-1.125045073,deepskyblue2,ITPKC,IP3KC_HUMAN,"Inositol-trisphosphate 3-kinase C (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase C) (IP3 3-kinase C) (IP3K C) (InsP 3-kinase C)",ITPKC IP3KC,80271;,"ENST00000263370.3; ENSP00000263370.1; ENSG00000086544.4.;""ENST00000699490.1; ENSP00000514401.1; ENSG00000086544.4."";","ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol tetrakisphosphate kinase activity [GO:0051765]; inositol-1,4,5-trisphosphate 3-kinase activity [GO:0008440]",cellular response to calcium ion [GO:0071277]; inositol phosphate biosynthetic process [GO:0032958]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]
Q14571,S2,-1.169177556,-1.446439941,0.205333771,0.834508218,0.706040761,orange,ITPR2,ITPR2_HUMAN,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Inositol 1,4,5-trisphosphate receptor type 2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor)",ITPR2,3709;,"ENST00000242737.5; ENSP00000242737.5; ENSG00000123104.12. [Q14571-2];""ENST00000381340.8; ENSP00000370744.3; ENSG00000123104.12. [Q14571-1]"";","calcium ion binding [GO:0005509]; calcium ion transmembrane transporter activity [GO:0015085]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-gated calcium channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; scaffold protein binding [GO:0097110]; transmembrane transporter binding [GO:0044325]",cellular response to cAMP [GO:0071320]; cellular response to ethanol [GO:0071361]; release of sequestered calcium ion into cytosol [GO:0051209]; response to hypoxia [GO:0001666]; signal transduction [GO:0007165],cell cortex [GO:0005938]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; secretory granule membrane [GO:0030667]
Q14573,S2,-1.213456849,-1.456165503,0.24436866,0.775198433,0.714519169,orange,ITPR3,ITPR3_HUMAN,"Inositol 1,4,5-trisphosphate-gated calcium channel ITPR3 (IP3 receptor isoform 3) (IP3R-3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",ITPR3,3710;,"ENST00000374316.9; ENSP00000363435.4; ENSG00000096433.11.;""ENST00000605930.3; ENSP00000475177.1; ENSG00000096433.11."";","calcium ion binding [GO:0005509]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; inositol 1,4,5 trisphosphate binding [GO:0070679]; inositol 1,4,5-trisphosphate-gated calcium channel activity [GO:0005220]; inositol hexakisphosphate binding [GO:0000822]; intracellularly gated calcium channel activity [GO:0015278]; phosphatidylinositol binding [GO:0035091]",calcium ion homeostasis [GO:0055074]; G protein-coupled receptor signaling pathway [GO:0007186]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein homotetramerization [GO:0051289]; release of sequestered calcium ion into cytosol [GO:0051209]; response to calcium ion [GO:0051592]; sensory perception of bitter taste [GO:0050913]; sensory perception of sweet taste [GO:0050916]; sensory perception of taste [GO:0050909]; sensory perception of umami taste [GO:0050917],apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; receptor complex [GO:0043235]; sarcoplasmic reticulum [GO:0016529]; secretory granule membrane [GO:0030667]
Q96ST2,N4,-0.5288024,1.04021093,0.410597826,-0.557588004,-1.069049352,grey30,IWS1,IWS1_HUMAN,Protein IWS1 homolog (IWS1-like protein),IWS1 IWS1L,55677;,ENST00000295321.9; ENSP00000295321.4; ENSG00000163166.15. [Q96ST2-1];,0,chromatin remodeling [GO:0006338]; mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380]; transcription elongation-coupled chromatin remodeling [GO:0140673],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8N5M9,S2,-1.472287206,-1.515074056,0.32635145,0.939415261,0.585931976,orange,JAGN1,JAGN1_HUMAN,Protein jagunal homolog 1,JAGN1,84522;,ENST00000647897.1; ENSP00000496942.1; ENSG00000171135.15.;,0,defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; exocytosis [GO:0006887]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
P23458,S4,-0.746130661,-0.959471711,0.351306829,0.820234846,0.282044267,tomato2,JAK1,JAK1_HUMAN,Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1),JAK1 JAK1A JAK1B,3716;,"ENST00000342505.5; ENSP00000343204.4; ENSG00000162434.14.;""ENST00000671929.2; ENSP00000500485.1; ENSG00000162434.14."";""ENST00000671954.2; ENSP00000500841.1; ENSG00000162434.14."";""ENST00000672179.2; ENSP00000500296.1; ENSG00000162434.14."";""ENST00000672247.2; ENSP00000499884.1; ENSG00000162434.14."";""ENST00000672434.2; ENSP00000499900.1; ENSG00000162434.14."";""ENST00000672751.2; ENSP00000500745.2; ENSG00000162434.14."";""ENST00000699262.1; ENSP00000514243.1; ENSG00000162434.14."";""ENST00000699312.1; ENSP00000514291.1; ENSG00000162434.14."";",ATP binding [GO:0005524]; CCR5 chemokine receptor binding [GO:0031730]; growth hormone receptor binding [GO:0005131]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625],cell differentiation [GO:0030154]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; interleukin-10-mediated signaling pathway [GO:0140105]; interleukin-11-mediated signaling pathway [GO:0038154]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-6-mediated signaling pathway [GO:0070102]; interleukin-9-mediated signaling pathway [GO:0038113]; intracellular signal transduction [GO:0035556]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; response to antibiotic [GO:0046677]; T-helper 17 cell lineage commitment [GO:0072540]; type I interferon-mediated signaling pathway [GO:0060337]; type II interferon-mediated signaling pathway [GO:0060333]; type III interferon-mediated signaling pathway [GO:0038196],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O60674,S3,0.010767036,-0.702366539,0.27657906,0.612623297,0.367294352,salmon,JAK2,JAK2_HUMAN,Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2),JAK2,3717;,ENST00000381652.4; ENSP00000371067.4; ENSG00000096968.14.;,acetylcholine receptor binding [GO:0033130]; ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; heme binding [GO:0020037]; histone binding [GO:0042393]; histone H3Y41 kinase activity [GO:0035401]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; interleukin-12 receptor binding [GO:0005143]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; peptide hormone receptor binding [GO:0051428]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein tyrosine kinase activity [GO:0004713]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; type 1 angiotensin receptor binding [GO:0031702],actin filament polymerization [GO:0030041]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; activation of Janus kinase activity [GO:0042976]; adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to interleukin-3 [GO:0036016]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; collagen-activated signaling pathway [GO:0038065]; cytokine-mediated signaling pathway [GO:0019221]; enzyme-linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; immune response [GO:0006955]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-3-mediated signaling pathway [GO:0038156]; interleukin-35-mediated signaling pathway [GO:0070757]; interleukin-5-mediated signaling pathway [GO:0038043]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; mammary gland epithelium development [GO:0061180]; mesoderm development [GO:0007498]; microglial cell activation [GO:0001774]; mineralocorticoid receptor signaling pathway [GO:0031959]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA binding [GO:0043392]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of epithelial cell apoptotic process [GO:1904037]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet activation [GO:0010572]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type II interferon production [GO:0032729]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; post-embryonic hemopoiesis [GO:0035166]; post-translational protein modification [GO:0043687]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of inflammatory response [GO:0050727]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of postsynapse to nucleus signaling pathway [GO:1905539]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; response to amine [GO:0014075]; response to antibiotic [GO:0046677]; response to hydroperoxide [GO:0033194]; response to interleukin-12 [GO:0070671]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165]; symbiont-induced defense-related programmed cell death [GO:0034050]; transcription by RNA polymerase II [GO:0006366]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type II interferon-mediated signaling pathway [GO:0060333]; tyrosine phosphorylation of STAT protein [GO:0007260],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; euchromatin [GO:0000791]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of plasma membrane [GO:0019897]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; interleukin-12 receptor complex [GO:0042022]; interleukin-23 receptor complex [GO:0072536]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]
Q92833,N1,-1.263874511,-0.722208345,0.348609808,-0.307951886,1.330730659,grey90,JARID2,JARD2_HUMAN,Protein Jumonji (Jumonji/ARID domain-containing protein 2),JARID2 JMJ,3720;,"ENST00000341776.7; ENSP00000341280.2; ENSG00000008083.14. [Q92833-1];""ENST00000397311.4; ENSP00000380478.3; ENSG00000008083.14. [Q92833-3]"";",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K27 methyltransferase activity [GO:0046976]; ubiquitin binding [GO:0043130]; ubiquitin-modified histone reader activity [GO:0061649],cardiac muscle cell proliferation [GO:0060038]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; facultative heterochromatin formation [GO:0140718]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization to pericentric heterochromatin [GO:1902682]; random inactivation of X chromosome [GO:0060816]; regulation of gene expression [GO:0010468]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538],chromatin [GO:0000785]; ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q15652,N4,-0.90622071,1.286706895,-0.089373617,-0.53904965,-0.283934352,grey30,JMJD1C,JHD2C_HUMAN,Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8),JMJD1C JHDM2C KIAA1380 TRIP8,221037;,"ENST00000399262.7; ENSP00000382204.2; ENSG00000171988.20. [Q15652-1];""ENST00000542921.5; ENSP00000444682.1; ENSG00000171988.20. [Q15652-3]"";",chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone H3K9 demethylase activity [GO:0032454]; metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712],blood coagulation [GO:0007596]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]
Q9HDC5,S3,-0.966142917,-0.69648865,0.249558997,0.748662958,0.511349954,salmon,JPH1,JPH1_HUMAN,Junctophilin-1 (JP-1) (Junctophilin type 1),JPH1 JP1,56704;,ENST00000342232.5; ENSP00000344488.4; ENSG00000104369.5.;,structural constituent of muscle [GO:0008307],calcium ion transport into cytosol [GO:0060402]; muscle organ development [GO:0007517]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314],endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]
O76095,S1,-2.586356323,-2.614361699,-0.362506178,0.973673526,1.157413639,gold,JTB,JTB_HUMAN,Protein JTB (Jumping translocation breakpoint protein) (Prostate androgen-regulated protein) (PAR protein),JTB HSPC222,10899;,"ENST00000271843.9; ENSP00000271843.4; ENSG00000143543.15. [O76095-1];""ENST00000356648.5; ENSP00000349069.1; ENSG00000143543.15. [O76095-2]"";""ENST00000368589.5; ENSP00000357578.1; ENSG00000143543.15. [O76095-2]"";""ENST00000428469.1; ENSP00000395250.1; ENSG00000143543.15. [O76095-2]"";",protein kinase binding [GO:0019901],apoptotic mitochondrial changes [GO:0008637]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; positive regulation of protein kinase activity [GO:0045860]; regulation of cell population proliferation [GO:0042127],centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; spindle [GO:0005819]
P14923,M1,-0.747754258,-1.06498949,0.53036297,0.831763251,0.002401957,burlywood4,JUP,PLAK_HUMAN,Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3),JUP CTNNG DP3,3728;,"ENST00000310706.9; ENSP00000311113.5; ENSG00000173801.17.;""ENST00000393930.5; ENSP00000377507.1; ENSG00000173801.17."";""ENST00000393931.8; ENSP00000377508.3; ENSG00000173801.17."";",alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; cytoskeletal protein-membrane anchor activity [GO:0106006]; nuclear receptor binding [GO:0016922]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; structural molecule activity [GO:0005198]; transcription coactivator activity [GO:0003713],bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cellular response to indole-3-methanol [GO:0071681]; desmosome assembly [GO:0002159]; detection of mechanical stimulus [GO:0050982]; endothelial cell-cell adhesion [GO:0071603]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of cell population proliferation [GO:0042127]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; skin development [GO:0043588],adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; gamma-catenin-TCF7L2 complex [GO:0071665]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; specific granule lumen [GO:0035580]; Z disc [GO:0030018]; zonula adherens [GO:0005915]
Q92794,N3,-1.123354913,-1.237406058,1.166845776,-0.044908107,0.20775997,grey50,KAT6A,KAT6A_HUMAN,"Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)",KAT6A MOZ MYST3 RUNXBP2 ZNF220,7994;,"ENST00000265713.8; ENSP00000265713.2; ENSG00000083168.11.;""ENST00000396930.4; ENSP00000380136.3; ENSG00000083168.11."";",acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270],cellular senescence [GO:0090398]; chromosome organization [GO:0051276]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein acetylation [GO:0006473]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; PML body [GO:0016605]
O95251,N2,-0.994284832,-0.516977431,1.188987296,0.160004779,-0.464764181,grey70,KAT7,KAT7_HUMAN,"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)",KAT7 HBO1 HBOa MYST2,11143;,"ENST00000259021.9; ENSP00000259021.4; ENSG00000136504.15. [O95251-1];""ENST00000424009.6; ENSP00000398961.2; ENSG00000136504.15. [O95251-4]"";""ENST00000454930.6; ENSP00000413415.2; ENSG00000136504.15. [O95251-5]"";""ENST00000509773.5; ENSP00000424577.1; ENSG00000136504.15. [O95251-2]"";""ENST00000510819.5; ENSP00000423385.1; ENSG00000136504.15. [O95251-3]"";""ENST00000706506.1; ENSP00000516419.1; ENSG00000136504.15. [O95251-4]"";",chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H3K23 acetyltransferase activity [GO:0043994]; histone H3K4 acetyltransferase activity [GO:0044016]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270],"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin disassembly [GO:0140889]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of DNA-templated transcription [GO:0006355]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]; transcription initiation-coupled chromatin remodeling [GO:0045815]","chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]"
Q9P0J7,C1,1.35589733,0.043989743,-0.597097538,-0.346410498,0.182155773,lightblue,KCMF1,KCMF1_HUMAN,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (ZZ-type zinc finger-containing protein 1),KCMF1 FIGC ZZZ1,56888;,ENST00000409785.9; ENSP00000386738.3; ENSG00000176407.18.;,ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; synaptic signaling [GO:0099536],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; synapse [GO:0045202]
Q7L273,C1,1.471797412,0.247586692,-0.418461367,-0.264395042,-0.505441206,lightblue,KCTD9,KCTD9_HUMAN,BTB/POZ domain-containing protein KCTD9,KCTD9,54793;,ENST00000221200.9; ENSP00000221200.4; ENSG00000104756.17.;,cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802],intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567],0
O60341,N4,-0.896597788,0.793564762,0.325253387,-0.31629017,-0.238752548,grey30,KDM1A,KDM1A_HUMAN,Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A),KDM1A AOF2 KDM1 KIAA0601 LSD1,23028;,"ENST00000356634.7; ENSP00000349049.3; ENSG00000004487.18. [O60341-1];""ENST00000400181.9; ENSP00000383042.5; ENSG00000004487.18. [O60341-2]"";",chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3K4 demethylase activity [GO:0032453]; histone H3K9 demethylase activity [GO:0032454]; identical protein binding [GO:0042802]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric repeat-containing RNA binding [GO:0061752]; transcription coactivator activity [GO:0003713],"cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; chromatin remodeling [GO:0006338]; DNA repair-dependent chromatin remodeling [GO:0140861]; guanine metabolic process [GO:0046098]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA methylation-dependent heterochromatin formation [GO:0090308]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]"
Q9Y2K7,N2,-1.139106843,0.096295166,1.225666495,-0.012911528,-0.788189442,grey70,KDM2A,KDM2A_HUMAN,Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A),KDM2A CXXC8 FBL11 FBL7 FBXL11 JHDM1A KIAA1004,22992;,"ENST00000398645.6; ENSP00000381640.2; ENSG00000173120.15. [Q9Y2K7-3];""ENST00000529006.7; ENSP00000432786.1; ENSG00000173120.15. [Q9Y2K7-1]"";""ENST00000530342.2; ENSP00000435776.1; ENSG00000173120.15. [Q9Y2K7-5]"";",histone demethylase activity [GO:0032452]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270],circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of transcription by competitive promoter binding [GO:0010944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357],chromosome [GO:0005694]; nucleoplasm [GO:0005654]
Q7LBC6,N4,-0.538094493,1.03613337,0.035896497,-0.205360064,-0.504579279,grey30,KDM3B,KDM3B_HUMAN,Lysine-specific demethylase 3B (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA) ([histone H3]-dimethyl-L-lysine(9) demethylase 3B),KDM3B C5orf7 JHDM2B JMJD1B KIAA1082,51780;,ENST00000314358.10; ENSP00000326563.5; ENSG00000120733.15. [Q7LBC6-1];,antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712],regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]
O75164,N4,-0.106958199,1.068856815,-0.118361523,-0.327151663,-0.573262165,grey30,KDM4A,KDM4A_HUMAN,Lysine-specific demethylase 4A (EC 1.14.11.66) (EC 1.14.11.69) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) ([histone H3]-trimethyl-L-lysine(36) demethylase 4A) ([histone H3]-trimethyl-L-lysine(9) demethylase 4A),KDM4A JHDM3A JMJD2 JMJD2A KIAA0677,9682;,ENST00000372396.4; ENSP00000361473.3; ENSG00000066135.13. [O75164-1];,histone demethylase activity [GO:0032452]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me2/H3K36me3 demethylase activity [GO:0140681]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me2/H3K9me3 demethylase activity [GO:0140684]; methylated histone binding [GO:0035064]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],apoptotic chromosome condensation [GO:0030263]; cardiac muscle hypertrophy in response to stress [GO:0014898]; chromatin remodeling [GO:0006338]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; regulation of gene expression [GO:0010468]; response to nutrient levels [GO:0031667],chromatin [GO:0000785]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]
Q9UGL1,N2,-0.373200252,0.063458382,0.990898763,-0.067326516,-0.569498567,grey70,KDM5B,KDM5B_HUMAN,Lysine-specific demethylase 5B (EC 1.14.11.67) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B),KDM5B JARID1B PLU1 RBBP2H1,10765;,"ENST00000367264.7; ENSP00000356233.2; ENSG00000117139.18. [Q9UGL1-2];""ENST00000367265.9; ENSP00000356234.3; ENSG00000117139.18. [Q9UGL1-1]"";",DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone H3K4 demethylase activity [GO:0032453]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; nucleic acid binding [GO:0003676]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; regulation of estradiol secretion [GO:2000864]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O15054,N2,-0.664728,-0.622894871,0.925049153,0.113528941,0.002029003,grey70,KDM6B,KDM6B_HUMAN,Lysine-specific demethylase 6B (EC 1.14.11.68) (JmjC domain-containing protein 3) (Jumonji domain-containing protein 3) (Lysine demethylase 6B) ([histone H3]-trimethyl-L-lysine(27) demethylase 6B),KDM6B JMJD3 KIAA0346,23135;,"ENST00000254846.9; ENSP00000254846.5; ENSG00000132510.11. [O15054-1];""ENST00000448097.7; ENSP00000412513.2; ENSG00000132510.11. [O15054-2]"";",beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],cardiac muscle cell differentiation [GO:0055007]; cell fate commitment [GO:0045165]; cellular response to hydrogen peroxide [GO:0070301]; chromatin remodeling [GO:0006338]; endothelial cell differentiation [GO:0045446]; hippocampus development [GO:0021766]; inflammatory response to antigenic stimulus [GO:0002437]; mesodermal cell differentiation [GO:0048333]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to activity [GO:0014823]; response to fungicide [GO:0060992],MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q06136,S2,-1.188055825,-1.374022748,0.197214109,0.856991997,0.702237872,orange,KDSR,KDSR_HUMAN,3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1),KDSR FVT1 SDR35C1,2531;,"ENST00000326575.9; ENSP00000312939.5; ENSG00000119537.18. [Q06136-2];""ENST00000645214.2; ENSP00000494352.1; ENSG00000119537.18. [Q06136-1]"";",3-dehydrosphinganine reductase activity [GO:0047560]; NADPH binding [GO:0070402],3-keto-sphinganine metabolic process [GO:0006666]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; membrane [GO:0016020]
P50053,C5,2.11610749,0.445737515,-0.935877772,-1.06518462,-1.342993755,turquoise3,KHK,KHK_HUMAN,Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase),KHK,3795;,"ENST00000260598.10; ENSP00000260598.5; ENSG00000138030.14. [P50053-1];""ENST00000260599.11; ENSP00000260599.6; ENSG00000138030.14. [P50053-2]"";",ATP binding [GO:0005524]; ketohexokinase activity [GO:0004454],fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q15397,N3,-1.209488284,-1.428811945,1.386355276,-0.215897892,-0.141283921,grey50,KIAA0020,PUM3_HUMAN,Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8) (HLA-HA8),PUM3 cPERP-C KIAA0020 PUF-A XTP5,9933;,ENST00000397885.3; ENSP00000380982.2; ENSG00000080608.10.;,DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417],chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q14667,S3,-0.747024248,-1.091791445,0.157903579,0.818242836,0.624736275,salmon,KIAA0100,BLTP2_HUMAN,Bridge-like lipid transfer protein family member 2 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein) (Protein hobbit homolog),BLTP2 BCOX1 KIAA0100,9703;,ENST00000528896.7; ENSP00000436773.2; ENSG00000007202.16. [Q14667-1];,phosphatidylinositol binding [GO:0035091],0,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]
Q8IZA0,S1,-1.34626619,-1.707720579,-0.309735421,0.923212162,0.963731347,gold,KIAA0319L,K319L_HUMAN,Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR),KIAA0319L AAVR KIAA1837 PP791,79932;,"ENST00000325722.8; ENSP00000318406.3; ENSG00000142687.19. [Q8IZA0-1];""ENST00000426982.7; ENSP00000395883.3; ENSG00000142687.19. [Q8IZA0-1]"";""ENST00000469892.6; ENSP00000419396.2; ENSG00000142687.19. [Q8IZA0-1]"";",0,neuron migration [GO:0001764],cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]
O60268,C4,2.111731837,0.125049815,-0.865096993,-0.726047487,-1.179233986,deepskyblue2,KIAA0513,K0513_HUMAN,Uncharacterized protein KIAA0513,KIAA0513,9764;,"ENST00000538274.6; ENSP00000446439.1; ENSG00000135709.14. [O60268-3];""ENST00000566428.5; ENSP00000457408.1; ENSG00000135709.14. [O60268-1]"";""ENST00000567328.6; ENSP00000455544.1; ENSG00000135709.14. [O60268-2]"";""ENST00000683363.1; ENSP00000507772.1; ENSG00000135709.14. [O60268-1]"";",0,0,cytoplasm [GO:0005737]
Q2KHM9,S1,-0.671515461,-0.548479705,-0.064315186,0.451981775,0.910654187,gold,KIAA0753,MOONR_HUMAN,Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein),KIAA0753 MNR OFIP,9851;,"ENST00000361413.8; ENSP00000355250.3; ENSG00000198920.11. [Q2KHM9-1];""ENST00000572370.5; ENSP00000460050.1; ENSG00000198920.11. [Q2KHM9-2]"";","2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]",centriole replication [GO:0007099]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; protein localization to centrosome [GO:0071539],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]
Q9UPN3,S4,-0.502731974,-0.417217926,0.465300453,0.674561246,0.114877539,tomato2,KIAA0754,MACF1_HUMAN,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)",MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251,23499;,ENST00000361689.7; ENSP00000354573.2; ENSG00000127603.32. [Q9UPN3-2];,actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; microtubule minus-end binding [GO:0051011]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198],Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; positive regulation of axon extension [GO:0045773]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]
Q7Z7F0,N4,-0.262256048,1.245428111,-0.286578361,-0.369612402,-0.770151095,grey30,KIAA0907,KHDC4_HUMAN,KH homology domain-containing protein 4 (Brings lots of money 7) (Pre-mRNA splicing factor protein KHDC4),KHDC4 BLOM7 KIAA0907 SNORA80EHG,22889;,"ENST00000368319.3; ENSP00000357302.3; ENSG00000132680.11. [Q7Z7F0-3];""ENST00000368320.7; ENSP00000357303.3; ENSG00000132680.11. [Q7Z7F0-2]"";""ENST00000368321.8; ENSP00000357304.3; ENSG00000132680.11. [Q7Z7F0-1]"";",RNA binding [GO:0003723],mRNA splice site recognition [GO:0006376],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
A2VDJ0,S3,-1.05635965,-0.932378569,0.181328657,0.918759239,0.461178913,salmon,KIAA0922,T131L_HUMAN,Transmembrane protein 131-like,TMEM131L KIAA0922,23240;,"ENST00000409663.7; ENSP00000386574.3; ENSG00000121210.16. [A2VDJ0-1];""ENST00000409959.8; ENSP00000386787.3; ENSG00000121210.16. [A2VDJ0-5]"";",0,negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]
Q2LD37,S4,-0.675881709,-0.94041751,0.50322052,0.838710864,0.257111388,tomato2,KIAA1109,BLTP1_HUMAN,Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein),BLTP1 FSA KIAA1109 KIAA1371 TWEEK,84162;,ENST00000264501.8; ENSP00000264501.4; ENSG00000138688.17. [Q2LD37-1];,phosphatidylethanolamine transfer activity [GO:1904121],endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intermembrane lipid transfer [GO:0120009]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]
A4D1U4,S1,-0.645072944,-0.779602025,-0.077657698,0.588801449,0.855294813,gold,KIAA1147,DEN11_HUMAN,DENN domain-containing protein 11 (DENND11) (Protein LCHN),DENND11 KIAA1147 LCHN,57189;,"ENST00000536163.6; ENSP00000445768.1; ENSG00000257093.7.;""ENST00000575464.5; ENSP00000459381.1; ENSG00000262599.5."";",guanyl-nucleotide exchange factor activity [GO:0005085],0,cytoplasm [GO:0005737]
Q5TH69,C1,1.298000754,-0.00153859,-0.368009234,-0.139858806,-0.145783947,lightblue,KIAA1244,BIG3_HUMAN,Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3),ARFGEF3 BIG3 C6orf92 KIAA1244,57221;,ENST00000251691.5; ENSP00000251691.4; ENSG00000112379.9.;,guanyl-nucleotide exchange factor activity [GO:0005085],regulation of ARF protein signal transduction [GO:0032012],Golgi apparatus [GO:0005794]; transport vesicle membrane [GO:0030658]
Q96EK5,C3,1.539558413,0.138691162,-0.376747377,-0.4609308,-0.569616408,cyan,KIAA1279,KBP_HUMAN,KIF-binding protein (KIF1-binding protein) (Kinesin family binding protein),KIFBP KBP KIAA1279 KIF1BP,26128;,ENST00000361983.7; ENSP00000354848.4; ENSG00000198954.9.;,kinesin binding [GO:0019894]; protein sequestering activity [GO:0140311],central nervous system projection neuron axonogenesis [GO:0021952]; in utero embryonic development [GO:0001701]; microtubule cytoskeleton organization [GO:0000226]; mitochondrion transport along microtubule [GO:0047497]; neuron projection maintenance [GO:1990535]; transport along microtubule [GO:0010970],cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]
Q69YN4,N2,-1.044907309,-0.124687892,0.980496429,-0.199263321,0.106010512,grey70,KIAA1429,VIR_HUMAN,Protein virilizer homolog,VIRMA KIAA1429 MSTP054,25962;,"ENST00000297591.10; ENSP00000297591.5; ENSG00000164944.12. [Q69YN4-1];""ENST00000421249.2; ENSP00000398390.2; ENSG00000164944.12. [Q69YN4-4]"";",RNA binding [GO:0003723],mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]
A2RU67,S1,-0.549349379,-1.182398872,-0.166527159,0.681940612,1.030555289,gold,KIAA1467,F234B_HUMAN,Protein FAM234B,FAM234B KIAA1467,57613;,"ENST00000197268.13; ENSP00000197268.8; ENSG00000084444.14.;""ENST00000416494.6; ENSP00000394063.2; ENSG00000084444.14."";",0,0,Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]
Q9P206,S3,-0.502183462,-0.15195556,0.04517852,0.466410398,0.497541829,salmon,KIAA1522,NHSL3_HUMAN,NHS-like protein 3,NHSL3 KIAA1522,57648;,"ENST00000294521.7; ENSP00000294521.3; ENSG00000162522.11. [Q9P206-4];""ENST00000373480.1; ENSP00000362579.1; ENSG00000162522.11. [Q9P206-1]"";""ENST00000373481.7; ENSP00000362580.3; ENSG00000162522.11. [Q9P206-3]"";""ENST00000401073.7; ENSP00000383851.2; ENSG00000162522.11. [Q9P206-2]"";",0,cell differentiation [GO:0030154],0
A0MZ66,C4,2.017536299,0.150232804,-0.922897426,-1.012721514,-1.277202039,deepskyblue2,KIAA1598,SHOT1_HUMAN,Shootin-1 (Shootin1),SHTN1 KIAA1598,57698;,"ENST00000260777.14; ENSP00000260777.11; ENSG00000187164.20. [A0MZ66-5];""ENST00000355371.9; ENSP00000347532.4; ENSG00000187164.20. [A0MZ66-1]"";""ENST00000392901.10; ENSP00000376635.4; ENSG00000187164.20. [A0MZ66-8]"";""ENST00000392903.3; ENSP00000376636.3; ENSG00000187164.20. [A0MZ66-4]"";""ENST00000615301.4; ENSP00000480109.1; ENSG00000187164.20. [A0MZ66-2]"";",actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894],"actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]",axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]
Q9C0E8,S2,-1.276660727,-1.567263742,0.111792238,0.959518115,0.800863871,orange,KIAA1715,LNP_HUMAN,Endoplasmic reticulum junction formation protein lunapark (ER junction formation factor lunapark),LNPK KIAA1715 LNP,80856;,"ENST00000272748.9; ENSP00000272748.4; ENSG00000144320.14. [Q9C0E8-1];""ENST00000409660.5; ENSP00000386237.1; ENSG00000144320.14. [Q9C0E8-3]"";""ENST00000544803.5; ENSP00000440905.1; ENSG00000144320.14. [Q9C0E8-4]"";",identical protein binding [GO:0042802]; metal ion binding [GO:0046872],blood coagulation [GO:0007596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network maintenance [GO:0071788]; endoplasmic reticulum tubular network organization [GO:0071786]; limb development [GO:0060173]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; regulation of chondrocyte differentiation [GO:0032330],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
Q5TF39,S1,-1.30885672,-1.90161254,-0.400453552,0.674346237,1.2486059,gold,KIAA1919,MFS4B_HUMAN,Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B),MFSD4B KIAA1919 NAGLT1 HSPC100,91749;,"ENST00000671876.2; ENSP00000500934.1; ENSG00000173214.7.;""ENST00000671883.1; ENSP00000499903.1; ENSG00000173214.7."";""ENST00000672191.1; ENSP00000500175.1; ENSG00000173214.7."";""ENST00000672750.1; ENSP00000500686.1; ENSG00000173214.7."";",glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293],sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]
Q9ULH0,S4,-1.148262034,-1.428143856,0.629943626,0.868557377,0.052328948,tomato2,KIDINS220,KDIS_HUMAN,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),KIDINS220 ARMS KIAA1250,57498;,"ENST00000256707.8; ENSP00000256707.4; ENSG00000134313.17. [Q9ULH0-1];""ENST00000319688.5; ENSP00000319947.5; ENSG00000134313.17. [Q9ULH0-3]"";""ENST00000473731.5; ENSP00000418974.1; ENSG00000134313.17. [Q9ULH0-4]"";""ENST00000685097.1; ENSP00000510510.1; ENSG00000134313.17. [Q9ULH0-2]"";",PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887],cellular response to nerve growth factor stimulus [GO:1990090]; dendrite morphogenesis [GO:0048813]; in utero embryonic development [GO:0001701]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976],cytosol [GO:0005829]; late endosome [GO:0005770]; membrane [GO:0016020]; protein-containing complex [GO:0032991]
Q9NQT8,C1,1.529576953,0.073857515,-0.229106841,-0.139035876,-0.421563946,lightblue,KIF13B,KI13B_HUMAN,Kinesin-like protein KIF13B (Kinesin-like protein GAKIN),KIF13B GAKIN KIAA0639,23303;,ENST00000524189.6; ENSP00000427900.1; ENSG00000197892.13. [Q9NQT8-1];,14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901],cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; protein targeting [GO:0006605]; regulation of axonogenesis [GO:0050770]; signal transduction [GO:0007165]; T cell activation [GO:0042110],axon [GO:0030424]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]
Q15058,S4,-0.611006533,-0.424447708,0.457430419,0.704720991,0.182751967,tomato2,KIF14,KIF14_HUMAN,Kinesin-like protein KIF14,KIF14 KIAA0042,9928;,"ENST00000367350.5; ENSP00000356319.4; ENSG00000118193.12.;""ENST00000614960.4; ENSP00000483069.1; ENSG00000118193.12."";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631],activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446],cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]
Q9NS87,C4,1.962970878,0.189428252,-0.823542401,-0.679335661,-1.092631286,deepskyblue2,KIF15,KIF15_HUMAN,Kinesin-like protein KIF15 (Kinesin-like protein 2) (hKLP2) (Kinesin-like protein 7) (Serologically defined breast cancer antigen NY-BR-62),KIF15 KLP2 KNSL7,56992;,"ENST00000326047.9; ENSP00000324020.4; ENSG00000163808.17. [Q9NS87-1];""ENST00000627272.3; ENSP00000486004.1; ENSG00000280610.3. [Q9NS87-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574],centrosome separation [GO:0051299]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307],centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; plus-end kinesin complex [GO:0005873]; spindle pole [GO:0000922]
Q8NI77,N1,-0.842209612,-0.403790185,0.029018419,0.060331016,1.099990197,grey90,KIF18A,KI18A_HUMAN,Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A),KIF18A OK/SW-cl.108,81930;,ENST00000263181.7; ENSP00000263181.6; ENSG00000121621.7.;,actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463],cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520],caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule cytoskeleton [GO:0015630]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726]
Q7Z4S6,C3,1.761400112,0.2974349,-0.645299536,-0.692903709,-0.770625308,cyan,KIF21A,KI21A_HUMAN,Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62),KIF21A KIAA1708 KIF2,55605;,"ENST00000361418.10; ENSP00000354878.5; ENSG00000139116.19. [Q7Z4S6-1];""ENST00000361961.7; ENSP00000354851.3; ENSG00000139116.19. [Q7Z4S6-2]"";""ENST00000541463.6; ENSP00000438075.2; ENSG00000139116.19. [Q7Z4S6-6]"";""ENST00000544797.6; ENSP00000445606.2; ENSG00000139116.19. [Q7Z4S6-5]"";",ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],microtubule-based movement [GO:0007018],axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]
Q14807,N2,-1.07999356,-0.341131207,0.906007035,0.373358091,-0.220015257,grey70,KIF22,KIF22_HUMAN,Kinesin-like protein KIF22 (Kinesin-like DNA-binding protein) (Kinesin-like protein 4),KIF22 KID KNSL4,3835;,"ENST00000160827.9; ENSP00000160827.5; ENSG00000079616.14. [Q14807-1];""ENST00000400751.9; ENSP00000383562.5; ENSG00000079616.14. [Q14807-2]"";""ENST00000561482.6; ENSP00000454957.1; ENSG00000079616.14. [Q14807-2]"";""ENST00000690258.1; ENSP00000509977.1; ENSG00000079616.14. [Q14807-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],DNA repair [GO:0006281]; metaphase chromosome alignment [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; sister chromatid cohesion [GO:0007062],chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; nucleus [GO:0005634]
O15066,C3,1.787597839,0.310127822,-0.708576378,-0.643463676,-0.820718442,cyan,KIF3B,KIF3B_HUMAN,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",KIF3B KIAA0359,9371;,ENST00000375712.4; ENSP00000364864.3; ENSG00000101350.8. [O15066-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267],anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]
O95239,N4,-0.921779032,1.139784444,0.081038966,-0.45763211,-0.314061556,grey30,KIF4A,KIF4A_HUMAN,Chromosome-associated kinesin KIF4A (Chromokinesin-A),KIF4A KIF4,24137;,ENST00000374403.4; ENSP00000363524.3; ENSG00000090889.12. [O95239-1];,ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],anterograde axonal transport [GO:0008089]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; organelle organization [GO:0006996]; spindle elongation [GO:0051231],axon cytoplasm [GO:1904115]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; midbody [GO:0030496]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spindle microtubule [GO:0005876]
P33176,C4,1.836656488,0.105021198,-0.798634467,-0.736229627,-1.073944144,deepskyblue2,KIF5B,KINH_HUMAN,Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC),KIF5B KNS KNS1,3799;,ENST00000302418.5; ENSP00000307078.4; ENSG00000170759.11.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein-containing complex binding [GO:0044877],"anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; anterograde neuronal dense core vesicle transport [GO:1990048]; axon guidance [GO:0007411]; cellular response to type II interferon [GO:0071346]; centrosome localization [GO:0051642]; cytoplasm organization [GO:0007028]; lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018]; mitochondrion transport along microtubule [GO:0047497]; mitocytosis [GO:0160040]; natural killer cell mediated cytotoxicity [GO:0042267]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of membrane potential [GO:0042391]; retrograde neuronal dense core vesicle transport [GO:1990049]; stress granule disassembly [GO:0035617]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]",axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary rootlet [GO:0035253]; cytolytic granule membrane [GO:0101004]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; vesicle [GO:0031982]
Q9H0B6,C3,1.602663975,0.258359172,-0.298989784,-0.439636246,-0.779076587,cyan,KLC2,KLC2_HUMAN,Kinesin light chain 2 (KLC 2),KLC2,64837;,"ENST00000316924.9; ENSP00000314837.5; ENSG00000174996.12. [Q9H0B6-1];""ENST00000394066.6; ENSP00000377630.2; ENSG00000174996.12. [Q9H0B6-2]"";""ENST00000394067.7; ENSP00000377631.2; ENSG00000174996.12. [Q9H0B6-1]"";""ENST00000417856.5; ENSP00000399403.1; ENSG00000174996.12. [Q9H0B6-1]"";""ENST00000421552.5; ENSP00000408484.1; ENSG00000174996.12. [Q9H0B6-2]"";",cadherin binding [GO:0045296]; kinesin binding [GO:0019894],lysosome localization [GO:0032418]; microtubule-based movement [GO:0007018],cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinesin I complex [GO:0016938]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q9NSK0,C3,1.57078354,0.412181135,-0.573831062,-0.554290978,-0.779459424,cyan,KLC4,KLC4_HUMAN,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),KLC4 KNSL8,89953;,"ENST00000259708.7; ENSP00000259708.3; ENSG00000137171.15. [Q9NSK0-3];""ENST00000347162.10; ENSP00000340221.5; ENSG00000137171.15. [Q9NSK0-1]"";""ENST00000394056.6; ENSP00000377620.2; ENSG00000137171.15. [Q9NSK0-1]"";""ENST00000453940.6; ENSP00000395806.2; ENSG00000137171.15. [Q9NSK0-5]"";""ENST00000458460.6; ENSP00000410358.2; ENSG00000137171.15. [Q9NSK0-4]"";""ENST00000467906.5; ENSP00000418759.1; ENSG00000137171.15. [Q9NSK0-2]"";""ENST00000479388.5; ENSP00000418031.1; ENSG00000137171.15. [Q9NSK0-1]"";",kinesin binding [GO:0019894],microtubule-based movement [GO:0007018],cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]
Q9NVR0,C1,1.366631216,0.389959337,-0.420934483,-0.197062207,-0.470825761,lightblue,KLHL11,KLH11_HUMAN,Kelch-like protein 11,KLHL11,55175;,ENST00000319121.4; ENSP00000314608.3; ENSG00000178502.6.;,0,0,cytosol [GO:0005829]
Q53HC5,C2,1.241530371,0.308942376,-0.344218052,-0.150754028,-0.171747737,aquamarine,KLHL26,KLH26_HUMAN,Kelch-like protein 26,KLHL26,55295;,ENST00000300976.9; ENSP00000300976.3; ENSG00000167487.12.;,0,0,0
Q8N4N3,C5,0.948685099,0.813016234,-0.462531936,-0.741558958,-0.619957484,turquoise3,KLHL36,KLH36_HUMAN,Kelch-like protein 36,KLHL36 C16orf44,79786;,"ENST00000258157.9; ENSP00000258157.5; ENSG00000135686.13. [Q8N4N3-2];""ENST00000564996.6; ENSP00000456743.1; ENSG00000135686.13. [Q8N4N3-1]"";",cullin family protein binding [GO:0097602],protein ubiquitination [GO:0016567],0
Q03164,N3,-0.979521717,-0.862244842,1.112112355,0.115754232,0.121996838,grey50,KMT2A,KMT2A_HUMAN,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.364) (ALL-1) (CXXC-type zinc finger protein 7) (Cysteine methyltransferase KMT2A) (EC 2.1.1.-) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1,4297;,"ENST00000389506.10; ENSP00000374157.5; ENSG00000118058.25. [Q03164-1];""ENST00000534358.8; ENSP00000436786.2; ENSG00000118058.25. [Q03164-3]"";""ENST00000649699.1; ENSP00000496927.1; ENSG00000118058.25. [Q03164-2]"";",chromatin binding [GO:0003682]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; protein homodimerization activity [GO:0042803]; protein-cysteine methyltransferase activity [GO:0106363]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270],anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; circadian regulation of gene expression [GO:0032922]; definitive hemopoiesis [GO:0060216]; embryonic hemopoiesis [GO:0035162]; exploration behavior [GO:0035640]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells within a tissue [GO:0048873]; membrane depolarization [GO:0051899]; methylation [GO:0032259]; negative regulation of DNA methylation-dependent heterochromatin formation [GO:0090310]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein modification process [GO:0036211]; protein-containing complex assembly [GO:0065003]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to potassium ion [GO:0035864]; spleen development [GO:0048536]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815]; visual learning [GO:0008542],cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P50748,C3,1.747240047,0.063183217,-0.786999794,-0.630346201,-0.319707311,cyan,KNTC1,KNTC1_HUMAN,Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod),KNTC1 KIAA0166,9735;,ENST00000333479.12; ENSP00000328236.6; ENSG00000184445.12. [P50748-1];,small GTPase binding [GO:0031267],cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]
P52292,C1,1.236780866,-0.050049199,0.096716038,-0.273065779,-0.120943823,lightblue,KPNA2,IMA1_HUMAN,Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha),KPNA2 RCH1 SRP1,3838;,"ENST00000330459.8; ENSP00000332455.3; ENSG00000182481.10.;""ENST00000537025.6; ENSP00000438483.2; ENSG00000182481.10."";""ENST00000579754.2; ENSP00000462331.2; ENSG00000182481.10."";""ENST00000584026.6; ENSP00000463602.2; ENSG00000182481.10."";""ENST00000677086.1; ENSP00000504655.1; ENSG00000182481.10."";""ENST00000679078.1; ENSP00000504685.1; ENSG00000182481.10."";",histone deacetylase binding [GO:0042826]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723],DNA metabolic process [GO:0006259]; entry of viral genome into host nucleus through nuclear pore complex via importin [GO:0075506]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral life cycle [GO:1903902]; protein import into nucleus [GO:0006606]; regulation of DNA recombination [GO:0000018],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; host cell [GO:0043657]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O00629,C2,0.829334906,0.137771826,0.201688064,-0.092449257,-0.313391634,aquamarine,KPNA4,IMA3_HUMAN,Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4),KPNA4 QIP1,3840;,ENST00000334256.9; ENSP00000334373.4; ENSG00000186432.10.;,nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139],dopamine secretion [GO:0014046]; gene expression [GO:0010467]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606],cytosol [GO:0005829]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P01116,S3,-0.671234873,-1.030089827,0.240247028,0.766313617,0.428307056,salmon,KRAS,RASK_HUMAN,"GTPase KRas (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]",KRAS KRAS2 RASK2,3845;,"ENST00000256078.10; ENSP00000256078.5; ENSG00000133703.14. [P01116-1];""ENST00000311936.8; ENSP00000308495.3; ENSG00000133703.14. [P01116-2]"";""ENST00000685328.1; ENSP00000508921.1; ENSG00000133703.14. [P01116-2]"";""ENST00000688940.1; ENSP00000509238.1; ENSG00000133703.14. [P01116-2]"";",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495],"actin cytoskeleton organization [GO:0030036]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain astrocyte development [GO:0021897]; gene expression [GO:0010467]; glial cell proliferation [GO:0014009]; homeostasis of number of cells within a tissue [GO:0048873]; MAPK cascade [GO:0000165]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rac protein signal transduction [GO:0035022]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic transmission, GABAergic [GO:0032228]; skeletal muscle cell differentiation [GO:0035914]; striated muscle cell differentiation [GO:0051146]; type I pneumocyte differentiation [GO:0060509]; visual learning [GO:0008542]",cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]
Q8N9T8,N3,-1.48711777,-0.89082201,1.144960494,-0.180357605,0.567295429,grey50,KRI1,KRI1_HUMAN,Protein KRI1 homolog,KRI1,65095;,ENST00000312962.12; ENSP00000320917.9; ENSG00000129347.21.;,RNA binding [GO:0003723],"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]",90S preribosome [GO:0030686]; nucleolus [GO:0005730]
Q13601,N3,-1.171979526,-0.936838898,1.203478078,-0.077145136,0.407744067,grey50,KRR1,KRR1_HUMAN,KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2) (KRR-R motif-containing protein 1) (Rev-interacting protein 1) (Rip-1),KRR1 HRB2,11103;,"ENST00000229214.9; ENSP00000229214.4; ENSG00000111615.14. [Q13601-1];""ENST00000438169.6; ENSP00000411740.2; ENSG00000111615.14. [Q13601-2]"";",RNA binding [GO:0003723],ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],chromosome [GO:0005694]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q6KB66,C2,0.906418079,-0.017019246,0.115946454,0.191649838,-0.316999711,aquamarine,KRT80,K2C80_HUMAN,"Keratin, type II cytoskeletal 80 (Cytokeratin-80) (CK-80) (Keratin-80) (K80) (Type-II keratin Kb20)",KRT80 KB20,144501;,"ENST00000313234.9; ENSP00000369361.2; ENSG00000167767.14. [Q6KB66-2];""ENST00000394815.3; ENSP00000378292.2; ENSG00000167767.14. [Q6KB66-1]"";",structural constituent of skin epidermis [GO:0030280],intermediate filament organization [GO:0045109]; keratinization [GO:0031424],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; keratin filament [GO:0045095]
Q86UP2,S2,-1.211147255,-1.494784516,0.05862588,1.052744791,0.532754031,orange,KTN1,KTN1_HUMAN,Kinectin (CG-1 antigen) (Kinesin receptor),KTN1 CG1 KIAA0004,3895;,"ENST00000395308.5; ENSP00000378719.1; ENSG00000126777.18. [Q86UP2-3];""ENST00000395309.7; ENSP00000378720.4; ENSG00000126777.18. [Q86UP2-3]"";""ENST00000395311.5; ENSP00000378722.1; ENSG00000126777.18. [Q86UP2-3]"";""ENST00000395314.8; ENSP00000378725.3; ENSG00000126777.18. [Q86UP2-1]"";""ENST00000413890.6; ENSP00000394992.2; ENSG00000126777.18. [Q86UP2-3]"";""ENST00000438792.6; ENSP00000391964.2; ENSG00000126777.18. [Q86UP2-2]"";""ENST00000459737.5; ENSP00000432149.1; ENSG00000126777.18. [Q86UP2-1]"";",cadherin binding [GO:0045296]; kinesin binding [GO:0019894]; RNA binding [GO:0003723],microtubule-based movement [GO:0007018]; protein transport [GO:0015031],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9H9P8,M1,-1.210079944,-0.588483361,0.388368382,0.979740887,-0.259901144,burlywood4,L2HGDH,L2HDH_HUMAN,"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2) (Duranin)",L2HGDH C14orf160,79944;,"ENST00000267436.9; ENSP00000267436.4; ENSG00000087299.12. [Q9H9P8-1];""ENST00000421284.7; ENSP00000405559.3; ENSG00000087299.12. [Q9H9P8-1]"";",2-hydroxyglutarate dehydrogenase activity [GO:0047545],2-oxoglutarate metabolic process [GO:0006103]; small molecule metabolic process [GO:0044281],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
P83111,S2,-1.28989786,-1.358244534,0.284533306,1.00844764,0.392894961,orange,LACTB,LACTB_HUMAN,"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)",LACTB MRPL56 UNQ843/PRO1781,114294;,"ENST00000261893.9; ENSP00000261893.4; ENSG00000103642.12. [P83111-1];""ENST00000413507.3; ENSP00000392956.2; ENSG00000103642.12. [P83111-2]"";",identical protein binding [GO:0042802]; peptidase activity [GO:0008233],lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216],cytosol [GO:0005829]; mitochondrion [GO:0005739]
O15230,S1,-0.864878485,-0.403626923,0.043795836,0.525558857,0.794783354,gold,LAMA5,LAMA5_HUMAN,Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha),LAMA5 KIAA0533 KIAA1907,3911;,ENST00000252999.7; ENSP00000252999.3; ENSG00000130702.15. [O15230-1];,integrin binding [GO:0005178],branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; odontogenesis of dentin-containing tooth [GO:0042475]; postsynapse organization [GO:0099173]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; regulation of epithelial cell proliferation [GO:0050678]; skeletal system morphogenesis [GO:0048705]; substrate adhesion-dependent cell spreading [GO:0034446]; trunk neural crest cell migration [GO:0036484],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix of synaptic cleft [GO:0098965]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083]
Q13751,S3,-1.124718659,-0.784006326,0.269371546,0.728858002,0.46459909,salmon,LAMB3,LAMB3_HUMAN,Laminin subunit beta-3 (Epiligrin subunit bata) (Kalinin B1 chain) (Kalinin subunit beta) (Laminin B1k chain) (Laminin-5 subunit beta) (Nicein subunit beta),LAMB3 LAMNB1,3914;,"ENST00000356082.9; ENSP00000348384.3; ENSG00000196878.15.;""ENST00000367030.7; ENSP00000355997.3; ENSG00000196878.15."";""ENST00000391911.5; ENSP00000375778.1; ENSG00000196878.15."";",protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198],brown fat cell differentiation [GO:0050873]; cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin-5 complex [GO:0005610]
P11279,S1,-0.722702883,-0.767060577,-0.414535118,0.722594289,0.907725034,gold,LAMP1,LAMP1_HUMAN,Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a),LAMP1,3916;,ENST00000332556.5; ENSP00000333298.4; ENSG00000185896.11. [P11279-1];,enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein domain specific binding [GO:0019904]; virus receptor activity [GO:0001618],establishment of protein localization to organelle [GO:0072594]; Golgi to lysosome transport [GO:0090160]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; lysosomal lumen acidification [GO:0007042]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; protein stabilization [GO:0050821]; regulation of organelle transport along microtubule [GO:1902513],autolysosome [GO:0044754]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagolysosome membrane [GO:0061474]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021]
P13473,S1,-0.996140913,-1.129358787,-0.19154723,0.700083059,1.074700292,gold,LAMP2,LAMP2_HUMAN,Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b),LAMP2,3920;,"ENST00000200639.9; ENSP00000200639.4; ENSG00000005893.17. [P13473-1];""ENST00000371335.4; ENSP00000360386.4; ENSG00000005893.17. [P13473-2]"";""ENST00000434600.6; ENSP00000408411.2; ENSG00000005893.17. [P13473-3]"";",enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein domain specific binding [GO:0019904]; signaling adaptor activity [GO:0035591],autophagosome maturation [GO:0097352]; cellular response to starvation [GO:0009267]; chaperone-mediated autophagy [GO:0061684]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of protein-containing complex assembly [GO:0031333]; protein catabolic process [GO:0030163]; protein import [GO:0017038]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; regulation of protein stability [GO:0031647],autolysosome [GO:0044754]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; chaperone-mediated autophagy translocation complex [GO:0061742]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; trans-Golgi network [GO:0005802]
Q6IAA8,S1,-0.560135734,-1.035807783,-0.309510634,0.705559907,0.941782963,gold,LAMTOR1,LTOR1_HUMAN,Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho),LAMTOR1 C11orf59 PDRO PP7157,55004;,ENST00000278671.10; ENSP00000278671.5; ENSG00000149357.10.;,GTPase binding [GO:0051020]; protein-membrane adaptor activity [GO:0043495],cellular response to amino acid stimulus [GO:0071230]; cellular response to nutrient levels [GO:0031669]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to lysosome [GO:0150032]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; protein localization to membrane [GO:0072657]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919]; TORC1 signaling [GO:0038202],azurophil granule membrane [GO:0035577]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; FNIP-folliculin RagC/D GAP [GO:1990877]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579]
Q9UHA4,S1,-0.982033016,-1.005916861,-0.419609254,0.69021344,1.097571796,gold,LAMTOR3,LTOR3_HUMAN,Ragulator complex protein LAMTOR3 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3) (MEK-binding partner 1) (Mp1) (Mitogen-activated protein kinase kinase 1-interacting protein 1) (Mitogen-activated protein kinase scaffold protein 1),LAMTOR3 MAP2K1IP1 MAPKSP1 PRO2783,8649;,"ENST00000226522.8; ENSP00000226522.8; ENSG00000109270.13. [Q9UHA4-2];""ENST00000499666.7; ENSP00000424183.1; ENSG00000109270.13. [Q9UHA4-1]"";",kinase activator activity [GO:0019209],cellular response to amino acid stimulus [GO:0071230]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; protein localization to cell junction [GO:1902414]; TORC1 signaling [GO:0038202],endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; FNIP-folliculin RagC/D GAP [GO:1990877]; focal adhesion [GO:0005925]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]
Q15012,S1,-0.859950307,-0.975757435,0.130495261,0.727818976,0.688946821,gold,LAPTM4A,LAP4A_HUMAN,Lysosomal-associated transmembrane protein 4A (Golgi 4-transmembrane-spanning transporter MTP),LAPTM4A KIAA0108 LAPTM4 MBNT MTRP UNQ1846/PRO3574,9741;,ENST00000175091.5; ENSP00000175091.4; ENSG00000068697.7.;,0,0,Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]
Q6PKG0,N1,0.02172957,0.023768738,-0.517570859,-0.333519237,1.174912585,grey90,LARP1,LARP1_HUMAN,La-related protein 1 (La ribonucleoprotein domain family member 1),LARP1 KIAA0731 LARP,23367;,"ENST00000336314.9; ENSP00000336721.4; ENSG00000155506.19. [Q6PKG0-3];""ENST00000518297.6; ENSP00000428589.2; ENSG00000155506.19. [Q6PKG0-1]"";",cadherin binding [GO:0045296]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; ribosomal small subunit binding [GO:0043024]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369],cell population proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; positive regulation of macroautophagy [GO:0016239]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; post-transcriptional regulation of gene expression [GO:0010608]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]
Q659C4,N1,0.256295256,-0.047663377,-0.297606084,-0.106890162,1.082607151,grey90,LARP1B,LAR1B_HUMAN,La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2),LARP1B LARP2,55132;,"ENST00000326639.11; ENSP00000321997.6; ENSG00000138709.20. [Q659C4-1];""ENST00000394288.7; ENSP00000377829.3; ENSG00000138709.20. [Q659C4-3]"";""ENST00000648358.2; ENSP00000497514.2; ENSG00000138709.20. [Q659C4-3]"";""ENST00000649983.2; ENSP00000497192.2; ENSG00000138709.20. [Q659C4-1]"";",RNA binding [GO:0003723]; RNA cap binding [GO:0000339],mRNA stabilization [GO:0048255]; positive regulation of translation [GO:0045727],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q92615,N1,-0.593518357,0.212647306,-0.394918741,-0.13114034,1.007796735,grey90,LARP4B,LAR4B_HUMAN,La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5),LARP4B KIAA0217 LARP5,23185;,ENST00000316157.8; ENSP00000326128.3; ENSG00000107929.16.;,mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723],positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of translation [GO:0045727],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]
Q4G0J3,N4,-1.089871229,0.835716371,0.027587457,-0.594782381,0.257905288,grey30,LARP7,LARP7_HUMAN,La-related protein 7 (La ribonucleoprotein domain family member 7) (hLARP7) (P-TEFb-interaction protein for 7SK stability) (PIP7S),LARP7 HDCMA18P,51574;,"ENST00000344442.10; ENSP00000344950.5; ENSG00000174720.18. [Q4G0J3-1];""ENST00000505034.6; ENSP00000421541.2; ENSG00000174720.18. [Q4G0J3-1]"";""ENST00000509061.5; ENSP00000422626.2; ENSG00000174720.18. [Q4G0J3-1]"";""ENST00000651579.1; ENSP00000499190.1; ENSG00000174720.18. [Q4G0J3-1]"";""ENST00000694894.1; ENSP00000511572.1; ENSG00000174720.18. [Q4G0J3-1]"";",7SK snRNA binding [GO:0097322]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070],"box C/D sno(s)RNA 3'-end processing [GO:0000494]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; negative regulation of viral transcription [GO:0032897]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]",7SK snRNP [GO:0120259]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
Q9Y4W2,N3,-0.809939488,-1.480627123,1.013923598,-0.332508426,0.663038208,grey50,LAS1L,LAS1L_HUMAN,Ribosomal biogenesis protein LAS1L (Endoribonuclease LAS1L) (EC 3.1.-.-) (Protein LAS1 homolog),LAS1L MSTP060,81887;,"ENST00000374804.9; ENSP00000363937.5; ENSG00000001497.18. [Q9Y4W2-3];""ENST00000374807.9; ENSP00000363940.5; ENSG00000001497.18. [Q9Y4W2-2]"";""ENST00000374811.8; ENSP00000363944.3; ENSG00000001497.18. [Q9Y4W2-1]"";""ENST00000484069.1; ENSP00000473471.1; ENSG00000001497.18. [Q9Y4W2-4]"";",endonuclease activity [GO:0004519]; RNA binding [GO:0003723],maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364],"Las1 complex [GO:0090730]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"
Q14847,C4,2.076289018,0.161173888,-0.801858286,-0.859192555,-0.965087174,deepskyblue2,LASP1,LASP1_HUMAN,LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50),LASP1 MLN50,3927;,"ENST00000318008.11; ENSP00000325240.6; ENSG00000002834.19. [Q14847-1];""ENST00000433206.6; ENSP00000401048.2; ENSG00000002834.19. [Q14847-3]"";",actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; monoatomic ion transmembrane transporter activity [GO:0015075],monoatomic ion transport [GO:0006811],cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]
Q14739,S4,-1.008930857,-1.090179607,0.693267989,0.623268729,0.258192603,tomato2,LBR,LBR_HUMAN,Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase),LBR,3930;,"ENST00000272163.9; ENSP00000272163.4; ENSG00000143815.15.;""ENST00000338179.6; ENSP00000339883.2; ENSG00000143815.15."";",chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; lamin binding [GO:0005521]; NADPH binding [GO:0070402]; RNA binding [GO:0003723],cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]
Q6UWP7,S3,-0.816481936,-0.999646931,0.316565691,0.721030491,0.569269553,salmon,LCLAT1,LCLT1_HUMAN,Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1),LCLAT1 AGPAT8 ALCAT1 LYCAT UNQ1849/PRO3579,253558;,"ENST00000309052.8; ENSP00000310551.4; ENSG00000172954.14. [Q6UWP7-1];""ENST00000319406.8; ENSP00000368826.1; ENSG00000172954.14. [Q6UWP7-2]"";""ENST00000379509.8; ENSP00000368823.3; ENSG00000172954.14. [Q6UWP7-3]"";",1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; O-acyltransferase activity [GO:0008374],cardiolipin acyl-chain remodeling [GO:0035965]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149],cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
P07195,C4,2.11454019,0.223474671,-1.187248539,-1.144244429,-1.280567774,deepskyblue2,LDHB,LDHB_HUMAN,L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46),LDHB,3945;,"ENST00000350669.5; ENSP00000229319.1; ENSG00000111716.14.;""ENST00000396076.5; ENSP00000379386.1; ENSG00000111716.14."";",identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-lactate dehydrogenase activity [GO:0004459]; NAD binding [GO:0051287],lactate metabolic process [GO:0006089]; NAD metabolic process [GO:0019674]; pyruvate metabolic process [GO:0006090],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204]
P01130,S1,-1.008451966,-1.118184445,-0.00901965,0.630713539,0.897454914,gold,LDLR,LDLR_HUMAN,Low-density lipoprotein receptor (LDL receptor),LDLR,3949;,"ENST00000455727.6; ENSP00000397829.2; ENSG00000130164.15. [P01130-3];""ENST00000535915.5; ENSP00000440520.1; ENSG00000130164.15. [P01130-4]"";""ENST00000545707.5; ENSP00000437639.1; ENSG00000130164.15. [P01130-2]"";""ENST00000558013.5; ENSP00000453346.1; ENSG00000130164.15. [P01130-5]"";""ENST00000558518.6; ENSP00000454071.1; ENSG00000130164.15. [P01130-1]"";",amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; clathrin heavy chain binding [GO:0032050]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; molecular adaptor activity [GO:0060090]; protease binding [GO:0002020]; very-low-density lipoprotein particle receptor activity [GO:0030229]; virus receptor activity [GO:0001618],amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; artery morphogenesis [GO:0048844]; cellular response to fatty acid [GO:0071398]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endocytosis [GO:0006897]; high-density lipoprotein particle clearance [GO:0034384]; intestinal cholesterol absorption [GO:0030299]; lipid metabolic process [GO:0006629]; lipoprotein catabolic process [GO:0042159]; long-term memory [GO:0007616]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of gene expression [GO:0010629]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of receptor recycling [GO:0001920]; phagocytosis [GO:0006909]; phospholipid transport [GO:0015914]; plasma lipoprotein particle clearance [GO:0034381]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of triglyceride biosynthetic process [GO:0010867]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cholesterol metabolic process [GO:0090181]; regulation of phosphatidylcholine catabolic process [GO:0010899]; regulation of protein metabolic process [GO:0051246]; response to caloric restriction [GO:0061771],apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; low-density lipoprotein particle [GO:0034362]; lysosome [GO:0005764]; membrane [GO:0016020]; PCSK9-LDLR complex [GO:1990666]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; somatodendritic compartment [GO:0036477]; sorting endosome [GO:0097443]
Q8NC56,M1,-0.803155327,-0.913092674,0.851415341,0.551114053,0.141242539,burlywood4,LEMD2,LEMD2_HUMAN,LEM domain-containing protein 2 (hLEM2),LEMD2,221496;,"ENST00000293760.10; ENSP00000293760.5; ENSG00000161904.13. [Q8NC56-1];""ENST00000508327.5; ENSP00000421704.1; ENSG00000161904.13. [Q8NC56-2]"";",0,heart formation [GO:0060914]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; neurogenesis [GO:0022008]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; protein localization to chromatin [GO:0071168]; skeletal muscle cell differentiation [GO:0035914],chromatin [GO:0000785]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; spindle [GO:0005819]
Q9Y2U8,N3,-0.960344257,-1.112429856,1.168251356,0.287614806,-0.379110205,grey50,LEMD3,MAN1_HUMAN,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),LEMD3 MAN1,23592;,ENST00000308330.3; ENSP00000308369.2; ENSG00000174106.3.;,DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]
Q8WVC0,N4,-0.642570796,1.111073843,0.335421769,-0.709367471,-0.840429276,grey30,LEO1,LEO1_HUMAN,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),LEO1 RDL,123169;,"ENST00000299601.10; ENSP00000299601.5; ENSG00000166477.13. [Q8WVC0-1];""ENST00000315141.5; ENSP00000314610.5; ENSG00000166477.13. [Q8WVC0-2]"";",RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269],endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593]; centrosome [GO:0005813]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q32P28,S3,-0.906046742,0.088481832,0.101378398,0.560965761,0.263065622,salmon,LEPRE1,P3H1_HUMAN,Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1),P3H1 GROS1 LEPRE1 PSEC0109,64175;,"ENST00000236040.8; ENSP00000236040.4; ENSG00000117385.16. [Q32P28-3];""ENST00000296388.10; ENSP00000296388.5; ENSG00000117385.16. [Q32P28-1]"";""ENST00000397054.7; ENSP00000380245.3; ENSG00000117385.16. [Q32P28-4]"";",iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797],bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen metabolic process [GO:0032963]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of protein secretion [GO:0050708],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
O15243,S2,-2.150579246,-1.633803393,0.18479366,0.607635703,1.088452763,orange,LEPROT,OBRG_HUMAN,Leptin receptor gene-related protein (Endospanin-1) (Leptin receptor overlapping transcript protein) (OB-R gene-related protein) (OB-RGRP),LEPROT LEPR OBR,54741;,ENST00000371065.9; ENSP00000360104.4; ENSG00000213625.9.;,signaling receptor binding [GO:0005102],late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; positive regulation of protein targeting to mitochondrion [GO:1903955],endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
O95214,S1,-1.433951196,-1.57032901,0.095952437,0.732774792,0.859980351,gold,LEPROTL1,LERL1_HUMAN,Leptin receptor overlapping transcript-like 1 (Endospanin-2),LEPROTL1 My047 UNQ577/PRO1139,23484;,"ENST00000321250.13; ENSP00000314625.8; ENSG00000104660.19. [O95214-1];""ENST00000523116.5; ENSP00000428281.1; ENSG00000104660.19. [O95214-2]"";",identical protein binding [GO:0042802],late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; negative regulation of growth hormone receptor signaling pathway [GO:0060400],endosome [GO:0005768]; membrane [GO:0016020]
O95202,M2,-1.280266466,-1.476645821,0.347044847,1.209708282,-0.202787028,tan4,LETM1,LETM1_HUMAN,Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1),LETM1,3954;,ENST00000302787.3; ENSP00000305653.2; ENSG00000168924.15. [O95202-1];,calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022],calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; intracellular monoatomic cation homeostasis [GO:0030003]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial potassium ion transmembrane transport [GO:0140141]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q3ZCW2,C5,1.873903487,0.119619133,-0.391969549,-0.818132377,-0.900951,turquoise3,LGALSL,LEGL_HUMAN,Galectin-related protein (Galectin-like protein) (Lectin galactoside-binding-like protein),LGALSL GRP HSPC159,29094;,ENST00000238875.10; ENSP00000238875.4; ENSG00000119862.13.;,carbohydrate binding [GO:0030246],0,0
Q9UGP4,C3,1.69937727,0.323760931,-0.45383858,-0.469227768,-0.898017775,cyan,LIMD1,LIMD1_HUMAN,LIM domain-containing protein 1,LIMD1,8994;,ENST00000273317.5; ENSP00000273317.4; ENSG00000144791.10.;,metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714],cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hippo signaling [GO:0035331]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast development [GO:0002076]; P-body assembly [GO:0033962]; phosphorylation [GO:0016310]; regulation of cell shape [GO:0008360]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RISC complex [GO:0016442]; transcription regulator complex [GO:0005667]
P48059,C1,1.598693409,-0.278279392,-0.591477757,-0.421605773,-0.501486367,lightblue,LIMS1,LIMS1_HUMAN,LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48),LIMS1 PINCH PINCH1,3987;,"ENST00000332345.10; ENSP00000331775.6; ENSG00000169756.17. [P48059-1];""ENST00000338045.7; ENSP00000337598.4; ENSG00000169756.17. [P48059-3]"";""ENST00000393310.5; ENSP00000376987.1; ENSG00000169756.17. [P48059-1]"";""ENST00000409441.5; ENSP00000387264.1; ENSG00000169756.17. [P48059-5]"";""ENST00000410093.5; ENSP00000386926.1; ENSG00000169756.17. [P48059-4]"";""ENST00000544547.6; ENSP00000437912.1; ENSG00000169756.17. [P48059-2]"";""ENST00000695518.1; ENSP00000511981.1; ENSG00000169756.17. [P48059-1]"";""ENST00000695521.1; ENSP00000511984.1; ENSG00000169756.17. [P48059-1]"";",protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270],cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to transforming growth factor beta stimulus [GO:0071560]; establishment of protein localization [GO:0045184]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; tumor necrosis factor-mediated signaling pathway [GO:0033209],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q9NUP9,S4,-0.484325745,-0.448557408,0.402197064,0.726253577,0.083795441,tomato2,LIN7C,LIN7C_HUMAN,Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3),LIN7C MALS3 VELI3,55327;,ENST00000278193.7; ENSP00000278193.2; ENSG00000148943.12.;,cytoskeletal protein binding [GO:0008092]; L27 domain binding [GO:0097016]; protein domain specific binding [GO:0019904],exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]
Q6P1M3,S3,-0.549932227,-0.519490519,0.278266885,0.687582496,0.430346508,salmon,LLGL2,L2GL2_HUMAN,LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2),LLGL2,3993;,"ENST00000167462.9; ENSP00000167462.5; ENSG00000073350.14. [Q6P1M3-2];""ENST00000375227.8; ENSP00000364375.4; ENSG00000073350.14. [Q6P1M3-3]"";""ENST00000392550.8; ENSP00000376333.4; ENSG00000073350.14. [Q6P1M3-1]"";""ENST00000578363.5; ENSP00000464603.1; ENSG00000073350.14. [Q6P1M3-3]"";",GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165],cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]
Q9BRT6,N1,-1.070259995,-1.109456567,0.69632616,-0.309509985,1.254006565,grey90,LLPH,LLPH_HUMAN,Protein LLP homolog (Protein LAPS18-like),LLPH C12orf31 cPERP-G,84298;,"ENST00000266604.7; ENSP00000266604.2; ENSG00000139233.7.;""ENST00000446587.2; ENSP00000437372.1; ENSG00000139233.7."";",basal RNA polymerase II transcription machinery binding [GO:0001099]; RNA binding [GO:0003723],dendrite extension [GO:0097484]; positive regulation of dendritic spine development [GO:0060999],chromosome [GO:0005694]; nucleolus [GO:0005730]
P49257,S1,-0.987554641,-1.284307309,0.05340407,0.782684826,0.805861017,gold,LMAN1,LMAN1_HUMAN,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),LMAN1 ERGIC53 F5F8D,3998;,ENST00000251047.6; ENSP00000251047.4; ENSG00000074695.6.;,mannose binding [GO:0005537]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082],blood coagulation [GO:0007596]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of organelle organization [GO:0010638]; protein folding [GO:0006457]; protein transport [GO:0015031],collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; sarcomere [GO:0030017]
Q12907,S1,-0.944989373,-1.220408259,0.100543104,0.715950215,0.870871736,gold,LMAN2,LMAN2_HUMAN,Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36),LMAN2 C5orf8,10960;,ENST00000303127.12; ENSP00000303366.7; ENSG00000169223.16.;,carbohydrate binding [GO:0030246]; heat shock protein binding [GO:0031072]; mannose binding [GO:0005537]; metal ion binding [GO:0046872],"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of phagocytosis [GO:0050766]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]
Q9H0V9,S1,-1.049606593,-1.303559748,0.116956287,0.768378138,0.958022644,gold,LMAN2L,LMA2L_HUMAN,VIP36-like protein (Lectin mannose-binding 2-like) (LMAN2-like protein),LMAN2L VIPL PSEC0028 UNQ368/PRO704,81562;,"ENST00000264963.9; ENSP00000264963.4; ENSG00000114988.12. [Q9H0V9-1];""ENST00000377079.8; ENSP00000366280.4; ENSG00000114988.12. [Q9H0V9-2]"";",mannose binding [GO:0005537]; metal ion binding [GO:0046872],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein folding [GO:0006457]; protein transport [GO:0015031],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9NUN5,S1,-1.085073784,-1.960807408,-0.363433228,0.794360871,0.950603132,gold,LMBRD1,LMBD1_HUMAN,Lysosomal cobalamin transport escort protein LMBD1 (LMBD1) (HDAg-L-interacting protein NESI) (LMBR1 domain-containing protein 1) (Nuclear export signal-interacting protein),LMBRD1 C6orf209 NESI BM-021 CD001 MSTP044,55788;,"ENST00000370570.6; ENSP00000359602.1; ENSG00000168216.13. [Q9NUN5-3];""ENST00000647964.1; ENSP00000496784.1; ENSG00000168216.13. [Q9NUN5-3]"";""ENST00000648168.1; ENSP00000498178.1; ENSG00000168216.13. [Q9NUN5-3]"";""ENST00000648394.1; ENSP00000497302.1; ENSG00000168216.13. [Q9NUN5-3]"";""ENST00000648743.1; ENSP00000497135.1; ENSG00000168216.13. [Q9NUN5-3]"";""ENST00000649028.1; ENSP00000498034.1; ENSG00000168216.13. [Q9NUN5-3]"";""ENST00000649679.1; ENSP00000497387.1; ENSG00000168216.13. [Q9NUN5-3]"";""ENST00000649918.1; ENSP00000497487.1; ENSG00000168216.13. [Q9NUN5-3]"";""ENST00000649934.3; ENSP00000497690.1; ENSG00000168216.13. [Q9NUN5-1]"";""ENST00000650035.1; ENSP00000497703.1; ENSG00000168216.13. [Q9NUN5-3]"";""ENST00000650107.1; ENSP00000497124.1; ENSG00000168216.13. [Q9NUN5-3]"";",AP-2 adaptor complex binding [GO:0035612]; clathrin heavy chain binding [GO:0032050]; cobalamin binding [GO:0031419]; insulin receptor binding [GO:0005158]; protein transporter activity [GO:0140318],clathrin-dependent endocytosis [GO:0072583]; gastrulation [GO:0007369]; insulin receptor internalization [GO:0038016]; protein localization to lysosome [GO:0061462],clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated vesicle [GO:0030136]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q68DH5,S1,-1.089368656,-1.351804786,-0.183002193,0.621466546,1.237280745,gold,LMBRD2,LMBD2_HUMAN,G-protein coupled receptor-associated protein LMBRD2 (LMBR1 domain-containing protein 2),LMBRD2,92255;,ENST00000296603.5; ENSP00000296603.4; ENSG00000164187.7.;,0,adrenergic receptor signaling pathway [GO:0071875],membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9NZU5,C4,2.02893836,0.283915982,-0.894149453,-0.962725556,-1.252814341,deepskyblue2,LMCD1,LMCD1_HUMAN,LIM and cysteine-rich domains protein 1 (Dyxin),LMCD1,29995;,"ENST00000157600.8; ENSP00000157600.3; ENSG00000071282.12. [Q9NZU5-1];""ENST00000454244.4; ENSP00000396515.1; ENSG00000071282.12. [Q9NZU5-2]"";",transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; regulation of cardiac muscle hypertrophy [GO:0010611],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96KR4,S3,-1.279008412,-0.624026652,0.234545205,0.906563837,0.428977618,salmon,LMLN,LMLN_HUMAN,Leishmanolysin-like peptidase (EC 3.4.24.-) (Invadolysin),LMLN,89782;,"ENST00000330198.8; ENSP00000328829.5; ENSG00000185621.11. [Q96KR4-1];""ENST00000420910.7; ENSP00000410926.3; ENSG00000185621.11. [Q96KR4-3]"";",metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233],cell adhesion [GO:0007155]; cell division [GO:0051301]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lipid droplet [GO:0005811]; membrane [GO:0016020]
P02545,N2,-1.027730725,-0.024735716,1.141641914,-0.003861428,-1.094388728,grey70,LMNA,LMNA_HUMAN,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],LMNA LMN1,4000;,"ENST00000361308.9; ENSP00000355292.6; ENSG00000160789.24. [P02545-1];""ENST00000368299.7; ENSP00000357282.3; ENSG00000160789.24. [P02545-6]"";""ENST00000368300.9; ENSP00000357283.4; ENSG00000160789.24. [P02545-1]"";""ENST00000368301.6; ENSP00000357284.2; ENSG00000160789.24. [P02545-2]"";""ENST00000448611.6; ENSP00000395597.2; ENSG00000160789.24. [P02545-4]"";""ENST00000473598.6; ENSP00000421821.1; ENSG00000160789.24. [P02545-5]"";""ENST00000675939.1; ENSP00000502256.1; ENSG00000160789.24. [P02545-1]"";""ENST00000676385.2; ENSP00000502091.1; ENSG00000160789.24. [P02545-3]"";""ENST00000677389.1; ENSP00000503633.1; ENSG00000160789.24. [P02545-2]"";""ENST00000682650.1; ENSP00000506904.1; ENSG00000160789.24. [P02545-3]"";""ENST00000683032.1; ENSP00000506771.1; ENSG00000160789.24. [P02545-1]"";",identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of nuclear lamina [GO:0160123]; structural molecule activity [GO:0005198],cellular response to hypoxia [GO:0071456]; cellular senescence [GO:0090398]; DNA double-strand break attachment to nuclear envelope [GO:1990683]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; heterochromatin formation [GO:0031507]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; positive regulation of gene expression [GO:0010628]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504]; regulation of cell migration [GO:0030334]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of telomere maintenance [GO:0032204]; ventricular cardiac muscle cell development [GO:0055015],cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; site of double-strand break [GO:0035861]
P20700,N2,-1.164298759,-0.98466279,1.273563895,0.280941284,-0.68314097,grey70,LMNB1,LMNB1_HUMAN,Lamin-B1,LMNB1 LMN2 LMNB,4001;,ENST00000261366.10; ENSP00000261366.5; ENSG00000113368.12.;,phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of nuclear lamina [GO:0160123],heterochromatin formation [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435],lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8IWU2,S1,-1.110764987,-1.170730854,0.054950874,0.618277875,1.019353734,gold,LMTK2,LMTK2_HUMAN,Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2),LMTK2 AATYK2 BREK KIAA1079 KPI2 LMR2,22853;,ENST00000297293.6; ENSP00000297293.5; ENSG00000164715.6.;,ATP binding [GO:0005524]; myosin VI binding [GO:0070853]; protein kinase activity [GO:0004672]; protein phosphatase inhibitor activity [GO:0004864]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; receptor recycling [GO:0001881]; transferrin transport [GO:0033572],early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]
Q9UIQ6,S1,-0.804252439,-1.20762912,-0.106347878,0.593671112,1.235952183,gold,LNPEP,LCAP_HUMAN,"Leucyl-cystinyl aminopeptidase (Cystinyl aminopeptidase) (EC 3.4.11.3) (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase) (IRAP) (Oxytocinase) (OTase) (Placental leucine aminopeptidase) (P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form]",LNPEP OTASE,4012;,"ENST00000231368.10; ENSP00000231368.5; ENSG00000113441.16. [Q9UIQ6-1];""ENST00000395770.3; ENSP00000379117.3; ENSG00000113441.16. [Q9UIQ6-2]"";",aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent [GO:0002480]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; negative regulation of cold-induced thermogenesis [GO:0120163]; peptide catabolic process [GO:0043171]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]",cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome lumen [GO:0031905]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q969J3,S1,-0.172058631,-0.551121501,-0.288361596,0.511958957,0.905878789,gold,LOH12CR1,BORC5_HUMAN,BLOC-1-related complex subunit 5 (Loss of heterozygosity 12 chromosomal region 1) (Myristoylated lysosomal protein) (Myrlysin),BORCS5 LOH12CR1,118426;,"ENST00000298571.6; ENSP00000298571.6; ENSG00000165714.11. [Q969J3-2];""ENST00000314565.9; ENSP00000321546.4; ENSG00000165714.11. [Q969J3-1]"";""ENST00000627374.3; ENSP00000486120.1; ENSG00000280689.3. [Q969J3-1]"";""ENST00000627461.1; ENSP00000486584.1; ENSG00000280689.3. [Q969J3-2]"";",0,lysosome localization [GO:0032418]; organelle transport along microtubule [GO:0072384]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of endosome size [GO:0051036]; regulation of lysosome size [GO:0062196],BORC complex [GO:0099078]; cytoplasmic side of lysosomal membrane [GO:0098574]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]
Q8NF37,S2,-1.09731747,-1.367605926,0.206700789,0.832568139,0.544887195,orange,LPCAT1,PCAT1_HUMAN,Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3),LPCAT1 AYTL2 PFAAP3,79888;,"ENST00000283415.4; ENSP00000283415.3; ENSG00000153395.10.;""ENST00000475622.5; ENSP00000423472.1; ENSG00000153395.10."";",1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 1-alkylglycerophosphocholine O-acyltransferase activity [GO:0047191]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; lysophosphatidic acid acyltransferase activity [GO:0042171]; plasmalogen synthase activity [GO:0050200],negative regulation of phosphatidylcholine biosynthetic process [GO:2001246]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; retina development in camera-type eye [GO:0060041]; surfactant homeostasis [GO:0043129],azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q7L5N7,S2,-1.354353536,-1.423846155,0.274818348,0.819642709,0.6591544,orange,LPCAT2,PCAT2_HUMAN,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha),LPCAT2 AGPAT11 AYTL1,54947;,ENST00000262134.10; ENSP00000262134.5; ENSG00000087253.13. [Q7L5N7-1];,1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphocholine O-acyltransferase activity [GO:0047159]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; calcium ion binding [GO:0005509]; lysophosphatidic acid acyltransferase activity [GO:0042171]; plasmalogen synthase activity [GO:0050200],membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]
Q6ZWT7,S2,-1.362330986,-1.725888238,0.348093612,0.813825611,0.593996087,orange,LPCAT4,MBOA2_HUMAN,Lysophospholipid acyltransferase 2 (LPLAT 2) (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase MBOAT2) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase MBOAT2) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),MBOAT2 LPCAT4 OACT2,129642;,ENST00000305997.8; ENSP00000302177.3; ENSG00000143797.12.;,1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746],lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q92604,S2,-1.275953765,-1.455398618,0.411575959,0.788619485,0.653753685,orange,LPGAT1,LGAT1_HUMAN,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (2-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.62) (Acyl-CoA:monoacylglycerol acyltransferase LPGAT1) (EC 2.3.1.22) (Lysophospholipid acyltransferase 7) (LPLAT7) (EC 2.3.1.-) (Stearoyl-CoA:1-lyso-2-acyl-PE acyltransferase),LPGAT1 FAM34A KIAA0205,9926;,"ENST00000366996.1; ENSP00000355963.1; ENSG00000123684.13.;""ENST00000366997.9; ENSP00000355964.4; ENSG00000123684.13."";",1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol O-acyltransferase activity [GO:0003846]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; 2-acylglycerophosphocholine O-acyltransferase activity [GO:0047190]; acyltransferase activity [GO:0016746]; lysophosphatidylethanolamine acyltransferase activity [GO:0071618]; lysophospholipid acyltransferase activity [GO:0071617],phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654]; positive regulation of fatty acid biosynthetic process [GO:0045723]; triglyceride biosynthetic process [GO:0019432],cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q92539,C1,1.457917837,-0.04602788,-0.452681481,-0.294936205,-0.263592008,lightblue,LPIN2,LPIN2_HUMAN,Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2),LPIN2 KIAA0249,9663;,"ENST00000261596.9; ENSP00000261596.4; ENSG00000101577.11.;""ENST00000677752.1; ENSP00000504857.1; ENSG00000101577.11."";""ENST00000697040.1; ENSP00000513062.1; ENSG00000101577.11."";",phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713],cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]
Q93052,C4,1.833692712,0.149947697,-0.656131898,-0.675744172,-0.893113403,deepskyblue2,LPP,LPP_HUMAN,Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma),LPP,4026;,"ENST00000414139.6; ENSP00000392667.2; ENSG00000145012.15.;""ENST00000420410.6; ENSP00000405138.2; ENSG00000145012.15."";""ENST00000617246.5; ENSP00000478901.1; ENSG00000145012.15."";""ENST00000618621.5; ENSP00000482617.2; ENSG00000145012.15."";",metal ion binding [GO:0046872],cell-cell adhesion [GO:0098609],cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]
O75427,S1,-0.68234976,-0.679196624,0.146436006,0.390718805,0.875238727,gold,LRCH4,LRCH4_HUMAN,Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein),LRCH4 LRN LRRN1 LRRN4,4034;,ENST00000310300.11; ENSP00000309689.6; ENSG00000077454.17.;,0,membrane raft assembly [GO:0001765]; nervous system development [GO:0007399]; positive regulation of toll-like receptor signaling pathway [GO:0034123],plasma membrane [GO:0005886]; PML body [GO:0016605]
Q5T3J3,N2,-0.863217523,0.077871313,1.073631676,0.020571709,-0.898813006,grey70,LRIF1,LRIF1_HUMAN,Ligand-dependent nuclear receptor-interacting factor 1 (HP1-binding protein enriched in inactive X chromosome protein 1) (HBiX1) (Receptor-interacting factor 1),LRIF1 C1orf103 RIF1,55791;,"ENST00000369763.5; ENSP00000358778.4; ENSG00000121931.16. [Q5T3J3-1];""ENST00000485275.2; ENSP00000432290.1; ENSG00000121931.16. [Q5T3J3-2]"";""ENST00000494675.5; ENSP00000435259.1; ENSG00000121931.16. [Q5T3J3-2]"";",nuclear retinoic acid receptor binding [GO:0042974],dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of DNA-templated transcription [GO:0006355],Barr body [GO:0001740]; centriolar satellite [GO:0034451]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]
O94898,S4,-0.817501618,-1.044627869,0.276153056,0.741586745,0.560508742,tomato2,LRIG2,LRIG2_HUMAN,Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2),LRIG2 KIAA0806 LIG2,9860;,ENST00000361127.6; ENSP00000355396.4; ENSG00000198799.12.;,signaling receptor binding [GO:0005102],innervation [GO:0060384]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of axon regeneration [GO:0048681]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to cell surface [GO:0034394]; regulation of neuron migration [GO:2001222]; regulation of platelet-derived growth factor receptor signaling pathway [GO:0010640]; sensory perception of sound [GO:0007605],cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]
Q07954,S1,-0.827958709,-0.95872537,0.010064277,0.614278066,0.903879542,gold,LRP1,LRP1_HUMAN,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],LRP1 A2MR APR,4035;,"ENST00000243077.8; ENSP00000243077.3; ENSG00000123384.14. [Q07954-1];""ENST00000338962.8; ENSP00000341264.4; ENSG00000123384.14. [Q07954-2]"";",alpha-2 macroglobulin receptor activity [GO:0016964]; amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; apolipoprotein receptor activity [GO:0030226]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; heparan sulfate proteoglycan binding [GO:0043395]; lipoprotein particle receptor binding [GO:0070325]; low-density lipoprotein particle receptor activity [GO:0005041]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023],amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cellular response to amyloid-beta [GO:1904646]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; lysosomal transport [GO:0007041]; negative regulation of gene expression [GO:0010629]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcytosis [GO:1904300]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of phospholipase A2 activity [GO:0032429]; retinoid metabolic process [GO:0001523]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104],basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; early endosome [GO:0005769]; endocytic vesicle membrane [GO:0030666]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235]
Q7Z4F1,S1,-0.900641999,-1.415092828,-0.041802969,0.78326457,0.765316934,gold,LRP10,LRP10_HUMAN,Low-density lipoprotein receptor-related protein 10 (LRP-10),LRP10 MSTP087 SP220 UNQ389/PRO724,26020;,"ENST00000359591.9; ENSP00000352601.4; ENSG00000197324.9. [Q7Z4F1-1];""ENST00000546834.5; ENSP00000447559.1; ENSG00000197324.9. [Q7Z4F1-2]"";",low-density lipoprotein particle receptor activity [GO:0005041],endocytosis [GO:0006897]; inner ear development [GO:0048839]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869],clathrin-coated pit [GO:0005905]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q86VZ4,S3,-0.406856837,-0.570103703,-0.101128822,0.72877239,0.616894549,salmon,LRP11,LRP11_HUMAN,Low-density lipoprotein receptor-related protein 11 (LRP-11),LRP11,84918;,ENST00000239367.7; ENSP00000239367.2; ENSG00000120256.11. [Q86VZ4-1];,phosphoprotein binding [GO:0051219],multicellular organismal response to stress [GO:0033555]; response to cold [GO:0009409]; response to heat [GO:0009408]; response to immobilization stress [GO:0035902]; response to mechanical stimulus [GO:0009612]; response to starvation [GO:0042594]; response to water deprivation [GO:0009414],plasma membrane [GO:0005886]
Q9Y561,S1,-0.833060067,-0.840832976,0.089407009,0.724950626,0.645600714,gold,LRP12,LRP12_HUMAN,Low-density lipoprotein receptor-related protein 12 (LDLR-related protein 12) (LRP-12) (Suppressor of tumorigenicity 7 protein),LRP12 ST7,29967;,"ENST00000276654.10; ENSP00000276654.5; ENSG00000147650.12. [Q9Y561-1];""ENST00000424843.6; ENSP00000399148.2; ENSG00000147650.12. [Q9Y561-2]"";",low-density lipoprotein particle receptor activity [GO:0005041],endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; regulation of growth [GO:0040008]; signal transduction [GO:0007165],clathrin-coated pit [GO:0005905]; membrane [GO:0016020]; plasma membrane [GO:0005886]
O75197,S3,-0.918916885,-0.897652988,0.228401369,0.708079198,0.563610521,salmon,LRP5,LRP5_HUMAN,Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7),LRP5 LR3 LRP7,4041;,ENST00000294304.12; ENSP00000294304.6; ENSG00000162337.12.;,coreceptor activity [GO:0015026]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],adipose tissue development [GO:0060612]; amino acid transport [GO:0006865]; anatomical structure regression [GO:0060033]; anterior/posterior pattern specification [GO:0009952]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cell-cell signaling involved in mammary gland development [GO:0060764]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; extracellular matrix-cell signaling [GO:0035426]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; glucose catabolic process [GO:0006007]; mesodermal cell migration [GO:0008078]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; osteoblast development [GO:0002076]; osteoblast proliferation [GO:0033687]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to peptide hormone [GO:0043434]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; somatic stem cell population maintenance [GO:0035019],endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]
O75581,S4,-0.572399856,-0.754835138,0.321275165,0.709681447,0.448533014,tomato2,LRP6,LRP6_HUMAN,Low-density lipoprotein receptor-related protein 6 (LRP-6),LRP6,4040;,"ENST00000261349.9; ENSP00000261349.4; ENSG00000070018.9.;""ENST00000628182.3; ENSP00000486315.1; ENSG00000281324.3."";",coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]
Q14114,S1,-1.125141482,-1.364343914,-0.008176239,0.674058977,0.983294542,gold,LRP8,LRP8_HUMAN,Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2),LRP8 APOER2,7804;,"ENST00000306052.12; ENSP00000303634.6; ENSG00000157193.18. [Q14114-1];""ENST00000347547.7; ENSP00000334522.2; ENSG00000157193.18. [Q14114-4]"";""ENST00000354412.7; ENSP00000346391.3; ENSG00000157193.18. [Q14114-2]"";""ENST00000371454.6; ENSP00000360509.2; ENSG00000157193.18. [Q14114-3]"";",amyloid-beta binding [GO:0001540]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; cargo receptor activity [GO:0038024]; high-density lipoprotein particle binding [GO:0008035]; kinesin binding [GO:0019894]; low-density lipoprotein particle receptor activity [GO:0005041]; reelin receptor activity [GO:0038025]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle receptor activity [GO:0030229],ammon gyrus development [GO:0021541]; cellular response to cholesterol [GO:0071397]; cellular response to growth factor stimulus [GO:0071363]; chemical synaptic transmission [GO:0007268]; cytokine-mediated signaling pathway [GO:0019221]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; layer formation in cerebral cortex [GO:0021819]; lipid metabolic process [GO:0006629]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of dendrite development [GO:1900006]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; proteolysis [GO:0006508]; reelin-mediated signaling pathway [GO:0038026]; regulation of apoptotic process [GO:0042981]; regulation of innate immune response [GO:0045088]; response to xenobiotic stimulus [GO:0009410]; retinoid metabolic process [GO:0001523]; signal transduction [GO:0007165]; ventral spinal cord development [GO:0021517],axon [GO:0030424]; caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; synapse [GO:0045202]
P30533,N4,-1.05515543,0.498949639,-0.183095021,0.503022895,0.052336674,grey30,LRPAP1,AMRP_HUMAN,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),LRPAP1 A2MRAP,4043;,ENST00000650182.1; ENSP00000497444.1; ENSG00000163956.13.;,amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326],amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259]; signal transduction [GO:0007165],cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]
Q9BTT6,M1,-0.906750552,-0.77998522,0.579078151,0.732336421,-0.035897232,burlywood4,LRRC1,LRRC1_HUMAN,Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein),LRRC1 LANO,55227;,"ENST00000370888.6; ENSP00000359925.1; ENSG00000137269.15. [Q9BTT6-1];""ENST00000487251.5; ENSP00000435217.1; ENSG00000137269.15. [Q9BTT6-2]"";",0,0,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]
Q5VZK9,C1,1.650041597,-0.1017345,-0.430390885,-0.063940473,-0.332207762,lightblue,LRRC16A,CARL1_HUMAN,"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)",CARMIL1 CARMIL LRRC16 LRRC16A,55604;,ENST00000329474.7; ENSP00000331983.6; ENSG00000079691.19. [Q5VZK9-1];,protein-containing complex binding [GO:0044877],actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q96AG4,S2,-1.018845249,-1.309123337,0.156378487,0.975314831,0.426033227,orange,LRRC59,LRC59_HUMAN,"Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34) (p34) [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]",LRRC59 PRO1855,55379;,ENST00000225972.8; ENSP00000225972.7; ENSG00000108829.10.;,cadherin binding [GO:0045296]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723],signal transduction [GO:0007165],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]
Q8IWT6,S4,-1.091487526,-1.305424292,0.55160305,0.757130659,0.222042418,tomato2,LRRC8A,LRC8A_HUMAN,Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (HsLRRC8A) (Swelling protein 1),LRRC8A KIAA1437 LRRC8 SWELL1 UNQ221/PRO247,56262;,"ENST00000259324.5; ENSP00000259324.5; ENSG00000136802.12.;""ENST00000372599.7; ENSP00000361680.3; ENSG00000136802.12."";""ENST00000372600.9; ENSP00000361682.4; ENSG00000136802.12."";",cyclic-GMP-AMP transmembrane transporter activity [GO:0140360]; identical protein binding [GO:0042802]; volume-sensitive anion channel activity [GO:0005225],aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; chloride transmembrane transport [GO:1902476]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; intracellular glucose homeostasis [GO:0001678]; monoatomic anion transmembrane transport [GO:0098656]; monoatomic anion transport [GO:0006820]; positive regulation of insulin secretion [GO:0032024]; positive regulation of myoblast differentiation [GO:0045663]; pre-B cell differentiation [GO:0002329]; protein hexamerization [GO:0034214]; response to osmotic stress [GO:0006970]; spermatogenesis [GO:0007283]; taurine transmembrane transport [GO:0015734],cell surface [GO:0009986]; cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]
Q6P9F7,S4,-0.839600706,-1.419791172,0.55928546,0.906889844,0.341206623,tomato2,LRRC8B,LRC8B_HUMAN,Volume-regulated anion channel subunit LRRC8B (Leucine-rich repeat-containing protein 8B) (T-cell activation leucine repeat-rich protein) (TA-LRRP),LRRC8B KIAA0231 UNQ6413/PRO21207,23507;,"ENST00000330947.7; ENSP00000332674.2; ENSG00000197147.15.;""ENST00000639264.1; ENSP00000492151.1; ENSG00000197147.15."";""ENST00000640258.1; ENSP00000491377.1; ENSG00000197147.15."";",0,aspartate transmembrane transport [GO:0015810]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; monoatomic anion transmembrane transport [GO:0098656],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]
Q7L1W4,S4,-1.588142527,-1.503069253,0.549539571,0.918810284,0.329721509,tomato2,LRRC8D,LRC8D_HUMAN,Volume-regulated anion channel subunit LRRC8D (Leucine-rich repeat-containing protein 5) (Leucine-rich repeat-containing protein 8D) (HsLRRC8D),LRRC8D LRRC5 UNQ213/PRO239,55144;,"ENST00000337338.9; ENSP00000338887.5; ENSG00000171492.14.;""ENST00000394593.7; ENSP00000378093.3; ENSG00000171492.14."";",volume-sensitive anion channel activity [GO:0005225],aspartate transmembrane transport [GO:0015810]; cellular response to osmotic stress [GO:0071470]; intracellular glucose homeostasis [GO:0001678]; monoatomic anion transmembrane transport [GO:0098656]; protein hexamerization [GO:0034214]; taurine transmembrane transport [GO:0015734],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]
Q6NSJ5,S4,-1.184142061,-1.293259731,0.449226948,0.982484372,0.358215817,tomato2,LRRC8E,LRC8E_HUMAN,Volume-regulated anion channel subunit LRRC8E (Leucine-rich repeat-containing protein 8E),LRRC8E,80131;,"ENST00000306708.11; ENSP00000306524.5; ENSG00000171017.11.;""ENST00000618098.4; ENSP00000479953.1; ENSG00000171017.11."";",volume-sensitive anion channel activity [GO:0005225],aspartate transmembrane transport [GO:0015810]; cell volume homeostasis [GO:0006884]; cellular response to osmotic stress [GO:0071470]; cyclic-GMP-AMP transmembrane import across plasma membrane [GO:0140361]; monoatomic anion transmembrane transport [GO:0098656],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886]
Q6UWE0,C3,1.746782999,-0.008212628,-0.562318712,-0.531679363,-0.681595797,cyan,LRSAM1,LRSM1_HUMAN,E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase) (hTAL),LRSAM1 TAL UNQ6496/PRO21356,90678;,"ENST00000300417.11; ENSP00000300417.6; ENSG00000148356.15. [Q6UWE0-1];""ENST00000323301.8; ENSP00000322937.4; ENSG00000148356.15. [Q6UWE0-1]"";""ENST00000373322.1; ENSP00000362419.1; ENSG00000148356.15. [Q6UWE0-1]"";""ENST00000373324.8; ENSP00000362421.4; ENSG00000148356.15. [Q6UWE0-2]"";""ENST00000675448.1; ENSP00000502167.1; ENSG00000148356.15. [Q6UWE0-1]"";""ENST00000675883.1; ENSP00000501592.1; ENSG00000148356.15. [Q6UWE0-2]"";",metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]
O15116,C1,1.788005016,0.366934865,-0.920266689,-0.855308222,-0.150076135,lightblue,LSM1,LSM1_HUMAN,U6 snRNA-associated Sm-like protein LSm1 (Cancer-associated Sm-like) (Small nuclear ribonuclear CaSm),LSM1 CASM,27257;,ENST00000311351.9; ENSP00000310596.4; ENSG00000175324.10.;,mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723],"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; neuron differentiation [GO:0030182]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; stem cell population maintenance [GO:0019827]",axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Lsm1-7-Pat1 complex [GO:1990726]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]
P48449,S2,-1.026461556,-1.190871168,0.195854504,0.805459477,0.653039275,orange,LSS,LSS_HUMAN,"Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC)",LSS OSC,4047;,"ENST00000356396.8; ENSP00000348762.3; ENSG00000160285.15. [P48449-1];""ENST00000397728.8; ENSP00000380837.2; ENSG00000160285.15. [P48449-1]"";""ENST00000457828.6; ENSP00000409191.2; ENSG00000160285.15. [P48449-2]"";""ENST00000522411.5; ENSP00000429133.1; ENSG00000160285.15. [P48449-3]"";",lanosterol synthase activity [GO:0000250],cholesterol biosynthetic process [GO:0006695]; regulation of protein stability [GO:0031647]; steroid biosynthetic process [GO:0006694]; triterpenoid biosynthetic process [GO:0016104],endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]
P09960,C4,1.946770641,0.657579766,-1.122340144,-1.213909325,-1.420661213,deepskyblue2,LTA4H,LKHA4_HUMAN,Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4),LTA4H LTA4,4048;,"ENST00000228740.7; ENSP00000228740.2; ENSG00000111144.10. [P09960-1];""ENST00000413268.6; ENSP00000395051.2; ENSG00000111144.10. [P09960-3]"";""ENST00000552789.5; ENSP00000449958.1; ENSG00000111144.10. [P09960-4]"";",aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; RNA binding [GO:0003723]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270],leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]
P36941,S2,-1.276963158,-1.473033666,0.287103101,0.850538586,0.517324187,orange,LTBR,TNR3_HUMAN,Tumor necrosis factor receptor superfamily member 3 (Lymphotoxin-beta receptor) (Tumor necrosis factor C receptor) (Tumor necrosis factor receptor 2-related protein) (Tumor necrosis factor receptor type III) (TNF-RIII) (TNFR-III),LTBR D12S370 TNFCR TNFR3 TNFRSF3,4055;,"ENST00000228918.9; ENSP00000228918.4; ENSG00000111321.11. [P36941-1];""ENST00000539925.5; ENSP00000440875.1; ENSG00000111321.11. [P36941-2]"";",identical protein binding [GO:0042802]; ubiquitin protein ligase binding [GO:0031625],apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; hematopoietic or lymphoid organ development [GO:0048534]; immune response [GO:0006955]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of JNK cascade [GO:0046330]; signal transduction [GO:0007165],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]
Q9NX58,N3,-1.304705886,-0.977387656,0.5639337,-0.252948804,1.174962161,grey50,LYAR,LYAR_HUMAN,Cell growth-regulating nucleolar protein,LYAR PNAS-5,55646;,"ENST00000343470.9; ENSP00000345917.4; ENSG00000145220.14.;""ENST00000452476.5; ENSP00000397367.1; ENSG00000145220.14."";",DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription regulator inhibitor activity [GO:0140416],erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]
P07948,S4,-1.196598061,-1.554756345,0.352116033,1.021405642,0.465451809,tomato2,LYN,LYN_HUMAN,Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn),LYN JTK8,4067;,"ENST00000519728.6; ENSP00000428924.1; ENSG00000254087.8. [P07948-1];""ENST00000520220.6; ENSP00000428424.1; ENSG00000254087.8. [P07948-2]"";",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; gamma-tubulin binding [GO:0043015]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphoprotein binding [GO:0051219]; phosphorylation-dependent protein binding [GO:0140031]; platelet-derived growth factor receptor binding [GO:0005161]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625],adaptive immune response [GO:0002250]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; C-X-C chemokine receptor CXCR4 signaling pathway [GO:0038159]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to extracellular stimulus [GO:0031668]; cellular response to heat [GO:0034605]; cellular response to retinoic acid [GO:0071300]; dendritic cell differentiation [GO:0097028]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; eosinophil differentiation [GO:0030222]; ephrin receptor signaling pathway [GO:0048013]; erythrocyte differentiation [GO:0030218]; fatty acid transport [GO:0015908]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; Fc receptor mediated stimulatory signaling pathway [GO:0002431]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; hematopoietic progenitor cell differentiation [GO:0002244]; histamine secretion by mast cell [GO:0002553]; immune response-regulating cell surface receptor signaling pathway [GO:0002768]; innate immune response [GO:0045087]; interleukin-5-mediated signaling pathway [GO:0038043]; leukocyte migration [GO:0050900]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of immune response [GO:0050777]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intracellular signal transduction [GO:1902532]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; neuron projection development [GO:0031175]; oligodendrocyte development [GO:0014003]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet degranulation [GO:0002576]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cytokine production [GO:0001817]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of erythrocyte differentiation [GO:0045646]; regulation of mast cell activation [GO:0033003]; regulation of mast cell degranulation [GO:0043304]; regulation of monocyte chemotaxis [GO:0090025]; regulation of platelet aggregation [GO:0090330]; regulation of protein phosphorylation [GO:0001932]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to carbohydrate [GO:0009743]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to organic cyclic compound [GO:0014070]; response to sterol depletion [GO:0006991]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; tolerance induction to self antigen [GO:0002513]; toll-like receptor 4 signaling pathway [GO:0034142],"adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integrin alpha2-beta1 complex [GO:0034666]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane raft [GO:0045121]; mitochondrial crista [GO:0030061]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]"
O75608,C1,1.499607345,-0.09238856,-0.388185504,-0.058283478,-0.948862769,lightblue,LYPLA1,LYPA1_HUMAN,Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I) (Palmitoyl-protein hydrolase) (EC 3.1.2.22),LYPLA1 APT1 LPL1,10434;,"ENST00000316963.8; ENSP00000320043.3; ENSG00000120992.18. [O75608-1];""ENST00000343231.10; ENSP00000344477.6; ENSG00000120992.18. [O75608-2]"";",carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; phospholipase activity [GO:0004620],fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; negative regulation of aggrephagy [GO:1905336]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; protein depalmitoylation [GO:0002084],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
O43325,M1,-1.798795195,-0.214988597,0.454131414,1.112671155,-0.881437087,burlywood4,LYRM1,LYRM1_HUMAN,LYR motif-containing protein 1,LYRM1,57149;,"ENST00000219168.8; ENSP00000219168.4; ENSG00000102897.10.;""ENST00000396052.3; ENSP00000379367.2; ENSG00000102897.10."";""ENST00000439021.5; ENSP00000407883.1; ENSG00000102897.10."";""ENST00000567954.6; ENSP00000457333.1; ENSG00000102897.10."";""ENST00000568663.5; ENSP00000454826.1; ENSG00000102897.10."";""ENST00000569023.5; ENSP00000454551.1; ENSG00000102897.10."";",0,0,midbody [GO:0030496]; nucleoplasm [GO:0005654]
Q5U5X0,M1,-1.533395629,0.246256631,0.358768358,0.868521456,-1.087474874,burlywood4,LYRM7,LYRM7_HUMAN,Complex III assembly factor LYRM7 (LYR motif-containing protein 7),LYRM7 C5orf31 MZM1L,90624;,ENST00000379380.9; ENSP00000368688.4; ENSG00000186687.16.;,protein folding chaperone [GO:0044183],cellular respiration [GO:0045333]; mitochondrial respiratory chain complex III assembly [GO:0034551],mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]
Q8IV50,C5,1.825524029,0.338181638,-0.466425433,-0.698893977,-0.798363806,turquoise3,LYSMD2,LYSM2_HUMAN,LysM and putative peptidoglycan-binding domain-containing protein 2,LYSMD2,256586;,"ENST00000267838.7; ENSP00000267838.3; ENSG00000140280.14. [Q8IV50-1];""ENST00000454181.6; ENSP00000410424.2; ENSG00000140280.14. [Q8IV50-2]"";""ENST00000560491.2; ENSP00000453933.1; ENSG00000140280.14. [Q8IV50-2]"";",0,0,0
Q7Z3D4,S2,-1.522625874,-1.448807358,0.062756092,0.811269896,0.855311547,orange,LYSMD3,LYSM3_HUMAN,LysM and putative peptidoglycan-binding domain-containing protein 3,LYSMD3,116068;,"ENST00000315948.11; ENSP00000314518.6; ENSG00000176018.13. [Q7Z3D4-1];""ENST00000500869.6; ENSP00000427020.1; ENSG00000176018.13. [Q7Z3D4-3]"";""ENST00000509384.5; ENSP00000427683.1; ENSG00000176018.13. [Q7Z3D4-2]"";",peptidoglycan binding [GO:0042834],Golgi organization [GO:0007030],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]
Q8WZA0,C4,1.960799515,0.345330332,-1.153098608,-1.331995427,-1.654875518,deepskyblue2,LZIC,LZIC_HUMAN,Protein LZIC (Leucine zipper and CTNNBIP1 domain-containing protein) (Leucine zipper and ICAT homologous domain-containing protein),LZIC,84328;,"ENST00000377213.1; ENSP00000366418.1; ENSG00000162441.12. [Q8WZA0-1];""ENST00000377223.6; ENSP00000366430.1; ENSG00000162441.12. [Q8WZA0-1]"";""ENST00000400903.6; ENSP00000383695.2; ENSG00000162441.12. [Q8WZA0-1]"";",beta-catenin binding [GO:0008013],0,0
Q9NQ48,C4,2.176831004,-0.022972899,-1.076256098,-0.989593482,-1.169369094,deepskyblue2,LZTFL1,LZTL1_HUMAN,Leucine zipper transcription factor-like protein 1,LZTFL1,54585;,"ENST00000296135.11; ENSP00000296135.6; ENSG00000163818.20. [Q9NQ48-1];""ENST00000539217.5; ENSP00000441784.1; ENSG00000163818.20. [Q9NQ48-3]"";""ENST00000684620.1; ENSP00000506925.1; ENSG00000163818.20. [Q9NQ48-2]"";",identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877],flagellated sperm motility [GO:0030317]; negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]; spermatogenesis [GO:0007283],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]
P20645,S1,-0.901446379,-1.215944839,-0.269903151,0.414551337,1.37808313,gold,M6PR,MPRD_HUMAN,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),M6PR MPR46 MPRD,4074;,ENST00000000412.8; ENSP00000000412.3; ENSG00000003056.8.;,protein domain specific binding [GO:0019904]; protein transporter activity [GO:0140318]; retromer complex binding [GO:1905394]; transmembrane signaling receptor activity [GO:0004888],endosome to lysosome transport [GO:0008333]; glycosphingolipid catabolic process [GO:0046479]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; secretion of lysosomal enzymes [GO:0033299],clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]
Q9BQ69,M1,-0.443391341,0.117598608,0.374458617,0.707045468,-0.53479538,burlywood4,MACROD1,MACD1_HUMAN,ADP-ribose glycohydrolase MACROD1 (MACRO domain-containing protein 1) (O-acetyl-ADP-ribose deacetylase MACROD1) (EC 3.1.1.106) (Protein LRP16) ([Protein ADP-ribosylaspartate] hydrolase MACROD1) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD1) (EC 3.2.2.-),MACROD1 LRP16,28992;,ENST00000255681.7; ENSP00000255681.6; ENSG00000133315.12.;,"ADP-ribosylglutamate hydrolase activity [GO:0140293]; deacetylase activity [GO:0019213]; hydrolase activity, acting on glycosyl bonds [GO:0016798]",DNA damage response [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y6D9,N4,-0.6259956,0.961273423,-0.005858261,0.017135339,-0.514434587,grey30,MAD1L1,MD1L1_HUMAN,Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181),MAD1L1 MAD1 TXBP181,8379;,"ENST00000265854.12; ENSP00000265854.7; ENSG00000002822.16. [Q9Y6D9-1];""ENST00000399654.6; ENSP00000382562.2; ENSG00000002822.16. [Q9Y6D9-1]"";""ENST00000402746.5; ENSP00000384155.1; ENSG00000002822.16. [Q9Y6D9-3]"";""ENST00000406869.5; ENSP00000385334.1; ENSG00000002822.16. [Q9Y6D9-1]"";",identical protein binding [GO:0042802]; kinetochore binding [GO:0043515],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; deactivation of mitotic spindle assembly checkpoint [GO:1902426]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; MAD1 complex [GO:1990706]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]
Q13257,C1,1.628526828,0.298099406,-0.480296624,-0.324693215,-0.47609264,lightblue,MAD2L1,MD2L1_HUMAN,Mitotic spindle assembly checkpoint protein MAD2A (HsMAD2) (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1),MAD2L1 MAD2,4085;,"ENST00000296509.11; ENSP00000296509.5; ENSG00000164109.14. [Q13257-1];""ENST00000333047.9; ENSP00000332295.5; ENSG00000164109.14. [Q13257-2]"";",identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],cell division [GO:0051301]; establishment of centrosome localization [GO:0051660]; establishment of mitotic spindle orientation [GO:0000132]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267],cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; mitotic spindle [GO:0072686]; mitotic spindle assembly checkpoint MAD1-MAD2 complex [GO:1990728]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]
Q9H063,C2,1.317488466,0.466099477,-0.552158568,-0.714261531,-0.062188768,aquamarine,MAF1,MAF1_HUMAN,Repressor of RNA polymerase III transcription MAF1 homolog,MAF1,84232;,"ENST00000322428.10; ENSP00000318604.5; ENSG00000179632.10.;""ENST00000532522.5; ENSP00000436720.1; ENSG00000179632.10."";",RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006],negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O15525,N3,-0.900695605,-0.923024131,1.167824369,0.269215057,-0.396298693,grey50,MAFG,MAFG_HUMAN,Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF),MAFG,4097;,"ENST00000357736.9; ENSP00000350369.4; ENSG00000197063.11.;""ENST00000392366.7; ENSP00000376173.3; ENSG00000197063.11."";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",adult behavior [GO:0030534]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]
Q5TCQ9,C5,1.348137584,0.572398568,-0.49380252,-0.403524228,-0.923094933,turquoise3,MAGI3,MAGI3_HUMAN,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3)",MAGI3 KIAA1634,260425;,"ENST00000307546.14; ENSP00000304604.9; ENSG00000081026.19. [Q5TCQ9-4];""ENST00000369611.4; ENSP00000358624.4; ENSG00000081026.19. [Q5TCQ9-3]"";""ENST00000369615.5; ENSP00000358628.1; ENSG00000081026.19. [Q5TCQ9-3]"";""ENST00000369617.8; ENSP00000358630.4; ENSG00000081026.19. [Q5TCQ9-2]"";",ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385],apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9UDY8,C3,1.892941697,-0.157340083,-0.561033361,-0.518748378,-0.955468514,cyan,MALT1,MALT1_HUMAN,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),MALT1 MLT,10892;,"ENST00000345724.7; ENSP00000304161.3; ENSG00000172175.16. [Q9UDY8-2];""ENST00000649217.2; ENSP00000497997.1; ENSG00000172175.16. [Q9UDY8-1]"";",cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; small molecule binding [GO:0036094]; ubiquitin-protein transferase activity [GO:0004842],B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991]
Q92585,N4,-0.224723746,1.268490909,-0.39933731,-0.494487092,-0.853800874,grey30,MAML1,MAML1_HUMAN,Mastermind-like protein 1 (Mam-1),MAML1 KIAA0200,9794;,"ENST00000292599.4; ENSP00000292599.3; ENSG00000161021.13.;""ENST00000638220.2; ENSP00000491444.1; ENSG00000283780.3."";",peptide antigen binding [GO:0042605]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713],atrioventricular node cell development [GO:0060928]; atrioventricular node development [GO:0003162]; myoblast differentiation [GO:0045445]; Notch signaling pathway [GO:0007219]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; protein phosphorylation [GO:0006468],MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O60476,S1,-0.976109161,-1.452646214,-0.247128432,0.888647012,0.890357392,gold,MAN1A2,MA1A2_HUMAN,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",MAN1A2 MAN1B,10905;,ENST00000356554.7; ENSP00000348959.3; ENSG00000198162.12.;,"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",carbohydrate metabolic process [GO:0005975]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9UKM7,S1,-1.393769482,-1.622474987,-0.116724609,0.942140031,0.863811365,gold,MAN1B1,MA1B1_HUMAN,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)",MAN1B1 UNQ747/PRO1477,11253;,ENST00000371589.9; ENSP00000360645.4; ENSG00000177239.16.;,"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]","ERAD pathway [GO:0036503]; mannoprotein catabolic process [GO:0006058]; oligosaccharide metabolic process [GO:0009311]; protein alpha-1,2-demannosylation [GO:0036508]; protein glycosylation [GO:0006486]; viral protein processing [GO:0019082]",cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]
Q16706,S1,-1.196899827,-1.492874596,-0.062079405,0.935232638,0.949209259,gold,MAN2A1,MA2A1_HUMAN,"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",MAN2A1 MANA2,4124;,ENST00000261483.5; ENSP00000261483.4; ENSG00000112893.10.;,"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]",in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033]; viral protein processing [GO:0019082],cis-Golgi network [GO:0005801]; extracellular exosome [GO:0070062]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
P49641,S1,-0.912437186,-0.786626627,8.88E-04,0.790391376,0.688363915,gold,MAN2A2,MA2A2_HUMAN,"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",MAN2A2 MANA2X,4122;,"ENST00000360468.7; ENSP00000353655.3; ENSG00000196547.15. [P49641-3];""ENST00000559717.6; ENSP00000452948.1; ENSG00000196547.15. [P49641-3]"";","alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]",mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486],Golgi membrane [GO:0000139]
Q9NQG1,S2,-0.942853405,-0.848889777,-0.0346207,0.792112233,0.297309984,orange,MANBAL,MANBL_HUMAN,Protein MANBAL,MANBAL,63905;,"ENST00000373605.7; ENSP00000362707.3; ENSG00000101363.13.;""ENST00000373606.8; ENSP00000362708.3; ENSG00000101363.13."";""ENST00000397151.1; ENSP00000380338.1; ENSG00000101363.13."";""ENST00000397152.7; ENSP00000380339.3; ENSG00000101363.13."";""ENST00000709385.1; ENSP00000517661.1; ENSG00000291969.1."";""ENST00000709387.1; ENSP00000517663.1; ENSG00000291969.1."";""ENST00000709388.1; ENSP00000517664.1; ENSG00000291969.1."";""ENST00000709389.1; ENSP00000517665.1; ENSG00000291969.1."";",0,0,membrane [GO:0016020]
Q5SRI9,S1,-0.217292002,-0.717309848,-0.09206911,0.658359189,0.636288175,gold,MANEA,MANEA_HUMAN,"Glycoprotein endo-alpha-1,2-mannosidase (Endo-alpha mannosidase) (Endomannosidase) (hEndo) (EC 3.2.1.130) (Mandaselin)",MANEA,79694;,"ENST00000358812.9; ENSP00000351669.4; ENSG00000172469.17.;""ENST00000682663.1; ENSP00000507267.1; ENSG00000172469.17."";""ENST00000684753.1; ENSP00000506887.1; ENSG00000172469.17."";","alpha-mannosidase activity [GO:0004559]; glycoprotein endo-alpha-1,2-mannosidase activity [GO:0004569]",0,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q02750,C4,1.873200326,-0.337348376,-0.864880975,-0.678257023,-0.884983768,deepskyblue2,MAP2K1,MP2K1_HUMAN,Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1),MAP2K1 MEK1 PRKMK1,5604;,ENST00000307102.10; ENSP00000302486.5; ENSG00000169032.11. [Q02750-1];,ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; MAP-kinase scaffold activity [GO:0005078]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110],Bergmann glial cell differentiation [GO:0060020]; cell motility [GO:0048870]; cellular senescence [GO:0090398]; cerebellar cortex formation [GO:0021697]; chemotaxis [GO:0006935]; endodermal cell differentiation [GO:0035987]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; keratinocyte differentiation [GO:0030216]; labyrinthine layer development [GO:0060711]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of cell population proliferation [GO:0008285]; neuron differentiation [GO:0030182]; placenta blood vessel development [GO:0060674]; positive regulation of axonogenesis [GO:0050772]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of axon regeneration [GO:0048679]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of stress-activated MAPK cascade [GO:0032872]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; type B pancreatic cell proliferation [GO:0044342],centrosome [GO:0005813]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole body [GO:0005816]
O43318,C3,1.77534483,0.268079529,-0.537189081,-0.438994699,-0.788045303,cyan,MAP3K7,M3K7_HUMAN,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1),MAP3K7 TAK1,6885;,"ENST00000369325.7; ENSP00000358331.3; ENSG00000135341.19. [O43318-3];""ENST00000369327.7; ENSP00000358333.3; ENSG00000135341.19. [O43318-4]"";""ENST00000369329.8; ENSP00000358335.3; ENSG00000135341.19. [O43318-1]"";""ENST00000369332.7; ENSP00000358338.3; ENSG00000135341.19. [O43318-2]"";""ENST00000700580.1; ENSP00000515074.1; ENSG00000135341.19. [O43318-2]"";",ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625],"anoikis [GO:0043276]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of gene expression [GO:0010629]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; p38MAPK cascade [GO:0038066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]",ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P27816,C5,1.494779005,0.836929822,-0.733957533,-0.824474469,-0.872002571,turquoise3,MAP4,MAP4_HUMAN,Microtubule-associated protein 4 (MAP-4),MAP4,4134;,"ENST00000360240.10; ENSP00000353375.6; ENSG00000047849.22. [P27816-1];""ENST00000395734.8; ENSP00000379083.3; ENSG00000047849.22. [P27816-6]"";""ENST00000434267.5; ENSP00000402767.1; ENSG00000047849.22. [P27816-7]"";""ENST00000439356.2; ENSP00000397414.1; ENSG00000047849.22. [P27816-7]"";",microtubule binding [GO:0008017]; microtubule stabilizing activity [GO:0140778]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198],cell division [GO:0051301]; cilium disassembly [GO:0061523]; establishment of spindle orientation [GO:0051294]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; microtubule sliding [GO:0051012]; mitotic spindle organization [GO:0007052]; negative regulation of non-motile cilium assembly [GO:1902856]; neuron projection development [GO:0031175],axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]
Q12851,C1,1.559051987,0.002849091,-0.427966739,-0.23845654,-0.517427432,lightblue,MAP4K2,M4K2_HUMAN,Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein),MAP4K2 GCK RAB8IP,5871;,"ENST00000294066.7; ENSP00000294066.2; ENSG00000168067.12. [Q12851-1];""ENST00000377350.7; ENSP00000366567.3; ENSG00000168067.12. [Q12851-2]"";",ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468]; vesicle targeting [GO:0006903],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]
Q8IVH8,C2,0.914258218,0.324112422,-0.21398358,0.006263432,-0.113709359,aquamarine,MAP4K3,M4K3_HUMAN,Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3),MAP4K3 RAB8IPL1,8491;,"ENST00000263881.8; ENSP00000263881.3; ENSG00000011566.15. [Q8IVH8-1];""ENST00000341681.9; ENSP00000345434.5; ENSG00000011566.15. [Q8IVH8-3]"";",ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; protein phosphorylation [GO:0006468]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411],cytoplasm [GO:0005737]
Q9Y4K4,C3,1.748835768,0.369137947,-0.710627716,-0.582950808,-0.858883077,cyan,MAP4K5,M4K5_HUMAN,Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5),MAP4K5,11183;,"ENST00000013125.9; ENSP00000013125.5; ENSG00000012983.12.;""ENST00000682126.1; ENSP00000507200.1; ENSG00000012983.12."";",ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],intracellular signal transduction [GO:0035556],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
P28482,C5,1.993912503,0.378535831,-0.864938482,-0.788322806,-0.953328036,turquoise3,MAPK1,MK01_HUMAN,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),MAPK1 ERK2 PRKM1 PRKM2,5594;,"ENST00000215832.11; ENSP00000215832.7; ENSG00000100030.15. [P28482-1];""ENST00000398822.7; ENSP00000381803.3; ENSG00000100030.15. [P28482-1]"";""ENST00000544786.1; ENSP00000440842.1; ENSG00000100030.15. [P28482-2]"";",ATP binding [GO:0005524]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],androgen receptor signaling pathway [GO:0030521]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; cytosine metabolic process [GO:0019858]; DNA damage response [GO:0006974]; ERBB signaling pathway [GO:0038127]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; learning or memory [GO:0007611]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; myelination [GO:0042552]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; progesterone receptor signaling pathway [GO:0050847]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; steroid hormone mediated signaling pathway [GO:0043401]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440],azurophil granule lumen [GO:0035578]; caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202]
P53778,C5,1.762509329,0.620555452,-0.785229414,-0.772975364,-1.145366342,turquoise3,MAPK12,MK12_HUMAN,Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3),MAPK12 ERK6 SAPK3,6300;,"ENST00000215659.13; ENSP00000215659.8; ENSG00000188130.14. [P53778-1];""ENST00000622558.4; ENSP00000479972.1; ENSG00000188130.14. [P53778-2]"";",ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; negative regulation of cell cycle [GO:0045786]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of peptidase activity [GO:0010952]; regulation of cell cycle [GO:0051726]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q16539,C5,2.053276148,0.458332067,-0.927878712,-0.892241887,-1.30991842,turquoise3,MAPK14,MK14_HUMAN,Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a),MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A,1432;,"ENST00000229794.9; ENSP00000229794.4; ENSG00000112062.12. [Q16539-1];""ENST00000229795.8; ENSP00000229795.3; ENSG00000112062.12. [Q16539-2]"";""ENST00000310795.8; ENSP00000308669.4; ENSG00000112062.12. [Q16539-4]"";",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase p38 binding [GO:0048273]; NFAT protein binding [GO:0051525]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],3'-UTR-mediated mRNA stabilization [GO:0070935]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage condensation [GO:0001502]; cell morphogenesis [GO:0000902]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cell surface receptor signaling pathway [GO:0007166]; cellular response to ionizing radiation [GO:0071479]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; chemotaxis [GO:0006935]; chondrocyte differentiation [GO:0002062]; DNA damage checkpoint signaling [GO:0000077]; fatty acid oxidation [GO:0019395]; glucose import [GO:0046323]; glucose metabolic process [GO:0006006]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hippo signaling [GO:0035331]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; p38MAPK cascade [GO:0038066]; peptidyl-serine phosphorylation [GO:0018105]; placenta development [GO:0001890]; platelet activation [GO:0030168]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cyclase activity [GO:0031281]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of ossification [GO:0030278]; regulation of synaptic membrane adhesion [GO:0099179]; regulation of transcription by RNA polymerase II [GO:0006357]; response to dietary excess [GO:0002021]; response to insulin [GO:0032868]; response to muramyl dipeptide [GO:0032495]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098]; stress-induced premature senescence [GO:0090400]; striated muscle cell differentiation [GO:0051146]; transcription by RNA polymerase II [GO:0006366]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; spindle pole [GO:0000922]
P45983,C5,1.590333896,0.521584097,-0.491926546,-0.513453613,-0.827881139,turquoise3,MAPK8,MK08_HUMAN,Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1),MAPK8 JNK1 PRKM8 SAPK1 SAPK1C,5599;,"ENST00000360332.7; ENSP00000353483.4; ENSG00000107643.17. [P45983-5];""ENST00000374176.8; ENSP00000363291.4; ENSG00000107643.17. [P45983-4]"";""ENST00000374179.8; ENSP00000363294.3; ENSG00000107643.17. [P45983-3]"";""ENST00000374182.7; ENSP00000363297.3; ENSG00000107643.17. [P45983-2]"";""ENST00000374189.6; ENSP00000363304.1; ENSG00000107643.17. [P45983-1]"";""ENST00000395611.7; ENSP00000378974.4; ENSG00000107643.17. [P45983-4]"";",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; JUN kinase activity [GO:0004705]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283],cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; energy homeostasis [GO:0097009]; Fc-epsilon receptor signaling pathway [GO:0038095]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein binding [GO:0032091]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell killing [GO:0031343]; positive regulation of cyclase activity [GO:0031281]; positive regulation of gene expression [GO:0010628]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein metabolic process [GO:0051247]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of macroautophagy [GO:0016241]; regulation of protein localization [GO:0032880]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; stress-activated MAPK cascade [GO:0051403],axon [GO:0030424]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]
P45984,C5,2.00190763,0.333186914,-0.77009561,-0.755337888,-0.889229002,turquoise3,MAPK9,MK09_HUMAN,Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2),MAPK9 JNK2 PRKM9 SAPK1A,5601;,"ENST00000343111.10; ENSP00000345524.6; ENSG00000050748.18. [P45984-3];""ENST00000393360.7; ENSP00000377028.3; ENSG00000050748.18. [P45984-2]"";""ENST00000425491.6; ENSP00000397422.2; ENSG00000050748.18. [P45984-5]"";""ENST00000452135.7; ENSP00000394560.2; ENSG00000050748.18. [P45984-1]"";""ENST00000455781.5; ENSP00000389338.1; ENSG00000050748.18. [P45984-4]"";",ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],apoptotic signaling pathway [GO:0097190]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; inflammatory response to wounding [GO:0090594]; JNK cascade [GO:0007254]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein localization to tricellular tight junction [GO:0061833]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]
Q9BPZ7,C1,1.112527802,-0.162605672,-0.326284445,0.033487802,0.303509589,lightblue,MAPKAP1,SIN1_HUMAN,Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1) (mSIN1),MAPKAP1 MIP1 SIN1,79109;,"ENST00000265960.8; ENSP00000265960.3; ENSG00000119487.17. [Q9BPZ7-1];""ENST00000350766.7; ENSP00000265961.5; ENSG00000119487.17. [Q9BPZ7-2]"";""ENST00000373498.5; ENSP00000362597.1; ENSG00000119487.17. [Q9BPZ7-1]"";""ENST00000373503.7; ENSP00000362602.3; ENSG00000119487.17. [Q9BPZ7-4]"";""ENST00000373511.6; ENSP00000362610.2; ENSG00000119487.17. [Q9BPZ7-3]"";""ENST00000394060.7; ENSP00000377624.3; ENSG00000119487.17. [Q9BPZ7-5]"";""ENST00000394063.5; ENSP00000377627.1; ENSG00000119487.17. [Q9BPZ7-4]"";","molecular adaptor activity [GO:0060090]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]",cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of cell growth [GO:0030307]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cellular response to oxidative stress [GO:1900407]; substantia nigra development [GO:0021762]; TORC2 signaling [GO:0038203],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932]
Q15691,C5,1.876067163,0.333847105,-0.812206247,-0.684862722,-0.997668628,turquoise3,MAPRE1,MARE1_HUMAN,Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1),MAPRE1,22919;,ENST00000375571.6; ENSP00000364721.5; ENSG00000101367.9.;,cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; negative regulation of microtubule polymerization [GO:0031115]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116]; protein localization [GO:0008104]; protein localization to astral microtubule [GO:1902888]; protein localization to centrosome [GO:0071539]; protein localization to microtubule [GO:0035372]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],cell projection membrane [GO:0031253]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; mitotic spindle astral microtubule end [GO:1905721]; mitotic spindle pole [GO:0097431]; spindle midzone [GO:0051233]
Q969Z3,M2,-1.151810838,-1.071130343,0.291194105,1.174756678,-0.13112529,tan4,MARC2,MARC2_HUMAN,Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2),MTARC2 MARC2 MOSC2,54996;,"ENST00000359316.6; ENSP00000352266.2; ENSG00000117791.16. [Q969Z3-2];""ENST00000366913.8; ENSP00000355880.3; ENSG00000117791.16. [Q969Z3-1]"";","molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase activity [GO:0098809]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; pyridoxal phosphate binding [GO:0030170]",cellular detoxification of nitrogen compound [GO:0070458]; detoxification of nitrogen compound [GO:0051410]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]
Q9NX47,M2,-0.929810744,-1.206001302,0.333505412,1.056338997,-0.024742938,tan4,MARCH5,MARH5_HUMAN,E3 ubiquitin-protein ligase MARCHF5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (Mitochondrial ubiquitin ligase) (MITOL) (RING finger protein 153) (RING-type E3 ubiquitin transferase MARCHF5),MARCHF5 MARCH5 RNF153,54708;,ENST00000358935.3; ENSP00000351813.2; ENSG00000198060.10.;,GTPase binding [GO:0051020]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
O60337,S3,-0.99160655,-0.982145383,0.19072193,0.773545901,0.529368979,salmon,MARCH6,MARH6_HUMAN,E3 ubiquitin-protein ligase MARCHF6 (EC 2.3.2.27) (Doa10 homolog) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (Protein TEB-4) (RING finger protein 176) (RING-type E3 ubiquitin transferase MARCHF6),MARCHF6 KIAA0597 MARCH6 RNF176 TEB4,10299;,"ENST00000274140.10; ENSP00000274140.4; ENSG00000145495.17. [O60337-4];""ENST00000449913.6; ENSP00000414643.2; ENSG00000145495.17. [O60337-5]"";""ENST00000503788.5; ENSP00000425930.1; ENSG00000145495.17. [O60337-6]"";",enzyme binding [GO:0019899]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-specific protease binding [GO:1990381]; zinc ion binding [GO:0008270],ERAD pathway [GO:0036503]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER ubiquitin ligase complex [GO:0000835]; membrane [GO:0016020]
O15021,C3,1.62024016,0.300736185,-0.560751054,-0.493053382,-0.574990269,cyan,MAST4,MAST4_HUMAN,Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1),MAST4 KIAA0303,375449;,"ENST00000261569.11; ENSP00000261569.7; ENSG00000069020.19. [O15021-2];""ENST00000403625.7; ENSP00000385727.1; ENSG00000069020.19. [O15021-5]"";""ENST00000403666.5; ENSP00000384313.1; ENSG00000069020.19. [O15021-3]"";""ENST00000405643.5; ENSP00000384099.1; ENSG00000069020.19. [O15021-6]"";""ENST00000406374.5; ENSP00000385088.1; ENSG00000069020.19. [O15021-4]"";",ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556],cytoplasm [GO:0005737]
P31153,C5,1.39321772,0.896758041,-0.574606176,-0.810476283,-0.885655373,turquoise3,MAT2A,METK2_HUMAN,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),MAT2A AMS2 MATA2,4144;,"ENST00000306434.8; ENSP00000303147.3; ENSG00000168906.13. [P31153-1];""ENST00000409017.1; ENSP00000386353.1; ENSG00000168906.13. [P31153-2]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; small molecule binding [GO:0036094],cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269]
Q9NZL9,C5,1.184153888,0.926141717,-0.60189309,-0.812882918,-0.939845824,turquoise3,MAT2B,MAT2B_HUMAN,Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta) (Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase),MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995,27430;,"ENST00000280969.9; ENSP00000280969.5; ENSG00000038274.18. [Q9NZL9-2];""ENST00000321757.11; ENSP00000325425.6; ENSG00000038274.18. [Q9NZL9-1]"";""ENST00000518095.5; ENSP00000428046.1; ENSG00000038274.18. [Q9NZL9-3]"";""ENST00000694943.1; ENSP00000511609.1; ENSG00000038274.18. [Q9NZL9-3]"";",enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270],one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634]
P43243,N3,-1.055491055,-1.161901717,1.014345538,0.065602097,0.318790471,grey50,MATR3,MATR3_HUMAN,Matrin-3,MATR3 KIAA0723,9782;,"ENST00000394805.8; ENSP00000378284.3; ENSG00000015479.20. [P43243-1];""ENST00000503811.5; ENSP00000423587.1; ENSG00000015479.20. [P43243-2]"";""ENST00000618441.5; ENSP00000482895.1; ENSG00000015479.20. [P43243-1]"";",identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; zinc ion binding [GO:0008270],activation of innate immune response [GO:0002218]; blastocyst formation [GO:0001825]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; post-transcriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]
Q7Z434,M2,-0.845018081,-1.051772784,0.354317783,0.972138489,-0.252011481,tan4,MAVS,MAVS_HUMAN,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),MAVS IPS1 KIAA1271 VISA,57506;,"ENST00000416600.6; ENSP00000413749.2; ENSG00000088888.18. [Q7Z434-4];""ENST00000428216.4; ENSP00000401980.2; ENSG00000088888.18. [Q7Z434-1]"";",CARD domain binding [GO:0050700]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; protein kinase binding [GO:0019901]; RIG-I binding [GO:0039552]; signaling adaptor activity [GO:0035591],activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of IP-10 production [GO:0071660]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein localization to mitochondrion [GO:0070585]; regulation of peroxisome organization [GO:1900063]; signal transduction [GO:0007165]; type I interferon-mediated signaling pathway [GO:0060337],mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; ubiquitin ligase complex [GO:0000151]
P61244,N4,-0.957458279,0.786791971,0.515791853,-0.108135374,-0.512656818,grey30,MAX,MAX_HUMAN,Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X),MAX BHLHD4,4149;,"ENST00000246163.2; ENSP00000246163.2; ENSG00000125952.21. [P61244-5];""ENST00000284165.10; ENSP00000284165.6; ENSG00000125952.21. [P61244-4]"";""ENST00000341653.6; ENSP00000342482.2; ENSG00000125952.21. [P61244-6]"";""ENST00000358402.8; ENSP00000351175.4; ENSG00000125952.21. [P61244-2]"";""ENST00000358664.9; ENSP00000351490.4; ENSG00000125952.21. [P61244-1]"";""ENST00000394606.6; ENSP00000378104.2; ENSG00000125952.21. [P61244-3]"";""ENST00000553928.5; ENSP00000451907.1; ENSG00000125952.21. [P61244-3]"";""ENST00000556979.6; ENSP00000452378.1; ENSG00000125952.21. [P61244-3]"";","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; sequence-specific double-stranded DNA binding [GO:1990837]",negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; dendrite [GO:0030425]; Mad-Max complex [GO:0070443]; MLL1 complex [GO:0071339]; Myc-Max complex [GO:0071943]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]
Q9UIS9,N3,-1.533953924,-1.543006493,1.475329797,0.14873471,-0.674598626,grey50,MBD1,MBD1_HUMAN,Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1),MBD1 CXXC3 PCM1,4152;,"ENST00000269468.10; ENSP00000269468.5; ENSG00000141644.19. [Q9UIS9-1];""ENST00000269471.9; ENSP00000269471.5; ENSG00000141644.19. [Q9UIS9-2]"";""ENST00000339998.10; ENSP00000339546.5; ENSG00000141644.19. [Q9UIS9-6]"";""ENST00000347968.7; ENSP00000285102.5; ENSG00000141644.19. [Q9UIS9-7]"";""ENST00000353909.7; ENSP00000269469.5; ENSG00000141644.19. [Q9UIS9-5]"";""ENST00000382948.9; ENSP00000372407.5; ENSG00000141644.19. [Q9UIS9-1]"";""ENST00000398488.5; ENSP00000381502.1; ENSG00000141644.19. [Q9UIS9-4]"";""ENST00000398493.5; ENSP00000381506.1; ENSG00000141644.19. [Q9UIS9-7]"";""ENST00000457839.6; ENSP00000405268.2; ENSG00000141644.19. [Q9UIS9-9]"";""ENST00000585595.5; ENSP00000468430.1; ENSG00000141644.19. [Q9UIS9-9]"";""ENST00000585672.5; ENSP00000466092.1; ENSG00000141644.19. [Q9UIS9-10]"";""ENST00000587605.5; ENSP00000468042.1; ENSG00000141644.19. [Q9UIS9-11]"";""ENST00000588937.5; ENSP00000467763.1; ENSG00000141644.19. [Q9UIS9-2]"";""ENST00000590208.5; ENSP00000468785.1; ENSG00000141644.19. [Q9UIS9-12]"";""ENST00000591416.5; ENSP00000467017.1; ENSG00000141644.19. [Q9UIS9-1]"";""ENST00000591535.5; ENSP00000465923.1; ENSG00000141644.19. [Q9UIS9-8]"";",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; methyl-CpG binding [GO:0008327]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270],epigenetic regulation of gene expression [GO:0040029]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; neuron differentiation [GO:0030182]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; transcription by RNA polymerase II [GO:0006366]; ventricular cardiac muscle tissue development [GO:0003229],chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UBB5,N2,-1.628144705,-0.00364867,0.832146908,-0.086362499,0.459878632,grey70,MBD2,MBD2_HUMAN,Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2),MBD2,8932;,"ENST00000256429.8; ENSP00000256429.3; ENSG00000134046.12. [Q9UBB5-1];""ENST00000583046.1; ENSP00000464554.1; ENSG00000134046.12. [Q9UBB5-3]"";",C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197],cellular response to organic cyclic compound [GO:0071407]; chromatin remodeling [GO:0006338]; DNA methylation-dependent heterochromatin formation [GO:0006346]; embryonic organ development [GO:0048568]; maternal behavior [GO:0042711]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; ventricular cardiac muscle tissue development [GO:0003229]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]
Q68D91,S2,-1.173644285,-1.475185642,0.343976775,0.925273214,0.68071865,orange,MBLAC2,MBLC2_HUMAN,Acyl-coenzyme A thioesterase MBLAC2 (Acyl-CoA thioesterase MBLAC2) (EC 3.1.2.2) (Beta-lactamase MBLAC2) (EC 3.5.2.6) (Metallo-beta-lactamase domain-containing protein 2) (Palmitoyl-coenzyme A thioesterase MBLAC2),MBLAC2,153364;,"ENST00000316610.7; ENSP00000314776.6; ENSG00000176055.10. [Q68D91-1];""ENST00000514906.1; ENSP00000425600.1; ENSG00000176055.10. [Q68D91-2]"";",beta-lactamase activity [GO:0008800]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; metal ion binding [GO:0046872],fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
Q6ZWT7,S2,-1.013736626,-1.314763995,0.215544182,0.809652373,0.559140044,orange,MBOAT2,MBOA2_HUMAN,Lysophospholipid acyltransferase 2 (LPLAT 2) (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase MBOAT2) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase MBOAT2) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),MBOAT2 LPCAT4 OACT2,129642;,ENST00000305997.8; ENSP00000302177.3; ENSG00000143797.12.;,1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746],lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q96N66,S2,-1.225223784,-1.279024456,0.272823309,0.758827644,0.503756996,orange,MBOAT7,MBOA7_HUMAN,Lysophospholipid acyltransferase 7 (LPLAT 7) (EC 2.3.1.-) (1-acylglycerophosphatidylinositol O-acyltransferase) (Bladder and breast carcinoma-overexpressed gene 1 protein) (Leukocyte receptor cluster member 4) (Lysophosphatidylinositol acyltransferase) (LPIAT) (Lyso-PI acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7) (h-mboa-7),MBOAT7 BB1 LENG4 OACT7,79143;,"ENST00000245615.6; ENSP00000245615.1; ENSG00000125505.17. [Q96N66-1];""ENST00000338624.10; ENSP00000344377.5; ENSG00000125505.17. [Q96N66-2]"";""ENST00000391754.5; ENSP00000375634.1; ENSG00000125505.17. [Q96N66-3]"";""ENST00000431666.6; ENSP00000410503.2; ENSG00000125505.17. [Q96N66-2]"";""ENST00000610862.4; ENSP00000481119.1; ENSG00000276935.4. [Q96N66-3]"";""ENST00000611239.1; ENSP00000481947.1; ENSG00000277025.4. [Q96N66-2]"";""ENST00000611602.4; ENSP00000482369.1; ENSG00000278322.4. [Q96N66-2]"";""ENST00000612053.1; ENSP00000482884.1; ENSG00000278519.4. [Q96N66-2]"";""ENST00000612567.1; ENSP00000483526.1; ENSG00000277733.4. [Q96N66-2]"";""ENST00000613506.4; ENSP00000478965.1; ENSG00000274194.4. [Q96N66-1]"";""ENST00000613746.4; ENSP00000484933.1; ENSG00000275118.4. [Q96N66-1]"";""ENST00000614279.1; ENSP00000480894.1; ENSG00000276935.4. [Q96N66-2]"";""ENST00000615282.4; ENSP00000483987.1; ENSG00000275118.4. [Q96N66-2]"";""ENST00000615453.4; ENSP00000482625.1; ENSG00000278519.4. [Q96N66-1]"";""ENST00000617012.4; ENSP00000484199.1; ENSG00000276935.4. [Q96N66-1]"";""ENST00000617656.4; ENSP00000481864.1; ENSG00000274194.4. [Q96N66-2]"";""ENST00000617772.1; ENSP00000480575.1; ENSG00000274194.4. [Q96N66-2]"";""ENST00000618378.4; ENSP00000482252.1; ENSG00000277025.4. [Q96N66-1]"";""ENST00000618826.4; ENSP00000483839.1; ENSG00000277923.4. [Q96N66-2]"";""ENST00000618899.4; ENSP00000480531.1; ENSG00000273592.4. [Q96N66-3]"";""ENST00000619670.4; ENSP00000479750.1; ENSG00000275118.4. [Q96N66-3]"";""ENST00000619745.4; ENSP00000481544.1; ENSG00000277025.4. [Q96N66-2]"";""ENST00000619842.4; ENSP00000481455.1; ENSG00000277923.4. [Q96N66-1]"";""ENST00000619855.4; ENSP00000484954.1; ENSG00000273592.4. [Q96N66-1]"";""ENST00000620311.1; ENSP00000478522.1; ENSG00000277923.4. [Q96N66-2]"";""ENST00000620371.1; ENSP00000479760.1; ENSG00000273592.4. [Q96N66-2]"";""ENST00000620636.1; ENSP00000482742.1; ENSG00000278322.4. [Q96N66-2]"";""ENST00000621146.4; ENSP00000481758.1; ENSG00000277733.4. [Q96N66-2]"";""ENST00000621455.4; ENSP00000477891.1; ENSG00000278519.4. [Q96N66-2]"";""ENST00000621612.4; ENSP00000478088.1; ENSG00000278322.4. [Q96N66-1]"";""ENST00000621875.4; ENSP00000478041.1; ENSG00000277733.4. [Q96N66-1]"";",1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374],layer formation in cerebral cortex [GO:0021819]; lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207]; ventricular system development [GO:0021591],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]
Q14703,S1,-0.893273848,-1.12689192,0.033904927,0.899202306,0.72379153,gold,MBTPS1,MBTP1_HUMAN,Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1),MBTPS1 KIAA0091 S1P SKI1,8720;,ENST00000343411.8; ENSP00000344223.3; ENSG00000140943.18.;,serine-type endopeptidase activity [GO:0004252],ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]
Q07820,M2,-0.447695843,-1.015698262,0.205371959,1.05658958,-0.046838813,tan4,MCL1,MCL1_HUMAN,Induced myeloid leukemia cell differentiation protein Mcl-1 (Bcl-2-like protein 3) (Bcl2-L-3) (Bcl-2-related protein EAT/mcl1) (mcl1/EAT),MCL1 BCL2L3,4170;,"ENST00000307940.3; ENSP00000309973.3; ENSG00000143384.14. [Q07820-2];""ENST00000369026.3; ENSP00000358022.2; ENSG00000143384.14. [Q07820-1]"";""ENST00000678770.1; ENSP00000502859.1; ENSG00000143384.14. [Q07820-1]"";",BH domain binding [GO:0051400]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; protein heterodimerization activity [GO:0046982]; protein transmembrane transporter activity [GO:0008320],cell fate determination [GO:0001709]; cellular homeostasis [GO:0019725]; DNA damage response [GO:0006974]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitochondrial fusion [GO:0008053]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of apoptotic process [GO:0043065]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; regulation of apoptotic process [GO:0042981]; release of cytochrome c from mitochondria [GO:0001836]; response to cytokine [GO:0034097],Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P33993,N4,-0.724108021,1.256133028,-0.302888908,-0.663379517,-0.290346565,grey30,MCM2,MCM7_HUMAN,DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3),MCM7 CDC47 MCM2,4176;,"ENST00000303887.10; ENSP00000307288.5; ENSG00000166508.19. [P33993-1];""ENST00000343023.10; ENSP00000344006.6; ENSG00000166508.19. [P33993-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; single-stranded DNA binding [GO:0003697],cell population proliferation [GO:0008283]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of phosphorylation [GO:0042325],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
P25205,N4,-0.742688755,1.182522503,-0.246429846,-0.562353581,-0.290101165,grey30,MCM3,MCM3_HUMAN,DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102),MCM3,4172;,"ENST00000596288.7; ENSP00000472940.2; ENSG00000112118.20. [P25205-1];""ENST00000616552.4; ENSP00000480987.1; ENSG00000112118.20. [P25205-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; single-stranded DNA binding [GO:0003697],DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; regulation of DNA-templated DNA replication initiation [GO:0030174],"alpha DNA polymerase:primase complex [GO:0005658]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]"
O60318,N2,-0.990891522,-0.759652153,1.221169972,0.191259554,-0.767397116,grey70,MCM3AP,GANP_HUMAN,Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (80 kDa MCM3-associated protein) (MCM3 acetylating protein) (MCM3AP) (EC 2.3.1.-) (MCM3 acetyltransferase),MCM3AP GANP KIAA0572 MAP80,8888;,"ENST00000291688.6; ENSP00000291688.1; ENSG00000160294.11. [O60318-1];""ENST00000397708.1; ENSP00000380820.1; ENSG00000160294.11. [O60318-1]"";",chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H3 acetyltransferase activity [GO:0010484]; nucleic acid binding [GO:0003676],mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]
Q8NE86,M2,-1.048110049,-1.446732028,0.325913472,1.116088904,-0.182388071,tan4,MCU,MCU_HUMAN,"Calcium uniporter protein, mitochondrial (HsMCU) (Coiled-coil domain-containing protein 109A)",MCU C10orf42 CCDC109A,90550;,"ENST00000357157.10; ENSP00000349680.6; ENSG00000156026.15. [Q8NE86-2];""ENST00000373053.8; ENSP00000362144.3; ENSG00000156026.15. [Q8NE86-1]"";""ENST00000536019.5; ENSP00000440913.1; ENSG00000156026.15. [Q8NE86-3]"";",calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292],calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein complex oligomerization [GO:0051259],calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]
Q96AQ8,M2,-1.2165812,-1.553434107,0.400561744,1.291487978,-0.10696303,tan4,MCUR1,MCUR1_HUMAN,"Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial)",MCUR1 C6orf79 CCDC90A,63933;,"ENST00000379170.9; ENSP00000368468.3; ENSG00000050393.12. [Q96AQ8-1];""ENST00000488770.1; ENSP00000476162.1; ENSG00000050393.12. [Q96AQ8-2]"";",0,calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
P40925,C4,2.134201963,0.290249503,-1.137452263,-0.876674003,-1.252362688,deepskyblue2,MDH1,MDHC_HUMAN,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Aromatic alpha-keto acid reductase) (KAR) (EC 1.1.1.96) (Cytosolic malate dehydrogenase)",MDH1 MDHA,4190;,"ENST00000233114.13; ENSP00000233114.8; ENSG00000014641.21. [P40925-1];""ENST00000432309.6; ENSP00000410073.2; ENSG00000014641.21. [P40925-3]"";""ENST00000544381.4; ENSP00000446395.2; ENSG00000014641.21. [P40925-1]"";",diiodophenylpyruvate reductase activity [GO:0047860]; hydroxyphenylpyruvate reductase activity [GO:0047995]; L-malate dehydrogenase activity [GO:0030060]; malic enzyme activity [GO:0004470],gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]
P21741,S1,-0.977329647,-0.886813942,-0.049611704,0.359893469,1.07217319,gold,MDK,MK_HUMAN,Midkine (MK) (Amphiregulin-associated protein) (ARAP) (Midgestation and kidney protein) (Neurite outgrowth-promoting factor 2) (Neurite outgrowth-promoting protein),MDK MK1 NEGF2,4192;,"ENST00000359803.7; ENSP00000352852.2; ENSG00000110492.17. [P21741-1];""ENST00000395565.5; ENSP00000378932.1; ENSG00000110492.17. [P21741-1]"";""ENST00000395566.9; ENSP00000378933.4; ENSG00000110492.17. [P21741-1]"";""ENST00000395569.8; ENSP00000378936.4; ENSG00000110492.17. [P21741-2]"";""ENST00000405308.6; ENSP00000385451.2; ENSG00000110492.17. [P21741-1]"";""ENST00000407067.1; ENSP00000384034.1; ENSG00000110492.17. [P21741-1]"";",chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201],adrenal gland development [GO:0030325]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cerebellar granular layer development [GO:0021681]; cerebral cortex development [GO:0021987]; cytoskeleton organization [GO:0007010]; defecation [GO:0030421]; dentate gyrus development [GO:0021542]; estrous cycle [GO:0044849]; glial cell projection elongation [GO:0106091]; intracellular signal transduction [GO:0035556]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion [GO:0007162]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of regulatory T cell differentiation [GO:0045590]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of inflammatory response [GO:0050729]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of behavior [GO:0050795]; regulation of bone remodeling [GO:0046850]; regulation of chondrocyte differentiation [GO:0032330]; response to auditory stimulus [GO:0010996]; response to wounding [GO:0009611]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; T cell activation involved in immune response [GO:0002286]; tissue regeneration [GO:0042246],extracellular region [GO:0005576]
Q9NU22,N2,-0.814689793,0.118559103,0.730331004,-0.261772334,0.148346783,grey70,MDN1,MDN1_HUMAN,Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein),MDN1 KIAA0301,23195;,ENST00000369393.8; ENSP00000358400.3; ENSG00000112159.13.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit export from nucleus [GO:0000055],"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]"
P51608,N3,-1.260381729,-1.211494175,1.235375286,0.243222075,-0.351639937,grey50,MECP2,MECP2_HUMAN,Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2),MECP2,4204;,"ENST00000303391.11; ENSP00000301948.6; ENSG00000169057.25. [P51608-1];""ENST00000453960.7; ENSP00000395535.2; ENSG00000169057.25. [P51608-2]"";",chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; histone reader activity [GO:0140566]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714]; unmethylated CpG binding [GO:0045322],adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; biogenic amine metabolic process [GO:0006576]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; glial cell proliferation [GO:0014009]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin formation [GO:0031507]; hippocampus development [GO:0021766]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; lung alveolus development [GO:0048286]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of respiratory gaseous exchange [GO:1903941]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; Notch signaling pathway [GO:0007219]; olfactory bulb development [GO:0021772]; oligodendrocyte development [GO:0014003]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of action potential firing threshold [GO:0099611]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; startle response [GO:0001964]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; thalamus development [GO:0021794]; trans-synaptic signaling by BDNF [GO:0099191]; ventricular cardiac muscle tissue development [GO:0003229]; ventricular system development [GO:0021591]; visual learning [GO:0008542],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]
Q9H1U4,S1,-1.618798598,-1.806037921,0.033402952,0.742342255,1.24922283,gold,MEGF9,MEGF9_HUMAN,Multiple epidermal growth factor-like domains protein 9 (Multiple EGF-like domains protein 9) (Epidermal growth factor-like protein 5) (EGF-like protein 5),MEGF9 EGFL5 KIAA0818 UNQ671/PRO1305,1955;,ENST00000373930.4; ENSP00000363040.3; ENSG00000106780.9.;,small GTPase binding [GO:0031267],regulation of actin filament polymerization [GO:0030833],basement membrane [GO:0005604]; cytoplasm [GO:0005737]; membrane [GO:0016020]
Q9Y316,C5,1.948054383,0.460717348,-0.846205034,-0.828908968,-1.081648847,turquoise3,MEMO1,MEMO1_HUMAN,Protein MEMO1 (C21orf19-like protein) (Hepatitis C virus NS5A-transactivated protein 7) (HCV NS5A-transactivated protein 7) (Mediator of ErbB2-driven cell motility 1) (Mediator of cell motility 1) (Memo-1),MEMO1 C2orf4 MEMO NS5ATP7 CGI-27,51072;,"ENST00000295065.9; ENSP00000295065.4; ENSG00000162959.14. [Q9Y316-1];""ENST00000379383.7; ENSP00000368691.3; ENSG00000162959.14. [Q9Y316-3]"";""ENST00000404530.6; ENSP00000385557.1; ENSG00000162959.14. [Q9Y316-1]"";""ENST00000426310.6; ENSP00000400795.2; ENSG00000162959.14. [Q9Y316-2]"";",0,regulation of microtubule-based process [GO:0032886],cytosol [GO:0005829]; nucleus [GO:0005634]
O00255,N3,-1.148610888,-0.850821434,1.12959986,-0.172259323,0.193081173,grey50,MEN1,MEN1_HUMAN,Menin,MEN1 SCG2,4221;,"ENST00000312049.11; ENSP00000308975.6; ENSG00000133895.19. [O00255-2];""ENST00000315422.9; ENSP00000323747.4; ENSG00000133895.19. [O00255-2]"";""ENST00000377313.7; ENSP00000366530.1; ENSG00000133895.19. [O00255-1]"";""ENST00000377326.7; ENSP00000366543.3; ENSG00000133895.19. [O00255-2]"";""ENST00000413626.2; ENSP00000411218.2; ENSG00000133895.19. [O00255-2]"";""ENST00000424912.2; ENSP00000388016.2; ENSG00000133895.19. [O00255-2]"";""ENST00000429702.6; ENSP00000402752.2; ENSG00000133895.19. [O00255-2]"";""ENST00000440873.6; ENSP00000413944.2; ENSG00000133895.19. [O00255-2]"";""ENST00000450708.7; ENSP00000394933.3; ENSG00000133895.19. [O00255-2]"";""ENST00000710881.1; ENSP00000518530.1; ENSG00000133895.19. [O00255-1]"";",chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; phosphoprotein binding [GO:0051219]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; Y-form DNA binding [GO:0000403],DNA damage response [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of JNK cascade [GO:0046329]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast development [GO:0002076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gamma radiation [GO:0010332]; response to UV [GO:0009411]; T-helper 2 cell differentiation [GO:0045064]; transcription initiation-coupled chromatin remodeling [GO:0045815],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]"
Q7L2J0,N4,-0.505791779,0.940975453,-0.148438372,-0.562683922,0.453696438,grey30,MEPCE,MEPCE_HUMAN,7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog),MEPCE BCDIN3,56257;,"ENST00000310512.4; ENSP00000308546.2; ENSG00000146834.15. [Q7L2J0-1];""ENST00000414441.5; ENSP00000400875.1; ENSG00000146834.15. [Q7L2J0-2]"";""ENST00000479201.2; ENSP00000511704.1; ENSG00000146834.15. [Q7L2J0-2]"";""ENST00000497759.2; ENSP00000511703.1; ENSG00000146834.15. [Q7L2J0-2]"";""ENST00000695111.1; ENSP00000511702.1; ENSG00000146834.15. [Q7L2J0-2]"";",7SK snRNA binding [GO:0097322]; O-methyltransferase activity [GO:0008171]; RNA 5'-gamma-phosphate methyltransferase activity [GO:1990276]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069],negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031],7SK snRNP [GO:0120259]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
Q14696,N4,-1.104659705,0.65553912,-0.141139559,0.50232663,-0.038525036,grey30,MESDC2,MESD_HUMAN,LRP chaperone MESD (LDLR chaperone MESD) (Mesoderm development LRP chaperone MESD) (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61),MESD KIAA0081 MESDC2 MESDM UNQ1911/PRO4369,23184;,"ENST00000261758.6; ENSP00000261758.4; ENSG00000117899.11. [Q14696-1];""ENST00000422879.3; ENSP00000403839.3; ENSG00000117899.11. [Q14696-2]"";""ENST00000561312.5; ENSP00000453430.1; ENSG00000117899.11. [Q14696-1]"";""ENST00000619987.4; ENSP00000482455.1; ENSG00000117899.11. [Q14696-1]"";",identical protein binding [GO:0042802]; low-density lipoprotein particle receptor binding [GO:0050750],mesoderm development [GO:0007498]; ossification [GO:0001503]; phagocytosis [GO:0006909]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; protein localization to cell surface [GO:0034394]; Wnt signaling pathway [GO:0016055],endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]
P08581,S4,-1.016489446,-0.877398056,0.341936967,0.868936464,0.336237998,tomato2,MET,MET_HUMAN,Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met),MET,4233;,"ENST00000318493.11; ENSP00000317272.6; ENSG00000105976.16. [P08581-2];""ENST00000397752.8; ENSP00000380860.3; ENSG00000105976.16. [P08581-1]"";""ENST00000436117.3; ENSP00000410980.2; ENSG00000105976.16. [P08581-3]"";",ATP binding [GO:0005524]; hepatocyte growth factor receptor activity [GO:0005008]; identical protein binding [GO:0042802]; molecular function activator activity [GO:0140677]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; semaphorin receptor activity [GO:0017154],branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; endothelial cell morphogenesis [GO:0001886]; establishment of skin barrier [GO:0061436]; excitatory postsynaptic potential [GO:0060079]; liver development [GO:0001889]; negative regulation of autophagy [GO:0010507]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; phagocytosis [GO:0006909]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription by RNA polymerase II [GO:0045944]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165],basal plasma membrane [GO:0009925]; cell surface [GO:0009986]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]
P50579,C1,1.501261859,0.328215243,-0.776083315,-0.528684704,-0.430596474,lightblue,METAP2,MAP2_HUMAN,Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M),METAP2 MNPEP P67EIF2,10988;,"ENST00000261220.13; ENSP00000261220.9; ENSG00000111142.14. [P50579-2];""ENST00000323666.10; ENSP00000325312.5; ENSG00000111142.14. [P50579-1]"";""ENST00000546753.5; ENSP00000448169.1; ENSG00000111142.14. [P50579-3]"";",aminopeptidase activity [GO:0004177]; initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; RNA binding [GO:0003723],N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein processing [GO:0016485],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q5JPI9,C1,1.557809012,0.133289283,-0.567035946,-0.520485185,-0.198702789,lightblue,METTL10,EFMT2_HUMAN,EEF1A lysine methyltransferase 2 (EC 2.1.1.-) (Methyltransferase-like protein 10) (Protein-lysine N-methyltransferase METTL10),EEF1AKMT2 C10orf138 METTL10,399818;,ENST00000368836.7; ENSP00000357829.2; ENSG00000203791.15.;,histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279],peptidyl-lysine methylation [GO:0018022],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6P1Q9,C4,2.430743275,-0.137592924,-1.603802629,-1.461194009,-2.031067153,deepskyblue2,METTL2B,MET2B_HUMAN,tRNA N(3)-methylcytidine methyltransferase METTL2B (EC 2.1.1.-) (Methyltransferase-like protein 2B),METTL2B,55798;,"ENST00000262432.13; ENSP00000262432.9; ENSG00000165055.16. [Q6P1Q9-1];""ENST00000480046.5; ENSP00000418402.1; ENSG00000165055.16. [Q6P1Q9-2]"";",tRNA (cytidine) methyltransferase activity [GO:0016427]; tRNA (cytidine-3-)-methyltransferase activity [GO:0052735],tRNA metabolic process [GO:0006399]; tRNA methylation [GO:0030488],cytoplasm [GO:0005737]
Q9NRN9,C5,1.977110762,0.578127219,-1.229543427,-1.221128159,-1.530753824,turquoise3,METTL5,METL5_HUMAN,rRNA N6-adenosine-methyltransferase METTL5 (EC 2.1.1.-) (Methyltransferase-like protein 5),METTL5 DC3 HSPC133,29081;,"ENST00000260953.10; ENSP00000260953.5; ENSG00000138382.15.;""ENST00000392640.6; ENSP00000376415.2; ENSG00000138382.15."";""ENST00000409965.5; ENSP00000386582.1; ENSG00000138382.15."";",nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047],positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364]; stem cell differentiation [GO:0048863],cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]
Q9H8H3,S2,-1.257313869,-1.212577221,0.250109056,0.825863293,0.691181459,orange,METTL7A,TMT1A_HUMAN,Thiol S-methyltransferase TMT1A (EC 2.1.1.9) (Methyltransferase-like protein 7A) (N6-adenosine-methyltransferase TMT1A) (EC 2.1.1.348) (Protein AAM-B) (Thiol methyltransferase 1A),TMT1A METTL7A PRO0066 UNQ1902/PRO4348,25840;,"ENST00000332160.5; ENSP00000331787.4; ENSG00000185432.12.;""ENST00000547104.1; ENSP00000447542.1; ENSG00000185432.12."";""ENST00000548553.1; ENSP00000448785.1; ENSG00000185432.12."";",methyltransferase activity [GO:0008168]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA methyltransferase activity [GO:0008173]; thiol S-methyltransferase activity [GO:0018708],lncRNA processing [GO:0180035]; methylation [GO:0032259]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724]
Q9H1A3,S2,-1.33714129,-1.610937325,0.215480082,1.073307944,0.406891954,orange,METTL9,METL9_HUMAN,Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (DORA reverse strand protein) (DREV) (DREV1) (Methyltransferase-like protein 9) (hMETTL9),METTL9 DREV CGI-81,51108;,"ENST00000358154.8; ENSP00000350874.3; ENSG00000197006.15. [Q9H1A3-1];""ENST00000396014.8; ENSP00000379335.4; ENSG00000197006.15. [Q9H1A3-2]"";",protein-L-histidine N-pros-methyltransferase activity [GO:0106370],methylation [GO:0032259],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]
Q9GZY8,M2,-0.924362675,-1.099058714,0.297734031,1.072235542,-0.025867837,tan4,MFF,MFF_HUMAN,Mitochondrial fission factor,MFF C2orf33 AD030 AD033 GL004,56947;,"ENST00000304593.14; ENSP00000304898.10; ENSG00000168958.21. [Q9GZY8-2];""ENST00000337110.11; ENSP00000338412.7; ENSG00000168958.21. [Q9GZY8-3]"";""ENST00000349901.11; ENSP00000304134.9; ENSG00000168958.21. [Q9GZY8-5]"";""ENST00000353339.8; ENSP00000302037.4; ENSG00000168958.21. [Q9GZY8-1]"";""ENST00000354503.10; ENSP00000346498.6; ENSG00000168958.21. [Q9GZY8-4]"";""ENST00000409565.5; ENSP00000386964.1; ENSG00000168958.21. [Q9GZY8-4]"";",identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein targeting to mitochondrion [GO:0006626]; regulation of mitochondrion organization [GO:0010821]; regulation of peroxisome organization [GO:1900063]; release of cytochrome c from mitochondria [GO:0001836],mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle [GO:0008021]
P08582,S3,-0.864301686,-0.870924177,0.235012188,0.805293665,0.631230267,salmon,MFI2,TRFM_HUMAN,Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228),MELTF MAP97 MFI2,4241;,"ENST00000296350.10; ENSP00000296350.5; ENSG00000163975.14. [P08582-1];""ENST00000296351.8; ENSP00000296351.4; ENSG00000163975.14. [P08582-2]"";",iron ion binding [GO:0005506],iron ion transport [GO:0006826]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of plasminogen activation [GO:0010756],cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; side of membrane [GO:0098552]
Q8IWA4,M2,-1.142498705,-1.448118813,0.402063975,1.127124828,-0.11555418,tan4,MFN1,MFN1_HUMAN,Mitofusin-1 (EC 3.6.5.-) (Fzo homolog) (Transmembrane GTPase MFN1),MFN1,55669;,"ENST00000263969.9; ENSP00000263969.5; ENSG00000171109.19. [Q8IWA4-1];""ENST00000357390.8; ENSP00000349963.4; ENSG00000171109.19. [Q8IWA4-2]"";""ENST00000471841.6; ENSP00000420617.1; ENSG00000171109.19. [Q8IWA4-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],GTP metabolic process [GO:0046039]; mitochondrial fusion [GO:0008053]; mitochondrion localization [GO:0051646]; positive regulation of mitochondrial membrane potential [GO:0010918],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; outer mitochondrial membrane protein complex [GO:0098799]
O95140,M2,-1.385982959,-1.421600874,0.383787105,1.154428728,-0.069907242,tan4,MFN2,MFN2_HUMAN,Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2),MFN2 CPRP1 KIAA0214,9927;,"ENST00000235329.10; ENSP00000235329.5; ENSG00000116688.18. [O95140-1];""ENST00000444836.5; ENSP00000416338.1; ENSG00000116688.18. [O95140-1]"";""ENST00000674548.1; ENSP00000502185.1; ENSG00000116688.18. [O95140-1]"";""ENST00000674817.1; ENSP00000502151.1; ENSG00000116688.18. [O95140-1]"";""ENST00000674910.1; ENSP00000501716.1; ENSG00000116688.18. [O95140-1]"";""ENST00000675053.1; ENSP00000501646.1; ENSG00000116688.18. [O95140-1]"";""ENST00000675113.1; ENSP00000502623.1; ENSG00000116688.18. [O95140-1]"";""ENST00000675231.1; ENSP00000502404.1; ENSG00000116688.18. [O95140-1]"";""ENST00000675919.1; ENSP00000501776.1; ENSG00000116688.18. [O95140-1]"";""ENST00000676293.1; ENSP00000502362.1; ENSG00000116688.18. [O95140-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625],aerobic respiration [GO:0009060]; apoptotic process [GO:0006915]; blastocyst formation [GO:0001825]; camera-type eye morphogenesis [GO:0048593]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein localization to phagophore assembly site [GO:0034497]; protein targeting to mitochondrion [GO:0006626]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q9H3U5,S1,-1.124180308,-1.257061055,-0.251690023,0.780898948,1.129262245,gold,MFSD1,MFSD1_HUMAN,Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1) (Smooth muscle cell-associated protein 4) (SMAP-4),MFSD1 SMAP4 UG0581B09,64747;,"ENST00000264266.12; ENSP00000264266.5; ENSG00000118855.21. [Q9H3U5-1];""ENST00000392813.8; ENSP00000376560.4; ENSG00000118855.21. [Q9H3U5-5]"";""ENST00000415822.8; ENSP00000403117.3; ENSG00000118855.21. [Q9H3U5-1]"";""ENST00000480292.5; ENSP00000419467.2; ENSG00000118855.21. [Q9H3U5-2]"";""ENST00000484166.5; ENSP00000417950.2; ENSG00000118855.21. [Q9H3U5-2]"";""ENST00000622669.4; ENSP00000484175.1; ENSG00000118855.21. [Q9H3U5-6]"";",dipeptide uniporter activity [GO:0160178]; protein homodimerization activity [GO:0042803],dipeptide transmembrane transport [GO:0035442]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]
Q6ZSS7,S1,-1.344128476,-1.843293718,-0.116579308,0.538597861,1.108236808,gold,MFSD6,MFSD6_HUMAN,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog),MFSD6 MMR2,54842;,"ENST00000281416.11; ENSP00000281416.7; ENSG00000151690.15.;""ENST00000392328.6; ENSP00000376141.1; ENSG00000151690.15."";",0,antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590],membrane [GO:0016020]; plasma membrane [GO:0005886]
Q8NHS3,S1,-0.895644223,-1.199075422,-0.32075671,0.719280309,1.311045198,gold,MFSD8,MFSD8_HUMAN,Major facilitator superfamily domain-containing protein 8 (Ceroid-lipofuscinosis neuronal protein 7),MFSD8 CLN7,256471;,"ENST00000296468.8; ENSP00000296468.3; ENSG00000164073.11. [Q8NHS3-1];""ENST00000641434.1; ENSP00000493279.1; ENSG00000164073.11. [Q8NHS3-1]"";""ENST00000641464.1; ENSP00000493438.1; ENSG00000164073.11. [Q8NHS3-2]"";""ENST00000641686.2; ENSP00000493218.2; ENSG00000164073.11. [Q8NHS3-1]"";""ENST00000641748.1; ENSP00000493330.1; ENSG00000164073.11. [Q8NHS3-1]"";""ENST00000641928.1; ENSP00000493418.1; ENSG00000164073.11. [Q8NHS3-2]"";",chloride channel activity [GO:0005254]; fluoride channel activity [GO:0062054]; iodide transmembrane transporter activity [GO:0015111],autophagosome maturation [GO:0097352]; lysosome organization [GO:0007040]; neuron development [GO:0048666]; regulation of autophagy [GO:0010506]; regulation of lysosomal protein catabolic process [GO:1905165]; TORC1 signaling [GO:0038202],chloride channel complex [GO:0034707]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]
P26572,S1,-0.657258796,-1.09062523,-0.165354003,0.925269459,0.801034729,gold,MGAT1,MGAT1_HUMAN,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)",MGAT1 GGNT1 GLCT1 GLYT1 MGAT,4245;,"ENST00000307826.5; ENSP00000311888.4; ENSG00000131446.17.;""ENST00000333055.8; ENSP00000332073.3; ENSG00000131446.17."";""ENST00000393340.7; ENSP00000377010.3; ENSG00000131446.17."";""ENST00000427865.2; ENSP00000402838.2; ENSG00000131446.17."";""ENST00000446023.6; ENSP00000404718.2; ENSG00000131446.17."";","acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]",in utero embryonic development [GO:0001701]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049]; viral protein processing [GO:0019082],endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]
Q10469,S1,-0.836375415,-1.289878075,-0.225359706,0.873338208,0.826889498,gold,MGAT2,MGAT2_HUMAN,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",MGAT2,4247;,ENST00000305386.4; ENSP00000307423.2; ENSG00000168282.6.;,"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]",oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]
Q9UQ53,S1,-1.577399386,-1.618284574,-0.19986143,0.968260748,0.93860278,gold,MGAT4B,MGT4B_HUMAN,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)",MGAT4B UNQ906/PRO1927,11282;,"ENST00000292591.12; ENSP00000292591.7; ENSG00000161013.17. [Q9UQ53-1];""ENST00000337755.9; ENSP00000338487.5; ENSG00000161013.17. [Q9UQ53-3]"";""ENST00000638266.2; ENSP00000492708.1; ENSG00000284501.2. [Q9UQ53-1]"";""ENST00000639538.1; ENSP00000491766.1; ENSG00000284501.2. [Q9UQ53-3]"";","acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]
Q09328,S1,-0.91282736,-1.185382533,-0.205819469,0.820122758,0.994050414,gold,MGAT5,MGT5A_HUMAN,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",MGAT5 GGNT5,4249;,"ENST00000281923.4; ENSP00000281923.2; ENSG00000152127.9.;""ENST00000409645.5; ENSP00000386377.1; ENSG00000152127.9."";","alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]",negative regulation of protein tyrosine phosphatase activity [GO:1903614]; positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
O60502,C5,1.799818185,0.363131973,-0.842502054,-0.848334334,-1.051608415,turquoise3,MGEA5,OGA_HUMAN,Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT),OGA HEXC KIAA0679 MEA5 MGEA5,10724;,"ENST00000357797.9; ENSP00000350445.4; ENSG00000198408.14. [O60502-2];""ENST00000361464.8; ENSP00000354850.3; ENSG00000198408.14. [O60502-1]"";""ENST00000370094.7; ENSP00000359112.3; ENSG00000198408.14. [O60502-3]"";""ENST00000439817.5; ENSP00000409973.1; ENSG00000198408.14. [O60502-4]"";",[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; identical protein binding [GO:0042802],glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493],cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]
Q9BQP7,M1,-1.461797137,-0.079784912,0.3882284,0.994418999,-0.62638036,burlywood4,MGME1,MGME1_HUMAN,Mitochondrial genome maintenance exonuclease 1 (EC 3.1.-.-),MGME1 C20orf72 DDK1,92667;,ENST00000377710.10; ENSP00000366939.5; ENSG00000125871.14.;,single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145]; single-stranded DNA exodeoxyribonuclease activity [GO:0008297],mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002],mitochondrion [GO:0005739]
O60291,S3,-0.786298681,-0.958427705,0.192130728,0.8076633,0.630008516,salmon,MGRN1,MGRN1_HUMAN,E3 ubiquitin-protein ligase MGRN1 (EC 2.3.2.27) (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1),MGRN1 KIAA0544 RNF156,23295;,"ENST00000262370.12; ENSP00000262370.6; ENSG00000102858.13. [O60291-2];""ENST00000399577.9; ENSP00000382487.4; ENSG00000102858.13. [O60291-1]"";""ENST00000415496.5; ENSP00000393311.2; ENSG00000102858.13. [O60291-4]"";""ENST00000586183.5; ENSP00000465860.1; ENSG00000102858.13. [O60291-4]"";""ENST00000588994.5; ENSP00000468819.1; ENSG00000102858.13. [O60291-3]"";",metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],endosome to lysosome transport [GO:0008333]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of smoothened signaling pathway [GO:0045879]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O14880,M2,-0.736756024,-0.959460487,0.282428269,0.972587868,-0.058432364,tan4,MGST3,MGST3_HUMAN,"Glutathione S-transferase 3, mitochondrial (GST-3) (EC 2.5.1.-) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (LTC4 synthase MGST3) (EC 4.4.1.20)",MGST3,4259;,"ENST00000367884.6; ENSP00000356859.1; ENSG00000143198.13.;""ENST00000367889.8; ENSP00000356864.3; ENSG00000143198.13."";",glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464],arachidonic acid metabolic process [GO:0019369]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; prostanoid metabolic process [GO:0006692],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]
Q5JRA6,S2,-1.30787908,-1.453541415,0.052343184,0.99853515,0.539354711,orange,MIA3,TGO1_HUMAN,Transport and Golgi organization protein 1 homolog (TANGO1) (C219-reactive peptide) (D320) (Melanoma inhibitory activity protein 3),MIA3 KIAA0268 TANGO UNQ6077/PRO20088,375056;,"ENST00000340535.11; ENSP00000345866.7; ENSG00000154305.18. [Q5JRA6-4];""ENST00000344922.10; ENSP00000340900.5; ENSG00000154305.18. [Q5JRA6-1]"";",cargo receptor activity [GO:0038024],cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell migration [GO:0030336]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of lymphocyte migration [GO:2000402]; positive regulation of leukocyte migration [GO:0002687]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031]; vesicle cargo loading [GO:0035459]; wound healing [GO:0042060],endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
O94851,S2,-1.246590287,-1.143052291,0.131789237,0.676457733,0.797628337,orange,MICAL2,MICA2_HUMAN,[F-actin]-monooxygenase MICAL2 (EC 1.14.13.225) (MICAL C-terminal-like protein) (Mical-cL) (Molecule interacting with CasL protein 2) (MICAL-2),MICAL2 KIAA0750 MICAL2PV1 MICAL2PV2 MICALCL,9645;,"ENST00000256194.8; ENSP00000256194.4; ENSG00000133816.19. [O94851-1];""ENST00000527546.5; ENSP00000433965.1; ENSG00000133816.19. [O94851-5]"";""ENST00000528931.5; ENSP00000499778.1; ENSG00000133816.19. [O94851-6]"";""ENST00000646065.1; ENSP00000494982.1; ENSG00000133816.19. [O94851-7]"";""ENST00000675839.1; ENSP00000502351.1; ENSG00000133816.19. [O94851-3]"";""ENST00000683283.1; ENSP00000507067.1; ENSG00000133816.19. [O94851-1]"";""ENST00000707072.1; ENSP00000516723.1; ENSG00000133816.19. [O94851-4]"";","actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; monooxygenase activity [GO:0004497]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; heart development [GO:0007507]; heart looping [GO:0001947]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sulfur oxidation [GO:0019417],actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q7RTP6,C2,0.751659141,0.516366245,-0.163793495,0.002068583,-0.262807815,aquamarine,MICAL3,MICA3_HUMAN,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),MICAL3 KIAA0819 KIAA1364,57553;,"ENST00000383094.7; ENSP00000372574.3; ENSG00000243156.9. [Q7RTP6-2];""ENST00000400561.6; ENSP00000383406.2; ENSG00000243156.9. [Q7RTP6-4]"";""ENST00000414725.6; ENSP00000391827.2; ENSG00000243156.9. [Q7RTP6-3]"";""ENST00000441493.7; ENSP00000416015.2; ENSG00000243156.9. [Q7RTP6-1]"";""ENST00000585038.1; ENSP00000462033.1; ENSG00000243156.9. [Q7RTP6-5]"";","actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",actin filament depolymerization [GO:0030042]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; Flemming body [GO:0090543]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]
Q9BPX6,M2,-1.047258792,-1.075212214,0.309667508,1.07825049,-0.096153699,tan4,MICU1,MICU1_HUMAN,"Calcium uptake protein 1, mitochondrial (Atopy-related autoantigen CALC) (ara CALC) (Calcium-binding atopy-related autoantigen 1) (allergen Hom s 4)",MICU1 CALC CBARA1,10367;,"ENST00000361114.10; ENSP00000354415.5; ENSG00000107745.20. [Q9BPX6-1];""ENST00000398763.8; ENSP00000381747.4; ENSG00000107745.20. [Q9BPX6-5]"";""ENST00000418483.6; ENSP00000402470.2; ENSG00000107745.20. [Q9BPX6-4]"";",calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982],calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; defense response [GO:0006952]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of cristae formation [GO:1903852]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein homooligomerization [GO:0051260]; regulation of cellular hyperosmotic salinity response [GO:1900069],calcium channel complex [GO:0034704]; mitochondrial crista junction [GO:0044284]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]
Q8IYU8,M2,-1.373984378,-1.10470283,0.446865914,1.069066247,-0.088217347,tan4,MICU2,MICU2_HUMAN,"Calcium uptake protein 2, mitochondrial (hMICU3) (EF-hand domain-containing family member A1)",MICU2 EFHA1,221154;,ENST00000382374.9; ENSP00000371811.4; ENSG00000165487.14.;,calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982],calcium import into the mitochondrion [GO:0036444]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246]
Q9NQG6,M2,-0.143735339,-1.000873181,0.323479352,0.932435013,-0.006873924,tan4,MIEF1,MID51_HUMAN,Mitochondrial dynamics protein MIEF1 (Mitochondrial dynamics protein of 51 kDa) (Mitochondrial elongation factor 1) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein-like) (SMCR7-like protein),MIEF1 MID51 SMCR7L,54471;,"ENST00000325301.7; ENSP00000327124.2; ENSG00000100335.15. [Q9NQG6-1];""ENST00000404569.5; ENSP00000385191.1; ENSG00000100335.15. [Q9NQG6-1]"";""ENST00000428069.1; ENSP00000413730.1; ENSG00000100335.15. [Q9NQG6-2]"";""ENST00000433117.6; ENSP00000404096.2; ENSG00000100335.15. [Q9NQG6-2]"";",ADP binding [GO:0043531]; GDP binding [GO:0019003]; identical protein binding [GO:0042802],cellular response to hypoxia [GO:0071456]; mitochondrial fission [GO:0000266]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of protein targeting to membrane [GO:0090314],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q9BRT3,C5,2.017583234,0.363764651,-0.831133665,-0.926271375,-1.340651308,turquoise3,MIEN1,MIEN1_HUMAN,Migration and invasion enhancer 1 (HBV X-transactivated gene 4 protein) (HBV XAg-transactivated protein 4) (Protein C35),MIEN1 C17orf37 RDX12 XTP4,84299;,ENST00000394231.8; ENSP00000377778.3; ENSG00000141741.12.;,0,apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell migration [GO:0030335]; positive regulation of filopodium assembly [GO:0051491],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
A9UHW6,C5,1.74352746,0.654964212,-0.737013676,-0.902633671,-1.16505059,turquoise3,MIF4GD,MI4GD_HUMAN,MIF4G domain-containing protein (SLBP-interacting protein 1) (hSLIP1),MIF4GD SLIP1,57409;,"ENST00000245551.9; ENSP00000245551.5; ENSG00000125457.15. [A9UHW6-2];""ENST00000325102.13; ENSP00000321625.8; ENSG00000125457.15. [A9UHW6-1]"";""ENST00000577542.5; ENSP00000463334.1; ENSG00000125457.15. [A9UHW6-3]"";""ENST00000579194.6; ENSP00000462655.2; ENSG00000125457.15. [A9UHW6-3]"";""ENST00000579297.5; ENSP00000462459.1; ENSG00000125457.15. [A9UHW6-3]"";""ENST00000618645.5; ENSP00000484245.1; ENSG00000125457.15. [A9UHW6-1]"";",identical protein binding [GO:0042802]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],cap-dependent translational initiation [GO:0002191]; regulation of translational initiation [GO:0006446],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone mRNA stem-loop binding complex [GO:0062073]; nucleolus [GO:0005730]
Q6P0N0,N3,-0.807063519,-0.961909278,1.239437458,0.22060407,-0.317427306,grey50,MIS18BP1,M18BP_HUMAN,Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog) (HsKNL-2) (P243),MIS18BP1 C14orf106 KIAA1903 KNL2 M18BP1,55320;,ENST00000310806.9; ENSP00000309790.4; ENSG00000129534.14. [Q6P0N0-1];,DNA binding [GO:0003677],cell division [GO:0051301],"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]"
P46013,N3,-1.306726955,-1.184460959,1.236030648,0.277402388,-0.306860822,grey50,MKI67,KI67_HUMAN,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67),MKI67,4288;,"ENST00000368653.7; ENSP00000357642.3; ENSG00000148773.14. [P46013-2];""ENST00000368654.8; ENSP00000357643.3; ENSG00000148773.14. [P46013-1]"";",ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723],cell population proliferation [GO:0008283]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088],chromosome [GO:0005694]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NPJ1,M2,-0.885006251,-1.300834777,0.351673431,1.12472521,-0.169676962,tan4,MKKS,MKKS_HUMAN,Molecular chaperone MKKS (Bardet-Biedl syndrome 6 protein) (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin),MKKS BBS6,8195;,"ENST00000347364.7; ENSP00000246062.4; ENSG00000125863.20.;""ENST00000399054.6; ENSP00000382008.2; ENSG00000125863.20."";""ENST00000651692.1; ENSP00000498849.1; ENSG00000125863.20."";",ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082],artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; convergent extension involved in gastrulation [GO:0060027]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; determination of left/right symmetry [GO:0007368]; developmental process [GO:0032502]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gonad development [GO:0008406]; heart development [GO:0007507]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; melanosome transport [GO:0032402]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; pigment granule aggregation in cell center [GO:0051877]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634]
Q969V6,C3,1.468279746,0.538954073,-0.493936927,-0.732279816,-0.828504382,cyan,MKL1,MRTFA_HUMAN,Myocardin-related transcription factor A (MRTF-A) (MKL/myocardin-like protein 1) (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein),MRTFA KIAA1438 MAL MKL1,57591;,ENST00000407029.7; ENSP00000385835.1; ENSG00000196588.21.;,actin binding [GO:0003779]; actin monomer binding [GO:0003785]; leucine zipper domain binding [GO:0043522]; transcription coactivator activity [GO:0003713],"actin cytoskeleton organization [GO:0030036]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145]; wound healing, spreading of cells [GO:0044319]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9ULH7,C3,1.611238903,0.374561439,-0.486636233,-0.616420882,-0.75590101,cyan,MKL2,MRTFB_HUMAN,Myocardin-related transcription factor B (MRTF-B) (MKL/myocardin-like protein 2) (Megakaryoblastic leukemia 2),MRTFB KIAA1243 MKL2,57496;,"ENST00000318282.9; ENSP00000339086.4; ENSG00000186260.17. [Q9ULH7-4];""ENST00000571589.6; ENSP00000459626.2; ENSG00000186260.17. [Q9ULH7-5]"";""ENST00000573051.1; ENSP00000460589.1; ENSG00000186260.17. [Q9ULH7-2]"";""ENST00000574045.5; ENSP00000459205.1; ENSG00000186260.17. [Q9ULH7-4]"";",cadherin binding [GO:0045296]; transcription coactivator activity [GO:0003713],muscle organ development [GO:0007517]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of striated muscle tissue development [GO:0045844]; positive regulation of transcription by RNA polymerase II [GO:0045944]; smooth muscle cell differentiation [GO:0051145],nucleus [GO:0005634]
Q9BUB5,C4,1.978703382,0.128909964,-0.741016846,-0.856798259,-0.998796055,deepskyblue2,MKNK1,MKNK1_HUMAN,MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1),MKNK1 MNK1,8569;,"ENST00000649800.1; ENSP00000498083.1; ENSG00000079277.22. [Q9BUB5-1];""ENST00000650026.1; ENSP00000497380.1; ENSG00000079277.22. [Q9BUB5-3]"";""ENST00000650508.1; ENSP00000498143.1; ENSG00000079277.22. [Q9BUB5-2]"";",ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of translation [GO:0006417],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q14165,S2,-1.254655298,-1.597721624,0.215395236,1.02027173,0.455494131,orange,MLEC,MLEC_HUMAN,Malectin,MLEC KIAA0152,9761;,ENST00000228506.8; ENSP00000228506.3; ENSG00000110917.8.;,carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899],protein N-linked glycosylation [GO:0006487],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]
Q8NB16,C4,2.067650344,0.053632957,-0.817747997,-0.885720825,-0.955416189,deepskyblue2,MLKL,MLKL_HUMAN,Mixed lineage kinase domain-like protein (hMLKL),MLKL,197259;,"ENST00000306247.11; ENSP00000303118.7; ENSG00000168404.13. [Q8NB16-2];""ENST00000308807.12; ENSP00000308351.7; ENSG00000168404.13. [Q8NB16-1]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; execution phase of necroptosis [GO:0097528]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; protein homotrimerization [GO:0070207],cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q03111,N4,-0.848153533,0.887212752,0.337866422,-0.235101748,-0.338263926,grey30,MLLT1,ENL_HUMAN,Protein ENL (YEATS domain-containing protein 1),MLLT1 ENL LTG19 YEATS1,4298;,ENST00000252674.9; ENSP00000252674.6; ENSG00000130382.9.;,chromatin binding [GO:0003682]; lysine-acetylated histone binding [GO:0070577],positive regulation of DNA-templated transcription [GO:0045893],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]
Q96EY8,M1,-1.401021039,-0.345851147,0.480292387,0.987193288,-0.637164789,burlywood4,MMAB,MMAB_HUMAN,Corrinoid adenosyltransferase MMAB (EC 2.5.1.-) (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B protein),MMAB,326625;,ENST00000545712.7; ENSP00000445920.1; ENSG00000139428.12.;,"ATP binding [GO:0005524]; cobalamin binding [GO:0031419]; corrinoid adenosyltransferase activity [GO:0008817]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]",cobalamin metabolic process [GO:0009235],mitochondrial matrix [GO:0005759]
Q9H3L0,C2,1.012820007,-0.100515455,0.110174075,0.27901732,-0.402204304,aquamarine,MMADHC,MMAD_HUMAN,"Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial)",MMADHC C2orf25 CL25022 HSPC161 My011,27249;,"ENST00000303319.10; ENSP00000301920.5; ENSG00000168288.13.;""ENST00000428879.5; ENSP00000389060.1; ENSG00000168288.13."";",0,cobalamin metabolic process [GO:0009235],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]
Q8N4V1,S2,-1.612126006,-1.757245401,0.326423747,0.975944457,0.503494911,orange,MMGT1,EMC5_HUMAN,ER membrane protein complex subunit 5 (Membrane magnesium transporter 1) (Transmembrane protein 32),MMGT1 EMC5 TMEM32,93380;,"ENST00000305963.3; ENSP00000306220.2; ENSG00000169446.6. [Q8N4V1-1];""ENST00000679621.1; ENSP00000505226.1; ENSG00000169446.6. [Q8N4V1-1]"";",cobalt ion transmembrane transporter activity [GO:0015087]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095],copper ion transport [GO:0006825]; magnesium ion transport [GO:0015693]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P51948,N4,-0.481198728,1.262809453,-0.1502469,-0.325230067,-0.658374577,grey30,MNAT1,MAT1_HUMAN,CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Cyclin-G1-interacting protein) (Menage a trois) (RING finger protein 66) (RING finger protein MAT1) (p35) (p36),MNAT1 CAP35 MAT1 RNF66,4331;,"ENST00000261245.9; ENSP00000261245.4; ENSG00000020426.11. [P51948-1];""ENST00000539616.6; ENSP00000446437.2; ENSG00000020426.11. [P51948-2]"";",cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; zinc ion binding [GO:0008270],adult heart development [GO:0007512]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ventricular system development [GO:0021591],CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985]
Q70IA6,C5,2.084834658,0.202674942,-0.754953804,-0.629737266,-1.11027583,turquoise3,MOB2,MOB2_HUMAN,MOB kinase activator 2 (HCCA2) (Mob2 homolog) (Mps one binder kinase activator-like 2),MOB2 HCCA2,81532;,"ENST00000329957.7; ENSP00000328694.6; ENSG00000182208.15. [Q70IA6-3];""ENST00000707570.1; ENSP00000516915.1; ENSG00000291442.1. [Q70IA6-3]"";""ENST00000710276.1; ENSP00000518169.1; ENSG00000291442.1. [Q70IA6-1]"";",metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295],positive regulation of protein phosphorylation [GO:0001934]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
O96033,C5,1.910968399,0.33486503,-1.007791663,-1.05999696,-1.079882534,turquoise3,MOCS2,MOC2A_HUMAN,Molybdopterin synthase sulfur carrier subunit (MOCO1-A) (Molybdenum cofactor synthesis protein 2 small subunit) (Molybdenum cofactor synthesis protein 2A) (MOCS2A) (Molybdopterin-synthase small subunit) (Sulfur carrier protein MOCS2A),MOCS2 MOCO1,4338;,"ENST00000361377.8; ENSP00000355160.4; ENSG00000164172.20.;""ENST00000450852.8; ENSP00000411022.3; ENSG00000164172.20."";""ENST00000508922.5; ENSP00000426274.1; ENSG00000164172.20."";""ENST00000510818.6; ENSP00000424267.2; ENSG00000164172.20."";""ENST00000582677.5; ENSP00000462870.1; ENSG00000164172.20."";""ENST00000584946.5; ENSP00000464663.1; ENSG00000164172.20."";",molybdopterin synthase activity [GO:0030366]; nucleotide binding [GO:0000166],Mo-molybdopterin cofactor biosynthetic process [GO:0006777],cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]
Q14149,N4,-0.77495203,1.232552895,-0.075177958,-0.487693783,-0.718029395,grey30,MORC3,MORC3_HUMAN,MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3),MORC3 KIAA0136 NXP2 ZCWCC3,23515;,ENST00000400485.6; ENSP00000383333.1; ENSG00000159256.13.;,ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],antiviral innate immune response [GO:0140374]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular senescence [GO:2000774]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821],chromatin [GO:0000785]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]
Q9UBU8,N4,-0.745558015,0.485814622,0.31843332,-0.050756131,0.145430469,grey30,MORF4L1,MO4L1_HUMAN,Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (MRG15) (Protein MSL3-1) (Transcription factor-like protein MRG15),MORF4L1 MRG15 FWP006 HSPC008 HSPC061 PP368,10933;,"ENST00000331268.9; ENSP00000331310.5; ENSG00000185787.15. [Q9UBU8-1];""ENST00000426013.7; ENSP00000408880.2; ENSG00000185787.15. [Q9UBU8-2]"";""ENST00000558502.5; ENSP00000452808.1; ENSG00000185787.15. [Q9UBU8-3]"";""ENST00000559345.5; ENSP00000452717.1; ENSG00000185787.15. [Q9UBU8-3]"";",0,chromatin organization [GO:0006325]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779],NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; Sin3-type complex [GO:0070822]
Q15014,N1,-0.855472279,0.141954979,0.105808937,-0.217696917,0.76478793,grey90,MORF4L2,MO4L2_HUMAN,Mortality factor 4-like protein 2 (MORF-related gene X protein) (Protein MSL3-2) (Transcription factor-like protein MRGX),MORF4L2 KIAA0026 MRGX,9643;,"ENST00000360458.5; ENSP00000353643.1; ENSG00000123562.18.;""ENST00000433176.6; ENSP00000415476.2; ENSG00000123562.18."";""ENST00000441076.7; ENSP00000391969.2; ENSG00000123562.18."";""ENST00000451301.5; ENSP00000410532.1; ENSG00000123562.18."";",0,chromatin organization [GO:0006325]; DNA repair [GO:0006281]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779],NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; plasma membrane [GO:0005886]
Q8NHP6,S2,-1.239386047,-1.473898722,0.090548942,0.914870688,0.737808773,orange,MOSPD2,MSPD2_HUMAN,Motile sperm domain-containing protein 2,MOSPD2,158747;,ENST00000380492.8; ENSP00000369860.3; ENSG00000130150.12. [Q8NHP6-1];,FFAT motif binding [GO:0033149],chemotaxis [GO:0006935]; lipid droplet formation [GO:0140042]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein homooligomerization [GO:0051260],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]
Q9HCE1,N1,-0.191702689,-0.800194391,-0.538213766,-0.26197837,1.420660136,grey90,MOV10,MOV10_HUMAN,Helicase MOV-10 (EC 3.6.4.13) (Armitage homolog) (Moloney leukemia virus 10 protein),MOV10 KIAA1631,4343;,"ENST00000357443.2; ENSP00000350028.2; ENSG00000155363.19. [Q9HCE1-1];""ENST00000369645.6; ENSP00000358659.1; ENSG00000155363.19. [Q9HCE1-1]"";""ENST00000413052.6; ENSP00000399797.2; ENSG00000155363.19. [Q9HCE1-1]"";",5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723],3'-UTR-mediated mRNA destabilization [GO:0061158]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of neuron projection arborization [GO:0150011]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; retrotransposon silencing [GO:0010526]; retrotransposon silencing by mRNA destabilization [GO:0141008],cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]
O00566,N3,-1.272613369,-1.23598897,1.206201045,0.019798336,0.367658112,grey50,MPHOSPH10,MPP10_HUMAN,U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10),MPHOSPH10 MPP10,10199;,ENST00000244230.7; ENSP00000244230.2; ENSG00000124383.11.;,RNA binding [GO:0003723],"maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]
Q99549,N2,-0.978790509,-0.660480664,1.212052797,0.203856873,-0.34509197,grey70,MPHOSPH8,MPP8_HUMAN,M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3),MPHOSPH8 MPP8,54737;,ENST00000361479.10; ENSP00000355388.4; ENSG00000196199.14. [Q99549-1];,chromatin binding [GO:0003682]; histone reader activity [GO:0140566]; methylated histone binding [GO:0035064],"negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P34949,C4,1.975425274,0.555090504,-1.292361698,-1.529944583,-1.679548319,deepskyblue2,MPI,MPI_HUMAN,Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI),MPI PMI1,4351;,"ENST00000323744.10; ENSP00000318192.6; ENSG00000178802.18. [P34949-2];""ENST00000352410.9; ENSP00000318318.6; ENSG00000178802.18. [P34949-1]"";",mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270],GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate metabolic process [GO:0061611],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q99547,M1,-0.924630478,-0.743680036,0.53701032,0.812060653,-0.17983956,burlywood4,MPP6,MPH6_HUMAN,M-phase phosphoprotein 6,MPHOSPH6 MPP6,10200;,ENST00000258169.9; ENSP00000258169.4; ENSG00000135698.10.;,RNA binding [GO:0003723],maturation of 5.8S rRNA [GO:0000460],cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q5T2T1,M1,-0.874013649,-0.689814989,0.594130786,0.83718729,-0.139461152,burlywood4,MPP7,MPP7_HUMAN,MAGUK p55 subfamily member 7,MPP7,143098;,"ENST00000337532.9; ENSP00000337907.5; ENSG00000150054.19. [Q5T2T1-1];""ENST00000375719.7; ENSP00000364871.3; ENSG00000150054.19. [Q5T2T1-1]"";""ENST00000375732.5; ENSP00000364884.1; ENSG00000150054.19. [Q5T2T1-1]"";""ENST00000683449.1; ENSP00000507917.1; ENSG00000150054.19. [Q5T2T1-1]"";",cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; signaling adaptor activity [GO:0035591],bicellular tight junction assembly [GO:0070830]; establishment of cell polarity [GO:0030010]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to adherens junction [GO:0071896],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; lateral plasma membrane [GO:0016328]; MPP7-DLG1-LIN7 complex [GO:0097025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q567V2,M2,-0.401641531,-1.012816998,0.565397264,0.882161139,0.19300121,tan4,MPV17L2,M17L2_HUMAN,Mpv17-like protein 2,MPV17L2 FKSG24,84769;,ENST00000599612.3; ENSP00000469836.2; ENSG00000254858.10. [Q567V2-1];,0,mitochondrial ribosome assembly [GO:0061668]; positive regulation of mitochondrial translation [GO:0070131],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
O95297,S4,-0.820198764,-1.067984613,0.292354509,0.90731564,0.411604843,tomato2,MPZL1,MPZL1_HUMAN,Myelin protein zero-like protein 1 (Protein zero-related),MPZL1 PZR UNQ849/PRO1787,9019;,"ENST00000359523.7; ENSP00000352513.2; ENSG00000197965.12. [O95297-1];""ENST00000392121.7; ENSP00000375968.3; ENSG00000197965.12. [O95297-5]"";""ENST00000474859.5; ENSP00000420455.1; ENSG00000197965.12. [O95297-3]"";",structural molecule activity [GO:0005198],cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell-cell signaling [GO:0007267],cell surface [GO:0009986]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]
Q8N565,S1,-0.621719433,-1.32885805,-0.313744898,0.675076542,1.195369911,gold,MREG,MREG_HUMAN,Melanoregulin (Dilute suppressor protein homolog),MREG DSU HDCGA21P,55686;,ENST00000263268.11; ENSP00000263268.6; ENSG00000118242.17. [Q8N565-1];,phosphatidylinositol binding [GO:0035091],melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; minus-end-directed organelle transport along microtubule [GO:0072385]; phagosome maturation [GO:0090382],apical plasma membrane [GO:0016324]; cytoplasmic vesicle membrane [GO:0030659]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; organelle membrane [GO:0031090]; protein-containing complex [GO:0032991]
Q9BV20,C5,1.846174416,0.469051427,-0.757992542,-0.857927315,-1.203264766,turquoise3,MRI1,MTNA_HUMAN,Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein),MRI1 MRDI UNQ6390/PRO21135,84245;,"ENST00000040663.8; ENSP00000040663.5; ENSG00000037757.14. [Q9BV20-1];""ENST00000319545.12; ENSP00000314871.7; ENSG00000037757.14. [Q9BV20-2]"";",identical protein binding [GO:0042802]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523],L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],cell projection [GO:0042995]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]
Q6IN84,S3,-0.960921892,-0.774650885,0.164145741,0.71298503,0.577835843,salmon,MRM1,MRM1_HUMAN,"rRNA methyltransferase 1, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase)",MRM1,79922;,"ENST00000611231.2; ENSP00000478520.1; ENSG00000274853.2. [Q6IN84-1];""ENST00000614766.5; ENSP00000481559.1; ENSG00000278619.5. [Q6IN84-1]"";",RNA binding [GO:0003723]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039],rRNA 2'-O-methylation [GO:0000451]; rRNA modification [GO:0000154],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q9BYD6,S3,-1.248553554,-1.064228076,0.166309708,0.987537791,0.465288302,salmon,MRPL1,RM01_HUMAN,"Large ribosomal subunit protein uL1m (39S ribosomal protein L1, mitochondrial) (L1mt) (MRP-L1)",MRPL1 BM-022,65008;,ENST00000315567.13; ENSP00000315017.8; ENSG00000169288.18.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]
Q9Y3B7,S3,-0.962536581,-0.991144998,0.249799166,0.866373164,0.473717002,salmon,MRPL11,RM11_HUMAN,"Large ribosomal subunit protein uL11m (39S ribosomal protein L11, mitochondrial) (L11mt) (MRP-L11)",MRPL11 CGI-113,65003;,"ENST00000310999.11; ENSP00000308897.7; ENSG00000174547.13. [Q9Y3B7-1];""ENST00000329819.4; ENSP00000329630.4; ENSG00000174547.13. [Q9Y3B7-3]"";""ENST00000430466.6; ENSP00000415356.2; ENSG00000174547.13. [Q9Y3B7-2]"";",large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
Q9BYD1,S3,-0.818094255,-0.802147303,0.177750638,0.785591204,0.532805384,salmon,MRPL13,RM13_HUMAN,"Large ribosomal subunit protein uL13m (39S ribosomal protein L13, mitochondrial) (L13mt) (MRP-L13)",MRPL13,28998;,ENST00000306185.8; ENSP00000306548.3; ENSG00000172172.8.;,mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; negative regulation of translation [GO:0017148]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; ribosome [GO:0005840]
Q6P1L8,M1,-0.816037487,-0.467240247,0.305409508,0.912521838,0.032673481,burlywood4,MRPL14,RM14_HUMAN,"Large ribosomal subunit protein uL14m (39S ribosomal protein L14, mitochondrial) (L14mt) (MRP-L14) (39S ribosomal protein L32, mitochondrial) (L32mt) (MRP-L32)",MRPL14 MRPL32 RPML32,64928;,ENST00000372014.5; ENSP00000361084.3; ENSG00000180992.7.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
P49406,S3,-0.798256268,-1.04560129,0.161103288,0.883471946,0.525700628,salmon,MRPL15,RM19_HUMAN,"Large ribosomal subunit protein bL19m (39S ribosomal protein L15, mitochondrial) (L15mt) (MRP-L15) (39S ribosomal protein L19, mitochondrial) (L19mt) (MRP-L19)",MRPL19 KIAA0104 MRPL15,9801;,"ENST00000393909.7; ENSP00000377486.2; ENSG00000115364.14.;""ENST00000409374.5; ENSP00000387284.1; ENSG00000115364.14."";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q9NX20,S4,-1.052070193,-1.115310866,0.272093322,0.83639562,0.459066677,tomato2,MRPL16,RM16_HUMAN,"Large ribosomal subunit protein uL16m (39S ribosomal protein L16, mitochondrial) (L16mt) (MRP-L16)",MRPL16 PNAS-111,54948;,ENST00000300151.5; ENSP00000300151.4; ENSG00000166902.5.;,rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q9NRX2,S2,-1.396930186,-1.339522824,0.168647195,0.784965217,0.590730427,orange,MRPL17,RM17_HUMAN,"Large ribosomal subunit protein bL17m (39S ribosomal protein L17, mitochondrial) (L17mt) (MRP-L17) (LYST-interacting protein 2)",MRPL17 LIP2,63875;,ENST00000288937.7; ENSP00000288937.6; ENSG00000158042.9.;,protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q9H0U6,S3,-0.931124324,-0.621890655,0.251936681,0.734917622,0.516927995,salmon,MRPL18,RM18_HUMAN,"Large ribosomal subunit protein uL18m (39S ribosomal protein L18, mitochondrial) (L18mt) (MRP-L18)",MRPL18 HSPC071,29074;,ENST00000367034.5; ENSP00000356001.4; ENSG00000112110.10.;,5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412],extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
P49406,S3,-1.225576482,-1.008278091,0.291711375,0.831269623,0.509154102,salmon,MRPL19,RM19_HUMAN,"Large ribosomal subunit protein bL19m (39S ribosomal protein L15, mitochondrial) (L15mt) (MRP-L15) (39S ribosomal protein L19, mitochondrial) (L19mt) (MRP-L19)",MRPL19 KIAA0104 MRPL15,9801;,"ENST00000393909.7; ENSP00000377486.2; ENSG00000115364.14.;""ENST00000409374.5; ENSP00000387284.1; ENSG00000115364.14."";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q5T653,S3,-0.691595925,-0.611612521,0.240928998,0.685630987,0.427552223,salmon,MRPL2,RM02_HUMAN,"Large ribosomal subunit protein uL2m (39S ribosomal protein L2, mitochondrial) (L2mt) (MRP-L2)",MRPL2 CGI-22,51069;,ENST00000388752.8; ENSP00000373404.3; ENSG00000112651.12.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q7Z2W9,S3,-0.895033931,-0.716426244,0.176966865,0.792518162,0.404887501,salmon,MRPL21,RM21_HUMAN,"Large ribosomal subunit protein bL21m (39S ribosomal protein L21, mitochondrial) (L21mt) (MRP-L21)",MRPL21,219927;,"ENST00000362034.7; ENSP00000354580.2; ENSG00000197345.13. [Q7Z2W9-1];""ENST00000450904.6; ENSP00000389400.2; ENSG00000197345.13. [Q7Z2W9-2]"";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q9NWU5,S3,-0.727509913,-0.984241489,0.215827191,0.79125606,0.544725698,salmon,MRPL22,RM22_HUMAN,"Large ribosomal subunit protein uL22m (39S ribosomal protein L22, mitochondrial) (L22mt) (MRP-L22) (39S ribosomal protein L25, mitochondrial) (L25mt) (MRP-L25)",MRPL22 MRPL25 RPML25 HSPC158,29093;,"ENST00000265229.12; ENSP00000265229.8; ENSG00000082515.18. [Q9NWU5-3];""ENST00000523037.6; ENSP00000431040.1; ENSG00000082515.18. [Q9NWU5-1]"";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q96A35,S3,-0.887538798,-0.951698142,0.180483773,0.860453367,0.481914565,salmon,MRPL24,RM24_HUMAN,"Large ribosomal subunit protein uL24m (39S ribosomal protein L24, mitochondrial) (L24mt) (MRP-L24)",MRPL24,79590;,"ENST00000361531.6; ENSP00000354525.2; ENSG00000143314.12.;""ENST00000368211.8; ENSP00000357194.4; ENSG00000143314.12."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q8IXM3,S3,-0.093576801,-0.587907444,0.186745033,0.575855641,0.415581089,salmon,MRPL27,RM41_HUMAN,"Large ribosomal subunit protein mL41 (39S ribosomal protein L41, mitochondrial) (L41mt) (MRP-L41) (Bcl-2-interacting mitochondrial ribosomal protein L41) (Cell proliferation-inducing gene 3 protein) (MRP-L27 homolog)",MRPL41 BMRP MRPL27 RPML27 PIG3,64975;,ENST00000371443.6; ENSP00000360498.5; ENSG00000182154.8.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]
Q13084,S3,-1.147284911,-1.298204354,0.232306716,0.8374902,0.519263091,salmon,MRPL28,RM28_HUMAN,"Large ribosomal subunit protein bL28m (39S ribosomal protein L28, mitochondrial) (L28mt) (MRP-L28) (Melanoma antigen p15) (Melanoma-associated antigen recognized by T-lymphocytes)",MRPL28 MAAT1,10573;,"ENST00000199706.13; ENSP00000199706.7; ENSG00000086504.18.;""ENST00000389675.6; ENSP00000374326.2; ENSG00000086504.18."";""ENST00000648346.1; ENSP00000497004.1; ENSG00000086504.18."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
P09001,S3,-0.688359016,-0.777722566,0.195700601,0.655603735,0.502193975,salmon,MRPL3,RM03_HUMAN,"Large ribosomal subunit protein uL3m (39S ribosomal protein L3, mitochondrial) (L3mt) (MRP-L3)",MRPL3 MRL3 RPML3,11222;,ENST00000264995.8; ENSP00000264995.2; ENSG00000114686.9.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q9BQ48,S2,-2.170568138,-1.43452198,0.233748079,0.978887941,0.512865568,orange,MRPL34,RM34_HUMAN,"Large ribosomal subunit protein bL34m (39S ribosomal protein L34, mitochondrial) (L34mt) (MRP-L34)",MRPL34,64981;,"ENST00000252602.2; ENSP00000252602.1; ENSG00000130312.7.;""ENST00000594999.1; ENSP00000471820.1; ENSG00000130312.7."";""ENST00000600434.5; ENSP00000469581.1; ENSG00000130312.7."";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
Q9NYK5,S3,-1.375399265,-1.148994684,0.240612945,0.965642912,0.523641517,salmon,MRPL39,RM39_HUMAN,"Large ribosomal subunit protein mL39 (39S ribosomal protein L39, mitochondrial) (L39mt) (MRP-L39) (39S ribosomal protein L5, mitochondrial) (L5mt) (MRP-L5)",MRPL39 C21orf92 MRPL5 RPML5 MSTP003 PRED22,54148;,"ENST00000307301.11; ENSP00000305682.7; ENSG00000154719.14. [Q9NYK5-2];""ENST00000352957.9; ENSP00000284967.7; ENSG00000154719.14. [Q9NYK5-1]"";",nucleotide binding [GO:0000166]; RNA binding [GO:0003723],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
Q9NQ50,S3,-1.006924411,-0.903055819,0.18870067,0.812511295,0.492358165,salmon,MRPL40,RM40_HUMAN,"Large ribosomal subunit protein mL40 (39S ribosomal protein L40, mitochondrial) (L40mt) (MRP-L40) (Nuclear localization signal-containing protein deleted in velocardiofacial syndrome) (Up-regulated in metastasis)",MRPL40 NLVCF URIM,64976;,ENST00000333130.4; ENSP00000333401.3; ENSG00000185608.9.;,RNA binding [GO:0003723],anatomical structure morphogenesis [GO:0009653]; mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]
Q8IXM3,S2,-1.574320376,-1.411245596,0.14167252,1.016671801,0.520217957,orange,MRPL41,RM41_HUMAN,"Large ribosomal subunit protein mL41 (39S ribosomal protein L41, mitochondrial) (L41mt) (MRP-L41) (Bcl-2-interacting mitochondrial ribosomal protein L41) (Cell proliferation-inducing gene 3 protein) (MRP-L27 homolog)",MRPL41 BMRP MRPL27 RPML27 PIG3,64975;,ENST00000371443.6; ENSP00000360498.5; ENSG00000182154.8.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904]
Q9Y6G3,S3,-0.836959812,-0.603062218,0.131971972,0.792922137,0.41903899,salmon,MRPL42,RM42_HUMAN,"Large ribosomal subunit protein mL42 (39S ribosomal protein L31, mitochondrial) (L31mt) (MRP-L31) (39S ribosomal protein L42, mitochondrial) (L42mt) (MRP-L42)",MRPL42 MRPL31 MRPS32 RPML31 HSPC204 PTD007,28977;,"ENST00000549561.6; ENSP00000449392.1; ENSG00000198015.14.;""ENST00000549982.6; ENSP00000449884.1; ENSG00000198015.14."";""ENST00000552217.6; ENSP00000447547.1; ENSG00000198015.14."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q8N983,S3,-1.295312593,-1.141161388,0.249336556,0.753104184,0.583186695,salmon,MRPL43,RM43_HUMAN,"Large ribosomal subunit protein mL43 (39S ribosomal protein L43, mitochondrial) (L43mt) (MRP-L43) (Mitochondrial ribosomal protein bMRP36a)",MRPL43,84545;,"ENST00000299179.9; ENSP00000299179.5; ENSG00000055950.17. [Q8N983-2];""ENST00000318325.6; ENSP00000315364.2; ENSG00000055950.17. [Q8N983-1]"";""ENST00000318364.13; ENSP00000315948.8; ENSG00000055950.17. [Q8N983-4]"";""ENST00000342071.5; ENSP00000339844.1; ENSG00000055950.17. [Q8N983-6]"";""ENST00000370234.4; ENSP00000359254.4; ENSG00000055950.17. [Q8N983-3]"";""ENST00000370236.5; ENSP00000359256.1; ENSG00000055950.17. [Q8N983-4]"";""ENST00000370242.8; ENSP00000359262.4; ENSG00000055950.17. [Q8N983-7]"";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
Q9BRJ2,S3,-1.175669799,-0.917810633,0.237065296,0.907158515,0.485311797,salmon,MRPL45,RM45_HUMAN,"Large ribosomal subunit protein mL45 (39S ribosomal protein L45, mitochondrial) (L45mt) (MRP-L45)",MRPL45,0,ENST00000621878.4; ENSP00000483030.1; ENSG00000277936.4.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q9H2W6,S3,-1.383410257,-1.01686927,0.284434176,0.952136646,0.320301435,salmon,MRPL46,RM46_HUMAN,"Large ribosomal subunit protein mL46 (39S ribosomal protein L46, mitochondrial) (L46mt) (MRP-L46) (P2ECSL)",MRPL46 C15orf4 LIECG2,26589;,ENST00000312475.5; ENSP00000312311.4; ENSG00000259494.2.;,structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q9HD33,S3,-1.144773911,-1.060082226,0.178624809,0.938368203,0.455081062,salmon,MRPL47,RM47_HUMAN,"Large ribosomal subunit protein uL29m (39S ribosomal protein L47, mitochondrial) (L47mt) (MRP-L47) (Nasopharyngeal carcinoma metastasis-related protein 1)",MRPL47 NCM1 CGI-204,57129;,"ENST00000259038.6; ENSP00000259038.2; ENSG00000136522.14. [Q9HD33-2];""ENST00000392659.2; ENSP00000376427.2; ENSG00000136522.14. [Q9HD33-3]"";""ENST00000476781.6; ENSP00000417602.1; ENSG00000136522.14. [Q9HD33-1]"";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q96GC5,S3,-1.068297899,-1.095016955,0.174098213,0.924414939,0.450734539,salmon,MRPL48,RM48_HUMAN,"Large ribosomal subunit protein mL48 (39S ribosomal protein L48, mitochondrial) (L48mt) (MRP-L48)",MRPL48 CGI-118 HSPC290,51642;,ENST00000310614.12; ENSP00000308717.7; ENSG00000175581.14. [Q96GC5-1];,0,mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
Q13405,S3,-1.325359738,-1.0147186,0.283639016,0.825905786,0.523076513,salmon,MRPL49,RM49_HUMAN,"Large ribosomal subunit protein mL49 (39S ribosomal protein L49, mitochondrial) (L49mt) (MRP-L49) (Neighbor of FAU) (NOF) (Protein NOF1)",MRPL49 C11orf4 NOF1 OK/SW-cl.67,740;,"ENST00000279242.7; ENSP00000279242.2; ENSG00000149792.9.;""ENST00000526319.5; ENSP00000434190.1; ENSG00000149792.9."";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
Q8N5N7,S3,-0.859602205,-0.71620436,0.251796967,0.678679842,0.453156413,salmon,MRPL50,RM50_HUMAN,"Large ribosomal subunit protein mL50 (39S ribosomal protein L50, mitochondrial) (L50mt) (MRP-L50)",MRPL50,54534;,ENST00000374865.5; ENSP00000363999.4; ENSG00000136897.8. [Q8N5N7-1];,0,mitochondrial translation [GO:0032543],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q96EL3,S3,-0.912834075,-0.877268194,0.163499556,0.81876945,0.37443743,salmon,MRPL53,RM53_HUMAN,"Large ribosomal subunit protein mL53 (39S ribosomal protein L53, mitochondrial) (L53mt) (MRP-L53)",MRPL53,116540;,ENST00000258105.8; ENSP00000258105.7; ENSG00000204822.7.;,0,mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q6P161,S3,-1.125883689,-1.025781015,0.183821253,0.94149837,0.514186435,salmon,MRPL54,RM54_HUMAN,"Large ribosomal subunit protein mL54 (39S ribosomal protein L54, mitochondrial) (L54mt) (MRP-L54)",MRPL54,116541;,ENST00000330133.5; ENSP00000331849.3; ENSG00000183617.5.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q7Z7F7,S3,-0.392146636,-0.568796795,0.184012977,0.637971724,0.387755588,salmon,MRPL55,RM55_HUMAN,"Large ribosomal subunit protein mL55 (39S ribosomal protein L55, mitochondrial) (L55mt) (MRP-L55) (Mitochondrial large ribosomal subunit protein bL31m)",MRPL55 UNQ5835/PRO19675,128308;,"ENST00000295008.8; ENSP00000295008.4; ENSG00000162910.19. [Q7Z7F7-1];""ENST00000336300.9; ENSP00000337361.5; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000336520.8; ENSP00000337342.3; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000348259.9; ENSP00000338189.5; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366733.5; ENSP00000355694.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366734.5; ENSP00000355695.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366735.5; ENSP00000355696.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366736.5; ENSP00000355697.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366738.5; ENSP00000355699.1; ENSG00000162910.19. [Q7Z7F7-2]"";""ENST00000366739.5; ENSP00000355700.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366740.5; ENSP00000355701.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366741.5; ENSP00000355702.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366742.5; ENSP00000355703.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366744.5; ENSP00000355705.1; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366746.7; ENSP00000355707.3; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000366747.7; ENSP00000355708.3; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000391867.8; ENSP00000375740.3; ENSG00000162910.19. [Q7Z7F7-1]"";""ENST00000430433.5; ENSP00000403614.1; ENSG00000162910.19. [Q7Z7F7-2]"";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; synapse [GO:0045202]
Q9BYD2,S3,-0.995440635,-1.021278111,0.232647589,0.758737288,0.649103188,salmon,MRPL9,RM09_HUMAN,"Large ribosomal subunit protein bL9m (39S ribosomal protein L9, mitochondrial) (L9mt) (MRP-L9)",MRPL9,65005;,ENST00000368830.8; ENSP00000357823.3; ENSG00000143436.11.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]
P82664,S3,-1.095605443,-0.508388417,0.242704396,0.789440651,0.248559775,salmon,MRPS10,RT10_HUMAN,"Small ribosomal subunit protein uS10m (28S ribosomal protein S10, mitochondrial) (MRP-S10) (S10mt)",MRPS10 MSTP040,55173;,ENST00000053468.4; ENSP00000053468.3; ENSG00000048544.6.;,0,mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
P82912,S3,-0.36319035,-0.466077769,0.11925945,0.568749719,0.414482334,salmon,MRPS11,RT11_HUMAN,"Small ribosomal subunit protein uS11m (28S ribosomal protein S11, mitochondrial) (MRP-S11) (S11mt) (Cervical cancer proto-oncogene 2 protein) (HCC-2)",MRPS11 RPMS11 HCC2,64963;,"ENST00000325844.9; ENSP00000317376.4; ENSG00000181991.16. [P82912-1];""ENST00000353598.6; ENSP00000318054.7; ENSG00000181991.16. [P82912-3]"";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
O15235,S4,-0.524850373,-0.518521724,0.372820212,0.634139108,0.196217727,tomato2,MRPS12,RT12_HUMAN,"Small ribosomal subunit protein uS12m (28S ribosomal protein S12, mitochondrial) (MRP-S12) (S12mt) (MT-RPS12)",MRPS12 RPMS12 RPSM12,6183;,"ENST00000308018.9; ENSP00000308845.3; ENSG00000128626.12.;""ENST00000402029.3; ENSP00000384579.2; ENSG00000128626.12."";""ENST00000407800.2; ENSP00000384952.1; ENSG00000128626.12."";""ENST00000634246.1; ENSP00000488926.1; ENSG00000283018.1."";""ENST00000634400.1; ENSP00000489467.1; ENSG00000283018.1."";""ENST00000634704.1; ENSP00000489374.1; ENSG00000283018.1."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; ribosome [GO:0005840]
O60783,S3,-1.287625543,-0.793591699,0.236813552,0.844361675,0.430723053,salmon,MRPS14,RT14_HUMAN,"Small ribosomal subunit protein uS14m (28S ribosomal protein S14, mitochondrial) (MRP-S14) (S14mt)",MRPS14,63931;,ENST00000476371.1; ENSP00000420714.1; ENSG00000120333.4.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]
P82914,S3,-1.235243431,-0.91595654,0.223013744,0.771170521,0.638886255,salmon,MRPS15,RT15_HUMAN,"Small ribosomal subunit protein uS15m (28S ribosomal protein S15, mitochondrial) (MRP-S15) (S15mt)",MRPS15 RPMS15 DC37,64960;,ENST00000373116.6; ENSP00000362208.5; ENSG00000116898.12.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9Y3D3,S3,-0.431670337,-0.451260508,0.270350686,0.586936732,0.385178705,salmon,MRPS16,RT16_HUMAN,"Small ribosomal subunit protein bS16m (28S ribosomal protein S16, mitochondrial) (MRP-S16) (S16mt)",MRPS16 RPMS16 CGI-132,51021;,ENST00000372945.8; ENSP00000362036.3; ENSG00000182180.14. [Q9Y3D3-1];,structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
Q9NVS2,S3,-1.016992283,-0.868799065,0.25471316,0.669054632,0.549607894,salmon,MRPS18A,RT18A_HUMAN,"Large ribosomal subunit protein mL66 (39S ribosomal protein S18-3, mitochondrial) (MRP-S18-3) (39S ribosomal protein S18a, mitochondrial) (MRP-S18-a) (Mrps18a) (S18mt-a) (Large ribosomal subunit protein bS18a)",MRPS18A,55168;,"ENST00000372116.5; ENSP00000361188.1; ENSG00000096080.12. [Q9NVS2-3];""ENST00000372133.8; ENSP00000361206.3; ENSG00000096080.12. [Q9NVS2-1]"";",small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
Q9Y676,S3,-0.985783816,-0.674332273,0.21476445,0.617392075,0.391589093,salmon,MRPS18B,RT18B_HUMAN,"Small ribosomal subunit protein mS40 (28S ribosomal protein S18-2, mitochondrial) (MRP-S18-2) (28S ribosomal protein S18b, mitochondrial) (MRP-S18-b) (Mrps18-b) (S18mt-b) (Small ribosomal subunit protein bS18b)",MRPS18B C6orf14 HSPC183 PTD017,28973;,"ENST00000259873.5; ENSP00000259873.4; ENSG00000204568.12.;""ENST00000327800.10; ENSP00000383438.3; ENSG00000203624.10."";""ENST00000412451.6; ENSP00000402718.2; ENSG00000223775.8."";""ENST00000426945.6; ENSP00000397790.2; ENSG00000229861.8."";""ENST00000430402.6; ENSP00000398494.2; ENSG00000233813.8."";""ENST00000451032.6; ENSP00000415703.2; ENSG00000226111.8."";""ENST00000454427.6; ENSP00000414972.2; ENSG00000227420.8."";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],cell junction [GO:0030054]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
P82650,S3,-1.013565246,-0.644370582,0.259086549,0.84746806,0.3729238,salmon,MRPS22,RT22_HUMAN,"Small ribosomal subunit protein mS22 (28S ribosomal protein S22, mitochondrial) (MRP-S22) (S22mt)",MRPS22 C3orf5 RPMS22 GK002,56945;,"ENST00000495075.5; ENSP00000418008.1; ENSG00000175110.14. [P82650-1];""ENST00000498505.5; ENSP00000420482.1; ENSG00000175110.14. [P82650-2]"";""ENST00000680020.1; ENSP00000505414.1; ENSG00000175110.14. [P82650-1]"";""ENST00000688697.1; ENSP00000510396.1; ENSG00000175110.14. [P82650-1]"";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial ribosome [GO:0005761]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
Q9Y3D9,S3,-0.958151779,-0.521299172,0.23838496,0.733804349,0.275222606,salmon,MRPS23,RT23_HUMAN,"Small ribosomal subunit protein mS23 (28S ribosomal protein S23, mitochondrial) (MRP-S23) (S23mt)",MRPS23 CGI-138 HSPC329,51649;,ENST00000313608.13; ENSP00000320184.8; ENSG00000181610.13.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]
P82663,S3,-1.02284237,-0.719961346,0.189656323,0.819263758,0.433132156,salmon,MRPS25,RT25_HUMAN,"Small ribosomal subunit protein mS25 (28S ribosomal protein S25, mitochondrial) (MRP-S25) (S25mt)",MRPS25 RPMS25,64432;,"ENST00000253686.7; ENSP00000253686.2; ENSG00000131368.9. [P82663-1];""ENST00000444840.6; ENSP00000407733.2; ENSG00000131368.9. [P82663-3]"";""ENST00000449354.7; ENSP00000390882.2; ENSG00000131368.9. [P82663-2]"";""ENST00000474866.3; ENSP00000511860.1; ENSG00000131368.9. [P82663-1]"";""ENST00000496484.3; ENSP00000511856.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695334.2; ENSP00000511812.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695376.1; ENSP00000511849.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695379.1; ENSP00000511852.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695380.2; ENSP00000511853.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695382.1; ENSP00000511855.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695386.1; ENSP00000511862.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695387.1; ENSP00000511863.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695391.1; ENSP00000511867.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695392.1; ENSP00000511868.1; ENSG00000131368.9. [P82663-1]"";""ENST00000695394.1; ENSP00000511870.1; ENSG00000131368.9. [P82663-1]"";""ENST00000698782.1; ENSP00000513929.1; ENSG00000131368.9. [P82663-1]"";""ENST00000698783.1; ENSP00000513930.1; ENSG00000131368.9. [P82663-1]"";",structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
Q9Y2Q9,S3,-1.352202656,-0.508020426,0.282915567,0.772930339,0.484219982,salmon,MRPS28,RT28_HUMAN,"Small ribosomal subunit protein bS1m (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt) (28S ribosomal protein S35, mitochondrial) (MRP-S35) (S35mt)",MRPS28 MRPS35 HSPC007,28957;,ENST00000276585.9; ENSP00000276585.4; ENSG00000147586.10.;,RNA binding [GO:0003723],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
Q9NP92,S3,-1.120180042,-1.188789388,0.22724044,0.813646813,0.478460125,salmon,MRPS30,RT30_HUMAN,"Large ribosomal subunit protein mL65 (39S ribosomal protein S30, mitochondrial) (MRP-S30) (S30mt) (Large ribosomal subunit protein mS30) (Programmed cell death protein 9)",MRPS30 PDCD9 BM-047,10884;,ENST00000507110.6; ENSP00000424328.1; ENSG00000112996.11.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],apoptotic process [GO:0006915]; mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]
Q92665,S3,-1.08626685,-0.82047363,0.189145694,0.895252625,0.342446055,salmon,MRPS31,RT31_HUMAN,"Small ribosomal subunit protein mS31 (28S ribosomal protein S31, mitochondrial) (MRP-S31) (S31mt) (Imogen 38)",MRPS31 IMOGN38,10240;,ENST00000323563.8; ENSP00000315397.6; ENSG00000102738.8.;,protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]
P82930,S3,-0.919565431,-0.506136807,0.306312217,0.580826568,0.428299579,salmon,MRPS34,RT34_HUMAN,"Small ribosomal subunit protein mS34 (28S ribosomal protein S34, mitochondrial) (MRP-S34) (S34mt)",MRPS34,65993;,ENST00000397375.7; ENSP00000380531.3; ENSG00000074071.15.;,structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
Q9Y2Q9,S3,-0.916693428,-0.407641397,0.174535235,0.732632944,0.226418394,salmon,MRPS35,RT28_HUMAN,"Small ribosomal subunit protein bS1m (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt) (28S ribosomal protein S35, mitochondrial) (MRP-S35) (S35mt)",MRPS28 MRPS35 HSPC007,28957;,ENST00000276585.9; ENSP00000276585.4; ENSG00000147586.10.;,RNA binding [GO:0003723],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
P82675,S3,-1.053402088,-0.661980227,0.264385677,0.806324097,0.492709679,salmon,MRPS5,RT05_HUMAN,"Small ribosomal subunit protein uS5m (28S ribosomal protein S5, mitochondrial) (MRP-S5) (S5mt)",MRPS5,64969;,"ENST00000272418.7; ENSP00000272418.2; ENSG00000144029.14. [P82675-1];""ENST00000345084.11; ENSP00000341660.5; ENSG00000144029.14. [P82675-2]"";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]
P82933,S3,-0.950448817,-0.765909768,0.199738265,0.699542827,0.374900094,salmon,MRPS9,RT09_HUMAN,"Small ribosomal subunit protein uS9m (28S ribosomal protein S9, mitochondrial) (MRP-S9) (S9mt)",MRPS9 RPMS9,64965;,ENST00000258455.8; ENSP00000258455.3; ENSG00000135972.9.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]
Q9HD23,M2,-0.595014805,-1.19267201,0.35127418,1.05808581,-0.199268038,tan4,MRS2,MRS2_HUMAN,"Magnesium transporter MRS2 homolog, mitochondrial (MRS2-like protein)",MRS2 HPT MRS2L,57380;,"ENST00000378353.5; ENSP00000367604.1; ENSG00000124532.15. [Q9HD23-2];""ENST00000378386.8; ENSP00000367637.3; ENSG00000124532.15. [Q9HD23-1]"";""ENST00000443868.6; ENSP00000399585.2; ENSG00000124532.15. [Q9HD23-4]"";",magnesium ion transmembrane transporter activity [GO:0015095],lactate metabolic process [GO:0006089]; mitochondrial magnesium ion transmembrane transport [GO:0045016]; transmembrane transport [GO:0055085],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
P20585,N4,-0.663636953,0.752546133,0.232960534,-0.122909834,0.187262052,grey30,MSH3,MSH3_HUMAN,DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1),MSH3 DUC1 DUG,4437;,ENST00000265081.7; ENSP00000265081.6; ENSG00000113318.11.;,ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983],DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; somatic recombination of immunoglobulin gene segments [GO:0016447],membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96DH6,N1,-0.68796915,-0.726785212,-0.041416266,-0.199253935,1.348276889,grey90,MSI2,MSI2H_HUMAN,RNA-binding protein Musashi homolog 2 (Musashi-2),MSI2,124540;,"ENST00000284073.7; ENSP00000284073.2; ENSG00000153944.12. [Q96DH6-1];""ENST00000322684.7; ENSP00000313616.3; ENSG00000153944.12. [Q96DH6-2]"";""ENST00000579180.2; ENSP00000462264.1; ENSG00000153944.12. [Q96DH6-3]"";""ENST00000674964.1; ENSP00000502137.1; ENSG00000153944.12. [Q96DH6-1]"";",identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723],central nervous system development [GO:0007417]; regulation of translation [GO:0006417]; stem cell development [GO:0048864],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]
Q9BUK6,C3,1.749181373,-0.033473873,-0.550589204,-0.376617363,-0.627171392,cyan,MSTO1,MSTO1_HUMAN,Protein misato homolog 1,MSTO1 LST005 SLTP005,55154;,"ENST00000245564.8; ENSP00000245564.3; ENSG00000125459.18. [Q9BUK6-1];""ENST00000368341.8; ENSP00000357325.4; ENSG00000125459.18. [Q9BUK6-7]"";""ENST00000490743.5; ENSP00000476353.1; ENSG00000125459.18. [Q9BUK6-4]"";",0,mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
P00395,M2,-2.489589194,-2.513033989,0.402551323,1.386554405,-0.206986826,tan4,MT-CO1,COX1_HUMAN,Cytochrome c oxidase subunit 1 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide I),MT-CO1 COI COXI MTCO1,4512;,ENST00000361624.2; ENSP00000354499.2; ENSG00000198804.2.;,cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872],"cellular respiration [GO:0045333]; cerebellum development [GO:0021549]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; response to copper ion [GO:0046688]; response to electrical stimulus [GO:0051602]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277]
P00403,M2,-0.930146799,-1.341407176,0.330764133,1.054779631,-0.200927838,tan4,MT-CO2,COX2_HUMAN,Cytochrome c oxidase subunit 2 (EC 7.1.1.9) (Cytochrome c oxidase polypeptide II),MT-CO2 COII COX2 COXII MTCO2,4513;,ENST00000361739.1; ENSP00000354876.1; ENSG00000198712.1.;,copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129],"ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; lactation [GO:0007595]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; response to hypoxia [GO:0001666]",membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277]
Q13330,N2,-1.194308273,0.210348628,0.806332583,-0.148459622,0.175462835,grey70,MTA1,MTA1_HUMAN,Metastasis-associated protein MTA1,MTA1,9112;,"ENST00000331320.12; ENSP00000333633.7; ENSG00000182979.18. [Q13330-1];""ENST00000405646.5; ENSP00000384180.1; ENSG00000182979.18. [Q13330-3]"";""ENST00000438610.5; ENSP00000393438.1; ENSG00000182979.18. [Q13330-2]"";",chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]
Q9NZJ7,M2,-1.143562756,-1.458454974,0.367733991,1.136437332,-0.169550507,tan4,MTCH1,MTCH1_HUMAN,Mitochondrial carrier homolog 1 (Presenilin-associated protein),MTCH1 PSAP CGI-64 UNQ1871/PRO4314,23787;,"ENST00000373616.9; ENSP00000362718.5; ENSG00000137409.21. [Q9NZJ7-2];""ENST00000373627.10; ENSP00000362730.5; ENSG00000137409.21. [Q9NZJ7-1]"";",membrane insertase activity [GO:0032977],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; neuronal ion channel clustering [GO:0045161]; positive regulation of apoptotic process [GO:0043065]; protein insertion into mitochondrial outer membrane [GO:0045040]; regulation of signal transduction [GO:0009966],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q9Y6C9,M2,-1.223874249,-1.463098535,0.36092832,1.220621335,-0.225769134,tan4,MTCH2,MTCH2_HUMAN,Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein),MTCH2 MIMP HSPC032,23788;,"ENST00000302503.8; ENSP00000303222.3; ENSG00000109919.10.;""ENST00000643223.2; ENSP00000495027.1; ENSG00000285121.2."";",membrane insertase activity [GO:0032977],lipid homeostasis [GO:0055088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of stem cell differentiation [GO:2000738]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q86UE4,S2,-1.220609242,-1.067151914,0.091897106,1.028363132,0.440799627,orange,MTDH,LYRIC_HUMAN,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),MTDH AEG1 LYRIC,92140;,ENST00000336273.8; ENSP00000338235.3; ENSG00000147649.10.;,double-stranded RNA binding [GO:0003725]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of transcription by RNA polymerase II [GO:0006357],apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; intercellular canaliculus [GO:0046581]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q96E29,S3,-1.264766618,-0.781329665,0.248743123,0.779437412,0.313142873,salmon,MTERFD1,MTEF3_HUMAN,"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTERF3) (mTERF domain-containing protein 1, mitochondrial)",MTERF3 MTERFD1 CGI-12,51001;,"ENST00000287025.4; ENSP00000287025.3; ENSG00000156469.9. [Q96E29-1];""ENST00000522822.5; ENSP00000430138.1; ENSG00000156469.9. [Q96E29-3]"";",transcription cis-regulatory region binding [GO:0000976],mitochondrial ribosome assembly [GO:0061668]; mitochondrial transcription [GO:0006390]; negative regulation of DNA-templated transcription [GO:0045892],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q7Z6M4,M1,-1.082506493,-0.336402312,0.387684718,0.852432547,-0.355082429,burlywood4,MTERFD2,MTEF4_HUMAN,"Transcription termination factor 4, mitochondrial (Mitochondrial transcription termination factor 4) (mTERF domain-containing protein 2) [Cleaved into: mTERF domain-containing protein 2 processed]",MTERF4 MTERFD2 HSPC096,130916;,"ENST00000241527.10; ENSP00000241527.6; ENSG00000122085.17.;""ENST00000391980.7; ENSP00000375840.2; ENSG00000122085.17."";""ENST00000614476.4; ENSP00000480378.1; ENSG00000122085.17."";",double-stranded DNA binding [GO:0003690]; rRNA binding [GO:0019843],camera-type eye development [GO:0043010]; heart development [GO:0007507]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial transcription [GO:0006390]; protein targeting to mitochondrion [GO:0006626]; regulation of DNA-templated transcription [GO:0006355]; rRNA processing [GO:0006364],cytosol [GO:0005829]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q9Y483,N3,-1.302659763,-0.976534301,0.989596017,-0.09969058,0.605892295,grey50,MTF2,MTF2_HUMAN,Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2) (hPCl2),MTF2 PCL2,22823;,"ENST00000370298.9; ENSP00000359321.4; ENSG00000143033.18. [Q9Y483-1];""ENST00000370303.4; ENSP00000359326.4; ENSG00000143033.18. [Q9Y483-4]"";""ENST00000540243.5; ENSP00000443295.1; ENSG00000143033.18. [Q9Y483-3]"";""ENST00000545708.5; ENSP00000444962.1; ENSG00000143033.18. [Q9Y483-3]"";",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222],"cellular response to leukemia inhibitory factor [GO:1990830]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of gene expression, epigenetic [GO:0045814]; segment specification [GO:0007379]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]",cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q15390,M2,-1.316047716,-1.02208516,0.344953047,1.2097815,-0.23965811,tan4,MTFR1,MTFR1_HUMAN,Mitochondrial fission regulator 1 (Chondrocyte protein with a poly-proline region),MTFR1 CHPPR FAM54A2 KIAA0009,9650;,"ENST00000262146.9; ENSP00000262146.4; ENSG00000066855.16. [Q15390-1];""ENST00000458689.2; ENSP00000391502.2; ENSG00000066855.16. [Q15390-2]"";",0,aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q9H019,M2,-0.860635071,-1.089572983,0.350411337,1.187876193,-0.470320711,tan4,MTFR1L,MFR1L_HUMAN,Mitochondrial fission regulator 1-like,MTFR1L FAM54B HYST1888 MSTP116,56181;,"ENST00000374300.7; ENSP00000363418.3; ENSG00000117640.18. [Q9H019-1];""ENST00000374301.7; ENSP00000363419.3; ENSG00000117640.18. [Q9H019-1]"";""ENST00000374303.7; ENSP00000363421.2; ENSG00000117640.18. [Q9H019-1]"";""ENST00000374307.9; ENSP00000363426.5; ENSG00000117640.18. [Q9H019-3]"";""ENST00000466284.1; ENSP00000434751.1; ENSG00000117640.18. [Q9H019-2]"";""ENST00000474295.5; ENSP00000435461.1; ENSG00000117640.18. [Q9H019-2]"";",0,aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266],mitochondrion [GO:0005739]
Q6P444,M2,-1.155531187,-1.369375694,0.408870366,1.219381003,-0.242051517,tan4,MTFR2,MTFR2_HUMAN,Mitochondrial fission regulator 2 (DUF729 domain-containing protein 1),MTFR2 DUFD1 FAM54A,113115;,"ENST00000367784.6; ENSP00000356758.2; ENSG00000146410.12. [Q6P444-2];""ENST00000420702.6; ENSP00000395232.1; ENSG00000146410.12. [Q6P444-1]"";""ENST00000451457.6; ENSP00000407010.2; ENSG00000146410.12. [Q6P444-1]"";",0,aerobic respiration [GO:0009060]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005],mitochondrion [GO:0005739]
Q6UB35,M1,-1.275232808,-0.088738719,0.422811259,0.848312312,-0.612095677,burlywood4,MTHFD1L,C1TM_HUMAN,"Monofunctional C1-tetrahydrofolate synthase, mitochondrial (EC 6.3.4.3) (Formyltetrahydrofolate synthetase)",MTHFD1L FTHFSDC1,25902;,"ENST00000367307.8; ENSP00000356276.4; ENSG00000120254.16. [Q6UB35-2];""ENST00000367321.8; ENSP00000356290.3; ENSG00000120254.16. [Q6UB35-1]"";",ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; protein homodimerization activity [GO:0042803],10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid-containing compound metabolic process [GO:0006760]; formate metabolic process [GO:0015942]; neural tube closure [GO:0001843]; tetrahydrofolate interconversion [GO:0035999],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q13613,C2,1.479061224,0.40324976,-0.509460807,-0.227861731,-0.323572855,aquamarine,MTMR1,MTMR1_HUMAN,"Myotubularin-related protein 1 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)",MTMR1,8776;,"ENST00000370390.7; ENSP00000359417.3; ENSG00000063601.17. [Q13613-1];""ENST00000485376.5; ENSP00000434105.1; ENSG00000063601.17. [Q13613-2]"";","phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein homodimerization activity [GO:0042803]",phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9C0I1,C3,1.744931916,-0.087249333,-0.550311173,-0.475502484,-0.653560589,cyan,MTMR12,MTMRC_HUMAN,Myotubularin-related protein 12 (Inactive phosphatidylinositol 3-phosphatase 12) (Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit) (3-PAP) (3-phosphatase adapter protein),MTMR12 KIAA1682 PIP3AP,54545;,"ENST00000264934.5; ENSP00000264934.5; ENSG00000150712.11. [Q9C0I1-3];""ENST00000280285.9; ENSP00000280285.5; ENSG00000150712.11. [Q9C0I1-2]"";""ENST00000382142.8; ENSP00000371577.3; ENSG00000150712.11. [Q9C0I1-1]"";",0,phosphatidylinositol dephosphorylation [GO:0046856],cytoplasm [GO:0005737]; cytosol [GO:0005829]; sarcomere [GO:0030017]; sarcoplasmic reticulum [GO:0016529]
Q13614,C5,1.715580015,0.270813472,-0.71672288,-0.604792495,-0.693396024,turquoise3,MTMR2,MTMR2_HUMAN,"Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)",MTMR2 KIAA1073,8898;,"ENST00000346299.10; ENSP00000345752.6; ENSG00000087053.20. [Q13614-1];""ENST00000352297.11; ENSP00000343737.7; ENSG00000087053.20. [Q13614-2]"";""ENST00000393223.8; ENSP00000376915.3; ENSG00000087053.20. [Q13614-2]"";""ENST00000409459.5; ENSP00000386882.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000444541.7; ENSP00000396020.2; ENSG00000087053.20. [Q13614-2]"";""ENST00000470293.6; ENSP00000502515.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000481642.6; ENSP00000502505.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000484818.6; ENSP00000501963.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000495134.6; ENSP00000501894.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000497683.6; ENSP00000501753.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000674528.1; ENSP00000501567.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000674610.1; ENSP00000501688.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000674924.1; ENSP00000502433.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000674968.1; ENSP00000502567.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000674989.1; ENSP00000502829.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675174.1; ENSP00000502032.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675196.1; ENSP00000501867.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675362.1; ENSP00000501989.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675454.1; ENSP00000501781.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675477.1; ENSP00000501751.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675489.1; ENSP00000501702.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675636.1; ENSP00000501850.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675652.1; ENSP00000502694.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675933.1; ENSP00000502575.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000675981.1; ENSP00000502204.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000676166.1; ENSP00000501632.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000676261.1; ENSP00000501675.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000676272.1; ENSP00000501601.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000676378.1; ENSP00000502736.1; ENSG00000087053.20. [Q13614-2]"";""ENST00000676440.1; ENSP00000501926.1; ENSG00000087053.20. [Q13614-2]"";","identical protein binding [GO:0042802]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]",dendritic spine maintenance [GO:0097062]; myelin assembly [GO:0032288]; negative regulation of endocytosis [GO:0045806]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of early endosome to late endosome transport [GO:2000643]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774]
Q13615,C1,1.354368577,-0.514220339,-0.41468623,0.009274324,-0.001408572,lightblue,MTMR3,MTMR3_HUMAN,"Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)",MTMR3 KIAA0371 ZFYVE10,8897;,"ENST00000333027.7; ENSP00000331649.3; ENSG00000100330.16. [Q13615-2];""ENST00000351488.7; ENSP00000307271.6; ENSG00000100330.16. [Q13615-3]"";""ENST00000401950.7; ENSP00000384651.3; ENSG00000100330.16. [Q13615-1]"";""ENST00000406629.1; ENSP00000384077.1; ENSG00000100330.16. [Q13615-2]"";","metal ion binding [GO:0046872]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]",cellular response to glucose starvation [GO:0042149]; macroautophagy [GO:0016236]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]
Q9Y217,C1,1.52778558,-0.553797315,-0.628931037,-0.450794584,0.39229121,lightblue,MTMR6,MTMR6_HUMAN,"Myotubularin-related protein 6 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)",MTMR6,9107;,ENST00000381801.6; ENSP00000371221.5; ENSG00000139505.13. [Q9Y217-1];,"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]",endocytosis [GO:0006897]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587]
Q9NVV4,M2,-1.075905137,-0.934520185,0.42666617,0.833576058,0.087720271,tan4,MTPAP,PAPD1_HUMAN,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",MTPAP PAPD1,55149;,ENST00000263063.9; ENSP00000263063.3; ENSG00000107951.15. [Q9NVV4-1];,ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134],histone mRNA catabolic process [GO:0071044]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397],intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q99707,C3,1.927516897,-0.041313015,-0.701658237,-0.577912167,-1.009521795,cyan,MTR,METH_HUMAN,Methionine synthase (MS) (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase),MTR,4548;,"ENST00000366577.10; ENSP00000355536.5; ENSG00000116984.15. [Q99707-1];""ENST00000535889.6; ENSP00000441845.1; ENSG00000116984.15. [Q99707-2]"";",cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270],axon regeneration [GO:0031103]; cellular response to nitric oxide [GO:0071732]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; methylation [GO:0032259]; nervous system development [GO:0007399]; response to axon injury [GO:0048678]; tetrahydrofolate metabolic process [GO:0046653],cytosol [GO:0005829]
Q13505,M2,-0.675783717,-1.078456944,0.387554893,1.012523772,-0.217386773,tan4,MTX1,MTX1_HUMAN,Metaxin-1 (Mitochondrial outer membrane import complex protein 1),MTX1 MTX MTXN,4580;,"ENST00000316721.8; ENSP00000317106.4; ENSG00000173171.15. [Q13505-2];""ENST00000368376.8; ENSP00000357360.3; ENSG00000173171.15. [Q13505-1]"";""ENST00000609421.1; ENSP00000476632.1; ENSG00000173171.15. [Q13505-3]"";",0,inner mitochondrial membrane organization [GO:0007007]; lactation [GO:0007595]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040],cytoplasm [GO:0005737]; membrane [GO:0016020]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; SAM complex [GO:0001401]
O75431,M2,-0.850029801,-1.194186658,0.411366326,1.059072555,-0.380416298,tan4,MTX2,MTX2_HUMAN,Metaxin-2 (Mitochondrial outer membrane import complex protein 2),MTX2,10651;,ENST00000249442.11; ENSP00000249442.6; ENSG00000128654.14. [O75431-1];,0,inner mitochondrial membrane organization [GO:0007007]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040],cytoplasm [GO:0005737]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401]
Q5HYI7,M2,-1.240995006,-1.510289524,0.438616544,1.221782811,-0.400798621,tan4,MTX3,MTX3_HUMAN,Metaxin-3,MTX3,345778;,"ENST00000509852.6; ENSP00000423302.1; ENSG00000177034.18. [Q5HYI7-4];""ENST00000512528.3; ENSP00000424798.2; ENSG00000177034.18. [Q5HYI7-1]"";""ENST00000512560.5; ENSP00000423600.1; ENSG00000177034.18. [Q5HYI7-5]"";",0,inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005]; protein transport [GO:0015031],cytoplasm [GO:0005737]; MIB complex [GO:0140275]; SAM complex [GO:0001401]
P15941,S1,-0.385767681,-0.875657303,0.233088351,0.430576081,0.837242782,gold,MUC1,MUC1_HUMAN,Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],MUC1 PUM,4582;,"ENST00000337604.6; ENSP00000338983.5; ENSG00000185499.17. [P15941-8];""ENST00000342482.8; ENSP00000342814.4; ENSG00000185499.17. [P15941-16]"";""ENST00000343256.9; ENSP00000339690.5; ENSG00000185499.17. [P15941-10]"";""ENST00000368389.6; ENSP00000357374.2; ENSG00000185499.17. [P15941-9]"";""ENST00000368390.7; ENSP00000357375.3; ENSG00000185499.17. [P15941-7]"";""ENST00000368392.7; ENSP00000357377.3; ENSG00000185499.17. [P15941-11]"";""ENST00000368393.7; ENSP00000357378.3; ENSG00000185499.17. [P15941-13]"";""ENST00000368396.8; ENSP00000357381.4; ENSG00000185499.17. [P15941-12]"";""ENST00000368398.7; ENSP00000357383.3; ENSG00000185499.17. [P15941-6]"";",p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712],"DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; positive regulation of transcription by RNA polymerase II [GO:0045944]",apical plasma membrane [GO:0016324]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]
Q969V5,M2,-0.684931179,-1.377391061,0.38285506,1.015891462,-0.021081453,tan4,MUL1,MUL1_HUMAN,Mitochondrial ubiquitin ligase activator of NFKB 1 (EC 2.3.2.27) (E3 SUMO-protein ligase MUL1) (E3 ubiquitin-protein ligase MUL1) (Growth inhibition and death E3 ligase) (Mitochondrial-anchored protein ligase) (Protein Hades) (Putative NF-kappa-B-activating protein 266) (RING finger protein 218) (RING-type E3 ubiquitin transferase NFKB 1),MUL1 C1orf166 GIDE MAPL MULAN RNF218,79594;,ENST00000264198.5; ENSP00000264198.3; ENSG00000090432.7.;,identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of cell growth [GO:0030308]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite extension [GO:1903861]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein sumoylation [GO:0033235]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of mitochondrion organization [GO:0010821],axon [GO:0030424]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]
Q96NY9,N1,-1.231109495,-0.715490833,-0.219936314,-0.203932405,1.404356602,grey90,MUS81,MUS81_HUMAN,Crossover junction endonuclease MUS81 (EC 3.1.22.-),MUS81,80198;,ENST00000308110.9; ENSP00000307853.4; ENSG00000172732.12.;,3'-flap endonuclease activity [GO:0048257]; crossover junction DNA endonuclease activity [GO:0008821]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872],DNA catabolic process [GO:0006308]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via break-induced replication [GO:0000727]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; osteoblast proliferation [GO:0033687]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429],endodeoxyribonuclease complex [GO:1905347]; Holliday junction resolvase complex [GO:0048476]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]
P53602,C5,1.908598268,0.537232884,-0.909375777,-1.175056385,-1.285928546,turquoise3,MVD,MVD1_HUMAN,Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase),MVD MPD,4597;,ENST00000301012.8; ENSP00000301012.3; ENSG00000167508.12.;,ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803],"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell population proliferation [GO:0008284]",cytosol [GO:0005829]
Q03426,C4,2.05666356,0.723058981,-1.065946125,-1.105505998,-1.460275309,deepskyblue2,MVK,KIME_HUMAN,Mevalonate kinase (MK) (EC 2.7.1.36),MVK,4598;,"ENST00000228510.8; ENSP00000228510.3; ENSG00000110921.14.;""ENST00000546277.6; ENSP00000438153.2; ENSG00000110921.14."";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; mevalonate kinase activity [GO:0004496],"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; negative regulation of inflammatory response [GO:0050728]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisome [GO:0005777]
Q14764,N1,0.329696533,-1.021240253,-0.923035278,-0.566652245,1.619228299,grey90,MVP,MVP_HUMAN,Major vault protein (MVP) (Lung resistance-related protein),MVP LRP,9961;,"ENST00000357402.10; ENSP00000349977.5; ENSG00000013364.19.;""ENST00000395353.5; ENSP00000378760.1; ENSG00000013364.19."";",identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903],cell population proliferation [GO:0008283]; ERBB signaling pathway [GO:0038127]; mRNA transport [GO:0051028]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein tyrosine kinase activity [GO:0061099]; protein activation cascade [GO:0072376]; protein transport [GO:0015031],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]
P84157,S2,-1.818579935,-1.508304075,0.171411166,0.953502748,0.731124058,orange,MXRA7,MXRA7_HUMAN,Matrix-remodeling-associated protein 7,MXRA7,439921;,"ENST00000355797.7; ENSP00000348050.2; ENSG00000182534.14. [P84157-1];""ENST00000375036.6; ENSP00000364176.1; ENSG00000182534.14. [P84157-3]"";""ENST00000449428.7; ENSP00000391466.1; ENSG00000182534.14. [P84157-2]"";",0,0,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]
Q96S97,S2,-1.483566934,-1.303168685,0.36962191,0.549514184,0.757653051,orange,MYADM,MYADM_HUMAN,Myeloid-associated differentiation marker (Protein SB135),MYADM UNQ553/PRO1110,91663;,"ENST00000391768.2; ENSP00000375648.2; ENSG00000179820.16.;""ENST00000391769.2; ENSP00000375649.2; ENSG00000179820.16."";""ENST00000391770.9; ENSP00000375650.4; ENSG00000179820.16."";""ENST00000391771.1; ENSP00000375651.1; ENSG00000179820.16."";""ENST00000421337.6; ENSP00000398269.2; ENSG00000179820.16."";",0,establishment of endothelial barrier [GO:0061028]; membrane raft organization [GO:0031579]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of protein kinase C signaling [GO:0090038]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to plasma membrane raft [GO:0044860],cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ruffle [GO:0001726]
Q9BQG0,N3,-1.176710106,-1.399908553,1.165592547,-0.540820637,0.403822128,grey50,MYBBP1A,MBB1A_HUMAN,Myb-binding protein 1A,MYBBP1A P160,10514;,"ENST00000254718.9; ENSP00000254718.4; ENSG00000132382.15. [Q9BQG0-1];""ENST00000381556.6; ENSP00000370968.2; ENSG00000132382.15. [Q9BQG0-2]"";",E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714],cellular response to glucose starvation [GO:0042149]; chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of DNA-templated transcription [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of DNA-templated transcription [GO:0006355]; regulation of G1 to G0 transition [GO:1903450]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254],B-WICH complex [GO:0110016]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P10244,N4,-0.814805033,1.111074242,-0.111325341,-0.109835624,-0.386527524,grey30,MYBL2,MYBB_HUMAN,Myb-related protein B (B-Myb) (Myb-like protein 2),MYBL2 BMYB,4605;,"ENST00000217026.5; ENSP00000217026.4; ENSG00000101057.16. [P10244-1];""ENST00000396863.8; ENSP00000380072.4; ENSG00000101057.16. [P10244-2]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",cellular response to leukemia inhibitory factor [GO:1990830]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O75592,S1,-0.261540388,-1.04990527,-0.299547313,0.148356219,1.293491705,gold,MYCBP2,MYCB2_HUMAN,E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc),MYCBP2 KIAA0916 PAM,23077;,ENST00000544440.7; ENSP00000444596.2; ENSG00000005810.20. [O75592-1];,guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q7Z406,C1,1.346416897,0.318005703,-0.184315119,-0.279606899,-0.394188949,lightblue,MYH14,MYH14_HUMAN,"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)",MYH14 KIAA2034 FP17425,79784;,"ENST00000376970.6; ENSP00000366169.3; ENSG00000105357.20. [Q7Z406-1];""ENST00000425460.6; ENSP00000407879.1; ENSG00000105357.20. [Q7Z406-6]"";""ENST00000596571.5; ENSP00000472819.1; ENSG00000105357.20. [Q7Z406-1]"";""ENST00000598205.5; ENSP00000472543.1; ENSG00000105357.20. [Q7Z406-6]"";""ENST00000642316.2; ENSP00000493594.1; ENSG00000105357.20. [Q7Z406-2]"";",actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146],actin filament-based movement [GO:0030048]; actomyosin structure organization [GO:0031032]; mitochondrion organization [GO:0007005]; neuronal action potential [GO:0019228]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal muscle contraction [GO:0003009]; skeletal muscle tissue development [GO:0007519]; vocalization behavior [GO:0071625],actomyosin [GO:0042641]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; growth cone [GO:0030426]; membrane [GO:0016020]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; stress fiber [GO:0001725]
Q96H55,M2,-1.171190092,-1.388064162,0.427982514,1.15969076,-0.292632015,tan4,MYO19,MYO19_HUMAN,Unconventional myosin-XIX (Myosin head domain-containing protein 1),MYO19 MYOHD1,80179;,"ENST00000610930.4; ENSP00000478437.1; ENSG00000278259.5. [Q96H55-4];""ENST00000610992.4; ENSP00000480125.1; ENSG00000278259.5. [Q96H55-3]"";""ENST00000613929.2; ENSP00000478355.1; ENSG00000278372.4. [Q96H55-4]"";""ENST00000614623.5; ENSP00000479518.1; ENSG00000278259.5. [Q96H55-1]"";""ENST00000618519.4; ENSP00000480242.1; ENSG00000278372.4. [Q96H55-1]"";""ENST00000621344.4; ENSP00000477559.1; ENSG00000278259.5. [Q96H55-2]"";""ENST00000633264.1; ENSP00000487617.1; ENSG00000278372.4. [Q96H55-3]"";""ENST00000633938.1; ENSP00000488204.1; ENSG00000278372.4. [Q96H55-2]"";",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microfilament motor activity [GO:0000146]; myosin light chain binding [GO:0032027]; plus-end directed microfilament motor activity [GO:0060002],actin filament organization [GO:0007015]; mitochondrion migration along actin filament [GO:0034642]; mitocytosis [GO:0160040]; regulation of cytokinesis [GO:0032465]; regulation of mitochondrial fission [GO:0090140]; vesicle transport along actin filament [GO:0030050],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; myosin complex [GO:0016459]; vesicle [GO:0031982]
O43795,S4,-0.700139034,-0.688549229,0.417742152,0.777407471,0.371323963,tomato2,MYO1B,MYO1B_HUMAN,Unconventional myosin-Ib (MYH-1c) (Myosin I alpha) (MMI-alpha) (MMIa),MYO1B,4430;,"ENST00000304164.8; ENSP00000306382.4; ENSG00000128641.19. [O43795-1];""ENST00000339514.8; ENSP00000341903.4; ENSG00000128641.19. [O43795-2]"";""ENST00000392318.8; ENSP00000376132.3; ENSG00000128641.19. [O43795-1]"";","actin filament binding [GO:0051015]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; post-Golgi vesicle-mediated transport [GO:0006892],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
B2RTY4,C2,1.079469573,-0.114766132,-0.110254183,0.073415486,0.063798572,aquamarine,MYO9A,MYO9A_HUMAN,Unconventional myosin-IXa (Unconventional myosin-9a),MYO9A MYR7,4649;,ENST00000356056.10; ENSP00000348349.5; ENSG00000066933.17. [B2RTY4-1];,actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146],cell junction assembly [GO:0034329]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; regulation of neuron projection arborization [GO:0150011]; regulation of small GTPase mediated signal transduction [GO:0051056]; visual perception [GO:0007601],actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytosol [GO:0005829]; membrane [GO:0016020]; synapse [GO:0045202]; unconventional myosin complex [GO:0016461]
Q13459,C3,1.626201173,-0.094356219,-0.442917429,-0.428986262,-0.520354976,cyan,MYO9B,MYO9B_HUMAN,Unconventional myosin-IXb (Unconventional myosin-9b),MYO9B MYR5,4650;,"ENST00000397274.6; ENSP00000380444.2; ENSG00000099331.14. [Q13459-2];""ENST00000595618.5; ENSP00000471457.1; ENSG00000099331.14. [Q13459-2]"";""ENST00000682292.1; ENSP00000507803.1; ENSG00000099331.14. [Q13459-1]"";",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microfilament motor activity [GO:0000146]; Roundabout binding [GO:0048495]; small GTPase binding [GO:0031267],actin filament-based movement [GO:0030048]; lamellipodium morphogenesis [GO:0072673]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Roundabout signaling pathway [GO:0035385],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]
Q9NZM1,S1,-0.992792023,-1.21999472,0.031640134,0.53051793,1.009694817,gold,MYOF,MYOF_HUMAN,Myoferlin (Fer-1-like protein 3),MYOF FER1L3 KIAA1207,26509;,"ENST00000358334.9; ENSP00000351094.5; ENSG00000138119.17. [Q9NZM1-6];""ENST00000359263.9; ENSP00000352208.4; ENSG00000138119.17. [Q9NZM1-1]"";""ENST00000371488.3; ENSP00000360543.3; ENSG00000138119.17. [Q9NZM1-4]"";""ENST00000371489.5; ENSP00000360544.1; ENSG00000138119.17. [Q9NZM1-7]"";",calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]
O75113,C3,1.653022539,0.313553379,-0.463874023,-0.340488684,-0.775231502,cyan,N4BP1,N4BP1_HUMAN,NEDD4-binding protein 1 (N4BP1) (EC 3.1.-.-),N4BP1 KIAA0615,9683;,ENST00000262384.4; ENSP00000262384.3; ENSG00000102921.8.;,mRNA binding [GO:0003729]; RNA nuclease activity [GO:0004540]; ubiquitin binding [GO:0043130],cellular response to UV [GO:0034644]; innate immune response [GO:0045087]; negative regulation of cytokine production [GO:0001818]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of viral genome replication [GO:0045071]; regulation of innate immune response [GO:0045088],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]
Q92802,N2,-1.000420011,-0.474869976,0.948036267,0.030056502,0.453458608,grey70,N4BP2L2,N42L2_HUMAN,NEDD4-binding protein 2-like 2 (Phosphonoformate immuno-associated protein 5),N4BP2L2 CG005 PFAAP5,10443;,"ENST00000267068.6; ENSP00000267068.3; ENSG00000244754.9. [Q92802-1];""ENST00000399396.7; ENSP00000382328.3; ENSG00000244754.9. [Q92802-3]"";""ENST00000446957.6; ENSP00000394239.2; ENSG00000244754.9. [Q92802-2]"";""ENST00000674349.1; ENSP00000501516.1; ENSG00000244754.9. [Q92802-1]"";""ENST00000674421.1; ENSP00000501518.1; ENSG00000244754.9. [Q92802-1]"";""ENST00000674465.1; ENSP00000501416.1; ENSG00000244754.9. [Q92802-1]"";""ENST00000674484.1; ENSP00000501537.1; ENSG00000244754.9. [Q92802-1]"";",enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714],blastocyst development [GO:0001824]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035],extracellular exosome [GO:0070062]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]
P41227,C5,1.659822913,0.679551845,-0.881715001,-1.023959835,-1.082045059,turquoise3,NAA10,NAA10_HUMAN,N-alpha-acetyltransferase 10 (EC 2.3.1.255) (N-terminal acetyltransferase complex ARD1 subunit homolog A) (hARD1) (NatA catalytic subunit Naa10),NAA10 ARD1 ARD1A TE2,8260;,"ENST00000370009.5; ENSP00000359026.1; ENSG00000102030.16. [P41227-2];""ENST00000464845.6; ENSP00000417763.1; ENSG00000102030.16. [P41227-1]"";",N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-alpha-N-acetyltransferase activity [GO:1990190]; peptide-serine-alpha-N-acetyltransferase activity [GO:1990189],"chromosome organization [GO:0051276]; internal protein amino acid acetylation [GO:0006475]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]; protein acetylation [GO:0006473]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]
Q9GZZ1,C5,1.796166196,0.494233177,-0.88229646,-0.993855439,-1.190137905,turquoise3,NAA50,NAA50_HUMAN,N-alpha-acetyltransferase 50 (hNaa50p) (EC 2.3.1.258) (N-acetyltransferase 13) (N-acetyltransferase 5) (hNAT5) (N-acetyltransferase san homolog) (hSAN) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit),NAA50 MAK3 NAT13 NAT5,80218;,ENST00000240922.8; ENSP00000240922.2; ENSG00000121579.14. [Q9GZZ1-1];,histone H4 acetyltransferase activity [GO:0010485]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858],"establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]
Q13765,C5,1.236423153,1.066126229,-0.776521809,-0.982145464,-1.050297414,turquoise3,NACA,NACA_HUMAN,Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC) (allergen Hom s 2),NACA HSD48,4666;,"ENST00000356769.7; ENSP00000349212.3; ENSG00000196531.14. [Q13765-1];""ENST00000393891.8; ENSP00000377469.4; ENSG00000196531.14. [Q13765-1]"";""ENST00000546392.6; ENSP00000446801.1; ENSG00000196531.14. [Q13765-1]"";""ENST00000552540.5; ENSP00000447821.1; ENSG00000196531.14. [Q13765-1]"";""ENST00000678066.1; ENSP00000503345.1; ENSG00000196531.14. [Q13765-1]"";",DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713],cardiac ventricle development [GO:0003231]; heart trabecula morphogenesis [GO:0061384]; negative regulation of protein localization to endoplasmic reticulum [GO:1905551]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of skeletal muscle fiber development [GO:0048742]; skeletal muscle tissue regeneration [GO:0043403]; translation [GO:0006412]; wound healing [GO:0042060],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]
Q13564,C5,1.263787883,0.968164203,-0.74978212,-0.832675707,-1.119512707,turquoise3,NAE1,ULA1_HUMAN,"NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa) (APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)",NAE1 APPBP1 HPP1,8883;,"ENST00000290810.8; ENSP00000290810.3; ENSG00000159593.15. [Q13564-1];""ENST00000359087.8; ENSP00000351990.4; ENSG00000159593.15. [Q13564-4]"";""ENST00000379463.6; ENSP00000368776.2; ENSG00000159593.15. [Q13564-2]"";""ENST00000394074.6; ENSP00000377637.2; ENSG00000159593.15. [Q13564-3]"";",NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982]; ubiquitin activating enzyme activity [GO:0004839]; ubiquitin protein ligase binding [GO:0031625],DNA damage response [GO:0006974]; mitotic DNA replication checkpoint signaling [GO:0033314]; neuron apoptotic process [GO:0051402]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of neuron apoptotic process [GO:0043523]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q9UJ70,C5,2.118870609,0.465651069,-1.018228273,-1.227490376,-1.434315374,turquoise3,NAGK,NAGK_HUMAN,N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase) (Muramyl dipeptide kinase) (EC 2.7.1.-) (N-acetyl-D-mannosamine kinase) (EC 2.7.1.60),NAGK,55577;,"ENST00000244204.11; ENSP00000244204.5; ENSG00000124357.13. [Q9UJ70-1];""ENST00000455662.6; ENSP00000389087.2; ENSG00000124357.13. [Q9UJ70-2]"";""ENST00000613852.4; ENSP00000477639.1; ENSG00000124357.13. [Q9UJ70-2]"";",ATP binding [GO:0005524]; muramyl dipeptide kinase activity [GO:0160047]; N-acetylglucosamine kinase activity [GO:0045127],defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; response to muramyl dipeptide [GO:0032495],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9UK23,S1,-0.637479032,-0.467249125,-0.25066916,0.521850627,0.740694722,gold,NAGPA,NAGPA_HUMAN,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase),NAGPA,51172;,"ENST00000312251.8; ENSP00000310998.3; ENSG00000103174.13. [Q9UK23-1];""ENST00000381955.7; ENSP00000371381.3; ENSG00000103174.13. [Q9UK23-2]"";""ENST00000562746.5; ENSP00000455900.1; ENSG00000103174.13. [Q9UK23-3]"";""ENST00000649828.1; ENSP00000498032.1; ENSG00000103174.13. [Q9UK23-3]"";",N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [GO:0003944],carbohydrate metabolic process [GO:0005975]; lysosome organization [GO:0007040]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020]
P43490,C5,1.584882038,0.731900221,-0.662004183,-0.722680751,-0.896791011,turquoise3,NAMPT,NAMPT_HUMAN,Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin),NAMPT PBEF PBEF1,10135;,"ENST00000222553.8; ENSP00000222553.3; ENSG00000105835.13.;""ENST00000424768.2; ENSP00000390591.2; ENSG00000105835.13."";""ENST00000681255.1; ENSP00000506129.1; ENSG00000105835.13."";""ENST00000681491.1; ENSP00000506540.1; ENSG00000105835.13."";",cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; nicotinamide phosphoribosyltransferase activity [GO:0047280],cell-cell signaling [GO:0007267]; circadian regulation of gene expression [GO:0032922]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; NAD biosynthetic process [GO:0009435]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165],cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]
Q8TBE9,C3,2.030820373,0.039468609,-0.797375305,-0.803816712,-1.0643582,cyan,NANP,NANP_HUMAN,N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase),NANP C20orf147 HDHD4,140838;,ENST00000304788.4; ENSP00000302441.3; ENSG00000170191.5.;,N-acylneuraminate-9-phosphatase activity [GO:0050124],N-acetylglucosamine biosynthetic process [GO:0006045]; N-acetylneuraminate biosynthetic process [GO:0046380],cytosol [GO:0005829]
Q9NR45,C5,1.386131206,1.047433275,-0.887016166,-1.18664314,-1.431804203,turquoise3,NANS,SIAS_HUMAN,Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase),NANS SAS,54187;,ENST00000210444.6; ENSP00000210444.5; ENSG00000095380.11.;,N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444],carbohydrate biosynthetic process [GO:0016051]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; glycosylation [GO:0070085],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q99733,C5,1.881172903,0.290105367,-0.806926339,-0.927057598,-0.860611372,turquoise3,NAP1L4,NP1L4_HUMAN,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),NAP1L4 NAP2,4676;,"ENST00000380542.9; ENSP00000369915.4; ENSG00000205531.14. [Q99733-1];""ENST00000526115.5; ENSP00000436397.1; ENSG00000205531.14. [Q99733-2]"";""ENST00000616696.1; ENSP00000478654.1; ENSG00000273562.4. [Q99733-2]"";""ENST00000619695.4; ENSP00000483728.1; ENSG00000273562.4. [Q99733-1]"";""ENST00000620138.4; ENSP00000481412.1; ENSG00000205531.14. [Q99733-2]"";""ENST00000632791.1; ENSP00000487984.1; ENSG00000273562.4. [Q99733-2]"";",chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082],nucleosome assembly [GO:0006334],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q9H115,C1,1.303450218,-0.281738108,-0.494480882,0.049174289,0.368542875,lightblue,NAPB,SNAB_HUMAN,Beta-soluble NSF attachment protein (SNAP-beta) (N-ethylmaleimide-sensitive factor attachment protein beta),NAPB SNAPB,63908;,"ENST00000377026.4; ENSP00000366225.4; ENSG00000125814.17. [Q9H115-1];""ENST00000398425.7; ENSP00000381459.3; ENSG00000125814.17. [Q9H115-3]"";""ENST00000432543.6; ENSP00000413600.2; ENSG00000125814.17. [Q9H115-2]"";",soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905],"intracellular protein transport [GO:0006886]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission, glutamatergic [GO:0035249]",extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]
Q6IQ20,S3,-0.723959776,-0.682730731,0.396314738,0.667926622,0.555779713,salmon,NAPEPLD,NAPEP_HUMAN,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),NAPEPLD C7orf18,222236;,"ENST00000341533.8; ENSP00000340093.4; ENSG00000161048.12.;""ENST00000417955.5; ENSP00000407112.1; ENSG00000161048.12."";""ENST00000422589.5; ENSP00000412376.1; ENSG00000161048.12."";""ENST00000427257.5; ENSP00000392775.1; ENSG00000161048.12."";""ENST00000465647.6; ENSP00000419188.1; ENSG00000161048.12."";""ENST00000611100.2; ENSP00000482162.1; ENSG00000275723.4."";""ENST00000622712.4; ENSP00000481285.1; ENSG00000275723.4."";""ENST00000632159.1; ENSP00000488504.1; ENSG00000275723.4."";""ENST00000632703.1; ENSP00000488648.1; ENSG00000275723.4."";""ENST00000633783.1; ENSP00000487770.1; ENSG00000275723.4."";",bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipase activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659],cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]
O43776,C5,1.864237545,0.448833263,-0.906878165,-1.016045929,-0.806170719,turquoise3,NARS,SYNC_HUMAN,"Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) (Asparaginyl-tRNA synthetase 1)",NARS1 NARS NRS,4677;,"ENST00000256854.10; ENSP00000256854.4; ENSG00000134440.12. [O43776-1];""ENST00000540592.5; ENSP00000442496.1; ENSG00000134440.12. [O43776-2]"";",asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; CCR3 chemokine receptor binding [GO:0031728]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983],asparaginyl-tRNA aminoacylation [GO:0006421]; cell migration [GO:0016477]; cerebral cortex development [GO:0021987]; tRNA aminoacylation for protein translation [GO:0006418],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P49321,N4,0.213968434,1.564134613,-0.653222238,-1.073854218,-1.498569088,grey30,NASP,NASP_HUMAN,Nuclear autoantigenic sperm protein (NASP),NASP,4678;,"ENST00000350030.8; ENSP00000255120.5; ENSG00000132780.17. [P49321-1];""ENST00000351223.7; ENSP00000255121.4; ENSG00000132780.17. [P49321-2]"";""ENST00000537798.5; ENSP00000438871.1; ENSG00000132780.17. [P49321-4]"";",histone binding [GO:0042393]; protein-containing complex binding [GO:0044877],blastocyst development [GO:0001824]; CENP-A containing chromatin assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
P23975,C5,2.178804565,0.28329519,-1.108076985,-1.217059558,-1.77969085,turquoise3,NAT1,SC6A2_HUMAN,Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2),SLC6A2 NAT1 NET1 SLC6A5,6530;,"ENST00000219833.13; ENSP00000219833.8; ENSG00000103546.19. [P23975-2];""ENST00000379906.6; ENSP00000369237.2; ENSG00000103546.19. [P23975-1]"";""ENST00000567238.1; ENSP00000457375.1; ENSG00000103546.19. [P23975-3]"";""ENST00000568943.6; ENSP00000457473.1; ENSG00000103546.19. [P23975-1]"";",actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334],amino acid transport [GO:0006865]; chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725],axon [GO:0030424]; cell surface [GO:0009986]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]
Q9H0A0,N3,-0.99488081,-1.189124532,1.158150133,-0.008897598,0.295651586,grey50,NAT10,NAT10_HUMAN,RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP),NAT10 ALP KIAA1709,55226;,"ENST00000257829.8; ENSP00000257829.3; ENSG00000135372.10. [Q9H0A0-1];""ENST00000531159.6; ENSP00000433011.2; ENSG00000135372.10. [Q9H0A0-2]"";",ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; mRNA N-acetyltransferase activity [GO:0106162]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; tRNA binding [GO:0000049]; tRNA N-acetyltransferase activity [GO:0051392],negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of translation [GO:0045727]; protein acetylation [GO:0006473]; regulation of centrosome duplication [GO:0010824]; regulation of translation [GO:0006417]; ribosomal small subunit biogenesis [GO:0042274]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391],"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; telomerase holoenzyme complex [GO:0005697]"
Q8WUY8,S2,-0.759553285,-1.441916954,0.230186262,0.861051218,0.579108499,orange,NAT14,NAT14_HUMAN,Probable N-acetyltransferase 14 (EC 2.3.1.-) (K562 cell-derived leucine-zipper-like protein 1),NAT14 KLP1,57106;,ENST00000205194.5; ENSP00000205194.3; ENSG00000090971.5.;,DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080],DNA-templated transcription initiation [GO:0006352]; positive regulation of DNA-templated transcription [GO:0045893],membrane [GO:0016020]; nucleus [GO:0005634]
A2RRP1,S2,-1.157596383,-1.395870763,0.114556927,0.807251384,0.733474138,orange,NBAS,NBAS_HUMAN,NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein) (Neuroblastoma-amplified sequence),NBAS NAG,51594;,ENST00000281513.10; ENSP00000281513.5; ENSG00000151779.14. [A2RRP1-1];,SNARE binding [GO:0000149],"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
O60934,N4,-1.325024724,1.203678888,-0.057833496,-0.735240041,-0.523064716,grey30,NBN,NBN_HUMAN,Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1) (hNbs1),NBN NBS NBS1 P95,4683;,"ENST00000265433.8; ENSP00000265433.4; ENSG00000104320.15.;""ENST00000697292.1; ENSP00000513229.1; ENSG00000104320.15."";""ENST00000697310.1; ENSP00000513245.1; ENSG00000104320.15."";",chromatin-protein adaptor activity [GO:0140463]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],"blastocyst growth [GO:0001832]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of telomere capping [GO:1904354]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein K63-linked ubiquitination [GO:0070534]; protein localization to site of double-strand break [GO:1990166]; R-loop processing [GO:0062176]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated DNA replication initiation [GO:0030174]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860]","BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]"
P42695,N4,-0.741727836,0.600261218,-0.071943395,-0.133557217,0.560578912,grey30,NCAPD3,CNDD3_HUMAN,Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3),NCAPD3 CAPD3 KIAA0056,23310;,"ENST00000534548.7; ENSP00000433681.3; ENSG00000151503.14.;""ENST00000685324.1; ENSP00000508707.1; ENSG00000151503.14."";""ENST00000688672.1; ENSP00000510391.1; ENSG00000151503.14."";",histone binding [GO:0042393]; methylated histone binding [GO:0035064],cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820],"condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]"
Q6IBW4,N4,-0.618411921,0.746188452,-0.144627801,-0.255383723,0.386216733,grey30,NCAPH2,CNDH2_HUMAN,Condensin-2 complex subunit H2 (Chromosome-associated protein H2) (hCAP-H2) (Kleisin-beta) (Non-SMC condensin II complex subunit H2),NCAPH2 CAPH2,29781;,"ENST00000299821.15; ENSP00000299821.11; ENSG00000025770.19. [Q6IBW4-4];""ENST00000395698.7; ENSP00000379050.3; ENSG00000025770.19. [Q6IBW4-5]"";""ENST00000420993.7; ENSP00000410088.2; ENSG00000025770.19. [Q6IBW4-1]"";",chromatin binding [GO:0003682],female meiosis chromosome separation [GO:0051309]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; T cell differentiation in thymus [GO:0033077],cell junction [GO:0030054]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q09161,N1,-0.736300213,0.190534099,0.216304878,-0.23618325,0.854709524,grey90,NCBP1,NCBP1_HUMAN,Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit),NCBP1 CBP80 NCBP,4686;,ENST00000375147.8; ENSP00000364289.3; ENSG00000136937.13.;,molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339],"7-methylguanosine mRNA capping [GO:0006370]; alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; defense response to virus [GO:0051607]; histone mRNA metabolic process [GO:0008334]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA metabolic process [GO:0016071]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cell growth [GO:0030307]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of RNA binding [GO:1905216]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; primary miRNA processing [GO:0031053]; regulation of mRNA processing [GO:0050684]; regulation of translational initiation [GO:0006446]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]; spliceosomal complex assembly [GO:0000245]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA cap binding complex [GO:0034518]
Q6PIU2,S2,-1.038910867,-1.475600518,0.273402603,0.843451006,0.501388301,orange,NCEH1,NCEH1_HUMAN,Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Acetylalkylglycerol acetylhydrolase) (2-acetyl MAGE hydrolase) (EC 3.1.1.71) (Arylacetamide deacetylase-like 1),NCEH1 AADACL1 KIAA1363,57552;,"ENST00000475381.7; ENSP00000418571.4; ENSG00000144959.11. [Q6PIU2-1];""ENST00000543711.5; ENSP00000443227.1; ENSG00000144959.11. [Q6PIU2-3]"";",acetylalkylglycerol acetylhydrolase activity [GO:0047378]; phosphate ion binding [GO:0042301]; serine hydrolase activity [GO:0017171]; sterol esterase activity [GO:0004771],ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P16333,C3,1.823580782,0.162848419,-0.650606142,-0.584651805,-0.910229452,cyan,NCK1,NCK1_HUMAN,SH2/SH3 adapter protein NCK1 (Cytoplasmic protein NCK1) (NCK adapter protein 1) (Nck-1) (SH2/SH3 adapter protein NCK-alpha),NCK1 NCK,4690;,"ENST00000288986.6; ENSP00000288986.2; ENSG00000158092.7. [P16333-1];""ENST00000469404.1; ENSP00000419631.1; ENSG00000158092.7. [P16333-2]"";""ENST00000481752.6; ENSP00000417273.1; ENSG00000158092.7. [P16333-1]"";",cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; molecular condensate scaffold activity [GO:0140693]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159],"actin filament organization [GO:0007015]; antiviral innate immune response [GO:0140374]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to endoplasmic reticulum stress [GO:0034976]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]",cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506]
O43639,C2,1.17514284,0.200194097,-0.251688813,-0.0724848,-0.387284381,aquamarine,NCK2,NCK2_HUMAN,Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta),NCK2 GRB4,8440;,"ENST00000233154.9; ENSP00000233154.4; ENSG00000071051.14.;""ENST00000393349.2; ENSP00000377018.2; ENSG00000071051.14."";",cytoskeletal anchor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159],actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of peptidyl-serine dephosphorylation [GO:1902310]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]
P19338,N1,-1.427344928,-0.707315301,-0.500426537,-0.636417579,1.769155596,grey90,NCL,NUCL_HUMAN,Nucleolin (Protein C23),NCL,4691;,ENST00000322723.9; ENSP00000318195.4; ENSG00000115053.17.;,DNA topoisomerase binding [GO:0044547]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; mRNA 5'-UTR binding [GO:0048027]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],"angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of translation [GO:0017148]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]",cell cortex [GO:0005938]; chromosome [GO:0005694]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular exosome [GO:0070062]; macropinosome membrane [GO:0160056]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]
Q969V3,S2,-0.954158985,-1.236640424,0.226786206,0.905794022,0.385433411,orange,NCLN,NCLN_HUMAN,BOS complex subunit NCLN (Nicalin) (Nicastrin-like protein),NCLN,56926;,ENST00000246117.9; ENSP00000246117.3; ENSG00000125912.11. [Q969V3-1];,ribosome binding [GO:0043022],determination of left/right asymmetry in lateral mesoderm [GO:0003140]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; negative regulation of nodal signaling pathway [GO:1900108]; protein stabilization [GO:0050821]; regulation of protein complex stability [GO:0061635]; regulation of protein-containing complex assembly [GO:0043254]; regulation of signal transduction [GO:0009966],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; multi-pass translocon complex [GO:0160064]; protein-containing complex [GO:0032991]
Q9HCD5,N2,-1.240972275,-0.408938498,1.150784667,-0.083867376,-0.326988607,grey70,NCOA5,NCOA5_HUMAN,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),NCOA5 KIAA1637,57727;,ENST00000290231.11; ENSP00000290231.6; ENSG00000124160.12.;,chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714],glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966],actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]
Q14686,N4,-0.951809642,1.04604807,-0.191513012,-0.726969503,0.005463615,grey30,NCOA6,NCOA6_HUMAN,"Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)",NCOA6 AIB3 KIAA0181 RAP250 TRBP,23054;,"ENST00000359003.7; ENSP00000351894.2; ENSG00000198646.14.;""ENST00000374796.6; ENSP00000363929.2; ENSG00000198646.14."";",chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor coactivator activity [GO:0030374]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713],brain development [GO:0007420]; DNA damage response [GO:0006974]; DNA-templated transcription initiation [GO:0006352]; heart development [GO:0007507]; myeloid cell differentiation [GO:0030099]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to hormone [GO:0009725],cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]
O75376,N4,-0.726342435,1.102485498,0.061294542,-0.493211637,-0.473795798,grey30,NCOR1,NCOR1_HUMAN,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),NCOR1 KIAA1047,9611;,"ENST00000268712.8; ENSP00000268712.2; ENSG00000141027.23. [O75376-1];""ENST00000395848.5; ENSP00000379189.1; ENSG00000141027.23. [O75376-3]"";""ENST00000395851.5; ENSP00000379192.1; ENSG00000141027.23. [O75376-2]"";",histone deacetylase binding [GO:0042826]; nuclear receptor binding [GO:0016922]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],chromatin organization [GO:0006325]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; spindle assembly [GO:0051225],chromatin [GO:0000785]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]
Q9Y618,N4,-0.668839621,1.139600002,-0.093642326,-0.386825647,-0.398651965,grey30,NCOR2,NCOR2_HUMAN,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",NCOR2 CTG26,9612;,ENST00000405201.6; ENSP00000384018.1; ENSG00000196498.15. [Q9Y618-1];,chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; Notch binding [GO:0005112]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear retinoid X receptor binding [GO:0046965]; transcription corepressor activity [GO:0003714],cerebellum development [GO:0021549]; estrous cycle [GO:0044849]; lactation [GO:0007595]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cellular ketone metabolic process [GO:0010565]; response to estradiol [GO:0032355]; response to organonitrogen compound [GO:0010243],chromatin [GO:0000785]; membrane [GO:0016020]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]
Q9BTX1,S4,-1.009582558,-1.467334809,0.891658114,0.509570597,0.284433801,tomato2,NDC1,NDC1_HUMAN,Nucleoporin NDC1 (hNDC1) (Transmembrane protein 48),NDC1 TMEM48,55706;,ENST00000371429.4; ENSP00000360483.3; ENSG00000058804.12. [Q9BTX1-1];,protein-macromolecule adaptor activity [GO:0030674]; structural constituent of nuclear pore [GO:0017056],homologous chromosome pairing at meiosis [GO:0007129]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore localization [GO:0051664]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; spermatogenesis [GO:0007283],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore transmembrane ring [GO:0070762]; plasma membrane [GO:0005886]
O14777,C3,1.588768111,0.230943819,-0.568535519,-0.411484387,-0.689449932,cyan,NDC80,NDC80_HUMAN,Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1) (HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC),NDC80 HEC HEC1 KNTC2,10403;,ENST00000261597.9; ENSP00000261597.4; ENSG00000080986.13.;,cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; microtubule binding [GO:0008017],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase chromosome alignment [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle assembly involved in female meiosis I [GO:0007057],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]"
Q9NXR1,C2,1.084608506,0.503541528,-0.373039787,-0.198640481,-0.529872035,aquamarine,NDE1,NDE1_HUMAN,Nuclear distribution protein nudE homolog 1 (NudE),NDE1 NUDE,54820;,"ENST00000396354.6; ENSP00000379642.1; ENSG00000072864.16. [Q9NXR1-2];""ENST00000396355.5; ENSP00000379643.1; ENSG00000072864.16. [Q9NXR1-2]"";""ENST00000631844.1; ENSP00000488199.1; ENSG00000275911.3. [Q9NXR1-2]"";""ENST00000631923.1; ENSP00000488050.1; ENSG00000275911.3. [Q9NXR1-2]"";""ENST00000674554.1; ENSP00000502635.1; ENSG00000072864.16. [Q9NXR1-2]"";""ENST00000674888.1; ENSP00000501936.1; ENSG00000072864.16. [Q9NXR1-2]"";""ENST00000675926.1; ENSP00000502354.1; ENSG00000072864.16. [Q9NXR1-2]"";""ENST00000675951.1; ENSP00000502160.1; ENSG00000072864.16. [Q9NXR1-2]"";",identical protein binding [GO:0042802]; microtubule binding [GO:0008017],cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; vesicle transport along microtubule [GO:0047496],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]
Q9GZM8,C2,0.768823478,0.253855662,-0.047124582,0.147251881,-0.193953791,aquamarine,NDEL1,NDEL1_HUMAN,Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1),NDEL1 EOPA MITAP1 NUDEL,81565;,"ENST00000334527.12; ENSP00000333982.7; ENSG00000166579.16. [Q9GZM8-1];""ENST00000402554.7; ENSP00000384963.3; ENSG00000166579.16. [Q9GZM8-3]"";",alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017],cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron projection extension [GO:1990138]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; radial glia-guided pyramidal neuron migration [GO:0140650]; regulation of intracellular protein transport [GO:0033157]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]
Q9BT67,S1,-0.913861934,-1.460045296,-0.239095312,0.752022423,1.032648876,gold,NDFIP1,NFIP1_HUMAN,NEDD4 family-interacting protein 1 (Breast cancer-associated protein SGA-1M) (NEDD4 WW domain-binding protein 5) (Putative MAPK-activating protein PM13) (Putative NF-kappa-B-activating protein 164) (Putative NFKB and MAPK-activating protein),NDFIP1 N4WBP5 PSEC0192 PSEC0223,80762;,ENST00000253814.6; ENSP00000253814.3; ENSG00000131507.11. [Q9BT67-1];,WW domain binding [GO:0050699],"CD4-positive, alpha-beta T cell proliferation [GO:0035739]; intracellular iron ion homeostasis [GO:0006879]; metal ion transport [GO:0030001]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of protein transport [GO:0051224]; negative regulation of transporter activity [GO:0032410]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of lymphocyte differentiation [GO:0045619]; regulation of myeloid leukocyte differentiation [GO:0002761]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034]",cell cortex [GO:0005938]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]
Q9NV92,S1,-0.876412705,-1.205822973,-0.117800409,0.727100493,0.960154414,gold,NDFIP2,NFIP2_HUMAN,NEDD4 family-interacting protein 2 (NEDD4 WW domain-binding protein 5A) (Putative MAPK-activating protein PM04/PM05/PM06/PM07) (Putative NF-kappa-B-activating protein 413),NDFIP2 KIAA1165 N4WBP5A,54602;,ENST00000218652.12; ENSP00000218652.7; ENSG00000102471.16.;,WW domain binding [GO:0050699],metal ion transport [GO:0030001]; negative regulation of gene expression [GO:0010629]; negative regulation of protein transport [GO:0051224]; negative regulation of transporter activity [GO:0032410]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; ubiquitin-dependent protein catabolic process [GO:0006511]; vacuolar transport [GO:0007034],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; perinuclear region of cytoplasm [GO:0048471]
Q9UHB4,C5,1.913306645,0.402171028,-0.779840153,-0.832920139,-1.028264968,turquoise3,NDOR1,NDOR1_HUMAN,NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) (Novel reductase 1),NDOR1 NR1,27158;,"ENST00000371521.8; ENSP00000360576.4; ENSG00000188566.15. [Q9UHB4-2];""ENST00000427047.6; ENSP00000394309.1; ENSG00000188566.15. [Q9UHB4-3]"";""ENST00000458322.2; ENSP00000389905.1; ENSG00000188566.15. [Q9UHB4-4]"";""ENST00000684003.1; ENSP00000507194.1; ENSG00000188566.15. [Q9UHB4-1]"";","electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor [GO:0016731]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]",electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]
Q92597,C1,1.71120851,0.004388454,-0.578708094,-0.341602125,-0.555493893,lightblue,NDRG1,NDRG1_HUMAN,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),NDRG1 CAP43 DRG1 RTP,10397;,"ENST00000323851.13; ENSP00000319977.8; ENSG00000104419.17. [Q92597-1];""ENST00000414097.6; ENSP00000404854.2; ENSG00000104419.17. [Q92597-1]"";""ENST00000522476.5; ENSP00000427894.1; ENSG00000104419.17. [Q92597-2]"";",cadherin binding [GO:0045296]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; small GTPase binding [GO:0031267],"cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; mast cell activation [GO:0045576]; negative regulation of cell population proliferation [GO:0008285]; peripheral nervous system myelin maintenance [GO:0032287]; response to metal ion [GO:0010038]; signal transduction [GO:0007165]",adherens junction [GO:0005912]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]
Q9UN36,C4,1.92962379,0.127112855,-0.947313854,-0.874041644,-1.27443703,deepskyblue2,NDRG2,NDRG2_HUMAN,Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613),NDRG2 KIAA1248 SYLD,57447;,"ENST00000298684.9; ENSP00000298684.5; ENSG00000165795.25. [Q9UN36-4];""ENST00000298687.9; ENSP00000298687.5; ENSG00000165795.25. [Q9UN36-1]"";""ENST00000350792.7; ENSP00000344620.3; ENSG00000165795.25. [Q9UN36-2]"";""ENST00000360463.7; ENSP00000353649.3; ENSG00000165795.25. [Q9UN36-2]"";""ENST00000397844.6; ENSP00000380943.2; ENSG00000165795.25. [Q9UN36-5]"";""ENST00000397847.6; ENSP00000380945.2; ENSG00000165795.25. [Q9UN36-3]"";""ENST00000397851.6; ENSP00000380949.2; ENSG00000165795.25. [Q9UN36-1]"";""ENST00000397853.7; ENSP00000380951.3; ENSG00000165795.25. [Q9UN36-1]"";""ENST00000397858.5; ENSP00000380956.1; ENSG00000165795.25. [Q9UN36-1]"";""ENST00000403829.7; ENSP00000385889.3; ENSG00000165795.25. [Q9UN36-6]"";""ENST00000553503.5; ENSP00000452306.1; ENSG00000165795.25. [Q9UN36-2]"";""ENST00000554143.5; ENSP00000452006.1; ENSG00000165795.25. [Q9UN36-2]"";""ENST00000555158.5; ENSP00000452038.1; ENSG00000165795.25. [Q9UN36-2]"";""ENST00000556147.6; ENSP00000451712.1; ENSG00000165795.25. [Q9UN36-1]"";",0,cell differentiation [GO:0030154]; negative regulation of cytokine production [GO:0001818]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; regulation of platelet-derived growth factor production [GO:0090361]; regulation of vascular endothelial growth factor production [GO:0010574]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]; vascular associated smooth muscle cell proliferation [GO:1990874]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q9UGV2,C1,1.689331569,-0.019414292,-0.45811554,-0.247216637,-0.565334089,lightblue,NDRG3,NDRG3_HUMAN,Protein NDRG3 (N-myc downstream-regulated gene 3 protein),NDRG3,57446;,"ENST00000349004.6; ENSP00000345292.1; ENSG00000101079.21. [Q9UGV2-1];""ENST00000359675.6; ENSP00000352703.2; ENSG00000101079.21. [Q9UGV2-2]"";",0,cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]
P52848,S1,-0.889693531,-1.170577417,-0.130774287,0.762334936,1.023248527,gold,NDST1,NDST1_HUMAN,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (Glucosaminyl N-deacetylase/N-sulfotransferase 1) (NDST-1) (N-heparan sulfate sulfotransferase 1) (N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1) (HSNST 1) [Includes: Heparan sulfate N-deacetylase 1 (EC 3.5.1.-); Heparan sulfate N-sulfotransferase 1 (EC 2.8.2.8)],NDST1 HSST HSST1,3340;,"ENST00000261797.7; ENSP00000261797.6; ENSG00000070614.15. [P52848-1];""ENST00000523767.5; ENSP00000428604.1; ENSG00000070614.15. [P52848-3]"";",[heparan sulfate]-glucosamine N-sulfotransferase activity [GO:0015016]; deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; N-acetylglucosamine deacetylase activity [GO:0050119],"aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell population proliferation [GO:0008283]; coronary vasculature development [GO:0060976]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain development [GO:0030900]; heparan sulfate proteoglycan biosynthetic process, enzymatic modification [GO:0015015]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; inflammatory response [GO:0006954]; midbrain development [GO:0030901]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smoothened signaling pathway [GO:0045880]; respiratory gaseous exchange by respiratory system [GO:0007585]",Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network membrane [GO:0032588]
O95299,M2,-1.510725239,-1.567642409,0.400240375,1.299535495,-0.224127898,tan4,NDUFA10,NDUAA_HUMAN,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)",NDUFA10,4705;,"ENST00000252711.7; ENSP00000252711.2; ENSG00000130414.13. [O95299-1];""ENST00000307300.8; ENSP00000302321.4; ENSG00000130414.13. [O95299-2]"";""ENST00000676929.1; ENSP00000503956.1; ENSG00000130414.13. [O95299-1]"";""ENST00000678158.1; ENSP00000504765.1; ENSG00000130414.13. [O95299-1]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
Q9UI09,M2,-0.896556022,-1.125497129,0.417919005,1.114763864,-0.100285188,tan4,NDUFA12,NDUAC_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 (13 kDa differentiation-associated protein) (Complex I-B17.2) (CI-B17.2) (CIB17.2) (NADH-ubiquinone oxidoreductase subunit B17.2),NDUFA12 DAP13,55967;,"ENST00000327772.7; ENSP00000330737.2; ENSG00000184752.14. [Q9UI09-1];""ENST00000547986.5; ENSP00000450130.1; ENSG00000184752.14. [Q9UI09-2]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O43678,M2,-1.250817306,-0.659172558,0.341124143,1.169792175,-0.313876261,tan4,NDUFA2,NDUA2_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit),NDUFA2,4695;,"ENST00000252102.9; ENSP00000252102.5; ENSG00000131495.9. [O43678-1];""ENST00000512088.1; ENSP00000427220.1; ENSG00000131495.9. [O43678-2]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; blastocyst hatching [GO:0001835]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]
O95167,M2,-1.273978136,-1.468003832,0.332905875,1.083179035,-0.082381422,tan4,NDUFA3,NDUA3_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 (Complex I-B9) (CI-B9) (NADH-ubiquinone oxidoreductase B9 subunit),NDUFA3,4696;,"ENST00000419113.5; ENSP00000398290.1; ENSG00000170906.16.;""ENST00000485876.6; ENSP00000418438.1; ENSG00000170906.16."";""ENST00000610406.1; ENSP00000478119.1; ENSG00000275724.1."";""ENST00000612327.1; ENSP00000480437.1; ENSG00000276220.1."";""ENST00000613276.1; ENSP00000477919.1; ENSG00000273642.1."";""ENST00000617282.1; ENSP00000482015.1; ENSG00000278365.1."";""ENST00000618338.1; ENSP00000481545.1; ENSG00000274359.1."";""ENST00000619253.1; ENSP00000483934.1; ENSG00000275605.1."";""ENST00000619966.1; ENSP00000484436.1; ENSG00000276766.1."";""ENST00000620289.4; ENSP00000477783.1; ENSG00000276061.4."";""ENST00000621307.1; ENSP00000483002.1; ENSG00000277722.1."";""ENST00000622523.4; ENSP00000483683.1; ENSG00000276061.4."";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O00483,M2,-1.141812619,-1.263645391,0.392745763,1.175273315,-0.06393367,tan4,NDUFA4,NDUA4_HUMAN,Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ) (CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit),NDUFA4,4697;,ENST00000339600.6; ENSP00000339720.5; ENSG00000189043.10.;,NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protein-containing complex binding [GO:0044877],"cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; positive regulation of cytochrome-c oxidase activity [GO:1904960]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]
Q16718,M2,-1.74319071,-1.232269059,0.453079417,1.171421126,-0.286926731,tan4,NDUFA5,NDUA5_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit),NDUFA5,4698;,"ENST00000355749.7; ENSP00000347988.2; ENSG00000128609.16. [Q16718-1];""ENST00000471770.5; ENSP00000417142.1; ENSG00000128609.16. [Q16718-2]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]
P51970,M2,-1.120998267,-1.103432796,0.417632469,1.084945293,-0.272182755,tan4,NDUFA8,NDUA8_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (Complex I-PGIV) (CI-PGIV) (NADH-ubiquinone oxidoreductase 19 kDa subunit),NDUFA8,4702;,ENST00000373768.4; ENSP00000362873.3; ENSG00000119421.7.;,NADH dehydrogenase (ubiquinone) activity [GO:0008137]; protein-containing complex binding [GO:0044877],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O14561,M1,-1.319943371,-0.057745141,0.287844334,0.939991909,-0.714387043,burlywood4,NDUFAB1,ACPM_HUMAN,"Acyl carrier protein, mitochondrial (ACP) (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)",NDUFAB1,4706;,"ENST00000007516.8; ENSP00000007516.2; ENSG00000004779.10.;""ENST00000570319.5; ENSP00000458770.1; ENSG00000004779.10."";",acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; calcium ion binding [GO:0005509]; fatty acid binding [GO:0005504]; mitochondrial large ribosomal subunit binding [GO:0140978],"[2Fe-2S] cluster assembly [GO:0044571]; aerobic respiration [GO:0009060]; fatty acid biosynthetic process [GO:0006633]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein lipoylation [GO:0009249]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q9Y375,M2,-1.671055425,-1.838924355,0.375688044,1.210293729,-0.174086267,tan4,NDUFAF1,CIA30_HUMAN,"Complex I intermediate-associated protein 30, mitochondrial (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1)",NDUFAF1 CIA30 CGI-65,51103;,"ENST00000260361.9; ENSP00000260361.4; ENSG00000137806.10.;""ENST00000560978.2; ENSP00000453944.2; ENSG00000137806.10."";",unfolded protein binding [GO:0051082],"chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein-containing complex assembly [GO:0065003]",cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
Q8N183,M2,-0.934317652,-1.144984397,0.319315276,1.085435918,-0.053084568,tan4,NDUFAF2,NDUF2_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 (B17.2-like) (B17.2L) (Mimitin) (Myc-induced mitochondrial protein) (MMTN) (NDUFA12-like protein),NDUFAF2 NDUFA12L,91942;,ENST00000296597.10; ENSP00000296597.5; ENSG00000164182.12.;,protein-containing complex binding [GO:0044877],mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9BU61,M2,-0.680023226,-0.940513113,0.336618375,0.97662333,-0.166206778,tan4,NDUFAF3,NDUF3_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,NDUFAF3 C3orf60,25915;,"ENST00000326912.8; ENSP00000323003.4; ENSG00000178057.15. [Q9BU61-2];""ENST00000326925.11; ENSP00000323076.5; ENSG00000178057.15. [Q9BU61-1]"";""ENST00000395458.6; ENSP00000378843.2; ENSG00000178057.15. [Q9BU61-2]"";""ENST00000451378.2; ENSP00000402465.2; ENSG00000178057.15. [Q9BU61-2]"";",0,mitochondrial respiratory chain complex I assembly [GO:0032981],mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]
Q9P032,M2,-1.531586623,-1.466327933,0.382016057,1.241110973,-0.206576569,tan4,NDUFAF4,NDUF4_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa),NDUFAF4 C6orf66 HRPAP20 HSPC125 My013,29078;,ENST00000316149.8; ENSP00000358272.4; ENSG00000123545.6.;,calmodulin binding [GO:0005516],defense response to virus [GO:0051607]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]
Q7L592,M1,-1.062845248,-0.259633997,0.476296529,0.868567932,-0.412507973,burlywood4,NDUFAF7,NDUF7_HUMAN,"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)",NDUFAF7 C2orf56 PRO1853,55471;,"ENST00000002125.9; ENSP00000002125.4; ENSG00000003509.16. [Q7L592-1];""ENST00000336237.10; ENSP00000337431.6; ENSG00000003509.16. [Q7L592-2]"";",enzyme binding [GO:0019899]; methyltransferase activity [GO:0008168]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243],"mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]",extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
O75438,M2,-1.256144755,-1.422925515,0.34163635,1.208512829,-0.215433178,tan4,NDUFB1,NDUB1_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 (Complex I-MNLL) (CI-MNLL) (NADH-ubiquinone oxidoreductase MNLL subunit),NDUFB1,4707;,"ENST00000329559.8; ENSP00000330787.4; ENSG00000183648.11. [O75438-1];""ENST00000553514.5; ENSP00000451090.2; ENSG00000183648.11. [O75438-1]"";""ENST00000555441.5; ENSP00000450776.1; ENSG00000183648.11. [O75438-1]"";""ENST00000605997.6; ENSP00000475170.1; ENSG00000183648.11. [O75438-1]"";""ENST00000617122.1; ENSP00000483888.1; ENSG00000183648.11. [O75438-2]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]
O96000,M2,-0.90388266,-1.142936353,0.391772315,1.121776034,-0.153793435,tan4,NDUFB10,NDUBA_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Complex I-PDSW) (CI-PDSW) (NADH-ubiquinone oxidoreductase PDSW subunit),NDUFB10,4716;,"ENST00000268668.11; ENSP00000268668.6; ENSG00000140990.15. [O96000-1];""ENST00000543683.6; ENSP00000445086.2; ENSG00000140990.15. [O96000-2]"";""ENST00000709233.1; ENSP00000517571.1; ENSG00000291930.1. [O96000-1]"";""ENST00000709234.1; ENSP00000517572.1; ENSG00000291930.1. [O96000-2]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]
Q9NX14,M2,-1.005711034,-1.461701567,0.247793502,1.226766689,-0.127267107,tan4,NDUFB11,NDUBB_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) (Neuronal protein 17.3) (Np17.3) (p17.3)",NDUFB11 UNQ111/PRO1064,54539;,"ENST00000377811.4; ENSP00000367042.3; ENSG00000147123.12. [Q9NX14-1];""ENST00000687244.1; ENSP00000509334.1; ENSG00000147123.12. [Q9NX14-2]"";",0,aerobic respiration [GO:0009060]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O43676,M2,-1.413419061,-1.509287683,0.393114801,1.266441139,-0.174578887,tan4,NDUFB3,NDUB3_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit),NDUFB3,4709;,"ENST00000237889.9; ENSP00000237889.4; ENSG00000119013.10.;""ENST00000433898.5; ENSP00000410600.1; ENSG00000119013.10."";""ENST00000450023.6; ENSP00000401834.2; ENSG00000119013.10."";""ENST00000454214.1; ENSP00000407336.1; ENSG00000119013.10."";""ENST00000682325.1; ENSP00000507925.1; ENSG00000119013.10."";""ENST00000684175.1; ENSP00000508132.1; ENSG00000119013.10."";""ENST00000684420.1; ENSP00000508208.1; ENSG00000119013.10."";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]
O95168,M2,-0.3721381,-0.764002723,0.254043199,0.85403256,-0.092205859,tan4,NDUFB4,NDUB4_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 (Complex I-B15) (CI-B15) (NADH-ubiquinone oxidoreductase B15 subunit),NDUFB4,4710;,"ENST00000184266.3; ENSP00000184266.2; ENSG00000065518.8. [O95168-1];""ENST00000485064.1; ENSP00000419578.1; ENSG00000065518.8. [O95168-2]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
O43674,M2,-1.167917496,-1.57859505,0.355186497,1.279738872,-0.109401941,tan4,NDUFB5,NDUB5_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)",NDUFB5,4711;,"ENST00000259037.8; ENSP00000259037.3; ENSG00000136521.13. [O43674-1];""ENST00000493866.5; ENSP00000419656.1; ENSG00000136521.13. [O43674-2]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
O95139,M2,-0.941460719,-1.139252362,0.30328694,1.187783753,-0.047366499,tan4,NDUFB6,NDUB6_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 (Complex I-B17) (CI-B17) (NADH-ubiquinone oxidoreductase B17 subunit),NDUFB6,4712;,"ENST00000350021.2; ENSP00000297983.3; ENSG00000165264.11. [O95139-2];""ENST00000379847.8; ENSP00000369176.3; ENSG00000165264.11. [O95139-1]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
P17568,M2,-1.060888315,-1.210373844,0.362746875,1.077650826,-0.122442936,tan4,NDUFB7,NDUB7_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 (Cell adhesion protein SQM1) (Complex I-B18) (CI-B18) (NADH-ubiquinone oxidoreductase B18 subunit),NDUFB7,4713;,ENST00000215565.3; ENSP00000215565.1; ENSG00000099795.7.;,NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O95169,M2,-0.517448864,-1.173831016,0.37149946,1.113959877,-0.10884753,tan4,NDUFB8,NDUB8_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)",NDUFB8,4714;,"ENST00000299166.9; ENSP00000299166.4; ENSG00000166136.16. [O95169-1];""ENST00000370320.4; ENSP00000359344.4; ENSG00000166136.16. [O95169-2]"";""ENST00000370322.5; ENSP00000359346.1; ENSG00000166136.16. [O95169-3]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
Q9Y6M9,M2,-0.75247723,-1.211105048,0.276951594,1.003993149,-0.278164406,tan4,NDUFB9,NDUB9_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (LYR motif-containing protein 3) (NADH-ubiquinone oxidoreductase B22 subunit),NDUFB9 LYRM3 UQOR22,4715;,"ENST00000276689.8; ENSP00000276689.3; ENSG00000147684.10.;""ENST00000677021.1; ENSP00000504235.1; ENSG00000147684.10."";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; sensory perception of sound [GO:0007605]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O95298,M2,-1.194502303,-1.464663899,0.287243264,1.300087652,-0.097677592,tan4,NDUFC2,NDUC2_HUMAN,NADH dehydrogenase [ubiquinone] 1 subunit C2 (Complex I-B14.5b) (CI-B14.5b) (Human lung cancer oncogene 1 protein) (HLC-1) (NADH-ubiquinone oxidoreductase subunit B14.5b),NDUFC2 HLC1,4718;,"ENST00000281031.5; ENSP00000281031.4; ENSG00000151366.13. [O95298-1];""ENST00000525085.1; ENSP00000434262.1; ENSG00000151366.13. [O95298-2]"";""ENST00000527806.1; ENSP00000432739.1; ENSG00000151366.13. [O95298-3]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",azurophil granule membrane [GO:0035577]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
P28331,M2,-0.894366231,-0.775498726,0.339386883,1.049731152,-0.233353791,tan4,NDUFS1,NDUS1_HUMAN,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 7.1.1.2) (Complex I-75kD) (CI-75kD)",NDUFS1,4719;,"ENST00000233190.11; ENSP00000233190.5; ENSG00000023228.15. [P28331-1];""ENST00000423725.5; ENSP00000397760.1; ENSG00000023228.15. [P28331-4]"";""ENST00000432169.5; ENSP00000409689.1; ENSG00000023228.15. [P28331-3]"";""ENST00000440274.5; ENSP00000409766.1; ENSG00000023228.15. [P28331-5]"";""ENST00000449699.5; ENSP00000399912.1; ENSG00000023228.15. [P28331-1]"";""ENST00000635748.2; ENSP00000489640.1; ENSG00000283447.3. [P28331-1]"";""ENST00000636505.1; ENSP00000490898.1; ENSG00000283447.3. [P28331-1]"";""ENST00000637298.1; ENSP00000490583.1; ENSG00000283447.3. [P28331-4]"";""ENST00000637631.1; ENSP00000489705.1; ENSG00000283447.3. [P28331-3]"";""ENST00000637990.1; ENSP00000490766.1; ENSG00000283447.3. [P28331-5]"";","2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]","aerobic respiration [GO:0009060]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]",mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O75306,M2,-0.947697929,-1.209585528,0.493877155,1.000951801,-0.187630433,tan4,NDUFS2,NDUS2_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",NDUFS2,4720;,"ENST00000367993.7; ENSP00000356972.3; ENSG00000158864.13. [O75306-1];""ENST00000392179.5; ENSP00000376018.4; ENSG00000158864.13. [O75306-2]"";""ENST00000676600.1; ENSP00000503989.1; ENSG00000158864.13. [O75306-1]"";""ENST00000676972.1; ENSP00000503117.1; ENSG00000158864.13. [O75306-1]"";""ENST00000677457.1; ENSP00000503294.1; ENSG00000158864.13. [O75306-2]"";""ENST00000677550.1; ENSP00000503353.1; ENSG00000158864.13. [O75306-2]"";""ENST00000678507.1; ENSP00000504199.1; ENSG00000158864.13. [O75306-1]"";""ENST00000678511.1; ENSP00000504846.1; ENSG00000158864.13. [O75306-1]"";""ENST00000678605.1; ENSP00000503969.1; ENSG00000158864.13. [O75306-2]"";""ENST00000679176.1; ENSP00000504170.1; ENSG00000158864.13. [O75306-2]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxygen sensor activity [GO:0019826]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]","aerobic respiration [GO:0009060]; cellular response to oxygen levels [GO:0071453]; gliogenesis [GO:0042063]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]",mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
O75489,M2,-1.071353419,-1.155425906,0.390866667,1.082500662,-0.159463032,tan4,NDUFS3,NDUS3_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)",NDUFS3,4722;,ENST00000263774.9; ENSP00000263774.4; ENSG00000213619.11. [O75489-1];,electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762]",mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]
O43181,M2,-0.99119203,-1.055199821,0.296717807,1.206143591,-0.254376307,tan4,NDUFS4,NDUS4_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)",NDUFS4,4724;,ENST00000296684.10; ENSP00000296684.5; ENSG00000164258.12.;,NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular respiration [GO:0045333]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; reactive oxygen species metabolic process [GO:0072593]; regulation of protein phosphorylation [GO:0001932]; response to cAMP [GO:0051591]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O43920,M2,-1.453768735,-1.51984121,0.519482645,1.078259028,-0.133733026,tan4,NDUFS5,NDUS5_HUMAN,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa) (CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit),NDUFS5,4725;,"ENST00000372967.3; ENSP00000362058.3; ENSG00000168653.11.;""ENST00000372969.8; ENSP00000362060.3; ENSG00000168653.11."";",NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
O75380,M2,-0.875906962,-0.95390561,0.294122622,1.037884324,-0.205544628,tan4,NDUFS6,NDUS6_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)",NDUFS6,4726;,ENST00000274137.10; ENSP00000274137.6; ENSG00000145494.12.;,electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]
O75251,M2,-0.885705723,-1.245938833,0.334321804,1.116931148,-0.19874386,tan4,NDUFS7,NDUS7_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)",NDUFS7,374291;,"ENST00000233627.14; ENSP00000233627.9; ENSG00000115286.21. [O75251-1];""ENST00000313408.11; ENSP00000364262.5; ENSG00000115286.21. [O75251-2]"";""ENST00000546283.5; ENSP00000440348.1; ENSG00000115286.21. [O75251-2]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; protease binding [GO:0002020]; quinone binding [GO:0048038]","aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; neuronal cell body [GO:0043025]; synaptic membrane [GO:0097060]
O00217,M2,-1.541056346,-1.571654908,0.400609102,1.263311372,-0.08266122,tan4,NDUFS8,NDUS8_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)",NDUFS8,4728;,ENST00000313468.10; ENSP00000315774.5; ENSG00000110717.13.;,"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]","aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; response to oxidative stress [GO:0006979]",mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
P49821,M2,-1.16789119,-1.061127855,0.447646561,1.107178428,-0.221800014,tan4,NDUFV1,NDUV1_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (NDUFV1) (EC 7.1.1.2) (Complex I-51kD) (CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)",NDUFV1 UQOR1,4723;,"ENST00000322776.11; ENSP00000322450.6; ENSG00000167792.13. [P49821-1];""ENST00000529927.5; ENSP00000436766.1; ENSG00000167792.13. [P49821-2]"";""ENST00000647561.1; ENSP00000497587.1; ENSG00000167792.13. [P49821-1]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]","aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
P19404,M2,-0.94291943,-0.711164349,0.343137314,1.11664694,-0.446285994,tan4,NDUFV2,NDUV2_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (NDUFV2) (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit)",NDUFV2,4729;,ENST00000318388.11; ENSP00000327268.6; ENSG00000178127.13.;,"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]","aerobic respiration [GO:0009060]; cardiac muscle tissue development [GO:0048738]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
P56181,M2,-0.864714203,-0.786468153,0.327593825,1.071981731,-0.318811352,tan4,NDUFV3,NDUV3_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial (Complex I-9kD) (CI-9kD) (NADH-ubiquinone oxidoreductase 9 kDa subunit) (Renal carcinoma antigen NY-REN-4)",NDUFV3,4731;,"ENST00000340344.4; ENSP00000342895.3; ENSG00000160194.18. [P56181-1];""ENST00000354250.7; ENSP00000346196.2; ENSG00000160194.18. [P56181-2]"";",NADH dehydrogenase (ubiquinone) activity [GO:0008137]; RNA binding [GO:0003723],"aerobic respiration [GO:0009060]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]
Q8NC96,C3,1.802235459,0.197031101,-0.541351949,-0.445458996,-0.749268416,cyan,NECAP1,NECP1_HUMAN,Adaptin ear-binding coat-associated protein 1 (NECAP endocytosis-associated protein 1) (NECAP-1),NECAP1,25977;,"ENST00000339754.11; ENSP00000341737.5; ENSG00000089818.18. [Q8NC96-1];""ENST00000450991.6; ENSP00000401963.2; ENSG00000089818.18. [Q8NC96-2]"";""ENST00000639955.1; ENSP00000491067.1; ENSG00000089818.18. [Q8NC96-1]"";",0,endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q9NVZ3,C3,1.781269307,0.266329992,-0.527279351,-0.511931167,-0.693679921,cyan,NECAP2,NECP2_HUMAN,Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2) (NECAP-2),NECAP2,55707;,"ENST00000337132.10; ENSP00000338746.5; ENSG00000157191.20. [Q9NVZ3-1];""ENST00000443980.6; ENSP00000391942.2; ENSG00000157191.20. [Q9NVZ3-2]"";""ENST00000457722.6; ENSP00000407091.2; ENSG00000157191.20. [Q9NVZ3-4]"";""ENST00000492095.5; ENSP00000427620.1; ENSG00000157191.20. [Q9NVZ3-1]"";""ENST00000707372.1; ENSP00000516847.1; ENSG00000291380.1. [Q9NVZ3-1]"";""ENST00000707374.1; ENSP00000516849.1; ENSG00000291380.1. [Q9NVZ3-4]"";""ENST00000707376.1; ENSP00000516850.1; ENSG00000291380.1. [Q9NVZ3-2]"";""ENST00000707379.1; ENSP00000516852.1; ENSG00000291380.1. [Q9NVZ3-1]"";",0,endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]
Q8TDX7,C3,1.635851349,-0.022901064,-0.418869652,-0.320027131,-0.491331619,cyan,NEK7,NEK7_HUMAN,Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),NEK7,140609;,"ENST00000367383.5; ENSP00000356353.1; ENSG00000151414.15. [Q8TDX7-2];""ENST00000367385.9; ENSP00000356355.4; ENSG00000151414.15. [Q8TDX7-1]"";""ENST00000538004.5; ENSP00000444621.1; ENSG00000151414.15. [Q8TDX7-1]"";",ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]
Q9H3P2,N4,-0.963727921,1.115429797,-0.047848237,-0.211378914,-0.299741912,grey30,NELFA,NELFA_HUMAN,Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 protein),NELFA WHSC2 P/OKcl.15,7469;,ENST00000382882.9; ENSP00000372335.4; ENSG00000185049.16. [Q9H3P2-1];,chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090],negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of protein modification process [GO:0031401]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P18615,N4,-0.791354846,1.14071198,-0.187507613,-0.533667725,0.104740255,grey30,NELFE,NELFE_HUMAN,Negative elongation factor E (NELF-E) (RNA-binding protein RD),NELFE RD RDBP,7936;,"ENST00000375425.9; ENSP00000364574.5; ENSG00000204356.14. [P18615-3];""ENST00000375429.8; ENSP00000364578.3; ENSG00000204356.14. [P18615-1]"";""ENST00000383174.8; ENSP00000372660.4; ENSG00000206268.11. [P18615-1]"";""ENST00000383343.8; ENSP00000372834.4; ENSG00000206357.11. [P18615-1]"";""ENST00000429857.6; ENSP00000403623.2; ENSG00000231044.10. [P18615-1]"";""ENST00000444811.6; ENSP00000388400.2; ENSG00000204356.14. [P18615-4]"";""ENST00000448628.6; ENSP00000394879.2; ENSG00000229363.9. [P18615-1]"";""ENST00000457397.6; ENSP00000393005.2; ENSG00000233801.9. [P18615-1]"";",chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein modification process [GO:0031401]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q92859,S3,-0.767082087,-0.394632754,0.27477162,0.688901501,0.194430419,salmon,NEO1,NEO1_HUMAN,Neogenin (Immunoglobulin superfamily DCC subclass member 2),NEO1 IGDCC2 NGN,4756;,"ENST00000261908.11; ENSP00000261908.6; ENSG00000067141.17. [Q92859-1];""ENST00000339362.9; ENSP00000341198.5; ENSG00000067141.17. [Q92859-1]"";""ENST00000558964.5; ENSP00000453200.1; ENSG00000067141.17. [Q92859-4]"";""ENST00000560262.5; ENSP00000453317.1; ENSG00000067141.17. [Q92859-3]"";",BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023],axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of DNA-templated transcription [GO:0006355],axonal growth cone [GO:0044295]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; intracellular vesicle [GO:0097708]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]
P23975,S3,-0.805585559,-0.793519106,0.1662332,0.838926632,0.525107561,salmon,NET1,SC6A2_HUMAN,Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2),SLC6A2 NAT1 NET1 SLC6A5,6530;,"ENST00000219833.13; ENSP00000219833.8; ENSG00000103546.19. [P23975-2];""ENST00000379906.6; ENSP00000369237.2; ENSG00000103546.19. [P23975-1]"";""ENST00000567238.1; ENSP00000457375.1; ENSG00000103546.19. [P23975-3]"";""ENST00000568943.6; ENSP00000457473.1; ENSG00000103546.19. [P23975-1]"";",actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dopamine:sodium symporter activity [GO:0005330]; metal ion binding [GO:0046872]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; neurotransmitter:sodium symporter activity [GO:0005328]; norepinephrine:sodium symporter activity [GO:0005334],amino acid transport [GO:0006865]; chemical synaptic transmission [GO:0007268]; dopamine uptake involved in synaptic transmission [GO:0051583]; monoamine transport [GO:0015844]; neuron cellular homeostasis [GO:0070050]; neurotransmitter transport [GO:0006836]; norepinephrine transport [GO:0015874]; norepinephrine uptake [GO:0051620]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sodium ion transmembrane transport [GO:0035725],axon [GO:0030424]; cell surface [GO:0009986]; membrane [GO:0016020]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]
Q96JN8,S1,-0.14940913,-0.816507224,-0.127787285,0.525216179,0.889884951,gold,NEURL4,NEUL4_HUMAN,Neuralized-like protein 4,NEURL4 KIAA1787,84461;,"ENST00000315614.11; ENSP00000319826.7; ENSG00000215041.10. [Q96JN8-2];""ENST00000399464.7; ENSP00000382390.2; ENSG00000215041.10. [Q96JN8-1]"";""ENST00000671847.1; ENSP00000500916.1; ENSG00000288301.1. [Q96JN8-1]"";""ENST00000673081.1; ENSP00000500667.1; ENSG00000288301.1. [Q96JN8-2]"";",ubiquitin protein ligase activity [GO:0061630],0,centriole [GO:0005814]; cytoplasm [GO:0005737]
Q14494,S3,-1.330775864,-0.827465953,0.483306916,0.833120087,0.444389675,salmon,NFE2L1,NF2L1_HUMAN,"Endoplasmic reticulum membrane sensor NFE2L1 (Locus control region-factor 1) (LCR-F1) (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) (Protein NRF1, p120 form) (Transcription factor 11) (TCF-11) [Cleaved into: Transcription factor NRF1 (Protein NRF1, p110 form)]",NFE2L1 HBZ17 NRF1 TCF11,4779;,"ENST00000357480.9; ENSP00000350072.5; ENSG00000082641.16. [Q14494-2];""ENST00000362042.8; ENSP00000354855.3; ENSG00000082641.16. [Q14494-1]"";""ENST00000585291.5; ENSP00000461960.1; ENSG00000082641.16. [Q14494-2]"";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",anatomical structure morphogenesis [GO:0009653]; cholesterol metabolic process [GO:0008203]; heme biosynthetic process [GO:0006783]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P19838,C3,1.802921746,0.131872597,-0.584122747,-0.660666336,-1.017213219,cyan,NFKB1,NFKB1_HUMAN,Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit],NFKB1,4790;,"ENST00000226574.9; ENSP00000226574.4; ENSG00000109320.14. [P19838-2];""ENST00000394820.8; ENSP00000378297.4; ENSG00000109320.14. [P19838-1]"";""ENST00000505458.5; ENSP00000424790.1; ENSG00000109320.14. [P19838-1]"";""ENST00000509165.2; ENSP00000423877.2; ENSG00000109320.14. [P19838-2]"";","actinin binding [GO:0042805]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]",antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to dsRNA [GO:0071359]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-17 [GO:0097398]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; JNK cascade [GO:0007254]; mammary gland involution [GO:0060056]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vitamin D biosynthetic process [GO:0010957]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of miRNA metabolic process [GO:2000630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to muscle stretch [GO:0035994]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; I-kappaB/NF-kappaB complex [GO:0033256]; mitochondrion [GO:0005739]; NF-kappaB p50/p65 complex [GO:0035525]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; transcription regulator complex [GO:0005667]
Q00653,C3,1.825050036,0.053561144,-0.450347739,-0.573111642,-0.845789713,cyan,NFKB2,NFKB2_HUMAN,Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit],NFKB2 LYT10,4791;,"ENST00000189444.11; ENSP00000189444.6; ENSG00000077150.21. [Q00653-4];""ENST00000369966.8; ENSP00000358983.3; ENSG00000077150.21. [Q00653-1]"";""ENST00000428099.6; ENSP00000410256.1; ENSG00000077150.21. [Q00653-4]"";""ENST00000652277.1; ENSP00000498308.1; ENSG00000077150.21. [Q00653-4]"";""ENST00000661543.1; ENSP00000499294.1; ENSG00000077150.21. [Q00653-1]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",canonical NF-kappaB signal transduction [GO:0007249]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; rhythmic process [GO:0048511]; spleen development [GO:0048536],Bcl3/NF-kappaB2 complex [GO:0033257]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q15653,C4,2.070523301,0.276403651,-1.115887753,-1.133723637,-1.334250134,deepskyblue2,NFKBIB,IKBB_HUMAN,NF-kappa-B inhibitor beta (NF-kappa-BIB) (I-kappa-B-beta) (IkB-B) (IkB-beta) (IkappaBbeta) (Thyroid receptor-interacting protein 9) (TR-interacting protein 9) (TRIP-9),NFKBIB IKBB TRIP9,4793;,"ENST00000313582.6; ENSP00000312988.5; ENSG00000104825.17. [Q15653-1];""ENST00000572515.5; ENSP00000459728.1; ENSG00000104825.17. [Q15653-2]"";""ENST00000634647.1; ENSP00000489145.1; ENSG00000282905.2. [Q15653-2]"";""ENST00000635517.2; ENSP00000489138.1; ENSG00000282905.2. [Q15653-1]"";",transcription coactivator activity [GO:0003713],cellular response to lipopolysaccharide [GO:0071222]; DNA-templated transcription [GO:0006351]; inflammatory response [GO:0006954]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleus [GO:0005634]
Q9UBC1,N2,-0.724871704,-0.012039637,0.673302703,0.075979029,0.423448749,grey70,NFKBIL1,IKBL1_HUMAN,NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein) (I-kappa-B-like protein) (IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1),NFKBIL1 IKBL,4795;,"ENST00000376145.8; ENSP00000365315.4; ENSG00000204498.11. [Q9UBC1-3];""ENST00000376146.8; ENSP00000365316.4; ENSG00000204498.11. [Q9UBC1-2]"";""ENST00000376148.9; ENSP00000365318.4; ENSG00000204498.11. [Q9UBC1-1]"";""ENST00000383500.4; ENSP00000372992.4; ENSG00000206440.10."";""ENST00000400279.7; ENSP00000383137.3; ENSG00000206440.10."";""ENST00000400285.7; ENSP00000383142.3; ENSG00000206440.10."";""ENST00000414391.6; ENSP00000414084.2; ENSG00000234530.8."";""ENST00000419122.6; ENSP00000394486.2; ENSG00000234530.8."";""ENST00000419623.6; ENSP00000414206.2; ENSG00000236346.8."";""ENST00000421396.2; ENSP00000399871.2; ENSG00000235125.8."";""ENST00000424652.6; ENSP00000395544.2; ENSG00000236346.8."";""ENST00000428467.6; ENSP00000407809.2; ENSG00000236346.8."";""ENST00000430501.2; ENSP00000404901.2; ENSG00000236196.8."";""ENST00000430961.6; ENSP00000411174.2; ENSG00000235125.8."";""ENST00000432160.6; ENSP00000411611.2; ENSG00000227565.8."";""ENST00000434332.6; ENSP00000413952.2; ENSG00000234530.8."";""ENST00000442947.6; ENSP00000396656.2; ENSG00000235125.8."";""ENST00000451911.2; ENSP00000413643.2; ENSG00000227565.8."";""ENST00000453377.6; ENSP00000395977.2; ENSG00000227565.8."";""ENST00000455376.6; ENSP00000408426.2; ENSG00000236196.8."";""ENST00000456607.6; ENSP00000401830.2; ENSG00000236196.8."";",transcription regulator inhibitor activity [GO:0140416],cellular response to lipopolysaccharide [GO:0071222]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6ZNB6,S2,-1.209473652,-1.447140606,0.076107767,0.917039947,0.53032959,orange,NFXL1,NFXL1_HUMAN,NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein) (hOZFP),NFXL1 OZFP,152518;,"ENST00000329043.7; ENSP00000333113.4; ENSG00000170448.12. [Q6ZNB6-1];""ENST00000381538.7; ENSP00000370949.3; ENSG00000170448.12. [Q6ZNB6-1]"";""ENST00000464756.6; ENSP00000425812.1; ENSG00000170448.12. [Q6ZNB6-2]"";""ENST00000507489.2; ENSP00000422037.1; ENSG00000170448.12. [Q6ZNB6-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; membrane [GO:0016020]; nucleus [GO:0005634]
Q8NEJ9,N3,-1.232910072,-1.082211923,1.099164028,0.117967555,0.275928087,grey50,NGDN,NGDN_HUMAN,Neuroguidin (Centromere accumulated nuclear protein 1) (CANu1) (EIF4E-binding protein),NGDN C14orf120,25983;,"ENST00000397154.7; ENSP00000380340.3; ENSG00000129460.17. [Q8NEJ9-2];""ENST00000408901.8; ENSP00000386134.3; ENSG00000129460.17. [Q8NEJ9-1]"";",RNA binding [GO:0003723],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of protein localization to plasma membrane [GO:1903077]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of translation at postsynapse [GO:0140245]; ribosomal small subunit biogenesis [GO:0042274]","axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perforant pathway to dendrate granule cell synapse [GO:0140240]; postsynapse [GO:0098794]; small-subunit processome [GO:0032040]"
Q96IV0,C2,1.146665512,0.358113711,-0.229159559,-0.058379368,-0.303260388,aquamarine,NGLY1,NGLY1_HUMAN,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (hPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase),NGLY1 PNG1,55768;,"ENST00000280700.10; ENSP00000280700.5; ENSG00000151092.18. [Q96IV0-1];""ENST00000396649.7; ENSP00000379886.3; ENSG00000151092.18. [Q96IV0-3]"";""ENST00000417874.6; ENSP00000389888.2; ENSG00000151092.18. [Q96IV0-5]"";""ENST00000428257.5; ENSP00000387430.1; ENSG00000151092.18. [Q96IV0-2]"";",metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224],glycoprotein catabolic process [GO:0006516]; protein folding [GO:0006457],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q9NPE2,S3,-1.10613038,-0.61553074,0.171992412,0.721307685,0.546983974,salmon,NGRN,NGRN_HUMAN,Neugrin (Mesenchymal stem cell protein DSC92) (Neurite outgrowth-associated protein) (Spinal cord-derived protein FI58G),NGRN FI58G HT020,51335;,ENST00000379095.5; ENSP00000368389.4; ENSG00000182768.9. [Q9NPE2-2];,RNA binding [GO:0003723]; rRNA binding [GO:0019843],mitochondrial ribosome assembly [GO:0061668]; neuron differentiation [GO:0030182]; positive regulation of mitochondrial translation [GO:0070131],extracellular region [GO:0005576]; intercellular bridge [GO:0045171]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P55769,N3,-0.986057554,-0.927563767,1.232812821,-0.043452966,-0.033720521,grey50,NHP2L1,NH2L1_HUMAN,"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (OTK27) (SNU13 homolog) (hSNU13) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]",SNU13 NHP2L1,4809;,"ENST00000215956.10; ENSP00000215956.5; ENSG00000100138.15.;""ENST00000401959.6; ENSP00000383949.1; ENSG00000100138.15."";""ENST00000648674.1; ENSP00000497142.1; ENSG00000100138.15."";",ATPase binding [GO:0051117]; box C/D sno(s)RNA binding [GO:0034512]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622],"box C/D snoRNP assembly [GO:0000492]; maturation of SSU-rRNA [GO:0030490]; mRNA splicing, via spliceosome [GO:0000398]; ribosomal small subunit biogenesis [GO:0042274]; single fertilization [GO:0007338]",box C/D methylation guide snoRNP complex [GO:0031428]; dense fibrillar component [GO:0001651]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]
Q9GZT8,C5,1.493011068,0.62102603,-0.691149195,-0.358775108,-0.839570236,turquoise3,NIF3L1,NIF3L_HUMAN,NIF3-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein),NIF3L1 ALS2CR1 MDS015 My018,60491;,"ENST00000359683.8; ENSP00000352711.4; ENSG00000196290.17. [Q9GZT8-2];""ENST00000409020.6; ENSP00000386394.1; ENSG00000196290.17. [Q9GZT8-1]"";""ENST00000409357.5; ENSP00000387315.1; ENSG00000196290.17. [Q9GZT8-1]"";""ENST00000409588.1; ENSP00000387021.1; ENSG00000196290.17. [Q9GZT8-3]"";""ENST00000651500.1; ENSP00000498853.1; ENSG00000196290.17. [Q9GZT8-1]"";",identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q9BYG3,N3,-0.936717117,-1.148779371,1.098094127,-0.143231322,0.538922051,grey50,NIFK,MK67I_HUMAN,MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar phosphoprotein Nopp34) (Nucleolar protein interacting with the FHA domain of pKI-67) (hNIFK),NIFK MKI67IP NOPP34,84365;,ENST00000285814.9; ENSP00000285814.4; ENSG00000155438.12.;,RNA binding [GO:0003723],"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein-containing complex assembly [GO:0065003]; rRNA metabolic process [GO:0016072]; rRNA transcription [GO:0009303]",chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9Y221,N3,-0.878020833,-0.976890775,1.030226156,-0.222493356,0.526283489,grey50,NIP7,NIP7_HUMAN,60S ribosome subunit biogenesis protein NIP7 homolog (KD93) (Nucleolar pre-rRNA processing protein NIP7),NIP7 CGI-37 HSPC031 HSPC180 OK/SW-cl.76 OK/SW-cl.78,51388;,"ENST00000254940.10; ENSP00000254940.5; ENSG00000132603.15. [Q9Y221-1];""ENST00000254941.6; ENSP00000254941.6; ENSG00000132603.15. [Q9Y221-2]"";",RNA binding [GO:0003723],ribosomal large subunit biogenesis [GO:0042273]; ribosome assembly [GO:0042255],"cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"
Q8N8Q9,S1,-0.718108777,-1.088862998,-0.138073934,0.636580389,0.909750978,gold,NIPA2,NIPA2_HUMAN,Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2),NIPA2,81614;,"ENST00000337451.8; ENSP00000337618.3; ENSG00000140157.16. [Q8N8Q9-1];""ENST00000359727.8; ENSP00000352762.4; ENSG00000140157.16. [Q8N8Q9-2]"";""ENST00000398013.7; ENSP00000381095.3; ENSG00000140157.16. [Q8N8Q9-1]"";""ENST00000398014.7; ENSP00000381096.3; ENSG00000140157.16. [Q8N8Q9-2]"";""ENST00000539711.2; ENSP00000437746.2; ENSG00000140157.16. [Q8N8Q9-2]"";""ENST00000674173.1; ENSP00000501408.1; ENSG00000140157.16. [Q8N8Q9-1]"";""ENST00000674289.1; ENSP00000501412.1; ENSG00000140157.16. [Q8N8Q9-1]"";""ENST00000674330.1; ENSP00000501373.1; ENSG00000140157.16. [Q8N8Q9-1]"";""ENST00000674477.1; ENSP00000501489.1; ENSG00000140157.16. [Q8N8Q9-1]"";",magnesium ion transmembrane transporter activity [GO:0015095],magnesium ion transport [GO:0015693],early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q6KC79,N2,-1.170369893,-0.498441441,1.270631216,-0.046802683,-0.804961982,grey70,NIPBL,NIPBL_HUMAN,Nipped-B-like protein (Delangin) (SCC2 homolog),NIPBL IDN3 SCC2,25836;,"ENST00000282516.13; ENSP00000282516.8; ENSG00000164190.19. [Q6KC79-1];""ENST00000448238.2; ENSP00000406266.2; ENSG00000164190.19. [Q6KC79-2]"";",chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic cohesin loading [GO:0061780]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]
Q9NQR4,C5,1.656065309,0.333636223,-0.677300486,-0.478454534,-1.281322718,turquoise3,NIT2,NIT2_HUMAN,Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2),NIT2 CUA002,56954;,ENST00000394140.9; ENSP00000377696.3; ENSG00000114021.12.;,2-oxoglutaramate amidase activity [GO:0106008]; omega-amidase activity [GO:0050152],asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]
Q9NYS0,C1,1.819698094,0.308733993,-0.488258523,-0.335503182,-0.762139902,lightblue,NKIRAS1,KBRS1_HUMAN,NF-kappa-B inhibitor-interacting Ras-like protein 1 (I-kappa-B-interacting Ras-like protein 1) (Kappa B-Ras protein 1) (KappaB-Ras1),NKIRAS1 KBRAS1,28512;,"ENST00000388759.7; ENSP00000373411.3; ENSG00000197885.11.;""ENST00000416026.2; ENSP00000394214.2; ENSG00000197885.11."";""ENST00000421515.6; ENSP00000392307.2; ENSG00000197885.11."";""ENST00000425478.7; ENSP00000400385.2; ENSG00000197885.11."";""ENST00000443659.6; ENSP00000393785.2; ENSG00000197885.11."";""ENST00000614374.4; ENSP00000483749.1; ENSG00000197885.11."";",GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924],lung alveolus development [GO:0048286]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]
O15226,N3,-1.070825991,-1.023498349,0.993839159,-0.112343585,0.550064614,grey50,NKRF,NKRF_HUMAN,NF-kappa-B-repressing factor (NFkB-repressing factor) (NRF) (Protein ITBA4),NKRF ITBA4 NRF,55922;,"ENST00000304449.8; ENSP00000304803.5; ENSG00000186416.18. [O15226-1];""ENST00000542113.3; ENSP00000442308.1; ENSG00000186416.18. [O15226-2]"";","ATPase activator activity [GO:0001671]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q86UT6,M2,-0.821393614,-0.938131408,0.373001979,0.94378796,-0.167205773,tan4,NLRX1,NLRX1_HUMAN,NLR family member X1 (Caterpiller protein 11.3) (CLR11.3) (Nucleotide-binding oligomerization domain protein 5) (Nucleotide-binding oligomerization domain protein 9),NLRX1 NOD5 NOD9,79671;,"ENST00000292199.6; ENSP00000292199.2; ENSG00000160703.17. [Q86UT6-1];""ENST00000409109.6; ENSP00000387334.1; ENSG00000160703.17. [Q86UT6-1]"";""ENST00000409991.5; ENSP00000386851.1; ENSG00000160703.17. [Q86UT6-1]"";""ENST00000525863.1; ENSP00000433442.1; ENSG00000160703.17. [Q86UT6-2]"";""ENST00000706729.1; ENSP00000516519.1; ENSG00000160703.17. [Q86UT6-1]"";",ATP binding [GO:0005524],innate immune response [GO:0045087]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of RIG-I signaling pathway [GO:0039536],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
P15531,C5,1.839843468,0.406360912,-0.769233502,-0.909726567,-1.106400753,turquoise3,NME1,NDKA_HUMAN,Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein),NME1 NDPKA NM23,4830;,"ENST00000013034.3; ENSP00000013034.3; ENSG00000239672.8. [P15531-2];""ENST00000336097.7; ENSP00000337060.3; ENSG00000239672.8. [P15531-2]"";""ENST00000393196.8; ENSP00000376892.3; ENSG00000239672.8. [P15531-1]"";",3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; DNA nuclease activity [GO:0004536]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723],cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ruffle membrane [GO:0032587]
Q13232,M2,-0.778623442,-0.588676174,0.361392445,0.957665004,-0.192729665,tan4,NME3,NDK3_HUMAN,Nucleoside diphosphate kinase 3 (NDK 3) (NDP kinase 3) (EC 2.7.4.6) (DR-nm23) (Nucleoside diphosphate kinase C) (NDPKC) (nm23-H3),NME3,4832;,ENST00000219302.8; ENSP00000219302.3; ENSG00000103024.8.;,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550],apoptotic process [GO:0006915]; CTP biosynthetic process [GO:0006241]; DNA repair [GO:0006281]; GTP biosynthetic process [GO:0006183]; mitochondrial fusion [GO:0008053]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP biosynthetic process [GO:0006228],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]
Q13287,C5,1.643393159,0.465277436,-0.692488242,-0.565574479,-0.731797966,turquoise3,NMI,NMI_HUMAN,N-myc-interactor (Nmi) (N-myc and STAT interactor),NMI,9111;,ENST00000243346.10; ENSP00000243346.5; ENSG00000123609.11.;,identical protein binding [GO:0042802],cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; innate immune response [GO:0045087]; macrophage activation involved in immune response [GO:0002281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein K48-linked ubiquitination [GO:0070936]; response to virus [GO:0009615]; toll-like receptor 4 signaling pathway [GO:0034142],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P30419,N4,0.663942376,1.106424053,-0.47885237,-0.784936278,-0.238143721,grey30,NMT1,NMT1_HUMAN,Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (HsNMT1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1) (Protein-lysine myristoyltransferase NMT1) (EC 2.3.1.-),NMT1 NMT,4836;,"ENST00000258960.7; ENSP00000258960.2; ENSG00000136448.13. [P30419-1];""ENST00000592654.3; ENSP00000466827.2; ENSG00000136448.13. [P30419-2]"";""ENST00000592782.5; ENSP00000468424.1; ENSG00000136448.13. [P30419-1]"";""ENST00000676828.1; ENSP00000504192.1; ENSG00000136448.13. [P30419-1]"";""ENST00000678938.1; ENSP00000503621.1; ENSG00000136448.13. [P30419-2]"";",glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030],cellular ketone metabolic process [GO:0042180]; in utero embryonic development [GO:0001701]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; protein localization to membrane [GO:0072657]; regulation of opsin-mediated signaling pathway [GO:0022400],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
O60551,C2,1.172810105,0.704379047,-0.405305109,-0.816985183,-0.403509741,aquamarine,NMT2,NMT2_HUMAN,Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Protein-lysine myristoyltransferase NMT2) (EC 2.3.1.-) (Type II N-myristoyltransferase),NMT2,9397;,ENST00000378165.9; ENSP00000367407.3; ENSG00000152465.18.;,glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030],intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of opsin-mediated signaling pathway [GO:0022400],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]
Q13423,M2,-1.067636493,-1.390499456,0.383386858,1.185009961,-0.14071368,tan4,NNT,NNTM_HUMAN,"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)",NNT,23530;,"ENST00000264663.9; ENSP00000264663.5; ENSG00000112992.18.;""ENST00000344920.9; ENSP00000343873.4; ENSG00000112992.18."";""ENST00000653251.1; ENSP00000499281.1; ENSG00000112992.18."";""ENST00000656666.1; ENSP00000499249.1; ENSG00000112992.18."";""ENST00000662525.1; ENSP00000499639.1; ENSG00000112992.18."";""ENST00000669601.1; ENSP00000499527.1; ENSG00000112992.18."";""ENST00000670904.1; ENSP00000499611.1; ENSG00000112992.18."";""ENST00000671668.1; ENSP00000499494.1; ENSG00000112992.18."";",NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661],cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; intracellular oxygen homeostasis [GO:0032364]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]
Q9Y3T9,N3,-1.197035351,-1.259787698,1.330510772,-0.143699684,-0.033311561,grey50,NOC2L,NOC2L_HUMAN,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),NOC2L NIR,26155;,ENST00000327044.7; ENSP00000317992.6; ENSG00000188976.11.;,chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714],apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromosome [GO:0005694]; cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BVI4,N3,-0.936643919,-0.911591835,0.952832601,-0.232821675,0.498838012,grey50,NOC4L,NOC4L_HUMAN,Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein),NOC4L,79050;,"ENST00000330579.6; ENSP00000328854.1; ENSG00000184967.7.;""ENST00000672504.1; ENSP00000500901.1; ENSG00000288146.1."";",RNA binding [GO:0003723],rRNA processing [GO:0006364],Noc4p-Nop14p complex [GO:0030692]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q9BSC4,N3,-0.880936079,-1.100675256,1.203182551,-0.03151143,0.201426411,grey50,NOL10,NOL10_HUMAN,Nucleolar protein 10,NOL10,79954;,"ENST00000345985.7; ENSP00000263837.4; ENSG00000115761.17. [Q9BSC4-2];""ENST00000381685.10; ENSP00000371101.5; ENSG00000115761.17. [Q9BSC4-1]"";""ENST00000538384.5; ENSP00000439663.1; ENSG00000115761.17. [Q9BSC4-4]"";",RNA binding [GO:0003723],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]",nucleolus [GO:0005730]; small-subunit processome [GO:0032040]
Q9H8H0,N3,-0.88624041,-1.131970602,1.283672524,0.075252399,-0.321343362,grey50,NOL11,NOL11_HUMAN,Nucleolar protein 11,NOL11 L14,25926;,"ENST00000253247.9; ENSP00000253247.4; ENSG00000130935.10. [Q9H8H0-1];""ENST00000581375.5; ENSP00000463219.1; ENSG00000130935.10. [Q9H8H0-2]"";",RNA binding [GO:0003723],maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; t-UTP complex [GO:0034455]
Q9H6R4,N3,-0.949459366,-1.268330335,1.283837095,-0.1221885,0.093053898,grey50,NOL6,NOL6_HUMAN,Nucleolar protein 6 (Nucleolar RNA-associated protein) (Nrap),NOL6,65083;,"ENST00000297990.9; ENSP00000297990.4; ENSG00000165271.17. [Q9H6R4-1];""ENST00000353159.6; ENSP00000313978.4; ENSG00000165271.17. [Q9H6R4-3]"";",RNA binding [GO:0003723],ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409],condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]
Q9UMY1,N3,-1.551367094,-1.497813838,1.244036632,-0.044602429,0.257857297,grey50,NOL7,UTP16_HUMAN,U3 small nucleolar RNA-associated protein NOL7 (U3 snoRNA-associated protein NOL7) (Nucleolar protein 7) (Nucleolar protein of 27 kDa),NOL7 C6orf90 NOP27,51406;,ENST00000451315.7; ENSP00000405674.2; ENSG00000225921.7. [Q9UMY1-1];,RNA binding [GO:0003723],maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]
Q76FK4,N3,-1.249736786,-1.368447937,1.389270105,0.064663665,-0.497756782,grey50,NOL8,NOL8_HUMAN,Nucleolar protein 8 (Nucleolar protein Nop132),NOL8 C9orf34 NOP132,55035;,"ENST00000358855.8; ENSP00000351723.4; ENSG00000198000.12. [Q76FK4-2];""ENST00000442668.7; ENSP00000401177.2; ENSG00000198000.12. [Q76FK4-1]"";""ENST00000535387.5; ENSP00000441300.1; ENSG00000198000.12. [Q76FK4-4]"";""ENST00000542053.5; ENSP00000440709.1; ENSG00000198000.12. [Q76FK4-2]"";""ENST00000545558.5; ENSP00000441140.1; ENSG00000198000.12. [Q76FK4-1]"";""ENST00000707203.1; ENSP00000516776.1; ENSG00000291347.1. [Q76FK4-1]"";""ENST00000707204.1; ENSP00000516777.1; ENSG00000291347.1. [Q76FK4-2]"";""ENST00000707208.1; ENSP00000516780.1; ENSG00000291347.1. [Q76FK4-1]"";""ENST00000707211.1; ENSP00000516783.1; ENSG00000291347.1. [Q76FK4-4]"";""ENST00000707212.1; ENSP00000516784.1; ENSG00000291347.1. [Q76FK4-2]"";",RNA binding [GO:0003723],protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364],chromosome [GO:0005694]; nucleolus [GO:0005730]
Q5SY16,N3,-1.411676847,-1.48346848,1.044137525,-0.214538986,0.670752743,grey50,NOL9,NOL9_HUMAN,Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.78) (Nucleolar protein 9),NOL9,79707;,ENST00000377705.6; ENSP00000366934.5; ENSG00000162408.11.;,ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723],"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]",intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q14978,N2,-0.983965465,-0.715904154,1.327388466,-0.019323178,-0.557971269,grey70,NOLC1,NOLC1_HUMAN,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),NOLC1 KIAA0035 NS5ATP13,9221;,"ENST00000405356.5; ENSP00000385410.1; ENSG00000166197.17. [Q14978-2];""ENST00000488254.6; ENSP00000475080.1; ENSG00000166197.17. [Q14978-3]"";""ENST00000605788.6; ENSP00000474710.2; ENSG00000166197.17. [Q14978-1]"";",ATP binding [GO:0005524]; GTP binding [GO:0005525]; molecular function inhibitor activity [GO:0140678]; protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723],mitotic cell cycle [GO:0000278]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364],Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q5C9Z4,N3,-1.189457808,-1.079407715,0.711198739,-0.067368818,0.856087872,grey50,NOM1,NOM1_HUMAN,Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog),NOM1 C7orf3,64434;,ENST00000275820.4; ENSP00000275820.3; ENSG00000146909.8.;,RNA binding [GO:0003723],hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730]
Q15155,S2,-1.69556488,-1.885125987,0.110827063,1.014939678,0.529009113,orange,NOMO1,NOMO1_HUMAN,BOS complex subunit NOMO1 (Nodal modulator 1) (pM5 protein),NOMO1 PM5,23420;,"ENST00000287667.12; ENSP00000287667.7; ENSG00000103512.16.;""ENST00000619292.4; ENSP00000482008.1; ENSG00000274779.4."";",carbohydrate binding [GO:0030246]; ribosome binding [GO:0043022],multi-pass transmembrane protein insertion into ER membrane [GO:0160063],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; multi-pass translocon complex [GO:0160064]
P78316,N3,-1.010688755,-0.850836223,0.941512884,0.065691669,0.494179638,grey50,NOP14,NOP14_HUMAN,Nucleolar protein 14 (Nucleolar complex protein 14),NOP14 C4orf9 NOL14 RES4-25,8602;,"ENST00000314262.10; ENSP00000315674.6; ENSG00000087269.16. [P78316-1];""ENST00000398071.4; ENSP00000381146.4; ENSG00000087269.16. [P78316-2]"";""ENST00000416614.7; ENSP00000405068.2; ENSG00000087269.16. [P78316-1]"";",enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515],"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]",90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q9Y3C1,N3,-1.141666301,-1.093863139,0.693478565,-0.260043274,0.845295547,grey50,NOP16,NOP16_HUMAN,Nucleolar protein 16 (HBV pre-S2 trans-regulated protein 3),NOP16 CGI-117 HSPC111,51491;,"ENST00000614830.5; ENSP00000480832.2; ENSG00000048162.22. [Q9Y3C1-1];""ENST00000618911.4; ENSP00000483001.1; ENSG00000048162.22. [Q9Y3C1-3]"";",RNA binding [GO:0003723],ribosomal large subunit biogenesis [GO:0042273],intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P46087,N3,-1.129315287,-1.28468974,1.120023212,-0.115088669,0.60694459,grey50,NOP2,NOP2_HUMAN,28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),NOP2 NOL1 NSUN1,4839;,"ENST00000322166.10; ENSP00000313272.6; ENSG00000111641.13. [P46087-1];""ENST00000382421.7; ENSP00000371858.3; ENSG00000111641.13. [P46087-4]"";""ENST00000399466.6; ENSP00000382392.2; ENSG00000111641.13. [P46087-2]"";""ENST00000537442.5; ENSP00000444437.1; ENSG00000111641.13. [P46087-1]"";""ENST00000541778.5; ENSP00000443150.1; ENSG00000111641.13. [P46087-2]"";""ENST00000545200.5; ENSP00000439422.1; ENSG00000111641.13. [P46087-3]"";",RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383],maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O00567,N3,-1.107558597,-1.236594755,1.314408593,0.051521171,-0.354418649,grey50,NOP56,NOP56_HUMAN,Nucleolar protein 56 (Nucleolar protein 5A),NOP56 NOL5A,10528;,ENST00000329276.10; ENSP00000370589.3; ENSG00000101361.17.;,cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515],ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],box C/D methylation guide snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]
Q9Y2X3,N3,-1.056283316,-1.084730686,1.312525969,0.097848273,-0.208997643,grey50,NOP58,NOP58_HUMAN,Nucleolar protein 58 (Nucleolar protein 5),NOP58 NOL5 NOP5 HSPC120,51602;,ENST00000264279.10; ENSP00000264279.5; ENSG00000055044.11.;,ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094],ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254],box C/D methylation guide snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]
Q86U38,N1,-1.067031728,-0.62914177,0.602383743,-0.203455308,0.804282725,grey90,NOP9,NOP9_HUMAN,Nucleolar protein 9,NOP9 C14orf21 KIAA2021,161424;,"ENST00000267425.8; ENSP00000267425.3; ENSG00000196943.14. [Q86U38-1];""ENST00000396802.7; ENSP00000380020.3; ENSG00000196943.14. [Q86U38-2]"";""ENST00000642262.1; ENSP00000493692.1; ENSG00000285326.3. [Q86U38-2]"";""ENST00000644840.2; ENSP00000495668.1; ENSG00000285326.3. [Q86U38-1]"";",RNA binding [GO:0003723],"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit export from nucleus [GO:0000056]","90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]"
P46531,S3,-0.805703278,-0.556712955,0.26002782,0.768697892,0.261822913,salmon,NOTCH1,NOTC1_HUMAN,Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],NOTCH1 TAN1,4851;,ENST00000651671.1; ENSP00000498587.1; ENSG00000148400.13.;,"calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q04721,S4,-0.826604846,-0.820178544,0.33047123,0.789209681,0.339301226,tomato2,NOTCH2,NOTC2_HUMAN,Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)],NOTCH2,4853;,ENST00000256646.7; ENSP00000256646.2; ENSG00000134250.21.;,"calcium ion binding [GO:0005509]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; NF-kappaB binding [GO:0051059]; signaling receptor activity [GO:0038023]",animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060],cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q9UM47,S3,-0.843057258,-0.265662744,0.224870213,0.646480827,0.460796322,salmon,NOTCH3,NOTC3_HUMAN,Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain],NOTCH3,4854;,ENST00000263388.7; ENSP00000263388.1; ENSG00000074181.9.;,cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; signaling receptor activity [GO:0038023],artery morphogenesis [GO:0048844]; axon guidance [GO:0007411]; forebrain development [GO:0030900]; glomerular capillary formation [GO:0072104]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast differentiation [GO:0014016]; neuron fate commitment [GO:0048663]; Notch signaling pathway [GO:0007219]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944],cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
O15118,S1,-1.072964175,-1.236282796,-0.231884715,0.726975735,1.136574805,gold,NPC1,NPC1_HUMAN,NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein),NPC1,4864;,ENST00000269228.10; ENSP00000269228.4; ENSG00000141458.13. [O15118-1];,cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618],adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intestinal cholesterol absorption [GO:0030299]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; symbiont entry into host cell [GO:0046718],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q8NDH3,C5,0.470461169,1.424271485,-0.695853835,-1.189266001,-0.936298569,turquoise3,NPEPL1,PEPL1_HUMAN,Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1),NPEPL1 KIAA1974,79716;,"ENST00000356091.11; ENSP00000348395.6; ENSG00000215440.12. [Q8NDH3-1];""ENST00000525817.5; ENSP00000437112.1; ENSG00000215440.12. [Q8NDH3-5]"";""ENST00000525967.5; ENSP00000434810.1; ENSG00000215440.12. [Q8NDH3-4]"";",manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233],proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634]
P55786,C5,2.024309221,0.394970843,-0.845178312,-0.788371594,-1.216144985,turquoise3,NPEPPS,PSA_HUMAN,Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S),NPEPPS PSA,9520;,"ENST00000322157.9; ENSP00000320324.4; ENSG00000141279.18. [P55786-1];""ENST00000677120.1; ENSP00000503682.1; ENSG00000141279.18. [P55786-1]"";",aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]
Q8TAT6,N4,0.458138422,0.92655039,-0.200209737,-0.324143666,-0.635931115,grey30,NPLOC4,NPL4_HUMAN,Nuclear protein localization protein 4 homolog (Protein NPL4),NPLOC4 KIAA1499 NPL4,55666;,"ENST00000331134.11; ENSP00000331487.5; ENSG00000182446.15. [Q8TAT6-1];""ENST00000374747.9; ENSP00000363879.5; ENSG00000182446.15. [Q8TAT6-2]"";",ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]
P06748,N1,-0.994189657,-0.372411833,0.364438825,-0.303871741,1.12726309,grey90,NPM1,NPM_HUMAN,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),NPM1 NPM,4869;,"ENST00000296930.10; ENSP00000296930.5; ENSG00000181163.14. [P06748-1];""ENST00000351986.10; ENSP00000341168.6; ENSG00000181163.14. [P06748-2]"";""ENST00000393820.2; ENSP00000377408.2; ENSG00000181163.14. [P06748-3]"";""ENST00000517671.5; ENSP00000428755.1; ENSG00000181163.14. [P06748-1]"";""ENST00000678280.1; ENSP00000503235.1; ENSG00000181163.14. [P06748-3]"";",chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; NF-kappaB binding [GO:0051059]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082],cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; protein localization [GO:0008104]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; ribosome assembly [GO:0042255]; signal transduction [GO:0007165],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; granular component [GO:0001652]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; spindle pole centrosome [GO:0031616]
O75607,N1,-0.669417316,0.432530039,-0.030808672,-0.316954973,0.869243709,grey90,NPM3,NPM3_HUMAN,Nucleoplasmin-3,NPM3,10360;,ENST00000370110.6; ENSP00000359128.5; ENSG00000107833.11.;,chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723],chromatin remodeling [GO:0006338]; rRNA processing [GO:0006364]; rRNA transcription [GO:0009303],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9Y639,S4,-1.232003816,-1.360310588,0.4310054,0.893627477,0.23562741,tomato2,NPTN,NPTN_HUMAN,Neuroplastin (Stromal cell-derived receptor 1) (SDR-1),NPTN SDFR1 SDR1,27020;,"ENST00000345330.9; ENSP00000290401.4; ENSG00000156642.17. [Q9Y639-2];""ENST00000351217.10; ENSP00000342958.6; ENSG00000156642.17. [Q9Y639-1]"";""ENST00000562924.5; ENSP00000456349.1; ENSG00000156642.17. [Q9Y639-3]"";""ENST00000563691.5; ENSP00000457028.1; ENSG00000156642.17. [Q9Y639-5]"";",cell adhesion molecule binding [GO:0050839]; type 1 fibroblast growth factor receptor binding [GO:0005105],excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intracellular calcium ion homeostasis [GO:0006874]; long-term synaptic potentiation [GO:0060291]; negative regulation of cytokine production [GO:0001818]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934]; regulation of receptor localization to synapse [GO:1902683],cell surface [GO:0009986]; immunological synapse [GO:0001772]; postsynaptic density [GO:0014069]; presynaptic membrane [GO:0042734]
P15559,C4,2.047060726,0.197029399,-1.076167485,-0.966901813,-1.242490148,deepskyblue2,NQO1,NQO1_HUMAN,NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1),NQO1 DIA4 NMOR1,1728;,"ENST00000320623.10; ENSP00000319788.5; ENSG00000181019.13. [P15559-1];""ENST00000379046.6; ENSP00000368334.2; ENSG00000181019.13. [P15559-3]"";""ENST00000379047.7; ENSP00000368335.3; ENSG00000181019.13. [P15559-2]"";","cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; identical protein binding [GO:0042802]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADH dehydrogenase (quinone) activity [GO:0050136]; NADPH dehydrogenase (quinone) activity [GO:0008753]; RNA binding [GO:0003723]; superoxide dismutase activity [GO:0004784]","cell redox homeostasis [GO:0045454]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to metal ion [GO:0071248]; cellular response to oxidative stress [GO:0034599]; innate immune response [GO:0045087]; NADH oxidation [GO:0006116]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of neuron apoptotic process [GO:0043525]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; removal of superoxide radicals [GO:0019430]; response to alkaloid [GO:0043279]; response to amine [GO:0014075]; response to carbohydrate [GO:0009743]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to flavonoid [GO:1905395]; response to hormone [GO:0009725]; response to hydrogen sulfide [GO:1904880]; response to ischemia [GO:0002931]; response to L-glutamine [GO:1904844]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to testosterone [GO:0033574]; response to tetrachloromethane [GO:1904772]; response to toxic substance [GO:0009636]; synaptic transmission, cholinergic [GO:0007271]; ubiquinone metabolic process [GO:0006743]; vitamin E metabolic process [GO:0042360]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synapse [GO:0045202]
P16083,C4,1.723906818,0.350982368,-0.915315349,-0.968795354,-1.101758094,deepskyblue2,NQO2,NQO2_HUMAN,Ribosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.5.1) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2),NQO2 NMOR2,4835;,"ENST00000338130.7; ENSP00000337773.2; ENSG00000124588.22.;""ENST00000380430.6; ENSP00000369795.1; ENSG00000124588.22."";""ENST00000380455.11; ENSP00000369822.4; ENSG00000124588.22."";","chloride ion binding [GO:0031404]; dihydronicotinamide riboside quinone reductase activity [GO:0001512]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; melatonin binding [GO:1904408]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on other nitrogenous compounds as donors [GO:0016661]; protein homodimerization activity [GO:0042803]; resveratrol binding [GO:1905594]; zinc ion binding [GO:0008270]",quinone catabolic process [GO:1901662],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]
P04150,C3,1.557342054,0.320567112,-0.64101787,-0.47414902,-0.587287222,cyan,NR3C1,GCR_HUMAN,Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1),NR3C1 GRL,2908;,"ENST00000231509.7; ENSP00000231509.3; ENSG00000113580.15. [P04150-3];""ENST00000343796.6; ENSP00000343205.2; ENSG00000113580.15. [P04150-1]"";""ENST00000394464.7; ENSP00000377977.2; ENSG00000113580.15. [P04150-1]"";""ENST00000394466.6; ENSP00000377979.2; ENSG00000113580.15. [P04150-3]"";""ENST00000415690.6; ENSP00000387672.2; ENSG00000113580.15. [P04150-2]"";""ENST00000424646.6; ENSP00000405282.2; ENSG00000113580.15. [P04150-10]"";""ENST00000503201.1; ENSP00000427672.1; ENSG00000113580.15. [P04150-1]"";""ENST00000504572.5; ENSP00000422518.1; ENSG00000113580.15. [P04150-3]"";","core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; estrogen response element binding [GO:0034056]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor activity [GO:0004883]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone binding [GO:1990239]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270]","adrenal gland development [GO:0030325]; apoptotic process [GO:0006915]; astrocyte differentiation [GO:0048708]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; glucocorticoid metabolic process [GO:0008211]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; mammary gland duct morphogenesis [GO:0060603]; maternal behavior [GO:0042711]; microglia differentiation [GO:0014004]; motor behavior [GO:0061744]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroinflammatory response [GO:0150076]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucocorticoid biosynthetic process [GO:0031946]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]",centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; synapse [GO:0045202]
Q9UHY1,C5,1.999724537,-0.076464737,-0.844846505,-0.860442726,-1.148481596,turquoise3,NRBP1,NRBP_HUMAN,Nuclear receptor-binding protein,NRBP1 BCON3 NRBP,29959;,"ENST00000233557.7; ENSP00000233557.3; ENSG00000115216.14.;""ENST00000379852.8; ENSP00000369181.3; ENSG00000115216.14."";",ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
O43847,C4,2.091782022,0.513554133,-1.156857608,-1.270366281,-1.389927269,deepskyblue2,NRD1,NRDC_HUMAN,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase),NRDC NRD1,4898;,"ENST00000352171.12; ENSP00000262679.8; ENSG00000078618.23. [O43847-1];""ENST00000354831.11; ENSP00000346890.7; ENSG00000078618.23. [O43847-2]"";",epidermal growth factor binding [GO:0048408]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; proteolysis [GO:0006508]; regulation of endopeptidase activity [GO:0052548],cell surface [GO:0009986]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]
Q14494,N4,-0.082115526,1.14832326,0.076228933,-0.534086506,-0.709499956,grey30,NRF1,NF2L1_HUMAN,"Endoplasmic reticulum membrane sensor NFE2L1 (Locus control region-factor 1) (LCR-F1) (Nuclear factor erythroid 2-related factor 1) (NF-E2-related factor 1) (NFE2-related factor 1) (Nuclear factor, erythroid derived 2, like 1) (Protein NRF1, p120 form) (Transcription factor 11) (TCF-11) [Cleaved into: Transcription factor NRF1 (Protein NRF1, p110 form)]",NFE2L1 HBZ17 NRF1 TCF11,4779;,"ENST00000357480.9; ENSP00000350072.5; ENSG00000082641.16. [Q14494-2];""ENST00000362042.8; ENSP00000354855.3; ENSG00000082641.16. [Q14494-1]"";""ENST00000585291.5; ENSP00000461960.1; ENSG00000082641.16. [Q14494-2]"";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",anatomical structure morphogenesis [GO:0009653]; cholesterol metabolic process [GO:0008203]; heme biosynthetic process [GO:0006783]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q92832,S3,-1.020073787,-0.898017753,0.260845716,0.810498246,0.55447178,salmon,NRP1,NELL1_HUMAN,Protein kinase C-binding protein NELL1 (NEL-like protein 1) (Nel-related protein 1),NELL1 NRP1,4745;,"ENST00000357134.10; ENSP00000349654.5; ENSG00000165973.19. [Q92832-1];""ENST00000532434.5; ENSP00000437170.1; ENSG00000165973.19. [Q92832-2]"";",calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080],cell differentiation [GO:0030154]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; nervous system development [GO:0007399]; positive regulation of bone mineralization [GO:0030501]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]
O60462,S3,-0.958555502,-0.853455387,0.269127828,0.792122245,0.441690871,salmon,NRP2,NRP2_HUMAN,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),NRP2 VEGF165R2,8828;,"ENST00000272849.7; ENSP00000272849.3; ENSG00000118257.17. [O60462-5];""ENST00000357118.8; ENSP00000349632.4; ENSG00000118257.17. [O60462-4]"";""ENST00000357785.10; ENSP00000350432.5; ENSG00000118257.17. [O60462-3]"";""ENST00000360409.7; ENSP00000353582.3; ENSG00000118257.17. [O60462-1]"";""ENST00000412873.2; ENSP00000407626.2; ENSG00000118257.17. [O60462-2]"";""ENST00000417189.5; ENSP00000387519.1; ENSG00000118257.17. [O60462-6]"";",cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor receptor activity [GO:0005021],angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116]
Q96L73,N1,-1.009610288,-0.86117203,0.666809749,-0.140733098,0.853224089,grey90,NSD1,NSD1_HUMAN,"Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein)",NSD1 ARA267 KMT3B,64324;,"ENST00000439151.7; ENSP00000395929.2; ENSG00000165671.22. [Q96L73-1];""ENST00000687453.1; ENSP00000508426.1; ENSG00000165671.22. [Q96L73-3]"";",chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H4K20 methyltransferase activity [GO:0042799]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q15738,S2,-1.099071768,-1.250953104,0.163823941,0.886800277,0.606071395,orange,NSDHL,NSDHL_HUMAN,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (EC 1.1.1.170) (Protein H105e3)",NSDHL H105E3,50814;,"ENST00000370274.8; ENSP00000359297.3; ENSG00000147383.11.;""ENST00000440023.5; ENSP00000391854.1; ENSG00000147383.11."";""ENST00000709998.1; ENSP00000517980.1; ENSG00000292192.1."";""ENST00000710000.1; ENSP00000517982.1; ENSG00000292192.1."";","3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; 3-beta-hydroxysteroid dehydrogenase/C4-decarboxylase activity [GO:0102175]; 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity [GO:0103066]; 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity [GO:0103067]; C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity [GO:0000252]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity [GO:0047012]",cholesterol biosynthetic process [GO:0006695]; cholesterol metabolic process [GO:0008203]; hair follicle development [GO:0001942]; labyrinthine layer blood vessel development [GO:0060716]; smoothened signaling pathway [GO:0007224],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]
P46459,S1,-0.122156023,-1.110428688,-0.16255063,0.613027475,0.840934388,gold,NSF,NSF_HUMAN,Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF),NSF,4905;,"ENST00000398238.8; ENSP00000381293.4; ENSG00000073969.19. [P46459-1];""ENST00000611398.3; ENSP00000478614.1; ENSG00000278174.3. [P46459-1]"";""ENST00000620290.2; ENSP00000481714.1; ENSG00000276262.2. [P46459-1]"";""ENST00000706392.1; ENSP00000516369.1; ENSG00000073969.19. [P46459-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075],exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; plasma membrane fusion [GO:0045026]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of receptor recycling [GO:0001921]; potassium ion transport [GO:0006813]; regulation of exocytosis [GO:0017157]; SNARE complex disassembly [GO:0035494]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; dendritic shaft [GO:0043198]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]
Q9UNZ2,C5,1.399904521,0.808646136,-0.689515059,-0.812732924,-1.002961383,turquoise3,NSFL1C,NSF1C_HUMAN,NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47),NSFL1C UBXN2C,55968;,"ENST00000216879.9; ENSP00000216879.4; ENSG00000088833.18. [Q9UNZ2-1];""ENST00000353088.6; ENSP00000338643.2; ENSG00000088833.18. [Q9UNZ2-4]"";""ENST00000476071.5; ENSP00000418529.1; ENSG00000088833.18. [Q9UNZ2-5]"";",lipid binding [GO:0008289]; ubiquitin binding [GO:0043130],autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; VCP-NSFL1C complex [GO:1990730]
Q7Z3B3,N4,-0.58946484,0.950192615,0.290343013,-0.122278243,-0.656679752,grey30,NSL1,KANL1_HUMAN,KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog),KANSL1 CENP-36 KIAA1267 MSL1V1 NSL1,284058;,"ENST00000262419.10; ENSP00000262419.6; ENSG00000120071.15. [Q7Z3B3-1];""ENST00000432791.7; ENSP00000387393.3; ENSG00000120071.15. [Q7Z3B3-1]"";""ENST00000572904.6; ENSP00000461484.1; ENSG00000120071.15. [Q7Z3B3-1]"";",histone acetyltransferase binding [GO:0035035],chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q92636,C5,2.033035296,0.185674981,-0.963910961,-1.010772718,-1.305989847,turquoise3,NSMAF,FAN_HUMAN,Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation),NSMAF FAN,8439;,"ENST00000038176.8; ENSP00000038176.3; ENSG00000035681.9. [Q92636-1];""ENST00000427130.6; ENSP00000411012.2; ENSG00000035681.9. [Q92636-2]"";",sphingomyelin phosphodiesterase activator activity [GO:0016230],ceramide metabolic process [GO:0006672]; positive regulation of amide metabolic process [GO:0034250]; positive regulation of apoptotic process [GO:0043065]; positive regulation of lipid metabolic process [GO:0045834]; regulation of membrane lipid metabolic process [GO:1905038]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q96CB9,M1,-0.958000174,-0.537592075,0.439309415,0.805700718,0.159709222,burlywood4,NSUN4,NSUN4_HUMAN,5-methylcytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (5-methylcytosine tRNA methyltransferase NSUN4) (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4),NSUN4,387338;,"ENST00000474844.6; ENSP00000419740.1; ENSG00000117481.11. [Q96CB9-1];""ENST00000537428.2; ENSP00000437758.1; ENSG00000117481.11. [Q96CB9-4]"";",methyltransferase activity [GO:0008168]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; rRNA binding [GO:0019843]; rRNA methyltransferase activity [GO:0008649]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428],rRNA methylation [GO:0031167],mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial matrix [GO:0005759]
Q8TEA1,C3,1.899214162,0.311329004,-0.71864395,-0.733529083,-0.959644101,cyan,NSUN6,NSUN6_HUMAN,tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 (EC 2.1.1.-) (NOL1/NOP2/Sun and PUA domain-containing protein 1) (NOL1/NOP2/Sun domain family member 6),NSUN6 NOPD1,221078;,ENST00000377304.7; ENSP00000366519.4; ENSG00000241058.4.;,tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049],RNA methylation [GO:0001510]; tRNA C5-cytosine methylation [GO:0002946]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q8TCD5,C1,1.553725861,0.417862826,-0.347393737,-0.30897011,-0.985093796,lightblue,NT5C,NT5C_HUMAN,"5'(3')-deoxyribonucleotidase, cytosolic type (EC 3.1.3.-) (Cytosolic 5',3'-pyrimidine nucleotidase) (Deoxy-5'-nucleotidase 1) (dNT-1)",NT5C DNT1 UMPH2,30833;,"ENST00000245552.7; ENSP00000245552.2; ENSG00000125458.7. [Q8TCD5-1];""ENST00000580758.5; ENSP00000462123.1; ENSG00000125458.7. [Q8TCD5-2]"";",5'-nucleotidase activity [GO:0008253]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; pyrimidine nucleotide binding [GO:0019103],allantoin metabolic process [GO:0000255]; amide catabolic process [GO:0043605]; dCMP catabolic process [GO:0006249]; dephosphorylation [GO:0016311]; dGMP catabolic process [GO:0046055]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; IMP catabolic process [GO:0006204]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; UMP catabolic process [GO:0046050],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
P49902,C5,2.015979487,0.32573329,-0.964970368,-1.084987669,-1.059732331,turquoise3,NT5C2,5NTC_HUMAN,Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic 5'-nucleotidase II) (cN-II) (Cytosolic IMP/GMP-specific 5'-nucleotidase) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77) (High Km 5'-nucleotidase),NT5C2 NT5B NT5CP PNT5,22978;,"ENST00000343289.9; ENSP00000339479.5; ENSG00000076685.19. [P49902-1];""ENST00000404739.8; ENSP00000383960.3; ENSG00000076685.19. [P49902-1]"";""ENST00000674696.1; ENSP00000502679.1; ENSG00000076685.19. [P49902-1]"";""ENST00000675326.1; ENSP00000502205.1; ENSG00000076685.19. [P49902-1]"";""ENST00000675985.1; ENSP00000502215.1; ENSG00000076685.19. [P49902-2]"";""ENST00000676428.1; ENSP00000501689.1; ENSG00000076685.19. [P49902-1]"";""ENST00000676449.1; ENSP00000502801.1; ENSG00000076685.19. [P49902-1]"";",5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]; ubiquitin protein ligase activity [GO:0061630]; XMP 5'-nucleosidase activity [GO:0106411],adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP catabolic process [GO:0006204]; IMP metabolic process [GO:0046040]; negative regulation of defense response to virus by host [GO:0050689]; protein K48-linked ubiquitination [GO:0070936],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q969T7,C3,1.864822697,0.059252593,-0.712754436,-0.566524203,-0.866528205,cyan,NT5C3B,5NT3B_HUMAN,7-methylguanosine phosphate-specific 5'-nucleotidase (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein) (cN-III-like protein) (EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase),NT5C3B NT5C3L,115024;,ENST00000435506.7; ENSP00000389948.2; ENSG00000141698.17. [Q969T7-1];,5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166],nucleotide metabolic process [GO:0009117],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q5TFE4,C5,1.66182952,1.012865391,-1.021605221,-1.275903728,-1.577138005,turquoise3,NT5DC1,NT5D1_HUMAN,5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-),NT5DC1 NT5C2L1 LP2642,221294;,ENST00000319550.9; ENSP00000326858.3; ENSG00000178425.14. [Q5TFE4-1];,5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872],0,0
P21589,S2,-0.808289238,-1.226126752,0.346999876,0.566759529,0.677372649,orange,NT5E,5NTD_HUMAN,5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73),NT5E NT5 NTE,4907;,"ENST00000257770.8; ENSP00000257770.3; ENSG00000135318.12. [P21589-1];""ENST00000369651.7; ENSP00000358665.3; ENSG00000135318.12. [P21589-2]"";",5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; nucleotide binding [GO:0000166]; thymidylate 5'-phosphatase activity [GO:0050340]; XMP 5'-nucleosidase activity [GO:0106411]; zinc ion binding [GO:0008270],adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; calcium ion homeostasis [GO:0055074]; DNA metabolic process [GO:0006259]; inhibition of non-skeletal tissue mineralization [GO:0140928]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198]; response to inorganic substance [GO:0010035],cell surface [GO:0009986]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q96AB6,C5,1.76002488,0.353619949,-0.548577738,-0.787876126,-0.797023745,turquoise3,NTAN1,NTAN1_HUMAN,Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein N-terminal asparagine amidase) (Protein NTN-amidase),NTAN1,123803;,"ENST00000287706.8; ENSP00000287706.3; ENSG00000157045.9.;""ENST00000620176.4; ENSP00000484380.1; ENSG00000275779.4."";",protein-N-terminal asparagine amidohydrolase activity [GO:0008418],adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]
P78549,N2,-1.180965648,-0.255073633,0.714394831,0.147791576,0.4337895,grey70,NTHL1,NTH_HUMAN,Endonuclease III-like protein 1 (hNTH1) (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase),NTHL1 NTH1 OCTS3,4913;,"ENST00000219066.5; ENSP00000219066.1; ENSG00000065057.9. [P78549-1];""ENST00000651570.2; ENSP00000498421.1; ENSG00000065057.9. [P78549-2]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]","base-excision repair, AP site formation [GO:0006285]; depyrimidination [GO:0045008]; nucleotide-excision repair [GO:0006289]",mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9HB63,S3,-1.445582336,-0.732685924,0.159919367,0.574367219,0.716994195,salmon,NTN4,NET4_HUMAN,Netrin-4 (Beta-netrin) (Hepar-derived netrin-like protein),NTN4,59277;,"ENST00000343702.9; ENSP00000340998.4; ENSG00000074527.13. [Q9HB63-1];""ENST00000344911.8; ENSP00000339436.4; ENSG00000074527.13. [Q9HB63-3]"";""ENST00000538383.5; ENSP00000444432.1; ENSG00000074527.13. [Q9HB63-3]"";""ENST00000553059.1; ENSP00000447292.1; ENSG00000074527.13. [Q9HB63-2]"";",laminin-1 binding [GO:0043237],animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; neuron remodeling [GO:0016322]; regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling [GO:0060668]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888],extracellular region [GO:0005576]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]
Q9Y5A7,C5,1.234373179,0.700399218,-0.360986071,-0.553798452,-0.69284831,turquoise3,NUB1,NUB1_HUMAN,NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18),NUB1 NYREN18,51667;,"ENST00000413040.7; ENSP00000398644.3; ENSG00000013374.17. [Q9Y5A7-2];""ENST00000470229.6; ENSP00000418234.2; ENSG00000013374.17. [Q9Y5A7-1]"";""ENST00000568733.6; ENSP00000454264.2; ENSG00000013374.17. [Q9Y5A7-1]"";",0,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q8TB37,M1,-1.241268065,-0.409752011,0.450040934,1.036677082,-0.378697087,burlywood4,NUBPL,NUBPL_HUMAN,Iron-sulfur cluster transfer protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1),NUBPL C14orf127,80224;,"ENST00000281081.12; ENSP00000281081.7; ENSG00000151413.17. [Q8TB37-1];""ENST00000547839.5; ENSP00000449918.1; ENSG00000151413.17. [Q8TB37-2]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; metal ion binding [GO:0046872]",iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q9Y266,C4,1.986614092,0.056377608,-0.901589831,-0.889680368,-1.157209222,deepskyblue2,NUDC,NUDC_HUMAN,Nuclear migration protein nudC (Nuclear distribution protein C homolog),NUDC,10726;,ENST00000321265.10; ENSP00000319664.5; ENSG00000090273.14.;,cadherin binding [GO:0045296]; unfolded protein binding [GO:0051082],cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; nuclear migration [GO:0007097]; protein folding [GO:0006457]; response to peptide hormone [GO:0043434],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle [GO:0005819]
Q96RS6,C5,1.248950008,0.787657845,-0.381267497,-0.45763698,-0.686248053,turquoise3,NUDCD1,NUDC1_HUMAN,NudC domain-containing protein 1 (Chronic myelogenous leukemia tumor antigen 66) (Tumor antigen CML66),NUDCD1 CML66,84955;,"ENST00000239690.9; ENSP00000239690.4; ENSG00000120526.12. [Q96RS6-1];""ENST00000427660.6; ENSP00000410707.2; ENSG00000120526.12. [Q96RS6-2]"";",0,immune system process [GO:0002376],cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q8WVJ2,C4,2.218686304,0.211739135,-1.153745211,-1.055981948,-1.557003718,deepskyblue2,NUDCD2,NUDC2_HUMAN,NudC domain-containing protein 2,NUDCD2,134492;,ENST00000302764.9; ENSP00000304854.3; ENSG00000170584.11.;,unfolded protein binding [GO:0051082],protein folding [GO:0006457],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]
Q8IVD9,C1,1.670634235,0.197966727,-0.516790705,-0.293086217,-0.423655155,lightblue,NUDCD3,NUDC3_HUMAN,NudC domain-containing protein 3,NUDCD3 KIAA1068,23386;,ENST00000355451.8; ENSP00000347626.6; ENSG00000015676.18.;,unfolded protein binding [GO:0051082],cilium assembly [GO:0060271]; protein folding [GO:0006457]; protein localization to pericentriolar material [GO:1905793],cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]
P36639,C4,1.847732769,-0.005519026,-0.766132459,-0.626533247,-1.044342865,deepskyblue2,NUDT1,8ODP_HUMAN,"Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)",NUDT1 MTH1,4521;,"ENST00000339737.6; ENSP00000343439.2; ENSG00000106268.16. [P36639-4];""ENST00000343985.8; ENSP00000339503.4; ENSG00000106268.16. [P36639-2]"";""ENST00000356714.6; ENSP00000349148.1; ENSG00000106268.16. [P36639-4]"";""ENST00000397046.5; ENSP00000380239.1; ENSG00000106268.16. [P36639-4]"";""ENST00000397048.5; ENSP00000380241.1; ENSG00000106268.16. [P36639-2]"";""ENST00000397049.2; ENSP00000380242.2; ENSG00000106268.16. [P36639-4]"";","2-hydroxy-ATP hydrolase activity [GO:0106377]; 2-hydroxy-dATP hydrolase activity [GO:0106378]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; dATP diphosphatase activity [GO:0008828]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]; N6-methyl-(d)ATP hydrolase activity [GO:0106431]; O6-methyl-dGTP hydrolase activity [GO:0106433]; snoRNA binding [GO:0030515]",DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleoside catabolic process [GO:0006152]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]
O95848,C3,1.862315024,0.119991166,-0.583500294,-0.546212014,-0.647975401,cyan,NUDT14,NUD14_HUMAN,Uridine diphosphate glucose pyrophosphatase NUDT14 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14),NUDT14 UGPP,256281;,ENST00000392568.7; ENSP00000376349.2; ENSG00000183828.15.;,ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768],nucleoside phosphate metabolic process [GO:0006753]; protein N-linked glycosylation via asparagine [GO:0018279]; ribose phosphate metabolic process [GO:0019693],cytosol [GO:0005829]
Q9NV35,C4,2.190180121,0.342177319,-1.166390409,-1.396771796,-1.424421253,deepskyblue2,NUDT15,NUD15_HUMAN,Nucleotide triphosphate diphosphatase NUDT15 (EC 3.6.1.9) (MutT homolog 2) (MTH2) (Nucleoside diphosphate-linked moiety X motif 15) (Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15) (Nudix hydrolase 15),NUDT15 MTH2,55270;,ENST00000258662.3; ENSP00000258662.1; ENSG00000136159.4.;,"8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; 8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872]; nucleoside triphosphate diphosphatase activity [GO:0047429]",dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; mitotic cell cycle [GO:0000278]; nucleobase-containing small molecule metabolic process [GO:0055086]; nucleoside phosphate catabolic process [GO:1901292]; purine nucleotide catabolic process [GO:0006195]; regulation of proteasomal protein catabolic process [GO:0061136]; response to reactive oxygen species [GO:0000302]; xenobiotic catabolic process [GO:0042178],cytosol [GO:0005829]
Q96DE0,C5,2.016870064,0.260893623,-0.70074116,-0.727238039,-1.065513814,turquoise3,NUDT16,NUD16_HUMAN,U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (Nudix hydrolase 16) (U8 snoRNA-binding protein H29K) (m7GpppN-mRNA hydrolase),NUDT16,131870;,"ENST00000502852.1; ENSP00000422375.1; ENSG00000198585.12. [Q96DE0-4];""ENST00000521288.2; ENSP00000429274.2; ENSG00000198585.12. [Q96DE0-1]"";""ENST00000537561.5; ENSP00000440230.1; ENSG00000198585.12. [Q96DE0-3]"";",5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO:0140933]; chloride ion binding [GO:0031404]; cobalt ion binding [GO:0050897]; dIDP phosphatase activity [GO:0097383]; dITP diphosphatase activity [GO:0035870]; identical protein binding [GO:0042802]; IDP phosphatase activity [GO:1990003]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; phosphodiesterase decapping endonuclease activity [GO:1990174]; protein homodimerization activity [GO:0042803]; RNA NAD-cap (NMN-forming) hydrolase activity [GO:0110153]; snoRNA binding [GO:0030515],dITP catabolic process [GO:0035863]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; sno(s)RNA catabolic process [GO:0016077],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P50583,C5,1.949166823,0.195943432,-0.664933002,-0.799078502,-1.113468085,turquoise3,NUDT2,AP4A_HUMAN,"Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.17) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nucleoside diphosphate-linked moiety X motif 2) (Nudix motif 2)",NUDT2 APAH1,318;,"ENST00000346365.8; ENSP00000344187.4; ENSG00000164978.18.;""ENST00000379155.9; ENSP00000368452.5; ENSG00000164978.18."";""ENST00000379158.7; ENSP00000368455.1; ENSG00000164978.18."";""ENST00000618590.1; ENSP00000482384.1; ENSG00000164978.18."";",bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity [GO:0008803]; GTP binding [GO:0005525],AMP biosynthetic process [GO:0006167]; apoptotic process [GO:0006915]; ATP biosynthetic process [GO:0006754]; cellular response to oxidative stress [GO:0034599]; nucleobase-containing compound metabolic process [GO:0006139],mitochondrial matrix [GO:0005759]
Q9BZD4,C1,1.690843715,0.048262961,-0.493146397,-0.397566114,-0.759147558,lightblue,NUF2,NUF2_HUMAN,Kinetochore protein Nuf2 (hNuf2) (hNuf2R) (hsNuf2) (Cell division cycle-associated protein 1),NUF2 CDCA1 NUF2R,83540;,"ENST00000271452.8; ENSP00000271452.3; ENSG00000143228.13.;""ENST00000367900.7; ENSP00000356875.3; ENSG00000143228.13."";",microtubule binding [GO:0008017]; protein-containing complex binding [GO:0044877],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore organization [GO:0051383]; meiotic chromosome segregation [GO:0045132]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052],cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; Ndc80 complex [GO:0031262]; nucleoplasm [GO:0005654]
P49757,S3,-0.334007006,-0.440307599,0.355532966,0.652137203,0.201862486,salmon,NUMB,NUMB_HUMAN,Protein numb homolog (h-Numb) (Protein S171),NUMB C14orf41,8650;,"ENST00000355058.7; ENSP00000347169.3; ENSG00000133961.21. [P49757-1];""ENST00000356296.8; ENSP00000348644.4; ENSG00000133961.21. [P49757-2]"";""ENST00000359560.7; ENSP00000352563.3; ENSG00000133961.21. [P49757-3]"";""ENST00000535282.5; ENSP00000441258.2; ENSG00000133961.21. [P49757-2]"";""ENST00000544991.7; ENSP00000446001.3; ENSG00000133961.21. [P49757-7]"";""ENST00000554521.6; ENSP00000450817.2; ENSG00000133961.21. [P49757-8]"";""ENST00000554546.5; ENSP00000452416.1; ENSG00000133961.21. [P49757-4]"";""ENST00000555238.6; ENSP00000451300.1; ENSG00000133961.21. [P49757-1]"";""ENST00000555394.5; ENSP00000451625.1; ENSG00000133961.21. [P49757-2]"";""ENST00000555738.6; ENSP00000452069.2; ENSG00000133961.21. [P49757-6]"";""ENST00000557597.5; ENSP00000451117.1; ENSG00000133961.21. [P49757-3]"";""ENST00000559312.5; ENSP00000452888.1; ENSG00000133961.21. [P49757-7]"";""ENST00000560335.5; ENSP00000453209.1; ENSG00000133961.21. [P49757-5]"";",alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; lateral ventricle development [GO:0021670]; negative regulation of protein localization to plasma membrane [GO:1903077]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of cell migration [GO:0030335]; positive regulation of neurogenesis [GO:0050769]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149],apical part of cell [GO:0045177]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]
P57740,N3,-0.591905676,-0.767037431,1.091555771,0.196381458,-0.498169151,grey50,NUP107,NU107_HUMAN,Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107),NUP107,57122;,"ENST00000229179.9; ENSP00000229179.4; ENSG00000111581.10. [P57740-1];""ENST00000378905.6; ENSP00000368185.2; ENSG00000111581.10. [P57740-3]"";""ENST00000539906.5; ENSP00000441448.1; ENSG00000111581.10. [P57740-2]"";",structural constituent of nuclear pore [GO:0017056],female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606],cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]
Q8WUM0,N3,-0.516509304,-0.772883751,1.076686902,0.224138026,-0.439128252,grey50,NUP133,NU133_HUMAN,Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133),NUP133,55746;,ENST00000261396.6; ENSP00000261396.3; ENSG00000069248.12.;,structural constituent of nuclear pore [GO:0017056],mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; paraxial mesoderm development [GO:0048339]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]
P49790,N2,-1.216725328,-0.080622185,1.207310533,0.171852326,-0.588526095,grey70,NUP153,NU153_HUMAN,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),NUP153,9972;,"ENST00000262077.3; ENSP00000262077.3; ENSG00000124789.12. [P49790-1];""ENST00000537253.5; ENSP00000444029.1; ENSG00000124789.12. [P49790-3]"";""ENST00000613258.4; ENSP00000478627.1; ENSG00000124789.12. [P49790-2]"";",DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; nuclear localization sequence binding [GO:0008139]; protein-membrane adaptor activity [GO:0043495]; structural constituent of nuclear pore [GO:0017056],amyloid fibril formation [GO:1990000]; mRNA transport [GO:0051028]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; symbiont entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732],cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
O75694,N3,-0.391054032,-0.740718127,1.052394888,0.252682234,-0.40772876,grey50,NUP155,NU155_HUMAN,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),NUP155 KIAA0791,9631;,"ENST00000231498.8; ENSP00000231498.3; ENSG00000113569.16. [O75694-1];""ENST00000381843.6; ENSP00000371265.2; ENSG00000113569.16. [O75694-2]"";",structural constituent of nuclear pore [GO:0017056],atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]
Q92621,N3,-0.455866022,-0.889694809,1.094803263,0.17511946,-0.466500517,grey50,NUP205,NU205_HUMAN,Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205),NUP205 C7orf14 KIAA0225,23165;,ENST00000285968.11; ENSP00000285968.6; ENSG00000155561.15.;,structural constituent of nuclear pore [GO:0017056],mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]
Q8TEM1,N3,-0.949038023,-1.21679821,1.020837249,0.376097738,-0.226853151,grey50,NUP210,PO210_HUMAN,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),NUP210 KIAA0906 PSEC0245,23225;,ENST00000254508.7; ENSP00000254508.5; ENSG00000132182.13. [Q8TEM1-1];,0,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]
Q9UKX7,N2,-1.242805461,0.251309507,1.066106403,-0.065973399,-0.659856888,grey70,NUP50,NUP50_HUMAN,Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50),NUP50 NPAP60L PRO1146,10762;,"ENST00000347635.9; ENSP00000345895.3; ENSG00000093000.19. [Q9UKX7-1];""ENST00000396096.6; ENSP00000379403.2; ENSG00000093000.19. [Q9UKX7-2]"";""ENST00000407019.6; ENSP00000385555.2; ENSG00000093000.19. [Q9UKX7-2]"";",0,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606],nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]
Q8N1F7,N3,-0.029649492,-0.628399903,1.015839788,0.198804902,-0.459303595,grey50,NUP93,NUP93_HUMAN,Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93),NUP93 KIAA0095,9688;,"ENST00000308159.10; ENSP00000310668.5; ENSG00000102900.13. [Q8N1F7-1];""ENST00000542526.5; ENSP00000440235.1; ENSG00000102900.13. [Q8N1F7-2]"";""ENST00000564887.5; ENSP00000458039.1; ENSG00000102900.13. [Q8N1F7-2]"";",structural constituent of nuclear pore [GO:0017056],nuclear envelope organization [GO:0006998]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein import into nucleus [GO:0006606],centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]
P52948,N2,-1.013370898,-0.684886286,1.165804687,0.187671113,-0.539495278,grey70,NUP98,NUP98_HUMAN,Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],NUP98 ADAR2,4928;,"ENST00000324932.12; ENSP00000316032.7; ENSG00000110713.18. [P52948-5];""ENST00000355260.8; ENSP00000347404.3; ENSG00000110713.18. [P52948-2]"";""ENST00000359171.8; ENSP00000352091.5; ENSG00000110713.18. [P52948-1]"";""ENST00000397004.9; ENSP00000380199.4; ENSG00000110713.18. [P52948-4]"";""ENST00000397007.10; ENSP00000380202.4; ENSG00000110713.18. [P52948-3]"";""ENST00000700606.1; ENSP00000515094.1; ENSG00000110713.18. [P52948-4]"";",molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713],"mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]",cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]
O15504,N1,-0.955828854,-1.284172688,0.940111302,0.242344954,0.562485577,grey90,NUPL2,NUP42_HUMAN,Nucleoporin NUP42 (NLP-1) (NUP42 homolog) (Nucleoporin hCG1) (Nucleoporin-42) (Nucleoporin-like protein 2),NUP42 CG1 NUPL2,11097;,"ENST00000258742.10; ENSP00000258742.5; ENSG00000136243.18. [O15504-1];""ENST00000438012.5; ENSP00000415511.1; ENSG00000136243.18. [O15504-2]"";",metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; RNA binding [GO:0003723],mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611],cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96E22,S2,-1.721355412,-1.711099673,0.075132942,1.062073698,0.636971563,orange,NUS1,NGBR_HUMAN,Dehydrodolichyl diphosphate synthase complex subunit NUS1 (EC 2.5.1.87) (Cis-prenyltransferase subunit NgBR) (Nogo-B receptor) (NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog),NUS1 C6orf68 NGBR,116150;,ENST00000368494.4; ENSP00000357480.3; ENSG00000153989.8.;,dehydrodolichyl diphosphate synthase activity [GO:0045547]; metal ion binding [GO:0046872],angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; dolichol biosynthetic process [GO:0019408]; dolichyl diphosphate biosynthetic process [GO:0006489]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein glycosylation [GO:0006486]; protein mannosylation [GO:0035268]; regulation of intracellular cholesterol transport [GO:0032383]; vascular endothelial growth factor signaling pathway [GO:0038084],dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789]
Q9UBU9,N2,-0.735554767,-0.882999791,0.94702662,0.230058858,0.263678929,grey70,NXF1,NXF1_HUMAN,Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP),NXF1 TAP,10482;,"ENST00000294172.7; ENSP00000294172.2; ENSG00000162231.14. [Q9UBU9-1];""ENST00000531709.6; ENSP00000453885.1; ENSG00000162231.14. [Q9UBU9-2]"";""ENST00000532297.5; ENSP00000436679.1; ENSG00000162231.14. [Q9UBU9-1]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UKK6,N2,-0.715531447,-0.990077407,0.99524632,0.257617348,0.297340288,grey70,NXT1,NXT1_HUMAN,NTF2-related export protein 1 (Protein p15),NXT1,29107;,ENST00000254998.3; ENSP00000254998.2; ENSG00000132661.4.;,small GTPase binding [GO:0031267],mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein export from nucleus [GO:0006611],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NPJ8,N2,-0.530493567,-0.88455382,0.958254645,0.355320086,0.052578828,grey70,NXT2,NXT2_HUMAN,NTF2-related export protein 2 (Protein p15-2),NXT2 BM-025 DC9,55916;,"ENST00000218004.5; ENSP00000218004.1; ENSG00000101888.12. [Q9NPJ8-3];""ENST00000372103.1; ENSP00000361175.1; ENSG00000101888.12. [Q9NPJ8-4]"";""ENST00000372106.6; ENSP00000361178.1; ENSG00000101888.12. [Q9NPJ8-1]"";""ENST00000372107.5; ENSP00000361179.1; ENSG00000101888.12. [Q9NPJ8-4]"";",0,mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031],cytosol [GO:0005829]; nuclear pore central transport channel [GO:0044613]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q9Y530,C5,1.429095491,0.335623587,-0.391891363,-0.480068622,-0.289801206,turquoise3,OARD1,OARD1_HUMAN,ADP-ribose glycohydrolase OARD1 (O-acetyl-ADP-ribose deacetylase 1) (EC 3.5.1.-) (Terminal ADP-ribose protein glycohydrolase 1) ([Protein ADP-ribosylglutamate] hydrolase OARD1) (EC 3.2.2.-),OARD1 C6orf130 TARG1,221443;,"ENST00000424266.7; ENSP00000416829.2; ENSG00000124596.17.;""ENST00000463088.5; ENSP00000420193.1; ENSG00000124596.17."";""ENST00000468811.5; ENSP00000420601.1; ENSG00000124596.17."";""ENST00000479950.5; ENSP00000420484.1; ENSG00000124596.17."";",ADP-ribosylglutamate hydrolase activity [GO:0140293]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]; purine nucleoside binding [GO:0001883],DNA damage response [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; site of DNA damage [GO:0090734]
O75147,C1,0.406411719,-0.10730673,-0.092439711,-0.026613766,0.621670972,lightblue,OBSL1,OBSL1_HUMAN,Obscurin-like protein 1,OBSL1 KIAA0657,23363;,"ENST00000373873.8; ENSP00000362980.4; ENSG00000124006.15. [O75147-2];""ENST00000404537.6; ENSP00000385636.1; ENSG00000124006.15. [O75147-3]"";""ENST00000603926.5; ENSP00000474519.1; ENSG00000124006.15. [O75147-4]"";",cytoskeletal anchor activity [GO:0008093],cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088],3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]
Q9NX40,M2,-0.813992244,-1.066041069,0.331117725,1.045209115,-0.091810835,tan4,OCIAD1,OCAD1_HUMAN,OCIA domain-containing protein 1 (Ovarian cancer immunoreactive antigen domain containing 1) (Ovarian carcinoma immunoreactive antigen),OCIAD1 ASRIJ OCIA,54940;,"ENST00000264312.12; ENSP00000264312.7; ENSG00000109180.15. [Q9NX40-1];""ENST00000381473.7; ENSP00000370882.3; ENSG00000109180.15. [Q9NX40-1]"";""ENST00000396448.6; ENSP00000379725.2; ENSG00000109180.15. [Q9NX40-2]"";""ENST00000425583.6; ENSP00000416943.2; ENSG00000109180.15. [Q9NX40-4]"";""ENST00000444354.6; ENSP00000399656.2; ENSG00000109180.15. [Q9NX40-4]"";""ENST00000508293.5; ENSP00000423002.1; ENSG00000109180.15. [Q9NX40-1]"";""ENST00000513391.2; ENSP00000423909.2; ENSG00000109180.15. [Q9NX40-1]"";",0,endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of stem cell differentiation [GO:2000736],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]
Q56VL3,M2,-1.108363997,-1.256504761,0.393024357,1.03009512,-0.089333108,tan4,OCIAD2,OCAD2_HUMAN,OCIA domain-containing protein 2 (Ovarian carcinoma immunoreactive antigen-like protein),OCIAD2,132299;,"ENST00000273860.8; ENSP00000273860.4; ENSG00000145247.12. [Q56VL3-2];""ENST00000508632.6; ENSP00000423014.1; ENSG00000145247.12. [Q56VL3-1]"";""ENST00000620187.4; ENSP00000483997.1; ENSG00000145247.12. [Q56VL3-2]"";",0,endocytosis [GO:0006897]; hematopoietic stem cell homeostasis [GO:0061484]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; response to bacterium [GO:0009617],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]
Q16625,S4,-0.972579296,-1.204224049,0.491008325,0.714118045,0.20127198,tomato2,OCLN,OCLN_HUMAN,Occludin,OCLN,100506658;,"ENST00000355237.6; ENSP00000347379.2; ENSG00000197822.12. [Q16625-1];""ENST00000396442.7; ENSP00000379719.2; ENSG00000197822.12. [Q16625-1]"";""ENST00000538151.2; ENSP00000445940.1; ENSG00000197822.12. [Q16625-4]"";""ENST00000680027.1; ENSP00000506162.1; ENSG00000197822.12. [Q16625-1]"";""ENST00000680496.1; ENSP00000504966.1; ENSG00000197822.12. [Q16625-2]"";""ENST00000680784.1; ENSP00000506305.1; ENSG00000197822.12. [Q16625-2]"";""ENST00000681041.1; ENSP00000505426.1; ENSG00000197822.12. [Q16625-1]"";""ENST00000681586.1; ENSP00000505541.1; ENSG00000197822.12. [Q16625-1]"";",protein domain specific binding [GO:0019904],bicellular tight junction assembly [GO:0070830]; cell-cell junction organization [GO:0045216]; maintenance of blood-brain barrier [GO:0035633]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of wound healing [GO:0090303]; protein localization to cell leading edge [GO:1902463]; protein-containing complex assembly [GO:0065003]; regulation of glucose transmembrane transport [GO:0010827],apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; endocytic vesicle [GO:0030139]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160]
Q5BJF6,M2,-0.543551379,-0.604881404,0.355171697,0.912010437,-0.120489344,tan4,ODF2,ODFP2_HUMAN,Outer dense fiber protein 2 (Cenexin) (Outer dense fiber of sperm tails protein 2),ODF2,4957;,"ENST00000372791.8; ENSP00000361877.3; ENSG00000136811.17. [Q5BJF6-5];""ENST00000372807.10; ENSP00000361893.5; ENSG00000136811.17. [Q5BJF6-4]"";""ENST00000372814.7; ENSP00000361901.3; ENSG00000136811.17. [Q5BJF6-7]"";""ENST00000393533.6; ENSP00000377166.2; ENSG00000136811.17. [Q5BJF6-10]"";""ENST00000434106.7; ENSP00000403453.2; ENSG00000136811.17. [Q5BJF6-1]"";""ENST00000448249.8; ENSP00000396687.2; ENSG00000136811.17. [Q5BJF6-9]"";""ENST00000546203.5; ENSP00000437579.1; ENSG00000136811.17. [Q5BJF6-8]"";""ENST00000604420.5; ENSP00000473949.2; ENSG00000136811.17. [Q5BJF6-1]"";",small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198],cell differentiation [GO:0030154]; centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle pole [GO:0000922]
Q9NZT2,C5,1.415438625,1.025430868,-0.807647159,-1.097515439,-1.443699043,turquoise3,OGFR,OGFR_HUMAN,Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor),OGFR,11054;,ENST00000290291.10; ENSP00000290291.6; ENSG00000060491.17. [Q9NZT2-1];,opioid growth factor receptor activity [GO:0140625],regulation of cell growth [GO:0001558],cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]
Q9NTK5,C4,2.150998048,0.044592001,-1.010287454,-1.111017053,-1.25118614,deepskyblue2,OLA1,OLA1_HUMAN,Obg-like ATPase 1 (DNA damage-regulated overexpressed in cancer 45) (DOC45) (GTP-binding protein 9),OLA1 GTPBP9 PRO2455 PTD004,29789;,"ENST00000284719.8; ENSP00000284719.3; ENSG00000138430.16. [Q9NTK5-1];""ENST00000344357.9; ENSP00000340167.5; ENSG00000138430.16. [Q9NTK5-2]"";""ENST00000428402.6; ENSP00000410385.2; ENSG00000138430.16. [Q9NTK5-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023],ATP metabolic process [GO:0046034],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093]
Q96E52,M2,-1.429259324,-1.356490731,0.406486503,1.256212381,-0.290002035,tan4,OMA1,OMA1_HUMAN,"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Metalloprotease-related protein 1) (MPRP-1) (Overlapping with the m-AAA protease 1 homolog)",OMA1 MPRP1,115209;,ENST00000371226.8; ENSP00000360270.3; ENSG00000162600.12. [Q96E52-1];,lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]
O60313,M2,-1.238742043,-1.253102397,0.443948066,1.158872256,-0.235575903,tan4,OPA1,OPA1_HUMAN,"Dynamin-like GTPase OPA1, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1) [Cleaved into: Dynamin-like GTPase OPA1, long form (L-OPA1); Dynamin-like GTPase OPA1, short form (S-OPA1)]",OPA1 KIAA0567,4976;,"ENST00000361150.6; ENSP00000354781.2; ENSG00000198836.11. [O60313-9];""ENST00000361510.8; ENSP00000355324.2; ENSG00000198836.11. [O60313-10]"";""ENST00000361828.7; ENSP00000354429.3; ENSG00000198836.11. [O60313-1]"";""ENST00000361908.8; ENSP00000354681.3; ENSG00000198836.11. [O60313-2]"";""ENST00000392437.6; ENSP00000376232.2; ENSG00000198836.11. [O60313-11]"";""ENST00000646793.1; ENSP00000494512.1; ENSG00000198836.11. [O60313-13]"";",cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; magnesium ion binding [GO:0000287]; membrane bending activity [GO:0180020]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300],apoptotic process [GO:0006915]; axonal transport of mitochondrion [GO:0019896]; cellular senescence [GO:0090398]; cristae formation [GO:0042407]; GTP metabolic process [GO:0046039]; inner mitochondrial membrane organization [GO:0007007]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrial genome maintenance [GO:0000002]; mitochondrial inner membrane fusion [GO:1990627]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neural tube closure [GO:0001843]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein complex oligomerization [GO:0051259]; visual perception [GO:0007601],axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q96SN7,S4,-1.602538649,-1.39085214,0.370530306,0.859157005,0.209462925,tomato2,ORAI2,ORAI2_HUMAN,Protein orai-2 (CAP-binding protein complex-interacting protein 2) (Transmembrane protein 142B),ORAI2 C7orf19 CBCIP2 TMEM142B PP1729,80228;,"ENST00000356387.6; ENSP00000348752.2; ENSG00000160991.17.;""ENST00000403646.8; ENSP00000385489.3; ENSG00000160991.17."";""ENST00000473939.2; ENSP00000417928.1; ENSG00000160991.17."";""ENST00000478730.7; ENSP00000418140.1; ENSG00000160991.17."";""ENST00000495936.7; ENSP00000420178.2; ENSG00000160991.17."";""ENST00000498661.6; ENSP00000418464.2; ENSG00000160991.17."";""ENST00000611770.5; ENSP00000478113.1; ENSG00000160991.17."";",store-operated calcium channel activity [GO:0015279],store-operated calcium entry [GO:0002115],growth cone [GO:0030426]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9Y619,N3,-0.757183217,-0.936298856,1.113866153,0.254993002,-0.360945026,grey50,ORC1,ORNT1_HUMAN,Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15),SLC25A15 ORC1 ORNT1 SP1855,10166;,"ENST00000338625.9; ENSP00000342267.4; ENSG00000102743.16.;""ENST00000707033.1; ENSP00000516711.1; ENSG00000102743.16."";",antiporter activity [GO:0015297]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q13438,S3,-1.158292353,-1.318997866,0.122239493,0.890208313,0.575669106,salmon,OS9,OS9_HUMAN,Protein OS-9 (Amplified in osteosarcoma 9),OS9,10956;,"ENST00000257966.13; ENSP00000257966.8; ENSG00000135506.17. [Q13438-7];""ENST00000315970.12; ENSP00000318165.7; ENSG00000135506.17. [Q13438-1]"";""ENST00000389142.10; ENSP00000373794.5; ENSG00000135506.17. [Q13438-3]"";""ENST00000389146.11; ENSP00000373798.6; ENSG00000135506.17. [Q13438-4]"";""ENST00000435406.6; ENSP00000389632.2; ENSG00000135506.17. [Q13438-6]"";""ENST00000439210.6; ENSP00000407360.2; ENSG00000135506.17. [Q13438-8]"";""ENST00000551035.5; ENSP00000447866.1; ENSG00000135506.17. [Q13438-5]"";""ENST00000552285.6; ENSP00000450010.1; ENSG00000135506.17. [Q13438-2]"";",carbohydrate binding [GO:0030246]; protease binding [GO:0002020],"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]
Q9H1P3,C3,1.771197438,0.234515405,-0.601451433,-0.510295051,-0.884789345,cyan,OSBPL2,OSBL2_HUMAN,Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2),OSBPL2 KIAA0772 ORP2,9885;,"ENST00000313733.9; ENSP00000316649.3; ENSG00000130703.17. [Q9H1P3-1];""ENST00000358053.3; ENSP00000350755.2; ENSG00000130703.17. [Q9H1P3-2]"";""ENST00000643412.1; ENSP00000494549.1; ENSG00000130703.17. [Q9H1P3-1]"";""ENST00000643981.1; ENSP00000495379.1; ENSG00000130703.17. [Q9H1P3-1]"";","cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidylinositol transfer activity [GO:0008526]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",bile acid biosynthetic process [GO:0006699]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; plasma membrane organization [GO:0007009]; protein homotetramerization [GO:0051289]; regulation of synaptic vesicle priming [GO:0010807],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]
Q9H0X9,S3,-0.655480905,-1.193867863,0.273624586,0.838593726,0.422427639,salmon,OSBPL5,OSBL5_HUMAN,Oxysterol-binding protein-related protein 5 (ORP-5) (OSBP-related protein 5) (Oxysterol-binding protein homolog 1),OSBPL5 KIAA1534 OBPH1 ORP5,114879;,"ENST00000263650.12; ENSP00000263650.7; ENSG00000021762.20. [Q9H0X9-1];""ENST00000348039.9; ENSP00000302872.8; ENSG00000021762.20. [Q9H0X9-2]"";""ENST00000389989.7; ENSP00000374639.3; ENSG00000021762.20. [Q9H0X9-2]"";""ENST00000525498.5; ENSP00000433342.1; ENSG00000021762.20. [Q9H0X9-3]"";",cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934],cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
Q9BZF1,S2,-0.986138117,-1.238410154,0.173068275,0.829156191,0.545330037,orange,OSBPL8,OSBL8_HUMAN,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),OSBPL8 KIAA1451 ORP8 OSBP10,114882;,"ENST00000261183.8; ENSP00000261183.3; ENSG00000091039.17. [Q9BZF1-1];""ENST00000393249.6; ENSP00000376939.2; ENSG00000091039.17. [Q9BZF1-3]"";""ENST00000393250.8; ENSP00000376940.4; ENSG00000091039.17. [Q9BZF1-3]"";""ENST00000611266.4; ENSP00000478240.1; ENSG00000091039.17. [Q9BZF1-3]"";",cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343]; phospholipid transporter activity [GO:0005548],fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization to nuclear pore [GO:0090204],cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]
Q99650,S2,-1.380175811,-1.38933606,0.104250759,0.935695228,0.736335573,orange,OSMR,OSMR_HUMAN,Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB),OSMR OSMRB,9180;,"ENST00000274276.8; ENSP00000274276.3; ENSG00000145623.13. [Q99650-1];""ENST00000502536.5; ENSP00000422023.1; ENSG00000145623.13. [Q99650-2]"";",ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838],cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q96FW1,C5,1.925336241,0.289045874,-0.898816571,-0.831307705,-1.166272571,turquoise3,OTUB1,OTUB1_HUMAN,Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1),OTUB1 OTB1 OTU1 HSPC263,55611;,"ENST00000428192.6; ENSP00000402551.2; ENSG00000167770.13. [Q96FW1-1];""ENST00000538426.6; ENSP00000444357.1; ENSG00000167770.13. [Q96FW1-1]"";",cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105],adaptive immune response [GO:0002250]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]
Q96G74,N4,0.241643151,1.135127208,-0.312084189,-0.439706822,-0.813818158,grey30,OTUD5,OTUD5_HUMAN,OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA),OTUD5,55593;,"ENST00000156084.8; ENSP00000156084.4; ENSG00000068308.15. [Q96G74-1];""ENST00000376488.8; ENSP00000365671.3; ENSG00000068308.15. [Q96G74-5]"";""ENST00000396743.7; ENSP00000379969.3; ENSG00000068308.15. [Q96G74-5]"";""ENST00000428668.2; ENSP00000401629.2; ENSG00000068308.15. [Q96G74-4]"";""ENST00000710072.1; ENSP00000518038.1; ENSG00000292211.1. [Q96G74-5]"";""ENST00000710073.1; ENSP00000518039.1; ENSG00000292211.1. [Q96G74-5]"";""ENST00000710075.1; ENSP00000518041.1; ENSG00000292211.1. [Q96G74-1]"";""ENST00000710076.1; ENSP00000518042.1; ENSG00000292211.1. [Q96G74-4]"";",cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578],negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of type I interferon production [GO:0032480]; neural crest cell differentiation [GO:0014033]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; response to lipopolysaccharide [GO:0032496],cytosol [GO:0005829]; nucleus [GO:0005634]
Q8WZ82,C1,1.548140425,0.206292778,-0.309275256,-0.009098456,-0.823214195,lightblue,OVCA2,OVCA2_HUMAN,Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein),OVCA2,124641;,ENST00000572195.3; ENSP00000461388.1; ENSG00000262664.3.;,hydrolase activity [GO:0016787],response to retinoic acid [GO:0032526],cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q15070,M2,-1.244921724,-1.277265863,0.462551768,1.007439812,-0.026305819,tan4,OXA1L,OXA1L_HUMAN,Mitochondrial inner membrane protein OXA1L (OXA1Hs) (Oxidase assembly 1-like protein) (OXA1-like protein),OXA1L,5018;,"ENST00000358043.5; ENSP00000350740.5; ENSG00000155463.14. [Q15070-2];""ENST00000612549.6; ENSP00000483491.2; ENSG00000155463.14. [Q15070-1]"";",membrane insertase activity [GO:0032977]; mitochondrial ribosome binding [GO:0097177]; protein homodimerization activity [GO:0042803],aerobic respiration [GO:0009060]; mitochondrial protein quality control [GO:0141164]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of oxidoreductase activity [GO:0051354]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; protein tetramerization [GO:0051262],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]
Q8N573,C3,1.931654786,-0.10287767,-0.652530947,-0.520507572,-0.859722324,cyan,OXR1,OXR1_HUMAN,Oxidation resistance protein 1,OXR1 Nbla00307,55074;,"ENST00000297447.10; ENSP00000297447.6; ENSG00000164830.19. [Q8N573-4];""ENST00000312046.10; ENSP00000311026.6; ENSG00000164830.19. [Q8N573-2]"";""ENST00000442977.6; ENSP00000405424.2; ENSG00000164830.19. [Q8N573-1]"";""ENST00000449762.6; ENSP00000408659.2; ENSG00000164830.19. [Q8N573-7]"";""ENST00000497705.5; ENSP00000431014.1; ENSG00000164830.19. [Q8N573-3]"";""ENST00000517566.7; ENSP00000429205.2; ENSG00000164830.19. [Q8N573-8]"";""ENST00000531443.6; ENSP00000431966.1; ENSG00000164830.19. [Q8N573-5]"";",oxidoreductase activity [GO:0016491],adult walking behavior [GO:0007628]; cellular response to hydroperoxide [GO:0071447]; negative regulation of cellular response to oxidative stress [GO:1900408]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; neuron apoptotic process [GO:0051402]; response to oxidative stress [GO:0006979],mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]
Q99571,S1,-1.764318424,-1.59174254,-0.467549836,0.870778897,1.065034112,gold,P2RX4,P2RX4_HUMAN,P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor),P2RX4,5025;,"ENST00000337233.9; ENSP00000336607.4; ENSG00000135124.16. [Q99571-1];""ENST00000359949.11; ENSP00000353032.7; ENSG00000135124.16. [Q99571-2]"";""ENST00000542067.5; ENSP00000438329.1; ENSG00000135124.16. [Q99571-3]"";",ATP binding [GO:0005524]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; extracellularly ATP-gated monoatomic cation channel activity [GO:0004931]; identical protein binding [GO:0042802]; ligand-gated calcium channel activity [GO:0099604]; purinergic nucleotide receptor activity [GO:0001614]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270],apoptotic signaling pathway [GO:0097190]; behavioral response to pain [GO:0048266]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; cellular response to ATP [GO:0071318]; cellular response to zinc ion [GO:0071294]; endothelial cell activation [GO:0042118]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; neuronal action potential [GO:0019228]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of prostaglandin secretion [GO:0032308]; purinergic nucleotide receptor signaling pathway [GO:0035590]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of chemotaxis [GO:0050920]; regulation of sodium ion transport [GO:0002028]; relaxation of cardiac muscle [GO:0055119]; response to ATP [GO:0033198]; response to axon injury [GO:0048678]; response to fluid shear stress [GO:0034405]; response to ischemia [GO:0002931]; sensory perception of pain [GO:0019233]; sensory perception of touch [GO:0050975]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894],cell body [GO:0044297]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]
P07237,N4,-1.195576881,0.530588383,-0.17963738,0.55718633,0.033990249,grey30,P4HB,PDIA1_HUMAN,Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55),P4HB ERBA2L PDI PDIA1 PO4DB,5034;,ENST00000331483.9; ENSP00000327801.4; ENSG00000185624.16.;,actin binding [GO:0003779]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723]; thiol oxidase activity [GO:0016972],cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; insulin processing [GO:0030070]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-23-mediated signaling pathway [GO:0038155]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of cell adhesion [GO:0045785]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; protein-containing complex [GO:0032991]
Q9BRP4,C5,1.651035766,0.699220461,-0.723741324,-0.623530951,-0.586015773,turquoise3,PAAF1,PAAF1_HUMAN,Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71),PAAF1 WDR71,80227;,"ENST00000310571.8; ENSP00000311665.4; ENSG00000175575.13. [Q9BRP4-1];""ENST00000376384.9; ENSP00000365564.5; ENSG00000175575.13. [Q9BRP4-2]"";""ENST00000535604.5; ENSP00000438789.1; ENSG00000175575.13. [Q9BRP4-3]"";""ENST00000536003.5; ENSP00000438124.1; ENSG00000175575.13. [Q9BRP4-2]"";""ENST00000541951.5; ENSP00000441333.1; ENSG00000175575.13. [Q9BRP4-3]"";""ENST00000544552.5; ENSP00000441494.1; ENSG00000175575.13. [Q9BRP4-2]"";",0,transcription initiation at RNA polymerase II promoter [GO:0006367],proteasome complex [GO:0000502]; transcription factor TFIID complex [GO:0005669]
P11940,N1,0.057323146,-0.299184074,-0.373150456,-0.297242933,1.038676582,grey90,PABPC1,PABP1_HUMAN,Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1),PABPC1 PAB1 PABP PABP1 PABPC2,26986;,"ENST00000318607.10; ENSP00000313007.5; ENSG00000070756.17. [P11940-1];""ENST00000520142.2; ENSP00000430012.2; ENSG00000070756.17. [P11940-1]"";""ENST00000520804.2; ENSP00000428749.2; ENSG00000070756.17. [P11940-1]"";""ENST00000521865.6; ENSP00000429119.2; ENSG00000070756.17. [P11940-1]"";""ENST00000522658.6; ENSP00000428840.2; ENSG00000070756.17. [P11940-1]"";""ENST00000522720.2; ENSP00000429790.2; ENSG00000070756.17. [P11940-1]"";""ENST00000523555.6; ENSP00000429892.2; ENSG00000070756.17. [P11940-1]"";",mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],"CRD-mediated mRNA stabilization [GO:0070934]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; regulatory ncRNA-mediated gene silencing [GO:0031047]",catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
Q9UNF0,C3,1.536294197,0.307625694,-0.50798744,-0.483051858,-0.569436114,cyan,PACSIN2,PACN2_HUMAN,Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II) (SdpII),PACSIN2,11252;,"ENST00000263246.8; ENSP00000263246.3; ENSG00000100266.19. [Q9UNF0-1];""ENST00000337959.8; ENSP00000338379.4; ENSG00000100266.19. [Q9UNF0-2]"";""ENST00000402229.5; ENSP00000385040.1; ENSG00000100266.19. [Q9UNF0-1]"";""ENST00000403744.7; ENSP00000385372.3; ENSG00000100266.19. [Q9UNF0-1]"";""ENST00000407585.5; ENSP00000385952.1; ENSG00000100266.19. [Q9UNF0-2]"";",cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543],actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; regulation of endocytosis [GO:0030100],caveola [GO:0005901]; cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]
Q8N7H5,N4,-1.068630404,1.114633194,0.344221034,-0.726861589,-0.667410322,grey30,PAF1,PAF1_HUMAN,RNA polymerase II-associated factor 1 homolog (hPAF1) (Pancreatic differentiation protein 2),PAF1 PD2,54623;,"ENST00000221265.8; ENSP00000221265.2; ENSG00000006712.15. [Q8N7H5-1];""ENST00000595564.5; ENSP00000468874.1; ENSG00000006712.15. [Q8N7H5-3]"";",chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993],cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
Q9H074,C1,1.627408159,0.121784612,-0.710806033,-0.928071176,-0.481799003,lightblue,PAIP1,PAIP1_HUMAN,Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1),PAIP1,10605;,"ENST00000306846.8; ENSP00000302768.3; ENSG00000172239.14. [Q9H074-1];""ENST00000338972.8; ENSP00000339622.4; ENSG00000172239.14. [Q9H074-3]"";""ENST00000436644.6; ENSP00000387729.2; ENSG00000172239.14. [Q9H074-2]"";",RNA binding [GO:0003723]; translation activator activity [GO:0008494],"CRD-mediated mRNA stabilization [GO:0070934]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation by host of viral process [GO:0044794]; positive regulation of cytoplasmic translation [GO:2000767]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translation [GO:0019081]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mCRD-mediated mRNA stability complex [GO:0106002]
Q9BPZ3,C1,1.648804812,0.151261175,-0.78907363,-0.564145733,-0.218571422,lightblue,PAIP2,PAIP2_HUMAN,Polyadenylate-binding protein-interacting protein 2 (PABP-interacting protein 2) (PAIP-2) (Poly(A)-binding protein-interacting protein 2),PAIP2 PAIP2A HSPC218,51247;,"ENST00000265192.9; ENSP00000265192.4; ENSG00000120727.13.;""ENST00000394795.6; ENSP00000378275.2; ENSG00000120727.13."";""ENST00000510080.1; ENSP00000422508.1; ENSG00000120727.13."";",mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; translation repressor activity [GO:0030371],memory [GO:0007613]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; regulation of long-term synaptic potentiation [GO:1900271]; spermatogenesis [GO:0007283]; translation [GO:0006412],cytoplasm [GO:0005737]
Q9ULR5,C1,1.707149972,0.466550823,-1.088039729,-0.947701243,-0.042631748,lightblue,PAIP2B,PAI2B_HUMAN,Polyadenylate-binding protein-interacting protein 2B (PABP-interacting protein 2B) (PAIP-2B) (Poly(A)-binding protein-interacting protein 2B),PAIP2B KIAA1155,400961;,ENST00000244221.9; ENSP00000244221.8; ENSG00000124374.9.;,mRNA regulatory element binding translation repressor activity [GO:0000900]; translation repressor activity [GO:0030371],negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947],cytoplasm [GO:0005737]
Q16512,C3,2.003874115,0.149325377,-0.837235302,-0.644042299,-0.948486351,cyan,PAK1,PKN1_HUMAN,Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N),PKN1 PAK1 PKN PRK1 PRKCL1,5585;,"ENST00000242783.11; ENSP00000242783.7; ENSG00000123143.13. [Q16512-1];""ENST00000342216.8; ENSP00000343325.4; ENSG00000123143.13. [Q16512-2]"";",ATP binding [GO:0005524]; chromatin binding [GO:0003682]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3T11 kinase activity [GO:0035402]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267],B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; epithelial cell migration [GO:0010631]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of protein phosphorylation [GO:0001933]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of cell motility [GO:2000145]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of transcription by RNA polymerase II [GO:0006357]; renal system process [GO:0003014]; signal transduction [GO:0007165]; spleen development [GO:0048536],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q9NWT1,N3,-0.820868195,-0.992805958,0.935069263,-0.118191505,0.809168673,grey50,PAK1IP1,PK1IP_HUMAN,p21-activated protein kinase-interacting protein 1 (PAK/PLC-interacting protein 1) (hPIP1) (PAK1-interacting protein 1) (WD repeat-containing protein 84),PAK1IP1 PIP1 WDR84,55003;,"ENST00000379568.4; ENSP00000368887.3; ENSG00000111845.5.;""ENST00000644756.2; ENSP00000496482.1; ENSG00000285226.2."";",0,cell population proliferation [GO:0008283]; negative regulation of signal transduction [GO:0009968]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit biogenesis [GO:0042273]; roof of mouth development [GO:0060021],nucleolus [GO:0005730]
Q13177,C3,1.986667749,0.119666332,-0.701897339,-0.604062208,-0.958090625,cyan,PAK2,PAK2_HUMAN,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)],PAK2,5062;,ENST00000327134.7; ENSP00000314067.3; ENSG00000180370.10.;,ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activator activity [GO:0030296]; small GTPase binding [GO:0031267],adherens junction assembly [GO:0034333]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; cardiac muscle hypertrophy [GO:0003300]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendritic spine development [GO:0060996]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress fiber assembly [GO:0051497]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein autophosphorylation [GO:0046777]; protein localization to cell-cell junction [GO:0150105]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of cytoskeleton organization [GO:0051493]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; secretory granule [GO:0030141]
Q8WX93,C3,1.51992853,0.383570532,-0.460755013,-0.52519088,-0.844514116,cyan,PALLD,PALLD_HUMAN,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),PALLD KIAA0992 CGI-151,23022;,"ENST00000261509.10; ENSP00000261509.6; ENSG00000129116.20. [Q8WX93-2];""ENST00000505667.6; ENSP00000425556.1; ENSG00000129116.20. [Q8WX93-9]"";""ENST00000507735.6; ENSP00000424016.1; ENSG00000129116.20. [Q8WX93-4]"";""ENST00000512127.5; ENSP00000426947.1; ENSG00000129116.20. [Q8WX93-8]"";",actin binding [GO:0003779]; cell-cell adhesion mediator activity [GO:0098632]; muscle alpha-actinin binding [GO:0051371],actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; dendrite self-avoidance [GO:0070593]; epithelial cell morphogenesis [GO:0003382]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; keratinocyte development [GO:0003334],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cytosol [GO:0005829]; excitatory synapse [GO:0060076]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; Z disc [GO:0030018]
O75592,S3,-0.98065027,-0.718583828,-0.001954302,0.728967392,0.735743717,salmon,PAM,MYCB2_HUMAN,E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.33) (Myc-binding protein 2) (Protein associated with Myc),MYCBP2 KIAA0916 PAM,23077;,ENST00000544440.7; ENSP00000444596.2; ENSG00000005810.20. [O75592-1];,guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; circadian regulation of gene expression [GO:0032922]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; positive regulation of protein ubiquitination [GO:0031398]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880]; regulation of synaptic assembly at neuromuscular junction [GO:0008582],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q8TE04,C5,1.330427163,0.663882871,-0.457234295,-0.758932014,-0.943557632,turquoise3,PANK1,PANK1_HUMAN,Pantothenate kinase 1 (hPanK) (hPanK1) (EC 2.7.1.33) (Pantothenic acid kinase 1),PANK1 PANK,53354;,"ENST00000322191.10; ENSP00000318526.6; ENSG00000152782.19. [Q8TE04-3];""ENST00000342512.4; ENSP00000345118.3; ENSG00000152782.19. [Q8TE04-2]"";",acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803],coenzyme A biosynthetic process [GO:0015937],clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; recycling endosome [GO:0055037]
Q9BZ23,C4,2.205151851,0.380166337,-1.178740765,-1.167346853,-1.569756524,deepskyblue2,PANK2,PANK2_HUMAN,"Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2) [Cleaved into: Pantothenate kinase 2, mitochondrial intermediate form (iPanK2); Pantothenate kinase 2, mitochondrial mature form (mPanK2)]",PANK2 C20orf48,80025;,"ENST00000316562.9; ENSP00000313377.4; ENSG00000125779.24. [Q9BZ23-1];""ENST00000497424.5; ENSP00000417609.1; ENSG00000125779.24. [Q9BZ23-2]"";""ENST00000610179.7; ENSP00000477429.2; ENSG00000125779.24. [Q9BZ23-4]"";""ENST00000621507.1; ENSP00000481523.1; ENSG00000125779.24. [Q9BZ23-2]"";",ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594],aerobic respiration [GO:0009060]; angiogenesis [GO:0001525]; coenzyme A biosynthetic process [GO:0015937]; mitochondrion organization [GO:0007005]; pantothenate metabolic process [GO:0015939]; phosphorylation [GO:0016310]; regulation of bile acid metabolic process [GO:1904251]; regulation of fatty acid metabolic process [GO:0019217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of triglyceride metabolic process [GO:0090207]; spermatid development [GO:0007286],cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q9H999,C4,2.204980317,0.526732467,-1.344037736,-1.317807719,-1.668410286,deepskyblue2,PANK3,PANK3_HUMAN,Pantothenate kinase 3 (hPanK3) (EC 2.7.1.33) (Pantothenic acid kinase 3),PANK3,79646;,ENST00000239231.7; ENSP00000239231.6; ENSG00000120137.7.;,acetyl-CoA binding [GO:1905502]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; protein homodimerization activity [GO:0042803]; vitamin binding [GO:0019842],coenzyme A biosynthetic process [GO:0015937]; phosphorylation [GO:0016310],cytosol [GO:0005829]; nucleus [GO:0005634]
Q9NVE7,C3,1.812481959,0.129565747,-0.607720534,-0.638291133,-0.741661445,cyan,PANK4,PANK4_HUMAN,4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4),PANK4,55229;,"ENST00000378466.9; ENSP00000367727.5; ENSG00000157881.16.;""ENST00000615291.3; ENSP00000478189.1; ENSG00000273494.3."";",ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791],coenzyme A biosynthetic process [GO:0015937]; pantothenate metabolic process [GO:0015939],cytosol [GO:0005829]; nucleus [GO:0005634]
Q96RD7,S4,-1.247650207,-1.510072523,0.576572259,0.843655498,0.270445682,tomato2,PANX1,PANX1_HUMAN,Pannexin-1 (PANX1) [Cleaved into: Caspase-activated pannexin-1 (Caspase-activated PANX1)],PANX1 MRS1 UNQ2529/PRO6028,24145;,"ENST00000227638.8; ENSP00000227638.3; ENSG00000110218.9. [Q96RD7-1];""ENST00000436171.2; ENSP00000411461.2; ENSG00000110218.9. [Q96RD7-2]"";",actin filament binding [GO:0051015]; ATP transmembrane transporter activity [GO:0005347]; calcium channel activity [GO:0005262]; gap junction channel activity [GO:0005243]; identical protein binding [GO:0042802]; leak channel activity [GO:0022840]; monoatomic anion channel activity [GO:0005253]; protease binding [GO:0002020]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; transmembrane transporter binding [GO:0044325]; wide pore channel activity [GO:0022829],ATP transport [GO:0015867]; calcium ion transport [GO:0006816]; cell-cell signaling [GO:0007267]; monoatomic anion transmembrane transport [GO:0098656]; monoatomic cation transport [GO:0006812]; oogenesis [GO:0048477]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage cytokine production [GO:0060907]; response to ATP [GO:0033198]; response to ischemia [GO:0002931],bleb [GO:0032059]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gap junction [GO:0005921]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q8NDF8,N3,-0.970120749,-0.747363541,1.056820486,-0.206579725,0.237362662,grey50,PAPD5,PAPD5_HUMAN,Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2),TENT4B GLD4 PAPD5 TRF4-2 TUT3,64282;,ENST00000436909.8; ENSP00000396995.3; ENSG00000121274.14. [Q8NDF8-5];,ATP binding [GO:0005524]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],carbohydrate homeostasis [GO:0033500]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA 3'-end processing [GO:0031124]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; polyadenylation-dependent ncRNA catabolic process [GO:0043634]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; TRAMP complex [GO:0031499]
O95340,C5,1.380773412,0.868365194,-0.446002788,-0.52805526,-0.810234308,turquoise3,PAPSS2,PAPS2_HUMAN,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPS synthase 2) (PAPSS 2) (Sulfurylase kinase 2) (SK 2) (SK2) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],PAPSS2 ATPSK2,9060;,"ENST00000361175.8; ENSP00000354436.4; ENSG00000198682.13. [O95340-1];""ENST00000456849.2; ENSP00000406157.1; ENSG00000198682.13. [O95340-2]"";",adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781],3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; blood coagulation [GO:0007596]; bone development [GO:0060348]; hormone metabolic process [GO:0042445]; sulfate assimilation [GO:0000103],cytosol [GO:0005829]
Q99497,C5,1.662149239,0.372113246,-0.852284827,-0.802130021,-1.204816613,turquoise3,PARK7,PARK7_HUMAN,"Parkinson disease protein 7 (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-, EC 3.5.1.-, EC 3.5.1.124)",PARK7,11315;,"ENST00000338639.10; ENSP00000340278.5; ENSG00000116288.13.;""ENST00000377488.5; ENSP00000366708.1; ENSG00000116288.13."";""ENST00000377491.5; ENSP00000366711.1; ENSG00000116288.13."";""ENST00000493373.5; ENSP00000465404.1; ENSG00000116288.13."";""ENST00000493678.5; ENSP00000418770.1; ENSG00000116288.13."";","cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]","activation of protein kinase B activity [GO:0032148]; adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of hydrogen peroxide [GO:0061691]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; methylglyoxal metabolic process [GO:0009438]; mitochondrion organization [GO:0007005]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of death-inducing signaling complex assembly [GO:1903073]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of supramolecular fiber organization [GO:1902903]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]",adherens junction [GO:0005912]; axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]
Q9H300,M2,-1.499559029,-1.657034501,0.353703607,1.121329967,-0.13007742,tan4,PARL,PARL_HUMAN,"Presenilin-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]",PARL PSARL PRO2207,55486;,"ENST00000311101.9; ENSP00000310676.5; ENSG00000175193.14. [Q9H300-2];""ENST00000317096.9; ENSP00000325421.5; ENSG00000175193.14. [Q9H300-1]"";",endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252],membrane protein proteolysis [GO:0033619]; mitochondrial fusion [GO:0008053]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of mitochondrion organization [GO:0010821]; regulation of mitophagy [GO:1901524]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of proteolysis [GO:0030162]; regulation of reactive oxygen species metabolic process [GO:2000377]; signal peptide processing [GO:0006465],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q8N5Y8,S2,-1.183494282,-1.809159336,0.347334086,0.912430786,0.581366573,orange,PARP16,PAR16_HUMAN,Protein mono-ADP-ribosyltransferase PARP16 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16),PARP16 ARTD15 C15orf30,54956;,"ENST00000261888.10; ENSP00000261888.6; ENSG00000138617.16. [Q8N5Y8-3];""ENST00000444347.2; ENSP00000396118.2; ENSG00000138617.16. [Q8N5Y8-2]"";""ENST00000649807.2; ENSP00000496935.1; ENSG00000138617.16. [Q8N5Y8-1]"";",kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+- protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+- protein-lysine ADP-ribosyltransferase activity [GO:0140804]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; protein serine/threonine kinase activator activity [GO:0043539],cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of cytoplasmic translation [GO:2000766]; protein auto-ADP-ribosylation [GO:0070213]; viral protein processing [GO:0019082],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; membrane [GO:0016020]; nuclear envelope [GO:0005635]
Q9UGN5,N1,-1.207941015,-0.531629848,0.176008031,0.278457035,1.032573399,grey90,PARP2,PARP2_HUMAN,Poly [ADP-ribose] polymerase 2 (PARP-2) (hPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-),PARP2 ADPRT2 ADPRTL2,10038;,"ENST00000250416.9; ENSP00000250416.5; ENSG00000129484.14. [Q9UGN5-1];""ENST00000429687.8; ENSP00000392972.3; ENSG00000129484.14. [Q9UGN5-2]"";""ENST00000708822.1; ENSP00000517361.1; ENSG00000291803.1. [Q9UGN5-2]"";""ENST00000708823.1; ENSP00000517362.1; ENSG00000291803.1. [Q9UGN5-1]"";",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+- protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; poly-ADP-D-ribose binding [GO:0072572]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004],base-excision repair [GO:0006284]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; hippocampal neuron apoptotic process [GO:0110088]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; response to oxygen-glucose deprivation [GO:0090649],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]
Q9UKK3,N1,0.592693278,-0.613374237,-0.625005131,-0.375342547,1.160007605,grey90,PARP4,PARP4_HUMAN,Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP),PARP4 ADPRTL1 KIAA0177 PARPL,143;,ENST00000381989.4; ENSP00000371419.3; ENSG00000102699.6.;,DNA binding [GO:0003677]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; nucleotidyltransferase activity [GO:0016779],DNA damage response [GO:0006974]; DNA repair [GO:0006281]; inflammatory response [GO:0006954]; protein modification process [GO:0036211]; regulation of telomerase activity [GO:0051972]; response to xenobiotic stimulus [GO:0009410],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle microtubule [GO:0005876]
Q9NVD7,C3,1.559139966,-0.062309583,-0.49286822,-0.083519658,-0.423162227,cyan,PARVA,PARVA_HUMAN,Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2),PARVA MXRA2,55742;,ENST00000334956.15; ENSP00000334008.9; ENSG00000197702.14. [Q9NVD7-1];,actin binding [GO:0003779]; cadherin binding [GO:0045296]; protein kinase inhibitor activity [GO:0004860],actin cytoskeleton organization [GO:0030036]; actin-mediated cell contraction [GO:0070252]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; heterotypic cell-cell adhesion [GO:0034113]; outflow tract septum morphogenesis [GO:0003148]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360]; smooth muscle cell chemotaxis [GO:0071670]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Z disc [GO:0030018]
Q96RG2,C3,1.899379824,-0.050109009,-0.645673982,-0.584782692,-0.777608509,cyan,PASK,PASK_HUMAN,PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1),PASK KIAA0135,23178;,"ENST00000234040.9; ENSP00000234040.5; ENSG00000115687.14. [Q96RG2-1];""ENST00000358649.8; ENSP00000351475.4; ENSG00000115687.14. [Q96RG2-2]"";""ENST00000403638.7; ENSP00000384438.3; ENSG00000115687.14. [Q96RG2-4]"";""ENST00000405260.5; ENSP00000384016.1; ENSG00000115687.14. [Q96RG2-1]"";""ENST00000544142.5; ENSP00000441374.2; ENSG00000115687.14. [Q96RG2-1]"";",ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q86TB9,C1,1.074924022,0.071279747,-0.380155058,-0.388147361,0.473257695,lightblue,PATL1,PATL1_HUMAN,Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b) (hPat1b),PATL1 OK/KNS-cl.5,219988;,ENST00000300146.10; ENSP00000300146.9; ENSG00000166889.14. [Q86TB9-1];,poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723],deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; P-body assembly [GO:0033962],cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]
Q9HBE1,N1,-0.749899888,-0.697250097,0.380667336,-9.62E-04,1.087226958,grey90,PATZ1,PATZ1_HUMAN,"POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)",PATZ1 PATZ RIAZ ZBTB19 ZNF278 ZSG,23598;,"ENST00000215919.3; ENSP00000215919.3; ENSG00000100105.18. [Q9HBE1-4];""ENST00000266269.10; ENSP00000266269.5; ENSG00000100105.18. [Q9HBE1-1]"";""ENST00000351933.8; ENSP00000337520.4; ENSG00000100105.18. [Q9HBE1-3]"";""ENST00000405309.7; ENSP00000384173.3; ENSG00000100105.18. [Q9HBE1-2]"";","chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]",male gonad development [GO:0008584]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cytokine production [GO:0001817]; regulation of DNA-templated transcription [GO:0006355]; regulation of immune system process [GO:0002682]; spermatogenesis [GO:0007283]; T cell differentiation [GO:0030217],male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y5B6,N2,-1.240367285,0.198811121,0.782301093,0.020871749,0.230899145,grey70,PAXBP1,PAXB1_HUMAN,PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1),PAXBP1 C21orf66 GCFC GCFC1,94104;,"ENST00000290178.4; ENSP00000290178.4; ENSG00000159086.15. [Q9Y5B6-2];""ENST00000331923.9; ENSP00000328992.4; ENSG00000159086.15. [Q9Y5B6-1]"";""ENST00000443785.5; ENSP00000393038.1; ENSG00000159086.15. [Q9Y5B6-4]"";""ENST00000573680.5; ENSP00000458892.2; ENSG00000263141.5."";""ENST00000574159.2; ENSP00000458262.2; ENSG00000263141.5."";",DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226],"mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; transcription by RNA polymerase II [GO:0006366]",cytosol [GO:0005829]; nucleus [GO:0005634]
Q9BVG4,C4,1.940215624,0.409183182,-1.067648926,-1.029366077,-1.34436757,deepskyblue2,PBDC1,PBDC1_HUMAN,Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1),PBDC1 CXorf26,51260;,ENST00000373358.8; ENSP00000362456.3; ENSG00000102390.11.;,0,0,0
Q96KB5,C3,1.869924791,0.047227491,-0.651878297,-0.69742815,-1.050346918,cyan,PBK,TOPK_HUMAN,Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (Cancer/testis antigen 84) (CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase) (SPK) (T-LAK cell-originated protein kinase),PBK TOPK,55872;,"ENST00000301905.9; ENSP00000301905.4; ENSG00000168078.10. [Q96KB5-1];""ENST00000522944.5; ENSP00000428489.1; ENSG00000168078.10. [Q96KB5-2]"";",ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],cellular response to UV [GO:0034644]; mitotic cell cycle [GO:0000278]; negative regulation of inflammatory response [GO:0050728]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; stress-activated MAPK cascade [GO:0051403],nucleus [GO:0005634]
P40425,N4,-0.462486704,1.021362923,-0.019626567,-0.043216441,-0.507964072,grey30,PBX2,PBX2_HUMAN,Pre-B-cell leukemia transcription factor 2 (Homeobox protein PBX2) (Protein G17),PBX2 G17,5089;,"ENST00000375050.6; ENSP00000364190.3; ENSG00000204304.12.;""ENST00000383270.4; ENSP00000372757.4; ENSG00000206315.9."";""ENST00000420432.2; ENSP00000410710.2; ENSG00000236353.7."";""ENST00000431537.2; ENSP00000390009.2; ENSG00000232005.7."";""ENST00000433552.2; ENSP00000391745.2; ENSG00000224952.7."";""ENST00000453487.2; ENSP00000403948.2; ENSG00000225987.7."";""ENST00000453961.2; ENSP00000397177.2; ENSG00000237344.7."";","chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; eye development [GO:0001654]; neuron development [GO:0048666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]
Q96AQ6,S2,-0.883864726,-1.175765146,0.125274911,0.759528751,0.612783526,orange,PBXIP1,PBIP1_HUMAN,Pre-B-cell leukemia transcription factor-interacting protein 1 (Hematopoietic PBX-interacting protein),PBXIP1 HPIP,57326;,"ENST00000368463.8; ENSP00000357448.3; ENSG00000163346.17. [Q96AQ6-1];""ENST00000368465.5; ENSP00000357450.1; ENSG00000163346.17. [Q96AQ6-2]"";",DNA-binding transcription factor binding [GO:0140297]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],articular cartilage development [GO:0061975]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; extracellular matrix disassembly [GO:0022617]; gene expression involved in extracellular matrix organization [GO:1901148]; hemopoiesis [GO:0030097]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of Wnt signaling pathway [GO:0030177]; production of molecular mediator involved in inflammatory response [GO:0002532],chromatin [GO:0000785]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]
Q15365,C1,1.292519133,0.245372046,-0.006870722,-0.327001898,-0.406828526,lightblue,PCBP1,PCBP1_HUMAN,Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3),PCBP1,5093;,ENST00000303577.7; ENSP00000305556.5; ENSG00000169564.7.;,"cadherin binding [GO:0045296]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]",positive regulation of transcription by RNA polymerase II [GO:0045944]; viral RNA genome replication [GO:0039694],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]
Q08174,S3,-1.055300916,-0.361832383,0.268832517,0.808130977,0.212010498,salmon,PCDH1,PCDH1_HUMAN,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),PCDH1,5097;,"ENST00000287008.8; ENSP00000287008.3; ENSG00000156453.14. [Q08174-2];""ENST00000394536.4; ENSP00000378043.3; ENSG00000156453.14. [Q08174-1]"";",calcium ion binding [GO:0005509],cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399],cell junction [GO:0030054]; cell-cell junction [GO:0005911]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
O94913,N4,-0.800811376,1.12585058,-0.054800494,-0.449406049,-0.338805119,grey30,PCF11,PCF11_HUMAN,Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11),PCF11 KIAA0824,51585;,ENST00000298281.8; ENSP00000298281.4; ENSG00000165494.12.;,mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993],"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; termination of RNA polymerase II transcription [GO:0006369]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BSM1,N2,-0.737136236,-0.142212889,0.761304065,0.101665023,0.234263285,grey70,PCGF1,PCGF1_HUMAN,Polycomb group RING finger protein 1 (Nervous system Polycomb-1) (NSPc1) (RING finger protein 68),PCGF1 NSPC1 RNF68,84759;,ENST00000233630.11; ENSP00000233630.6; ENSG00000115289.14. [Q9BSM1-1];,metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841],chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]
Q86SE9,N4,-0.723083168,1.106549604,-0.042026539,-0.304695701,-0.314355948,grey30,PCGF5,PCGF5_HUMAN,Polycomb group RING finger protein 5 (RING finger protein 159),PCGF5 RNF159,84333;,"ENST00000336126.6; ENSP00000337500.5; ENSG00000180628.15. [Q86SE9-1];""ENST00000543648.5; ENSP00000445704.1; ENSG00000180628.15. [Q86SE9-1]"";""ENST00000614189.4; ENSP00000479492.1; ENSG00000180628.15. [Q86SE9-1]"";",histone H2AK119 ubiquitin ligase activity [GO:0140862]; metal ion binding [GO:0046872],positive regulation of transcription by RNA polymerase II [GO:0045944]; random inactivation of X chromosome [GO:0060816]; regulation of transcription by RNA polymerase II [GO:0006357],centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; X chromosome [GO:0000805]
Q5JVF3,C2,0.924145618,0.254764576,0.310468115,-0.280162338,-0.494132583,aquamarine,PCID2,PCID2_HUMAN,PCI domain-containing protein 2 (CSN12-like protein),PCID2 HT004,55795;,"ENST00000246505.9; ENSP00000246505.5; ENSG00000126226.22. [Q5JVF3-4];""ENST00000337344.9; ENSP00000337405.4; ENSG00000126226.22. [Q5JVF3-1]"";""ENST00000375457.2; ENSP00000364606.2; ENSG00000126226.22. [Q5JVF3-2]"";""ENST00000375459.5; ENSP00000364608.1; ENSG00000126226.22. [Q5JVF3-2]"";""ENST00000375477.5; ENSP00000364626.1; ENSG00000126226.22. [Q5JVF3-1]"";""ENST00000375479.6; ENSP00000364628.2; ENSG00000126226.22. [Q5JVF3-1]"";""ENST00000622406.4; ENSP00000479494.1; ENSG00000126226.22. [Q5JVF3-4]"";",double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723],heterochromatin organization [GO:0070828]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; negative regulation of transcription initiation by RNA polymerase II [GO:0060633]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation by RNA polymerase II [GO:0006368],cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]
P22061,C1,1.805563072,0.387775175,-0.650238584,-0.319292985,-0.800257546,lightblue,PCMT1,PIMT_HUMAN,Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase),PCMT1,5110;,"ENST00000367378.6; ENSP00000356348.2; ENSG00000120265.21. [P22061-1];""ENST00000367384.8; ENSP00000356354.3; ENSG00000120265.21. [P22061-2]"";""ENST00000464889.7; ENSP00000420813.2; ENSG00000120265.21. [P22061-1]"";",cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719],protein methylation [GO:0006479]; protein repair [GO:0030091],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]
P12004,C5,0.708004917,1.207528403,-0.297015057,-0.896970316,-1.129517469,turquoise3,PCNA,PCNA_HUMAN,Proliferating cell nuclear antigen (PCNA) (Cyclin),PCNA,5111;,"ENST00000379143.10; ENSP00000368438.5; ENSG00000132646.11.;""ENST00000379160.3; ENSP00000368458.3; ENSG00000132646.11."";",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971],"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]","centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]"
Q96RV3,S2,-0.975818076,-1.110917576,0.377705509,0.987762811,0.491816082,orange,PCNX,PCX1_HUMAN,Pecanex-like protein 1 (Pecanex homolog protein 1),PCNX1 KIAA0805 KIAA0995 PCNX PCNXL1,22990;,"ENST00000304743.7; ENSP00000304192.2; ENSG00000100731.16. [Q96RV3-1];""ENST00000439984.7; ENSP00000396617.3; ENSG00000100731.16. [Q96RV3-4]"";",0,0,membrane [GO:0016020]
Q9H6A9,S4,-0.690415841,-0.837885638,0.377571096,0.700542725,0.280535647,tomato2,PCNXL3,PCX3_HUMAN,Pecanex-like protein 3 (Pecanex homolog protein 3),PCNX3 PCNXL3,399909;,ENST00000355703.4; ENSP00000347931.3; ENSG00000197136.5. [Q9H6A9-1];,0,0,membrane [GO:0016020]
Q9UHG3,S2,-1.144872443,-1.538063039,0.376242551,0.787466294,0.457167062,orange,PCYOX1,PCYOX_HUMAN,Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase),PCYOX1 KIAA0908 PCL1 UNQ597/PRO1183,51449;,ENST00000433351.7; ENSP00000387654.2; ENSG00000116005.12. [Q9UHG3-1];,FAD binding [GO:0071949]; farnesylcysteine lyase activity [GO:0102149]; prenylcysteine oxidase activity [GO:0001735],prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328],extracellular exosome [GO:0070062]; lysosome [GO:0005764]; very-low-density lipoprotein particle [GO:0034361]
Q99447,C5,1.881541804,0.494414771,-0.785971953,-1.089991012,-1.205274316,turquoise3,PCYT2,PCY2_HUMAN,Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase),PCYT2,5833;,"ENST00000331285.7; ENSP00000331719.3; ENSG00000185813.11. [Q99447-2];""ENST00000538721.6; ENSP00000442050.2; ENSG00000185813.11. [Q99447-3]"";""ENST00000538936.7; ENSP00000439245.3; ENSG00000185813.11. [Q99447-1]"";""ENST00000570388.5; ENSP00000458330.1; ENSG00000185813.11. [Q99447-2]"";""ENST00000570391.5; ENSP00000461190.1; ENSG00000185813.11. [Q99447-4]"";",ethanolamine-phosphate cytidylyltransferase activity [GO:0004306],phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]
Q13442,C5,1.562682918,1.100380537,-0.917940534,-1.107657774,-1.148298199,turquoise3,PDAP1,HAP28_HUMAN,28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1),PDAP1 HASPP28,11333;,ENST00000350498.8; ENSP00000222968.4; ENSG00000106244.13.;,RNA binding [GO:0003723],signal transduction [GO:0007165],cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]
Q9BUL8,C3,1.639404288,0.056998625,-0.452146726,-0.042547276,-0.409764392,cyan,PDCD10,PDC10_HUMAN,Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15),PDCD10 CCM3 TFAR15,11235;,"ENST00000392750.7; ENSP00000376506.2; ENSG00000114209.15.;""ENST00000461494.5; ENSP00000420021.1; ENSG00000114209.15."";""ENST00000470131.5; ENSP00000417202.1; ENSG00000114209.15."";""ENST00000473645.6; ENSP00000418317.2; ENSG00000114209.15."";""ENST00000497056.6; ENSP00000420553.2; ENSG00000114209.15."";",protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901],"angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; endothelium development [GO:0003158]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; regulation of angiogenesis [GO:0045765]; regulation of Golgi organization [GO:1903358]; wound healing, spreading of cells [GO:0044319]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]
Q14690,N3,-1.208270793,-1.303816905,1.396832203,0.040275689,-0.523221974,grey50,PDCD11,RRP5_HUMAN,Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11),PDCD11 KIAA0185,22984;,ENST00000369797.8; ENSP00000358812.3; ENSG00000148843.15.;,NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723],rRNA processing [GO:0006364],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]
Q16342,C2,1.016358777,0.286506427,-0.186650026,-0.016150298,-0.315259646,aquamarine,PDCD2,PDCD2_HUMAN,Programmed cell death protein 2 (Zinc finger MYND domain-containing protein 7) (Zinc finger protein Rp-8),PDCD2 RP8 ZMYND7,5134;,"ENST00000392090.6; ENSP00000375940.2; ENSG00000071994.11. [Q16342-3];""ENST00000443345.2; ENSP00000397272.2; ENSG00000071994.11. [Q16342-2]"";""ENST00000453163.6; ENSP00000402524.2; ENSG00000071994.11. [Q16342-4]"";""ENST00000537445.5; ENSP00000440572.1; ENSG00000071994.11. [Q16342-5]"";""ENST00000541970.6; ENSP00000439467.1; ENSG00000071994.11. [Q16342-1]"";",DNA binding [GO:0003677]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; regulation of hematopoietic progenitor cell differentiation [GO:1901532],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
Q9BRP1,C3,1.768370017,0.247956167,-0.409399195,-0.681994274,-0.458654652,cyan,PDCD2L,PDD2L_HUMAN,Programmed cell death protein 2-like,PDCD2L,84306;,ENST00000246535.4; ENSP00000246535.1; ENSG00000126249.8.;,0,apoptotic process [GO:0006915],cytoplasm [GO:0005737]; membrane [GO:0016020]
Q9H2J4,C1,1.760325234,0.222456375,-0.795690766,-0.806276761,-0.264591533,lightblue,PDCL3,PDCL3_HUMAN,Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1) (VIAF-1),PDCL3 PhLP2A VIAF1,79031;,ENST00000264254.11; ENSP00000264254.6; ENSG00000115539.14.;,protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184],actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; chaperone-mediated protein folding [GO:0061077]; negative regulation of chaperone-mediated protein folding [GO:1903645]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; perinucleolar compartment [GO:0097356]; protein-containing complex [GO:0032991]
O76074,C4,1.973275682,-0.092189104,-0.905289784,-0.800967698,-0.92842278,deepskyblue2,PDE5A,PDE5A_HUMAN,"cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE)",PDE5A PDE5,8654;,"ENST00000264805.9; ENSP00000264805.5; ENSG00000138735.16. [O76074-2];""ENST00000354960.8; ENSP00000347046.3; ENSG00000138735.16. [O76074-1]"";","3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",cAMP-mediated signaling [GO:0019933]; cGMP catabolic process [GO:0046069]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of T cell proliferation [GO:0042130]; oocyte development [GO:0048599]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of oocyte development [GO:0060282]; regulation of nitric oxide mediated signal transduction [GO:0010749]; relaxation of cardiac muscle [GO:0055119]; T cell proliferation [GO:0042098],cytosol [GO:0005829]
O43924,C5,1.792891561,0.270317947,-0.550311502,-0.903305931,-1.439266812,turquoise3,PDE6D,PDE6D_HUMAN,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta) (Protein p17)",PDE6D PDED,5147;,ENST00000287600.9; ENSP00000287600.4; ENSG00000156973.14.;,GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267],visual perception [GO:0007601],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]
Q99988,M2,-0.975422427,-1.285241664,0.453498349,0.983296494,-0.038121566,tan4,PDF,GDF15_HUMAN,Growth/differentiation factor 15 (GDF-15) (Macrophage inhibitory cytokine 1) (MIC-1) (NSAID-activated gene 1 protein) (NAG-1) (NSAID-regulated gene 1 protein) (NRG-1) (Placental TGF-beta) (Placental bone morphogenetic protein) (Prostate differentiation factor),GDF15 MIC1 PDF PLAB PTGFB,9518;,"ENST00000252809.3; ENSP00000252809.3; ENSG00000130513.7.;""ENST00000595973.3; ENSP00000470531.3; ENSG00000130513.7."";""ENST00000597765.2; ENSP00000469819.2; ENSG00000130513.7."";",cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; protein homodimerization activity [GO:0042803],cell-cell signaling [GO:0007267]; cellular response to chemical stress [GO:0062197]; GDF15-GFRAL signaling pathway [GO:0160144]; negative regulation of appetite [GO:0032099]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; response to metformin [GO:1901558]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]
O00330,S3,-1.011060779,-0.466343121,0.186266354,0.901854082,0.433642904,salmon,PDHX,ODPX_HUMAN,"Pyruvate dehydrogenase protein X component, mitochondrial (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (E3-binding protein) (E3BP) (Lipoyl-containing pyruvate dehydrogenase complex component X) (proX)",PDHX PDX1,8050;,"ENST00000227868.9; ENSP00000227868.4; ENSG00000110435.13. [O00330-1];""ENST00000430469.6; ENSP00000415695.2; ENSG00000110435.13. [O00330-2]"";",acyltransferase activity [GO:0016746],acetyl-CoA biosynthetic process from pyruvate [GO:0006086],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]
Q15118,M1,-1.625910449,-0.414567273,0.393148487,0.856565945,-0.296209861,burlywood4,PDK1,PDK1_HUMAN,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1)",PDK1 PDHK1,5163;,"ENST00000282077.8; ENSP00000282077.3; ENSG00000152256.14. [Q15118-1];""ENST00000392571.6; ENSP00000376352.2; ENSG00000152256.14. [Q15118-2]"";""ENST00000410055.5; ENSP00000386985.1; ENSG00000152256.14. [Q15118-1]"";",ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],cell population proliferation [GO:0008283]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q96HC4,C4,1.929796247,0.242544882,-0.684492202,-0.61791172,-1.104014815,deepskyblue2,PDLIM5,PDLI5_HUMAN,PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein),PDLIM5 ENH L9,10611;,"ENST00000317968.9; ENSP00000321746.4; ENSG00000163110.15. [Q96HC4-1];""ENST00000318007.9; ENSP00000322021.5; ENSG00000163110.15. [Q96HC4-3]"";""ENST00000359265.8; ENSP00000352210.4; ENSG00000163110.15. [Q96HC4-5]"";""ENST00000380180.7; ENSP00000369527.3; ENSG00000163110.15. [Q96HC4-2]"";""ENST00000503974.5; ENSP00000424297.1; ENSG00000163110.15. [Q96HC4-7]"";""ENST00000508216.5; ENSP00000426804.1; ENSG00000163110.15. [Q96HC4-2]"";""ENST00000514743.5; ENSP00000424360.1; ENSG00000163110.15. [Q96HC4-6]"";""ENST00000542407.5; ENSP00000442187.2; ENSG00000163110.15. [Q96HC4-4]"";""ENST00000615540.4; ENSP00000480359.1; ENSG00000163110.15. [Q96HC4-6]"";",actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase C binding [GO:0005080],actin cytoskeleton organization [GO:0030036]; cell growth involved in cardiac muscle cell development [GO:0061049]; heart development [GO:0007507]; muscle structure development [GO:0061061]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cell projection [GO:0042995]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; stress fiber [GO:0001725]; Z disc [GO:0030018]
Q29RF7,N4,-1.104807884,0.785431183,0.208451353,-0.006088945,-0.137323815,grey30,PDS5A,PDS5A_HUMAN,Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112),PDS5A KIAA0648 PDS5 PIG54,23244;,"ENST00000303538.13; ENSP00000303427.8; ENSG00000121892.15. [Q29RF7-1];""ENST00000503396.5; ENSP00000426749.1; ENSG00000121892.15. [Q29RF7-3]"";",0,cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]"
Q9NTI5,N2,-1.059743516,0.25192093,0.916850739,-0.275519146,-0.213777603,grey70,PDS5B,PDS5B_HUMAN,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),PDS5B APRIN AS3 KIAA0979,23047;,"ENST00000315596.15; ENSP00000313851.10; ENSG00000083642.19. [Q9NTI5-1];""ENST00000450460.5; ENSP00000401619.1; ENSG00000083642.19. [Q9NTI5-2]"";",DNA binding [GO:0003677],cell division [GO:0051301]; cell population proliferation [GO:0008283]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell population proliferation [GO:0042127],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q5T2R2,M1,-1.266983119,-0.33634441,0.435654021,0.915087115,-0.332086532,burlywood4,PDSS1,DPS1_HUMAN,All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),PDSS1 DPS1 TPRT,23590;,ENST00000376215.10; ENSP00000365388.5; ENSG00000148459.16. [Q5T2R2-1];,all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982],isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]
Q86YH6,M1,-1.386289497,-0.259999971,0.416335075,0.897700186,-0.262235236,burlywood4,PDSS2,DLP1_HUMAN,All trans-polyprenyl-diphosphate synthase PDSS2 (All-trans-decaprenyl-diphosphate synthase subunit 2) (EC 2.5.1.91) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2) (Decaprenyl-diphosphate synthase subunit 2) (Solanesyl-diphosphate synthase subunit 2),PDSS2 C6orf210 DLP1,57107;,"ENST00000369031.4; ENSP00000358027.4; ENSG00000164494.12. [Q86YH6-2];""ENST00000369037.9; ENSP00000358033.4; ENSG00000164494.12. [Q86YH6-1]"";",all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982],cerebellum development [GO:0021549]; isoprenoid biosynthetic process [GO:0008299]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744],cytosol [GO:0005829]; heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]
Q96GD0,C5,1.850740027,0.339914895,-0.621809196,-0.520796203,-1.054511921,turquoise3,PDXP,PLPP_HUMAN,Chronophin (EC 3.1.3.16) (EC 3.1.3.74) (Pyridoxal phosphate phosphatase) (PLP phosphatase),PDXP CIN PLP PLPP,57026;,ENST00000215904.7; ENSP00000215904.6; ENSG00000241360.2. [Q96GD0-1];,heat shock protein binding [GO:0031072]; magnesium ion binding [GO:0000287]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; pyridoxal phosphatase activity [GO:0033883],actin rod assembly [GO:0031247]; cellular response to ATP [GO:0071318]; dephosphorylation [GO:0016311]; positive regulation of actin filament depolymerization [GO:0030836]; protein dephosphorylation [GO:0006470]; pyridoxal phosphate catabolic process [GO:0032361]; regulation of cytokinesis [GO:0032465]; regulation of mitotic nuclear division [GO:0007088],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium membrane [GO:0031258]; ruffle membrane [GO:0032587]
Q8NEN9,S3,-1.032209967,-0.876104699,0.057030768,0.782426697,0.710001121,salmon,PDZD8,PDZD8_HUMAN,PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104),PDZD8 PDZK8,118987;,ENST00000334464.7; ENSP00000334642.5; ENSG00000165650.12.;,lipid binding [GO:0008289]; metal ion binding [GO:0046872],cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]
P30086,C4,2.120363084,0.414130019,-1.027013644,-1.079440676,-1.225428545,deepskyblue2,PEBP1,PEBP1_HUMAN,Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)],PEBP1 PBP PEBP,5037;,ENST00000261313.3; ENSP00000261313.2; ENSG00000089220.5.;,ATP binding [GO:0005524]; enzyme binding [GO:0019899]; phosphatidylethanolamine binding [GO:0008429]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; serine-type endopeptidase inhibitor activity [GO:0004867],negative regulation of MAPK cascade [GO:0043409],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
P12955,C4,2.059242359,0.420716515,-0.86604643,-1.090973731,-1.177309889,deepskyblue2,PEPD,PEPD_HUMAN,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase),PEPD PRD,5184;,"ENST00000244137.12; ENSP00000244137.5; ENSG00000124299.16. [P12955-1];""ENST00000397032.8; ENSP00000380226.3; ENSG00000124299.16. [P12955-2]"";""ENST00000436370.7; ENSP00000391890.2; ENSG00000124299.16. [P12955-3]"";",manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009],amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],extracellular exosome [GO:0070062]
Q6UWS5,M2,-1.779854373,-1.986548048,0.292792034,1.369523349,-0.159169176,tan4,PET117,PT117_HUMAN,"Protein PET117 homolog, mitochondrial",PET117 UNQ607/PRO1194,100303755;,ENST00000432901.4; ENSP00000397881.2; ENSG00000232838.4.;,0,mitochondrial cytochrome c oxidase assembly [GO:0033617],mitochondrion [GO:0005739]
O60683,S2,-1.076173501,-1.370936856,0.203314273,0.8310656,0.655477182,orange,PEX10,PEX10_HUMAN,Peroxisome biogenesis factor 10 (EC 2.3.2.27) (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10) (RING finger protein 69),PEX10 RNF69,5192;,"ENST00000288774.8; ENSP00000288774.3; ENSG00000157911.11. [O60683-2];""ENST00000447513.7; ENSP00000407922.2; ENSG00000157911.11. [O60683-1]"";",protein transmembrane transporter activity [GO:0008320]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],"cellular response to reactive oxygen species [GO:0034614]; peroxisome organization [GO:0007031]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]",peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
O96011,S2,-0.904865347,-1.316233441,0.063101691,0.999486056,0.329633623,orange,PEX11B,PX11B_HUMAN,Peroxisomal membrane protein 11B (Peroxin-11B) (Peroxisomal biogenesis factor 11B) (Protein PEX11 homolog beta) (PEX11-beta),PEX11B,8799;,"ENST00000369306.8; ENSP00000358312.3; ENSG00000131779.11. [O96011-1];""ENST00000537888.1; ENSP00000437510.1; ENSG00000131779.11. [O96011-2]"";",identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],peroxisome fission [GO:0016559]; peroxisome organization [GO:0007031]; regulation of peroxisome size [GO:0044375]; signal transduction [GO:0007165],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]
Q92968,S3,-0.270525804,-0.837349746,0.016513149,0.887432945,0.504972602,salmon,PEX13,PEX13_HUMAN,Peroxisomal membrane protein PEX13 (Peroxin-13),PEX13,5194;,ENST00000295030.6; ENSP00000295030.4; ENSG00000162928.9.;,protein transmembrane transporter activity [GO:0008320],"cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; suckling behavior [GO:0001967]",cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
O75381,S2,-1.249295778,-1.421921538,-0.15220956,1.058856509,0.435678836,orange,PEX14,PEX14_HUMAN,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),PEX14,5195;,ENST00000356607.9; ENSP00000349016.4; ENSG00000142655.13. [O75381-1];,beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein transmembrane transporter activity [GO:0008320]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714],"cellular response to reactive oxygen species [GO:0034614]; microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein binding [GO:0032091]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein-containing complex assembly [GO:0065003]",cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]
Q9Y5Y5,S2,-0.68542255,-1.340775,-0.117333508,0.936503266,0.319394868,orange,PEX16,PEX16_HUMAN,Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16),PEX16,9409;,"ENST00000241041.7; ENSP00000241041.3; ENSG00000121680.16. [Q9Y5Y5-2];""ENST00000378750.10; ENSP00000368024.5; ENSG00000121680.16. [Q9Y5Y5-1]"";",0,ER-dependent peroxisome localization [GO:0106101]; ER-dependent peroxisome organization [GO:0032581]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein to membrane docking [GO:0022615],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
P40855,C5,1.725364394,0.337879313,-0.962601796,-0.731455785,-1.115051089,turquoise3,PEX19,PEX19_HUMAN,Peroxisomal biogenesis factor 19 (33 kDa housekeeping protein) (Peroxin-19) (Peroxisomal farnesylated protein),PEX19 HK33 PXF OK/SW-cl.22,5824;,"ENST00000368072.10; ENSP00000357051.5; ENSG00000162735.19. [P40855-1];""ENST00000472750.5; ENSP00000434633.1; ENSG00000162735.19. [P40855-6]"";",ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; peroxisome membrane targeting sequence binding [GO:0033328]; protein carrier chaperone [GO:0140597],chaperone-mediated protein folding [GO:0061077]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]
Q7Z412,S3,-0.559234865,-1.027631025,0.119913444,0.942547752,0.558467979,salmon,PEX26,PEX26_HUMAN,Peroxisome assembly protein 26 (Peroxin-26),PEX26,55670;,"ENST00000329627.11; ENSP00000331106.5; ENSG00000215193.14. [Q7Z412-1];""ENST00000399744.8; ENSP00000382648.4; ENSG00000215193.14. [Q7Z412-1]"";""ENST00000428061.2; ENSP00000412441.2; ENSG00000215193.14. [Q7Z412-2]"";",ATPase binding [GO:0051117]; protein-containing complex binding [GO:0044877]; protein-membrane adaptor activity [GO:0043495],protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome membrane [GO:0045046]; protein to membrane docking [GO:0022615],cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
Q13608,S3,-0.612315827,-0.985312913,-0.096750794,0.88963499,0.512129068,salmon,PEX6,PEX6_HUMAN,Peroxisomal ATPase PEX6 (EC 3.6.4.-) (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1) (Peroxisome assembly factor 2) (PAF-2),PEX6 PXAAA1,5190;,"ENST00000244546.4; ENSP00000244546.4; ENSG00000124587.14. [Q13608-2];""ENST00000304611.13; ENSP00000303511.8; ENSG00000124587.14. [Q13608-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein transporter activity [GO:0140318]; protein-containing complex binding [GO:0044877]; ubiquitin-modified protein reader activity [GO:0140036],"peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; protein unfolding [GO:0043335]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]
O15067,C5,1.837012103,0.555534855,-0.769405254,-0.958578717,-0.957300255,turquoise3,PFAS,PUR4_HUMAN,Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Phosphoribosylformylglycineamide amidotransferase),PFAS KIAA0361,5198;,ENST00000314666.11; ENSP00000313490.6; ENSG00000178921.14.;,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642],'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to xenobiotic stimulus [GO:0009410],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
O60925,C5,1.367038575,0.653078713,-0.561282933,-0.668173181,-0.782607749,turquoise3,PFDN1,PFD1_HUMAN,Prefoldin subunit 1,PFDN1 PFD1,5201;,ENST00000261813.9; ENSP00000261813.4; ENSG00000113068.10.;,amyloid-beta binding [GO:0001540]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082],chaperone-mediated protein folding [GO:0061077]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457],cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]
Q9UHV9,C5,1.591353946,0.804358246,-0.870062486,-1.116421997,-1.18587724,turquoise3,PFDN2,PFD2_HUMAN,Prefoldin subunit 2,PFDN2 PFD2 HSPC231,5202;,ENST00000368010.4; ENSP00000356989.3; ENSG00000143256.5.;,amyloid-beta binding [GO:0001540]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082],chaperone-mediated protein folding [GO:0061077]; negative regulation of amyloid fibril formation [GO:1905907]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding chaperone complex [GO:0101031]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]
Q99471,C5,1.714569054,0.83866799,-1.022335864,-1.097124258,-1.156477792,turquoise3,PFDN5,PFD5_HUMAN,Prefoldin subunit 5 (Myc modulator 1) (c-Myc-binding protein Mm-1),PFDN5 MM1 PFD5,5204;,"ENST00000243040.10; ENSP00000243040.6; ENSG00000123349.15. [Q99471-2];""ENST00000334478.9; ENSP00000334188.4; ENSG00000123349.15. [Q99471-1]"";""ENST00000351500.7; ENSP00000266964.4; ENSG00000123349.15. [Q99471-3]"";""ENST00000551018.5; ENSP00000447942.1; ENSG00000123349.15. [Q99471-1]"";""ENST00000708922.1; ENSP00000517421.1; ENSG00000291834.1. [Q99471-1]"";""ENST00000708930.1; ENSP00000517425.1; ENSG00000291834.1. [Q99471-3]"";""ENST00000708936.1; ENSP00000517428.1; ENSG00000291834.1. [Q99471-2]"";""ENST00000708937.1; ENSP00000517429.1; ENSG00000291834.1. [Q99471-1]"";",amyloid-beta binding [GO:0001540]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082],chaperone-mediated protein folding [GO:0061077]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; protein folding [GO:0006457]; regulation of DNA-templated transcription [GO:0006355]; retina development in camera-type eye [GO:0060041]; RNA polymerase I assembly [GO:1990113]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase III assembly [GO:1990115],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]
O15212,C5,1.731465466,0.736908649,-0.827012583,-0.805115186,-0.968663657,turquoise3,PFDN6,PFD6_HUMAN,Prefoldin subunit 6 (Protein Ke2),PFDN6 HKE2 PFD6,10471;,"ENST00000374606.10; ENSP00000363734.5; ENSG00000204220.12.;""ENST00000374607.5; ENSP00000363735.1; ENSG00000204220.12."";""ENST00000374610.6; ENSP00000363738.2; ENSG00000204220.12."";""ENST00000383207.6; ENSP00000372694.2; ENSG00000206283.10."";""ENST00000395131.5; ENSP00000378563.1; ENSG00000204220.12."";""ENST00000399383.7; ENSP00000382314.3; ENSG00000206283.10."";""ENST00000399385.5; ENSP00000382316.1; ENSG00000206283.10."";""ENST00000412289.5; ENSP00000402212.1; ENSG00000224782.8."";""ENST00000425878.6; ENSP00000395462.2; ENSG00000224782.8."";""ENST00000431830.5; ENSP00000402553.1; ENSG00000235692.8."";""ENST00000432391.6; ENSP00000400152.2; ENSG00000235692.8."";""ENST00000442285.5; ENSP00000404773.1; ENSG00000224782.8."";""ENST00000445559.5; ENSP00000398171.1; ENSG00000237335.8."";""ENST00000448594.5; ENSP00000403771.1; ENSG00000237335.8."";""ENST00000451970.5; ENSP00000415678.1; ENSG00000235692.8."";""ENST00000452658.6; ENSP00000412319.2; ENSG00000237335.8."";""ENST00000547641.2; ENSP00000449925.1; ENSG00000235692.8."";""ENST00000547952.2; ENSP00000448784.1; ENSG00000237335.8."";""ENST00000548040.2; ENSP00000447540.1; ENSG00000206283.10."";""ENST00000552711.2; ENSP00000448607.1; ENSG00000224782.8."";",amyloid-beta binding [GO:0001540]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; prefoldin complex [GO:0016272]; protein folding chaperone complex [GO:0101031]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]
O60825,C5,1.72600958,0.552711322,-0.58136941,-0.728411388,-1.037524276,turquoise3,PFKFB2,F262_HUMAN,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",PFKFB2,5208;,"ENST00000367079.3; ENSP00000356046.2; ENSG00000123836.15. [O60825-2];""ENST00000367080.8; ENSP00000356047.3; ENSG00000123836.15. [O60825-1]"";","6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]; protein kinase binding [GO:0019901]","fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glucose catabolic process [GO:0006007]; glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; positive regulation of insulin secretion [GO:0032024]; response to glucose [GO:0009749]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]
P17858,C5,1.765579334,0.377090741,-0.765982248,-0.843787549,-0.802835491,turquoise3,PFKL,PFKAL_HUMAN,"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)",PFKL,5211;,ENST00000349048.9; ENSP00000269848.6; ENSG00000141959.17. [P17858-1];,6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029],"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glycolytic process [GO:0006096]; negative regulation of insulin secretion [GO:0046676]; response to glucose [GO:0009749]",6-phosphofructokinase complex [GO:0005945]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]
P07737,C5,2.136715366,0.183528419,-0.99142891,-1.111236836,-1.328911067,turquoise3,PFN1,PROF1_HUMAN,Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I),PFN1,5216;,ENST00000225655.6; ENSP00000225655.5; ENSG00000108518.8.;,"actin binding [GO:0003779]; actin monomer binding [GO:0003785]; adenyl-nucleotide exchange factor activity [GO:0000774]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]",actin cytoskeleton organization [GO:0030036]; modification of postsynaptic actin cytoskeleton [GO:0098885]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of stress fiber assembly [GO:0051497]; neural tube closure [GO:0001843]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ruffle assembly [GO:1900029]; protein stabilization [GO:0050821]; regulation of actin filament polymerization [GO:0030833]; regulation of transcription by RNA polymerase II [GO:0006357]; synapse maturation [GO:0060074],blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleus [GO:0005634]
P35080,C4,2.000947908,0.059245185,-0.862662604,-1.028258834,-1.030217309,deepskyblue2,PFN2,PROF2_HUMAN,Profilin-2 (Profilin II),PFN2,5217;,"ENST00000239940.12; ENSP00000239940.7; ENSG00000070087.15. [P35080-1];""ENST00000452853.6; ENSP00000410464.2; ENSG00000070087.15. [P35080-2]"";","actin binding [GO:0003779]; actin monomer binding [GO:0003785]; ATP hydrolysis activity [GO:0016887]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",actin cytoskeleton organization [GO:0030036]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of ruffle assembly [GO:1900028]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein stabilization [GO:0050821]; regulation of actin filament polymerization [GO:0030833]; regulation of synaptic vesicle exocytosis [GO:2000300],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]
P18669,C4,2.04426425,0.436957239,-1.301306367,-1.366539467,-1.550641725,deepskyblue2,PGAM1,PGAM1_HUMAN,Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B),PGAM1 PGAMA CDABP0006,5223;,ENST00000334828.6; ENSP00000359991.4; ENSG00000171314.9.;,"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; protein kinase binding [GO:0019901]",canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]
Q96HS1,M2,-0.808788615,-0.998003634,0.332444713,1.063318638,-0.135442174,tan4,PGAM5,PGAM5_HUMAN,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Bcl-XL-binding protein v68) (Phosphoglycerate mutase family member 5)",PGAM5,192111;,"ENST00000317555.6; ENSP00000321503.2; ENSG00000247077.8. [Q96HS1-2];""ENST00000498926.7; ENSP00000438465.1; ENSG00000247077.8. [Q96HS1-1]"";",GTPase activator activity [GO:0005096]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877],macroautophagy [GO:0016236]; necroptotic process [GO:0070266]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of mitochondrial fission [GO:0090141],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q75T13,S2,-0.899805481,-1.305919973,0.25812791,0.808821488,0.617941121,orange,PGAP1,PGAP1_HUMAN,GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1),PGAP1 UNQ3024/PRO9822,80055;,"ENST00000354764.9; ENSP00000346809.3; ENSG00000197121.15. [Q75T13-1];""ENST00000409475.5; ENSP00000387028.1; ENSG00000197121.15. [Q75T13-3]"";","hydrolase activity, acting on ester bonds [GO:0016788]; phosphatidylinositol deacylase activity [GO:0050185]",anterior/posterior axis specification [GO:0009948]; attachment of GPI anchor to protein [GO:0016255]; embryonic pattern specification [GO:0009880]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; forebrain regionalization [GO:0021871]; GPI anchor metabolic process [GO:0006505]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; protein transport [GO:0015031]; sensory perception of sound [GO:0007605],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q9UHJ9,S1,-1.506417831,-1.877291,-0.054529459,1.067175805,0.795203101,gold,PGAP2,PGAP2_HUMAN,Post-GPI attachment to proteins factor 2 (FGF receptor-activating protein 1),PGAP2 FRAG1,27315;,"ENST00000278243.9; ENSP00000278243.4; ENSG00000148985.20. [Q9UHJ9-2];""ENST00000300730.10; ENSP00000300730.6; ENSG00000148985.20. [Q9UHJ9-5]"";""ENST00000463452.6; ENSP00000435223.1; ENSG00000148985.20. [Q9UHJ9-1]"";""ENST00000464906.6; ENSP00000434631.2; ENSG00000148985.20. [Q9UHJ9-2]"";""ENST00000493547.6; ENSP00000431851.1; ENSG00000148985.20. [Q9UHJ9-4]"";",0,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
P00558,C4,1.986693232,0.509697651,-1.218841802,-1.365747215,-1.710295389,deepskyblue2,PGK1,PGK1_HUMAN,Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2),PGK1 PGKA MIG10 OK/SW-cl.110,5230;,"ENST00000373316.5; ENSP00000362413.4; ENSG00000102144.15. [P00558-1];""ENST00000644362.1; ENSP00000496140.1; ENSG00000102144.15. [P00558-2]"";",ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase (NAD(P)H) activity [GO:0047134],canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]
P36871,C4,2.016861136,0.303138436,-0.830527837,-0.934188723,-1.117679046,deepskyblue2,PGM1,PGM1_HUMAN,Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1),PGM1,5236;,"ENST00000371083.4; ENSP00000360124.4; ENSG00000079739.17. [P36871-2];""ENST00000371084.8; ENSP00000360125.3; ENSG00000079739.17. [P36871-1]"";""ENST00000540265.5; ENSP00000443449.1; ENSG00000079739.17. [P36871-3]"";",magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614],carbohydrate metabolic process [GO:0005975]; galactose catabolic process via UDP-galactose [GO:0033499]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]
Q96G03,C5,1.671562831,0.707323763,-0.875863484,-0.98656391,-1.194509781,turquoise3,PGM2,PGM2_HUMAN,Phosphopentomutase (EC 5.4.2.7) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphoglucomutase-2) (EC 5.4.2.2),PGM2 MSTP006,55276;,ENST00000381967.9; ENSP00000371393.4; ENSG00000169299.14. [Q96G03-1];,magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973],glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; purine ribonucleoside salvage [GO:0006166],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]
Q6PCE3,C5,2.121014269,0.345644119,-0.918569998,-1.01517846,-1.240381181,turquoise3,PGM2L1,PGM2L_HUMAN,"Glucose 1,6-bisphosphate synthase (EC 2.7.1.106) (PMMLP) (Phosphoglucomutase-2-like 1)",PGM2L1 BM32A,283209;,ENST00000298198.5; ENSP00000298198.4; ENSG00000165434.8.;,"glucose-1,6-bisphosphate synthase activity [GO:0047933]; intramolecular phosphotransferase activity [GO:0016868]; metal ion binding [GO:0046872]",glucose metabolic process [GO:0006006],cytosol [GO:0005829]
O95394,C5,2.043141455,0.359224499,-0.91680266,-0.979251917,-1.103784148,turquoise3,PGM3,AGM1_HUMAN,Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3),PGM3 AGM1,5238;,"ENST00000506587.5; ENSP00000425809.1; ENSG00000013375.17. [O95394-4];""ENST00000507554.2; ENSP00000425558.2; ENSG00000013375.17. [O95394-1]"";""ENST00000508748.6; ENSP00000424865.2; ENSG00000013375.17. [O95394-4]"";""ENST00000512866.5; ENSP00000421565.1; ENSG00000013375.17. [O95394-3]"";""ENST00000513973.6; ENSP00000424874.1; ENSG00000013375.17. [O95394-1]"";""ENST00000698524.1; ENSP00000513773.1; ENSG00000013375.17. [O95394-1]"";",magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610],carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],cytosol [GO:0005829]
A6NDG6,C5,1.901530531,0.479842344,-1.231926939,-1.437409892,-1.637684335,turquoise3,PGP,PGP_HUMAN,Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP),PGP,283871;,ENST00000333503.8; ENSP00000330918.7; ENSG00000184207.9.;,ADP phosphatase activity [GO:0043262]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725],glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721],cytoplasm [GO:0005737]
O00264,S3,-0.649483526,-0.852316586,0.258715659,0.616530687,0.500027266,salmon,PGRMC1,PGRC1_HUMAN,Membrane-associated progesterone receptor component 1 (mPR) (Dap1) (IZA),PGRMC1 HPR6.6 PGRMC,10857;,"ENST00000217971.8; ENSP00000217971.7; ENSG00000101856.10. [O00264-1];""ENST00000535419.2; ENSP00000442821.1; ENSG00000101856.10. [O00264-2]"";",amyloid-beta binding [GO:0001540]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; steroid binding [GO:0005496],heme biosynthetic process [GO:0006783]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of protein localization to plasma membrane [GO:1903078],cell body [GO:0044297]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; specific granule membrane [GO:0035579]; synapse [GO:0045202]
O15173,S2,-1.208093607,-1.232685534,0.284513576,0.692029158,0.61277101,orange,PGRMC2,PGRC2_HUMAN,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),PGRMC2 DG6 PMBP,10424;,"ENST00000296425.10; ENSP00000296425.4; ENSG00000164040.18. [O15173-1];""ENST00000520121.6; ENSP00000429301.2; ENSG00000164040.18. [O15173-1]"";""ENST00000613358.4; ENSP00000481886.1; ENSG00000164040.18. [O15173-2]"";",heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; nuclear steroid receptor activity [GO:0003707]; steroid binding [GO:0005496],adipose tissue development [GO:0060612],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]
Q32NB8,M2,-1.148830028,-1.160757068,0.387252079,0.962044958,0.227284476,tan4,PGS1,PGPS1_HUMAN,"CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1)",PGS1,9489;,"ENST00000262764.11; ENSP00000262764.5; ENSG00000087157.19. [Q32NB8-1];""ENST00000589425.5; ENSP00000465278.1; ENSG00000087157.19. [Q32NB8-4]"";""ENST00000589426.5; ENSP00000468431.1; ENSG00000087157.19. [Q32NB8-2]"";",ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444],cardiolipin biosynthetic process [GO:0032049]; diacylglycerol metabolic process [GO:0046339]; phosphatidylglycerol biosynthetic process [GO:0006655],endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
O75167,C3,1.545837559,0.107328311,-0.700854273,-0.169221968,-0.464332807,cyan,PHACTR2,PHAR2_HUMAN,Phosphatase and actin regulator 2,PHACTR2 C6orf56 KIAA0680,9749;,"ENST00000305766.10; ENSP00000305530.6; ENSG00000112419.15. [O75167-5];""ENST00000367582.7; ENSP00000356554.3; ENSG00000112419.15. [O75167-2]"";""ENST00000427704.6; ENSP00000391763.2; ENSG00000112419.15. [O75167-1]"";""ENST00000440869.7; ENSP00000417038.2; ENSG00000112419.15. [O75167-4]"";",actin binding [GO:0003779]; protein phosphatase inhibitor activity [GO:0004864],actin cytoskeleton organization [GO:0030036],plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]
Q8IZ21,C2,1.467199974,0.386576462,-0.415608273,-0.165081823,-0.324963761,aquamarine,PHACTR4,PHAR4_HUMAN,Phosphatase and actin regulator 4,PHACTR4 PRO2963,65979;,"ENST00000373836.4; ENSP00000362942.3; ENSG00000204138.13. [Q8IZ21-2];""ENST00000373839.8; ENSP00000362945.3; ENSG00000204138.13. [Q8IZ21-1]"";""ENST00000493669.2; ENSP00000488359.1; ENSG00000204138.13. [Q8IZ21-4]"";",actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase activator activity [GO:0072542],actin cytoskeleton organization [GO:0030036]; closure of optic fissure [GO:0061386]; enteric nervous system development [GO:0048484]; negative regulation of integrin-mediated signaling pathway [GO:2001045]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of catalytic activity [GO:0043085]; regulation of cell cycle [GO:0051726]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; lamellipodium [GO:0030027]
P35232,M2,-1.131930157,-1.300041295,0.374185395,1.142884824,-0.163774864,tan4,PHB,PHB1_HUMAN,Prohibitin 1,PHB1 PHB,5245;,"ENST00000300408.8; ENSP00000300408.3; ENSG00000167085.14. [P35232-1];""ENST00000419140.7; ENSP00000393320.3; ENSG00000167085.14. [P35232-1]"";""ENST00000504124.6; ENSP00000426433.3; ENSG00000167085.14. [P35232-1]"";""ENST00000511832.6; ENSP00000425035.2; ENSG00000167085.14. [P35232-1]"";""ENST00000512041.7; ENSP00000422182.3; ENSG00000167085.14. [P35232-1]"";""ENST00000614445.5; ENSP00000479488.1; ENSG00000167085.14. [P35232-1]"";""ENST00000617874.5; ENSP00000484113.1; ENSG00000167085.14. [P35232-1]"";""ENST00000696365.1; ENSP00000512581.1; ENSG00000167085.14. [P35232-2]"";",complement component C3a binding [GO:0001850]; complement component C3b binding [GO:0001851]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; proteinase activated receptor binding [GO:0031871]; transcription corepressor activity [GO:0003714],activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cellular response to interleukin-6 [GO:0071354]; DNA biosynthetic process [GO:0071897]; epigenetic regulation of gene expression [GO:0040029]; mitochondrion organization [GO:0007005]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of complement activation [GO:0045917]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; progesterone receptor signaling pathway [GO:0050847]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of DNA-templated transcription [GO:0006355]; RIG-I signaling pathway [GO:0039529]; signal transduction [GO:0007165]; symbiont entry into host cell [GO:0046718]; T-helper 17 type immune response [GO:0072538],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q99623,M2,-1.140296381,-1.439975854,0.36538611,1.206908141,-0.16993075,tan4,PHB2,PHB2_HUMAN,Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity),PHB2 BAP REA,11331;,"ENST00000440277.6; ENSP00000412856.1; ENSG00000215021.10. [Q99623-2];""ENST00000535923.6; ENSP00000441875.1; ENSG00000215021.10. [Q99623-1]"";",amide binding [GO:0033218]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sphingolipid binding [GO:0046625],activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; antiviral innate immune response [GO:0140374]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; intracellular estrogen receptor signaling pathway [GO:0030520]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; mammary gland epithelial cell proliferation [GO:0033598]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of cardiolipin metabolic process [GO:1900208]; regulation of cytochrome-c oxidase activity [GO:1904959]; RIG-I signaling pathway [GO:0039529]; sister chromatid cohesion [GO:0007062],axon [GO:0030424]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial prohibitin complex [GO:0035632]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]
O75151,N3,-1.05503331,-1.051429452,1.227791064,0.112171676,-0.209718687,grey50,PHF2,PHF2_HUMAN,Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2),PHF2 CENP-35 KIAA0662,5253;,ENST00000359246.9; ENSP00000352185.4; ENSG00000197724.12.;,histone H3K9 demethylase activity [GO:0032454]; histone H4K20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270],liver development [GO:0001889]; negative regulation of rDNA heterochromatin formation [GO:0061188]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815],kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O43175,C3,1.889312972,-0.072050731,-0.578734916,-0.418496069,-0.583873096,cyan,PHGDH,SERA_HUMAN,D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37),PHGDH PGDH3,26227;,"ENST00000641023.2; ENSP00000493175.1; ENSG00000092621.13.;""ENST00000641597.1; ENSP00000493382.1; ENSG00000092621.13."";",electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617],brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q8WWQ0,N3,-1.174836137,-1.316312647,1.38927972,0.100745977,-0.828275344,grey50,PHIP,PHIP_HUMAN,PH-interacting protein (PHIP) (DDB1- and CUL4-associated factor 14) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11),PHIP DCAF14 WDR11,55023;,ENST00000275034.5; ENSP00000275034.3; ENSG00000146247.15.;,insulin receptor binding [GO:0005158]; lysine-acetylated histone binding [GO:0070577],cytoskeleton organization [GO:0007010]; insulin receptor signaling pathway [GO:0008286]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell morphogenesis [GO:0022604]; regulation of cell shape [GO:0008360]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
P46020,C1,1.596600592,-0.091781736,-0.688101846,-0.665175927,0.196076017,lightblue,PHKA1,KPB1_HUMAN,"Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform (Phosphorylase kinase alpha M subunit)",PHKA1 PHKA,5255;,"ENST00000339490.7; ENSP00000342469.3; ENSG00000067177.15. [P46020-2];""ENST00000373542.9; ENSP00000362643.4; ENSG00000067177.15. [P46020-1]"";""ENST00000541944.5; ENSP00000441251.1; ENSG00000067177.15. [P46020-3]"";",calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819],cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]
Q93100,C1,1.482839798,-0.018138983,-0.558883583,-0.548286842,0.162511088,lightblue,PHKB,KPBB_HUMAN,Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta),PHKB,5257;,"ENST00000299167.12; ENSP00000299167.8; ENSG00000102893.18. [Q93100-3];""ENST00000323584.10; ENSP00000313504.5; ENSG00000102893.18. [Q93100-1]"";""ENST00000566044.5; ENSP00000456729.1; ENSG00000102893.18. [Q93100-4]"";",calmodulin binding [GO:0005516],generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977],cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]
P15735,C1,1.667910602,-0.093961059,-0.734739102,-0.627847899,0.089532635,lightblue,PHKG2,PHKG2_HUMAN,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2)",PHKG2,5261;,"ENST00000424889.7; ENSP00000388571.3; ENSG00000156873.16. [P15735-2];""ENST00000563588.6; ENSP00000455607.1; ENSG00000156873.16. [P15735-1]"";",ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; phosphorylase kinase activity [GO:0004689]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321],generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; protein phosphorylation [GO:0006468],cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]
O60346,C2,1.15525051,0.289222178,-0.373133341,-0.253954958,-0.380515333,aquamarine,PHLPP1,PHLP1_HUMAN,PH domain leucine-rich repeat-containing protein phosphatase 1 (EC 3.1.3.16) (Pleckstrin homology domain-containing family E member 1) (PH domain-containing family E member 1) (Suprachiasmatic nucleus circadian oscillatory protein) (hSCOP),PHLPP1 KIAA0606 PHLPP PLEKHE1 SCOP,23239;,ENST00000262719.10; ENSP00000262719.4; ENSG00000081913.14. [O60346-1];,metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722],apoptotic process [GO:0006915]; entrainment of circadian clock [GO:0009649]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; regulation of apoptotic process [GO:0042981]; regulation of JNK cascade [GO:0046328]; regulation of MAPK cascade [GO:0043408]; regulation of p38MAPK cascade [GO:1900744]; regulation of T cell anergy [GO:0002667]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q6ZVD8,C2,1.305430522,0.24802372,-0.302598175,-0.01739871,-0.361974209,aquamarine,PHLPP2,PHLP2_HUMAN,PH domain leucine-rich repeat-containing protein phosphatase 2 (EC 3.1.3.16) (PH domain leucine-rich repeat-containing protein phosphatase-like) (PHLPP-like),PHLPP2 KIAA0931 PHLPPL,23035;,"ENST00000393524.6; ENSP00000377159.2; ENSG00000040199.18. [Q6ZVD8-3];""ENST00000568954.5; ENSP00000457991.1; ENSG00000040199.18. [Q6ZVD8-1]"";",metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722],hippocampus development [GO:0021766]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment membrane [GO:0042622]
Q9NRX4,C4,2.30446413,0.039652206,-1.260088015,-1.464984801,-1.552052081,deepskyblue2,PHPT1,PHP14_HUMAN,14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (PHPT1) (Protein histidine phosphatase) (PHP) (Protein janus-A homolog),PHPT1 PHP14 CGI-202 HSPC141,29085;,"ENST00000247665.12; ENSP00000247665.10; ENSG00000054148.18. [Q9NRX4-1];""ENST00000371661.5; ENSP00000360724.1; ENSG00000054148.18. [Q9NRX4-2]"";",actin filament binding [GO:0051015]; calcium channel inhibitor activity [GO:0019855]; protein histidine phosphatase activity [GO:0101006]; transmembrane transporter binding [GO:0044325],actin cytoskeleton organization [GO:0030036]; lamellipodium organization [GO:0097581]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; protein dephosphorylation [GO:0006470],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; leading edge of lamellipodium [GO:0061851]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
O14832,S3,-0.657542509,-0.53860953,-0.094754392,0.824957689,0.364056984,salmon,PHYH,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)",PHYH PAHX,5264;,"ENST00000263038.9; ENSP00000263038.4; ENSG00000107537.14. [O14832-1];""ENST00000396913.6; ENSP00000380121.2; ENSG00000107537.14. [O14832-2]"";",carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244],2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089],9+0 non-motile cilium [GO:0097731]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]
Q8IUZ5,C5,1.809723219,0.42720637,-0.706408495,-0.86074354,-1.110001907,turquoise3,PHYKPL,AT2L2_HUMAN,5-phosphohydroxy-L-lysine phospho-lyase (EC 4.2.3.134) (Alanine--glyoxylate aminotransferase 2-like 2),PHYKPL AGXT2L2 PP9286,85007;,ENST00000308158.10; ENSP00000310978.5; ENSG00000175309.15. [Q8IUZ5-1];,identical protein binding [GO:0042802]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],0,mitochondrial matrix [GO:0005759]
Q9BTU6,S1,-0.78980698,-0.815082392,-0.306518443,0.616265128,1.100273938,gold,PI4K2A,P4K2A_HUMAN,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),PI4K2A,55361;,ENST00000370631.4; ENSP00000359665.3; ENSG00000155252.14.;,1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287],endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; growing cell tip [GO:0035838]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; trans-Golgi network [GO:0005802]
Q8TCG2,S1,-0.469141197,-1.420887594,-0.265473092,0.716343169,1.22001752,gold,PI4K2B,P4K2B_HUMAN,Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) (PI4KII-BETA),PI4K2B,55300;,ENST00000264864.8; ENSP00000264864.6; ENSG00000038210.14.;,1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524],endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
Q9UBF8,C3,1.495801232,0.134568821,-0.471406954,-0.250782076,-0.479569386,cyan,PI4KB,PI4KB_HUMAN,Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) (NPIK) (PI4K92) (PI4KIII),PI4KB PIK4CB,5298;,"ENST00000368872.5; ENSP00000357866.1; ENSG00000143393.17. [Q9UBF8-2];""ENST00000368873.6; ENSP00000357867.1; ENSG00000143393.17. [Q9UBF8-1]"";""ENST00000368874.8; ENSP00000357868.4; ENSG00000143393.17. [Q9UBF8-2]"";""ENST00000529142.5; ENSP00000433149.1; ENSG00000143393.17. [Q9UBF8-3]"";",1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524],inner ear development [GO:0048839]; lysosome organization [GO:0007040]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015]; receptor-mediated endocytosis [GO:0006898]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum membrane [GO:0030867]
Q92521,S4,-0.615464354,-0.876023772,0.340872326,0.644902629,0.570790938,tomato2,PIGB,PIGB_HUMAN,GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B),PIGB,9488;,ENST00000164305.10; ENSP00000164305.5; ENSG00000069943.10.;,"alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]",GPI anchor biosynthetic process [GO:0006506]; mannosylation [GO:0097502]; preassembly of GPI anchor in ER membrane [GO:0016254],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q5H8A4,S2,-1.117323657,-1.567535533,0.258339387,0.826513927,0.796255202,orange,PIGG,PIGG_HUMAN,GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G),PIGG GPI7 UNQ1930/PRO4405,54872;,"ENST00000310340.9; ENSP00000311750.5; ENSG00000174227.16. [Q5H8A4-2];""ENST00000383028.8; ENSP00000372494.4; ENSG00000174227.16. [Q5H8A4-3]"";""ENST00000453061.7; ENSP00000415203.2; ENSG00000174227.16. [Q5H8A4-1]"";""ENST00000503111.5; ENSP00000426002.1; ENSG00000174227.16. [Q5H8A4-5]"";","CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; transferase activity [GO:0016740]",GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q92643,S2,-0.974626105,-1.393915604,0.267968891,0.886523691,0.430428779,orange,PIGK,GPI8_HUMAN,GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (GPI8 homolog) (hGPI8) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),PIGK GPI8,10026;,ENST00000370812.8; ENSP00000359848.3; ENSG00000142892.15. [Q92643-1];,GPI-anchor transamidase activity [GO:0003923]; protein disulfide isomerase activity [GO:0003756],attachment of GPI anchor to protein [GO:0016255]; proteolysis [GO:0006508],endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]
Q9H3S5,S3,-0.701280558,-1.127288078,0.118253396,0.826920926,0.606374475,salmon,PIGM,PIGM_HUMAN,GPI mannosyltransferase 1 (EC 2.4.1.-) (GPI mannosyltransferase I) (GPI-MT-I) (Phosphatidylinositol-glycan biosynthesis class M protein) (PIG-M),PIGM,93183;,ENST00000368090.5; ENSP00000357069.2; ENSG00000143315.8.;,"alpha-1,4-mannosyltransferase activity [GO:0051751]; glycolipid mannosyltransferase activity [GO:0004376]; mannosyltransferase activity [GO:0000030]",GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-mannosyltransferase I complex [GO:1990529]
O95427,S2,-1.675977974,-1.671393331,0.376571017,0.849697316,0.598673016,orange,PIGN,PIGN_HUMAN,GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N),PIGN MCD4,23556;,"ENST00000357637.10; ENSP00000350263.4; ENSG00000197563.11.;""ENST00000400334.7; ENSP00000383188.2; ENSG00000197563.11."";""ENST00000638936.1; ENSP00000492592.1; ENSG00000197563.11."";""ENST00000640050.1; ENSP00000492051.1; ENSG00000197563.11."";""ENST00000640145.1; ENSP00000491525.1; ENSG00000197563.11."";""ENST00000640252.2; ENSP00000492233.1; ENSG00000197563.11."";""ENST00000640876.1; ENSP00000491628.1; ENSG00000197563.11."";",mannose-ethanolamine phosphotransferase activity [GO:0051377],GPI anchor biosynthetic process [GO:0006506]; preassembly of GPI anchor in ER membrane [GO:0016254],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P57054,S2,-1.292796549,-1.42771893,0.342991894,0.878983817,0.636918753,orange,PIGP,PIGP_HUMAN,Phosphatidylinositol N-acetylglucosaminyltransferase subunit P (Down syndrome critical region protein 5) (Down syndrome critical region protein C) (Phosphatidylinositol-glycan biosynthesis class P protein) (PIG-P),PIGP DCRC DSCR5 DSCRC NPD010,51227;,"ENST00000360525.9; ENSP00000353719.3; ENSG00000185808.14. [P57054-2];""ENST00000399098.5; ENSP00000382049.1; ENSG00000185808.14. [P57054-3]"";""ENST00000399102.5; ENSP00000382053.1; ENSG00000185808.14. [P57054-2]"";""ENST00000399103.5; ENSP00000382054.1; ENSG00000185808.14. [P57054-2]"";""ENST00000464265.5; ENSP00000420037.1; ENSG00000185808.14. [P57054-1]"";",phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176],GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]
Q9BRB3,S3,-0.367044615,-0.872069199,0.254762298,0.733765521,0.490279465,salmon,PIGQ,PIGQ_HUMAN,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein) (PIG-Q),PIGQ GPI1,9091;,"ENST00000026218.9; ENSP00000026218.5; ENSG00000007541.17. [Q9BRB3-1];""ENST00000321878.10; ENSP00000326674.6; ENSG00000007541.17. [Q9BRB3-2]"";""ENST00000409527.6; ENSP00000386760.2; ENSG00000007541.17. [Q9BRB3-2]"";""ENST00000470411.2; ENSP00000439650.1; ENSG00000007541.17. [Q9BRB3-3]"";",0,carbohydrate metabolic process [GO:0005975]; GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]
Q9H490,S2,-1.355665816,-1.559376328,0.285625448,0.913726683,0.536348206,orange,PIGU,PIGU_HUMAN,Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U),PIGU CDC91L1 PSEC0205 UNQ3055/PRO9875,128869;,"ENST00000217446.8; ENSP00000217446.3; ENSG00000101464.11. [Q9H490-1];""ENST00000374820.6; ENSP00000363953.2; ENSG00000101464.11. [Q9H490-2]"";",0,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425],endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9NWS0,C2,1.24851712,0.55069412,-0.523751772,-0.578315732,-0.201580313,aquamarine,PIH1D1,PIHD1_HUMAN,PIH1 domain-containing protein 1 (Nucleolar protein 17 homolog),PIH1D1 NOP17,55011;,"ENST00000262265.10; ENSP00000262265.4; ENSG00000104872.11. [Q9NWS0-1];""ENST00000596049.5; ENSP00000470445.1; ENSG00000104872.11. [Q9NWS0-1]"";",ATPase binding [GO:0051117]; histone binding [GO:0042393]; histone reader activity [GO:0140566]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901],box C/D snoRNP assembly [GO:0000492]; chromatin remodeling [GO:0006338]; epithelial cell differentiation [GO:0030855]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; protein stabilization [GO:0050821]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254]; TORC1 complex assembly [GO:1905669],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]
P42336,C3,1.731328939,0.132101237,-0.711442424,-0.376919598,-0.597584166,cyan,PIK3CA,PK3CA_HUMAN,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1)",PIK3CA,5290;,ENST00000263967.4; ENSP00000263967.3; ENSG00000121879.6.;,"1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; kinase activity [GO:0016301]; protein kinase activator activity [GO:0030295]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]",actin cytoskeleton organization [GO:0030036]; adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; anoikis [GO:0043276]; autosome genomic imprinting [GO:0141068]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle contraction [GO:0060048]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrostatic pressure [GO:0071464]; cellular response to insulin stimulus [GO:0032869]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; epidermal growth factor receptor signaling pathway [GO:0007173]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; liver development [GO:0001889]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of anoikis [GO:2000811]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron apoptotic process [GO:0043524]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TOR signaling [GO:0032008]; regulation of actin filament organization [GO:0110053]; regulation of cellular respiration [GO:0043457]; regulation of multicellular organism growth [GO:0040014]; regulation of protein phosphorylation [GO:0001932]; relaxation of cardiac muscle [GO:0055119]; response to activity [GO:0014823]; response to butyrate [GO:1903544]; response to dexamethasone [GO:0071548]; response to L-leucine [GO:0043201]; response to muscle inactivity [GO:0014870]; response to muscle stretch [GO:0035994]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; phosphatidylinositol 3-kinase complex, class IB [GO:0005944]; plasma membrane [GO:0005886]"
Q9Y237,C5,2.000005608,0.450195997,-1.203600361,-1.372854939,-1.59714998,turquoise3,PIN4,PIN4_HUMAN,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (hPar14) (Parvulin-17) (Par17) (hPar17) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Peptidyl-prolyl cis/trans isomerase EPVH) (hEPVH) (Rotamase Pin4),PIN4,5303;,"ENST00000373669.8; ENSP00000362773.3; ENSG00000102309.15. [Q9Y237-1];""ENST00000423432.6; ENSP00000409154.2; ENSG00000102309.15. [Q9Y237-3]"";""ENST00000664196.1; ENSP00000499466.1; ENSG00000102309.15. [Q9Y237-2]"";",bent DNA binding [GO:0003681]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723],rRNA processing [GO:0006364],chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819]
Q96BK5,N2,-1.114996741,-1.305752019,1.233643289,0.088957696,0.117798971,grey70,PINX1,PINX1_HUMAN,PIN2/TERF1-interacting telomerase inhibitor 1 (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (Protein 67-11-3) (TRF1-interacting protein 1),PINX1 LPTL LPTS,54984;,"ENST00000314787.8; ENSP00000318966.3; ENSG00000254093.9. [Q96BK5-1];""ENST00000519088.5; ENSP00000428853.1; ENSG00000254093.9. [Q96BK5-2]"";""ENST00000647329.2; ENSP00000495173.2; ENSG00000284764.2. [Q96BK5-1]"";""ENST00000710827.1; ENSP00000518505.1; ENSG00000284764.2. [Q96BK5-2]"";",protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034],"mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004]","chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]"
Q99755,S3,-0.69530824,-0.696407298,0.30615575,0.772175907,0.434114531,salmon,PIP5K1A,PI51A_HUMAN,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha),PIP5K1A,8394;,"ENST00000349792.9; ENSP00000271663.7; ENSG00000143398.20. [Q99755-3];""ENST00000368888.9; ENSP00000357883.4; ENSG00000143398.20. [Q99755-1]"";""ENST00000368890.8; ENSP00000357885.4; ENSG00000143398.20. [Q99755-2]"";""ENST00000441902.6; ENSP00000415648.2; ENSG00000143398.20. [Q99755-4]"";",1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; phosphatidylinositol kinase activity [GO:0052742],actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; glycerophospholipid metabolic process [GO:0006650]; keratinocyte differentiation [GO:0030216]; phagocytosis [GO:0006909]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phospholipid biosynthetic process [GO:0008654]; protein localization to plasma membrane [GO:0072659]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; ruffle assembly [GO:0097178]; signal transduction [GO:0007165],cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]
O00625,C4,2.003505833,0.398831303,-0.949773623,-1.034771854,-1.394889689,deepskyblue2,PIR,PIR_HUMAN,"Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase)",PIR,8544;,"ENST00000380420.10; ENSP00000369785.5; ENSG00000087842.11.;""ENST00000380421.3; ENSP00000369786.3; ENSG00000087842.11."";","metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]",digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UG56,M2,-0.683055162,-1.227206489,0.394710704,1.036124661,0.026366163,tan4,PISD,PISD_HUMAN,"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]",PISD,23761;,"ENST00000266095.9; ENSP00000266095.5; ENSG00000241878.12. [Q9UG56-2];""ENST00000382151.6; ENSP00000371586.2; ENSG00000241878.12. [Q9UG56-2]"";""ENST00000439502.7; ENSP00000391739.2; ENSG00000241878.12. [Q9UG56-3]"";",phosphatidylserine decarboxylase activity [GO:0004609],lipid droplet formation [GO:0140042]; mitochondrial protein catabolic process [GO:0035694]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540]; regulation of mitochondrion organization [GO:0010821],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q00169,C3,1.957863923,-0.03717806,-0.890090773,-0.771469672,-0.992883006,cyan,PITPNA,PIPNA_HUMAN,Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha),PITPNA PITPN,5306;,ENST00000313486.12; ENSP00000316809.7; ENSG00000174238.16.;,lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylglycerol binding [GO:1901611]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526],axonogenesis [GO:0007409]; lipid metabolic process [GO:0006629]; phospholipid transport [GO:0015914]; visual perception [GO:0007601],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
P48739,C3,2.017024251,0.053385038,-0.873319,-0.558362498,-1.075357275,cyan,PITPNB,PIPNB_HUMAN,Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta),PITPNB,23760;,"ENST00000320996.14; ENSP00000321266.10; ENSG00000180957.19. [P48739-2];""ENST00000335272.10; ENSP00000334738.5; ENSG00000180957.19. [P48739-1]"";""ENST00000634017.1; ENSP00000487693.1; ENSG00000180957.19. [P48739-3]"";",phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; sphingomyelin transfer activity [GO:0140338],"lipid metabolic process [GO:0006629]; nucleus organization [GO:0006997]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q9BZ71,S3,-0.398459471,-0.476553206,0.102862446,0.725155983,0.495022677,salmon,PITPNM3,PITM3_HUMAN,"Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3) (PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1) (NIR-1)",PITPNM3 NIR1,83394;,"ENST00000262483.13; ENSP00000262483.8; ENSG00000091622.16. [Q9BZ71-1];""ENST00000421306.7; ENSP00000407882.3; ENSG00000091622.16. [Q9BZ71-3]"";",calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; phosphatidylinositol transfer activity [GO:0008526]; phospholipase activity [GO:0004620]; receptor tyrosine kinase binding [GO:0030971],phosphatidylinositol biosynthetic process [GO:0006661],cell body [GO:0044297]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]
Q9BZL6,S2,-1.049663516,-1.267479304,0.151178227,0.833603471,0.49755623,orange,PKD2,KPCD2_HUMAN,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),PRKD2 PKD2 HSPC187,25865;,"ENST00000291281.9; ENSP00000291281.3; ENSG00000105287.13. [Q9BZL6-1];""ENST00000433867.5; ENSP00000393978.1; ENSG00000105287.13. [Q9BZL6-1]"";""ENST00000595515.5; ENSP00000470804.1; ENSG00000105287.13. [Q9BZL6-3]"";""ENST00000600194.5; ENSP00000472744.1; ENSG00000105287.13. [Q9BZL6-2]"";""ENST00000601806.5; ENSP00000469106.1; ENSG00000105287.13. [Q9BZL6-2]"";",ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of T cell apoptotic process [GO:0070232]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P14618,C4,2.178179681,0.315838656,-1.168709911,-1.214542277,-1.387368757,deepskyblue2,PKM,KPYM_HUMAN,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) (p58),PKM OIP3 PK2 PK3 PKM2,5315;,"ENST00000319622.10; ENSP00000320171.6; ENSG00000067225.21. [P14618-2];""ENST00000335181.10; ENSP00000334983.5; ENSG00000067225.21. [P14618-1]"";""ENST00000568459.5; ENSP00000456970.1; ENSG00000067225.21. [P14618-2]"";",ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone H3T11 kinase activity [GO:0035402]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501],cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]
Q6P5Z2,S3,-0.501644835,-0.819214516,0.299932978,0.753087087,0.531888186,salmon,PKN3,PKN3_HUMAN,Serine/threonine-protein kinase N3 (EC 2.7.11.13) (Protein kinase PKN-beta) (Protein-kinase C-related kinase 3),PKN3 PKNBETA,29941;,ENST00000291906.5; ENSP00000291906.4; ENSG00000160447.7.;,ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267],epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
P55347,N4,-0.827350863,1.168886631,0.257862294,-0.186412702,-0.778089281,grey30,PKNOX1,PKNX1_HUMAN,Homeobox protein PKNOX1 (Homeobox protein PREP-1) (PBX/knotted homeobox 1),PKNOX1 PREP1,5316;,ENST00000291547.10; ENSP00000291547.4; ENSG00000160199.15. [P55347-1];,"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",angiogenesis [GO:0001525]; camera-type eye development [GO:0043010]; erythrocyte differentiation [GO:0030218]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]
Q99959,M1,-0.732971841,-1.057260935,0.855320465,0.775472265,-0.166569941,burlywood4,PKP2,PKP2_HUMAN,Plakophilin-2,PKP2,5318;,"ENST00000070846.11; ENSP00000070846.6; ENSG00000057294.18. [Q99959-1];""ENST00000340811.9; ENSP00000342800.5; ENSG00000057294.18. [Q99959-2]"";",alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication [GO:0086083]; intermediate filament binding [GO:0019215]; molecular adaptor activity [GO:0060090]; protein kinase C binding [GO:0005080]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],bundle of His cell-Purkinje myocyte adhesion involved in cell communication [GO:0086073]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell communication by electrical coupling involved in cardiac conduction [GO:0086064]; cell-cell adhesion [GO:0098609]; cell-cell signaling involved in cardiac conduction [GO:0086019]; desmosome assembly [GO:0002159]; desmosome organization [GO:0002934]; heart development [GO:0007507]; intermediate filament bundle assembly [GO:0045110]; maintenance of animal organ identity [GO:0048496]; maintenance of protein localization at cell tip [GO:0099017]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of cell-substrate adhesion [GO:0010810]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; ventricular cardiac muscle cell action potential [GO:0086005]; ventricular cardiac muscle tissue morphogenesis [GO:0055010],adherens junction [GO:0005912]; cell junction [GO:0030054]; cell tip [GO:0051286]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q99569,M1,-0.876004999,-0.974206225,0.734668329,0.838868099,-0.202131577,burlywood4,PKP4,PKP4_HUMAN,Plakophilin-4 (p0071),PKP4,8502;,"ENST00000389757.7; ENSP00000374407.3; ENSG00000144283.23. [Q99569-2];""ENST00000389759.8; ENSP00000374409.3; ENSG00000144283.23. [Q99569-1]"";",cadherin binding [GO:0045296],cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-cell signaling [GO:0007267]; positive regulation of cytokinesis [GO:0032467]; positive regulation of GTPase activity [GO:0043547]; regulation of cell adhesion [GO:0030155],adherens junction [GO:0005912]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; desmosome [GO:0030057]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]
Q9BZM1,S3,-1.52140025,-0.16584774,0.130193136,0.876131943,0.32291654,salmon,PLA2G12A,PG12A_HUMAN,Group XIIA secretory phospholipase A2 (GXII sPLA2) (sPLA2-XII) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 12A),PLA2G12A PLA2G12 FKSG38 UNQ2519/PRO6012,81579;,ENST00000243501.10; ENSP00000243501.5; ENSG00000123739.11.;,calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipase A2 activity [GO:0004623],arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],cytoplasm [GO:0005737]; extracellular region [GO:0005576]
Q9Y263,C5,1.427404373,0.605437266,-0.346803362,-0.398722777,-0.606759553,turquoise3,PLAA,PLAP_HUMAN,Phospholipase A-2-activating protein (PLA2P) (PLAP),PLAA PLAP,9373;,ENST00000397292.8; ENSP00000380460.3; ENSG00000137055.15.;,phospholipase A2 activator activity [GO:0016005]; ubiquitin binding [GO:0043130],cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; nervous system development [GO:0007399]; phospholipid metabolic process [GO:0006644]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]; ubiquitin recycling [GO:0010992]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; synapse [GO:0045202]
Q03405,S2,-0.845612464,-0.858707199,0.146871715,0.767331682,0.567441061,orange,PLAUR,UPAR_HUMAN,Urokinase plasminogen activator surface receptor (U-PAR) (uPAR) (Monocyte activation antigen Mo3) (CD antigen CD87),PLAUR MO3 UPAR,5329;,"ENST00000221264.8; ENSP00000221264.3; ENSG00000011422.12. [Q03405-3];""ENST00000339082.7; ENSP00000342049.2; ENSG00000011422.12. [Q03405-2]"";""ENST00000340093.8; ENSP00000339328.3; ENSG00000011422.12. [Q03405-1]"";",enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; urokinase plasminogen activator receptor activity [GO:0030377],blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of cell adhesion [GO:0030155]; regulation of fibrinolysis [GO:0051917]; regulation of plasminogen activation [GO:0010755]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; urokinase plasminogen activator signaling pathway [GO:0038195],cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine-type endopeptidase complex [GO:1905370]; specific granule membrane [GO:0035579]
Q01970,C2,0.978590772,0.632456324,-0.360830911,-0.175216681,-0.035467716,aquamarine,PLCB3,PLCB3_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3)",PLCB3,5331;,"ENST00000279230.12; ENSP00000279230.6; ENSG00000149782.13. [Q01970-1];""ENST00000325234.5; ENSP00000324660.5; ENSG00000149782.13. [Q01970-2]"";""ENST00000540288.5; ENSP00000443631.1; ENSG00000149782.13. [Q01970-1]"";",cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; molecular adaptor activity [GO:0060090]; molecular function activator activity [GO:0140677]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629],G protein-coupled receptor signaling pathway [GO:0007186]; lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of systemic arterial blood pressure [GO:0003073]; release of sequestered calcium ion into cytosol [GO:0051209],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991]
P51178,S3,-0.733954581,-0.210963288,0.413875084,0.659198291,0.078268176,salmon,PLCD1,PLCD1_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III) (PLC-III) (Phospholipase C-delta-1) (PLC-delta-1)",PLCD1,5333;,"ENST00000334661.5; ENSP00000335600.4; ENSG00000187091.14. [P51178-1];""ENST00000463876.5; ENSP00000430344.1; ENSG00000187091.14. [P51178-2]"";","calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid metabolic process [GO:0006644]; release of sequestered calcium ion into cytosol [GO:0051209],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
Q8N3E9,S4,-0.464389365,-0.574126249,0.348251437,0.667229305,0.27952153,tomato2,PLCD3,PLCD3_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)",PLCD3 KIAA1964,113026;,ENST00000619929.5; ENSP00000479636.1; ENSG00000161714.12.;,metal ion binding [GO:0046872]; phosphatidylinositol phospholipase C activity [GO:0004435],angiogenesis [GO:0001525]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipid catabolic process [GO:0016042]; regulation of cell population proliferation [GO:0042127],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
P19174,C3,1.758231407,0.333842979,-0.795468977,-0.688407626,-0.971369239,cyan,PLCG1,PLCG1_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)",PLCG1 PLC1,5335;,"ENST00000244007.7; ENSP00000244007.3; ENSG00000124181.15. [P19174-2];""ENST00000373271.5; ENSP00000362368.1; ENSG00000124181.15. [P19174-1]"";""ENST00000685551.1; ENSP00000508698.1; ENSG00000124181.15. [P19174-2]"";",calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971],calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; in utero embryonic development [GO:0001701]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; release of sequestered calcium ion into cytosol [GO:0051209]; T cell receptor signaling pathway [GO:0050852],cell projection [GO:0042995]; cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685]
Q13393,S1,-0.701641809,-1.199244224,-0.010954047,0.680756523,0.895302204,gold,PLD1,PLD1_HUMAN,Phospholipase D1 (PLD 1) (hPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1),PLD1,5337;,"ENST00000351298.9; ENSP00000342793.4; ENSG00000075651.17. [Q13393-1];""ENST00000356327.9; ENSP00000348681.5; ENSG00000075651.17. [Q13393-2]"";",N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630],cellular response to nutrient [GO:0031670]; chemotaxis [GO:0006935]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; positive regulation of translation [GO:0045727]; Ras protein signal transduction [GO:0007265]; regulation of microvillus assembly [GO:0032534]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of vesicle-mediated transport [GO:0060627]; small GTPase-mediated signal transduction [GO:0007264],apical plasma membrane [GO:0016324]; cholinergic synapse [GO:0098981]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]
Q9HB19,C5,1.431542062,0.607747969,-0.223052461,-0.450121339,-0.698545182,turquoise3,PLEKHA2,PKHA2_HUMAN,Pleckstrin homology domain-containing family A member 2 (PH domain-containing family A member 2) (Tandem PH domain-containing protein 2) (TAPP-2),PLEKHA2 TAPP2,59339;,ENST00000617275.5; ENSP00000482228.1; ENSG00000169499.15.;,"fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]",positive regulation of cell-matrix adhesion [GO:0001954],cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q7Z736,S3,-0.650443044,-0.740333094,0.220390472,0.571858173,0.607974063,salmon,PLEKHH3,PKHH3_HUMAN,Pleckstrin homology domain-containing family H member 3 (PH domain-containing family H member 3),PLEKHH3,79990;,"ENST00000591022.6; ENSP00000468678.1; ENSG00000068137.15. [Q7Z736-1];""ENST00000591196.5; ENSP00000467824.1; ENSG00000068137.15. [Q7Z736-3]"";",0,signal transduction [GO:0007165],cytoskeleton [GO:0005856]; extracellular space [GO:0005615]
Q9HBL7,M2,-0.969872158,-1.289270169,0.424845821,1.183424909,-0.411279582,tan4,PLGRKT,PLRKT_HUMAN,Plasminogen receptor (KT) (Plg-R(KT)),PLGRKT C9orf46 AD025 MDS030,55848;,ENST00000223864.7; ENSP00000223864.2; ENSG00000107020.10.;,0,chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; positive regulation of plasminogen activation [GO:0010756],plasma membrane [GO:0005886]
O43660,N1,-1.17437231,-0.61927782,0.634322687,-0.247765406,0.982035389,grey90,PLRG1,PLRG1_HUMAN,Pleiotropic regulator 1,PLRG1,5356;,"ENST00000302078.9; ENSP00000303191.5; ENSG00000171566.12. [O43660-2];""ENST00000499023.7; ENSP00000424417.1; ENSG00000171566.12. [O43660-1]"";",0,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504]",catalytic step 2 spliceosome [GO:0071013]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]
P13797,C3,1.691195445,0.107019082,-0.67094667,-0.587850467,-0.991594315,cyan,PLS3,PLST_HUMAN,Plastin-3 (T-fimbrin) (T-plastin),PLS3,5358;,"ENST00000289290.7; ENSP00000289290.4; ENSG00000102024.19. [P13797-2];""ENST00000355899.8; ENSP00000348163.3; ENSG00000102024.19. [P13797-1]"";""ENST00000539310.5; ENSP00000445339.2; ENSG00000102024.19. [P13797-1]"";",actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; bone development [GO:0060348],actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
O15162,S4,-0.576110983,-0.86992263,0.273640651,0.721109662,0.466807274,tomato2,PLSCR1,PLS1_HUMAN,Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (Mg(2+)-dependent nuclease) (EC 3.1.-.-) (MmTRA1b),PLSCR1,5359;,"ENST00000342435.9; ENSP00000345494.4; ENSG00000188313.13. [O15162-1];""ENST00000448787.6; ENSP00000411675.2; ENSG00000188313.13. [O15162-2]"";","calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; lead ion binding [GO:0032791]; magnesium ion binding [GO:0000287]; mercury ion binding [GO:0045340]; nuclease activity [GO:0004518]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]",acute-phase response [GO:0006953]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of phagocytosis [GO:0050765]; negative regulation of viral genome replication [GO:0045071]; phosphatidylserine biosynthetic process [GO:0006659]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; plasma membrane phospholipid scrambling [GO:0017121]; platelet activation [GO:0030168]; positive regulation of chromosome separation [GO:1905820]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of mast cell activation [GO:0033003]; response to interferon-beta [GO:0035456]; response to lead ion [GO:0010288],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q9UIW2,S2,-1.15885525,-1.449700482,0.332408535,0.879534678,0.458286103,orange,PLXNA1,PLXA1_HUMAN,Plexin-A1 (Semaphorin receptor NOV),PLXNA1 NOV PLXN1,5361;,ENST00000393409.3; ENSP00000377061.2; ENSG00000114554.12.;,semaphorin receptor activity [GO:0017154],dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative regulation of cell adhesion [GO:0007162]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485]; olfactory nerve formation [GO:0021628]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of smooth muscle cell migration [GO:0014910],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]
O75051,S2,-0.711938588,-1.281074535,0.331825161,0.740786545,0.460410468,orange,PLXNA2,PLXA2_HUMAN,Plexin-A2 (Semaphorin receptor OCT),PLXNA2 KIAA0463 OCT PLXN2 UNQ209/PRO235,5362;,ENST00000367033.4; ENSP00000356000.3; ENSG00000076356.7. [O75051-1];,identical protein binding [GO:0042802]; semaphorin receptor activity [GO:0017154],centrosome localization [GO:0051642]; cerebellar granule cell precursor tangential migration [GO:0021935]; limb bud formation [GO:0060174]; negative regulation of cell adhesion [GO:0007162]; neural tube development [GO:0021915]; pharyngeal system development [GO:0060037]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756],plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]
P51805,S2,-1.043908045,-1.290212457,0.308516473,0.881961088,0.424799748,orange,PLXNA3,PLXA3_HUMAN,Plexin-A3 (Plexin-4) (Semaphorin receptor SEX),PLXNA3 PLXN4 SEX,55558;,ENST00000369682.4; ENSP00000358696.3; ENSG00000130827.6.;,semaphorin receptor activity [GO:0017154],axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hippocampus development [GO:0021766]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell adhesion [GO:0007162]; neuron projection guidance [GO:0097485]; olfactory nerve formation [GO:0021628]; positive regulation of axonogenesis [GO:0050772]; positive regulation of cytoskeleton organization [GO:0051495]; pyramidal neuron development [GO:0021860]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; trigeminal nerve structural organization [GO:0021637],plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]
O15031,S4,-1.042968439,-1.286984284,0.366792537,0.901611983,0.283767804,tomato2,PLXNB2,PLXB2_HUMAN,Plexin-B2 (MM1),PLXNB2 KIAA0315,23654;,"ENST00000359337.9; ENSP00000352288.4; ENSG00000196576.16.;""ENST00000449103.5; ENSP00000409171.1; ENSG00000196576.16."";",semaphorin receptor activity [GO:0017154],brain development [GO:0007420]; excitatory synapse assembly [GO:1904861]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; positive regulation of translation [GO:0045727]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526],cell surface [GO:0009986]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]
Q9Y4D7,S2,-1.133033427,-1.221379794,0.284749189,0.788070988,0.7478378,orange,PLXND1,PLXD1_HUMAN,Plexin-D1,PLXND1 KIAA0620,23129;,ENST00000324093.9; ENSP00000317128.4; ENSG00000004399.13. [Q9Y4D7-1];,protein domain specific binding [GO:0019904]; semaphorin receptor activity [GO:0017154],angiogenesis [GO:0001525]; aorta development [GO:0035904]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; endothelial cell migration [GO:0043542]; kidney development [GO:0001822]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; outflow tract morphogenesis [GO:0003151]; positive regulation of axonogenesis [GO:0050772]; regulation of angiogenesis [GO:0045765]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039],axon [GO:0030424]; cell body [GO:0044297]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]
Q8IYS1,C5,1.920394728,0.464775573,-0.604198401,-0.727566381,-0.850362256,turquoise3,PM20D2,P20D2_HUMAN,Xaa-Arg dipeptidase (EC 3.4.13.4) (Beta-Ala-Lys dipeptidase),PM20D2 ACY1L2,135293;,ENST00000275072.5; ENSP00000275072.4; ENSG00000146281.6.;,carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802],proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],nucleoplasm [GO:0005654]
Q969W9,S1,-0.99892077,-1.277447088,0.080901382,0.706112491,0.917265087,gold,PMEPA1,PMEPA_HUMAN,Protein TMEPAI (Prostate transmembrane protein androgen induced 1) (Solid tumor-associated 1 protein) (Transmembrane prostate androgen-induced protein),PMEPA1 STAG1 TMEPAI,56937;,"ENST00000265626.8; ENSP00000265626.4; ENSG00000124225.16. [Q969W9-3];""ENST00000341744.8; ENSP00000345826.3; ENSG00000124225.16. [Q969W9-1]"";""ENST00000347215.8; ENSP00000344014.4; ENSG00000124225.16. [Q969W9-2]"";""ENST00000395814.5; ENSP00000379159.1; ENSG00000124225.16. [Q969W9-3]"";""ENST00000395816.7; ENSP00000379161.3; ENSG00000124225.16. [Q969W9-3]"";",protein sequestering activity [GO:0140311]; R-SMAD binding [GO:0070412]; WW domain binding [GO:0050699],androgen receptor signaling pathway [GO:0030521]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q92871,C5,1.980556434,0.263189712,-0.698583687,-0.732438934,-1.136672238,turquoise3,PMM1,PMM1_HUMAN,Phosphomannomutase 1 (PMM 1) (EC 5.4.2.8) (PMMH-22),PMM1 PMMH22,5372;,ENST00000216259.8; ENSP00000216259.7; ENSG00000100417.12.;,metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615],cellular response to leukemia inhibitory factor [GO:1990830]; GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein N-linked glycosylation [GO:0006487],cytosol [GO:0005829]; neuronal cell body [GO:0043025]
O15305,C4,2.074586428,0.368848526,-1.0024812,-1.081822854,-1.254259311,deepskyblue2,PMM2,PMM2_HUMAN,Phosphomannomutase 2 (PMM 2) (EC 5.4.2.8),PMM2,5373;,"ENST00000268261.9; ENSP00000268261.4; ENSG00000140650.13. [O15305-1];""ENST00000566604.5; ENSP00000456774.1; ENSG00000140650.13. [O15305-2]"";""ENST00000683274.1; ENSP00000507262.1; ENSG00000140650.13. [O15305-2]"";",metal ion binding [GO:0046872]; phosphomannomutase activity [GO:0004615],GDP-mannose biosynthetic process [GO:0009298]; mannose metabolic process [GO:0006013]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]
Q15126,C3,1.81527996,-0.073702403,-0.557641718,-0.519094696,-0.73940502,cyan,PMVK,PMVK_HUMAN,Phosphomevalonate kinase (PMKase) (hPMK) (EC 2.7.4.2),PMVK PMKI,10654;,ENST00000368467.4; ENSP00000357452.3; ENSG00000163344.6.;,ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631],"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; response to cholesterol [GO:0070723]; sterol biosynthetic process [GO:0016126]",cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; peroxisome [GO:0005777]
Q8N490,M2,-0.770011974,-1.067722916,0.203202644,1.025284991,0.209920619,tan4,PNKD,PNKD_HUMAN,Probable hydrolase PNKD (EC 3.-.-.-) (Myofibrillogenesis regulator 1) (MR-1) (Paroxysmal nonkinesiogenic dyskinesia protein) (Trans-activated by hepatitis C virus core protein 2),PNKD KIAA1184 MR1 TAHCCP2 FKSG19 UNQ2491/PRO5778,25953;,"ENST00000248451.7; ENSP00000248451.3; ENSG00000127838.15. [Q8N490-2];""ENST00000258362.7; ENSP00000258362.3; ENSG00000127838.15. [Q8N490-3]"";""ENST00000273077.9; ENSP00000273077.4; ENSG00000127838.15. [Q8N490-1]"";",hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872],"methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929]; neuromuscular process controlling posture [GO:0050884]; regulation of dopamine metabolic process [GO:0042053]; regulation of synaptic transmission, dopaminergic [GO:0032225]",membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]
Q9H307,N3,-1.14180647,-1.232934569,1.081808282,0.30018506,0.067699993,grey50,PNN,PININ_HUMAN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),PNN DRS MEMA,5411;,ENST00000216832.9; ENSP00000216832.4; ENSG00000100941.9.;,DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198],"cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q8IY17,S3,-0.982654772,-1.113172743,0.165725756,0.822439902,0.648961681,salmon,PNPLA6,PLPL6_HUMAN,Patatin-like phospholipase domain-containing protein 6 (EC 3.1.1.5) (Neuropathy target esterase),PNPLA6 NTE,10908;,"ENST00000221249.10; ENSP00000221249.5; ENSG00000032444.17. [Q8IY17-2];""ENST00000414982.7; ENSP00000407509.2; ENSG00000032444.17. [Q8IY17-4]"";""ENST00000450331.7; ENSP00000394348.2; ENSG00000032444.17. [Q8IY17-2]"";""ENST00000545201.6; ENSP00000443323.1; ENSG00000032444.17. [Q8IY17-5]"";",lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545],glycerophospholipid catabolic process [GO:0046475]; phosphatidylcholine metabolic process [GO:0046470],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9NP80,M2,-0.969388713,-1.241802424,0.30180603,1.045026419,0.06546985,tan4,PNPLA8,PLPL8_HUMAN,Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (PNPLA-gamma) (Patatin-like phospholipase domain-containing protein 8) (iPLA2-2),PNPLA8 IPLA22 IPLA2G BM-043,50640;,"ENST00000257694.13; ENSP00000257694.8; ENSG00000135241.17. [Q9NP80-1];""ENST00000422087.5; ENSP00000410804.1; ENSG00000135241.17. [Q9NP80-1]"";""ENST00000426128.6; ENSP00000394988.2; ENSG00000135241.17. [Q9NP80-2]"";""ENST00000436062.5; ENSP00000406779.1; ENSG00000135241.17. [Q9NP80-1]"";""ENST00000453144.5; ENSP00000387789.1; ENSG00000135241.17. [Q9NP80-3]"";",ATP binding [GO:0005524]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phosphatidyl phospholipase B activity [GO:0102545]; phospholipase A1 activity [GO:0008970],arachidonic acid metabolic process [GO:0019369]; arachidonic acid secretion [GO:0050482]; cardiolipin metabolic process [GO:0032048]; fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; linoleic acid metabolic process [GO:0043651]; lipid homeostasis [GO:0055088]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; prostaglandin biosynthetic process [GO:0001516]; regulation of cellular response to oxidative stress [GO:1900407]; triglyceride homeostasis [GO:0070328],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]
Q9NVS9,C5,1.725779044,0.338222048,-0.718886113,-0.631219599,-1.170952119,turquoise3,PNPO,PNPO_HUMAN,Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase),PNPO,55163;,"ENST00000225573.5; ENSP00000225573.5; ENSG00000108439.11. [Q9NVS9-4];""ENST00000434554.7; ENSP00000399960.3; ENSG00000108439.11. [Q9NVS9-3]"";""ENST00000582171.6; ENSP00000463994.1; ENSG00000108439.11. [Q9NVS9-2]"";""ENST00000585320.5; ENSP00000462345.1; ENSG00000108439.11. [Q9NVS9-2]"";""ENST00000641856.1; ENSP00000493224.1; ENSG00000108439.11. [Q9NVS9-2]"";""ENST00000642017.2; ENSP00000493302.2; ENSG00000108439.11. [Q9NVS9-1]"";",FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine phosphate oxidase activity [GO:0004733],pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxamine metabolic process [GO:0042818]; pyridoxine biosynthetic process [GO:0008615],cytosol [GO:0005829]
O00592,S1,-1.303285836,-1.501541919,-0.011448856,0.669611027,1.087996808,gold,PODXL,PODXL_HUMAN,Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1),PODXL PCLP PCLP1,5420;,"ENST00000322985.9; ENSP00000319782.9; ENSG00000128567.17. [O00592-2];""ENST00000378555.8; ENSP00000367817.3; ENSG00000128567.17. [O00592-1]"";",0,cell adhesion [GO:0007155]; cell migration [GO:0016477]; epithelial tube formation [GO:0072175]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; podocyte development [GO:0072015]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; regulation of microvillus assembly [GO:0032534],apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]
Q7Z3K3,N2,-1.212748119,-0.008822722,1.099766413,-0.002013047,-0.620667258,grey70,POGZ,POGZ_HUMAN,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),POGZ KIAA0461 SUHW5 ZNF280E ZNF635 Nbla00003,23126;,"ENST00000271715.7; ENSP00000271715.2; ENSG00000143442.24. [Q7Z3K3-1];""ENST00000368863.6; ENSP00000357856.2; ENSG00000143442.24. [Q7Z3K3-5]"";""ENST00000392723.6; ENSP00000376484.1; ENSG00000143442.24. [Q7Z3K3-2]"";""ENST00000409503.5; ENSP00000386836.1; ENSG00000143442.24. [Q7Z3K3-6]"";""ENST00000439756.2; ENSP00000390156.2; ENSG00000143442.24. [Q7Z3K3-1]"";""ENST00000491586.5; ENSP00000418408.1; ENSG00000143442.24. [Q7Z3K3-3]"";""ENST00000531094.5; ENSP00000431259.1; ENSG00000143442.24. [Q7Z3K3-7]"";",DNA binding [GO:0003677]; metal ion binding [GO:0046872],cell division [GO:0051301]; double-strand break repair via homologous recombination [GO:0000724]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O95602,N3,-0.646519929,-0.700767461,0.869656666,-0.203049433,0.779147895,grey50,POLR1A,RPA1_HUMAN,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),POLR1A,25885;,ENST00000263857.11; ENSP00000263857.6; ENSG00000068654.17.;,chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270],negative regulation of protein localization to nucleolus [GO:1904750],chromosome [GO:0005694]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]
O15160,N1,-0.725628751,-0.498598462,0.528422465,-0.145867209,1.000464563,grey90,POLR1E,RPAC1_HUMAN,DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPA39) (RPC40),POLR1C POLR1E,9533;,"ENST00000304004.7; ENSP00000307212.3; ENSG00000171453.20. [O15160-2];""ENST00000607635.2; ENSP00000496683.1; ENSG00000171453.20. [O15160-2]"";""ENST00000642195.1; ENSP00000496044.1; ENSG00000171453.20. [O15160-1]"";",DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; RNA polymerase I activity [GO:0001054]; RNA polymerase III activity [GO:0001056],transcription by RNA polymerase I [GO:0006360],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]
P24928,N2,-0.963813976,-0.06834813,0.919350127,-0.240818405,0.183806362,grey70,POLR2A,RPB1_HUMAN,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),POLR2A POLR2,5430;,0,DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; hydrolase activity [GO:0016787]; kinase binding [GO:0019900]; magnesium ion binding [GO:0000287]; microfibril binding [GO:0050436]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II activity [GO:0001055]; RNA-dependent RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],DNA-templated transcription termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; regulation of DNA-templated transcription [GO:0006355]; transcription by RNA polymerase II [GO:0006366],"chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]"
Q9NW08,N1,-0.436978967,0.191439654,-0.087743262,-0.210229749,1.012296092,grey90,POLR3B,RPC2_HUMAN,DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B),POLR3B,55703;,"ENST00000228347.9; ENSP00000228347.4; ENSG00000013503.10. [Q9NW08-1];""ENST00000539066.5; ENSP00000445721.1; ENSG00000013503.10. [Q9NW08-2]"";",DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270],defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; snRNA transcription by RNA polymerase III [GO:0042796],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]
O00411,S3,-1.017637438,-0.868511845,0.280348537,0.674170124,0.496755357,salmon,POLRMT,RPOM_HUMAN,"DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6)",POLRMT,5442;,ENST00000588649.7; ENSP00000465759.2; ENSG00000099821.14.;,3'-5'-RNA exonuclease activity [GO:0000175]; DNA primase activity [GO:0003896]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565],mitochondrial transcription [GO:0006390]; transcription initiation at mitochondrial promoter [GO:0006391],mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]
Q96HA1,N3,-1.682060349,-1.287706399,1.268654556,0.192943627,-0.570035563,grey50,POM121,P121A_HUMAN,Nuclear envelope pore membrane protein POM 121 (Nuclear envelope pore membrane protein POM 121A) (Nucleoporin Nup121) (Pore membrane protein of 121 kDa),POM121 KIAA0618 NUP121 POM121A,9883;,"ENST00000395270.5; ENSP00000378687.1; ENSG00000196313.13. [Q96HA1-3];""ENST00000434423.5; ENSP00000405562.2; ENSG00000196313.13. [Q96HA1-1]"";""ENST00000627934.3; ENSP00000486504.1; ENSG00000196313.13. [Q96HA1-2]"";",nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056],mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405],endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]
A8CG34,N3,-2.481430142,-1.793776996,1.402078914,0.243880594,-0.609541748,grey50,POM121C,P121C_HUMAN,Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2) (POM121-2) (Pore membrane protein of 121 kDa C),POM121C,0,"ENST00000607367.5; ENSP00000476236.2; ENSG00000272391.6. [A8CG34-1];""ENST00000615331.5; ENSP00000481575.1; ENSG00000272391.6. [A8CG34-2]"";",nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056],mRNA transport [GO:0051028]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405],endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]
Q8WZA1,S1,-0.751924667,-0.901807566,-0.167353629,0.805172478,0.874773958,gold,POMGNT1,PMGT1_HUMAN,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2)",POMGNT1 MGAT1.2 UNQ746/PRO1475,55624;,"ENST00000371984.8; ENSP00000361052.3; ENSG00000085998.15. [Q8WZA1-1];""ENST00000371992.1; ENSP00000361060.1; ENSG00000085998.15. [Q8WZA1-2]"";""ENST00000396420.8; ENSP00000379698.4; ENSG00000085998.15. [Q8WZA1-1]"";""ENST00000686737.1; ENSP00000508736.1; ENSG00000085998.15. [Q8WZA1-1]"";""ENST00000687683.1; ENSP00000508522.1; ENSG00000085998.15. [Q8WZA1-1]"";""ENST00000690678.1; ENSP00000508703.1; ENSG00000085998.15. [Q8WZA1-1]"";","acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]",basement membrane organization [GO:0071711]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; localization of cell [GO:0051674]; myelination [GO:0042552]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; reactive gliosis [GO:0150103]; sensory perception of sound [GO:0007605],Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9H5K3,S2,-1.496909172,-1.54262665,0.258467696,0.905528478,0.507897438,orange,POMK,SG196_HUMAN,Protein O-mannose kinase (POMK) (EC 2.7.1.183) (Protein kinase-like protein SgK196) (Sugen kinase 196),POMK SGK196,84197;,"ENST00000331373.10; ENSP00000331258.5; ENSG00000185900.11.;""ENST00000676193.1; ENSP00000502774.1; ENSG00000185900.11."";","ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]",brain development [GO:0007420]; carbohydrate phosphorylation [GO:0046835]; learning or memory [GO:0007611]; neuromuscular process [GO:0050905]; protein O-linked glycosylation [GO:0006493]; sensory perception of pain [GO:0019233],endoplasmic reticulum membrane [GO:0005789]
Q15165,S2,-1.08213468,-1.373366115,0.244877714,0.882434197,0.521873972,orange,PON2,PON2_HUMAN,Serum paraoxonase/arylesterase 2 (PON 2) (EC 3.1.1.2) (EC 3.1.1.81) (Aromatic esterase 2) (A-esterase 2) (Serum aryldialkylphosphatase 2),PON2,5445;,"ENST00000222572.8; ENSP00000222572.3; ENSG00000105854.13. [Q15165-2];""ENST00000433091.6; ENSP00000404622.2; ENSG00000105854.13. [Q15165-3]"";""ENST00000633531.1; ENSP00000488838.1; ENSG00000105854.13. [Q15165-2]"";",acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; arylesterase activity [GO:0004064]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803],lactone catabolic process [GO:1901335]; response to toxic substance [GO:0009636],extracellular region [GO:0005576]; plasma membrane [GO:0005886]
Q99575,N1,-0.997087502,-0.140210009,0.124754391,-0.651092269,1.224116352,grey90,POP1,POP1_HUMAN,Ribonucleases P/MRP protein subunit POP1 (hPOP1),POP1 KIAA0061,10940;,"ENST00000349693.3; ENSP00000339529.3; ENSG00000104356.11.;""ENST00000401707.7; ENSP00000385787.2; ENSG00000104356.11."";",ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723],tRNA 5'-leader removal [GO:0001682]; tRNA decay [GO:0016078]; tRNA processing [GO:0008033],extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]
O95707,N1,-1.043874692,0.146671908,0.04105535,-0.839488324,1.190306397,grey90,POP4,RPP29_HUMAN,Ribonuclease P protein subunit p29 (hPOP4),POP4 RPP29,10775;,ENST00000585603.6; ENSP00000465213.1; ENSG00000105171.10.;,ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204],rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682],multimeric ribonuclease P complex [GO:0030681]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172]; ribonuclease P complex [GO:0030677]
P16435,S3,-0.874245903,-1.068117851,0.220428504,0.74575004,0.591386413,salmon,POR,NCPR_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),POR CYPOR,5447;,ENST00000461988.6; ENSP00000419970.2; ENSG00000127948.17.;,flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],cellular organofluorine metabolic process [GO:0090346]; electron transport chain [GO:0022900]; positive regulation of monooxygenase activity [GO:0032770]; response to hormone [GO:0009725]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
Q15181,C4,1.922229214,0.438330213,-1.178500936,-1.373160242,-1.589535915,deepskyblue2,PPA1,IPYR_HUMAN,Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase),PPA1 IOPPP PP,5464;,ENST00000373232.8; ENSP00000362329.2; ENSG00000180817.12.;,inorganic diphosphate phosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287],phosphate-containing compound metabolic process [GO:0006796],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q06203,C4,1.993375158,0.414040574,-0.927690843,-1.075139315,-1.118982679,deepskyblue2,PPAT,PUR1_HUMAN,Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT),PPAT GPAT,5471;,ENST00000264220.6; ENSP00000264220.2; ENSG00000128059.8.;,"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]",'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164],cytosol [GO:0005829]
Q9HAB8,C3,1.87095406,0.234520863,-0.760833017,-0.728042902,-0.916483273,cyan,PPCS,PPCS_HUMAN,Phosphopantothenate--cysteine ligase (EC 6.3.2.51) (Phosphopantothenoylcysteine synthetase) (PPC synthetase),PPCS COAB,79717;,"ENST00000372561.4; ENSP00000361642.3; ENSG00000127125.9. [Q9HAB8-1];""ENST00000372562.1; ENSP00000361643.1; ENSG00000127125.9. [Q9HAB8-2]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphopantothenate--cysteine ligase activity [GO:0004632]; protein homodimerization activity [GO:0042803],acetyl-CoA biosynthetic process [GO:0006085]; coenzyme A biosynthetic process [GO:0015937]; heart process [GO:0003015],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q8NEY8,N3,-1.007675144,-0.810831243,1.080662046,0.156592609,-0.107798629,grey50,PPHLN1,PPHLN_HUMAN,Periphilin-1 (CDC7 expression repressor) (CR) (Gastric cancer antigen Ga50),PPHLN1 HSPC206 HSPC232,51535;,"ENST00000358314.12; ENSP00000351066.7; ENSG00000134283.18. [Q8NEY8-8];""ENST00000395568.6; ENSP00000378935.2; ENSG00000134283.18. [Q8NEY8-1]"";""ENST00000395580.7; ENSP00000378947.3; ENSG00000134283.18. [Q8NEY8-2]"";""ENST00000432191.6; ENSP00000393965.2; ENSG00000134283.18. [Q8NEY8-3]"";""ENST00000449194.6; ENSP00000390681.2; ENSG00000134283.18. [Q8NEY8-9]"";""ENST00000552761.5; ENSP00000449331.1; ENSG00000134283.18. [Q8NEY8-6]"";""ENST00000610488.4; ENSP00000479913.1; ENSG00000134283.18. [Q8NEY8-1]"";""ENST00000613154.4; ENSP00000478872.1; ENSG00000134283.18. [Q8NEY8-9]"";""ENST00000619544.4; ENSP00000477681.1; ENSG00000134283.18. [Q8NEY8-3]"";",RNA binding [GO:0003723],"keratinization [GO:0031424]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]; protein localization to heterochromatin [GO:0097355]",chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]
P62937,C5,1.968114748,0.566458644,-1.029794064,-1.17100947,-1.364097347,turquoise3,PPIA,PPIA_HUMAN,"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]",PPIA CYPA,5478;,"ENST00000355968.10; ENSP00000430817.1; ENSG00000196262.15. [P62937-2];""ENST00000468812.6; ENSP00000419425.1; ENSG00000196262.15. [P62937-1]"";""ENST00000489459.5; ENSP00000427976.1; ENSG00000196262.15. [P62937-2]"";""ENST00000677022.1; ENSP00000504216.1; ENSG00000196262.15. [P62937-2]"";""ENST00000677107.1; ENSP00000504735.1; ENSG00000196262.15. [P62937-2]"";""ENST00000678789.1; ENSP00000503804.1; ENSG00000196262.15. [P62937-2]"";""ENST00000678805.1; ENSP00000502945.1; ENSG00000196262.15. [P62937-2]"";",cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790],activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; lipid droplet organization [GO:0034389]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of viral life cycle [GO:1903901]; neuron differentiation [GO:0030182]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]
Q08752,C5,1.882262816,0.445357377,-0.87805301,-1.008993423,-1.385779942,turquoise3,PPID,PPID_HUMAN,Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Rotamase D),PPID CYP40 CYPD,5481;,ENST00000307720.4; ENSP00000303754.3; ENSG00000171497.5.;,cyclosporin A binding [GO:0016018]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; nuclear estrogen receptor binding [GO:0030331]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134],apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13356,N4,-0.727952491,0.505502712,0.638088634,-0.147755103,0.116836276,grey30,PPIL2,PPIL2_HUMAN,RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2),PPIL2,23759;,"ENST00000335025.12; ENSP00000334553.7; ENSG00000100023.20. [Q13356-1];""ENST00000398831.8; ENSP00000381812.3; ENSG00000100023.20. [Q13356-1]"";""ENST00000406385.1; ENSP00000384299.1; ENSG00000100023.20. [Q13356-1]"";""ENST00000626352.2; ENSP00000486725.1; ENSG00000100023.20. [Q13356-2]"";""ENST00000679534.1; ENSP00000504893.1; ENSG00000100023.20. [Q13356-1]"";""ENST00000679540.1; ENSP00000506328.1; ENSG00000100023.20. [Q13356-1]"";""ENST00000679795.1; ENSP00000506144.1; ENSG00000100023.20. [Q13356-1]"";""ENST00000680061.1; ENSP00000505910.1; ENSG00000100023.20. [Q13356-1]"";""ENST00000680393.1; ENSP00000506542.1; ENSG00000100023.20. [Q13356-1]"";""ENST00000681956.1; ENSP00000506158.1; ENSG00000100023.20. [Q13356-1]"";",ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380],catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9H2H8,C1,1.336292374,0.174712781,0.196626825,-0.677500306,-0.403569837,lightblue,PPIL3,PPIL3_HUMAN,Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (Cyclophilin J) (CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3),PPIL3,53938;,"ENST00000286175.12; ENSP00000286175.8; ENSG00000240344.10. [Q9H2H8-2];""ENST00000392283.9; ENSP00000376107.4; ENSG00000240344.10. [Q9H2H8-1]"";""ENST00000409449.5; ENSP00000387012.1; ENSG00000240344.10. [Q9H2H8-2]"";",peptidyl-prolyl cis-trans isomerase activity [GO:0003755],"mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]",catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]
O43314,C3,1.75670605,0.453781182,-0.652797264,-0.717765844,-0.796029687,cyan,PPIP5K2,VIP2_HUMAN,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2),PPIP5K2 HISPPD1 KIAA0433 VIP2,23262;,"ENST00000321521.13; ENSP00000313070.8; ENSG00000145725.21. [O43314-2];""ENST00000358359.8; ENSP00000351126.3; ENSG00000145725.21. [O43314-1]"";""ENST00000414217.5; ENSP00000416016.1; ENSG00000145725.21. [O43314-2]"";","ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]",inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; sensory perception of sound [GO:0007605],cytosol [GO:0005829]
P35813,C5,1.887083834,0.267969052,-0.810704458,-0.818681212,-0.983714832,turquoise3,PPM1A,PPM1A_HUMAN,Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA),PPM1A PPPM1A,5494;,"ENST00000325642.7; ENSP00000327255.3; ENSG00000100614.18. [P35813-3];""ENST00000325658.3; ENSP00000314850.3; ENSG00000100614.18. [P35813-2]"";""ENST00000395076.9; ENSP00000378514.4; ENSG00000100614.18. [P35813-1]"";",calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412],cellular response to transforming growth factor beta stimulus [GO:0071560]; dephosphorylation [GO:0016311]; N-terminal protein myristoylation [GO:0006499]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein export from nucleus [GO:0046827]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611]; regulation of cell cycle [GO:0051726],cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O75688,C4,1.946140559,0.142782511,-0.829588138,-0.801953153,-0.990849512,deepskyblue2,PPM1B,PPM1B_HUMAN,Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta),PPM1B PP2CB,5495;,"ENST00000282412.9; ENSP00000282412.4; ENSG00000138032.21. [O75688-1];""ENST00000345249.8; ENSP00000326089.4; ENSG00000138032.21. [O75688-3]"";""ENST00000378551.6; ENSP00000367813.2; ENSG00000138032.21. [O75688-2]"";""ENST00000409432.7; ENSP00000387287.3; ENSG00000138032.21. [O75688-4]"";",magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722],N-terminal protein myristoylation [GO:0006499]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein dephosphorylation [GO:0006470],cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]
P49593,C3,1.617488532,0.072303927,-0.41942728,-0.440707141,-0.75746513,cyan,PPM1F,PPM1F_HUMAN,Protein phosphatase 1F (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase) (CaM-kinase phosphatase) (CaMKPase) (Partner of PIX 2) (Protein fem-2 homolog) (hFem-2),PPM1F KIAA0015 POPX2,9647;,ENST00000263212.10; ENSP00000263212.5; ENSG00000100034.14. [P49593-1];,calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138],cellular response to xenobiotic stimulus [GO:0071466]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein transport [GO:0051224]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of stress fiber assembly [GO:0051496]; regulation of protein localization [GO:0032880],cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]
Q9ULR3,C1,1.751732526,-0.022038477,-0.585002457,-0.291183213,-0.595991666,lightblue,PPM1H,PPM1H_HUMAN,Protein phosphatase 1H (EC 3.1.3.16),PPM1H ARHCL1 KIAA1157 URCC2,57460;,ENST00000228705.7; ENSP00000228705.5; ENSG00000111110.12.;,[pyruvate dehydrogenase (acetyl-transferring)]-phosphatase activity [GO:0004741]; identical protein binding [GO:0042802]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721],0,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q5SGD2,S1,-1.278028063,-1.348337193,0.098560641,0.805597926,0.954310491,gold,PPM1L,PPM1L_HUMAN,Protein phosphatase 1L (EC 3.1.3.16) (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon) (PP2C-epsilon),PPM1L PP2CE,151742;,"ENST00000295839.9; ENSP00000295839.9; ENSG00000163590.14. [Q5SGD2-3];""ENST00000464260.5; ENSP00000420746.1; ENSG00000163590.14. [Q5SGD2-2]"";""ENST00000497343.5; ENSP00000420354.1; ENSG00000163590.14. [Q5SGD2-4]"";""ENST00000498165.6; ENSP00000417659.1; ENSG00000163590.14. [Q5SGD2-1]"";",metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722],cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; MAPK cascade [GO:0000165]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]
Q9Y570,C4,1.97125798,0.455750621,-0.861524446,-1.02294691,-1.337251759,deepskyblue2,PPME1,PPME1_HUMAN,Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89),PPME1 PME1 PP2593 PRO0750,51400;,"ENST00000328257.13; ENSP00000329867.8; ENSG00000214517.10. [Q9Y570-1];""ENST00000398427.6; ENSP00000381461.4; ENSG00000214517.10. [Q9Y570-4]"";",cadherin binding [GO:0045296]; lncRNA binding [GO:0106222]; protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein methylesterase activity [GO:0051723]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888],G2/M transition of mitotic cell cycle [GO:0000086]; protein demethylation [GO:0006482],nucleoplasm [GO:0005654]
P62140,C2,0.851931148,0.245960335,0.242750482,-0.053013894,-0.206465777,aquamarine,PPP1CB,PP1B_HUMAN,Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (PPP1CD) (EC 3.1.3.16) (EC 3.1.3.53),PPP1CB,5500;,"ENST00000296122.10; ENSP00000296122.6; ENSG00000213639.11.;""ENST00000395366.3; ENSP00000378769.2; ENSG00000213639.11."";""ENST00000420282.6; ENSP00000398839.2; ENSG00000213639.11."";""ENST00000441461.6; ENSP00000414918.2; ENSG00000213639.11."";""ENST00000703173.1; ENSP00000515219.1; ENSG00000213639.11."";",metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; myosin-light-chain-phosphatase activity [GO:0050115]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722],cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]
O60927,C5,1.558821397,0.564447746,-0.481082007,-0.58061212,-0.715528413,turquoise3,PPP1R11,PP1RB_HUMAN,E3 ubiquitin-protein ligase PPP1R11 (EC 2.3.2.27) (Hemochromatosis candidate gene V protein) (HCG V) (Protein phosphatase 1 regulatory subunit 11) (Protein phosphatase inhibitor 3),PPP1R11 HCGV TCTE5,6992;,"ENST00000376772.8; ENSP00000365963.3; ENSG00000204619.8.;""ENST00000383612.8; ENSP00000373107.4; ENSG00000206501.8."";""ENST00000431424.6; ENSP00000411038.2; ENSG00000236560.6."";""ENST00000431977.6; ENSP00000407981.2; ENSG00000237829.6."";""ENST00000436591.6; ENSP00000414808.2; ENSG00000234058.6."";""ENST00000437937.6; ENSP00000394056.2; ENSG00000233314.6."";""ENST00000448378.6; ENSP00000403557.2; ENSG00000237403.6."";""ENST00000452679.6; ENSP00000412297.2; ENSG00000227720.6."";",phosphatase binding [GO:0019902]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ubiquitin protein ligase activity [GO:0061630],defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cytokine production [GO:0001818]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q96C90,C5,1.67335185,0.392281296,-0.686186462,-0.672250049,-1.079188198,turquoise3,PPP1R14B,PP14B_HUMAN,Protein phosphatase 1 regulatory subunit 14B (Phospholipase C-beta-3 neighbouring gene protein),PPP1R14B PLCB3N PNG,26472;,ENST00000309318.8; ENSP00000310117.3; ENSG00000173457.11.;,protein serine/threonine phosphatase inhibitor activity [GO:0004865],innate immune response [GO:0045087]; regulation of phosphorylation [GO:0042325],cytoplasm [GO:0005737]
Q96I34,S3,-0.831782905,-0.540528895,0.336807328,0.574523898,0.329672006,salmon,PPP1R16A,PP16A_HUMAN,Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3),PPP1R16A MYPT3,84988;,"ENST00000292539.8; ENSP00000292539.4; ENSG00000160972.10.;""ENST00000435887.2; ENSP00000391126.1; ENSG00000160972.10."";",enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020],0,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]
P41236,C5,1.712227956,0.581209434,-0.952595128,-1.173262283,-1.182351739,turquoise3,PPP1R2,IPP2_HUMAN,Protein phosphatase inhibitor 2 (IPP-2),PPP1R2 IPP2,5504;,ENST00000618156.5; ENSP00000484580.1; ENSG00000184203.8.;,molecular function inhibitor activity [GO:0140678]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of signal transduction [GO:0009966],0
Q15435,C5,2.024947273,0.411121702,-0.930357154,-1.057734713,-1.378420854,turquoise3,PPP1R7,PP1R7_HUMAN,Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22),PPP1R7 SDS22,5510;,"ENST00000234038.11; ENSP00000234038.6; ENSG00000115685.15. [Q15435-1];""ENST00000272983.12; ENSP00000272983.8; ENSG00000115685.15. [Q15435-2]"";""ENST00000401987.5; ENSP00000385466.1; ENSG00000115685.15. [Q15435-4]"";""ENST00000402734.5; ENSP00000385012.1; ENSG00000115685.15. [Q15435-5]"";""ENST00000406106.7; ENSP00000385022.3; ENSG00000115685.15. [Q15435-3]"";""ENST00000407025.5; ENSP00000385657.1; ENSG00000115685.15. [Q15435-1]"";",enzyme regulator activity [GO:0030234]; protein phosphatase regulator activity [GO:0019888],positive regulation of protein dephosphorylation [GO:0035307],chromosome [GO:0005694]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
P30153,C3,1.549469833,0.202728662,-0.389730666,-0.504968378,-0.516079481,cyan,PPP2R1A,2AAA_HUMAN,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha),PPP2R1A,5518;,ENST00000322088.11; ENSP00000324804.6; ENSG00000105568.19.;,protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722],"chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; intracellular signal transduction [GO:0035556]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; negative regulation of hippo signaling [GO:0035331]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein-containing complex assembly [GO:0065003]; regulation of cell differentiation [GO:0045595]; regulation of growth [GO:0040008]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]; T cell homeostasis [GO:0043029]","chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; FAR/SIN/STRIPAK complex [GO:0090443]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]"
P30154,C1,1.528692103,0.106974057,-0.395167095,-0.295608194,-0.412382152,lightblue,PPP2R1B,2AAB_HUMAN,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta),PPP2R1B,5519;,"ENST00000311129.9; ENSP00000311344.5; ENSG00000137713.16. [P30154-2];""ENST00000341980.10; ENSP00000343317.6; ENSG00000137713.16. [P30154-4]"";""ENST00000393055.6; ENSP00000376775.2; ENSG00000137713.16. [P30154-5]"";""ENST00000426998.6; ENSP00000410671.2; ENSG00000137713.16. [P30154-3]"";""ENST00000527614.6; ENSP00000437193.1; ENSG00000137713.16. [P30154-1]"";",protein phosphatase regulator activity [GO:0019888],apoptotic process involved in morphogenesis [GO:0060561]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]
P63151,C5,1.867125119,0.415134213,-0.785030261,-0.775440908,-0.886282296,turquoise3,PPP2R2A,2ABA_HUMAN,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha),PPP2R2A,5520;,"ENST00000315985.7; ENSP00000325074.7; ENSG00000221914.11. [P63151-2];""ENST00000380737.8; ENSP00000370113.3; ENSG00000221914.11. [P63151-1]"";",protein phosphatase regulator activity [GO:0019888],protein dephosphorylation [GO:0006470]; response to morphine [GO:0043278],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159]
Q06190,C1,1.643420269,-0.062374506,-0.366689318,-0.35738075,-0.716830262,lightblue,PPP2R3A,P2R3A_HUMAN,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B),PPP2R3A PPP2R3,5523;,"ENST00000264977.8; ENSP00000264977.3; ENSG00000073711.11. [Q06190-1];""ENST00000334546.6; ENSP00000334748.2; ENSG00000073711.11. [Q06190-2]"";""ENST00000490467.5; ENSP00000419344.1; ENSG00000073711.11. [Q06190-3]"";",calcium ion binding [GO:0005509]; protein phosphatase regulator activity [GO:0019888]; protein-macromolecule adaptor activity [GO:0030674],eye photoreceptor cell differentiation [GO:0001754]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein catabolic process [GO:0045732]; protein dephosphorylation [GO:0006470]; regulation of cell migration involved in somitogenic axis elongation [GO:0090249]; somatic muscle development [GO:0007525]; somite development [GO:0061053]; somitogenesis [GO:0001756],protein phosphatase type 2A complex [GO:0000159]
Q15257,C5,2.067645069,0.299127015,-0.906311637,-1.044404956,-1.13046312,turquoise3,PPP2R4,PTPA_HUMAN,"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')",PTPA PPP2R4,5524;,"ENST00000337738.6; ENSP00000337448.1; ENSG00000119383.21. [Q15257-1];""ENST00000355007.7; ENSP00000347109.3; ENSG00000119383.21. [Q15257-4]"";""ENST00000357197.8; ENSP00000349726.4; ENSG00000119383.21. [Q15257-3]"";""ENST00000393370.7; ENSP00000377036.2; ENSG00000119383.21. [Q15257-2]"";",ATP binding [GO:0005524]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102],mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; regulation of phosphoprotein phosphatase activity [GO:0043666],ATPase complex [GO:1904949]; calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]
Q13362,C2,0.998077794,0.111289971,-0.014849494,0.023277284,-0.154917731,aquamarine,PPP2R5C,2A5G_HUMAN,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29),PPP2R5C KIAA0044,5527;,"ENST00000328724.9; ENSP00000329009.5; ENSG00000078304.20. [Q13362-4];""ENST00000334743.9; ENSP00000333905.4; ENSG00000078304.20. [Q13362-1]"";""ENST00000350249.7; ENSP00000262239.5; ENSG00000078304.20. [Q13362-3]"";""ENST00000422945.6; ENSP00000412324.2; ENSG00000078304.20. [Q13362-5]"";""ENST00000445439.7; ENSP00000408389.3; ENSG00000078304.20. [Q13362-2]"";",protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888],"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; signal transduction [GO:0007165]","chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]"
Q14738,C3,1.785623094,-0.019323067,-0.529634619,-0.340136725,-0.495784785,cyan,PPP2R5D,2A5D_HUMAN,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),PPP2R5D,5528;,"ENST00000394110.7; ENSP00000377669.3; ENSG00000112640.16. [Q14738-2];""ENST00000461010.5; ENSP00000420674.1; ENSG00000112640.16. [Q14738-3]"";""ENST00000485511.6; ENSP00000417963.1; ENSG00000112640.16. [Q14738-1]"";",phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888],negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]
P16298,C1,1.277137552,0.303847243,-0.486608124,-0.295565174,-0.423054702,lightblue,PPP3CB,PP2BB_HUMAN,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta),PPP3CB CALNA2 CALNB CNA2,5532;,"ENST00000360663.10; ENSP00000353881.5; ENSG00000107758.16. [P16298-1];""ENST00000394828.6; ENSP00000378305.2; ENSG00000107758.16. [P16298-3]"";""ENST00000394829.6; ENSP00000378306.2; ENSG00000107758.16. [P16298-4]"";",calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; enzyme binding [GO:0019899]; myosin phosphatase activity [GO:0017018]; protein dimerization activity [GO:0046983]; protein phosphatase 2B binding [GO:0030346]; protein serine/threonine phosphatase activity [GO:0004722],axon extension [GO:0048675]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium-ion regulated exocytosis [GO:0017156]; dephosphorylation [GO:0016311]; heart development [GO:0007507]; learning [GO:0007612]; locomotion involved in locomotory behavior [GO:0031987]; lymphangiogenesis [GO:0001946]; memory [GO:0007613]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of signaling [GO:0023057]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lysosome organization [GO:1905673]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of insulin secretion [GO:0050796]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to cytokine [GO:0034097]; signal transduction [GO:0007165]; skeletal muscle fiber development [GO:0048741]; T cell activation [GO:0042110]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T cell mediated cytotoxicity [GO:0001913]; T cell proliferation [GO:0042098],calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein serine/threonine phosphatase complex [GO:0008287]; T-tubule [GO:0030315]; Z disc [GO:0030018]
P60510,C5,0.854627224,1.038978574,-0.452399384,-0.717174727,-0.809896145,turquoise3,PPP4C,PP4C_HUMAN,Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X),PPP4C PPP4 PPX,5531;,"ENST00000279387.12; ENSP00000279387.7; ENSG00000149923.14.;""ENST00000561610.1; ENSP00000455995.1; ENSG00000149923.14."";",metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; protein serine/threonine phosphatase activity [GO:0004722],double-strand break repair via homologous recombination [GO:0000724]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via homologous recombination [GO:0010569],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase 4 complex [GO:0030289]
Q8TF05,C3,1.773844955,-0.102269619,-0.708052161,-0.514439203,-1.035291989,cyan,PPP4R1,PP4R1_HUMAN,Serine/threonine-protein phosphatase 4 regulatory subunit 1,PPP4R1 MEG1 PP4R1,9989;,"ENST00000400555.7; ENSP00000383401.3; ENSG00000154845.16. [Q8TF05-2];""ENST00000400556.8; ENSP00000383402.3; ENSG00000154845.16. [Q8TF05-1]"";",protein phosphatase regulator activity [GO:0019888],protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; protein phosphatase 4 complex [GO:0030289]
P53041,C4,1.848702315,0.322240605,-1.003725355,-1.023947457,-1.014558701,deepskyblue2,PPP5C,PPP5_HUMAN,Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT),PPP5C PPP5,5536;,ENST00000012443.9; ENSP00000012443.4; ENSG00000011485.15.;,ADP binding [GO:0043531]; ATP binding [GO:0005524]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; tau protein binding [GO:0048156],DNA-templated transcription [GO:0006351]; double-strand break repair [GO:0006302]; MAPK cascade [GO:0000165]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein dephosphorylation [GO:0006470]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]
Q9UPN7,C3,1.671798615,-0.047100667,-0.656487594,-0.478593165,-0.479224137,cyan,PPP6R1,PP6R1_HUMAN,Serine/threonine-protein phosphatase 6 regulatory subunit 1 (SAPS domain family member 1),PPP6R1 KIAA1115 PP6R1 SAPS1,22870;,"ENST00000412770.7; ENSP00000414202.1; ENSG00000105063.19.;""ENST00000587283.5; ENSP00000467521.1; ENSG00000105063.19."";",protein phosphatase binding [GO:0019903]; protein phosphatase regulator activity [GO:0019888]; small GTPase binding [GO:0031267],regulation of phosphoprotein phosphatase activity [GO:0043666],cytosol [GO:0005829]; nucleus [GO:0005634]
P57071,N1,-1.113831509,-0.813812412,0.526115618,-0.401671044,1.034122854,grey90,PRDM15,PRD15_HUMAN,PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298),PRDM15 C21orf83 ZNF298,63977;,"ENST00000269844.5; ENSP00000269844.4; ENSG00000141956.14.;""ENST00000398548.6; ENSP00000381556.2; ENSG00000141956.14."";""ENST00000422911.6; ENSP00000408592.2; ENSG00000141956.14."";""ENST00000449395.6; ENSP00000396943.2; ENSG00000141956.14."";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",methylation [GO:0032259]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of stem cell division [GO:2000035]; regulation of transcription by RNA polymerase II [GO:0006357],nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13029,N3,-1.172394508,-0.645977654,1.110976118,-0.002095662,0.166825481,grey50,PRDM2,PRDM2_HUMAN,PR domain zinc finger protein 2 (EC 2.1.1.355) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ),PRDM2 KMT8 RIZ,7799;,"ENST00000235372.11; ENSP00000235372.6; ENSG00000116731.23. [Q13029-1];""ENST00000311066.10; ENSP00000312352.6; ENSG00000116731.23. [Q13029-1]"";""ENST00000343137.8; ENSP00000341621.4; ENSG00000116731.23. [Q13029-5]"";""ENST00000376048.9; ENSP00000365216.5; ENSG00000116731.23. [Q13029-4]"";""ENST00000413440.5; ENSP00000411103.1; ENSG00000116731.23. [Q13029-5]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone H3K9 trimethyltransferase activity [GO:0140949]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",determination of adult lifespan [GO:0008340]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q06830,C5,2.041906748,0.330235538,-1.11834254,-1.330262946,-1.478639424,turquoise3,PRDX1,PRDX1_HUMAN,Peroxiredoxin-1 (EC 1.11.1.24) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1),PRDX1 PAGA PAGB TDPX2,5052;,"ENST00000262746.5; ENSP00000262746.1; ENSG00000117450.15.;""ENST00000319248.13; ENSP00000361152.5; ENSG00000117450.15."";""ENST00000424390.2; ENSP00000389047.2; ENSG00000117450.15."";""ENST00000447184.6; ENSP00000407034.2; ENSG00000117450.15."";""ENST00000676549.1; ENSP00000503140.1; ENSG00000117450.15."";",cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; RNA binding [GO:0003723]; thioredoxin peroxidase activity [GO:0008379],canonical NF-kappaB signal transduction [GO:0007249]; cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; fibroblast proliferation [GO:0048144]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; skeletal system development [GO:0001501],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]
P30041,C4,2.132260281,0.462095586,-1.174789047,-1.446847956,-1.613466578,deepskyblue2,PRDX6,PRDX6_HUMAN,Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Liver 2D page spot 40) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12),PRDX6 AOP2 KIAA0106,9588;,ENST00000340385.6; ENSP00000342026.5; ENSG00000117592.9.;,1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623]; ubiquitin protein ligase binding [GO:0031625],"cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]",azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q9HCU5,S3,-0.703457971,-1.090976335,0.156201685,0.782071721,0.482530134,salmon,PREB,SEC12_HUMAN,Guanine nucleotide-exchange factor SEC12 (Prolactin regulatory element-binding protein),PREB SEC12,10113;,ENST00000260643.7; ENSP00000260643.2; ENSG00000138073.14.;,DNA binding [GO:0003677]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085],COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; lipoprotein transport [GO:0042953]; regulation of COPII vesicle coating [GO:0003400],endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634]
P48147,C4,2.172334231,0.283667663,-1.117126444,-1.340654203,-1.418156689,deepskyblue2,PREP,PPCE_HUMAN,Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme),PREP PEP,5550;,ENST00000652536.2; ENSP00000499089.1; ENSG00000085377.15.;,oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]
Q4J6C6,C1,1.560747221,0.12075301,-0.427268864,0.111428621,-1.010576505,lightblue,PREPL,PPCEL_HUMAN,Prolyl endopeptidase-like (EC 3.4.21.-) (Prolylendopeptidase-like),PREPL KIAA0436,9581;,"ENST00000260648.10; ENSP00000260648.6; ENSG00000138078.16. [Q4J6C6-1];""ENST00000378511.7; ENSP00000367772.3; ENSG00000138078.16. [Q4J6C6-3]"";""ENST00000378520.7; ENSP00000367781.3; ENSG00000138078.16. [Q4J6C6-2]"";""ENST00000409272.5; ENSP00000386909.1; ENSG00000138078.16. [Q4J6C6-1]"";""ENST00000409411.6; ENSP00000387095.2; ENSG00000138078.16. [Q4J6C6-4]"";""ENST00000409936.5; ENSP00000386543.1; ENSG00000138078.16. [Q4J6C6-1]"";""ENST00000409957.5; ENSP00000387241.1; ENSG00000138078.16. [Q4J6C6-4]"";""ENST00000410081.5; ENSP00000386509.1; ENSG00000138078.16. [Q4J6C6-1]"";""ENST00000425263.5; ENSP00000391456.1; ENSG00000138078.16. [Q4J6C6-1]"";""ENST00000426481.5; ENSP00000409480.1; ENSG00000138078.16. [Q4J6C6-1]"";""ENST00000541738.5; ENSP00000439626.1; ENSG00000138078.16. [Q4J6C6-4]"";",peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252],"Golgi to plasma membrane protein transport [GO:0043001]; proteolysis [GO:0006508]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde transport, endosome to Golgi [GO:0042147]",cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]
Q9Y478,C1,1.715387757,0.123003308,-0.416562863,-0.222641896,-0.600118756,lightblue,PRKAB1,AAKB1_HUMAN,5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb),PRKAB1 AMPK,5564;,"ENST00000229328.10; ENSP00000229328.5; ENSG00000111725.11.;""ENST00000541640.5; ENSP00000441369.1; ENSG00000111725.11."";",protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901],cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; nail development [GO:0035878]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]
O43741,C1,1.572407304,0.073826774,-0.356620337,-0.160405134,-0.438334878,lightblue,PRKAB2,AAKB2_HUMAN,5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2),PRKAB2,5565;,ENST00000254101.4; ENSP00000254101.3; ENSG00000131791.8. [O43741-1];,protein kinase binding [GO:0019901],cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; positive regulation of cold-induced thermogenesis [GO:0120162]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]
P31321,C2,1.050595154,0.274391333,-0.459200607,-0.106560466,-0.084751986,aquamarine,PRKAR1B,KAP1_HUMAN,cAMP-dependent protein kinase type I-beta regulatory subunit,PRKAR1B,5575;,"ENST00000360274.8; ENSP00000353415.4; ENSG00000188191.16.;""ENST00000403562.5; ENSP00000385349.1; ENSG00000188191.16."";""ENST00000406797.5; ENSP00000385749.1; ENSG00000188191.16."";""ENST00000537384.6; ENSP00000440449.1; ENSG00000188191.16."";""ENST00000544935.5; ENSP00000444487.1; ENSG00000188191.16."";",cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein kinase A catalytic subunit binding [GO:0034236],learning or memory [GO:0007611]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of fear response [GO:1903367]; positive regulation of long-term synaptic potentiation [GO:1900273]; protein phosphorylation [GO:0006468]; regulation of protein phosphorylation [GO:0001932]; regulation of synaptic vesicle cycle [GO:0098693],cAMP-dependent protein kinase complex [GO:0005952]; ciliary base [GO:0097546]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]
P17252,C3,1.81540865,0.138822734,-0.656782861,-0.658682931,-0.863362708,cyan,PRKCA,KPCA_HUMAN,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),PRKCA PKCA PRKACA,5578;,ENST00000413366.8; ENSP00000408695.3; ENSG00000154229.12.;,"ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; enzyme binding [GO:0019899]; histone H3T6 kinase activity [GO:0035403]; integrin binding [GO:0005178]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]",angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cell adhesion [GO:0007155]; desmosome assembly [GO:0002159]; intracellular signal transduction [GO:0035556]; mitotic nuclear membrane disassembly [GO:0007077]; negative regulation of glial cell apoptotic process [GO:0034351]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106071]; positive regulation of angiogenesis [GO:0045766]; positive regulation of angiotensin-activated signaling pathway [GO:0110063]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of mRNA stability [GO:0043488]; regulation of platelet aggregation [GO:0090330]; response to interleukin-1 [GO:0070555],alphav-beta3 integrin-PKCalpha complex [GO:0035866]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q9BZL6,C1,1.393826535,-0.374970708,-0.375813482,-0.229371289,-0.006366956,lightblue,PRKD2,KPCD2_HUMAN,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),PRKD2 PKD2 HSPC187,25865;,"ENST00000291281.9; ENSP00000291281.3; ENSG00000105287.13. [Q9BZL6-1];""ENST00000433867.5; ENSP00000393978.1; ENSG00000105287.13. [Q9BZL6-1]"";""ENST00000595515.5; ENSP00000470804.1; ENSG00000105287.13. [Q9BZL6-3]"";""ENST00000600194.5; ENSP00000472744.1; ENSG00000105287.13. [Q9BZL6-2]"";""ENST00000601806.5; ENSP00000469106.1; ENSG00000105287.13. [Q9BZL6-2]"";",ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endothelial tube morphogenesis [GO:0061154]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of T cell apoptotic process [GO:0070232]; sphingolipid biosynthetic process [GO:0030148]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O75569,N1,-0.40458284,-1.013886809,-0.492823534,-0.332457873,1.55153251,grey90,PRKRA,PRKRA_HUMAN,"Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double-stranded RNA-dependent activator)",PRKRA PACT RAX HSD-14 HSD14,8575;,"ENST00000325748.9; ENSP00000318176.4; ENSG00000180228.14. [O75569-1];""ENST00000432031.6; ENSP00000393883.2; ENSG00000180228.14. [O75569-2]"";""ENST00000487082.5; ENSP00000430604.1; ENSG00000180228.14. [O75569-3]"";",double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; pre-miRNA binding [GO:0070883]; protein homodimerization activity [GO:0042803]; protein kinase activator activity [GO:0030295]; RNA binding [GO:0003723]; siRNA binding [GO:0035197],antiviral innate immune response [GO:0140374]; cellular response to oxidative stress [GO:0034599]; immune response [GO:0006955]; middle ear morphogenesis [GO:0042474]; miRNA processing [GO:0035196]; negative regulation of cell population proliferation [GO:0008285]; outer ear morphogenesis [GO:0042473]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; pre-miRNA processing [GO:0031054]; protein stabilization [GO:0050821]; regulation of regulatory ncRNA processing [GO:0070920]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; siRNA processing [GO:0030422]; skeletal system morphogenesis [GO:0048705],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]
O60678,C4,2.053628426,-0.229321911,-0.848664883,-0.836155944,-1.006675685,deepskyblue2,PRMT3,ANM3_HUMAN,Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3),PRMT3 HRMT1L3,10196;,"ENST00000331079.11; ENSP00000331879.6; ENSG00000185238.13. [O60678-1];""ENST00000437750.2; ENSP00000397766.2; ENSG00000185238.13. [O60678-2]"";",histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; ribosome binding [GO:0043022],chromatin remodeling [GO:0006338]; methylation [GO:0032259]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
O14744,C2,1.26380816,0.609403485,-0.58752992,-0.737490018,-0.360714241,aquamarine,PRMT5,ANM5_HUMAN,"Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]",PRMT5 HRMT1L5 IBP72 JBP1 SKB1,10419;,"ENST00000216350.12; ENSP00000216350.8; ENSG00000100462.16. [O14744-3];""ENST00000324366.13; ENSP00000319169.8; ENSG00000100462.16. [O14744-1]"";""ENST00000397440.8; ENSP00000380582.4; ENSG00000100462.16. [O14744-4]"";""ENST00000397441.6; ENSP00000380583.2; ENSG00000100462.16. [O14744-2]"";""ENST00000553897.5; ENSP00000452555.1; ENSG00000100462.16. [O14744-5]"";",E-box binding [GO:0070888]; histone arginine N-methyltransferase activity [GO:0008469]; histone H3 methyltransferase activity [GO:0140938]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714],"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA-templated transcription [GO:0006355]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; spliceosomal snRNP assembly [GO:0000387]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P04156,S3,-0.786996841,-1.05685298,0.310664175,0.652799827,0.579227758,salmon,PRNP,PRIO_HUMAN,Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230),PRNP ALTPRP PRIP PRP,5621;,"ENST00000379440.9; ENSP00000368752.4; ENSG00000171867.18. [P04156-1];""ENST00000424424.2; ENSP00000411599.2; ENSG00000171867.18. [P04156-1]"";""ENST00000430350.2; ENSP00000399376.2; ENSG00000171867.18. [P04156-1]"";""ENST00000457586.2; ENSP00000415284.2; ENSG00000171867.18. [P04156-1]"";",amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP-dependent protein binding [GO:0043008]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; glycosaminoglycan binding [GO:0005539]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; signaling receptor activity [GO:0038023]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]; type 5 metabotropic glutamate receptor binding [GO:0031802],cellular response to amyloid-beta [GO:1904646]; cellular response to copper ion [GO:0071280]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic spine maintenance [GO:0097062]; intracellular copper ion homeostasis [GO:0006878]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of type II interferon production [GO:0032689]; neuron projection maintenance [GO:1990535]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; protein destabilization [GO:0031648]; protein homooligomerization [GO:0051260]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell cycle [GO:0051726]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of potassium ion transmembrane transport [GO:1901379]; response to amyloid-beta [GO:1904645]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979],cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195]
O94903,C5,1.806707187,0.396859279,-0.520386305,-0.418124856,-1.047642601,turquoise3,PROSC,PLPHP_HUMAN,Pyridoxal phosphate homeostasis protein (PLP homeostasis protein) (Proline synthase co-transcribed bacterial homolog protein) (Pyridoxal phosphate-binding protein),PLPBP PROSC,11212;,ENST00000328195.8; ENSP00000333551.3; ENSG00000147471.12.;,pyridoxal phosphate binding [GO:0030170],0,cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q9UMS4,N1,-0.750953848,-0.447990376,0.595033745,-0.230522733,0.967297755,grey90,PRPF19,PRP19_HUMAN,Pre-mRNA-processing factor 19 (EC 2.3.2.27) (Nuclear matrix protein 200) (PRP19/PSO4 homolog) (hPso4) (RING-type E3 ubiquitin transferase PRP19) (Senescence evasion factor),PRPF19 NMP200 PRP19 SNEV,27339;,ENST00000227524.9; ENSP00000227524.4; ENSG00000110107.9.;,identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],"DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]
Q8WWY3,N1,-0.929388825,-0.080359993,0.483556021,-0.264688354,0.881833257,grey90,PRPF31,PRP31_HUMAN,U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31),PRPF31 PRP31,26121;,"ENST00000321030.9; ENSP00000324122.4; ENSG00000105618.14. [Q8WWY3-1];""ENST00000419967.5; ENSP00000405166.2; ENSG00000105618.14. [Q8WWY3-4]"";""ENST00000613693.4; ENSP00000483929.1; ENSG00000275885.4. [Q8WWY3-1]"";""ENST00000619391.1; ENSP00000480636.1; ENSG00000275885.4. [Q8WWY3-4]"";",identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622],"mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]",Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]
Q8NAV1,N2,-0.504307959,-0.575671152,0.874147291,0.010661262,0.218073726,grey70,PRPF38A,PR38A_HUMAN,Pre-mRNA-splicing factor 38A,PRPF38A,84950;,ENST00000257181.10; ENSP00000257181.8; ENSG00000134748.13. [Q8NAV1-1];,RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]
O75400,N4,-1.335094705,0.906892057,0.411029762,-0.381223076,-0.500985784,grey30,PRPF40A,PR40A_HUMAN,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225,55660;,"ENST00000354363.11; ENSP00000346332.7; ENSG00000196504.21. [O75400-5];""ENST00000696381.1; ENSP00000512591.1; ENSG00000196504.21. [O75400-1]"";",RNA binding [GO:0003723],"cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]",membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]
P11908,C4,2.053659698,0.435176084,-0.988522471,-1.114016544,-0.831650229,deepskyblue2,PRPS2,PRPS2_HUMAN,Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase II) (PRS-II),PRPS2,5634;,"ENST00000380668.10; ENSP00000370043.5; ENSG00000101911.13. [P11908-1];""ENST00000398491.6; ENSP00000381504.2; ENSG00000101911.13. [P11908-2]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749],5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleobase-containing compound metabolic process [GO:0006139]; pentose-phosphate shunt [GO:0006098]; purine nucleotide biosynthetic process [GO:0006164]; ribonucleoside monophosphate biosynthetic process [GO:0009156],cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribose phosphate diphosphokinase complex [GO:0002189]
Q96HE9,S2,-1.171821891,-0.826487105,0.121582257,0.910625032,0.421013781,orange,PRR11,PRR11_HUMAN,Proline-rich protein 11,PRR11,55771;,"ENST00000262293.9; ENSP00000262293.5; ENSG00000068489.13.;""ENST00000578542.5; ENSP00000464171.1; ENSG00000068489.13."";""ENST00000580177.5; ENSP00000463733.1; ENSG00000068489.13."";""ENST00000614081.1; ENSP00000481852.1; ENSG00000068489.13."";",0,regulation of cell cycle [GO:0051726],cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]
Q9NRG1,C3,2.03281908,0.085971797,-1.007362437,-0.74949086,-0.929359388,cyan,PRTFDC1,PRDC1_HUMAN,Phosphoribosyltransferase domain-containing protein 1,PRTFDC1 HHGP,56952;,"ENST00000320152.11; ENSP00000318602.5; ENSG00000099256.19. [Q9NRG1-1];""ENST00000376376.3; ENSP00000365556.3; ENSG00000099256.19. [Q9NRG1-3]"";""ENST00000376378.5; ENSP00000365558.1; ENSG00000099256.19. [Q9NRG1-2]"";",magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803],purine ribonucleoside salvage [GO:0006166],cytosol [GO:0005829]
Q86TP1,C3,1.970285834,-0.321939496,-0.774643699,-0.593324939,-0.842065959,cyan,PRUNE,PRUN1_HUMAN,Exopolyphosphatase PRUNE1 (EC 3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37) (Protein prune homolog 1) (hPrune),PRUNE1 PRUNE,58497;,"ENST00000271620.8; ENSP00000271620.3; ENSG00000143363.17. [Q86TP1-1];""ENST00000368934.1; ENSP00000357930.1; ENSG00000143363.17. [Q86TP1-5]"";""ENST00000368935.1; ENSP00000357931.1; ENSG00000143363.17. [Q86TP1-6]"";""ENST00000368936.5; ENSP00000357932.1; ENSG00000143363.17. [Q86TP1-3]"";""ENST00000368937.5; ENSP00000357933.1; ENSG00000143363.17. [Q86TP1-5]"";",exopolyphosphatase activity [GO:0004309]; inorganic diphosphate phosphatase activity [GO:0004427]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; tubulin binding [GO:0015631],regulation of microtubule polymerization [GO:0031113]; regulation of neurogenesis [GO:0050767],cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]
P49768,S4,-0.749866934,-1.314592682,0.276373243,0.884507682,0.456814656,tomato2,PSEN1,PSN1_HUMAN,Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)],PSEN1 AD3 PS1 PSNL1,5663;,"ENST00000324501.10; ENSP00000326366.5; ENSG00000080815.20. [P49768-1];""ENST00000357710.8; ENSP00000350342.4; ENSG00000080815.20. [P49768-2]"";""ENST00000394157.7; ENSP00000377712.3; ENSG00000080815.20. [P49768-4]"";""ENST00000394164.5; ENSP00000377719.1; ENSG00000080815.20. [P49768-2]"";""ENST00000553599.6; ENSP00000452477.2; ENSG00000080815.20. [P49768-2]"";""ENST00000553855.5; ENSP00000452242.1; ENSG00000080815.20. [P49768-5]"";""ENST00000554131.6; ENSP00000451915.2; ENSG00000080815.20. [P49768-1]"";""ENST00000555386.6; ENSP00000450845.1; ENSG00000080815.20. [P49768-3]"";""ENST00000556951.6; ENSP00000450551.2; ENSG00000080815.20. [P49768-2]"";""ENST00000557511.5; ENSP00000451429.1; ENSG00000080815.20. [P49768-6]"";""ENST00000700265.1; ENSP00000514901.1; ENSG00000080815.20. [P49768-2]"";""ENST00000700267.1; ENSP00000514903.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700268.1; ENSP00000514904.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700269.1; ENSP00000514905.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700273.1; ENSP00000514908.1; ENSG00000080815.20. [P49768-2]"";""ENST00000700306.1; ENSP00000514933.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700313.1; ENSP00000514940.1; ENSG00000080815.20. [P49768-2]"";""ENST00000700317.1; ENSP00000514944.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700321.1; ENSP00000514948.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700322.1; ENSP00000514949.1; ENSG00000080815.20. [P49768-2]"";""ENST00000700323.1; ENSP00000514950.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700324.1; ENSP00000514951.1; ENSG00000080815.20. [P49768-2]"";""ENST00000700375.1; ENSP00000514966.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700378.1; ENSP00000514968.1; ENSG00000080815.20. [P49768-1]"";""ENST00000700389.1; ENSP00000514970.1; ENSG00000080815.20. [P49768-2]"";""ENST00000700436.1; ENSP00000514987.1; ENSG00000080815.20. [P49768-5]"";""ENST00000700469.1; ENSP00000515002.1; ENSG00000080815.20. [P49768-2]"";","aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; aspartic-type endopeptidase activity [GO:0004190]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; endopeptidase activity [GO:0004175]; growth factor receptor binding [GO:0070851]; PDZ domain binding [GO:0030165]","amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; autophagosome assembly [GO:0000045]; blood vessel development [GO:0001568]; brain morphogenesis [GO:0048854]; Cajal-Retzius cell differentiation [GO:0021870]; calcium ion homeostasis [GO:0055074]; cell fate specification [GO:0001708]; cell-cell adhesion [GO:0098609]; cellular response to amyloid-beta [GO:1904646]; cerebellum development [GO:0021549]; cerebral cortex cell migration [GO:0021795]; choline transport [GO:0015871]; DNA damage response [GO:0006974]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic limb morphogenesis [GO:0030326]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; L-glutamate import across plasma membrane [GO:0098712]; learning or memory [GO:0007611]; locomotion [GO:0040011]; membrane protein ectodomain proteolysis [GO:0006509]; memory [GO:0007613]; mitochondrial transport [GO:0006839]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of axonogenesis [GO:0050771]; negative regulation of core promoter binding [GO:1904797]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural retina development [GO:0003407]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron development [GO:0048666]; neuron migration [GO:0001764]; neuron projection maintenance [GO:1990535]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of coagulation [GO:0050820]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor recycling [GO:0001921]; positive regulation of tumor necrosis factor production [GO:0032760]; post-embryonic development [GO:0009791]; protein catabolic process at postsynapse [GO:0140249]; protein glycosylation [GO:0006486]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of gene expression [GO:0010468]; regulation of neuron projection development [GO:0010975]; regulation of phosphorylation [GO:0042325]; regulation of postsynapse organization [GO:0099175]; regulation of resting membrane potential [GO:0060075]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle cycle [GO:0098693]; response to oxidative stress [GO:0006979]; sequestering of calcium ion [GO:0051208]; skeletal system morphogenesis [GO:0048705]; skin morphogenesis [GO:0043589]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; somitogenesis [GO:0001756]; synapse organization [GO:0050808]; synaptic vesicle targeting [GO:0016080]; T cell activation involved in immune response [GO:0002286]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]",aggresome [GO:0016235]; azurophil granule membrane [GO:0035577]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]
P49810,S1,-1.879815494,-2.299850864,-0.214999328,0.803812775,1.193204601,gold,PSEN2,PSN2_HUMAN,Presenilin-2 (PS-2) (EC 3.4.23.-) (AD3LP) (AD5) (E5-1) (STM-2) [Cleaved into: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit],PSEN2 AD4 PS2 PSNL2 STM2,5664;,"ENST00000366782.6; ENSP00000355746.2; ENSG00000143801.18. [P49810-1];""ENST00000366783.8; ENSP00000355747.3; ENSG00000143801.18. [P49810-1]"";""ENST00000422240.6; ENSP00000403737.2; ENSG00000143801.18. [P49810-3]"";""ENST00000524196.6; ENSP00000429036.2; ENSG00000143801.18. [P49810-1]"";""ENST00000626989.3; ENSP00000486498.2; ENSG00000143801.18. [P49810-1]"";""ENST00000677414.1; ENSP00000503116.1; ENSG00000143801.18. [P49810-1]"";""ENST00000678233.1; ENSP00000504728.1; ENSG00000143801.18. [P49810-1]"";""ENST00000679088.1; ENSP00000504727.1; ENSG00000143801.18. [P49810-1]"";""ENST00000679098.1; ENSP00000504303.1; ENSG00000143801.18. [P49810-1]"";","aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]",amyloid precursor protein catabolic process [GO:0042987]; amyloid-beta formation [GO:0034205]; calcium ion homeostasis [GO:0055074]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; regulation of calcium import into the mitochondrion [GO:0110097]; response to hypoxia [GO:0001666],centrosome [GO:0005813]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synaptic vesicle [GO:0008021]
P25786,C1,1.210652307,0.461757782,-0.852205993,-0.957202369,0.150391301,lightblue,PSMA1,PSA1_HUMAN,Proteasome subunit alpha type-1 (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain),PSMA1 HC2 NU PROS30 PSC2,5682;,"ENST00000396394.7; ENSP00000379676.2; ENSG00000129084.18. [P25786-1];""ENST00000418988.2; ENSP00000414359.2; ENSG00000129084.18. [P25786-2]"";",lipopolysaccharide binding [GO:0001530],immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"
P25788,C1,1.324348067,0.468317179,-0.772728246,-0.859416558,0.260700449,lightblue,PSMA3,PSA3_HUMAN,Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8),PSMA3 HC8 PSC8,5684;,"ENST00000216455.9; ENSP00000216455.4; ENSG00000100567.13. [P25788-1];""ENST00000412908.6; ENSP00000390491.2; ENSG00000100567.13. [P25788-2]"";",ubiquitin protein ligase binding [GO:0031625],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]"
P25789,C1,1.268804046,0.45627284,-0.878227565,-1.065205417,0.515431162,lightblue,PSMA4,PSA4_HUMAN,Proteasome subunit alpha type-4 (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L),PSMA4 HC9 PSC9,5685;,"ENST00000044462.12; ENSP00000044462.7; ENSG00000041357.16. [P25789-1];""ENST00000413382.6; ENSP00000402118.2; ENSG00000041357.16. [P25789-2]"";""ENST00000559082.5; ENSP00000453887.1; ENSG00000041357.16. [P25789-1]"";",0,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"
P28066,C1,1.246593994,0.425971919,-0.728054435,-0.8756153,0.190631103,lightblue,PSMA5,PSA5_HUMAN,Proteasome subunit alpha type-5 (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain),PSMA5,5686;,"ENST00000271308.9; ENSP00000271308.4; ENSG00000143106.13. [P28066-1];""ENST00000538610.5; ENSP00000440618.1; ENSG00000143106.13. [P28066-2]"";",0,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]"
P60900,C1,1.163485349,0.508616786,-0.743828616,-0.908408287,0.298406456,lightblue,PSMA6,PSA6_HUMAN,Proteasome subunit alpha type-6 (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain),PSMA6 PROS27,5687;,"ENST00000261479.9; ENSP00000261479.4; ENSG00000100902.11. [P60900-1];""ENST00000540871.5; ENSP00000444844.1; ENSG00000100902.11. [P60900-2]"";""ENST00000555764.5; ENSP00000452566.1; ENSG00000100902.11. [P60900-3]"";""ENST00000622405.4; ENSP00000479620.1; ENSG00000100902.11. [P60900-3]"";",endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; purine ribonucleoside triphosphate binding [GO:0035639]; RNA binding [GO:0003723],positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of inflammatory response [GO:0050727],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; ribosome [GO:0005840]; sarcomere [GO:0030017]"
O14818,C1,1.432324802,0.529226036,-0.72251453,-1.02752081,0.092049908,lightblue,PSMA7,PSA7_HUMAN,Proteasome subunit alpha type-7 (Proteasome subunit RC6-1) (Proteasome subunit XAPC7),PSMA7 HSPC,5688;,"ENST00000370858.3; ENSP00000359895.3; ENSG00000101182.15. [O14818-4];""ENST00000370861.1; ENSP00000359898.1; ENSG00000101182.15. [O14818-2]"";""ENST00000370873.9; ENSP00000359910.4; ENSG00000101182.15. [O14818-1]"";",identical protein binding [GO:0042802],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]"
P49721,C1,1.178191314,0.480383787,-0.785364409,-0.951698887,0.509305823,lightblue,PSMB2,PSB2_HUMAN,Proteasome subunit beta type-2 (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I),PSMB2,5690;,ENST00000373237.4; ENSP00000362334.3; ENSG00000126067.12.;,0,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"
P28070,C1,1.007858198,0.329742087,-0.628640573,-0.618117496,0.510596059,lightblue,PSMB4,PSB4_HUMAN,Proteasome subunit beta type-4 (26 kDa prosomal protein) (HsBPROS26) (PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (HsN3),PSMB4 PROS26,5692;,ENST00000290541.7; ENSP00000290541.6; ENSG00000159377.11.;,lipopolysaccharide binding [GO:0001530],negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"
P28074,C1,1.11772504,0.373924409,-0.795346832,-0.750172699,0.471610077,lightblue,PSMB5,PSB5_HUMAN,Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit MB1) (Proteasome subunit X),PSMB5 LMPX MB1 X,5693;,"ENST00000361611.11; ENSP00000355325.6; ENSG00000100804.19. [P28074-1];""ENST00000425762.2; ENSP00000395206.2; ENSG00000100804.19. [P28074-3]"";""ENST00000493471.2; ENSP00000452424.1; ENSG00000100804.19. [P28074-2]"";",endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; threonine-type endopeptidase activity [GO:0004298],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508]; response to oxidative stress [GO:0006979],"centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]"
Q99436,C1,1.311606293,0.449452229,-0.74891355,-0.783633514,0.200667446,lightblue,PSMB7,PSB7_HUMAN,Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z),PSMB7 Z,5695;,ENST00000259457.8; ENSP00000259457.3; ENSG00000136930.13. [Q99436-1];,endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]; secretory granule lumen [GO:0034774]"
P62191,C1,0.944271986,0.212627778,-0.52748836,-0.545720747,0.577240297,lightblue,PSMC1,PRS4_HUMAN,26S proteasome regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1),PSMC1,5700;,"ENST00000261303.13; ENSP00000261303.8; ENSG00000100764.14. [P62191-1];""ENST00000543772.2; ENSP00000445147.2; ENSG00000100764.14. [P62191-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402]; RNA binding [GO:0003723],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"
P35998,C1,0.856502314,0.221884116,-0.589101681,-0.627021126,0.62889712,lightblue,PSMC2,PRS7_HUMAN,26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2),PSMC2 MSS1,5701;,"ENST00000292644.5; ENSP00000292644.3; ENSG00000161057.13. [P35998-1];""ENST00000435765.5; ENSP00000391211.1; ENSG00000161057.13. [P35998-1]"";""ENST00000678493.1; ENSP00000502939.1; ENSG00000161057.13. [P35998-1]"";""ENST00000679205.1; ENSP00000503179.1; ENSG00000161057.13. [P35998-1]"";""ENST00000679250.1; ENSP00000503663.1; ENSG00000161057.13. [P35998-2]"";""ENST00000679341.1; ENSP00000504608.1; ENSG00000161057.13. [P35998-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402],osteoblast differentiation [GO:0001649]; positive regulation of proteasomal protein catabolic process [GO:1901800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]"
P17980,C1,0.968036584,0.386744533,-0.66727633,-0.818275544,0.462127689,lightblue,PSMC3,PRS6A_HUMAN,26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1),PSMC3 TBP1,5702;,"ENST00000298852.8; ENSP00000298852.3; ENSG00000165916.9.;""ENST00000619920.4; ENSP00000481029.1; ENSG00000165916.9."";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402],modulation by host of viral transcription [GO:0043921]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; secretory granule lumen [GO:0034774]"
P43686,C1,0.905989591,0.364464738,-0.55650063,-0.669298577,0.645386514,lightblue,PSMC4,PRS6B_HUMAN,26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (MB67-interacting protein) (MIP224) (Proteasome 26S subunit ATPase 4) (Tat-binding protein 7) (TBP-7),PSMC4 MIP224 TBP7,5704;,"ENST00000157812.7; ENSP00000157812.1; ENSG00000013275.8. [P43686-1];""ENST00000455878.2; ENSP00000413869.1; ENSG00000013275.8. [P43686-2]"";""ENST00000629691.3; ENSP00000487367.1; ENSG00000281221.3. [P43686-1]"";""ENST00000630857.1; ENSP00000485851.1; ENSG00000281221.3. [P43686-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402],blastocyst development [GO:0001824]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis [GO:0006508],"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]; synapse [GO:0045202]"
P62195,C1,0.809294963,0.315265063,-0.526988673,-0.557955669,0.658826442,lightblue,PSMC5,PRS8_HUMAN,26S proteasome regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG),PSMC5 SUG1,5705;,"ENST00000310144.11; ENSP00000310572.6; ENSG00000087191.14. [P62195-1];""ENST00000375812.8; ENSP00000364970.4; ENSG00000087191.14. [P62195-2]"";""ENST00000580864.5; ENSP00000462495.1; ENSG00000087191.14. [P62195-2]"";""ENST00000581882.5; ENSP00000463938.1; ENSG00000087191.14. [P62195-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; general transcription initiation factor binding [GO:0140296]; proteasome-activating activity [GO:0036402]; thyrotropin-releasing hormone receptor binding [GO:0031531]; transcription factor binding [GO:0008134],negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of programmed cell death [GO:0043069]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteasomal protein catabolic process [GO:1901800]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of transcription by RNA polymerase II [GO:0006357],"blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]"
Q99460,C1,0.899668562,0.246448025,-0.611891683,-0.702202999,0.786430203,lightblue,PSMD1,PSMD1_HUMAN,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112),PSMD1,5707;,"ENST00000308696.11; ENSP00000309474.6; ENSG00000173692.14. [Q99460-1];""ENST00000373635.9; ENSP00000362738.4; ENSG00000173692.14. [Q99460-2]"";""ENST00000677230.1; ENSP00000503068.1; ENSG00000173692.14. [Q99460-1]"";",enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],"azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]"
O00231,C1,1.030594073,0.232184789,-0.605760407,-0.701905246,0.662049753,lightblue,PSMD11,PSD11_HUMAN,26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5),PSMD11,5717;,"ENST00000261712.8; ENSP00000261712.3; ENSG00000108671.11. [O00231-1];""ENST00000457654.6; ENSP00000393185.2; ENSG00000108671.11. [O00231-1]"";""ENST00000649012.1; ENSP00000497128.1; ENSG00000108671.11. [O00231-1]"";",structural molecule activity [GO:0005198],proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"
O00232,C1,0.833436855,0.128103302,-0.454803177,-0.558832506,0.743581857,lightblue,PSMD12,PSD12_HUMAN,26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55),PSMD12,5718;,"ENST00000356126.8; ENSP00000348442.3; ENSG00000197170.10. [O00232-1];""ENST00000357146.4; ENSP00000349667.4; ENSG00000197170.10. [O00232-2]"";",0,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"
Q9UNM6,C1,0.898033953,0.217661336,-0.489848684,-0.573306612,0.609121045,lightblue,PSMD13,PSD13_HUMAN,26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5),PSMD13,5719;,"ENST00000431206.6; ENSP00000396937.2; ENSG00000185627.19. [Q9UNM6-2];""ENST00000532097.6; ENSP00000436186.1; ENSG00000185627.19. [Q9UNM6-1]"";",structural molecule activity [GO:0005198],meiosis I [GO:0007127]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"
O00487,C1,0.971196715,0.226477326,-0.438614663,-0.559914355,0.555695711,lightblue,PSMD14,PSDE_HUMAN,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1),PSMD14 POH1,10213;,ENST00000409682.8; ENSP00000386541.3; ENSG00000115233.12.;,endopeptidase activator activity [GO:0061133]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628],double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"
Q13200,C1,1.253003267,0.197797652,-0.695993102,-0.701041444,0.52065425,lightblue,PSMD2,PSMD2_HUMAN,26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2),PSMD2 TRAP2,5708;,"ENST00000310118.9; ENSP00000310129.4; ENSG00000175166.17. [Q13200-1];""ENST00000435761.5; ENSP00000402618.1; ENSG00000175166.17. [Q13200-2]"";""ENST00000439383.5; ENSP00000416028.1; ENSG00000175166.17. [Q13200-3]"";",enzyme regulator activity [GO:0030234],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]"
O43242,C1,0.984982987,0.24035386,-0.630200124,-0.669137087,0.71562427,lightblue,PSMD3,PSMD3_HUMAN,26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58),PSMD3,5709;,ENST00000264639.9; ENSP00000264639.4; ENSG00000108344.15. [O43242-1];,enzyme regulator activity [GO:0030234],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]"
P51665,C1,0.794922763,0.196449567,-0.393521587,-0.38892291,0.62572906,lightblue,PSMD7,PSMD7_HUMAN,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),PSMD7 MOV34L,5713;,ENST00000219313.9; ENSP00000219313.4; ENSG00000103035.11.;,protein homodimerization activity [GO:0042803],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]
P48556,C1,0.899816501,0.140695975,-0.517749319,-0.527915598,0.770361621,lightblue,PSMD8,PSMD8_HUMAN,26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31),PSMD8,5714;,ENST00000215071.9; ENSP00000215071.4; ENSG00000099341.13.;,0,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]"
O00233,C5,1.80883088,0.327128322,-0.77379034,-0.865491895,-0.988726222,turquoise3,PSMD9,PSMD9_HUMAN,26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27),PSMD9,5715;,"ENST00000537407.5; ENSP00000445058.1; ENSG00000110801.14. [O00233-2];""ENST00000541212.6; ENSP00000440485.1; ENSG00000110801.14. [O00233-1]"";""ENST00000542602.1; ENSP00000443772.1; ENSG00000110801.14. [O00233-3]"";",bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713],negative regulation of insulin secretion [GO:0046676]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion [GO:0032024]; proteasome regulatory particle assembly [GO:0070682]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838]
Q14997,C1,1.017596023,0.53080699,-0.838014615,-0.991293169,0.541122082,lightblue,PSME4,PSME4_HUMAN,Proteasome activator complex subunit 4 (Proteasome activator PA200),PSME4 KIAA0077,23198;,ENST00000404125.6; ENSP00000384211.1; ENSG00000068878.15. [Q14997-1];,lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628],DNA damage response [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; sperm DNA condensation [GO:0035092],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]
O95456,C5,1.616257999,0.59163096,-0.777364517,-1.110210399,-0.828730863,turquoise3,PSMG1,PSMG1_HUMAN,Proteasome assembly chaperone 1 (PAC-1) (Chromosome 21 leucine-rich protein) (C21-LRP) (Down syndrome critical region protein 2),PSMG1 C21LRP DSCR2 PAC1,8624;,"ENST00000331573.8; ENSP00000329915.3; ENSG00000183527.12. [O95456-1];""ENST00000380900.2; ENSP00000370286.2; ENSG00000183527.12. [O95456-2]"";",molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628],cerebellar granule cell precursor proliferation [GO:0021930]; chaperone-mediated protein complex assembly [GO:0051131]; proteasome core complex assembly [GO:0080129],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]
Q5JS54,C5,1.510484477,0.842985226,-0.794181549,-1.202452893,-1.129830724,turquoise3,PSMG4,PSMG4_HUMAN,Proteasome assembly chaperone 4 (PAC-4) (hPAC4),PSMG4 C6orf86 PAC4,389362;,"ENST00000419065.6; ENSP00000392353.2; ENSG00000180822.12. [Q5JS54-2];""ENST00000438998.7; ENSP00000413353.3; ENSG00000180822.12. [Q5JS54-1]"";""ENST00000473000.2; ENSP00000418241.2; ENSG00000180822.12. [Q5JS54-3]"";",protein-containing complex binding [GO:0044877],proteasome assembly [GO:0043248],protein-containing complex [GO:0032991]
Q8WXF1,N4,-0.927395861,1.202386557,0.289413342,-0.581998616,-0.691907042,grey30,PSPC1,PSPC1_HUMAN,Paraspeckle component 1 (Paraspeckle protein 1),PSPC1 PSP1,55269;,"ENST00000338910.9; ENSP00000343966.4; ENSG00000121390.19. [Q8WXF1-1];""ENST00000471658.5; ENSP00000436038.1; ENSG00000121390.19. [Q8WXF1-2]"";""ENST00000492741.5; ENSP00000435921.1; ENSG00000121390.19. [Q8WXF1-2]"";""ENST00000619300.4; ENSP00000481916.1; ENSG00000121390.19. [Q8WXF1-1]"";",RNA binding [GO:0003723],activation of innate immune response [GO:0002218]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; non-membrane-bounded organelle assembly [GO:0140694]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]
Q8WV60,M1,-1.493177797,-0.761557649,0.478244114,0.942059568,0.003271496,burlywood4,PTCD2,PTCD2_HUMAN,"Pentatricopeptide repeat-containing protein 2, mitochondrial",PTCD2,79810;,"ENST00000308077.9; ENSP00000308948.5; ENSG00000049883.15. [Q8WV60-1];""ENST00000380639.10; ENSP00000370013.4; ENSG00000049883.15. [Q8WV60-1]"";""ENST00000503868.5; ENSP00000427349.1; ENSG00000049883.15. [Q8WV60-3]"";""ENST00000536805.5; ENSP00000444772.1; ENSG00000049883.15. [Q8WV60-2]"";",RNA binding [GO:0003723],kidney development [GO:0001822]; liver development [GO:0001889]; mitochondrion organization [GO:0007005]; mRNA processing [GO:0006397]; muscle cell development [GO:0055001]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; ventricular cardiac muscle tissue morphogenesis [GO:0055010],mitochondrion [GO:0005739]
P48651,S2,-1.316704967,-1.350015118,0.13498267,1.001458635,0.431561422,orange,PTDSS1,PTSS1_HUMAN,Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I),PTDSS1 KIAA0024 PSSA,9791;,"ENST00000517309.6; ENSP00000430548.1; ENSG00000156471.13. [P48651-1];""ENST00000522072.1; ENSP00000430928.1; ENSG00000156471.13. [P48651-3]"";",L-serine-phosphatidylcholine phosphatidyltransferase activity [GO:0106258]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740],phosphatidylserine biosynthetic process [GO:0006659],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9BVG9,S2,-1.37835977,-1.717090146,0.214141979,0.829964129,0.47144016,orange,PTDSS2,PTSS2_HUMAN,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),PTDSS2 PSS2,81490;,ENST00000308020.6; ENSP00000308258.5; ENSG00000174915.12.;,CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245]; transferase activity [GO:0016740],phosphatidylserine biosynthetic process [GO:0006659],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9H7Z7,M1,-0.886149857,-0.334714868,0.381432013,0.80132501,-0.0540474,burlywood4,PTGES2,PGES2_HUMAN,Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) (Prostaglandin-H(2) E-isomerase) [Cleaved into: Prostaglandin E synthase 2 truncated form],PTGES2 C9orf15 PGES2,80142;,ENST00000338961.11; ENSP00000345341.6; ENSG00000148334.16.;,12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; DNA binding [GO:0003677]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220],cyclooxygenase pathway [GO:0019371]; lipid metabolic process [GO:0006629]; positive regulation of DNA-templated transcription [GO:0045893]; secretion [GO:0046903],azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q15185,C5,1.789693746,0.667239444,-0.758798368,-0.958075437,-1.097507674,turquoise3,PTGES3,TEBP_HUMAN,Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23),PTGES3 P23 TEBP,10728;,"ENST00000262033.11; ENSP00000262033.6; ENSG00000110958.16. [Q15185-1];""ENST00000414274.7; ENSP00000405299.3; ENSG00000110958.16. [Q15185-3]"";""ENST00000436399.6; ENSP00000402385.2; ENSG00000110958.16. [Q15185-2]"";""ENST00000448157.6; ENSP00000414892.2; ENSG00000110958.16. [Q15185-4]"";",DNA polymerase binding [GO:0070182]; Hsp90 protein binding [GO:0051879]; prostaglandin-E synthase activity [GO:0050220]; protein-folding chaperone binding [GO:0051087]; telomerase activity [GO:0003720]; unfolded protein binding [GO:0051082],chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein complex assembly [GO:0051131]; cyclooxygenase pathway [GO:0019371]; fibroblast proliferation [GO:0048144]; glucocorticoid receptor signaling pathway [GO:0042921]; glycogen biosynthetic process [GO:0005978]; lung saccule development [GO:0060430]; positive regulation of phosphorylation [GO:0042327]; positive regulation of telomerase activity [GO:0051973]; prostaglandin biosynthetic process [GO:0001516]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; signal transduction [GO:0007165]; skin development [GO:0043588]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004],"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; telomerase holoenzyme complex [GO:0005697]"
Q9P2B2,S4,-0.763348273,-1.333631282,0.300832229,0.834732914,0.395675421,tomato2,PTGFRN,FPRP_HUMAN,Prostaglandin F2 receptor negative regulator (CD9 partner 1) (CD9P-1) (Glu-Trp-Ile EWI motif-containing protein F) (EWI-F) (Prostaglandin F2-alpha receptor regulatory protein) (Prostaglandin F2-alpha receptor-associated protein) (CD antigen CD315),PTGFRN CD9P1 EWIF FPRP KIAA1436,5738;,ENST00000393203.3; ENSP00000376899.2; ENSG00000134247.10.;,0,lipid droplet organization [GO:0034389]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905],cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]
Q14914,C4,2.097500141,0.258587615,-1.048831467,-1.042805686,-1.188008847,deepskyblue2,PTGR1,PTGR1_HUMAN,Prostaglandin reductase 1 (PRG-1) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (Dithiolethione-inducible gene 1 protein) (D3T-inducible gene 1 protein) (DIG-1) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase) (EC 1.3.1.74),PTGR1 LTB4DH,22949;,"ENST00000309195.9; ENSP00000311572.5; ENSG00000106853.20. [Q14914-1];""ENST00000407693.7; ENSP00000385763.2; ENSG00000106853.20. [Q14914-1]"";""ENST00000538962.7; ENSP00000440281.1; ENSG00000106853.20. [Q14914-2]"";",13-lipoxin reductase activity [GO:0036185]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase (NADPH) activity [GO:0035798]; leukotriene B4 12-hydroxy dehydrogenase activity [GO:0097257],leukotriene B4 metabolic process [GO:0036102]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; prostaglandin metabolic process [GO:0006693],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]
Q13308,S4,-1.064143201,-1.085448855,0.359415165,0.876153486,0.181996381,tomato2,PTK7,PTK7_HUMAN,Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7),PTK7 CCK4,5754;,"ENST00000230418.8; ENSP00000230418.4; ENSG00000112655.16. [Q13308-5];""ENST00000230419.9; ENSP00000230419.4; ENSG00000112655.16. [Q13308-1]"";""ENST00000345201.6; ENSP00000325992.4; ENSG00000112655.16. [Q13308-2]"";""ENST00000349241.6; ENSP00000325462.4; ENSG00000112655.16. [Q13308-3]"";""ENST00000352931.6; ENSP00000326029.3; ENSG00000112655.16. [Q13308-4]"";""ENST00000481273.5; ENSP00000418754.1; ENSG00000112655.16. [Q13308-6]"";",ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; coreceptor activity [GO:0015026]; protein kinase activity [GO:0004672],actin cytoskeleton organization [GO:0030036]; axis elongation [GO:0003401]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; convergent extension [GO:0060026]; coronary vasculature development [GO:0060976]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; kidney development [GO:0001822]; lung-associated mesenchyme development [GO:0060484]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neuron projection development [GO:0010976]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; ventricular septum development [GO:0003281]; wound healing [GO:0042060],axon [GO:0030424]; cell-cell junction [GO:0005911]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]
Q12974,C2,0.92309724,0.509931414,-0.150317343,1.42E-04,-0.53861183,aquamarine,PTP4A2,TP4A2_HUMAN,Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2),PTP4A2 PRL2 PTPCAAX2 BM-008,8073;,"ENST00000457805.6; ENSP00000409260.2; ENSG00000184007.22. [Q12974-3];""ENST00000602683.5; ENSP00000473490.1; ENSG00000184007.22. [Q12974-4]"";""ENST00000602725.5; ENSP00000473259.1; ENSG00000184007.22. [Q12974-1]"";""ENST00000647444.2; ENSP00000493688.1; ENSG00000184007.22. [Q12974-1]"";""ENST00000649841.1; ENSP00000497092.1; ENSG00000184007.22. [Q12974-1]"";",prenylated protein tyrosine phosphatase activity [GO:0004727]; protein tyrosine phosphatase activity [GO:0004725],0,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
B0YJ81,S2,-0.5805729,-1.015361009,0.120909035,0.858961766,0.557549263,orange,PTPLA,HACD1_HUMAN,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 1) (HACD1) (Cementum-attachment protein) (CAP) (Protein-tyrosine phosphatase-like member A),HACD1 PTPLA,9200;,ENST00000361271.8; ENSP00000355308.3; ENSG00000165996.14. [B0YJ81-1];,3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; hydroxyapatite binding [GO:0046848]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158],cementum mineralization [GO:0071529]; fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; positive regulation of cell-substrate adhesion [GO:0010811]; protein-containing complex assembly [GO:0065003]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q9P035,S2,-0.986355432,-1.251371694,0.330635042,0.742879697,0.461838431,orange,PTPLAD1,HACD3_HUMAN,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (hB-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1),HACD3 BIND1 PTPLAD1,51495;,"ENST00000261875.10; ENSP00000261875.5; ENSG00000074696.13. [Q9P035-1];""ENST00000442729.6; ENSP00000392491.2; ENSG00000074696.13. [Q9P035-2]"";",3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158],canonical NF-kappaB signal transduction [GO:0007249]; fatty acid elongation [GO:0030497]; JNK cascade [GO:0007254]; negative regulation of intracellular signal transduction [GO:1902532]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of viral genome replication [GO:0045070]; Rac protein signal transduction [GO:0016601]; Rho protein signal transduction [GO:0007266]; small GTPase-mediated signal transduction [GO:0007264]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; nuclear membrane [GO:0031965]
Q8WUK0,M2,-1.190913388,-1.1689623,0.372298093,1.085809007,0.072575029,tan4,PTPMT1,PTPM1_HUMAN,"Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1) (EC 3.1.3.16, EC 3.1.3.48)",PTPMT1 MOSP PLIP PNAS-129,114971;,"ENST00000326656.12; ENSP00000325882.8; ENSG00000110536.14. [Q8WUK0-2];""ENST00000326674.10; ENSP00000325958.9; ENSG00000110536.14. [Q8WUK0-1]"";""ENST00000426530.2; ENSP00000410272.2; ENSG00000110536.14. [Q8WUK0-3]"";","myosin phosphatase activity [GO:0017018]; phosphatidylglycerophosphatase activity [GO:0008962]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]",cardiolipin biosynthetic process [GO:0032049]; regulation of intrinsic apoptotic signaling pathway [GO:2001242],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
P18031,S2,-1.188950847,-1.341330325,0.183129603,0.930297191,0.54412971,orange,PTPN1,PTN1_HUMAN,Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B),PTPN1 PTP1B,5770;,ENST00000371621.5; ENSP00000360683.3; ENSG00000196396.10.;,cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],actin cytoskeleton organization [GO:0030036]; cellular response to unfolded protein [GO:0034620]; endoplasmic reticulum unfolded protein response [GO:0030968]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; insulin receptor recycling [GO:0038020]; insulin receptor signaling pathway [GO:0008286]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of signal transduction [GO:0009968]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; positive regulation of IRE1-mediated unfolded protein response [GO:1903896]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor catabolic process [GO:2000646]; protein dephosphorylation [GO:0006470]; regulation of endocytosis [GO:0030100]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of intracellular protein transport [GO:0033157]; regulation of signal transduction [GO:0009966]; regulation of type I interferon-mediated signaling pathway [GO:0060338],cytoplasm [GO:0005737]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; mitochondrial crista [GO:0030061]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; sorting endosome [GO:0097443]
Q06124,C3,1.592901231,0.140784958,-0.516097439,-0.474785045,-0.755598615,cyan,PTPN11,PTN11_HUMAN,Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3),PTPN11 PTP2C SHPTP2,5781;,"ENST00000351677.7; ENSP00000340944.3; ENSG00000179295.19. [Q06124-2];""ENST00000392597.5; ENSP00000376376.1; ENSG00000179295.19. [Q06124-3]"";""ENST00000635625.1; ENSP00000489597.1; ENSG00000179295.19. [Q06124-1]"";",cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; molecular adaptor activity [GO:0060090]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159],atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; negative regulation of type I interferon production [GO:0032480]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q05209,C3,1.849699694,-0.109984332,-0.710002431,-0.635755267,-0.905932531,cyan,PTPN12,PTN12_HUMAN,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),PTPN12,5782;,"ENST00000248594.11; ENSP00000248594.6; ENSG00000127947.16. [Q05209-1];""ENST00000415482.6; ENSP00000392429.2; ENSG00000127947.16. [Q05209-3]"";""ENST00000435495.6; ENSP00000397991.2; ENSG00000127947.16. [Q05209-2]"";",non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124],cellular response to epidermal growth factor stimulus [GO:0071364]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]
Q12923,S3,-0.255759573,-0.456915611,0.242675453,0.593762338,0.309889402,salmon,PTPN13,PTN13_HUMAN,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1),PTPN13 PNP1 PTP1E PTPL1,5783;,"ENST00000316707.10; ENSP00000322675.6; ENSG00000163629.13. [Q12923-2];""ENST00000411767.7; ENSP00000407249.2; ENSG00000163629.13. [Q12923-1]"";""ENST00000427191.6; ENSP00000408368.2; ENSG00000163629.13. [Q12923-3]"";""ENST00000436978.5; ENSP00000394794.1; ENSG00000163629.13. [Q12923-4]"";""ENST00000511467.1; ENSP00000426626.1; ENSG00000163629.13. [Q12923-4]"";",phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein tyrosine phosphatase activity [GO:0004725],cellular response to toxic substance [GO:0097237]; negative regulation of excitatory synapse assembly [GO:1904890]; negative regulation of protein phosphorylation [GO:0001933]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P18433,S4,-0.908131888,-0.94770964,0.37770405,0.798920586,0.212217147,tomato2,PTPRA,PTPRA_HUMAN,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48),PTPRA PTPA PTPRL2,5786;,"ENST00000216877.10; ENSP00000216877.6; ENSG00000132670.21. [P18433-6];""ENST00000318266.9; ENSP00000314568.5; ENSG00000132670.21. [P18433-6]"";""ENST00000356147.3; ENSP00000348468.3; ENSG00000132670.21. [P18433-6]"";""ENST00000399903.7; ENSP00000382787.2; ENSG00000132670.21. [P18433-5]"";",protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],insulin receptor signaling pathway [GO:0008286]; integrin-mediated signaling pathway [GO:0007229]; modulation of chemical synaptic transmission [GO:0050804]; regulation of focal adhesion assembly [GO:0051893],extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]
P23469,S4,-0.611885552,-1.219630859,0.408086875,0.793374519,0.198871539,tomato2,PTPRE,PTPRE_HUMAN,Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48),PTPRE,5791;,"ENST00000254667.8; ENSP00000254667.3; ENSG00000132334.17. [P23469-1];""ENST00000306042.9; ENSP00000303350.5; ENSG00000132334.17. [P23469-2]"";",protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P10586,S3,-0.993501946,-0.527310355,0.337166293,0.823309957,0.183689457,salmon,PTPRF,PTPRF_HUMAN,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR),PTPRF LAR,5792;,"ENST00000359947.9; ENSP00000353030.4; ENSG00000142949.17. [P10586-1];""ENST00000438120.5; ENSP00000398822.1; ENSG00000142949.17. [P10586-2]"";",cell adhesion molecule binding [GO:0050839]; chondroitin sulfate proteoglycan binding [GO:0035373]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; protein-containing complex binding [GO:0044877]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; negative regulation of receptor binding [GO:1900121]; neuron projection regeneration [GO:0031102]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of axon regeneration [GO:0048679]; synaptic membrane adhesion [GO:0099560],extracellular exosome [GO:0070062]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]
Q12913,S1,-1.056096736,-1.147644131,0.150689338,0.546906746,0.890108558,gold,PTPRJ,PTPRJ_HUMAN,Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148),PTPRJ DEP1,5795;,"ENST00000418331.7; ENSP00000400010.2; ENSG00000149177.15. [Q12913-1];""ENST00000440289.6; ENSP00000409733.2; ENSG00000149177.15. [Q12913-2]"";",beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; mitogen-activated protein kinase binding [GO:0051019]; phosphatase activity [GO:0016791]; platelet-derived growth factor receptor binding [GO:0005161]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725],angiogenesis [GO:0001525]; B cell differentiation [GO:0030183]; blood coagulation [GO:0007596]; contact inhibition [GO:0060242]; cytokine-mediated signaling pathway [GO:0019221]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion [GO:0045785]; positive regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060369]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet activation [GO:0010572]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell adhesion [GO:0030155]; T cell receptor signaling pathway [GO:0050852]; vasculogenesis [GO:0001570],cell surface [GO:0009986]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; specific granule membrane [GO:0035579]
Q15262,S3,-0.959928317,-0.485972533,0.45632119,0.714730517,0.096796656,salmon,PTPRK,PTPRK_HUMAN,Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48),PTPRK PTPK,5796;,"ENST00000368213.9; ENSP00000357196.5; ENSG00000152894.15. [Q15262-3];""ENST00000368215.7; ENSP00000357198.3; ENSG00000152894.15. [Q15262-1]"";""ENST00000368226.9; ENSP00000357209.4; ENSG00000152894.15. [Q15262-2]"";""ENST00000532331.5; ENSP00000432973.1; ENSG00000152894.15. [Q15262-4]"";""ENST00000618215.3; ENSP00000484742.2; ENSG00000273993.4. [Q15262-3]"";""ENST00000618924.4; ENSP00000483766.2; ENSG00000273993.4. [Q15262-2]"";""ENST00000619256.4; ENSP00000477791.2; ENSG00000273993.4. [Q15262-4]"";""ENST00000628183.2; ENSP00000486442.1; ENSG00000273993.4. [Q15262-1]"";",beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],adherens junction [GO:0005912]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q13332,S3,-0.731475556,-0.503907825,0.306662024,0.806994132,0.242912895,salmon,PTPRS,PTPRS_HUMAN,Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma),PTPRS,5802;,"ENST00000262963.11; ENSP00000262963.8; ENSG00000105426.19. [Q13332-1];""ENST00000587303.5; ENSP00000467537.1; ENSG00000105426.19. [Q13332-1]"";""ENST00000588012.5; ENSP00000465443.1; ENSG00000105426.19. [Q13332-6]"";""ENST00000592099.5; ENSP00000467398.1; ENSG00000105426.19. [Q13332-7]"";",chondroitin sulfate binding [GO:0035374]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725],cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; establishment of endothelial intestinal barrier [GO:0090557]; hippocampus development [GO:0021766]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of neuron projection development [GO:0010977]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of postsynaptic density assembly [GO:0099151]; spinal cord development [GO:0021510]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537],axon [GO:0030424]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672]
Q9Y3E5,S2,-1.416128612,-1.586376992,0.203904297,0.945619996,0.406423311,orange,PTRH2,PTH2_HUMAN,"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)",PTRH2 BIT1 PTH2 CGI-147,51651;,"ENST00000393038.3; ENSP00000376758.2; ENSG00000141378.15.;""ENST00000470557.2; ENSP00000464327.1; ENSG00000141378.15."";",aminoacyl-tRNA hydrolase activity [GO:0004045],apoptotic process [GO:0006915]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q6GMV3,C1,1.717600721,0.221746681,-0.557696998,-0.361550545,-0.729473148,lightblue,PTRHD1,PTRD1_HUMAN,Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1),PTRHD1 C2orf79,391356;,ENST00000328379.6; ENSP00000330389.4; ENSG00000184924.6.;,aminoacyl-tRNA hydrolase activity [GO:0004045],0,0
P53801,S1,-1.444647222,-1.826061499,-0.169489384,1.051976284,0.801134343,gold,PTTG1IP,PTTG_HUMAN,Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor) (PBF) (PTTG-binding factor),PTTG1IP C21orf1 C21orf3,754;,ENST00000330938.8; ENSP00000328325.3; ENSG00000183255.12.;,p53 binding [GO:0002039],"negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of protein ubiquitination [GO:0031398]; protein import into nucleus [GO:0006606]",cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BZE2,N4,0.392203076,1.316287533,-0.514451337,-0.713905567,-0.731184652,grey30,PUS3,PUS3_HUMAN,tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3),PUS3 FKSG32,83480;,"ENST00000227474.8; ENSP00000227474.3; ENSG00000110060.9.;""ENST00000530811.5; ENSP00000432386.1; ENSG00000110060.9."";",pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(38/39) synthase activity [GO:0160154],mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q8N0Z8,S3,-1.2523406,-0.955576677,0.43132875,0.850633486,0.315887065,salmon,PUSL1,PUSL1_HUMAN,tRNA pseudouridine synthase-like 1 (EC 5.4.99.-) (tRNA pseudouridylate synthase-like 1) (tRNA-uridine isomerase-like 1),PUSL1,126789;,ENST00000379031.10; ENSP00000368318.5; ENSG00000169972.13. [Q8N0Z8-1];,pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029],tRNA pseudouridine synthesis [GO:0031119],intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]
P15151,S4,-0.851160577,-1.112430218,0.385525627,0.733554967,0.407548456,tomato2,PVR,PVR_HUMAN,Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155),PVR PVS,5817;,"ENST00000344956.8; ENSP00000340870.3; ENSG00000073008.16. [P15151-3];""ENST00000403059.8; ENSP00000385344.3; ENSG00000073008.16. [P15151-2]"";",cell adhesion molecule binding [GO:0050839]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618],heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; susceptibility to T cell mediated cytotoxicity [GO:0060370],adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q15269,N3,-1.112006652,-1.172440292,1.325718842,-0.233666187,-0.072415953,grey50,PWP2,PWP2_HUMAN,Periodic tryptophan protein 2 homolog,PWP2 PWP2H,5822;,ENST00000291576.12; ENSP00000291576.6; ENSG00000241945.8.;,RNA binding [GO:0003723],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]",nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]
Q96N64,N3,-1.230491033,-1.412180189,1.256665084,-0.216497805,0.184793166,grey50,PWWP2A,PWP2A_HUMAN,PWWP domain-containing protein 2A,PWWP2A KIAA1935 MST101,114825;,"ENST00000307063.9; ENSP00000305151.7; ENSG00000170234.13. [Q96N64-1];""ENST00000456329.7; ENSP00000390462.2; ENSG00000170234.13. [Q96N64-2]"";""ENST00000523662.1; ENSP00000428143.1; ENSG00000170234.13. [Q96N64-3]"";",chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NuRD complex binding [GO:0120325],chromatin remodeling [GO:0006338]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178],nucleus [GO:0005634]
P49023,C4,2.072508136,0.122132618,-0.859537658,-0.847707909,-1.349981035,deepskyblue2,PXN,PAXI_HUMAN,Paxillin,PXN,5829;,"ENST00000228307.11; ENSP00000228307.7; ENSG00000089159.17. [P49023-1];""ENST00000267257.11; ENSP00000267257.7; ENSG00000089159.17. [P49023-3]"";""ENST00000424649.6; ENSP00000391283.2; ENSG00000089159.17. [P49023-2]"";""ENST00000458477.6; ENSP00000395536.2; ENSG00000089159.17. [P49023-4]"";",beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; protein phosphatase binding [GO:0019903]; vinculin binding [GO:0017166],cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; endothelial cell migration [GO:0043542]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of stress fiber assembly [GO:0051496]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]
P32322,M1,-0.828697814,-0.227270833,0.443144746,0.783193008,-0.416149053,burlywood4,PYCR1,P5CR1_HUMAN,"Pyrroline-5-carboxylate reductase 1, mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2)",PYCR1,5831;,"ENST00000329875.13; ENSP00000328858.8; ENSG00000183010.17. [P32322-1];""ENST00000337943.9; ENSP00000336579.5; ENSG00000183010.17. [P32322-2]"";""ENST00000402252.6; ENSP00000384949.2; ENSG00000183010.17. [P32322-3]"";""ENST00000619204.4; ENSP00000479793.1; ENSG00000183010.17. [P32322-1]"";",identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735],cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q96C36,M1,-1.238925189,-0.203791461,0.471464545,0.911949745,-0.504486017,burlywood4,PYCR2,P5CR2_HUMAN,Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2),PYCR2,29920;,ENST00000343818.11; ENSP00000342502.6; ENSG00000143811.20.;,pyrroline-5-carboxylate reductase activity [GO:0004735],cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
P06737,C5,1.841624434,0.673126711,-1.042724825,-0.99146085,-0.324184046,turquoise3,PYGL,PYGL_HUMAN,"Glycogen phosphorylase, liver form (EC 2.4.1.1)",PYGL,5836;,"ENST00000216392.8; ENSP00000216392.7; ENSG00000100504.17. [P06737-1];""ENST00000544180.6; ENSP00000443787.1; ENSG00000100504.17. [P06737-2]"";",AMP binding [GO:0016208]; ATP binding [GO:0005524]; bile acid binding [GO:0032052]; glucose binding [GO:0005536]; glycogen phosphorylase activity [GO:0008184]; identical protein binding [GO:0042802]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; purine nucleobase binding [GO:0002060]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; vitamin binding [GO:0019842],5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; necroptotic process [GO:0070266]; response to bacterium [GO:0009617],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]
Q9BRQ0,N4,-0.337025786,1.506634766,-0.544981098,-0.926927598,-1.311600352,grey30,PYGO2,PYGO2_HUMAN,Pygopus homolog 2,PYGO2 PP7910,90780;,ENST00000368457.3; ENSP00000357442.2; ENSG00000163348.4.;,chromatin binding [GO:0003682]; histone acetyltransferase regulator activity [GO:0035034]; histone binding [GO:0042393]; metal ion binding [GO:0046872],brain development [GO:0007420]; canonical Wnt signaling pathway [GO:0060070]; developmental growth [GO:0048589]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; mammary gland development [GO:0030879]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; roof of mouth development [GO:0060021]; spermatid nucleus differentiation [GO:0007289],beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]
Q8WU10,C5,1.746438034,0.400005838,-0.710094144,-0.684019143,-1.075476498,turquoise3,PYROXD1,PYRD1_HUMAN,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-),PYROXD1,79912;,"ENST00000240651.14; ENSP00000240651.9; ENSG00000121350.16. [Q8WU10-1];""ENST00000538582.5; ENSP00000438505.1; ENSG00000121350.16. [Q8WU10-2]"";",flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],cellular response to oxidative stress [GO:0034599],nucleus [GO:0005634]; sarcomere [GO:0030017]
P09417,C5,1.767001289,0.271260577,-0.752936528,-0.54190226,-1.364517616,turquoise3,QDPR,DHPR_HUMAN,Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1),QDPR DHPR SDR33C1,5860;,"ENST00000281243.10; ENSP00000281243.5; ENSG00000151552.13. [P09417-1];""ENST00000428702.6; ENSP00000390944.2; ENSG00000151552.13. [P09417-2]"";","6,7-dihydropteridine reductase activity [GO:0004155]; electron transfer activity [GO:0009055]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]",amino acid metabolic process [GO:0006520]; dihydrobiopterin metabolic process [GO:0051066]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9NXS2,S3,-0.704615751,-0.921621947,0.16889789,0.71331776,0.741400191,salmon,QPCTL,QPCTL_HUMAN,Glutaminyl-peptide cyclotransferase-like protein (EC 2.3.2.5) (Golgi-resident glutaminyl-peptide cyclotransferase) (isoQC) (gQC),QPCTL,54814;,"ENST00000012049.10; ENSP00000012049.4; ENSG00000011478.13. [Q9NXS2-1];""ENST00000366382.8; ENSP00000387944.2; ENSG00000011478.13. [Q9NXS2-3]"";",glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270],"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]",Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q2KHR3,N4,-0.858676001,1.034384511,-0.067345013,-0.029822124,-0.354836247,grey30,QSER1,QSER1_HUMAN,Glutamine and serine-rich protein 1,QSER1,79832;,0,0,0,chromosome [GO:0005694]
O00391,S3,-0.760401646,-0.644571002,0.10436729,0.592872167,0.716795862,salmon,QSOX1,QSOX1_HUMAN,Sulfhydryl oxidase 1 (hQSOX) (EC 1.8.3.2) (Quiescin Q6),QSOX1 QSCN6 UNQ2520/PRO6013,5768;,"ENST00000367600.5; ENSP00000356572.5; ENSG00000116260.17. [O00391-2];""ENST00000367602.8; ENSP00000356574.3; ENSG00000116260.17. [O00391-1]"";",FAD binding [GO:0071949]; flavin-dependent sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756],extracellular matrix assembly [GO:0085029]; negative regulation of macroautophagy [GO:0016242]; protein folding [GO:0006457],endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]
Q6ZRP7,S1,-0.849598332,-1.342640373,-0.191045704,0.802121449,0.873713941,gold,QSOX2,QSOX2_HUMAN,Sulfhydryl oxidase 2 (EC 1.8.3.2) (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1),QSOX2 QSCN6L1 SOXN,169714;,ENST00000358701.10; ENSP00000351536.5; ENSG00000165661.18.;,flavin-dependent sulfhydryl oxidase activity [GO:0016971]; protein disulfide isomerase activity [GO:0003756],protein folding [GO:0006457],extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q9BXR0,C1,1.472207722,0.479974594,-0.434784828,-0.103544086,-1.025145528,lightblue,QTRT1,TGT_HUMAN,Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.64) (Guanine insertion enzyme) (tRNA-guanine transglycosylase),QTRT1 TGT TGUT,81890;,"ENST00000250237.10; ENSP00000250237.4; ENSG00000213339.9. [Q9BXR0-1];""ENST00000421333.6; ENSP00000389126.2; ENSG00000213339.9. [Q9BXR0-2]"";",metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479],tRNA modification [GO:0006400]; tRNA-guanine transglycosylation [GO:0101030],mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]
Q9H974,C1,1.243745457,0.448550197,-0.237463028,0.011003888,-0.909946184,lightblue,QTRTD1,QTRT2_HUMAN,Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1),QTRT2 QTRTD1,79691;,"ENST00000281273.8; ENSP00000281273.4; ENSG00000151576.10. [Q9H974-1];""ENST00000479882.5; ENSP00000418056.1; ENSG00000151576.10. [Q9H974-2]"";""ENST00000485050.5; ENSP00000420682.1; ENSG00000151576.10. [Q9H974-4]"";""ENST00000493014.1; ENSP00000419169.1; ENSG00000151576.10. [Q9H974-3]"";",metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479],tRNA-guanine transglycosylation [GO:0101030],cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234]
Q9Y3T6,C1,1.374290352,0.043491324,-0.485081183,-0.407049254,0.16027991,lightblue,R3HCC1,R3HC1_HUMAN,R3H and coiled-coil domain-containing protein 1,R3HCC1,203069;,"ENST00000265806.12; ENSP00000265806.8; ENSG00000104679.12. [Q9Y3T6-1];""ENST00000625275.3; ENSP00000486278.2; ENSG00000104679.12. [Q9Y3T6-3]"";",nucleic acid binding [GO:0003676],0,0
Q9Y2K5,C2,1.308303231,0.509097451,-0.516531278,-0.573379552,-0.079182183,aquamarine,R3HDM2,R3HD2_HUMAN,R3H domain-containing protein 2,R3HDM2 KIAA1002,22864;,"ENST00000347140.7; ENSP00000317903.6; ENSG00000179912.21. [Q9Y2K5-1];""ENST00000358907.6; ENSP00000351784.2; ENSG00000179912.21. [Q9Y2K5-1]"";""ENST00000441731.6; ENSP00000408536.2; ENSG00000179912.21. [Q9Y2K5-3]"";",RNA binding [GO:0003723],0,nucleus [GO:0005634]
P61026,S2,-0.690938589,-1.438799562,0.235476166,0.82869365,0.633907568,orange,RAB10,RAB10_HUMAN,Ras-related protein Rab-10 (EC 3.6.5.2),RAB10,10890;,ENST00000264710.5; ENSP00000264710.4; ENSG00000084733.11.;,cadherin binding involved in cell-cell adhesion [GO:0098641]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; myosin V binding [GO:0031489],antigen processing and presentation [GO:0019882]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; establishment of protein localization to membrane [GO:0090150]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulated exocytosis [GO:0045055]; vesicle-mediated transport [GO:0016192],adherens junction [GO:0005912]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; endosome membrane [GO:0010008]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802]
P62491,S1,-0.632754846,-0.879553407,-0.018664666,0.4062074,0.96204966,gold,RAB11A,RB11A_HUMAN,Ras-related protein Rab-11A (Rab-11) (EC 3.6.5.2) (YL8),RAB11A RAB11,8766;,"ENST00000261890.7; ENSP00000261890.2; ENSG00000103769.10. [P62491-1];""ENST00000569896.1; ENSP00000456420.1; ENSG00000103769.10. [P62491-2]"";",dynein light intermediate chain binding [GO:0051959]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; syntaxin binding [GO:0019905],"amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; early endosome to recycling endosome transport [GO:0061502]; establishment of protein localization to membrane [GO:0090150]; establishment of protein localization to organelle [GO:0072594]; establishment of vesicle localization [GO:0051650]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; Golgi to plasma membrane protein transport [GO:0043001]; melanosome transport [GO:0032402]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; plasma membrane to endosome transport [GO:0048227]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein localization to cell surface [GO:0034394]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein transmembrane transport [GO:0071806]; regulation of cilium assembly [GO:1902017]; regulation of cytokinesis [GO:0032465]; regulation of early endosome to recycling endosome transport [GO:1902954]; regulation of endocytic recycling [GO:2001135]; regulation of multivesicular body size [GO:0010796]; regulation of protein localization to centrosome [GO:1904779]; regulation of vesicle-mediated transport [GO:0060627]; vesicle-mediated transport [GO:0016192]",centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]; vesicle [GO:0031982]
Q9BXF6,S1,-0.925690614,-0.253165768,0.053999271,0.287182719,0.943545484,gold,RAB11FIP5,RFIP5_HUMAN,Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11),RAB11FIP5 GAF1 KIAA0857 RIP11,26056;,ENST00000258098.6; ENSP00000258098.6; ENSG00000135631.17.;,gamma-tubulin binding [GO:0043015]; small GTPase binding [GO:0031267],cellular response to acidic pH [GO:0071468]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; negative regulation of adiponectin secretion [GO:0070164]; regulated exocytosis [GO:0045055]; regulation of protein localization to cell surface [GO:2000008],centriolar satellite [GO:0034451]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658]
Q6IQ22,S3,-0.294966475,-1.468324292,0.09668719,0.798951087,0.71484966,salmon,RAB12,RAB12_HUMAN,Ras-related protein Rab-12,RAB12,201475;,0,GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],autophagy [GO:0006914]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; exocytosis [GO:0006887]; protein catabolic process [GO:0030163]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482],autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]
P51153,S3,-0.506027636,-1.080877812,0.167411028,0.847533342,0.6231837,salmon,RAB13,RAB13_HUMAN,Ras-related protein Rab-13 (Cell growth-inhibiting gene 4 protein),RAB13 GIG4,5872;,ENST00000368575.5; ENSP00000357564.3; ENSG00000143545.10.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924],bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endothelial cell chemotaxis [GO:0035767]; establishment of Sertoli cell barrier [GO:0097368]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; trans-Golgi network to recycling endosome transport [GO:0044795],bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]
P61106,S1,-0.350082147,-0.989377439,-0.139072373,0.550542662,0.96474681,gold,RAB14,RAB14_HUMAN,Ras-related protein Rab-14 (EC 3.6.5.2),RAB14,51552;,"ENST00000373840.9; ENSP00000362946.4; ENSG00000119396.12.;""ENST00000703999.1; ENSP00000515613.1; ENSG00000119396.12."";""ENST00000704000.1; ENSP00000515614.1; ENSG00000119396.12."";",GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489],defense response to bacterium [GO:0042742]; early endosome to Golgi transport [GO:0034498]; endocytic recycling [GO:0032456]; endosomal vesicle fusion [GO:0034058]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; phagolysosome assembly involved in apoptotic cell clearance [GO:0090387]; phagosome maturation [GO:0090382]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; rough endoplasmic reticulum [GO:0005791]; tertiary granule membrane [GO:0070821]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]
P59190,S2,-0.69282266,-1.305567071,0.041903866,0.838987041,0.798816938,orange,RAB15,RAB15_HUMAN,Ras-related protein Rab-15,RAB15,376267;,"ENST00000267512.9; ENSP00000267512.5; ENSG00000139998.16. [P59190-2];""ENST00000533601.7; ENSP00000434103.3; ENSG00000139998.16. [P59190-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],exocytosis [GO:0006887]; positive regulation of regulated secretory pathway [GO:1903307]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482],cilium [GO:0005929]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q9NP72,S2,-0.824485885,-1.286051702,0.190629261,0.856032928,0.730264193,orange,RAB18,RAB18_HUMAN,Ras-related protein Rab-18,RAB18,22931;,"ENST00000356940.11; ENSP00000349415.7; ENSG00000099246.18. [Q9NP72-1];""ENST00000621805.5; ENSP00000478479.1; ENSG00000099246.18. [Q9NP72-2]"";""ENST00000682082.1; ENSP00000507542.1; ENSG00000099246.18. [Q9NP72-1]"";""ENST00000682389.1; ENSP00000507154.1; ENSG00000099246.18. [Q9NP72-3]"";",GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],brain development [GO:0007420]; endoplasmic reticulum tubular network organization [GO:0071786]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389]; small GTPase-mediated signal transduction [GO:0007264],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]
P62820,S1,-0.338052592,-1.098024526,-0.119138029,0.69674361,0.938049131,gold,RAB1A,RAB1A_HUMAN,Ras-related protein Rab-1A (EC 3.6.5.2) (YPT1-related protein),RAB1A RAB1,5861;,"ENST00000398529.7; ENSP00000381540.3; ENSG00000138069.18. [P62820-3];""ENST00000409784.8; ENSP00000387286.3; ENSG00000138069.18. [P62820-1]"";""ENST00000409892.5; ENSP00000386451.1; ENSG00000138069.18. [P62820-2]"";""ENST00000649427.1; ENSP00000497078.1; ENSG00000138069.18. [P62820-1]"";",cadherin binding [GO:0045296]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192]; virion assembly [GO:0019068],cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; transport vesicle membrane [GO:0030658]
Q9H0U4,S1,-0.087842705,-0.994679677,-0.087619314,0.684998312,0.826456491,gold,RAB1B,RAB1B_HUMAN,Ras-related protein Rab-1B (EC 3.6.5.2),RAB1B,81876;,ENST00000311481.11; ENSP00000310226.6; ENSG00000174903.16.;,G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],autophagosome assembly [GO:0000045]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of glycoprotein metabolic process [GO:1903020]; regulation of autophagosome assembly [GO:2000785]; virion assembly [GO:0019068],cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site membrane [GO:0034045]; transport vesicle [GO:0030133]
Q9NX57,S2,-0.807393385,-1.421713957,0.232528237,0.794257129,0.618379415,orange,RAB20,RAB20_HUMAN,Ras-related protein Rab-20,RAB20,55647;,ENST00000267328.5; ENSP00000267328.3; ENSG00000139832.5.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924],cellular response to type II interferon [GO:0071346]; intracellular protein transport [GO:0006886]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385],endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]
Q9UL25,S3,-0.607613708,-0.89123066,0.080396604,0.753328558,0.624644948,salmon,RAB21,RAB21_HUMAN,Ras-related protein Rab-21,RAB21 KIAA0118,23011;,ENST00000261263.5; ENSP00000261263.3; ENSG00000080371.6.;,GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157],axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]
Q9UL26,S3,-0.332605937,-1.502326537,0.046794307,0.904725398,0.575830856,salmon,RAB22A,RB22A_HUMAN,Ras-related protein Rab-22A (Rab-22),RAB22A RAB22,57403;,ENST00000244040.4; ENSP00000244040.3; ENSG00000124209.4.;,GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],endocytosis [GO:0006897]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; regulation of vesicle size [GO:0097494],actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726]
Q9ULC3,S3,-1.044851652,-0.934261375,0.201337338,0.929968632,0.470723917,salmon,RAB23,RAB23_HUMAN,Ras-related protein Rab-23,RAB23 HSPC137,51715;,"ENST00000317483.4; ENSP00000320413.3; ENSG00000112210.12.;""ENST00000468148.6; ENSP00000417610.1; ENSG00000112210.12."";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308],autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]
Q969Q5,S4,-0.644604585,-1.45833573,0.252614685,1.045919234,0.311505679,tomato2,RAB24,RAB24_HUMAN,Ras-related protein Rab-24,RAB24,53917;,"ENST00000303251.11; ENSP00000304376.6; ENSG00000169228.14.;""ENST00000393611.6; ENSP00000377235.2; ENSG00000169228.14."";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],autophagy [GO:0006914]; intracellular protein transport [GO:0006886],autophagosome [GO:0005776]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]
P51159,S2,-1.159403276,-0.977285528,0.14519512,0.824142927,0.766017723,orange,RAB27A,RB27A_HUMAN,Ras-related protein Rab-27A (Rab-27) (EC 3.6.5.2) (GTP-binding protein Ram),RAB27A RAB27,5873;,"ENST00000336787.6; ENSP00000337761.1; ENSG00000069974.17. [P51159-1];""ENST00000396307.6; ENSP00000379601.2; ENSG00000069974.17. [P51159-1]"";""ENST00000564609.5; ENSP00000455012.1; ENSG00000069974.17. [P51159-1]"";""ENST00000569493.5; ENSP00000456059.1; ENSG00000069974.17. [P51159-1]"";""ENST00000697642.1; ENSP00000513368.1; ENSG00000069974.17. [P51159-1]"";""ENST00000697643.1; ENSP00000513369.1; ENSG00000069974.17. [P51159-1]"";",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904],antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein secretion [GO:0009306]; synaptic vesicle transport [GO:0048489],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; specific granule lumen [GO:0035580]; Weibel-Palade body [GO:0033093]
O00194,S2,-1.027748163,-1.711761695,0.143998118,0.798442831,0.803573842,orange,RAB27B,RB27B_HUMAN,Ras-related protein Rab-27B (EC 3.6.5.2) (C25KG),RAB27B,5874;,ENST00000262094.10; ENSP00000262094.4; ENSG00000041353.10.;,G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904],anterograde axonal protein transport [GO:0099641]; exocytosis [GO:0006887]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exocytosis [GO:0045921]; synaptic vesicle endocytosis [GO:0048488],apical plasma membrane [GO:0016324]; axon cytoplasm [GO:1904115]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; late endosome [GO:0005770]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network transport vesicle [GO:0030140]; zymogen granule membrane [GO:0042589]
P61019,S1,-1.376399785,-1.577612658,-0.043324442,0.957199056,0.855647658,gold,RAB2A,RAB2A_HUMAN,Ras-related protein Rab-2A (EC 3.6.5.2),RAB2A RAB2,5862;,"ENST00000262646.12; ENSP00000262646.7; ENSG00000104388.15. [P61019-1];""ENST00000531289.5; ENSP00000431846.1; ENSG00000104388.15. [P61019-2]"";",GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; macroautophagy [GO:0016236]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],acrosomal vesicle [GO:0001669]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleus [GO:0005634]
Q8WUD1,S1,-0.878316029,-1.083992986,-0.064644159,0.788253786,0.827019814,gold,RAB2B,RAB2B_HUMAN,Ras-related protein Rab-2B (EC 3.6.5.2),RAB2B,84932;,ENST00000397762.6; ENSP00000380869.1; ENSG00000129472.15. [Q8WUD1-1];,GTP binding [GO:0005525]; GTPase activity [GO:0003924],defense response to virus [GO:0051607]; Golgi organization [GO:0007030]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; positive regulation of exocytosis [GO:0045921]; positive regulation of type I interferon production [GO:0032481]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],acrosomal vesicle [GO:0001669]; autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]
Q15771,S1,-1.32981422,-1.139921252,0.134815241,0.790968221,0.975473771,gold,RAB30,RAB30_HUMAN,Ras-related protein Rab-30,RAB30,27314;,"ENST00000260056.6; ENSP00000260056.2; ENSG00000137502.10. [Q15771-1];""ENST00000527633.6; ENSP00000435089.1; ENSG00000137502.10. [Q15771-1]"";""ENST00000533486.5; ENSP00000435189.1; ENSG00000137502.10. [Q15771-1]"";""ENST00000534141.5; ENSP00000434974.1; ENSG00000137502.10. [Q15771-2]"";""ENST00000612684.4; ENSP00000478702.1; ENSG00000137502.10. [Q15771-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]
Q13636,S3,-0.614426223,-1.073615197,0.179425833,0.766841647,0.66842842,salmon,RAB31,RAB31_HUMAN,Ras-related protein Rab-31 (Ras-related protein Rab-22B),RAB31 RAB22B,11031;,ENST00000578921.6; ENSP00000461945.2; ENSG00000168461.13.;,GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],"cellular response to insulin stimulus [GO:0032869]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; positive regulation of phagocytosis, engulfment [GO:0060100]; receptor internalization [GO:0031623]; regulated exocytosis [GO:0045055]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome membrane [GO:0036186]; endomembrane system [GO:0012505]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588]
Q13637,S1,-0.68937531,-1.210074269,0.105941419,0.794017102,0.842878544,gold,RAB32,RAB32_HUMAN,Ras-related protein Rab-32,RAB32,10981;,ENST00000367495.4; ENSP00000356465.3; ENSG00000118508.5.;,AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924],antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]
Q9H082,S1,-0.697282374,-1.080470117,0.010022176,0.744077282,0.835609822,gold,RAB33B,RB33B_HUMAN,Ras-related protein Rab-33B,RAB33B,83452;,ENST00000305626.6; ENSP00000306496.5; ENSG00000172007.7.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924],"autophagosome assembly [GO:0000045]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport, Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705]",endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]
Q15286,S4,-0.741168614,-1.285595786,0.232331444,0.918727918,0.455054506,tomato2,RAB35,RAB35_HUMAN,Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C),RAB35 RAB1C RAY,11021;,"ENST00000229340.10; ENSP00000229340.5; ENSG00000111737.12. [Q15286-1];""ENST00000534951.5; ENSP00000441883.1; ENSG00000111737.12. [Q15286-2]"";","GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization [GO:0008104]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482],cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]
Q86YS6,S1,-0.818272924,-1.190603654,0.083091451,0.632592269,1.076297153,gold,RAB43,RAB43_HUMAN,Ras-related protein Rab-43 (Ras-related protein Rab-41),RAB43 RAB41,339122;,"ENST00000315150.10; ENSP00000319781.6; ENSG00000172780.17. [Q86YS6-1];""ENST00000393304.5; ENSP00000376981.1; ENSG00000172780.17. [Q86YS6-1]"";""ENST00000393305.5; ENSP00000376982.1; ENSG00000172780.17. [Q86YS6-1]"";""ENST00000393307.5; ENSP00000376984.1; ENSG00000172780.17. [Q86YS6-1]"";""ENST00000393308.5; ENSP00000376985.1; ENSG00000172780.17. [Q86YS6-1]"";""ENST00000476465.5; ENSP00000427632.1; ENSG00000172780.17. [Q86YS6-2]"";""ENST00000615093.1; ENSP00000481399.1; ENSG00000172780.17. [Q86YS6-2]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],"autophagosome assembly [GO:0000045]; cellular response to type II interferon [GO:0071346]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]",endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]
P20338,S1,-0.11775964,-1.060057346,-0.216517722,0.475096973,0.978359205,gold,RAB4A,RAB4A_HUMAN,Ras-related protein Rab-4A (EC 3.6.5.2),RAB4A RAB4,5867;,ENST00000366690.5; ENSP00000355651.4; ENSG00000168118.12.;,G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],antigen processing and presentation [GO:0019882]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192],cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982]
P20339,S3,0.334228096,-0.918489766,0.024727388,0.661951336,0.421415623,salmon,RAB5A,RAB5A_HUMAN,Ras-related protein Rab-5A (EC 3.6.5.2),RAB5A RAB5,5868;,"ENST00000273047.9; ENSP00000273047.4; ENSG00000144566.11. [P20339-1];""ENST00000422242.1; ENSP00000411941.1; ENSG00000144566.11. [P20339-2]"";",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],amyloid-beta clearance by transcytosis [GO:0150093]; canonical Wnt signaling pathway [GO:0060070]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; modulation by host of viral process [GO:0044788]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; receptor internalization [GO:0031623]; regulation of autophagosome assembly [GO:2000785]; regulation of endosome size [GO:0051036]; regulation of filopodium assembly [GO:0051489]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon terminus [GO:0043679]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytoplasmic side of early endosome membrane [GO:0098559]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endomembrane system [GO:0012505]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic early endosome [GO:0098842]; ruffle [GO:0001726]; somatodendritic compartment [GO:0036477]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]
P20340,S1,-0.515818969,-1.043406025,-0.100123382,0.659921081,0.985541871,gold,RAB6A,RAB6A_HUMAN,Ras-related protein Rab-6A (Rab-6),RAB6A RAB6,5870;,"ENST00000310653.10; ENSP00000311449.5; ENSG00000175582.20. [P20340-2];""ENST00000336083.8; ENSP00000336850.3; ENSG00000175582.20. [P20340-1]"";""ENST00000541588.5; ENSP00000445350.1; ENSG00000175582.20. [P20340-3]"";""ENST00000541973.5; ENSP00000443782.2; ENSG00000175582.20. [P20340-4]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904],"antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; minus-end-directed organelle transport along microtubule [GO:0072385]; neuron projection development [GO:0031175]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",acrosomal membrane [GO:0002080]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]
P51149,S2,-0.613515582,-1.343902187,0.094568336,0.852523057,0.747308046,orange,RAB7A,RAB7A_HUMAN,Ras-related protein Rab-7a (EC 3.6.5.2),RAB7A RAB7,7879;,"ENST00000265062.8; ENSP00000265062.3; ENSG00000075785.14.;""ENST00000674589.1; ENSP00000502088.1; ENSG00000075785.14."";""ENST00000675342.1; ENSP00000502486.1; ENSG00000075785.14."";""ENST00000675497.1; ENSP00000502000.1; ENSG00000075785.14."";""ENST00000676214.1; ENSP00000501618.1; ENSG00000075785.14."";",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; retromer complex binding [GO:1905394]; small GTPase binding [GO:0031267],"autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; early endosome to late endosome transport [GO:0045022]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome to plasma membrane protein transport [GO:0099638]; epidermal growth factor catabolic process [GO:0007174]; establishment of vesicle localization [GO:0051650]; intracellular transport [GO:0046907]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; negative regulation of exosomal secretion [GO:1903542]; negative regulation of intralumenal vesicle formation [GO:1905366]; phagosome acidification [GO:0090383]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; viral release from host cell [GO:0019076]",alveolar lamellar body [GO:0097208]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagophore assembly site membrane [GO:0034045]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]
O14966,S2,-1.909286913,-2.020428348,0.231007256,0.989567004,0.761227012,orange,RAB7L1,RAB7L_HUMAN,Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29),RAB29 RAB7L1,8934;,"ENST00000235932.8; ENSP00000235932.4; ENSG00000117280.13. [O14966-1];""ENST00000367139.8; ENSP00000356107.3; ENSG00000117280.13. [O14966-1]"";""ENST00000414729.1; ENSP00000402910.1; ENSG00000117280.13. [O14966-1]"";""ENST00000437324.6; ENSP00000416613.2; ENSG00000117280.13. [O14966-3]"";""ENST00000446390.6; ENSP00000389899.2; ENSG00000117280.13. [O14966-2]"";",dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267],"cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]",cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]
P61006,S3,-0.364599058,-1.000587796,0.19303997,0.731840209,0.567078733,salmon,RAB8A,RAB8A_HUMAN,Ras-related protein Rab-8A (EC 3.6.5.2) (Oncogene c-mel),RAB8A MEL RAB8,4218;,"ENST00000300935.8; ENSP00000300935.2; ENSG00000167461.12. [P61006-1];""ENST00000586682.1; ENSP00000467501.1; ENSG00000167461.12. [P61006-2]"";",GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein tyrosine kinase binding [GO:1990782]; small GTPase binding [GO:0031267],"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of autophagy [GO:0010506]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]",centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]
Q92930,S2,-0.996190655,-1.14423538,0.277266005,0.830295661,0.723952728,orange,RAB8B,RAB8B_HUMAN,Ras-related protein Rab-8B,RAB8B,51762;,ENST00000321437.9; ENSP00000312734.4; ENSG00000166128.13.;,GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signaling receptor binding [GO:0005102]; TPR domain binding [GO:0030911],antigen processing and presentation [GO:0019882]; cell-substrate junction organization [GO:0150115]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; positive regulation of cell projection organization [GO:0031346]; positive regulation of corticotropin secretion [GO:0051461]; protein import into peroxisome membrane [GO:0045046]; protein secretion [GO:0009306],cell tip [GO:0051286]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]
P51151,S1,-0.604402351,-1.197371935,-0.030049326,0.748411214,0.759975586,gold,RAB9A,RAB9A_HUMAN,Ras-related protein Rab-9A,RAB9A RAB9,9367;,"ENST00000464506.2; ENSP00000420127.1; ENSG00000123595.8.;""ENST00000618931.2; ENSP00000480777.1; ENSG00000123595.8."";",GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],"negative regulation by host of symbiont catalytic activity [GO:0052403]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]
Q9UI14,S1,-0.642625486,-1.023645552,-0.209037837,0.767140305,0.896275058,gold,RABAC1,PRAF1_HUMAN,Prenylated Rab acceptor protein 1 (PRA1 family protein 1),RABAC1 PRA1 PRAF1,10567;,ENST00000222008.11; ENSP00000222008.5; ENSG00000105404.11.;,GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064],0,Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]
Q15276,C5,1.693480431,0.431736357,-0.767605226,-0.764228558,-1.064935693,turquoise3,RABEP1,RABE1_HUMAN,Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17),RABEP1 RAB5EP RABPT5 RABPT5A,9135;,"ENST00000341923.10; ENSP00000339569.6; ENSG00000029725.17. [Q15276-2];""ENST00000537505.6; ENSP00000445408.2; ENSG00000029725.17. [Q15276-1]"";",growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803],apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]
Q7Z6M1,C5,2.061280435,0.35144278,-0.901463478,-1.085952619,-1.268692404,turquoise3,RABEPK,RABEK_HUMAN,Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40),RABEPK RAB9P40,10244;,"ENST00000259460.12; ENSP00000259460.8; ENSG00000136933.17. [Q7Z6M1-2];""ENST00000373538.8; ENSP00000362639.3; ENSG00000136933.17. [Q7Z6M1-1]"";""ENST00000394125.8; ENSP00000377683.4; ENSG00000136933.17. [Q7Z6M1-1]"";",0,receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904],cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]
Q9Y3P9,C1,1.594332367,-0.067018027,-0.631392313,-0.206012107,-0.116635826,lightblue,RABGAP1,RBGP1_HUMAN,Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA),RABGAP1 HSPC094,23637;,"ENST00000373647.9; ENSP00000362751.4; ENSG00000011454.18. [Q9Y3P9-1];""ENST00000456584.5; ENSP00000414386.1; ENSG00000011454.18. [Q9Y3P9-2]"";",GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631],regulation of GTPase activity [GO:0043087],centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]
Q5R372,C3,1.737347097,-0.218519396,-0.633444828,-0.394195492,-0.720471491,cyan,RABGAP1L,RBG1L_HUMAN,Rab GTPase-activating protein 1-like,RABGAP1L HHL KIAA0471,9910;,"ENST00000251507.8; ENSP00000251507.4; ENSG00000152061.24. [Q5R372-1];""ENST00000325589.9; ENSP00000318603.5; ENSG00000152061.24. [Q5R372-7]"";""ENST00000347255.6; ENSP00000281844.5; ENSG00000152061.24. [Q5R372-5]"";""ENST00000357444.10; ENSP00000350027.6; ENSG00000152061.24. [Q5R372-2]"";""ENST00000367687.5; ENSP00000356660.1; ENSG00000152061.24. [Q5R372-6]"";""ENST00000478442.5; ENSP00000434600.1; ENSG00000152061.24. [Q5R372-9]"";""ENST00000486220.5; ENSP00000432490.1; ENSG00000152061.24. [Q5R372-9]"";""ENST00000489615.5; ENSP00000420660.1; ENSG00000152061.24. [Q5R372-8]"";",GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],endocytosis [GO:0006897]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880],early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]
Q92696,C4,2.092837027,0.142852469,-1.004330537,-0.996538071,-1.210685326,deepskyblue2,RABGGTA,PGTA_HUMAN,Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha),RABGGTA,5875;,"ENST00000216840.11; ENSP00000216840.6; ENSG00000100949.15.;""ENST00000399409.7; ENSP00000382341.3; ENSG00000100949.15."";""ENST00000644383.1; ENSP00000494636.1; ENSG00000285193.1."";""ENST00000646658.1; ENSP00000496595.1; ENSG00000285193.1."";",Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]
P53611,C4,2.102578144,0.01799297,-1.013114995,-1.140240047,-1.325656006,deepskyblue2,RABGGTB,PGTB2_HUMAN,Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta),RABGGTB GGTB,5876;,ENST00000319942.8; ENSP00000317473.3; ENSG00000137955.16.;,Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601],cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968]
P47224,C3,1.855018118,-0.011349608,-0.548939772,-0.120330529,-0.874487189,cyan,RABIF,MSS4_HUMAN,Guanine nucleotide exchange factor MSS4 (Rab-interacting factor),RABIF MSS4 RASGRF3,5877;,ENST00000367262.4; ENSP00000356231.3; ENSG00000183155.5.;,guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270],membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; membrane [GO:0016020]
Q5HYI8,S2,-1.203909959,-1.155156111,0.2453544,0.751319693,0.705355131,orange,RABL3,RABL3_HUMAN,Rab-like protein 3,RABL3,285282;,ENST00000273375.8; ENSP00000273375.4; ENSG00000144840.10.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803],B cell differentiation [GO:0030183]; intracellular protein transport [GO:0006886]; natural killer cell differentiation [GO:0001779]; protein stabilization [GO:0050821]; regulation of protein lipidation [GO:1903059]; regulation of Ras protein signal transduction [GO:0046578]; T cell differentiation in thymus [GO:0033077],endomembrane system [GO:0012505]
Q9H7X7,C1,1.572104796,0.259200073,-0.579903816,-0.403206812,-0.497479974,lightblue,RABL5,IFT22_HUMAN,Intraflagellar transport protein 22 homolog (Rab-like protein 5),IFT22 RABL5,64792;,"ENST00000315322.10; ENSP00000320359.4; ENSG00000128581.17. [Q9H7X7-1];""ENST00000422177.5; ENSP00000392087.1; ENSG00000128581.17. [Q9H7X7-1]"";""ENST00000437644.2; ENSP00000390770.2; ENSG00000128581.17. [Q9H7X7-2]"";""ENST00000498704.6; ENSP00000429648.1; ENSG00000128581.17. [Q9H7X7-3]"";""ENST00000517481.5; ENSP00000429202.1; ENSG00000128581.17. [Q9H7X7-3]"";""ENST00000621899.4; ENSP00000478948.1; ENSG00000128581.17. [Q9H7X7-3]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924],cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary anterograde transport [GO:0035720],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; endomembrane system [GO:0012505]; intraciliary transport particle B [GO:0030992]
Q3YEC7,C3,1.817852604,0.041364989,-0.768421433,-0.662335378,-0.845854248,cyan,RABL6,RABL6_HUMAN,Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1),RABL6 C9orf86 PARF,55684;,"ENST00000311502.12; ENSP00000311134.7; ENSG00000196642.19. [Q3YEC7-1];""ENST00000357466.6; ENSP00000350056.2; ENSG00000196642.19. [Q3YEC7-3]"";""ENST00000371663.10; ENSP00000360727.6; ENSG00000196642.19. [Q3YEC7-2]"";""ENST00000371671.9; ENSP00000360736.4; ENSG00000196642.19. [Q3YEC7-6]"";",GTP binding [GO:0005525],0,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q9H0H5,M1,-1.00801389,-0.770859308,0.792928685,0.618986326,-0.079534695,burlywood4,RACGAP1,RGAP1_HUMAN,Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4),RACGAP1 KIAA1478 MGCRACGAP,29127;,"ENST00000312377.10; ENSP00000309871.5; ENSG00000161800.13.;""ENST00000427314.6; ENSP00000404190.2; ENSG00000161800.13."";""ENST00000454520.6; ENSP00000404808.2; ENSG00000161800.13."";""ENST00000547905.5; ENSP00000449370.1; ENSG00000161800.13."";""ENST00000551016.5; ENSP00000449374.1; ENSG00000161800.13."";","alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]",actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transport [GO:0008272],acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233]
O60216,N2,-1.092688761,0.076430576,0.945831455,-0.037682111,-0.373682149,grey70,RAD21,RAD21_HUMAN,Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product) (65-kDa carboxy-terminal product)],RAD21 HR21 KIAA0078 NXP1 SCC1,5885;,"ENST00000297338.7; ENSP00000297338.2; ENSG00000164754.16.;""ENST00000517485.6; ENSP00000427923.2; ENSG00000164754.16."";""ENST00000517749.2; ENSP00000430273.2; ENSG00000164754.16."";""ENST00000519837.6; ENSP00000430524.2; ENSG00000164754.16."";""ENST00000520992.6; ENSP00000429342.2; ENSG00000164754.16."";""ENST00000522699.2; ENSP00000428158.2; ENSG00000164754.16."";""ENST00000687358.1; ENSP00000509687.1; ENSG00000164754.16."";",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; lncRNA binding [GO:0106222],apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin looping [GO:0140588]; chromosome segregation [GO:0007059]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; establishment of meiotic sister chromatid cohesion [GO:0034089]; establishment of mitotic sister chromatid cohesion [GO:0034087]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; reciprocal meiotic recombination [GO:0007131]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to hypoxia [GO:0001666]; sister chromatid cohesion [GO:0007062],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; meiotic cohesin complex [GO:0030893]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic cohesin complex [GO:0030892]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]"
P54725,C5,1.501744192,0.784286223,-0.835356876,-0.895829684,-1.134303697,turquoise3,RAD23A,RD23A_HUMAN,UV excision repair protein RAD23 homolog A (HR23A) (hHR23A),RAD23A,5886;,"ENST00000316856.7; ENSP00000321365.3; ENSG00000179262.10. [P54725-3];""ENST00000586534.6; ENSP00000467024.1; ENSG00000179262.10. [P54725-1]"";""ENST00000592268.5; ENSP00000468674.1; ENSG00000179262.10. [P54725-2]"";",damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; ubiquitin-specific protease binding [GO:1990381],nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]
P54727,C5,1.416304183,0.9177789,-0.59476936,-0.838093501,-0.917152696,turquoise3,RAD23B,RD23B_HUMAN,UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58),RAD23B,5887;,"ENST00000358015.8; ENSP00000350708.3; ENSG00000119318.13. [P54727-1];""ENST00000416373.6; ENSP00000405623.2; ENSG00000119318.13. [P54727-2]"";",damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130],cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; nucleotide-excision repair [GO:0006289]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]
Q06609,C2,0.625230045,0.685641874,-0.132651781,-0.21809783,-0.359892805,aquamarine,RAD51,RAD51_HUMAN,DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (RAD51 homolog A),RAD51 RAD51A RECA,5888;,"ENST00000267868.8; ENSP00000267868.3; ENSG00000051180.17. [Q06609-1];""ENST00000382643.7; ENSP00000372088.3; ENSG00000051180.17. [Q06609-4]"";""ENST00000423169.6; ENSP00000406602.2; ENSG00000051180.17. [Q06609-3]"";""ENST00000532743.6; ENSP00000433924.2; ENSG00000051180.17. [Q06609-1]"";""ENST00000557850.5; ENSP00000454176.1; ENSG00000051180.17. [Q06609-2]"";""ENST00000645673.2; ENSP00000493712.2; ENSG00000051180.17. [Q06609-4]"";","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; DNA strand exchange activity [GO:0000150]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]",cellular response to camptothecin [GO:0072757]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response [GO:0006974]; DNA recombinase assembly [GO:0000730]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair involved in meiotic recombination [GO:1990918]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833],"centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nuclear ubiquitin ligase complex [GO:0000152]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; presynaptic intermediate filament cytoskeleton [GO:0099182]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]"
Q7Z5J4,N3,-1.260288328,-0.950280833,1.260385984,0.092307032,-0.265214317,grey50,RAI1,RAI1_HUMAN,Retinoic acid-induced protein 1,RAI1 KIAA1820,10743;,ENST00000353383.6; ENSP00000323074.4; ENSG00000108557.20. [Q7Z5J4-1];,metal ion binding [GO:0046872],circadian regulation of gene expression [GO:0032922]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P11233,S4,-1.199643376,-1.373017984,0.36473434,0.946244048,0.476615023,tomato2,RALA,RALA_HUMAN,Ras-related protein Ral-A (EC 3.6.5.2),RALA RAL,5898;,ENST00000005257.7; ENSP00000005257.2; ENSG00000006451.8.;,ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625],cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; signal transduction [GO:0007165],cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]
P11234,S2,-1.153640146,-1.338978951,0.270047921,0.811375239,0.512185422,orange,RALB,RALB_HUMAN,Ras-related protein Ral-B (EC 3.6.5.2),RALB,5899;,"ENST00000272519.10; ENSP00000272519.4; ENSG00000144118.14. [P11234-1];""ENST00000420510.5; ENSP00000414224.1; ENSG00000144118.14. [P11234-1]"";",ATPase binding [GO:0051117]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ubiquitin protein ligase binding [GO:0031625],apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to starvation [GO:0009267]; negative regulation of protein binding [GO:0032091]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of exocyst assembly [GO:0001928]; regulation of exocyst localization [GO:0060178]; signal transduction [GO:0007165],extracellular exosome [GO:0070062]; midbody [GO:0030496]; plasma membrane [GO:0005886]
Q2PPJ7,C2,0.964169142,0.23514013,-0.1835881,0.092217603,0.08571426,aquamarine,RALGAPA2,RGPA2_HUMAN,Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220),RALGAPA2 C20orf74 KIAA1272,57186;,ENST00000202677.12; ENSP00000202677.6; ENSG00000188559.16. [Q2PPJ7-1];,GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982],activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q86X27,C3,1.88233498,-0.164541981,-0.776388089,-0.489571587,-0.702289281,cyan,RALGPS2,RGPS2_HUMAN,Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2),RALGPS2,55103;,"ENST00000367634.7; ENSP00000356606.2; ENSG00000116191.19. [Q86X27-3];""ENST00000367635.8; ENSP00000356607.3; ENSG00000116191.19. [Q86X27-1]"";",guanyl-nucleotide exchange factor activity [GO:0005085],Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]
Q9UKM9,N3,-1.083247673,-1.221063969,1.045658078,-0.165064735,0.355405473,grey50,RALY,RALY_HUMAN,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),RALY HNRPCL2 P542,22913;,"ENST00000246194.8; ENSP00000246194.3; ENSG00000125970.12. [Q9UKM9-1];""ENST00000375114.7; ENSP00000364255.3; ENSG00000125970.12. [Q9UKM9-2]"";",RNA binding [GO:0003723]; transcription coregulator activity [GO:0003712],"cholesterol homeostasis [GO:0042632]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]
P62826,C5,1.744673741,0.469835115,-0.116885732,-0.86025456,-1.152841902,turquoise3,RAN,RAN_HUMAN,GTP-binding nuclear protein Ran (EC 3.6.5.-) (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein),RAN ARA24 OK/SW-cl.81,5901;,"ENST00000392369.6; ENSP00000376176.2; ENSG00000132341.12.;""ENST00000543796.6; ENSP00000446215.1; ENSG00000132341.12."";",cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; dynein intermediate chain binding [GO:0045505]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; importin-alpha family protein binding [GO:0061676]; magnesium ion binding [GO:0000287]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723],actin cytoskeleton organization [GO:0030036]; cell division [GO:0051301]; cellular response to mineralocorticoid stimulus [GO:0071389]; DNA metabolic process [GO:0006259]; GTP metabolic process [GO:0046039]; hippocampus development [GO:0021766]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization to nucleolus [GO:1902570]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015]; spermatid development [GO:0007286]; viral process [GO:0016032],centriole [GO:0005814]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; manchette [GO:0002177]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; RNA nuclear export complex [GO:0042565]; sperm flagellum [GO:0036126]
P43487,C4,2.125876513,0.001390318,-1.205307741,-1.32049036,-1.342244848,deepskyblue2,RANBP1,RANG_HUMAN,Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1),RANBP1,5902;,"ENST00000331821.8; ENSP00000327583.3; ENSG00000099901.18. [P43487-1];""ENST00000402752.5; ENSP00000384925.1; ENSG00000099901.18. [P43487-2]"";",cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],nucleocytoplasmic transport [GO:0006913]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]
P49792,N2,-0.971150047,-0.249953158,0.94010864,0.262858185,-0.241482191,grey70,RANBP2,RBP2_HUMAN,E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270),RANBP2 NUP358,5903;,ENST00000283195.11; ENSP00000283195.6; ENSG00000153201.17.;,metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789],centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975],annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068]
Q9H6Z4,N4,-0.275700885,1.457937844,-0.620749748,-0.807732295,-1.155945625,grey30,RANBP3,RANB3_HUMAN,Ran-binding protein 3 (RanBP3),RANBP3,8498;,"ENST00000034275.12; ENSP00000034275.7; ENSG00000031823.14. [Q9H6Z4-3];""ENST00000340578.10; ENSP00000341483.5; ENSG00000031823.14. [Q9H6Z4-1]"";""ENST00000439268.6; ENSP00000404837.1; ENSG00000031823.14. [Q9H6Z4-2]"";",R-SMAD binding [GO:0070412]; small GTPase binding [GO:0031267],protein export from nucleus [GO:0006611],cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P62834,S3,-0.580306104,-1.213980602,0.12366032,0.846955812,0.57956776,salmon,RAP1A,RAP1A_HUMAN,Ras-related protein Rap-1A (EC 3.6.5.2) (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1),RAP1A KREV1,5906;,"ENST00000356415.5; ENSP00000348786.1; ENSG00000116473.15.;""ENST00000369709.4; ENSP00000358723.3; ENSG00000116473.15."";""ENST00000687939.1; ENSP00000509234.1; ENSG00000116473.15."";",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; synaptic vesicle exocytosis [GO:0016079],anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; specific granule membrane [GO:0035579]; sperm midpiece [GO:0097225]
P61224,S3,-0.9139828,-1.184842102,0.156154539,0.967064091,0.554898246,salmon,RAP1B,RAP1B_HUMAN,Ras-related protein Rap-1b (EC 3.6.5.2) (GTP-binding protein smg p21B),RAP1B OK/SW-cl.11,5908;,"ENST00000250559.14; ENSP00000250559.9; ENSG00000127314.18. [P61224-1];""ENST00000341355.9; ENSP00000441275.1; ENSG00000127314.18. [P61224-1]"";""ENST00000393436.9; ENSP00000377085.5; ENSG00000127314.18. [P61224-1]"";""ENST00000450214.6; ENSP00000399986.2; ENSG00000127314.18. [P61224-4]"";""ENST00000537460.5; ENSP00000439966.1; ENSG00000127314.18. [P61224-1]"";""ENST00000539091.5; ENSP00000444830.1; ENSG00000127314.18. [P61224-4]"";""ENST00000540209.5; ENSP00000446318.1; ENSG00000127314.18. [P61224-3]"";""ENST00000542145.5; ENSP00000440014.1; ENSG00000127314.18. [P61224-2]"";",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877],calcium-ion regulated exocytosis [GO:0017156]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; establishment of localization in cell [GO:0051649]; modification of postsynaptic structure [GO:0099010]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of integrin activation [GO:0033625]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of establishment of cell polarity [GO:2000114],azurophil granule membrane [GO:0035577]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P52306,C4,2.133203854,-0.247531237,-0.950854089,-0.963610054,-1.276547986,deepskyblue2,RAP1GDS1,GDS1_HUMAN,Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein),RAP1GDS1 SMGGDS,5910;,"ENST00000264572.11; ENSP00000264572.7; ENSG00000138698.15. [P52306-6];""ENST00000339360.9; ENSP00000340454.5; ENSG00000138698.15. [P52306-5]"";""ENST00000380158.8; ENSP00000369503.4; ENSG00000138698.15. [P52306-3]"";""ENST00000408900.7; ENSP00000386223.3; ENSG00000138698.15. [P52306-2]"";""ENST00000408927.8; ENSP00000386153.4; ENSG00000138698.15. [P52306-1]"";""ENST00000453712.6; ENSP00000407157.2; ENSG00000138698.15. [P52306-4]"";",guanyl-nucleotide exchange factor activity [GO:0005085],angiotensin-activated signaling pathway involved in heart process [GO:0086098]; CAAX-box protein maturation [GO:0080120]; cardiac muscle hypertrophy [GO:0003300]; myosin filament assembly [GO:0031034]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein localization to nucleus [GO:0034504]; regulation of ERK5 cascade [GO:0070376]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of mitochondrion organization [GO:0010821]; vascular associated smooth muscle contraction [GO:0014829],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
P10114,S3,-0.442883226,-0.917193733,0.098835818,0.677691519,0.322312084,salmon,RAP2A,RAP2A_HUMAN,Ras-related protein Rap-2a (EC 3.6.5.2) (RbBP-30),RAP2A,5911;,ENST00000245304.5; ENSP00000245304.3; ENSG00000125249.7.;,G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287],actin cytoskeleton organization [GO:0030036]; cellular response to xenobiotic stimulus [GO:0071466]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse assembly [GO:0051963],cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]
P61225,S2,-0.976227912,-1.668568549,0.361831676,0.604009203,0.707542948,orange,RAP2B,RAP2B_HUMAN,Ras-related protein Rap-2b (EC 3.6.5.2),RAP2B,5912;,ENST00000323534.5; ENSP00000319096.2; ENSG00000181467.5.;,G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904],negative regulation of cell migration [GO:0030336]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097]; signal transduction [GO:0007165],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]
Q9Y3L5,S4,-1.178270785,-1.327974633,0.37471677,0.793805465,0.324913299,tomato2,RAP2C,RAP2C_HUMAN,Ras-related protein Rap-2c (EC 3.6.5.2),RAP2C,57826;,"ENST00000342983.6; ENSP00000340274.2; ENSG00000123728.10.;""ENST00000370874.2; ENSP00000359911.1; ENSG00000123728.10."";",G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; transcription coactivator activity [GO:0003713],establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; Rap protein signal transduction [GO:0032486]; regulation of protein tyrosine kinase activity [GO:0061097],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; tertiary granule membrane [GO:0070821]
Q70E73,C3,1.808502856,0.0851467,-0.585965529,-0.462155573,-0.724518106,cyan,RAPH1,RAPH1_HUMAN,Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1),RAPH1 ALS2CR18 ALS2CR9 KIAA1681 LPD PREL2 RMO1,65059;,"ENST00000308091.8; ENSP00000311293.4; ENSG00000173166.18. [Q70E73-9];""ENST00000319170.10; ENSP00000316543.5; ENSG00000173166.18. [Q70E73-10]"";""ENST00000418114.5; ENSP00000396711.1; ENSG00000173166.18. [Q70E73-2]"";""ENST00000419464.5; ENSP00000390578.1; ENSG00000173166.18. [Q70E73-5]"";""ENST00000423104.5; ENSP00000397751.1; ENSG00000173166.18. [Q70E73-7]"";""ENST00000439222.5; ENSP00000411138.1; ENSG00000173166.18. [Q70E73-8]"";""ENST00000453034.5; ENSP00000406662.1; ENSG00000173166.18. [Q70E73-6]"";",0,axon extension [GO:0048675]; signal transduction [GO:0007165],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]
P20936,C3,1.597113214,0.184355139,-0.631687511,-0.413167188,-0.706479213,cyan,RASA1,RASA1_HUMAN,Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP),RASA1 GAP RASA,5921;,"ENST00000274376.11; ENSP00000274376.6; ENSG00000145715.15. [P20936-1];""ENST00000456692.6; ENSP00000411221.2; ENSG00000145715.15. [P20936-2]"";""ENST00000512763.5; ENSP00000422008.1; ENSG00000145715.15. [P20936-4]"";""ENST00000515800.6; ENSP00000423395.2; ENSG00000145715.15. [P20936-3]"";",GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102],blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]
Q15291,N4,-0.538516834,0.663622182,0.437589226,-0.384463557,2.14E-04,grey30,RBBP5,RBBP5_HUMAN,Retinoblastoma-binding protein 5 (RBBP-5) (Retinoblastoma-binding protein RBQ-3),RBBP5 RBQ3,5929;,"ENST00000264515.11; ENSP00000264515.6; ENSG00000117222.14. [Q15291-1];""ENST00000367164.1; ENSP00000356132.1; ENSG00000117222.14. [Q15291-2]"";",histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976],DNA damage response [GO:0006974]; response to estrogen [GO:0043627]; transcription initiation-coupled chromatin remodeling [GO:0045815],histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]
Q99708,N4,-0.582797113,1.124109458,0.198642469,-0.369608594,-0.800384704,grey30,RBBP8,CTIP_HUMAN,DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2),RBBP8 CTIP,5932;,"ENST00000327155.10; ENSP00000323050.5; ENSG00000101773.19. [Q99708-1];""ENST00000399722.6; ENSP00000382628.2; ENSG00000101773.19. [Q99708-1]"";""ENST00000399725.6; ENSP00000382630.2; ENSG00000101773.19. [Q99708-3]"";",damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; transcription corepressor activity [GO:0003714],blastocyst hatching [GO:0001835]; cell division [GO:0051301]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous recombination [GO:0035825]; meiotic cell cycle [GO:0051321]; mitotic G2/M transition checkpoint [GO:0044818]; regulation of transcription by RNA polymerase II [GO:0006357],BRCA1-C complex [GO:0070533]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; transcription repressor complex [GO:0017053]
O75884,C4,2.117339579,0.352044207,-1.037160508,-1.143075829,-1.066470458,deepskyblue2,RBBP9,RBBP9_HUMAN,Serine hydrolase RBBP9 (EC 3.-.-.-) (B5T-overexpressed gene protein) (Protein BOG) (Retinoblastoma-binding protein 10) (RBBP-10) (Retinoblastoma-binding protein 9) (RBBP-9),RBBP9 BOG RBBP10,10741;,ENST00000337227.9; ENSP00000336866.4; ENSG00000089050.16. [O75884-1];,hydrolase activity [GO:0016787],positive regulation of gene expression [GO:0010628]; response to nematode [GO:0009624]; type II pneumocyte differentiation [GO:0060510],nucleoplasm [GO:0005654]
Q9BYM8,C3,1.73365507,0.189404738,-0.583784059,-0.468654734,-0.778058762,cyan,RBCK1,HOIL1_HUMAN,RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3),RBCK1 C20orf18 RNF54 UBCE7IP3 XAP3 XAP4,10616;,"ENST00000353660.7; ENSP00000254960.5; ENSG00000125826.22. [Q9BYM8-3];""ENST00000356286.10; ENSP00000348632.6; ENSG00000125826.22. [Q9BYM8-1]"";""ENST00000382181.2; ENSP00000371616.3; ENSG00000125826.22. [Q9BYM8-4]"";",identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-protein transferase activity [GO:0004842],cytoplasmic sequestering of protein [GO:0051220]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852],cytosol [GO:0005829]; LUBAC complex [GO:0071797]
Q9H477,C4,2.121159488,0.377706698,-1.159785758,-1.314946408,-1.766317789,deepskyblue2,RBKS,RBSK_HUMAN,Ribokinase (RK) (EC 2.7.1.15),RBKS RBSK,64080;,ENST00000302188.8; ENSP00000306817.3; ENSG00000171174.15. [Q9H477-1];,ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747],D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098],cytosol [GO:0005829]; nucleus [GO:0005634]
Q8IXT5,N2,-1.043583324,-0.224329089,1.028942177,0.044814768,-0.339630356,grey70,RBM12B,RB12B_HUMAN,RNA-binding protein 12B (RNA-binding motif protein 12B),RBM12B,389677;,"ENST00000399300.7; ENSP00000382239.2; ENSG00000183808.12.;""ENST00000517700.6; ENSP00000427729.2; ENSG00000183808.12."";""ENST00000518597.2; ENSP00000428269.2; ENSG00000183808.12."";""ENST00000519109.6; ENSP00000430474.2; ENSG00000183808.12."";""ENST00000520560.6; ENSP00000429807.2; ENSG00000183808.12."";",RNA binding [GO:0003723],regulation of RNA splicing [GO:0043484],nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]
Q96PK6,N2,-0.920383967,-0.698441684,0.902590629,0.177466548,0.268918085,grey70,RBM14,RBM14_HUMAN,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),RBM14 SIP,100526737;10432;,"ENST00000310137.5; ENSP00000311747.5; ENSG00000239306.5. [Q96PK6-1];""ENST00000393979.3; ENSP00000377548.3; ENSG00000239306.5. [Q96PK6-2]"";""ENST00000409738.4; ENSP00000386995.4; ENSG00000239306.5. [Q96PK6-4]"";",mRNA binding [GO:0003729]; nuclear receptor coactivator activity [GO:0030374]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935],"activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; centriole assembly [GO:0098534]; gastrulation [GO:0007369]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centriole replication [GO:0046600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of response to DNA integrity checkpoint signaling [GO:1902151]; response to hormone [GO:0009725]; transcription initiation-coupled chromatin remodeling [GO:0045815]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; transcription regulator complex [GO:0005667]
Q96T37,N2,-1.014443238,-0.364967231,0.888093402,-0.024386997,0.218573691,grey70,RBM15,RBM15_HUMAN,RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),RBM15 OTT OTT1,64783;,"ENST00000369784.9; ENSP00000358799.3; ENSG00000162775.17. [Q96T37-1];""ENST00000487146.8; ENSP00000473552.3; ENSG00000162775.17. [Q96T37-3]"";""ENST00000602849.1; ENSP00000473638.1; ENSG00000162775.17. [Q96T37-2]"";""ENST00000618772.4; ENSP00000483133.1; ENSG00000162775.17. [Q96T37-1]"";""ENST00000652342.2; ENSP00000498328.1; ENSG00000162775.17. [Q96T37-4]"";""ENST00000652747.1; ENSP00000498634.1; ENSG00000162775.17. [Q96T37-3]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],"branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]",nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]
Q8NDT2,N2,-0.540313738,-0.510125765,0.879112131,0.061879351,0.340270649,grey70,RBM15B,RB15B_HUMAN,Putative RNA-binding protein 15B (One-twenty two protein 3) (HsOTT3) (HuOTT3) (RNA-binding motif protein 15B),RBM15B OTT3,29890;,ENST00000563281.2; ENSP00000454545.1; ENSG00000259956.2. [Q8NDT2-1];,mRNA binding [GO:0003729]; RNA binding [GO:0003723],"dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA methylation [GO:0001510]; RNA splicing [GO:0008380]",nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]
Q9Y4C8,N3,-1.257745146,-1.193139144,1.374163995,0.039913494,-0.31189401,grey50,RBM19,RBM19_HUMAN,Probable RNA-binding protein 19 (RNA-binding motif protein 19),RBM19 KIAA0682,9904;,"ENST00000261741.10; ENSP00000261741.5; ENSG00000122965.11.;""ENST00000392561.7; ENSP00000376344.3; ENSG00000122965.11."";""ENST00000545145.6; ENSP00000442053.2; ENSG00000122965.11."";",RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of embryonic development [GO:0040019]",chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P49756,N4,-1.246804266,0.902352946,0.435502992,-0.424336308,-0.614752649,grey30,RBM25,RBM25_HUMAN,RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7),RBM25 RNPC7,58517;,"ENST00000261973.12; ENSP00000261973.7; ENSG00000119707.14. [P49756-1];""ENST00000525321.5; ENSP00000436868.1; ENSG00000119707.14. [P49756-3]"";""ENST00000526754.5; ENSP00000436225.1; ENSG00000119707.14. [P49756-2]"";""ENST00000527432.5; ENSP00000431150.1; ENSG00000119707.14. [P49756-1]"";""ENST00000528081.5; ENSP00000434444.1; ENSG00000119707.14. [P49756-4]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],"mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]
P42696,N3,-0.901254199,-1.179829897,1.108216918,-0.090621787,0.196961659,grey50,RBM34,RBM34_HUMAN,RNA-binding protein 34 (RNA-binding motif protein 34),RBM34 KIAA0117,23029;,ENST00000408888.8; ENSP00000386226.3; ENSG00000188739.15. [P42696-1];,RNA binding [GO:0003723]; rRNA binding [GO:0019843],"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]",chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9BTD8,N1,-1.027040141,-0.370127626,0.431781767,-0.449431903,1.161407812,grey90,RBM42,RBM42_HUMAN,RNA-binding protein 42 (RNA-binding motif protein 42),RBM42,79171;,"ENST00000262633.9; ENSP00000262633.3; ENSG00000126254.12. [Q9BTD8-1];""ENST00000588161.5; ENSP00000466044.1; ENSG00000126254.12. [Q9BTD8-2]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]",cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U4/U6 x U5 tri-snRNP complex [GO:0046540]
A0AV96,N1,-0.768206793,-0.253447307,0.059212805,-0.250667644,1.166141469,grey90,RBM47,RBM47_HUMAN,RNA-binding protein 47 (RNA-binding motif protein 47),RBM47,54502;,"ENST00000295971.12; ENSP00000295971.7; ENSG00000163694.15. [A0AV96-1];""ENST00000381793.6; ENSP00000371212.2; ENSG00000163694.15. [A0AV96-1]"";""ENST00000381795.10; ENSP00000371214.6; ENSG00000163694.15. [A0AV96-2]"";",enzyme binding [GO:0019899]; enzyme-substrate adaptor activity [GO:0140767]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],"3'-UTR-mediated mRNA stabilization [GO:0070935]; cytidine to uridine editing [GO:0016554]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA processing [GO:0006397]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; nucleus [GO:0005634]
P52756,N1,-1.097072025,-0.453775148,0.819507791,-0.007374451,0.542071879,grey90,RBM5,RBM5_HUMAN,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),RBM5 H37 LUCA15,10181;,"ENST00000347869.8; ENSP00000343054.3; ENSG00000003756.17. [P52756-1];""ENST00000469838.5; ENSP00000419534.1; ENSG00000003756.17. [P52756-2]"";",DNA binding [GO:0003677]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]
P78332,N2,-1.065577309,0.203012821,0.685436191,-0.21823853,0.489545349,grey70,RBM6,RBM6_HUMAN,RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3),RBM6 DEF3,10180;,"ENST00000266022.9; ENSP00000266022.4; ENSG00000004534.15. [P78332-1];""ENST00000422955.5; ENSP00000392939.1; ENSG00000004534.15. [P78332-2]"";""ENST00000425608.5; ENSP00000408665.1; ENSG00000004534.15. [P78332-3]"";""ENST00000442092.5; ENSP00000393530.1; ENSG00000004534.15. [P78332-2]"";",DNA binding [GO:0003677]; RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]",nucleus [GO:0005634]
Q15434,N1,-0.774374938,-0.580144785,-0.027371555,0.19936516,1.174098125,grey90,RBMS2,RBMS2_HUMAN,"RNA-binding motif, single-stranded-interacting protein 2 (Suppressor of CDC2 with RNA-binding motif 3)",RBMS2 SCR3,5939;,ENST00000262031.10; ENSP00000262031.5; ENSG00000076067.14.;,mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723],RNA processing [GO:0006396],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
P38159,N3,-0.793563522,-0.985952904,1.01712175,-0.016633397,0.274020296,grey50,RBMX,RBMX_HUMAN,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",RBMX HNRPG RBMXP1,27316;,"ENST00000320676.11; ENSP00000359645.3; ENSG00000147274.14. [P38159-1];""ENST00000431446.7; ENSP00000411989.3; ENSG00000147274.14. [P38159-3]"";",chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],"cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; osteoblast differentiation [GO:0001649]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]",catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]
Q96E39,N2,-0.994062783,-1.042909372,1.191269527,-0.138244177,0.044668848,grey70,RBMXL1,RMXL1_HUMAN,"RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1)",RBMXL1,494115;,"ENST00000321792.5; ENSP00000318415.5; ENSG00000213516.10.;""ENST00000399794.6; ENSP00000446099.1; ENSG00000213516.10."";""ENST00000652648.1; ENSP00000498248.1; ENSG00000213516.10."";",RNA binding [GO:0003723],"mRNA processing [GO:0006397]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; RNA splicing [GO:0008380]",spliceosomal complex [GO:0005681]
Q06330,N4,-0.59417092,1.029072287,0.265513835,-0.334369204,-0.231892342,grey30,RBPJ,SUH_HUMAN,Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa) (RBP-J) (RBP-JK) (Renal carcinoma antigen NY-REN-30),RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH,3516;,"ENST00000342295.6; ENSP00000345206.1; ENSG00000168214.22. [Q06330-1];""ENST00000342320.8; ENSP00000340124.4; ENSG00000168214.22. [Q06330-6]"";""ENST00000345843.8; ENSP00000305815.6; ENSG00000168214.22. [Q06330-5]"";""ENST00000348160.9; ENSP00000339699.5; ENSG00000168214.22. [Q06330-6]"";""ENST00000355476.8; ENSP00000347659.4; ENSG00000168214.22. [Q06330-7]"";""ENST00000361572.10; ENSP00000354528.6; ENSG00000168214.22. [Q06330-1]"";""ENST00000504423.2; ENSP00000421804.2; ENSG00000168214.22. [Q06330-5]"";""ENST00000505958.6; ENSP00000426872.2; ENSG00000168214.22. [Q06330-6]"";""ENST00000507561.5; ENSP00000423907.1; ENSG00000168214.22. [Q06330-5]"";""ENST00000512671.6; ENSP00000423644.2; ENSG00000168214.22. [Q06330-1]"";""ENST00000680928.1; ENSP00000505493.1; ENSG00000168214.22. [Q06330-6]"";""ENST00000681093.1; ENSP00000504964.1; ENSG00000168214.22. [Q06330-6]"";""ENST00000681264.1; ENSP00000505255.1; ENSG00000168214.22. [Q06330-5]"";""ENST00000681484.1; ENSP00000505636.1; ENSG00000168214.22. [Q06330-5]"";","chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]",angiogenesis [GO:0001525]; aortic valve development [GO:0003176]; arterial endothelial cell fate commitment [GO:0060844]; atrioventricular canal development [GO:0036302]; auditory receptor cell fate commitment [GO:0009912]; B cell differentiation [GO:0030183]; blood vessel endothelial cell fate specification [GO:0097101]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; club cell differentiation [GO:0060486]; defense response to bacterium [GO:0042742]; dorsal aorta morphogenesis [GO:0035912]; endocardium morphogenesis [GO:0003160]; epidermal cell fate specification [GO:0009957]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; keratinocyte differentiation [GO:0030216]; labyrinthine layer blood vessel development [GO:0060716]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ossification [GO:0030279]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERBB signaling pathway [GO:1901186]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; pulmonary valve development [GO:0003177]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of generation of precursor metabolites and energy [GO:0043467]; regulation of reproductive process [GO:2000241]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; sebaceous gland development [GO:0048733]; secondary heart field specification [GO:0003139]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],chromatin [GO:0000785]; cytoplasm [GO:0005737]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]
P62877,C2,1.118816514,0.561104669,-0.204903016,-0.295229328,-0.397471411,aquamarine,RBX1,RBX1_HUMAN,"E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (E3 ubiquitin-protein transferase RBX1) (Protein ZYP) (RING finger protein 75) (RING-box protein 1) (Rbx1) (Regulator of cullins 1) (ROC1) [Cleaved into: E3 ubiquitin-protein ligase RBX1, N-terminally processed (E3 ubiquitin-protein transferase RBX1, N-terminally processed)]",RBX1 RNF75 ROC1,9978;,ENST00000216225.9; ENSP00000216225.8; ENSG00000100387.9.;,cullin family protein binding [GO:0097602]; molecular adaptor activity [GO:0060090]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270],cellular response to amino acid stimulus [GO:0071230]; cellular response to chemical stress [GO:0062197]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of type I interferon production [GO:0032480]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of TORC1 signaling [GO:1904263]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cellular response to insulin stimulus [GO:1900076]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; spermatogenesis [GO:0007283]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]
P18754,N2,-0.839517502,0.252911646,0.846024605,-0.161479531,-0.663657933,grey70,RCC1,RCC1_HUMAN,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),RCC1 CHC1,1104;,"ENST00000373831.7; ENSP00000362937.3; ENSG00000180198.17. [P18754-2];""ENST00000373832.5; ENSP00000362938.1; ENSG00000180198.17. [P18754-1]"";""ENST00000373833.10; ENSP00000362939.5; ENSG00000180198.17. [P18754-1]"";""ENST00000398958.6; ENSP00000381931.2; ENSG00000180198.17. [P18754-1]"";""ENST00000649185.1; ENSP00000497402.1; ENSG00000180198.17. [P18754-2]"";""ENST00000683442.1; ENSP00000508074.1; ENSG00000180198.17. [P18754-1]"";",chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199],cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032],chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q9Y256,S2,-0.807055469,-1.177562806,0.355470663,0.800278964,0.59324834,orange,RCE1,FACE2_HUMAN,CAAX prenyl protease 2 (EC 3.4.-.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1),RCE1 FACE2 RCE1A RCE1B,9986;,ENST00000309657.8; ENSP00000309163.3; ENSG00000173653.8.;,cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222],CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9Y2P8,N3,-1.335897164,-1.383670319,1.252130686,-0.386154979,0.350754136,grey50,RCL1,RCL1_HUMAN,RNA 3'-terminal phosphate cyclase-like protein,RCL1 RNAC RPC2 RPCL1 RTC2 HSPC338,10171;,"ENST00000381728.5; ENSP00000371147.1; ENSG00000120158.12. [Q9Y2P8-2];""ENST00000381730.5; ENSP00000371149.1; ENSG00000120158.12. [Q9Y2P8-2]"";""ENST00000381750.9; ENSP00000371169.4; ENSG00000120158.12. [Q9Y2P8-1]"";""ENST00000448872.6; ENSP00000388096.2; ENSG00000120158.12. [Q9Y2P8-2]"";",RNA endonuclease activity [GO:0004521],"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; ribosomal small subunit biogenesis [GO:0042274]",nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q15293,N4,-1.047076407,0.5801923,-0.244761622,0.494766302,0.043278642,grey30,RCN1,RCN1_HUMAN,Reticulocalbin-1,RCN1 RCN,5954;,ENST00000054950.4; ENSP00000054950.4; ENSG00000049449.10. [Q15293-1];,calcium ion binding [GO:0005509],camera-type eye development [GO:0043010]; in utero embryonic development [GO:0001701],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]
Q9UKL0,N4,-1.12016909,0.913056177,0.323105529,-0.286318402,-0.3355933,grey30,RCOR1,RCOR1_HUMAN,REST corepressor 1 (Protein CoREST),RCOR1 KIAA0071 RCOR,23186;,ENST00000262241.7; ENSP00000262241.5; ENSG00000089902.10.;,chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714],chromatin organization [GO:0006325]; erythrocyte differentiation [GO:0030218]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357],DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]
Q9P2K3,N4,-1.136218408,1.08359253,0.369844531,-0.501162079,-0.395372362,grey30,RCOR3,RCOR3_HUMAN,REST corepressor 3,RCOR3 KIAA1343,55758;,"ENST00000367005.8; ENSP00000355972.4; ENSG00000117625.14. [Q9P2K3-1];""ENST00000367006.8; ENSP00000355973.4; ENSG00000117625.14. [Q9P2K3-2]"";""ENST00000419091.7; ENSP00000413929.2; ENSG00000117625.14. [Q9P2K3-3]"";""ENST00000452621.6; ENSP00000398558.2; ENSG00000117625.14. [Q9P2K3-4]"";",transcription corepressor activity [GO:0003714],negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667]
Q8IZV5,S3,-0.712754193,-1.01877438,0.146971085,0.704822958,0.592899635,salmon,RDH10,RDH10_HUMAN,Retinol dehydrogenase 10 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 16C member 4),RDH10 SDR16C4 UNQ9375/PRO34191,157506;,ENST00000240285.10; ENSP00000240285.5; ENSG00000121039.10.;,"all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",bud elongation involved in lung branching [GO:0060449]; ear development [GO:0043583]; embryonic camera-type eye development [GO:0031076]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; metanephros development [GO:0001656]; neural crest cell development [GO:0014032]; nose development [GO:0043584]; positive regulation of retinoic acid biosynthetic process [GO:1900054]; primary lung bud formation [GO:0060431]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]
Q8TC12,S2,-1.077981949,-1.373592231,0.207326273,0.797887009,0.738713393,orange,RDH11,RDH11_HUMAN,Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1),RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82,51109;,"ENST00000381346.9; ENSP00000370750.4; ENSG00000072042.13. [Q8TC12-1];""ENST00000428130.6; ENSP00000416395.2; ENSG00000072042.13. [Q8TC12-3]"";""ENST00000553384.5; ENSP00000452079.1; ENSG00000072042.13. [Q8TC12-2]"";","11-cis-retinol dehydrogenase activity [GO:0102354]; aldehyde dehydrogenase (NADP+) activity [GO:0033721]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",cellular detoxification of aldehyde [GO:0110095]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]
Q8NBN7,M2,-0.98851649,-0.951613433,0.415985704,1.042587657,-0.098105744,tan4,RDH13,RDH13_HUMAN,Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3),RDH13 SDR7C3 PSEC0082 UNQ736/PRO1430,112724;,"ENST00000396247.7; ENSP00000379547.2; ENSG00000160439.16. [Q8NBN7-2];""ENST00000415061.8; ENSP00000391121.2; ENSG00000160439.16. [Q8NBN7-1]"";""ENST00000610356.4; ENSP00000477732.1; ENSG00000160439.16. [Q8NBN7-2]"";""ENST00000613257.1; ENSP00000479552.1; ENSG00000276341.1. [Q8NBN7-2]"";""ENST00000613935.1; ENSP00000482809.1; ENSG00000274504.1. [Q8NBN7-2]"";""ENST00000615256.4; ENSP00000477512.1; ENSG00000276684.4. [Q8NBN7-1]"";""ENST00000615688.1; ENSP00000482782.1; ENSG00000275474.1. [Q8NBN7-2]"";""ENST00000616348.1; ENSP00000477884.1; ENSG00000276826.1. [Q8NBN7-2]"";""ENST00000620423.1; ENSP00000482051.1; ENSG00000278149.1. [Q8NBN7-2]"";""ENST00000621614.4; ENSP00000484637.1; ENSG00000276684.4. [Q8NBN7-2]"";""ENST00000621849.1; ENSP00000480095.1; ENSG00000273944.1. [Q8NBN7-2]"";""ENST00000622200.1; ENSP00000484111.1; ENSG00000274418.1. [Q8NBN7-2]"";""ENST00000622572.1; ENSP00000484246.1; ENSG00000278284.1. [Q8NBN7-2]"";",all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],mitochondrial inner membrane [GO:0005743]
Q9HBH5,S2,-1.119852041,-1.126055215,0.189588879,0.838461691,0.528808563,orange,RDH14,RDH14_HUMAN,Retinol dehydrogenase 14 (EC 1.1.1.300) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4),RDH14 PAN2 SDR7C4 UNQ529/PRO1072,57665;,ENST00000381249.4; ENSP00000370648.3; ENSG00000240857.2.;,11-cis-retinol dehydrogenase activity [GO:0102354]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],osteoblast differentiation [GO:0001649],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P35241,C2,1.333500499,0.308986899,-0.478778767,-0.20934131,-0.193975468,aquamarine,RDX,RADI_HUMAN,Radixin,RDX,5962;,"ENST00000528498.5; ENSP00000432112.1; ENSG00000137710.17. [P35241-5];""ENST00000528900.5; ENSP00000433580.1; ENSG00000137710.17. [P35241-2]"";""ENST00000530301.5; ENSP00000436277.1; ENSG00000137710.17. [P35241-3]"";""ENST00000530749.5; ENSP00000437301.1; ENSG00000137710.17. [P35241-5]"";""ENST00000544551.5; ENSP00000445826.1; ENSG00000137710.17. [P35241-4]"";""ENST00000645495.2; ENSP00000496503.2; ENSG00000137710.17. [P35241-1]"";""ENST00000647231.1; ENSP00000496414.1; ENSG00000137710.17. [P35241-5]"";",actin binding [GO:0003779]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein kinase A binding [GO:0051018]; RNA binding [GO:0003723],apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to early endosome [GO:1902966]; protein kinase A signaling [GO:0010737]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of Rap protein signal transduction [GO:0032487]; regulation of ruffle assembly [GO:1900027],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044]; T-tubule [GO:0030315]
O94762,N1,-0.971215826,0.290891637,0.1403699,-0.307590005,0.866675,grey90,RECQL5,RECQ5_HUMAN,"ATP-dependent DNA helicase Q5 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ5) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5)",RECQL5 RECQ5,9400;,"ENST00000317905.10; ENSP00000317636.5; ENSG00000108469.15. [O94762-1];""ENST00000340830.9; ENSP00000341983.5; ENSG00000108469.15. [O94762-3]"";""ENST00000420326.6; ENSP00000414933.2; ENSG00000108469.15. [O94762-2]"";""ENST00000423245.6; ENSP00000394820.2; ENSG00000108469.15. [O94762-4]"";""ENST00000584999.1; ENSP00000462248.1; ENSG00000108469.15. [O94762-3]"";",3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993],cell division [GO:0051301]; cellular response to camptothecin [GO:0072757]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome separation [GO:0051304]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle [GO:0000278]; mitotic DNA-templated DNA replication [GO:1990506]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; transcription preinitiation complex [GO:0097550]
Q6NUK4,S1,-0.580682378,-1.103273347,0.127563287,0.63308458,0.763189085,gold,REEP3,REEP3_HUMAN,Receptor expression-enhancing protein 3,REEP3 C10orf74,221035;,ENST00000373758.5; ENSP00000362863.4; ENSG00000165476.14. [Q6NUK4-1];,microtubule binding [GO:0008017],cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998],cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]
Q9H6H4,S3,-0.63917863,-0.859396654,0.18805821,0.628375804,0.677155008,salmon,REEP4,REEP4_HUMAN,Receptor expression-enhancing protein 4,REEP4 C8orf20 PP432,80346;,"ENST00000306306.8; ENSP00000303482.3; ENSG00000168476.12. [Q9H6H4-1];""ENST00000334530.9; ENSP00000333889.5; ENSG00000168476.12. [Q9H6H4-2]"";",microtubule binding [GO:0008017],cell division [GO:0051301]; endoplasmic reticulum tubular network organization [GO:0071786]; mitotic nuclear membrane reassembly [GO:0007084]; nuclear envelope organization [GO:0006998],cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]
Q00765,S1,-1.170988073,-1.148919915,0.048847768,0.671649362,0.985620539,gold,REEP5,REEP5_HUMAN,Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2),REEP5 C5orf18 DP1 TB2,7905;,ENST00000379638.9; ENSP00000368959.4; ENSG00000129625.13. [Q00765-1];,0,endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; regulation of intracellular transport [GO:0032386],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; sarcoplasmic reticulum membrane [GO:0033017]
Q04864,C3,1.801198566,0.201057219,-0.50859787,-0.532646392,-0.856759196,cyan,REL,REL_HUMAN,Proto-oncogene c-Rel,REL,5966;,"ENST00000295025.12; ENSP00000295025.7; ENSG00000162924.16. [Q04864-1];""ENST00000394479.4; ENSP00000377989.4; ENSG00000162924.16. [Q04864-2]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",canonical NF-kappaB signal transduction [GO:0007249]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q01201,C3,1.603700383,0.254535223,-0.403791011,-0.460133548,-0.760728892,cyan,RELB,RELB_HUMAN,Transcription factor RelB (I-Rel),RELB,5971;,ENST00000221452.13; ENSP00000221452.7; ENSG00000104856.15.;,"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",antigen processing and presentation [GO:0019882]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to osmotic stress [GO:0071470]; circadian regulation of gene expression [GO:0032922]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lymphocyte differentiation [GO:0030098]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interferon-beta production [GO:0032688]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cytokine [GO:0034097]; T-helper 1 cell differentiation [GO:0045063],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; NF-kappaB complex [GO:0071159]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transcription repressor complex [GO:0017053]
Q8IUW5,S4,-1.584383402,-1.737398669,0.573764606,1.132016095,0.123127097,tomato2,RELL1,RELL1_HUMAN,RELT-like protein 1,RELL1 PSEC0162,768211;,"ENST00000314117.8; ENSP00000313385.4; ENSG00000181826.10.;""ENST00000454158.7; ENSP00000398778.2; ENSG00000181826.10."";",0,positive regulation of p38MAPK cascade [GO:1900745],microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]
O15258,S1,-0.705188965,-0.850935117,0.012536182,0.300210787,1.002913889,gold,RER1,RER1_HUMAN,Protein RER1,RER1,11079;,"ENST00000488353.2; ENSP00000464222.1; ENSG00000157916.20.;""ENST00000605895.6; ENSP00000475168.1; ENSG00000157916.20."";",acetylcholine receptor binding [GO:0033130],"positive regulation of protein localization to plasma membrane [GO:1903078]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]",cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]
Q6NUM9,S3,-0.658521606,-1.130509668,0.219393839,0.764504093,0.57443011,salmon,RETSAT,RETST_HUMAN,"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)",RETSAT PPSIG UNQ439/PRO872,54884;,"ENST00000295802.9; ENSP00000295802.4; ENSG00000042445.14. [Q6NUM9-1];""ENST00000709863.1; ENSP00000517901.1; ENSG00000292155.1. [Q6NUM9-1]"";","all-trans-retinol 13,14-reductase activity [GO:0051786]",retinol metabolic process [GO:0042572],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]
Q9Y3B8,C1,1.31184065,0.457571473,-0.256922946,-0.162299721,-1.316604222,lightblue,REXO2,ORN_HUMAN,"Oligoribonuclease, mitochondrial (EC 3.1.15.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)",REXO2 SFN SMFN CGI-114,25996;,ENST00000265881.10; ENSP00000265881.5; ENSG00000076043.11. [Q9Y3B8-1];,3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676],nucleobase-containing compound metabolic process [GO:0006139]; nucleotide metabolic process [GO:0009117],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]
Q9GZR2,N3,-1.04824652,-1.08822797,1.176664575,-0.047584887,0.35962541,grey50,REXO4,REXO4_HUMAN,RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog) (hPMC2),REXO4 PMC2 XPMC2H,57109;,"ENST00000371935.6; ENSP00000361003.2; ENSG00000148300.12. [Q9GZR2-2];""ENST00000371942.8; ENSP00000361010.3; ENSG00000148300.12. [Q9GZR2-1]"";""ENST00000628678.2; ENSP00000487504.1; ENSG00000280706.3. [Q9GZR2-2]"";""ENST00000630460.3; ENSP00000486065.1; ENSG00000280706.3. [Q9GZR2-1]"";",3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],DNA catabolic process [GO:0006308]; DNA repair [GO:0006281]; regulation of DNA-templated transcription [GO:0006355]; rRNA processing [GO:0006364],nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P35251,N1,-1.211680372,-0.651498008,0.269983221,0.196914394,1.14004608,grey90,RFC1,RFC1_HUMAN,Replication factor C subunit 1 (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit),RFC1 RFC140,5981;,"ENST00000349703.7; ENSP00000261424.4; ENSG00000035928.17. [P35251-2];""ENST00000381897.5; ENSP00000371321.1; ENSG00000035928.17. [P35251-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565],DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; telomere maintenance via telomerase [GO:0007004],DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8WZ73,S1,-0.483639066,-0.79422597,0.030179275,0.497271753,0.888769041,gold,RFFL,RFFL_HUMAN,E3 ubiquitin-protein ligase rififylin (EC 2.3.2.27) (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2) (CARP-2) (FYVE-RING finger protein Sakura) (Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like) (RING-type E3 ubiquitin transferase rififylin),RFFL RNF189 RNF34L,117584;,"ENST00000315249.11; ENSP00000326170.7; ENSG00000092871.17. [Q8WZ73-1];""ENST00000394597.7; ENSP00000378096.3; ENSG00000092871.17. [Q8WZ73-1]"";""ENST00000413582.6; ENSP00000408513.2; ENSG00000092871.17. [Q8WZ73-2]"";""ENST00000415395.6; ENSP00000412322.2; ENSG00000092871.17. [Q8WZ73-1]"";""ENST00000447669.6; ENSP00000389832.2; ENSG00000092871.17. [Q8WZ73-1]"";""ENST00000584655.5; ENSP00000463035.1; ENSG00000092871.17. [Q8WZ73-3]"";",metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625],apoptotic process [GO:0006915]; negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001271]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of fibroblast migration [GO:0010762]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of TOR signaling [GO:0032006]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]
P22670,N4,-0.983912967,0.632859555,0.49129207,0.024833261,-0.211813802,grey30,RFX1,RFX1_HUMAN,MHC class II regulatory factor RFX1 (Enhancer factor C) (EF-C) (Regulatory factor X 1) (RFX) (Transcription factor RFX1),RFX1,5989;,"ENST00000254325.9; ENSP00000254325.3; ENSG00000132005.9.;""ENST00000672295.1; ENSP00000500760.1; ENSG00000288283.1."";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",immune response [GO:0006955]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]
Q8TEB9,S3,-0.464293151,-0.838229162,0.295268927,0.663055188,0.456634012,salmon,RHBDD1,RHBL4_HUMAN,Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4),RHBDD1 RHBDL4 HSD-50 HSD50,84236;,"ENST00000341329.7; ENSP00000344779.3; ENSG00000144468.17. [Q8TEB9-1];""ENST00000392062.7; ENSP00000375914.2; ENSG00000144468.17. [Q8TEB9-1]"";",endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252],"apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966]
Q9Y3P4,S1,-0.531762247,-0.821995965,-0.007389948,0.655676705,0.801879774,gold,RHBDD3,RHBD3_HUMAN,Rhomboid domain-containing protein 3,RHBDD3 C22orf3,25807;,ENST00000216085.12; ENSP00000216085.7; ENSG00000100263.14.;,serine-type endopeptidase activity [GO:0004252],liver development [GO:0001889]; MAPK cascade [GO:0000165]; negative regulation of natural killer cell activation [GO:0032815]; positive regulation of protein catabolic process [GO:0045732]; regulation of acute inflammatory response [GO:0002673]; regulation of protein secretion [GO:0050708]; response to xenobiotic stimulus [GO:0009410],membrane [GO:0016020]
Q96CC6,S4,-0.803979308,-1.032677596,0.429755982,0.801002422,0.326355422,tomato2,RHBDF1,RHDF1_HUMAN,Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho),RHBDF1 C16orf8 DIST1 IRHOM1,64285;,ENST00000262316.10; ENSP00000262316.5; ENSG00000007384.15.;,growth factor binding [GO:0019838],cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]
Q6PJF5,S4,-0.930350742,-1.258258605,0.439458634,0.924534114,0.193393861,tomato2,RHBDF2,RHDF2_HUMAN,Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6),RHBDF2 IRHOM2 RHBDL5 RHBDL6,79651;,"ENST00000313080.8; ENSP00000322775.3; ENSG00000129667.13. [Q6PJF5-1];""ENST00000591885.5; ENSP00000466867.1; ENSG00000129667.13. [Q6PJF5-2]"";""ENST00000675367.1; ENSP00000501790.1; ENSG00000129667.13. [Q6PJF5-2]"";",growth factor binding [GO:0019838]; protein transporter activity [GO:0140318],negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of protein secretion [GO:0050709]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708],endoplasmic reticulum membrane [GO:0005789]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]
Q15382,C3,1.667348696,0.313727413,-0.594706464,-0.458003754,-0.587107838,cyan,RHEB,RHEB_HUMAN,GTP-binding protein Rheb (Ras homolog enriched in brain) (EC 3.6.5.-),RHEB RHEB2,6009;,ENST00000262187.10; ENSP00000262187.5; ENSG00000106615.10.;,GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539],cellular response to nutrient levels [GO:0031669]; negative regulation of cold-induced thermogenesis [GO:0120163]; oligodendrocyte differentiation [GO:0048709]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell cycle [GO:0051726]; regulation of macroautophagy [GO:0016241]; regulation of type B pancreatic cell development [GO:2000074]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]
P62745,S2,-0.771537557,-1.11917446,0.255209358,0.858641775,0.587301131,orange,RHOB,RHOB_HUMAN,Rho-related GTP-binding protein RhoB (Rho cDNA clone 6) (h6),RHOB ARH6 ARHB,388;,ENST00000272233.6; ENSP00000272233.4; ENSG00000143878.10.;,GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],actin filament organization [GO:0007015]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; endosome to lysosome transport [GO:0008333]; endothelial tube morphogenesis [GO:0061154]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; regulation of cell migration [GO:0030334]; regulation of modification of postsynaptic structure [GO:0099159]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]
P84095,S3,-0.715537732,-0.970917334,0.224031133,0.684043391,0.684825507,salmon,RHOG,RHOG_HUMAN,Rho-related GTP-binding protein RhoG,RHOG ARHG,391;,"ENST00000351018.5; ENSP00000339467.4; ENSG00000177105.10.;""ENST00000396978.1; ENSP00000380175.1; ENSG00000177105.10."";""ENST00000396979.1; ENSP00000380176.1; ENSG00000177105.10."";""ENST00000533217.1; ENSP00000436932.1; ENSG00000177105.10."";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to plasma membrane [GO:1903078]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of postsynapse assembly [GO:0150052]; regulation of ruffle assembly [GO:1900027]; Rho protein signal transduction [GO:0007266],cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; secretory granule membrane [GO:0030667]
Q8IXI2,M2,-1.131865767,-1.296992556,0.430137439,1.062331169,-0.092466763,tan4,RHOT1,MIRO1_HUMAN,Mitochondrial Rho GTPase 1 (MIRO-1) (hMiro-1) (EC 3.6.5.-) (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1),RHOT1 ARHT1,55288;,"ENST00000333942.10; ENSP00000334724.6; ENSG00000126858.19. [Q8IXI2-1];""ENST00000358365.7; ENSP00000351132.3; ENSG00000126858.19. [Q8IXI2-3]"";""ENST00000394692.6; ENSP00000378184.2; ENSG00000126858.19. [Q8IXI2-2]"";""ENST00000545287.7; ENSP00000439737.2; ENSG00000126858.19. [Q8IXI2-7]"";""ENST00000581031.5; ENSP00000464094.1; ENSG00000126858.19. [Q8IXI2-5]"";""ENST00000581094.5; ENSP00000462669.1; ENSG00000126858.19. [Q8IXI2-4]"";",calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; regulation of mitochondrion organization [GO:0010821]; small GTPase-mediated signal transduction [GO:0007264],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q8IXI1,M2,-1.243988826,-1.437322346,0.381259991,1.20136657,-0.208168629,tan4,RHOT2,MIRO2_HUMAN,Mitochondrial Rho GTPase 2 (MIRO-2) (hMiro-2) (EC 3.6.5.-) (Ras homolog gene family member T2),RHOT2 ARHT2 C16orf39,89941;,ENST00000315082.9; ENSP00000321971.4; ENSG00000140983.15. [Q8IXI1-1];,calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497]; small GTPase-mediated signal transduction [GO:0007264],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q6R327,C1,0.98451663,-0.208164047,-0.278588445,0.049823224,0.292114863,lightblue,RICTOR,RICTR_HUMAN,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3),RICTOR KIAA1999,253260;,"ENST00000296782.10; ENSP00000296782.5; ENSG00000164327.14. [Q6R327-3];""ENST00000357387.8; ENSP00000349959.3; ENSG00000164327.14. [Q6R327-1]"";""ENST00000511516.5; ENSP00000423019.1; ENSG00000164327.14. [Q6R327-4]"";",molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022],actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; negative regulation of apoptotic process [GO:0043066]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; TORC2 signaling [GO:0038203],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; TORC2 complex [GO:0031932]
Q5T3J3,N2,-1.252505683,-0.562681405,1.127521874,0.19935877,-0.22369639,grey70,RIF1,LRIF1_HUMAN,Ligand-dependent nuclear receptor-interacting factor 1 (HP1-binding protein enriched in inactive X chromosome protein 1) (HBiX1) (Receptor-interacting factor 1),LRIF1 C1orf103 RIF1,55791;,"ENST00000369763.5; ENSP00000358778.4; ENSG00000121931.16. [Q5T3J3-1];""ENST00000485275.2; ENSP00000432290.1; ENSG00000121931.16. [Q5T3J3-2]"";""ENST00000494675.5; ENSP00000435259.1; ENSG00000121931.16. [Q5T3J3-2]"";",nuclear retinoic acid receptor binding [GO:0042974],dosage compensation by inactivation of X chromosome [GO:0009048]; regulation of DNA-templated transcription [GO:0006355],Barr body [GO:0001740]; centriolar satellite [GO:0034451]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]
Q8TB24,C3,1.43665194,0.08124963,-0.360751548,-0.161410852,-0.388882076,cyan,RIN3,RIN3_HUMAN,Ras and Rab interactor 3 (Ras interaction/interference protein 3),RIN3,79890;,ENST00000216487.12; ENSP00000216487.7; ENSG00000100599.16. [Q8TB24-1];,GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],endocytosis [GO:0006897]; negative regulation of mast cell chemotaxis [GO:0060755]; negative regulation of receptor internalization [GO:0002091]; regulation of vesicle size [GO:0097494]; signal transduction [GO:0007165],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; vesicle [GO:0031982]
Q96DB5,N4,-1.557612129,0.924634691,0.157751625,0.362999494,-0.715456498,grey30,RMDN1,RMD1_HUMAN,Regulator of microtubule dynamics protein 1 (RMD-1) (hRMD-1) (Protein FAM82B),RMDN1 FAM82B CGI-90,51115;,"ENST00000406452.8; ENSP00000385927.3; ENSG00000176623.12. [Q96DB5-1];""ENST00000430676.6; ENSP00000409661.2; ENSG00000176623.12. [Q96DB5-2]"";""ENST00000519966.5; ENSP00000428661.1; ENSG00000176623.12. [Q96DB5-3]"";",microtubule binding [GO:0008017],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; mitotic spindle organization [GO:0007052],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]
Q96LZ7,M2,-1.993216538,-2.227143652,0.483650398,1.354367127,-0.17724759,tan4,RMDN2,RMD2_HUMAN,Regulator of microtubule dynamics protein 2 (RMD-2) (hRMD-2) (Protein FAM82A1),RMDN2 FAM82A FAM82A1 BLOCK18 UNQ9371/PRO34163,151393;,"ENST00000354545.8; ENSP00000346549.3; ENSG00000115841.21. [Q96LZ7-1];""ENST00000406384.5; ENSP00000386004.1; ENSG00000115841.21. [Q96LZ7-1]"";""ENST00000417700.6; ENSP00000392977.2; ENSG00000115841.21. [Q96LZ7-4]"";",microtubule binding [GO:0008017],0,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; spindle microtubule [GO:0005876]
Q96TC7,M2,-0.952521423,-1.217704776,0.282135357,1.143041034,-0.259951539,tan4,RMDN3,RMD3_HUMAN,Regulator of microtubule dynamics protein 3 (RMD-3) (hRMD-3) (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51),RMDN3 FAM82A2 FAM82C PTPIP51 hucep-10 UNQ3122/PRO10274,55177;,"ENST00000260385.10; ENSP00000260385.6; ENSG00000137824.16. [Q96TC7-1];""ENST00000338376.8; ENSP00000342493.3; ENSG00000137824.16. [Q96TC7-1]"";",microtubule binding [GO:0008017],apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; intracellular calcium ion homeostasis [GO:0006874],cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; organelle membrane contact site [GO:0044232]; spindle microtubule [GO:0005876]
Q9NWS8,M2,-1.40421554,-1.75995315,0.477329343,1.16902459,-0.180574445,tan4,RMND1,RMND1_HUMAN,Required for meiotic nuclear division protein 1 homolog,RMND1 C6orf96,55005;,"ENST00000444024.3; ENSP00000412708.2; ENSG00000155906.20. [Q9NWS8-1];""ENST00000491268.2; ENSP00000494948.1; ENSG00000155906.20. [Q9NWS8-3]"";""ENST00000683724.1; ENSP00000507984.1; ENSG00000155906.20. [Q9NWS8-1]"";""ENST00000684301.1; ENSP00000507824.1; ENSG00000155906.20. [Q9NWS8-3]"";",0,positive regulation of mitochondrial translation [GO:0070131]; translation [GO:0006412],mitochondrion [GO:0005739]
Q5XPI4,C3,1.747097526,0.018205128,-0.634222874,-0.520675819,-0.590696493,cyan,RNF123,RN123_HUMAN,E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123),RNF123 KPC1 FP1477,63891;,ENST00000327697.11; ENSP00000328287.6; ENSG00000164068.16. [Q5XPI4-1];,metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],protein maturation [GO:0051604]; protein polyubiquitination [GO:0000209]; proteolysis involved in protein catabolic process [GO:0051603]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]
Q9BV68,C2,1.222505551,0.171947951,-0.334600806,-0.036566815,-0.081382978,aquamarine,RNF126,RN126_HUMAN,E3 ubiquitin-protein ligase RNF126 (EC 2.3.2.27) (RING finger protein 126),RNF126,55658;,ENST00000292363.10; ENSP00000292363.3; ENSG00000070423.18.;,epidermal growth factor receptor binding [GO:0005154]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],"cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; retrograde transport, endosome to Golgi [GO:0042147]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O43567,S1,-1.205197549,-0.967855333,-0.279733618,0.721151373,1.156047066,gold,RNF13,RNF13_HUMAN,E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13),RNF13 RZF,11342;,"ENST00000344229.7; ENSP00000341361.3; ENSG00000082996.20. [O43567-1];""ENST00000361785.10; ENSP00000355268.6; ENSG00000082996.20. [O43567-2]"";""ENST00000392894.8; ENSP00000376628.3; ENSG00000082996.20. [O43567-1]"";",JUN kinase binding [GO:0008432]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],organelle localization [GO:0051640]; positive regulation of JNK cascade [GO:0046330]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]
Q86XS8,S3,-0.422709389,-0.852072262,-0.025061227,0.714170028,0.666249548,salmon,RNF130,GOLI_HUMAN,E3 ubiquitin-protein ligase RNF130 (EC 2.3.2.27) (Goliath homolog) (H-Goliath) (RING finger protein 130) (RING-type E3 ubiquitin transferase RNF130),RNF130,55819;,"ENST00000261947.4; ENSP00000261947.4; ENSG00000113269.14. [Q86XS8-2];""ENST00000521389.6; ENSP00000430237.1; ENSG00000113269.14. [Q86XS8-1]"";",metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],apoptotic process [GO:0006915]; programmed cell death [GO:0012501]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; membrane [GO:0016020]
Q8WU17,S3,-1.060301259,-1.146753379,0.240745623,0.805932005,0.536789541,salmon,RNF139,RN139_HUMAN,E3 ubiquitin-protein ligase RNF139 (EC 2.3.2.27) (RING finger protein 139) (RING-type E3 ubiquitin transferase RNF139) (Translocation in renal carcinoma on chromosome 8 protein),RNF139 TRC8,11236;,"ENST00000303545.4; ENSP00000304051.4; ENSG00000170881.5.;""ENST00000708475.1; ENSP00000517238.1; ENSG00000291729.1."";",protease binding [GO:0002020]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],ERAD pathway [GO:0036503]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of translation [GO:0017148]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein processing [GO:0070613],Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9UBS8,C4,1.995602211,-0.13160191,-0.882448775,-0.725460558,-0.960778491,deepskyblue2,RNF14,RNF14_HUMAN,E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14),RNF14 ARA54 HRIHFB2038,9604;,"ENST00000347642.7; ENSP00000324956.3; ENSG00000013561.18. [Q9UBS8-1];""ENST00000356143.5; ENSP00000348462.1; ENSG00000013561.18. [Q9UBS8-1]"";""ENST00000394514.6; ENSP00000378022.2; ENSG00000013561.18. [Q9UBS8-2]"";""ENST00000394519.5; ENSP00000378027.1; ENSG00000013561.18. [Q9UBS8-1]"";""ENST00000394520.7; ENSP00000378028.2; ENSG00000013561.18. [Q9UBS8-1]"";",nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; zinc ion binding [GO:0008270],androgen receptor signaling pathway [GO:0030521]; positive regulation of DNA-templated transcription [GO:0045893]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; rescue of stalled ribosome [GO:0072344]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
Q96MT1,S3,-0.5890113,-1.165426917,-0.0135388,0.713421046,0.479184238,salmon,RNF145,RN145_HUMAN,RING finger protein 145 (EC 2.3.2.27),RNF145,153830;,"ENST00000274542.6; ENSP00000274542.2; ENSG00000145860.13. [Q96MT1-2];""ENST00000424310.7; ENSP00000409064.2; ENSG00000145860.13. [Q96MT1-1]"";""ENST00000518802.5; ENSP00000430955.1; ENSG00000145860.13. [Q96MT1-5]"";""ENST00000519865.5; ENSP00000430397.1; ENSG00000145860.13. [Q96MT1-1]"";""ENST00000520638.1; ENSP00000429071.1; ENSG00000145860.13. [Q96MT1-4]"";""ENST00000521606.6; ENSP00000430753.2; ENSG00000145860.13. [Q96MT1-3]"";",ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]
Q9NTX7,C4,2.050978213,0.153799542,-0.825645461,-0.816411641,-0.983997151,deepskyblue2,RNF146,RN146_HUMAN,E3 ubiquitin-protein ligase RNF146 (EC 2.3.2.27) (Dactylidin) (Iduna) (RING finger protein 146) (RING-type E3 ubiquitin transferase RNF146),RNF146,81847;,"ENST00000368314.6; ENSP00000357297.1; ENSG00000118518.17. [Q9NTX7-1];""ENST00000608991.5; ENSP00000477168.1; ENSG00000118518.17. [Q9NTX7-2]"";""ENST00000610153.1; ENSP00000476814.1; ENSG00000118518.17. [Q9NTX7-1]"";",poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q8NCN4,N2,-1.145701912,0.075436021,1.135567436,0.039324785,-0.78002462,grey70,RNF169,RN169_HUMAN,E3 ubiquitin-protein ligase RNF169 (EC 2.3.2.27) (RING finger protein 169) (RING-type E3 ubiquitin transferase RNF169),RNF169 KIAA1991,254225;,ENST00000299563.5; ENSP00000299563.4; ENSG00000166439.6.;,K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; ubiquitin-modified histone reader activity [GO:0061649]; ubiquitin-protein transferase activity [GO:0004842],DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair [GO:2000780]; protein ubiquitination [GO:0016567],cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]
Q96K19,S2,-1.281416869,-1.283532679,0.201548723,0.747270573,0.446752393,orange,RNF170,RN170_HUMAN,E3 ubiquitin-protein ligase RNF170 (EC 2.3.2.27) (Putative LAG1-interacting protein) (RING finger protein 170) (RING-type E3 ubiquitin transferase RNF170),RNF170,81790;,"ENST00000240159.8; ENSP00000240159.4; ENSG00000120925.16. [Q96K19-5];""ENST00000319073.5; ENSP00000325969.5; ENSG00000120925.16. [Q96K19-5]"";""ENST00000319104.7; ENSP00000326138.3; ENSG00000120925.16. [Q96K19-3]"";""ENST00000526349.5; ENSP00000435782.1; ENSG00000120925.16. [Q96K19-6]"";""ENST00000527424.6; ENSP00000434797.1; ENSG00000120925.16. [Q96K19-1]"";""ENST00000534961.5; ENSP00000445725.1; ENSG00000120925.16. [Q96K19-1]"";",metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; protein K48-linked ubiquitination [GO:0070936],endoplasmic reticulum membrane [GO:0005789]
Q9NV58,S2,-1.01430666,-1.341912383,0.261701726,0.68538259,0.717904892,orange,RNF19A,RN19A_HUMAN,E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38),RNF19A RNF19,25897;,"ENST00000341084.7; ENSP00000342667.2; ENSG00000034677.13. [Q9NV58-1];""ENST00000519449.5; ENSP00000428968.1; ENSG00000034677.13. [Q9NV58-1]"";",ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],"microtubule cytoskeleton organization [GO:0000226]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]
Q99496,N1,-1.428710124,0.034666152,0.703961377,-0.548597865,0.589185391,grey90,RNF2,RING2_HUMAN,E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (Huntingtin-interacting protein 2-interacting protein 3) (HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2),RNF2 BAP1 DING HIPI3 RING1B,6045;,"ENST00000367509.8; ENSP00000356479.4; ENSG00000121481.11. [Q99496-2];""ENST00000367510.8; ENSP00000356480.3; ENSG00000121481.11. [Q99496-1]"";",chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],anterior/posterior axis specification [GO:0009948]; chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]
Q5VTR2,N4,-0.824087505,1.423633076,-0.221725607,-0.588697574,-0.669469443,grey30,RNF20,BRE1A_HUMAN,E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 2.3.2.27) (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A),RNF20 BRE1A,56254;,ENST00000389120.8; ENSP00000373772.3; ENSG00000155827.12.;,chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone H2B C-terminal K residue ubiquitin ligase activity [GO:0140850]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],negative regulation of cell migration [GO:0030336]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of DNA-templated transcription [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511],HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
Q9NWF9,C2,0.37367638,0.851571236,-0.127089393,-0.029039823,-0.588975944,aquamarine,RNF216,RN216_HUMAN,E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (Ubiquitin-conjugating enzyme 7-interacting protein 1) (Zinc finger protein inhibiting NF-kappa-B),RNF216 TRIAD3 UBCE7IP1 ZIN,54476;,"ENST00000389902.8; ENSP00000374552.3; ENSG00000011275.19. [Q9NWF9-1];""ENST00000425013.6; ENSP00000404602.2; ENSG00000011275.19. [Q9NWF9-2]"";",ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],apoptotic process [GO:0006915]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648],clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96BH1,C3,1.465292216,0.370441062,-0.417802439,-0.215291907,-0.604987218,cyan,RNF25,RNF25_HUMAN,E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING finger protein AO7),RNF25,64320;,ENST00000295704.7; ENSP00000295704.2; ENSG00000163481.8.;,metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; protein-RNA covalent cross-linking repair [GO:0160127]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]
O75150,N4,-0.832127745,1.320702686,-0.217904856,-0.499379841,-0.524180573,grey30,RNF40,BRE1B_HUMAN,E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (95 kDa retinoblastoma-associated protein) (RBP95) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B),RNF40 BRE1B KIAA0661,9810;,"ENST00000324685.11; ENSP00000325677.6; ENSG00000103549.22. [O75150-1];""ENST00000357890.9; ENSP00000350563.5; ENSG00000103549.22. [O75150-4]"";",metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625],chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],HULC complex [GO:0033503]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
Q99942,S2,-1.167011393,-1.853289852,0.340368968,0.762969241,0.695061687,orange,RNF5,RNF5_HUMAN,E3 ubiquitin-protein ligase RNF5 (EC 2.3.2.27) (RING finger protein 5) (Ram1 homolog) (HsRma1),RNF5 G16 NG2 RMA1,6048;,"ENST00000375094.4; ENSP00000364235.3; ENSG00000204308.8.;""ENST00000413786.2; ENSP00000387879.2; ENSG00000225452.5."";""ENST00000432616.2; ENSP00000413131.2; ENSG00000183574.12."";""ENST00000445885.6; ENSP00000401172.2; ENSG00000227277.9."";""ENST00000449794.2; ENSP00000415784.2; ENSG00000223767.5."";""ENST00000453473.2; ENSP00000415127.2; ENSG00000228907.5."";""ENST00000456167.2; ENSP00000388795.2; ENSG00000228405.5."";",identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],ERAD pathway [GO:0036503]; negative regulation of autophagy [GO:0010507]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; regulation of autophagosome assembly [GO:2000785]; response to bacterium [GO:0009617]; transmembrane transport [GO:0055085]; ubiquitin-dependent protein catabolic process [GO:0006511],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]
O43148,N4,-1.176597898,1.128841267,-0.177675099,-0.604807728,-0.032930675,grey30,RNMT,MCES_HUMAN,mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase) (hCMT1) (hMet) (hcm1p),RNMT KIAA0398,8731;,"ENST00000262173.7; ENSP00000262173.3; ENSG00000101654.18. [O43148-1];""ENST00000383314.7; ENSP00000372804.2; ENSG00000101654.18. [O43148-1]"";""ENST00000543302.6; ENSP00000446426.1; ENSG00000101654.18. [O43148-1]"";""ENST00000589866.5; ENSP00000466252.1; ENSG00000101654.18. [O43148-1]"";""ENST00000592764.5; ENSP00000466111.1; ENSG00000101654.18. [O43148-2]"";",mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723],7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830],fibrillar center [GO:0001650]; mRNA cap methyltransferase RNMT:RAMAC complex [GO:0160130]; mRNA capping enzyme complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]
Q9HC36,S3,-1.236177417,-1.161658028,0.256735041,0.880555651,0.619648816,salmon,RNMTL1,MRM3_HUMAN,"rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)",MRM3 RNMTL1 HC90,55178;,ENST00000304478.9; ENSP00000306080.4; ENSG00000171861.11.;,identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039],rRNA 2'-O-methylation [GO:0000451],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q96LT9,N3,-1.284119621,-0.954340511,0.688760307,-0.239257731,1.002525202,grey50,RNPC3,RNPC3_HUMAN,RNA-binding region-containing protein 3 (RNA-binding motif protein 40) (RNA-binding protein 40) (U11/U12 small nuclear ribonucleoprotein 65 kDa protein) (U11/U12 snRNP 65 kDa protein) (U11/U12-65K),RNPC3 KIAA1839 RBM40 RNP SNRNP65,55599;,"ENST00000423855.7; ENSP00000391432.1; ENSG00000185946.16. [Q96LT9-1];""ENST00000524631.5; ENSP00000437278.1; ENSG00000185946.16. [Q96LT9-2]"";""ENST00000533099.5; ENSP00000432886.1; ENSG00000185946.16. [Q96LT9-1]"";",pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626],"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]
Q9H4A4,C5,1.976877352,0.473429993,-0.988786942,-1.118792163,-1.185299178,turquoise3,RNPEP,AMPB_HUMAN,Aminopeptidase B (AP-B) (EC 3.4.11.6) (Arginine aminopeptidase) (Arginyl aminopeptidase),RNPEP APB,6051;,ENST00000295640.9; ENSP00000295640.4; ENSG00000176393.11.;,aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; zinc ion binding [GO:0008270],proteolysis [GO:0006508],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]
Q15287,N3,-1.233876535,-1.009969455,1.175779688,0.201892145,0.042072981,grey50,RNPS1,RNPS1_HUMAN,RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2),RNPS1 LDC2,10921;,"ENST00000301730.12; ENSP00000301730.8; ENSG00000205937.12. [Q15287-1];""ENST00000320225.10; ENSP00000315859.5; ENSG00000205937.12. [Q15287-1]"";""ENST00000397086.6; ENSP00000380275.2; ENSG00000205937.12. [Q15287-1]"";""ENST00000565678.5; ENSP00000457723.1; ENSG00000205937.12. [Q15287-1]"";""ENST00000566458.5; ENSP00000456352.1; ENSG00000205937.12. [Q15287-2]"";""ENST00000568631.5; ENSP00000457820.1; ENSG00000205937.12. [Q15287-1]"";",mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723],"DNA-templated transcription [GO:0006351]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13464,C3,1.545747299,0.397339135,-0.636597067,-0.499053214,-0.875947308,cyan,ROCK1,ROCK1_HUMAN,"Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)",ROCK1,6093;,ENST00000399799.3; ENSP00000382697.1; ENSG00000067900.9.;,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; small GTPase binding [GO:0031267]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; apical constriction [GO:0003383]; bleb assembly [GO:0032060]; blood vessel diameter maintenance [GO:0097746]; canonical NF-kappaB signal transduction [GO:0007249]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration [GO:0050900]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; mitotic cytokinesis [GO:0000281]; motor neuron apoptotic process [GO:0097049]; mRNA destabilization [GO:0061157]; myoblast migration [GO:0051451]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; peptidyl-serine phosphorylation [GO:0018105]; podocyte cell migration [GO:0090521]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatase activity [GO:0010922]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell migration [GO:0030334]; regulation of cell motility [GO:2000145]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of neuron differentiation [GO:0045664]; regulation of stress fiber assembly [GO:0051492]; regulation of synapse maturation [GO:0090128]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to angiotensin [GO:1990776]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; smooth muscle contraction [GO:0006939],bleb [GO:0032059]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule lumen [GO:0034774]
O75116,C3,1.641445289,0.265582447,-0.616547696,-0.59608812,-0.928824319,cyan,ROCK2,ROCK2_HUMAN,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",ROCK2 KIAA0619,9475;,ENST00000315872.11; ENSP00000317985.6; ENSG00000134318.16.;,ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O75695,S2,-0.953375834,-1.475614234,0.350603149,0.771691078,0.42839682,orange,RP2,XRP2_HUMAN,Protein XRP2,RP2,6102;,ENST00000218340.4; ENSP00000218340.3; ENSG00000102218.6.;,GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; unfolded protein binding [GO:0051082],cilium assembly [GO:0060271]; post-Golgi vesicle-mediated transport [GO:0006892]; protein folding [GO:0006457]; protein transport [GO:0015031]; visual perception [GO:0007601],centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; periciliary membrane compartment [GO:1990075]; plasma membrane [GO:0005886]
C9J7I0,C4,1.955697115,0.355931322,-0.938472012,-0.691603088,-0.946105848,deepskyblue2,RPA3-AS1,UMAD1_HUMAN,UBAP1-MVB12-associated (UMA)-domain containing protein 1 (RPA3 antisense RNA 1) (RPA3 opposite strand),UMAD1 RPA3-AS1 RPA3OS,729852;,"ENST00000636849.1; ENSP00000489648.1; ENSG00000219545.12.;""ENST00000682710.1; ENSP00000507605.1; ENSG00000219545.12."";",0,0,0
Q86UA6,N4,0.807381041,1.090774385,-0.458416365,-0.467322466,-0.731452069,grey30,RPAIN,RIP_HUMAN,RPA-interacting protein (hRIP),RPAIN RIP,84268;,"ENST00000327154.10; ENSP00000315069.6; ENSG00000129197.15. [Q86UA6-9];""ENST00000381208.9; ENSP00000370605.5; ENSG00000129197.15. [Q86UA6-2]"";""ENST00000381209.8; ENSP00000370606.3; ENSG00000129197.15. [Q86UA6-1]"";""ENST00000405578.8; ENSP00000385814.4; ENSG00000129197.15. [Q86UA6-8]"";""ENST00000536255.6; ENSP00000439939.2; ENSG00000129197.15. [Q86UA6-6]"";""ENST00000539417.6; ENSP00000446453.2; ENSG00000129197.15. [Q86UA6-4]"";""ENST00000571558.5; ENSP00000458699.1; ENSG00000129197.15. [Q86UA6-7]"";""ENST00000573577.5; ENSP00000460162.1; ENSG00000129197.15. [Q86UA6-7]"";""ENST00000574003.1; ENSP00000467178.1; ENSG00000129197.15. [Q86UA6-5]"";""ENST00000575112.5; ENSP00000460354.1; ENSG00000129197.15. [Q86UA6-7]"";""ENST00000575599.5; ENSP00000458218.1; ENSG00000129197.15. [Q86UA6-5]"";",metal ion binding [GO:0046872],protein import into nucleus [GO:0006606]; response to UV [GO:0009411],cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]
Q96AT9,C4,1.944574898,0.58997517,-1.009799466,-1.287405749,-1.35305467,deepskyblue2,RPE,RPE_HUMAN,Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase),RPE HUSSY-17,6120;,"ENST00000354506.10; ENSP00000346501.7; ENSG00000197713.15. [Q96AT9-4];""ENST00000359429.11; ENSP00000352401.6; ENSG00000197713.15. [Q96AT9-1]"";""ENST00000411934.6; ENSP00000389411.1; ENSG00000197713.15. [Q96AT9-5]"";""ENST00000429921.5; ENSP00000401838.1; ENSG00000197713.15. [Q96AT9-3]"";""ENST00000436630.6; ENSP00000403808.2; ENSG00000197713.15. [Q96AT9-3]"";""ENST00000438204.6; ENSP00000402061.1; ENSG00000197713.15. [Q96AT9-5]"";""ENST00000454822.5; ENSP00000394455.1; ENSG00000197713.15. [Q96AT9-3]"";",D-ribulose-phosphate 3-epimerase activity [GO:0004750]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803],"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]",cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P46934,N3,-1.103856704,-1.318443337,1.216874039,-0.125853319,0.06416526,grey50,RPF1,NEDD4_HUMAN,E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4),NEDD4 KIAA0093 NEDD4-1 RPF1 PIG53,4734;,"ENST00000338963.6; ENSP00000345530.2; ENSG00000069869.17. [P46934-3];""ENST00000435532.8; ENSP00000410613.3; ENSG00000069869.17. [P46934-4]"";""ENST00000506154.1; ENSP00000422705.1; ENSG00000069869.17. [P46934-2]"";""ENST00000508342.5; ENSP00000424827.1; ENSG00000069869.17. [P46934-1]"";",beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; proline-rich region binding [GO:0070064]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; sodium channel inhibitor activity [GO:0019871]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630],cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; formation of structure involved in a symbiotic process [GO:0044111]; glucocorticoid receptor signaling pathway [GO:0042921]; innate immune response [GO:0045087]; lysosomal transport [GO:0007041]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of nucleocytoplasmic transport [GO:0046824]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein catabolic process [GO:0045732]; progesterone receptor signaling pathway [GO:0050847]; protein K63-linked ubiquitination [GO:0070534]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of macroautophagy [GO:0016241]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; regulation of synapse organization [GO:0050807]; response to calcium ion [GO:0051592]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755],apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]
Q9H7B2,N3,-1.421652046,-1.246956147,1.292486184,-0.114567409,0.031536036,grey50,RPF2,RPF2_HUMAN,Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog),RPF2 BXDC1,84154;,ENST00000441448.7; ENSP00000402338.2; ENSG00000197498.13.;,5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; rRNA binding [GO:0019843],"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit biogenesis [GO:0042273]",chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q92834,C1,1.48220934,0.217480009,-0.451317878,-0.176049974,-0.293590492,lightblue,RPGR,RPGR_HUMAN,X-linked retinitis pigmentosa GTPase regulator,RPGR RP3 XLRP3,6103;,"ENST00000339363.7; ENSP00000343671.3; ENSG00000156313.15. [Q92834-1];""ENST00000474584.5; ENSP00000418926.1; ENSG00000156313.15. [Q92834-5]"";""ENST00000482855.5; ENSP00000419276.1; ENSG00000156313.15. [Q92834-3]"";""ENST00000642395.2; ENSP00000493468.2; ENSG00000156313.15. [Q92834-2]"";""ENST00000644337.1; ENSP00000494557.1; ENSG00000156313.15. [Q92834-4]"";""ENST00000645032.1; ENSP00000495537.1; ENSG00000156313.15. [Q92834-6]"";",guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630],cilium assembly [GO:0060271]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126]
P27635,N1,-0.580760511,-0.731613337,-0.409106814,-0.190463067,1.432383581,grey90,RPL10,RL10_HUMAN,Large ribosomal subunit protein uL16 (60S ribosomal protein L10) (Laminin receptor homolog) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM),RPL10 DXS648E QM,6134;,"ENST00000344746.8; ENSP00000341730.4; ENSG00000147403.18.;""ENST00000369817.7; ENSP00000358832.2; ENSG00000147403.18."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182],cytoplasmic translation [GO:0002181]; embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417]; translation [GO:0006412],cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
P62913,N1,-0.72000497,-0.912622194,-0.391254714,-0.363645774,1.617644826,grey90,RPL11,RL11_HUMAN,Large ribosomal subunit protein uL5 (60S ribosomal protein L11) (CLL-associated antigen KW-12),RPL11,6135;,"ENST00000374550.8; ENSP00000363676.4; ENSG00000142676.14. [P62913-2];""ENST00000643754.2; ENSP00000496250.1; ENSG00000142676.14. [P62913-1]"";",5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]
P30050,N1,-0.338288248,-0.901826479,-0.405429703,-0.299089588,1.400648685,grey90,RPL12,RL12_HUMAN,Large ribosomal subunit protein uL11 (60S ribosomal protein L12),RPL12,6136;,"ENST00000361436.10; ENSP00000354739.5; ENSG00000197958.13. [P30050-1];""ENST00000536368.1; ENSP00000441179.1; ENSG00000197958.13. [P30050-2]"";",large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]
P40429,N1,-0.438408019,-1.064386189,-0.387792968,-0.301280256,1.572279348,grey90,RPL13A,RL13A_HUMAN,Large ribosomal subunit protein uL13 (23 kDa highly basic protein) (60S ribosomal protein L13a),RPL13A,23521;,ENST00000391857.9; ENSP00000375730.4; ENSG00000142541.18.;,mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cellular response to type II interferon [GO:0071346]; cytoplasmic translation [GO:0002181]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202]
P50914,N1,-0.511592931,-1.21921955,-0.457879602,-0.389338579,1.629978856,grey90,RPL14,RL14_HUMAN,Large ribosomal subunit protein eL14 (60S ribosomal protein L14) (CAG-ISL 7),RPL14,9045;,"ENST00000338970.10; ENSP00000345156.6; ENSG00000188846.14.;""ENST00000396203.7; ENSP00000379506.2; ENSG00000188846.14."";",cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; postsynaptic density [GO:0014069]
P61313,N1,-0.436680267,-1.174601935,-0.290684637,-0.290929542,1.463338971,grey90,RPL15,RL15_HUMAN,Large ribosomal subunit protein eL15 (60S ribosomal protein L15),RPL15 EC45 TCBAP0781,6138;,"ENST00000307839.10; ENSP00000309334.5; ENSG00000174748.22. [P61313-1];""ENST00000354811.5; ENSP00000346867.5; ENSG00000174748.22. [P61313-1]"";""ENST00000413699.7; ENSP00000416692.1; ENSG00000174748.22. [P61313-1]"";""ENST00000415719.5; ENSP00000388529.1; ENSG00000174748.22. [P61313-1]"";""ENST00000456530.7; ENSP00000398788.2; ENSG00000174748.22. [P61313-2]"";""ENST00000611050.4; ENSP00000483260.1; ENSG00000174748.22. [P61313-1]"";""ENST00000644185.1; ENSP00000493759.1; ENSG00000174748.22. [P61313-1]"";",cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; response to ethanol [GO:0045471]; translation [GO:0006412],A band [GO:0031672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; ribosome [GO:0005840]; synapse [GO:0045202]
Q07020,N1,-0.621646716,-1.140231825,-0.369333,-0.333668935,1.616262084,grey90,RPL18,RL18_HUMAN,Large ribosomal subunit protein eL18 (60S ribosomal protein L18),RPL18,6141;,"ENST00000549920.6; ENSP00000447001.1; ENSG00000063177.13. [Q07020-1];""ENST00000552588.5; ENSP00000449204.1; ENSG00000063177.13. [Q07020-2]"";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]
Q02543,N1,-0.723475398,-1.367918968,-0.509947602,-0.416951066,1.703713575,grey90,RPL18A,RL18A_HUMAN,Large ribosomal subunit protein eL20 (60S ribosomal protein L18a),RPL18A,6142;,ENST00000222247.10; ENSP00000222247.4; ENSG00000105640.13.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]
P46778,N1,-0.786830616,-1.309497947,-0.599362197,-0.349220361,1.714317724,grey90,RPL21,RL21_HUMAN,Large ribosomal subunit protein eL21 (60S ribosomal protein L21),RPL21,6144;,"ENST00000272274.8; ENSP00000351021.2; ENSG00000122026.11.;""ENST00000311549.11; ENSP00000346027.4; ENSG00000122026.11."";""ENST00000319826.8; ENSP00000370574.1; ENSG00000122026.11."";""ENST00000326092.8; ENSP00000370569.1; ENSG00000122026.11."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; synapse [GO:0045202]
Q6P5R6,N1,-0.628060909,-0.532685013,0.025670912,0.138412419,1.117755124,grey90,RPL22L1,RL22L_HUMAN,Ribosomal protein eL22-like (60S ribosomal protein L22-like 1) (Large ribosomal subunit protein eL22-like 1),RPL22L1,200916;,ENST00000295830.13; ENSP00000346080.7; ENSG00000163584.18.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181],ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]
P62750,N1,-0.667857759,-0.788553623,-0.36849978,-0.379390747,1.526924203,grey90,RPL23A,RL23A_HUMAN,Large ribosomal subunit protein uL23 (60S ribosomal protein L23a),RPL23A,6147;,ENST00000422514.7; ENSP00000389103.2; ENSG00000198242.14.;,cadherin binding [GO:0045296]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleus [GO:0005634]
P61353,N1,-0.596179901,-1.095280225,-0.261623333,-0.365388696,1.533198116,grey90,RPL27,RL27_HUMAN,Large ribosomal subunit protein eL27 (60S ribosomal protein L27),RPL27,6155;,"ENST00000253788.12; ENSP00000253788.5; ENSG00000131469.15.;""ENST00000589037.5; ENSP00000467587.1; ENSG00000131469.15."";""ENST00000589913.6; ENSP00000464813.1; ENSG00000131469.15."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412],cytoplasm [GO:0005737]; cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202]
P46779,N1,-0.982721783,-1.621879411,-0.656802739,-0.373692383,1.840652899,grey90,RPL28,RL28_HUMAN,Large ribosomal subunit protein eL28 (60S ribosomal protein L28),RPL28,6158;,"ENST00000344063.7; ENSP00000342787.3; ENSG00000108107.15. [P46779-1];""ENST00000428193.6; ENSP00000391665.2; ENSG00000108107.15. [P46779-4]"";""ENST00000431533.6; ENSP00000400596.2; ENSG00000108107.15. [P46779-5]"";""ENST00000558815.5; ENSP00000452909.1; ENSG00000108107.15. [P46779-3]"";""ENST00000559463.5; ENSP00000453319.1; ENSG00000108107.15. [P46779-1]"";""ENST00000560583.5; ENSP00000453029.1; ENSG00000108107.15. [P46779-2]"";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; synapse [GO:0045202]
P39023,N1,-0.524714449,-1.310210022,-0.465040587,-0.346241929,1.649859397,grey90,RPL3,RL3_HUMAN,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (HIV-1 TAR RNA-binding protein B) (TARBP-B),RPL3 OK/SW-cl.32,6122;,ENST00000216146.9; ENSP00000346001.3; ENSG00000100316.16.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
P62888,N1,-0.661715376,-1.127394461,-0.447059773,-0.336647966,1.655704979,grey90,RPL30,RL30_HUMAN,Large ribosomal subunit protein eL30 (60S ribosomal protein L30),RPL30,6156;,"ENST00000287038.8; ENSP00000287038.3; ENSG00000156482.11.;""ENST00000521291.5; ENSP00000428085.1; ENSG00000156482.11."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-negative bacterium [GO:0050829]; killing of cells of another organism [GO:0031640]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]
P49207,N1,-0.96117714,-1.343751284,-0.459305033,-0.452306755,1.742533555,grey90,RPL34,RL34_HUMAN,Large ribosomal subunit protein eL34 (60S ribosomal protein L34),RPL34,6164;,"ENST00000394665.5; ENSP00000378160.1; ENSG00000109475.17.;""ENST00000394667.8; ENSP00000378162.3; ENSG00000109475.17."";""ENST00000394668.2; ENSP00000378163.2; ENSG00000109475.17."";""ENST00000502534.5; ENSP00000423983.1; ENSG00000109475.17."";""ENST00000506397.5; ENSP00000423316.1; ENSG00000109475.17."";",cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; synapse [GO:0045202]
P18077,N1,-0.436791398,-1.120752905,-0.499359755,-0.327683968,1.625276371,grey90,RPL35A,RL35A_HUMAN,Large ribosomal subunit protein eL33 (60S ribosomal protein L35a) (Cell growth-inhibiting gene 33 protein),RPL35A GIG33,6165;,"ENST00000448864.6; ENSP00000393393.1; ENSG00000182899.17.;""ENST00000647248.2; ENSP00000495672.1; ENSG00000182899.17."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049],cytoplasmic translation [GO:0002181]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]
Q9Y3U8,N1,-0.449543537,-0.990631433,-0.230531071,-0.395769349,1.534127295,grey90,RPL36,RL36_HUMAN,Large ribosomal subunit protein eL36 (60S ribosomal protein L36),RPL36,25873;,"ENST00000347512.8; ENSP00000252543.3; ENSG00000130255.13.;""ENST00000394580.2; ENSP00000378081.2; ENSG00000130255.13."";""ENST00000577222.5; ENSP00000464342.1; ENSG00000130255.13."";""ENST00000579649.5; ENSP00000462609.1; ENSG00000130255.13."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; nucleolus [GO:0005730]; synapse [GO:0045202]
P61513,N1,-0.567916982,-1.016627455,-0.519174152,-0.41605825,1.643736392,grey90,RPL37A,RL37A_HUMAN,Large ribosomal subunit protein eL43 (60S ribosomal protein L37a),RPL37A,6168;,ENST00000491306.6; ENSP00000418082.1; ENSG00000197756.10.;,metal ion binding [GO:0046872]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]
Q92901,N1,-0.5860638,-0.924247894,-0.298639557,-0.173387317,1.508879813,grey90,RPL3L,RL3L_HUMAN,Ribosomal protein uL3-like (60S ribosomal protein L3-like) (Large ribosomal subunit protein uL3-like),RPL3L,6123;,"ENST00000268661.8; ENSP00000268661.7; ENSG00000140986.8.;""ENST00000709230.1; ENSP00000517569.1; ENSG00000291929.1."";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],negative regulation of myotube differentiation [GO:0010832]; regulation of striated muscle tissue development [GO:0016202]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; ribosome [GO:0005840]
P36578,N1,-0.70904674,-1.351077161,-0.397339124,-0.490065905,1.665012645,grey90,RPL4,RL4_HUMAN,Large ribosomal subunit protein uL4 (60S ribosomal protein L1) (60S ribosomal protein L4),RPL4 RPL1,6124;,ENST00000307961.11; ENSP00000311430.6; ENSG00000174444.15.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]
Q02878,N1,-0.436412465,-1.061355356,-0.39047402,-0.342953058,1.482638982,grey90,RPL6,RL6_HUMAN,Large ribosomal subunit protein eL6 (60S ribosomal protein L6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107),RPL6 TXREB1,6128;,"ENST00000202773.14; ENSP00000202773.9; ENSG00000089009.16.;""ENST00000424576.6; ENSP00000403172.2; ENSG00000089009.16."";",cadherin binding [GO:0045296]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; regulation of DNA-templated transcription [GO:0006355]; translation [GO:0006412],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]
P18124,N1,-0.41080304,-1.084920946,-0.360250526,-0.303082412,1.478176568,grey90,RPL7,RL7_HUMAN,Large ribosomal subunit protein uL30 (60S ribosomal protein L7),RPL7,6129;,ENST00000352983.7; ENSP00000339795.2; ENSG00000147604.14.;,DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]
P62424,N1,-0.575638963,-1.150389226,-0.343994018,-0.458347603,1.669142206,grey90,RPL7A,RL7A_HUMAN,Large ribosomal subunit protein eL8 (60S ribosomal protein L7a) (PLA-X polypeptide) (Surfeit locus protein 3),RPL7A SURF-3 SURF3,6130;,"ENST00000323345.11; ENSP00000361076.3; ENSG00000148303.17.;""ENST00000630979.3; ENSP00000487443.1; ENSG00000280858.3."";",cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosome [GO:0005840]; synapse [GO:0045202]
Q6DKI1,N3,-0.945449085,-1.097583123,1.20381568,-0.281356079,0.352264679,grey50,RPL7L1,RL7L_HUMAN,Ribosomal protein uL30-like (60S ribosomal protein L7-like 1) (Large ribosomal subunit protein uL30-like 1),RPL7L1,285855;,"ENST00000304734.9; ENSP00000346063.4; ENSG00000146223.16. [Q6DKI1-1];""ENST00000493763.7; ENSP00000418221.3; ENSG00000146223.16. [Q6DKI1-1]"";",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],"blastocyst formation [GO:0001825]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]",cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]
P32969,N1,-0.625846587,-1.082069531,-0.437045816,-0.324236506,1.676354224,grey90,RPL9,RL9_HUMAN,Large ribosomal subunit protein uL6 (60S ribosomal protein L9),RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9,6133;,"ENST00000295955.14; ENSP00000346022.7; ENSG00000163682.17.;""ENST00000449470.6; ENSP00000400467.2; ENSG00000163682.17."";""ENST00000645496.2; ENSP00000494697.1; ENSG00000163682.17."";",RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840]
P05388,N1,-0.794521822,-1.572158255,-0.535313074,-0.345449587,1.719447686,grey90,RPLP0,RLA0_HUMAN,Large ribosomal subunit protein uL10 (60S acidic ribosomal protein P0) (60S ribosomal protein L10E),RPLP0,6175;,"ENST00000228306.8; ENSP00000339027.3; ENSG00000089157.16. [P05388-1];""ENST00000313104.9; ENSP00000366471.4; ENSG00000089157.16. [P05388-2]"";""ENST00000392514.9; ENSP00000376299.4; ENSG00000089157.16. [P05388-1]"";""ENST00000551150.5; ENSP00000449328.1; ENSG00000089157.16. [P05388-1]"";",large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; ribosome biogenesis [GO:0042254]; translation [GO:0006412],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]
P05387,N1,-0.350853163,-0.722342167,-0.813241019,-0.499083775,1.584997467,grey90,RPLP2,RLA2_HUMAN,Large ribosomal subunit protein P2 (60S acidic ribosomal protein P2) (Renal carcinoma antigen NY-REN-44),RPLP2 D11S2243E RPP2,6181;,"ENST00000321153.9; ENSP00000322419.4; ENSG00000177600.9.;""ENST00000530797.5; ENSP00000431240.1; ENSG00000177600.9."";",structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; cytoplasmic translational elongation [GO:0002182]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]
P04843,S2,-1.253235563,-1.324071542,0.240056659,0.91000896,0.430707368,orange,RPN1,RPN1_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1),RPN1,6184;,ENST00000296255.8; ENSP00000296255.3; ENSG00000163902.12.;,RNA binding [GO:0003723],protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; melanosome [GO:0042470]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]
P04844,S2,-1.130006205,-1.4611538,0.21883264,0.928980284,0.40540627,orange,RPN2,RPN2_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II) (RPN-II) (Ribophorin-2),RPN2,6185;,"ENST00000237530.11; ENSP00000237530.6; ENSG00000118705.18. [P04844-1];""ENST00000373622.9; ENSP00000362724.5; ENSG00000118705.18. [P04844-2]"";""ENST00000709409.1; ENSP00000517677.1; ENSG00000291973.1. [P04844-2]"";""ENST00000709412.1; ENSP00000517679.1; ENSG00000291973.1. [P04844-1]"";",0,protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear body [GO:0016604]; oligosaccharyltransferase complex [GO:0008250]
Q5VT52,N4,-0.98833402,0.636076377,0.847742686,-0.163006712,-0.725559716,grey30,RPRD2,RPRD2_HUMAN,Regulation of nuclear pre-mRNA domain-containing protein 2,RPRD2 KIAA0460 HSPC099,23248;,"ENST00000369067.7; ENSP00000358063.3; ENSG00000163125.16. [Q5VT52-4];""ENST00000369068.5; ENSP00000358064.4; ENSG00000163125.16. [Q5VT52-1]"";""ENST00000401000.8; ENSP00000383785.4; ENSG00000163125.16. [Q5VT52-3]"";",RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993],mRNA 3'-end processing [GO:0031124],nucleoplasm [GO:0005654]; transcription preinitiation complex [GO:0097550]
P62701,N1,-0.55935793,-1.102689503,-0.239391183,-0.062297358,1.565834544,grey90,RPS4X,RS4X_HUMAN,"Small ribosomal subunit protein eS4, X isoform (40S ribosomal protein S4) (SCR10) (Single copy abundant mRNA protein)",RPS4X CCG2 RPS4 SCAR,6191;,ENST00000316084.10; ENSP00000362744.4; ENSG00000198034.11.;,RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytoplasmic translation [GO:0002181]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of translation [GO:0045727]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; small-subunit processome [GO:0032040]; synapse [GO:0045202]
Q15418,C3,1.846055478,-0.165342071,-0.589211739,-0.463119123,-0.843648305,cyan,RPS6KA1,KS6A1_HUMAN,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),RPS6KA1 MAPKAPK1A RSK1,6195;,"ENST00000374168.7; ENSP00000363283.2; ENSG00000117676.14. [Q15418-1];""ENST00000526792.5; ENSP00000431651.1; ENSG00000117676.14. [Q15418-3]"";""ENST00000530003.5; ENSP00000432281.1; ENSG00000117676.14. [Q15418-4]"";""ENST00000531382.5; ENSP00000435412.1; ENSG00000117676.14. [Q15418-2]"";""ENST00000628081.2; ENSP00000487553.1; ENSG00000281877.3. [Q15418-4]"";""ENST00000628256.2; ENSP00000487349.1; ENSG00000281877.3. [Q15418-2]"";""ENST00000629832.3; ENSP00000486881.1; ENSG00000281877.3. [Q15418-1]"";""ENST00000631108.2; ENSP00000487166.1; ENSG00000281877.3. [Q15418-3]"";",ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711],chemical synaptic transmission [GO:0007268]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of TOR signaling [GO:0032007]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of translation in response to stress [GO:0043555]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synapse [GO:0045202]
P23443,C1,1.694455721,0.108952949,-0.363635278,-0.342826065,-0.723625393,lightblue,RPS6KB1,KS6B1_HUMAN,Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA),RPS6KB1 STK14A,6198;,"ENST00000225577.9; ENSP00000225577.4; ENSG00000108443.14. [P23443-1];""ENST00000393021.7; ENSP00000376744.3; ENSG00000108443.14. [P23443-3]"";""ENST00000406116.7; ENSP00000384335.3; ENSG00000108443.14. [P23443-4]"";""ENST00000443572.6; ENSP00000441993.1; ENSG00000108443.14. [P23443-5]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711],apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; cellular response to nutrient [GO:0031670]; cellular response to type II interferon [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; long-chain fatty acid import into cell [GO:0044539]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; regulation of glucose import [GO:0046324]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to L-leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929],cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]
P62081,N1,-0.438704215,-0.695380606,-0.271027639,-0.199781454,1.42037528,grey90,RPS7,RS7_HUMAN,Small ribosomal subunit protein eS7 (40S ribosomal protein S7),RPS7,6201;,"ENST00000403564.5; ENSP00000385018.1; ENSG00000171863.15.;""ENST00000406376.1; ENSP00000385286.1; ENSG00000171863.15."";""ENST00000462576.5; ENSP00000495273.1; ENSG00000171863.15."";""ENST00000645674.2; ENSP00000496757.1; ENSG00000171863.15."";""ENST00000646909.1; ENSP00000496654.1; ENSG00000171863.15."";",mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948],cytoplasmic translation [GO:0002181]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural crest cell differentiation [GO:0014033]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202]
P62241,N1,-0.551139489,-0.971830438,-0.51979515,-0.429359927,1.676348428,grey90,RPS8,RS8_HUMAN,Small ribosomal subunit protein eS8 (40S ribosomal protein S8),RPS8 OK/SW-cl.83,6202;,ENST00000396651.8; ENSP00000379888.3; ENSG00000142937.12.;,RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],"cytoplasmic translation [GO:0002181]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040]
P10301,S3,-0.88853201,-0.842726035,0.207839304,0.736385716,0.674854937,salmon,RRAS,RRAS_HUMAN,Ras-related protein R-Ras (EC 3.6.5.-) (p23),RRAS,6237;,ENST00000246792.4; ENSP00000246792.2; ENSG00000126458.4.;,GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex binding [GO:0044877],face morphogenesis [GO:0060325]; leukocyte differentiation [GO:0002521]; negative regulation of Schwann cell migration [GO:1900148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906]; positive regulation of vasculogenesis [GO:2001214]; Ras protein signal transduction [GO:0007265]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; Schwann cell migration [GO:0036135],extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]
P62070,S2,-1.28799683,-0.856598956,0.33741023,0.805191513,0.344172162,orange,RRAS2,RRAS2_HUMAN,Ras-related protein R-Ras2 (EC 3.6.5.-) (Ras-like protein TC21) (Teratocarcinoma oncogene),RRAS2 TC21,22800;,"ENST00000256196.9; ENSP00000256196.4; ENSG00000133818.14. [P62070-1];""ENST00000414023.6; ENSP00000403282.2; ENSG00000133818.14. [P62070-2]"";""ENST00000526063.5; ENSP00000434104.1; ENSG00000133818.14. [P62070-2]"";""ENST00000529237.5; ENSP00000433230.1; ENSG00000133818.14. [P62070-2]"";""ENST00000532814.5; ENSP00000431954.1; ENSG00000133818.14. [P62070-2]"";""ENST00000534746.5; ENSP00000437083.1; ENSG00000133818.14. [P62070-2]"";""ENST00000537760.5; ENSP00000437547.1; ENSG00000133818.14. [P62070-3]"";",GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],osteoblast differentiation [GO:0001649]; positive regulation of Schwann cell migration [GO:1900149]; Ras protein signal transduction [GO:0007265]; Schwann cell migration [GO:0036135],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9P2E9,S3,-1.292824848,-0.714015614,7.81E-04,0.959042908,0.466040022,salmon,RRBP1,RRBP1_HUMAN,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),RRBP1 KIAA1398,6238;,"ENST00000246043.8; ENSP00000246043.4; ENSG00000125844.17. [Q9P2E9-1];""ENST00000360807.8; ENSP00000354045.4; ENSG00000125844.17. [Q9P2E9-3]"";""ENST00000377807.6; ENSP00000367038.2; ENSG00000125844.17. [Q9P2E9-3]"";""ENST00000377813.6; ENSP00000367044.1; ENSG00000125844.17. [Q9P2E9-1]"";",RNA binding [GO:0003723]; signaling receptor activity [GO:0038023],osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; translation [GO:0006412],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; ribosome [GO:0005840]
Q92766,N3,-0.974101216,-0.806131125,1.156570924,0.303888371,-0.382477952,grey50,RREB1,RREB1_HUMAN,Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1),RREB1 FINB,6239;,"ENST00000334984.10; ENSP00000335574.6; ENSG00000124782.21. [Q92766-3];""ENST00000349384.10; ENSP00000305560.10; ENSG00000124782.21. [Q92766-1]"";""ENST00000379933.7; ENSP00000369265.3; ENSG00000124782.21. [Q92766-1]"";""ENST00000379938.7; ENSP00000369270.2; ENSG00000124782.21. [Q92766-2]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]","negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]",cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]
P31350,C3,1.91567479,0.083196819,-0.583330646,-0.583350498,-0.909045263,cyan,RRM2,RIR2_HUMAN,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),RRM2 RR2,6241;,"ENST00000304567.10; ENSP00000302955.4; ENSG00000171848.16. [P31350-1];""ENST00000360566.6; ENSP00000353770.2; ENSG00000171848.16. [P31350-2]"";""ENST00000641198.1; ENSP00000493399.1; ENSG00000171848.16. [P31350-1]"";","ferric iron binding [GO:0008199]; protein homodimerization activity [GO:0042803]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",2'-deoxyribonucleotide biosynthetic process [GO:0009265]; blastocyst development [GO:0001824]; deoxyribonucleotide biosynthetic process [GO:0009263]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein heterotetramerization [GO:0051290]; ribonucleoside diphosphate metabolic process [GO:0009185],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoside-diphosphate reductase complex [GO:0005971]
Q7LG56,C4,1.92657481,0.278973114,-0.717881658,-0.907156566,-1.498211161,deepskyblue2,RRM2B,RIR2B_HUMAN,Ribonucleoside-diphosphate reductase subunit M2 B (EC 1.17.4.1) (TP53-inducible ribonucleotide reductase M2 B) (p53-inducible ribonucleotide reductase small subunit 2-like protein) (p53R2),RRM2B P53R2,50484;,"ENST00000251810.8; ENSP00000251810.3; ENSG00000048392.13. [Q7LG56-1];""ENST00000395912.6; ENSP00000379248.2; ENSG00000048392.13. [Q7LG56-2]"";""ENST00000519317.5; ENSP00000430641.1; ENSG00000048392.13. [Q7LG56-3]"";""ENST00000519962.5; ENSP00000429140.1; ENSG00000048392.13. [Q7LG56-4]"";""ENST00000522394.1; ENSP00000429578.1; ENSG00000048392.13. [Q7LG56-5]"";","identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",2'-deoxyribonucleotide biosynthetic process [GO:0009265]; deoxyribonucleoside triphosphate metabolic process [GO:0009200]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA repair [GO:0006281]; DNA synthesis involved in DNA repair [GO:0000731]; kidney development [GO:0001822]; mitochondrial DNA replication [GO:0006264]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; renal system process [GO:0003014]; response to amine [GO:0014075]; response to oxidative stress [GO:0006979]; ribonucleoside diphosphate metabolic process [GO:0009185],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoside-diphosphate reductase complex [GO:0005971]
Q5JTH9,N3,-0.864011094,-1.007781649,1.021107518,-0.119773445,0.427963071,grey50,RRP12,RRP12_HUMAN,RRP12-like protein,RRP12 KIAA0690,23223;,"ENST00000315563.10; ENSP00000324315.6; ENSG00000052749.14. [Q5JTH9-2];""ENST00000370992.9; ENSP00000360031.4; ENSG00000052749.14. [Q5JTH9-1]"";""ENST00000414986.5; ENSP00000414863.1; ENSG00000052749.14. [Q5JTH9-3]"";""ENST00000536831.5; ENSP00000446184.2; ENSG00000052749.14. [Q5JTH9-1]"";",RNA binding [GO:0003723],rRNA processing [GO:0006364],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]
Q96EU6,N3,-1.031476212,-1.241263031,1.171034928,0.186085734,0.141289072,grey50,RRP36,RRP36_HUMAN,Ribosomal RNA processing protein 36 homolog,RRP36 C6orf153 HSPC253,88745;,ENST00000244496.6; ENSP00000244496.5; ENSG00000124541.7. [Q96EU6-1];,RNA binding [GO:0003723],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]",90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9Y3A4,N3,-1.075917265,-1.180086385,1.239342918,-0.006063652,0.235667624,grey50,RRP7A,RRP7A_HUMAN,Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14),RRP7A CGI-96,27341;,ENST00000323013.7; ENSP00000321449.6; ENSG00000189306.11.;,RNA binding [GO:0003723],blastocyst formation [GO:0001825]; cilium disassembly [GO:0061523]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],centrosome [GO:0005813]; cilium [GO:0005929]; CURI complex [GO:0032545]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]
Q15050,N3,-1.40244468,-1.596727985,1.205223498,-0.238448006,0.131289818,grey50,RRS1,RRS1_HUMAN,Ribosome biogenesis regulatory protein homolog,RRS1 KIAA0112 RRR,23212;,ENST00000320270.4; ENSP00000322396.2; ENSG00000179041.4.;,5S rRNA binding [GO:0008097]; RNA binding [GO:0003723],"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase chromosome alignment [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]","condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]"
Q5VWQ0,N1,-0.979990873,0.392489431,-0.300541844,-0.679354513,1.040177709,grey90,RSBN1,RSBN1_HUMAN,Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1),RSBN1,54665;,"ENST00000261441.9; ENSP00000261441.5; ENSG00000081019.14. [Q5VWQ0-1];""ENST00000612242.4; ENSP00000479490.1; ENSG00000081019.14. [Q5VWQ0-1]"";",histone H4K20 demethylase activity [GO:0035575]; metal ion binding [GO:0046872],0,nucleus [GO:0005634]
Q6PCB5,N1,-1.157111189,0.506042179,-0.331255852,-0.702135457,1.078266742,grey90,RSBN1L,RSBNL_HUMAN,Lysine-specific demethylase RSBN1L (EC 1.14.11.-) (Round spermatid basic protein 1-like protein),RSBN1L,222194;,"ENST00000334955.13; ENSP00000334040.7; ENSG00000187257.16. [Q6PCB5-1];""ENST00000445288.5; ENSP00000393888.1; ENSG00000187257.16. [Q6PCB5-2]"";",dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],0,nucleus [GO:0005634]
Q96T23,N3,-1.188664224,-1.292177555,1.299425426,0.359571027,-0.667191302,grey50,RSF1,RSF1_HUMAN,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),RSF1 HBXAP XAP8,51773;,"ENST00000308488.11; ENSP00000311513.6; ENSG00000048649.14. [Q96T23-1];""ENST00000480887.5; ENSP00000434509.1; ENSG00000048649.14. [Q96T23-3]"";",histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; metal ion binding [GO:0046872],chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213]
O76021,N3,-1.403466448,-1.428964574,1.449618058,-0.035046242,-0.274682687,grey50,RSL1D1,RL1D1_HUMAN,Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1),RSL1D1 CATX11 CSIG PBK1 L12,26156;,ENST00000571133.6; ENSP00000460871.1; ENSG00000171490.13. [O76021-1];,cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; osteoblast differentiation [GO:0001649]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880]",chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]
Q96DX4,S4,-1.156170996,-1.280726076,0.417531156,0.949678689,0.341027642,tomato2,RSPRY1,RSPRY_HUMAN,RING finger and SPRY domain-containing protein 1,RSPRY1 KIAA1972 UNQ328/PRO444,89970;,"ENST00000394420.9; ENSP00000377942.4; ENSG00000159579.14. [Q96DX4-1];""ENST00000537866.5; ENSP00000443176.1; ENSG00000159579.14. [Q96DX4-1]"";",metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],proteolysis involved in protein catabolic process [GO:0051603],cytoplasm [GO:0005737]; extracellular region [GO:0005576]
O95197,S1,-1.018440806,-0.980044701,0.116604517,0.546574983,1.038135601,gold,RTN3,RTN3_HUMAN,Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII),RTN3 ASYIP NSPL2,10313;,"ENST00000339997.8; ENSP00000344106.4; ENSG00000133318.14. [O95197-2];""ENST00000341307.6; ENSP00000340903.2; ENSG00000133318.14. [O95197-5]"";""ENST00000354497.4; ENSP00000346492.4; ENSG00000133318.14. [O95197-6]"";""ENST00000356000.7; ENSP00000348279.3; ENSG00000133318.14. [O95197-4]"";""ENST00000377819.10; ENSP00000367050.5; ENSG00000133318.14. [O95197-1]"";""ENST00000537981.5; ENSP00000440874.1; ENSG00000133318.14. [O95197-3]"";""ENST00000540798.5; ENSP00000442733.1; ENSG00000133318.14. [O95197-7]"";",0,apoptotic process [GO:0006915]; brain development [GO:0007420]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of amyloid-beta formation [GO:1902430]; neuron differentiation [GO:0030182]; vesicle-mediated transport [GO:0016192],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]
Q9NQC3,S1,-0.921470746,-0.978121881,0.082447908,0.466052097,0.985728529,gold,RTN4,RTN4_HUMAN,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),RTN4 KIAA0886 NOGO My043 SP1507,57142;,"ENST00000317610.11; ENSP00000322147.7; ENSG00000115310.19. [Q9NQC3-2];""ENST00000337526.11; ENSP00000337838.6; ENSG00000115310.19. [Q9NQC3-1]"";""ENST00000357376.7; ENSP00000349944.3; ENSG00000115310.19. [Q9NQC3-6]"";""ENST00000357732.8; ENSP00000350365.4; ENSG00000115310.19. [Q9NQC3-5]"";""ENST00000394609.6; ENSP00000378107.2; ENSG00000115310.19. [Q9NQC3-3]"";""ENST00000394611.6; ENSP00000378109.2; ENSG00000115310.19. [Q9NQC3-6]"";""ENST00000404909.5; ENSP00000385650.1; ENSG00000115310.19. [Q9NQC3-6]"";""ENST00000405240.5; ENSP00000384471.1; ENSG00000115310.19. [Q9NQC3-6]"";",cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; brain development [GO:0007420]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; intracellular sphingolipid homeostasis [GO:0090156]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; neuron differentiation [GO:0030182]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],anchoring junction [GO:0070161]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202]
Q7L099,C1,1.259115892,0.141101714,-0.360149884,-0.009729025,-0.340396144,lightblue,RUFY3,RUFY3_HUMAN,Protein RUFY3 (RUN and FYVE domain-containing protein 3) (Rap2-interacting protein x) (RIPx) (Single axon-regulated protein) (Singar),RUFY3 KIAA0871,22902;,"ENST00000226328.8; ENSP00000226328.4; ENSG00000018189.13. [Q7L099-1];""ENST00000381006.8; ENSP00000370394.3; ENSG00000018189.13. [Q7L099-3]"";""ENST00000417478.6; ENSP00000399771.2; ENSG00000018189.13. [Q7L099-2]"";""ENST00000502653.5; ENSP00000425400.1; ENSG00000018189.13. [Q7L099-4]"";",0,actin filament organization [GO:0007015]; cell differentiation [GO:0030154]; negative regulation of axonogenesis [GO:0050771]; nervous system development [GO:0007399]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of intracellular protein transport [GO:0090316]; regulation of axonogenesis [GO:0050770]; regulation of establishment of cell polarity [GO:2000114],anchoring junction [GO:0070161]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]
Q9H446,C4,2.145045814,0.336412211,-1.38585926,-1.778218637,-2.270694277,deepskyblue2,RWDD1,RWDD1_HUMAN,RWD domain-containing protein 1 (DRG family-regulatory protein 2),RWDD1 DFRP2 CGI-24 PTD013,51389;,"ENST00000466444.7; ENSP00000420357.2; ENSG00000111832.13. [Q9H446-1];""ENST00000487832.6; ENSP00000428778.1; ENSG00000111832.13. [Q9H446-2]"";",0,androgen receptor signaling pathway [GO:0030521]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181],cytosol [GO:0005829]
P57060,C3,1.755345809,0.449223649,-0.575071219,-0.540780423,-0.749961971,cyan,RWDD2B,RWD2B_HUMAN,RWD domain-containing protein 2B,RWDD2B C21orf6 GL011,10069;,"ENST00000493196.2; ENSP00000418693.1; ENSG00000156253.7.;""ENST00000707843.1; ENSP00000516999.1; ENSG00000291523.1."";",0,0,0
Q6NW29,C5,1.777889272,0.430465812,-0.651355702,-0.764366681,-1.009314904,turquoise3,RWDD4,RWDD4_HUMAN,RWD domain-containing protein 4 (Protein FAM28A),RWDD4 FAM28A RWDD4A,201965;,"ENST00000326397.10; ENSP00000388920.2; ENSG00000182552.15. [Q6NW29-1];""ENST00000510968.5; ENSP00000426329.1; ENSG00000182552.15. [Q6NW29-2]"";",0,0,0
Q8N488,N4,-0.608057685,1.360365466,0.219567031,-0.643116148,-1.086535886,grey30,RYBP,RYBP_HUMAN,RING1 and YY1-binding protein (Apoptin-associating protein 1) (APAP-1) (Death effector domain-associated factor) (DED-associated factor) (YY1 and E4TF1-associated factor 1),RYBP DEDAF YEAF1,23429;,"ENST00000477973.5; ENSP00000419494.4; ENSG00000163602.12.;""ENST00000628983.2; ENSP00000486012.2; ENSG00000281766.4."";""ENST00000643872.3; ENSP00000493835.1; ENSG00000281766.4."";",DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]
P06703,C5,1.996951902,0.452421319,-0.878619721,-1.168436272,-1.444054182,turquoise3,S100A6,S10A6_HUMAN,Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6),S100A6 CACY,6277;,"ENST00000368719.9; ENSP00000357708.3; ENSG00000197956.10.;""ENST00000368720.6; ENSP00000357709.1; ENSG00000197956.10."";""ENST00000496817.5; ENSP00000473589.1; ENSG00000197956.10."";",calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; monoatomic ion transmembrane transporter activity [GO:0015075]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tropomyosin binding [GO:0005523]; zinc ion binding [GO:0008270],axonogenesis [GO:0007409]; positive regulation of fibroblast proliferation [GO:0048146]; signal transduction [GO:0007165],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]
O95136,S2,-1.310081464,-2.059593891,0.387419017,0.876387337,0.739325841,orange,S1PR2,S1PR2_HUMAN,Sphingosine 1-phosphate receptor 2 (S1P receptor 2) (S1P2) (Endothelial differentiation G-protein coupled receptor 5) (Sphingosine 1-phosphate receptor Edg-5) (S1P receptor Edg-5),S1PR2 EDG5,9294;,ENST00000646641.1; ENSP00000496438.1; ENSG00000267534.4.;,G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; sphingosine-1-phosphate receptor activity [GO:0038036],actin cytoskeleton organization [GO:0030036]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; excitatory postsynaptic potential [GO:0060079]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of excitatory postsynaptic potential [GO:0090394]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of establishment of endothelial barrier [GO:1903142]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; regulation of metabolic process [GO:0019222]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]
Q9NTJ5,S2,-0.852225632,-1.206724945,0.122059959,0.83063769,0.593768044,orange,SACM1L,SAC1_HUMAN,Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein),SACM1L KIAA0851 SAC1,22908;,"ENST00000389061.10; ENSP00000373713.4; ENSG00000211456.14. [Q9NTJ5-1];""ENST00000438671.4; ENSP00000411966.2; ENSG00000211456.14. [Q9NTJ5-2]"";",phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812],phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q15424,N3,-1.23553546,-1.085418623,1.113862799,0.117373269,-0.00646193,grey50,SAFB,SAFB1_HUMAN,Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein),SAFB HAP HET SAFB1,6294;,"ENST00000292123.9; ENSP00000292123.4; ENSG00000160633.13. [Q15424-1];""ENST00000454510.5; ENSP00000415895.1; ENSG00000160633.13. [Q15424-2]"";""ENST00000588852.2; ENSP00000467423.1; ENSG00000160633.13. [Q15424-3]"";""ENST00000592224.5; ENSP00000464840.1; ENSG00000160633.13. [Q15424-4]"";",chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],chromatin organization [GO:0006325]; intracellular estrogen receptor signaling pathway [GO:0030520]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357],midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q14151,N3,-1.161228666,-1.048624121,1.137664494,0.139813823,0.088334954,grey50,SAFB2,SAFB2_HUMAN,Scaffold attachment factor B2 (SAF-B2),SAFB2 KIAA0138,9667;,"ENST00000252542.9; ENSP00000252542.3; ENSG00000130254.12. [Q14151-1];""ENST00000591120.1; ENSP00000468505.1; ENSG00000130254.12. [Q14151-2]"";",identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565],regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y512,M2,-1.193818948,-1.429995221,0.43259322,1.158066661,-0.296416651,tan4,SAMM50,SAM50_HUMAN,Sorting and assembly machinery component 50 homolog (Transformation-related gene 3 protein) (TRG-3),SAMM50 SAM50 CGI-51 TRG3,25813;,ENST00000350028.5; ENSP00000345445.4; ENSG00000100347.15.;,0,cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial respiratory chain complex assembly [GO:0033108]; protein insertion into mitochondrial outer membrane [GO:0045040],extracellular exosome [GO:0070062]; membrane [GO:0016020]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]
O00422,N3,-1.369740219,-1.220287301,1.199082637,0.119579864,0.072214113,grey50,SAP18,SAP18_HUMAN,Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (2HOR0202) (Cell growth-inhibiting gene 38 protein) (Sin3-associated polypeptide p18),SAP18 GIG38,10284;,"ENST00000382533.9; ENSP00000371973.4; ENSG00000150459.13. [O00422-2];""ENST00000607003.5; ENSP00000475925.1; ENSG00000150459.13. [O00422-1]"";""ENST00000621421.4; ENSP00000481842.1; ENSG00000150459.13. [O00422-2]"";",RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714],"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]",ASAP complex [GO:0061574]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NR31,C3,1.418279539,-0.793603193,-0.053680257,0.388554017,-0.445873607,cyan,SAR1A,SAR1A_HUMAN,Small COPII coat GTPase SAR1A (EC 3.6.5.2) (COPII-associated small GTPase) (Secretion-associated Ras-related GTPase 1A),SAR1A SAR1 SARA SARA1,56681;,"ENST00000373238.5; ENSP00000362335.1; ENSG00000079332.16. [Q9NR31-1];""ENST00000373241.9; ENSP00000362338.4; ENSG00000079332.16. [Q9NR31-1]"";""ENST00000373242.6; ENSP00000362339.1; ENSG00000079332.16. [Q9NR31-1]"";",amino acid sensor activity [GO:0140785]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],cellular response to leucine starvation [GO:1990253]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; regulation of TORC1 signaling [GO:1903432]; vesicle organization [GO:0016050],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765]
Q9Y6B6,C3,1.488815743,-0.703671731,-0.147575688,0.144222455,-0.359406581,cyan,SAR1B,SAR1B_HUMAN,Small COPII coat GTPase SAR1B (EC 3.6.5.2) (GTP-binding protein B) (GTBPB) (Secretion-associated Ras-related GTPase 1B),SAR1B SARA2 SARB,51128;,"ENST00000402673.7; ENSP00000385432.2; ENSG00000152700.14.;""ENST00000439578.5; ENSP00000404997.1; ENSG00000152700.14."";",amino acid sensor activity [GO:0140785]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cellular response to leucine starvation [GO:1990253]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lipid export from cell [GO:0140353]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; membrane organization [GO:0061024]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; regulation of lipid transport [GO:0032368]; regulation of TORC1 signaling [GO:1903432]; vesicle organization [GO:0016050],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765]
Q15020,N1,-1.081102964,0.708592514,-0.256385117,-0.59592897,0.874380601,grey90,SART3,SART3_HUMAN,Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3) (Tat-interacting protein of 110 kDa) (Tip110) (p110 nuclear RNA-binding protein),SART3 KIAA0156 TIP110,9733;,"ENST00000431469.6; ENSP00000414453.2; ENSG00000075856.12. [Q15020-4];""ENST00000546611.1; ENSP00000448554.1; ENSG00000075856.12. [Q15020-3]"";""ENST00000546728.5; ENSP00000449743.1; ENSG00000075856.12. [Q15020-2]"";""ENST00000546815.6; ENSP00000449386.2; ENSG00000075856.12. [Q15020-1]"";",histone binding [GO:0042393]; RNA binding [GO:0003723]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; U6atac snRNA binding [GO:0030624]; ubiquitin-specific protease binding [GO:1990381],"cell morphogenesis [GO:0000902]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; mRNA splicing, via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; regulation of gene expression [GO:0010468]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244]; transcription elongation-coupled chromatin remodeling [GO:0140673]",ASAP complex [GO:0061574]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O94885,C3,1.91948862,0.134702631,-0.642130721,-0.606770495,-0.683636961,cyan,SASH1,SASH1_HUMAN,SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein),SASH1 KIAA0790 PEPE1,23328;,ENST00000367467.8; ENSP00000356437.3; ENSG00000111961.19.;,G-protein alpha-subunit binding [GO:0001965]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901],positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; protein polyubiquitination [GO:0000209]; regulation of epithelial cell migration [GO:0010632]; regulation of protein autoubiquitination [GO:1902498]; regulation of protein K63-linked ubiquitination [GO:1900044],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]
Q6UVJ0,C1,1.37954075,0.059242886,-0.265207924,-0.083910523,-0.507355454,lightblue,SASS6,SAS6_HUMAN,Spindle assembly abnormal protein 6 homolog (HsSAS-6) (Spindle assembly defective protein 6),SASS6 SAS6,163786;,ENST00000287482.6; ENSP00000287482.5; ENSG00000156876.10.;,0,centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; regulation of mitotic spindle organization [GO:0060236],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; procentriole replication complex [GO:0120099]
Q9Y3A5,C5,1.447166999,0.693585416,-0.705568093,-0.854158969,-1.116243687,turquoise3,SBDS,SBDS_HUMAN,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein),SBDS CGI-97,51119;,"ENST00000246868.7; ENSP00000246868.2; ENSG00000126524.12.;""ENST00000697897.1; ENSP00000513469.1; ENSG00000126524.12."";",microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; rRNA binding [GO:0019843],bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cytosolic ribosome assembly [GO:0042256]; hematopoietic progenitor cell differentiation [GO:0002244]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]
Q9H7N4,N3,-0.98851692,-1.054528307,0.938827547,-0.157900702,0.410708397,grey50,SCAF1,SFR19_HUMAN,"Splicing factor, arginine/serine-rich 19 (SR-related C-terminal domain-associated factor 1) (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",SCAF1 SFRS19 SRA1,58506;,ENST00000360565.8; ENSP00000353769.2; ENSG00000126461.15.;,protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122],mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634]
O95104,N4,-1.236081459,0.822623523,0.35313193,-0.242934501,-0.292417761,grey30,SCAF4,SCAF4_HUMAN,"SR-related and CTD-associated factor 4 (CTD-binding SR-like protein RA4) (Splicing factor, arginine/serine-rich 15)",SCAF4 KIAA1172 SFRS15,57466;,"ENST00000286835.12; ENSP00000286835.7; ENSG00000156304.15. [O95104-1];""ENST00000399804.5; ENSP00000382703.1; ENSG00000156304.15. [O95104-2]"";""ENST00000434667.3; ENSP00000402377.2; ENSG00000156304.15. [O95104-3]"";",RNA binding [GO:0003723]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269],"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UPN6,N4,-1.051526084,0.846895787,0.230952961,-0.082737607,-0.242637218,grey30,SCAF8,SCAF8_HUMAN,SR-related and CTD-associated factor 8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16),SCAF8 CCAP7 KIAA1116 RBM16,22828;,"ENST00000367178.8; ENSP00000356146.3; ENSG00000213079.10. [Q9UPN6-1];""ENST00000367186.7; ENSP00000356154.4; ENSG00000213079.10. [Q9UPN6-2]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; RNA polymerase II complex binding [GO:0000993],"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000805]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; termination of RNA polymerase II transcription [GO:0006369]",cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O15126,S1,-0.847055763,-1.248102362,-0.166024254,0.560108089,1.166502808,gold,SCAMP1,SCAM1_HUMAN,Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1),SCAMP1 SCAMP,9522;,"ENST00000614488.4; ENSP00000478071.1; ENSG00000085365.18. [O15126-2];""ENST00000621999.5; ENSP00000481022.1; ENSG00000085365.18. [O15126-1]"";",protein domain specific binding [GO:0019904],endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031],clathrin-coated vesicle [GO:0030136]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]
O15127,S1,-1.313074376,-1.652640641,-0.130756211,0.479007486,1.232877814,gold,SCAMP2,SCAM2_HUMAN,Secretory carrier-associated membrane protein 2 (Secretory carrier membrane protein 2),SCAMP2,10066;,ENST00000268099.13; ENSP00000268099.9; ENSG00000140497.16.;,0,post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]
O14828,S1,-0.581532825,-1.23183962,-0.196580105,0.495195926,1.106287828,gold,SCAMP3,SCAM3_HUMAN,Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3),SCAMP3 C1orf3 PROPIN1,10067;,"ENST00000302631.8; ENSP00000307275.3; ENSG00000116521.11. [O14828-1];""ENST00000355379.3; ENSP00000347540.3; ENSG00000116521.11. [O14828-2]"";""ENST00000570831.5; ENSP00000461521.1; ENSG00000263290.5. [O14828-1]"";""ENST00000573013.1; ENSP00000458542.1; ENSG00000263290.5. [O14828-2]"";",ubiquitin protein ligase binding [GO:0031625],post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031],extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]
Q969E2,S1,-0.868000077,-1.259607219,0.229064216,0.587131826,0.84051153,gold,SCAMP4,SCAM4_HUMAN,Secretory carrier-associated membrane protein 4 (Secretory carrier membrane protein 4),SCAMP4,113178;,"ENST00000316097.13; ENSP00000316007.7; ENSG00000227500.11. [Q969E2-1];""ENST00000409472.6; ENSP00000386865.1; ENSG00000227500.11. [Q969E2-2]"";""ENST00000621748.1; ENSP00000479083.1; ENSG00000227500.11. [Q969E2-1]"";",0,protein transport [GO:0015031],recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]
Q9NP31,S3,-0.579317518,-0.97184345,0.239527612,0.72692663,0.689127292,salmon,SCAP,SH22A_HUMAN,SH2 domain-containing protein 2A (SH2 domain-containing adapter protein) (T cell-specific adapter protein) (TSAd) (VEGF receptor-associated protein),SH2D2A SCAP TSAD VRAP,9047;,"ENST00000368198.7; ENSP00000357181.3; ENSG00000027869.12. [Q9NP31-4];""ENST00000368199.8; ENSP00000357182.3; ENSG00000027869.12. [Q9NP31-1]"";""ENST00000392306.2; ENSP00000376123.2; ENSG00000027869.12. [Q9NP31-2]"";",SH3 domain binding [GO:0017124],angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q14108,S1,-0.980803074,-1.23302795,-0.372629586,0.823169991,1.067123802,gold,SCARB2,SCRB2_HUMAN,Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36),SCARB2 CD36L2 LIMP2 LIMPII,950;,"ENST00000264896.8; ENSP00000264896.2; ENSG00000138760.11. [Q14108-1];""ENST00000452464.6; ENSP00000399154.2; ENSG00000138760.11. [Q14108-2]"";",cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618],aminophospholipid transport [GO:0015917]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; regulation of endosome organization [GO:1904978]; regulation of glucosylceramide catabolic process [GO:2000752]; regulation of lysosome organization [GO:1905671]; sensory perception of sound [GO:0007605],clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q8NBX0,M2,-0.958785699,-0.96823036,0.340783151,0.904062499,0.215522668,tan4,SCCPDH,SCPDL_HUMAN,Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-),SCCPDH CGI-49,51097;,ENST00000366510.4; ENSP00000355467.3; ENSG00000143653.10.;,oxidoreductase activity [GO:0016491],glycolipid biosynthetic process [GO:0009247],extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]
O00767,S2,-1.43833551,-1.760929889,0.270058062,0.940409326,0.582728063,orange,SCD,SCD_HUMAN,Stearoyl-CoA desaturase (hSCD1) (EC 1.14.19.1) (Acyl-CoA desaturase) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase),SCD FADS5 SCD1 SCDOS,6319;,ENST00000370355.3; ENSP00000359380.2; ENSG00000099194.6.;,iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; palmitoyl-CoA 9-desaturase activity [GO:0032896]; stearoyl-CoA 9-desaturase activity [GO:0004768],monounsaturated fatty acid biosynthetic process [GO:1903966]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to fatty acid [GO:0070542]; unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleolus [GO:0005730]
Q86SK9,S2,-1.560894167,-1.768750863,0.183182865,0.882268993,0.520598245,orange,SCD5,SCD5_HUMAN,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (HSCD5) (Stearoyl-CoA 9-desaturase) (Stearoyl-CoA desaturase 2),SCD5 ACOD4 SCD2 SCD4,79966;,"ENST00000273908.4; ENSP00000273908.4; ENSG00000145284.12. [Q86SK9-2];""ENST00000319540.9; ENSP00000316329.4; ENSG00000145284.12. [Q86SK9-1]"";",metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789]
Q8WVM8,S1,-0.972288295,-1.158329078,0.004183312,0.758381954,0.887730549,gold,SCFD1,SCFD1_HUMAN,Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2),SCFD1 C14orf163 KIAA0917 STXBP1L2 FKSG23,23256;,"ENST00000396629.6; ENSP00000379870.2; ENSG00000092108.22. [Q8WVM8-2];""ENST00000458591.7; ENSP00000390783.2; ENSG00000092108.22. [Q8WVM8-1]"";""ENST00000544052.6; ENSP00000443010.2; ENSG00000092108.22. [Q8WVM8-3]"";""ENST00000678124.1; ENSP00000503029.1; ENSG00000092108.22. [Q8WVM8-3]"";",protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905],"cell morphogenesis [GO:0000902]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]
Q8WU76,S2,-1.179589526,-1.304348113,0.181088141,0.72894827,0.672056048,orange,SCFD2,SCFD2_HUMAN,Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1),SCFD2 STXBP1L1,152579;,"ENST00000388940.8; ENSP00000373592.4; ENSG00000184178.17. [Q8WU76-2];""ENST00000401642.8; ENSP00000384182.3; ENSG00000184178.17. [Q8WU76-1]"";",0,intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],0
Q96NL6,C2,1.164806282,0.241184337,-0.322444426,0.021000404,-0.629650732,aquamarine,SCLT1,SCLT1_HUMAN,Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1),SCLT1 SAP1,132320;,"ENST00000281142.10; ENSP00000281142.5; ENSG00000151466.12. [Q96NL6-1];""ENST00000439369.6; ENSP00000395292.2; ENSG00000151466.12. [Q96NL6-3]"";""ENST00000511426.5; ENSP00000420861.1; ENSG00000151466.12. [Q96NL6-4]"";",clathrin binding [GO:0030276]; sodium channel regulator activity [GO:0017080],cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]
Q9UQR0,N4,-1.072263817,0.930777491,0.442396132,-0.204069187,-0.317216891,grey30,SCML2,SCML2_HUMAN,Sex comb on midleg-like protein 2,SCML2,10389;,"ENST00000251900.9; ENSP00000251900.4; ENSG00000102098.19. [Q9UQR0-1];""ENST00000398048.4; ENSP00000381126.4; ENSG00000102098.19. [Q9UQR0-2]"";",chromatin binding [GO:0003682]; histone binding [GO:0042393],anatomical structure morphogenesis [GO:0009653]; negative regulation of DNA-templated transcription [GO:0045892],nucleus [GO:0005634]; PcG protein complex [GO:0031519]
O75880,M2,-0.624802478,-0.943367852,0.161364864,1.047897859,-0.066734227,tan4,SCO1,SCO1_HUMAN,"Protein SCO1 homolog, mitochondrial",SCO1 SCOD1,6341;,ENST00000255390.10; ENSP00000255390.5; ENSG00000133028.12.;,copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507],intracellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myofibril [GO:0030016]
O43819,M2,-0.518869514,-0.727857749,0.355666166,0.809227208,-0.066623646,tan4,SCO2,SCO2_HUMAN,"Protein SCO2 homolog, mitochondrial",SCO2,9997;,"ENST00000252785.3; ENSP00000252785.3; ENSG00000284194.3.;""ENST00000395693.8; ENSP00000379046.4; ENSG00000284194.3."";""ENST00000535425.5; ENSP00000444242.1; ENSG00000284194.3."";""ENST00000543927.6; ENSP00000444433.1; ENSG00000284194.3."";",copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; protein-disulfide reductase activity [GO:0015035],eye development [GO:0001654]; in utero embryonic development [GO:0001701]; intracellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; muscle system process [GO:0003012]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myofibril [GO:0030016]
Q14160,M1,-0.813718573,-0.471291994,0.610691722,0.644291095,-0.229561145,burlywood4,SCRIB,SCRIB_HUMAN,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL,23513;,"ENST00000320476.7; ENSP00000322938.3; ENSG00000180900.20. [Q14160-1];""ENST00000356994.7; ENSP00000349486.2; ENSG00000180900.20. [Q14160-3]"";""ENST00000377533.7; ENSP00000366756.3; ENSG00000180900.20. [Q14160-2]"";""ENST00000611528.2; ENSP00000479898.1; ENSG00000274287.4. [Q14160-2]"";""ENST00000612204.4; ENSP00000484041.1; ENSG00000274287.4. [Q14160-3]"";""ENST00000622455.4; ENSP00000482406.1; ENSG00000274287.4. [Q14160-1]"";",cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591],"activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; establishment of apical/basal cell polarity [GO:0035089]; establishment of T cell polarity [GO:0001768]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; polarized epithelial cell differentiation [GO:0030859]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of receptor recycling [GO:0001921]; positive regulation of type II interferon production [GO:0032729]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]",adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750]
Q12765,C4,2.230994219,-0.050078221,-1.189478997,-1.17985595,-1.384480265,deepskyblue2,SCRN1,SCRN1_HUMAN,Secernin-1,SCRN1 KIAA0193,9805;,"ENST00000242059.10; ENSP00000242059.5; ENSG00000136193.17. [Q12765-1];""ENST00000409497.5; ENSP00000386872.1; ENSG00000136193.17. [Q12765-1]"";""ENST00000425819.6; ENSP00000414245.2; ENSG00000136193.17. [Q12765-3]"";""ENST00000426154.5; ENSP00000409068.1; ENSG00000136193.17. [Q12765-1]"";""ENST00000434476.6; ENSP00000388942.1; ENSG00000136193.17. [Q12765-2]"";",cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805],exocytosis [GO:0006887]; proteolysis [GO:0006508]; regulation of synaptic vesicle cycle [GO:0098693],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; presynapse [GO:0098793]
Q0VDG4,C5,2.045749216,0.488744191,-1.002175659,-1.113165405,-1.381300763,turquoise3,SCRN3,SCRN3_HUMAN,Secernin-3,SCRN3,79634;,"ENST00000272732.11; ENSP00000272732.6; ENSG00000144306.15. [Q0VDG4-1];""ENST00000409673.7; ENSP00000387142.3; ENSG00000144306.15. [Q0VDG4-2]"";",cysteine-type exopeptidase activity [GO:0070004]; dipeptidase activity [GO:0016805],proteolysis [GO:0006508],0
Q9NVU7,N1,-0.806775882,-0.862854585,0.145305141,-0.067896865,1.331190018,grey90,SDAD1,SDA1_HUMAN,Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA),SDAD1 NUC130,55153;,ENST00000356260.10; ENSP00000348596.5; ENSG00000198301.12. [Q9NVU7-1];,0,protein transport [GO:0015031]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P18827,S4,-0.965217935,-1.372079066,0.31902525,0.811242533,0.24876644,tomato2,SDC1,SDC1_HUMAN,Syndecan-1 (SYND1) (CD antigen CD138),SDC1 SDC,6382;,"ENST00000254351.9; ENSP00000254351.4; ENSG00000115884.11.;""ENST00000381150.5; ENSP00000370542.1; ENSG00000115884.11."";",cargo receptor activity [GO:0038024]; identical protein binding [GO:0042802],canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; myoblast development [GO:0048627]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; receptor-mediated endocytosis [GO:0006898]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to toxic substance [GO:0009636]; Sertoli cell development [GO:0060009]; striated muscle cell development [GO:0055002]; ureteric bud development [GO:0001657],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
P31431,S2,-1.282652583,-1.277008516,0.298108428,0.895627903,0.449840098,orange,SDC4,SDC4_HUMAN,Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein),SDC4,6385;,ENST00000372733.3; ENSP00000361818.3; ENSG00000124145.6. [P31431-1];,fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]; thrombospondin receptor activity [GO:0070053],cell migration [GO:0016477]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of stress fiber assembly [GO:0051496]; regulation of fibroblast migration [GO:0010762]; ureteric bud development [GO:0001657]; wound healing [GO:0042060],cell surface [GO:0009986]; costamere [GO:0043034]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]
O00560,C1,0.953306363,-0.51335795,-0.42601447,0.117447067,0.72568571,lightblue,SDCBP,SDCB1_HUMAN,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),SDCBP MDA9 SYCL,6386;,"ENST00000260130.9; ENSP00000260130.4; ENSG00000137575.12. [O00560-1];""ENST00000413219.6; ENSP00000411771.2; ENSG00000137575.12. [O00560-1]"";""ENST00000424270.6; ENSP00000395351.2; ENSG00000137575.12. [O00560-3]"";""ENST00000447182.6; ENSP00000409288.2; ENSG00000137575.12. [O00560-2]"";","cell adhesion molecule binding [GO:0050839]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; ionotropic glutamate receptor binding [GO:0035255]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]","actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]",adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]
Q99470,S3,-2.172475723,-0.377413014,-0.009056902,0.769875589,0.398603488,salmon,SDF2,SDF2_HUMAN,Stromal cell-derived factor 2 (SDF-2),SDF2,6388;,ENST00000247020.9; ENSP00000247020.3; ENSG00000132581.10.;,misfolded protein binding [GO:0051787],chaperone cofactor-dependent protein refolding [GO:0051085],endoplasmic reticulum [GO:0005783]; protein folding chaperone complex [GO:0101031]
P31040,M2,-1.024777909,-0.693791684,0.388189745,0.986007083,-0.283273461,tan4,SDHA,SDHA_HUMAN,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) (Malate dehydrogenase [quinone] flavoprotein subunit) (EC 1.1.5.-)",SDHA SDH2 SDHF,6389;,"ENST00000264932.11; ENSP00000264932.6; ENSG00000073578.18. [P31040-1];""ENST00000510361.5; ENSP00000427703.1; ENSG00000073578.18. [P31040-2]"";",electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (quinone) activity [GO:0008177],"mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; nervous system development [GO:0007399]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]","mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]"
P21912,M2,-1.383404516,-1.360363638,0.383666367,1.097933213,-0.202403824,tan4,SDHB,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) (Malate dehydrogenase [quinone] iron-sulfur subunit) (EC 1.1.5.-)",SDHB SDH SDH1,6390;,ENST00000375499.8; ENSP00000364649.3; ENSG00000117118.11.;,"2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (quinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]","aerobic respiration [GO:0009060]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099]","mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]"
P67812,S2,-1.099169864,-1.601553809,0.295817245,0.781014875,0.382084487,orange,SEC11A,SC11A_HUMAN,Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18),SEC11A SEC11L1 SPC18 SPCS4A,23478;,"ENST00000268220.12; ENSP00000268220.7; ENSG00000140612.14. [P67812-1];""ENST00000455959.7; ENSP00000413121.3; ENSG00000140612.14. [P67812-2]"";""ENST00000558134.5; ENSP00000452697.1; ENSG00000140612.14. [P67812-3]"";""ENST00000560266.5; ENSP00000452684.1; ENSG00000140612.14. [P67812-4]"";",peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252],response to virus [GO:0009615]; signal peptide processing [GO:0006465],endoplasmic reticulum membrane [GO:0005789]; signal peptidase complex [GO:0005787]
Q96IW7,S1,-1.313540188,-1.606137157,-0.033309564,0.860723497,0.817474089,gold,SEC22A,SC22A_HUMAN,Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2),SEC22A SEC22L2,26984;,"ENST00000309934.4; ENSP00000310521.4; ENSG00000121542.12.;""ENST00000492595.6; ENSP00000417972.1; ENSG00000121542.12."";",SNAP receptor activity [GO:0005484],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031],endoplasmic reticulum membrane [GO:0005789]
Q9Y6Y8,C1,1.260003623,-0.084214075,-0.491755073,-0.222295176,0.28718019,lightblue,SEC23IP,S23IP_HUMAN,SEC23-interacting protein (p125),SEC23IP MSTP053,11196;,ENST00000369075.8; ENSP00000358071.3; ENSG00000107651.15. [Q9Y6Y8-1];,metal ion binding [GO:0046872]; RNA binding [GO:0003723],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]
P60468,S2,-0.646182556,-1.191191082,0.364914987,0.922955192,0.544313578,orange,SEC61B,SC61B_HUMAN,Protein transport protein Sec61 subunit beta,SEC61B,10952;,ENST00000223641.5; ENSP00000223641.4; ENSG00000106803.10.;,epidermal growth factor binding [GO:0048408]; guanyl-nucleotide exchange factor activity [GO:0005085]; ribosome binding [GO:0043022]; RNA binding [GO:0003723],"ERAD pathway [GO:0036503]; post-translational protein targeting to membrane, translocation [GO:0031204]; retrograde protein transport, ER to cytosol [GO:0030970]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum Sec complex [GO:0031205]; membrane [GO:0016020]; Sec61 translocon complex [GO:0005784]
Q99442,S2,-0.89493673,-1.163687192,0.149602848,0.866104853,0.539319145,orange,SEC62,SEC62_HUMAN,Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1),SEC62 TLOC1,7095;,"ENST00000337002.9; ENSP00000337688.4; ENSG00000008952.17.;""ENST00000480708.5; ENSP00000420331.1; ENSG00000008952.17."";",signaling receptor activity [GO:0038023],"cotranslational protein targeting to membrane [GO:0006613]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]
Q9UGP8,S2,-1.050431589,-1.384693067,0.185839419,0.941448592,0.506035867,orange,SEC63,SEC63_HUMAN,Translocation protein SEC63 homolog (DnaJ homolog subfamily C member 23),SEC63 DNAJC23 SEC63L,11231;,ENST00000369002.9; ENSP00000357998.4; ENSG00000025796.14.;,protein transmembrane transporter activity [GO:0008320]; RNA binding [GO:0003723]; signaling receptor activity [GO:0038023],"liver development [GO:0001889]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein targeting to membrane [GO:0006612]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]",endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]
Q9UBV2,S2,-1.103779138,-1.60096466,0.194017156,0.929146476,0.56862352,orange,SEL1L,SE1L1_HUMAN,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),SEL1L TSA305 UNQ128/PRO1063,6400;,"ENST00000336735.9; ENSP00000337053.4; ENSG00000071537.14. [Q9UBV2-1];""ENST00000555824.5; ENSP00000450709.1; ENSG00000071537.14. [Q9UBV2-2]"";",0,"ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]",Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]
Q99985,S1,-0.598312624,-0.795488504,0.081369806,0.328632178,1.069373119,gold,SEMA3C,SEM3C_HUMAN,Semaphorin-3C (Semaphorin-E) (Sema E),SEMA3C SEMAE,10512;,"ENST00000265361.8; ENSP00000265361.3; ENSG00000075223.14. [Q99985-1];""ENST00000419255.6; ENSP00000411193.2; ENSG00000075223.14. [Q99985-1]"";",chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215],axon guidance [GO:0007411]; blood vessel remodeling [GO:0001974]; cardiac endothelial to mesenchymal transition [GO:0140074]; cardiac right ventricle morphogenesis [GO:0003215]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; immune response [GO:0006955]; limb bud formation [GO:0060174]; negative chemotaxis [GO:0050919]; neural crest cell migration [GO:0001755]; neural tube development [GO:0021915]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell migration [GO:0030335]; post-embryonic development [GO:0009791]; pulmonary myocardium development [GO:0003350]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]
Q9C0C4,S1,-0.853463692,-1.010205863,0.202483742,0.663621139,0.709927954,gold,SEMA4C,SEM4C_HUMAN,Semaphorin-4C,SEMA4C KIAA1739 SEMAI UNQ5855/PRO34487,54910;,ENST00000305476.10; ENSP00000306844.5; ENSG00000168758.11.;,chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215],axon guidance [GO:0007411]; cell migration in hindbrain [GO:0021535]; cerebellum development [GO:0021549]; muscle cell differentiation [GO:0042692]; negative chemotaxis [GO:0050919]; neural crest cell migration [GO:0001755]; neural tube closure [GO:0001843]; positive regulation of cell migration [GO:0030335]; positive regulation of stress-activated MAPK cascade [GO:0032874]; semaphorin-plexin signaling pathway [GO:0071526],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; synaptic vesicle membrane [GO:0030672]
Q92854,S4,-1.188314986,-0.992576346,0.419335954,0.88428915,0.201027912,tomato2,SEMA4D,SEM4D_HUMAN,Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100),SEMA4D C9orf164 CD100 SEMAJ,10507;,"ENST00000339861.8; ENSP00000344923.4; ENSG00000187764.12. [Q92854-2];""ENST00000356444.6; ENSP00000348822.2; ENSG00000187764.12. [Q92854-1]"";""ENST00000420987.5; ENSP00000391733.1; ENSG00000187764.12. [Q92854-2]"";""ENST00000422704.7; ENSP00000388768.2; ENSG00000187764.12. [Q92854-1]"";""ENST00000438547.6; ENSP00000405102.2; ENSG00000187764.12. [Q92854-1]"";""ENST00000450295.5; ENSP00000416523.1; ENSG00000187764.12. [Q92854-1]"";""ENST00000455551.6; ENSP00000411981.2; ENSG00000187764.12. [Q92854-2]"";",chemorepellent activity [GO:0045499]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; transmembrane signaling receptor activity [GO:0004888],axon guidance [GO:0007411]; bone trabecula morphogenesis [GO:0061430]; cell adhesion [GO:0007155]; immune response [GO:0006955]; leukocyte aggregation [GO:0070486]; negative chemotaxis [GO:0050919]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; ossification involved in bone maturation [GO:0043931]; positive regulation of cell migration [GO:0030335]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inhibitory synapse assembly [GO:1905704]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of cell projection organization [GO:0031344]; regulation of cell shape [GO:0008360]; regulation of dendrite morphogenesis [GO:0048814]; semaphorin-plexin signaling pathway [GO:0071526],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]
O75326,S4,-0.853546448,-0.801483993,0.202630199,0.769636984,0.473678459,tomato2,SEMA7A,SEM7A_HUMAN,Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1) (Sema K1) (Semaphorin-L) (Sema L) (CD antigen CD108),SEMA7A CD108 SEMAL,8482;,"ENST00000261918.9; ENSP00000261918.4; ENSG00000138623.10. [O75326-1];""ENST00000543145.6; ENSP00000438966.2; ENSG00000138623.10. [O75326-2]"";""ENST00000671713.1; ENSP00000500448.1; ENSG00000288455.1. [O75326-1]"";""ENST00000672978.1; ENSP00000500204.1; ENSG00000288455.1. [O75326-2]"";",chemorepellent activity [GO:0045499]; integrin binding [GO:0005178]; semaphorin receptor binding [GO:0030215],axon extension [GO:0048675]; axon guidance [GO:0007411]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; neural crest cell migration [GO:0001755]; olfactory lobe development [GO:0021988]; osteoblast differentiation [GO:0001649]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of protein phosphorylation [GO:0001934]; regulation of inflammatory response [GO:0050727]; semaphorin-plexin signaling pathway [GO:0071526],external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9H4L4,N3,-1.287564731,-1.351601488,0.918817418,-0.154105929,0.67749356,grey50,SENP3,SENP3_HUMAN,Sentrin-specific protease 3 (EC 3.4.22.-) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3),SENP3 SSP3 SUSP3,26168;,ENST00000321337.12; ENSP00000314029.8; ENSG00000161956.14.;,cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; deSUMOylase activity [GO:0016929],negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96HI0,N1,-0.713404697,-0.552078462,0.500975424,0.027069929,0.976306848,grey90,SENP5,SENP5_HUMAN,Sentrin-specific protease 5 (EC 3.4.22.-) (Sentrin/SUMO-specific protease SENP5),SENP5 FKSG45,205564;,"ENST00000323460.10; ENSP00000327197.5; ENSG00000119231.11. [Q96HI0-1];""ENST00000445299.6; ENSP00000390231.2; ENSG00000119231.11. [Q96HI0-2]"";",deSUMOylase activity [GO:0016929]; SUMO-specific endopeptidase activity [GO:0070139],cell division [GO:0051301]; protein desumoylation [GO:0016926]; protein sumoylation [GO:0016925]; proteolysis [GO:0006508],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BQF6,N2,-0.990441231,-0.45505261,1.187658229,0.208144355,-0.481220142,grey70,SENP7,SENP7_HUMAN,Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7),SENP7 KIAA1707 SSP2 SUSP2,57337;,"ENST00000314261.11; ENSP00000313624.7; ENSG00000138468.16. [Q9BQF6-5];""ENST00000348610.3; ENSP00000342159.3; ENSG00000138468.16. [Q9BQF6-2]"";""ENST00000394085.7; ENSP00000377647.3; ENSG00000138468.16. [Q9BQF6-3]"";""ENST00000394091.5; ENSP00000377651.1; ENSG00000138468.16. [Q9BQF6-4]"";""ENST00000394095.7; ENSP00000377655.2; ENSG00000138468.16. [Q9BQF6-1]"";",SUMO-specific endopeptidase activity [GO:0070139],antiviral innate immune response [GO:0140374]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q9NZV5,S3,-0.88316504,-1.020491848,0.214181197,0.830832504,0.557426156,salmon,SEPN1,SELN_HUMAN,Selenoprotein N (SelN),SELENON SELN SEPN1,57190;,"ENST00000361547.7; ENSP00000355141.2; ENSG00000162430.18. [Q9NZV5-1];""ENST00000374315.1; ENSP00000363434.1; ENSG00000162430.18. [Q9NZV5-2]"";",calcium ion binding [GO:0005509]; oxidoreductase activity [GO:0016491],calcium ion homeostasis [GO:0055074]; cellular response to caffeine [GO:0071313]; cellular response to oxidative stress [GO:0034599]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; multicellular organismal response to stress [GO:0033555]; positive regulation of response to oxidative stress [GO:1902884]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; respiratory system process [GO:0003016]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]; skeletal muscle fiber development [GO:0048741]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834],endoplasmic reticulum membrane [GO:0005789]
Q9HD40,C4,2.023757344,0.293848322,-1.039860743,-1.209700732,-0.680975593,deepskyblue2,SEPSECS,SPCS_HUMAN,O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Liver-pancreas antigen) (LP) (SLA-p35) (SLA/LP autoantigen) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (Soluble liver antigen) (SLA) (UGA suppressor tRNA-associated protein) (tRNA(Ser/Sec)-associated antigenic protein),SEPSECS TRNP48,51091;,"ENST00000382103.7; ENSP00000371535.2; ENSG00000109618.13. [Q9HD40-1];""ENST00000514585.5; ENSP00000421880.1; ENSG00000109618.13. [Q9HD40-2]"";",O-phosphoseryl-tRNA(Sec) selenium transferase activity [GO:0098621]; tRNA binding [GO:0000049],conversion of seryl-tRNAsec to selenocys-tRNAsec [GO:0001717]; selenocysteine incorporation [GO:0001514],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q9P0V9,C5,1.41037207,0.740341213,-0.502062136,-0.484773007,-0.718009642,turquoise3,SEPT10,SEP10_HUMAN,Septin-10,SEPTIN10 SEPT10,151011;,"ENST00000397712.7; ENSP00000380824.2; ENSG00000186522.15. [Q9P0V9-1];""ENST00000397714.6; ENSP00000380826.2; ENSG00000186522.15. [Q9P0V9-3]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090],cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104],cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; septin complex [GO:0031105]; septin ring [GO:0005940]
Q9NVA2,C5,1.35300513,0.649223487,-0.483577904,-0.429291403,-0.690892101,turquoise3,SEPT11,SEP11_HUMAN,Septin-11,SEPTIN11 SEPT11,55752;,"ENST00000264893.11; ENSP00000264893.6; ENSG00000138758.12. [Q9NVA2-1];""ENST00000510515.5; ENSP00000422896.1; ENSG00000138758.12. [Q9NVA2-2]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090],cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of synapse organization [GO:0050807],axon [GO:0030424]; cell division site [GO:0032153]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; microtubule cytoskeleton [GO:0015630]; postsynaptic specialization of symmetric synapse [GO:0099629]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]
Q15019,C5,1.323576114,0.742930343,-0.464383243,-0.478553982,-0.618029955,turquoise3,SEPT2,SEPT2_HUMAN,Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5) (NEDD-5),SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2,4735;,"ENST00000360051.7; ENSP00000353157.3; ENSG00000168385.18. [Q15019-1];""ENST00000391971.7; ENSP00000375832.2; ENSG00000168385.18. [Q15019-1]"";""ENST00000391973.6; ENSP00000375834.2; ENSG00000168385.18. [Q15019-1]"";""ENST00000401990.5; ENSP00000385109.1; ENSG00000168385.18. [Q15019-3]"";""ENST00000402092.6; ENSP00000385172.2; ENSG00000168385.18. [Q15019-1]"";""ENST00000616972.4; ENSP00000479861.1; ENSG00000168385.18. [Q15019-2]"";",cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104]; regulation of exocytosis [GO:0017157]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; synaptic vesicle [GO:0008021]
Q9UH03,C5,1.387013543,0.626846468,-0.336901598,-0.415045777,-0.733764974,turquoise3,SEPT3,SEPT3_HUMAN,Neuronal-specific septin-3,SEPTIN3 SEP3 SEPT3,55964;,"ENST00000396417.2; ENSP00000379695.2; ENSG00000100167.21. [Q9UH03-3];""ENST00000396425.8; ENSP00000379703.3; ENSG00000100167.21. [Q9UH03-2]"";""ENST00000396426.7; ENSP00000379704.3; ENSG00000100167.21. [Q9UH03-1]"";",GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104],cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; presynapse [GO:0098793]; presynaptic cytoskeleton [GO:0099569]; septin complex [GO:0031105]; septin ring [GO:0005940]
Q16181,C5,1.167577638,0.74736852,-0.417360415,-0.483019441,-0.640361503,turquoise3,SEPT7,SEPT7_HUMAN,Septin-7 (CDC10 protein homolog),SEPTIN7 CDC10 SEPT7,989;,"ENST00000350320.11; ENSP00000344868.8; ENSG00000122545.22. [Q16181-1];""ENST00000705486.1; ENSP00000516132.1; ENSG00000122545.22. [Q16181-2]"";",cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198],cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725]
Q9UHD8,C5,0.964505574,0.76885256,-0.366574323,-0.4132484,-0.603458092,turquoise3,SEPT9,SEPT9_HUMAN,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),SEPTIN9 KIAA0991 MSF SEPT9,10801;,"ENST00000329047.13; ENSP00000329161.8; ENSG00000184640.20. [Q9UHD8-2];""ENST00000423034.6; ENSP00000405877.1; ENSG00000184640.20. [Q9UHD8-5]"";""ENST00000427177.6; ENSP00000391249.1; ENSG00000184640.20. [Q9UHD8-1]"";""ENST00000427180.5; ENSP00000504196.1; ENSG00000184640.20. [Q9UHD8-4]"";""ENST00000427674.6; ENSP00000403194.1; ENSG00000184640.20. [Q9UHD8-3]"";""ENST00000431235.6; ENSP00000406987.2; ENSG00000184640.20. [Q9UHD8-3]"";""ENST00000449803.6; ENSP00000400181.2; ENSG00000184640.20. [Q9UHD8-3]"";""ENST00000541152.6; ENSP00000438089.2; ENSG00000184640.20. [Q9UHD8-4]"";""ENST00000585930.5; ENSP00000468120.1; ENSG00000184640.20. [Q9UHD8-9]"";""ENST00000588690.6; ENSP00000468668.1; ENSG00000184640.20. [Q9UHD8-3]"";""ENST00000591088.5; ENSP00000466247.1; ENSG00000184640.20. [Q9UHD8-4]"";""ENST00000591198.5; ENSP00000468406.1; ENSG00000184640.20. [Q9UHD8-7]"";""ENST00000592951.5; ENSP00000466648.1; ENSG00000184640.20. [Q9UHD8-4]"";",cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090],cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104],actin cytoskeleton [GO:0015629]; axoneme [GO:0005930]; cell division site [GO:0032153]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; non-motile cilium [GO:0097730]; perinuclear region of cytoplasm [GO:0048471]; septin complex [GO:0031105]; septin ring [GO:0005940]; stress fiber [GO:0001725]
Q96JX3,M2,-1.377995658,-1.26445282,0.440480664,0.985303619,-0.01488325,tan4,SERAC1,SRAC1_HUMAN,Protein SERAC1 (Serine active site-containing protein 1),SERAC1,84947;,"ENST00000367101.5; ENSP00000356068.1; ENSG00000122335.17. [Q96JX3-2];""ENST00000647468.2; ENSP00000496731.1; ENSG00000122335.17. [Q96JX3-1]"";",0,extracellular matrix organization [GO:0030198]; intracellular cholesterol transport [GO:0032367]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phospholipid biosynthetic process [GO:0008654],endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]
Q13530,S1,-0.921790574,-1.334537084,-0.168946863,0.572570294,1.231583738,gold,SERINC3,SERC3_HUMAN,Serine incorporator 3 (Tumor differentially expressed protein 1),SERINC3 DIFF33 TDE1 SBBI99,10955;,"ENST00000255175.5; ENSP00000255175.1; ENSG00000132824.14. [Q13530-1];""ENST00000342374.5; ENSP00000340243.4; ENSG00000132824.14. [Q13530-1]"";",L-serine transmembrane transporter activity [GO:0015194],defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237],Golgi membrane [GO:0000139]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q86VE9,S2,-1.224632852,-1.44937822,0.299265065,0.907537869,0.466412232,orange,SERINC5,SERC5_HUMAN,Serine incorporator 5,SERINC5 C5orf12,256987;,"ENST00000507668.7; ENSP00000426237.3; ENSG00000164300.17. [Q86VE9-4];""ENST00000509193.5; ENSP00000426134.2; ENSG00000164300.17. [Q86VE9-2]"";""ENST00000512972.6; ENSP00000421665.2; ENSG00000164300.17. [Q86VE9-3]"";",L-serine transmembrane transporter activity [GO:0015194],defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; L-serine biosynthetic process [GO:0006564]; myelination [GO:0042552]; phosphatidylserine metabolic process [GO:0006658]; phospholipid biosynthetic process [GO:0008654]; positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:1904219]; positive regulation of serine C-palmitoyltransferase activity [GO:1904222],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
P30740,C5,1.940144508,0.359396352,-0.823560104,-0.884052804,-1.070999787,turquoise3,SERPINB1,ILEU_HUMAN,Leukocyte elastase inhibitor (LEI) (Monocyte/neutrophil elastase inhibitor) (EI) (M/NEI) (Peptidase inhibitor 2) (PI-2) (Serpin B1),SERPINB1 ELANH2 MNEI PI2,1992;,ENST00000380739.6; ENSP00000370115.5; ENSG00000021355.13. [P30740-1];,peptidase inhibitor activity [GO:0030414]; serine-type endopeptidase inhibitor activity [GO:0004867],negative regulation of endopeptidase activity [GO:0010951]; negative regulation of interleukin-1 beta production [GO:0032691]; type B pancreatic cell proliferation [GO:0044342],collagen-containing extracellular matrix [GO:0062023]; cytolytic granule [GO:0044194]; cytoplasmic ribonucleoprotein granule [GO:0036464]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]
P58004,C1,1.369715573,0.342544177,-0.418128782,-0.298555443,-0.458141678,lightblue,SESN2,SESN2_HUMAN,Sestrin-2 (EC 1.11.1.-) (Hypoxia-induced gene),SESN2 Hi95 SEST2,83667;,"ENST00000253063.4; ENSP00000253063.3; ENSG00000130766.5.;""ENST00000645231.2; ENSP00000496365.1; ENSG00000285069.2."";","GDP-dissociation inhibitor activity [GO:0005092]; L-leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]; PH domain binding [GO:0042731]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; sulfiredoxin activity [GO:0032542]","cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of TORC1 signaling [GO:1904263]; reactive oxygen species metabolic process [GO:0072593]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; regulation of TORC1 signaling [GO:1903432]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]",Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]
Q01105,N4,0.050396886,1.491986222,-0.694108629,-1.22105083,-1.407483752,grey30,SET,SET_HUMAN,Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I),SET,6418;,"ENST00000322030.13; ENSP00000318012.9; ENSG00000119335.18. [Q01105-2];""ENST00000372692.8; ENSP00000361777.4; ENSG00000119335.18. [Q01105-1]"";""ENST00000409104.7; ENSP00000387321.3; ENSG00000119335.18. [Q01105-4]"";""ENST00000686840.1; ENSP00000509032.1; ENSG00000119335.18. [Q01105-1]"";",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888],DNA replication [GO:0006260]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]
Q9UPS6,N4,-0.433345091,0.659383809,0.31445001,-0.043901839,-0.188971639,grey30,SETD1B,SET1B_HUMAN,Histone-lysine N-methyltransferase SETD1B (EC 2.1.1.364) (Lysine N-methyltransferase 2G) (SET domain-containing protein 1B) (hSET1B),SETD1B KIAA1076 KMT2G SET1B,0,"ENST00000542440.5; ENSP00000442924.1; ENSG00000139718.12. [Q9UPS6-2];""ENST00000604567.6; ENSP00000474253.1; ENSG00000139718.12. [Q9UPS6-1]"";""ENST00000619791.1; ENSP00000481531.1; ENSG00000139718.12. [Q9UPS6-1]"";",histone H3 methyltransferase activity [GO:0140938]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; RNA binding [GO:0003723],methylation [GO:0032259],chromosome [GO:0005694]; cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]
Q8WTS6,C5,1.550478202,0.728860524,-1.056297214,-1.226645184,-1.283508946,turquoise3,SETD7,SETD7_HUMAN,Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.364) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9),SETD7 KIAA1717 KMT7 SET7 SET9,80854;,ENST00000274031.8; ENSP00000274031.3; ENSG00000145391.14.;,chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone methyltransferase activity [GO:0042054]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279],chromatin organization [GO:0006325]; DNA damage response [GO:0006974]; heterochromatin organization [GO:0070828]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of DNA-templated transcription [GO:0045893]; response to ethanol [GO:0045471],chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8NE22,M2,-1.250225503,-1.056868399,0.517797488,1.081537777,0.039436952,tan4,SETD9,SETD9_HUMAN,SET domain-containing protein 9 (EC 2.1.1.-),SETD9 C5orf35,133383;,"ENST00000285947.5; ENSP00000285947.2; ENSG00000155542.12. [Q8NE22-1];""ENST00000628593.1; ENSP00000486609.1; ENSG00000155542.12. [Q8NE22-2]"";",lysine N-methyltransferase activity [GO:0016278],methylation [GO:0032259]; regulation of signal transduction by p53 class mediator [GO:1901796],nucleoplasm [GO:0005654]
Q6UXD5,S1,-0.793562394,-0.86071501,-0.113506825,0.597376688,0.977843179,gold,SEZ6L2,SE6L2_HUMAN,Seizure 6-like protein 2,SEZ6L2 PSK UNQ1903/PRO4349,26470;,"ENST00000308713.9; ENSP00000312550.5; ENSG00000174938.15. [Q6UXD5-1];""ENST00000346932.9; ENSP00000319215.6; ENSG00000174938.15. [Q6UXD5-6]"";""ENST00000350527.7; ENSP00000310206.3; ENSG00000174938.15. [Q6UXD5-3]"";""ENST00000537485.5; ENSP00000439412.1; ENSG00000174938.15. [Q6UXD5-5]"";",0,regulation of protein kinase C signaling [GO:0090036]; synapse maturation [GO:0060074],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]
Q15459,N2,-0.962486474,0.361195794,0.702577225,-0.22732662,0.175309437,grey70,SF3A1,SF3A1_HUMAN,Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114),SF3A1 SAP114,10291;,ENST00000215793.13; ENSP00000215793.7; ENSG00000099995.19. [Q15459-1];,RNA binding [GO:0003723],"mRNA 3'-splice site recognition [GO:0000389]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]",catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]
Q15428,N2,-1.125230173,0.227882435,0.776223184,-0.363530206,0.184371323,grey70,SF3A2,SF3A2_HUMAN,Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62),SF3A2 SAP62,8175;,ENST00000221494.10; ENSP00000221494.3; ENSG00000104897.10.;,RNA binding [GO:0003723]; zinc ion binding [GO:0008270],"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]",catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]
Q12874,N2,-1.076193653,0.225490799,0.666531553,-0.243651365,0.198782642,grey70,SF3A3,SF3A3_HUMAN,Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61),SF3A3 SAP61,10946;,ENST00000373019.5; ENSP00000362110.4; ENSG00000183431.12.;,RNA binding [GO:0003723]; zinc ion binding [GO:0008270],"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]",catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]
O75533,N2,-1.037378237,0.041445818,0.814016464,-0.195122051,0.394132456,grey70,SF3B1,SF3B1_HUMAN,Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155),SF3B1 SAP155,23451;,"ENST00000335508.11; ENSP00000335321.6; ENSG00000115524.17. [O75533-1];""ENST00000409915.8; ENSP00000428820.1; ENSG00000115524.17. [O75533-2]"";""ENST00000414963.2; ENSP00000402997.2; ENSG00000115524.17. [O75533-2]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935],"chromatin remodeling [GO:0006338]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]",B-WICH complex [GO:0110016]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]
O95562,S1,-0.701891222,-0.850285982,0.075327977,0.454981336,0.891325753,gold,SFT2D2,SFT2B_HUMAN,Vesicle transport protein SFT2B (SFT2 domain-containing protein 2),SFT2D2 UNQ512/PRO1027,375035;,ENST00000271375.7; ENSP00000271375.3; ENSG00000213064.10.;,0,protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
Q587I9,S1,-0.843035859,-1.343815446,-0.267575264,0.817546328,1.097764399,gold,SFT2D3,SFT2C_HUMAN,Vesicle transport protein SFT2C (SFT2 domain-containing protein 3),SFT2D3,84826;,ENST00000310981.6; ENSP00000310803.3; ENSG00000173349.6.;,0,protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
Q9H9B4,M2,-0.950374187,-1.185665209,0.347821817,1.090820806,-0.089786351,tan4,SFXN1,SFXN1_HUMAN,Sideroflexin-1,SFXN1,94081;,ENST00000321442.10; ENSP00000316905.5; ENSG00000164466.13.;,L-alanine transmembrane transporter activity [GO:0015180]; L-serine transmembrane transporter activity [GO:0015194]; monoatomic ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857],erythrocyte differentiation [GO:0030218]; iron ion transport [GO:0006826]; L-alanine transport [GO:0015808]; L-serine transport [GO:0015825]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q96NB2,M2,-1.010556579,-1.494987486,0.286603066,1.180079331,-0.107329653,tan4,SFXN2,SFXN2_HUMAN,Sideroflexin-2,SFXN2,118980;,ENST00000369893.10; ENSP00000358909.4; ENSG00000156398.13.;,monoatomic ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857],mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q9BWM7,M2,-0.60300706,-0.890939378,0.316982083,1.05782629,-0.053224585,tan4,SFXN3,SFXN3_HUMAN,Sideroflexin-3,SFXN3,81855;,ENST00000393459.6; ENSP00000377103.1; ENSG00000107819.15.;,L-serine transmembrane transporter activity [GO:0015194]; monoatomic ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857],mitochondrial transmembrane transport [GO:1990542]; one-carbon metabolic process [GO:0006730]; serine import into mitochondrion [GO:0140300],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q6P4A7,M2,-0.911300052,-0.92752207,0.332000702,0.893728694,-0.020207786,tan4,SFXN4,SFXN4_HUMAN,Sideroflexin-4 (Breast cancer resistance marker 1),SFXN4 BCRM1,119559;,ENST00000355697.7; ENSP00000347924.2; ENSG00000183605.17. [Q6P4A7-1];,monoatomic ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857],amino acid transport [GO:0006865]; mitochondrial transmembrane transport [GO:1990542],intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q86VZ5,S1,-0.96243399,-1.028815683,-0.351748879,0.712200867,1.044520994,gold,SGMS1,SMS1_HUMAN,Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Medulla oblongata-derived protein) (Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23),SGMS1 MOB SMS1 TMEM23,259230;,ENST00000361781.7; ENSP00000354829.2; ENSG00000198964.14. [Q86VZ5-1];,ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188],apoptotic process [GO:0006915]; ceramide biosynthetic process [GO:0046513]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q8NHU3,S1,-1.078941758,-1.374511122,-0.189079979,0.702597803,0.8510491,gold,SGMS2,SMS2_HUMAN,Phosphatidylcholine:ceramide cholinephosphotransferase 2 (EC 2.7.8.27) (Sphingomyelin synthase 2),SGMS2 SMS2,166929;,"ENST00000359079.8; ENSP00000351981.4; ENSG00000164023.15.;""ENST00000394684.8; ENSP00000378176.4; ENSG00000164023.15."";""ENST00000394686.3; ENSP00000378178.3; ENSG00000164023.15."";""ENST00000690982.1; ENSP00000508566.1; ENSG00000164023.15."";",ceramide cholinephosphotransferase activity [GO:0047493]; ceramide phosphoethanolamine synthase activity [GO:0002950]; kinase activity [GO:0016301]; sphingomyelin synthase activity [GO:0033188],ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of bone mineralization [GO:0030500]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q5FBB7,N2,-1.16774726,-0.910041632,1.081903318,0.086847982,0.12250929,grey70,SGOL1,SGO1_HUMAN,Shugoshin 1 (Serologically defined breast cancer antigen NY-BR-85) (Shugoshin-like 1),SGO1 SGOL1,151648;,"ENST00000263753.8; ENSP00000263753.4; ENSG00000129810.15. [Q5FBB7-1];""ENST00000306698.6; ENSP00000306581.2; ENSG00000129810.15. [Q5FBB7-3]"";""ENST00000412997.6; ENSP00000410458.1; ENSG00000129810.15. [Q5FBB7-6]"";""ENST00000417364.1; ENSP00000394613.1; ENSG00000129810.15. [Q5FBB7-4]"";""ENST00000419233.6; ENSP00000394625.2; ENSG00000129810.15. [Q5FBB7-2]"";""ENST00000421451.5; ENSP00000414129.1; ENSG00000129810.15. [Q5FBB7-1]"";""ENST00000425061.5; ENSP00000414960.1; ENSG00000129810.15. [Q5FBB7-2]"";""ENST00000437051.5; ENSP00000389034.1; ENSG00000129810.15. [Q5FBB7-4]"";""ENST00000442720.5; ENSP00000394957.1; ENSG00000129810.15. [Q5FBB7-5]"";""ENST00000443724.5; ENSP00000413070.1; ENSG00000129810.15. [Q5FBB7-7]"";""ENST00000452020.5; ENSP00000411200.1; ENSG00000129810.15. [Q5FBB7-3]"";",kinase binding [GO:0019900],"attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; chromosome segregation [GO:0007059]; meiotic chromosome segregation [GO:0045132]; mitotic sister chromatid cohesion, centromeric [GO:0071962]","centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]"
Q562F6,N1,-1.114560876,-0.47522799,0.265608994,0.276107651,1.011234646,grey90,SGOL2,SGO2_HUMAN,Shugoshin 2 (Shugoshin-2) (Shugoshin-like 2) (Tripin),SGO2 SGOL2,151246;,"ENST00000357799.9; ENSP00000350447.4; ENSG00000163535.18. [Q562F6-1];""ENST00000409203.3; ENSP00000386249.3; ENSG00000163535.18. [Q562F6-3]"";",0,cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; meiotic sister chromatid cohesion [GO:0051177],"chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic cohesin complex [GO:0030892]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]"
O95470,S2,-1.428459058,-1.419240968,0.306390891,0.866628521,0.478652265,orange,SGPL1,SGPL1_HUMAN,Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),SGPL1 KIAA1252,8879;,"ENST00000373202.8; ENSP00000362298.3; ENSG00000166224.18.;""ENST00000697928.1; ENSP00000513482.1; ENSG00000166224.18."";""ENST00000697931.1; ENSP00000513485.1; ENSG00000166224.18."";""ENST00000697932.1; ENSP00000513486.1; ENSG00000166224.18."";",pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117],androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q9BX95,S2,-1.151733183,-1.41566251,0.34856518,0.73563662,0.663420244,orange,SGPP1,SGPP1_HUMAN,Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1) (SPP-1),SGPP1 SPP1,81537;,"ENST00000247225.7; ENSP00000247225.6; ENSG00000126821.8.;""ENST00000645915.2; ENSP00000496280.1; ENSG00000285281.2."";",dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392],ER to Golgi ceramide transport [GO:0035621]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway [GO:0097193]; phospholipid dephosphorylation [GO:0046839]; regulation of epidermis development [GO:0045682]; regulation of keratinocyte differentiation [GO:0045616]; sphinganine-1-phosphate metabolic process [GO:0006668]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]
O43765,C5,1.825589587,0.610972287,-0.91347726,-0.821424502,-1.244585722,turquoise3,SGTA,SGTA_HUMAN,Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP),SGTA SGT SGT1,6449;,"ENST00000221566.7; ENSP00000221566.1; ENSG00000104969.11.;""ENST00000676943.1; ENSP00000504495.1; ENSG00000104969.11."";""ENST00000677149.1; ENSP00000503397.1; ENSG00000104969.11."";",BAT3 complex binding [GO:1904288]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],ERAD pathway [GO:0036503]; negative regulation of ERAD pathway [GO:1904293]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; TRC complex [GO:0072380]
Q96EQ0,C1,1.652949259,0.243442681,-0.529904327,-0.394804483,-0.628700858,lightblue,SGTB,SGTB_HUMAN,Small glutamine-rich tetratricopeptide repeat-containing protein beta (Beta-SGT) (Small glutamine-rich protein with tetratricopeptide repeats 2),SGTB SGT2,54557;,ENST00000381007.9; ENSP00000370395.4; ENSG00000197860.10.;,Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260],membrane [GO:0016020]; TRC complex [GO:0072380]
Q9H788,C3,1.779503423,0.099238717,-0.460788168,-0.494296245,-0.935812545,cyan,SH2D4A,SH24A_HUMAN,SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38),SH2D4A PPP1R38 SH2A,63898;,"ENST00000265807.8; ENSP00000265807.3; ENSG00000104611.12. [Q9H788-1];""ENST00000518040.5; ENSP00000429482.1; ENSG00000104611.12. [Q9H788-2]"";""ENST00000519207.5; ENSP00000428684.1; ENSG00000104611.12. [Q9H788-1]"";",phosphatase binding [GO:0019902],0,cytoplasm [GO:0005737]; cytosol [GO:0005829]
P78314,C3,1.677467561,0.197855415,-0.440537513,-0.553044905,-0.534390313,cyan,SH3BP2,3BP2_HUMAN,SH3 domain-binding protein 2 (3BP-2),SH3BP2 3BP2 RES4-23,6452;,"ENST00000356331.9; ENSP00000348685.5; ENSG00000087266.17. [P78314-1];""ENST00000435136.8; ENSP00000403231.3; ENSG00000087266.17. [P78314-3]"";""ENST00000503393.8; ENSP00000422168.3; ENSG00000087266.17. [P78314-1]"";""ENST00000511747.6; ENSP00000424846.2; ENSG00000087266.17. [P78314-4]"";""ENST00000513020.5; ENSP00000424072.1; ENSG00000087266.17. [P78314-2]"";""ENST00000515737.5; ENSP00000422605.1; ENSG00000087266.17. [P78314-2]"";",phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124],signal transduction [GO:0007165],0
Q9P0V3,S4,-0.485666127,-0.933088856,0.334924901,0.7706096,0.448724194,tomato2,SH3BP4,SH3B4_HUMAN,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),SH3BP4 BOG25 EHB10 TTP,23677;,"ENST00000344528.8; ENSP00000340237.4; ENSG00000130147.16. [Q9P0V3-1];""ENST00000392011.7; ENSP00000375867.2; ENSG00000130147.16. [Q9P0V3-1]"";""ENST00000409212.5; ENSP00000386862.1; ENSG00000130147.16. [Q9P0V3-1]"";",GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267],cellular response to amino acid stimulus [GO:0071230]; endocytosis [GO:0006897]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of GTPase activity [GO:0034260]; negative regulation of TOR signaling [GO:0032007]; positive regulation of autophagy [GO:0010508]; protein localization to lysosome [GO:0061462]; regulation of catalytic activity [GO:0050790],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
Q7L8J4,C1,1.575440815,-0.164946581,-0.551210665,-0.537564005,-0.159593766,lightblue,SH3BP5L,3BP5L_HUMAN,SH3 domain-binding protein 5-like (SH3BP-5-like),SH3BP5L KIAA1720 UNQ2766/PRO7133,80851;,ENST00000366472.6; ENSP00000355428.5; ENSG00000175137.11. [Q7L8J4-1];,guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase inhibitor activity [GO:0004860],intracellular signal transduction [GO:0035556],cytoplasm [GO:0005737]
Q5HYK7,C5,1.182258228,0.859901016,-0.433029739,-0.458846468,-0.632056609,turquoise3,SH3D19,SH319_HUMAN,SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein) (EBP),SH3D19,152503;,"ENST00000409252.6; ENSP00000386848.2; ENSG00000109686.20. [Q5HYK7-1];""ENST00000409598.8; ENSP00000387030.4; ENSG00000109686.20. [Q5HYK7-2]"";""ENST00000427414.2; ENSP00000415694.1; ENSG00000109686.20. [Q5HYK7-3]"";""ENST00000514152.5; ENSP00000423449.1; ENSG00000109686.20. [Q5HYK7-2]"";""ENST00000709914.1; ENSP00000517934.1; ENSG00000292165.1. [Q5HYK7-2]"";""ENST00000709915.1; ENSP00000517935.1; ENSG00000292165.1. [Q5HYK7-1]"";""ENST00000709917.1; ENSP00000517936.1; ENSG00000292165.1. [Q5HYK7-2]"";""ENST00000709920.1; ENSP00000517939.1; ENSG00000292165.1. [Q5HYK7-3]"";""ENST00000709926.1; ENSP00000517941.1; ENSG00000292165.1. [Q5HYK7-1]"";",proline-rich region binding [GO:0070064],cytoskeleton organization [GO:0007010]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of cell morphogenesis [GO:0022604],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q99961,C3,1.812543318,0.127396779,-0.812900731,-0.658952045,-0.988113984,cyan,SH3GL1,SH3G1_HUMAN,Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1),SH3GL1 CNSA1 SH3D2B,6455;,"ENST00000269886.7; ENSP00000269886.2; ENSG00000141985.9. [Q99961-1];""ENST00000417295.6; ENSP00000404568.2; ENSG00000141985.9. [Q99961-2]"";""ENST00000598564.5; ENSP00000470792.1; ENSG00000141985.9. [Q99961-3]"";",cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],central nervous system development [GO:0007417]; signal transduction [GO:0007165]; synaptic vesicle uncoating [GO:0016191],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]
Q96B97,C5,1.81842295,0.653143175,-0.814541733,-0.811503418,-1.079326176,turquoise3,SH3KBP1,SH3K1_HUMAN,SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1),SH3KBP1 CIN85,30011;,"ENST00000379698.8; ENSP00000369020.4; ENSG00000147010.19. [Q96B97-2];""ENST00000379716.5; ENSP00000369039.1; ENSG00000147010.19. [Q96B97-3]"";""ENST00000397821.8; ENSP00000380921.3; ENSG00000147010.19. [Q96B97-1]"";""ENST00000699723.1; ENSP00000514545.1; ENSG00000147010.19. [Q96B97-2]"";",SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625],actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]
A1X283,C3,1.819571244,0.202717913,-0.595795338,-0.684445408,-0.834876633,cyan,SH3PXD2B,SPD2B_HUMAN,SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains),SH3PXD2B FAD49 KIAA1295 TKS4,285590;,ENST00000311601.6; ENSP00000309714.5; ENSG00000174705.13.;,"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]; superoxide-generating NADPH oxidase activator activity [GO:0016176]",adipose tissue development [GO:0060612]; bone development [GO:0060348]; cell differentiation [GO:0030154]; extracellular matrix disassembly [GO:0022617]; eye development [GO:0001654]; heart development [GO:0007507]; podosome assembly [GO:0071800]; protein localization to membrane [GO:0072657]; skeletal system development [GO:0001501]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102]
Q7Z6J0,C4,2.019714427,0.117439417,-0.73423571,-0.743652034,-1.27507973,deepskyblue2,SH3RF1,SH3R1_HUMAN,E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING finger protein 142) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2),SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2,57630;,ENST00000284637.14; ENSP00000284637.9; ENSG00000154447.15. [Q7Z6J0-1];,MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],"negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; response to aldosterone [GO:1904044]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]
Q8NEM2,C2,0.598279123,0.582059322,-0.148891111,-0.062795694,-0.334174455,aquamarine,SHCBP1,SHCBP_HUMAN,SHC SH2 domain-binding protein 1,SHCBP1,79801;,ENST00000303383.8; ENSP00000306473.3; ENSG00000171241.9.;,SH2 domain binding [GO:0042169],fibroblast growth factor receptor signaling pathway [GO:0008543]; regulation of neural precursor cell proliferation [GO:2000177],cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]
Q6PI26,C1,1.309882204,0.095316203,-0.429939148,-0.40305908,-0.022652797,lightblue,SHQ1,SHQ1_HUMAN,Protein SHQ1 homolog,SHQ1,55164;,"ENST00000325599.13; ENSP00000315182.8; ENSG00000144736.14. [Q6PI26-1];""ENST00000463369.5; ENSP00000417452.1; ENSG00000144736.14. [Q6PI26-2]"";",unfolded protein binding [GO:0051082],box H/ACA snoRNP assembly [GO:0000493]; negative regulation of rRNA processing [GO:2000233]; positive regulation of apoptotic process [GO:0043065]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; protein-RNA complex assembly [GO:0022618],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q8NBJ9,S1,-1.254624442,-1.514470707,-0.352112877,0.766815265,1.144586368,gold,SIDT2,SIDT2_HUMAN,SID1 transmembrane family member 2,SIDT2 CGI-40 PSEC0072 UNQ685/PRO1325,51092;,ENST00000324225.9; ENSP00000314023.4; ENSG00000149577.17. [Q8NBJ9-1];,AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033],cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]
Q96ST3,N1,-1.16300075,0.091751411,0.538166995,-0.431509996,0.74135453,grey90,SIN3A,SIN3A_HUMAN,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),SIN3A,25942;,"ENST00000360439.8; ENSP00000353622.4; ENSG00000169375.17.;""ENST00000394947.8; ENSP00000378402.3; ENSG00000169375.17."";""ENST00000394949.8; ENSP00000378403.4; ENSG00000169375.17."";""ENST00000564778.6; ENSP00000455204.2; ENSG00000169375.17."";""ENST00000565264.2; ENSP00000454296.2; ENSG00000169375.17."";""ENST00000704312.1; ENSP00000515834.1; ENSG00000169375.17."";",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416],activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337],chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053]
Q96EB6,N4,-0.413190043,1.417684023,-0.303666332,-0.632096028,-0.966200388,grey30,SIRT1,SIR1_HUMAN,NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)],SIRT1 SIR2L1,23411;,ENST00000212015.11; ENSP00000212015.6; ENSG00000096717.12. [Q96EB6-1];,bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; histone H3K deacetylase activity [GO:0141050]; histone H4K12 deacetylase activity [GO:0140937]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent histone H3K14 deacetylase activity [GO:0032041]; NAD-dependent histone H3K9 deacetylase activity [GO:0046969]; NAD-dependent histone H4K16 deacetylase activity [GO:0046970]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein lysine deacetylase activity [GO:0033558]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; DNA methylation-dependent heterochromatin formation [GO:0006346]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902424]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of helicase activity [GO:0051097]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]",chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]
Q96BD8,C3,1.504475614,0.539579934,-0.456791085,-0.44399708,-0.820822173,cyan,SKA1,SKA1_HUMAN,Spindle and kinetochore-associated protein 1,SKA1 C18orf24,220134;,"ENST00000285116.8; ENSP00000285116.3; ENSG00000154839.10. [Q96BD8-1];""ENST00000398452.6; ENSP00000381470.1; ENSG00000154839.10. [Q96BD8-1]"";""ENST00000417656.6; ENSP00000397222.1; ENSG00000154839.10. [Q96BD8-2]"";""ENST00000571751.5; ENSP00000458992.1; ENSG00000262634.5. [Q96BD8-1]"";""ENST00000616604.2; ENSP00000478259.1; ENSG00000262634.5. [Q96BD8-1]"";""ENST00000633940.1; ENSP00000488815.1; ENSG00000262634.5. [Q96BD8-2]"";",microtubule binding [GO:0008017],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110],centriolar satellite [GO:0034451]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876]
Q8WVK7,C3,1.597266758,0.494915899,-0.566226994,-0.509798395,-0.845789898,cyan,SKA2,SKA2_HUMAN,Spindle and kinetochore-associated protein 2 (Protein FAM33A),SKA2 FAM33A,348235;,"ENST00000330137.12; ENSP00000333433.7; ENSG00000182628.13. [Q8WVK7-1];""ENST00000437036.6; ENSP00000411231.2; ENSG00000182628.13. [Q8WVK7-2]"";",microtubule binding [GO:0008017],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytosol [GO:0005829]; kinetochore [GO:0000776]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876]
Q8IX90,C5,1.631500204,0.45981965,-0.625155193,-0.713998235,-1.05841094,turquoise3,SKA3,SKA3_HUMAN,Spindle and kinetochore-associated protein 3,SKA3 C13orf3 RAMA1,221150;,"ENST00000298260.8; ENSP00000298260.4; ENSG00000165480.16. [Q8IX90-2];""ENST00000314759.6; ENSP00000319417.5; ENSG00000165480.16. [Q8IX90-1]"";""ENST00000400018.7; ENSP00000382896.3; ENSG00000165480.16. [Q8IX90-3]"";",microtubule binding [GO:0008017],attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110],centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876]
Q15477,C1,1.322817934,0.312701374,-0.567044314,-0.436840356,0.024580667,lightblue,SKIV2L,SKI2_HUMAN,Superkiller complex protein 2 (Ski2) (EC 3.6.4.13) (Helicase-like protein) (HLP),SKIC2 DDX13 SKI2W SKIV2 SKIV2L W,6499;,"ENST00000375394.7; ENSP00000364543.2; ENSG00000204351.13.;""ENST00000383336.6; ENSP00000372827.4; ENSG00000206353.11."";""ENST00000412823.4; ENSP00000400626.2; ENSG00000232616.9."";""ENST00000421789.4; ENSP00000399530.2; ENSG00000228896.9."";""ENST00000429465.4; ENSP00000412310.2; ENSG00000223493.9."";""ENST00000448219.4; ENSP00000394400.2; ENSG00000225737.9."";",3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; rescue of stalled ribosome [GO:0072344]",cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]
P42285,N1,-1.052073958,-0.130985791,0.600894998,-0.294729288,0.937905961,grey90,SKIV2L2,MTREX_HUMAN,Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase),MTREX DOB1 KIAA0052 MTR4 SKIV2L2,23517;,ENST00000230640.10; ENSP00000230640.5; ENSG00000039123.16.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],"DNA damage response [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing, via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; snRNA catabolic process [GO:0016076]",catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]
P09131,S1,-1.381746215,-1.859581193,-0.019237966,0.801771381,1.045298664,gold,SLC10A3,P3_HUMAN,P3 protein (Solute carrier family 10 member 3),SLC10A3 DXS253E P3,8273;,"ENST00000263512.5; ENSP00000263512.4; ENSG00000126903.16. [P09131-1];""ENST00000369649.8; ENSP00000358663.4; ENSG00000126903.16. [P09131-2]"";""ENST00000393587.4; ENSP00000377212.4; ENSG00000126903.16. [P09131-1]"";""ENST00000651600.1; ENSP00000499188.1; ENSG00000126903.16. [P09131-1]"";",bile acid:sodium symporter activity [GO:0008508],bile acid and bile salt transport [GO:0015721]; response to retinoic acid [GO:0032526],membrane [GO:0016020]
Q0GE19,S1,-1.484433107,-2.380080865,-0.172922883,1.068935584,1.021212595,gold,SLC10A7,NTCP7_HUMAN,Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7),SLC10A7 C4orf13 P7 PSEC0051,84068;,"ENST00000335472.12; ENSP00000334594.8; ENSG00000120519.16. [Q0GE19-2];""ENST00000394059.8; ENSP00000377623.4; ENSG00000120519.16. [Q0GE19-5]"";""ENST00000432059.6; ENSP00000411297.2; ENSG00000120519.16. [Q0GE19-3]"";""ENST00000502607.1; ENSP00000422577.1; ENSG00000120519.16. [Q0GE19-6]"";""ENST00000507030.5; ENSP00000421275.1; ENSG00000120519.16. [Q0GE19-1]"";""ENST00000511374.5; ENSP00000421603.1; ENSG00000120519.16. [Q0GE19-7]"";",bile acid transmembrane transporter activity [GO:0015125]; symporter activity [GO:0015293],bone development [GO:0060348]; glycoprotein transport [GO:0034436]; Golgi vesicle transport [GO:0048193]; heparin biosynthetic process [GO:0030210]; intracellular calcium ion homeostasis [GO:0006874]; sodium ion transport [GO:0006814],cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
P49281,S1,-0.960334282,-0.868540778,-0.080701107,0.616279881,0.974440829,gold,SLC11A2,NRAM2_HUMAN,Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2),SLC11A2 DCT1 DMT1 NRAMP2 OK/SW-cl.20,4891;,"ENST00000262052.9; ENSP00000262052.5; ENSG00000110911.17. [P49281-2];""ENST00000394904.9; ENSP00000378364.3; ENSG00000110911.17. [P49281-3]"";""ENST00000541174.6; ENSP00000444542.2; ENSG00000110911.17. [P49281-2]"";""ENST00000545993.7; ENSP00000442810.2; ENSG00000110911.17. [P49281-5]"";""ENST00000546636.5; ENSP00000449008.1; ENSG00000110911.17. [P49281-1]"";""ENST00000547198.5; ENSP00000446769.1; ENSG00000110911.17. [P49281-1]"";""ENST00000547688.7; ENSP00000449200.2; ENSG00000110911.17. [P49281-4]"";""ENST00000644495.1; ENSP00000494107.1; ENSG00000110911.17. [P49281-1]"";",cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; inorganic cation transmembrane transporter activity [GO:0022890]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; nickel cation transmembrane transporter activity [GO:0015099]; retromer complex binding [GO:1905394]; solute:proton symporter activity [GO:0015295]; transition metal ion transmembrane transporter activity [GO:0046915]; vanadium ion transmembrane transporter activity [GO:0015100]; zinc ion transmembrane transporter activity [GO:0005385],activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; cadmium ion transmembrane transport [GO:0070574]; cellular response to oxidative stress [GO:0034599]; cobalt ion transport [GO:0006824]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detection of oxygen [GO:0003032]; erythrocyte development [GO:0048821]; heme biosynthetic process [GO:0006783]; intracellular iron ion homeostasis [GO:0006879]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lead ion transport [GO:0015692]; learning or memory [GO:0007611]; manganese ion transport [GO:0006828]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nickel cation transport [GO:0015675]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; vanadium ion transport [GO:0015676],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]
P55011,S4,-1.125093173,-1.344364735,0.530505693,0.907072196,0.234052177,tomato2,SLC12A2,S12A2_HUMAN,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2),SLC12A2 NKCC1,6558;,"ENST00000262461.7; ENSP00000262461.2; ENSG00000064651.14. [P55011-1];""ENST00000343225.4; ENSP00000340878.4; ENSG00000064651.14. [P55011-3]"";",ammonium transmembrane transporter activity [GO:0008519]; chloride:monoatomic cation symporter activity [GO:0015377]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]; protein-folding chaperone binding [GO:0051087]; sodium:potassium:chloride symporter activity [GO:0008511],ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; monoatomic ion transport [GO:0006811]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]
Q9UP95,S1,-0.939830099,-1.210091225,-0.12073716,0.536218996,1.208786388,gold,SLC12A4,S12A4_HUMAN,Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (hKCC1),SLC12A4 KCC1,6560;,"ENST00000316341.8; ENSP00000318557.3; ENSG00000124067.17. [Q9UP95-1];""ENST00000537830.6; ENSP00000445962.2; ENSG00000124067.17. [Q9UP95-6]"";""ENST00000541864.7; ENSP00000438334.2; ENSG00000124067.17. [Q9UP95-5]"";""ENST00000576616.5; ENSP00000458902.1; ENSG00000124067.17. [Q9UP95-2]"";",ammonium transmembrane transporter activity [GO:0008519]; ATP binding [GO:0005524]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901],ammonium import across plasma membrane [GO:0140157]; cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; monoatomic ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805],lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]
Q9UHW9,S2,-1.15624853,-1.528152148,0.18562515,0.776913457,0.853598806,orange,SLC12A6,S12A6_HUMAN,Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3),SLC12A6 KCC3,9990;,"ENST00000290209.9; ENSP00000290209.5; ENSG00000140199.13. [Q9UHW9-2];""ENST00000354181.8; ENSP00000346112.3; ENSG00000140199.13. [Q9UHW9-1]"";""ENST00000397702.6; ENSP00000380814.2; ENSG00000140199.13. [Q9UHW9-5]"";""ENST00000397707.6; ENSP00000380819.2; ENSG00000140199.13. [Q9UHW9-3]"";""ENST00000458406.6; ENSP00000387725.2; ENSG00000140199.13. [Q9UHW9-5]"";""ENST00000558589.5; ENSP00000452776.1; ENSG00000140199.13. [Q9UHW9-4]"";""ENST00000558667.5; ENSP00000453473.1; ENSG00000140199.13. [Q9UHW9-1]"";""ENST00000560611.5; ENSP00000454168.1; ENSG00000140199.13. [Q9UHW9-1]"";",ammonium transmembrane transporter activity [GO:0008519]; metal ion binding [GO:0046872]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901],ammonium import across plasma membrane [GO:0140157]; angiogenesis [GO:0001525]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; monoatomic ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805],axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]
Q9BXP2,S1,-1.204724068,-1.695698264,-0.174363481,0.734608966,1.1405119,gold,SLC12A9,S12A9_HUMAN,Solute carrier family 12 member 9 (Cation-chloride cotransporter 6) (hCCC6) (Cation-chloride cotransporter-interacting protein 1) (CCC-interacting protein 1) (hCIP1) (Potassium-chloride transporter 9) (WO3.3),SLC12A9 CCC6 CIP1,56996;,"ENST00000354161.8; ENSP00000275730.4; ENSG00000146828.18. [Q9BXP2-1];""ENST00000415287.5; ENSP00000413796.1; ENSG00000146828.18. [Q9BXP2-2]"";""ENST00000540482.5; ENSP00000443702.1; ENSG00000146828.18. [Q9BXP2-4]"";",chloride:monoatomic cation symporter activity [GO:0015377]; potassium:chloride symporter activity [GO:0015379],cell volume homeostasis [GO:0006884]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; potassium ion homeostasis [GO:0055075],extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q8N697,S1,-1.763659734,-2.073901664,-0.411627731,0.9228975,1.303678239,gold,SLC15A4,S15A4_HUMAN,Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1),SLC15A4 PHT1 PTR4 FP12591,121260;,ENST00000266771.10; ENSP00000266771.5; ENSG00000139370.12. [Q8N697-1];,dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],"dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; monoatomic ion transport [GO:0006811]; peptide transport [GO:0015833]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]
P53985,S4,-1.287769369,-1.479592386,0.412978405,0.979493885,0.134853524,tomato2,SLC16A1,MOT1_HUMAN,Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1),SLC16A1 MCT1,6566;,"ENST00000369626.8; ENSP00000358640.4; ENSG00000155380.13. [P53985-1];""ENST00000429288.2; ENSP00000397106.2; ENSG00000155380.13. [P53985-1]"";""ENST00000443580.6; ENSP00000399104.2; ENSG00000155380.13. [P53985-1]"";""ENST00000458229.6; ENSP00000416167.2; ENSG00000155380.13. [P53985-1]"";""ENST00000538576.5; ENSP00000441065.1; ENSG00000155380.13. [P53985-1]"";""ENST00000628110.2; ENSP00000485688.1; ENSG00000281917.4. [P53985-1]"";""ENST00000630362.4; ENSP00000486000.1; ENSG00000281917.4. [P53985-1]"";""ENST00000679803.1; ENSP00000505879.1; ENSG00000155380.13. [P53985-1]"";",carboxylic acid transmembrane transporter activity [GO:0046943]; identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; lactate:proton symporter activity [GO:0015650]; mevalonate transmembrane transporter activity [GO:0015130]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic cyclic compound binding [GO:0097159]; succinate transmembrane transporter activity [GO:0015141],behavioral response to nutrient [GO:0051780]; carboxylic acid transmembrane transport [GO:1905039]; cellular response to organic cyclic compound [GO:0071407]; centrosome cycle [GO:0007098]; glucose homeostasis [GO:0042593]; lipid metabolic process [GO:0006629]; mevalonate transport [GO:0015728]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475]; regulation of insulin secretion [GO:0050796]; response to food [GO:0032094]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; centrosome [GO:0005813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]
O15427,S4,-1.206566192,-1.413925833,0.460536989,0.850179944,0.163336543,tomato2,SLC16A3,MOT4_HUMAN,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),SLC16A3 MCT3 MCT4,9123;,"ENST00000392339.6; ENSP00000376150.1; ENSG00000141526.18.;""ENST00000392341.6; ENSP00000376152.1; ENSG00000141526.18."";""ENST00000580189.6; ENSP00000464112.2; ENSG00000141526.18."";""ENST00000581287.5; ENSP00000463978.1; ENSG00000141526.18."";""ENST00000582743.6; ENSP00000462405.1; ENSG00000141526.18."";""ENST00000584689.6; ENSP00000464625.2; ENSG00000141526.18."";""ENST00000617373.5; ENSP00000483212.1; ENSG00000141526.18."";""ENST00000619321.2; ENSP00000482013.1; ENSG00000141526.18."";",lactate:proton symporter activity [GO:0015650]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; RNA binding [GO:0003723],lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]
P43007,S4,-1.702694606,-2.043950516,0.428127061,0.992213685,0.16151446,tomato2,SLC1A4,SATT_HUMAN,Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1) (ASCT-1) (Solute carrier family 1 member 4),SLC1A4 ASCT1 SATT,6509;,"ENST00000234256.4; ENSP00000234256.3; ENSG00000115902.11. [P43007-1];""ENST00000531327.5; ENSP00000431942.1; ENSG00000115902.11. [P43007-2]"";",amino acid transmembrane transporter activity [GO:0015171]; chloride channel activity [GO:0005254]; L-alanine transmembrane transporter activity [GO:0015180]; L-aspartate transmembrane transporter activity [GO:0015183]; L-cystine transmembrane transporter activity [GO:0015184]; L-glutamine transmembrane transporter activity [GO:0015186]; L-hydroxyproline transmembrane transporter activity [GO:0034590]; L-proline transmembrane transporter activity [GO:0015193]; L-serine transmembrane transporter activity [GO:0015194]; L-threonine transmembrane transporter activity [GO:0015195]; symporter activity [GO:0015293],"amino acid transport [GO:0006865]; cognition [GO:0050890]; glutamine transport [GO:0006868]; hydroxyproline transport [GO:0034589]; L-alanine import across plasma membrane [GO:1904273]; L-alanine transport [GO:0015808]; L-aspartate import across plasma membrane [GO:0140009]; L-cystine transport [GO:0015811]; L-glutamate transmembrane transport [GO:0015813]; L-serine import across plasma membrane [GO:1903812]; L-serine transport [GO:0015825]; proline transport [GO:0015824]; synaptic transmission, glutamatergic [GO:0035249]; threonine transport [GO:0015826]; transport across blood-brain barrier [GO:0150104]",cell surface [GO:0009986]; centrosome [GO:0005813]; extracellular exosome [GO:0070062]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]
Q15758,S4,-1.564314265,-1.692065697,0.525724878,0.864521827,0.287356492,tomato2,SLC1A5,AAAT_HUMAN,Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5),SLC1A5 ASCT2 M7V1 RDR RDRC,6510;,"ENST00000412532.6; ENSP00000397924.1; ENSG00000105281.12. [Q15758-3];""ENST00000434726.6; ENSP00000406532.1; ENSG00000105281.12. [Q15758-2]"";""ENST00000542575.6; ENSP00000444408.1; ENSG00000105281.12. [Q15758-1]"";",amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; ligand-gated channel activity [GO:0022834]; metal ion binding [GO:0046872]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; signaling receptor activity [GO:0038023]; symporter activity [GO:0015293]; virus receptor activity [GO:0001618],amino acid transport [GO:0006865]; erythrocyte differentiation [GO:0030218]; glutamine secretion [GO:0010585]; glutamine transport [GO:0006868]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamine import across plasma membrane [GO:1903803]; neutral amino acid transport [GO:0015804]; protein homotrimerization [GO:0070207]; transport across blood-brain barrier [GO:0150104],basal plasma membrane [GO:0009925]; extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q8WUM9,S4,-0.696146873,-1.082780591,0.292228667,0.719035742,0.421794687,tomato2,SLC20A1,S20A1_HUMAN,Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1),SLC20A1 GLVR1 PIT1,6574;,ENST00000272542.8; ENSP00000272542.3; ENSG00000144136.11.;,high-affinity phosphate:sodium symporter activity [GO:0005316]; phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436],biomineral tissue development [GO:0031214]; cell population proliferation [GO:0008283]; monoatomic ion transport [GO:0006811]; phosphate ion transmembrane transport [GO:0035435]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],membrane [GO:0016020]; plasma membrane [GO:0005886]
Q08357,S2,-0.9587333,-1.501492285,0.092619026,0.730941615,0.843703664,orange,SLC20A2,S20A2_HUMAN,Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2),SLC20A2 GLVR2 PIT2,6575;,"ENST00000342228.7; ENSP00000340465.3; ENSG00000168575.10.;""ENST00000520179.5; ENSP00000429712.1; ENSG00000168575.10."";""ENST00000520262.6; ENSP00000429754.1; ENSG00000168575.10."";",phosphate transmembrane transporter activity [GO:0005315]; signaling receptor activity [GO:0038023]; sodium:phosphate symporter activity [GO:0005436]; virus receptor activity [GO:0001618],monoatomic ion transport [GO:0006811]; phosphate ion transmembrane transport [GO:0035435]; positive regulation of bone mineralization [GO:0030501],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]
A1A5C7,S3,-0.29080571,-1.308041787,0.203556882,0.985043392,0.470613607,salmon,SLC22A23,S22AN_HUMAN,Solute carrier family 22 member 23,SLC22A23 C6orf85,63027;,"ENST00000380298.2; ENSP00000369653.2; ENSG00000137266.15. [A1A5C7-4];""ENST00000380302.8; ENSP00000369657.4; ENSG00000137266.15. [A1A5C7-2]"";""ENST00000406686.8; ENSP00000385028.3; ENSG00000137266.15. [A1A5C7-1]"";""ENST00000490273.5; ENSP00000419463.1; ENSG00000137266.15. [A1A5C7-2]"";",transmembrane transporter activity [GO:0022857],monoatomic ion transport [GO:0006811],plasma membrane [GO:0005886]
O76082,S2,-0.562040889,-1.838529328,0.284220153,0.867290212,0.496079924,orange,SLC22A5,S22A5_HUMAN,Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5),SLC22A5 OCTN2,6584;,"ENST00000245407.8; ENSP00000245407.3; ENSG00000197375.14. [O76082-1];""ENST00000435065.7; ENSP00000402760.2; ENSG00000197375.14. [O76082-3]"";",(R)-carnitine transmembrane transporter activity [GO:1901235]; amino-acid betaine transmembrane transporter activity [GO:0015199]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910],(R)-carnitine transmembrane transport [GO:1902270]; (R)-carnitine transport [GO:1900749]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
Q9UGH3,S2,-2.156844862,-2.146053894,0.528362426,0.905538259,0.393355637,orange,SLC23A2,S23A2_HUMAN,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2),SLC23A2 KIAA0238 NBTL1 SLC23A1 SVCT2 YSPL2,9962;,"ENST00000338244.6; ENSP00000344322.1; ENSG00000089057.15. [Q9UGH3-1];""ENST00000379333.5; ENSP00000368637.1; ENSG00000089057.15. [Q9UGH3-1]"";",L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229],blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P53007,M2,-1.049828484,-0.881911704,0.397726326,0.946170214,-0.017802587,tan4,SLC25A1,TXTP_HUMAN,"Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Mitochondrial citrate carrier) (CIC) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)",SLC25A1 SLC20A3,6576;,ENST00000215882.10; ENSP00000215882.5; ENSG00000100075.10.;,antiporter activity [GO:0015297]; citrate secondary active transmembrane transporter activity [GO:0071913]; citrate transmembrane transporter activity [GO:0015137]; tricarboxylic acid transmembrane transporter activity [GO:0015142],fatty-acyl-CoA biosynthetic process [GO:0046949]; gluconeogenesis [GO:0006094]; mitochondrial citrate transmembrane transport [GO:0006843],extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
O75746,M2,-1.030809991,-1.388641351,0.374217814,0.993811235,-0.139261617,tan4,SLC25A12,S2512_HUMAN,"Electrogenic aspartate/glutamate antiporter SLC25A12, mitochondrial (Araceli hiperlarga) (Aralar) (Aralar1) (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12)",SLC25A12 AGC1 ARALAR1,8604;,"ENST00000422440.7; ENSP00000388658.2; ENSG00000115840.14. [O75746-1];""ENST00000709717.1; ENSP00000517838.1; ENSG00000292099.1. [O75746-1]"";","3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]",aspartate family amino acid metabolic process [GO:0009066]; aspartate transmembrane transport [GO:0015810]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9UJS0,M2,-1.108206507,-1.423124372,0.375537736,1.123200194,-0.137657602,tan4,SLC25A13,S2513_HUMAN,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Calcium-binding mitochondrial carrier protein Aralar2) (ARALAR-related gene 2) (ARALAR2) (Citrin) (Mitochondrial aspartate glutamate carrier 2) (Solute carrier family 25 member 13)",SLC25A13,10165;,"ENST00000265631.10; ENSP00000265631.6; ENSG00000004864.14. [Q9UJS0-1];""ENST00000416240.6; ENSP00000400101.2; ENSG00000004864.14. [Q9UJS0-2]"";","3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]",aspartate family amino acid metabolic process [GO:0009066]; aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; response to calcium ion [GO:0051592],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q9Y619,M2,-1.396294997,-1.749693773,0.460804231,1.310866213,-0.146906203,tan4,SLC25A15,ORNT1_HUMAN,Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15),SLC25A15 ORC1 ORNT1 SP1855,10166;,"ENST00000338625.9; ENSP00000342267.4; ENSG00000102743.16.;""ENST00000707033.1; ENSP00000516711.1; ENSG00000102743.16."";",antiporter activity [GO:0015297]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9HC21,M2,-1.447957391,-1.655632697,0.601338345,1.085132401,-0.101030235,tan4,SLC25A19,TPC_HUMAN,Mitochondrial thiamine pyrophosphate carrier (Mitochondrial thiamine pyrophosphate transporter) (MTPPT) (Mitochondrial uncoupling protein 1) (Solute carrier family 25 member 19),SLC25A19 DNC MUP1,60386;,"ENST00000320362.7; ENSP00000319574.3; ENSG00000125454.12. [Q9HC21-1];""ENST00000375261.8; ENSP00000364410.4; ENSG00000125454.12. [Q9HC21-2]"";""ENST00000402418.7; ENSP00000385312.3; ENSG00000125454.12. [Q9HC21-1]"";""ENST00000416858.7; ENSP00000397818.2; ENSG00000125454.12. [Q9HC21-1]"";""ENST00000442286.6; ENSP00000402202.2; ENSG00000125454.12. [Q9HC21-1]"";""ENST00000580994.5; ENSP00000463795.1; ENSG00000125454.12. [Q9HC21-1]"";",antiporter activity [GO:0015297]; deoxynucleotide transmembrane transporter activity [GO:0030233]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422]; thiamine transmembrane transporter activity [GO:0015234],deoxynucleotide transport [GO:0030302]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine pyrophosphate transmembrane transport [GO:0030974]; thiamine-containing compound metabolic process [GO:0042723],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q9H936,M2,-1.003567068,-1.132976213,0.314277574,0.986805066,-0.085198825,tan4,SLC25A22,GHC1_HUMAN,Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22),SLC25A22 GC1,79751;,"ENST00000320230.9; ENSP00000322020.5; ENSG00000177542.11.;""ENST00000531214.5; ENSP00000437236.1; ENSG00000177542.11."";""ENST00000628067.3; ENSP00000486058.1; ENSG00000177542.11."";",amino acid:proton symporter activity [GO:0005280]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313],aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; monoatomic ion transport [GO:0006811]; regulation of insulin secretion [GO:0050796],mitochondrial inner membrane [GO:0005743]
Q6NUK1,M2,-1.128992289,-1.312875023,0.385018537,1.15844917,-0.139005936,tan4,SLC25A24,SCMC1_HUMAN,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2+)-dependent solute carrier protein 1) (Short calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),SLC25A24 APC1 MCSC1 SCAMC1,29957;,"ENST00000370041.4; ENSP00000359058.4; ENSG00000085491.17. [Q6NUK1-2];""ENST00000565488.6; ENSP00000457733.1; ENSG00000085491.17. [Q6NUK1-1]"";""ENST00000639032.1; ENSP00000492810.1; ENSG00000284468.3. [Q6NUK1-2]"";""ENST00000640416.2; ENSP00000491572.1; ENSG00000284468.3. [Q6NUK1-1]"";",adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; cellular response to oxidative stress [GO:0034599]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial transport [GO:0006839],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q6KCM7,M2,-1.314048771,-1.50692667,0.464814318,1.141874831,-0.19076247,tan4,SLC25A25,SCMC2_HUMAN,Mitochondrial adenyl nucleotide antiporter SLC25A25 (Mitochondrial ATP-Mg/Pi carrier protein 3) (Mitochondrial Ca(2+)-dependent solute carrier protein 3) (Short calcium-binding mitochondrial carrier protein 2) (SCaMC-2) (Solute carrier family 25 member 25),SLC25A25 APC3 KIAA1896 MCSC3 SCAMC2 UNQ549/PRO1106,114789;,"ENST00000373064.9; ENSP00000362155.5; ENSG00000148339.13. [Q6KCM7-1];""ENST00000373066.9; ENSP00000362157.5; ENSG00000148339.13. [Q6KCM7-5]"";""ENST00000373068.6; ENSP00000362159.2; ENSG00000148339.13. [Q6KCM7-2]"";""ENST00000373069.10; ENSP00000362160.5; ENSG00000148339.13. [Q6KCM7-3]"";""ENST00000432073.6; ENSP00000410053.2; ENSG00000148339.13. [Q6KCM7-4]"";",ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],adipose tissue development [GO:0060612]; ADP transport [GO:0015866]; ATP metabolic process [GO:0046034]; ATP transport [GO:0015867]; calcium ion transmembrane transport [GO:0070588]; camera-type eye development [GO:0043010]; cellular respiration [GO:0045333]; multicellular organism growth [GO:0035264]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to food [GO:0032094],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q00325,M2,-1.016850996,-1.448839889,0.429474478,1.134043901,-0.105171095,tan4,SLC25A3,S25A3_HUMAN,"Solute carrier family 25 member 3 (Phosphate carrier protein, mitochondrial) (Phosphate transport protein) (PTP)",SLC25A3 PHC OK/SW-cl.48,5250;,"ENST00000188376.9; ENSP00000188376.5; ENSG00000075415.15. [Q00325-2];""ENST00000228318.8; ENSP00000228318.3; ENSG00000075415.15. [Q00325-1]"";""ENST00000401722.7; ENSP00000383898.3; ENSG00000075415.15. [Q00325-2]"";""ENST00000549338.5; ENSP00000447740.1; ENSG00000075415.15. [Q00325-2]"";""ENST00000551917.5; ENSP00000447310.1; ENSG00000075415.15. [Q00325-1]"";""ENST00000552981.6; ENSP00000448708.2; ENSG00000075415.15. [Q00325-2]"";",phosphate transmembrane transporter activity [GO:0005315]; phosphate:proton symporter activity [GO:0015317]; protein-containing complex binding [GO:0044877],mitochondrial phosphate ion transmembrane transport [GO:1990547]; phosphate ion transmembrane transport [GO:0035435],extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q3KQZ1,M2,-0.89944359,-1.382488681,0.424647232,1.033144014,-0.134702823,tan4,SLC25A35,S2535_HUMAN,Solute carrier family 25 member 35,SLC25A35,399512;,"ENST00000380067.6; ENSP00000369407.2; ENSG00000125434.11. [Q3KQZ1-4];""ENST00000577745.2; ENSP00000464231.1; ENSG00000125434.11. [Q3KQZ1-1]"";""ENST00000579192.5; ENSP00000462395.1; ENSG00000125434.11. [Q3KQZ1-4]"";""ENST00000579681.5; ENSP00000464307.1; ENSG00000125434.11. [Q3KQZ1-3]"";""ENST00000580340.5; ENSP00000464071.1; ENSG00000125434.11. [Q3KQZ1-4]"";""ENST00000585311.5; ENSP00000464191.1; ENSG00000125434.11. [Q3KQZ1-2]"";",0,0,mitochondrial inner membrane [GO:0005743]
Q96CQ1,M2,-1.461901436,-2.060658255,0.249832732,1.305073565,-0.167319563,tan4,SLC25A36,S2536_HUMAN,Solute carrier family 25 member 36,SLC25A36,55186;,"ENST00000324194.12; ENSP00000320688.6; ENSG00000114120.14. [Q96CQ1-1];""ENST00000446041.6; ENSP00000401938.2; ENSG00000114120.14. [Q96CQ1-3]"";""ENST00000502594.5; ENSP00000423319.1; ENSG00000114120.14. [Q96CQ1-2]"";""ENST00000631654.1; ENSP00000487839.1; ENSG00000114120.14. [Q96CQ1-2]"";",pyrimidine nucleotide transmembrane transporter activity [GO:0015218],mitochondrial genome maintenance [GO:0000002]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519]; pyrimidine nucleotide transport [GO:0006864]; regulation of mitochondrial membrane potential [GO:0051881],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q96AG3,M2,-0.938471509,-1.257390489,0.350971225,1.122775761,-0.316885177,tan4,SLC25A46,S2546_HUMAN,Mitochondrial outer membrane protein SLC25A46 (Solute carrier family 25 member 46),SLC25A46 TB1,91137;,"ENST00000355943.8; ENSP00000348211.3; ENSG00000164209.17. [Q96AG3-1];""ENST00000447245.6; ENSP00000399717.2; ENSG00000164209.17. [Q96AG3-3]"";""ENST00000504098.1; ENSP00000425708.1; ENSG00000164209.17. [Q96AG3-2]"";",protein-containing complex binding [GO:0044877],axon development [GO:0061564]; cerebellar Purkinje cell differentiation [GO:0021702]; cristae formation [GO:0042407]; dendrite development [GO:0016358]; establishment of localization in cell [GO:0051649]; locomotion involved in locomotory behavior [GO:0031987]; mitochondrial fission [GO:0000266]; mitochondrial membrane fission [GO:0090149]; mitochondrial transport [GO:0006839]; myelination in peripheral nervous system [GO:0022011]; optic nerve development [GO:0021554]; peripheral nervous system neuron axonogenesis [GO:0048936]; phospholipid homeostasis [GO:0055091]; protein-containing complex assembly [GO:0065003]; respiratory chain complex IV assembly [GO:0008535]; synapse assembly [GO:0007416],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
P05141,M2,-1.265501859,-1.564695727,0.439056805,1.17342948,-0.096127023,tan4,SLC25A5,ADT2_HUMAN,"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (ADP,ATP carrier protein, fibroblast isoform) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]",SLC25A5 AAC2 ANT2,292;,ENST00000317881.9; ENSP00000360671.4; ENSG00000005022.6.;,adenine nucleotide transmembrane transporter activity [GO:0000295]; adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]; oxidative phosphorylation uncoupler activity [GO:0017077]; proton transmembrane transporter activity [GO:0015078]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],adaptive thermogenesis [GO:1990845]; adenine nucleotide transport [GO:0051503]; B cell differentiation [GO:0030183]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; erythrocyte differentiation [GO:0030218]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitophagy [GO:1901526]; regulation of mitochondrial membrane permeability [GO:0046902],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
P12236,M2,-1.323629962,-1.728823258,0.437457211,1.212451762,-0.167329225,tan4,SLC25A6,ADT3_HUMAN,"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]",SLC25A6 AAC3 ANT3 CDABP0051,293;,"ENST00000381401.11; ENSP00000370808.5; ENSG00000169100.14.;""ENST00000711214.1; ENSP00000518609.1; ENSG00000292334.1."";",ATP:ADP antiporter activity [GO:0005471],apoptotic process [GO:0006915]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]
P50443,S4,-1.165791741,-1.428503174,0.479351634,0.899278146,0.33742766,tomato2,SLC26A2,S26A2_HUMAN,Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2),SLC26A2 DTD DTDST,1836;,ENST00000286298.5; ENSP00000286298.4; ENSG00000155850.9.;,bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; secondary active sulfate transmembrane transporter activity [GO:0008271]; solute:inorganic anion antiporter activity [GO:0005452]; sulfate transmembrane transporter activity [GO:0015116],chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; ossification [GO:0001503]; sulfate transmembrane transport [GO:1902358]; sulfate transport [GO:0008272],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]
Q9BXS9,S4,-1.27411152,-1.419421418,0.475925591,0.844427332,0.376876675,tomato2,SLC26A6,S26A6_HUMAN,Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1) (Pendrin-L1),SLC26A6,65010;,"ENST00000383733.7; ENSP00000373239.3; ENSG00000225697.13. [Q9BXS9-2];""ENST00000395550.7; ENSP00000378920.2; ENSG00000225697.13. [Q9BXS9-1]"";""ENST00000420764.6; ENSP00000404684.2; ENSG00000225697.13. [Q9BXS9-3]"";""ENST00000455886.6; ENSP00000401066.2; ENSG00000225697.13. [Q9BXS9-7]"";",bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; efflux transmembrane transporter activity [GO:0015562]; formate transmembrane transporter activity [GO:0015499]; identical protein binding [GO:0042802]; oxalate transmembrane transporter activity [GO:0019531]; PDZ domain binding [GO:0030165]; secondary active sulfate transmembrane transporter activity [GO:0008271]; solute:inorganic anion antiporter activity [GO:0005452]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:bicarbonate antiporter activity [GO:0015383]; transferase activity [GO:0016740],angiotensin-activated signaling pathway [GO:0038166]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to fructose stimulus [GO:0071332]; cellular response to type II interferon [GO:0071346]; chloride transport [GO:0006821]; epithelial fluid transport [GO:0042045]; establishment of localization in cell [GO:0051649]; estrous cycle [GO:0044849]; formate transport [GO:0015724]; intestinal absorption [GO:0050892]; intracellular pH elevation [GO:0051454]; mannitol transmembrane transport [GO:0015797]; monoatomic ion transport [GO:0006811]; oxalate transport [GO:0019532]; oxalic acid secretion [GO:0046724]; positive regulation of dipeptide transmembrane transport [GO:2001150]; protein kinase C signaling [GO:0070528]; regulation of intracellular pH [GO:0051453]; sperm capacitation [GO:0048240]; sulfate transport [GO:0008272]; transepithelial chloride transport [GO:0030321]; transepithelial transport [GO:0070633],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; vesicle membrane [GO:0012506]
Q6PCB7,S2,-1.107186754,-1.206538927,0.210230922,0.845027303,0.608072079,orange,SLC27A1,S27A1_HUMAN,Long-chain fatty acid transport protein 1 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 1) (FATP-1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 1) (Very long-chain acyl-CoA synthetase) (EC 6.2.1.-),SLC27A1 ACSVL5 FATP1,376497;,"ENST00000252595.12; ENSP00000252595.6; ENSG00000130304.17. [Q6PCB7-1];""ENST00000598424.5; ENSP00000472313.1; ENSG00000130304.17. [Q6PCB7-2]"";",arachidonate-CoA ligase activity [GO:0047676]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; fatty acid transmembrane transporter activity [GO:0015245]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; protein serine/threonine kinase activator activity [GO:0043539]; very long-chain fatty acid-CoA ligase activity [GO:0031957],adiponectin-activated signaling pathway [GO:0033211]; biotin import across plasma membrane [GO:1905135]; biotin transport [GO:0015878]; cardiolipin biosynthetic process [GO:0032049]; export across plasma membrane [GO:0140115]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import across plasma membrane [GO:0015911]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of phospholipid biosynthetic process [GO:0071072]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phosphatidylglycerol biosynthetic process [GO:0006655]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylserine biosynthetic process [GO:0006659]; positive regulation of heat generation [GO:0031652]; positive regulation of triglyceride biosynthetic process [GO:0010867]; response to cold [GO:0009409]; transport across blood-brain barrier [GO:0150104],basal plasma membrane [GO:0009925]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q6P1M0,S2,-1.216925452,-1.439705873,0.156414798,0.875403892,0.611766874,orange,SLC27A4,S27A4_HUMAN,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-),SLC27A4 ACSVL4 FATP4,10999;,"ENST00000300456.5; ENSP00000300456.3; ENSG00000167114.13. [Q6P1M0-1];""ENST00000372870.5; ENSP00000361961.1; ENSG00000167114.13. [Q6P1M0-2]"";",arachidonate-CoA ligase activity [GO:0047676]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleate transmembrane transporter activity [GO:1901480]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957],activation of GTPase activity [GO:0090630]; establishment of localization in cell [GO:0051649]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; transport across blood-brain barrier [GO:0150104]; very long-chain fatty acid catabolic process [GO:0042760],brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]
Q96QE2,S1,-1.174968656,-1.440858722,-0.269810057,0.618713951,1.266564195,gold,SLC2A13,MYCT_HUMAN,Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13),SLC2A13,114134;,ENST00000280871.9; ENSP00000280871.4; ENSG00000151229.13.;,ATPase binding [GO:0051117]; myo-inositol transmembrane transporter activity [GO:0005365]; myo-inositol:proton symporter activity [GO:0005366]; protease binding [GO:0002020],myo-inositol transport [GO:0015798]; positive regulation of amyloid-beta formation [GO:1902004]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; astrocyte end-foot [GO:0097450]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]
Q9UGQ3,S1,-1.235828402,-1.343012982,-0.421198923,0.781560085,1.267157626,gold,SLC2A6,GTR6_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 6 (Glucose transporter type 6) (GLUT-6)",SLC2A6 GLUT6,11182;,"ENST00000371897.8; ENSP00000360964.4; ENSG00000160326.14. [Q9UGQ3-2];""ENST00000371899.9; ENSP00000360966.4; ENSG00000160326.14. [Q9UGQ3-1]"";""ENST00000625425.2; ENSP00000486637.1; ENSG00000281165.3. [Q9UGQ3-2]"";""ENST00000626271.3; ENSP00000487067.1; ENSG00000281165.3. [Q9UGQ3-1]"";",D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353]; glucose transmembrane transporter activity [GO:0005355]; transmembrane transporter activity [GO:0022857],dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; glucose transmembrane transport [GO:1904659]; hexose transmembrane transport [GO:0008645]; regulation of glycolytic process [GO:0006110]; transmembrane transport [GO:0055085],lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9Y6M5,S4,-1.100136193,-1.265664884,0.552930287,0.959470552,0.144602099,tomato2,SLC30A1,ZNT1_HUMAN,Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1) (Zinc transporter 1),SLC30A1 ZNT1,7779;,ENST00000367001.5; ENSP00000355968.4; ENSG00000170385.10.;,calcium channel inhibitor activity [GO:0019855]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826],cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; defense response to bacterium [GO:0042742]; detoxification of cadmium ion [GO:0071585]; detoxification of zinc ion [GO:0010312]; in utero embryonic development [GO:0001701]; intracellular calcium ion homeostasis [GO:0006874]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; positive regulation of dendritic spine morphogenesis [GO:0061003]; regulation of postsynaptic density protein 95 clustering [GO:1902897]; zinc export across plasma membrane [GO:0140882]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829],"basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic postsynaptic density [GO:0099573]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic density, intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]"
Q8TAD4,S1,-1.20740719,-1.435539301,0.030925273,0.99107542,0.891125402,gold,SLC30A5,ZNT5_HUMAN,Proton-coupled zinc antiporter SLC30A5 (Solute carrier family 30 member 5) (Zinc transporter 5) (ZnT-5) (ZnT-like transporter 1) (hZTL1),SLC30A5 ZNT5 ZNTL1 ZTL1 UNQ863/PRO1879,64924;,"ENST00000380860.8; ENSP00000370241.4; ENSG00000145740.20. [Q8TAD4-3];""ENST00000396591.8; ENSP00000379836.3; ENSG00000145740.20. [Q8TAD4-1]"";""ENST00000502979.1; ENSP00000421251.1; ENSG00000145740.20. [Q8TAD4-4]"";",antiporter activity [GO:0015297]; metal ion binding [GO:0046872]; zinc efflux transmembrane transporter activity [GO:0022883]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826],cobalt ion transport [GO:0006824]; GPI anchor biosynthetic process [GO:0006506]; insulin processing [GO:0030070]; intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc ion import across plasma membrane [GO:0071578]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829],apical plasma membrane [GO:0016324]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588]
Q6NXT4,S1,-1.158684521,-1.71414323,-0.032263475,0.990754367,0.839501494,gold,SLC30A6,ZNT6_HUMAN,Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6),SLC30A6 ZNT6,55676;,"ENST00000282587.9; ENSP00000282587.5; ENSG00000152683.14. [Q6NXT4-1];""ENST00000357055.7; ENSP00000349563.4; ENSG00000152683.14. [Q6NXT4-4]"";""ENST00000379343.6; ENSP00000368648.2; ENSG00000152683.14. [Q6NXT4-2]"";""ENST00000435660.5; ENSP00000399005.1; ENSG00000152683.14. [Q6NXT4-3]"";",antiporter activity [GO:0015297]; zinc ion transmembrane transporter activity [GO:0005385],regulation of zinc ion transport [GO:0071579]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion transport [GO:0006829],Golgi apparatus [GO:0005794]; trans-Golgi network membrane [GO:0032588]
Q8NEW0,S1,-0.971459268,-0.941421493,-0.005165522,0.627256427,0.891903883,gold,SLC30A7,ZNT7_HUMAN,Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) (Znt-like transporter 2),SLC30A7 ZNT7 ZNTL2,148867;,"ENST00000357650.9; ENSP00000350278.4; ENSG00000162695.12.;""ENST00000370112.8; ENSP00000359130.4; ENSG00000162695.12."";",identical protein binding [GO:0042802]; zinc ion transmembrane transporter activity [GO:0005385],intracellular zinc ion homeostasis [GO:0006882]; zinc ion import into Golgi lumen [GO:1904257],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; vesicle [GO:0031982]
Q6PML9,M2,-1.138651159,-1.411602538,0.299325291,1.146235214,-0.090201696,tan4,SLC30A9,ZNT9_HUMAN,"Proton-coupled zinc antiporter SLC30A9, mitochondrial (Human embryonic lung protein) (HuEL) (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9)",SLC30A9 C4orf1 HUEL,10463;,ENST00000264451.12; ENSP00000264451.6; ENSG00000014824.14.;,antiporter activity [GO:0015297]; chromatin binding [GO:0003682]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; zinc ion transmembrane transporter activity [GO:0005385],intracellular zinc ion homeostasis [GO:0006882]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrion organization [GO:0010821]; zinc ion transport [GO:0006829],cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]
O15431,S1,-0.707204879,-0.67511479,0.094083923,0.679187132,0.749841441,gold,SLC31A1,COPT1_HUMAN,High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form],SLC31A1 COPT1 CTR1,1317;,ENST00000374212.5; ENSP00000363329.4; ENSG00000136868.11.;,copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910],angiogenesis [GO:0001525]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]
O00400,S2,-1.025217543,-1.537813323,0.260987085,0.795758446,0.668877204,orange,SLC33A1,ACATN_HUMAN,Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1),SLC33A1 ACATN AT1,9197;,"ENST00000359479.7; ENSP00000352456.3; ENSG00000169359.16.;""ENST00000643144.2; ENSP00000496241.1; ENSG00000169359.16."";",acetyl-CoA transmembrane transporter activity [GO:0008521]; protein homodimerization activity [GO:0042803],acetyl-CoA transmembrane transport [GO:0035348]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P78382,S1,-2.751844799,-2.402256579,-0.336649377,0.943922495,1.122264162,gold,SLC35A1,S35A1_HUMAN,CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (CST) (Solute carrier family 35 member A1),SLC35A1,10559;,"ENST00000369552.9; ENSP00000358565.4; ENSG00000164414.19. [P78382-1];""ENST00000369556.7; ENSP00000358569.3; ENSG00000164414.19. [P78382-2]"";",antiporter activity [GO:0015297]; CMP-N-acetylneuraminate transmembrane transporter activity [GO:0005456],carbohydrate metabolic process [GO:0005975]; CMP-N-acetylneuraminate transmembrane transport [GO:0015782]; protein modification process [GO:0036211],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P78381,S1,-0.874886963,-1.525003073,-0.174256625,0.801925683,1.215431315,gold,SLC35A2,S35A2_HUMAN,UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT),SLC35A2 UGALT UGT UGTL,7355;,"ENST00000247138.11; ENSP00000247138.5; ENSG00000102100.16. [P78381-1];""ENST00000376521.6; ENSP00000365704.1; ENSG00000102100.16. [P78381-2]"";""ENST00000445167.7; ENSP00000402726.2; ENSG00000102100.16. [P78381-3]"";""ENST00000452555.7; ENSP00000416002.2; ENSG00000102100.16. [P78381-4]"";""ENST00000635285.1; ENSP00000489484.1; ENSG00000102100.16. [P78381-2]"";""ENST00000635589.1; ENSP00000489197.1; ENSG00000102100.16. [P78381-5]"";""ENST00000710051.1; ENSP00000518018.1; ENSG00000292209.1. [P78381-2]"";""ENST00000710052.1; ENSP00000518019.1; ENSG00000292209.1. [P78381-1]"";""ENST00000710056.1; ENSP00000518023.1; ENSG00000292209.1. [P78381-2]"";""ENST00000710057.1; ENSP00000518024.1; ENSG00000292209.1. [P78381-3]"";""ENST00000710060.1; ENSP00000518027.1; ENSG00000292209.1. [P78381-5]"";""ENST00000710062.1; ENSP00000518029.1; ENSG00000292209.1. [P78381-4]"";",antiporter activity [GO:0015297]; UDP-galactose transmembrane transporter activity [GO:0005459],galactose metabolic process [GO:0006012]; UDP-galactose transmembrane transport [GO:0072334],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]
Q9BS91,S1,-1.265625644,-1.297411674,-0.401217597,0.695826853,1.152033219,gold,SLC35A5,S35A5_HUMAN,UDP-sugar transporter protein SLC35A5 (Solute carrier family 35 member A5),SLC35A5 UNQ164/PRO190,55032;,ENST00000492406.6; ENSP00000417654.1; ENSG00000138459.9.;,antiporter activity [GO:0015297]; pyrimidine nucleotide-sugar transmembrane transporter activity [GO:0015165]; transmembrane transporter activity [GO:0022857],transmembrane transport [GO:0055085],Golgi membrane [GO:0000139]
Q8TB61,S1,-0.731155889,-1.126698321,-0.251384192,0.725405149,1.015066259,gold,SLC35B2,S35B2_HUMAN,Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2),SLC35B2 PAPST1 PSEC0149,347734;,"ENST00000393812.4; ENSP00000377401.3; ENSG00000157593.20. [Q8TB61-1];""ENST00000537814.2; ENSP00000440340.1; ENSG00000157593.20. [Q8TB61-5]"";""ENST00000538577.5; ENSP00000443845.1; ENSG00000157593.20. [Q8TB61-4]"";""ENST00000615337.4; ENSP00000480681.1; ENSG00000157593.20. [Q8TB61-3]"";",3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; antiporter activity [GO:0015297],3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; 5'-adenylyl sulfate transmembrane transport [GO:1902558]; chondroitin sulfate biosynthetic process [GO:0030206]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9H1N7,S1,-1.326368201,-1.590940263,-0.244998056,1.012080164,0.919631868,gold,SLC35B3,S35B3_HUMAN,Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (3'-phosphoadenosine 5'-phosphosulfate transporter) (PAPS transporter 2) (Solute carrier family 35 member B3),SLC35B3 C6orf196 PAPST2 CGI-19,51000;,"ENST00000379660.4; ENSP00000368981.4; ENSG00000124786.13. [Q9H1N7-1];""ENST00000644923.2; ENSP00000496368.1; ENSG00000124786.13. [Q9H1N7-1]"";""ENST00000648867.1; ENSP00000497645.1; ENSG00000124786.13. [Q9H1N7-3]"";",3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity [GO:0046964]; antiporter activity [GO:0015297],3'-phosphoadenosine 5'-phosphosulfate transport [GO:0046963]; 5'-adenylyl sulfate transmembrane transport [GO:1902558]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]
Q96A29,S1,-1.576223545,-1.982659728,-0.217530041,1.010181617,1.079875915,gold,SLC35C1,FUCT1_HUMAN,GDP-fucose transporter 1 (Solute carrier family 35 member C1),SLC35C1 FUCT1,55343;,"ENST00000314134.4; ENSP00000313318.3; ENSG00000181830.9. [Q96A29-1];""ENST00000442528.2; ENSP00000412408.2; ENSG00000181830.9. [Q96A29-2]"";""ENST00000526817.2; ENSP00000432145.2; ENSG00000181830.9. [Q96A29-2]"";",antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457],GDP-fucose import into Golgi lumen [GO:0036085]; lipid glycosylation [GO:0030259]; negative regulation of Notch signaling pathway [GO:0045746]; protein O-linked fucosylation [GO:0036066],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q9NQQ7,S1,-1.609016015,-1.767923442,-0.393256362,0.742794005,0.80028467,gold,SLC35C2,S35C2_HUMAN,Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein),SLC35C2 C20orf5 OVCOV1 CGI-15,51006;,"ENST00000243896.6; ENSP00000243896.2; ENSG00000080189.15. [Q9NQQ7-1];""ENST00000317734.12; ENSP00000318960.9; ENSG00000080189.15. [Q9NQQ7-3]"";""ENST00000372227.5; ENSP00000361301.1; ENSG00000080189.15. [Q9NQQ7-1]"";""ENST00000372230.10; ENSP00000361304.5; ENSG00000080189.15. [Q9NQQ7-1]"";""ENST00000543605.5; ENSP00000439974.2; ENSG00000080189.15. [Q9NQQ7-2]"";",antiporter activity [GO:0015297],negative regulation of gene expression [GO:0010629]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066]; UDP-glucose transmembrane transport [GO:0015786],cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]
Q96K37,S2,-0.925544571,-1.417485836,-0.181910449,0.909559644,0.745495501,orange,SLC35E1,S35E1_HUMAN,Solute carrier family 35 member E1,SLC35E1 PSEC0038,79939;,ENST00000595753.6; ENSP00000470652.1; ENSG00000127526.15. [Q96K37-1];,antiporter activity [GO:0015297],transmembrane transport [GO:0055085],Golgi apparatus [GO:0005794]; membrane [GO:0016020]
Q8WV83,S1,-0.622682691,-1.303944448,-0.299063855,0.685160366,0.994146491,gold,SLC35F5,S35F5_HUMAN,Solute carrier family 35 member F5 (Hepatitis C virus NS5A-transactivated protein 3) (HCV NS5A-transactivated protein 3),SLC35F5 NS5ATP3 UNQ2545/PRO6097,80255;,ENST00000245680.7; ENSP00000245680.2; ENSG00000115084.15. [Q8WV83-1];,0,0,membrane [GO:0016020]
Q8N357,S1,-1.345551356,-1.889364309,-0.569602696,0.808319272,1.143566101,gold,SLC35F6,S35F6_HUMAN,Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog),SLC35F6 C2orf18 UNQ3047/PRO9863,54978;,ENST00000344420.10; ENSP00000345528.5; ENSG00000213699.9.;,transmembrane transporter activity [GO:0022857],negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
O43826,S2,-1.252417622,-1.78280545,0.367138556,0.874061556,0.572436617,orange,SLC37A4,G6PT1_HUMAN,Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19),SLC37A4 G6PT G6PT1 PRO0685 TRG19,2542;,"ENST00000642844.3; ENSP00000493469.1; ENSG00000281500.5. [O43826-1];""ENST00000710540.1; ENSP00000518334.1; ENSG00000281500.5. [O43826-2]"";""ENST00000710542.1; ENSP00000518335.1; ENSG00000281500.5. [O43826-1]"";""ENST00000710545.1; ENSP00000518336.1; ENSG00000281500.5. [O43826-2]"";""ENST00000710550.1; ENSP00000518339.1; ENSG00000281500.5. [O43826-1]"";",glucose 6-phosphate:phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152],gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9H2H9,S1,-1.059995657,-1.501289008,0.163033908,0.767000431,0.878221473,gold,SLC38A1,S38A1_HUMAN,Sodium-coupled neutral amino acid symporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1),SLC38A1 ATA1 NAT2 SAT1 SNAT1,81539;,"ENST00000398637.10; ENSP00000381634.4; ENSG00000111371.16.;""ENST00000439706.5; ENSP00000398142.1; ENSG00000111371.16."";""ENST00000546893.5; ENSP00000447853.1; ENSG00000111371.16."";""ENST00000549049.5; ENSP00000449607.1; ENSG00000111371.16."";",alanine:sodium symporter activity [GO:0015655]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium symporter activity [GO:0005295]; proline:sodium symporter activity [GO:0005298],"amino acid import [GO:0043090]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; female pregnancy [GO:0007565]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamine metabolic process [GO:0006541]; glutamine transport [GO:0006868]; L-alpha-amino acid transmembrane transport [GO:1902475]; neurotransmitter uptake [GO:0001504]; neutral amino acid transport [GO:0015804]; positive regulation of L-glutamine import across plasma membrane [GO:1901036]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; transport across blood-brain barrier [GO:0150104]",axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]
Q9HBR0,S1,-1.244460749,-1.416443169,-0.061115493,0.845318719,0.943770408,gold,SLC38A10,S38AA_HUMAN,Solute carrier family 38 member 10 (Amino acid transporter SLC38A10),SLC38A10 PP1744,124565;,"ENST00000288439.9; ENSP00000288439.5; ENSG00000157637.13. [Q9HBR0-2];""ENST00000374759.8; ENSP00000363891.3; ENSG00000157637.13. [Q9HBR0-1]"";",L-amino acid transmembrane transporter activity [GO:0015179],amino acid transmembrane transport [GO:0003333]; bone development [GO:0060348],Golgi apparatus [GO:0005794]; membrane [GO:0016020]
Q96QD8,S2,-1.436660717,-2.17059781,0.06682987,0.877303138,0.887659852,orange,SLC38A2,S38A2_HUMAN,Sodium-coupled neutral amino acid symporter 2 (Amino acid transporter A2) (Protein 40-9-1) (Solute carrier family 38 member 2) (System A amino acid transporter 2) (System A transporter 1) (System N amino acid transporter 2),SLC38A2 ATA2 KIAA1382 SAT2 SNAT2,54407;,"ENST00000256689.10; ENSP00000256689.5; ENSG00000134294.14. [Q96QD8-1];""ENST00000612232.1; ENSP00000482873.1; ENSG00000134294.14. [Q96QD8-2]"";",acidic amino acid transmembrane transporter activity [GO:0015172]; alanine:sodium symporter activity [GO:0015655]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; L-glutamine transmembrane transporter activity [GO:0015186]; L-serine transmembrane transporter activity [GO:0015194]; neutral L-amino acid:sodium symporter activity [GO:0005295]; proline:sodium symporter activity [GO:0005298],"alanine transport [GO:0032328]; amino acid import [GO:0043090]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; cellular response to amino acid starvation [GO:0034198]; cellular response to arsenite(3-) [GO:1903841]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; female pregnancy [GO:0007565]; glutamine transport [GO:0006868]; glycine betaine transport [GO:0031460]; L-glutamine import across plasma membrane [GO:1903803]; L-proline import across plasma membrane [GO:1904271]; L-serine import across plasma membrane [GO:1903812]; L-serine transport [GO:0015825]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA splicing [GO:0033120]; proline transport [GO:0015824]; regulation of cellular response to stress [GO:0080135]; regulation of glutamate secretion, neurotransmission [GO:1903294]; response to muscle activity [GO:0014850]; transport across blood-brain barrier [GO:0150104]",axon [GO:0030424]; brush border [GO:0005903]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]
Q8NBW4,S1,-0.640344924,-1.101138961,-0.253900885,0.732939523,0.837156911,gold,SLC38A9,S38A9_HUMAN,Neutral amino acid transporter 9 (Solute carrier family 38 member 9) (Up-regulated in lung cancer 11),SLC38A9 URLC11,153129;,"ENST00000318672.7; ENSP00000316596.3; ENSG00000177058.12. [Q8NBW4-1];""ENST00000396865.7; ENSP00000380074.2; ENSG00000177058.12. [Q8NBW4-1]"";""ENST00000512595.5; ENSP00000427335.1; ENSG00000177058.12. [Q8NBW4-3]"";""ENST00000515629.5; ENSP00000420934.1; ENSG00000177058.12. [Q8NBW4-4]"";",amino acid transmembrane transporter activity [GO:0015171]; arginine binding [GO:0034618]; cholesterol binding [GO:0015485]; guanyl-nucleotide exchange factor activity [GO:0005085]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-asparagine transmembrane transporter activity [GO:0015182]; L-glutamine transmembrane transporter activity [GO:0015186]; L-leucine transmembrane transporter activity [GO:0015190]; metal ion binding [GO:0046872]; sterol sensor activity [GO:0032935],amino acid transmembrane transport [GO:0003333]; asparagine transport [GO:0006867]; cellular response to amino acid stimulus [GO:0071230]; glutamine transport [GO:0006868]; L-arginine transmembrane transport [GO:1903826]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263],FNIP-folliculin RagC/D GAP [GO:1990877]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]
Q9ULF5,S4,-1.254338478,-1.339020063,0.35844754,1.014170745,0.248978067,tomato2,SLC39A10,S39AA_HUMAN,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),SLC39A10 KIAA1265 ZIP10,57181;,"ENST00000359634.10; ENSP00000352655.5; ENSG00000196950.14. [Q9ULF5-1];""ENST00000409086.7; ENSP00000386766.3; ENSG00000196950.14. [Q9ULF5-1]"";",monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385],epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886]
Q8N1S5,S3,-0.782479381,-0.87717887,0.069354458,0.804460966,0.598532536,salmon,SLC39A11,S39AB_HUMAN,Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11),SLC39A11 C17orf26 ZIP11,201266;,"ENST00000255559.8; ENSP00000255559.3; ENSG00000133195.12. [Q8N1S5-2];""ENST00000542342.6; ENSP00000445829.2; ENSG00000133195.12. [Q8N1S5-1]"";",copper ion transmembrane transporter activity [GO:0005375]; zinc ion transmembrane transporter activity [GO:0005385],zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577],cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q15043,S4,-1.246418355,-1.491852364,0.340737728,0.942636892,0.463071694,tomato2,SLC39A14,S39AE_HUMAN,Metal cation symporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14),SLC39A14 KIAA0062 ZIP14,23516;,"ENST00000240095.10; ENSP00000240095.6; ENSG00000104635.15. [Q15043-2];""ENST00000289952.9; ENSP00000289952.5; ENSG00000104635.15. [Q15043-1]"";""ENST00000359741.10; ENSP00000352779.5; ENSG00000104635.15. [Q15043-3]"";""ENST00000381237.6; ENSP00000370635.1; ENSG00000104635.15. [Q15043-1]"";",cadmium ion transmembrane transporter activity [GO:0015086]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; monoatomic anion:monoatomic cation symporter activity [GO:0015296]; monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385],cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; chondrocyte differentiation [GO:0002062]; gluconeogenesis [GO:0006094]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; insulin receptor signaling pathway [GO:0008286]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; regulation of hormone levels [GO:0010817]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q13433,S4,-1.102992716,-1.394713023,0.310635442,0.970250634,0.26947857,tomato2,SLC39A6,S39A6_HUMAN,Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6),SLC39A6 LIV1 ZIP6,25800;,"ENST00000269187.10; ENSP00000269187.4; ENSG00000141424.13. [Q13433-1];""ENST00000440549.6; ENSP00000401139.1; ENSG00000141424.13. [Q13433-2]"";""ENST00000590986.5; ENSP00000465915.1; ENSG00000141424.13. [Q13433-1]"";",monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385],epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; lymphocyte activation [GO:0046649]; T cell receptor signaling pathway [GO:0050852]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; lamellipodium membrane [GO:0031258]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]
Q92504,S2,-2.160640246,-1.938057761,0.139317171,1.019491271,0.389200498,orange,SLC39A7,S39A7_HUMAN,"Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)",SLC39A7 HKE4 RING5,7922;,"ENST00000374675.7; ENSP00000363807.3; ENSG00000112473.19.;""ENST00000374677.8; ENSP00000363809.3; ENSG00000112473.19."";""ENST00000383213.8; ENSP00000372700.4; ENSG00000206288.13."";""ENST00000383214.8; ENSP00000372701.4; ENSG00000206288.13."";""ENST00000416369.6; ENSP00000403583.2; ENSG00000229802.11."";""ENST00000418477.6; ENSP00000416439.2; ENSG00000226614.11."";""ENST00000423043.6; ENSP00000389623.2; ENSG00000226614.11."";""ENST00000431735.6; ENSP00000410656.2; ENSG00000224399.11."";""ENST00000441854.6; ENSP00000391735.2; ENSG00000229802.11."";""ENST00000441953.6; ENSP00000413027.2; ENSG00000224399.11."";""ENST00000443773.6; ENSP00000407093.2; ENSG00000227402.11."";""ENST00000456261.6; ENSP00000414145.2; ENSG00000227402.11."";",zinc ion transmembrane transporter activity [GO:0005385],B cell differentiation [GO:0030183]; intracellular zinc ion homeostasis [GO:0006882]; regulation of ferroptosis [GO:0110075]; skin epidermis development [GO:0098773]; zinc ion transmembrane transport [GO:0071577],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
P08195,S4,-0.977656051,-1.462778141,0.57453829,0.86452978,0.063383807,tomato2,SLC3A2,4F2_HUMAN,Amino acid transporter heavy chain SLC3A2 (4F2 cell-surface antigen heavy chain) (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98),SLC3A2 MDU1,6520;,"ENST00000338663.12; ENSP00000340815.7; ENSG00000168003.19. [P08195-2];""ENST00000377889.6; ENSP00000367121.2; ENSG00000168003.19. [P08195-3]"";""ENST00000377890.6; ENSP00000367122.2; ENSG00000168003.19. [P08195-1]"";""ENST00000377891.6; ENSP00000367123.2; ENSG00000168003.19. [P08195-5]"";""ENST00000538084.2; ENSP00000440001.2; ENSG00000168003.19. [P08195-4]"";""ENST00000544377.2; ENSP00000442135.2; ENSG00000168003.19. [P08195-2]"";""ENST00000680631.1; ENSP00000506006.1; ENSG00000168003.19. [P08195-2]"";""ENST00000681657.1; ENSP00000505110.1; ENSG00000168003.19. [P08195-2]"";",aromatic amino acid transmembrane transporter activity [GO:0015173]; cadherin binding [GO:0045296]; calcium:sodium antiporter activity [GO:0005432]; double-stranded RNA binding [GO:0003725]; exogenous protein binding [GO:0140272]; L-alanine transmembrane transporter activity [GO:0015180]; L-leucine transmembrane transporter activity [GO:0015190]; neutral L-amino acid secondary active transmembrane transporter activity [GO:0005294]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; virus receptor activity [GO:0001618],amino acid transport [GO:0006865]; calcium ion transport [GO:0006816]; carbohydrate metabolic process [GO:0005975]; isoleucine transport [GO:0015818]; L-alanine import across plasma membrane [GO:1904273]; L-histidine transport [GO:1902024]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; methionine transport [GO:0015821]; phenylalanine transport [GO:0015823]; proline transport [GO:0015824]; response to exogenous dsRNA [GO:0043330]; symbiont entry into host cell [GO:0046718]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828]; valine transport [GO:0015829],amino acid transport complex [GO:1990184]; anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; apical pole of neuron [GO:0044225]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]
Q8IVJ1,S1,-0.928541379,-1.132590184,-0.246931071,0.530954478,1.058078945,gold,SLC41A1,S41A1_HUMAN,Solute carrier family 41 member 1,SLC41A1,254428;,ENST00000367137.4; ENSP00000356105.3; ENSG00000133065.11.;,inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857],cellular response to magnesium ion [GO:0071286]; intracellular magnesium ion homeostasis [GO:0010961]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q8WWI5,S4,-1.02685758,-1.296757829,0.444995322,0.754989473,0.297726893,tomato2,SLC44A1,CTL1_HUMAN,Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92),SLC44A1 CD92 CDW92 CTL1,23446;,"ENST00000374720.8; ENSP00000363852.3; ENSG00000070214.17. [Q8WWI5-1];""ENST00000374723.5; ENSP00000363855.1; ENSG00000070214.17. [Q8WWI5-3]"";""ENST00000374724.1; ENSP00000363856.1; ENSG00000070214.17. [Q8WWI5-2]"";""ENST00000470972.5; ENSP00000433072.1; ENSG00000070214.17. [Q8WWI5-1]"";",antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228],choline catabolic process [GO:0042426]; choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; phosphatidylcholine biosynthetic process [GO:0006656]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q8IWA5,S4,-1.174666054,-1.377483529,0.364363448,0.777638853,0.400359862,tomato2,SLC44A2,CTL2_HUMAN,Choline transporter-like protein 2 (Solute carrier family 44 member 2),SLC44A2 CTL2 PSEC0210,57153;,"ENST00000335757.10; ENSP00000336888.4; ENSG00000129353.15. [Q8IWA5-1];""ENST00000407327.8; ENSP00000385135.3; ENSG00000129353.15. [Q8IWA5-3]"";""ENST00000586078.5; ENSP00000466664.1; ENSG00000129353.15. [Q8IWA5-2]"";",antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; ethanolamine transmembrane transporter activity [GO:0034228]; transmembrane transporter activity [GO:0022857],choline transport [GO:0015871]; ethanolamine transport [GO:0034229]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; transmembrane transport [GO:0055085],extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]
Q9BWU0,N4,-0.648488228,1.35306623,-0.291402236,-0.958569306,-0.281069433,grey30,SLC4A1AP,NADAP_HUMAN,Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein),SLC4A1AP HLC3,22950;,"ENST00000326019.11; ENSP00000323837.7; ENSG00000163798.14. [Q9BWU0-2];""ENST00000618046.4; ENSP00000483501.1; ENSG00000163798.14. [Q9BWU0-2]"";",mRNA binding [GO:0003729],0,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
P04920,S4,-0.942111308,-1.032202778,0.360299331,0.794284276,0.379808964,tomato2,SLC4A2,B3A2_HUMAN,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2),SLC4A2 AE2 EPB3L1 HKB3 MPB3L,6522;,"ENST00000392826.6; ENSP00000376571.2; ENSG00000164889.15. [P04920-3];""ENST00000413384.7; ENSP00000405600.2; ENSG00000164889.15. [P04920-1]"";""ENST00000461735.1; ENSP00000419164.1; ENSG00000164889.15. [P04920-2]"";""ENST00000485713.5; ENSP00000419412.1; ENSG00000164889.15. [P04920-1]"";",chloride:bicarbonate antiporter activity [GO:0140900]; enzyme binding [GO:0019899]; monoatomic anion transmembrane transporter activity [GO:0008509]; solute:inorganic anion antiporter activity [GO:0005452]; transmembrane transporter activity [GO:0022857],"amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; digestive tract development [GO:0048565]; monoatomic anion transport [GO:0006820]; negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; positive regulation of enamel mineralization [GO:0070175]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]; spermatogenesis [GO:0007283]; transmembrane transport [GO:0055085]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; focal adhesion [GO:0005925]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q9Y6M7,S4,-1.080007548,-1.385909743,0.580751861,0.95916311,0.051951574,tomato2,SLC4A7,S4A7_HUMAN,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),SLC4A7 BT NBC2 NBC2B NBC3 NBCn1 SBC2 SLC4A6,9497;,"ENST00000295736.9; ENSP00000295736.5; ENSG00000033867.18. [Q9Y6M7-1];""ENST00000428386.5; ENSP00000416368.1; ENSG00000033867.18. [Q9Y6M7-2]"";""ENST00000437179.5; ENSP00000394252.1; ENSG00000033867.18. [Q9Y6M7-9]"";""ENST00000437266.5; ENSP00000409418.1; ENSG00000033867.18. [Q9Y6M7-11]"";""ENST00000438530.5; ENSP00000407304.1; ENSG00000033867.18. [Q9Y6M7-10]"";""ENST00000440156.5; ENSP00000414797.1; ENSG00000033867.18. [Q9Y6M7-8]"";""ENST00000446700.5; ENSP00000406605.1; ENSG00000033867.18. [Q9Y6M7-12]"";""ENST00000454389.6; ENSP00000390394.1; ENSG00000033867.18. [Q9Y6M7-7]"";""ENST00000455077.5; ENSP00000407382.1; ENSG00000033867.18. [Q9Y6M7-6]"";""ENST00000457377.5; ENSP00000408323.1; ENSG00000033867.18. [Q9Y6M7-11]"";",monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],auditory receptor cell development [GO:0060117]; bicarbonate transport [GO:0015701]; cellular response to growth factor stimulus [GO:0071363]; phagosome acidification [GO:0090383]; purine nucleotide biosynthetic process [GO:0006164]; pyrimidine nucleotide biosynthetic process [GO:0006221]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]
P48067,S4,-0.675143385,-1.097420522,0.418858217,0.894817614,0.347386395,tomato2,SLC6A9,SC6A9_HUMAN,Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9),SLC6A9,6536;,"ENST00000357730.6; ENSP00000350362.2; ENSG00000196517.13. [P48067-3];""ENST00000360584.6; ENSP00000353791.2; ENSG00000196517.13. [P48067-1]"";""ENST00000372310.8; ENSP00000361384.4; ENSG00000196517.13. [P48067-2]"";""ENST00000673836.1; ENSP00000501314.1; ENSG00000196517.13. [P48067-2]"";",glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375],"glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; neurotransmitter transport [GO:0006836]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; regulation of synaptic transmission, glycinergic [GO:0060092]; sodium ion transmembrane transport [GO:0035725]; synaptic transmission, glycinergic [GO:0060012]; transport across blood-brain barrier [GO:0150104]",apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; dense core granule [GO:0031045]; endosome [GO:0005768]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]
P30825,S3,-1.077673509,-1.07081249,0.114370969,0.786517683,0.582052638,salmon,SLC7A1,CTR1_HUMAN,High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter),SLC7A1 ATRC1 ERR REC1L,6541;,ENST00000380752.10; ENSP00000370128.5; ENSG00000139514.13.;,amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618],amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; ornithine transport [GO:0015822]; positive regulation of T cell proliferation [GO:0042102]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q01650,S4,-1.326253263,-1.656277689,0.594661719,1.031891879,0.086858107,tomato2,SLC7A5,LAT1_HUMAN,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),SLC7A5 CD98LC LAT1 MPE16,8140;,ENST00000261622.5; ENSP00000261622.4; ENSG00000103257.9.;,amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349],alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; cellular response to glucose starvation [GO:0042149]; cellular response to L-arginine [GO:1903577]; cellular response to lipopolysaccharide [GO:0071222]; isoleucine transport [GO:0015818]; L-histidine transport [GO:1902024]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; L-tryptophan transmembrane transport [GO:1904556]; liver regeneration [GO:0097421]; methionine transport [GO:0015821]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of L-leucine import across plasma membrane [GO:1905534]; positive regulation of type II interferon production [GO:0032729]; proline transport [GO:0015824]; response to hyperoxia [GO:0055093]; response to muscle activity [GO:0014850]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828]; valine transport [GO:0015829]; xenobiotic transport [GO:0042908],amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]
P19634,S4,-0.501580024,-0.89445185,0.329531749,0.752971732,0.184447962,tomato2,SLC9A1,SL9A1_HUMAN,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",SLC9A1 APNH1 NHE1,6548;,"ENST00000263980.8; ENSP00000263980.3; ENSG00000090020.11. [P19634-1];""ENST00000374086.3; ENSP00000363199.3; ENSG00000090020.11. [P19634-2]"";","calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; protein-macromolecule adaptor activity [GO:0030674]; sodium:proton antiporter activity [GO:0015385]; sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086040]",cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell differentiation [GO:0055007]; cell migration [GO:0016477]; cellular response to acidic pH [GO:0071468]; cellular response to antibiotic [GO:0071236]; cellular response to cold [GO:0070417]; cellular response to electrical stimulus [GO:0071257]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of cell polarity [GO:0030011]; monoatomic ion transport [GO:0006811]; negative regulation of apoptotic process [GO:0043066]; positive regulation of action potential [GO:0045760]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium:sodium antiporter activity [GO:1903281]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; proton transmembrane transport [GO:1902600]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of focal adhesion assembly [GO:0051893]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of stress fiber assembly [GO:0051492]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]
Q92581,S1,-1.099855759,-1.354686999,-0.060583334,0.597006789,1.041215711,gold,SLC9A6,SL9A6_HUMAN,Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Solute carrier family 9 member 6),SLC9A6 KIAA0267 NHE6,10479;,"ENST00000370695.8; ENSP00000359729.4; ENSG00000198689.13. [Q92581-2];""ENST00000370698.7; ENSP00000359732.3; ENSG00000198689.13. [Q92581-1]"";""ENST00000370701.6; ENSP00000359735.1; ENSG00000198689.13. [Q92581-3]"";""ENST00000636092.1; ENSP00000490406.1; ENSG00000198689.13. [Q92581-3]"";""ENST00000636347.1; ENSP00000490648.1; ENSG00000198689.13. [Q92581-3]"";""ENST00000637234.1; ENSP00000490527.1; ENSG00000198689.13. [Q92581-3]"";""ENST00000637581.1; ENSP00000490731.1; ENSG00000198689.13. [Q92581-3]"";",identical protein binding [GO:0042802]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],axon extension [GO:0048675]; dendrite extension [GO:0097484]; establishment of cell polarity [GO:0030010]; monoatomic ion transport [GO:0006811]; neuron projection morphogenesis [GO:0048812]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719],early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]
Q96T83,S1,-0.96182728,-1.152698601,-0.028636224,0.535809542,1.08424207,gold,SLC9A7,SL9A7_HUMAN,Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7),SLC9A7 NHE7,84679;,ENST00000328306.4; ENSP00000330320.4; ENSG00000065923.10.;,potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; sodium ion import across plasma membrane [GO:0098719],Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]
Q9Y2E8,S1,-1.398682697,-1.4295759,-0.304510452,0.738872852,1.146914373,gold,SLC9A8,SL9A8_HUMAN,Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8),SLC9A8 KIAA0939 NHE8,23315;,"ENST00000361573.3; ENSP00000354966.2; ENSG00000197818.12. [Q9Y2E8-1];""ENST00000417961.5; ENSP00000416418.1; ENSG00000197818.12. [Q9Y2E8-2]"";",potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],acrosome assembly [GO:0001675]; monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; sodium ion transmembrane transport [GO:0035725],acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; multivesicular body membrane [GO:0032585]; trans-Golgi network membrane [GO:0032588]
Q9H2G2,C3,2.014884702,-0.11494764,-0.840236516,-0.665640862,-0.894872736,cyan,SLK,SLK_HUMAN,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),SLK KIAA0204 STK2,9748;,"ENST00000335753.8; ENSP00000336824.4; ENSG00000065613.15. [Q9H2G2-2];""ENST00000369755.4; ENSP00000358770.3; ENSG00000065613.15. [Q9H2G2-1]"";",ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],apoptotic process [GO:0006915]; cytoplasmic microtubule organization [GO:0031122]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of cell migration [GO:0030334]; regulation of focal adhesion assembly [GO:0051893],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]
Q14BN4,S2,-1.129392931,-1.199715183,0.17497617,0.888550151,0.553306766,orange,SLMAP,SLMAP_HUMAN,Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein),SLMAP KIAA1601 SLAP UNQ1847/PRO3577,7871;,"ENST00000295951.7; ENSP00000295951.3; ENSG00000163681.17. [Q14BN4-3];""ENST00000295952.7; ENSP00000295952.3; ENSG00000163681.17. [Q14BN4-3]"";""ENST00000383718.7; ENSP00000373224.3; ENSG00000163681.17. [Q14BN4-6]"";""ENST00000449503.6; ENSP00000412945.2; ENSG00000163681.17. [Q14BN4-2]"";""ENST00000494088.6; ENSP00000418218.2; ENSG00000163681.17. [Q14BN4-5]"";""ENST00000659705.1; ENSP00000499241.1; ENSG00000163681.17. [Q14BN4-1]"";",protein-macromolecule adaptor activity [GO:0030674],muscle contraction [GO:0006936]; negative regulation of hippo signaling [GO:0035331]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150],centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; FAR/SIN/STRIPAK complex [GO:0090443]; M band [GO:0031430]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]
Q9NWH9,N3,-1.266829225,-1.294238682,1.127252716,0.145279055,0.20398047,grey50,SLTM,SLTM_HUMAN,SAFB-like transcription modulator (Modulator of estrogen-induced transcription),SLTM MET,79811;,ENST00000380516.7; ENSP00000369887.2; ENSG00000137776.17. [Q9NWH9-1];,RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565],apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357],nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q15796,C3,1.822171746,0.453774546,-0.509506604,-0.525531042,-1.131338984,cyan,SMAD2,SMAD2_HUMAN,Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2),SMAD2 MADH2 MADR2,4087;,"ENST00000262160.11; ENSP00000262160.6; ENSG00000175387.16. [Q15796-1];""ENST00000356825.8; ENSP00000349282.4; ENSG00000175387.16. [Q15796-2]"";""ENST00000402690.6; ENSP00000384449.1; ENSG00000175387.16. [Q15796-1]"";""ENST00000586040.5; ENSP00000466193.1; ENSG00000175387.16. [Q15796-2]"";","chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]",activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; DNA-templated transcription [GO:0006351]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion morphogenesis [GO:0003203]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; nodal signaling pathway [GO:0038092]; odontoblast differentiation [GO:0071895]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; pulmonary valve morphogenesis [GO:0003184]; regulation of binding [GO:0051098]; regulation of DNA-templated transcription [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; zygotic specification of dorsal/ventral axis [GO:0007352],activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]
Q13485,C5,1.542514936,0.420450786,-0.395565111,-0.563152102,-0.858537722,turquoise3,SMAD4,SMAD4_HUMAN,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),SMAD4 DPC4 MADH4,4089;,"ENST00000342988.8; ENSP00000341551.3; ENSG00000141646.16.;""ENST00000398417.6; ENSP00000381452.1; ENSG00000141646.16."";""ENST00000588860.6; ENSP00000465878.2; ENSG00000141646.16."";""ENST00000589076.6; ENSP00000466934.2; ENSG00000141646.16."";""ENST00000589941.2; ENSP00000465874.2; ENSG00000141646.16."";""ENST00000590061.2; ENSP00000464772.2; ENSG00000141646.16."";","chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667]
Q99717,C2,0.949530087,0.428448138,-0.137314956,0.086069772,-0.523981285,aquamarine,SMAD5,SMAD5_HUMAN,Mothers against decapentaplegic homolog 5 (MAD homolog 5) (Mothers against DPP homolog 5) (JV5-1) (SMAD family member 5) (SMAD 5) (Smad5) (hSmad5),SMAD5 MADH5,4090;,"ENST00000509297.6; ENSP00000426696.2; ENSG00000113658.18.;""ENST00000545279.6; ENSP00000441954.2; ENSG00000113658.18."";""ENST00000545620.5; ENSP00000446474.2; ENSG00000113658.18."";","DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin protein ligase binding [GO:0031625]",anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac conduction system development [GO:0003161]; cardiac muscle contraction [GO:0060048]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to organic cyclic compound [GO:0071407]; embryonic pattern specification [GO:0009880]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; Mullerian duct regression [GO:0001880]; negative regulation of apoptotic process [GO:0043066]; negative regulation of Fas signaling pathway [GO:1902045]; negative regulation of gene expression [GO:0010629]; osteoblast differentiation [GO:0001649]; osteoblast fate commitment [GO:0002051]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]
Q9H3U1,C4,2.144359346,-0.11586639,-1.138711223,-1.082491807,-1.336878398,deepskyblue2,SMAP1,UN45A_HUMAN,Protein unc-45 homolog A (Unc-45A) (GCUNC-45) (Smooth muscle cell-associated protein 1) (SMAP-1),UNC45A SMAP1,55898;,"ENST00000394275.7; ENSP00000377816.2; ENSG00000140553.18. [Q9H3U1-2];""ENST00000418476.2; ENSP00000407487.2; ENSG00000140553.18. [Q9H3U1-1]"";",cadherin binding [GO:0045296]; Hsp90 protein binding [GO:0051879],cell differentiation [GO:0030154]; chaperone-mediated protein folding [GO:0061077]; muscle organ development [GO:0007517],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]
P28370,N2,-1.048043064,-0.807754348,1.07496182,0.207355802,0.106241299,grey70,SMARCA1,SMCA1_HUMAN,Probable global transcription activator SNF2L1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA1) (Nucleosome-remodeling factor subunit SNF2L) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1),SMARCA1 SNF2L SNF2L1,6594;,ENST00000371122.8; ENSP00000360163.4; ENSG00000102038.16. [P28370-1];,ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; nucleosome binding [GO:0031491]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],brain development [GO:0007420]; chromatin remodeling [GO:0006338]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355],ATPase complex [GO:1904949]; CERF complex [GO:0090537]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]
O60264,N3,-1.245364081,-0.955647987,1.123811066,0.159921871,0.022619296,grey50,SMARCA5,SMCA5_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H),SMARCA5 SNF2H WCRF135,8467;,ENST00000283131.4; ENSP00000283131.3; ENSG00000153147.6.;,"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone octamer slider activity [GO:0140751]; nucleosome binding [GO:0031491]",antiviral innate immune response [GO:0140374]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA methylation-dependent heterochromatin formation [GO:0006346]; DNA repair [GO:0006281]; DNA-templated transcription initiation [GO:0006352]; heterochromatin formation [GO:0031507]; negative regulation of mitotic chromosome condensation [GO:1905213]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; rDNA heterochromatin formation [GO:0000183]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],ACF complex [GO:0016590]; B-WICH complex [GO:0110016]; CHRAC [GO:0008623]; chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; NoRC complex [GO:0090536]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; pericentric heterochromatin [GO:0005721]; RSF complex [GO:0031213]; site of double-strand break [GO:0035861]; WICH complex [GO:0090535]
Q9H4L7,N4,-0.817720919,0.703792068,8.11E-04,0.322343296,0.001508492,grey30,SMARCAD1,SMRCD_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1),SMARCAD1 KIAA1122,56916;,"ENST00000354268.9; ENSP00000346217.4; ENSG00000163104.18. [Q9H4L7-1];""ENST00000359052.8; ENSP00000351947.4; ENSG00000163104.18. [Q9H4L7-2]"";""ENST00000457823.6; ENSP00000415576.2; ENSG00000163104.18. [Q9H4L7-2]"";""ENST00000509418.1; ENSP00000423286.1; ENSG00000163104.18. [Q9H4L7-3]"";","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; ubiquitin binding [GO:0043130]",chromatin remodeling [GO:0006338]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; regulation of DNA recombination [GO:0000018],heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]
Q14683,N2,-0.961839449,0.362557537,0.866003665,-0.115624123,-0.446531769,grey70,SMC1A,SMC1A_HUMAN,Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Sb1.8),SMC1A DXS423E KIAA0178 SB1.8 SMC1 SMC1L1,8243;,ENST00000322213.9; ENSP00000323421.3; ENSG00000072501.19.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723],cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; establishment of mitotic sister chromatid cohesion [GO:0034087]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; somatic stem cell population maintenance [GO:0035019],"chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q8IY18,N2,-0.781548872,0.27164043,0.77852052,0.058666869,-0.182978611,grey70,SMC5,SMC5_HUMAN,Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (hSMC5),SMC5 KIAA0594 SMC5L1,23137;,ENST00000361138.7; ENSP00000354957.5; ENSG00000198887.9.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA secondary structure binding [GO:0000217]; single-stranded DNA binding [GO:0003697],"cell division [GO:0051301]; cellular senescence [GO:0090398]; chromatin looping [GO:0140588]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle phase transition [GO:0044772]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]","cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"
Q96SB8,N2,-0.946164702,0.356537648,0.908858402,-0.042836409,-0.353489076,grey70,SMC6,SMC6_HUMAN,Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (hSMC6),SMC6 SMC6L1,79677;,"ENST00000351948.8; ENSP00000323439.4; ENSG00000163029.16. [Q96SB8-1];""ENST00000402989.5; ENSP00000384539.1; ENSG00000163029.16. [Q96SB8-1]"";""ENST00000448223.7; ENSP00000404092.2; ENSG00000163029.16. [Q96SB8-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA secondary structure binding [GO:0000217]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625],cellular senescence [GO:0090398]; chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of chromosome segregation [GO:0051984]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via recombination [GO:0000722],"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]"
A6NHR9,N4,-0.950943269,0.77835609,0.59387416,-0.281143431,-0.660961798,grey30,SMCHD1,SMHD1_HUMAN,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-),SMCHD1 KIAA0650,23347;,ENST00000320876.11; ENSP00000326603.7; ENSG00000101596.17. [A6NHR9-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803],chromosome organization [GO:0051276]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],Barr body [GO:0001740]; site of double-strand break [GO:0035861]
Q5MIZ7,N4,-0.8500324,1.27935608,-0.236822031,-0.331193673,-0.543737204,grey30,SMEK2,P4R3B_HUMAN,Serine/threonine-protein phosphatase 4 regulatory subunit 3B (SMEK homolog 2),PPP4R3B KIAA1387 PP4R3B SMEK2,57223;,"ENST00000611717.4; ENSP00000478677.1; ENSG00000275052.5. [Q5MIZ7-3];""ENST00000616288.4; ENSP00000484116.1; ENSG00000275052.5. [Q5MIZ7-2]"";""ENST00000616407.2; ENSP00000483228.1; ENSG00000275052.5. [Q5MIZ7-1]"";",protein phosphatase activator activity [GO:0072542],DNA damage response [GO:0006974]; gluconeogenesis [GO:0006094]; positive regulation of gluconeogenesis [GO:0045722]; regulation of double-strand break repair [GO:2000779],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein phosphatase 4 complex [GO:0030289]
Q8ND04,C1,1.200961101,0.359529562,-0.510008474,-0.311206662,0.044490136,lightblue,SMG8,SMG8_HUMAN,Nonsense-mediated mRNA decay factor SMG8 (Amplified in breast cancer gene 2 protein) (Protein smg-8 homolog),SMG8 ABC2 C17orf71,55181;,"ENST00000300917.10; ENSP00000300917.4; ENSG00000167447.13. [Q8ND04-1];""ENST00000543872.6; ENSP00000438748.2; ENSG00000167447.13. [Q8ND04-1]"";""ENST00000578922.1; ENSP00000462119.1; ENSG00000167447.13. [Q8ND04-3]"";",0,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of protein kinase activity [GO:0045859]",cytosol [GO:0005829]
Q96EX1,M2,-1.722381975,-1.808771623,0.428398083,1.34065786,-0.083848408,tan4,SMIM12,SIM12_HUMAN,Small integral membrane protein 12,SMIM12 C1orf212,113444;,"ENST00000417239.1; ENSP00000428541.1; ENSG00000163866.9.;""ENST00000423898.1; ENSP00000428984.1; ENSG00000163866.9."";""ENST00000446026.1; ENSP00000430285.1; ENSG00000163866.9."";""ENST00000456842.1; ENSP00000430198.1; ENSG00000163866.9."";""ENST00000521580.3; ENSP00000428585.1; ENSG00000163866.9."";",0,0,membrane [GO:0016020]
Q96QK8,S3,-0.592637025,-1.422863097,0.324244516,0.771527663,0.584761787,salmon,SMIM14,SIM14_HUMAN,Small integral membrane protein 14,SMIM14 C4orf34,201895;,ENST00000295958.10; ENSP00000295958.4; ENSG00000163683.12.;,0,blastocyst hatching [GO:0001835],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q96E16,S2,-0.929270231,-1.57432771,0.246298185,0.826576444,0.724083909,orange,SMIM19,SMI19_HUMAN,Small integral membrane protein 19,SMIM19 C8orf40,114926;,"ENST00000414154.6; ENSP00000408997.2; ENSG00000176209.12.;""ENST00000416469.6; ENSP00000390750.2; ENSG00000176209.12."";""ENST00000417410.7; ENSP00000405694.2; ENSG00000176209.12."";""ENST00000438528.7; ENSP00000391549.2; ENSG00000176209.12."";""ENST00000490331.2; ENSP00000429586.1; ENSG00000176209.12."";",0,0,membrane [GO:0016020]
Q8WVI0,M2,-1.321628909,-1.32998868,0.404335711,1.17628252,0.040403709,tan4,SMIM4,UQCC5_HUMAN,Ubiquinol-cytochrome c reductase complex assembly factor 5 (Small integral membrane protein 4),UQCC5 C3orf78 SMIM4,440957;,ENST00000477703.6; ENSP00000417806.1; ENSG00000168273.8.;,mitochondrial ribosome binding [GO:0097177],mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex III assembly [GO:0034551],mitochondrial inner membrane [GO:0005743]
P17405,S3,-1.061941473,-0.204080868,0.155333917,0.635862418,0.526229753,salmon,SMPD1,ASM_HUMAN,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase) [Cleaved into: Sphingomyelin phosphodiesterase, processed form]",SMPD1 ASM,6609;,"ENST00000342245.9; ENSP00000340409.4; ENSG00000166311.10. [P17405-1];""ENST00000527275.5; ENSP00000435350.1; ENSG00000166311.10. [P17405-4]"";","acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphatidylcholine phospholipase C activity [GO:0034480]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]",cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid catabolic process [GO:0046479]; negative regulation of MAP kinase activity [GO:0043407]; nervous system development [GO:0007399]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of viral entry into host cell [GO:0046598]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; symbiont entry into host cell [GO:0046718]; termination of signal transduction [GO:0023021]; wound healing [GO:0042060],endolysosome [GO:0036019]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]
O60906,S2,-0.986036867,-1.374388868,0.176186615,0.93892901,0.530265942,orange,SMPD2,NSMA_HUMAN,Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase) (nSMase1),SMPD2,6610;,ENST00000258052.8; ENSP00000258052.3; ENSG00000135587.9.;,metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767],ceramide biosynthetic process [GO:0046513]; sphingolipid catabolic process [GO:0030149]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684],caveola [GO:0005901]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]
Q9NXE4,N2,-0.92560873,-1.215054345,1.142935878,0.296284553,-0.114658188,grey70,SMPD4,NSMA3_HUMAN,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),SMPD4 KIAA1418 SKNY,55627;,"ENST00000351288.10; ENSP00000259217.8; ENSG00000136699.20. [Q9NXE4-2];""ENST00000409031.5; ENSP00000386531.1; ENSG00000136699.20. [Q9NXE4-1]"";""ENST00000431183.6; ENSP00000405187.2; ENSG00000136699.20. [Q9NXE4-6]"";""ENST00000709800.1; ENSP00000517878.1; ENSG00000292130.1. [Q9NXE4-6]"";""ENST00000709804.1; ENSP00000517882.1; ENSG00000292130.1. [Q9NXE4-2]"";""ENST00000709809.1; ENSP00000517885.1; ENSG00000292130.1. [Q9NXE4-1]"";",metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290],cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; endoplasmic reticulum organization [GO:0007029]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; sarcolemma [GO:0042383]; trans-Golgi network [GO:0005802]
P52788,C4,2.137089959,0.46115095,-1.111954403,-1.120725124,-1.28541935,deepskyblue2,SMS,SPSY_HUMAN,Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase),SMS,6611;,"ENST00000379404.5; ENSP00000368714.1; ENSG00000102172.16. [P52788-2];""ENST00000404933.7; ENSP00000385746.2; ENSG00000102172.16. [P52788-1]"";",spermine synthase activity [GO:0016768],methionine metabolic process [GO:0006555]; polyamine metabolic process [GO:0006595]; spermine biosynthetic process [GO:0006597],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9HAU4,C1,1.242142995,0.123947565,-0.433747271,-0.265533371,0.324961409,lightblue,SMURF2,SMUF2_HUMAN,E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),SMURF2,64750;,ENST00000262435.14; ENSP00000262435.9; ENSG00000108854.16.;,identical protein binding [GO:0042802]; SMAD binding [GO:0046332]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of trophoblast cell migration [GO:1901165]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]
Q9NRG4,C4,1.974335057,0.285934856,-0.939895626,-0.964997481,-1.155673311,deepskyblue2,SMYD2,SMYD2_HUMAN,N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (HSKM-B) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2),SMYD2 KMT3C,56950;,ENST00000366957.10; ENSP00000355924.5; ENSG00000143499.14. [Q9NRG4-1];,histone H3 methyltransferase activity [GO:0140938]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 trimethyltransferase activity [GO:0140999]; lysine N-methyltransferase activity [GO:0016278]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II complex binding [GO:0000993],"heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of signal transduction by p53 class mediator [GO:1901796]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6GMV2,C4,1.971128184,0.366284106,-0.600532704,-0.89105598,-0.969703297,deepskyblue2,SMYD5,SMYD5_HUMAN,Histone-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.372) (Protein NN8-4AG) (Retinoic acid-induced protein 15) (SET and MYND domain-containing protein 5) ([histone H4]-lysine20 N-trimethyltransferase SMYD5),SMYD5 RAI15,10322;,ENST00000389501.9; ENSP00000374152.4; ENSG00000135632.12.;,histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 trimethyltransferase activity [GO:0140943]; metal ion binding [GO:0046872],"methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]; retrotransposon silencing by heterochromatin formation [GO:0141005]",0
O00161,S4,-0.717648944,-1.328017583,0.250403088,0.968217501,0.486728539,tomato2,SNAP23,SNP23_HUMAN,Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23),SNAP23,8773;,"ENST00000249647.8; ENSP00000249647.3; ENSG00000092531.10. [O00161-1];""ENST00000349777.5; ENSP00000207062.1; ENSG00000092531.10. [O00161-2]"";""ENST00000397138.5; ENSP00000380327.1; ENSG00000092531.10. [O00161-2]"";",SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],exocytosis [GO:0006887]; histamine secretion by mast cell [GO:0002553]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle targeting [GO:0006903],adherens junction [GO:0005912]; azurophil granule [GO:0042582]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; specific granule membrane [GO:0035579]; synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex [GO:0070032]; tertiary granule membrane [GO:0070821]
Q5SQN1,S3,-0.233682166,-0.789434784,0.12144355,0.600112696,0.544436824,salmon,SNAP47,SNP47_HUMAN,Synaptosomal-associated protein 47 (SNAP-47) (Epididymis luminal protein 170) (Synaptosomal-associated 47 kDa protein),SNAP47 C1orf142 HEL170 SVAP1,116841;,"ENST00000366760.5; ENSP00000355722.1; ENSG00000143740.15. [Q5SQN1-4];""ENST00000418653.6; ENSP00000402730.2; ENSG00000143740.15. [Q5SQN1-3]"";""ENST00000679561.1; ENSP00000504959.1; ENSG00000143740.15. [Q5SQN1-4]"";""ENST00000680695.1; ENSP00000506091.1; ENSG00000143740.15. [Q5SQN1-4]"";""ENST00000681929.1; ENSP00000505648.1; ENSG00000143740.15. [Q5SQN1-4]"";",SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905],exocytosis [GO:0006887]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],endomembrane system [GO:0012505]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201]
Q13487,N4,-0.627885132,0.947983279,0.174213894,0.056881261,-0.50014474,grey30,SNAPC2,SNPC2_HUMAN,snRNA-activating protein complex subunit 2 (SNAPc subunit 2) (Proximal sequence element-binding transcription factor subunit delta) (PSE-binding factor subunit delta) (PTF subunit delta) (Small nuclear RNA-activating complex polypeptide 2) (snRNA-activating protein complex 45 kDa subunit) (SNAPc 45 kDa subunit),SNAPC2 SNAP45,6618;,ENST00000221573.11; ENSP00000221573.5; ENSG00000104976.13.;,RNA polymerase II general transcription initiation factor activity [GO:0016251],snRNA transcription [GO:0009301]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q16560,N1,-0.971204356,-0.725527749,0.642983265,-0.385793505,0.803415485,grey90,SNRNP35,U1SBP_HUMAN,U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U11/U12-35K) (Protein HM-1) (U1 snRNP-binding protein homolog),SNRNP35 HM1 U1SNRNPBP,11066;,"ENST00000350887.5; ENSP00000340774.5; ENSG00000184209.15. [Q16560-1];""ENST00000412157.2; ENSP00000403310.2; ENSG00000184209.15. [Q16560-2]"";""ENST00000526639.3; ENSP00000432595.2; ENSG00000184209.15. [Q16560-1]"";",mRNA binding [GO:0003729]; snRNA binding [GO:0017069],"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]
Q13425,M1,-0.63151701,-0.950302991,0.606701699,0.731328684,-0.121584166,burlywood4,SNTB2,SNTB2_HUMAN,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),SNTB2 D16S2531E SNT2B2 SNTL,6645;,"ENST00000336278.9; ENSP00000338191.4; ENSG00000168807.17. [Q13425-1];""ENST00000467311.5; ENSP00000436443.1; ENSG00000168807.17. [Q13425-2]"";",actin binding [GO:0003779]; calmodulin binding [GO:0005516]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198],0,cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658]
Q13596,C1,1.595208696,0.057335129,-0.575938315,-0.430940465,-0.239414682,lightblue,SNX1,SNX1_HUMAN,Sorting nexin-1,SNX1,6642;,"ENST00000261889.9; ENSP00000261889.5; ENSG00000028528.15. [Q13596-3];""ENST00000559844.6; ENSP00000453785.1; ENSG00000028528.15. [Q13596-1]"";""ENST00000561026.5; ENSP00000453567.1; ENSG00000028528.15. [Q13596-2]"";",cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459],"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; vesicle [GO:0031982]"
Q9Y5W8,S1,-1.144243734,-1.29285401,0.134120404,0.68455131,1.022539624,gold,SNX13,SNX13_HUMAN,Sorting nexin-13 (RGS domain- and PHOX domain-containing protein) (RGS-PX1),SNX13 KIAA0713,23161;,ENST00000428135.7; ENSP00000398789.2; ENSG00000071189.21. [Q9Y5W8-2];,phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266],intracellular protein transport [GO:0006886]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547],early endosome [GO:0005769]; early endosome membrane [GO:0031901]
Q9Y5W7,S1,-1.066079903,-1.307370948,0.139668951,0.631939103,0.7949983,gold,SNX14,SNX14_HUMAN,Sorting nexin-14,SNX14,57231;,"ENST00000314673.8; ENSP00000313121.3; ENSG00000135317.14. [Q9Y5W7-1];""ENST00000346348.7; ENSP00000257769.3; ENSG00000135317.14. [Q9Y5W7-2]"";""ENST00000369627.6; ENSP00000358641.2; ENSG00000135317.14. [Q9Y5W7-4]"";""ENST00000505648.5; ENSP00000427380.1; ENSG00000135317.14. [Q9Y5W7-3]"";","phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]",autophagosome maturation [GO:0097352]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein transport [GO:0015031],cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; postsynapse [GO:0098794]
Q9NRS6,C2,1.15210895,0.519648078,-0.312951136,-0.141989186,-0.435708133,aquamarine,SNX15,SNX15_HUMAN,Sorting nexin-15,SNX15,29907;,"ENST00000352068.5; ENSP00000316410.5; ENSG00000110025.13. [Q9NRS6-2];""ENST00000377244.8; ENSP00000366452.3; ENSG00000110025.13. [Q9NRS6-1]"";",phosphatidylinositol binding [GO:0035091],intracellular protein transport [GO:0006886],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]
Q92543,S1,-0.690206608,-0.98926316,0.083106971,0.532371746,0.821366535,gold,SNX19,SNX19_HUMAN,Sorting nexin-19,SNX19 KIAA0254,399979;,"ENST00000265909.9; ENSP00000265909.4; ENSG00000120451.11. [Q92543-1];""ENST00000533214.1; ENSP00000435390.1; ENSG00000120451.11. [Q92543-2]"";",phosphatidylinositol binding [GO:0035091],chondrocyte differentiation [GO:0002062]; dense core granule maturation [GO:1990502]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; insulin secretion [GO:0030073],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]
O60749,C1,1.427039666,-0.022051817,-0.501139089,-0.19707514,-0.149690945,lightblue,SNX2,SNX2_HUMAN,Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9),SNX2 TRG9,6643;,"ENST00000379516.7; ENSP00000368831.2; ENSG00000205302.7. [O60749-1];""ENST00000514949.1; ENSP00000421663.1; ENSG00000205302.7. [O60749-2]"";",cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459],"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]"
Q9H3E2,S1,-1.156088909,-1.142166245,0.19412091,0.584606292,0.990497693,gold,SNX25,SNX25_HUMAN,Sorting nexin-25,SNX25 MSTP043,83891;,"ENST00000264694.13; ENSP00000264694.8; ENSG00000109762.17. [Q9H3E2-1];""ENST00000504273.5; ENSP00000426255.1; ENSG00000109762.17. [Q9H3E2-1]"";""ENST00000618785.4; ENSP00000483653.1; ENSG00000109762.17. [Q9H3E2-2]"";",phosphatidylinositol binding [GO:0035091],negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]
Q9Y5X3,C1,1.684337575,-0.104894099,-0.565232143,-0.367067211,-0.345287397,lightblue,SNX5,SNX5_HUMAN,Sorting nexin-5,SNX5,27131;,"ENST00000377759.9; ENSP00000366988.3; ENSG00000089006.17. [Q9Y5X3-1];""ENST00000377768.7; ENSP00000366998.3; ENSG00000089006.17. [Q9Y5X3-1]"";""ENST00000606557.1; ENSP00000475510.1; ENSG00000089006.17. [Q9Y5X3-2]"";","cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]","epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin receptor signaling pathway [GO:0046628]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]","brush border [GO:0005903]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; macropinocytic cup [GO:0070685]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]"
Q9UNH7,C1,1.585861237,-0.029891524,-0.582483429,-0.39006845,-0.062088083,lightblue,SNX6,SNX6_HUMAN,"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]",SNX6,58533;,"ENST00000362031.10; ENSP00000355217.5; ENSG00000129515.20. [Q9UNH7-1];""ENST00000396526.7; ENSP00000379779.3; ENSG00000129515.20. [Q9UNH7-2]"";",dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; type I transforming growth factor beta receptor binding [GO:0034713],"cellular response to amyloid-beta [GO:1904646]; cellular response to epidermal growth factor stimulus [GO:0071364]; intracellular protein transport [GO:0006886]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; retrograde transport, endosome to Golgi [GO:0042147]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; tubular endosome [GO:0097422]"
Q9Y5X1,C2,1.264417011,0.646009285,-0.49167434,-0.309708249,-0.460455898,aquamarine,SNX9,SNX9_HUMAN,Sorting nexin-9 (SH3 and PX domain-containing protein 1) (Protein SDP1) (SH3 and PX domain-containing protein 3A),SNX9 SH3PX1 SH3PXD3A,51429;,"ENST00000392185.8; ENSP00000376024.3; ENSG00000130340.17.;""ENST00000679814.1; ENSP00000506326.1; ENSG00000130340.17."";",1-phosphatidylinositol binding [GO:0005545]; Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625],cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; lipid tube assembly [GO:0060988]; mitotic cytokinesis [GO:0000281]; plasma membrane tubulation [GO:0097320]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein kinase activity [GO:0045860]; protein-containing complex assembly [GO:0065003]; receptor-mediated endocytosis [GO:0006898]; regulation of synaptic vesicle endocytosis [GO:1900242],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ruffle [GO:0001726]; trans-Golgi network [GO:0005802]
P35610,S2,-1.399722165,-1.577050512,0.159040231,0.815072779,0.507771031,orange,SOAT1,SOAT1_HUMAN,Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1),SOAT1 ACACT ACACT1 ACAT ACAT1 SOAT STAT,6646;,"ENST00000367619.8; ENSP00000356591.3; ENSG00000057252.13. [P35610-1];""ENST00000539888.5; ENSP00000441356.1; ENSG00000057252.13. [P35610-3]"";""ENST00000540564.5; ENSP00000445315.1; ENSG00000057252.13. [P35610-2]"";",cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; identical protein binding [GO:0042802]; sterol O-acyltransferase activity [GO:0004772],cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; low-density lipoprotein particle clearance [GO:0034383]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
P00441,C4,2.182227196,-0.197909446,-1.062119012,-0.88666123,-1.211329768,deepskyblue2,SOD1,SODC_HUMAN,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1),SOD1,6647;,ENST00000270142.11; ENSP00000270142.7; ENSG00000142168.15.;,copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; protein-folding chaperone binding [GO:0051087]; small GTPase binding [GO:0031267]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270],action potential initiation [GO:0099610]; anterograde axonal transport [GO:0008089]; apoptotic process [GO:0006915]; auditory receptor cell stereocilium organization [GO:0060088]; determination of adult lifespan [GO:0008340]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; gene expression [GO:0010467]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; intracellular iron ion homeostasis [GO:0006879]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of developmental process [GO:0051093]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reproductive process [GO:2000242]; neurofilament cytoskeleton organization [GO:0060052]; neuronal action potential [GO:0019228]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; placenta development [GO:0001890]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of phagocytosis [GO:0050766]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of organ growth [GO:0046620]; regulation of protein kinase activity [GO:0045859]; regulation of T cell differentiation in thymus [GO:0033081]; relaxation of vascular associated smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to axon injury [GO:0048678]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to organic substance [GO:0010033]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; thymus development [GO:0048538]; transmission of nerve impulse [GO:0019226],axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]
O60504,C5,1.684880087,0.506242401,-0.402633815,-0.500328732,-0.699072139,turquoise3,SORBS3,VINEX_HUMAN,Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3),SORBS3 SCAM1,10174;,"ENST00000240123.12; ENSP00000240123.7; ENSG00000120896.14. [O60504-1];""ENST00000523965.5; ENSP00000429764.2; ENSG00000120896.14. [O60504-2]"";",structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166],cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; MAPK cascade [GO:0000165]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoskeleton organization [GO:0051495]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of stress fiber assembly [GO:0051496],cell-substrate junction [GO:0030055]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]
Q00796,C5,1.970301461,0.33262688,-0.862124314,-0.925081342,-1.004257798,turquoise3,SORD,DHSO_HUMAN,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)",SORD,6652;,"ENST00000267814.14; ENSP00000267814.9; ENSG00000140263.15. [Q00796-1];""ENST00000558789.5; ENSP00000453904.1; ENSG00000140263.15. [Q00796-2]"";","(R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase activity [GO:0050255]; zinc ion binding [GO:0008270]",flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; L-xylitol catabolic process [GO:0051160]; L-xylitol metabolic process [GO:0051164]; sorbitol catabolic process [GO:0006062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]
Q99523,S1,-1.280383244,-1.318949681,-0.206543667,0.484403032,1.354534126,gold,SORT1,SORT_HUMAN,Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3),SORT1,6272;,"ENST00000256637.8; ENSP00000256637.6; ENSG00000134243.12. [Q99523-1];""ENST00000538502.5; ENSP00000438597.1; ENSG00000134243.12. [Q99523-2]"";","enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394]",endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose import [GO:0046323]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; maintenance of synapse structure [GO:0099558]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of lipoprotein lipase activity [GO:0051005]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050],cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]
Q07889,C3,1.531947942,-0.177376902,-0.493427612,-0.136318424,-0.561565822,cyan,SOS1,SOS1_HUMAN,Son of sevenless homolog 1 (SOS-1),SOS1,6654;,ENST00000402219.8; ENSP00000384675.2; ENSG00000115904.15. [Q07889-1];,epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular condensate scaffold activity [GO:0140693]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124],axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; vitellogenesis [GO:0007296],cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]
Q53LP3,C3,1.813405087,0.130049863,-0.505229445,-0.3860633,-0.517560878,cyan,SOWAHC,SWAHC_HUMAN,Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C),SOWAHC ANKRD57 C2orf26,65124;,ENST00000356454.5; ENSP00000365830.2; ENSG00000198142.5.;,0,0,0
P08047,N4,-1.345874821,1.270654471,-0.167242929,-0.352701655,-0.694390155,grey30,SP1,SP1_HUMAN,Transcription factor Sp1,SP1 TSFP1,6667;,"ENST00000327443.9; ENSP00000329357.4; ENSG00000185591.10. [P08047-1];""ENST00000426431.2; ENSP00000404263.2; ENSG00000185591.10. [P08047-2]"";","bHLH transcription factor binding [GO:0043425]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]",cellular response to estrogen stimulus [GO:0071391]; cellular response to insulin stimulus [GO:0032869]; cellular response to wortmannin [GO:1904568]; cellular response to zinc ion starvation [GO:0034224]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511],chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]
Q15506,C5,1.688039692,0.58749425,-0.816521699,-0.947552866,-1.417537187,turquoise3,SPA17,SP17_HUMAN,Sperm surface protein Sp17 (Cancer/testis antigen 22) (CT22) (Sp17-1) (Sperm autoantigenic protein 17) (Sperm protein 17),SPA17 SP17,53340;,"ENST00000227135.7; ENSP00000227135.2; ENSG00000064199.7.;""ENST00000532692.1; ENSP00000432305.1; ENSG00000064199.7."";",calmodulin binding [GO:0005516],binding of sperm to zona pellucida [GO:0007339]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],cilium [GO:0005929]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; sperm fibrous sheath [GO:0035686]; sperm principal piece [GO:0097228]
O60271,C4,1.962780222,0.024150825,-0.939089401,-0.817470062,-0.896478984,deepskyblue2,SPAG9,JIP4_HUMAN,C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1),SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6,9043;,"ENST00000262013.12; ENSP00000262013.7; ENSG00000008294.22. [O60271-1];""ENST00000357122.8; ENSP00000349636.4; ENSG00000008294.22. [O60271-4]"";""ENST00000505279.5; ENSP00000426900.1; ENSG00000008294.22. [O60271-2]"";""ENST00000510283.5; ENSP00000423165.1; ENSG00000008294.22. [O60271-9]"";",identical protein binding [GO:0042802]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; signaling receptor complex adaptor activity [GO:0030159],"lysosome localization [GO:0032418]; negative regulation of dendrite extension [GO:1903860]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; retrograde transport, endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192]",acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]
Q8NB90,C1,1.279390102,-0.701832525,-0.457046522,-0.46895758,0.864001499,lightblue,SPATA5,AFG2A_HUMAN,ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5),AFG2A SPAF SPATA5,166378;,ENST00000274008.5; ENSP00000274008.3; ENSG00000145375.9. [Q8NB90-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; spindle [GO:0005819]
Q9BVQ7,C1,1.09122211,-0.611084993,-0.322559662,-0.23201925,0.757554163,lightblue,SPATA5L1,AFG2B_HUMAN,ATPase family gene 2 protein homolog B (EC 3.6.4.10) (AFG2 AAA ATPase homolog B) (Ribosome biogenesis protein SPATA5L1) (Spermatogenesis-associated protein 5-like protein 1),AFG2B SPATA5L1,79029;,"ENST00000305560.11; ENSP00000305494.6; ENSG00000171763.20. [Q9BVQ7-1];""ENST00000531970.5; ENSP00000436823.1; ENSG00000171763.20. [Q9BVQ7-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],ribosomal large subunit biogenesis [GO:0042273],cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]
Q8NBT2,C3,1.605213754,0.198974213,-0.4374934,-0.445946554,-0.754075729,cyan,SPC24,SPC24_HUMAN,Kinetochore protein Spc24 (hSpc24),SPC24 SPBC24,147841;,ENST00000592540.6; ENSP00000465075.1; ENSG00000161888.12. [Q8NBT2-1];,0,attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic spindle assembly checkpoint signaling [GO:0007094],cytosol [GO:0005829]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9Y6A9,S2,-1.037069786,-1.655875719,0.338674548,0.954724702,0.534037673,orange,SPCS1,SPCS1_HUMAN,Signal peptidase complex subunit 1 (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit),SPCS1 SPC12 HSPC033,28972;,ENST00000233025.11; ENSP00000233025.7; ENSG00000114902.14.;,0,protein targeting to ER [GO:0045047]; proteolysis [GO:0006508]; signal peptide processing [GO:0006465]; viral protein processing [GO:0019082]; virion assembly [GO:0019068],endoplasmic reticulum membrane [GO:0005789]; signal peptidase complex [GO:0005787]
Q15005,S2,-0.938939274,-1.287683349,0.309194384,0.859885624,0.496891424,orange,SPCS2,SPCS2_HUMAN,Signal peptidase complex subunit 2 (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit),SPCS2 KIAA0102 SPC25,9789;,ENST00000263672.11; ENSP00000263672.6; ENSG00000118363.13.;,0,protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],endoplasmic reticulum membrane [GO:0005789]; signal peptidase complex [GO:0005787]
P61009,S2,-1.045406934,-1.344053612,0.298652644,0.869742927,0.465541611,orange,SPCS3,SPCS3_HUMAN,Signal peptidase complex subunit 3 (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit),SPCS3 SPC22 UNQ1841/PRO3567,60559;,ENST00000503362.2; ENSP00000427463.1; ENSG00000129128.13.;,0,protein targeting to ER [GO:0045047]; proteolysis [GO:0006508]; signal peptide processing [GO:0006465]; viral protein processing [GO:0019082],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; signal peptidase complex [GO:0005787]
Q5M775,S3,-1.000755164,-0.73608694,0.332717899,0.794668251,0.464781281,salmon,SPECC1,CYTSB_HUMAN,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),SPECC1 CYTSB NSP5,92521;,"ENST00000261503.9; ENSP00000261503.5; ENSG00000128487.19. [Q5M775-1];""ENST00000395522.6; ENSP00000378893.2; ENSG00000128487.19. [Q5M775-5]"";""ENST00000395525.7; ENSP00000378896.3; ENSG00000128487.19. [Q5M775-3]"";""ENST00000395527.9; ENSP00000378898.4; ENSG00000128487.19. [Q5M775-1]"";""ENST00000395529.7; ENSP00000378900.3; ENSG00000128487.19. [Q5M775-2]"";""ENST00000395530.6; ENSP00000378901.2; ENSG00000128487.19. [Q5M775-4]"";""ENST00000676570.1; ENSP00000503507.1; ENSG00000128487.19. [Q5M775-2]"";""ENST00000677914.1; ENSP00000503971.1; ENSG00000128487.19. [Q5M775-1]"";""ENST00000679049.1; ENSP00000503499.1; ENSG00000128487.19. [Q5M775-2]"";""ENST00000679058.1; ENSP00000502924.1; ENSG00000128487.19. [Q5M775-1]"";""ENST00000679255.1; ENSP00000504211.1; ENSG00000128487.19. [Q5M775-1]"";""ENST00000680373.1; ENSP00000506254.1; ENSG00000128487.19. [Q5M775-5]"";""ENST00000680374.1; ENSP00000505715.1; ENSG00000128487.19. [Q5M775-2]"";""ENST00000680572.1; ENSP00000505383.1; ENSG00000128487.19. [Q5M775-2]"";""ENST00000681593.1; ENSP00000504996.1; ENSG00000128487.19. [Q5M775-2]"";",0,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]
Q96T58,N3,-1.089137077,-0.946458292,1.057155052,0.150276607,0.054270539,grey50,SPEN,MINT_HUMAN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),SPEN KIAA0929 MINT SHARP,23013;,ENST00000375759.8; ENSP00000364912.3; ENSG00000065526.13.;,DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357],extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]
Q9UQ90,M2,-0.874804801,-1.191247792,0.375055443,1.130489167,-0.127866747,tan4,SPG7,SPG7_HUMAN,Mitochondrial inner membrane m-AAA protease component paraplegin (EC 3.4.24.-) (EC 3.6.-.-) (Cell matrix adhesion regulator) (Paraplegin) (Spastic paraplegia 7 protein),SPG7 CAR CMAR PGN,6687;,"ENST00000341316.6; ENSP00000341157.2; ENSG00000197912.16. [Q9UQ90-2];""ENST00000645818.2; ENSP00000495795.2; ENSG00000197912.16. [Q9UQ90-1]"";""ENST00000646263.1; ENSP00000494119.1; ENSG00000197912.16. [Q9UQ90-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],anterograde axonal transport [GO:0008089]; mitochondrial outer membrane permeabilization involved in programmed cell death [GO:1902686]; mitochondrial protein processing [GO:0034982]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of mitochondrial membrane permeability [GO:0046902],axon cytoplasm [GO:1904115]; m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]
Q9Y657,N4,-0.616450388,0.713049419,0.44500356,-0.330205993,-0.018710442,grey30,SPIN1,SPIN1_HUMAN,Spindlin-1 (Ovarian cancer-related protein) (Spindlin1),SPIN1 OCR SPIN,10927;,ENST00000375859.4; ENSP00000365019.3; ENSG00000106723.17.;,methylated histone binding [GO:0035064],chromatin organization [GO:0006325]; gamete generation [GO:0007276]; meiotic cell cycle [GO:0051321]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of DNA-templated transcription [GO:0006355]; rRNA transcription [GO:0009303]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]
O43791,N2,-0.876373763,-0.666424929,0.87185738,0.185355972,0.362502203,grey70,SPOP,SPOP_HUMAN,Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1),SPOP,8405;,"ENST00000347630.6; ENSP00000240327.2; ENSG00000121067.19.;""ENST00000393328.6; ENSP00000377001.2; ENSG00000121067.19."";""ENST00000503676.5; ENSP00000420908.1; ENSG00000121067.19."";""ENST00000504102.6; ENSP00000425905.1; ENSG00000121067.19."";""ENST00000509079.6; ENSP00000426986.2; ENSG00000121067.19."";""ENST00000514121.6; ENSP00000424119.2; ENSG00000121067.19."";""ENST00000665825.1; ENSP00000499562.1; ENSG00000121067.19."";",identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; ubiquitin protein ligase binding [GO:0031625],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of proteolysis [GO:0030162],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8TCT8,S1,-1.257745779,-1.083620894,-0.051564119,0.696594009,0.969704941,gold,SPPL2A,SPP2A_HUMAN,Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2),SPPL2A IMP3 PSL2 PSEC0147,84888;,ENST00000261854.10; ENSP00000261854.5; ENSG00000138600.11.;,"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]",membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; extracellular exosome [GO:0070062]; Golgi-associated vesicle membrane [GO:0030660]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]
P35270,C1,1.212026603,0.053944759,-0.150566264,0.143866375,-0.652113994,lightblue,SPR,SPRE_HUMAN,Sepiapterin reductase (SPR) (EC 1.1.1.153),SPR,6697;,ENST00000234454.6; ENSP00000234454.5; ENSG00000116096.6.;,aldo-keto reductase (NADPH) activity [GO:0004033]; NADP binding [GO:0050661]; sepiapterin reductase activity [GO:0004757],nitric oxide biosynthetic process [GO:0006809]; tetrahydrobiopterin biosynthetic process [GO:0006729],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]
Q7Z699,S4,-0.290186834,-0.827191827,0.261798568,0.663915668,0.264522231,tomato2,SPRED1,SPRE1_HUMAN,"Sprouty-related, EVH1 domain-containing protein 1 (Spred-1) (hSpred1)",SPRED1,161742;,ENST00000299084.9; ENSP00000299084.4; ENSG00000166068.13.;,phosphatase binding [GO:0019902]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; stem cell factor receptor binding [GO:0005173],"negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; regulation of MAPK cascade [GO:0043408]; regulation of protein deacetylation [GO:0090311]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]",caveola [GO:0005901]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
O43609,S1,-1.198632758,-1.178693332,0.058116928,0.690420526,1.016492159,gold,SPRY1,SPY1_HUMAN,Protein sprouty homolog 1 (Spry-1),SPRY1,10252;,"ENST00000339241.1; ENSP00000343785.1; ENSG00000164056.11.;""ENST00000394339.2; ENSP00000377871.2; ENSG00000164056.11."";""ENST00000610581.4; ENSP00000481675.1; ENSG00000164056.11."";""ENST00000622283.1; ENSP00000480540.1; ENSG00000164056.11."";""ENST00000651917.1; ENSP00000498292.1; ENSG00000164056.11."";",0,animal organ development [GO:0048513]; bud elongation involved in lung branching [GO:0060449]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; organ induction [GO:0001759]; ureteric bud development [GO:0001657],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q8NCJ5,S1,-0.226847542,-1.014955877,-0.208456325,0.165222547,1.267346432,gold,SPRYD3,SPRY3_HUMAN,SPRY domain-containing protein 3,SPRYD3,84926;,ENST00000301463.9; ENSP00000301463.4; ENSG00000167778.9.;,0,0,0
Q5W111,S1,-0.874276424,-0.972534111,-0.288317988,0.719077631,0.885131378,gold,SPRYD7,SPRY7_HUMAN,SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein) (CLL deletion region gene 6 protein),SPRYD7 C13orf1 CLLD6,57213;,"ENST00000361840.8; ENSP00000354774.3; ENSG00000123178.16. [Q5W111-1];""ENST00000378195.6; ENSP00000367437.2; ENSG00000123178.16. [Q5W111-2]"";",0,0,0
O15269,S3,-0.739461646,-1.040507899,0.13850815,0.710502996,0.45748855,salmon,SPTLC1,SPTC1_HUMAN,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),SPTLC1 LCB1,10558;,"ENST00000262554.7; ENSP00000262554.2; ENSG00000090054.16. [O15269-1];""ENST00000337841.4; ENSP00000337635.4; ENSG00000090054.16. [O15269-2]"";""ENST00000690139.1; ENSP00000510483.1; ENSG00000090054.16. [O15269-2]"";",pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; regulation of fat cell apoptotic process [GO:1904649]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid metabolic process [GO:0006665]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine C-palmitoyltransferase complex [GO:0017059]; SPOTS complex [GO:0035339]
O15270,S2,-1.201214104,-1.522119296,0.175756575,0.840606578,0.672133785,orange,SPTLC2,SPTC2_HUMAN,Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2),SPTLC2 KIAA0526 LCB2,9517;,ENST00000216484.7; ENSP00000216484.2; ENSG00000100596.8.;,pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum membrane [GO:0005789]; serine C-palmitoyltransferase complex [GO:0017059]
Q68D10,N1,-1.192769429,-0.737234932,-0.010413422,-0.04010412,1.320882972,grey90,SPTY2D1,SPT2_HUMAN,Protein SPT2 homolog (Protein KU002155) (SPT2 domain-containing protein 1),SPTY2D1,144108;,ENST00000336349.6; ENSP00000337991.5; ENSG00000179119.15. [Q68D10-1];,DNA binding [GO:0003677]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; RNA polymerase I core binding [GO:0001042],heterochromatin formation [GO:0031507]; nucleosome assembly [GO:0006334]; regulation of DNA-templated transcription [GO:0006355]; transcription by RNA polymerase I [GO:0006360],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q14534,S2,-1.083499299,-1.289891729,0.244339457,0.82949928,0.614435207,orange,SQLE,ERG1_HUMAN,Squalene monooxygenase (EC 1.14.14.17) (Squalene epoxidase) (SE),SQLE ERG1,6713;,ENST00000265896.10; ENSP00000265896.5; ENSG00000104549.12.;,FAD binding [GO:0071949]; squalene monooxygenase activity [GO:0004506],cholesterol metabolic process [GO:0008203]; lipid droplet formation [GO:0140042]; regulation of cell population proliferation [GO:0042127]; response to organic substance [GO:0010033]; sterol biosynthetic process [GO:0016126],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
Q9Y6N5,M2,-1.317411595,-1.605531294,0.388459094,1.232016707,-0.189255473,tan4,SQRDL,SQOR_HUMAN,"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)",SQOR SQRDL CGI-44,58472;,"ENST00000260324.12; ENSP00000260324.7; ENSG00000137767.14.;""ENST00000568606.5; ENSP00000456019.1; ENSG00000137767.14."";",FAD binding [GO:0071949]; glutathione-dependent sulfide quinone oxidoreductase activity [GO:0106436]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224],"sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q6ZRS2,N2,-1.010143405,-0.280701257,1.02510911,-0.007944103,-0.276099922,grey70,SRCAP,SRCAP_HUMAN,Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator),SRCAP KIAA0309,10847;,"ENST00000262518.9; ENSP00000262518.4; ENSG00000080603.17. [Q6ZRS2-1];""ENST00000411466.7; ENSP00000405186.3; ENSG00000080603.17. [Q6ZRS2-1]"";""ENST00000706321.1; ENSP00000516346.1; ENSG00000080603.17. [Q6ZRS2-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; transcription coactivator activity [GO:0003713],chromatin remodeling [GO:0006338]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]
P36956,S2,-1.232513107,-1.184089942,0.194415215,0.820387291,0.607036779,orange,SREBF1,SRBP1_HUMAN,Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)],SREBF1 BHLHD1 SREBP1,6720;,"ENST00000261646.11; ENSP00000261646.5; ENSG00000072310.18. [P36956-1];""ENST00000355815.8; ENSP00000348069.4; ENSG00000072310.18. [P36956-4]"";""ENST00000395757.6; ENSP00000379106.2; ENSG00000072310.18. [P36956-2]"";","chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; sterol response element binding [GO:0032810]; transcription coregulator binding [GO:0001221]",cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol biosynthetic process [GO:0006695]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; insulin secretion [GO:0030073]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to fructose [GO:0009750]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q12772,S2,-1.087557145,-1.318875964,0.209092044,0.827670586,0.613596112,orange,SREBF2,SRBP2_HUMAN,Sterol regulatory element-binding protein 2 (SREBP-2) (Class D basic helix-loop-helix protein 2) (bHLHd2) (Sterol regulatory element-binding transcription factor 2) [Cleaved into: Processed sterol regulatory element-binding protein 2 (Transcription factor SREBF2)],SREBF2 BHLHD2 SREBP2,6721;,ENST00000361204.9; ENSP00000354476.4; ENSG00000198911.13. [Q12772-1];,"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",cellular response to laminar fluid shear stress [GO:0071499]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; lipid metabolic process [GO:0006629]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitophagy [GO:1901524]; regulation of Notch signaling pathway [GO:0008593]; SREBP signaling pathway [GO:0032933],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SREBP-SCAP-Insig complex [GO:0032937]
Q8NEF9,N3,-1.177355318,-0.693134569,1.038557568,-0.015877172,0.241227143,grey50,SRFBP1,SRFB1_HUMAN,Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP),SRFBP1,153443;,ENST00000339397.5; ENSP00000341324.4; ENSG00000151304.6.;,RNA binding [GO:0003723],maturation of SSU-rRNA [GO:0030490],90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q7Z6B7,C2,1.010099253,0.068756098,-0.233933474,0.063417822,-0.163797035,aquamarine,SRGAP1,SRGP1_HUMAN,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),SRGAP1 ARHGAP13 KIAA1304,57522;,"ENST00000355086.8; ENSP00000347198.3; ENSG00000196935.10. [Q7Z6B7-1];""ENST00000631006.3; ENSP00000485752.2; ENSG00000196935.10. [Q7Z6B7-2]"";",GTPase activator activity [GO:0005096],negative regulation of cell migration [GO:0030336]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]
P30626,C5,2.04274256,0.090843659,-0.902411901,-0.900279416,-1.139226864,turquoise3,SRI,SORCN_HUMAN,Sorcin (22 kDa protein) (CP-22) (CP22) (V19),SRI,6717;,"ENST00000265729.7; ENSP00000265729.3; ENSG00000075142.14. [P30626-1];""ENST00000394641.7; ENSP00000378137.3; ENSG00000075142.14. [P30626-2]"";""ENST00000431660.5; ENSP00000391148.1; ENSG00000075142.14. [P30626-3]"";",calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],action potential [GO:0001508]; calcium ion transport [GO:0006816]; heart development [GO:0007507]; intracellular sequestering of iron ion [GO:0006880]; muscle organ development [GO:0007517]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart contraction [GO:0008016]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of striated muscle contraction [GO:0006942]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018]
P19623,C5,1.890881381,0.345163463,-0.596083581,-0.755578925,-0.777246872,turquoise3,SRM,SPEE_HUMAN,Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase),SRM SPS1 SRML1,6723;,ENST00000376957.7; ENSP00000366156.2; ENSG00000116649.10.;,identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766],cellular response to leukemia inhibitory factor [GO:1990830]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],cytosol [GO:0005829]
Q9UHB9,C2,0.801093261,0.397789792,-0.178122761,0.019521441,0.001916325,aquamarine,SRP68,SRP68_HUMAN,Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein),SRP68,6730;,"ENST00000307877.7; ENSP00000312066.1; ENSG00000167881.15. [Q9UHB9-1];""ENST00000539137.5; ENSP00000446136.1; ENSG00000167881.15. [Q9UHB9-4]"";""ENST00000602720.5; ENSP00000473613.1; ENSG00000167881.15. [Q9UHB9-3]"";",7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047],response to xenobiotic stimulus [GO:0009410]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"
O76094,C2,0.820154313,0.384438532,-0.20558962,-0.044818152,0.098759773,aquamarine,SRP72,SRP72_HUMAN,Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein),SRP72,6731;,"ENST00000510663.6; ENSP00000424576.1; ENSG00000174780.17. [O76094-2];""ENST00000642900.1; ENSP00000495128.1; ENSG00000174780.17. [O76094-1]"";",7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911],SRP-dependent cotranslational protein targeting to membrane [GO:0006614],"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]"
P08240,S2,-1.142800233,-1.3983013,0.191112244,0.904186618,0.492902134,orange,SRPR,SRPRA_HUMAN,Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha),SRPRA SRPR,6734;,"ENST00000332118.11; ENSP00000328023.5; ENSG00000182934.12. [P08240-1];""ENST00000532259.1; ENSP00000435508.1; ENSG00000182934.12. [P08240-2]"";",ATP hydrolysis activity [GO:0016887]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047],"cotranslational protein targeting to membrane [GO:0006613]; intracellular protein transport [GO:0006886]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]",endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]
Q9Y5M8,S2,-1.1276128,-1.618749252,0.245840497,0.879542873,0.548833861,orange,SRPRB,SRPRB_HUMAN,Signal recognition particle receptor subunit beta (SR-beta) (Protein APMCF1),SRPRB PSEC0230,58477;,"ENST00000466490.7; ENSP00000418401.1; ENSG00000144867.13.;""ENST00000678299.1; ENSP00000503923.1; ENSG00000144867.13."";",GTP binding [GO:0005525],"protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]",cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]
Q9GZT4,C3,2.054102432,-0.16275456,-0.887317183,-0.496701053,-0.777131658,cyan,SRR,SRR_HUMAN,Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17),SRR,63826;,ENST00000344595.10; ENSP00000339435.5; ENSG00000167720.13.;,ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114],D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; serine family amino acid metabolic process [GO:0009069],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]
Q9BXP5,N4,-1.248279229,0.789913531,0.279516833,-0.415018358,0.1718394,grey30,SRRT,SRRT_HUMAN,Serrate RNA effector molecule homolog (Arsenite-resistance protein 2),SRRT ARS2 ASR2,51593;,"ENST00000611405.5; ENSP00000480421.1; ENSG00000087087.20. [Q9BXP5-1];""ENST00000614484.4; ENSP00000481173.1; ENSG00000087087.20. [Q9BXP5-3]"";""ENST00000618262.4; ENSP00000478341.1; ENSG00000087087.20. [Q9BXP5-2]"";""ENST00000618411.4; ENSP00000483556.1; ENSG00000087087.20. [Q9BXP5-4]"";",DNA binding [GO:0003677]; mRNA cap binding complex binding [GO:0140262]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723],mRNA processing [GO:0006397]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of neurogenesis [GO:0050769]; primary miRNA processing [GO:0031053]; regulation of DNA-templated transcription [GO:0006355]; response to arsenic-containing substance [GO:0046685],cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]
Q07955,N1,-0.93840527,-0.001946861,0.456275001,-0.25941452,0.854631225,grey90,SRSF1,SRSF1_HUMAN,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3,6426;,"ENST00000258962.5; ENSP00000258962.4; ENSG00000136450.13. [Q07955-1];""ENST00000581979.5; ENSP00000463223.1; ENSG00000136450.13. [Q07955-3]"";""ENST00000582730.6; ENSP00000462215.1; ENSG00000136450.13. [Q07955-3]"";",DNA topoisomerase binding [GO:0044547]; mRNA binding [GO:0003729]; protein kinase B binding [GO:0043422]; RNA binding [GO:0003723],"alternative mRNA splicing, via spliceosome [GO:0000380]; liver regeneration [GO:0097421]; mRNA 5'-splice site recognition [GO:0000395]; mRNA processing [GO:0006397]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; oligodendrocyte differentiation [GO:0048709]; positive regulation of RNA splicing [GO:0033120]; regulation of RNA splicing [GO:0043484]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P84103,N1,-1.121823408,-0.130286966,0.60585288,-0.318785,0.830210218,grey90,SRSF3,SRSF3_HUMAN,"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)",SRSF3 SFRS3 SRP20,6428;,"ENST00000373715.11; ENSP00000362820.5; ENSG00000112081.17. [P84103-1];""ENST00000477442.6; ENSP00000436036.1; ENSG00000112081.17. [P84103-2]"";""ENST00000620941.1; ENSP00000482833.1; ENSG00000112081.17. [P84103-1]"";",phospholipase binding [GO:0043274]; primary miRNA binding [GO:0070878]; protein-RNA sequence-specific adaptor activity [GO:0160134]; RNA binding [GO:0003723],"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; primary miRNA processing [GO:0031053]; regulation of mRNA splicing, via spliceosome [GO:0048024]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]
Q08170,N1,-1.171715498,-0.117072963,0.24889657,-0.58403514,1.245511313,grey90,SRSF4,SRSF4_HUMAN,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",SRSF4 SFRS4 SRP75,6429;,ENST00000373795.7; ENSP00000362900.4; ENSG00000116350.18.;,RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13243,N1,-1.522049611,-0.343710399,-0.240968433,-0.477411908,1.455118361,grey90,SRSF5,SRSF5_HUMAN,"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)",SRSF5 HRS SFRS5 SRP40,6430;,"ENST00000394366.6; ENSP00000377892.2; ENSG00000100650.16. [Q13243-1];""ENST00000553521.5; ENSP00000452123.1; ENSG00000100650.16. [Q13243-1]"";""ENST00000553635.5; ENSP00000451391.1; ENSG00000100650.16. [Q13243-3]"";""ENST00000557154.6; ENSP00000451088.1; ENSG00000100650.16. [Q13243-1]"";",RNA binding [GO:0003723],"mRNA processing [GO:0006397]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]",cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q16629,N1,-1.209631006,-0.3580542,0.959609466,-0.250535699,0.763117105,grey90,SRSF7,SRSF7_HUMAN,"Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)",SRSF7 SFRS7,6432;,"ENST00000313117.11; ENSP00000325905.6; ENSG00000115875.19. [Q16629-1];""ENST00000431066.5; ENSP00000398159.1; ENSG00000115875.19. [Q16629-3]"";""ENST00000443213.5; ENSP00000402544.1; ENSG00000115875.19. [Q16629-3]"";""ENST00000446327.6; ENSP00000402264.2; ENSG00000115875.19. [Q16629-4]"";",mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],"cellular response to leukemia inhibitory factor [GO:1990830]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13242,N3,-1.281056188,-1.009753724,1.034364787,0.003301015,0.508596064,grey50,SRSF9,SRSF9_HUMAN,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",SRSF9 SFRS9 SRP30C,8683;,ENST00000229390.8; ENSP00000229390.3; ENSG00000111786.10.;,protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA processing [GO:0006397]; mRNA splice site recognition [GO:0006376]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]",nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9BYN0,C3,1.762414681,0.072644111,-0.513338891,-0.561111588,-0.771884404,cyan,SRXN1,SRXN1_HUMAN,Sulfiredoxin-1 (EC 1.8.98.2),SRXN1 C20orf139 SRX SRX1,140809;,ENST00000381962.4; ENSP00000371388.4; ENSG00000271303.2.;,"ATP binding [GO:0005524]; oxidoreductase activity, acting on a sulfur group of donors [GO:0016667]; sulfiredoxin activity [GO:0032542]",cellular response to oxidative stress [GO:0034599]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]
Q04837,M1,-1.371191361,-0.512744998,0.448465986,1.067026961,-0.374906141,burlywood4,SSBP1,SSBP_HUMAN,"Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) (PWP1-interacting protein 17)",SSBP1 SSBP,6742;,"ENST00000265304.11; ENSP00000265304.6; ENSG00000106028.11.;""ENST00000465582.5; ENSP00000420485.1; ENSG00000106028.11."";""ENST00000481508.1; ENSP00000419665.1; ENSG00000106028.11."";""ENST00000484178.5; ENSP00000419388.1; ENSG00000106028.11."";""ENST00000498107.5; ENSP00000419541.1; ENSG00000106028.11."";""ENST00000570667.5; ENSP00000460028.2; ENSG00000262771.5."";""ENST00000571430.5; ENSP00000459367.2; ENSG00000262771.5."";""ENST00000574199.5; ENSP00000461884.2; ENSG00000262771.5."";""ENST00000575059.5; ENSP00000458815.2; ENSG00000262771.5."";""ENST00000576834.2; ENSP00000459208.2; ENSG00000262771.5."";""ENST00000612337.4; ENSP00000480488.1; ENSG00000106028.11."";",chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],DNA unwinding involved in DNA replication [GO:0006268]; mitochondrial DNA replication [GO:0006264]; positive regulation of helicase activity [GO:0051096]; positive regulation of mitochondrial DNA replication [GO:0090297]; protein homotetramerization [GO:0051289],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q8TE77,C3,1.965992452,0.142668241,-0.827582132,-0.694651962,-1.135941663,cyan,SSH3,SSH3_HUMAN,Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 3) (SSH-3L) (hSSH-3L),SSH3 SSH3L,54961;,"ENST00000308127.9; ENSP00000312081.4; ENSG00000172830.13. [Q8TE77-1];""ENST00000376757.9; ENSP00000365948.6; ENSG00000172830.13. [Q8TE77-3]"";""ENST00000532881.5; ENSP00000431788.2; ENSG00000172830.13. [Q8TE77-2]"";",actin binding [GO:0003779]; myosin phosphatase activity [GO:0017018]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725],actin cytoskeleton organization [GO:0030036]; negative regulation of actin filament polymerization [GO:0030837],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]
O43805,C5,1.830739046,0.583578904,-0.678810007,-0.451606146,-1.207999525,turquoise3,SSNA1,SSNA1_HUMAN,Microtubule nucleation factor SSNA1 (Nuclear autoantigen of 14 kDa) (Sjoegren syndrome nuclear autoantigen 1),SSNA1 NA14,8636;,ENST00000322310.10; ENSP00000313752.5; ENSG00000176101.12.;,identical protein binding [GO:0042802]; microtubule binding [GO:0008017],axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; receptor clustering [GO:0043113],axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; supramolecular fiber [GO:0099512]
P43307,S2,-1.01503924,-1.511719058,0.165685038,1.029784172,0.463590491,orange,SSR1,SSRA_HUMAN,Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha),SSR1 TRAPA PSEC0262,6745;,ENST00000244763.9; ENSP00000244763.4; ENSG00000124783.14. [P43307-1];,0,cotranslational protein targeting to membrane [GO:0006613]; positive regulation of cell population proliferation [GO:0008284],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q9UNL2,S2,-1.664415382,-1.660668743,0.18370223,1.034749854,0.489563423,orange,SSR3,SSRG_HUMAN,Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma),SSR3 TRAPG,6747;,"ENST00000265044.7; ENSP00000265044.2; ENSG00000114850.7. [Q9UNL2-1];""ENST00000467789.5; ENSP00000420641.1; ENSG00000114850.7. [Q9UNL2-2]"";",0,SRP-dependent cotranslational protein targeting to membrane [GO:0006614],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
P51571,S2,-1.058386345,-1.390244926,0.263607778,0.918252306,0.391902104,orange,SSR4,SSRD_HUMAN,Translocon-associated protein subunit delta (TRAP-delta) (Signal sequence receptor subunit delta) (SSR-delta),SSR4 TRAPD,6748;,"ENST00000320857.7; ENSP00000317331.3; ENSG00000180879.14.;""ENST00000370086.8; ENSP00000359103.3; ENSG00000180879.14."";""ENST00000370087.5; ENSP00000359104.1; ENSG00000180879.14."";",0,0,endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Sec61 translocon complex [GO:0005784]
Q9NP77,C5,0.81578172,1.175664086,-0.344983066,-0.975301679,-1.163360461,turquoise3,SSU72,SSU72_HUMAN,RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16),SSU72 HSPC182 PNAS-120,29101;,"ENST00000291386.4; ENSP00000291386.3; ENSG00000160075.12. [Q9NP77-1];""ENST00000359060.5; ENSP00000351955.3; ENSG00000160075.12. [Q9NP77-2]"";",myosin phosphatase activity [GO:0017018]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420],"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; termination of RNA polymerase II transcription [GO:0006369]",cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]
P50502,C5,1.86844307,0.515374473,-1.075266047,-1.16881441,-1.47176665,turquoise3,ST13,F10A1_HUMAN,Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein),ST13 AAG2 FAM10A1 HIP SNC6,6767;,ENST00000216218.8; ENSP00000216218.3; ENSG00000100380.15.;,Hsp70 protein binding [GO:0030544]; protein dimerization activity [GO:0046983]; protein-macromolecule adaptor activity [GO:0030674],chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; response to bacterium [GO:0009617],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q11201,S1,-0.872173136,-0.995486806,-0.25476237,0.752378016,1.026642359,gold,ST3GAL1,SIA4A_HUMAN,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (Alpha 2,3-ST 1) (Beta-galactoside alpha-2,3-sialyltransferase 1) (EC 2.4.3.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Monosialoganglioside sialyltransferase) (EC 2.4.3.2) (SIATFL) (ST3Gal I) (ST3GalI) (ST3GalA.1) (ST3O) (Sialyltransferase 4A) (SIAT4-A)",ST3GAL1 SIAT4 SIAT4A,6482;,"ENST00000521180.5; ENSP00000428540.1; ENSG00000008513.17.;""ENST00000522652.6; ENSP00000430515.1; ENSG00000008513.17."";""ENST00000648219.1; ENSP00000497381.1; ENSG00000008513.17."";","beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase [GO:0047288]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; sialyltransferase activity [GO:0008373]","ganglioside biosynthetic process via lactosylceramide [GO:0010706]; keratan sulfate biosynthetic process [GO:0018146]; memory B cell differentiation [GO:0002319]; N-acetylneuraminate metabolic process [GO:0006054]; negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process [GO:1905403]; O-glycan processing [GO:0016266]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein N-linked glycosylation [GO:0006487]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082]",extracellular exosome [GO:0070062]; Golgi medial cisterna membrane [GO:1990675]; Golgi membrane [GO:0000139]; Golgi trans cisterna membrane [GO:1990676]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]
Q11206,S1,-1.648433665,-1.763785422,-0.216338681,0.963917173,1.178221932,gold,ST3GAL4,SIA4C_HUMAN,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 (Alpha 2,3-ST 4) (Beta-galactoside alpha-2,3-sialyltransferase 4) (EC 2.4.3.2) (EC 2.4.3.4) (Alpha 2,3-sialyltransferase IV) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Gal-beta-1,4-GlcNAc-alpha-2,3-sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (EC 2.4.3.6) (SAT-3) (ST-4) (ST3Gal IV) (ST3GalIV) (ST3GalA.2) (STZ) (Sialyltransferase 4C) (SIAT4-C)",ST3GAL4 CGS23 NANTA3 SIAT4C STZ,6484;,"ENST00000227495.10; ENSP00000227495.6; ENSG00000110080.20. [Q11206-5];""ENST00000392669.6; ENSP00000376437.2; ENSG00000110080.20. [Q11206-1]"";""ENST00000444328.7; ENSP00000394354.2; ENSG00000110080.20. [Q11206-1]"";""ENST00000449406.6; ENSP00000399444.2; ENSG00000110080.20. [Q11206-3]"";""ENST00000526727.5; ENSP00000436047.1; ENSG00000110080.20. [Q11206-1]"";""ENST00000530591.5; ENSP00000433989.1; ENSG00000110080.20. [Q11206-5]"";""ENST00000532243.5; ENSP00000434349.1; ENSG00000110080.20. [Q11206-2]"";""ENST00000534083.5; ENSP00000433318.1; ENSG00000110080.20. [Q11206-1]"";""ENST00000534457.5; ENSP00000434668.1; ENSG00000110080.20. [Q11206-6]"";","beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase [GO:0047288]; beta-galactoside (CMP) alpha-2,3-sialyltransferase activity [GO:0003836]; N-acetyllactosaminide alpha-2,3-sialyltransferase activity [GO:0008118]; sialyltransferase activity [GO:0008373]",cognition [GO:0050890]; glycolipid biosynthetic process [GO:0009247]; glycoprotein biosynthetic process [GO:0009101]; keratan sulfate biosynthetic process [GO:0018146]; lipid glycosylation [GO:0030259]; O-glycan processing [GO:0016266]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of blood coagulation [GO:0030194]; positive regulation of leukocyte tethering or rolling [GO:1903238]; protein glycosylation [GO:0006486]; protein sialylation [GO:1990743]; sialylation [GO:0097503]; viral protein processing [GO:0019082],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9Y561,S3,-0.495214261,-1.026560942,0.280050489,0.657645207,0.462310191,salmon,ST7,LRP12_HUMAN,Low-density lipoprotein receptor-related protein 12 (LDLR-related protein 12) (LRP-12) (Suppressor of tumorigenicity 7 protein),LRP12 ST7,29967;,"ENST00000276654.10; ENSP00000276654.5; ENSG00000147650.12. [Q9Y561-1];""ENST00000424843.6; ENSP00000399148.2; ENSG00000147650.12. [Q9Y561-2]"";",low-density lipoprotein particle receptor activity [GO:0005041],endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; regulation of growth [GO:0040008]; signal transduction [GO:0007165],clathrin-coated pit [GO:0005905]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q969W9,N2,-0.974535112,-0.203661795,1.123799916,-0.213440248,-0.552025743,grey70,STAG1,PMEPA_HUMAN,Protein TMEPAI (Prostate transmembrane protein androgen induced 1) (Solid tumor-associated 1 protein) (Transmembrane prostate androgen-induced protein),PMEPA1 STAG1 TMEPAI,56937;,"ENST00000265626.8; ENSP00000265626.4; ENSG00000124225.16. [Q969W9-3];""ENST00000341744.8; ENSP00000345826.3; ENSG00000124225.16. [Q969W9-1]"";""ENST00000347215.8; ENSP00000344014.4; ENSG00000124225.16. [Q969W9-2]"";""ENST00000395814.5; ENSP00000379159.1; ENSG00000124225.16. [Q969W9-3]"";""ENST00000395816.7; ENSP00000379161.3; ENSG00000124225.16. [Q969W9-3]"";",protein sequestering activity [GO:0140311]; R-SMAD binding [GO:0070412]; WW domain binding [GO:0050699],androgen receptor signaling pathway [GO:0030521]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]
Q8N3U4,N2,-0.907007794,0.202452097,0.977388329,-0.274072002,-0.391057285,grey70,STAG2,STAG2_HUMAN,Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2),STAG2 SA2,10735;,"ENST00000218089.13; ENSP00000218089.9; ENSG00000101972.20. [Q8N3U4-2];""ENST00000371144.7; ENSP00000360186.3; ENSG00000101972.20. [Q8N3U4-1]"";""ENST00000371145.8; ENSP00000360187.4; ENSG00000101972.20. [Q8N3U4-2]"";""ENST00000371157.7; ENSP00000360199.3; ENSG00000101972.20. [Q8N3U4-1]"";""ENST00000371160.5; ENSP00000360202.1; ENSG00000101972.20. [Q8N3U4-1]"";""ENST00000455404.6; ENSP00000397265.2; ENSG00000101972.20. [Q8N3U4-1]"";""ENST00000687852.1; ENSP00000509048.1; ENSG00000101972.20. [Q8N3U4-2]"";",chromatin binding [GO:0003682],cell division [GO:0051301]; establishment of mitotic sister chromatid cohesion [GO:0034087]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
O95630,C5,1.700038937,0.461621771,-0.61435925,-0.474469148,-0.742681929,turquoise3,STAMBP,STABP_HUMAN,STAM-binding protein (EC 3.4.19.-) (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase),STAMBP AMSH,10617;,"ENST00000339566.7; ENSP00000344742.3; ENSG00000124356.17. [O95630-1];""ENST00000394070.7; ENSP00000377633.2; ENSG00000124356.17. [O95630-1]"";""ENST00000394073.6; ENSP00000377636.1; ENSG00000124356.17. [O95630-1]"";""ENST00000409707.6; ENSP00000386548.1; ENSG00000124356.17. [O95630-1]"";""ENST00000432295.7; ENSP00000413874.3; ENSG00000124356.17. [O95630-2]"";""ENST00000682351.1; ENSP00000506833.1; ENSG00000124356.17. [O95630-1]"";""ENST00000682379.1; ENSP00000507081.1; ENSG00000124356.17. [O95630-1]"";""ENST00000682558.1; ENSP00000507014.1; ENSG00000124356.17. [O95630-1]"";""ENST00000682847.1; ENSP00000507864.1; ENSG00000124356.17. [O95630-1]"";""ENST00000683036.1; ENSP00000507639.1; ENSG00000124356.17. [O95630-1]"";""ENST00000683317.1; ENSP00000507092.1; ENSG00000124356.17. [O95630-1]"";""ENST00000683518.1; ENSP00000506865.1; ENSG00000124356.17. [O95630-1]"";""ENST00000683818.1; ENSP00000507658.1; ENSG00000124356.17. [O95630-1]"";""ENST00000684095.1; ENSP00000506845.1; ENSG00000124356.17. [O95630-1]"";""ENST00000684312.1; ENSP00000506958.1; ENSG00000124356.17. [O95630-1]"";""ENST00000684585.1; ENSP00000507054.1; ENSG00000124356.17. [O95630-1]"";",deubiquitinase activity [GO:0101005]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; protein domain specific binding [GO:0019904],cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; hippocampal neuron apoptotic process [GO:0110088]; mitotic cytokinesis [GO:0000281]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of cell population proliferation [GO:0008284]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cleavage furrow [GO:0032154]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q14849,S1,-0.890202455,-1.44448284,-0.369316458,0.813863231,1.147932546,gold,STARD3,STAR3_HUMAN,StAR-related lipid transfer protein 3 (Metastatic lymph node gene 64 protein) (MLN 64) (Protein CAB1) (START domain-containing protein 3) (StARD3),STARD3 CAB1 MLN64,10948;,"ENST00000336308.10; ENSP00000337446.5; ENSG00000131748.16. [Q14849-1];""ENST00000394250.8; ENSP00000377794.4; ENSG00000131748.16. [Q14849-2]"";""ENST00000544210.6; ENSP00000439869.2; ENSG00000131748.16. [Q14849-3]"";",cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; protein homodimerization activity [GO:0042803],cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; lipid metabolic process [GO:0006629]; mitochondrial transport [GO:0006839]; progesterone biosynthetic process [GO:0006701]; steroid metabolic process [GO:0008202]; vesicle tethering to endoplasmic reticulum [GO:0099044],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; organelle membrane contact site [GO:0044232]
O95772,S1,-1.063561418,-1.097099043,-0.333881772,0.814267982,1.007727869,gold,STARD3NL,STR3N_HUMAN,STARD3 N-terminal-like protein (MLN64 N-terminal domain homolog),STARD3NL MENTHO UNQ855/PRO1864,83930;,"ENST00000009041.12; ENSP00000009041.7; ENSG00000010270.14. [O95772-1];""ENST00000396013.5; ENSP00000379334.1; ENSG00000010270.14. [O95772-1]"";",cholesterol binding [GO:0015485]; protein homodimerization activity [GO:0042803],cholesterol transport [GO:0030301]; vesicle tethering to endoplasmic reticulum [GO:0099044],cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]
P42224,C3,1.711137281,0.219753674,-0.543852585,-0.445166927,-0.69800339,cyan,STAT1,STAT1_HUMAN,Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84),STAT1,6772;,"ENST00000361099.8; ENSP00000354394.4; ENSG00000115415.21. [P42224-1];""ENST00000392322.7; ENSP00000376136.3; ENSG00000115415.21. [P42224-2]"";""ENST00000392323.6; ENSP00000376137.3; ENSG00000115415.21. [P42224-2]"";""ENST00000409465.5; ENSP00000386244.1; ENSG00000115415.21. [P42224-1]"";""ENST00000415035.2; ENSP00000388240.2; ENSG00000115415.21. [P42224-1]"";""ENST00000540176.6; ENSP00000438703.2; ENSG00000115415.21. [P42224-1]"";""ENST00000673841.1; ENSP00000501225.1; ENSG00000115415.21. [P42224-2]"";""ENST00000674080.1; ENSP00000501164.1; ENSG00000115415.21. [P42224-2]"";""ENST00000698141.1; ENSP00000513582.1; ENSG00000115415.21. [P42224-1]"";","cadherin binding [GO:0045296]; CCR5 chemokine receptor binding [GO:0031730]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-like protein ligase binding [GO:0044389]",blood circulation [GO:0008015]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; defense response to virus [GO:0051607]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-9-mediated signaling pathway [GO:0038113]; macrophage derived foam cell differentiation [GO:0010742]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; renal tubule development [GO:0061326]; response to cAMP [GO:0051591]; response to cytokine [GO:0034097]; response to hydrogen peroxide [GO:0042542]; response to interferon-beta [GO:0035456]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to peptide hormone [GO:0043434]; response to type II interferon [GO:0034341]; response to xenobiotic stimulus [GO:0009410]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon-mediated signaling pathway [GO:0060337]; type II interferon-mediated signaling pathway [GO:0060333],axon [GO:0030424]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; ISGF3 complex [GO:0070721]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]
P51692,C1,1.653682464,0.134181813,-0.532003116,-0.238690419,-0.490243146,lightblue,STAT5B,STA5B_HUMAN,Signal transducer and activator of transcription 5B,STAT5B,6777;,"ENST00000293328.8; ENSP00000293328.3; ENSG00000173757.11.;""ENST00000415845.2; ENSP00000398379.2; ENSG00000173757.11."";""ENST00000698776.1; ENSP00000513923.1; ENSG00000173757.11."";""ENST00000698777.1; ENSP00000513924.1; ENSG00000173757.11."";","chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; erythrocyte differentiation [GO:0030218]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; mitotic cell cycle [GO:0000278]; myeloid cell apoptotic process [GO:0033028]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; natural killer cell proliferation [GO:0001787]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of myeloid cell apoptotic process [GO:0033033]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to peptide hormone [GO:0043434]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]
O95793,N1,-0.547871095,-0.92689086,-0.200879359,-0.028447362,1.38771208,grey90,STAU1,STAU1_HUMAN,Double-stranded RNA-binding protein Staufen homolog 1,STAU1 STAU,6780;,"ENST00000340954.11; ENSP00000345425.6; ENSG00000124214.21. [O95793-2];""ENST00000347458.9; ENSP00000323443.7; ENSG00000124214.21. [O95793-2]"";""ENST00000360426.8; ENSP00000353604.4; ENSG00000124214.21. [O95793-2]"";""ENST00000371802.5; ENSP00000360867.1; ENSG00000124214.21. [O95793-3]"";""ENST00000371828.7; ENSP00000360893.3; ENSG00000124214.21. [O95793-3]"";""ENST00000371856.7; ENSP00000360922.2; ENSG00000124214.21. [O95793-1]"";",double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723],anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; lncRNA-mediated post-transcriptional gene silencing [GO:0000512]; modification of postsynaptic structure [GO:0099010]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of viral genome replication [GO:0045070]; protein localization to synapse [GO:0035418],cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]
Q9NUL3,N1,-0.895417851,-1.025045546,-0.444090033,-0.184416695,1.530636461,grey90,STAU2,STAU2_HUMAN,Double-stranded RNA-binding protein Staufen homolog 2,STAU2,27067;,"ENST00000355780.9; ENSP00000348026.5; ENSG00000040341.18. [Q9NUL3-3];""ENST00000517542.5; ENSP00000431111.1; ENSG00000040341.18. [Q9NUL3-8]"";""ENST00000521210.5; ENSP00000429173.1; ENSG00000040341.18. [Q9NUL3-7]"";""ENST00000521451.5; ENSP00000428476.1; ENSG00000040341.18. [Q9NUL3-4]"";""ENST00000522509.5; ENSP00000427977.1; ENSG00000040341.18. [Q9NUL3-3]"";""ENST00000522695.5; ENSP00000428456.1; ENSG00000040341.18. [Q9NUL3-2]"";""ENST00000523558.5; ENSP00000428741.1; ENSG00000040341.18. [Q9NUL3-6]"";""ENST00000524104.5; ENSP00000430611.1; ENSG00000040341.18. [Q9NUL3-5]"";""ENST00000524300.6; ENSP00000428756.1; ENSG00000040341.18. [Q9NUL3-1]"";",double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; kinesin binding [GO:0019894]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; RNA binding [GO:0003723],anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; cellular response to oxidative stress [GO:0034599]; eye morphogenesis [GO:0048592]; germ cell development [GO:0007281]; intracellular mRNA localization [GO:0008298]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein localization to synapse [GO:0035418]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of filopodium assembly [GO:0051489],axon [GO:0030424]; cytoplasmic stress granule [GO:0010494]; dendrite cytoplasm [GO:0032839]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]
Q13586,S2,-1.1827866,-1.098354985,0.143614832,0.79102896,0.477422011,orange,STIM1,STIM1_HUMAN,Stromal interaction molecule 1,STIM1 GOK,6786;,"ENST00000300737.8; ENSP00000300737.4; ENSG00000167323.13. [Q13586-1];""ENST00000527651.5; ENSP00000436208.1; ENSG00000167323.13. [Q13586-2]"";",calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; protease binding [GO:0002020],activation of store-operated calcium channel activity [GO:0032237]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of angiogenesis [GO:0045766]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115],cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; sarcoplasmic reticulum membrane [GO:0033017]
P31948,C5,1.793719511,0.702923615,-0.97084684,-1.059368819,-1.310595027,turquoise3,STIP1,STIP1_HUMAN,Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521),STIP1,10963;,"ENST00000305218.9; ENSP00000305958.5; ENSG00000168439.17. [P31948-1];""ENST00000358794.9; ENSP00000351646.5; ENSG00000168439.17. [P31948-2]"";""ENST00000538945.5; ENSP00000445957.1; ENSG00000168439.17. [P31948-3]"";",Hsp90 protein binding [GO:0051879]; RNA binding [GO:0003723],cellular response to interleukin-7 [GO:0098761],cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]
Q9Y6E0,C1,1.518067477,0.237271205,-0.54165008,-0.304038899,-0.534717237,lightblue,STK24,STK24_HUMAN,Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)],STK24 MST3 STK3,8428;,"ENST00000376547.7; ENSP00000365730.3; ENSG00000102572.15. [Q9Y6E0-1];""ENST00000539966.6; ENSP00000442539.2; ENSG00000102572.15. [Q9Y6E0-2]"";",ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],cellular response to oxidative stress [GO:0034599]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of cell migration [GO:0030336]; positive regulation of axon regeneration [GO:0048680]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q15208,C1,1.692655502,0.118924053,-0.411964289,-0.453928161,-0.702817879,lightblue,STK38,STK38_HUMAN,Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1),STK38 NDR1,11329;,ENST00000229812.8; ENSP00000229812.7; ENSG00000112079.9.;,ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone reader activity [GO:0140566]; magnesium ion binding [GO:0000287]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; UFM1-modified protein reader activity [GO:0141185],DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; negative regulation of MAP kinase activity [GO:0043407]; postsynapse organization [GO:0099173]; protein modification process [GO:0036211]; protein phosphorylation [GO:0006468],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]
Q9Y2H1,C1,1.65941723,0.183296414,-0.396174668,-0.171065511,-0.701025149,lightblue,STK38L,ST38L_HUMAN,Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2),STK38L KIAA0965 NDR2,23012;,ENST00000389032.8; ENSP00000373684.3; ENSG00000211455.8. [Q9Y2H1-1];,actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]
Q13043,C4,1.744980742,-0.131935076,-0.612028411,-0.623966819,-0.809019675,deepskyblue2,STK4,STK4_HUMAN,Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)],STK4 KRS2 MST1,6789;,"ENST00000372801.5; ENSP00000361887.1; ENSG00000101109.13. [Q13043-2];""ENST00000372806.8; ENSP00000361892.3; ENSG00000101109.13. [Q13043-1]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],"apoptotic process [GO:0006915]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; cell morphogenesis [GO:0000902]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; keratinocyte differentiation [GO:0030216]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte apoptotic process [GO:1903945]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; primitive hemopoiesis [GO:0060215]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408]; signal transduction [GO:0007165]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
P16949,C4,2.081401602,0.280306876,-1.057889877,-1.083429535,-1.341459125,deepskyblue2,STMN1,STMN1_HUMAN,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),STMN1 C1orf215 LAP18 OP18,3925;,"ENST00000357865.6; ENSP00000350531.2; ENSG00000117632.23. [P16949-1];""ENST00000374291.5; ENSP00000363409.1; ENSG00000117632.23. [P16949-1]"";""ENST00000399728.5; ENSP00000382633.1; ENSG00000117632.23. [P16949-1]"";""ENST00000426559.6; ENSP00000410452.2; ENSG00000117632.23. [P16949-2]"";""ENST00000455785.7; ENSP00000387858.2; ENSG00000117632.23. [P16949-1]"";",tubulin binding [GO:0015631],axonogenesis [GO:0007409]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; regulation of cell migration [GO:0030334]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]
Q93045,C4,2.241149303,0.345718808,-1.452623837,-1.473051406,-1.63001383,deepskyblue2,STMN2,STMN2_HUMAN,Stathmin-2 (Superior cervical ganglion-10 protein) (Protein SCG10),STMN2 SCG10 SCGN10,11075;,"ENST00000220876.12; ENSP00000220876.7; ENSG00000104435.14. [Q93045-1];""ENST00000518111.5; ENSP00000429243.1; ENSG00000104435.14. [Q93045-2]"";",calcium-dependent protein binding [GO:0048306]; tubulin binding [GO:0015631],cellular response to nerve growth factor stimulus [GO:1990090]; microtubule depolymerization [GO:0007019]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of neuron projection development [GO:0010976]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]
P27105,S1,-0.992082028,-1.177083116,0.084483249,0.86072512,0.760110556,gold,STOM,STOM_HUMAN,Stomatin (Erythrocyte band 7 integral membrane protein) (Erythrocyte membrane protein band 7.2) (Protein 7.2b),STOM BND7 EPB72,2040;,"ENST00000286713.7; ENSP00000286713.2; ENSG00000148175.13. [P27105-1];""ENST00000347359.3; ENSP00000339607.2; ENSG00000148175.13. [P27105-2]"";",identical protein binding [GO:0042802]; ion channel inhibitor activity [GO:0008200]; protein homodimerization activity [GO:0042803]; RNA polymerase binding [GO:0070063],positive regulation by host of viral genome replication [GO:0044829]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of viral process [GO:0048524]; regulation of monoatomic ion transmembrane transport [GO:0034765],azurophil granule membrane [GO:0035577]; blood microparticle [GO:0072562]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; vesicle [GO:0031982]
Q9UJZ1,M2,-1.282321654,-1.442301514,0.365898249,1.207874512,-0.272962867,tan4,STOML2,STML2_HUMAN,"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)",STOML2 SLP2 HSPC108,30968;,"ENST00000356493.10; ENSP00000348886.5; ENSG00000165283.16. [Q9UJZ1-1];""ENST00000452248.6; ENSP00000395743.2; ENSG00000165283.16. [Q9UJZ1-2]"";",cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; T cell receptor binding [GO:0042608],"CD4-positive, alpha-beta T cell activation [GO:0035710]; intracellular calcium ion homeostasis [GO:0006874]; lipid localization [GO:0010876]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of interleukin-2 production [GO:0032743]; protein complex oligomerization [GO:0051259]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852]",actin cytoskeleton [GO:0015629]; immunological synapse [GO:0001772]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q9BX79,S2,-1.389772808,-1.262060757,0.326452723,0.75566473,0.556340028,orange,STRA6,STRA6_HUMAN,Receptor for retinol uptake STRA6 (Retinol-binding protein receptor STRA6) (Stimulated by retinoic acid gene 6 protein homolog),STRA6 PP14296 UNQ3126/PRO10282/PRO19578,64220;,"ENST00000323940.9; ENSP00000326085.5; ENSG00000137868.19. [Q9BX79-1];""ENST00000395105.9; ENSP00000378537.4; ENSG00000137868.19. [Q9BX79-1]"";""ENST00000423167.6; ENSP00000413012.2; ENSG00000137868.19. [Q9BX79-3]"";""ENST00000432245.6; ENSP00000407176.2; ENSG00000137868.19. [Q9BX79-2]"";""ENST00000449139.6; ENSP00000410221.2; ENSG00000137868.19. [Q9BX79-1]"";""ENST00000535552.5; ENSP00000440238.1; ENSG00000137868.19. [Q9BX79-5]"";""ENST00000563965.5; ENSP00000456609.1; ENSG00000137868.19. [Q9BX79-4]"";""ENST00000574278.5; ENSP00000458827.1; ENSG00000137868.19. [Q9BX79-6]"";""ENST00000616000.4; ENSP00000479112.1; ENSG00000137868.19. [Q9BX79-1]"";""ENST00000672446.1; ENSP00000500590.1; ENSG00000288257.1. [Q9BX79-3]"";""ENST00000672526.1; ENSP00000500345.1; ENSG00000288257.1. [Q9BX79-1]"";""ENST00000672584.1; ENSP00000499915.1; ENSG00000288257.1. [Q9BX79-1]"";""ENST00000672836.1; ENSP00000500033.1; ENSG00000288257.1. [Q9BX79-5]"";""ENST00000673026.1; ENSP00000499878.1; ENSG00000288257.1. [Q9BX79-1]"";""ENST00000673039.1; ENSP00000500335.1; ENSG00000288257.1. [Q9BX79-6]"";""ENST00000673241.1; ENSP00000499866.1; ENSG00000288257.1. [Q9BX79-4]"";""ENST00000673414.1; ENSP00000500241.1; ENSG00000288257.1. [Q9BX79-1]"";""ENST00000673519.1; ENSP00000500334.1; ENSG00000288257.1. [Q9BX79-2]"";",retinal binding [GO:0016918]; retinol binding [GO:0019841]; retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023],adrenal gland development [GO:0030325]; alveolar primary septum development [GO:0061143]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; camera-type eye development [GO:0043010]; cognition [GO:0050890]; developmental growth [GO:0048589]; diaphragm development [GO:0060539]; digestive tract morphogenesis [GO:0048546]; ductus arteriosus closure [GO:0097070]; ear development [GO:0043583]; embryonic camera-type eye formation [GO:0060900]; embryonic digestive tract development [GO:0048566]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; feeding behavior [GO:0007631]; female genitalia development [GO:0030540]; head development [GO:0060322]; head morphogenesis [GO:0060323]; heart development [GO:0007507]; kidney development [GO:0001822]; learning [GO:0007612]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; neuromuscular process [GO:0050905]; nose morphogenesis [GO:0043585]; paramesonephric duct development [GO:0061205]; positive regulation of behavior [GO:0048520]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; retinol transport [GO:0034633]; smooth muscle tissue development [GO:0048745]; uterus morphogenesis [GO:0061038]; ventricular septum development [GO:0003281]; vitamin A import into cell [GO:0071939]; vocal learning [GO:0042297],plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q9Y3F4,C2,1.44596017,0.598751314,-0.753333015,-0.915849468,-0.035153363,aquamarine,STRAP,STRAP_HUMAN,Serine-threonine kinase receptor-associated protein (MAP activator with WD repeats) (UNR-interacting protein) (WD-40 repeat protein PT-WD),STRAP MAWD UNRIP,11171;,"ENST00000025399.10; ENSP00000025399.6; ENSG00000023734.11. [Q9Y3F4-2];""ENST00000419869.7; ENSP00000392270.2; ENSG00000023734.11. [Q9Y3F4-1]"";",mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447],"alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; spliceosomal snRNP assembly [GO:0000387]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]
Q96SI9,N3,-1.540880883,-1.163078944,0.934363943,-0.090930921,0.720603557,grey50,STRBP,STRBP_HUMAN,Spermatid perinuclear RNA-binding protein,STRBP SPNR,55342;,"ENST00000348403.10; ENSP00000321347.7; ENSG00000165209.19. [Q96SI9-1];""ENST00000360998.3; ENSP00000354271.3; ENSG00000165209.19. [Q96SI9-2]"";""ENST00000447404.6; ENSP00000415968.2; ENSG00000165209.19. [Q96SI9-1]"";",DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727],cell motility [GO:0048870]; mechanosensory behavior [GO:0007638]; spermatid development [GO:0007286],cytoplasm [GO:0005737]; manchette [GO:0002177]; nucleus [GO:0005634]
P08842,S2,-0.770552073,-0.944047256,0.289175429,0.852017379,0.427732046,orange,STS,STS_HUMAN,Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase),STS ARSC1,412;,0,arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; steryl-sulfatase activity [GO:0004773]; sulfuric ester hydrolase activity [GO:0008484],epidermis development [GO:0008544]; female pregnancy [GO:0007565]; steroid catabolic process [GO:0006706],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; microneme membrane [GO:0033163]; plasma membrane [GO:0005886]
P46977,S2,-1.412393294,-1.664555301,0.274679937,0.929026809,0.423604771,orange,STT3A,STT3A_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1) (Transmembrane protein TMC),STT3A ITM1 TMC,3703;,"ENST00000392708.9; ENSP00000376472.3; ENSG00000134910.14. [P46977-1];""ENST00000529196.5; ENSP00000436962.1; ENSG00000134910.14. [P46977-1]"";""ENST00000531491.5; ENSP00000432820.1; ENSG00000134910.14. [P46977-2]"";""ENST00000649491.1; ENSP00000497336.1; ENSG00000134910.14. [P46977-1]"";",dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872],co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase III complex [GO:0035000]
Q8TCJ2,S2,-1.40026614,-1.586648332,0.264157999,0.841691151,0.452485933,orange,STT3B,STT3B_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),STT3B SIMP,201595;,ENST00000295770.4; ENSP00000295770.2; ENSG00000163527.10.;,dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872],co-translational protein modification [GO:0043686]; ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase I complex [GO:0034998]; protein-containing complex [GO:0032991]
O60499,S1,-0.765065759,-0.857732617,-0.077288349,0.453716954,1.096688117,gold,STX10,STX10_HUMAN,Syntaxin-10 (Syn10),STX10 SYN10,8677;,"ENST00000343587.9; ENSP00000339350.4; ENSG00000104915.15. [O60499-2];""ENST00000587230.6; ENSP00000466298.1; ENSG00000104915.15. [O60499-1]"";",SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],"Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]",cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]
Q86Y82,S1,-0.741172587,-1.02495022,-0.103599612,0.536757901,1.095839438,gold,STX12,STX12_HUMAN,Syntaxin-12,STX12,23673;,ENST00000373943.9; ENSP00000363054.4; ENSG00000117758.14.;,SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982]
O14662,S1,-0.970034543,-1.298981307,-0.189629824,0.631774674,1.122034684,gold,STX16,STX16_HUMAN,Syntaxin-16 (Syn16),STX16,8675;,"ENST00000355957.9; ENSP00000348229.5; ENSG00000124222.23. [O14662-4];""ENST00000358029.8; ENSP00000350723.4; ENSG00000124222.23. [O14662-5]"";""ENST00000359617.8; ENSP00000352634.4; ENSG00000124222.23. [O14662-6]"";""ENST00000371132.8; ENSP00000360173.4; ENSG00000124222.23. [O14662-2]"";""ENST00000371141.8; ENSP00000360183.4; ENSG00000124222.23. [O14662-1]"";""ENST00000467096.5; ENSP00000434369.1; ENSG00000124222.23. [O14662-3]"";",SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]
P56962,S3,-1.123456037,-0.86922534,0.14750449,0.894097096,0.422876179,salmon,STX17,STX17_HUMAN,Syntaxin-17,STX17,55014;,"ENST00000259400.11; ENSP00000259400.6; ENSG00000136874.11.;""ENST00000525640.5; ENSP00000435981.1; ENSG00000136874.11."";""ENST00000534052.1; ENSP00000433484.1; ENSG00000136874.11."";",protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201]
Q9P2W9,S2,-0.961656447,-1.293289627,0.092962567,0.819550781,0.694105055,orange,STX18,STX18_HUMAN,Syntaxin-18 (Cell growth-inhibiting gene 9 protein),STX18 GIG9,53407;,ENST00000306200.7; ENSP00000305810.2; ENSG00000168818.10.;,protein domain specific binding [GO:0019904]; SNAP receptor activity [GO:0005484],"endoplasmic reticulum membrane organization [GO:0090158]; intracellular protein transport [GO:0006886]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of organelle assembly [GO:1902117]; regulation of Golgi organization [GO:1903358]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201]
Q13277,S1,-0.708202019,-1.134204615,0.059493585,0.580594624,0.830107345,gold,STX3,STX3_HUMAN,Syntaxin-3,STX3 STX3A,6809;,"ENST00000337979.9; ENSP00000338562.4; ENSG00000166900.17. [Q13277-1];""ENST00000529177.5; ENSP00000433248.1; ENSG00000166900.17. [Q13277-3]"";",arachidonic acid binding [GO:0050544]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; neuron projection development [GO:0031175]; organelle membrane fusion [GO:0090174]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of gene expression [GO:0010468]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278],apical plasma membrane [GO:0016324]; azurophil granule [GO:0042582]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; vacuole [GO:0005773]; zymogen granule membrane [GO:0042589]
Q12846,S4,-1.205481909,-1.442144087,0.509691658,0.799412276,0.286928583,tomato2,STX4,STX4_HUMAN,Syntaxin-4 (Renal carcinoma antigen NY-REN-31),STX4 STX4A,6810;,"ENST00000313843.8; ENSP00000317714.3; ENSG00000103496.15. [Q12846-1];""ENST00000394998.5; ENSP00000378447.1; ENSG00000103496.15. [Q12846-2]"";",SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; sphingomyelin phosphodiesterase activator activity [GO:0016230],cellular response to oxidative stress [GO:0034599]; cellular response to type II interferon [GO:0071346]; cornified envelope assembly [GO:1903575]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; long-term synaptic potentiation [GO:0060291]; neurotransmitter transport [GO:0006836]; organelle fusion [GO:0048284]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of eosinophil degranulation [GO:0043311]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; regulation of exocytosis [GO:0017157]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; SNARE complex assembly [GO:0035493]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lateral loop [GO:0043219]; membrane [GO:0016020]; myelin sheath adaxonal region [GO:0035749]; neuron projection membrane [GO:0032589]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; SNARE complex [GO:0031201]; somatodendritic compartment [GO:0036477]; specific granule [GO:0042581]; storage vacuole [GO:0000322]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]
Q13190,S1,-0.906527813,-1.25741422,-0.089176333,0.849864258,0.908592278,gold,STX5,STX5_HUMAN,Syntaxin-5,STX5 STX5A,6811;,"ENST00000294179.8; ENSP00000294179.3; ENSG00000162236.13. [Q13190-1];""ENST00000377897.8; ENSP00000367129.4; ENSG00000162236.13. [Q13190-4]"";""ENST00000394690.5; ENSP00000378182.1; ENSG00000162236.13. [Q13190-2]"";",cadherin binding [GO:0045296]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],"early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]; vesicle fusion with Golgi apparatus [GO:0048280]",cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201]; vesicle [GO:0031982]
O43752,S1,-1.126971627,-1.515463145,-0.12113245,0.630859,1.205676108,gold,STX6,STX6_HUMAN,Syntaxin-6,STX6,10228;,"ENST00000258301.6; ENSP00000258301.5; ENSG00000135823.14. [O43752-1];""ENST00000542060.5; ENSP00000440188.1; ENSG00000135823.14. [O43752-2]"";",SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],"endocytic recycling [GO:0032456]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]
O15400,S1,-1.049989369,-1.219933217,-0.080819043,0.560494227,0.996414564,gold,STX7,STX7_HUMAN,Syntaxin-7,STX7,8417;,"ENST00000367937.4; ENSP00000356914.4; ENSG00000079950.14. [O15400-2];""ENST00000367941.7; ENSP00000356918.1; ENSG00000079950.14. [O15400-1]"";",chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]
Q9UNK0,S1,-1.035648564,-1.28708173,-0.166978708,0.740877786,0.976809023,gold,STX8,STX8_HUMAN,Syntaxin-8,STX8,9482;,ENST00000306357.9; ENSP00000305255.2; ENSG00000170310.15.;,chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625],cellular response to type II interferon [GO:0071346]; early endosome to late endosome transport [GO:0045022]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982]
O00186,S4,-0.627389913,-0.81859373,0.457340427,0.766442918,0.287851032,tomato2,STXBP3,STXB3_HUMAN,Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C),STXBP3,6814;,ENST00000370008.4; ENSP00000359025.3; ENSG00000116266.11.;,protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],brain development [GO:0007420]; cellular response to type II interferon [GO:0071346]; insulin secretion [GO:0030073]; intracellular glucose homeostasis [GO:0001678]; intracellular protein transport [GO:0006886]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of glucose import [GO:0046325]; neurotransmitter secretion [GO:0007269]; neutrophil degranulation [GO:0043312]; platelet aggregation [GO:0070527]; protein to membrane docking [GO:0022615]; response to insulin [GO:0032868]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; presynapse [GO:0098793]; secretory granule [GO:0030141]; specific granule [GO:0042581]; tertiary granule [GO:0070820]
Q9UBS9,S2,-1.461166761,-1.408635564,0.113947584,1.016828296,0.535651274,orange,SUCO,SUCO_HUMAN,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1),SUCO C1orf9 CH1 OPT SLP1,51430;,"ENST00000263688.4; ENSP00000263688.3; ENSG00000094975.15. [Q9UBS9-1];""ENST00000367723.8; ENSP00000356696.4; ENSG00000094975.15. [Q9UBS9-2]"";",0,ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850],cytoplasm [GO:0005737]; membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]
Q8IWZ8,N4,-0.810981679,1.087786841,0.135284119,-0.354572376,-0.435274227,grey30,SUGP1,SUGP1_HUMAN,SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4),SUGP1 SF4,57794;,"ENST00000247001.10; ENSP00000247001.3; ENSG00000105705.16. [Q8IWZ8-1];""ENST00000588731.6; ENSP00000465413.2; ENSG00000105705.16. [Q8IWZ8-2]"";",RNA binding [GO:0003723],mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]
Q8IX01,N3,-1.28163328,-1.179206879,1.071000848,0.030303425,0.410869882,grey50,SUGP2,SUGP2_HUMAN,"SURP and G-patch domain-containing protein 2 (Arginine/serine-rich-splicing factor 14) (Splicing factor, arginine/serine-rich 14)",SUGP2 KIAA0365 SFRS14,10147;,"ENST00000330854.15; ENSP00000332373.10; ENSG00000064607.17. [Q8IX01-4];""ENST00000337018.10; ENSP00000337926.5; ENSG00000064607.17. [Q8IX01-1]"";""ENST00000452918.7; ENSP00000389380.1; ENSG00000064607.17. [Q8IX01-1]"";""ENST00000594773.5; ENSP00000470915.1; ENSG00000064607.17. [Q8IX01-3]"";""ENST00000601879.5; ENSP00000472286.1; ENSG00000064607.17. [Q8IX01-1]"";",RNA binding [GO:0003723],mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nuclear body [GO:0016604]; nucleoplasm [GO:0005654]
Q9Y2Z0,C3,1.597071135,0.422051975,-0.534817866,-0.408803336,-0.685981926,cyan,SUGT1,SGT1_HUMAN,Protein SGT1 homolog (Protein 40-6-3) (Sgt1) (Suppressor of G2 allele of SKP1 homolog),SUGT1,10910;,"ENST00000310528.9; ENSP00000308067.7; ENSG00000165416.15. [Q9Y2Z0-2];""ENST00000343788.10; ENSP00000367208.4; ENSG00000165416.15. [Q9Y2Z0-1]"";",lncRNA binding [GO:0106222]; protein-folding chaperone binding [GO:0051087],kinetochore assembly [GO:0051382]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle organization [GO:0007051],cytosol [GO:0005829]; kinetochore [GO:0000776]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]
O94901,N3,-1.009534964,-1.176270414,1.225411555,0.298763164,-0.542498508,grey50,SUN1,SUN1_HUMAN,SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1),SUN1 KIAA0810 UNC84A,23353;,"ENST00000389574.7; ENSP00000374225.3; ENSG00000164828.18. [O94901-5];""ENST00000401592.6; ENSP00000384015.1; ENSG00000164828.18. [O94901-8]"";""ENST00000403868.5; ENSP00000383947.1; ENSG00000164828.18. [O94901-2]"";""ENST00000425407.6; ENSP00000392309.2; ENSG00000164828.18. [O94901-5]"";""ENST00000457378.6; ENSP00000395952.2; ENSG00000164828.18. [O94901-7]"";",cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein-membrane adaptor activity [GO:0043495],centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; ossification [GO:0001503]; response to mechanical stimulus [GO:0009612]; spermatogenesis [GO:0007283],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]"
Q9UH99,N3,-1.106104365,-1.231723778,1.155559938,0.246562122,-0.183396276,grey50,SUN2,SUN2_HUMAN,SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein) (Rab5IP) (Sad1/unc-84 protein-like 2),SUN2 FRIGG KIAA0668 RAB5IP UNC84B,25777;,"ENST00000405018.5; ENSP00000385616.1; ENSG00000100242.16. [Q9UH99-2];""ENST00000405510.5; ENSP00000385740.1; ENSG00000100242.16. [Q9UH99-1]"";""ENST00000406622.5; ENSP00000383992.1; ENSG00000100242.16. [Q9UH99-1]"";""ENST00000689035.1; ENSP00000508608.1; ENSG00000100242.16. [Q9UH99-1]"";",cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; protein-membrane adaptor activity [GO:0043495],centrosome localization [GO:0051642]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335],"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; endosome membrane [GO:0010008]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]"
P51687,N4,-0.545446768,0.804917423,0.043888257,0.298676788,-0.690785575,grey30,SUOX,SUOX_HUMAN,"Sulfite oxidase, mitochondrial (EC 1.8.3.1)",SUOX,6821;,"ENST00000266971.8; ENSP00000266971.3; ENSG00000139531.13.;""ENST00000356124.8; ENSP00000348440.4; ENSG00000139531.13."";""ENST00000394109.7; ENSP00000377668.3; ENSG00000139531.13."";""ENST00000394115.6; ENSP00000377674.2; ENSG00000139531.13."";""ENST00000548274.5; ENSP00000450245.1; ENSG00000139531.13."";""ENST00000550065.1; ENSP00000450264.1; ENSG00000139531.13."";",heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482],sulfur compound metabolic process [GO:0006790],mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q9Y5B9,N3,-0.849418176,-0.815880837,1.094199703,0.397607674,-0.48283393,grey50,SUPT16H,SP16H_HUMAN,FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16),SUPT16H FACT140 FACTP140,11198;,ENST00000216297.7; ENSP00000216297.2; ENSG00000092201.10.;,nucleosome binding [GO:0031491]; RNA binding [GO:0003723],"DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]",FACT complex [GO:0035101]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
P63272,N4,0.004238091,1.067637641,0.360197526,-0.493197414,-1.090365686,grey30,SUPT4H1,SPT4H_HUMAN,Transcription elongation factor SPT4 (hSPT4) (DRB sensitivity-inducing factor 14 kDa subunit) (DSIF p14) (DRB sensitivity-inducing factor small subunit) (DSIF small subunit),SUPT4H1 SPT4H SUPT4H,6827;,"ENST00000225504.8; ENSP00000225504.3; ENSG00000213246.7.;""ENST00000580947.1; ENSP00000462670.1; ENSG00000213246.7."";",protein heterodimerization activity [GO:0046982]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270],"negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]",DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O00267,N4,-0.667730103,0.910422125,0.546936979,-0.409998548,-0.845245023,grey30,SUPT5H,SPT5H_HUMAN,Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein),SUPT5H SPT5 SPT5H,6829;,"ENST00000359191.10; ENSP00000352117.6; ENSG00000196235.14. [O00267-2];""ENST00000402194.6; ENSP00000384505.2; ENSG00000196235.14. [O00267-2]"";""ENST00000432763.7; ENSP00000404029.4; ENSG00000196235.14. [O00267-1]"";""ENST00000598725.5; ENSP00000469090.1; ENSG00000196235.14. [O00267-1]"";""ENST00000599117.5; ENSP00000470252.1; ENSG00000196235.14. [O00267-1]"";",chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723],"negative regulation of DNA-templated transcription, elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673]",DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q7KZ85,N2,-0.946907679,0.472137907,0.754236864,-0.130444658,-0.36780211,grey70,SUPT6H,SPT6H_HUMAN,Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),SUPT6H KIAA0162 SPT6H,6830;,"ENST00000314616.11; ENSP00000319104.6; ENSG00000109111.15. [Q7KZ85-1];""ENST00000347486.8; ENSP00000338143.4; ENSG00000109111.15. [Q7KZ85-1]"";",DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723],blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673],nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023]
Q8IYB8,M1,-0.933698888,-0.360724741,0.428526784,0.849335101,-0.292695149,burlywood4,SUPV3L1,SUV3_HUMAN,"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)",SUPV3L1 SUV3,6832;,ENST00000359655.9; ENSP00000352678.4; ENSG00000156502.14.;,3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401],mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
Q15526,M2,-0.80444934,-1.044283757,0.240167666,1.15173667,-0.142704153,tan4,SURF1,SURF1_HUMAN,Surfeit locus protein 1,SURF1 SURF-1,6834;,"ENST00000371974.8; ENSP00000361042.3; ENSG00000148290.10. [Q15526-1];""ENST00000626663.3; ENSP00000487158.1; ENSG00000280627.3. [Q15526-1]"";",cytochrome-c oxidase activity [GO:0004129],aerobic respiration [GO:0009060]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; respiratory chain complex IV assembly [GO:0008535],mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]
O15260,S2,-0.838010706,-1.637464539,0.13882039,0.548701262,0.893179579,orange,SURF4,SURF4_HUMAN,Surfeit locus protein 4,SURF4 SURF-4,6836;,"ENST00000371989.8; ENSP00000361057.3; ENSG00000148248.14. [O15260-1];""ENST00000485435.6; ENSP00000419853.2; ENSG00000148248.14. [O15260-2]"";""ENST00000545297.5; ENSP00000446061.1; ENSG00000148248.14. [O15260-3]"";""ENST00000626303.2; ENSP00000487537.1; ENSG00000280951.3. [O15260-2]"";""ENST00000629119.2; ENSP00000486869.1; ENSG00000280951.3. [O15260-3]"";""ENST00000629578.3; ENSP00000486049.1; ENSG00000280951.3. [O15260-1]"";",cargo receptor activity [GO:0038024]; COPII receptor activity [GO:0097020],COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lipid export from cell [GO:0140353]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; positive regulation of organelle organization [GO:0010638]; regulation of lipid transport [GO:0032368],azurophil granule membrane [GO:0035577]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]
O75683,N3,-1.086673023,-1.147183598,1.161126376,-0.151068318,0.27224841,grey50,SURF6,SURF6_HUMAN,Surfeit locus protein 6,SURF6 SURF-6,6838;,"ENST00000372022.6; ENSP00000361092.4; ENSG00000148296.7.;""ENST00000629980.2; ENSP00000485909.1; ENSG00000281309.2."";",DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274],chromosome [GO:0005694]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9H5I1,N3,-1.355074049,-1.313559377,1.461086555,0.174850185,-0.916645212,grey50,SUV39H2,SUV92_HUMAN,Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 2) (H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2),SUV39H2 KMT1B,79723;,"ENST00000313519.9; ENSP00000319208.5; ENSG00000152455.16. [Q9H5I1-2];""ENST00000354919.11; ENSP00000346997.6; ENSG00000152455.16. [Q9H5I1-1]"";""ENST00000378325.7; ENSP00000367576.3; ENSG00000152455.16. [Q9H5I1-3]"";",histone H3 methyltransferase activity [GO:0140938]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 trimethyltransferase activity [GO:0140949]; S-adenosyl-L-methionine binding [GO:1904047]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270],"cell differentiation [GO:0030154]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; circadian rhythm [GO:0007623]; epigenetic programming in the zygotic pronuclei [GO:0044725]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]","chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q4FZB7,N3,-0.729290263,-1.184439274,1.343653332,0.100468016,-0.682958211,grey50,SUV420H1,KMT5B_HUMAN,Histone-lysine N-methyltransferase KMT5B (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361),KMT5B SUV420H1 CGI-85,51111;,"ENST00000304363.9; ENSP00000305899.4; ENSG00000110066.16. [Q4FZB7-1];""ENST00000401547.6; ENSP00000385965.2; ENSG00000110066.16. [Q4FZB7-2]"";""ENST00000405515.5; ENSP00000385640.1; ENSG00000110066.16. [Q4FZB7-2]"";""ENST00000441488.6; ENSP00000411146.2; ENSG00000110066.16. [Q4FZB7-4]"";""ENST00000615954.4; ENSP00000484858.1; ENSG00000110066.16. [Q4FZB7-1]"";",chromatin binding [GO:0003682]; histone H4 methyltransferase activity [GO:0140939]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047],DNA repair [GO:0006281]; methylation [GO:0032259]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830],"condensed chromosome, centromeric region [GO:0000779]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
Q9UH65,C3,1.851142825,0.509537576,-0.830048165,-0.734139171,-0.970263532,cyan,SWAP70,SWP70_HUMAN,Switch-associated protein 70 (SWAP-70),SWAP70 KIAA0640 HSPC321,23075;,ENST00000318950.11; ENSP00000315630.6; ENSG00000133789.15.;,ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of protein localization [GO:0032880]; regulation of small GTPase mediated signal transduction [GO:0051056],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]
Q92797,N2,-1.261816898,-0.319074538,0.955264652,-0.03591337,0.269720945,grey70,SYMPK,SYMPK_HUMAN,Symplekin,SYMPK SPK,8189;,ENST00000245934.12; ENSP00000245934.7; ENSG00000125755.19. [Q92797-1];,0,cell adhesion [GO:0007155]; mRNA processing [GO:0006397]; negative regulation of protein binding [GO:0032091],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
O60506,N1,-0.728867011,-0.665735438,0.282030206,-0.286838284,1.138467643,grey90,SYNCRIP,HNRPQ_HUMAN,"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)",SYNCRIP HNRPQ NSAP1,10492;,"ENST00000355238.11; ENSP00000347380.6; ENSG00000135316.20. [O60506-3];""ENST00000369622.8; ENSP00000358635.3; ENSG00000135316.20. [O60506-1]"";""ENST00000444272.2; ENSP00000397782.2; ENSG00000135316.20. [O60506-3]"";""ENST00000676637.1; ENSP00000502974.1; ENSG00000135316.20. [O60506-3]"";""ENST00000676688.1; ENSP00000504706.1; ENSG00000135316.20. [O60506-1]"";""ENST00000678355.1; ENSP00000503783.1; ENSG00000135316.20. [O60506-1]"";""ENST00000678528.1; ENSP00000503246.1; ENSG00000135316.20. [O60506-3]"";""ENST00000678930.1; ENSP00000504120.1; ENSG00000135316.20. [O60506-2]"";",mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723],"cellular response to type II interferon [GO:0071346]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; negative regulation of translation [GO:0017148]; osteoblast differentiation [GO:0001649]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA demethylation [GO:1901537]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GAIT complex [GO:0097452]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
Q8WXH0,N3,-0.855701822,-1.080555206,1.184571293,0.275474753,-0.325698649,grey50,SYNE2,SYNE2_HUMAN,Nesprin-2 (KASH domain-containing protein 2) (KASH2) (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),SYNE2 KIAA1011 NUA,23224;,"ENST00000341472.9; ENSP00000344528.5; ENSG00000054654.20. [Q8WXH0-8];""ENST00000344113.8; ENSP00000341781.4; ENSG00000054654.20. [Q8WXH0-1]"";""ENST00000358025.7; ENSP00000350719.3; ENSG00000054654.20. [Q8WXH0-2]"";""ENST00000458046.6; ENSP00000391937.2; ENSG00000054654.20. [Q8WXH0-5]"";""ENST00000555002.6; ENSP00000450831.2; ENSG00000054654.20. [Q8WXH0-2]"";",actin binding [GO:0003779]; cytoskeleton-nuclear membrane anchor activity [GO:0140444],centrosome localization [GO:0051642]; nuclear migration [GO:0007097]; nuclear migration along microfilament [GO:0031022]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; positive regulation of cell migration [GO:0030335]; regulation of cilium assembly [GO:1902017],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium membrane [GO:0031258]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear lumen [GO:0031981]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]
Q6ZMZ3,N3,-0.837797402,-0.810702945,1.071420168,0.29430629,-0.236458519,grey50,SYNE3,SYNE3_HUMAN,Nesprin-3 (KASH domain-containing protein 3) (KASH3) (Nuclear envelope spectrin repeat protein 3),SYNE3 C14orf139 C14orf49 LINC00341,161176;,"ENST00000334258.9; ENSP00000334308.4; ENSG00000176438.13. [Q6ZMZ3-1];""ENST00000553340.1; ENSP00000450774.1; ENSG00000176438.13. [Q6ZMZ3-3]"";""ENST00000557275.5; ENSP00000450562.1; ENSG00000176438.13. [Q6ZMZ3-2]"";""ENST00000682763.1; ENSP00000507501.1; ENSG00000176438.13. [Q6ZMZ3-1]"";",actin filament binding [GO:0051015]; cytoskeleton-nuclear membrane anchor activity [GO:0140444],cytoskeleton organization [GO:0007010]; establishment of protein localization to membrane [GO:0090150]; nuclear migration [GO:0007097]; regulation of cell shape [GO:0008360],cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; rough endoplasmic reticulum [GO:0005791]
O43760,S1,-0.485423455,-1.098907882,-0.264875134,0.589450754,1.075617415,gold,SYNGR2,SNG2_HUMAN,Synaptogyrin-2 (Cellugyrin),SYNGR2 UNQ352/PRO615,9144;,"ENST00000225777.8; ENSP00000225777.2; ENSG00000108639.8. [O43760-1];""ENST00000585591.5; ENSP00000465678.1; ENSG00000108639.8. [O43760-1]"";""ENST00000588282.5; ENSP00000467600.1; ENSG00000108639.8. [O43760-2]"";",0,regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499],extracellular exosome [GO:0070062]; lipid droplet [GO:0005811]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]
O43426,C2,1.042249403,0.475165223,-0.279542704,-0.217800929,-0.405891303,aquamarine,SYNJ1,SYNJ1_HUMAN,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)",SYNJ1 KIAA0910,8867;,"ENST00000357345.7; ENSP00000349903.3; ENSG00000159082.18. [O43426-4];""ENST00000674204.1; ENSP00000501504.1; ENSG00000159082.18. [O43426-2]"";""ENST00000674308.1; ENSP00000501426.1; ENSG00000159082.18. [O43426-1]"";""ENST00000674351.1; ENSP00000501530.1; ENSG00000159082.18. [O43426-2]"";","inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]",inositol phosphate metabolic process [GO:0043647]; learning [GO:0007612]; membrane organization [GO:0061024]; neurotransmitter transport [GO:0006836]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of endosome organization [GO:1904980]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]
P57105,M2,-0.581439042,-0.964068041,0.379291092,0.980953746,-0.154143991,tan4,SYNJ2BP,SYJ2B_HUMAN,Synaptojanin-2-binding protein (Mitochondrial outer membrane protein 25),SYNJ2BP OMP25,55333;,ENST00000256366.6; ENSP00000256366.4; ENSG00000213463.5.;,0,negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; protein targeting [GO:0006605]; regulation of endocytosis [GO:0030100]; regulation of Notch signaling pathway [GO:0008593]; Rho protein signal transduction [GO:0007266],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q9UMZ2,C2,1.507965519,0.215433496,-0.478009346,-0.205257391,-0.067663446,aquamarine,SYNRG,SYNRG_HUMAN,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),SYNRG AP1GBP1 SYNG,11276;,"ENST00000610513.2; ENSP00000478707.1; ENSG00000274047.4. [Q9UMZ2-6];""ENST00000612223.5; ENSP00000483453.1; ENSG00000275066.5. [Q9UMZ2-1]"";""ENST00000613407.4; ENSP00000483152.1; ENSG00000274047.4. [Q9UMZ2-7]"";""ENST00000614941.4; ENSP00000481151.1; ENSG00000275066.5. [Q9UMZ2-6]"";""ENST00000616179.4; ENSP00000482962.1; ENSG00000275066.5. [Q9UMZ2-9]"";""ENST00000618176.4; ENSP00000482597.1; ENSG00000274047.4. [Q9UMZ2-4]"";""ENST00000618402.4; ENSP00000480288.1; ENSG00000274047.4. [Q9UMZ2-1]"";""ENST00000619541.4; ENSP00000477885.1; ENSG00000275066.5. [Q9UMZ2-8]"";""ENST00000621136.4; ENSP00000484529.1; ENSG00000275066.5. [Q9UMZ2-4]"";""ENST00000622045.4; ENSP00000483063.1; ENSG00000275066.5. [Q9UMZ2-7]"";""ENST00000632841.1; ENSP00000487672.1; ENSG00000274047.4. [Q9UMZ2-9]"";""ENST00000633429.1; ENSP00000488473.1; ENSG00000274047.4. [Q9UMZ2-8]"";",0,endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],AP-1 adaptor complex [GO:0030121]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]
Q16563,S1,-0.614612869,-0.659649525,-0.107722297,0.378601603,0.99582948,gold,SYPL1,SYPL1_HUMAN,Synaptophysin-like protein 1 (Pantophysin),SYPL1 SYPL,6856;,"ENST00000011473.6; ENSP00000011473.2; ENSG00000008282.10. [Q16563-1];""ENST00000455385.7; ENSP00000388336.2; ENSG00000008282.10. [Q16563-2]"";",0,chemical synaptic transmission [GO:0007268],extracellular exosome [GO:0070062]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672]
Q8N2H4,S1,-0.515263008,-0.958341585,-0.254952492,0.671588575,0.83773291,gold,SYS1,SYS1_HUMAN,Protein SYS1 homolog,SYS1 C20orf169,90196;,"ENST00000243918.10; ENSP00000243918.5; ENSG00000204070.10. [Q8N2H4-1];""ENST00000372727.5; ENSP00000361812.1; ENSG00000204070.10. [Q8N2H4-1]"";""ENST00000426004.5; ENSP00000416506.1; ENSG00000204070.10. [Q8N2H4-2]"";",0,Golgi to endosome transport [GO:0006895]; Golgi to plasma membrane protein transport [GO:0043001]; protein localization to Golgi apparatus [GO:0034067],cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]
Q86TM6,S2,-1.140967472,-1.169098507,0.183199294,0.700064424,0.542386879,orange,SYVN1,SYVN1_HUMAN,E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1),SYVN1 HRD1 KIAA1810,84447;,"ENST00000294256.12; ENSP00000294256.8; ENSG00000162298.19. [Q86TM6-3];""ENST00000307289.10; ENSP00000302035.6; ENSG00000162298.19. [Q86TM6-2]"";""ENST00000377190.8; ENSP00000366395.3; ENSG00000162298.19. [Q86TM6-1]"";""ENST00000526060.5; ENSP00000436984.1; ENSG00000162298.19. [Q86TM6-3]"";",ATPase binding [GO:0051117]; metal ion binding [GO:0046872]; protein-folding chaperone binding [GO:0051087]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082],"ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytoplasm [GO:0005737]; Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790]
Q7Z422,C2,1.430499872,0.712443742,-0.80850386,-0.708688601,-0.164793244,aquamarine,SZRD1,SZRD1_HUMAN,SUZ RNA-binding domain-containing (SUZ domain-containing protein 1) (Putative MAPK-activating protein PM18/PM20/PM22),SZRD1 C1orf144,26099;,"ENST00000401088.9; ENSP00000383866.4; ENSG00000055070.17. [Q7Z422-1];""ENST00000401089.3; ENSP00000383867.3; ENSG00000055070.17. [Q7Z422-4]"";""ENST00000471507.5; ENSP00000419589.1; ENSG00000055070.17. [Q7Z422-5]"";""ENST00000492354.1; ENSP00000418012.1; ENSG00000055070.17. [Q7Z422-2]"";""ENST00000707363.1; ENSP00000516842.1; ENSG00000291379.1. [Q7Z422-1]"";""ENST00000707364.1; ENSP00000516843.1; ENSG00000291379.1. [Q7Z422-5]"";""ENST00000707365.1; ENSP00000516844.1; ENSG00000291379.1. [Q7Z422-4]"";""ENST00000707370.1; ENSP00000516846.1; ENSG00000291379.1. [Q7Z422-2]"";",0,0,0
Q15750,C5,1.762108312,0.392752297,-0.571122378,-0.593721989,-0.859565605,turquoise3,TAB1,TAB1_HUMAN,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1),TAB1 MAP3K7IP1,10454;,"ENST00000216160.11; ENSP00000216160.6; ENSG00000100324.14. [Q15750-1];""ENST00000331454.3; ENSP00000333049.3; ENSG00000100324.14. [Q15750-2]"";",mitogen-activated protein kinase p38 binding [GO:0048273]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877],aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]
Q9NYJ8,C3,1.745715128,0.314718232,-0.400126731,-0.462853504,-0.876126714,cyan,TAB2,TAB2_HUMAN,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2) (TAB-2) (TGF-beta-activated kinase 1-binding protein 2),TAB2 KIAA0733 MAP3K7IP2,23118;,"ENST00000367456.5; ENSP00000356426.1; ENSG00000055208.20. [Q9NYJ8-1];""ENST00000470466.5; ENSP00000432709.1; ENSG00000055208.20. [Q9NYJ8-2]"";""ENST00000637181.2; ENSP00000490618.1; ENSG00000055208.20. [Q9NYJ8-1]"";",K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular adaptor activity [GO:0060090]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270],defense response to bacterium [GO:0042742]; heart development [GO:0007507]; inflammatory response [GO:0006954]; negative regulation of autophagy [GO:0010507]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein kinase activity [GO:0045860]; response to lipopolysaccharide [GO:0032496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
O95359,C5,1.688633664,0.748712375,-0.739303484,-0.732255186,-0.915535067,turquoise3,TACC2,TACC2_HUMAN,Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1),TACC2,10579;,"ENST00000260733.7; ENSP00000260733.3; ENSG00000138162.19. [O95359-1];""ENST00000334433.7; ENSP00000334280.2; ENSG00000138162.19. [O95359-4]"";""ENST00000358010.5; ENSP00000350701.1; ENSG00000138162.19. [O95359-5]"";""ENST00000360561.7; ENSP00000353763.3; ENSG00000138162.19. [O95359-6]"";""ENST00000369000.5; ENSP00000357996.1; ENSG00000138162.19. [O95359-2]"";""ENST00000369005.6; ENSP00000358001.1; ENSG00000138162.19. [O95359-4]"";""ENST00000513429.5; ENSP00000425062.1; ENSG00000138162.19. [O95359-5]"";",nuclear receptor binding [GO:0016922],cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q9Y6A5,C4,1.965343163,0.430191506,-0.84557817,-1.012364194,-1.3121482,deepskyblue2,TACC3,TACC3_HUMAN,Transforming acidic coiled-coil-containing protein 3 (ERIC-1),TACC3 ERIC1,10460;,"ENST00000313288.9; ENSP00000326550.4; ENSG00000013810.21.;""ENST00000651472.1; ENSP00000498361.1; ENSG00000013810.21."";",0,cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule cytoskeleton organization [GO:0000226]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mitotic spindle organization [GO:0007052]; regulation of mitotic spindle organization [GO:0060236],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]
Q53T94,N1,-0.361907112,-0.709529737,0.319150199,-0.21765109,1.115551204,grey90,TAF1B,TAF1B_HUMAN,TATA box-binding protein-associated factor RNA polymerase I subunit B (RNA polymerase I-specific TBP-associated factor 63 kDa) (TAFI63) (TATA box-binding protein-associated factor 1B) (TBP-associated factor 1B) (Transcription initiation factor SL1/TIF-IB subunit B),TAF1B,9014;,ENST00000263663.10; ENSP00000263663.4; ENSG00000115750.17. [Q53T94-1];,metal ion binding [GO:0046872]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; TBP-class protein binding [GO:0017025],DNA-templated transcription [GO:0006351]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I core factor complex [GO:0070860]; RNA polymerase transcription factor SL1 complex [GO:0005668]
O00268,N4,-1.155799742,0.844338104,0.410373998,-0.5305492,0.105735049,grey30,TAF4,TAF4_HUMAN,Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135),TAF4 TAF2C TAF2C1 TAF4A TAFII130 TAFII135,6874;,ENST00000252996.9; ENSP00000252996.3; ENSG00000130699.20.;,aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; ovarian follicle development [GO:0001541]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],chromatin [GO:0000785]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]
Q15545,C2,1.075145488,0.550376619,-0.066271826,-0.518645748,-0.34613355,aquamarine,TAF7,TAF7_HUMAN,Transcription initiation factor TFIID subunit 7 (RNA polymerase II TBP-associated factor subunit F) (Transcription initiation factor TFIID 55 kDa subunit) (TAF(II)55) (TAFII-55) (TAFII55),TAF7 TAF2F TAFII55,6879;,"ENST00000313368.8; ENSP00000312709.5; ENSG00000178913.9.;""ENST00000624761.2; ENSP00000485510.2; ENSG00000178913.9."";",DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase binding [GO:0035035]; nuclear thyroid hormone receptor binding [GO:0046966]; nuclear vitamin D receptor binding [GO:0042809]; P-TEFb complex binding [GO:0106140]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription cis-regulatory region binding [GO:0000976],DNA-templated transcription initiation [GO:0006352]; intracellular estrogen receptor signaling pathway [GO:0030520]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of MHC class I biosynthetic process [GO:0045344]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spermine transport [GO:0000296]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]
P37802,C4,2.318904227,0.327093389,-1.254667694,-1.430815343,-1.741272483,deepskyblue2,TAGLN2,TAGL2_HUMAN,Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog),TAGLN2 KIAA0120 CDABP0035,8407;,"ENST00000320307.8; ENSP00000357075.1; ENSG00000158710.15. [P37802-1];""ENST00000368096.5; ENSP00000357076.1; ENSG00000158710.15. [P37802-2]"";""ENST00000368097.9; ENSP00000357077.5; ENSG00000158710.15. [P37802-1]"";",actin filament binding [GO:0051015]; cadherin binding [GO:0045296],actin filament organization [GO:0007015]; epithelial cell differentiation [GO:0030855],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982]
P37837,C5,1.452969898,1.136770167,-0.859512965,-1.230699721,-1.47242499,turquoise3,TALDO1,TALDO_HUMAN,Transaldolase (EC 2.2.1.2),TALDO1 TAL TALDO TALDOR,6888;,ENST00000319006.8; ENSP00000321259.3; ENSG00000177156.11. [P37837-1];,monosaccharide binding [GO:0048029]; transaldolase activity [GO:0004801],"carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]
Q96BW9,M2,-0.769357295,-1.052021925,0.350741206,0.844796535,-0.072887748,tan4,TAMM41,TAM41_HUMAN,"Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41)",TAMM41 C3orf31,132001;,"ENST00000273037.9; ENSP00000273037.5; ENSG00000144559.11. [Q96BW9-2];""ENST00000444133.6; ENSP00000388598.2; ENSG00000144559.11. [Q96BW9-1]"";""ENST00000455809.6; ENSP00000398596.1; ENSG00000144559.11. [Q96BW9-3]"";",phosphatidate cytidylyltransferase activity [GO:0004605],cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9C0D5,C2,0.879135961,0.356787425,-0.120335362,0.097067566,-0.273804382,aquamarine,TANC1,TANC1_HUMAN,"Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)",TANC1 KIAA1728,85461;,ENST00000263635.8; ENSP00000263635.6; ENSG00000115183.15. [Q9C0D5-1];,0,dendritic spine maintenance [GO:0097062]; myoblast fusion [GO:0007520]; regulation of postsynapse organization [GO:0099175]; visual learning [GO:0008542],axon terminus [GO:0043679]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]
Q6ICL3,C5,2.033585106,0.263398394,-0.828372623,-0.636447004,-1.364987164,turquoise3,TANGO2,TNG2_HUMAN,Transport and Golgi organization protein 2 homolog,TANGO2 C22orf25,128989;,"ENST00000327374.9; ENSP00000332721.4; ENSG00000183597.16. [Q6ICL3-1];""ENST00000398042.6; ENSP00000381122.2; ENSG00000183597.16. [Q6ICL3-2]"";""ENST00000401833.5; ENSP00000384827.1; ENSG00000183597.16. [Q6ICL3-4]"";""ENST00000401886.5; ENSP00000385662.1; ENSG00000183597.16. [Q6ICL3-2]"";""ENST00000432883.5; ENSP00000402926.2; ENSG00000183597.16. [Q6ICL3-5]"";""ENST00000434570.6; ENSP00000391262.2; ENSG00000183597.16. [Q6ICL3-6]"";""ENST00000456048.5; ENSP00000403645.2; ENSG00000183597.16. [Q6ICL3-4]"";",0,Golgi organization [GO:0007030]; protein secretion [GO:0009306],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]
Q92844,C3,1.766536825,0.389850102,-0.656976763,-0.610264911,-1.046103659,cyan,TANK,TANK_HUMAN,TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein) (I-TRAF),TANK ITRAF TRAF2,10010;,"ENST00000259075.6; ENSP00000259075.2; ENSG00000136560.14. [Q92844-1];""ENST00000392749.7; ENSP00000376505.2; ENSG00000136560.14. [Q92844-1]"";""ENST00000403609.1; ENSP00000385983.1; ENSG00000136560.14. [Q92844-3]"";",deubiquitinase activator activity [GO:0035800]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; molecular function inhibitor activity [GO:0140678]; ubiquitin protein ligase binding [GO:0031625],cellular response to interleukin-1 [GO:0071347]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; DNA damage response [GO:0006974]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of type I interferon production [GO:0032481]; positive regulation of ubiquitin-specific protease activity [GO:2000158]; signal transduction [GO:0007165]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554]
Q03518,S2,-1.504042151,-1.697944782,0.2369463,0.886343731,0.621048152,orange,TAP1,TAP1_HUMAN,Antigen peptide transporter 1 (APT1) (EC 7.4.2.14) (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1) (PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein) (RING4),TAP1 ABCB2 PSF1 RING4 Y3,6890;,"ENST00000354258.5; ENSP00000346206.5; ENSG00000168394.13. [Q03518-1];""ENST00000383235.4; ENSP00000372722.4; ENSG00000206297.7. [Q03518-2]"";""ENST00000414467.2; ENSP00000405356.2; ENSG00000226173.4. [Q03518-2]"";""ENST00000418205.2; ENSP00000401149.2; ENSG00000227816.4. [Q03518-2]"";""ENST00000424897.2; ENSP00000413080.2; ENSG00000230705.4. [Q03518-2]"";""ENST00000439781.2; ENSP00000415660.2; ENSG00000224212.4. [Q03518-2]"";""ENST00000440894.2; ENSP00000402316.2; ENSG00000232367.5. [Q03518-2]"";",ABC-type peptide antigen transporter activity [GO:0015433]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; MHC class I protein binding [GO:0042288]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; peptide transmembrane transporter activity [GO:1904680]; protein homodimerization activity [GO:0042803]; TAP1 binding [GO:0046978]; TAP2 binding [GO:0046979],adaptive immune response [GO:0002250]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; cytosol to endoplasmic reticulum transport [GO:0046967]; defense response [GO:0006952]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085],centriolar satellite [GO:0034451]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]
Q03519,S2,-1.025416413,-1.51524675,0.1601143,0.979691521,0.712961954,orange,TAP2,TAP2_HUMAN,Antigen peptide transporter 2 (APT2) (EC 7.4.2.14) (ATP-binding cassette sub-family B member 3) (Peptide supply factor 2) (Peptide transporter PSF2) (PSF-2) (Peptide transporter TAP2) (Peptide transporter involved in antigen processing 2) (Really interesting new gene 11 protein) (RING11),TAP2 ABCB3 PSF2 RING11 Y1,6891;,"ENST00000374897.4; ENSP00000364032.3; ENSG00000204267.19. [Q03519-1];""ENST00000383118.8; ENSP00000372599.4; ENSG00000206235.8. [Q03519-1]"";""ENST00000383119.8; ENSP00000372600.4; ENSG00000206235.8. [Q03519-2]"";""ENST00000383239.8; ENSP00000372726.4; ENSG00000206299.8. [Q03519-1]"";""ENST00000383240.8; ENSP00000372727.4; ENSG00000206299.8. [Q03519-2]"";""ENST00000414145.6; ENSP00000401377.2; ENSG00000228582.9. [Q03519-2]"";""ENST00000419142.6; ENSP00000390013.2; ENSG00000237599.9."";""ENST00000426977.2; ENSP00000387553.2; ENSG00000232326.9. [Q03519-2]"";""ENST00000439425.6; ENSP00000396156.2; ENSG00000225967.9. [Q03519-2]"";""ENST00000443713.6; ENSP00000394101.2; ENSG00000228582.9. [Q03519-1]"";""ENST00000451907.2; ENSP00000392172.2; ENSG00000223481.9. [Q03519-2]"";""ENST00000652259.1; ENSP00000498827.1; ENSG00000204267.19. [Q03519-2]"";""ENST00000698440.1; ENSP00000513722.1; ENSG00000204267.19. [Q03519-1]"";""ENST00000698448.1; ENSP00000513733.1; ENSG00000204267.19. [Q03519-1]"";",ABC-type peptide antigen transporter activity [GO:0015433]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; MHC class Ib protein binding [GO:0023029]; peptide antigen binding [GO:0042605]; TAP1 binding [GO:0046978]; tapasin binding [GO:0046980],"antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent [GO:0002485]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent [GO:0002489]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; cytosol to endoplasmic reticulum transport [GO:0046967]; peptide antigen transport [GO:0046968]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein transport [GO:0015031]; response to molecule of bacterial origin [GO:0002237]; T cell mediated cytotoxicity [GO:0001913]; transmembrane transport [GO:0055085]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear speck [GO:0016607]; phagocytic vesicle membrane [GO:0030670]; TAP complex [GO:0042825]
Q6NXT6,S2,-1.265570563,-1.594667174,0.171099713,0.95903439,0.531433318,orange,TAPT1,TAPT1_HUMAN,Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor),TAPT1 CMVFR,202018;,ENST00000405303.7; ENSP00000385347.2; ENSG00000169762.17. [Q6NXT6-1];,growth hormone-releasing hormone receptor activity [GO:0016520],cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654]
P26639,C4,2.04516116,0.113251956,-0.963313446,-1.177110876,-1.174799585,deepskyblue2,TARS,SYTC_HUMAN,"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)",TARS1 TARS,6897;,"ENST00000265112.8; ENSP00000265112.3; ENSG00000113407.14. [P26639-1];""ENST00000455217.6; ENSP00000387710.2; ENSG00000113407.14. [P26639-2]"";""ENST00000502553.5; ENSP00000424387.1; ENSG00000113407.14. [P26639-1]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],threonyl-tRNA aminoacylation [GO:0006435],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9BW92,M1,-0.894540514,-0.218023858,0.414798188,0.853044602,-0.380189792,burlywood4,TARS2,SYTM_HUMAN,"Threonine--tRNA ligase, mitochondrial (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like 1)",TARS2 TARSL1,80222;,"ENST00000369054.6; ENSP00000358050.2; ENSG00000143374.18. [Q9BW92-2];""ENST00000369064.8; ENSP00000358060.3; ENSG00000143374.18. [Q9BW92-1]"";",aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; threonine-tRNA ligase activity [GO:0004829],mitochondrial threonyl-tRNA aminoacylation [GO:0070159]; threonyl-tRNA aminoacylation [GO:0006435],mitochondrial matrix [GO:0005759]
Q9H6P5,N1,-1.041633706,0.633420433,-0.3096787,-0.569588236,0.834645181,grey90,TASP1,TASP1_HUMAN,Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta],TASP1 C20orf13,55617;,ENST00000337743.9; ENSP00000338624.4; ENSG00000089123.16. [Q9H6P5-1];,identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298],epigenetic regulation of gene expression [GO:0040029]; positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q6P1N9,C5,1.693547178,0.297434874,-0.792362038,-0.47220442,-1.004985135,turquoise3,TATDN1,TATD1_HUMAN,Deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein),TATDN1 CDA11,83940;,"ENST00000276692.11; ENSP00000276692.6; ENSG00000147687.19. [Q6P1N9-1];""ENST00000519548.5; ENSP00000428336.1; ENSG00000147687.19. [Q6P1N9-2]"";""ENST00000708478.1; ENSP00000517241.1; ENSG00000291730.1. [Q6P1N9-1]"";""ENST00000708482.1; ENSP00000517244.1; ENSG00000291730.1. [Q6P1N9-2]"";",3'-5'-DNA exonuclease activity [GO:0008296]; metal ion binding [GO:0046872],0,nucleoplasm [GO:0005654]
Q17R31,C5,1.420549205,0.47143498,-0.408773331,-0.306343897,-0.658550273,turquoise3,TATDN3,TATD3_HUMAN,Putative deoxyribonuclease TATDN3 (EC 3.1.21.-),TATDN3,128387;,"ENST00000366973.8; ENSP00000355940.4; ENSG00000203705.11. [Q17R31-2];""ENST00000366974.9; ENSP00000355941.4; ENSG00000203705.11. [Q17R31-1]"";""ENST00000526641.5; ENSP00000434801.1; ENSG00000203705.11. [Q17R31-4]"";""ENST00000531963.5; ENSP00000433755.1; ENSG00000203705.11. [Q17R31-5]"";""ENST00000532324.5; ENSP00000431376.1; ENSG00000203705.11. [Q17R31-3]"";",metal ion binding [GO:0046872]; nuclease activity [GO:0004518],0,nucleus [GO:0005634]
O14907,C3,1.441388649,0.182392886,-0.420111119,-0.330408563,-0.706002754,cyan,TAX1BP3,TX1B3_HUMAN,Tax1-binding protein 3 (Glutaminase-interacting protein 3) (Tax interaction protein 1) (TIP-1) (Tax-interacting protein 1),TAX1BP3 TIP1,30851;,ENST00000225525.4; ENSP00000225525.3; ENSG00000213977.8.;,beta-catenin binding [GO:0008013],activation of GTPase activity [GO:0090630]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of Wnt signaling pathway [GO:0030178]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway [GO:0016055],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]
Q86TI0,C3,1.662505782,-0.161595834,-0.499486587,-0.356571201,-0.470739718,cyan,TBC1D1,TBCD1_HUMAN,TBC1 domain family member 1,TBC1D1 KIAA1108,23216;,"ENST00000261439.9; ENSP00000261439.4; ENSG00000065882.18. [Q86TI0-1];""ENST00000508802.5; ENSP00000423651.1; ENSG00000065882.18. [Q86TI0-2]"";",GTPase activator activity [GO:0005096],0,nucleus [GO:0005634]
Q9NVG8,C5,1.906398216,0.605868662,-0.776214807,-0.808883806,-0.991611362,turquoise3,TBC1D13,TBC13_HUMAN,TBC1 domain family member 13,TBC1D13,54662;,"ENST00000223865.8; ENSP00000223865.8; ENSG00000107021.16. [Q9NVG8-2];""ENST00000372648.10; ENSP00000361731.5; ENSG00000107021.16. [Q9NVG8-1]"";",GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],intracellular protein transport [GO:0006886],cytosol [GO:0005829]; membrane [GO:0016020]
Q9BYX2,C3,1.715132403,0.130893546,-0.474425911,-0.387763207,-0.506992809,cyan,TBC1D2,TBD2A_HUMAN,TBC1 domain family member 2A (Armus) (Prostate antigen recognized and identified by SEREX 1) (PARIS-1),TBC1D2 PARIS1 PP8997 TBC1D2A,55357;,"ENST00000342112.9; ENSP00000341567.5; ENSG00000095383.20. [Q9BYX2-4];""ENST00000375063.5; ENSP00000364203.1; ENSG00000095383.20. [Q9BYX2-6]"";""ENST00000375064.5; ENSP00000364205.1; ENSG00000095383.20. [Q9BYX2-3]"";""ENST00000375066.6; ENSP00000364207.5; ENSG00000095383.20. [Q9BYX2-2]"";""ENST00000465784.7; ENSP00000481721.1; ENSG00000095383.20. [Q9BYX2-1]"";",cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096],positive regulation of GTPase activity [GO:0043547],anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q96BZ9,S2,-1.030635946,-1.00297734,0.234345249,0.741727334,0.608888315,orange,TBC1D20,TBC20_HUMAN,TBC1 domain family member 20,TBC1D20 C20orf140,128637;,"ENST00000354200.5; ENSP00000346139.4; ENSG00000125875.15. [Q96BZ9-1];""ENST00000461304.5; ENSP00000432280.1; ENSG00000125875.15. [Q96BZ9-1]"";""ENST00000679741.1; ENSP00000504904.1; ENSG00000125875.15. [Q96BZ9-1]"";""ENST00000679944.1; ENSP00000506278.1; ENSG00000125875.15. [Q96BZ9-1]"";""ENST00000680106.1; ENSP00000505500.1; ENSG00000125875.15. [Q96BZ9-1]"";""ENST00000680284.1; ENSP00000506231.1; ENSG00000125875.15. [Q96BZ9-1]"";""ENST00000680792.1; ENSP00000506012.1; ENSG00000125875.15. [Q96BZ9-1]"";""ENST00000681539.1; ENSP00000505557.1; ENSG00000125875.15. [Q96BZ9-1]"";""ENST00000681636.1; ENSP00000506155.1; ENSG00000125875.15. [Q96BZ9-1]"";""ENST00000681742.1; ENSP00000506122.1; ENSG00000125875.15. [Q96BZ9-1]"";",GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],acrosome assembly [GO:0001675]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lens fiber cell morphogenesis [GO:0070309]; lipid droplet organization [GO:0034389]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of GTPase activity [GO:0043547]; seminiferous tubule development [GO:0072520]; virion assembly [GO:0019068],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]
Q8WUA7,C1,1.539284105,0.284143034,-0.260528698,-0.421291314,-0.625168679,lightblue,TBC1D22A,TB22A_HUMAN,TBC1 domain family member 22A,TBC1D22A C22orf4,25771;,"ENST00000337137.9; ENSP00000336724.4; ENSG00000054611.14. [Q8WUA7-1];""ENST00000355704.7; ENSP00000347932.3; ENSG00000054611.14. [Q8WUA7-2]"";""ENST00000406733.1; ENSP00000385634.1; ENSG00000054611.14. [Q8WUA7-4]"";""ENST00000441162.5; ENSP00000406214.1; ENSG00000054611.14. [Q8WUA7-3]"";",14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803],0,0
Q9UPU7,C3,1.715011312,0.113010861,-0.639768274,-0.54784543,-0.793678248,cyan,TBC1D2B,TBD2B_HUMAN,TBC1 domain family member 2B,TBC1D2B KIAA1055,23102;,"ENST00000300584.8; ENSP00000300584.3; ENSG00000167202.12. [Q9UPU7-1];""ENST00000409931.7; ENSP00000387165.3; ENSG00000167202.12. [Q9UPU7-2]"";",GTPase activator activity [GO:0005096],endocytosis [GO:0006897],cytosol [GO:0005829]; early endosome [GO:0005769]
Q96DN5,S1,-0.695495063,-1.158425224,-0.008191508,0.752716562,0.880850681,gold,TBC1D31,TBC31_HUMAN,TBC1 domain family member 31 (WD repeat-containing protein 67),TBC1D31 WDR67,93594;,"ENST00000287380.6; ENSP00000287380.1; ENSG00000156787.17. [Q96DN5-1];""ENST00000327098.9; ENSP00000312701.5; ENSG00000156787.17. [Q96DN5-3]"";",molecular adaptor activity [GO:0060090],cilium assembly [GO:0060271],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]
Q92609,C2,0.947615601,0.269804398,-0.273997727,-0.034501925,-0.04178545,aquamarine,TBC1D5,TBCD5_HUMAN,TBC1 domain family member 5,TBC1D5 KIAA0210,9779;,"ENST00000253692.11; ENSP00000253692.6; ENSG00000131374.15. [Q92609-1];""ENST00000429383.8; ENSP00000398127.4; ENSG00000131374.15. [Q92609-1]"";""ENST00000446818.6; ENSP00000402935.2; ENSG00000131374.15. [Q92609-2]"";""ENST00000696125.1; ENSP00000512418.1; ENSG00000131374.15. [Q92609-2]"";",AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394],"autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]",autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904]
Q99426,C4,1.841649845,0.386391871,-0.950352867,-1.016431687,-1.263922432,deepskyblue2,TBCB,TBCB_HUMAN,Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B),TBCB CG22 CKAP1,1155;,"ENST00000221855.8; ENSP00000221855.3; ENSG00000105254.12. [Q99426-1];""ENST00000585746.1; ENSP00000467487.1; ENSG00000105254.12. [Q99426-2]"";",alpha-tubulin binding [GO:0043014]; microtubule plus-end binding [GO:0051010],cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]
Q15814,C3,1.881598077,0.159746614,-0.575163524,-0.583645262,-0.922447118,cyan,TBCC,TBCC_HUMAN,Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC),TBCC,6903;,ENST00000372876.2; ENSP00000361967.1; ENSG00000124659.7.;,GTPase activity [GO:0003924]; protein-folding chaperone binding [GO:0051087]; tubulin binding [GO:0015631],post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microtubule [GO:0005874]; photoreceptor connecting cilium [GO:0032391]
Q15813,C4,1.877601705,-0.078374261,-0.700950375,-0.721946887,-1.055064459,deepskyblue2,TBCE,TBCE_HUMAN,Tubulin-specific chaperone E (Tubulin-folding cofactor E),TBCE,6905;,"ENST00000406207.5; ENSP00000384571.1; ENSG00000284770.2. [Q15813-1];""ENST00000543662.4; ENSP00000439170.1; ENSG00000284770.2. [Q15813-2]"";""ENST00000642610.2; ENSP00000494796.1; ENSG00000284770.2. [Q15813-1]"";",alpha-tubulin binding [GO:0043014]; protein-folding chaperone binding [GO:0051087],adult locomotory behavior [GO:0008344]; developmental growth [GO:0048589]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; muscle atrophy [GO:0014889]; peripheral nervous system neuron axonogenesis [GO:0048936]; post-chaperonin tubulin folding pathway [GO:0007023]; post-embryonic development [GO:0009791]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],cytoplasm [GO:0005737]; microtubule [GO:0005874]
Q5QJ74,C1,1.698513214,0.264710929,-0.582881342,-0.42905674,-0.863153837,lightblue,TBCEL,TBCEL_HUMAN,Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35),TBCEL LRRC35,219899;,"ENST00000422003.6; ENSP00000403925.2; ENSG00000154114.13.;""ENST00000529397.5; ENSP00000437184.1; ENSG00000154114.13."";""ENST00000683345.1; ENSP00000507873.1; ENSG00000154114.13."";",alpha-tubulin binding [GO:0043014],microtubule cytoskeleton organization [GO:0000226]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]
Q9UHD2,C1,1.461781462,-0.056984715,-0.365610936,-0.237489211,-0.418942881,lightblue,TBK1,TBK1_HUMAN,Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1),TBK1 NAK,29110;,"ENST00000331710.10; ENSP00000329967.5; ENSG00000183735.11.;""ENST00000650790.1; ENSP00000498995.1; ENSG00000183735.11."";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554]
Q9BZK7,N4,0.243513558,1.228176171,-0.065156704,-0.713956107,-0.854478961,grey30,TBL1XR1,TBL1R_HUMAN,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),TBL1XR1 IRA1 TBLR1,79718;,"ENST00000352800.10; ENSP00000263964.11; ENSG00000177565.19.;""ENST00000422066.6; ENSP00000398477.2; ENSG00000177565.19."";""ENST00000422442.6; ENSP00000387849.3; ENSG00000177565.19."";""ENST00000430069.5; ENSP00000405574.1; ENSG00000177565.19."";""ENST00000457928.7; ENSP00000413251.3; ENSG00000177565.19."";""ENST00000673974.1; ENSP00000501274.1; ENSG00000177565.19."";""ENST00000704383.1; ENSP00000515885.1; ENSG00000177565.19."";""ENST00000704384.1; ENSP00000515886.1; ENSG00000177565.19."";""ENST00000704385.1; ENSP00000515887.1; ENSG00000177565.19."";",beta-catenin binding [GO:0008013]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]
Q9Y4P3,S2,-0.972460284,-1.211093383,0.155472619,0.909711168,0.488603451,orange,TBL2,TBL2_HUMAN,Transducin beta-like protein 2 (WS beta-transducin repeats protein) (WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein),TBL2 WBSCR13 UNQ563/PRO1125,26608;,ENST00000305632.11; ENSP00000307260.4; ENSG00000106638.18.;,phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369],cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q12788,N3,-0.894240204,-0.827301869,1.194583473,-0.029355073,0.015016406,grey50,TBL3,TBL3_HUMAN,Transducin beta-like protein 3 (WD repeat-containing protein SAZD),TBL3 SAZD,10607;,"ENST00000568546.6; ENSP00000454836.1; ENSG00000183751.16.;""ENST00000709263.1; ENSP00000517587.1; ENSG00000291938.1."";",RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511],"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit biogenesis [GO:0042274]",90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
P62380,C5,0.75368291,1.298917845,-0.408340907,-0.794781822,-1.301097866,turquoise3,TBPL1,TBPL1_HUMAN,TATA box-binding protein-like 1 (TBP-like 1) (21 kDa TBP-like protein) (Second TBP of unique DNA protein) (STUD) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor) (TBP-related protein),TBPL1 TLF TLP TLP21 TRF2 TRP,9519;,"ENST00000237264.9; ENSP00000237264.3; ENSG00000028839.10.;""ENST00000613034.4; ENSP00000478795.1; ENSG00000028839.10."";",general transcription initiation factor activity [GO:0140223]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251],acrosome assembly [GO:0001675]; DNA-templated transcription initiation [GO:0006352]; dTTP biosynthetic process [GO:0006235]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; transcription factor TFIIA complex [GO:0005672]
Q969Z0,M1,-0.84031527,-0.330051447,0.394170859,0.844918106,-0.351415968,burlywood4,TBRG4,FAKD4_HUMAN,FAST kinase domain-containing protein 4 (Cell cycle progression restoration protein 2) (Cell cycle progression protein 2) (Protein TBRG4) (Transforming growth factor beta regulator 4),TBRG4 CPR2 FASTKD4 KIAA0948,9238;,"ENST00000258770.8; ENSP00000258770.3; ENSG00000136270.14. [Q969Z0-1];""ENST00000361278.7; ENSP00000354992.3; ENSG00000136270.14. [Q969Z0-2]"";""ENST00000395655.8; ENSP00000379016.4; ENSG00000136270.14. [Q969Z0-2]"";""ENST00000494076.5; ENSP00000420597.1; ENSG00000136270.14. [Q969Z0-1]"";",RNA binding [GO:0003723],mitochondrial mRNA processing [GO:0090615]; mitochondrial RNA processing [GO:0000963]; mRNA metabolic process [GO:0016071]; positive regulation of cell population proliferation [GO:0008284]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial mRNA stability [GO:0044528],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]
Q15369,C5,1.513163242,0.845020476,-0.756140852,-0.917979962,-0.69733527,turquoise3,TCEB1,ELOC_HUMAN,Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1),ELOC TCEB1,6921;,"ENST00000284811.12; ENSP00000284811.8; ENSG00000154582.18. [Q15369-1];""ENST00000518127.5; ENSP00000428334.1; ENSG00000154582.18. [Q15369-1]"";""ENST00000520210.1; ENSP00000430224.1; ENSG00000154582.18. [Q15369-2]"";""ENST00000520242.6; ENSP00000428171.1; ENSG00000154582.18. [Q15369-1]"";""ENST00000522337.5; ENSP00000429906.1; ENSG00000154582.18. [Q15369-1]"";""ENST00000523815.5; ENSP00000428074.1; ENSG00000154582.18. [Q15369-1]"";""ENST00000622804.2; ENSP00000478121.1; ENSG00000154582.18. [Q15369-1]"";""ENST00000687224.1; ENSP00000509184.1; ENSG00000154582.18. [Q15369-1]"";""ENST00000688584.1; ENSP00000509989.1; ENSG00000154582.18. [Q15369-2]"";",protein-macromolecule adaptor activity [GO:0030674]; transcription corepressor binding [GO:0001222],protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; target-directed miRNA degradation [GO:0140958]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]
O14776,N4,-0.935133158,1.131103582,0.091840024,-0.564452454,-0.458879514,grey30,TCERG1,TCRG1_HUMAN,Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150),TCERG1 CA150 TAF2S,10915;,"ENST00000296702.9; ENSP00000296702.5; ENSG00000113649.14. [O14776-1];""ENST00000394421.7; ENSP00000377943.2; ENSG00000113649.14. [O14776-2]"";",identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation factor activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390],mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UGU0,N2,-1.089916074,-0.533350587,1.173886068,0.150569599,-0.662196506,grey70,TCF20,TCF20_HUMAN,Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein),TCF20 KIAA0292 SPBP,6942;,"ENST00000335626.8; ENSP00000335561.4; ENSG00000100207.21. [Q9UGU0-2];""ENST00000359486.8; ENSP00000352463.3; ENSG00000100207.21. [Q9UGU0-1]"";""ENST00000574943.5; ENSP00000460328.1; ENSG00000262024.6. [Q9UGU0-1]"";""ENST00000576946.5; ENSP00000460587.1; ENSG00000262024.6. [Q9UGU0-2]"";""ENST00000619505.3; ENSP00000478503.2; ENSG00000276461.4. [Q9UGU0-2]"";""ENST00000621408.4; ENSP00000483199.1; ENSG00000276461.4. [Q9UGU0-1]"";""ENST00000677622.1; ENSP00000503828.1; ENSG00000100207.21. [Q9UGU0-1]"";""ENST00000683686.1; ENSP00000508272.1; ENSG00000100207.21. [Q9UGU0-1]"";",DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BQ70,S3,0.077444508,-0.407941233,0.056419381,0.558412228,0.40274107,salmon,TCF25,TCF25_HUMAN,Ribosome quality control complex subunit TCF25 (Nuclear localized protein 1) (Transcription factor 25) (TCF-25),TCF25 KIAA1049 NULP1 FKSG26,22980;,"ENST00000263346.13; ENSP00000263346.8; ENSG00000141002.20.;""ENST00000640279.1; ENSP00000491638.1; ENSG00000141002.20."";",DNA binding [GO:0003677]; transcription corepressor activity [GO:0003714],heart development [GO:0007507]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of protein K48-linked ubiquitination [GO:0061945]; rescue of stalled ribosome [GO:0072344],cytosol [GO:0005829]; nucleus [GO:0005634]; RQC complex [GO:1990112]
Q13488,S1,-0.893454487,-1.0865657,-0.311108182,0.691930336,0.995301801,gold,TCIRG1,VPP3_HUMAN,V-type proton ATPase 116 kDa subunit a 3 (V-ATPase 116 kDa subunit a 3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3),TCIRG1 ATP6N1C ATP6V0A3,10312;,"ENST00000265686.8; ENSP00000265686.3; ENSG00000110719.11. [Q13488-1];""ENST00000532635.5; ENSP00000434407.1; ENSG00000110719.11. [Q13488-2]"";","ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; B cell differentiation [GO:0030183]; bone resorption [GO:0045453]; cellular defense response [GO:0006968]; cellular response to cytokine stimulus [GO:0071345]; dentin mineralization [GO:0097188]; enamel mineralization [GO:0070166]; establishment of cell polarity [GO:0030010]; establishment of vesicle localization [GO:0051650]; gene expression [GO:0010467]; hematopoietic stem cell homeostasis [GO:0061484]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; lysosomal lumen acidification [GO:0007042]; macroautophagy [GO:0016236]; memory T cell activation [GO:0035709]; optic nerve development [GO:0021554]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; pH reduction [GO:0045851]; phagosome acidification [GO:0090383]; positive regulation of cell population proliferation [GO:0008284]; protein catabolic process in the vacuole [GO:0007039]; protein localization to organelle [GO:0033365]; proton transmembrane transport [GO:1902600]; regulation of gene expression [GO:0010468]; regulation of insulin secretion [GO:0050796]; regulation of osteoblast differentiation [GO:0045667]; regulation of proton transport [GO:0010155]; response to silver ion [GO:0010272]; retina development in camera-type eye [GO:0060041]; ruffle organization [GO:0031529]; T cell differentiation [GO:0030217]; T cell homeostasis [GO:0043029]; T-helper 1 cell activation [GO:0035711]; tooth eruption [GO:0044691]; vacuolar acidification [GO:0007035],"apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; ficolin-1-rich granule membrane [GO:0101003]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase complex [GO:0033176]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]"
Q13428,N4,-1.123497537,0.666620214,0.661982292,-0.45603661,-0.187462924,grey30,TCOF1,TCOF_HUMAN,Treacle protein (Treacher Collins syndrome protein),TCOF1,6949;,"ENST00000323668.11; ENSP00000325223.6; ENSG00000070814.22. [Q13428-2];""ENST00000377797.7; ENSP00000367028.4; ENSG00000070814.22. [Q13428-1]"";""ENST00000394269.7; ENSP00000377811.3; ENSG00000070814.22. [Q13428-5]"";""ENST00000427724.7; ENSP00000390717.3; ENSG00000070814.22. [Q13428-6]"";""ENST00000439160.6; ENSP00000406888.2; ENSG00000070814.22. [Q13428-7]"";""ENST00000445265.6; ENSP00000409944.2; ENSG00000070814.22. [Q13428-8]"";""ENST00000504761.6; ENSP00000421655.2; ENSG00000070814.22. [Q13428-1]"";""ENST00000643257.2; ENSP00000493815.1; ENSG00000070814.22. [Q13428-3]"";",protein heterodimerization activity [GO:0046982]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110],neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; regulation of translation [GO:0006417]; skeletal system development [GO:0001501],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
P17987,C1,1.077163442,0.404493869,-0.71170526,-0.637446939,0.531016613,lightblue,TCP1,TCPA_HUMAN,T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Chaperonin containing T-complex polypeptide 1 subunit 1),TCP1 CCT1 CCTA,6950;,ENST00000321394.12; ENSP00000317334.7; ENSG00000120438.12.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; tubulin complex assembly [GO:0007021],acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]
Q96GX1,S3,-0.700180635,-1.113216304,0.368835916,0.786383329,0.492117298,salmon,TCTN2,TECT2_HUMAN,Tectonic-2,TCTN2 C12orf38 TECT2,79867;,"ENST00000303372.7; ENSP00000304941.5; ENSG00000168778.13. [Q96GX1-1];""ENST00000426174.6; ENSP00000395171.2; ENSG00000168778.13. [Q96GX1-2]"";",0,cilium assembly [GO:0060271]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224],ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; MKS complex [GO:0036038]
Q9Y2W6,M2,-0.799811033,-1.330274192,0.24209107,1.043775137,0.039750832,tan4,TDRKH,TDRKH_HUMAN,Tudor and KH domain-containing protein (Tudor domain-containing protein 2),TDRKH TDRD2,11022;,"ENST00000368822.5; ENSP00000357812.1; ENSG00000182134.17. [Q9Y2W6-2];""ENST00000368824.8; ENSP00000357815.3; ENSG00000182134.17. [Q9Y2W6-2]"";""ENST00000368825.7; ENSP00000357817.3; ENSG00000182134.17. [Q9Y2W6-3]"";""ENST00000368827.10; ENSP00000357819.6; ENSG00000182134.17. [Q9Y2W6-2]"";""ENST00000458431.6; ENSP00000395718.2; ENSG00000182134.17. [Q9Y2W6-2]"";",RNA binding [GO:0003723],fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283],mitochondrion [GO:0005739]; P granule [GO:0043186]; pi-body [GO:0071546]; piP-body [GO:0071547]
O15040,C5,1.278760552,0.582023112,-0.478646604,-0.398542703,-0.561217498,turquoise3,TECPR2,TCPR2_HUMAN,Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297),TECPR2 KIAA0297 KIAA0329,9895;,"ENST00000359520.12; ENSP00000352510.7; ENSG00000196663.16. [O15040-1];""ENST00000558678.1; ENSP00000453671.1; ENSG00000196663.16. [O15040-2]"";",0,autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527],cytoplasm [GO:0005737]
Q9NZ01,S2,-0.987573462,-1.25610566,0.261158582,0.855653197,0.549504726,orange,TECR,TECR_HUMAN,"Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER)",TECR GPSN2 SC2,9524;,ENST00000215567.10; ENSP00000215567.4; ENSG00000099797.15. [Q9NZ01-1];,oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099],fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid metabolic process [GO:0006665]; very long-chain fatty acid biosynthetic process [GO:0042761],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]
P60484,N1,0.368063336,-0.675008703,-0.646435588,-0.406693066,1.28280525,grey90,TEP1,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Inositol polyphosphate 3-phosphatase) (EC 3.1.3.-) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",PTEN MMAC1 TEP1,5728;,"ENST00000371953.8; ENSP00000361021.3; ENSG00000171862.15. [P60484-1];""ENST00000644628.2; ENSP00000494918.2; ENSG00000284792.2. [P60484-1]"";""ENST00000688308.1; ENSP00000508752.1; ENSG00000171862.15. [P60484-1]"";""ENST00000710385.1; ENSP00000518242.1; ENSG00000284792.2. [P60484-1]"";""ENST00000710387.1; ENSP00000518244.1; ENSG00000284792.2. [P60484-2]"";","anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; lipid binding [GO:0008289]; molecular function inhibitor activity [GO:0140678]; myosin phosphatase activity [GO:0017018]; PDZ domain binding [GO:0030165]; phosphatidylinositol phosphate phosphatase activity [GO:0052866]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-specific protease binding [GO:1990381]","adult behavior [GO:0030534]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell migration [GO:0016477]; cell motility [GO:0048870]; cellular response to electrical stimulus [GO:0071257]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; maternal behavior [GO:0042711]; multicellular organismal response to stress [GO:0033555]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of cellular senescence [GO:2000773]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of neuron projection development [GO:0010977]; negative regulation of organ growth [GO:0046621]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing, spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; protein dephosphorylation [GO:0006470]; protein stabilization [GO:0050821]; regulation of neuron projection development [GO:0010975]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein stability [GO:0031647]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; spindle assembly involved in female meiosis [GO:0007056]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]",apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]
Q9NXF1,N3,-1.098184656,-1.252282573,0.965493478,-0.434379977,0.631609622,grey50,TEX10,TEX10_HUMAN,Testis-expressed protein 10,TEX10 L18 Nbla10363,54881;,"ENST00000374902.9; ENSP00000364037.4; ENSG00000136891.14. [Q9NXF1-1];""ENST00000535814.5; ENSP00000444555.1; ENSG00000136891.14. [Q9NXF1-2]"";",0,0,mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8IWB9,S1,-1.266493089,-1.109858139,0.080704853,0.583617365,1.060489875,gold,TEX2,TEX2_HUMAN,Testis-expressed protein 2 (Transmembrane protein 96),TEX2 KIAA1738 TMEM96,55852;,"ENST00000258991.7; ENSP00000258991.3; ENSG00000136478.9. [Q8IWB9-2];""ENST00000583097.5; ENSP00000462665.1; ENSG00000136478.9. [Q8IWB9-1]"";""ENST00000584379.6; ENSP00000463001.1; ENSG00000136478.9. [Q8IWB9-1]"";",lipid binding [GO:0008289],lipid transport [GO:0006869]; signal transduction [GO:0007165]; sphingolipid metabolic process [GO:0006665],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]
Q9Y6I9,S2,-1.056517412,-1.269240404,0.315586451,0.815972226,0.645678319,orange,TEX264,TX264_HUMAN,Testis-expressed protein 264 (Putative secreted protein Zsig11),TEX264 ZSIG11 UNQ337/PRO536,51368;,"ENST00000341333.10; ENSP00000340969.5; ENSG00000164081.13.;""ENST00000395057.5; ENSP00000378497.1; ENSG00000164081.13."";""ENST00000415259.5; ENSP00000396628.1; ENSG00000164081.13."";""ENST00000416589.5; ENSP00000398802.1; ENSG00000164081.13."";""ENST00000457573.5; ENSP00000408186.1; ENSG00000164081.13."";""ENST00000611400.4; ENSP00000477946.1; ENSG00000164081.13."";",signaling receptor activity [GO:0038023],protein-DNA covalent cross-linking repair [GO:0106300]; reticulophagy [GO:0061709],autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; replication fork [GO:0005657]
Q5JUR7,C5,1.210506315,0.902453856,-0.596071311,-0.790388362,-0.923664401,turquoise3,TEX30,TEX30_HUMAN,Testis-expressed protein 30,TEX30 C13orf27,93081;,"ENST00000376027.5; ENSP00000365195.1; ENSG00000151287.17. [Q5JUR7-2];""ENST00000376029.3; ENSP00000365197.3; ENSG00000151287.17. [Q5JUR7-2]"";""ENST00000376032.9; ENSP00000365200.4; ENSG00000151287.17. [Q5JUR7-1]"";",0,0,0
Q00059,M2,-1.121667328,-1.19723423,0.855916792,0.796251729,-0.376570835,tan4,TFAM,TFAM_HUMAN,"Transcription factor A, mitochondrial (mtTFA) (Mitochondrial transcription factor 1) (MtTF1) (Transcription factor 6) (TCF-6) (Transcription factor 6-like 2)",TFAM TCF6 TCF6L2,7019;,"ENST00000373895.7; ENSP00000363002.3; ENSG00000108064.11. [Q00059-2];""ENST00000487519.6; ENSP00000420588.1; ENSG00000108064.11. [Q00059-1]"";",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223],mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrial transcription [GO:0006390]; positive regulation of DNA-templated transcription [GO:0045893]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; transcription initiation at mitochondrial promoter [GO:0006391],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
P05549,N3,-0.579866076,-0.727644602,1.040753414,0.165758165,-0.181887968,grey50,TFAP2A,AP2A_HUMAN,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),TFAP2A AP2TF TFAP2,7020;,"ENST00000319516.8; ENSP00000316516.4; ENSG00000137203.15. [P05549-6];""ENST00000379608.9; ENSP00000368928.3; ENSG00000137203.15. [P05549-5]"";","chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; nuclear receptor corepressor activity [GO:0140536]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; eyelid development in camera-type eye [GO:0061029]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; trigeminal nerve development [GO:0021559],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q92754,N3,-1.110294872,-1.076602716,1.256185967,0.104813689,-0.331711079,grey50,TFAP2C,AP2C_HUMAN,Transcription factor AP-2 gamma (AP2-gamma) (Activating enhancer-binding protein 2 gamma) (Transcription factor ERF-1),TFAP2C,7022;,ENST00000201031.3; ENSP00000201031.2; ENSG00000087510.7. [Q92754-1];,"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]","cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8WVM0,S3,-1.200570908,-1.191301557,0.349378107,0.720161011,0.510592291,salmon,TFB1M,TFB1M_HUMAN,"Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (h-mtTFB) (h-mtTFB1) (hTFB1M) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)",TFB1M CGI-75,51106;,ENST00000367166.5; ENSP00000356134.4; ENSG00000029639.11.;,"DNA binding [GO:0003677]; mitochondrial transcription factor activity [GO:0034246]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; S-adenosyl-L-methionine binding [GO:1904047]",rRNA methylation [GO:0031167]; rRNA modification [GO:0000154]; transcription initiation at mitochondrial promoter [GO:0006391],mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]
Q92734,C4,1.752628155,0.303553553,-0.642238019,-0.734280244,-0.891302433,deepskyblue2,TFG,TFG_HUMAN,Protein TFG (TRK-fused gene protein),TFG,10342;,"ENST00000240851.9; ENSP00000240851.4; ENSG00000114354.15. [Q92734-1];""ENST00000463568.6; ENSP00000419504.2; ENSG00000114354.15. [Q92734-2]"";""ENST00000476228.5; ENSP00000417952.1; ENSG00000114354.15. [Q92734-2]"";""ENST00000487505.6; ENSP00000420797.2; ENSG00000114354.15. [Q92734-1]"";""ENST00000490574.6; ENSP00000419960.1; ENSG00000114354.15. [Q92734-1]"";""ENST00000615993.2; ENSP00000479269.2; ENSG00000114354.15. [Q92734-4]"";""ENST00000620299.5; ENSP00000479981.1; ENSG00000114354.15. [Q92734-3]"";""ENST00000674615.1; ENSP00000502734.1; ENSG00000114354.15. [Q92734-1]"";""ENST00000674645.1; ENSP00000501892.1; ENSG00000114354.15. [Q92734-2]"";""ENST00000674758.1; ENSP00000502502.1; ENSG00000114354.15. [Q92734-2]"";""ENST00000675047.1; ENSP00000502497.1; ENSG00000114354.15. [Q92734-2]"";""ENST00000675243.1; ENSP00000502592.1; ENSG00000114354.15. [Q92734-1]"";""ENST00000675420.1; ENSP00000502516.1; ENSG00000114354.15. [Q92734-2]"";""ENST00000675499.1; ENSP00000502450.1; ENSG00000114354.15. [Q92734-1]"";""ENST00000675543.1; ENSP00000502229.1; ENSG00000114354.15. [Q92734-3]"";""ENST00000675553.1; ENSP00000501815.1; ENSG00000114354.15. [Q92734-1]"";""ENST00000675586.1; ENSP00000502329.1; ENSG00000114354.15. [Q92734-4]"";""ENST00000676111.1; ENSP00000502139.1; ENSG00000114354.15. [Q92734-4]"";""ENST00000676308.1; ENSP00000502697.1; ENSG00000114354.15. [Q92734-4]"";""ENST00000676395.1; ENSP00000502071.1; ENSG00000114354.15. [Q92734-1]"";""ENST00000676431.1; ENSP00000502698.1; ENSG00000114354.15. [Q92734-2]"";",identical protein binding [GO:0042802],COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; intracellular membrane-bounded organelle [GO:0043231]
Q9UBB9,N2,-0.690143865,0.088322238,0.607222264,0.087310593,0.351380641,grey70,TFIP11,TFP11_HUMAN,Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1),TFIP11 STIP HSPC006,24144;,"ENST00000405938.5; ENSP00000384297.1; ENSG00000100109.17. [Q9UBB9-1];""ENST00000407148.5; ENSP00000385861.1; ENSG00000100109.17. [Q9UBB9-1]"";""ENST00000407431.5; ENSP00000383892.1; ENSG00000100109.17. [Q9UBB9-1]"";""ENST00000407690.6; ENSP00000384421.1; ENSG00000100109.17. [Q9UBB9-1]"";""ENST00000619735.4; ENSP00000480171.1; ENSG00000100109.17. [Q9UBB9-1]"";",nucleic acid binding [GO:0003676],"biomineral tissue development [GO:0031214]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA ligase activity [GO:1904876]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; protection from non-homologous end joining at telomere [GO:0031848]; RNA processing [GO:0006396]; spliceosomal complex disassembly [GO:0000390]","catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]"
P02786,S1,-0.970224283,-1.21630969,-0.004390544,0.625267716,1.079328534,gold,TFRC,TFR1_HUMAN,"Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]",TFRC,7037;,"ENST00000360110.9; ENSP00000353224.4; ENSG00000072274.14.;""ENST00000392396.7; ENSP00000376197.3; ENSG00000072274.14."";""ENST00000698280.1; ENSP00000513646.1; ENSG00000072274.14."";""ENST00000698291.1; ENSP00000513654.1; ENSG00000072274.14."";",double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618],acute-phase response [GO:0006953]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of gene expression [GO:0010628]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104],basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]
P36897,S3,0.059896432,-0.603097073,0.131021764,0.755540619,0.388704246,salmon,TGFBR1,TGFR1_HUMAN,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),TGFBR1 ALK5 SKR4,7046;,"ENST00000374990.6; ENSP00000364129.2; ENSG00000106799.14. [P36897-3];""ENST00000374994.9; ENSP00000364133.4; ENSG00000106799.14. [P36897-1]"";""ENST00000552516.5; ENSP00000447297.1; ENSG00000106799.14. [P36897-2]"";","activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]",activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; peptidyl-serine phosphorylation [GO:0018105]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060],activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]
P37173,S3,-0.664807421,-1.181435676,0.086047726,0.829542519,0.690154162,salmon,TGFBR2,TGFR2_HUMAN,TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II),TGFBR2,7048;,"ENST00000295754.10; ENSP00000295754.5; ENSG00000163513.19. [P37173-1];""ENST00000359013.4; ENSP00000351905.4; ENSG00000163513.19. [P37173-2]"";","activin binding [GO:0048185]; activin receptor activity [GO:0017002]; ATP binding [GO:0005524]; glycosaminoglycan binding [GO:0005539]; kinase activator activity [GO:0019209]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type II [GO:0005026]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type I transforming growth factor beta receptor binding [GO:0034713]; type III transforming growth factor beta receptor binding [GO:0034714]","activation of protein kinase activity [GO:0032147]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; brain development [GO:0007420]; branching involved in blood vessel morphogenesis [GO:0001569]; bronchus morphogenesis [GO:0060434]; cardiac left ventricle morphogenesis [GO:0003214]; cellular response to growth factor stimulus [GO:0071363]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic hemopoiesis [GO:0035162]; endocardial cushion fusion [GO:0003274]; epithelial to mesenchymal transition [GO:0001837]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte growth [GO:0003430]; heart development [GO:0007507]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; inferior endocardial cushion morphogenesis [GO:1905317]; Langerhans cell differentiation [GO:0061520]; lens development in camera-type eye [GO:0002088]; lens fiber cell apoptotic process [GO:1990086]; lung lobe morphogenesis [GO:0060463]; mammary gland morphogenesis [GO:0060443]; membranous septum morphogenesis [GO:0003149]; miRNA transport [GO:1990428]; myeloid dendritic cell differentiation [GO:0043011]; Notch signaling pathway [GO:0007219]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell tolerance induction [GO:0002663]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction to self antigen [GO:0002651]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell proliferation [GO:0072091]; response to cholesterol [GO:0070723]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; secondary palate development [GO:0062009]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; trachea formation [GO:0060440]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; vasculogenesis [GO:0001570]; ventricular septum morphogenesis [GO:0060412]",caveola [GO:0005901]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021]
Q8WUH2,C2,0.890406497,0.609273749,-0.403930026,-0.070615432,-0.258085288,aquamarine,TGFBRAP1,TGFA1_HUMAN,Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1),TGFBRAP1,9392;,"ENST00000393359.7; ENSP00000377027.2; ENSG00000135966.14.;""ENST00000595531.5; ENSP00000471434.2; ENSG00000135966.14."";",SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160],autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of DNA-templated transcription [GO:0006355]; regulation of SNARE complex assembly [GO:0035542]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]
O43493,S1,-1.750000849,-1.934127868,-0.354546144,0.798947628,1.174990425,gold,TGOLN2,TGON2_HUMAN,Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46) (TGN38 homolog) (hTGN46) (Trans-Golgi network glycoprotein 48) (hTGN48) (Trans-Golgi network glycoprotein 51) (hTGN51) (Trans-Golgi network protein 2),TGOLN2 TGN46 TGN51,10618;,"ENST00000377386.8; ENSP00000366603.3; ENSG00000152291.15. [O43493-2];""ENST00000398263.6; ENSP00000381312.2; ENSG00000152291.15. [O43493-4]"";""ENST00000409015.5; ENSP00000387035.1; ENSG00000152291.15. [O43493-7]"";""ENST00000444342.2; ENSP00000391190.2; ENSG00000152291.15. [O43493-5]"";""ENST00000710332.1; ENSP00000518212.1; ENSG00000292253.1. [O43493-4]"";",0,0,clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]
Q6YHU6,C3,1.785977744,-0.275748751,-0.716609766,-0.630776622,-0.705817638,cyan,THADA,THADA_HUMAN,tRNA (32-2'-O)-methyltransferase regulator THADA (Gene inducing thyroid adenomas protein) (Thyroid adenoma-associated protein),THADA GITA KIAA1767,63892;,"ENST00000402360.6; ENSP00000385441.2; ENSG00000115970.19. [Q6YHU6-5];""ENST00000404790.5; ENSP00000384266.1; ENSG00000115970.19. [Q6YHU6-6]"";""ENST00000405006.8; ENSP00000385995.4; ENSG00000115970.19. [Q6YHU6-1]"";""ENST00000405975.7; ENSP00000386088.2; ENSG00000115970.19. [Q6YHU6-1]"";",enzyme regulator activity [GO:0030234],adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]; tRNA nucleoside ribose methylation [GO:0002128],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]
Q96EK4,N1,-1.671034646,-1.035990814,0.198116071,-0.537502839,1.488702812,grey90,THAP11,THA11_HUMAN,THAP domain-containing protein 11,THAP11 HRIHFB2206,57215;,ENST00000303596.3; ENSP00000304689.1; ENSG00000168286.3.;,"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",cell population proliferation [GO:0008283]; electron transport chain [GO:0022900]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; regulation of mitochondrial transcription [GO:1903108]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q8WY91,N1,-0.999680151,-0.413205906,-0.285543949,-0.001917245,1.349572203,grey90,THAP4,THAP4_HUMAN,Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric Homo sapiens nitrobindin) (Hs-Nb(III)) (THAP domain-containing protein 4),THAP4 CGI-36 PP238,51078;,"ENST00000402136.5; ENSP00000385931.1; ENSG00000176946.13. [Q8WY91-2];""ENST00000407315.6; ENSP00000385006.1; ENSG00000176946.13. [Q8WY91-1]"";",DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213],nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570],cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q8WUY1,S2,-1.324619213,-1.698387213,0.290708271,0.836239891,0.539356227,orange,THEM6,THEM6_HUMAN,Protein THEM6 (Mesenchymal stem cell protein DSCD75) (Thioesterase superfamily member 6),THEM6 C8orf55 PSEC0098,51337;,ENST00000336138.4; ENSP00000338607.3; ENSG00000130193.8.;,0,0,extracellular region [GO:0005576]
Q9NWX6,C2,1.004494445,0.347404664,-0.19063755,-0.035018041,-0.731167055,aquamarine,THG1L,THG1_HUMAN,Probable tRNA(His) guanylyltransferase (EC 2.7.7.79) (Induced in high glucose-1) (IHG-1) (Interphase cytoplasmic foci protein 45) (tRNA-histidine guanylyltransferase),THG1L ICF45,54974;,ENST00000231198.12; ENSP00000231198.7; ENSG00000113272.14.;,ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; tRNA guanylyltransferase activity [GO:0008193],mitochondrial fusion [GO:0008053]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; stress-induced mitochondrial fusion [GO:1990046]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; transferase complex [GO:1990234]
P52888,C5,1.891484878,0.624852512,-0.901796727,-0.981465004,-1.090926144,turquoise3,THOP1,THOP1_HUMAN,Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78),THOP1,7064;,"ENST00000307741.11; ENSP00000304467.5; ENSG00000172009.15. [P52888-1];""ENST00000395212.8; ENSP00000378638.3; ENSG00000172009.15. [P52888-2]"";",metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],peptide metabolic process [GO:0006518]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]
Q9BU02,C1,1.848316428,0.192282254,-0.590416529,-0.47066257,-0.589036905,lightblue,THTPA,THTPA_HUMAN,Thiamine-triphosphatase (ThTPase) (EC 3.6.1.28),THTPA,79178;,"ENST00000288014.7; ENSP00000288014.6; ENSG00000259431.6. [Q9BU02-1];""ENST00000404535.3; ENSP00000384580.3; ENSG00000259431.6. [Q9BU02-1]"";""ENST00000554789.1; ENSP00000450459.1; ENSG00000259431.6. [Q9BU02-2]"";""ENST00000556015.5; ENSP00000451835.1; ENSG00000259431.6. [Q9BU02-2]"";",hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; thiamine triphosphate phosphatase activity [GO:0050333],dephosphorylation [GO:0016311]; generation of precursor metabolites and energy [GO:0006091]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772],cytosol [GO:0005829]
Q9BV44,C4,2.04080531,-0.126773586,-0.985494716,-0.958266948,-1.079961979,deepskyblue2,THUMPD3,THUM3_HUMAN,tRNA (guanine(6)-N2)-methyltransferase THUMP3 (EC 2.1.1.256) (THUMP domain-containing protein 3),THUMPD3,25917;,"ENST00000345094.7; ENSP00000339532.3; ENSG00000134077.16.;""ENST00000452837.7; ENSP00000395893.2; ENSG00000134077.16."";""ENST00000515662.6; ENSP00000424064.1; ENSG00000134077.16."";",tRNA (guanine(6)-N2)-methyltransferase activity [GO:0160117]; tRNA (guanine(7)-N2)-methyltransferase activity [GO:0160118]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA binding [GO:0000049],tRNA methylation [GO:0030488],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]
Q7Z2Z1,N1,-1.011922626,-0.281675209,0.281039868,0.21247567,0.854520845,grey90,TICRR,TICRR_HUMAN,"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)",TICRR C15orf42,90381;,"ENST00000268138.12; ENSP00000268138.7; ENSG00000140534.14. [Q7Z2Z1-1];""ENST00000560985.5; ENSP00000453306.1; ENSG00000140534.14. [Q7Z2Z1-2]"";",chromatin binding [GO:0003682],DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; regulation of DNA-templated DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q4W5G0,N2,-1.081606243,-1.344192197,1.110698408,0.383143136,0.07309563,grey70,TIGD2,TIGD2_HUMAN,Tigger transposable element-derived protein 2,TIGD2,166815;,ENST00000603357.3; ENSP00000486687.1; ENSG00000180346.5.;,DNA binding [GO:0003677],0,nucleus [GO:0005634]
P62072,M2,-0.978499723,-0.413803632,0.278849047,1.068639605,-0.530400657,tan4,TIMM10,TIM10_HUMAN,Mitochondrial import inner membrane translocase subunit Tim10,TIMM10 TIM10,26519;,"ENST00000257245.9; ENSP00000257245.4; ENSG00000134809.9.;""ENST00000525158.1; ENSP00000433627.1; ENSG00000134809.9."";""ENST00000525587.1; ENSP00000435678.1; ENSG00000134809.9."";",membrane insertase activity [GO:0032977]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; zinc ion binding [GO:0008270],protein insertion into mitochondrial inner membrane [GO:0045039]; protein targeting to mitochondrion [GO:0006626]; sensory perception of sound [GO:0007605],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial intermembrane space protein transporter complex [GO:0042719]; mitochondrion [GO:0005739]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]
O60830,M2,-1.390996949,-1.267517556,0.281878056,1.123417039,-0.282031237,tan4,TIMM17B,TI17B_HUMAN,Mitochondrial import inner membrane translocase subunit Tim17-B,TIMM17B TIM17B JM3,10245;,"ENST00000376582.7; ENSP00000365766.3; ENSG00000126768.13. [O60830-1];""ENST00000396779.7; ENSP00000379999.3; ENSG00000126768.13. [O60830-2]"";""ENST00000465150.6; ENSP00000477073.1; ENSG00000126768.13. [O60830-2]"";""ENST00000696123.1; ENSP00000512416.1; ENSG00000126768.13. [O60830-1]"";""ENST00000710084.1; ENSP00000518046.1; ENSG00000292215.1. [O60830-2]"";""ENST00000710085.1; ENSP00000518047.1; ENSG00000292215.1. [O60830-1]"";""ENST00000710086.1; ENSP00000518048.1; ENSG00000292215.1. [O60830-2]"";""ENST00000710087.1; ENSP00000518049.1; ENSG00000292215.1. [O60830-1]"";",protein transmembrane transporter activity [GO:0008320],intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]
Q9BVV7,M2,-1.134579665,-1.305742272,0.345595929,1.158904939,-0.182922419,tan4,TIMM21,TIM21_HUMAN,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)",TIMM21 C18orf55 TIM21 HSPC154,29090;,ENST00000169551.11; ENSP00000169551.6; ENSG00000075336.12.;,0,intracellular protein transport [GO:0006886]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; mitochondrial respiratory chain complex I assembly [GO:0032981]; protein import into mitochondrial matrix [GO:0030150],mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]
Q9Y584,M2,-1.510349654,-1.592854443,0.460460338,1.22922827,-0.269842598,tan4,TIMM22,TIM22_HUMAN,Mitochondrial import inner membrane translocase subunit Tim22 (Testis-expressed protein 4),TIMM22 TEX4 TIM22,29928;,"ENST00000327158.5; ENSP00000320236.2; ENSG00000177370.5.;""ENST00000613269.2; ENSP00000482204.1; ENSG00000278501.2."";""ENST00000617832.2; ENSP00000478463.1; ENSG00000277649.2."";",mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320]; protein transporter activity [GO:0140318],protein insertion into mitochondrial inner membrane [GO:0045039],mitochondrial inner membrane [GO:0005743]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]
O43615,M2,-0.982778891,-0.778600579,0.385662807,0.947659872,-0.158553804,tan4,TIMM44,TIM44_HUMAN,Mitochondrial import inner membrane translocase subunit TIM44,TIMM44 MIMT44 TIM44,10469;,ENST00000270538.8; ENSP00000270538.2; ENSG00000104980.8.;,ATP binding [GO:0005524]; protein-folding chaperone binding [GO:0051087],intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],fibrillar center [GO:0001650]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]
Q3ZCQ8,M2,-0.98274622,-1.137849067,0.44346178,1.024057774,-0.176246247,tan4,TIMM50,TIM50_HUMAN,Mitochondrial import inner membrane translocase subunit TIM50,TIMM50 TIM50 PRO1512,92609;,"ENST00000544017.5; ENSP00000445806.2; ENSG00000105197.11. [Q3ZCQ8-2];""ENST00000607714.6; ENSP00000475531.1; ENSG00000105197.11. [Q3ZCQ8-1]"";",cysteine-type endopeptidase activator activity [GO:0140608]; interleukin-2 receptor binding [GO:0005134]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723],intracellular protein transport [GO:0006886]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150]; release of cytochrome c from mitochondria [GO:0001836],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]
Q9NPL8,M2,-0.867252965,-1.204070457,0.346677366,1.145933912,-0.138047999,tan4,TIMMDC1,TIDC1_HUMAN,"Complex I assembly factor TIMMDC1, mitochondrial (Protein M5-14) (Translocase of inner mitochondrial membrane domain-containing protein 1) (TIMM domain containing-protein 1)",TIMMDC1 C3orf1 UNQ247/PRO284,51300;,ENST00000494664.6; ENSP00000418803.1; ENSG00000113845.10.;,0,0,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
P16035,S3,-1.133139787,0.254743262,-0.193463828,0.414625356,0.598716884,salmon,TIMP2,TIMP2_HUMAN,Metalloproteinase inhibitor 2 (CSC-21K) (Tissue inhibitor of metalloproteinases 2) (TIMP-2),TIMP2,7077;,ENST00000262768.11; ENSP00000262768.6; ENSG00000035862.13.;,metalloendopeptidase inhibitor activity [GO:0008191]; molecular function inhibitor activity [GO:0140678]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270],negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metallopeptidase activity [GO:1905049]; response to cytokine [GO:0034097]; response to hormone [GO:0009725],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]
Q9BVW5,N4,-0.106542608,1.262089513,-0.017189654,-0.623074459,-1.219016112,grey30,TIPIN,TIPIN_HUMAN,TIMELESS-interacting protein,TIPIN,54962;,ENST00000261881.9; ENSP00000261881.4; ENSG00000075131.10.;,DNA binding [GO:0003677],cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; positive regulation of cell population proliferation [GO:0008284]; regulation of nuclear cell cycle DNA replication [GO:0033262]; replication fork arrest [GO:0043111]; replication fork processing [GO:0031297]; response to UV [GO:0009411],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]
O75663,C3,1.910427871,0.317314316,-0.793438691,-0.656008626,-0.968924639,cyan,TIPRL,TIPRL_HUMAN,TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein) (TIP),TIPRL,261726;,"ENST00000367830.3; ENSP00000356804.3; ENSG00000143155.13. [O75663-2];""ENST00000367833.7; ENSP00000356807.2; ENSG00000143155.13. [O75663-1]"";",0,DNA damage checkpoint signaling [GO:0000077]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; TOR signaling [GO:0031929],cytosol [GO:0005829]
P04183,C5,1.782577969,0.307860513,-0.598090397,-0.738519294,-1.004289196,turquoise3,TK1,KITH_HUMAN,"Thymidine kinase, cytosolic (EC 2.7.1.21)",TK1,7083;,ENST00000301634.12; ENSP00000301634.6; ENSG00000167900.12.;,ATP binding [GO:0005524]; identical protein binding [GO:0042802]; thymidine kinase activity [GO:0004797]; zinc ion binding [GO:0008270],DNA synthesis involved in mitotic DNA replication [GO:1904860]; nucleobase-containing compound metabolic process [GO:0006139]; protein homotetramerization [GO:0051289]; thymidine biosynthetic process [GO:0046105]; thymidine metabolic process [GO:0046104],cytosol [GO:0005829]; nucleus [GO:0005634]
Q9UKI8,N4,-0.321321123,1.22988337,-0.315640903,-0.539627053,-0.821468081,grey30,TLK1,TLK1_HUMAN,Serine/threonine-protein kinase tousled-like 1 (EC 2.7.11.1) (PKU-beta) (Tousled-like kinase 1),TLK1 KIAA0137,9874;,"ENST00000360843.7; ENSP00000354089.3; ENSG00000198586.14. [Q9UKI8-2];""ENST00000431350.7; ENSP00000411099.2; ENSG00000198586.14. [Q9UKI8-1]"";""ENST00000434911.6; ENSP00000409222.2; ENSG00000198586.14. [Q9UKI8-4]"";""ENST00000521943.5; ENSP00000428113.1; ENSG00000198586.14. [Q9UKI8-5]"";",ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of chromatin organization [GO:1902275],nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q86UE8,N4,-0.486107007,1.405281096,-0.374812619,-0.674187178,-0.838593225,grey30,TLK2,TLK2_HUMAN,Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2),TLK2,11011;,"ENST00000326270.13; ENSP00000316512.9; ENSG00000146872.19. [Q86UE8-1];""ENST00000343388.11; ENSP00000340800.7; ENSG00000146872.19. [Q86UE8-3]"";""ENST00000346027.10; ENSP00000275780.7; ENSG00000146872.19. [Q86UE8-2]"";""ENST00000682085.1; ENSP00000506744.1; ENSG00000146872.19. [Q86UE8-2]"";""ENST00000683104.1; ENSP00000508242.1; ENSG00000146872.19. [Q86UE8-3]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nucleus localization [GO:0051647]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of chromatin organization [GO:1902275],intermediate filament [GO:0005882]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q9Y490,C3,1.659764466,0.151512985,-0.452219834,-0.348716573,-0.594181756,cyan,TLN1,TLN1_HUMAN,Talin-1,TLN1 KIAA1027 TLN,7094;,"ENST00000314888.10; ENSP00000316029.9; ENSG00000137076.22. [Q9Y490-1];""ENST00000706939.1; ENSP00000516659.1; ENSG00000137076.22. [Q9Y490-2]"";",actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166],cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; platelet aggregation [GO:0070527]; regulation of focal adhesion assembly [GO:0051893],adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]
Q99805,S1,-0.933470833,-1.225831905,-0.298806225,0.712025877,1.068450233,gold,TM9SF2,TM9S2_HUMAN,Transmembrane 9 superfamily member 2 (p76),TM9SF2,9375;,"ENST00000376387.5; ENSP00000365567.3; ENSG00000125304.10.;""ENST00000642475.1; ENSP00000493515.1; ENSG00000125304.10."";",0,ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688]; protein localization to membrane [GO:0072657]; regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010908],endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]
Q9HD45,S1,-1.178523968,-1.487970641,-0.167436198,0.939912784,0.925303715,gold,TM9SF3,TM9S3_HUMAN,Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein),TM9SF3 SMBP UNQ245/PRO282,56889;,ENST00000371142.9; ENSP00000360184.4; ENSG00000077147.16.;,0,protein localization to membrane [GO:0072657],membrane [GO:0016020]
Q92544,S1,-1.107940494,-1.52012966,-0.290587707,0.862541013,0.967461271,gold,TM9SF4,TM9S4_HUMAN,Transmembrane 9 superfamily member 4 (Tumor cannibalism associated protein 1),TM9SF4 KIAA0255 TUCAP1,9777;,ENST00000398022.7; ENSP00000381104.2; ENSG00000101337.16.;,0,cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]
Q7Z402,S4,-0.869636239,-1.25612934,0.456889115,0.830003658,0.539388879,tomato2,TMC7,TMC7_HUMAN,Transmembrane channel-like protein 7,TMC7,79905;,"ENST00000304381.10; ENSP00000304710.5; ENSG00000170537.13. [Q7Z402-1];""ENST00000421369.3; ENSP00000397081.3; ENSG00000170537.13. [Q7Z402-2]"";",mechanosensitive monoatomic ion channel activity [GO:0008381],0,plasma membrane [GO:0005886]
O94876,S3,-0.695234733,-0.962941281,0.18655655,0.684085603,0.504934838,salmon,TMCC1,TMCC1_HUMAN,Transmembrane and coiled-coil domains protein 1,TMCC1 KIAA0779,23023;,"ENST00000393238.8; ENSP00000376930.3; ENSG00000172765.19. [O94876-1];""ENST00000698215.1; ENSP00000513609.1; ENSG00000172765.19. [O94876-2]"";",identical protein binding [GO:0042802],endoplasmic reticulum organization [GO:0007029]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; membrane fission [GO:0090148],cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; rough endoplasmic reticulum [GO:0005791]
Q9ULS5,S3,-0.959140654,-1.051614275,0.299907811,0.785308423,0.573997279,salmon,TMCC3,TMCC3_HUMAN,Transmembrane and coiled-coil domain protein 3,TMCC3 KIAA1145,57458;,ENST00000261226.9; ENSP00000261226.4; ENSG00000057704.13.;,14-3-3 protein binding [GO:0071889]; identical protein binding [GO:0042802],0,endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q9UM00,S2,-0.894370868,-1.086553878,0.156270639,0.9003598,0.36297025,orange,TMCO1,TMCO1_HUMAN,Calcium load-activated calcium channel (CLAC channel) (GEL complex subunit TMCO1) (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3),TMCO1 TMCC4 PNAS-10 PNAS-136 UNQ151/PRO177,54499;,"ENST00000367881.11; ENSP00000356856.6; ENSG00000143183.18. [Q9UM00-1];""ENST00000612311.4; ENSP00000480514.1; ENSG00000143183.18. [Q9UM00-3]"";",calcium channel activity [GO:0005262]; ribosome binding [GO:0043022],calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; ossification [GO:0001503],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; multi-pass translocon complex [GO:0160064]
Q6UWJ1,S1,-1.205345607,-1.484581842,0.013391084,0.826378836,0.898637349,gold,TMCO3,TMCO3_HUMAN,Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein),TMCO3 C13orf11 UNQ2419/PRO4976,55002;,"ENST00000375391.5; ENSP00000364540.1; ENSG00000150403.18. [Q6UWJ1-3];""ENST00000434316.7; ENSP00000389399.2; ENSG00000150403.18. [Q6UWJ1-1]"";""ENST00000474393.5; ENSP00000484053.1; ENSG00000150403.18. [Q6UWJ1-2]"";",potassium:proton antiporter activity [GO:0015386],0,membrane [GO:0016020]
Q13445,S1,-0.822617874,-1.20290187,0.095204421,0.847811022,0.933462135,gold,TMED1,TMED1_HUMAN,Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1) (Tp24) (p24gamma1),TMED1 IL1RL1L IL1RL1LG,11018;,ENST00000214869.7; ENSP00000214869.1; ENSG00000099203.7.;,cargo receptor activity [GO:0038024]; signaling receptor binding [GO:0005102],cell-cell signaling [GO:0007267]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]
P49755,S1,-1.289502795,-1.677742341,0.050802942,0.922628263,0.882299612,gold,TMED10,TMEDA_HUMAN,Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (S31I125) (S31III125) (Tmp-21-I) (Transmembrane protein Tmp21) (p23) (p24 family protein delta-1) (p24delta1) (p24delta),TMED10 TMP21,10972;,ENST00000303575.9; ENSP00000303145.4; ENSG00000170348.9.;,cargo receptor activity [GO:0038024]; protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905],"COPI coating of Golgi vesicle [GO:0048205]; COPI-coated vesicle budding [GO:0035964]; COPII vesicle coating [GO:0048208]; cytosol to ERGIC protein transport [GO:0106273]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle cargo loading [GO:0035459]; vesicle targeting, to, from or within Golgi [GO:0048199]",cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; zymogen granule membrane [GO:0042589]
Q15363,S1,-1.344605753,-1.629095757,-0.019711076,0.749897169,0.881701676,gold,TMED2,TMED2_HUMAN,Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1),TMED2 RNP24,10959;,ENST00000262225.8; ENSP00000262225.3; ENSG00000086598.11.;,cargo receptor activity [GO:0038024]; frizzled binding [GO:0005109]; smoothened binding [GO:0005119],allantois development [GO:1905069]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; chorion development [GO:0060717]; COPI coating of Golgi vesicle [GO:0048205]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; heart looping [GO:0001947]; inflammatory response [GO:0006954]; intracellular protein transport [GO:0006886]; labyrinthine layer blood vessel development [GO:0060716]; maintenance of protein localization in organelle [GO:0072595]; maternal placenta development [GO:0001893]; multicellular organism growth [GO:0035264]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of GTPase activity [GO:0034260]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of gene expression [GO:0010628]; post-anal tail morphogenesis [GO:0036342]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; regulation of SREBP signaling pathway [GO:2000638]; somite rostral/caudal axis specification [GO:0032525]; vesicle cargo loading [GO:0035459],COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; transport vesicle [GO:0030133]; zymogen granule membrane [GO:0042589]
Q9Y3Q3,S1,-0.681124358,-1.08687842,0.063897346,0.774464732,0.81995029,gold,TMED3,TMED3_HUMAN,Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4) (p24gamma4) (p26),TMED3 C15orf22 UNQ5357/PRO1078,23423;,"ENST00000299705.10; ENSP00000299705.5; ENSG00000166557.14. [Q9Y3Q3-1];""ENST00000424155.6; ENSP00000414983.2; ENSG00000166557.14. [Q9Y3Q3-2]"";",cargo receptor activity [GO:0038024],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],COPI vesicle coat [GO:0030126]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]
Q7Z7H5,S1,-1.098832179,-1.33049887,-0.09557454,0.857846395,0.941611327,gold,TMED4,TMED4_HUMAN,Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3),TMED4 ERS25,222068;,"ENST00000457408.7; ENSP00000404042.2; ENSG00000158604.15. [Q7Z7H5-1];""ENST00000481238.1; ENSP00000417443.1; ENSG00000158604.15. [Q7Z7H5-3]"";",cargo receptor activity [GO:0038024],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]
Q9Y3A6,S1,-0.905308583,-1.403322725,0.211594009,0.810208687,0.981036831,gold,TMED5,TMED5_HUMAN,Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma-2) (p24gamma2) (p28),TMED5 CGI-100 UNQ397/PRO733,50999;,"ENST00000370282.8; ENSP00000359305.3; ENSG00000117500.13. [Q9Y3A6-1];""ENST00000479918.5; ENSP00000418992.1; ENSG00000117500.13. [Q9Y3A6-2]"";",cargo receptor activity [GO:0038024],endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886],cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]
Q9BVK6,S1,-1.049395884,-1.517579906,0.11221884,0.804559475,0.910265579,gold,TMED9,TMED9_HUMAN,Transmembrane emp24 domain-containing protein 9 (GMP25) (Glycoprotein 25L2) (p24 family protein alpha-2) (p24alpha2) (p25),TMED9 GP25L2,54732;,ENST00000332598.7; ENSP00000330945.6; ENSG00000184840.12.;,cargo receptor activity [GO:0038024]; syntaxin binding [GO:0019905],COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of organelle organization [GO:0010638],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]
Q9NUM4,S1,-1.089387668,-0.989205007,-0.270892387,0.689777606,0.891685778,gold,TMEM106B,T106B_HUMAN,Transmembrane protein 106B,TMEM106B,54664;,"ENST00000396667.7; ENSP00000379901.2; ENSG00000106460.20.;""ENST00000396668.8; ENSP00000379902.3; ENSG00000106460.20."";""ENST00000444443.6; ENSP00000401302.2; ENSG00000106460.20."";""ENST00000704455.1; ENSP00000515905.1; ENSG00000106460.20."";",ATPase binding [GO:0051117],dendrite morphogenesis [GO:0048813]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; neuron cellular homeostasis [GO:0070050]; positive regulation of dendrite development [GO:1900006]; regulation of lysosome organization [GO:1905671],endosome [GO:0005768]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]
Q9BVX2,S1,-0.726940079,-1.259596916,-0.11282564,0.629275697,0.82518697,gold,TMEM106C,T106C_HUMAN,Transmembrane protein 106C (Endoplasmic reticulum membrane protein overexpressed in cancer),TMEM106C EMOC,79022;,"ENST00000256686.10; ENSP00000256686.6; ENSG00000134291.12. [Q9BVX2-2];""ENST00000429772.7; ENSP00000400471.2; ENSG00000134291.12. [Q9BVX2-1]"";""ENST00000449758.6; ENSP00000402705.2; ENSG00000134291.12. [Q9BVX2-2]"";""ENST00000550552.5; ENSP00000449737.1; ENSG00000134291.12. [Q9BVX2-2]"";""ENST00000552561.5; ENSP00000446657.1; ENSG00000134291.12. [Q9BVX2-1]"";",0,0,endoplasmic reticulum membrane [GO:0005789]
P17152,M2,-1.16947783,-1.350592547,0.366770455,1.208710568,-0.261296529,tan4,TMEM11,TMM11_HUMAN,"Transmembrane protein 11, mitochondrial (Protein PM1) (Protein PMI)",TMEM11 C17orf35 PM1,8834;,ENST00000317635.6; ENSP00000319992.6; ENSG00000178307.10.;,0,inner mitochondrial membrane organization [GO:0007007]; mitochondrion organization [GO:0007005],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q12893,S1,-0.387875346,-1.001315547,-0.175460816,0.689990585,0.825287733,gold,TMEM115,TM115_HUMAN,Transmembrane protein 115 (Placental protein 6) (Protein PL6),TMEM115 PL6 LUCA11.2,11070;,ENST00000266025.4; ENSP00000266025.3; ENSG00000126062.4.;,identical protein binding [GO:0042802],"negative regulation of cell population proliferation [GO:0008285]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]
Q9BXJ8,S2,-1.327306398,-1.59872905,0.329292456,0.903806928,0.605950935,orange,TMEM120A,TACAN_HUMAN,Ion channel TACAN (Transmembrane protein 120A) (Transmembrane protein induced by tumor necrosis factor alpha),TMEM120A TACAN TMPIT,83862;,ENST00000493111.7; ENSP00000473983.1; ENSG00000189077.11. [Q9BXJ8-1];,monoatomic ion channel activity [GO:0005216],detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; fat cell differentiation [GO:0045444]; monoatomic ion transmembrane transport [GO:0034220]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]
A0PK00,S2,-1.021551213,-1.425344342,0.189872408,0.779178847,0.625244121,orange,TMEM120B,T120B_HUMAN,Transmembrane protein 120B,TMEM120B,144404;,"ENST00000342607.10; ENSP00000345152.6; ENSG00000188735.13.;""ENST00000449592.7; ENSP00000404991.2; ENSG00000188735.13."";",0,fat cell differentiation [GO:0045444]; protein heterooligomerization [GO:0051291],nuclear inner membrane [GO:0005637]
Q8N131,S1,-0.589458391,-1.163729966,0.058023303,0.594230603,0.746974561,gold,TMEM123,PORIM_HUMAN,Porimin (Keratinocytes-associated transmembrane protein 3) (KCT-3) (Pro-oncosis receptor inducing membrane injury) (Transmembrane protein 123),TMEM123 KCT3 PSEC0111 UNQ641/PRO1271,114908;,"ENST00000361236.7; ENSP00000355285.3; ENSG00000152558.15. [Q8N131-2];""ENST00000398136.7; ENSP00000381204.2; ENSG00000152558.15. [Q8N131-1]"";",signaling receptor activity [GO:0038023],0,cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]
Q9H061,M2,-0.585071651,-1.078183687,0.346933184,1.078524543,-0.165156001,tan4,TMEM126A,T126A_HUMAN,Transmembrane protein 126A,TMEM126A,84233;,"ENST00000304511.7; ENSP00000306887.2; ENSG00000171202.7. [Q9H061-1];""ENST00000528105.5; ENSP00000436590.1; ENSG00000171202.7. [Q9H061-2]"";""ENST00000532180.1; ENSP00000434357.1; ENSG00000171202.7. [Q9H061-2]"";",0,mitochondrial protein quality control [GO:0141164]; mitochondrial respiratory chain complex I assembly [GO:0032981]; optic nerve development [GO:0021554]; protein insertion into mitochondrial inner membrane from matrix [GO:0032979]; toll-like receptor 4 signaling pathway [GO:0034142],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q8IUX1,M2,-1.275824195,-1.612138453,0.330457386,1.098976029,0.022516406,tan4,TMEM126B,T126B_HUMAN,"Complex I assembly factor TMEM126B, mitochondrial (Transmembrane protein 126B)",TMEM126B HT007,55863;,"ENST00000358867.11; ENSP00000351737.7; ENSG00000171204.13. [Q8IUX1-1];""ENST00000393375.5; ENSP00000377039.1; ENSG00000171204.13. [Q8IUX1-5]"";""ENST00000534341.1; ENSP00000433471.1; ENSG00000171204.13. [Q8IUX1-4]"";",0,mitochondrial respiratory chain complex I assembly [GO:0032981]; response to food [GO:0032094],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q5BJH2,S2,-1.90791396,-2.042092162,0.29609369,0.816031461,0.856554272,orange,TMEM128,TM128_HUMAN,Transmembrane protein 128,TMEM128,85013;,"ENST00000254742.6; ENSP00000254742.2; ENSG00000132406.12. [Q5BJH2-2];""ENST00000382753.5; ENSP00000372201.4; ENSG00000132406.12. [Q5BJH2-1]"";",0,0,membrane [GO:0016020]
Q92545,S2,-1.214131476,-1.230704705,0.145470236,0.941332431,0.536927684,orange,TMEM131,TM131_HUMAN,Transmembrane protein 131 (Protein RW1),TMEM131 KIAA0257 RW1,23505;,"ENST00000186436.10; ENSP00000186436.5; ENSG00000075568.17.;""ENST00000708031.1; ENSP00000517074.1; ENSG00000291574.1."";",0,0,membrane [GO:0016020]
Q9H6X4,S1,-1.718945473,-1.714629389,0.0551435,0.75695418,1.070919325,gold,TMEM134,TM134_HUMAN,Transmembrane protein 134,TMEM134,80194;,"ENST00000308022.7; ENSP00000312615.2; ENSG00000172663.9. [Q9H6X4-1];""ENST00000393877.3; ENSP00000377455.3; ENSG00000172663.9. [Q9H6X4-2]"";""ENST00000545682.5; ENSP00000438439.1; ENSG00000172663.9. [Q9H6X4-3]"";",0,0,cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]
Q96I45,M2,-1.488136135,-1.318835072,0.386288382,1.173403871,-0.052574,tan4,TMEM141,TM141_HUMAN,Transmembrane protein 141,TMEM141,85014;,ENST00000290079.9; ENSP00000290079.8; ENSG00000244187.8.;,0,0,membrane [GO:0016020]
Q9BVK8,S2,-1.791872809,-2.120737754,0.202881769,0.927845737,0.548750975,orange,TMEM147,TM147_HUMAN,BOS complex subunit TMEM147 (Protein NIFIE 14) (Transmembrane protein 147),TMEM147,10430;,"ENST00000222284.10; ENSP00000222284.4; ENSG00000105677.12. [Q9BVK8-1];""ENST00000392204.6; ENSP00000376040.1; ENSG00000105677.12. [Q9BVK8-2]"";",ribosome binding [GO:0043022],multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; protein localization to nuclear inner membrane [GO:0036228],endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]
Q9NX61,S2,-0.584970794,-1.245388469,0.12242384,0.682274872,0.50490471,orange,TMEM161A,T161A_HUMAN,Transmembrane protein 161A (Adaptive response to oxidative stress protein 29) (AROS-29),TMEM161A UNQ582/PRO1152,54929;,"ENST00000162044.14; ENSP00000162044.7; ENSG00000064545.15. [Q9NX61-1];""ENST00000450333.6; ENSP00000404208.2; ENSG00000064545.15. [Q9NX61-2]"";",0,cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; positive regulation of DNA repair [GO:0045739]; response to retinoic acid [GO:0032526],membrane [GO:0016020]
Q8NDZ6,S2,-1.145641677,-1.731005252,0.067041622,0.920270719,0.420193732,orange,TMEM161B,T161B_HUMAN,Transmembrane protein 161B,TMEM161B UNQ679/PRO1313,153396;,"ENST00000296595.11; ENSP00000296595.6; ENSG00000164180.14. [Q8NDZ6-1];""ENST00000510089.5; ENSP00000423380.1; ENSG00000164180.14. [Q8NDZ6-3]"";",0,regulation of cardiac muscle cell action potential [GO:0098901]; regulation of heart rate [GO:0002027],plasma membrane [GO:0005886]
Q5U3C3,S2,-2.663670058,-3.044984045,0.160008218,0.69414632,0.498794166,orange,TMEM164,TM164_HUMAN,Transmembrane protein 164 (Arachidonoyl ether phospholipid synthase),TMEM164,84187;,"ENST00000372068.7; ENSP00000361138.2; ENSG00000157600.12. [Q5U3C3-1];""ENST00000372072.7; ENSP00000384075.2; ENSG00000157600.12. [Q5U3C3-2]"";""ENST00000372073.5; ENSP00000361143.1; ENSG00000157600.12. [Q5U3C3-1]"";",0,positive regulation of ferroptosis [GO:0160020],membrane [GO:0016020]
Q9HC07,S1,-2.023483059,-2.153882729,-0.391362423,0.937609549,0.945844912,gold,TMEM165,TM165_HUMAN,Putative divalent cation/proton antiporter TMEM165 (Transmembrane protein 165) (Transmembrane protein PT27) (Transmembrane protein TPARL),TMEM165 TPARL,55858;,ENST00000381334.10; ENSP00000370736.5; ENSG00000134851.13. [Q9HC07-1];,antiporter activity [GO:0015297]; calcium ion transmembrane transporter activity [GO:0015085]; manganese ion transmembrane transporter activity [GO:0005384],calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; intracellular calcium ion homeostasis [GO:0006874]; manganese ion transmembrane transport [GO:0071421]; manganese ion transport [GO:0006828]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751],cis-Golgi network membrane [GO:0033106]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]
Q9H0V1,S1,-1.470944799,-1.857422083,-0.142964143,0.910741901,1.160141081,gold,TMEM168,TM168_HUMAN,Transmembrane protein 168,TMEM168,64418;,"ENST00000312814.11; ENSP00000323068.4; ENSG00000146802.13. [Q9H0V1-1];""ENST00000447395.5; ENSP00000410307.1; ENSG00000146802.13. [Q9H0V1-2]"";""ENST00000454074.5; ENSP00000390696.1; ENSG00000146802.13. [Q9H0V1-1]"";",sodium channel regulator activity [GO:0017080],regulation of ubiquitin-dependent protein catabolic process [GO:2000058],nuclear membrane [GO:0031965]; transport vesicle [GO:0030133]
Q53S58,M2,-1.454403186,-1.645530349,0.457202687,1.146597146,0.049856263,tan4,TMEM177,TM177_HUMAN,Transmembrane protein 177,TMEM177,80775;,"ENST00000272521.7; ENSP00000272521.6; ENSG00000144120.13.;""ENST00000401466.5; ENSP00000385966.1; ENSG00000144120.13."";""ENST00000424086.5; ENSP00000402661.1; ENSG00000144120.13."";",0,0,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]
Q7Z7N9,S1,-0.909610498,-0.76659952,-0.167340367,0.616202552,1.048165238,gold,TMEM179B,T179B_HUMAN,Transmembrane protein 179B,TMEM179B,374395;,ENST00000333449.9; ENSP00000333697.3; ENSG00000185475.11.;,0,0,azurophil granule membrane [GO:0035577]; ficolin-1-rich granule membrane [GO:0101003]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]
Q9P2C4,S1,-1.498101957,-1.681210939,-0.160702441,0.799518322,1.035442122,gold,TMEM181,TM181_HUMAN,Transmembrane protein 181,TMEM181 GPR178 KIAA1423,57583;,"ENST00000367090.4; ENSP00000356057.4; ENSG00000146433.10. [Q9P2C4-1];""ENST00000684151.1; ENSP00000507085.1; ENSG00000146433.10. [Q9P2C4-2]"";",toxic substance binding [GO:0015643],0,membrane [GO:0016020]
Q9NVA4,S1,-1.230521756,-1.502465956,-0.422786079,0.847725359,1.163418447,gold,TMEM184C,T184C_HUMAN,Transmembrane protein 184C (Transmembrane protein 34),TMEM184C TMEM34 PRO1355,55751;,ENST00000296582.8; ENSP00000296582.3; ENSG00000164168.8. [Q9NVA4-1];,0,0,membrane [GO:0016020]
Q96B77,M2,-0.967724647,-1.265510098,0.347322659,1.105135986,0.050191007,tan4,TMEM186,TM186_HUMAN,Transmembrane protein 186,TMEM186 C16orf51,25880;,ENST00000333050.7; ENSP00000331640.6; ENSG00000184857.8.;,0,mitochondrial respiratory chain complex I assembly [GO:0032981],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q8IY95,S1,-1.502995707,-1.656057221,-0.418370369,0.863789643,1.170025343,gold,TMEM192,TM192_HUMAN,Transmembrane protein 192,TMEM192,201931;,"ENST00000306480.11; ENSP00000305069.4; ENSG00000170088.14. [Q8IY95-1];""ENST00000506087.5; ENSP00000425335.1; ENSG00000170088.14. [Q8IY95-2]"";",protein homodimerization activity [GO:0042803],0,endosome [GO:0005768]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]
O14524,N3,-1.38591924,-1.449441755,1.221784704,0.438152841,-0.381477911,grey50,TMEM194A,NEMP1_HUMAN,Nuclear envelope integral membrane protein 1,NEMP1 KIAA0286 TMEM194 TMEM194A,23306;,"ENST00000300128.9; ENSP00000300128.4; ENSG00000166881.10. [O14524-1];""ENST00000379391.7; ENSP00000368701.3; ENSG00000166881.10. [O14524-2]"";",0,erythrocyte enucleation [GO:0043131]; erythrocyte maturation [GO:0043249]; nuclear membrane organization [GO:0071763],nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]
Q8N511,S3,-0.945309646,-1.092032056,0.215108831,0.69260425,0.466628775,salmon,TMEM199,TM199_HUMAN,Transmembrane protein 199,TMEM199 C17orf32,147007;,ENST00000292114.8; ENSP00000292114.3; ENSG00000244045.13.;,oxysterol binding [GO:0008142],cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],COPI-coated vesicle membrane [GO:0030663]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]
Q9UHN6,S4,-0.964863598,-1.172654839,0.313829955,0.76526389,0.41397976,tomato2,TMEM2,CEIP2_HUMAN,Inactive cell surface hyaluronidase CEMIP2 (Cell migration-inducing hyaluronidase 2) (Transmembrane protein 2),CEMIP2 KIAA1412 TMEM2,23670;,"ENST00000377044.9; ENSP00000366243.4; ENSG00000135048.14. [Q9UHN6-1];""ENST00000377066.9; ENSP00000366266.5; ENSG00000135048.14. [Q9UHN6-2]"";",cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246],angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]
Q5SNT2,N3,-0.930849633,-1.334283727,1.291311658,0.087016988,-0.436159884,grey50,TMEM201,TM201_HUMAN,Transmembrane protein 201 (Spindle-associated membrane protein 1),TMEM201 NET5 SAMP1,199953;,"ENST00000340305.9; ENSP00000344772.5; ENSG00000188807.13. [Q5SNT2-2];""ENST00000340381.11; ENSP00000344503.6; ENSG00000188807.13. [Q5SNT2-1]"";",actin filament binding [GO:0051015]; lamin binding [GO:0005521],centrosome localization [GO:0051642]; fibroblast migration [GO:0010761]; nuclear envelope organization [GO:0006998]; nuclear migration along microtubule [GO:0030473]; protein localization to nuclear envelope [GO:0090435],cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; spindle pole [GO:0000922]
Q6UW68,S3,-0.743057467,-1.079199106,0.211544647,0.708106488,0.343920543,salmon,TMEM205,TM205_HUMAN,Transmembrane protein 205,TMEM205 UNQ501/PRO1018,374882;,"ENST00000354882.10; ENSP00000346954.4; ENSG00000105518.14.;""ENST00000447337.5; ENSP00000398258.1; ENSG00000105518.14."";""ENST00000586590.5; ENSP00000466986.1; ENSG00000105518.14."";""ENST00000586956.5; ENSP00000465483.1; ENSG00000105518.14."";""ENST00000587948.5; ENSP00000465149.1; ENSG00000105518.14."";""ENST00000588560.5; ENSP00000466495.1; ENSG00000105518.14."";""ENST00000589555.5; ENSP00000465553.1; ENSG00000105518.14."";""ENST00000593256.6; ENSP00000468733.1; ENSG00000105518.14."";",0,0,membrane [GO:0016020]
Q9H813,S1,-0.957295043,-1.396286858,0.028629921,0.691579509,1.010797265,gold,TMEM206,PACC1_HUMAN,Proton-activated chloride channel (PAC) (hPAC) (Acid-sensitive outwardly-rectifying anion channel) (ASOR) (Proton-activated outwardly rectifying anion channel) (PAORAC) (Transmembrane protein 206) (hTMEM206),PACC1 C1orf75 TMEM206,55248;,"ENST00000261455.9; ENSP00000261455.4; ENSG00000065600.13. [Q9H813-1];""ENST00000535273.2; ENSP00000438863.1; ENSG00000065600.13. [Q9H813-2]"";",pH-gated chloride channel activity [GO:0061797],chloride transport [GO:0006821],cell surface [GO:0009986]; chloride channel complex [GO:0034707]; plasma membrane [GO:0005886]
Q96SK2,N3,-1.471855475,-1.748692569,1.304182229,0.477241401,-0.250212134,grey50,TMEM209,TM209_HUMAN,Transmembrane protein 209,TMEM209,84928;,"ENST00000397622.7; ENSP00000380747.2; ENSG00000146842.17. [Q96SK2-1];""ENST00000462753.5; ENSP00000419697.1; ENSG00000146842.17. [Q96SK2-2]"";""ENST00000473456.5; ENSP00000417258.1; ENSG00000146842.17. [Q96SK2-3]"";",0,0,Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear envelope [GO:0005635]
Q6NUQ4,S4,-1.014127192,-1.190078149,0.443668332,0.807133094,0.302581796,tomato2,TMEM214,TM214_HUMAN,Transmembrane protein 214,TMEM214 PP446,54867;,"ENST00000238788.14; ENSP00000238788.9; ENSG00000119777.20. [Q6NUQ4-1];""ENST00000321326.11; ENSP00000319469.7; ENSG00000119777.20. [Q6NUQ4-1]"";""ENST00000404032.7; ENSP00000384417.3; ENSG00000119777.20. [Q6NUQ4-2]"";",0,apoptotic process [GO:0006915],cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]
Q9H0R3,S2,-1.751042401,-2.034553191,0.309391388,0.847358986,0.859258533,orange,TMEM222,TM222_HUMAN,Transmembrane protein 222,TMEM222 C1orf160,84065;,"ENST00000374076.9; ENSP00000363189.4; ENSG00000186501.15. [Q9H0R3-1];""ENST00000611517.4; ENSP00000483276.1; ENSG00000186501.15. [Q9H0R3-1]"";",0,0,dendrite [GO:0030425]; membrane [GO:0016020]
A0PJW6,M2,-1.113326703,-1.473556684,0.279028561,1.064648516,-0.185807026,tan4,TMEM223,TM223_HUMAN,Transmembrane protein 223,TMEM223,79064;,ENST00000307366.8; ENSP00000303987.7; ENSG00000168569.8.;,mitochondrial ribosome binding [GO:0097177],mitochondrial cytochrome c oxidase assembly [GO:0033617]; nervous system development [GO:0007399],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q96A57,S2,-1.058145656,-1.57981025,0.181051342,0.921703766,0.769828292,orange,TMEM230,TM230_HUMAN,Transmembrane protein 230,TMEM230 C20orf30 HSPC274 UNQ2432/PRO4992,29058;,"ENST00000202834.11; ENSP00000202834.7; ENSG00000089063.15. [Q96A57-1];""ENST00000342308.10; ENSP00000341364.5; ENSG00000089063.15. [Q96A57-2]"";""ENST00000379277.6; ENSP00000368579.2; ENSG00000089063.15. [Q96A57-1]"";""ENST00000379279.6; ENSP00000368581.2; ENSG00000089063.15. [Q96A57-1]"";""ENST00000379283.6; ENSP00000368585.2; ENSG00000089063.15. [Q96A57-1]"";""ENST00000379286.6; ENSP00000368588.2; ENSG00000089063.15. [Q96A57-1]"";""ENST00000379299.6; ENSP00000368601.2; ENSG00000089063.15. [Q96A57-1]"";",0,axonal transport [GO:0098930]; synaptic vesicle transport [GO:0048489],autophagosome [GO:0005776]; axon [GO:0030424]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; membrane [GO:0016020]; recycling endosome [GO:0055037]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]
Q96Q45,S4,-0.949500621,-1.203469169,0.333580712,0.909107985,0.442438669,tomato2,TMEM237,TM237_HUMAN,Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein),TMEM237 ALS2CR4,65062;,"ENST00000409444.6; ENSP00000387203.2; ENSG00000155755.20. [Q96Q45-2];""ENST00000409883.7; ENSP00000386264.2; ENSG00000155755.20. [Q96Q45-1]"";",0,cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111],ciliary transition zone [GO:0035869]; cone photoreceptor outer segment [GO:0120199]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; rod photoreceptor outer segment [GO:0120200]
Q9H330,S2,-1.55468047,-1.624278526,0.187178144,0.977876822,0.527127215,orange,TMEM245,TM245_HUMAN,Transmembrane protein 245 (Protein CG-2),TMEM245 C9orf5,23731;,ENST00000374586.8; ENSP00000363714.3; ENSG00000106771.13. [Q9H330-2];,0,0,membrane [GO:0016020]
Q9NWD8,S1,-0.862571768,-1.72081612,0.064066682,0.790999344,0.970981883,gold,TMEM248,TM248_HUMAN,Transmembrane protein 248,TMEM248 C7orf42,55069;,"ENST00000341567.8; ENSP00000340668.4; ENSG00000106609.16. [Q9NWD8-1];""ENST00000433271.6; ENSP00000405558.2; ENSG00000106609.16. [Q9NWD8-2]"";",0,0,membrane [GO:0016020]
Q4ZIN3,S3,-1.45492053,-1.197605015,0.199220571,0.841596744,0.558597667,salmon,TMEM259,MBRL_HUMAN,Membralin (Transmembrane protein 259),TMEM259 C19orf6,91304;,"ENST00000333175.9; ENSP00000331423.4; ENSG00000182087.14. [Q4ZIN3-2];""ENST00000356663.8; ENSP00000349087.2; ENSG00000182087.14. [Q4ZIN3-1]"";",0,positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q9NX78,S3,-1.073162287,-0.830518051,0.33978344,0.846983227,0.516168267,salmon,TMEM260,TM260_HUMAN,Protein O-mannosyl-transferase TMEM260 (EC 2.4.1.109) (Transmembrane protein 260),TMEM260 C14orf101,54916;,"ENST00000261556.11; ENSP00000261556.6; ENSG00000070269.14. [Q9NX78-1];""ENST00000538838.5; ENSP00000441934.1; ENSG00000070269.14. [Q9NX78-3]"";",dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169],protein maturation [GO:0051604],endoplasmic reticulum membrane [GO:0005789]
Q9NV96,S1,-0.727219322,-1.287954686,0.145489939,0.817573221,0.742782075,gold,TMEM30A,CC50A_HUMAN,Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A),TMEM30A C6orf67 CDC50A,55754;,"ENST00000230461.11; ENSP00000230461.6; ENSG00000112697.17. [Q9NV96-1];""ENST00000370050.9; ENSP00000359067.5; ENSG00000112697.17. [Q9NV96-3]"";""ENST00000475111.6; ENSP00000431007.1; ENSG00000112697.17. [Q9NV96-2]"";""ENST00000674151.1; ENSP00000500998.1; ENSG00000112697.17. [Q9NV96-3]"";",aminophospholipid flippase activity [GO:0015247]; structural molecule activity [GO:0005198],aminophospholipid transport [GO:0015917]; phospholipid translocation [GO:0045332]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein localization to endosome [GO:0036010]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; transport vesicle membrane [GO:0030658]
Q9NVV0,S2,-1.500146799,-1.778638431,0.138722454,1.013796209,0.390911976,orange,TMEM38B,TM38B_HUMAN,Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B),TMEM38B C9orf87,55151;,ENST00000374692.8; ENSP00000363824.3; ENSG00000095209.12.;,identical protein binding [GO:0042802]; potassium channel activity [GO:0005267],bone development [GO:0060348]; bone mineralization [GO:0030282]; cellular response to caffeine [GO:0071313]; endoplasmic reticulum organization [GO:0007029]; establishment of localization in cell [GO:0051649]; extracellular matrix constituent secretion [GO:0070278]; lung alveolus development [GO:0048286]; lung epithelial cell differentiation [GO:0060487]; phospholipid biosynthetic process [GO:0008654]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; secretion by lung epithelial cell involved in lung growth [GO:0061033],nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sarcoplasmic reticulum membrane [GO:0033017]
Q9GZU3,S2,-1.008373089,-1.067740507,0.165223667,0.928489611,0.640061923,orange,TMEM39B,TM39B_HUMAN,Transmembrane protein 39B,TMEM39B,55116;,ENST00000336294.10; ENSP00000338165.5; ENSG00000121775.18. [Q9GZU3-1];,0,0,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q8WWA1,S2,-1.057885158,-1.31377784,0.28011632,0.79006049,0.691436076,orange,TMEM40,TMM40_HUMAN,Transmembrane protein 40,TMEM40,55287;,"ENST00000264728.8; ENSP00000264728.8; ENSG00000088726.16. [Q8WWA1-1];""ENST00000314124.12; ENSP00000322837.7; ENSG00000088726.16. [Q8WWA1-1]"";""ENST00000435218.6; ENSP00000405740.2; ENSG00000088726.16. [Q8WWA1-2]"";""ENST00000435575.5; ENSP00000396895.1; ENSG00000088726.16. [Q8WWA1-3]"";",0,0,membrane [GO:0016020]
Q9BTV4,S2,-0.99191816,-1.322639385,0.36295674,0.745255633,0.363275178,orange,TMEM43,TMM43_HUMAN,Transmembrane protein 43 (Protein LUMA),TMEM43 UNQ2564/PRO6244,79188;,ENST00000306077.5; ENSP00000303992.5; ENSG00000170876.8.;,identical protein binding [GO:0042802],innate immune response [GO:0045087]; lipid metabolic process [GO:0006629]; nuclear membrane organization [GO:0071763],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear inner membrane [GO:0005637]; plasma membrane [GO:0005886]
Q9NW97,S4,-1.543449678,-1.807113527,0.368025729,0.951794394,0.325715661,tomato2,TMEM51,TMM51_HUMAN,Transmembrane protein 51,TMEM51 C1orf72,55092;,"ENST00000376008.3; ENSP00000365176.1; ENSG00000171729.14.;""ENST00000376014.7; ENSP00000365182.3; ENSG00000171729.14."";""ENST00000400796.7; ENSP00000383600.2; ENSG00000171729.14."";""ENST00000428417.5; ENSP00000394899.1; ENSG00000171729.14."";",0,0,membrane [GO:0016020]
Q8N4L2,S1,-0.981515066,-1.506672796,-0.512875128,0.836220902,1.199148841,gold,TMEM55A,PP4P2_HUMAN,"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 2 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)",PIP4P2 TMEM55A,55529;,ENST00000285419.8; ENSP00000285419.3; ENSG00000155099.8.;,"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]",negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]
Q86T03,S1,-0.783568976,-1.457087879,-0.439418697,0.762581601,1.141016502,gold,TMEM55B,PP4P1_HUMAN,"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B)",PIP4P1 C14orf9 TMEM55B,90809;,"ENST00000250489.9; ENSP00000250489.4; ENSG00000165782.11. [Q86T03-1];""ENST00000398020.6; ENSP00000381102.4; ENSG00000165782.11. [Q86T03-2]"";""ENST00000708815.1; ENSP00000517357.1; ENSG00000291802.1. [Q86T03-1]"";""ENST00000708818.1; ENSP00000517359.1; ENSG00000291802.1. [Q86T03-2]"";","phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]",cholesterol metabolic process [GO:0008203]; lysosome localization [GO:0032418]; phosphatidylinositol dephosphorylation [GO:0046856]; phospholipid metabolic process [GO:0006644]; positive regulation of TORC1 signaling [GO:1904263]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to sterol depletion [GO:0006991],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]
Q8N5G2,S2,-1.357004712,-1.274759869,0.216713087,0.951726612,0.506981444,orange,TMEM57,MACOI_HUMAN,Macoilin (Macoilin-1) (Transmembrane protein 57),MACO1 TMEM57,55219;,"ENST00000374343.5; ENSP00000363463.4; ENSG00000204178.11. [Q8N5G2-1];""ENST00000399766.7; ENSP00000382668.3; ENSG00000204178.11. [Q8N5G2-3]"";",microtubule binding [GO:0008017],brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041],axon [GO:0030424]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]
Q9BXS4,S1,-0.993188617,-1.242751934,-0.109074294,0.890693445,0.796324956,gold,TMEM59,TMM59_HUMAN,Transmembrane protein 59 (Liver membrane-bound protein),TMEM59 C1orf8 HSPC001 UNQ169/PRO195,9528;,ENST00000234831.10; ENSP00000234831.5; ENSG00000116209.12.;,endopeptidase activity [GO:0004175],autophagy [GO:0006914]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of autophagy [GO:0010508]; protein glycosylation [GO:0006486],extracellular exosome [GO:0070062]; Golgi cis cisterna [GO:0000137]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]
O94886,S1,-0.7184729,-1.015687004,-0.109949716,0.615575826,0.93840535,gold,TMEM63A,CSCL1_HUMAN,CSC1-like protein 1 (Transmembrane protein 63A),TMEM63A KIAA0489 KIAA0792,9725;,ENST00000366835.8; ENSP00000355800.3; ENSG00000196187.12.;,calcium-activated cation channel activity [GO:0005227]; mechanosensitive monoatomic ion channel activity [GO:0008381]; nucleic acid binding [GO:0003676]; osmolarity-sensing monoatomic cation channel activity [GO:1990760],surfactant secretion [GO:0160069],centriolar satellite [GO:0034451]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]
Q5T3F8,S1,-0.487807563,-1.091265205,0.11959454,0.604353578,0.829388284,gold,TMEM63B,CSCL2_HUMAN,CSC1-like protein 2 (Transmembrane protein 63B),TMEM63B C6orf110,55362;,"ENST00000259746.13; ENSP00000259746.9; ENSG00000137216.19. [Q5T3F8-1];""ENST00000323267.11; ENSP00000327154.6; ENSG00000137216.19. [Q5T3F8-1]"";",calcium-activated cation channel activity [GO:0005227]; mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; osmolarity-sensing monoatomic cation channel activity [GO:1990760],sensory perception of sound [GO:0007605]; surfactant secretion [GO:0160069],actin cytoskeleton [GO:0015629]; alveolar lamellar body membrane [GO:0097233]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]
Q6PI78,M2,-1.08228982,-1.314455683,0.472181509,1.072272514,0.047184116,tan4,TMEM65,TMM65_HUMAN,Transmembrane protein 65,TMEM65,157378;,ENST00000297632.8; ENSP00000297632.6; ENSG00000164983.9.;,0,cardiac conduction [GO:0061337]; cardiac ventricle development [GO:0003231]; regulation of cardiac conduction [GO:1903779],intercalated disc [GO:0014704]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]
Q5HYA8,S2,-1.109976554,-1.150038984,0.411327646,0.836487917,0.50152978,orange,TMEM67,MKS3_HUMAN,Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67),TMEM67 MKS3,91147;,"ENST00000323130.8; ENSP00000314488.4; ENSG00000164953.17.;""ENST00000453321.8; ENSP00000389998.3; ENSG00000164953.17."";",filamin binding [GO:0031005]; unfolded protein binding [GO:0051082],cilium assembly [GO:0060271]; ERAD pathway [GO:0036503]; negative regulation of centrosome duplication [GO:0010826]; non-canonical Wnt signaling pathway [GO:0035567],centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; MKS complex [GO:0036038]
Q9BUB7,M2,-1.20642421,-1.429341352,0.351683569,1.185960638,-0.096768462,tan4,TMEM70,TMM70_HUMAN,"Transmembrane protein 70, mitochondrial",TMEM70,54968;,"ENST00000312184.6; ENSP00000312599.5; ENSG00000175606.11. [Q9BUB7-1];""ENST00000517439.1; ENSP00000429467.1; ENSG00000175606.11. [Q9BUB7-3]"";",mitochondrial proton-transporting ATP synthase complex binding [GO:0140260],mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260],mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q8NBN3,S1,-1.219528595,-1.63141762,-0.258880002,0.668702074,1.217127823,gold,TMEM87A,TM87A_HUMAN,Transmembrane protein 87A (Elkin1),TMEM87A PSEC0094,25963;,"ENST00000307216.10; ENSP00000305894.6; ENSG00000103978.17. [Q8NBN3-2];""ENST00000389834.9; ENSP00000374484.4; ENSG00000103978.17. [Q8NBN3-1]"";",0,"cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ruffle [GO:0001726]
Q96K49,S1,-1.259513164,-1.810520277,-0.396356403,0.818170013,1.170955043,gold,TMEM87B,TM87B_HUMAN,Transmembrane protein 87B,TMEM87B,84910;,ENST00000283206.9; ENSP00000283206.4; ENSG00000153214.11. [Q96K49-1];,0,"retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9P0T7,S1,-0.40247618,-0.822152737,0.11733516,0.650871287,0.723426757,gold,TMEM9,TMEM9_HUMAN,Proton-transporting V-type ATPase complex assembly regulator TMEM9 (v-ATPase assembly regulator TMEM9) (Dermal papilla-derived protein 4) (Transmembrane protein 9) (Protein TMEM9),TMEM9 DERP4 TMEM9A HSPC186 PSEC0012 UNQ631/PRO1248,252839;,"ENST00000367330.6; ENSP00000356299.1; ENSG00000116857.17.;""ENST00000367333.6; ENSP00000356302.2; ENSG00000116857.17."";""ENST00000367334.9; ENSP00000356303.5; ENSG00000116857.17."";""ENST00000485839.6; ENSP00000476893.1; ENSG00000116857.17."";",0,endosomal lumen acidification [GO:0048388]; lysosomal lumen acidification [GO:0007042]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein transport [GO:0015031]; proton-transporting V-type ATPase complex assembly [GO:0070070]; regulation of protein catabolic process [GO:0042176],intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; multivesicular body membrane [GO:0032585]
Q5BJF2,S2,-1.166744524,-1.652462616,0.379989445,0.938924792,0.589613661,orange,TMEM97,SGMR2_HUMAN,Sigma intracellular receptor 2 (S2R) (Sigma-2 receptor) (Sigma2 receptor) (Meningioma-associated protein 30) (MAC30) (Transmembrane protein 97),TMEM97 MAC30 S2R,27346;,ENST00000226230.8; ENSP00000226230.6; ENSG00000109084.14.;,cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142],cholesterol homeostasis [GO:0042632]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of wound healing [GO:0090303]; regulation of cell growth [GO:0001558]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of intracellular lipid transport [GO:0032377],endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]
Q9NQ34,S1,-0.443483596,-0.716948148,-0.036869113,0.455846222,1.02136256,gold,TMEM9B,TMM9B_HUMAN,Transmembrane protein 9B,TMEM9B C11orf15 UNQ712/PRO1375,56674;,"ENST00000309134.9; ENSP00000311842.5; ENSG00000175348.11. [Q9NQ34-2];""ENST00000525069.5; ENSP00000431487.1; ENSG00000175348.11. [Q9NQ34-2]"";""ENST00000534025.6; ENSP00000433361.1; ENSG00000175348.11. [Q9NQ34-1]"";",0,positive regulation of canonical NF-kappaB signal transduction [GO:0043123],early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]
P42167,N2,-0.96424249,-0.2710542,1.060456108,0.271128414,-0.45513554,grey70,TMPO,LAP2B_HUMAN,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",TMPO LAP2,7112;,"ENST00000261210.9; ENSP00000261210.5; ENSG00000120802.14. [P42167-3];""ENST00000393053.6; ENSP00000376773.2; ENSG00000120802.14. [P42167-2]"";""ENST00000556029.6; ENSP00000450627.1; ENSG00000120802.14. [P42167-1]"";",DNA binding [GO:0003677]; lamin binding [GO:0005521],0,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]
Q6ZT21,S2,-0.712188391,-1.299922382,0.253253557,0.791044008,0.619987093,orange,TMPPE,TMPPE_HUMAN,Transmembrane protein with metallophosphoesterase domain (EC 3.1.-.-),TMPPE,643853;,"ENST00000342462.5; ENSP00000343398.4; ENSG00000188167.9. [Q6ZT21-1];""ENST00000416695.6; ENSP00000400715.2; ENSG00000188167.9. [Q6ZT21-2]"";",hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],0,membrane [GO:0016020]
Q8N394,S2,-0.799976615,-1.149617761,0.177910077,0.8282203,0.40212224,orange,TMTC2,TMTC2_HUMAN,Protein O-mannosyl-transferase TMTC2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2),TMTC2,160335;,ENST00000321196.8; ENSP00000322300.3; ENSG00000179104.9.;,dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030],calcium ion homeostasis [GO:0055074]; protein O-linked mannosylation [GO:0035269],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q6ZXV5,S2,-1.111630483,-1.584101807,0.195725748,0.844634998,0.414178517,orange,TMTC3,TMTC3_HUMAN,Protein O-mannosyl-transferase TMTC3 (EC 2.4.1.109) (Protein SMILE) (Transmembrane O-mannosyltransferase targeting cadherins 3) (Transmembrane and tetratricopeptide repeat-containing 3),TMTC3,160418;,ENST00000266712.11; ENSP00000266712.6; ENSG00000139324.12. [Q6ZXV5-2];,dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030],positive regulation of proteasomal protein catabolic process [GO:1901800]; protein O-linked mannosylation [GO:0035269]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]
Q71RG4,S2,-1.124795822,-1.385853469,0.211171109,0.811003207,0.624809525,orange,TMUB2,TMUB2_HUMAN,Transmembrane and ubiquitin-like domain-containing protein 2,TMUB2 FP2653 UNQ1897/PRO4343,79089;,"ENST00000319511.6; ENSP00000313214.5; ENSG00000168591.16. [Q71RG4-2];""ENST00000357984.7; ENSP00000350672.3; ENSG00000168591.16. [Q71RG4-2]"";""ENST00000538716.7; ENSP00000444565.1; ENSG00000168591.16. [Q71RG4-1]"";""ENST00000587172.1; ENSP00000465153.1; ENSG00000168591.16. [Q71RG4-4]"";""ENST00000587989.1; ENSP00000466971.1; ENSG00000168591.16. [Q71RG4-1]"";""ENST00000589785.1; ENSP00000467364.1; ENSG00000168591.16. [Q71RG4-2]"";""ENST00000589856.1; ENSP00000467960.1; ENSG00000168591.16. [Q71RG4-3]"";""ENST00000590235.5; ENSP00000465015.1; ENSG00000168591.16. [Q71RG4-4]"";""ENST00000592825.1; ENSP00000466189.1; ENSG00000168591.16. [Q71RG4-4]"";",0,ERAD pathway [GO:0036503],membrane [GO:0016020]
Q9H3N1,S2,-1.142957924,-1.235538926,0.357941347,0.794137718,0.524046168,orange,TMX1,TMX1_HUMAN,Thioredoxin-related transmembrane protein 1 (Protein disulfide-isomerase TMX1) (EC 5.3.4.1) (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268,81542;,ENST00000457354.7; ENSP00000393316.2; ENSG00000139921.13.;,disulfide oxidoreductase activity [GO:0015036]; enzyme inhibitor activity [GO:0004857]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],negative regulation of platelet aggregation [GO:0090331]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of ERAD pathway [GO:1904294]; regulation of calcium ion transport [GO:0051924]; response to endoplasmic reticulum stress [GO:0034976],endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]
Q9Y320,S2,-0.950685557,-1.200659957,0.217840182,0.811293602,0.580235684,orange,TMX2,TMX2_HUMAN,Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14),TMX2 TXNDC14 CGI-31 My009 PIG26 PSEC0045 UNQ237/PRO270,51075;,"ENST00000278422.9; ENSP00000278422.4; ENSG00000213593.10. [Q9Y320-1];""ENST00000378312.8; ENSP00000367562.4; ENSG00000213593.10. [Q9Y320-2]"";",disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802],brain development [GO:0007420],endoplasmic reticulum membrane [GO:0005789]; membrane-bounded organelle [GO:0043227]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]
Q96JJ7,S2,-1.362852923,-1.826368311,0.314557681,0.861542178,0.524400207,orange,TMX3,TMX3_HUMAN,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),TMX3 KIAA1830 TXNDC10,54495;,"ENST00000299608.7; ENSP00000299608.2; ENSG00000166479.10. [Q96JJ7-1];""ENST00000562706.5; ENSP00000457262.1; ENSG00000166479.10. [Q96JJ7-2]"";",protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],0,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]
O14763,S4,-1.123298681,-1.367380823,0.389607727,0.814485681,0.457286344,tomato2,TNFRSF10B,TR10B_HUMAN,Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2) (TRAIL receptor 2) (TRAIL-R2) (CD antigen CD262),TNFRSF10B DR5 KILLER TRAILR2 TRICK2 ZTNFR9 UNQ160/PRO186,8795;,"ENST00000276431.9; ENSP00000276431.4; ENSG00000120889.13. [O14763-1];""ENST00000347739.3; ENSP00000317859.3; ENSG00000120889.13. [O14763-2]"";",signaling receptor activity [GO:0038023]; TRAIL binding [GO:0045569]; TRAIL receptor activity [GO:0036463],activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; regulation of apoptotic process [GO:0042981]; response to endoplasmic reticulum stress [GO:0034976]; TRAIL-activated apoptotic signaling pathway [GO:0036462],cell surface [GO:0009986]; plasma membrane [GO:0005886]
P19438,S2,-1.206962494,-1.309099698,0.226563684,0.68311687,0.690084338,orange,TNFRSF1A,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)]",TNFRSF1A TNFAR TNFR1,7132;,"ENST00000162749.7; ENSP00000162749.2; ENSG00000067182.9. [P19438-1];""ENST00000437813.8; ENSP00000513672.1; ENSG00000067182.9. [P19438-5]"";""ENST00000698339.1; ENSP00000513670.1; ENSG00000067182.9. [P19438-5]"";""ENST00000698340.1; ENSP00000513671.1; ENSG00000067182.9. [P19438-4]"";",tumor necrosis factor binding [GO:0043120]; tumor necrosis factor receptor activity [GO:0005031],aortic valve development [GO:0003176]; cellular response to mechanical stimulus [GO:0071260]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of inflammatory response [GO:0050728]; positive regulation of amide metabolic process [GO:0034250]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin metabolic process [GO:0006693]; protein localization to plasma membrane [GO:0072659]; pulmonary valve development [GO:0003177]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of membrane lipid metabolic process [GO:1905038]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; transcription by RNA polymerase II [GO:0006366]; tumor necrosis factor-mediated signaling pathway [GO:0033209],cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947]
O75509,S1,-0.987840506,-1.095546451,-0.003664269,0.872388919,0.87338581,gold,TNFRSF21,TNR21_HUMAN,Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358),TNFRSF21 DR6 UNQ437/PRO868,27242;,ENST00000296861.2; ENSP00000296861.2; ENSG00000146072.6.;,0,adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell apoptotic process [GO:0001783]; cellular response to tumor necrosis factor [GO:0071356]; humoral immune response [GO:0006959]; myelination [GO:0042552]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of myelination [GO:0031642]; negative regulation of T cell proliferation [GO:0042130]; neuron apoptotic process [GO:0051402]; oligodendrocyte apoptotic process [GO:0097252]; regulation of oligodendrocyte differentiation [GO:0048713]; T cell receptor signaling pathway [GO:0050852],axon [GO:0030424]; plasma membrane [GO:0005886]
Q15025,C3,1.436598671,0.243223337,-0.651825726,-0.117076886,-0.577692289,cyan,TNIP1,TNIP1_HUMAN,TNFAIP3-interacting protein 1 (A20-binding inhibitor of NF-kappa-B activation 1) (ABIN-1) (HIV-1 Nef-interacting protein) (Nef-associated factor 1) (Naf1) (Nip40-1) (Virion-associated nuclear shuttling protein) (VAN) (hVAN),TNIP1 KIAA0113 NAF1,10318;,"ENST00000315050.11; ENSP00000317891.7; ENSG00000145901.16. [Q15025-1];""ENST00000518977.5; ENSP00000430971.1; ENSG00000145901.16. [Q15025-2]"";""ENST00000520931.5; ENSP00000429891.1; ENSG00000145901.16. [Q15025-3]"";""ENST00000521591.6; ENSP00000430760.1; ENSG00000145901.16. [Q15025-1]"";""ENST00000522226.5; ENSP00000428187.1; ENSG00000145901.16. [Q15025-1]"";""ENST00000523200.5; ENSP00000431105.1; ENSG00000145901.16. [Q15025-4]"";""ENST00000523338.5; ENSP00000428243.1; ENSG00000145901.16. [Q15025-2]"";""ENST00000524280.5; ENSP00000429912.1; ENSG00000145901.16. [Q15025-5]"";""ENST00000610535.5; ENSP00000483944.1; ENSG00000145901.16. [Q15025-4]"";""ENST00000610874.4; ENSP00000484665.1; ENSG00000145901.16. [Q15025-5]"";",identical protein binding [GO:0042802]; mitogen-activated protein kinase binding [GO:0051019],cellular response to lipopolysaccharide [GO:0071222]; defense response [GO:0006952]; glycoprotein biosynthetic process [GO:0009101]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of viral genome replication [GO:0045071]; positive regulation of inflammatory response [GO:0050729]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; translation [GO:0006412],cytosol [GO:0005829]; nucleoplasm [GO:0005654]
O95271,C1,0.607439823,-0.227798166,-0.116526352,0.250493896,0.364768821,lightblue,TNKS,TNKS1_HUMAN,Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I) (Tankyrase-1) (TANK1),TNKS PARP5A PARPL TIN1 TINF1 TNKS1,8658;,"ENST00000310430.11; ENSP00000311579.6; ENSG00000173273.17. [O95271-1];""ENST00000646522.2; ENSP00000493602.2; ENSG00000285372.2. [O95271-1]"";",histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],"cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; regulation of telomere maintenance via telomerase [GO:0032210]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055]","chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]"
Q96GM8,N1,-1.127822204,0.501795942,0.077706883,-0.409565261,0.82594388,grey90,TOE1,TOE1_HUMAN,Target of EGR1 protein 1,TOE1,114034;,ENST00000372090.6; ENSP00000361162.5; ENSG00000132773.12. [Q96GM8-1];,3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; snRNA binding [GO:0017069],snRNA 3'-end processing [GO:0034472],Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
O75674,C3,1.579177691,0.361676404,-0.556695515,-0.480077731,-0.700721169,cyan,TOM1L1,TM1L1_HUMAN,TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1),TOM1L1 SRCASM,10040;,"ENST00000348161.8; ENSP00000343901.4; ENSG00000141198.16. [O75674-3];""ENST00000536554.5; ENSP00000443099.1; ENSG00000141198.16. [O75674-3]"";""ENST00000570371.5; ENSP00000458553.1; ENSG00000141198.16. [O75674-2]"";""ENST00000575333.5; ENSP00000458918.1; ENSG00000141198.16. [O75674-2]"";""ENST00000575882.6; ENSP00000460823.1; ENSG00000141198.16. [O75674-1]"";",clathrin binding [GO:0030276]; phosphatidylinositol binding [GO:0035091]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130],activation of protein kinase activity [GO:0032147]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of protein autophosphorylation [GO:0031954]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; lysosome [GO:0005764]; membrane [GO:0016020]
Q15388,M2,-0.847281492,-1.33274942,0.373421357,1.128443174,-0.288275901,tan4,TOMM20,TOM20_HUMAN,Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20),TOMM20 KIAA0016,9804;,ENST00000366607.5; ENSP00000355566.4; ENSG00000173726.11.;,mitochondrion targeting sequence binding [GO:0030943]; protein-transporting ATPase activity [GO:0015450]; unfolded protein binding [GO:0051082],protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; tRNA import into mitochondrion [GO:0016031],cell periphery [GO:0071944]; migrasome [GO:0140494]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; sperm midpiece [GO:0097225]; TOM complex [GO:0140596]
Q9NS69,M2,-1.457789503,-1.633838125,0.376080407,1.161751092,-0.453694982,tan4,TOMM22,TOM22_HUMAN,Mitochondrial import receptor subunit TOM22 homolog (hTom22) (1C9-2) (Translocase of outer membrane 22 kDa subunit homolog),TOMM22 TOM22,56993;,ENST00000216034.6; ENSP00000216034.4; ENSG00000100216.6.;,mitochondrion targeting sequence binding [GO:0030943]; protein transmembrane transporter activity [GO:0008320],protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; TOM complex [GO:0140596]
Q15785,C5,1.914660241,0.400602845,-0.652045999,-0.725708711,-0.96909973,turquoise3,TOMM34,TOM34_HUMAN,Mitochondrial import receptor subunit TOM34 (hTom34) (Translocase of outer membrane 34 kDa subunit),TOMM34 URCC3,10953;,ENST00000372813.4; ENSP00000361900.3; ENSG00000025772.8.;,heat shock protein binding [GO:0031072],protein targeting to mitochondrion [GO:0006626],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]
O96008,M2,-0.988772798,-1.275989028,0.349475617,1.081720232,-0.242786639,tan4,TOMM40,TOM40_HUMAN,Mitochondrial import receptor subunit TOM40 homolog (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog) (p38.5),TOMM40 C19orf1 PEREC1 TOM40,10452;,"ENST00000252487.9; ENSP00000252487.4; ENSG00000130204.13. [O96008-1];""ENST00000405636.6; ENSP00000385184.2; ENSG00000130204.13. [O96008-1]"";""ENST00000426677.7; ENSP00000410339.1; ENSG00000130204.13. [O96008-1]"";""ENST00000592434.5; ENSP00000466084.1; ENSG00000130204.13. [O96008-2]"";",porin activity [GO:0015288]; protein transmembrane transporter activity [GO:0008320],monoatomic ion transport [GO:0006811]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; pore complex [GO:0046930]; TOM complex [GO:0140596]
Q8N4H5,M2,-1.040016761,-1.062240882,0.423370515,1.135549973,-0.16630461,tan4,TOMM5,TOM5_HUMAN,Mitochondrial import receptor subunit TOM5 homolog,TOMM5 C9orf105 TOM5,401505;,"ENST00000321301.7; ENSP00000313584.6; ENSG00000175768.13. [Q8N4H5-1];""ENST00000377773.9; ENSP00000367004.5; ENSG00000175768.13. [Q8N4H5-3]"";""ENST00000544379.1; ENSP00000438204.1; ENSG00000175768.13. [Q8N4H5-2]"";",0,protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626],mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; TOM complex [GO:0140596]
O94826,M2,-1.259891572,-1.420778182,0.391414193,1.187841285,-0.241259433,tan4,TOMM70A,TOM70_HUMAN,Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70),TOMM70 KIAA0719 TOM70 TOMM70A,9868;,ENST00000284320.6; ENSP00000284320.5; ENSG00000154174.8.;,mitochondrion targeting sequence binding [GO:0030943]; molecular adaptor activity [GO:0060090]; protein transmembrane transporter activity [GO:0008320],activation of innate immune response [GO:0002218]; cellular response to virus [GO:0098586]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein import into mitochondrial matrix [GO:0030150]; protein insertion into mitochondrial inner membrane [GO:0045039]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of apoptotic process [GO:0042981]; response to thyroxine [GO:0097068],extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; TOM complex [GO:0140596]
P11388,N3,-1.046388427,-1.309164367,1.296469478,0.362179706,-0.665425778,grey50,TOP2A,TOP2A_HUMAN,"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)",TOP2A TOP2,7153;,ENST00000423485.6; ENSP00000411532.1; ENSG00000131747.15. [P11388-1];,"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]",apoptotic chromosome condensation [GO:0030263]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]"
Q02880,N3,-1.150161951,-1.41994081,1.308869303,0.302250654,-0.757953326,grey50,TOP2B,TOP2B_HUMAN,"DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme)",TOP2B,7155;,"ENST00000264331.9; ENSP00000264331.4; ENSG00000077097.17. [Q02880-1];""ENST00000435706.6; ENSP00000396704.2; ENSG00000077097.17. [Q02880-2]"";","ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]",axonogenesis [GO:0007409]; B cell differentiation [GO:0030183]; cellular response to ATP [GO:0071318]; cellular response to hydrogen peroxide [GO:0070301]; cellular senescence [GO:0090398]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; neuron migration [GO:0001764]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]
Q9NS56,N2,-1.273099541,-0.021172404,0.718042869,-0.030209393,0.591144535,grey70,TOPORS,TOPRS_HUMAN,E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3),TOPORS LUN TP53BPL,10210;,"ENST00000360538.7; ENSP00000353735.2; ENSG00000197579.8. [Q9NS56-1];""ENST00000379858.1; ENSP00000369187.1; ENSG00000197579.8. [Q9NS56-2]"";",antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; metal ion binding [GO:0046872]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],DNA damage response [GO:0006974]; DNA-templated transcription [GO:0006351]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; retinal cone cell development [GO:0046549]; retinal rod cell development [GO:0046548]; ubiquitin-dependent protein catabolic process [GO:0006511],centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]
Q5JTV8,N3,-1.469563834,-1.491465787,1.243894832,0.365601334,-0.352190954,grey50,TOR1AIP1,TOIP1_HUMAN,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),TOR1AIP1 LAP1,26092;,"ENST00000435319.8; ENSP00000393292.3; ENSG00000143337.19. [Q5JTV8-4];""ENST00000528443.6; ENSP00000435365.2; ENSG00000143337.19. [Q5JTV8-3]"";""ENST00000606911.7; ENSP00000476687.1; ENSG00000143337.19. [Q5JTV8-1]"";",ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; lamin binding [GO:0005521],nuclear membrane organization [GO:0071763]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435]; protein localization to nucleus [GO:0034504],nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]
Q8NFQ8,S2,-1.315210673,-1.424516843,0.167272147,0.839226847,0.583007866,orange,TOR1AIP2,TOIP2_HUMAN,Torsin-1A-interacting protein 2 (Lumenal domain-like LAP1),TOR1AIP2 IFRG15 LULL1,163590;,"ENST00000367612.7; ENSP00000356584.3; ENSG00000169905.13. [Q8NFQ8-1];""ENST00000609928.6; ENSP00000477486.1; ENSG00000169905.13. [Q8NFQ8-1]"";",ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117],endoplasmic reticulum organization [GO:0007029]; membrane organization [GO:0061024]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to nuclear envelope [GO:0090435],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]
Q8N2E6,S3,-1.248162967,-0.829010896,0.265238748,0.639657821,0.544750483,salmon,TOR2A,TOR2X_HUMAN,Prosalusin (Torsin family 2 member A) (Torsin-2A) [Cleaved into: Salusin-alpha; Salusin-beta],TOR2A HEMBA1005096 PSEC0218,27433;,ENST00000336067.10; ENSP00000338317.6; ENSG00000160404.18. [Q8N2E6-1];,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hormone activity [GO:0005179],0,extracellular region [GO:0005576]
Q53FA7,C4,2.124391922,0.595994866,-1.061734279,-1.247701889,-1.312047727,deepskyblue2,TP53I3,QORX_HUMAN,Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein),TP53I3 PIG3,9540;,"ENST00000238721.9; ENSP00000238721.4; ENSG00000115129.14. [Q53FA7-1];""ENST00000335934.8; ENSP00000337834.4; ENSG00000115129.14. [Q53FA7-1]"";""ENST00000407482.5; ENSP00000384414.1; ENSG00000115129.14. [Q53FA7-2]"";",NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038],NADP metabolic process [GO:0006739],cytosol [GO:0005829]
Q9ULQ1,S1,-1.182297942,-1.542122239,0.0833365,0.481795535,1.15900955,gold,TPCN1,TPC1_HUMAN,Two pore channel protein 1 (Two pore calcium channel protein 1) (Voltage-dependent calcium channel protein TPC1),TPCN1 KIAA1169 TPC1,53373;,"ENST00000335509.11; ENSP00000335300.6; ENSG00000186815.13. [Q9ULQ1-1];""ENST00000541517.5; ENSP00000438125.1; ENSG00000186815.13. [Q9ULQ1-3]"";""ENST00000550785.5; ENSP00000448083.1; ENSG00000186815.13. [Q9ULQ1-3]"";","identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; voltage-gated channel activity [GO:0022832]; voltage-gated sodium channel activity [GO:0005248]",endocytosis involved in viral entry into host cell [GO:0075509]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of autophagy [GO:0010508],early endosome membrane [GO:0031901]; endolysosome [GO:0036019]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; monoatomic ion channel complex [GO:0034702]; recycling endosome membrane [GO:0055038]
P55327,C1,1.82358298,0.021131137,-0.882629197,-0.554131862,0.447339783,lightblue,TPD52,TPD52_HUMAN,Tumor protein D52 (Protein N8),TPD52,7163;,"ENST00000379096.9; ENSP00000368390.4; ENSG00000076554.16. [P55327-2];""ENST00000379097.7; ENSP00000368391.3; ENSG00000076554.16. [P55327-1]"";""ENST00000448733.3; ENSP00000410222.2; ENSG00000076554.16. [P55327-5]"";""ENST00000517427.5; ENSP00000429351.1; ENSG00000076554.16. [P55327-7]"";""ENST00000517462.6; ENSP00000429708.1; ENSG00000076554.16. [P55327-8]"";""ENST00000518937.6; ENSP00000429915.1; ENSG00000076554.16. [P55327-4]"";""ENST00000520527.5; ENSP00000429309.1; ENSG00000076554.16. [P55327-6]"";",calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803],anatomical structure morphogenesis [GO:0009653]; B cell differentiation [GO:0030183]; secretion [GO:0046903],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]
P60174,C5,1.810459662,0.707020585,-1.180731478,-1.475169019,-1.509736036,turquoise3,TPI1,TPIS_HUMAN,Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase),TPI1 TPI,7167;,"ENST00000229270.8; ENSP00000229270.4; ENSG00000111669.15. [P60174-3];""ENST00000396705.10; ENSP00000379933.4; ENSG00000111669.15. [P60174-1]"";""ENST00000488464.6; ENSP00000475620.1; ENSG00000111669.15. [P60174-4]"";""ENST00000535434.5; ENSP00000443599.1; ENSG00000111669.15. [P60174-4]"";""ENST00000613953.4; ENSP00000484435.1; ENSG00000111669.15. [P60174-3]"";",methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625],canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634]
P09493,C5,0.821297784,1.127422057,-0.612815746,-0.830061536,-1.040190677,turquoise3,TPM1,TPM1_HUMAN,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),TPM1 C15orf13 TMSA,7168;,"ENST00000267996.11; ENSP00000267996.7; ENSG00000140416.25. [P09493-7];""ENST00000288398.10; ENSP00000288398.6; ENSG00000140416.25. [P09493-10]"";""ENST00000334895.10; ENSP00000334624.4; ENSG00000140416.25. [P09493-5]"";""ENST00000358278.7; ENSP00000351022.3; ENSG00000140416.25. [P09493-3]"";""ENST00000403994.9; ENSP00000385107.4; ENSG00000140416.25. [P09493-1]"";""ENST00000559397.6; ENSP00000452879.1; ENSG00000140416.25. [P09493-8]"";""ENST00000559556.5; ENSP00000453941.1; ENSG00000140416.25. [P09493-9]"";""ENST00000561266.6; ENSP00000453955.2; ENSG00000140416.25. [P09493-6]"";",actin binding [GO:0003779]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],actin filament organization [GO:0007015]; cardiac muscle contraction [GO:0060048]; cellular response to reactive oxygen species [GO:0034614]; cytoskeleton organization [GO:0007010]; muscle filament sliding [GO:0030049]; negative regulation of cell migration [GO:0030336]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of cell adhesion [GO:0045785]; positive regulation of heart rate by epinephrine [GO:0003065]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell shape [GO:0008360]; regulation of heart contraction [GO:0008016]; regulation of muscle contraction [GO:0006937]; ruffle organization [GO:0031529]; sarcomere organization [GO:0045214]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; bleb [GO:0032059]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]; ruffle membrane [GO:0032587]; sarcomere [GO:0030017]; stress fiber [GO:0001725]
P07951,C5,1.566807348,0.984812538,-0.848646724,-1.132157399,-1.439796303,turquoise3,TPM2,TPM2_HUMAN,Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2),TPM2 TMSB,7169;,"ENST00000378292.9; ENSP00000367542.3; ENSG00000198467.16. [P07951-2];""ENST00000645482.3; ENSP00000496494.2; ENSG00000198467.16. [P07951-1]"";",actin binding [GO:0003779]; actin filament binding [GO:0051015]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307],actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; regulation of ATP-dependent activity [GO:0043462],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytosol [GO:0005829]; muscle thin filament tropomyosin [GO:0005862]
P06753,C5,1.319113069,0.983918088,-0.686677325,-0.783091688,-1.150544489,turquoise3,TPM3,TPM3_HUMAN,Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5),TPM3,7170;,"ENST00000302206.9; ENSP00000307712.5; ENSG00000143549.22. [P06753-7];""ENST00000323144.12; ENSP00000357518.4; ENSG00000143549.22. [P06753-4]"";""ENST00000328159.9; ENSP00000357520.1; ENSG00000143549.22. [P06753-6]"";""ENST00000330188.13; ENSP00000339035.7; ENSG00000143549.22. [P06753-5]"";""ENST00000341485.10; ENSP00000341653.6; ENSG00000143549.22. [P06753-4]"";""ENST00000368531.6; ENSP00000357517.2; ENSG00000143549.22. [P06753-3]"";""ENST00000368533.8; ENSP00000357521.3; ENSG00000143549.22. [P06753-2]"";""ENST00000651641.1; ENSP00000498577.1; ENSG00000143549.22. [P06753-1]"";",actin filament binding [GO:0051015],actin filament organization [GO:0007015]; muscle contraction [GO:0006936],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; muscle thin filament tropomyosin [GO:0005862]; stress fiber [GO:0001725]
P67936,C5,1.482003525,0.908490915,-0.699074715,-0.872564417,-1.052606192,turquoise3,TPM4,TPM4_HUMAN,Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4),TPM4,7171;,"ENST00000643579.2; ENSP00000495347.1; ENSG00000167460.17. [P67936-1];""ENST00000646974.2; ENSP00000494125.1; ENSG00000167460.17. [P67936-2]"";",actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of muscle [GO:0008307],actin filament organization [GO:0007015]; muscle contraction [GO:0006936]; osteoblast differentiation [GO:0001649]; platelet formation [GO:0030220],actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; muscle thin filament tropomyosin [GO:0005862]; podosome [GO:0002102]; stress fiber [GO:0001725]
P51580,C4,2.168795514,0.327193168,-1.190629927,-1.347850517,-1.493343093,deepskyblue2,TPMT,TPMT_HUMAN,Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase),TPMT,7172;,ENST00000309983.5; ENSP00000312304.4; ENSG00000137364.5.;,S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119],methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]
P29144,N1,-0.067746406,-0.608683051,-0.620904127,-0.432508552,1.418734657,grey90,TPP2,TPP2_HUMAN,Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II),TPP2,7174;,ENST00000376065.8; ENSP00000365233.4; ENSG00000134900.13.;,aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240],intracellular amino acid homeostasis [GO:0080144]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]
Q5T0D9,S1,-0.325406662,-0.94143608,-0.242171736,0.332273974,1.190103846,gold,TPRG1L,TPRGL_HUMAN,Tumor protein p63-regulated gene 1-like protein (Mossy fiber terminal-associated vertebrate-specific presynaptic protein) (Protein FAM79A),TPRG1L FAM79A MOVER,127262;,"ENST00000344579.5; ENSP00000339714.5; ENSG00000158109.15. [Q5T0D9-2];""ENST00000378344.7; ENSP00000367595.2; ENSG00000158109.15. [Q5T0D9-1]"";",calmodulin binding [GO:0005516]; identical protein binding [GO:0042802],"calmodulin dependent kinase signaling pathway [GO:0099004]; negative regulation of synaptic transmission [GO:0050805]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic vesicle docking [GO:0016081]",calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]
O60507,S1,-1.069105431,-1.31431169,-0.103667631,0.851538658,1.0535689,gold,TPST1,TPST1_HUMAN,Protein-tyrosine sulfotransferase 1 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 1) (TPST-1),TPST1,8460;,"ENST00000304842.6; ENSP00000302413.5; ENSG00000169902.15.;""ENST00000649664.1; ENSP00000497281.1; ENSG00000169902.15."";",protein homodimerization activity [GO:0042803]; protein-tyrosine sulfotransferase activity [GO:0008476],3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; post-translational protein modification [GO:0043687],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
P13693,C4,2.162068084,0.170460125,-1.129398495,-1.200707778,-1.258085393,deepskyblue2,TPT1,TCTP_HUMAN,Translationally-controlled tumor protein (TCTP) (Fortilin) (Histamine-releasing factor) (HRF) (p23),TPT1,7178;,"ENST00000379055.5; ENSP00000368344.1; ENSG00000133112.17. [P13693-2];""ENST00000379056.5; ENSP00000368345.1; ENSG00000133112.17. [P13693-2]"";""ENST00000530705.6; ENSP00000431872.2; ENSG00000133112.17. [P13693-1]"";",calcium ion binding [GO:0005509]; RNA binding [GO:0003723],calcium ion transport [GO:0006816]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of apoptotic process [GO:0042981]; response to virus [GO:0009615],cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; spindle pole [GO:0000922]
Q13595,N3,-0.987411853,-0.641298994,0.966002427,-0.118241709,0.231258768,grey50,TRA2A,TRA2A_HUMAN,Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A),TRA2A,29896;,"ENST00000297071.9; ENSP00000297071.4; ENSG00000164548.12. [Q13595-1];""ENST00000392502.8; ENSP00000376290.4; ENSG00000164548.12. [Q13595-4]"";""ENST00000621813.4; ENSP00000480822.1; ENSG00000164548.12. [Q13595-3]"";",RNA binding [GO:0003723],"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]",intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]
P62995,N3,-1.27806346,-0.847087635,0.966129181,-0.015083988,0.397847736,grey50,TRA2B,TRA2B_HUMAN,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",TRA2B SFRS10,6434;,"ENST00000382191.4; ENSP00000371626.4; ENSG00000136527.19. [P62995-3];""ENST00000453386.7; ENSP00000416959.2; ENSG00000136527.19. [P62995-1]"";""ENST00000456380.5; ENSP00000416887.1; ENSG00000136527.19. [P62995-2]"";",identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],"cellular response to glucose stimulus [GO:0071333]; cerebral cortex regionalization [GO:0021796]; embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]
Q9H4I3,M2,-1.289902759,-1.436135175,0.366726133,1.161465042,-0.121861646,tan4,TRABD,TRABD_HUMAN,TraB domain-containing protein (Protein TTG2),TRABD TTG2 PP2447,80305;,"ENST00000303434.8; ENSP00000305664.4; ENSG00000170638.10. [Q9H4I3-1];""ENST00000380909.9; ENSP00000370295.4; ENSG00000170638.10. [Q9H4I3-1]"";""ENST00000395827.5; ENSP00000379171.1; ENSG00000170638.10. [Q9H4I3-1]"";",0,0,0
Q92844,C3,1.659034797,0.122356526,-0.679617758,-0.661907314,-0.743700126,cyan,TRAF2,TANK_HUMAN,TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein) (I-TRAF),TANK ITRAF TRAF2,10010;,"ENST00000259075.6; ENSP00000259075.2; ENSG00000136560.14. [Q92844-1];""ENST00000392749.7; ENSP00000376505.2; ENSG00000136560.14. [Q92844-1]"";""ENST00000403609.1; ENSP00000385983.1; ENSG00000136560.14. [Q92844-3]"";",deubiquitinase activator activity [GO:0035800]; metal ion binding [GO:0046872]; molecular adaptor activity [GO:0060090]; molecular function inhibitor activity [GO:0140678]; ubiquitin protein ligase binding [GO:0031625],cellular response to interleukin-1 [GO:0071347]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; defense response to virus [GO:0051607]; DNA damage response [GO:0006974]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of type I interferon production [GO:0032481]; positive regulation of ubiquitin-specific protease activity [GO:2000158]; signal transduction [GO:0007165]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; serine/threonine protein kinase complex [GO:1902554]
Q8TDR0,C2,0.892258475,0.314120467,-0.33884348,-0.267129488,0.040885107,aquamarine,TRAF3IP1,MIPT3_HUMAN,TRAF3-interacting protein 1 (Interleukin-13 receptor alpha 1-binding protein 1) (Intraflagellar transport protein 54 homolog) (Microtubule-interacting protein associated with TRAF3) (MIP-T3),TRAF3IP1 IFT54 MIPT3,26146;,"ENST00000373327.5; ENSP00000362424.4; ENSG00000204104.12. [Q8TDR0-1];""ENST00000391993.7; ENSP00000375851.3; ENSG00000204104.12. [Q8TDR0-2]"";",microtubule binding [GO:0008017],cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of defense response to virus [GO:0050687]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of type I interferon production [GO:0032480]; regulation of microtubule cytoskeleton organization [GO:0070507],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]
O14545,C3,1.683546063,0.338728639,-0.565156758,-0.608187996,-0.936022746,cyan,TRAFD1,TRAD1_HUMAN,TRAF-type zinc finger domain-containing protein 1 (Protein FLN29),TRAFD1 FLN29,10906;,"ENST00000257604.9; ENSP00000257604.5; ENSG00000135148.12. [O14545-1];""ENST00000412615.7; ENSP00000396526.2; ENSG00000135148.12. [O14545-1]"";""ENST00000552890.5; ENSP00000447340.1; ENSG00000135148.12. [O14545-2]"";",metal ion binding [GO:0046872],negative regulation of innate immune response [GO:0045824],mitochondrion [GO:0005739]
Q15629,S2,-1.760778024,-1.774412229,0.120686281,0.86501503,0.483734826,orange,TRAM1,TRAM1_HUMAN,Translocating chain-associated membrane protein 1 (Protein TRAM1),TRAM1 TRAM,23471;,ENST00000262213.7; ENSP00000262213.2; ENSG00000067167.8. [Q15629-1];,signaling receptor activity [GO:0038023],"cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]
Q15035,S2,-2.072307263,-2.170487242,0.141766284,1.044425756,0.613134858,orange,TRAM2,TRAM2_HUMAN,Translocating chain-associated membrane protein 2,TRAM2 KIAA0057,9697;,ENST00000182527.4; ENSP00000182527.3; ENSG00000065308.5.;,0,"collagen biosynthetic process [GO:0032964]; protein insertion into ER membrane [GO:0045048]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",endoplasmic reticulum membrane [GO:0005789]
Q12931,M1,-0.79994709,-0.145893472,0.391825889,0.890331247,-0.490406286,burlywood4,TRAP1,TRAP1_HUMAN,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (Heat shock protein family C member 5) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)",TRAP1 HSP75 HSPC5,10131;,"ENST00000246957.10; ENSP00000246957.5; ENSG00000126602.11. [Q12931-1];""ENST00000538171.5; ENSP00000442070.1; ENSG00000126602.11. [Q12931-2]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082],chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386],cell periphery [GO:0071944]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
O43617,C1,1.237593769,0.409395673,-0.456943835,-0.327075619,0.098394539,lightblue,TRAPPC3,TPPC3_HUMAN,Trafficking protein particle complex subunit 3 (BET3 homolog),TRAPPC3 BET3 CDABP0066,27095;,"ENST00000373162.5; ENSP00000362256.1; ENSG00000054116.12. [O43617-2];""ENST00000373163.5; ENSP00000362257.1; ENSG00000054116.12. [O43617-2]"";""ENST00000373166.8; ENSP00000362261.3; ENSG00000054116.12. [O43617-1]"";""ENST00000617904.4; ENSP00000480648.1; ENSG00000054116.12. [O43617-2]"";",0,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cis-Golgi network membrane [GO:0033106]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]
O43715,N4,-0.650172261,1.158351269,-0.043516049,0.198492419,-0.986952825,grey30,TRIAP1,TRIA1_HUMAN,TP53-regulated inhibitor of apoptosis 1 (Protein 15E1.1) (WF-1) (p53-inducible cell-survival factor) (p53CSV),TRIAP1 15E1.1 HSPC132,51499;,ENST00000546954.2; ENSP00000449795.1; ENSG00000170855.4.;,p53 binding [GO:0002039],"apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; intermembrane lipid transfer [GO:0120009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of membrane lipid distribution [GO:0097035]",mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
O60858,S4,-0.628146399,-0.898024997,0.445784738,0.731839471,0.276153008,tomato2,TRIM13,TRI13_HUMAN,E3 ubiquitin-protein ligase TRIM13 (EC 2.3.2.27) (B-cell chronic lymphocytic leukemia tumor suppressor Leu5) (Leukemia-associated protein 5) (Putative tumor suppressor RFP2) (RING finger protein 77) (RING-type E3 ubiquitin transferase TRIM13) (Ret finger protein 2) (Tripartite motif-containing protein 13),TRIM13 LEU5 RFP2 RNF77,10206;,"ENST00000356017.8; ENSP00000348299.4; ENSG00000204977.10. [O60858-3];""ENST00000378182.4; ENSP00000367424.3; ENSG00000204977.10. [O60858-1]"";""ENST00000420995.6; ENSP00000412943.2; ENSG00000204977.10. [O60858-1]"";""ENST00000457662.2; ENSP00000399206.2; ENSG00000204977.10. [O60858-1]"";",transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase activity [GO:0061659]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],anatomical structure morphogenesis [GO:0009653]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; negative regulation of viral transcription [GO:0032897]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum [GO:0097038]
P19474,C5,1.792420311,0.381940646,-0.776461705,-0.765216117,-0.869569481,turquoise3,TRIM21,RO52_HUMAN,E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21),TRIM21 RNF81 RO52 SSA1,6737;,ENST00000254436.8; ENSP00000254436.7; ENSG00000132109.10. [P19474-1];,DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],cellular response to chemical stress [GO:0062197]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein deubiquitination [GO:0090086]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein binding [GO:0032092]; positive regulation of viral entry into host cell [GO:0046598]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; pyroptosis [GO:0070269]; regulation of protein localization [GO:0032880]; regulation of type I interferon production [GO:0032479]; regulation of viral entry into host cell [GO:0046596]; response to type II interferon [GO:0034341]; stress granule disassembly [GO:0035617]; suppression of viral release by host [GO:0044790],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904]
O15164,N4,-1.062796122,0.792560716,0.54487541,-0.142329676,-0.667285664,grey30,TRIM24,TIF1A_HUMAN,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24),TRIM24 RNF82 TIF1 TIF1A,8805;,"ENST00000343526.9; ENSP00000340507.4; ENSG00000122779.18. [O15164-1];""ENST00000415680.6; ENSP00000390829.2; ENSG00000122779.18. [O15164-2]"";",chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell proliferation [GO:0050673]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of gene expression [GO:0010628]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; cytosol [GO:0005829]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]
Q12899,C1,1.49042983,0.007513923,-0.304274063,-0.544131828,-0.025811974,lightblue,TRIM26,TRI26_HUMAN,Tripartite motif-containing protein 26 (EC 2.3.2.27) (Acid finger protein) (AFP) (RING finger protein 95) (Zinc finger protein 173),TRIM26 RNF95 ZNF173,7726;,"ENST00000327357.9; ENSP00000331131.5; ENSG00000137313.15.;""ENST00000383607.6; ENSP00000373102.2; ENSG00000137313.15."";""ENST00000396558.5; ENSP00000379806.1; ENSG00000137313.15."";""ENST00000415923.6; ENSP00000415755.2; ENSG00000231002.7."";""ENST00000422349.5; ENSP00000396188.1; ENSG00000234046.7."";""ENST00000425523.5; ENSP00000393011.1; ENSG00000228881.7."";""ENST00000425831.5; ENSP00000394371.1; ENSG00000231641.9."";""ENST00000427535.5; ENSP00000398545.1; ENSG00000234046.7."";""ENST00000428486.5; ENSP00000414248.1; ENSG00000231002.7."";""ENST00000432326.5; ENSP00000407876.1; ENSG00000231641.9."";""ENST00000433314.5; ENSP00000402395.1; ENSG00000226060.7."";""ENST00000436219.5; ENSP00000390258.1; ENSG00000230230.7."";""ENST00000437089.5; ENSP00000395491.1; ENSG00000234127.9."";""ENST00000438384.5; ENSP00000416737.1; ENSG00000231641.9."";""ENST00000438908.5; ENSP00000409182.1; ENSG00000230230.7."";""ENST00000439094.6; ENSP00000389203.2; ENSG00000228881.7."";""ENST00000445259.6; ENSP00000407294.2; ENSG00000234046.7."";""ENST00000447711.6; ENSP00000408233.2; ENSG00000226060.7."";""ENST00000450392.5; ENSP00000394421.1; ENSG00000231002.7."";""ENST00000453195.5; ENSP00000391879.1; ENSG00000234127.9."";""ENST00000454678.7; ENSP00000410446.2; ENSG00000234127.9."";""ENST00000455000.6; ENSP00000392805.2; ENSG00000230230.7."";""ENST00000456093.5; ENSP00000406707.1; ENSG00000226060.7."";""ENST00000456770.5; ENSP00000415328.1; ENSG00000228881.7."";",DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q13263,N4,-0.808925752,0.94437981,-0.042193757,-0.424887917,0.044170977,grey30,TRIM28,TIF1B_HUMAN,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28),TRIM28 KAP1 RNF96 TIF1B,10155;,"ENST00000253024.10; ENSP00000253024.4; ENSG00000130726.12. [Q13263-1];""ENST00000341753.10; ENSP00000342232.5; ENSG00000130726.12. [Q13263-2]"";",chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; genomic imprinting [GO:0071514]; innate immune response [GO:0045087]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA methylation-dependent heterochromatin formation [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; protein sumoylation [GO:0016925]; suppression of viral release by host [GO:0044790],euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]
Q9UPN9,N4,-0.899887997,1.092167173,-0.066594201,-0.117397986,-0.313438099,grey30,TRIM33,TRI33_HUMAN,E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),TRIM33 KIAA1113 RFG7 TIF1G,51592;,"ENST00000358465.7; ENSP00000351250.2; ENSG00000197323.12. [Q9UPN9-1];""ENST00000369543.6; ENSP00000358556.2; ENSG00000197323.12. [Q9UPN9-2]"";",co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NQ86,C1,1.596150192,0.027655738,-0.668896717,-0.45112303,-0.667450888,lightblue,TRIM36,TRI36_HUMAN,E3 ubiquitin-protein ligase TRIM36 (EC 2.3.2.27) (RING finger protein 98) (RING-type E3 ubiquitin transferase TRIM36) (Tripartite motif-containing protein 36) (Zinc-binding protein Rbcc728),TRIM36 RBCC728 RNF98,55521;,"ENST00000282369.7; ENSP00000282369.3; ENSG00000152503.10. [Q9NQ86-1];""ENST00000379617.2; ENSP00000368937.2; ENSG00000152503.10. [Q9NQ86-3]"";""ENST00000379618.6; ENSP00000368938.2; ENSG00000152503.10. [Q9NQ86-2]"";""ENST00000513154.6; ENSP00000423934.1; ENSG00000152503.10. [Q9NQ86-4]"";",alpha-tubulin binding [GO:0043014]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],acrosome reaction [GO:0007340]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726]; regulation of microtubule cytoskeleton organization [GO:0070507]; spindle organization [GO:0007051],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q9C037,S3,-0.805664799,-0.78108673,0.12019467,0.793469115,0.663587458,salmon,TRIM4,TRIM4_HUMAN,E3 ubiquitin-protein ligase TRIM4 (EC 2.3.2.27) (RING finger protein 87) (RING-type E3 ubiquitin transferase TRIM4) (Tripartite motif-containing protein 4),TRIM4 RNF87,89122;,"ENST00000349062.7; ENSP00000275736.4; ENSG00000146833.16. [Q9C037-2];""ENST00000354241.5; ENSP00000346186.5; ENSG00000146833.16. [Q9C037-3]"";""ENST00000355947.6; ENSP00000348216.2; ENSG00000146833.16. [Q9C037-1]"";",identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of gene expression [GO:0010468],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q96LD4,C3,1.531837124,-0.007757849,-0.492854035,-0.3216069,-0.610482429,cyan,TRIM47,TRI47_HUMAN,E3 ubiquitin-protein ligase TRIM47 (EC 2.3.2.27) (Gene overexpressed in astrocytoma protein) (RING finger protein 100) (Tripartite motif-containing protein 47),TRIM47 GOA RNF100,91107;,ENST00000254816.6; ENSP00000254816.1; ENSG00000132481.7. [Q96LD4-1];,ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],protein ubiquitination [GO:0016567],cytosol [GO:0005829]; nucleus [GO:0005634]
Q9C035,C4,1.858248743,-0.106877713,-0.605021802,-0.747680381,-0.887854557,deepskyblue2,TRIM5,TRIM5_HUMAN,Tripartite motif-containing protein 5 (EC 2.3.2.27) (RING finger protein 88) (RING-type E3 ubiquitin transferase TRIM5),TRIM5 RNF88,85363;,"ENST00000380027.5; ENSP00000369366.1; ENSG00000132256.20. [Q9C035-4];""ENST00000380034.8; ENSP00000369373.3; ENSG00000132256.20. [Q9C035-1]"";""ENST00000396847.7; ENSP00000380058.3; ENSG00000132256.20. [Q9C035-3]"";""ENST00000433961.5; ENSP00000393052.1; ENSG00000132256.20. [Q9C035-5]"";""ENST00000684655.1; ENSP00000507420.1; ENSG00000132256.20. [Q9C035-1]"";",identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; suppression of viral release by host [GO:0044790],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932]
Q9BRZ2,N1,-0.260883713,-0.586332561,-0.386936223,-0.20035251,1.267576736,grey90,TRIM56,TRI56_HUMAN,E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING finger protein 109) (Tripartite motif-containing protein 56),TRIM56 RNF109,81844;,ENST00000306085.11; ENSP00000305161.6; ENSG00000169871.13. [Q9BRZ2-1];,RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q6PJ69,C5,1.520782427,0.560708712,-0.485374585,-0.450569778,-0.818541212,turquoise3,TRIM65,TRI65_HUMAN,E3 ubiquitin-protein ligase TRIM65 (EC 2.3.2.27) (Tripartite motif-containing protein 65),TRIM65,201292;,ENST00000269383.8; ENSP00000269383.3; ENSG00000141569.12.;,ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],antiviral innate immune response [GO:0140374]; negative regulation of inflammatory response [GO:0050728]; positive regulation of autophagy [GO:0010508]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of protein phosphorylation [GO:0001934]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q15642,C3,1.653175515,0.227504966,-0.746481989,-0.635424703,-0.679413149,cyan,TRIP10,CIP4_HUMAN,Cdc42-interacting protein 4 (Protein Felic) (Salt tolerant protein) (hSTP) (Thyroid receptor-interacting protein 10) (TR-interacting protein 10) (TRIP-10),TRIP10 CIP4 STOT STP,9322;,"ENST00000313244.14; ENSP00000320117.7; ENSG00000125733.18. [Q15642-1];""ENST00000313285.12; ENSP00000320493.6; ENSG00000125733.18. [Q15642-2]"";",identical protein binding [GO:0042802]; lipid binding [GO:0008289],actin cytoskeleton organization [GO:0030036]; cell communication [GO:0007154]; endocytosis [GO:0006897]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]
Q15643,S3,-0.964848268,-0.539138439,-0.164345464,0.946163898,0.561896471,salmon,TRIP11,TRIPB_HUMAN,Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230),TRIP11 CEV14,9321;,ENST00000267622.8; ENSP00000267622.4; ENSG00000100815.12. [Q15643-1];,small GTPase binding [GO:0031267]; transcription coactivator activity [GO:0003713],cartilage development [GO:0051216]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; inner ear receptor cell stereocilium organization [GO:0060122]; protein glycosylation [GO:0006486]; protein transmembrane transport [GO:0071806]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281]; vesicle tethering to Golgi [GO:0099041],cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]
Q14669,N1,-0.217743819,-0.796006033,0.482861582,-0.011906779,0.91003856,grey90,TRIP12,TRIPC_HUMAN,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (E3 ubiquitin-protein ligase for Arf) (ULF) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),TRIP12 KIAA0045 ULF,9320;,"ENST00000283943.9; ENSP00000283943.4; ENSG00000153827.15. [Q14669-1];""ENST00000389044.8; ENSP00000373696.4; ENSG00000153827.15. [Q14669-3]"";""ENST00000389045.7; ENSP00000373697.3; ENSG00000153827.15. [Q14669-4]"";""ENST00000704580.1; ENSP00000515955.1; ENSG00000153827.15. [Q14669-2]"";",nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630],DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q15654,C3,1.685630772,0.124404122,-0.456742685,-0.498271381,-0.68260639,cyan,TRIP6,TRIP6_HUMAN,Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Opa-interacting protein 1) (OIP-1) (Zyxin-related protein 1) (ZRP-1),TRIP6 OIP1,7205;,"ENST00000200457.9; ENSP00000200457.4; ENSG00000087077.14. [Q15654-1];""ENST00000417475.5; ENSP00000413817.1; ENSG00000087077.14. [Q15654-2]"";""ENST00000437505.5; ENSP00000410736.1; ENSG00000087077.14. [Q15654-3]"";""ENST00000619988.4; ENSP00000479865.1; ENSG00000087077.14. [Q15654-3]"";",interleukin-1 receptor binding [GO:0005149]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA binding [GO:0003723],chordate embryonic development [GO:0043009]; focal adhesion assembly [GO:0048041]; positive regulation of cell migration [GO:0030335]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]
Q7L0Y3,M1,-1.134760173,-0.270373805,0.394435559,0.754590774,-0.173999431,burlywood4,TRMT10C,TM10C_HUMAN,tRNA methyltransferase 10 homolog C (HBV pre-S2 trans-regulated protein 2) (Mitochondrial ribonuclease P protein 1) (Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (mRNA methyladenosine-N(1)-methyltransferase) (EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase) (EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase) (EC 2.1.1.221),TRMT10C MRPP1 RG9MTD1,54931;,ENST00000309922.7; ENSP00000312356.6; ENSG00000174173.7.;,identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tRNA (adenine(9)-N1)-methyltransferase activity [GO:0160106]; tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049],mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131],mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]
Q7Z2T5,N1,-1.039564792,-0.820414531,-0.464981646,-0.400142834,1.636644543,grey90,TRMT1L,TRM1L_HUMAN,TRMT1-like protein (EC 2.1.1.-),TRMT1L C1orf25 TRM1L MSTP070,81627;,ENST00000367506.10; ENSP00000356476.5; ENSG00000121486.12. [Q7Z2T5-1];,metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA (guanine(10)-N2)-methyltransferase activity [GO:0160102]; tRNA binding [GO:0000049],tRNA N2-guanine methylation [GO:0002940],nucleus [GO:0005634]
Q96GJ1,M1,-0.917130747,-0.537155706,0.360064203,0.847910769,-0.005929393,burlywood4,TRMT2B,TRM2B_HUMAN,tRNA (uracil-5-)-methyltransferase homolog B (EC 2.1.1.35) (TRM2 homolog B) (rRNA (uracil-5-)-methyltransferase TRMT2B) (EC 2.1.1.-),TRMT2B CXorf34,79979;,"ENST00000372935.5; ENSP00000362026.1; ENSG00000188917.15. [Q96GJ1-1];""ENST00000372936.4; ENSP00000362027.3; ENSG00000188917.15. [Q96GJ1-1]"";""ENST00000372939.5; ENSP00000362030.1; ENSG00000188917.15. [Q96GJ1-3]"";""ENST00000545398.5; ENSP00000438134.1; ENSG00000188917.15. [Q96GJ1-1]"";","rRNA (uridine-C5-)-methyltransferase activity [GO:0070041]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697]",tRNA processing [GO:0008033],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]
Q9UJA5,N1,-0.940242959,0.705827691,-0.530090463,-0.557299473,1.05842423,grey90,TRMT6,TRM6_HUMAN,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (mRNA methyladenosine-N(1)-methyltransferase non-catalytic subunit TRM6) (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6),TRMT6 KIAA1153 TRM6 CGI-09,51605;,"ENST00000203001.7; ENSP00000203001.2; ENSG00000089195.15. [Q9UJA5-1];""ENST00000453074.6; ENSP00000392070.2; ENSG00000089195.15. [Q9UJA5-4]"";",RNA binding [GO:0003723],mRNA processing [GO:0006397]; tRNA methylation [GO:0030488],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]
Q96QT4,S4,-0.923976748,-1.28037827,0.414258355,0.819562294,0.398246363,tomato2,TRPM7,TRPM7_HUMAN,Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7),TRPM7 CHAK1 LTRPC7,54822;,ENST00000646667.1; ENSP00000495860.1; ENSG00000092439.16.;,actin binding [GO:0003779]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],actomyosin structure organization [GO:0031032]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-matrix adhesion [GO:0016340]; monoatomic cation homeostasis [GO:0055080]; monoatomic cation transmembrane transport [GO:0098655]; necroptotic process [GO:0070266]; protein tetramerization [GO:0051262],plasma membrane [GO:0005886]; ruffle [GO:0001726]
O95900,S3,-1.548472676,-0.989191684,0.23469981,0.879435928,0.536340824,salmon,TRUB2,TRUB2_HUMAN,"Pseudouridylate synthase TRUB2, mitochondrial (EC 5.4.99.-) (TruB pseudouridine synthase homolog 2) (tRNA pseudouridine 55 synthase TRUB2) (Psi55 synthase TRUB2) (EC 5.4.99.25)",TRUB2,26995;,ENST00000372890.6; ENSP00000361982.4; ENSG00000167112.10. [O95900-1];,pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(55) synthase activity [GO:0160148],mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of mitochondrial translation [GO:0070131]; tRNA processing [GO:0008033],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]
Q92574,C1,1.442633224,-0.029910091,-0.444288428,-0.220513723,-0.333842011,lightblue,TSC1,TSC1_HUMAN,Hamartin (Tuberous sclerosis 1 protein),TSC1 KIAA0243 TSC,7248;,"ENST00000298552.9; ENSP00000298552.3; ENSG00000165699.15. [Q92574-1];""ENST00000440111.6; ENSP00000394524.2; ENSG00000165699.15. [Q92574-1]"";""ENST00000490179.4; ENSP00000495533.2; ENSG00000165699.15. [Q92574-1]"";""ENST00000545250.5; ENSP00000444017.1; ENSG00000165699.15. [Q92574-2]"";""ENST00000643072.1; ENSP00000496691.1; ENSG00000165699.15. [Q92574-2]"";""ENST00000643875.1; ENSP00000495158.1; ENSG00000165699.15. [Q92574-1]"";""ENST00000646440.2; ENSP00000495830.2; ENSG00000165699.15. [Q92574-1]"";""ENST00000646625.1; ENSP00000496263.1; ENSG00000165699.15. [Q92574-1]"";",ATPase inhibitor activity [GO:0042030]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087],activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; cardiac muscle cell differentiation [GO:0055007]; cell population proliferation [GO:0008283]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to starvation [GO:0009267]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; potassium ion transport [GO:0006813]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell-matrix adhesion [GO:0001952]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of stress fiber assembly [GO:0051492]; regulation of translation [GO:0006417]; response to insulin [GO:0032868]; ribosomal subunit export from nucleus [GO:0000054]; synapse organization [GO:0050808],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]
Q15714,C4,2.040124006,0.450586374,-1.114845868,-0.994516162,-1.298141365,deepskyblue2,TSC22D1,T22D1_HUMAN,TSC22 domain family protein 1 (Cerebral protein 2) (HUCEP-2) (Regulatory protein TSC-22) (TGFB-stimulated clone 22 homolog) (Transforming growth factor beta-1-induced transcript 4 protein),TSC22D1 KIAA1994 TGFB1I4 TSC22 hucep-2,8848;,"ENST00000261489.7; ENSP00000261489.2; ENSG00000102804.16. [Q15714-2];""ENST00000458659.3; ENSP00000397435.2; ENSG00000102804.16. [Q15714-1]"";""ENST00000611198.4; ENSP00000481585.1; ENSG00000102804.16. [Q15714-5]"";""ENST00000622051.1; ENSP00000483407.1; ENSG00000102804.16. [Q15714-5]"";",identical protein binding [GO:0042802]; transcription coactivator activity [GO:0003713],negative regulation of apoptotic process [GO:0043066]; negative regulation of hematopoietic stem cell proliferation [GO:1902034]; negative regulation of programmed cell death [GO:0043069]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
O75157,C4,1.929402848,0.42418908,-0.619141455,-0.827841516,-1.199555818,deepskyblue2,TSC22D2,T22D2_HUMAN,TSC22 domain family protein 2 (TSC22-related-inducible leucine zipper protein 4),TSC22D2 KIAA0669 TILZ4,9819;,"ENST00000361875.8; ENSP00000354543.2; ENSG00000196428.13. [O75157-1];""ENST00000688009.1; ENSP00000510392.1; ENSG00000196428.13. [O75157-2]"";",0,negative regulation of cell cycle [GO:0045786]; regulation of transcription by RNA polymerase II [GO:0006357]; response to osmotic stress [GO:0006970],0
Q8NG11,S2,-1.385057289,-2.054767665,0.331334371,0.888692155,0.581546571,orange,TSPAN14,TSN14_HUMAN,Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14),TSPAN14 TM4SF14,81619;,"ENST00000372156.5; ENSP00000361229.1; ENSG00000108219.16. [Q8NG11-1];""ENST00000372158.6; ENSP00000361231.1; ENSG00000108219.16. [Q8NG11-1]"";""ENST00000372164.7; ENSP00000361237.3; ENSG00000108219.16. [Q8NG11-2]"";""ENST00000429989.8; ENSP00000396270.2; ENSG00000108219.16. [Q8NG11-1]"";""ENST00000481124.5; ENSP00000418195.1; ENSG00000108219.16. [Q8NG11-3]"";""ENST00000616406.1; ENSP00000480263.1; ENSG00000108219.16. [Q8NG11-2]"";",enzyme binding [GO:0019899],positive regulation of Notch signaling pathway [GO:0045747]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; tetraspanin-enriched microdomain [GO:0097197]
O60637,S1,-0.459434718,-0.865078098,-0.109108693,0.584479256,0.916635747,gold,TSPAN3,TSN3_HUMAN,Tetraspanin-3 (Tspan-3) (Tetraspanin TM4-A) (Transmembrane 4 superfamily member 8),TSPAN3 TM4SF8,10099;,"ENST00000267970.9; ENSP00000267970.4; ENSG00000140391.15. [O60637-1];""ENST00000346495.6; ENSP00000341329.2; ENSG00000140391.15. [O60637-2]"";""ENST00000424443.7; ENSP00000407243.3; ENSG00000140391.15. [O60637-3]"";",0,0,extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
O14817,S1,-0.661526568,-1.433994466,0.27750902,0.591403435,0.89507874,gold,TSPAN4,TSN4_HUMAN,Tetraspanin-4 (Tspan-4) (Novel antigen 2) (NAG-2) (Transmembrane 4 superfamily member 7),TSPAN4 NAG2 TM4SF7,7106;,"ENST00000397397.7; ENSP00000380552.2; ENSG00000214063.12.;""ENST00000397404.5; ENSP00000380553.1; ENSG00000214063.12."";""ENST00000397406.5; ENSP00000380554.1; ENSG00000214063.12."";""ENST00000397408.5; ENSP00000380555.1; ENSG00000214063.12."";""ENST00000397411.6; ENSP00000380558.2; ENSG00000214063.12."";""ENST00000409543.6; ENSP00000386513.2; ENSG00000214063.12."";",antigen binding [GO:0003823]; integrin binding [GO:0005178],protein-containing complex assembly [GO:0065003],focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; vesicle [GO:0031982]
P30536,M2,-0.951175451,-1.16544754,0.460880375,1.019289203,-0.200413382,tan4,TSPO,TSPO_HUMAN,Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR),TSPO BZRP MBR,706;,"ENST00000329563.8; ENSP00000328973.4; ENSG00000100300.18. [P30536-1];""ENST00000337554.8; ENSP00000338004.3; ENSG00000100300.18. [P30536-1]"";""ENST00000396265.4; ENSP00000379563.4; ENSG00000100300.18. [P30536-1]"";",androgen binding [GO:0005497]; benzodiazepine receptor activity [GO:0008503]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; transmembrane transporter binding [GO:0044325],adrenal gland development [GO:0030325]; behavioral response to pain [GO:0048266]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular hypotonic response [GO:0071476]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to zinc ion [GO:0071294]; chloride transport [GO:0006821]; cholesterol homeostasis [GO:0042632]; contact inhibition [GO:0060242]; glial cell migration [GO:0008347]; heme biosynthetic process [GO:0006783]; maintenance of protein location in mitochondrion [GO:0072656]; monoatomic anion transport [GO:0006820]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of corticosterone secretion [GO:2000853]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitophagy [GO:1901525]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of tumor necrosis factor production [GO:0032720]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein targeting to mitochondrion [GO:0006626]; regulation of cell population proliferation [GO:0042127]; regulation of cholesterol transport [GO:0032374]; regulation of steroid biosynthetic process [GO:0050810]; response to acetylcholine [GO:1905144]; response to manganese ion [GO:0010042]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to vitamin B1 [GO:0010266]; response to xenobiotic stimulus [GO:0009410]; steroid metabolic process [GO:0008202],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]
Q13630,C5,1.982924627,0.379311652,-0.943110772,-0.920858991,-1.065071232,turquoise3,TSTA3,FCL_HUMAN,"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)",GFUS SDR4E1 TSTA3,7264;,"ENST00000425753.7; ENSP00000398803.2; ENSG00000104522.16.;""ENST00000529064.5; ENSP00000435386.1; ENSG00000104522.16."";""ENST00000612580.2; ENSP00000478042.1; ENSG00000278243.2."";""ENST00000633782.1; ENSP00000487640.1; ENSG00000278243.2."";","electron transfer activity [GO:0009055]; GDP-4-dehydro-D-rhamnose reductase activity [GO:0042356]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3,5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]",'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; leukocyte cell-cell adhesion [GO:0007159]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904906],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q8NFU3,C3,1.769519743,-0.14319891,-0.320331451,-0.04883822,-0.845133961,cyan,TSTD1,TSTD1_HUMAN,Thiosulfate:glutathione sulfurtransferase (TST) (EC 2.8.1.3),TSTD1 KAT,100131187;,"ENST00000318289.14; ENSP00000325518.10; ENSG00000215845.11. [Q8NFU3-3];""ENST00000368023.7; ENSP00000357002.3; ENSG00000215845.11. [Q8NFU3-4]"";""ENST00000368024.5; ENSP00000357003.1; ENSG00000215845.11. [Q8NFU3-2]"";""ENST00000423014.3; ENSP00000388293.2; ENSG00000215845.11. [Q8NFU3-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; sequence-specific DNA binding [GO:0043565]; thiosulfate-thiol sulfurtransferase activity [GO:0050337]","glucose metabolic process [GO:0006006]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]
Q5T7W7,C3,1.946420086,-0.206539702,-0.572932078,-0.613191698,-0.798109686,cyan,TSTD2,TSTD2_HUMAN,Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2 (Rhodanese domain-containing protein 2),TSTD2 C9orf97 PP4189,158427;,ENST00000341170.5; ENSP00000342499.4; ENSG00000136925.15. [Q5T7W7-1];,0,0,0
Q99614,C1,1.546777926,0.090063594,-0.653889808,-0.524079943,-0.602022939,lightblue,TTC1,TTC1_HUMAN,Tetratricopeptide repeat protein 1 (TPR repeat protein 1),TTC1 TPR1,7265;,"ENST00000231238.10; ENSP00000231238.4; ENSG00000113312.12.;""ENST00000522793.5; ENSP00000429225.1; ENSG00000113312.12."";""ENST00000682719.1; ENSP00000507891.1; ENSG00000113312.12."";",unfolded protein binding [GO:0051082],protein folding [GO:0006457],cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]
Q8NBP0,S2,-1.210215497,-1.50507128,0.123516454,0.973827924,0.583766956,orange,TTC13,TTC13_HUMAN,Tetratricopeptide repeat protein 13 (TPR repeat protein 13),TTC13 PSEC0076,79573;,"ENST00000366661.9; ENSP00000355621.4; ENSG00000143643.13. [Q8NBP0-1];""ENST00000366662.8; ENSP00000355622.4; ENSG00000143643.13. [Q8NBP0-2]"";",0,0,0
Q96AE7,S3,-1.020998278,-1.129750768,0.13989697,0.851637614,0.505106418,salmon,TTC17,TTC17_HUMAN,Tetratricopeptide repeat protein 17 (TPR repeat protein 17),TTC17,55761;,"ENST00000039989.9; ENSP00000039989.4; ENSG00000052841.16. [Q96AE7-1];""ENST00000299240.10; ENSP00000299240.5; ENSG00000052841.16. [Q96AE7-2]"";",0,actin filament polymerization [GO:0030041]; cilium organization [GO:0044782],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
P53804,S1,-0.387837483,-0.443210448,-0.168313969,0.176222866,0.989856474,gold,TTC3,TTC3_HUMAN,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3),TTC3 DCRR1 RNF105 TPRD,7267;,"ENST00000354749.6; ENSP00000346791.2; ENSG00000182670.14. [P53804-1];""ENST00000399017.6; ENSP00000381981.2; ENSG00000182670.14. [P53804-1]"";""ENST00000418766.6; ENSP00000403943.2; ENSG00000182670.14. [P53804-1]"";""ENST00000450533.6; ENSP00000408456.2; ENSG00000182670.14. [P53804-1]"";""ENST00000463216.6; ENSP00000512893.1; ENSG00000182670.14. [P53804-3]"";""ENST00000492275.6; ENSP00000512889.1; ENSG00000182670.14. [P53804-3]"";",metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6PGP7,C1,1.350625941,0.364648787,-0.677388576,-0.517915165,-0.081607174,lightblue,TTC37,SKI3_HUMAN,Superkiller complex protein 3 (Ski3) (Tetratricopeptide repeat protein 37) (TPR repeat protein 37) (Tricho-hepatic-enteric syndrome protein) (Thespin),SKIC3 KIAA0372 TTC37,9652;,"ENST00000358746.7; ENSP00000351596.3; ENSG00000198677.13.;""ENST00000649566.1; ENSP00000497948.1; ENSG00000198677.13."";",0,"nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; rescue of stalled ribosome [GO:0072344]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087]
O95801,C3,1.684102569,0.164819382,-0.51891865,-0.417933434,-0.807231012,cyan,TTC4,TTC4_HUMAN,Tetratricopeptide repeat protein 4 (TPR repeat protein 4),TTC4 My044,7268;,ENST00000371281.4; ENSP00000360329.3; ENSG00000243725.7.;,Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879],defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8N0Z6,C2,1.200514873,0.651778658,-0.399281732,-0.297123511,-0.473965042,aquamarine,TTC5,TTC5_HUMAN,Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Protein Strap),TTC5,91875;,"ENST00000258821.8; ENSP00000258821.3; ENSG00000136319.12.;""ENST00000708730.1; ENSP00000517308.1; ENSG00000291781.1."";",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ribosome binding [GO:0043022],cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q15361,N3,-1.12543913,-1.067086938,1.087301314,-0.096399954,0.620870501,grey50,TTF1,TTF1_HUMAN,Transcription termination factor 1 (TTF-1) (RNA polymerase I termination factor) (Transcription termination factor I) (TTF-I),TTF1,7270;,ENST00000334270.3; ENSP00000333920.2; ENSG00000125482.13.;,chromatin binding [GO:0003682]; DNA binding [GO:0003677],DNA-templated transcription termination [GO:0006353]; negative regulation of DNA replication [GO:0008156]; termination of RNA polymerase I transcription [GO:0006363],fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6NXR4,C1,1.263671266,0.127255106,-0.533727752,-0.201815197,-0.074402393,lightblue,TTI2,TTI2_HUMAN,TELO2-interacting protein 2,TTI2 C8orf41,80185;,"ENST00000360742.9; ENSP00000353971.5; ENSG00000129696.13.;""ENST00000431156.7; ENSP00000411169.3; ENSG00000129696.13."";""ENST00000613904.1; ENSP00000478396.1; ENSG00000129696.13."";",0,positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821],nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078]
Q8NG68,C4,1.977087831,0.00415479,-0.803840261,-0.71921306,-0.8253961,deepskyblue2,TTL,TTL_HUMAN,Tubulin--tyrosine ligase (TTL) (EC 6.3.2.25),TTL,150465;,ENST00000233336.7; ENSP00000233336.5; ENSG00000114999.8.;,ATP binding [GO:0005524]; tubulin-tyrosine ligase activity [GO:0004835],microtubule cytoskeleton organization [GO:0000226]; positive regulation of mitotic cell cycle [GO:0045931]; post-translational protein modification [GO:0043687]; regulation of axon extension [GO:0030516]; regulation of metaphase plate congression [GO:0090235],spindle microtubule [GO:0005876]
Q14166,C5,1.578495553,0.65499871,-0.643179643,-0.764333585,-0.904455608,turquoise3,TTLL12,TTL12_HUMAN,Tubulin--tyrosine ligase-like protein 12 (Inactive tubulin--tyrosine ligase-like protein 12),TTLL12 KIAA0153,23170;,ENST00000216129.7; ENSP00000216129.6; ENSG00000100304.13.;,ATP binding [GO:0005524]; H4K20me3 modified histone binding [GO:1990889]; tubulin binding [GO:0015631],innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein modification process [GO:0036211]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]
Q9C0H2,S1,-1.011459703,-1.437212729,-0.162795113,0.62444233,1.064381866,gold,TTYH3,TTYH3_HUMAN,Protein tweety homolog 3 (hTTY3) (Volume-regulated anion channel subunit TTYH3),TTYH3 KIAA1691,80727;,"ENST00000258796.12; ENSP00000258796.7; ENSG00000136295.16. [Q9C0H2-1];""ENST00000403167.5; ENSP00000385015.1; ENSG00000136295.16. [Q9C0H2-3]"";""ENST00000407643.5; ENSP00000385316.1; ENSG00000136295.16. [Q9C0H2-2]"";""ENST00000429448.2; ENSP00000413757.2; ENSG00000136295.16. [Q9C0H2-4]"";",calcium ion binding [GO:0005509]; chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; volume-sensitive chloride channel activity [GO:0072320],chloride transport [GO:0006821]; monoatomic ion transmembrane transport [GO:0034220],chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
P68366,C4,1.979165023,0.044668852,-1.044637348,-0.797260315,-0.89534209,deepskyblue2,TUBA4A,TBA4A_HUMAN,Tubulin alpha-4A chain (EC 3.6.5.-) (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain),TUBA4A TUBA1,7277;,"ENST00000248437.9; ENSP00000248437.4; ENSG00000127824.15. [P68366-1];""ENST00000392088.6; ENSP00000375938.2; ENSG00000127824.15. [P68366-2]"";",GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200],microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]
P07437,C4,2.102085985,-0.178783353,-0.967809792,-0.786412438,-0.88901241,deepskyblue2,TUBB,TBB5_HUMAN,Tubulin beta chain (Tubulin beta-5 chain),TUBB TUBB5 OK/SW-cl.56,203068;,"ENST00000327892.13; ENSP00000339001.7; ENSG00000196230.14.;""ENST00000383564.8; ENSP00000373058.4; ENSG00000183311.16."";""ENST00000419792.6; ENSP00000401317.2; ENSG00000235067.10."";""ENST00000421473.6; ENSP00000399155.2; ENSG00000224156.10."";""ENST00000422650.6; ENSP00000400663.2; ENSG00000229684.10."";""ENST00000422674.6; ENSP00000406811.2; ENSG00000227739.10."";""ENST00000432462.6; ENSP00000410829.2; ENSG00000232421.10."";""ENST00000436628.6; ENSP00000410071.2; ENSG00000232575.10."";",GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; MHC class I protein binding [GO:0042288]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625],cell division [GO:0051301]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; natural killer cell mediated cytotoxicity [GO:0042267]; odontoblast differentiation [GO:0071895]; regulation of synapse organization [GO:0050807]; spindle assembly [GO:0051225],azurophil granule lumen [GO:0035578]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; intercellular bridge [GO:0045171]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
P68371,C4,2.082640463,0.018202967,-0.97491494,-0.84516475,-1.045522748,deepskyblue2,TUBB4B,TBB4B_HUMAN,Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain),TUBB4B TUBB2C,10383;,ENST00000340384.5; ENSP00000341289.4; ENSG00000188229.6.;,double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; MHC class I protein binding [GO:0042288]; structural constituent of cytoskeleton [GO:0005200]; unfolded protein binding [GO:0051082],microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; natural killer cell mediated cytotoxicity [GO:0042267],axonemal microtubule [GO:0005879]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]
Q9BUF5,C4,2.111427755,-0.095920107,-0.808747902,-0.687421206,-0.702030625,deepskyblue2,TUBB6,TBB6_HUMAN,Tubulin beta-6 chain (Tubulin beta class V),TUBB6,84617;,ENST00000317702.10; ENSP00000318697.4; ENSG00000176014.13.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200],microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]
Q96RT7,C1,0.790095689,-0.36008152,-0.456922828,-0.02353907,0.803411112,lightblue,TUBGCP6,GCP6_HUMAN,Gamma-tubulin complex component 6 (GCP-6),TUBGCP6 GCP6 KIAA1669,85378;,ENST00000248846.10; ENSP00000248846.5; ENSG00000128159.12. [Q96RT7-1];,gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017],cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]
P49411,M1,-1.198909119,0.007629747,0.43252246,0.930316101,-0.671668829,burlywood4,TUFM,EFTU_HUMAN,"Elongation factor Tu, mitochondrial (EF-Tu) (P43)",TUFM,7284;,ENST00000313511.8; ENSP00000322439.3; ENSG00000178952.11.;,GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746],mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; synapse [GO:0045202]
Q9NNX1,C3,1.705674394,0.208237119,-0.4800544,-0.581804224,-0.875045805,cyan,TUFT1,TUFT1_HUMAN,Tuftelin,TUFT1,7286;,"ENST00000368848.6; ENSP00000357841.2; ENSG00000143367.17. [Q9NNX1-2];""ENST00000368849.8; ENSP00000357842.3; ENSG00000143367.17. [Q9NNX1-1]"";",structural constituent of skin epidermis [GO:0030280]; structural constituent of tooth enamel [GO:0030345],bone mineralization [GO:0030282]; intracellular signal transduction [GO:0035556]; odontogenesis [GO:0042476],cytoplasm [GO:0005737]; extracellular region [GO:0005576]
Q13454,S3,-0.657092308,-0.982117983,0.209969342,0.805744439,0.450850655,salmon,TUSC3,TUSC3_HUMAN,Tumor suppressor candidate 3 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3) (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33),TUSC3 N33,7991;,"ENST00000382020.8; ENSP00000371450.4; ENSG00000104723.21. [Q13454-2];""ENST00000503731.6; ENSP00000424544.1; ENSG00000104723.21. [Q13454-1]"";",magnesium ion transmembrane transporter activity [GO:0015095],cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]
Q9H6E5,N4,-0.799562269,0.93565343,-0.215483785,-0.126317653,0.02070876,grey30,TUT1,STPAP_HUMAN,Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52),TUT1 RBM21,64852;,ENST00000476907.6; ENSP00000419607.1; ENSG00000149016.16.;,ATP binding [GO:0005524]; enzyme binding [GO:0019899]; enzyme-substrate adaptor activity [GO:0140767]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; poly(A) RNA polymerase activity [GO:1990817]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; U6 snRNA binding [GO:0017070],"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; snRNA processing [GO:0016180]; U6 snRNA 3'-end processing [GO:0034477]",cytosol [GO:0005829]; mitochondrion [GO:0005739]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q6IBS0,C5,2.029527954,0.487098364,-0.900446153,-1.062863641,-1.147134511,turquoise3,TWF2,TWF2_HUMAN,Twinfilin-2 (A6-related protein) (hA6RP) (Protein tyrosine kinase 9-like) (Twinfilin-1-like protein),TWF2 PTK9L MSTP011,11344;,ENST00000305533.10; ENSP00000303908.4; ENSG00000247596.10.;,"actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]",actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; cell projection organization [GO:0030030]; cellular response to growth factor stimulus [GO:0071363]; cellular response to retinoic acid [GO:0071300]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of axon extension [GO:0045773]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of lamellipodium assembly [GO:0010591]; regulation of microvillus length [GO:0032532]; sequestering of actin monomers [GO:0042989],actin filament [GO:0005884]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; stereocilium [GO:0032420]
P40222,C5,1.018887288,0.970834415,-0.601419005,-0.765538277,-1.008783015,turquoise3,TXLNA,TXLNA_HUMAN,Alpha-taxilin,TXLNA TXLN,200081;,"ENST00000373609.1; ENSP00000362711.1; ENSG00000084652.16.;""ENST00000373610.8; ENSP00000362712.3; ENSG00000084652.16."";",syntaxin binding [GO:0019905],B cell activation [GO:0042113]; exocytosis [GO:0006887],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]
Q9NUQ3,C5,0.85966188,0.994086777,-0.595260632,-0.718526649,-1.026186869,turquoise3,TXLNG,TXLNG_HUMAN,Gamma-taxilin (Environmental lipopolysaccharide-responding gene protein) (Factor inhibiting ATF4-mediated transcription) (FIAT) (Lipopolysaccharide-specific response protein 5),TXLNG CXorf15 ELRG LSR5,55787;,"ENST00000380122.10; ENSP00000369465.5; ENSG00000086712.13. [Q9NUQ3-1];""ENST00000398155.4; ENSP00000381222.4; ENSG00000086712.13. [Q9NUQ3-2]"";",DNA-binding transcription factor binding [GO:0140297]; syntaxin binding [GO:0019905],regulation of bone mineralization [GO:0030500]; regulation of cell cycle [GO:0051726]; regulation of cell cycle process [GO:0010564],cytosol [GO:0005829]; nuclear membrane [GO:0031965]
Q6PKC3,S3,-0.868892009,-0.402528265,0.24004119,0.664466569,0.42815677,salmon,TXNDC11,TXD11_HUMAN,Thioredoxin domain-containing protein 11 (EF-hand-binding protein 1),TXNDC11 EFP1,51061;,"ENST00000283033.10; ENSP00000283033.5; ENSG00000153066.13. [Q6PKC3-2];""ENST00000356957.7; ENSP00000349439.3; ENSG00000153066.13. [Q6PKC3-1]"";",0,0,endoplasmic reticulum membrane [GO:0005789]
Q96J42,S2,-1.016592837,-1.524145308,0.152655448,0.858019934,0.491993812,orange,TXNDC15,TXD15_HUMAN,Thioredoxin domain-containing protein 15,TXNDC15 C5orf14 UNQ335/PRO534,79770;,ENST00000358387.9; ENSP00000351157.5; ENSG00000113621.15. [Q96J42-1];,0,cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880],ciliary membrane [GO:0060170]; cilium [GO:0005929]
Q8NBS9,N4,-0.934623985,0.533498027,-0.122434351,0.532007409,0.005444402,grey30,TXNDC5,TXND5_HUMAN,Thioredoxin domain-containing protein 5 (EC 1.8.4.-) (EC 5.3.4.1) (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46),TXNDC5 TLP46 UNQ364/PRO700,81567;,"ENST00000379757.9; ENSP00000369081.4; ENSG00000239264.9. [Q8NBS9-1];""ENST00000473453.2; ENSP00000420784.1; ENSG00000239264.9. [Q8NBS9-2]"";",protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],negative regulation of apoptotic process [GO:0043066]; protein folding [GO:0006457],azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]
O14530,C1,1.830576564,0.250558493,-0.919946953,-0.944574799,0.04220728,lightblue,TXNDC9,TXND9_HUMAN,Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4),TXNDC9 APACD,10190;,"ENST00000264255.8; ENSP00000264255.3; ENSG00000115514.12. [O14530-1];""ENST00000409434.5; ENSP00000387275.1; ENSG00000115514.12. [O14530-2]"";",cadherin binding [GO:0045296],microtubule cytoskeleton organization [GO:0000226],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]
O43396,C5,1.65345614,0.514217956,-0.855998142,-0.980579998,-0.675665598,turquoise3,TXNL1,TXNL1_HUMAN,Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein),TXNL1 TRP32 TXL TXNL,9352;,"ENST00000217515.11; ENSP00000217515.5; ENSG00000091164.13.;""ENST00000590954.5; ENSP00000464918.1; ENSG00000091164.13."";",disulfide oxidoreductase activity [GO:0015036]; protein-disulfide reductase activity [GO:0015035],0,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]
Q9NX01,C1,1.654480546,0.017397196,-0.575467378,-0.536345395,-0.183212046,lightblue,TXNL4B,TXN4B_HUMAN,Thioredoxin-like protein 4B (Dim1-like protein),TXNL4B DIM2 DLP,54957;,"ENST00000268483.8; ENSP00000268483.3; ENSG00000140830.9.;""ENST00000423037.5; ENSP00000408130.1; ENSG00000140830.9."";""ENST00000426362.6; ENSP00000392310.2; ENSG00000140830.9."";",0,"mRNA splicing, via spliceosome [GO:0000398]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]
Q16881,C4,2.031064057,0.441694502,-0.98748762,-1.023421918,-1.090816134,deepskyblue2,TXNRD1,TRXR1_HUMAN,"Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Peroxidase TXNRD1) (EC 1.11.1.2) (Thioredoxin reductase TR1)",TXNRD1 GRIM12 KDRF,7296;,"ENST00000503506.6; ENSP00000421934.2; ENSG00000198431.18. [Q16881-5];""ENST00000524698.5; ENSP00000433425.1; ENSG00000198431.18. [Q16881-5]"";""ENST00000525566.6; ENSP00000434516.1; ENSG00000198431.18. [Q16881-1]"";""ENST00000526390.5; ENSP00000435123.1; ENSG00000198431.18. [Q16881-2]"";""ENST00000526691.5; ENSP00000435929.1; ENSG00000198431.18. [Q16881-4]"";""ENST00000526950.2; ENSP00000432812.2; ENSG00000198431.18. [Q16881-6]"";""ENST00000529546.5; ENSP00000434919.1; ENSG00000198431.18. [Q16881-7]"";",FAD binding [GO:0071949]; identical protein binding [GO:0042802]; NADPH peroxidase activity [GO:0050137]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; mesoderm formation [GO:0001707]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
Q06418,S4,-0.771095747,-1.263731486,0.302191666,0.791046847,0.602686164,tomato2,TYRO3,TYRO3_HUMAN,Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF),TYRO3 BYK DTK RSE SKY TIF,7301;,ENST00000263798.8; ENSP00000263798.3; ENSG00000092445.12.;,ATP binding [GO:0005524]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; virus receptor activity [GO:0001618],apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; establishment of localization in cell [GO:0051649]; forebrain cell migration [GO:0021885]; natural killer cell differentiation [GO:0001779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of lymphocyte activation [GO:0051250]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; neuropeptide signaling pathway [GO:0007218]; ovulation cycle [GO:0042698]; phagocytosis [GO:0006909]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of viral life cycle [GO:1903902]; protein autophosphorylation [GO:0046777]; secretion by cell [GO:0032940]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283]; substrate adhesion-dependent cell spreading [GO:0034446]; vagina development [GO:0060068],cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]
Q9NV66,S2,-1.434923092,-1.499951489,0.170363786,1.008848889,0.702681513,orange,TYW1,TYW1_HUMAN,S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 (EC 4.1.3.44) (Radical S-adenosyl methionine and flavodoxin domain-containing protein 1) (tRNA wybutosine-synthesizing protein 1 homolog) (tRNA-yW-synthesizing protein),TYW1 RSAFD1,55253;,"ENST00000359626.10; ENSP00000352645.5; ENSG00000198874.14. [Q9NV66-1];""ENST00000361660.8; ENSP00000354795.4; ENSG00000198874.14. [Q9NV66-2]"";","4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; tRNA-4-demethylwyosine synthase activity [GO:0102521]",wybutosine biosynthetic process [GO:0031591],0
A2RUC4,C5,2.107592293,0.465869374,-0.928344311,-1.283413662,-1.082389752,turquoise3,TYW5,TYW5_HUMAN,tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),TYW5 C2orf60,129450;,ENST00000354611.9; ENSP00000346627.4; ENSG00000162971.11. [A2RUC4-1];,2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524],wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737]
Q01081,N4,-0.901151013,1.138261203,0.154854769,-0.493365363,-0.692846236,grey30,U2AF1,U2AF1_HUMAN,Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit),U2AF1 U2AF35 U2AFBP FP793,102724594;7307;,"ENST00000291552.9; ENSP00000291552.4; ENSG00000160201.12. [Q01081-1];""ENST00000380276.6; ENSP00000369629.2; ENSG00000160201.12. [Q01081-2]"";""ENST00000459639.5; ENSP00000418705.1; ENSG00000160201.12. [Q01081-4]"";""ENST00000464750.5; ENSP00000420672.1; ENSG00000160201.12. [Q01081-3]"";",metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; RS domain binding [GO:0050733],"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701]
P26368,N4,-1.063993969,1.206287863,0.47821499,-0.599671109,-0.588465146,grey30,U2AF2,U2AF2_HUMAN,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),U2AF2 U2AF65,11338;,"ENST00000308924.9; ENSP00000307863.3; ENSG00000063244.14. [P26368-1];""ENST00000450554.6; ENSP00000388475.1; ENSG00000063244.14. [P26368-2]"";",C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; molecular function inhibitor activity [GO:0140678]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723],"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; spliceosomal complex assembly [GO:0000245]",commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701]
Q16222,C4,1.977605996,0.182449209,-0.960857352,-0.929399729,-1.015830079,deepskyblue2,UAP1,UAP1_HUMAN,UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Protein-pyrophosphorylation enzyme) (EC 2.7.4.-) (Sperm-associated antigen 2) (UDP-N-acetylgalactosamine pyrophosphorylase) (EC 2.7.7.83) (UDP-N-acetylglucosamine pyrophosphorylase) (EC 2.7.7.23),UAP1 SPAG2,6675;,"ENST00000367925.6; ENSP00000356902.1; ENSG00000117143.14. [Q16222-1];""ENST00000367926.9; ENSP00000356903.4; ENSG00000117143.14. [Q16222-2]"";",identical protein binding [GO:0042802]; protein serine pyrophosphorylase activity [GO:0141090]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977],antiviral innate immune response [GO:0140374]; positive regulation of type I interferon production [GO:0032481]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q3KQV9,C5,1.892506026,0.270255928,-0.677029021,-0.704101844,-0.712803724,turquoise3,UAP1L1,UAP1L_HUMAN,UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-),UAP1L1,91373;,"ENST00000360271.3; ENSP00000353409.3; ENSG00000197355.11. [Q3KQV9-2];""ENST00000409858.8; ENSP00000386935.3; ENSG00000197355.11. [Q3KQV9-1]"";",UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977],UDP-N-acetylglucosamine biosynthetic process [GO:0006048],0
P22314,C5,1.4082167,0.754119339,-0.625274156,-0.729103331,-0.985671739,turquoise3,UBA1,UBA1_HUMAN,Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1),UBA1 A1S9T UBE1,7317;,"ENST00000335972.11; ENSP00000338413.6; ENSG00000130985.17. [P22314-1];""ENST00000377351.8; ENSP00000366568.4; ENSG00000130985.17. [P22314-1]"";",ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin activating enzyme activity [GO:0004839],DNA damage response [GO:0006974]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
A0AVT1,C5,1.90244822,0.194476672,-0.785457583,-0.696061574,-0.936942292,turquoise3,UBA6,UBA6_HUMAN,Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2),UBA6 MOP4 UBE1L2,55236;,"ENST00000322244.10; ENSP00000313454.4; ENSG00000033178.13. [A0AVT1-1];""ENST00000420827.2; ENSP00000399234.2; ENSG00000033178.13. [A0AVT1-3]"";",ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; nucleotidyltransferase activity [GO:0016779]; thiosulfate sulfurtransferase activity [GO:0004792]; ubiquitin activating enzyme activity [GO:0004839],amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q9BSL1,C5,1.894582354,0.214994464,-0.83840818,-0.836983628,-0.93299578,turquoise3,UBAC1,UBAC1_HUMAN,Ubiquitin-associated domain-containing protein 1 (UBA domain-containing protein 1) (Glialblastoma cell differentiation-related protein 1) (Kip1 ubiquitination-promoting complex protein 2),UBAC1 GBDR1 KPC2 UBADC1,10422;,ENST00000371756.4; ENSP00000360821.3; ENSG00000130560.9.;,polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628],protein maturation [GO:0051604]; protein ubiquitination [GO:0016567],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]
Q8NBM4,S2,-0.767636624,-1.580427211,0.151011443,0.823205257,0.730225155,orange,UBAC2,UBAC2_HUMAN,Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1),UBAC2 PHGDHL1 PSEC0110,337867;,"ENST00000376440.6; ENSP00000365623.2; ENSG00000134882.16. [Q8NBM4-2];""ENST00000403766.8; ENSP00000383911.3; ENSG00000134882.16. [Q8NBM4-1]"";",0,"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]
Q9NZ09,C3,1.864069926,-0.010846155,-0.721311687,-0.65093869,-0.762898552,cyan,UBAP1,UBAP1_HUMAN,Ubiquitin-associated protein 1 (UBAP-1) (Nasopharyngeal carcinoma-associated gene 20 protein),UBAP1 NAG20,51271;,"ENST00000297661.9; ENSP00000297661.4; ENSG00000165006.14. [Q9NZ09-1];""ENST00000359544.2; ENSP00000352541.2; ENSG00000165006.14. [Q9NZ09-1]"";""ENST00000379186.8; ENSP00000368484.3; ENSG00000165006.14. [Q9NZ09-2]"";""ENST00000625521.2; ENSP00000486574.1; ENSG00000165006.14. [Q9NZ09-4]"";",ubiquitin binding [GO:0043130],membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]
P49459,C5,1.317573698,1.033509792,-0.609760158,-1.155083573,-1.013070814,turquoise3,UBE2A,UBE2A_HUMAN,Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (hHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A),UBE2A RAD6A,7319;,"ENST00000371558.7; ENSP00000360613.2; ENSG00000077721.17. [P49459-1];""ENST00000625938.2; ENSP00000486599.1; ENSG00000077721.17. [P49459-2]"";""ENST00000630695.2; ENSP00000486550.1; ENSG00000077721.17. [P49459-3]"";""ENST00000696534.1; ENSP00000512695.1; ENSG00000077721.17. [P49459-1]"";",ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of mitophagy [GO:1901526]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511],chromatin [GO:0000785]; cytosol [GO:0005829]; HULC complex [GO:0033503]; nucleoplasm [GO:0005654]
P63146,C5,1.819962394,0.705910351,-0.914228539,-1.030000566,-1.146222541,turquoise3,UBE2B,UBE2B_HUMAN,Ubiquitin-conjugating enzyme E2 B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme B) (RAD6 homolog B) (HR6B) (hHR6B) (Ubiquitin carrier protein B) (Ubiquitin-conjugating enzyme E2-17 kDa) (Ubiquitin-protein ligase B),UBE2B RAD6B UBCH1,7320;,ENST00000265339.7; ENSP00000265339.2; ENSG00000119048.9.;,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],apoptotic process [GO:0006915]; chiasma assembly [GO:0051026]; chromatin organization [GO:0006325]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; ectopic germ cell programmed cell death [GO:0035234]; in utero embryonic development [GO:0001701]; meiotic telomere clustering [GO:0045141]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of developmental process [GO:0051093]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of reproductive process [GO:2000242]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of reciprocal meiotic recombination [GO:0010845]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411]; response to xenobiotic stimulus [GO:0009410]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; synaptonemal complex organization [GO:0070193]; ubiquitin-dependent protein catabolic process [GO:0006511],chromatin [GO:0000785]; cytoplasm [GO:0005737]; HULC complex [GO:0033503]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; replication fork [GO:0005657]; XY body [GO:0001741]
O00762,C5,2.222049987,0.113445688,-0.823892814,-0.868955258,-1.260595574,turquoise3,UBE2C,UBE2C_HUMAN,Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UbcH10) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C),UBE2C UBCH10,11065;,"ENST00000335046.7; ENSP00000335674.3; ENSG00000175063.17. [O00762-4];""ENST00000352551.9; ENSP00000333975.5; ENSG00000175063.17. [O00762-3]"";""ENST00000356455.9; ENSP00000348838.4; ENSG00000175063.17. [O00762-1]"";""ENST00000372568.4; ENSP00000361649.4; ENSG00000175063.17. [O00762-2]"";",ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842],anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]
P62837,C1,1.384378647,-0.08896241,-0.861051924,-0.307065912,0.165507065,lightblue,UBE2D2,UB2D2_HUMAN,Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2) (p53-regulated ubiquitin-conjugating enzyme 1),UBE2D2 PUBC1 UBC4 UBC5B UBCH4 UBCH5B,7322;,"ENST00000398733.8; ENSP00000381717.3; ENSG00000131508.17. [P62837-1];""ENST00000398734.8; ENSP00000381718.4; ENSG00000131508.17. [P62837-1]"";""ENST00000505548.5; ENSP00000424941.1; ENSG00000131508.17. [P62837-2]"";""ENST00000511725.5; ENSP00000429613.1; ENSG00000131508.17. [P62837-2]"";""ENST00000698321.1; ENSP00000513666.1; ENSG00000131508.17. [P62837-2]"";""ENST00000698322.1; ENSP00000513667.1; ENSG00000131508.17. [P62837-2]"";",ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151]
P62253,C5,1.858939161,0.395468003,-0.76393111,-1.004939027,-1.103144233,turquoise3,UBE2G1,UB2G1_HUMAN,"Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed]",UBE2G1 UBE2G,7326;,ENST00000396981.7; ENSP00000380178.2; ENSG00000132388.13.;,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; extracellular exosome [GO:0070062]
P60604,S2,-0.99270495,-1.269338977,0.283090637,0.672258174,0.597526587,orange,UBE2G2,UB2G2_HUMAN,Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2),UBE2G2 UBC7,7327;,"ENST00000330942.9; ENSP00000331384.5; ENSG00000184787.19. [P60604-2];""ENST00000345496.7; ENSP00000338348.3; ENSG00000184787.19. [P60604-1]"";",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],"cellular response to interferon-beta [GO:0035458]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]
P62256,C5,1.909400761,0.407055572,-0.647239363,-0.70817471,-1.008674905,turquoise3,UBE2H,UBE2H_HUMAN,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H),UBE2H,7328;,"ENST00000355621.8; ENSP00000347836.3; ENSG00000186591.13. [P62256-1];""ENST00000473814.6; ENSP00000419097.2; ENSG00000186591.13. [P62256-2]"";",ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634]
Q9Y385,S2,-1.361417557,-1.527066693,0.105287534,0.888228644,0.597800506,orange,UBE2J1,UB2J1_HUMAN,Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e),UBE2J1 NCUBE1 CGI-76 HSPC153 HSPC205,51465;,ENST00000435041.3; ENSP00000451261.1; ENSG00000198833.7.;,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],"ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein polyubiquitination [GO:0000209]; regulation of macrophage cytokine production [GO:0010935]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]",endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]
P61086,C5,1.917648855,0.185010246,-0.659555893,-0.602107012,-0.911479324,turquoise3,UBE2K,UBE2K_HUMAN,Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase),UBE2K HIP2 LIG,3093;,"ENST00000261427.10; ENSP00000261427.5; ENSG00000078140.14. [P61086-1];""ENST00000445950.2; ENSP00000390483.2; ENSG00000078140.14. [P61086-3]"";""ENST00000503368.5; ENSP00000421203.1; ENSG00000078140.14. [P61086-2]"";",ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium tip [GO:0032433]; nucleus [GO:0005634]
P68036,C5,1.856620727,0.244133008,-0.699909548,-0.905793734,-1.086061144,turquoise3,UBE2L3,UB2L3_HUMAN,Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3),UBE2L3 UBCE7 UBCH7,7332;,"ENST00000342192.9; ENSP00000344259.5; ENSG00000185651.16. [P68036-1];""ENST00000458578.6; ENSP00000400906.2; ENSG00000185651.16. [P68036-3]"";""ENST00000545681.2; ENSP00000445931.1; ENSG00000185651.16. [P68036-2]"";",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842],cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA-templated transcription [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151]
O14933,C1,1.853259607,0.040798298,-0.54814984,-0.375881548,-0.690602631,lightblue,UBE2L6,UB2L6_HUMAN,Ubiquitin/ISG15-conjugating enzyme E2 L6 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L6) (Retinoic acid-induced gene B protein) (RIG-B) (UbcH8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6),UBE2L6 UBCH8,9246;,"ENST00000287156.9; ENSP00000287156.4; ENSG00000156587.16. [O14933-1];""ENST00000340573.8; ENSP00000341980.4; ENSG00000156587.16. [O14933-2]"";",ISG15 transferase activity [GO:0042296]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],innate immune response [GO:0045087]; ISG15-protein conjugation [GO:0032020]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
P61081,C1,1.57503788,0.193833968,-0.548961926,-0.307685435,-0.670752375,lightblue,UBE2M,UBC12_HUMAN,NEDD8-conjugating enzyme Ubc12 (EC 2.3.2.34) (NEDD8 carrier protein) (Ubiquitin-conjugating enzyme E2 M),UBE2M UBC12,9040;,ENST00000253023.8; ENSP00000253023.2; ENSG00000130725.8.;,ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842],positive regulation of neuron apoptotic process [GO:0043525]; post-translational protein modification [GO:0043687]; protein modification process [GO:0036211]; protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9C0C9,C4,1.878242471,0.047380138,-0.841013911,-0.775392499,-0.886702667,deepskyblue2,UBE2O,UBE2O_HUMAN,(E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O),UBE2O KIAA1734,63893;,ENST00000319380.12; ENSP00000323687.6; ENSG00000175931.13.;,ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q712K3,C3,1.940107342,0.389242369,-0.664949756,-0.686716588,-1.099862494,cyan,UBE2R2,UB2R2_HUMAN,Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2),UBE2R2 CDC34B UBC3B,54926;,ENST00000263228.4; ENSP00000263228.3; ENSG00000107341.5.;,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]
Q9H832,C1,1.673719533,0.038538125,-0.375161624,-0.32925807,-0.584053865,lightblue,UBE2Z,UBE2Z_HUMAN,Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Uba6-specific E2 conjugating enzyme 1) (Use1) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z),UBE2Z HOYS7,65264;,ENST00000360943.10; ENSP00000354201.5; ENSG00000159202.18. [Q9H832-1];,ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; molecular adaptor activity [GO:0060090]; ubiquitin conjugating enzyme activity [GO:0061631],apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O14562,C5,1.650116685,0.664588014,-0.711671304,-0.84983952,-1.022239224,turquoise3,UBFD1,UBFD1_HUMAN,Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog),UBFD1 UBPH,56061;,ENST00000395878.8; ENSP00000379217.3; ENSG00000103353.16.;,cadherin binding [GO:0045296]; RNA binding [GO:0003723],0,0
Q9Y5Z9,S1,-0.556056927,-0.857662526,-0.152070497,0.640934089,0.997489464,gold,UBIAD1,UBIA1_HUMAN,UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (EC 2.5.1.39) (Transitional epithelial response protein 1),UBIAD1 TERE1,29914;,"ENST00000376804.2; ENSP00000366000.1; ENSG00000120942.14. [Q9Y5Z9-2];""ENST00000376810.6; ENSP00000366006.5; ENSG00000120942.14. [Q9Y5Z9-1]"";",4-hydroxybenzoate decaprenyltransferase activity [GO:0002083]; antioxidant activity [GO:0016209]; prenyltransferase activity [GO:0004659],"menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process [GO:0006744]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]; vitamin K metabolic process [GO:0042373]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]
O95164,S3,-0.811940143,-0.975165214,0.18570957,0.790573254,0.516874346,salmon,UBL3,UBL3_HUMAN,Ubiquitin-like protein 3 (Membrane-anchored ubiquitin-fold protein) (HsMUB) (MUB) (Protein HCG-1),UBL3 PNSC1,5412;,ENST00000380680.5; ENSP00000370055.4; ENSG00000122042.10.;,0,0,extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]
Q96S82,C5,1.637569698,0.712102611,-0.68747194,-0.708385831,-0.78683898,turquoise3,UBL7,UBL7_HUMAN,Ubiquitin-like protein 7 (Bone marrow stromal cell ubiquitin-like protein) (BMSC-UbP) (Ubiquitin-like protein SB132),UBL7 BMSCUBP SB132,84993;,"ENST00000361351.8; ENSP00000354883.4; ENSG00000138629.16.;""ENST00000395081.7; ENSP00000378518.2; ENSG00000138629.16."";""ENST00000564488.5; ENSP00000454828.1; ENSG00000138629.16."";""ENST00000565335.5; ENSP00000457708.1; ENSG00000138629.16."";""ENST00000567435.5; ENSP00000457703.1; ENSG00000138629.16."";""ENST00000673054.1; ENSP00000500520.1; ENSG00000288408.1."";""ENST00000673073.1; ENSP00000500266.1; ENSG00000288408.1."";""ENST00000673120.1; ENSP00000500882.1; ENSG00000288408.1."";""ENST00000673153.1; ENSP00000500164.1; ENSG00000288408.1."";""ENST00000673461.1; ENSP00000500442.1; ENSG00000288408.1."";",molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593],defense response to virus [GO:0051607]; innate immune response [GO:0045087]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q9NPG3,N2,-0.996571465,-1.126668487,1.159366866,0.246169478,0.112984705,grey70,UBN1,UBN1_HUMAN,Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein),UBN1,29855;,"ENST00000262376.11; ENSP00000262376.5; ENSG00000118900.15. [Q9NPG3-1];""ENST00000396658.8; ENSP00000379894.3; ENSG00000118900.15. [Q9NPG3-1]"";""ENST00000590769.5; ENSP00000468740.1; ENSG00000118900.15. [Q9NPG3-2]"";",DNA binding [GO:0003677],chromatin organization [GO:0006325]; nucleosome assembly [GO:0006334],bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]
Q6ZU65,N2,-1.056190324,-0.765512968,1.112147075,0.053854319,-0.102880133,grey70,UBN2,UBN2_HUMAN,Ubinuclein-2,UBN2 KIAA2030,254048;,ENST00000473989.8; ENSP00000418648.2; ENSG00000157741.15. [Q6ZU65-1];,0,chromatin organization [GO:0006325],extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NZI7,C2,0.49265969,0.543131133,0.23250231,-0.018215764,-0.602896424,aquamarine,UBP1,UBIP1_HUMAN,Upstream-binding protein 1 (Transcription factor LBP-1),UBP1 LBP1,7342;,"ENST00000283628.9; ENSP00000283628.5; ENSG00000153560.12. [Q9NZI7-1];""ENST00000283629.8; ENSP00000283629.3; ENSG00000153560.12. [Q9NZI7-1]"";""ENST00000447368.6; ENSP00000395558.2; ENSG00000153560.12. [Q9NZI7-4]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UMX0,C2,1.160365008,0.617496667,-0.3020196,-0.339177806,-0.460681294,aquamarine,UBQLN1,UBQL1_HUMAN,Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1),UBQLN1 DA41 PLIC1,29979;,"ENST00000257468.11; ENSP00000257468.7; ENSG00000135018.14. [Q9UMX0-2];""ENST00000376395.9; ENSP00000365576.4; ENSG00000135018.14. [Q9UMX0-1]"";",identical protein binding [GO:0042802]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593],aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of protein ubiquitination [GO:0031398]; regulation of macroautophagy [GO:0016241]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511],aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]
Q8IWV7,C2,1.246357009,0.541283865,-0.462059458,-0.271901989,-0.407112093,aquamarine,UBR1,UBR1_HUMAN,E3 ubiquitin-protein ligase UBR1 (EC 2.3.2.27) (N-recognin-1) (Ubiquitin-protein ligase E3-alpha-1) (Ubiquitin-protein ligase E3-alpha-I),UBR1,197131;,ENST00000290650.9; ENSP00000290650.4; ENSG00000159459.12. [Q8IWV7-1];,L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],cellular response to L-leucine [GO:0071233]; negative regulation of TOR signaling [GO:0032007]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; cytosol [GO:0005829]; proteasome complex [GO:0000502]; ubiquitin ligase complex [GO:0000151]
Q6ZT12,C2,1.154257566,0.293688864,-0.275342199,-0.037446984,-0.209360347,aquamarine,UBR3,UBR3_HUMAN,E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650),UBR3 KIAA2024 ZNF650,130507;,ENST00000272793.11; ENSP00000272793.5; ENSG00000144357.18. [Q6ZT12-1];,ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; olfactory behavior [GO:0042048]; positive regulation of protein catabolic process [GO:0045732]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; membrane [GO:0016020]; ubiquitin ligase complex [GO:0000151]
Q5T4S7,C1,1.492293408,-0.054368718,-0.624552876,-0.400449113,0.257546458,lightblue,UBR4,UBR4_HUMAN,E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600),UBR4 KIAA0462 KIAA1307 RBAF600,23352;,"ENST00000375218.3; ENSP00000364366.3; ENSG00000127481.15. [Q5T4S7-6];""ENST00000375254.8; ENSP00000364403.3; ENSG00000127481.15. [Q5T4S7-1]"";",calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; endosome organization [GO:0007032]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of autophagy [GO:0010508]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]
O95071,N1,-0.814727465,0.541055461,-0.352718754,-0.384516058,0.827464899,grey90,UBR5,UBR5_HUMAN,"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)",UBR5 EDD EDD1 HYD KIAA0896,51366;,"ENST00000220959.8; ENSP00000220959.4; ENSG00000104517.13. [O95071-2];""ENST00000520539.6; ENSP00000429084.1; ENSG00000104517.13. [O95071-1]"";",RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270],cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus [GO:0042307]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]
Q04323,C5,1.613320135,0.862092266,-0.893806735,-1.042973814,-1.138206461,turquoise3,UBXN1,UBXN1_HUMAN,UBX domain-containing protein 1 (SAPK substrate protein 1) (UBA/UBX 33.3 kDa protein),UBXN1 SAKS1,51035;,"ENST00000294119.6; ENSP00000294119.2; ENSG00000162191.14. [Q04323-2];""ENST00000301935.10; ENSP00000303991.5; ENSG00000162191.14. [Q04323-1]"";",ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome regulatory particle binding [GO:1904855]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],negative regulation of ERAD pathway [GO:1904293]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]
Q14CS0,C3,1.684446793,0.285546709,-0.543906434,-0.705089471,-1.06200466,cyan,UBXN2B,UBX2B_HUMAN,UBX domain-containing protein 2B (NSFL1 cofactor p37) (p97 cofactor p37),UBXN2B,137886;,ENST00000399598.7; ENSP00000382507.2; ENSG00000215114.10.;,ubiquitin binding [GO:0043130],autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616]
Q92575,S2,-1.13468272,-1.406942032,0.116015005,0.828507732,0.551270463,orange,UBXN4,UBXN4_HUMAN,UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2),UBXN4 KIAA0242 UBXD2 UBXDC1,23190;,ENST00000272638.14; ENSP00000272638.9; ENSG00000144224.17.;,0,ERAD pathway [GO:0036503]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]
Q9Y5K5,C1,0.881545241,0.281947841,-0.30600876,-0.464539494,0.362948492,lightblue,UCHL5,UCHL5_HUMAN,Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5),UCHL5 UCH37 AD-019 CGI-70,51377;,"ENST00000367448.5; ENSP00000356418.1; ENSG00000116750.14. [Q9Y5K5-4];""ENST00000367449.5; ENSP00000356419.1; ENSG00000116750.14. [Q9Y5K5-2]"";""ENST00000367454.6; ENSP00000356424.1; ENSG00000116750.14. [Q9Y5K5-3]"";""ENST00000367455.8; ENSP00000356425.3; ENSG00000116750.14. [Q9Y5K5-1]"";",cysteine-type deubiquitinase activity [GO:0004843]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; RNA binding [GO:0003723],chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of proteasomal protein catabolic process [GO:0061136]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BZX2,C5,1.272890701,0.820099529,-0.510478158,-0.773873487,-1.156102419,turquoise3,UCK2,UCK2_HUMAN,Uridine-cytidine kinase 2 (UCK 2) (EC 2.7.1.48) (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2),UCK2 UMPK,7371;,"ENST00000367879.9; ENSP00000356853.4; ENSG00000143179.16. [Q9BZX2-1];""ENST00000469256.6; ENSP00000476692.1; ENSG00000143179.16. [Q9BZX2-2]"";""ENST00000470820.1; ENSP00000476327.1; ENSG00000143179.16. [Q9BZX2-2]"";",ATP binding [GO:0005524]; cytidine kinase activity [GO:0043771]; identical protein binding [GO:0042802]; uridine kinase activity [GO:0004849],CTP salvage [GO:0044211]; UMP salvage [GO:0044206],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q8IX04,C1,1.767250367,-0.004159883,-0.599497983,-0.325285548,-0.538264027,lightblue,UEVLD,UEVLD_HUMAN,Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein),UEVLD UEV3,55293;,"ENST00000300038.7; ENSP00000300038.7; ENSG00000151116.17. [Q8IX04-5];""ENST00000320750.10; ENSP00000323353.6; ENSG00000151116.17. [Q8IX04-3]"";""ENST00000379387.8; ENSP00000368697.4; ENSG00000151116.17. [Q8IX04-6]"";""ENST00000396197.8; ENSP00000379500.2; ENSG00000151116.17. [Q8IX04-1]"";""ENST00000535484.5; ENSP00000441092.1; ENSG00000151116.17. [Q8IX04-4]"";""ENST00000541984.5; ENSP00000437538.1; ENSG00000151116.17. [Q8IX04-7]"";""ENST00000543987.5; ENSP00000442974.1; ENSG00000151116.17. [Q8IX04-2]"";","oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; ubiquitin binding [GO:0043130]",carboxylic acid metabolic process [GO:0019752]; endosome to lysosome transport [GO:0008333]; protein modification process [GO:0036211]; protein transport [GO:0015031],ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]
Q92890,N4,0.456698867,0.972537109,-0.278049466,-0.277465157,-0.686921307,grey30,UFD1L,UFD1_HUMAN,Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1),UFD1 UFD1L,7353;,"ENST00000263202.15; ENSP00000263202.9; ENSG00000070010.19. [Q92890-2];""ENST00000399523.5; ENSP00000382439.1; ENSG00000070010.19. [Q92890-3]"";",cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593],"cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]
O94874,S2,-0.915596963,-1.209299937,0.225072263,0.825876302,0.482189881,orange,UFL1,UFL1_HUMAN,E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1),UFL1 KIAA0776 MAXER NLBP RCAD,23376;,ENST00000369278.5; ENSP00000358283.4; ENSG00000014123.10. [O94874-1];,protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568],DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; osteoblast differentiation [GO:0001649]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of reticulophagy [GO:0140501]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; rescue of stalled ribosome [GO:0072344]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]; ribosome disassembly [GO:0032790],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]
Q16739,S1,-0.884791676,-1.242515423,-0.233702848,0.683782266,1.085159099,gold,UGCG,CEGT_HUMAN,Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase),UGCG,7357;,ENST00000374279.4; ENSP00000363397.3; ENSG00000148154.10.;,ceramide glucosyltransferase activity [GO:0008120]; dihydroceramide glucosyltransferase activity [GO:0102769],cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid biosynthetic process [GO:0006688]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966],Golgi membrane [GO:0000139]; membrane [GO:0016020]
O60701,C5,1.560373432,0.91405899,-0.728752322,-0.862312798,-0.922166848,turquoise3,UGDH,UGDH_HUMAN,UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22),UGDH,7358;,"ENST00000316423.11; ENSP00000319501.6; ENSG00000109814.12. [O60701-1];""ENST00000501493.6; ENSP00000422909.1; ENSG00000109814.12. [O60701-2]"";""ENST00000506179.5; ENSP00000421757.1; ENSG00000109814.12. [O60701-1]"";""ENST00000507089.5; ENSP00000426560.1; ENSG00000109814.12. [O60701-3]"";",identical protein binding [GO:0042802]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979],chondroitin sulfate biosynthetic process [GO:0030206]; gastrulation with mouth forming second [GO:0001702]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; neuron development [GO:0048666]; protein hexamerization [GO:0034214]; UDP-glucuronate biosynthetic process [GO:0006065],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q6BDS2,C1,1.537430794,0.18184579,-0.42598878,-0.240300862,-0.520131923,lightblue,UHRF1BP1,BLT3A_HUMAN,Bridge-like lipid transfer protein family member 3A (ICBP90-binding protein 1) (UHRF1-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1),BLTP3A C6orf107 UHRF1BP1,54887;,ENST00000192788.6; ENSP00000192788.5; ENSG00000065060.18.;,histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802],0,late endosome [GO:0005770]
Q96PU4,N4,-0.882400101,0.986814475,0.279138246,-0.273453287,-0.418841502,grey30,UHRF2,UHRF2_HUMAN,E3 ubiquitin-protein ligase UHRF2 (EC 2.3.2.27) (Np95/ICBP90-like RING finger protein) (Np95-like RING finger protein) (Nuclear protein 97) (Nuclear zinc finger protein Np97) (RING finger protein 107) (RING-type E3 ubiquitin transferase UHRF2) (Ubiquitin-like PHD and RING finger domain-containing protein 2) (Ubiquitin-like-containing PHD and RING finger domains protein 2),UHRF2 NIRF RNF107,115426;,"ENST00000276893.10; ENSP00000276893.5; ENSG00000147854.17. [Q96PU4-1];""ENST00000468435.6; ENSP00000434182.1; ENSG00000147854.17. [Q96PU4-2]"";",DNA binding [GO:0003677]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],cell differentiation [GO:0030154]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; protein autoubiquitination [GO:0051865]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726],heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]
Q9BZM4,S2,-0.65668925,-1.251522992,0.238523246,0.856426665,0.672239536,orange,ULBP3,ULBP3_HUMAN,UL16-binding protein 3 (ALCAN-gamma) (NKG2D ligand 3) (N2DL-3) (NKG2DL3) (Retinoic acid early transcript 1N),ULBP3 N2DL3 RAET1N,79465;,"ENST00000367339.7; ENSP00000356308.1; ENSG00000131019.11.;""ENST00000438272.2; ENSP00000403562.2; ENSG00000131019.11."";",natural killer cell lectin-like receptor binding [GO:0046703],"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent [GO:0002486]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; immune response [GO:0006955]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of T cell mediated cytotoxicity [GO:0001916]",external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]
Q13432,C5,1.487389604,0.608808869,-0.604233566,-0.554994619,-0.748184236,turquoise3,UNC119,U119A_HUMAN,Protein unc-119 homolog A (Retinal protein 4) (hRG4),UNC119 RG4,9094;,"ENST00000301032.8; ENSP00000301032.4; ENSG00000109103.12. [Q13432-2];""ENST00000335765.9; ENSP00000337040.3; ENSG00000109103.12. [Q13432-1]"";",lipid binding [GO:0008289],chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; lipoprotein transport [GO:0042953]; mitotic cytokinesis [GO:0000281]; negative regulation of caveolin-mediated endocytosis [GO:2001287]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; nervous system development [GO:0007399]; phototransduction [GO:0007602]; positive regulation of protein tyrosine kinase activity [GO:0061098]; visual perception [GO:0007601],centrosome [GO:0005813]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synapse [GO:0045202]
A6NIH7,C5,1.520261526,0.365587955,-0.470652068,-0.454108336,-0.677417789,turquoise3,UNC119B,U119B_HUMAN,Protein unc-119 homolog B,UNC119B,84747;,ENST00000344651.5; ENSP00000344942.4; ENSG00000175970.11.;,lipid binding [GO:0008289],cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]
O14795,C1,1.653838511,-0.040398054,-0.414188624,-0.346664741,-0.630810181,lightblue,UNC13B,UN13B_HUMAN,Protein unc-13 homolog B (Munc13-2) (munc13),UNC13B UNC13,10497;,"ENST00000378495.7; ENSP00000367756.3; ENSG00000198722.15. [O14795-1];""ENST00000619578.4; ENSP00000479261.1; ENSG00000198722.15. [O14795-2]"";",calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; diacylglycerol binding [GO:0019992]; GTP-dependent protein binding [GO:0030742]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075],"acrosomal vesicle exocytosis [GO:0060478]; cellular response to glucose stimulus [GO:0071333]; chemical synaptic transmission [GO:0007268]; dense core granule priming [GO:0061789]; neuronal dense core vesicle exocytosis [GO:0099011]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic vesicle priming [GO:0010808]; presynaptic dense core vesicle exocytosis [GO:0099525]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle docking [GO:0016081]; synaptic vesicle priming [GO:0016082]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]
Q70J99,C3,1.47628545,0.19522779,-0.287233418,-0.081279422,-0.236632835,cyan,UNC13D,UN13D_HUMAN,Protein unc-13 homolog D (Munc13-4),UNC13D,201294;,"ENST00000207549.9; ENSP00000207549.3; ENSG00000092929.13. [Q70J99-1];""ENST00000412096.6; ENSP00000388093.1; ENSG00000092929.13. [Q70J99-3]"";",metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],defense response to virus [GO:0051607]; germinal center formation [GO:0002467]; granuloma formation [GO:0002432]; natural killer cell degranulation [GO:0043320]; phagocytosis [GO:0006909]; positive regulation of exocytosis [GO:0045921]; positive regulation of regulated secretory pathway [GO:1903307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of mast cell degranulation [GO:0043304]; secretion [GO:0046903],azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; recycling endosome [GO:0055037]; Weibel-Palade body [GO:0033093]
Q9H1C4,S2,-1.473290439,-1.728922962,0.049270151,0.844665333,0.56944608,orange,UNC93B1,UN93B_HUMAN,Protein unc-93 homolog B1 (Unc-93B1) (hUNC93B1),UNC93B1 UNC93 UNC93B,81622;,ENST00000227471.7; ENSP00000227471.3; ENSG00000110057.9.;,Toll-like receptor binding [GO:0035325],antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell morphogenesis [GO:0000902]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; intracellular protein transport [GO:0006886]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; T cell antigen processing and presentation [GO:0002457]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224],early phagosome [GO:0032009]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]
Q96BW1,C5,1.487709005,0.339312337,-0.340810536,-0.621094122,-0.72556063,turquoise3,UPRT,UPP_HUMAN,Uracil phosphoribosyltransferase homolog,UPRT,139596;,"ENST00000373383.9; ENSP00000362481.4; ENSG00000094841.14. [Q96BW1-1];""ENST00000462237.5; ENSP00000433987.1; ENSG00000094841.14. [Q96BW1-2]"";",GTP binding [GO:0005525]; ribosylnicotinamide kinase activity [GO:0050262],female pregnancy [GO:0007565]; lactation [GO:0007595]; response to insulin [GO:0032868]; UMP biosynthetic process [GO:0006222],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]
Q9NVA1,M2,-0.924428011,-1.029527587,0.473680525,1.131743741,-0.233884997,tan4,UQCC1,UQCC1_HUMAN,Ubiquinol-cytochrome c reductase complex assembly factor 1 (Basic FGF-repressed Zic-binding protein) (bFGF-repressed Zic-binding protein) (bFZb) (Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog),UQCC1 BZFB C20orf44 UQCC,55245;,"ENST00000349714.9; ENSP00000335364.6; ENSG00000101019.22. [Q9NVA1-4];""ENST00000374380.6; ENSP00000363501.2; ENSG00000101019.22. [Q9NVA1-5]"";""ENST00000374384.6; ENSP00000363505.2; ENSG00000101019.22. [Q9NVA1-2]"";""ENST00000374385.10; ENSP00000363506.5; ENSG00000101019.22. [Q9NVA1-1]"";",0,mitochondrial respiratory chain complex III assembly [GO:0034551],cytoplasmic vesicle [GO:0031410]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]
Q9UDW1,M2,-1.105580914,-1.338410261,0.449503313,1.031264586,-0.123145226,tan4,UQCR10,QCR9_HUMAN,Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein),UQCR10 UCRC HSPC119,29796;,"ENST00000330029.6; ENSP00000332887.6; ENSG00000184076.13. [Q9UDW1-1];""ENST00000401406.3; ENSP00000384962.3; ENSG00000184076.13. [Q9UDW1-2]"";",ubiquinol-cytochrome-c reductase activity [GO:0008121],"cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]
P14927,M2,-1.240833844,-1.442484833,0.411282231,1.186115967,-0.16218402,tan4,UQCRB,QCR7_HUMAN,Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein),UQCRB UQBP,7381;,"ENST00000287022.10; ENSP00000287022.5; ENSG00000156467.10. [P14927-1];""ENST00000518406.5; ENSP00000430494.1; ENSG00000156467.10. [P14927-2]"";",0,"aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]",mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]
P31930,M2,-0.809375264,-1.004781595,0.357704876,0.975188962,-0.117787541,tan4,UQCRC1,QCR1_HUMAN,"Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)",UQCRC1,7384;,ENST00000203407.6; ENSP00000203407.5; ENSG00000010256.11.;,metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; ubiquitin protein ligase binding [GO:0031625],"aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; response to activity [GO:0014823]; response to alkaloid [GO:0043279]",mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]
P22695,M2,-0.699171828,-1.029804434,0.362362752,1.006321404,-0.209279702,tan4,UQCRC2,QCR2_HUMAN,"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)",UQCRC2,7385;,ENST00000268379.9; ENSP00000268379.4; ENSG00000140740.11.;,metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],"aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]; proteolysis [GO:0006508]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]
P47985,M2,-0.87335487,-0.941075748,0.349091447,1.027354975,-0.158459036,tan4,UQCRFS1,UCRI_HUMAN,"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 7.1.1.8) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Rieske protein UQCRFS1) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 9 (Su9) (Subunit 9) (8 kDa subunit 9) (Complex III subunit IX) (Cytochrome b-c1 complex subunit 11) (UQCRFS1 mitochondrial targeting sequence) (UQCRFS1 MTS) (Ubiquinol-cytochrome c reductase 8 kDa protein)]",UQCRFS1,7386;,ENST00000304863.6; ENSP00000306397.3; ENSG00000169021.6.;,"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinol-cytochrome-c reductase activity [GO:0008121]","mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; mitochondrial respiratory chain complex III assembly [GO:0034551]; respiratory electron transport chain [GO:0022904]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]
P07919,M2,-0.909863741,-1.162872349,0.3430981,1.14893195,-0.28662757,tan4,UQCRH,QCR6_HUMAN,"Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein)",UQCRH,7388;,ENST00000311672.10; ENSP00000309565.5; ENSG00000173660.12.;,ubiquinol-cytochrome-c reductase activity [GO:0008121],"aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]",mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]
O14949,M2,-1.058288007,-1.295707328,0.41505698,1.091416892,-0.093358323,tan4,UQCRQ,QCR8_HUMAN,Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C),UQCRQ,27089;,"ENST00000378665.1; ENSP00000367934.1; ENSG00000164405.11.;""ENST00000378667.1; ENSP00000367936.1; ENSG00000164405.11."";""ENST00000378670.8; ENSP00000367939.3; ENSG00000164405.11."";",0,"cellular respiration [GO:0045333]; cerebellar Purkinje cell layer development [GO:0021680]; hippocampus development [GO:0021766]; hypothalamus development [GO:0021854]; midbrain development [GO:0030901]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; pons development [GO:0021548]; pyramidal neuron development [GO:0021860]; subthalamus development [GO:0021539]; thalamus development [GO:0021794]",mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]
O60287,N3,-1.163338468,-1.24669363,1.37465763,-0.320832433,-0.239473391,grey50,URB1,NPA1P_HUMAN,Nucleolar pre-ribosomal-associated protein 1 (Nucleolar protein 254 kDa) (URB1 ribosome biogenesis 1 homolog),URB1 C21orf108 KIAA0539 NOP254 NPA1,9875;,ENST00000382751.4; ENSP00000372199.3; ENSG00000142207.7.;,RNA binding [GO:0003723],"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]",fibrillar center [GO:0001650]; nucleolus [GO:0005730]
Q14146,N3,-1.232238606,-1.475239606,1.41055055,-0.164266247,-0.271552056,grey50,URB2,URB2_HUMAN,Unhealthy ribosome biogenesis protein 2 homolog,URB2 KIAA0133,9816;,ENST00000258243.7; ENSP00000258243.2; ENSG00000135763.10.;,0,regulation of signal transduction by p53 class mediator [GO:1901796]; ribosome biogenesis [GO:0042254],aggresome [GO:0016235]; midbody [GO:0030496]; nucleolus [GO:0005730]
P06132,C5,1.594098055,0.730427299,-0.874804149,-0.971868261,-1.19880075,turquoise3,UROD,DCUP_HUMAN,Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37),UROD,7389;,ENST00000246337.9; ENSP00000246337.4; ENSG00000126088.14.;,uroporphyrinogen decarboxylase activity [GO:0004853],heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; porphyrin-containing compound catabolic process [GO:0006787]; porphyrin-containing compound metabolic process [GO:0006778]; protoporphyrinogen IX biosynthetic process [GO:0006782],cytosol [GO:0005829]; nucleoplasm [GO:0005654]
P10746,C4,1.763306819,0.52076878,-0.771215536,-1.057891398,-1.276465131,deepskyblue2,UROS,HEM4_HUMAN,Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase),UROS,7390;,"ENST00000368786.5; ENSP00000357775.1; ENSG00000188690.16.;""ENST00000368797.10; ENSP00000357787.4; ENSG00000188690.16."";""ENST00000713579.1; ENSP00000518871.1; ENSG00000188690.16."";",folic acid binding [GO:0005542]; uroporphyrinogen-III synthase activity [GO:0004852],cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780],cytosol [GO:0005829]; mitochondrion [GO:0005739]
Q9NZ43,S2,-1.535199081,-1.449043533,0.146313029,0.857204257,0.708801285,orange,USE1,USE1_HUMAN,Vesicle transport protein USE1 (Putative MAPK-activating protein PM26) (USE1-like protein) (p31),USE1 USE1L MDS032,55850;,"ENST00000263897.10; ENSP00000263897.4; ENSG00000053501.14. [Q9NZ43-1];""ENST00000595101.5; ENSP00000472362.1; ENSG00000053501.14. [Q9NZ43-3]"";""ENST00000596136.5; ENSP00000473239.1; ENSG00000053501.14. [Q9NZ43-2]"";",SNAP receptor activity [GO:0005484],"lysosomal transport [GO:0007041]; protein catabolic process [GO:0030163]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; secretion by cell [GO:0032940]",COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SNARE complex [GO:0031201]
Q96IX5,M2,-2.529022509,-2.610215471,0.455910303,1.42181027,-0.112654788,tan4,USMG5,ATPMK_HUMAN,"ATP synthase membrane subunit K, mitochondrial (ATP synthase membrane subunit DAPIT, mitochondrial) (Diabetes-associated protein in insulin-sensitive tissues) (HCV F-transactivated protein 2) (Up-regulated during skeletal muscle growth protein 5)",ATP5MK ATP5MD DAPIT HCVFTP2 USMG5 PD04912,84833;,"ENST00000309579.7; ENSP00000311245.3; ENSG00000173915.16.;""ENST00000337003.4; ENSP00000337705.4; ENSG00000173915.16."";""ENST00000369811.5; ENSP00000358826.1; ENSG00000173915.16."";""ENST00000369815.6; ENSP00000358830.1; ENSG00000173915.16."";""ENST00000369825.6; ENSP00000358840.1; ENSG00000173915.16."";",0,proton motive force-driven ATP synthesis [GO:0015986],mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrion [GO:0005739]
P51784,N4,0.383858248,1.134075706,-0.303748356,-0.46144414,-0.634415267,grey30,USP11,UBP11_HUMAN,Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11),USP11 UHX1,0,ENST00000218348.7; ENSP00000218348.3; ENSG00000102226.10.;,cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; transcription corepressor binding [GO:0001222],protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O75317,S1,-0.460199922,-0.63486983,-0.04302297,0.615229926,0.699316089,gold,USP12,UBP12_HUMAN,Ubiquitin carboxyl-terminal hydrolase 12 (EC 3.4.19.12) (Deubiquitinating enzyme 12) (Ubiquitin thioesterase 12) (Ubiquitin-hydrolyzing enzyme 1) (Ubiquitin-specific-processing protease 12),USP12 UBH1 USP12L1,219333;,ENST00000282344.11; ENSP00000282344.6; ENSG00000152484.14.;,cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; metal ion binding [GO:0046872],protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q92995,C5,1.44081266,0.675153169,-0.378685564,-0.363584726,-0.562424744,turquoise3,USP13,UBP13_HUMAN,Ubiquitin carboxyl-terminal hydrolase 13 (EC 3.4.19.12) (Deubiquitinating enzyme 13) (Isopeptidase T-3) (ISOT-3) (Ubiquitin thioesterase 13) (Ubiquitin-specific-processing protease 13),USP13 ISOT3,8975;,"ENST00000263966.8; ENSP00000263966.3; ENSG00000058056.10. [Q92995-1];""ENST00000496897.5; ENSP00000417146.1; ENSG00000058056.10. [Q92995-2]"";",BAT3 complex binding [GO:1904288]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; K48-linked deubiquitinase activity [GO:1990380]; proteasome binding [GO:0070628]; protein-folding chaperone binding [GO:0051087]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270],autophagy [GO:0006914]; cell population proliferation [GO:0008283]; maintenance of unfolded protein [GO:0036506]; melanocyte differentiation [GO:0030318]; positive regulation of ERAD pathway [GO:1904294]; protein K29-linked deubiquitination [GO:0035523]; protein K6-linked deubiquitination [GO:0044313]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y4E8,C5,1.622326248,0.509988606,-0.822078606,-0.873453176,-0.866476735,turquoise3,USP15,UBP15_HUMAN,Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4),USP15 KIAA0529,9958;,"ENST00000280377.10; ENSP00000280377.5; ENSG00000135655.16. [Q9Y4E8-1];""ENST00000312635.10; ENSP00000309240.6; ENSG00000135655.16. [Q9Y4E8-4]"";""ENST00000353364.7; ENSP00000258123.4; ENSG00000135655.16. [Q9Y4E8-2]"";",cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; identical protein binding [GO:0042802]; K48-linked deubiquitinase activity [GO:1990380]; SMAD binding [GO:0046332]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin-modified histone reader activity [GO:0061649],BMP signaling pathway [GO:0030509]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of RIG-I signaling pathway [GO:1900246]; protein deubiquitination [GO:0016579]; protein K27-linked deubiquitination [GO:1990167]; proteolysis [GO:0006508]; regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator [GO:1902238]; transcription elongation-coupled chromatin remodeling [GO:0140673]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y2K6,S3,-0.78431268,-1.198480626,0.161412939,0.834029275,0.674570441,salmon,USP20,UBP20_HUMAN,Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2),USP20 KIAA1003 LSFR3A VDU2,10868;,"ENST00000315480.9; ENSP00000313811.4; ENSG00000136878.14.;""ENST00000358355.5; ENSP00000351122.1; ENSG00000136878.14."";""ENST00000372429.8; ENSP00000361506.3; ENSG00000136878.14."";",cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; zinc ion binding [GO:0008270],antiviral innate immune response [GO:0140374]; endocytosis [GO:0006897]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of autophagy [GO:0010508]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]
Q9UPU5,C3,1.564390032,0.024445,-0.564786662,-0.393023272,-0.408540968,cyan,USP24,UBP24_HUMAN,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),USP24 KIAA1057,23358;,ENST00000294383.7; ENSP00000294383.5; ENSG00000162402.15.;,cysteine-type deubiquitinase activity [GO:0004843],proteolysis [GO:0006508],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UHP3,C3,1.573914333,0.255428458,-0.461790556,-0.301446863,-0.555148545,cyan,USP25,UBP25_HUMAN,Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (USP on chromosome 21) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25),USP25 USP21,29761;,"ENST00000285679.10; ENSP00000285679.6; ENSG00000155313.16. [Q9UHP3-2];""ENST00000285681.6; ENSP00000285681.2; ENSG00000155313.16. [Q9UHP3-1]"";""ENST00000400183.7; ENSP00000383044.2; ENSG00000155313.16. [Q9UHP3-3]"";",ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; peptidase activity [GO:0008233]; SUMO binding [GO:0032183]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein peptidase activity [GO:0019783],negative regulation of ERAD pathway [GO:1904293]; negative regulation of interleukin-17-mediated signaling pathway [GO:1903882]; negative regulation of response to oxidative stress [GO:1902883]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein modification process [GO:0036211]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]
Q70CQ3,M2,-1.20787511,-1.382864363,0.339932954,1.176557947,-0.183556928,tan4,USP30,UBP30_HUMAN,Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30),USP30,84749;,ENST00000257548.10; ENSP00000257548.5; ENSG00000135093.13.;,cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005],autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; negative regulation of mitophagy [GO:1901525]; pexophagy [GO:0000425]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; proteolysis [GO:0006508],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]
Q8TEY7,S2,-1.105941928,-1.312119108,0.304732091,0.836823286,0.648331287,orange,USP33,UBP33_HUMAN,Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33) (VHL-interacting deubiquitinating enzyme 1) (hVDU1),USP33 KIAA1097 VDU1,23032;,"ENST00000357428.5; ENSP00000350009.1; ENSG00000077254.14. [Q8TEY7-1];""ENST00000370792.7; ENSP00000359828.3; ENSG00000077254.14. [Q8TEY7-3]"";""ENST00000370793.5; ENSP00000359829.1; ENSG00000077254.14. [Q8TEY7-1]"";""ENST00000370794.7; ENSP00000359830.3; ENSG00000077254.14. [Q8TEY7-2]"";",cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],axon guidance [GO:0007411]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; negative regulation of protein binding [GO:0032091]; positive regulation of protein binding [GO:0032092]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of autophagy [GO:0010506]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; VCB complex [GO:0030891]
Q9P275,N3,-1.004422008,-1.135154752,1.193861698,-0.062879262,-0.045270948,grey50,USP36,UBP36_HUMAN,Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),USP36 KIAA1453,57602;,"ENST00000312010.10; ENSP00000310590.6; ENSG00000055483.20.;""ENST00000449938.7; ENSP00000401119.4; ENSG00000055483.20."";""ENST00000542802.7; ENSP00000441214.1; ENSG00000055483.20."";""ENST00000589225.5; ENSP00000467280.1; ENSG00000055483.20."";""ENST00000592231.6; ENSP00000465698.2; ENSG00000055483.20."";",cysteine-type deubiquitinase activity [GO:0004843]; histone H2B deubiquitinase activity [GO:0140936]; K48-linked deubiquitinase activity [GO:1990380]; RNA binding [GO:0003723]; transferase activity [GO:0016740],chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of mitophagy [GO:1901524]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13107,C4,1.987305878,0.280254598,-0.865030279,-0.863827683,-1.148351251,deepskyblue2,USP4,UBP4_HUMAN,Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) (Ubiquitous nuclear protein homolog),USP4 UNP UNPH,7375;,"ENST00000265560.9; ENSP00000265560.4; ENSG00000114316.13. [Q13107-1];""ENST00000351842.8; ENSP00000341028.4; ENSG00000114316.13. [Q13107-2]"";""ENST00000416417.5; ENSP00000400623.1; ENSG00000114316.13. [Q13107-3]"";",adenosine receptor binding [GO:0031685]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872],negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; spliceosomal tri-snRNP complex assembly [GO:0000244],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; plasma membrane [GO:0005886]
Q9H9J4,N3,-0.79724395,-0.74944557,0.968249675,-0.152752198,0.326760729,grey50,USP42,UBP42_HUMAN,Ubiquitin carboxyl-terminal hydrolase 42 (EC 3.4.19.12) (Deubiquitinating enzyme 42) (Ubiquitin thioesterase 42) (Ubiquitin-specific-processing protease 42),USP42,84132;,ENST00000306177.10; ENSP00000301962.5; ENSG00000106346.12. [Q9H9J4-2];,cysteine-type deubiquitinase activity [GO:0004843],cell differentiation [GO:0030154]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96K76,C4,1.935356276,-0.050794177,-0.914277179,-0.890118332,-1.120111649,deepskyblue2,USP47,UBP47_HUMAN,Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47),USP47,55031;,"ENST00000339865.9; ENSP00000339957.5; ENSG00000170242.19. [Q96K76-2];""ENST00000399455.2; ENSP00000382382.2; ENSG00000170242.19. [Q96K76-1]"";""ENST00000527733.7; ENSP00000433146.2; ENSG00000170242.19. [Q96K76-4]"";",cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987],base-excision repair [GO:0006284]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508]; response to xenobiotic stimulus [GO:0009410],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]
P45974,C5,1.674143206,0.789838914,-0.715660354,-0.783733769,-1.10240255,turquoise3,USP5,UBP5_HUMAN,Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5),USP5 ISOT,8078;,"ENST00000229268.13; ENSP00000229268.8; ENSG00000111667.14. [P45974-1];""ENST00000389231.9; ENSP00000373883.5; ENSG00000111667.14. [P45974-2]"";",cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270],negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508],cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]
Q93009,N4,-0.739727265,0.996282173,-0.013699694,-0.320950201,0.090300261,grey30,USP7,UBP7_HUMAN,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),USP7 HAUSP,7874;,"ENST00000344836.9; ENSP00000343535.4; ENSG00000187555.17. [Q93009-1];""ENST00000381886.8; ENSP00000371310.4; ENSG00000187555.17. [Q93009-3]"";",cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039],"DNA alkylation repair [GO:0006307]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of TORC1 signaling [GO:1904262]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; symbiont-mediated disruption of host cell PML body [GO:0075342]; transcription-coupled nucleotide-excision repair [GO:0006283]",chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]
P40818,C5,1.692521859,0.277190886,-0.931059596,-0.820237564,-1.0201244,turquoise3,USP8,UBP8_HUMAN,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),USP8 KIAA0055 UBPY,9101;,"ENST00000307179.9; ENSP00000302239.4; ENSG00000138592.14. [P40818-1];""ENST00000396444.7; ENSP00000379721.3; ENSG00000138592.14. [P40818-1]"";""ENST00000425032.7; ENSP00000412682.3; ENSG00000138592.14. [P40818-2]"";",cadherin binding [GO:0045296]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; SH3 domain binding [GO:0017124],"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]
Q93008,C1,1.567169948,0.235361425,-0.563960319,-0.483564915,-0.21793815,lightblue,USP9X,USP9X_HUMAN,"Ubiquitin carboxyl-terminal hydrolase 9X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",USP9X DFFRX FAM USP9,8239;,"ENST00000324545.9; ENSP00000316357.6; ENSG00000124486.15. [Q93008-3];""ENST00000378308.7; ENSP00000367558.2; ENSG00000124486.15. [Q93008-1]"";""ENST00000704650.1; ENSP00000515975.1; ENSG00000124486.15. [Q93008-1]"";",co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; K11-linked deubiquitinase activity [GO:0180017]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; molecular sequestering activity [GO:0140313],"amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]",centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]
Q9Y3A2,N3,-1.221711698,-1.35199055,1.378005535,0.003453662,-0.239545805,grey50,UTP11L,UTP11_HUMAN,Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11) (UTP11-like protein),UTP11 UTP11L CGI-94 HDCMB12P,51118;,ENST00000373014.5; ENSP00000362105.4; ENSG00000183520.12. [Q9Y3A2-1];,RNA binding [GO:0003723],nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q9BVJ6,N3,-1.228536227,-1.16836883,1.190470199,-0.095977007,0.272843026,grey50,UTP14A,UT14A_HUMAN,U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16),UTP14A SDCCAG16,10813;,"ENST00000394422.8; ENSP00000377944.3; ENSG00000156697.13. [Q9BVJ6-1];""ENST00000425117.6; ENSP00000388669.2; ENSG00000156697.13. [Q9BVJ6-3]"";",RNA binding [GO:0003723],rRNA processing [GO:0006364],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q8TED0,N3,-1.0749366,-1.114764765,1.223108877,0.093749023,-0.211182381,grey50,UTP15,UTP15_HUMAN,U3 small nucleolar RNA-associated protein 15 homolog,UTP15,84135;,"ENST00000296792.9; ENSP00000296792.4; ENSG00000164338.10. [Q8TED0-1];""ENST00000508491.1; ENSP00000424609.1; ENSG00000164338.10. [Q8TED0-3]"";""ENST00000543251.5; ENSP00000440796.1; ENSG00000164338.10. [Q8TED0-2]"";",RNA binding [GO:0003723],positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q9Y5J1,N3,-0.640080593,-0.807144663,1.090953389,0.064896308,-0.096422369,grey50,UTP18,UTP18_HUMAN,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),UTP18 WDR50 CDABP0061 CGI-48,51096;,ENST00000225298.12; ENSP00000225298.7; ENSG00000011260.14.;,RNA binding [GO:0003723],ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]
O75691,N3,-1.160111684,-1.27722398,1.296003909,-0.149945397,-0.107803056,grey50,UTP20,UTP20_HUMAN,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),UTP20 DRIM,27340;,ENST00000261637.5; ENSP00000261637.4; ENSG00000120800.5.;,RNA binding [GO:0003723],"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]"
Q9BRU9,N1,-1.17374245,-0.739835377,0.821848134,-0.241426477,0.948955293,grey90,UTP23,UTP23_HUMAN,rRNA-processing protein UTP23 homolog,UTP23 C8orf53,84294;,ENST00000309822.7; ENSP00000308332.2; ENSG00000147679.12. [Q9BRU9-1];,mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181],"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]",nucleolus [GO:0005730]; small-subunit processome [GO:0032040]
Q9NQZ2,N3,-1.071787339,-1.294920778,1.120141331,-0.048396496,0.33213712,grey50,UTP3,SAS10_HUMAN,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (CRL1) (Disrupter of silencing SAS10) (UTP3 homolog),UTP3 CRLZ1 SAS10,57050;,ENST00000254803.4; ENSP00000254803.2; ENSG00000132467.4.;,RNA binding [GO:0003723],"brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]",nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]
Q9NYH9,N3,-1.131810575,-1.014277322,1.355327591,0.068959576,-0.446530661,grey50,UTP6,UTP6_HUMAN,U3 small nucleolar RNA-associated protein 6 homolog (Hepatocellular carcinoma-associated antigen 66) (Multiple hat domains protein),UTP6 C17orf40 HCA66 MHAT,55813;,ENST00000261708.9; ENSP00000261708.4; ENSG00000108651.10.;,snoRNA binding [GO:0030515],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]",chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]
P46939,M1,-0.963649982,-0.974035375,0.620816664,0.75861835,-0.152442954,burlywood4,UTRN,UTRN_HUMAN,Utrophin (Dystrophin-related protein 1) (DRP-1),UTRN DMDL DRP1,7402;,ENST00000367545.8; ENSP00000356515.3; ENSG00000152818.20. [P46939-1];,actin binding [GO:0003779]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270],muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; synaptic signaling [GO:0099536],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]
Q8NBZ7,S1,-1.008911949,-1.125218421,-0.16657828,0.79315954,0.936781324,gold,UXS1,UXS1_HUMAN,UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1) (hUXS) (hUXS1),UXS1 UNQ2538/PRO6079,80146;,"ENST00000283148.12; ENSP00000283148.7; ENSG00000115652.15. [Q8NBZ7-2];""ENST00000409032.5; ENSP00000387096.1; ENSG00000115652.15. [Q8NBZ7-3]"";""ENST00000409501.7; ENSP00000387019.3; ENSG00000115652.15. [Q8NBZ7-1]"";",identical protein binding [GO:0042802]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; UDP-glucuronate decarboxylase activity [GO:0048040],D-xylose metabolic process [GO:0042732]; UDP-D-xylose biosynthetic process [GO:0033320],catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; Golgi cisterna membrane [GO:0032580]
Q15836,S1,-0.594652907,-1.030424371,-0.08650615,0.600965479,0.953263811,gold,VAMP3,VAMP3_HUMAN,Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3),VAMP3 SYB3,9341;,ENST00000054666.11; ENSP00000054666.6; ENSG00000049245.13.;,SNAP receptor activity [GO:0005484]; syntaxin-1 binding [GO:0017075],"calcium-ion regulated exocytosis [GO:0017156]; cellular response to type II interferon [GO:0071346]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; membrane fusion [GO:0061025]; negative regulation of secretion by cell [GO:1903531]; positive regulation of receptor recycling [GO:0001921]; protein-containing complex assembly [GO:0065003]; retrograde transport, endosome to Golgi [GO:0042147]; SNARE complex assembly [GO:0035493]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle docking involved in exocytosis [GO:0006904]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]",cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule [GO:0030141]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]
O75379,S1,-0.765150015,-1.493777805,-0.349503666,0.810956623,1.001666823,gold,VAMP4,VAMP4_HUMAN,Vesicle-associated membrane protein 4 (VAMP-4),VAMP4,8674;,"ENST00000236192.12; ENSP00000236192.7; ENSG00000117533.15. [O75379-1];""ENST00000367740.2; ENSP00000356714.2; ENSG00000117533.15. [O75379-2]"";""ENST00000474047.5; ENSP00000435933.1; ENSG00000117533.15. [O75379-1]"";",0,endocytic recycling [GO:0032456]; Golgi ribbon formation [GO:0090161]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189],cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133]
P51809,S1,-0.829648449,-1.553579414,-0.317098572,0.619543479,1.27071131,gold,VAMP7,VAMP7_HUMAN,Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1) (Tetanus-insensitive VAMP) (Ti-VAMP),VAMP7 SYBL1,6845;,"ENST00000262640.11; ENSP00000262640.6; ENSG00000124333.16. [P51809-2];""ENST00000286448.12; ENSP00000286448.6; ENSG00000124333.16. [P51809-1]"";""ENST00000460621.6; ENSP00000427822.1; ENSG00000124333.16. [P51809-3]"";""ENST00000711260.1; ENSP00000518622.1; ENSG00000292366.1. [P51809-1]"";""ENST00000711264.1; ENSP00000518620.1; ENSG00000292366.1. [P51809-2]"";""ENST00000711265.1; ENSP00000518619.1; ENSG00000292366.1. [P51809-3]"";",SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],"calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]",azurophil granule membrane [GO:0035577]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]
Q8TAA9,S4,-0.970333682,-1.137364118,0.452489274,0.696302488,0.403223667,tomato2,VANGL1,VANG1_HUMAN,Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1),VANGL1 STB2,81839;,"ENST00000310260.7; ENSP00000310800.3; ENSG00000173218.15. [Q8TAA9-1];""ENST00000355485.7; ENSP00000347672.2; ENSG00000173218.15. [Q8TAA9-1]"";""ENST00000369509.1; ENSP00000358522.1; ENSG00000173218.15. [Q8TAA9-1]"";""ENST00000369510.8; ENSP00000358523.3; ENSG00000173218.15. [Q8TAA9-2]"";",0,"pigmentation [GO:0043473]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]
Q9P0L0,S2,-1.406324432,-1.528038055,0.198380638,0.934350117,0.582689767,orange,VAPA,VAPA_HUMAN,Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33),VAPA VAP33,9218;,"ENST00000340541.4; ENSP00000345656.4; ENSG00000101558.14. [Q9P0L0-2];""ENST00000400000.7; ENSP00000382880.3; ENSG00000101558.14. [Q9P0L0-1]"";",cadherin binding [GO:0045296]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],ceramide transport [GO:0035627]; cholesterol transport [GO:0030301]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; membrane fusion [GO:0061025]; negative regulation by host of viral genome replication [GO:0044828]; neuron projection development [GO:0031175]; phospholipid transport [GO:0015914]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein localization to endoplasmic reticulum [GO:0070972]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918]; viral release from host cell [GO:0019076],azurophil granule membrane [GO:0035577]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; vesicle [GO:0031982]
O95292,S2,-1.161019631,-1.335731562,0.166344103,0.941735499,0.551612836,orange,VAPB,VAPB_HUMAN,Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C),VAPB UNQ484/PRO983,9217;,"ENST00000395802.7; ENSP00000379147.3; ENSG00000124164.16. [O95292-2];""ENST00000475243.6; ENSP00000417175.1; ENSG00000124164.16. [O95292-1]"";",beta-tubulin binding [GO:0048487]; cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; FFAT motif binding [GO:0033149]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],cholesterol transport [GO:0030301]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; intracellular calcium ion homeostasis [GO:0006874]; IRE1-mediated unfolded protein response [GO:0036498]; modulation by host of viral RNA genome replication [GO:0044830]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation by virus of viral protein levels in host cell [GO:0046725]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of viral genome replication [GO:0045070]; suppression of viral release by host [GO:0044790]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]
P26640,C2,1.141178086,0.466199829,-0.500857801,-0.408837882,-0.259640659,aquamarine,VARS,SYVC_HUMAN,Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS),VARS1 G7A VARS VARS2,7407;,"ENST00000211402.10; ENSP00000211402.6; ENSG00000096171.14. [P26640-1];""ENST00000375663.8; ENSP00000364815.3; ENSG00000204394.13. [P26640-1]"";""ENST00000422694.6; ENSP00000401121.2; ENSG00000224264.9."";""ENST00000435657.6; ENSP00000415316.2; ENSG00000231116.9."";""ENST00000457796.6; ENSP00000403359.2; ENSG00000226589.9. [P26640-1]"";",aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832],tRNA aminoacylation for protein translation [GO:0006418]; valyl-tRNA aminoacylation [GO:0006438],cytosol [GO:0005829]
P50552,C3,1.627010728,0.502526108,-0.442737069,-0.453362625,-0.881656467,cyan,VASP,VASP_HUMAN,Vasodilator-stimulated phosphoprotein (VASP),VASP,7408;,ENST00000245932.11; ENSP00000245932.5; ENSG00000125753.15.;,actin binding [GO:0003779]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124],actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]
P61758,C5,1.658852912,0.735238418,-0.78265126,-0.962525891,-1.085066095,turquoise3,VBP1,PFD3_HUMAN,Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1),VBP1 PFDN3,7411;,"ENST00000286428.7; ENSP00000286428.5; ENSG00000155959.12. [P61758-1];""ENST00000535916.5; ENSP00000438694.1; ENSG00000155959.12. [P61758-2]"";""ENST00000625964.2; ENSP00000486053.1; ENSG00000155959.12. [P61758-2]"";",amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082],chaperone-mediated protein folding [GO:0061077]; microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]
P18206,C4,1.966616813,0.088124102,-0.810502265,-0.729727914,-0.977624221,deepskyblue2,VCL,VINC_HUMAN,Vinculin (Metavinculin) (MV),VCL,7414;,"ENST00000211998.10; ENSP00000211998.5; ENSG00000035403.18. [P18206-1];""ENST00000372755.7; ENSP00000361841.3; ENSG00000035403.18. [P18206-2]"";",actin binding [GO:0003779]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; dystroglycan binding [GO:0002162]; molecular adaptor activity [GO:0060090]; structural molecule activity [GO:0005198]; ubiquitin protein ligase binding [GO:0031625],adherens junction assembly [GO:0034333]; apical junction assembly [GO:0043297]; axon extension [GO:0048675]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; lamellipodium assembly [GO:0030032]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of an epithelium [GO:0002009]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; protein localization to cell surface [GO:0034394]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization to adherens junction [GO:1904702],adherens junction [GO:0005912]; brush border [GO:0005903]; cell projection [GO:0042995]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cell-substrate junction [GO:0030055]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; fascia adherens [GO:0005916]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; inner dense plaque of desmosome [GO:0090637]; membrane raft [GO:0045121]; outer dense plaque of desmosome [GO:0090636]; plasma membrane [GO:0005886]; podosome ring [GO:0061826]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; secretory granule lumen [GO:0034774]; specific granule lumen [GO:0035580]; terminal web [GO:1990357]; zonula adherens [GO:0005915]
P55072,C2,0.347001581,0.855137289,-0.421561587,-0.32559877,0.069351482,aquamarine,VCP,TERA_HUMAN,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP),VCP HEL-220 HEL-S-70,7415;,ENST00000358901.11; ENSP00000351777.6; ENSG00000165280.18.;,ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-modified protein reader activity [GO:0140036]; ubiquitin-specific protease binding [GO:1990381],"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; flavin adenine dinucleotide catabolic process [GO:0072389]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral genome replication [GO:0019079]",ATPase complex [GO:1904949]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730]
Q96JH7,C5,1.394311083,0.548107015,-0.434957688,-0.426061235,-0.656319867,turquoise3,VCPIP1,VCIP1_HUMAN,Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein),VCPIP1 KIAA1850 VCIP135,80124;,ENST00000310421.5; ENSP00000309031.4; ENSG00000175073.8.;,cysteine-type deubiquitinase activity [GO:0004843],DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634],cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; Golgi stack [GO:0005795]; nucleus [GO:0005634]
P21796,M2,-1.284221181,-1.541580167,0.319916125,1.195574118,-0.299826347,tan4,VDAC1,VDAC1_HUMAN,Non-selective voltage-gated ion channel VDAC1 (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM) (Voltage-dependent anion-selective channel protein 1) (VDAC-1) (hVDAC1),VDAC1 VDAC,7416;,"ENST00000265333.8; ENSP00000265333.3; ENSG00000213585.11.;""ENST00000395044.7; ENSP00000378484.3; ENSG00000213585.11."";""ENST00000395047.6; ENSP00000378487.2; ENSG00000213585.11."";",ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; oxysterol binding [GO:0008142]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic anion channel activity [GO:0008308],apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; calcium import into the mitochondrion [GO:0036444]; epithelial cell differentiation [GO:0030855]; learning [GO:0007612]; monoatomic anion transport [GO:0006820]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcium import into the mitochondrion [GO:0110099]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron-neuron synaptic transmission [GO:0007270]; positive regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905091]; pyruvate metabolic process [GO:0006090]; regulation of autophagy of mitochondrion [GO:1903146],extracellular exosome [GO:0070062]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; synapse [GO:0045202]
P45880,M2,-1.38808582,-1.814999156,0.36868071,1.228770266,-0.338427278,tan4,VDAC2,VDAC2_HUMAN,Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2),VDAC2,7417;,"ENST00000313132.8; ENSP00000361635.1; ENSG00000165637.14. [P45880-1];""ENST00000332211.11; ENSP00000361686.3; ENSG00000165637.14. [P45880-3]"";""ENST00000543351.5; ENSP00000443092.1; ENSG00000165637.14. [P45880-3]"";",ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; nucleotide binding [GO:0000166]; oxysterol binding [GO:0008142]; phosphatidylcholine binding [GO:0031210]; porin activity [GO:0015288]; voltage-gated monoatomic anion channel activity [GO:0008308],binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; monoatomic anion transport [GO:0006820]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272],acrosomal vesicle [GO:0001669]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; sperm midpiece [GO:0097225]
Q9Y277,M2,-1.405967386,-1.600043367,0.413612837,1.178196364,-0.249802333,tan4,VDAC3,VDAC3_HUMAN,Voltage-dependent anion-selective channel protein 3 (VDAC-3) (hVDAC3) (Outer mitochondrial membrane protein porin 3),VDAC3,7419;,"ENST00000022615.9; ENSP00000022615.4; ENSG00000078668.14. [Q9Y277-1];""ENST00000521158.5; ENSP00000428845.1; ENSG00000078668.14. [Q9Y277-2]"";",nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated monoatomic anion channel activity [GO:0008308],adenine transport [GO:0015853]; behavioral fear response [GO:0001662]; learning [GO:0007612]; neuron-neuron synaptic transmission [GO:0007270]; sperm mitochondrial sheath assembly [GO:0120317]; spermatogenesis [GO:0007283],extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; synapse [GO:0045202]
Q9HBM0,S2,-1.331762119,-1.556462778,0.077458221,0.777598488,0.711420859,orange,VEZT,VEZA_HUMAN,Vezatin,VEZT,55591;,"ENST00000436874.6; ENSP00000410083.1; ENSG00000028203.19. [Q9HBM0-1];""ENST00000546557.5; ENSP00000447080.1; ENSG00000028203.19. [Q9HBM0-6]"";""ENST00000547484.5; ENSP00000447010.1; ENSG00000028203.19. [Q9HBM0-6]"";""ENST00000547997.5; ENSP00000449346.1; ENSG00000028203.19. [Q9HBM0-6]"";""ENST00000548455.5; ENSP00000447044.1; ENSG00000028203.19. [Q9HBM0-6]"";""ENST00000549624.5; ENSP00000448555.1; ENSG00000028203.19. [Q9HBM0-6]"";""ENST00000550803.5; ENSP00000449056.1; ENSG00000028203.19. [Q9HBM0-6]"";""ENST00000552660.5; ENSP00000447786.1; ENSG00000028203.19. [Q9HBM0-6]"";",myosin binding [GO:0017022],cell-cell adhesion [GO:0098609],acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171]
Q9BQE4,S2,-1.472327402,-1.690891389,0.080891948,0.920119449,0.771576798,orange,VIMP,SELS_HUMAN,Selenoprotein S (SelS) (VCP-interacting membrane protein),SELENOS SELS VIMP AD-015 SBBI8,55829;,"ENST00000398226.7; ENSP00000381282.3; ENSG00000131871.15.;""ENST00000526049.6; ENSP00000433541.1; ENSG00000131871.15."";",antioxidant activity [GO:0016209]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; signaling receptor activity [GO:0038023]; ubiquitin-specific protease binding [GO:1990381],"cell redox homeostasis [GO:0045454]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of glucose import [GO:0046325]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of tumor necrosis factor production [GO:0032720]; regulation of gluconeogenesis [GO:0006111]; regulation of nitric oxide metabolic process [GO:0080164]; response to glucose [GO:0009749]; response to redox state [GO:0051775]; retrograde protein transport, ER to cytosol [GO:0030970]",cytoplasmic microtubule [GO:0005881]; Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; low-density lipoprotein particle [GO:0034362]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]
Q9H9C1,C3,1.492048271,0.041486247,-0.485729868,-0.412135001,-0.591998164,cyan,VIPAS39,SPE39_HUMAN,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),VIPAS39 C14orf133 SPE39 VIPAR,63894;,"ENST00000327028.8; ENSP00000313098.5; ENSG00000151445.16. [Q9H9C1-2];""ENST00000343765.6; ENSP00000339122.2; ENSG00000151445.16. [Q9H9C1-1]"";""ENST00000448935.6; ENSP00000404815.2; ENSG00000151445.16. [Q9H9C1-2]"";""ENST00000553888.5; ENSP00000452181.1; ENSG00000151445.16. [Q9H9C1-1]"";""ENST00000557658.6; ENSP00000452191.1; ENSG00000151445.16. [Q9H9C1-1]"";",protein-containing complex binding [GO:0044877],cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283]; vacuolar transport [GO:0007034],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023]
Q96GC9,S2,-1.227246252,-1.531265498,0.170989125,0.874346452,0.497510798,orange,VMP1,VMP1_HUMAN,Vacuole membrane protein 1 (Transmembrane protein 49),VMP1 TDC1 TMEM49 HSPC292,81671;,"ENST00000262291.9; ENSP00000262291.3; ENSG00000062716.13. [Q96GC9-1];""ENST00000587259.6; ENSP00000465397.2; ENSG00000062716.13. [Q96GC9-1]"";""ENST00000591315.6; ENSP00000466511.2; ENSG00000062716.13. [Q96GC9-1]"";",phospholipid scramblase activity [GO:0017128],autophagosome assembly [GO:0000045]; autophagosome membrane docking [GO:0016240]; autophagy [GO:0006914]; cell junction assembly [GO:0034329]; cell-cell adhesion [GO:0098609]; embryo implantation [GO:0007566]; Golgi organization [GO:0007030]; lipoprotein transport [GO:0042953]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; organelle localization by membrane tethering [GO:0140056]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896],autophagosome membrane [GO:0000421]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; membrane [GO:0016020]; nucleolus [GO:0005730]; phagophore assembly site [GO:0000407]; plasma membrane [GO:0005886]
Q9Y4B6,N4,-0.949147056,0.942259285,-0.143701757,-0.370516625,0.194168058,grey30,VPRBP,DCAF1_HUMAN,DDB1- and CUL4-associated factor 1 (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein),DCAF1 KIAA0800 RIP VPRBP,9730;,"ENST00000423656.5; ENSP00000393183.2; ENSG00000145041.17. [Q9Y4B6-1];""ENST00000504652.5; ENSP00000421724.2; ENSG00000145041.17. [Q9Y4B6-2]"";""ENST00000684031.1; ENSP00000506880.1; ENSG00000145041.17. [Q9Y4B6-1]"";",ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q96RL7,S3,-0.727287341,-0.926216604,0.2022441,0.87299455,0.435973111,salmon,VPS13A,VP13A_HUMAN,Intermembrane lipid transfer protein VPS13A (Chorea-acanthocytosis protein) (Chorein) (Vacuolar protein sorting-associated protein 13A),VPS13A CHAC KIAA0986,23230;,"ENST00000360280.8; ENSP00000353422.3; ENSG00000197969.14. [Q96RL7-1];""ENST00000376636.7; ENSP00000365823.3; ENSG00000197969.14. [Q96RL7-3]"";""ENST00000643348.1; ENSP00000493592.1; ENSG00000197969.14. [Q96RL7-2]"";""ENST00000645632.1; ENSP00000496361.1; ENSG00000197969.14. [Q96RL7-4]"";",0,autophagy [GO:0006914]; flagellated sperm motility [GO:0030317]; Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; lysosomal protein catabolic process [GO:1905146]; nervous system development [GO:0007399]; protein localization [GO:0008104]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176]; sperm mitochondrion organization [GO:0030382],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; neuronal dense core vesicle lumen [GO:0099013]; sperm midpiece [GO:0097225]
Q709C8,C2,1.039650905,-0.472359736,-0.286509938,0.31991296,0.184292466,aquamarine,VPS13C,VP13C_HUMAN,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),VPS13C KIAA1421,54832;,"ENST00000249837.7; ENSP00000249837.3; ENSG00000129003.19. [Q709C8-3];""ENST00000395898.3; ENSP00000379235.3; ENSG00000129003.19. [Q709C8-4]"";""ENST00000644861.2; ENSP00000493560.2; ENSG00000129003.19. [Q709C8-1]"";""ENST00000645819.1; ENSP00000496179.1; ENSG00000129003.19. [Q709C8-2]"";",0,Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]
Q9BRG1,C3,1.77933208,0.328421389,-0.50030411,-0.36542648,-0.781046358,cyan,VPS25,VPS25_HUMAN,Vacuolar protein-sorting-associated protein 25 (hVps25) (Dermal papilla-derived protein 9) (ELL-associated protein of 20 kDa) (ESCRT-II complex subunit VPS25),VPS25 DERP9 EAP20,84313;,ENST00000253794.7; ENSP00000253794.1; ENSG00000131475.7.;,protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198],macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT II complex [GO:0000814]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O75436,C2,1.232503492,0.688075823,-0.683708929,-0.554285805,-0.392380755,aquamarine,VPS26A,VP26A_HUMAN,Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) (hVPS26),VPS26A VPS26,9559;,"ENST00000263559.11; ENSP00000263559.6; ENSG00000122958.15. [O75436-1];""ENST00000373382.5; ENSP00000362480.1; ENSG00000122958.15. [O75436-1]"";""ENST00000395098.5; ENSP00000378532.1; ENSG00000122958.15. [O75436-2]"";",0,"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; regulation of macroautophagy [GO:0016241]; retrograde transport, endosome to Golgi [GO:0042147]","cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosome [GO:0005764]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; vesicle [GO:0031982]"
Q9H267,C3,1.691758354,0.357414105,-0.669144273,-0.609293549,-0.728374043,cyan,VPS33B,VP33B_HUMAN,Vacuolar protein sorting-associated protein 33B (hVPS33B),VPS33B,26276;,ENST00000333371.8; ENSP00000327650.4; ENSG00000184056.15. [Q9H267-1];,protein-containing complex binding [GO:0044877],collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907]; lysosome localization [GO:0032418]; megakaryocyte development [GO:0035855]; melanosome localization [GO:0032400]; membrane fusion [GO:0061025]; peptidyl-lysine hydroxylation [GO:0017185]; phagosome-lysosome fusion [GO:0090385]; platelet alpha granule organization [GO:0070889]; protein transport [GO:0015031]; regulation of platelet aggregation [GO:0090330]; skin morphogenesis [GO:0043589]; vesicle-mediated transport [GO:0016192],clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; platelet alpha granule [GO:0031091]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023]
Q96QK1,C2,1.216653208,0.76433187,-0.536285772,-0.644878179,-0.357740863,aquamarine,VPS35,VPS35_HUMAN,Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35),VPS35 MEM3 TCCCTA00141,55737;,ENST00000299138.12; ENSP00000299138.7; ENSG00000069329.19.;,D1 dopamine receptor binding [GO:0031748],"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; regulation of dendritic spine maintenance [GO:1902950]; regulation of macroautophagy [GO:0016241]; regulation of mitochondrion organization [GO:0010821]; regulation of postsynapse assembly [GO:0150052]; regulation of presynapse assembly [GO:1905606]; regulation of protein metabolic process [GO:0051246]; regulation of protein stability [GO:0031647]; regulation of synapse maturation [GO:0090128]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]; Wnt signaling pathway [GO:0016055]","cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]"
Q9H9H4,C4,1.95201733,-0.126292231,-0.956138983,-0.791849971,-1.027304414,deepskyblue2,VPS37B,VP37B_HUMAN,Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B),VPS37B,79720;,ENST00000267202.7; ENSP00000267202.2; ENSG00000139722.7.;,calcium-dependent protein binding [GO:0048306],macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]
Q9UN37,C1,1.685214063,0.097423809,-0.397510627,-0.257795058,-0.314578771,lightblue,VPS4A,VPS4A_HUMAN,Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4),VPS4A VPS4,27183;,ENST00000254950.13; ENSP00000254950.11; ENSG00000132612.16.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; protein-containing complex binding [GO:0044877],abscission [GO:0009838]; actomyosin contractile ring contraction [GO:0000916]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; ESCRT complex disassembly [GO:1904896]; ESCRT III complex disassembly [GO:1904903]; intracellular cholesterol transport [GO:0032367]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic nuclear membrane reassembly [GO:0007084]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of cytokinesis [GO:0032466]; nuclear envelope organization [GO:0006998]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to lysosome [GO:0006622]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; vesicle budding from membrane [GO:0006900]; vesicle uncoating [GO:0072319]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; vacuolar membrane [GO:0005774]
O75351,C4,1.864996255,-0.014240308,-0.649137803,-0.763650058,-0.912365533,deepskyblue2,VPS4B,VPS4B_HUMAN,Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1),VPS4B SKD1 VPS42 MIG1,9525;,ENST00000238497.10; ENSP00000238497.4; ENSG00000119541.10.;,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],angiogenesis [GO:0001525]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; canonical Wnt signaling pathway [GO:0060070]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; establishment of blood-brain barrier [GO:0060856]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]
Q8N1B4,C2,1.046733409,0.320943185,-0.302224967,0.058828157,-0.284097827,aquamarine,VPS52,VPS52_HUMAN,Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein),VPS52 SACM2L,6293;,"ENST00000383210.4; ENSP00000372697.4; ENSG00000206286.11. [Q8N1B4-1];""ENST00000428608.2; ENSP00000406988.2; ENSG00000236014.10. [Q8N1B4-1]"";""ENST00000441058.2; ENSP00000390831.2; ENSG00000228425.9. [Q8N1B4-1]"";""ENST00000443860.2; ENSP00000404016.2; ENSG00000224455.9. [Q8N1B4-1]"";""ENST00000445902.3; ENSP00000409952.2; ENSG00000223501.9. [Q8N1B4-1]"";""ENST00000448042.2; ENSP00000391197.2; ENSG00000225590.9. [Q8N1B4-1]"";",syntaxin binding [GO:0019905],"ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein targeting [GO:0006605]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle-mediated cholesterol transport [GO:0090119]",cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]
Q8N0Z9,S1,-1.174751663,-1.179168783,0.005811828,0.686938018,1.058403381,gold,VSIG10,VSI10_HUMAN,V-set and immunoglobulin domain-containing protein 10,VSIG10,54621;,ENST00000359236.10; ENSP00000352172.5; ENSG00000176834.14. [Q8N0Z9-1];,cell adhesion molecule binding [GO:0050839],cell-cell adhesion [GO:0098609],cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]
Q9NP79,C3,1.71157023,0.279286079,-0.515767545,-0.43436413,-0.694806068,cyan,VTA1,VTA1_HUMAN,Vacuolar protein sorting-associated protein VTA1 homolog (Dopamine-responsive gene 1 protein) (DRG-1) (LYST-interacting protein 5) (LIP5) (SKD1-binding protein 1) (SBP1),VTA1 C6orf55 HSPC228 My012,51534;,"ENST00000367630.9; ENSP00000356602.3; ENSG00000009844.16. [Q9NP79-1];""ENST00000452973.6; ENSP00000395767.2; ENSG00000009844.16. [Q9NP79-2]"";",0,ESCRT III complex disassembly [GO:1904903]; late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; protein transport [GO:0015031],cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]
Q96AJ9,S1,-0.578198044,-0.883718429,-0.198437628,0.548550708,0.992658285,gold,VTI1A,VTI1A_HUMAN,Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2),VTI1A,143187;,"ENST00000393077.3; ENSP00000376792.2; ENSG00000151532.15. [Q96AJ9-2];""ENST00000432306.5; ENSP00000395017.1; ENSG00000151532.15. [Q96AJ9-1]"";",SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],"autophagy [GO:0006914]; endocytic recycling [GO:0032456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle to endosome fusion [GO:0016189]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882]",autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]
A3KMH1,M1,-0.902923999,-0.472425431,0.380249114,0.860109051,-0.087818034,burlywood4,VWA8,VWA8_HUMAN,von Willebrand factor A domain-containing protein 8 (PEX7-binding protein 2) (P7BP2),VWA8 KIAA0564,23078;,"ENST00000281496.6; ENSP00000281496.6; ENSG00000102763.18. [A3KMH1-2];""ENST00000379310.8; ENSP00000368612.3; ENSG00000102763.18. [A3KMH1-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],0,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]
Q9BTA9,N4,-1.021686392,1.124011565,-0.040265561,-0.081492082,-0.416445756,grey30,WAC,WAC_HUMAN,WW domain-containing adapter protein with coiled-coil,WAC KIAA1844,51322;,"ENST00000347934.8; ENSP00000311106.4; ENSG00000095787.26. [Q9BTA9-5];""ENST00000354911.9; ENSP00000346986.4; ENSG00000095787.26. [Q9BTA9-1]"";""ENST00000375664.8; ENSP00000364816.3; ENSG00000095787.26. [Q9BTA9-2]"";""ENST00000439676.5; ENSP00000415727.1; ENSG00000095787.26. [Q9BTA9-3]"";""ENST00000442148.6; ENSP00000400848.2; ENSG00000095787.26. [Q9BTA9-2]"";""ENST00000679398.1; ENSP00000506624.1; ENSG00000095787.26. [Q9BTA9-2]"";""ENST00000679428.1; ENSP00000506445.1; ENSG00000095787.26. [Q9BTA9-2]"";",chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993],chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]
Q7Z5K2,N4,-0.996031367,0.981765305,0.04686783,-0.091285052,-0.207651403,grey30,WAPAL,WAPL_HUMAN,Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor),WAPL FOE KIAA0261 WAPAL,23063;,ENST00000298767.10; ENSP00000298767.4; ENSG00000062650.20. [Q7Z5K2-1];,ATP-dependent protein-DNA unloader activity [GO:0140083],cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]"
P23381,C4,2.126914866,0.188963179,-1.051149429,-1.159203141,-1.240713445,deepskyblue2,WARS,SYWC_HUMAN,"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]",WARS1 IFI53 WARS WRS,7453;,"ENST00000344102.9; ENSP00000339485.5; ENSG00000140105.18. [P23381-2];""ENST00000355338.6; ENSP00000347495.2; ENSG00000140105.18. [P23381-1]"";""ENST00000358655.8; ENSP00000351481.4; ENSG00000140105.18. [P23381-2]"";""ENST00000392882.7; ENSP00000376620.2; ENSG00000140105.18. [P23381-1]"";""ENST00000556645.5; ENSP00000451887.1; ENSG00000140105.18. [P23381-2]"";""ENST00000557135.5; ENSP00000451460.1; ENSG00000140105.18. [P23381-1]"";",ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830],angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; translation [GO:0006412]; tryptophanyl-tRNA aminoacylation [GO:0006436],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
Q9UGM6,M1,-1.177574088,-0.618523433,0.499191265,0.96146597,-0.696468342,burlywood4,WARS2,SYWM_HUMAN,"Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)",WARS2,10352;,"ENST00000235521.5; ENSP00000235521.4; ENSG00000116874.12. [Q9UGM6-1];""ENST00000369426.9; ENSP00000358434.5; ENSG00000116874.12. [Q9UGM6-2]"";",ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830],mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; positive regulation of angiogenesis [GO:0045766]; tRNA aminoacylation for protein translation [GO:0006418]; vasculogenesis [GO:0001570],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
Q9Y2W2,N4,-0.567598248,0.661697037,0.464270238,-0.392263431,-0.144249902,grey30,WBP11,WBP11_HUMAN,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),WBP11 NPWBP SIPP1 SNP70,51729;,ENST00000261167.7; ENSP00000261167.2; ENSG00000084463.8.;,RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699],mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8IWB7,S1,-0.607175235,-0.722239558,-0.330549651,0.445944565,1.130756172,gold,WDFY1,WDFY1_HUMAN,WD repeat and FYVE domain-containing protein 1 (FYVE domain-containing protein localized to endosomes 1) (FENS-1) (Phosphoinositide-binding protein 1) (WD40- and FYVE domain-containing protein 1) (Zinc finger FYVE domain-containing protein 17),WDFY1 FENS1 KIAA1435 WDF1 ZFYVE17,57590;,ENST00000233055.9; ENSP00000233055.4; ENSG00000085449.15.;,1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145],cell junction [GO:0030054]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]
O75083,C5,2.027272594,0.40151953,-0.816050582,-0.768069839,-1.013540521,turquoise3,WDR1,WDR1_HUMAN,WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1),WDR1,9948;,"ENST00000499869.7; ENSP00000427687.1; ENSG00000071127.18. [O75083-1];""ENST00000502702.6; ENSP00000426725.1; ENSG00000071127.18. [O75083-3]"";""ENST00000699787.1; ENSP00000514593.1; ENSG00000071127.18. [O75083-1]"";""ENST00000699788.1; ENSP00000514594.1; ENSG00000071127.18. [O75083-3]"";""ENST00000699790.1; ENSP00000514595.1; ENSG00000071127.18. [O75083-3]"";",actin filament binding [GO:0051015],actin filament depolymerization [GO:0030042]; actin filament fragmentation [GO:0030043]; apical junction assembly [GO:0043297]; cortical cytoskeleton organization [GO:0030865]; establishment of planar polarity of follicular epithelium [GO:0042247]; locomotion [GO:0040011]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; platelet formation [GO:0030220]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of cell shape [GO:0008360]; regulation of oligodendrocyte differentiation [GO:0048713]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; sarcomere organization [GO:0045214]; sensory perception of sound [GO:0007605],cell junction [GO:0030054]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; podosome [GO:0002102]
Q9BV38,N3,-0.94124698,-1.065583176,1.028630617,-0.316289579,0.636325925,grey50,WDR18,WDR18_HUMAN,WD repeat-containing protein 18,WDR18,57418;,ENST00000585809.6; ENSP00000476117.3; ENSG00000065268.11.;,0,DNA-templated DNA replication [GO:0006261]; rRNA processing [GO:0006364],dynein axonemal particle [GO:0120293]; nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rixosome complex [GO:0120330]
Q9UNX4,N3,-0.963198031,-0.957599739,1.222015062,-0.076560759,0.027210712,grey50,WDR3,WDR3_HUMAN,WD repeat-containing protein 3,WDR3,10885;,ENST00000349139.6; ENSP00000308179.4; ENSG00000065183.16.;,RNA binding [GO:0003723]; snoRNA binding [GO:0030515],maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274],nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]
Q9C0J8,N2,-1.116130405,-0.484521523,0.987221045,-0.153074171,0.301913401,grey70,WDR33,WDR33_HUMAN,pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa),WDR33 WDC146,55339;,"ENST00000322313.9; ENSP00000325377.3; ENSG00000136709.12. [Q9C0J8-1];""ENST00000393006.5; ENSP00000376730.1; ENSG00000136709.12. [Q9C0J8-3]"";""ENST00000409658.7; ENSP00000387186.3; ENSG00000136709.12. [Q9C0J8-2]"";",RNA binding [GO:0003723],mRNA 3'-end processing [GO:0031124]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283],collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8NI36,N3,-0.903852743,-0.989634636,1.299603762,0.024251518,-0.041983374,grey50,WDR36,WDR36_HUMAN,WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP),WDR36,134430;,0,RNA binding [GO:0003723],ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; visual perception [GO:0007601],nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]
Q9Y2I8,C1,1.303445823,0.332686559,-0.393733045,-0.359548665,0.121658709,lightblue,WDR37,WDR37_HUMAN,WD repeat-containing protein 37,WDR37 KIAA0982,22884;,"ENST00000263150.9; ENSP00000263150.4; ENSG00000047056.18. [Q9Y2I8-1];""ENST00000358220.5; ENSP00000350954.1; ENSG00000047056.18. [Q9Y2I8-1]"";",0,corpus callosum development [GO:0022038]; lymphocyte homeostasis [GO:0002260],cytoplasm [GO:0005737]; nucleus [GO:0005634]
Q15061,N3,-0.858435864,-0.962146891,1.348576401,0.028674843,-0.326393404,grey50,WDR43,WDR43_HUMAN,WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog),WDR43 KIAA0007 UTP5,23160;,ENST00000407426.8; ENSP00000384302.3; ENSG00000163811.12.;,RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation factor activity [GO:0003711],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; ribosomal small subunit biogenesis [GO:0042274]",chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q5JSH3,C5,1.792922925,0.607032524,-0.765636983,-0.743803441,-0.973413684,turquoise3,WDR44,WDR44_HUMAN,WD repeat-containing protein 44 (Rab11-binding protein) (Rab11BP) (Rabphilin-11),WDR44 RPH11,54521;,"ENST00000254029.8; ENSP00000254029.3; ENSG00000131725.14. [Q5JSH3-1];""ENST00000371822.9; ENSP00000360887.5; ENSG00000131725.14. [Q5JSH3-4]"";""ENST00000371825.7; ENSP00000360890.3; ENSG00000131725.14. [Q5JSH3-2]"";",molecular sequestering activity [GO:0140313]; small GTPase binding [GO:0031267],cytosolic ciliogenesis [GO:0061824]; negative regulation of cilium assembly [GO:1902018]; regulation of vesicle-mediated transport [GO:0060627],cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]
Q9Y484,C3,1.906827847,0.09751957,-0.90947955,-0.297461352,-0.498460185,cyan,WDR45,WIPI4_HUMAN,WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45),WDR45 WDRX1 WDRXI4 WIPI4 JM5,11152;,"ENST00000322995.13; ENSP00000365543.5; ENSG00000196998.19. [Q9Y484-2];""ENST00000356463.7; ENSP00000348848.3; ENSG00000196998.19. [Q9Y484-3]"";""ENST00000376368.7; ENSP00000365546.2; ENSG00000196998.19. [Q9Y484-3]"";""ENST00000376372.9; ENSP00000365551.3; ENSG00000196998.19. [Q9Y484-1]"";""ENST00000634944.1; ENSP00000488972.1; ENSG00000196998.19. [Q9Y484-1]"";""ENST00000710219.1; ENSP00000518130.1; ENSG00000292221.1. [Q9Y484-1]"";""ENST00000710220.1; ENSP00000518131.1; ENSG00000292221.1. [Q9Y484-1]"";""ENST00000710225.1; ENSP00000518136.1; ENSG00000292221.1. [Q9Y484-2]"";""ENST00000710226.1; ENSP00000518137.1; ENSG00000292221.1. [Q9Y484-3]"";""ENST00000710231.1; ENSP00000518141.1; ENSG00000292221.1. [Q9Y484-3]"";","phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]",autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; positive regulation of autophagosome assembly [GO:2000786]; protein localization to phagophore assembly site [GO:0034497],cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]
O15213,N3,-1.132400185,-1.259251366,1.365665572,0.01844495,-0.256680158,grey50,WDR46,WDR46_HUMAN,WD repeat-containing protein 46 (WD repeat-containing protein BING4),WDR46 BING4 C6orf11 FP221,9277;,"ENST00000374617.9; ENSP00000363746.4; ENSG00000227057.10.;""ENST00000383208.8; ENSP00000372695.4; ENSG00000206284.8."";""ENST00000432609.6; ENSP00000402869.2; ENSG00000236222.8."";""ENST00000432933.6; ENSP00000399454.2; ENSG00000204221.11."";""ENST00000457382.6; ENSP00000405614.2; ENSG00000226916.8."";",RNA binding [GO:0003723],"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]",nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q7Z5U6,C5,1.385745448,0.765975886,-0.355302118,-0.755541693,-0.534273603,turquoise3,WDR53,WDR53_HUMAN,WD repeat-containing protein 53,WDR53,348793;,ENST00000332629.7; ENSP00000328079.5; ENSG00000185798.8.;,0,0,0
Q9NNW5,C1,0.969735908,-0.071767632,-0.256732298,-0.339134098,0.566944753,lightblue,WDR6,WDR6_HUMAN,tRNA (34-2'-O)-methyltransferase regulator WDR6 (WD repeat-containing protein 6),WDR6,11180;,ENST00000608424.6; ENSP00000477389.1; ENSG00000178252.19.;,enzyme regulator activity [GO:0030234]; RNA binding [GO:0003723]; tRNA binding [GO:0000049],G1 to G0 transition [GO:0070314]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; tRNA methylation [GO:0030488]; wobble position ribose methylation [GO:0002130],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]
Q9GZS3,C2,1.079226146,0.793175255,-0.040089976,-0.836479157,-0.439808732,aquamarine,WDR61,SKI8_HUMAN,"Superkiller complex protein 8 (Ski8) (Meiotic recombination REC14 protein homolog) (WD repeat-containing protein 61) [Cleaved into: Superkiller complex protein 8, N-terminally processed (WD repeat-containing protein 61, N-terminally processed)]",SKIC8 WDR61,80349;,"ENST00000267973.7; ENSP00000267973.2; ENSG00000140395.9.;""ENST00000558311.5; ENSP00000453801.1; ENSG00000140395.9."";",0,"negative regulation of myeloid cell differentiation [GO:0045638]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; rescue of stalled ribosome [GO:0072344]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055]",Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087]
Q9Y4E6,C2,1.026927777,0.076828402,-0.278342981,-0.130743648,0.057782956,aquamarine,WDR7,WDR7_HUMAN,WD repeat-containing protein 7 (Rabconnectin-3 beta) (TGF-beta resistance-associated protein TRAG),WDR7 KIAA0541 TRAG,23335;,"ENST00000254442.8; ENSP00000254442.3; ENSG00000091157.15. [Q9Y4E6-1];""ENST00000357574.7; ENSP00000350187.2; ENSG00000091157.15. [Q9Y4E6-2]"";",0,hematopoietic progenitor cell differentiation [GO:0002244],cytoplasm [GO:0005737]
Q8IWA0,N3,-0.881777663,-1.17202042,1.317841099,0.038671901,-0.293850154,grey50,WDR75,WDR75_HUMAN,WD repeat-containing protein 75 (U3 small nucleolar RNA-associated protein 17 homolog),WDR75 UTP17,84128;,ENST00000314761.9; ENSP00000314193.4; ENSG00000115368.10.;,RNA binding [GO:0003723],positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]
Q9H967,N1,-1.241347914,-0.87271575,0.633839991,0.033983261,0.969069626,grey90,WDR76,WDR76_HUMAN,WD repeat-containing protein 76,WDR76,79968;,ENST00000263795.11; ENSP00000263795.6; ENSG00000092470.12.;,DNA binding [GO:0003677]; enzyme binding [GO:0019899],DNA damage response [GO:0006974]; regulation of DNA damage checkpoint [GO:2000001],heterochromatin [GO:0000792]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]
Q9BQA1,C2,1.206068522,0.583834221,-0.543688666,-0.500084649,-0.180439311,aquamarine,WDR77,MEP50_HUMAN,Methylosome protein WDR77 (Androgen receptor cofactor p44) (Methylosome protein 50) (MEP-50) (WD repeat-containing protein 77) (p44/Mep50),WDR77 MEP50 WD45 HKMT1069 Nbla10071,79084;,ENST00000235090.10; ENSP00000235090.5; ENSG00000116455.14. [Q9BQA1-1];,methyl-CpG binding [GO:0008327]; nuclear receptor coactivator activity [GO:0030374]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],"epithelial cell proliferation involved in prostate gland development [GO:0060767]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; oocyte axis specification [GO:0007309]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; spliceosomal snRNP assembly [GO:0000387]; ubiquitin-dependent protein catabolic process [GO:0006511]",Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q562E7,C1,1.072239004,-0.205842859,-0.371691349,0.135375011,0.28161285,lightblue,WDR81,WDR81_HUMAN,WD repeat-containing protein 81,WDR81,124997;,"ENST00000309182.9; ENSP00000312074.5; ENSG00000167716.19. [Q562E7-3];""ENST00000409644.6; ENSP00000386609.1; ENSG00000167716.19. [Q562E7-1]"";""ENST00000419248.5; ENSP00000407845.1; ENSG00000167716.19. [Q562E7-6]"";""ENST00000437219.6; ENSP00000391074.2; ENSG00000167716.19. [Q562E7-5]"";""ENST00000611758.2; ENSP00000480442.1; ENSG00000276021.4. [Q562E7-3]"";""ENST00000613381.4; ENSP00000480101.1; ENSG00000276021.4. [Q562E7-6]"";""ENST00000613616.3; ENSP00000477991.1; ENSG00000276021.4. [Q562E7-5]"";",K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol 3-kinase regulator activity [GO:0035014],aggrephagy [GO:0035973]; early endosome to late endosome transport [GO:0045022]; mitochondrion organization [GO:0007005]; protein stabilization [GO:0050821]; ubiquitin-dependent protein catabolic process [GO:0006511],autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]
Q9BRX9,N4,-0.370643396,0.662928624,0.40169248,-0.175616726,0.190802844,grey30,WDR83,WDR83_HUMAN,WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1),WDR83 MORG1,84292;,ENST00000418543.8; ENSP00000402653.3; ENSG00000123154.12.;,0,"inflammatory response to wounding [GO:0090594]; mRNA splicing, via spliceosome [GO:0000398]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; RNA splicing, via transesterification reactions [GO:0000375]",catalytic step 2 spliceosome [GO:0071013]; endosome membrane [GO:0010008]; lysosome [GO:0005764]; spliceosomal complex [GO:0005681]
Q96MX6,C2,0.995702026,0.668074431,-0.599664061,-0.60132784,0.103544104,aquamarine,WDR92,DAA10_HUMAN,Dynein axonemal assembly factor 10 (WD repeat-containing protein 92) (WD repeat-containing protein Monad),DNAAF10 WDR92,116143;,"ENST00000295121.11; ENSP00000295121.6; ENSG00000243667.7. [Q96MX6-1];""ENST00000409164.1; ENSP00000386746.1; ENSG00000243667.7. [Q96MX6-2]"";",ubiquitin binding [GO:0043130],apoptotic process [GO:0006915]; axonemal dynein complex assembly [GO:0070286]; protein stabilization [GO:0050821],dynein axonemal particle [GO:0120293]; RPAP3/R2TP/prefoldin-like complex [GO:1990062]
Q8N9V3,C5,1.869955731,0.349031631,-0.981980236,-0.862966026,-1.221150022,turquoise3,WDSUB1,WSDU1_HUMAN,"WD repeat, SAM and U-box domain-containing protein 1",WDSUB1 WDSAM1,151525;,"ENST00000358147.8; ENSP00000350866.4; ENSG00000196151.11. [Q8N9V3-2];""ENST00000359774.9; ENSP00000352820.4; ENSG00000196151.11. [Q8N9V3-1]"";""ENST00000392796.7; ENSP00000376545.3; ENSG00000196151.11. [Q8N9V3-1]"";""ENST00000409990.7; ENSP00000387078.3; ENSG00000196151.11. [Q8N9V3-1]"";",ubiquitin-protein transferase activity [GO:0004842],protein ubiquitination [GO:0016567],0
Q8N5D0,C2,0.950083758,0.478286809,-0.288404791,-0.215889976,-0.080126934,aquamarine,WDTC1,WDTC1_HUMAN,WD and tetratricopeptide repeats protein 1,WDTC1 KIAA1037,23038;,"ENST00000319394.8; ENSP00000317971.3; ENSG00000142784.16. [Q8N5D0-1];""ENST00000361771.7; ENSP00000355317.3; ENSG00000142784.16. [Q8N5D0-4]"";""ENST00000447062.2; ENSP00000434578.1; ENSG00000142784.16. [Q8N5D0-2]"";",enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826],cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; intracellular chemical homeostasis [GO:0055082]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q96HA8,C5,1.755188083,0.592324057,-0.824085224,-0.919238836,-0.934846894,turquoise3,WDYHV1,NTAQ1_HUMAN,Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (WDYHV motif-containing protein 1),NTAQ1 C8orf32 WDYHV1,55093;,"ENST00000287387.7; ENSP00000287387.2; ENSG00000156795.8. [Q96HA8-1];""ENST00000523984.5; ENSP00000430427.1; ENSG00000156795.8. [Q96HA8-2]"";""ENST00000524254.5; ENSP00000497832.1; ENSG00000156795.8. [Q96HA8-2]"";",protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773],protein modification process [GO:0036211],cytosol [GO:0005829]; nucleus [GO:0005634]
O76024,S2,-1.04866778,-1.152828673,0.165651316,0.754627701,0.512497985,orange,WFS1,WFS1_HUMAN,Wolframin,WFS1,7466;,"ENST00000226760.5; ENSP00000226760.1; ENSG00000109501.15.;""ENST00000503569.5; ENSP00000423337.1; ENSG00000109501.15."";""ENST00000684087.1; ENSP00000506978.1; ENSG00000109501.15."";",ATPase binding [GO:0051117]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; DNA-binding transcription factor binding [GO:0140297]; proteasome binding [GO:0070628]; ubiquitin protein ligase binding [GO:0031625],calcium ion homeostasis [GO:0055074]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; glucose homeostasis [GO:0042593]; kidney development [GO:0001822]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATF6-mediated unfolded protein response [GO:1903892]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of programmed cell death [GO:0043069]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; nervous system process [GO:0050877]; olfactory behavior [GO:0042048]; pancreas development [GO:0031016]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of growth [GO:0045927]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein ubiquitination [GO:0031398]; protein maturation by protein folding [GO:0022417]; protein stabilization [GO:0050821]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; secretory granule [GO:0030141]; synaptic vesicle membrane [GO:0030672]
O96028,N3,-1.081710609,-1.010355356,0.79015616,-0.20153496,0.772160341,grey50,WHSC1,NSD2_HUMAN,Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein),NSD2 KIAA1090 MMSET TRX5 WHSC1,7468;,"ENST00000312087.10; ENSP00000308780.6; ENSG00000109685.19. [O96028-3];""ENST00000353275.9; ENSP00000329167.5; ENSG00000109685.19. [O96028-3]"";""ENST00000382888.3; ENSP00000372344.3; ENSG00000109685.19. [O96028-2]"";""ENST00000382891.9; ENSP00000372347.5; ENSG00000109685.19. [O96028-1]"";""ENST00000382892.6; ENSP00000372348.2; ENSG00000109685.19. [O96028-1]"";""ENST00000382895.7; ENSP00000372351.3; ENSG00000109685.19. [O96028-1]"";""ENST00000398261.6; ENSP00000381311.1; ENSG00000109685.19. [O96028-3]"";""ENST00000420906.6; ENSP00000399251.2; ENSG00000109685.19. [O96028-5]"";""ENST00000503128.5; ENSP00000425761.1; ENSG00000109685.19. [O96028-3]"";""ENST00000508803.6; ENSP00000423972.1; ENSG00000109685.19. [O96028-1]"";""ENST00000514045.5; ENSP00000421681.1; ENSG00000109685.19. [O96028-5]"";""ENST00000678714.1; ENSP00000504221.1; ENSG00000109685.19. [O96028-7]"";",chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565],atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9BZ95,N2,-0.899443175,-0.326381375,0.96960326,0.330579554,-0.100564488,grey70,WHSC1L1,NSD3_HUMAN,Histone-lysine N-methyltransferase NSD3 (EC 2.1.1.370) (EC 2.1.1.371) (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1) (WHSC1-like protein 1),NSD3 WHSC1L1 DC28,54904;,"ENST00000316985.7; ENSP00000313410.3; ENSG00000147548.17. [Q9BZ95-3];""ENST00000317025.13; ENSP00000313983.7; ENSG00000147548.17. [Q9BZ95-1]"";""ENST00000433384.6; ENSP00000393284.2; ENSG00000147548.17. [Q9BZ95-2]"";""ENST00000527502.5; ENSP00000434730.1; ENSG00000147548.17. [Q9BZ95-5]"";",histone H3 methyltransferase activity [GO:0140938]; histone H3K27 dimethyltransferase activity [GO:0140952]; histone H3K27 trimethyltransferase activity [GO:0140951]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 dimethyltransferase activity [GO:0140946]; metal ion binding [GO:0046872]; transcription regulator activator activity [GO:0140537],methylation [GO:0032259]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y4P8,C3,1.75161516,0.115826249,-0.564358752,-0.322889259,-0.70927067,cyan,WIPI2,WIPI2_HUMAN,WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2) (WIPI49-like protein 2),WIPI2 CGI-50,26100;,"ENST00000288828.9; ENSP00000288828.4; ENSG00000157954.15. [Q9Y4P8-1];""ENST00000382384.6; ENSP00000371821.2; ENSG00000157954.15. [Q9Y4P8-2]"";""ENST00000401525.7; ENSP00000384945.3; ENSG00000157954.15. [Q9Y4P8-4]"";""ENST00000404704.7; ENSP00000385297.3; ENSG00000157954.15. [Q9Y4P8-6]"";""ENST00000484262.1; ENSP00000429654.1; ENSG00000157954.15. [Q9Y4P8-3]"";","phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-5-phosphate binding [GO:0010314]",autophagosome assembly [GO:0000045]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792],cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]
O95785,N2,-1.011514685,0.256366392,0.870364335,-0.140286246,0.051445575,grey70,WIZ,WIZ_HUMAN,Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803),WIZ ZNF803,58525;,"ENST00000263381.12; ENSP00000263381.5; ENSG00000011451.21. [O95785-2];""ENST00000545156.5; ENSP00000445824.1; ENSG00000011451.21. [O95785-3]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone methyltransferase binding [GO:1990226]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]",positive regulation of nuclear cell cycle DNA replication [GO:0010571]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357],extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q5T9L3,S2,-0.916396289,-1.238005547,0.210715169,0.777686188,0.550420814,orange,WLS,WLS_HUMAN,Protein wntless homolog (Integral membrane protein GPR177) (Protein evenness interrupted homolog) (EVI) (Putative NF-kappa-B-activating protein 373),WLS C1orf139 GPR177 UNQ85/PRO18667,79971;,"ENST00000262348.9; ENSP00000262348.4; ENSG00000116729.14. [Q5T9L3-1];""ENST00000354777.6; ENSP00000346829.2; ENSG00000116729.14. [Q5T9L3-2]"";""ENST00000370976.7; ENSP00000360015.3; ENSG00000116729.14. [Q5T9L3-3]"";",identical protein binding [GO:0042802]; Wnt-protein binding [GO:0017147],anterior/posterior axis specification [GO:0009948]; cementum mineralization [GO:0071529]; exocrine pancreas development [GO:0031017]; hindbrain development [GO:0030902]; intracellular protein transport [GO:0006886]; mesoderm formation [GO:0001707]; midbrain development [GO:0030901]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
Q9H4A3,C3,1.497364989,0.168919506,-0.537283985,-0.304601766,-0.617138459,cyan,WNK1,WNK1_HUMAN,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),WNK1 HSN2 KDP KIAA0344 PRKWNK1,65125;,"ENST00000315939.11; ENSP00000313059.6; ENSG00000060237.19. [Q9H4A3-1];""ENST00000340908.9; ENSP00000341292.5; ENSG00000060237.19. [Q9H4A3-5]"";""ENST00000530271.6; ENSP00000433548.3; ENSG00000060237.19. [Q9H4A3-7]"";""ENST00000537687.5; ENSP00000444465.1; ENSG00000060237.19. [Q9H4A3-6]"";""ENST00000675631.1; ENSP00000502415.1; ENSG00000060237.19. [Q9H4A3-4]"";",ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; phosphatase binding [GO:0019902]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; heart development [GO:0007507]; intracellular chloride ion homeostasis [GO:0030644]; intracellular signal transduction [GO:0035556]; lymphocyte migration into lymph node [GO:0097022]; monoatomic cation homeostasis [GO:0055080]; monoatomic ion transport [GO:0006811]; negative regulation of autophagy [GO:0010507]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; non-membrane-bounded organelle assembly [GO:0140694]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of termination of RNA polymerase II transcription [GO:1904595]; potassium ion homeostasis [GO:0055075]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; protein phosphorylation [GO:0006468]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of mRNA export from nucleus [GO:0010793]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular non-membrane-bounded organelle [GO:0043232]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]
O00258,S3,-0.483623502,-1.08483601,0.108142653,0.740207507,0.452707791,salmon,WRB,GET1_HUMAN,Guided entry of tail-anchored proteins factor 1 (Congenital heart disease 5 protein) (Tail-anchored protein insertion receptor WRB) (Tryptophan-rich basic protein),GET1 CHD5 WRB,7485;,"ENST00000380708.5; ENSP00000370084.1; ENSG00000182093.16. [O00258-2];""ENST00000398753.5; ENSP00000381737.1; ENSG00000182093.16. [O00258-2]"";""ENST00000649170.1; ENSP00000496813.1; ENSG00000182093.16. [O00258-1]"";""ENST00000650376.1; ENSP00000497103.1; ENSG00000182093.16. [O00258-2]"";",protein-membrane adaptor activity [GO:0043495],protein insertion into ER membrane [GO:0045048]; protein stabilization [GO:0050821]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529]; nucleus [GO:0005634]
Q14191,N1,-0.801846935,-0.170425872,-0.00164874,0.040060555,1.004280601,grey90,WRN,WRN_HUMAN,"Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 5.6.2.4) (DNA 3'-5' helicase WRN)]",WRN RECQ3 RECQL2,7486;,ENST00000298139.7; ENSP00000298139.5; ENSG00000165392.11.;,3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403],base-excision repair [GO:0006284]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA metabolic process [GO:0006259]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820],"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]"
Q96S55,N4,-0.885059204,0.61532565,0.082274606,0.256701796,0.170699772,grey30,WRNIP1,WRIP1_HUMAN,ATPase WRNIP1 (EC 3.6.1.-) (Werner helicase-interacting protein 1),WRNIP1 WHIP,56897;,"ENST00000380764.1; ENSP00000370141.1; ENSG00000124535.16. [Q96S55-4];""ENST00000380769.8; ENSP00000370146.3; ENSG00000124535.16. [Q96S55-3]"";""ENST00000380771.8; ENSP00000370148.4; ENSG00000124535.16. [Q96S55-2]"";""ENST00000380773.9; ENSP00000370150.4; ENSG00000124535.16. [Q96S55-1]"";""ENST00000618555.4; ENSP00000477551.1; ENSG00000124535.16. [Q96S55-1]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA helicase activity [GO:0017116],DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA-templated DNA replication initiation [GO:0030174],membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]
Q6AWC2,C1,1.740363203,0.00520097,-0.420575361,-0.446430009,-0.76540155,lightblue,WWC2,WWC2_HUMAN,Protein WWC2 (BH-3-only member B) (WW domain-containing protein 2),WWC2 BOMB,80014;,"ENST00000403733.8; ENSP00000384222.3; ENSG00000151718.16. [Q6AWC2-1];""ENST00000438543.5; ENSP00000413521.1; ENSG00000151718.16. [Q6AWC2-5]"";""ENST00000448232.6; ENSP00000398577.2; ENSG00000151718.16. [Q6AWC2-6]"";""ENST00000504005.5; ENSP00000427569.1; ENSG00000151718.16. [Q6AWC2-3]"";""ENST00000508747.1; ENSP00000420835.1; ENSG00000151718.16. [Q6AWC2-7]"";""ENST00000513834.5; ENSP00000425054.1; ENSG00000151718.16. [Q6AWC2-4]"";",kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591],cell migration [GO:0016477]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q9ULE0,C2,1.300012312,0.112122421,-0.137902827,0.005287815,-0.417757939,aquamarine,WWC3,WWC3_HUMAN,Protein WWC3,WWC3 KIAA1280,55841;,ENST00000380861.10; ENSP00000370242.6; ENSG00000047644.20. [Q9ULE0-1];,kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591],cell migration [GO:0016477]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330],cytoplasm [GO:0005737]; cytosol [GO:0005829]
Q9H0M0,S3,-0.246751693,-0.423682448,0.066976289,0.439897696,0.634946107,salmon,WWP1,WWP1_HUMAN,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (Atrophin-1-interacting protein 5) (AIP5) (HECT-type E3 ubiquitin transferase WWP1) (TGIF-interacting ubiquitin ligase 1) (Tiul1) (WW domain-containing protein 1),WWP1,11059;,"ENST00000265428.4; ENSP00000265428.4; ENSG00000123124.14. [Q9H0M0-1];""ENST00000517970.6; ENSP00000427793.1; ENSG00000123124.14. [Q9H0M0-1]"";",ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],central nervous system development [GO:0007417]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; symbiont entry into host cell [GO:0046718],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]
O00308,S1,-0.414094873,-0.651362507,-0.015070547,0.580648415,0.903209592,gold,WWP2,WWP2_HUMAN,NEDD4-like E3 ubiquitin-protein ligase WWP2 (EC 2.3.2.26) (Atrophin-1-interacting protein 2) (AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2),WWP2,11060;,"ENST00000356003.6; ENSP00000348283.3; ENSG00000198373.13. [O00308-2];""ENST00000359154.7; ENSP00000352069.2; ENSG00000198373.13. [O00308-1]"";""ENST00000568684.1; ENSP00000456216.1; ENSG00000198373.13. [O00308-3]"";""ENST00000569174.5; ENSP00000455311.1; ENSG00000198373.13. [O00308-4]"";",RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; symbiont entry into host cell [GO:0046718]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]
P98170,C5,1.888046329,0.502633268,-0.682391598,-0.764437073,-1.066445379,turquoise3,XIAP,XIAP_HUMAN,E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP),XIAP API3 BIRC4 IAP3,331;,"ENST00000355640.3; ENSP00000347858.3; ENSG00000101966.14.;""ENST00000371199.8; ENSP00000360242.3; ENSG00000101966.14."";""ENST00000422098.6; ENSP00000405529.2; ENSG00000101966.14."";",cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; endopeptidase regulator activity [GO:0061135]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"copper ion homeostasis [GO:0055070]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron apoptotic process [GO:0051402]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of apoptotic process [GO:0042981]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; Wnt signaling pathway [GO:0016055]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q01831,N3,-1.103461792,-0.91590766,1.150690289,0.102380006,-0.063698522,grey50,XPC,XPC_HUMAN,DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125),XPC XPCC,7508;,"ENST00000285021.12; ENSP00000285021.8; ENSG00000154767.15. [Q01831-1];""ENST00000476581.6; ENSP00000424548.1; ENSG00000154767.15. [Q01831-3]"";",bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; heteroduplex DNA loop binding [GO:0000404]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713],DNA repair [GO:0006281]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; UV-damage excision repair [GO:0070914],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of DNA damage [GO:0090734]; XPC complex [GO:0071942]
Q9NQW7,C4,2.086456022,0.299474597,-0.953377098,-0.985464876,-1.191678062,deepskyblue2,XPNPEP1,XPP1_HUMAN,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",XPNPEP1 XPNPEPL XPNPEPL1,7511;,"ENST00000322238.12; ENSP00000324011.8; ENSG00000108039.18. [Q9NQW7-4];""ENST00000502935.6; ENSP00000421566.1; ENSG00000108039.18. [Q9NQW7-3]"";",aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]
Q9HAV4,C2,0.923210566,0.426339899,-0.265987033,-0.028873734,-0.284278221,aquamarine,XPO5,XPO5_HUMAN,Exportin-5 (Exp5) (Ran-binding protein 21),XPO5 KIAA1291 RANBP21,57510;,ENST00000265351.12; ENSP00000265351.7; ENSG00000124571.18.;,mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049],miRNA metabolic process [GO:0010586]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565]
P18887,N4,-0.682144135,0.71208921,0.051179155,-0.037684754,0.184810658,grey30,XRCC1,XRCC1_HUMAN,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),XRCC1,7515;,ENST00000262887.10; ENSP00000262887.5; ENSG00000073050.12.;,3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572],base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; response to xenobiotic stimulus [GO:0009410]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]"
Q13426,N4,0.003196014,1.323173178,-0.445070354,-0.590919798,-0.931068856,grey30,XRCC4,XRCC4_HUMAN,"DNA repair protein XRCC4 (hXRCC4) (X-ray repair cross-complementing protein 4) [Cleaved into: Protein XRCC4, C-terminus (XRCC4/C)]",XRCC4,7518;,"ENST00000282268.7; ENSP00000282268.3; ENSG00000152422.16. [Q13426-2];""ENST00000338635.10; ENSP00000342011.6; ENSG00000152422.16. [Q13426-1]"";""ENST00000396027.9; ENSP00000379344.4; ENSG00000152422.16. [Q13426-2]"";""ENST00000511817.1; ENSP00000421491.1; ENSG00000152422.16. [Q13426-1]"";",FHA domain binding [GO:0070975]; identical protein binding [GO:0042802],cellular response to lithium ion [GO:0071285]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; positive regulation of ligase activity [GO:0051351]; protein localization to site of double-strand break [GO:1990166]; response to X-ray [GO:0010165],cytosol [GO:0005829]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]
Q9H1B5,S1,-0.887692205,-0.990556358,-0.074206659,0.897669333,0.778166291,gold,XYLT2,XYLT2_HUMAN,Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II),XYLT2 XT2 UNQ3058/PRO9878,64132;,ENST00000017003.7; ENSP00000017003.2; ENSG00000015532.10. [Q9H1B5-1];,magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein xylosyltransferase activity [GO:0030158],chondroitin sulfate biosynthetic process [GO:0030206]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan metabolic process [GO:0030203]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210],extracellular space [GO:0005615]; Golgi membrane [GO:0000139]
Q9NRH1,C4,2.036002367,0.056166812,-0.978812731,-0.884986231,-1.376288856,deepskyblue2,YAE1D1,YAE1_HUMAN,Protein YAE1 homolog (Yae1 domain-containing protein 1),YAE1 C7orf36 YAE1D1 GK003,57002;,"ENST00000223273.7; ENSP00000223273.2; ENSG00000241127.8. [Q9NRH1-1];""ENST00000432096.2; ENSP00000395777.2; ENSG00000241127.8. [Q9NRH1-2]"";",0,protein maturation by [4Fe-4S] cluster transfer [GO:0106035],cytoplasm [GO:0005737]; nucleus [GO:0005634]
P46937,C5,1.293657526,0.656502051,-0.598935805,-0.802230055,-0.936625916,turquoise3,YAP1,YAP1_HUMAN,Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog),YAP1 YAP65,10413;,"ENST00000282441.10; ENSP00000282441.5; ENSG00000137693.14. [P46937-1];""ENST00000345877.6; ENSP00000331023.4; ENSG00000137693.14. [P46937-7]"";""ENST00000524575.5; ENSP00000435602.1; ENSG00000137693.14. [P46937-4]"";""ENST00000526343.5; ENSP00000434134.1; ENSG00000137693.14. [P46937-5]"";""ENST00000531439.5; ENSP00000431574.1; ENSG00000137693.14. [P46937-2]"";""ENST00000537274.5; ENSP00000445635.1; ENSG00000137693.14. [P46937-8]"";""ENST00000615667.4; ENSP00000478927.1; ENSG00000137693.14. [P46937-9]"";""ENST00000629586.2; ENSP00000487519.1; ENSG00000137693.14. [P46937-3]"";",chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; proline-rich region binding [GO:0070064]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],bud elongation involved in lung branching [GO:0060449]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue regeneration [GO:0061026]; cell morphogenesis [GO:0000902]; cellular response to gamma radiation [GO:0071480]; cellular response to retinoic acid [GO:0071300]; DNA damage response [GO:0006974]; embryonic heart tube morphogenesis [GO:0003143]; enterocyte differentiation [GO:1903703]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway [GO:0097191]; glandular epithelial cell differentiation [GO:0002067]; heart process [GO:0003015]; hippo signaling [GO:0035329]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; keratinocyte differentiation [GO:0030216]; lateral mesoderm development [GO:0048368]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cilium assembly [GO:1902018]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; notochord development [GO:0030903]; organ growth [GO:0035265]; paraxial mesoderm development [GO:0048339]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of keratinocyte proliferation [GO:0010837]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; response to progesterone [GO:0032570]; somatic stem cell population maintenance [GO:0035019]; tissue homeostasis [GO:0001894]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; wound healing [GO:0042060],cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germ cell nucleus [GO:0001674]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]
P54577,C5,1.866548897,0.348545121,-0.788246366,-0.768707657,-0.964221829,turquoise3,YARS,SYYC_HUMAN,"Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]",YARS1 YARS,8565;,ENST00000373477.9; ENSP00000362576.4; ENSG00000134684.13.;,ATP binding [GO:0005524]; interleukin-8 receptor binding [GO:0005153]; RNA binding [GO:0003723]; small molecule binding [GO:0036094]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831],apoptotic process [GO:0006915]; response to starvation [GO:0042594]; tyrosyl-tRNA aminoacylation [GO:0006437],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nuclear body [GO:0016604]; nucleus [GO:0005634]
P58557,M1,-2.27972773,-0.905547385,0.644783616,0.877966191,-0.173773086,burlywood4,YBEY,YBEY_HUMAN,Endoribonuclease YbeY (EC 3.1.-.-),YBEY C21orf57,54059;,"ENST00000329319.7; ENSP00000329614.3; ENSG00000182362.14. [P58557-1];""ENST00000339195.10; ENSP00000340675.6; ENSG00000182362.14. [P58557-2]"";""ENST00000397691.1; ENSP00000380805.1; ENSG00000182362.14. [P58557-1]"";""ENST00000397692.5; ENSP00000380806.1; ENSG00000182362.14. [P58557-4]"";""ENST00000397694.5; ENSP00000380808.1; ENSG00000182362.14. [P58557-3]"";""ENST00000397701.9; ENSP00000380813.4; ENSG00000182362.14. [P58557-1]"";",metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; RNA endonuclease activity [GO:0004521],rRNA processing [GO:0006364],nucleus [GO:0005634]
P07947,S4,-0.987027372,-1.420416743,0.369420894,0.750023227,0.451573256,tomato2,YES1,YES_HUMAN,Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes),YES1 YES,7525;,"ENST00000314574.5; ENSP00000324740.4; ENSG00000176105.14.;""ENST00000584307.5; ENSP00000462468.1; ENSG00000176105.14."";",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; innate immune response [GO:0045087]; leukocyte migration [GO:0050900]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of glucose transmembrane transport [GO:0010827]; regulation of vascular permeability [GO:0043114]; T cell costimulation [GO:0031295],actin filament [GO:0005884]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]
O95070,S1,-0.720537939,-1.069793918,0.089460979,0.678887742,0.928978313,gold,YIF1A,YIF1A_HUMAN,Protein YIF1A (54TMp) (YIP1-interacting factor homolog A),YIF1A 54TM HYIF1P YIF1,10897;,ENST00000376901.9; ENSP00000366098.4; ENSG00000174851.16.;,0,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]
Q5BJH7,S1,-0.583606458,-0.932189808,0.092967995,0.548416441,0.670869475,gold,YIF1B,YIF1B_HUMAN,Protein YIF1B (YIP1-interacting factor homolog B),YIF1B PP4519 UNQ3073/PRO9905,90522;,"ENST00000329420.12; ENSP00000329559.7; ENSG00000167645.17. [Q5BJH7-6];""ENST00000337679.12; ENSP00000337411.7; ENSG00000167645.17. [Q5BJH7-4]"";""ENST00000339413.11; ENSP00000343435.5; ENSG00000167645.17. [Q5BJH7-1]"";""ENST00000392124.7; ENSP00000375971.2; ENSG00000167645.17. [Q5BJH7-2]"";""ENST00000591755.5; ENSP00000465446.1; ENSG00000167645.17. [Q5BJH7-5]"";""ENST00000591784.5; ENSP00000465230.1; ENSG00000167645.17. [Q5BJH7-2]"";""ENST00000592694.5; ENSP00000466428.1; ENSG00000167645.17. [Q5BJH7-2]"";",0,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q9Y548,S1,-0.5350408,-0.922356109,-0.144518319,0.62486672,1.052037587,gold,YIPF1,YIPF1_HUMAN,Protein YIPF1 (YIP1 family member 1),YIPF1,54432;,"ENST00000072644.7; ENSP00000072644.1; ENSG00000058799.15. [Q9Y548-1];""ENST00000371399.5; ENSP00000360452.1; ENSG00000058799.15. [Q9Y548-2]"";""ENST00000464950.6; ENSP00000432266.1; ENSG00000058799.15. [Q9Y548-1]"";",small GTPase binding [GO:0031267],vesicle-mediated transport [GO:0016192],Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]
Q9BWQ6,S1,-1.021089439,-1.34355471,-0.337582435,0.564029653,1.247421353,gold,YIPF2,YIPF2_HUMAN,Protein YIPF2 (YIP1 family member 2),YIPF2,78992;,"ENST00000253031.6; ENSP00000253031.1; ENSG00000130733.11.;""ENST00000586748.6; ENSP00000466055.1; ENSG00000130733.11."";",small GTPase binding [GO:0031267],vesicle-mediated transport [GO:0016192],Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; late endosome membrane [GO:0031902]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]
Q9GZM5,S1,-0.546683129,-1.031864292,-0.128086227,0.734069791,0.923806728,gold,YIPF3,YIPF3_HUMAN,"Protein YIPF3 (Killer lineage protein 1) (Natural killer cell-specific antigen KLIP1) (YIP1 family member 3) [Cleaved into: Protein YIPF3, 36 kDa form III]",YIPF3 C6orf109 KLIP1,25844;,ENST00000372422.7; ENSP00000361499.2; ENSG00000137207.12.;,0,cell differentiation [GO:0030154],Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]
Q9BSR8,S1,-0.567277374,-0.978550405,-0.074339002,0.739375848,0.711663002,gold,YIPF4,YIPF4_HUMAN,Protein YIPF4 (YIP1 family member 4),YIPF4 Nbla11189,84272;,ENST00000238831.9; ENSP00000238831.3; ENSG00000119820.11.;,0,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle fusion with Golgi apparatus [GO:0048280],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]
Q969M3,S1,-0.966438682,-1.341203704,-0.066688751,0.726264045,1.08190692,gold,YIPF5,YIPF5_HUMAN,Protein YIPF5 (Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 5) (Smooth muscle cell-associated protein 5) (SMAP-5) (YIP1 family member 5) (YPT-interacting protein 1 A),YIPF5 FINGER5 YIP1A PP12723 SB140 UNQ3123/PRO10275,81555;,"ENST00000274496.10; ENSP00000274496.5; ENSG00000145817.17. [Q969M3-1];""ENST00000448443.6; ENSP00000397704.2; ENSG00000145817.17. [Q969M3-1]"";""ENST00000513112.5; ENSP00000425422.1; ENSG00000145817.17. [Q969M3-2]"";",0,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; insulin processing [GO:0030070]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; vesicle fusion with Golgi apparatus [GO:0048280],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]
O15498,C3,1.814894725,-0.705391744,-0.465938002,-0.067606007,-0.334314924,cyan,YKT6,YKT6_HUMAN,Synaptobrevin homolog YKT6 (EC 2.3.1.-),YKT6,10652;,"ENST00000223369.3; ENSP00000223369.2; ENSG00000106636.9. [O15498-1];""ENST00000496112.5; ENSP00000420805.1; ENSG00000106636.9. [O15498-2]"";""ENST00000679020.1; ENSP00000504623.1; ENSG00000106636.9. [O15498-1]"";",cadherin binding [GO:0045296]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484],"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]",apical dendrite [GO:0097440]; basal dendrite [GO:0097441]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; transport vesicle [GO:0030133]
P49750,N2,-1.158171189,0.447394004,0.865006369,-0.355218444,-0.672187938,grey70,YLPM1,YLPM1_HUMAN,YLP motif-containing protein 1 (Nuclear protein ZAP3) (ZAP113),YLPM1 C14orf170 ZAP3,56252;,ENST00000325680.12; ENSP00000324463.7; ENSG00000119596.18. [P49750-4];,RNA binding [GO:0003723],regulation of telomere maintenance [GO:0032204],nuclear speck [GO:0016607]; nucleus [GO:0005634]
Q96TA2,M2,-1.174015918,-1.461504884,0.38451036,1.247020885,-0.198374135,tan4,YME1L1,YMEL1_HUMAN,ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (EC 3.6.-.-) (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease) (PAMP) (YME1-like protein 1),YME1L1 FTSH1 YME1L UNQ1868/PRO4304,10730;,"ENST00000326799.7; ENSP00000318480.3; ENSG00000136758.20. [Q96TA2-1];""ENST00000376016.8; ENSP00000365184.3; ENSG00000136758.20. [Q96TA2-2]"";""ENST00000613434.4; ENSP00000481724.1; ENSG00000136758.20. [Q96TA2-3]"";",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],cell population proliferation [GO:0008283]; cellular response to starvation [GO:0009267]; mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of mitochondrial fusion [GO:0010636]; protein hexamerization [GO:0034214]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of stem cell division [GO:2000035],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]
Q9H6S0,N1,0.147377917,-0.264986887,-0.341247706,-0.246409999,1.175333149,grey90,YTHDC2,YTDC2_HUMAN,3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein 2) (hYTHDC2),YTHDC2,64848;,ENST00000161863.9; ENSP00000161863.4; ENSG00000047188.16.;,"3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; helicase activity [GO:0004386]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]","germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]",endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770]
P31946,C5,1.767463128,0.483443193,-0.946967078,-0.863013333,-1.336272331,turquoise3,YWHAB,1433B_HUMAN,"14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]",YWHAB,7529;,"ENST00000353703.9; ENSP00000300161.4; ENSG00000166913.13. [P31946-1];""ENST00000372839.7; ENSP00000361930.3; ENSG00000166913.13. [P31946-1]"";",cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860],cytoplasmic sequestering of protein [GO:0051220]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein dephosphorylation [GO:0035308]; positive regulation of catalytic activity [GO:0043085]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774]
P62258,C5,1.835570299,0.395501514,-0.787443842,-0.738305067,-1.07878104,turquoise3,YWHAE,1433E_HUMAN,14-3-3 protein epsilon (14-3-3E),YWHAE,7531;,"ENST00000264335.13; ENSP00000264335.8; ENSG00000108953.17. [P62258-1];""ENST00000571732.5; ENSP00000461762.1; ENSG00000108953.17. [P62258-2]"";""ENST00000616643.3; ENSP00000481059.2; ENSG00000274474.3. [P62258-2]"";""ENST00000627231.2; ENSP00000487356.1; ENSG00000274474.3. [P62258-1]"";",cadherin binding [GO:0045296]; calcium channel inhibitor activity [GO:0019855]; calcium channel regulator activity [GO:0005246]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625],cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytoplasmic sequestering of protein [GO:0051220]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neuron migration [GO:0001764]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein export from nucleus [GO:0046827]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane repolarization [GO:0060306]; regulation of mitotic cell cycle [GO:0007346]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]
P61981,C5,1.727984731,0.471416925,-0.7661036,-0.728141176,-0.968722456,turquoise3,YWHAG,1433G_HUMAN,"14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]",YWHAG,7532;,ENST00000307630.5; ENSP00000306330.3; ENSG00000170027.7.;,identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; phosphorylation-dependent protein binding [GO:0140031]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; protein sequestering activity [GO:0140311]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723],cellular response to glucose starvation [GO:0042149]; cellular response to insulin stimulus [GO:0032869]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TORC1 signaling [GO:1904262]; protein localization [GO:0008104]; protein targeting [GO:0006605]; regulation of neuron differentiation [GO:0045664]; regulation of signal transduction [GO:0009966]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; presynapse [GO:0098793]
Q04917,C5,1.668799531,0.490520454,-0.747441754,-0.583656731,-0.964314383,turquoise3,YWHAH,1433F_HUMAN,14-3-3 protein eta (Protein AS1),YWHAH YWHA1,7533;,ENST00000248975.6; ENSP00000248975.5; ENSG00000128245.15.;,actin binding [GO:0003779]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; nuclear glucocorticoid receptor binding [GO:0035259]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],glucocorticoid catabolic process [GO:0006713]; glucocorticoid receptor signaling pathway [GO:0042921]; intracellular protein transport [GO:0006886]; membrane depolarization during action potential [GO:0086010]; negative regulation of dendrite morphogenesis [GO:0050774]; positive regulation of DNA-templated transcription [GO:0045893]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein localization [GO:0008104]; regulation of neuron differentiation [GO:0045664]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of sodium ion transport [GO:0002028]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762],cerebellar granule cell to Purkinje cell synapse [GO:0150048]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercalated disc [GO:0014704]; plasma membrane [GO:0005886]; presynapse [GO:0098793]
P27348,C4,1.957099886,0.258633728,-1.127944494,-1.087229167,-1.494340246,deepskyblue2,YWHAQ,1433T_HUMAN,14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1),YWHAQ,10971;,"ENST00000238081.8; ENSP00000238081.3; ENSG00000134308.14.;""ENST00000381844.8; ENSP00000371267.4; ENSG00000134308.14."";",14-3-3 protein binding [GO:0071889]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monoatomic ion transmembrane transport [GO:0034766]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; substantia nigra development [GO:0021762],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; synapse [GO:0045202]
P63104,C4,1.982574402,0.31159783,-1.131678759,-1.156062485,-1.349341893,deepskyblue2,YWHAZ,1433Z_HUMAN,14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1),YWHAZ,7534;,"ENST00000353245.7; ENSP00000309503.3; ENSG00000164924.18. [P63104-1];""ENST00000395951.7; ENSP00000379281.3; ENSG00000164924.18. [P63104-1]"";""ENST00000395953.6; ENSP00000379283.2; ENSG00000164924.18. [P63104-1]"";""ENST00000395956.7; ENSP00000379286.3; ENSG00000164924.18. [P63104-1]"";""ENST00000395957.6; ENSP00000379287.2; ENSG00000164924.18. [P63104-1]"";""ENST00000395958.6; ENSP00000379288.2; ENSG00000164924.18. [P63104-1]"";""ENST00000419477.6; ENSP00000395114.2; ENSG00000164924.18. [P63104-1]"";""ENST00000457309.2; ENSP00000398599.1; ENSG00000164924.18. [P63104-1]"";""ENST00000522542.5; ENSP00000430072.1; ENSG00000164924.18. [P63104-2]"";",cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625],angiogenesis [GO:0001525]; cellular response to glucose starvation [GO:0042149]; ERK1 and ERK2 cascade [GO:0070371]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; lung development [GO:0030324]; negative regulation of apoptotic process [GO:0043066]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein stability [GO:0031647]; regulation of synapse maturation [GO:0090128]; respiratory system process [GO:0003016]; signal transduction [GO:0007165]; synaptic target recognition [GO:0008039]; tube formation [GO:0035148],blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; vesicle [GO:0031982]
Q49AG3,S3,-0.549095776,-0.1713748,0.208769785,0.558201463,0.381055606,salmon,ZBED5,ZBED5_HUMAN,Zinc finger BED domain-containing protein 5 (Transposon-derived Buster1 transposase-like protein),ZBED5 Buster1,58486;,"ENST00000413761.7; ENSP00000415939.2; ENSG00000236287.8.;""ENST00000432999.6; ENSP00000398106.2; ENSG00000236287.8."";",DNA binding [GO:0003677]; metal ion binding [GO:0046872],0,0
P86452,N1,-0.945902518,-0.564313297,0.156232869,-0.181949453,1.291368149,grey90,ZBED6,ZBED6_HUMAN,Zinc finger BED domain-containing protein 6,ZBED6,100381270;,ENST00000550078.3; ENSP00000447879.1; ENSG00000257315.4.;,"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; transcription cis-regulatory region binding [GO:0000976]",blastocyst hatching [GO:0001835]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of transcription by RNA polymerase II [GO:0006357],centriolar satellite [GO:0034451]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
O95625,N1,-1.325219111,-0.956845055,0.571784788,-0.391430433,1.063378568,grey90,ZBTB11,ZBT11_HUMAN,Zinc finger and BTB domain-containing protein 11,ZBTB11,27107;,ENST00000312938.5; ENSP00000326200.4; ENSG00000066422.7.;,"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of DNA-templated transcription [GO:0006355],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
O43829,N4,-1.149520971,1.006984234,0.129459335,-0.165211956,-0.328964963,grey30,ZBTB14,ZBT14_HUMAN,Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog) (Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog) (ZF5) (Zfp-5) (hZF5),ZBTB14 ZFP161 ZNF478,7541;,"ENST00000357006.8; ENSP00000349503.4; ENSG00000198081.11.;""ENST00000400143.7; ENSP00000383009.3; ENSG00000198081.11."";""ENST00000614697.4; ENSP00000484129.1; ENSG00000198081.11."";""ENST00000615385.4; ENSP00000478971.1; ENSG00000198081.11."";""ENST00000651870.1; ENSP00000499212.1; ENSG00000198081.11."";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart valve development [GO:0003170]; kidney development [GO:0001822]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357],aggresome [GO:0016235]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q13105,N1,-0.990177874,-0.651691784,0.875399665,-0.122539556,0.780397967,grey90,ZBTB17,ZBT17_HUMAN,Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60),ZBTB17 MIZ1 ZNF151 ZNF60,7709;,"ENST00000375733.6; ENSP00000364885.2; ENSG00000116809.12. [Q13105-2];""ENST00000375743.9; ENSP00000364895.4; ENSG00000116809.12. [Q13105-1]"";""ENST00000537142.5; ENSP00000438529.1; ENSG00000116809.12. [Q13105-3]"";","core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator binding [GO:0001223]",ectoderm development [GO:0007398]; G1 to G0 transition [GO:0070314]; gastrulation with mouth forming second [GO:0001702]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]; regulation of immune system process [GO:0002682],nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]
Q9ULJ3,N1,-0.943807997,0.193863941,0.06191772,-0.15588823,0.867436074,grey90,ZBTB21,ZBT21_HUMAN,Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295),ZBTB21 KIAA1227 ZNF295,49854;,"ENST00000310826.10; ENSP00000308759.5; ENSG00000173276.14. [Q9ULJ3-1];""ENST00000398499.5; ENSP00000381512.1; ENSG00000173276.14. [Q9ULJ3-1]"";""ENST00000398505.7; ENSP00000381517.3; ENSG00000173276.14. [Q9ULJ3-2]"";""ENST00000398511.3; ENSP00000381523.3; ENSG00000173276.14. [Q9ULJ3-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; POZ domain binding [GO:0031208]",negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8NAP3,N3,-0.904865239,-1.031218492,1.282653832,0.109533688,-0.402909633,grey50,ZBTB38,ZBT38_HUMAN,Zinc finger and BTB domain-containing protein 38,ZBTB38,253461;,"ENST00000321464.7; ENSP00000372635.5; ENSG00000177311.12.;""ENST00000441582.2; ENSP00000406955.2; ENSG00000177311.12."";""ENST00000514251.5; ENSP00000426387.1; ENSG00000177311.12."";""ENST00000637056.1; ENSP00000490041.1; ENSG00000177311.12."";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",DNA damage response [GO:0006974]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355],blood microparticle [GO:0072562]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9P1Z0,N2,-1.265375103,-0.93379606,1.226158919,0.228596048,-0.368613959,grey70,ZBTB4,ZBTB4_HUMAN,Zinc finger and BTB domain-containing protein 4 (KAISO-like zinc finger protein 1) (KAISO-L1),ZBTB4 KIAA1538,57659;,"ENST00000311403.4; ENSP00000307858.4; ENSG00000174282.12.;""ENST00000380599.9; ENSP00000369973.4; ENSG00000174282.12."";""ENST00000639670.2; ENSP00000492232.1; ENSG00000283868.2."";""ENST00000639962.1; ENSP00000492616.1; ENSG00000283868.2."";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyl-CpG binding [GO:0008327]; methyl-CpNpG binding [GO:0010428]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",DNA damage response [GO:0006974]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355],chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9NUA8,N2,-0.782174387,-0.240811128,0.521627255,0.214585609,0.401759947,grey70,ZBTB40,ZBT40_HUMAN,Zinc finger and BTB domain-containing protein 40,ZBTB40 KIAA0478,9923;,"ENST00000375647.5; ENSP00000364798.4; ENSG00000184677.18. [Q9NUA8-1];""ENST00000404138.5; ENSP00000384527.1; ENSG00000184677.18. [Q9NUA8-1]"";","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]",bone mineralization [GO:0030282]; DNA damage response [GO:0006974]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q5SVQ8,N1,-1.463303681,-0.837467693,0.260045324,-0.524299157,1.360158598,grey90,ZBTB41,ZBT41_HUMAN,Zinc finger and BTB domain-containing protein 41,ZBTB41 FRBZ1,360023;,"ENST00000367405.5; ENSP00000356375.3; ENSG00000177888.8. [Q5SVQ8-1];""ENST00000467322.1; ENSP00000502173.1; ENSG00000177888.8. [Q5SVQ8-2]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
P10074,N1,-1.095561693,-0.7076887,0.63662876,0.103586776,0.719697555,grey90,ZBTB48,TZAP_HUMAN,Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855),ZBTB48 HKR3 TZAP ZNF855,3104;,ENST00000377674.9; ENSP00000366902.4; ENSG00000204859.13.;,DNA-binding transcription factor activity [GO:0003700]; double-stranded telomeric DNA binding [GO:0003691]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976],positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; telomere maintenance via telomere lengthening [GO:0010833],"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]"
Q8IWT0,C4,2.108813252,0.403389924,-1.140648537,-1.197684794,-1.75179949,deepskyblue2,ZBTB8OS,ARCH_HUMAN,Protein archease (Protein ZBTB8OS) (Zinc finger and BTB domain-containing opposite strand protein 8),ZBTB8OS ARCH,339487;,"ENST00000436661.6; ENSP00000413485.2; ENSG00000176261.16. [Q8IWT0-2];""ENST00000468695.6; ENSP00000417677.2; ENSG00000176261.16. [Q8IWT0-1]"";",metal ion binding [GO:0046872],"tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]
O75152,N3,-1.262913992,-0.765886915,0.943813942,-0.114776596,0.68389861,grey50,ZC3H11A,ZC11A_HUMAN,Zinc finger CCCH domain-containing protein 11A,ZC3H11A KIAA0663 ZC3HDC11A,9877;,"ENST00000332127.8; ENSP00000333253.4; ENSG00000058673.17.;""ENST00000367210.3; ENSP00000356179.1; ENSG00000058673.17."";""ENST00000367212.7; ENSP00000356181.3; ENSG00000058673.17."";""ENST00000367214.5; ENSP00000356183.1; ENSG00000058673.17."";""ENST00000639812.1; ENSP00000491830.1; ENSG00000058673.17."";",metal ion binding [GO:0046872]; RNA binding [GO:0003723],poly(A)+ mRNA export from nucleus [GO:0016973],nucleoplasm [GO:0005654]
Q8N5P1,N1,-1.299706579,-0.07203623,-0.108422639,-0.588587267,1.255544123,grey90,ZC3H8,ZC3H8_HUMAN,Zinc finger CCCH domain-containing protein 8,ZC3H8 ZC3HDC8,84524;,ENST00000409573.7; ENSP00000386488.1; ENSG00000144161.14.;,"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]",apoptotic process [GO:0006915]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of T cell differentiation in thymus [GO:0033085]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase III [GO:0045945]; response to antibiotic [GO:0046677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]; T cell homeostasis [GO:0043029],Cajal body [GO:0015030]; chromatin [GO:0000785]; euchromatin [GO:0000791]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]
Q7Z2W4,S1,-0.542891933,-0.592055758,-0.159928428,0.385023415,1.081200245,gold,ZC3HAV1,ZCCHV_HUMAN,Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Inactive Poly [ADP-ribose] polymerase 13) (PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP),ZC3HAV1 ZC3HDC2 PRO1677,56829;,"ENST00000242351.10; ENSP00000242351.5; ENSG00000105939.14. [Q7Z2W4-1];""ENST00000471652.1; ENSP00000419855.1; ENSG00000105939.14. [Q7Z2W4-2]"";",cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; response to virus [GO:0009615],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]
Q86WB0,N4,-1.063951842,0.892494853,0.216987068,0.092066574,-0.287413319,grey30,ZC3HC1,ZC3C1_HUMAN,Zinc finger C3HC-type protein 1 (Nuclear-interacting partner of ALK) (hNIPA) (Nuclear-interacting partner of anaplastic lymphoma kinase),ZC3HC1 NIPA HSPC216,51530;,"ENST00000311873.9; ENSP00000309301.5; ENSG00000091732.17. [Q86WB0-2];""ENST00000358303.9; ENSP00000351052.4; ENSG00000091732.17. [Q86WB0-1]"";""ENST00000360708.9; ENSP00000353933.5; ENSG00000091732.17. [Q86WB0-3]"";",protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270],cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567],nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q8TBK6,N2,-1.162611195,-1.328625152,1.156899093,0.284206303,0.243944433,grey70,ZCCHC10,ZCH10_HUMAN,Zinc finger CCHC domain-containing protein 10,ZCCHC10,54819;,"ENST00000324170.7; ENSP00000324274.3; ENSG00000155329.12. [Q8TBK6-2];""ENST00000509437.6; ENSP00000423276.1; ENSG00000155329.12. [Q8TBK6-1]"";",nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],0,0
Q8N3Z6,N3,-1.066958493,-1.275667362,1.161655612,-0.238065574,0.199908785,grey50,ZCCHC7,ZCHC7_HUMAN,Zinc finger CCHC domain-containing protein 7 (TRAMP-like complex RNA-binding factor ZCCHC7),ZCCHC7 HSPC086,84186;,"ENST00000336755.10; ENSP00000337839.5; ENSG00000147905.18. [Q8N3Z6-1];""ENST00000534928.5; ENSP00000443113.2; ENSG00000147905.18. [Q8N3Z6-1]"";",RNA binding [GO:0003723]; zinc ion binding [GO:0008270],nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; TRAMP-dependent tRNA surveillance pathway [GO:0071038],cytosol [GO:0005829]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]
Q8N567,N3,-0.885401752,-0.658003298,0.85967117,-0.090098565,0.5425466,grey50,ZCCHC9,ZCHC9_HUMAN,Zinc finger CCHC domain-containing protein 9,ZCCHC9,84240;,"ENST00000254037.6; ENSP00000254037.2; ENSG00000131732.12.;""ENST00000380199.9; ENSP00000369546.5; ENSG00000131732.12."";""ENST00000407610.8; ENSP00000385047.3; ENSG00000131732.12."";""ENST00000438268.2; ENSP00000412637.2; ENSG00000131732.12."";",RNA binding [GO:0003723]; zinc ion binding [GO:0008270],0,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q8TBF4,N1,-1.056651933,-0.185382987,0.322111313,-0.444571202,1.152038865,grey90,ZCRB1,ZCRB1_HUMAN,Zinc finger CCHC-type and RNA-binding motif-containing protein 1 (U11/U12 small nuclear ribonucleoprotein 31 kDa protein) (U11/U12 snRNP 31 kDa protein) (U11/U12-31K),ZCRB1,85437;,"ENST00000266529.8; ENSP00000266529.3; ENSG00000139168.9.;""ENST00000677694.1; ENSP00000503171.1; ENSG00000139168.9."";""ENST00000679269.1; ENSP00000503413.1; ENSG00000139168.9."";",RNA binding [GO:0003723]; zinc ion binding [GO:0008270],"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689]
Q8IUH4,S1,-1.21011018,-1.516022435,-0.187940987,0.984097393,0.950642889,gold,ZDHHC13,ZDH13_HUMAN,Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Huntingtin-interacting protein 14-related protein) (HIP14-related protein) (Huntingtin-interacting protein HIP3RP) (Putative MAPK-activating protein PM03) (Putative NF-kappa-B-activating protein 209) (Zinc finger DHHC domain-containing protein 13) (DHHC-13),ZDHHC13 HIP14L HIP3RP,54503;,"ENST00000399351.7; ENSP00000382288.3; ENSG00000177054.14. [Q8IUH4-3];""ENST00000446113.7; ENSP00000400113.2; ENSG00000177054.14. [Q8IUH4-1]"";",magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],positive regulation of canonical NF-kappaB signal transduction [GO:0043123],endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]
Q8IUH5,S1,-0.348442654,-0.825465115,-0.14962874,0.7898749,0.681639202,gold,ZDHHC17,ZDH17_HUMAN,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (DHHC17) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17),ZDHHC17 HIP14 HIP3 HYPH KIAA0946 HSPC294,23390;,ENST00000426126.7; ENSP00000403397.2; ENSG00000186908.15. [Q8IUH5-1];,identical protein binding [GO:0042802]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; signaling receptor binding [GO:0005102],axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of programmed cell death [GO:0043067],cell projection [GO:0042995]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]
Q9NUE0,S4,-1.452053098,-1.232765001,0.489643949,0.826795862,0.393624481,tomato2,ZDHHC18,ZDH18_HUMAN,Palmitoyltransferase ZDHHC18 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 18) (DHHC-18) (Zinc finger DHHC domain-containing protein 18),ZDHHC18,84243;,"ENST00000374141.6; ENSP00000363256.2; ENSG00000204160.12. [Q9NUE0-2];""ENST00000374142.9; ENSP00000363257.3; ENSG00000204160.12. [Q9NUE0-1]"";",palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],innate immune response [GO:0045087]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of innate immune response [GO:0045824]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]
Q5W0Z9,S2,-1.641027471,-1.685752531,0.293586389,0.796330304,0.775854966,orange,ZDHHC20,ZDH20_HUMAN,Palmitoyltransferase ZDHHC20 (EC 2.3.1.225) (Acyltransferase ZDHHC20) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 20) (DHHC20) (Zinc finger DHHC domain-containing protein 20),ZDHHC20,253832;,"ENST00000320220.13; ENSP00000313583.9; ENSG00000180776.17. [Q5W0Z9-4];""ENST00000382466.7; ENSP00000371905.3; ENSG00000180776.17. [Q5W0Z9-3]"";""ENST00000400590.8; ENSP00000383433.3; ENSG00000180776.17. [Q5W0Z9-1]"";""ENST00000415724.2; ENSP00000401232.1; ENSG00000180776.17. [Q5W0Z9-1]"";",palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; zinc ion binding [GO:0008270],peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation by host of viral process [GO:0044794]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; synaptic vesicle maturation [GO:0016188],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]
Q9NYG2,S1,-1.03062107,-1.412515247,0.061427728,0.855437777,0.77324344,gold,ZDHHC3,ZDHC3_HUMAN,Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Acyltransferase ZDHHC3) (EC 2.3.1.-) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3),ZDHHC3 HSD49,51304;,"ENST00000296127.7; ENSP00000296127.3; ENSG00000163812.16. [Q9NYG2-2];""ENST00000424952.7; ENSP00000395502.2; ENSG00000163812.16. [Q9NYG2-1]"";",palmitoyltransferase activity [GO:0016409]; protein homodimerization activity [GO:0042803]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439],"lipoprotein localization to membrane [GO:0044873]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to membrane [GO:0072657]; protein localization to photoreceptor outer segment [GO:1903546]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; TRAIL-activated apoptotic signaling pathway [GO:0036462]",endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]
Q9C0B5,S4,-1.066772697,-1.381687918,0.376005662,0.895268351,0.25031687,tomato2,ZDHHC5,ZDHC5_HUMAN,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),ZDHHC5 KIAA1748 ZNF375,25921;,"ENST00000287169.8; ENSP00000287169.3; ENSG00000156599.11. [Q9C0B5-1];""ENST00000527985.5; ENSP00000432202.1; ENSG00000156599.11. [Q9C0B5-2]"";",palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],innate immune response [GO:0045087]; lipid transport [GO:0006869]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],"dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynaptic specialization, intracellular component [GO:0099091]"
Q9NXF8,S1,-1.215426067,-1.523153375,-0.263723392,0.928447555,1.049204422,gold,ZDHHC7,ZDHC7_HUMAN,Palmitoyltransferase ZDHHC7 (EC 2.3.1.225) (Acyltransferase ZDHHC7) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 7) (DHHC-7),ZDHHC7,55625;,"ENST00000313732.9; ENSP00000315604.5; ENSG00000153786.13. [Q9NXF8-1];""ENST00000344861.9; ENSP00000341681.5; ENSG00000153786.13. [Q9NXF8-2]"";""ENST00000564466.5; ENSP00000456782.1; ENSG00000153786.13. [Q9NXF8-2]"";",palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439],androgen receptor signaling pathway [GO:0030521]; glucose import in response to insulin stimulus [GO:0044381]; negative regulation of catabolic process [GO:0009895]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; polarized epithelial cell differentiation [GO:0030859]; progesterone receptor signaling pathway [GO:0050847]; protein localization to plasma membrane [GO:0072659]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; regulation of Fas signaling pathway [GO:1902044]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein localization to cell-cell junction [GO:0150106]; regulation of protein localization to plasma membrane [GO:1903076]; steroid hormone mediated signaling pathway [GO:0043401],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]
Q9Y397,S1,-0.960620405,-1.233413117,0.164832339,0.667953011,0.837317436,gold,ZDHHC9,ZDHC9_HUMAN,Palmitoyltransferase ZDHHC9 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 9) (DHHC-9) (DHHC9) (Zinc finger protein 379) (Zinc finger protein 380),ZDHHC9 CXorf11 ZDHHC10 ZNF379 ZNF380 CGI-89 UNQ261/PRO298,51114;,"ENST00000357166.11; ENSP00000349689.6; ENSG00000188706.13.;""ENST00000371064.7; ENSP00000360103.3; ENSG00000188706.13."";",palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; Ras palmitoyltransferase activity [GO:0043849],MAPK cascade [GO:0000165]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation by host of viral process [GO:0044794]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; palmitoyltransferase complex [GO:0002178]
Q8TCF1,C5,1.65246058,0.297071003,-0.442622695,-0.646814462,-0.793404217,turquoise3,ZFAND1,ZFAN1_HUMAN,AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1),ZFAND1,79752;,"ENST00000220669.10; ENSP00000220669.5; ENSG00000104231.11. [Q8TCF1-1];""ENST00000519523.5; ENSP00000429167.1; ENSG00000104231.11. [Q8TCF1-4]"";""ENST00000521287.5; ENSP00000428139.1; ENSG00000104231.11. [Q8TCF1-2]"";""ENST00000522520.5; ENSP00000429999.1; ENSG00000104231.11. [Q8TCF1-2]"";""ENST00000523096.5; ENSP00000430736.1; ENSG00000104231.11. [Q8TCF1-3]"";",proteasome binding [GO:0070628]; zinc ion binding [GO:0008270],cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]
O76080,C1,1.622822655,0.498597593,-0.766713199,-0.976446143,-0.393436983,lightblue,ZFAND5,ZFAN5_HUMAN,AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216),ZFAND5 ZA20D2 ZNF216,7763;,"ENST00000237937.7; ENSP00000237937.3; ENSG00000107372.13.;""ENST00000343431.6; ENSP00000350586.2; ENSG00000107372.13."";""ENST00000376960.8; ENSP00000366159.4; ENSG00000107372.13."";""ENST00000376962.10; ENSP00000366161.5; ENSG00000107372.13."";",DNA binding [GO:0003677]; zinc ion binding [GO:0008270],face development [GO:0060324]; fibroblast migration [GO:0010761]; in utero embryonic development [GO:0001701]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; respiratory system process [GO:0003016]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculature development [GO:0001944],cytoplasm [GO:0005737]
O60293,N1,-1.032039461,-0.765281012,0.303607696,-0.384195015,1.246852374,grey90,ZFC3H1,ZC3H1_HUMAN,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),ZFC3H1 CCDC131 KIAA0546 PSRC2,196441;,"ENST00000378743.9; ENSP00000368017.4; ENSG00000133858.17. [O60293-1];""ENST00000548100.1; ENSP00000450044.1; ENSG00000133858.17. [O60293-4]"";""ENST00000552994.5; ENSP00000446995.1; ENSG00000133858.17. [O60293-2]"";",metal ion binding [GO:0046872],RNA processing [GO:0006396],exosome (RNase complex) [GO:0000178]; extracellular space [GO:0005615]; nucleus [GO:0005634]
Q15911,N2,-1.132924816,-0.637651349,1.035385262,0.219670301,-0.187423209,grey70,ZFHX3,ZFHX3_HUMAN,Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3) (ZFH-3),ZFHX3 ATBF1 C16orf47,463;,"ENST00000268489.10; ENSP00000268489.5; ENSG00000140836.17. [Q15911-1];""ENST00000397992.5; ENSP00000438926.3; ENSG00000140836.17. [Q15911-2]"";""ENST00000641206.2; ENSP00000493252.1; ENSG00000140836.17. [Q15911-1]"";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell adhesion [GO:0045785]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to transforming growth factor beta [GO:0071559],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]
Q8NB50,N3,-1.104609426,-0.932117902,0.896252819,-0.303845388,0.873891817,grey50,ZFP62,ZFP62_HUMAN,Zinc finger protein 62 homolog (Zfp-62),ZFP62,643836;,"ENST00000502412.2; ENSP00000423820.1; ENSG00000196670.14. [Q8NB50-1];""ENST00000512132.5; ENSP00000426193.1; ENSG00000196670.14. [Q8NB50-3]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q9NTW7,N1,-0.935885167,-0.397847551,0.163368537,-0.472388415,1.342459239,grey90,ZFP64,ZF64B_HUMAN,Zinc finger protein 64 (Zfp-64) (Zinc finger protein 338),ZFP64 ZNF338,55734;,"ENST00000216923.5; ENSP00000216923.4; ENSG00000020256.20. [Q9NTW7-5];""ENST00000346617.8; ENSP00000344615.4; ENSG00000020256.20. [Q9NTW7-6]"";""ENST00000361387.6; ENSP00000355179.2; ENSG00000020256.20. [Q9NTW7-1]"";""ENST00000371515.8; ENSP00000360570.4; ENSG00000020256.20. [Q9NTW7-4]"";""ENST00000371518.6; ENSP00000360573.2; ENSG00000020256.20. [Q9NTW7-3]"";""ENST00000371523.8; ENSP00000360578.4; ENSG00000020256.20. [Q9NTW7-2]"";",DNA binding [GO:0003677]; metal ion binding [GO:0046872],mesenchymal cell differentiation [GO:0048762]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; megasporocyte nucleus [GO:0043076]; nucleus [GO:0005634]
O95159,S1,-1.087115547,-1.334467573,-0.183890483,0.77575379,0.7296692,gold,ZFPL1,ZFPL1_HUMAN,Zinc finger protein-like 1 (Zinc finger protein MCG4),ZFPL1,7542;,ENST00000294258.8; ENSP00000294258.3; ENSG00000162300.13.;,DNA binding [GO:0003677]; zinc ion binding [GO:0008270],regulation of DNA-templated transcription [GO:0006355]; vesicle-mediated transport [GO:0016192],Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]
Q96KR1,N3,-1.113576772,-0.923834848,0.954459228,-0.113489354,0.553175561,grey50,ZFR,ZFR_HUMAN,Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog),ZFR,51663;,ENST00000265069.13; ENSP00000265069.8; ENSG00000056097.16.;,DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],0,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]
P17010,N3,-1.010003699,-0.829050779,1.123820229,-0.273858264,0.534084506,grey50,ZFX,ZFX_HUMAN,Zinc finger X-chromosomal protein,ZFX,7543;,"ENST00000304543.10; ENSP00000304985.5; ENSG00000005889.16. [P17010-1];""ENST00000379177.5; ENSP00000368475.1; ENSG00000005889.16. [P17010-1]"";""ENST00000379188.7; ENSP00000368486.4; ENSG00000005889.16. [P17010-3]"";""ENST00000539115.5; ENSP00000438233.1; ENSG00000005889.16. [P17010-2]"";","chromatin insulator sequence binding [GO:0043035]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",fertilization [GO:0009566]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; parental behavior [GO:0060746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]
Q9HBF4,C1,1.31929516,-0.476972814,-0.300662152,0.062878484,0.169220439,lightblue,ZFYVE1,ZFYV1_HUMAN,Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1),ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436,53349;,"ENST00000318876.9; ENSP00000326921.5; ENSG00000165861.14. [Q9HBF4-3];""ENST00000394207.6; ENSP00000377757.2; ENSG00000165861.14. [Q9HBF4-2]"";""ENST00000555072.1; ENSP00000452232.1; ENSG00000165861.14. [Q9HBF4-2]"";""ENST00000556143.6; ENSP00000450742.1; ENSG00000165861.14. [Q9HBF4-1]"";","1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]",cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; positive regulation by host of viral genome replication [GO:0044829],autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]
Q96K21,C3,2.040504712,0.421201827,-0.688130664,-0.839785577,-1.064983955,cyan,ZFYVE19,ANCHR_HUMAN,Abscission/NoCut checkpoint regulator (ANCHR) (MLL partner containing FYVE domain) (Zinc finger FYVE domain-containing protein 19),ZFYVE19 ANCHR MPFYVE,84936;,"ENST00000299173.14; ENSP00000299173.10; ENSG00000166140.17. [Q96K21-3];""ENST00000336455.9; ENSP00000337824.5; ENSG00000166140.17. [Q96K21-2]"";""ENST00000355341.8; ENSP00000347498.4; ENSG00000166140.17. [Q96K21-1]"";""ENST00000564258.5; ENSP00000457617.1; ENSG00000166140.17. [Q96K21-4]"";",metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266],abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint signaling [GO:0044878]; negative regulation of cytokinesis [GO:0032466],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]
Q5T4F4,S1,-0.711030695,-0.816425767,0.117463332,0.44493583,0.701409139,gold,ZFYVE27,ZFY27_HUMAN,Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27),ZFYVE27 SPG33,118813;,"ENST00000337540.11; ENSP00000337993.7; ENSG00000155256.18. [Q5T4F4-8];""ENST00000357540.8; ENSP00000350148.4; ENSG00000155256.18. [Q5T4F4-5]"";""ENST00000359980.5; ENSP00000353069.3; ENSG00000155256.18. [Q5T4F4-2]"";""ENST00000370610.7; ENSP00000359642.3; ENSG00000155256.18. [Q5T4F4-7]"";""ENST00000370613.7; ENSP00000359646.3; ENSG00000155256.18. [Q5T4F4-6]"";""ENST00000393677.8; ENSP00000377282.3; ENSG00000155256.18. [Q5T4F4-1]"";""ENST00000423811.3; ENSP00000409594.2; ENSG00000155256.18. [Q5T4F4-3]"";""ENST00000684270.1; ENSP00000506975.1; ENSG00000155256.18. [Q5T4F4-1]"";",identical protein binding [GO:0042802]; metal ion binding [GO:0046872],endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192],axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]
Q9UKY1,N4,-0.968519704,1.216896888,0.098120405,-0.514549135,-0.171875408,grey30,ZHX1,ZHX1_HUMAN,Zinc fingers and homeoboxes protein 1,ZHX1,11244;,"ENST00000297857.3; ENSP00000297857.2; ENSG00000165156.15. [Q9UKY1-1];""ENST00000395571.8; ENSP00000378938.2; ENSG00000165156.15. [Q9UKY1-1]"";""ENST00000522655.5; ENSP00000428821.1; ENSG00000165156.15. [Q9UKY1-1]"";","DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]",cell differentiation [GO:0030154]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9Y6X8,N4,-0.279229497,1.359838303,-0.230944553,-0.687363582,-0.922669315,grey30,ZHX2,ZHX2_HUMAN,Zinc fingers and homeoboxes protein 2 (Alpha-fetoprotein regulator 1) (AFP regulator 1) (Regulator of AFP) (Zinc finger and homeodomain protein 2),ZHX2 AFR1 KIAA0854 RAF,22882;,ENST00000314393.6; ENSP00000314709.4; ENSG00000178764.8.;,"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]",mRNA catabolic process [GO:0006402]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal bipolar neuron differentiation [GO:0060040]; somatic stem cell population maintenance [GO:0035019],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9HA38,N1,-0.714644447,0.044483874,0.273639542,-0.403965435,1.016435877,grey90,ZMAT3,ZMAT3_HUMAN,Zinc finger matrin-type protein 3 (Zinc finger protein WIG-1) (p53-activated gene 608 protein),ZMAT3 PAG608 WIG1,64393;,"ENST00000311417.7; ENSP00000311221.2; ENSG00000172667.11. [Q9HA38-1];""ENST00000432729.5; ENSP00000396506.1; ENSG00000172667.11. [Q9HA38-2]"";",RNA binding [GO:0003723]; zinc ion binding [GO:0008270],apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; protein transport [GO:0015031],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]
O75844,S2,-1.009115758,-1.364614769,0.184423732,0.818695109,0.507521321,orange,ZMPSTE24,FACE1_HUMAN,CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog),ZMPSTE24 FACE1 STE24,10269;,ENST00000372759.4; ENSP00000361845.3; ENSG00000084073.10.;,double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloexopeptidase activity [GO:0008235],"adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to gamma radiation [GO:0071480]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of miRNA processing [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; prenylated protein catabolic process [GO:0030327]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]",early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]
Q9UBW7,N4,-1.083854706,0.94969961,0.442311811,-0.487062406,-0.435122722,grey30,ZMYM2,ZMYM2_HUMAN,Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198),ZMYM2 FIM RAMP ZNF198,7750;,"ENST00000382871.3; ENSP00000372324.2; ENSG00000121741.17. [Q9UBW7-1];""ENST00000382874.6; ENSP00000372327.2; ENSG00000121741.17. [Q9UBW7-1]"";""ENST00000610343.5; ENSP00000479904.1; ENSG00000121741.17. [Q9UBW7-1]"";",ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270],negative regulation of DNA-templated transcription [GO:0045892],cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]
Q15326,N3,-1.233475976,-1.512021423,1.427309043,0.220408724,-0.73174101,grey50,ZMYND11,ZMY11_HUMAN,Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69),ZMYND11 BRAM1 BS69,10771;,"ENST00000381591.5; ENSP00000371003.1; ENSG00000015171.21. [Q15326-1];""ENST00000381604.9; ENSP00000371017.6; ENSG00000015171.21. [Q15326-1]"";""ENST00000397962.8; ENSP00000381053.3; ENSG00000015171.21. [Q15326-1]"";""ENST00000509513.6; ENSP00000424205.2; ENSG00000015171.21. [Q15326-6]"";""ENST00000558098.4; ENSP00000452959.1; ENSG00000015171.21. [Q15326-3]"";""ENST00000602682.6; ENSP00000473321.1; ENSG00000015171.21. [Q15326-5]"";""ENST00000704295.1; ENSP00000515819.1; ENSG00000015171.21. [Q15326-2]"";""ENST00000704301.1; ENSP00000515825.1; ENSG00000015171.21. [Q15326-1]"";""ENST00000704303.1; ENSP00000515827.1; ENSG00000015171.21. [Q15326-2]"";""ENST00000704335.1; ENSP00000515849.1; ENSG00000015171.21. [Q15326-4]"";",double-stranded DNA binding [GO:0003690]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of JNK cascade [GO:0046329]; regulation of signal transduction [GO:0009966]; regulation of transcription elongation by RNA polymerase II [GO:0034243],chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9H2Y7,N2,-0.906131862,-0.434943616,0.895016687,0.085866631,0.425866267,grey70,ZNF106,ZN106_HUMAN,Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474),ZNF106 SH3BP3 ZFP106 ZNF474,64397;,"ENST00000263805.8; ENSP00000263805.4; ENSG00000103994.18. [Q9H2Y7-1];""ENST00000565380.5; ENSP00000455674.1; ENSG00000103994.18. [Q9H2Y7-2]"";",metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124],insulin receptor signaling pathway [GO:0008286],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]
P52739,N4,-0.713562231,1.115993474,0.287353879,-0.443189751,-0.732999546,grey30,ZNF131,ZN131_HUMAN,Zinc finger protein 131,ZNF131,7690;,"ENST00000306938.8; ENSP00000305804.4; ENSG00000172262.12. [P52739-2];""ENST00000505606.6; ENSP00000423945.1; ENSG00000172262.12. [P52739-2]"";""ENST00000509156.5; ENSP00000426504.1; ENSG00000172262.12. [P52739-1]"";""ENST00000509634.5; ENSP00000421246.1; ENSG00000172262.12. [P52739-2]"";""ENST00000682664.1; ENSP00000507111.1; ENSG00000172262.12. [P52739-1]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cytokine production [GO:0001817]; regulation of immune system process [GO:0002682],intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]
P52747,N4,-0.255230005,1.502247532,-0.345592321,-0.863537182,-0.975257543,grey30,ZNF143,ZN143_HUMAN,Zinc finger protein 143 (SPH-binding factor) (Selenocysteine tRNA gene transcription-activating factor) (hStaf),ZNF143 SBF STAF,7702;,"ENST00000396597.7; ENSP00000379843.3; ENSG00000166478.10. [P52747-2];""ENST00000396602.7; ENSP00000379847.2; ENSG00000166478.10. [P52747-1]"";""ENST00000396604.5; ENSP00000379849.1; ENSG00000166478.10. [P52747-3]"";""ENST00000530463.5; ENSP00000432154.1; ENSG00000166478.10. [P52747-3]"";","chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription by RNA polymerase III [GO:0006359],nucleoplasm [GO:0005654]
Q9UQR1,N2,-1.106250091,-0.52257854,0.914230932,0.371957599,-0.05933156,grey70,ZNF148,ZN148_HUMAN,Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89),ZNF148 ZBP89,7707;,"ENST00000360647.9; ENSP00000353863.4; ENSG00000163848.21. [Q9UQR1-1];""ENST00000471196.2; ENSP00000420038.2; ENSG00000163848.21. [Q9UQR1-1]"";""ENST00000484491.5; ENSP00000420335.1; ENSG00000163848.21. [Q9UQR1-1]"";""ENST00000485866.5; ENSP00000420448.1; ENSG00000163848.21. [Q9UQR1-1]"";""ENST00000492394.5; ENSP00000419322.1; ENSG00000163848.21. [Q9UQR1-1]"";""ENST00000700044.1; ENSP00000514760.1; ENSG00000163848.21. [Q9UQR1-1]"";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",cellular defense response [GO:0006968]; gamete generation [GO:0007276]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; substantia nigra development [GO:0021762],Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]
O75820,N1,-0.90168969,-0.586542332,0.38978423,-0.146141191,1.085824038,grey90,ZNF189,ZN189_HUMAN,Zinc finger protein 189,ZNF189,7743;,"ENST00000259395.4; ENSP00000259395.4; ENSG00000136870.11. [O75820-4];""ENST00000339664.7; ENSP00000342019.2; ENSG00000136870.11. [O75820-1]"";""ENST00000374861.7; ENSP00000363995.3; ENSG00000136870.11. [O75820-2]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
O95201,N1,-0.954547293,-0.669990952,0.061429721,0.110861424,1.168296056,grey90,ZNF205,RHIT_HUMAN,Transcriptional repressor RHIT (Repressor of heat-inducible transcription) (RhitH) (Zinc finger protein 205) (Zinc finger protein 210),ZNF205 RHIT ZNF210,7755;,"ENST00000219091.9; ENSP00000219091.4; ENSG00000122386.11.;""ENST00000382192.7; ENSP00000371627.3; ENSG00000122386.11."";""ENST00000620094.4; ENSP00000480401.1; ENSG00000122386.11."";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],mitochondrion [GO:0005739]; nucleus [GO:0005634]
O75362,N4,-1.183723672,1.468440986,-0.300531159,-0.906933977,-0.760345363,grey30,ZNF217,ZN217_HUMAN,Zinc finger protein 217,ZNF217 ZABC1,7764;,"ENST00000302342.3; ENSP00000304308.3; ENSG00000171940.14.;""ENST00000371471.7; ENSP00000360526.2; ENSG00000171940.14."";","DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]",negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355],histone deacetylase complex [GO:0000118]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UL36,N2,-1.132127842,-0.886151534,0.952484019,0.019385506,0.221174799,grey70,ZNF236,ZN236_HUMAN,Zinc finger protein 236,ZNF236,7776;,"ENST00000253159.12; ENSP00000253159.8; ENSG00000130856.18. [Q9UL36-1];""ENST00000543926.6; ENSP00000444524.2; ENSG00000130856.18. [Q9UL36-2]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",cellular response to glucose stimulus [GO:0071333]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
O75312,C4,2.05139684,0.08000569,-0.834917387,-0.913357573,-1.03265578,deepskyblue2,ZNF259,ZPR1_HUMAN,Zinc finger protein ZPR1 (Zinc finger protein 259),ZPR1 ZNF259,8882;,ENST00000227322.8; ENSP00000227322.3; ENSG00000109917.11.;,protein folding chaperone [GO:0044183]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270],apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; DNA replication [GO:0006260]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; pre-mRNA catabolic process [GO:1990261]; protein folding [GO:0006457]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834],axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]
Q9NSD4,N1,-1.11453164,-0.497135463,0.012238796,-0.232178936,1.428082769,grey90,ZNF275,ZN275_HUMAN,Zinc finger protein 275,ZNF275,0,"ENST00000370249.3; ENSP00000359269.2; ENSG00000063587.15. [Q9NSD4-2];""ENST00000650114.2; ENSP00000496975.2; ENSG00000063587.15. [Q9NSD4-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q8ND82,N3,-0.917567592,-1.057164022,1.317128061,0.111334196,-0.496721392,grey50,ZNF280C,Z280C_HUMAN,Zinc finger protein 280C (Suppressor of hairy wing homolog 3) (Zinc finger protein 633),ZNF280C SUHW3 ZNF633,55609;,ENST00000370978.9; ENSP00000360017.4; ENSG00000056277.16.;,"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634]
O60281,N3,-0.984127952,-0.795580165,1.246698901,0.274134377,-0.418007132,grey50,ZNF292,ZN292_HUMAN,Zinc finger protein 292,ZNF292 KIAA0530,23036;,ENST00000369577.8; ENSP00000358590.3; ENSG00000188994.14. [O60281-1];,"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q9NR11,N1,-1.254855509,0.667533144,-0.049461362,-0.698797188,0.905596584,grey90,ZNF302,ZN302_HUMAN,Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327),ZNF302 ZNF135L ZNF140L ZNF327,55900;,"ENST00000423823.6; ENSP00000405219.2; ENSG00000089335.22. [Q9NR11-2];""ENST00000457781.6; ENSP00000391067.2; ENSG00000089335.22. [Q9NR11-2]"";""ENST00000505242.6; ENSP00000421028.1; ENSG00000089335.22. [Q9NR11-2]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q5VUA4,N4,-0.971498136,0.731297435,0.444942305,0.001334258,-0.193833321,grey30,ZNF318,ZN318_HUMAN,Zinc finger protein 318 (Endocrine regulatory protein),ZNF318 HRIHFB2436,24149;,"ENST00000361428.3; ENSP00000354964.2; ENSG00000171467.16. [Q5VUA4-1];""ENST00000605935.5; ENSP00000475748.1; ENSG00000171467.16. [Q5VUA4-2]"";",nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],meiotic cell cycle [GO:0051321]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893],cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q5BKZ1,N3,-1.091435573,-1.050031812,1.017475767,-0.046857805,0.323166266,grey50,ZNF326,ZN326_HUMAN,DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs and DBC1),ZNF326 ZIRD,284695;,"ENST00000340281.9; ENSP00000340796.4; ENSG00000162664.17. [Q5BKZ1-1];""ENST00000361911.9; ENSP00000355318.5; ENSG00000162664.17. [Q5BKZ1-2]"";",DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993],mRNA processing [GO:0006397]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q9UL40,N1,-1.02907817,-0.700763373,0.489170006,-0.167529887,1.089104788,grey90,ZNF346,ZN346_HUMAN,Zinc finger protein 346 (Just another zinc finger protein),ZNF346 JAZ,23567;,"ENST00000358149.8; ENSP00000350869.3; ENSG00000113761.12. [Q9UL40-1];""ENST00000503039.1; ENSP00000424495.1; ENSG00000113761.12. [Q9UL40-2]"";""ENST00000503425.5; ENSP00000421212.1; ENSG00000113761.12. [Q9UL40-3]"";",double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],0,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q5T0B9,N2,-0.568007276,-0.729165806,0.793898284,0.339748372,0.214605898,grey70,ZNF362,ZN362_HUMAN,Zinc finger protein 362,ZNF362 PP6997,149076;,"ENST00000373428.5; ENSP00000362527.5; ENSG00000160094.15.;""ENST00000539719.6; ENSP00000446335.1; ENSG00000160094.15."";",DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q8TF68,N3,-1.473073547,-0.808630073,0.977422262,0.411318494,0.083906625,grey50,ZNF384,ZN384_HUMAN,Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein),ZNF384 CAGH1 CIZ NMP4 TNRC1,171017;,"ENST00000319770.7; ENSP00000321650.4; ENSG00000126746.19. [Q8TF68-2];""ENST00000355772.8; ENSP00000348018.4; ENSG00000126746.19. [Q8TF68-3]"";""ENST00000361959.7; ENSP00000354592.3; ENSG00000126746.19. [Q8TF68-1]"";""ENST00000396801.7; ENSP00000380019.3; ENSG00000126746.19. [Q8TF68-1]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q5JVG2,N1,-0.741196067,-0.387289593,0.333251613,-0.251330162,0.969400575,grey90,ZNF484,ZN484_HUMAN,Zinc finger protein 484,ZNF484,83744;,"ENST00000332591.6; ENSP00000364646.3; ENSG00000127081.14. [Q5JVG2-2];""ENST00000375495.8; ENSP00000364645.3; ENSG00000127081.14. [Q5JVG2-1]"";""ENST00000395505.6; ENSP00000378881.3; ENSG00000127081.14. [Q5JVG2-3]"";""ENST00000395506.7; ENSP00000378882.4; ENSG00000127081.14. [Q5JVG2-2]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q9Y2H8,N1,-1.019572331,-0.616294034,0.235738697,-0.434926399,1.304924098,grey90,ZNF510,ZN510_HUMAN,Zinc finger protein 510,ZNF510 KIAA0972,22869;,"ENST00000223428.9; ENSP00000223428.4; ENSG00000081386.13.;""ENST00000375231.5; ENSP00000364379.1; ENSG00000081386.13."";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q8NB15,C2,1.026154064,0.530932087,-0.121185353,-0.360253237,-0.422859626,aquamarine,ZNF511,ZN511_HUMAN,Zinc finger protein 511,ZNF511,118472;,"ENST00000359035.4; ENSP00000351929.3; ENSG00000198546.15. [Q8NB15-1];""ENST00000361518.10; ENSP00000355251.5; ENSG00000198546.15. [Q8NB15-2]"";",DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],0,nucleus [GO:0005634]
Q96ME7,N3,-1.298770746,-1.105469092,0.951928459,-0.073353698,0.596643739,grey50,ZNF512,ZN512_HUMAN,Zinc finger protein 512,ZNF512 KIAA1805,84450;,"ENST00000355467.6; ENSP00000347648.3; ENSG00000243943.10. [Q96ME7-1];""ENST00000413371.6; ENSP00000395660.2; ENSG00000243943.10. [Q96ME7-2]"";""ENST00000416005.6; ENSP00000407038.2; ENSG00000243943.10. [Q96ME7-3]"";""ENST00000556601.5; ENSP00000451572.2; ENSG00000243943.10. [Q96ME7-2]"";",DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270],0,nucleus [GO:0005634]
Q96KM6,N1,-1.3737331,-0.975511016,0.853011114,0.246094802,0.463487174,grey90,ZNF512B,Z512B_HUMAN,Zinc finger protein 512B,ZNF512B KIAA1196,57473;,ENST00000369888.6; ENSP00000358904.1; ENSG00000196700.9.;,"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",negative regulation of miRNA transcription [GO:1902894],nucleoplasm [GO:0005654]
Q6AHZ1,N2,-0.844436585,-0.775410025,1.057197009,0.076461486,0.104415934,grey70,ZNF518A,Z518A_HUMAN,Zinc finger protein 518A,ZNF518A KIAA0335 ZNF518,9849;,"ENST00000316045.10; ENSP00000479684.1; ENSG00000177853.15. [Q6AHZ1-1];""ENST00000614149.2; ENSP00000481657.1; ENSG00000177853.15. [Q6AHZ1-1]"";""ENST00000624776.4; ENSP00000485614.1; ENSG00000177853.15. [Q6AHZ1-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q8N587,N1,-1.144766583,-0.197211683,0.013840456,-0.272966527,1.258554303,grey90,ZNF561,ZN561_HUMAN,Zinc finger protein 561,ZNF561,93134;,ENST00000302851.8; ENSP00000303915.3; ENSG00000171469.11. [Q8N587-1];,"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q8N184,N1,-1.209787513,-0.701534902,0.082249506,-0.547255406,1.366697052,grey90,ZNF567,ZN567_HUMAN,Zinc finger protein 567,ZNF567,163081;,"ENST00000360729.8; ENSP00000353957.3; ENSG00000189042.14. [Q8N184-1];""ENST00000536254.6; ENSP00000441838.1; ENSG00000189042.14. [Q8N184-3]"";""ENST00000585696.5; ENSP00000467379.1; ENSG00000189042.14. [Q8N184-1]"";""ENST00000682579.1; ENSP00000507048.1; ENSG00000189042.14. [Q8N184-3]"";",DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q6ZN55,N1,-1.496160172,-0.404440259,0.098897419,-0.785758826,1.472997419,grey90,ZNF574,ZN574_HUMAN,Zinc finger protein 574,ZNF574,64763;,"ENST00000359044.5; ENSP00000351939.3; ENSG00000105732.13. [Q6ZN55-1];""ENST00000600245.1; ENSP00000469029.1; ENSG00000105732.13. [Q6ZN55-1]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q9UEG4,N1,-0.741399975,-0.205387026,0.013602197,-0.359865076,1.149918807,grey90,ZNF629,ZN629_HUMAN,Zinc finger protein 629 (Zinc finger protein 65),ZNF629 KIAA0326 ZNF65,23361;,ENST00000262525.6; ENSP00000262525.4; ENSG00000102870.6.;,"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q9H582,N2,-0.966461318,-0.401432199,0.873271875,0.123843153,0.282526896,grey70,ZNF644,ZN644_HUMAN,Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2) (Zep-2),ZNF644 KIAA1221 ZEP2,84146;,"ENST00000337393.10; ENSP00000337008.5; ENSG00000122482.22. [Q9H582-1];""ENST00000347275.9; ENSP00000340828.5; ENSG00000122482.22. [Q9H582-3]"";""ENST00000361321.5; ENSP00000354659.5; ENSG00000122482.22. [Q9H582-3]"";""ENST00000370440.5; ENSP00000359469.1; ENSG00000122482.22. [Q9H582-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
O15015,N2,-0.49279002,-0.631209998,1.092518752,0.001884801,0.153574996,grey70,ZNF646,ZN646_HUMAN,Zinc finger protein 646,ZNF646 KIAA0296,9726;,"ENST00000300850.5; ENSP00000300850.5; ENSG00000167395.10. [O15015-2];""ENST00000394979.2; ENSP00000378429.2; ENSG00000167395.10. [O15015-1]"";","DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634]
Q9Y2D9,N1,-0.59466343,-0.246288802,-0.032384267,-0.214641351,1.15184574,grey90,ZNF652,ZN652_HUMAN,Zinc finger protein 652,ZNF652 KIAA0924,22834;,"ENST00000362063.6; ENSP00000354686.2; ENSG00000198740.9.;""ENST00000430262.3; ENSP00000416305.2; ENSG00000198740.9."";","DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q96K58,N1,-0.815254718,-0.895933001,0.441127682,-0.246887238,1.151062299,grey90,ZNF668,ZN668_HUMAN,Zinc finger protein 668,ZNF668,79759;,"ENST00000300849.5; ENSP00000300849.4; ENSG00000167394.13. [Q96K58-1];""ENST00000394983.6; ENSP00000378434.2; ENSG00000167394.13. [Q96K58-1]"";""ENST00000426488.6; ENSP00000403975.2; ENSG00000167394.13. [Q96K58-2]"";""ENST00000535577.5; ENSP00000441349.1; ENSG00000167394.13. [Q96K58-1]"";""ENST00000538906.5; ENSP00000440149.1; ENSG00000167394.13. [Q96K58-1]"";""ENST00000539836.3; ENSP00000442573.3; ENSG00000167394.13. [Q96K58-2]"";","DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",DNA repair [GO:0006281]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q8N1G0,N1,-1.049219179,-0.120957828,0.76008924,-0.50086059,0.464886311,grey90,ZNF687,ZN687_HUMAN,Zinc finger protein 687,ZNF687 KIAA1441,57592;,"ENST00000324048.9; ENSP00000319829.5; ENSG00000143373.18. [Q8N1G0-1];""ENST00000336715.11; ENSP00000336620.5; ENSG00000143373.18. [Q8N1G0-1]"";",DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],0,cytosol [GO:0005829]; nucleoplasm [GO:0005654]
Q9H5H4,N1,-1.099895201,-0.512613012,-0.340735573,-0.641330893,1.43254067,grey90,ZNF768,ZN768_HUMAN,Zinc finger protein 768,ZNF768,79724;,ENST00000380412.7; ENSP00000369777.5; ENSG00000169957.10.;,"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromosome [GO:0005694]; nucleus [GO:0005634]
Q6IQ21,N1,-1.385603461,-1.170691894,0.370368826,-0.431131902,1.296148635,grey90,ZNF770,ZN770_HUMAN,Zinc finger protein 770,ZNF770,54989;,ENST00000356321.4; ENSP00000348673.4; ENSG00000198146.4.;,"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]
Q2TB10,N3,-1.507199424,-1.024991899,0.677061756,-0.293615151,0.824387039,grey50,ZNF800,ZN800_HUMAN,Zinc finger protein 800,ZNF800 PP902,168850;,"ENST00000265827.8; ENSP00000265827.3; ENSG00000048405.11.;""ENST00000393312.5; ENSP00000376988.1; ENSG00000048405.11."";""ENST00000393313.5; ENSP00000376989.1; ENSG00000048405.11."";",DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],acinar cell differentiation [GO:0090425]; endocrine pancreas development [GO:0031018],nucleus [GO:0005634]
Q9NWK9,N1,-1.131357228,0.310632511,-0.229426025,-0.370655951,1.172423158,grey90,ZNHIT6,BCD1_HUMAN,Box C/D snoRNA protein 1 (Serologically defined breast cancer antigen NY-BR-75) (Zinc finger HIT domain-containing protein 6),ZNHIT6 BCD1 C1orf181,54680;,"ENST00000370574.4; ENSP00000359606.3; ENSG00000117174.11. [Q9NWK9-1];""ENST00000431532.6; ENSP00000414344.2; ENSG00000117174.11. [Q9NWK9-2]"";",ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; TFIID-class transcription factor complex binding [GO:0001094],"box C/D snoRNP assembly [GO:0000492]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein complex oligomerization [GO:0051259]; snoRNA localization [GO:0048254]",extracellular exosome [GO:0070062]; nucleus [GO:0005634]; pre-snoRNP complex [GO:0070761]
Q9UGI0,C1,1.203540845,0.397776048,-0.331528481,-0.163861291,-0.564078772,lightblue,ZRANB1,ZRAN1_HUMAN,Ubiquitin thioesterase ZRANB1 (EC 3.4.19.12) (TRAF-binding domain-containing protein) (hTrabid) (Zinc finger Ran-binding domain-containing protein 1),ZRANB1 TRABID,54764;,ENST00000359653.4; ENSP00000352676.4; ENSG00000019995.6.;,cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593],cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]
Q5FWF4,N1,-0.733397401,-0.027385541,-0.121632169,0.190135939,0.952131547,grey90,ZRANB3,ZRAB3_HUMAN,DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)],ZRANB3,84083;,"ENST00000264159.11; ENSP00000264159.6; ENSG00000121988.18. [Q5FWF4-1];""ENST00000401392.5; ENSP00000383979.1; ENSG00000121988.18. [Q5FWF4-3]"";""ENST00000619650.4; ENSP00000480120.1; ENSG00000121988.18. [Q5FWF4-2]"";",ATP binding [GO:0005524]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork reversal [GO:0071932]; response to UV [GO:0009411],nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]
Q9Y5A6,N1,-1.192498006,-0.372834518,0.121706811,-0.342920041,1.15176559,grey90,ZSCAN21,ZSC21_HUMAN,Zinc finger and SCAN domain-containing protein 21 (Renal carcinoma antigen NY-REN-21) (Zinc finger protein 38 homolog) (Zfp-38),ZSCAN21 ZFP38 ZNF38,7589;,ENST00000292450.9; ENSP00000292450.4; ENSG00000166529.16.;,"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283],nucleus [GO:0005634]
O95229,C5,1.24618848,0.516592147,-0.353389307,-0.469441504,-0.56235873,turquoise3,ZWINT,ZWINT_HUMAN,ZW10 interactor (ZW10-interacting protein 1) (Zwint-1),ZWINT,11130;,"ENST00000361148.6; ENSP00000354921.6; ENSG00000122952.17. [O95229-2];""ENST00000373944.8; ENSP00000363055.3; ENSG00000122952.17. [O95229-1]"";""ENST00000395405.5; ENSP00000378801.1; ENSG00000122952.17. [O95229-1]"";",0,cell division [GO:0051301]; establishment of localization in cell [GO:0051649]; homologous chromosome orientation in meiotic metaphase I [GO:0031619]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; regulation of meiosis I spindle assembly checkpoint [GO:1905325],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinetochore [GO:0000776]; Knl1/Spc105 complex [GO:0180019]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]
Q15942,C3,1.597069252,0.362285705,-0.498262529,-0.614518219,-0.80816416,cyan,ZYX,ZYX_HUMAN,Zyxin (Zyxin-2),ZYX,7791;,"ENST00000322764.10; ENSP00000324422.5; ENSG00000159840.16. [Q15942-1];""ENST00000392910.6; ENSP00000376642.2; ENSG00000159840.16. [Q15942-2]"";""ENST00000645637.1; ENSP00000495629.1; ENSG00000285443.2. [Q15942-2]"";""ENST00000646695.2; ENSP00000494798.1; ENSG00000285443.2. [Q15942-1]"";",metal ion binding [GO:0046872]; RNA binding [GO:0003723],cell-cell signaling [GO:0007267]; cell-matrix adhesion [GO:0007160]; cellular response to type II interferon [GO:0071346]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]
O43149,C1,1.494806746,-0.288341824,-0.62314813,-0.435060568,0.388098307,lightblue,ZZEF1,ZZEF1_HUMAN,Zinc finger ZZ-type and EF-hand domain-containing protein 1,ZZEF1 KIAA0399,23140;,ENST00000381638.7; ENSP00000371051.2; ENSG00000074755.15. [O43149-1];,calcium ion binding [GO:0005509]; histone reader activity [GO:0140566]; lysine-acetylated histone binding [GO:0070577]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270],0,0